FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Zhao, HY
   Xu, LL
   Bombardi, R
   Nargi, R
   Deng, ZQ
   Errico, JM
   Nelson, CA
   Dowd, KA
   Pierson, TC
   Crowe, JE
   Diamond, MS
   Fremont, DH
AF Zhao, Haiyan
   Xu, Lily
   Bombardi, Robin
   Nargi, Rachel
   Deng, Zengqin
   Errico, John M.
   Nelson, Christopher A.
   Dowd, Kimberly A.
   Pierson, Theodore C.
   Crowe, James E., Jr.
   Diamond, Michael S.
   Fremont, Daved H.
TI Mechanism of differential Zika and dengue virus neutralization by a
   public antibody lineage targeting the DIII lateral ridge
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; STRUCTURAL BASIS; MONOCLONAL-ANTIBODIES;
   HIGHLY POTENT; RECOGNITION; FUSION; DOMAIN; FLAVIVIRUSES; GLYCOPROTEIN;
   PROTECTION
AB We previously generated a panel of human monoclonal antibodies (mAbs) against Zika virus (ZIKV) and identified one, ZIKV-116, that shares germline usage with mAbs identified in multiple donors. Here we show that ZIKV-116 interferes with ZIKV infection at a post-cellular attachment step by blocking viral fusion with host membranes. ZIKV-116 recognizes the lateral ridge of envelope protein domain III, with one critical residue varying between the Asian and African strains responsible for differential binding affinity and neutralization potency ((ED)-D-393). ZIKV-116 also binds to and cross-neutralizes some dengue virus serotype 1 (DENV1) strains, with genotype-dependent inhibition explained by variation in a domain II residue ((RK)-K-204) that potentially modulates exposure of the distally located, partially cryptic epitope. The V-J reverted germline configuration of ZIKV-116 preferentially binds to and neutralizes an Asian ZIKV strain, suggesting that this epitope may optimally induce related B cell clonotypes. Overall, these studies provide a structural and molecular mechanism for a cross-reactive mAb that uniquely neutralizes ZIKV and DENV1.
C1 [Zhao, Haiyan; Xu, Lily; Errico, John M.; Nelson, Christopher A.; Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.
   [Bombardi, Robin; Nargi, Rachel; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA.
   [Deng, Zengqin] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
   [Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.
RP Fremont, DH (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.
EM fremont@wustl.edu
RI Crowe, James E./B-5549-2009
OI Crowe, James E./0000-0002-0049-1079; Xu, Lily/0000-0002-1200-8937;
   Errico, John/0000-0002-4452-8152
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI073755, R01AI127828, HHSN272201400018C, HHSN272201200026C]
FX This work was supported by National Institute of Allergy and Infectious
   Diseases grant R01AI073755 (to M.S. Diamond and D.H. Fremont),
   R01AI127828 (to J.E. Crowe Jr. and M.S. Diamond), the intramural program
   (to T.C. Pierson) and contracts HHSN272201400018C (to J.E. Crowe Jr.,
   M.S. Diamond, and D.H. Fremont) and HHSN272201200026C (Center for
   Structural Genomics of Infectious Diseases; to D.H. Fremont).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burton DR, 2019, NAT REV IMMUNOL, V19, P77, DOI 10.1038/s41577-018-0103-6
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Duan HY, 2018, IMMUNITY, V49, P301, DOI 10.1016/j.immuni.2018.07.005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   EDWARDS J, 1986, J GEN VIROL, V67, P377, DOI 10.1099/0022-1317-67-2-377
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fuzik T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02882-0
   Gaudin A, 2018, DEV DURABLE TERRIT, V9
   GOLLINS SW, 1986, NATURE, V321, P244, DOI 10.1038/321244a0
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47
   Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195
   Keck ZY, 2016, J VIROL, V90, P3112, DOI 10.1128/JVI.02458-15
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li J, 2018, STRUCTURE, V26, P51, DOI 10.1016/j.str.2017.11.017
   Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053
   Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075
   Lindesmith LC, 2014, J VIROL, V88, P8826, DOI 10.1128/JVI.01192-14
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   Mengistu M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004772
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Niu XF, 2019, EMERG MICROBES INFEC, V8, P749, DOI 10.1080/22221751.2019.1614885
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Qiu XD, 2018, NAT MICROBIOL, V3, P287, DOI 10.1038/s41564-017-0099-x
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
   Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09
   Wang L, 2019, CELL REP, V26, P3360, DOI 10.1016/j.celrep.2019.02.062
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 71
TC 2
Z9 2
U1 5
U2 5
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD FEB
PY 2020
VL 217
IS 2
DI 10.1084/jem.20191792
PG 15
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LA0OS
UT WOS:000523657100019
PM 31757867
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gaunt, MW
   Gubler, DJ
   Pettersson, JHO
   Kuno, G
   Wilder-Smith, A
   de Lamballerie, X
   Gould, EA
   Falconar, AK
AF Gaunt, Michael W.
   Gubler, Duane J.
   Pettersson, John H-O
   Kuno, Goro
   Wilder-Smith, Annelies
   de Lamballerie, Xavier
   Gould, Ernest A.
   Falconar, Andrew K.
TI Recombination of B- and T-cell epitope-rich loci from Aedes- and
   Culex-borne flaviviruses shapes Zika virus epidemiology
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID DENGUE VIRUS; CROSS-REACTIVITY; ANTIBODY-RESPONSES; FRENCH-POLYNESIA;
   MOSQUITOS; PROTEIN; INFECTION; EVOLUTION; ENCEPHALITIS; IDENTIFICATION
AB Sporadic human Zika virus (ZIKV) infections have been recorded in Africa and Asia since the 1950s. Major epidemics occurred only after ZIKV emerged in the Pacific islands and spread to the Americas. Specific biological determinants of the explosive epidemic nature of ZIKV have not been identified. Phylogenetic studies revealed incongruence in ZIKV placement in relation to Aedes-borne dengue viruses (DENV) and Cu/ex-borne flaviviruses. We hypothesized that this incongruence reflects interspecies recombination resulting in ZIKV evasion of cross-protective T-cell immunity. We investigated ZIKV phylogenetic incongruence in relation to: DENV T-cell epitope maps experimentally identified ex vivo, published B-cell epitope loci, and CD8(+) T-cell epitopes predicted in silico for mosquito-borne flaviviruses. Our findings demonstrate that the ZIKV proteome is a hybrid of Aedes-borne DENV proteins interspersed amongst Cu/ex-borne flavivirus proteins derived through independent interspecies recombination events. These analyses infer that DENV-associated proteins in the ZIKV hybrid proteome generated immunodominant human B-cell responses, whereas ZIKV recombinant derived Cu/ex-borne flavivirus-associated proteins generated immunodominant CD8(+) and/or CD4(+) T-cell responses. In silico CD8(+) T-cell epitope ZIKV cross-reactive prediction analyses verified this observation. We propose that by acquiring cytotoxic T-cell epitope-rich regions from Cu/ex-borne flaviviruses, ZIKV evaded DENV-generated T-cell immune cross-protection. Thus, Cu/ex-borne flaviviruses, including West Nile virus and Japanese encephalitis virus, might induce cross-protective T-cell responses against ZIKV. This would explain why explosive ZIKV epidemics occurred in DENV-endemic regions of Micronesia, Polynesia and the Americas where Cu/ex-borne flavivirus outbreaks are infrequent and why ZIKV did not cause major epidemics in Asia where Culex-borne flaviviruses are widespread.
C1 [Gaunt, Michael W.; Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
   [Gubler, Duane J.] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
   [Pettersson, John H-O] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.
   [Pettersson, John H-O] Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.
   [Pettersson, John H-O] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Kuno, Goro] 1648 Collindale Dr, Ft Collins, CO 80525 USA.
   [Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Publ Hlth, Umea, Sweden.
   [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.
   [de Lamballerie, Xavier; Gould, Ernest A.] Aix Marseille Univ, UMR Unite Virus Emergents, IHU Mediterranee Infect 1207, INSERM,IRD 190, Marseille, France.
   [Falconar, Andrew K.] Univ Norte, Dept Med, Barranquilla, Colombia.
RP Gaunt, MW (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM Michael.Gaunt@lshtm.ac.uk
OI Pettersson, John H.-O./0000-0001-6665-7492
FU European Commission under Horizon 2020 funding [734584]
FX This work was designed, initiated, conducted and financially supported
   through ZikaPLAN Project number 734584 by the European Commission under
   Horizon 2020 funding. We are grateful for the full participation of our
   ZIKAlliance Project partners X de L, JP and EAG, also part of Horizon
   2020. We express sincere gratitude to Daniela Weiskopf and all
   associated colleagues at the La Jolla Institute for Allergy and
   Immunology, San Diego, California, USA for supplying the CD8<SUP>+</SUP>
   and CD4<SUP>+</SUP> T-cell epitope DENV maps and for their comments on
   the manuscript.
CR Aaskov J, 2007, J GEN VIROL, V88, P3334, DOI 10.1099/vir.0.83122-0
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Cao L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.27
   Carney J, 2012, ARCH VIROL, V157, P75, DOI 10.1007/s00705-011-1143-4
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Church SH, 2015, SYST BIOL, V64, P1048, DOI 10.1093/sysbio/syv055
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dick G.W., 1952, T ROY SOC TROP MED H, V47, P13
   Du SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09256-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edinur HA, 2013, HUM IMMUNOL, V74, P1119, DOI 10.1016/j.humimm.2013.06.011
   Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646
   Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Hamer D.H., 2019, J TRAVEL MED, V26
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P441, DOI 10.4269/ajtmh.1958.7.441
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121
   Huhtamo E, 2014, VIROLOGY, V464, P320, DOI 10.1016/j.virol.2014.07.015
   Huhtamo E, 2009, J VIROL, V83, P9532, DOI 10.1128/JVI.00529-09
   Kolodziejek J, 2013, J GEN VIROL, V94, P2449, DOI 10.1099/vir.0.056200-0
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuno G, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P219
   Kuno G, 2009, VIRAL GENOMES: DIVERSITY, PROPERTIES AND PARAMETERS, P1
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Larsen MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012697
   Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067
   Lemey P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-126
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   Liu PP, 2012, J GEN VIROL, V93, P2158, DOI 10.1099/vir.0.043554-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Masel J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007060
   Masrinoul P, 2013, VIRAL IMMUNOL, V26, P250, DOI 10.1089/vim.2012.0102
   McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pastorino B, 2019, AM J TROP MED HYG, V100, P639, DOI 10.4269/ajtmh.18-0439
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Phumee A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41727-8
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   da Silva ANMR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007425
   RAO TR, 1971, B WORLD HEALTH ORGAN, V44, P585
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tuite AR, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz063
   Turtle L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005263
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Vita R., 2018, NUCLEIC ACIDS RES, V47, P339
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wolf YI, 2018, MBIO, V9, DOI 10.1128/mBio.02329-18
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
   Zhao WL, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006457
NR 91
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD FEB
PY 2020
VL 174
AR 104676
DI 10.1016/j.antiviral.2019.104676
PG 13
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KZ9RQ
UT WOS:000523596900004
PM 31837392
DA 2020-07-08
ER

PT J
AU da Silva, MCPM
   Arnaud, MD
   Lyra, MCA
   de Alencar, AV
   Rocha, MAW
   Ramos, RCF
   Van Der Linden, V
   Caldas, AD
   Heimer, MV
   Rosenblatt, A
AF Paiva Machado da Silva, Mabel Cristina
   Arnaud, Manuela de Andrade
   Aroucha Lyra, Maria Carlla
   de Alencar Filho, Arnoldo Vasconcelos
   Wanderley Rocha, Maria Angela
   Ferreira Ramos, Regina Coeli
   Van Der Linden, Vanessa
   Caldas Junior, Arnaldo de Franca
   Heimer, Monica Vilela
   Rosenblatt, Aronita
TI Dental development in children born to Zikv-infected mothers: a
   case-based study
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE Zika virus; Child; Dental defect; Microcephaly; Diagnostic
ID CEREBRAL-PALSY; TOOTH ERUPTION; NEURAL CREST; CARIES; VIRUS; BRAIN;
   ASSOCIATION; DEFECTS; ENAMEL
AB Background: In Brazil, in October 2015, an outbreak of Zika virus (ZIKV) infection and an increase in newborns with microcephaly suggested a relationship between maternal infection and microcephaly in children.
   Objective: First, to assess the presence of dental bud sin 13 infants with a confirmed diagnosis of congenital ZIKV syndrome, born to mothers infected with the virus during pregnancy; second, to evaluate the dental development of these children at a 36-month follow-up.
   Design: Case-based longitudinal study.
   Results: Dental radiographs in the first semester showed that all children had dental buds. Along with the study, the individuals presented with various dental disturbances. M the end of the evaluation period, some children still had incomplete deciduous dentition.
   Conclusion: The abnormal chronology of dental eruption and dental development disturbances in children with microcephaly infected with ZIKV born to infected mothers indicate a possible role of the virus in odontogenesis.
C1 [Paiva Machado da Silva, Mabel Cristina; Arnaud, Manuela de Andrade; Aroucha Lyra, Maria Carlla; de Alencar Filho, Arnoldo Vasconcelos; Caldas Junior, Arnaldo de Franca; Heimer, Monica Vilela; Rosenblatt, Aronita] Univ Pernambuco, Sch Dent, Dept Pediat Dent, Camaragibe, PE, Brazil.
   [Wanderley Rocha, Maria Angela; Ferreira Ramos, Regina Coeli] Univ Pernambuco, Sch Med, Dept Infect Dis, Recife, PE, Brazil.
   [Van Der Linden, Vanessa] AACD Brazilian Assoc Welf Handicapped Children, Recife, PE, Brazil.
RP da Silva, MCPM (corresponding author), Univ Pernambuco, Sch Dent, Dept Pediat Dent, Camaragibe, PE, Brazil.
EM belpaivamachado@gmail.com; manuelaarnaud@gmail.com;
   mcarllalyra@gmail.com; arnoldoalencar@gmail.com;
   mangelarocha@uol.com.br; rcoeliramos@gmail.com; vanessavdl@hotmail.com;
   caldasfjr@alldeia.com.br; monica@heimer.com; aronitarosenblatt@gmail.com
CR Adewumi AO, 2010, PEDIATR DENT, V32, P151
   Albuquerque M, 2018, CAD SAUDE PUBLICA, V34
   ALVAREZ JO, 1989, AM J CLIN NUTR, V49, P417
   [Anonymous], 1992, Int Dent J, V42, P411
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bhat M, 1989, Adv Dent Res, V3, P132
   Santos MTB, 2009, SPEC CARE DENT, V29, P198, DOI 10.1111/j.1754-4505.2009.00092.x
   Brito C., 2016, LANCET NEUROL, V28, P679, DOI [10.1016/S1474-4422(16)00074-0, DOI 10.1016/S1474-4422(16)00074-0]
   Carvalho IF, 2019, J APPL ORAL SCI, V27, DOI 10.1590/1678-7757-2018-0276
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   Cobourne MT, 2006, J EXP ZOOL PART B, V306B, P251, DOI 10.1002/jez.b.21084
   Cobourne MT, 2003, ARCH ORAL BIOL, V48, P1, DOI 10.1016/S0003-9969(02)00208-X
   COHEN HJ, 1970, PEDIATRICS, V46, P737
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dourado MD, 2013, RES DEV DISABIL, V34, P2493, DOI 10.1016/j.ridd.2013.05.003
   FDA Administration, 2012, DENT RAD EX REC PAT
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hillson S., 1988, AM J PHYS ANTHROPOL, V107, P25
   Hu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124801
   Ioannou S, 2018, ARCH ORAL BIOL, V85, P192, DOI 10.1016/j.archoralbio.2017.10.017
   Jan BM, 2016, NEUROSCIENCES, V21, P314, DOI 10.17712/nsj.2016.4.20150729
   Jaskoll T, 2010, CELLS TISSUES ORGANS, V192, P221, DOI 10.1159/000314909
   KING NM, 1986, J AM DENT ASSOC, V112, P835, DOI 10.14219/jada.archive.1986.0115
   KolencFuse F., 2004, MED ORAL PATOL ORAL, V2, P385
   KRAUS BS, 1969, CLIN PEDIATR, V8, P204, DOI 10.1177/000992286900800408
   Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023
   LUNT RC, 1974, J AM DENT ASSOC, V89, P872, DOI 10.14219/jada.archive.1974.0484
   Magreni A., 2015, OPERATIVE TECHNIQUES, V26, P110
   Marcucio R, 2015, CURR TOP DEV BIOL, V115, P299, DOI 10.1016/bs.ctdb.2015.09.001
   Massignan C, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3501
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nelvo R. V., 2016, SEX SALUD SOC, V24, P246
   Neville BW, 2016, ORAL MAXILLOFACIAL P
   Pedreira EN, 2007, J APPL ORAL SCI, V15, P524, DOI 10.1590/S1678-77572007000600013
   Peedikayil F.C, 2011, J DENT, V1, P81
   POPE J E C, 1991, Pediatric Dentistry, V13, P156
   Prevital EF, 2009, PESQUI BRAS ODONTOPE, V9, P43, DOI 10.4034/1519.0501.2009.0091.0008
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ribeiro Bruno Niemeyer de Freitas, 2017, Radiol Bras, V50, P314, DOI 10.1590/0100-3984.2017.0098
   Scarpim MFPA, 2006, CLIN PESQ ODONTOL, V2, P203
   Siqueira R. M. P., 2018, INT J PAEDIATR DENT, V65, P59
   Slayton R L, 2001, Pediatr Dent, V23, P32
   Suri L, 2004, AM J ORTHOD DENTOFAC, V126, P432, DOI 10.1016/j.ajodo.2003.10.031
   Thesleff I., 2009, TOOTH ORGANOGENESIS
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 49
TC 0
Z9 0
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
EI 1879-1506
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD FEB
PY 2020
VL 110
AR 104598
DI 10.1016/j.archoralbio.2019.104598
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA LA0NN
UT WOS:000523654000005
PM 31775105
DA 2020-07-08
ER

PT J
AU Santos, FRS
   Lima, WG
   Maia, EHB
   Assis, LC
   Davyt, D
   Taranto, AG
   Ferreira, JMS
AF Santos, Felipe R. S.
   Lima, William G.
   Maia, Eduardo H. B.
   Assis, Leticia C.
   Davyt, Danilo
   Taranto, Alex Gutterres
   Ferreira, Jaqueline M. S.
TI Identification of a Potential Zika Virus Inhibitor Targeting NS5
   Methyltransferase Using Virtual Screening and Molecular Dynamics
   Simulations
SO JOURNAL OF CHEMICAL INFORMATION AND MODELING
LA English
DT Article
ID DRUG DISCOVERY; ACCURATE DOCKING; FORCE-FIELD; IN-VITRO; DENGUE;
   PROTEASE; TRANSMISSION; PERMEABILITY; LIGAND; AGENTS
AB The NS5 methyltransferase (MTase) has been reported as an attractive molecular target for antivirals discovery against the Zika virus (ZIKV). Here, we report structure-based virtual screening of 42 390 structures from the Development Therapeutics Program (DTP) AIDS Antiviral Screen Database. Among the docked compounds, ZINC1652386 stood out due to its high affinity for MTase in comparison to the cocrystallized ligand MS2042, which interacts with the Asp146 residue in the MTase binding site by hydrogen bonding. Subsequent molecular dynamics simulations predicted that this compound forms a stable complex with MTase within 50 ns. Thus, ZINC1652386 may represent a promising ZIKV methyltransferase inhibitor.
C1 [Santos, Felipe R. S.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao Del Rei, Lab Microbiol Med, Divinopolis, MG, Brazil.
   [Lima, William G.] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil.
   [Maia, Eduardo H. B.; Assis, Leticia C.; Taranto, Alex Gutterres] Univ Fed Sao Joao Del Rei, Lab Quim Farmaceut Med, Divinopolis, MG, Brazil.
   [Davyt, Danilo] Univ Republica, Dept Quim Organ, Montevideo, Uruguay.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao Del Rei, Lab Microbiol Med, Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI Gustavo de Lima, William/C-9258-2018; Santos, Felipe/J-3062-2017
OI Gustavo de Lima, William/0000-0001-8946-9363; Santos,
   Felipe/0000-0002-8392-1467
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Fundacao de Amparo a Pesquisa de Minas Gerais
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG) [APQ:02742-17];
   Federal University of Sao Joao del-Rei (UFSJ)/PPGBiotec and PPGCF
FX This work was supported by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior - Brasil (CAPES) [Finance Code 001]; Fundacao de
   Amparo a Pesquisa de Minas Gerais FAPEMIG [APQ:02742-17]; Federal
   University of Sao Joao del-Rei (UFSJ)/PPGBiotec and PPGCF.
CR Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905
   Almeida RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030062
   Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Chen CL, 2013, J IMMUNOL, V191, P1744, DOI 10.4049/jimmunol.1201976
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   da Cunha EFF, 2012, MED CHEM RES, V21, P590, DOI 10.1007/s00044-011-9554-z
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Devnarain N, 2018, CHEM BIOL DRUG DES, V92, P1838, DOI 10.1111/cbdd.13353
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Coelho IED, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-3078-x
   Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Dubankova A., 2019, ANTIVIR RES, V169, P169
   Elshahawi H, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040169
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hwu JR, 2017, ANTIVIR RES, V146, P96, DOI 10.1016/j.antiviral.2017.08.008
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Khanfar MA, 2010, J MED CHEM, V53, P8534, DOI 10.1021/jm100941j
   Kuca K, 2018, BMC PHARMACOL TOXICO, V19, DOI 10.1186/s40360-018-0196-3
   Kukic P, 2010, FUTURE MED CHEM, V2, P647, DOI 10.4155/FMC.10.6
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Leeson P, 2012, NATURE, V481, P455, DOI 10.1038/481455a
   Leonel CA, 2018, ARCH VIROL, V163, P575, DOI 10.1007/s00705-017-3641-5
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P
   MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e
   Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505
   Manvar D, 2016, BIOCHEM BIOPH RES CO, V469, P743, DOI 10.1016/j.bbrc.2015.12.042
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   Nunes RR, 2016, MEM I OSWALDO CRUZ, V111, P721, DOI 10.1590/0074-02760160207
   Nutho B, 2019, J MOL GRAPH MODEL, V92, P227, DOI 10.1016/j.jmgm.2019.08.001
   Onawole AT, 2017, J MOL GRAPH MODEL, V73, P54, DOI 10.1016/j.jmgm.2017.01.018
   Othman R, 2008, J CHEM INF MODEL, V48, P1582, DOI 10.1021/ci700388k
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Rusanov T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35511-3
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j
   Sinigaglia A, 2018, EXPERT OPIN DRUG DIS, V13, P825, DOI 10.1080/17460441.2018.1515909
   Tao ZY, 2018, EUR J MED CHEM, V157, P994, DOI 10.1016/j.ejmech.2018.08.057
   Verma A, 2008, EUR J MED CHEM, V43, P897, DOI 10.1016/j.ejmech.2007.07.017
   Viswanathan U, 2014, J CHEM INF MODEL, V54, P2816, DOI 10.1021/ci500531r
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 60
TC 0
Z9 0
U1 2
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9596
EI 1549-960X
J9 J CHEM INF MODEL
JI J. Chem Inf. Model.
PD FEB
PY 2020
VL 60
IS 2
BP 562
EP 568
DI 10.1021/acs.jcim.9b00809
PG 7
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science,
   Information Systems; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Chemistry; Computer Science
GA KQ1BQ
UT WOS:000516665600015
PM 31985225
DA 2020-07-08
ER

PT J
AU Santos, FRS
   Nunes, DAF
   Lima, WG
   Davyt, D
   Santos, LL
   Taranto, AG
   Ferreira, JMS
AF Santos, Felipe R. S.
   Nunes, Damiana A. F.
   Lima, William G.
   Davyt, Danilo
   Santos, Luciana L.
   Taranto, Alex G.
   Ferreira, Jaqueline M. S.
TI Identification of Zika Virus NS2B-NS3 Protease Inhibitors by
   Structure-Based Virtual Screening and Drug Repurposing Approaches
SO JOURNAL OF CHEMICAL INFORMATION AND MODELING
LA English
DT Article
ID MOLECULAR-DYNAMICS; ANTIVIRAL ACTIVITY; APPROVED DRUGS; FORCE-FIELD;
   INFECTION; DOCKING; ANTIPSYCHOTICS; SERENDIPITY; DISCOVERY; DENGUE
AB The NS2B-NS3 protease has been identified as an attractive target for drug development against Zika virus (ZIKV) and combined drug repurposing and structure-based virtual screening has improved the development of antiviral drugs. In this study, we performed a structure based virtual screening of 1861 Food and Administration (FDA) approved drugs available in DrugBank by the selection and docking validation of crystal structure of ZIKV NS2B-NS3 protease (PDB ID 5H4I) using Glide and DOCK 6 software. The antihistaminic chlorcyclizine (Grid score -24.8 kcal/mol) exhibited the most promising interaction with NS2B-NS3 protease in comparison to crystallography ligand (Grid score -15.6 kcal/mol) by interaction to Tyr161 by hydrophobic interactions in the binding site of NS2B-NS3 which is recognized as an important amino acid in substrate molecular recognition. Cytotoxicity and global antiviral activity assay in Vero cells by MTT method showed that chlorcyclizine reduced the ZIKV induced cytopathic effect (EC50 of 69.0 +/- 7.3 mu M and SI = 1.9), and explicit molecular dynamics simulations implemented on a NAMD program indicated great stability of chlorcyclizine in protease binding site, suggesting the repurposing of chlorcyclizine as a promising finding in anti-ZIKV drug development.
C1 [Santos, Felipe R. S.; Nunes, Damiana A. F.; Ferreira, Jaqueline M. S.] Univ Fed Sao Joao Del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
   [Santos, Felipe R. S.; Taranto, Alex G.] Univ Fed Sao Joao Del Rei UFSJ, Lab Quim Farmaceut Med, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
   [Lima, William G.] Univ Fed Sao Joao Del Rei UFSJ, Dept Prod Farmaceut, Fac Farm, BR-31270901 Belo Horizonte, MG, Brazil.
   [Davyt, Danilo] Univ Republica, Dept Quim Organ, Fac Quim, Montevideo 11800, Uruguay.
   [Santos, Luciana L.] Univ Fed Sao Joao Del Rei UFSJ, Lab Biol Mol, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
RP Ferreira, JMS (corresponding author), Univ Fed Sao Joao Del Rei UFSJ, Lab Microbiol Med, Campus Ctr Oeste Dona Lindu, BR-35501296 Divinopolis, MG, Brazil.
EM jackmaria4@gmail.com
RI Santos, Luciana/C-9688-2013; Santos, Felipe/J-3062-2017; Gustavo de
   Lima, William/C-9258-2018
OI Santos, Luciana/0000-0001-6186-4062; Santos, Felipe/0000-0002-8392-1467;
   Gustavo de Lima, William/0000-0001-8946-9363
FU Coordenacio de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Fundacio de Amparo a Pesquisa de Minas Gerais
   FAPEMIG [APQ-02742-17]; Federal University of Sao Joao del-Rei
   (UFSJ)/PPGBiotec; PPGCF
FX This work was supported by the Coordenacio de Aperfeicoamento de Pessoal
   de Nivel Superior - Brasil (CAPES) [Finance Code 001]; Fundacio de
   Amparo a Pesquisa de Minas Gerais FAPEMIG [APQ-02742-17]; Federal
   University of Sao Joao del-Rei (UFSJ)/PPGBiotec and PPGCF.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aggarwal M, 2017, ANTIVIR RES, V146, P102, DOI 10.1016/j.antiviral.2017.08.015
   Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Maia EHB, 2017, J MOL MODEL, V23, DOI 10.1007/s00894-016-3184-9
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x
   Bhargava S, 2019, NAT PROD RES, V33, P851, DOI 10.1080/14786419.2017.1413574
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bowen LR, 2019, J MOL MODEL, V25, DOI 10.1007/s00894-019-4076-6
   Campbell WC, 2005, ILAR J, V46, P352, DOI 10.1093/ilar.46.4.352
   Chakrabarty AN, 2000, INT J ANTIMICROB AG, V14, P215, DOI 10.1016/S0924-8579(99)00158-2
   Chance JP, 2018, BIOORG MED CHEM LETT, V28, P1846, DOI 10.1016/j.bmcl.2018.04.010
   Chen AT, 2019, SCHIZOPHR RES, V208, P1, DOI 10.1016/j.schres.2019.04.009
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Coelho IED, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-3078-x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Gentile S, 2004, ANN PHARMACOTHER, V38, P1265, DOI 10.1345/aph.1D485
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Hippius H, 1999, J CLIN PSYCHIAT, V60, P22
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Imbernon B, 2018, INT J HIGH PERFORM C, V32, P789, DOI 10.1177/1094342017697471
   JonesBrando LV, 1997, SCHIZOPHR RES, V25, P63, DOI 10.1016/S0920-9964(97)00007-8
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Macalino SJY, 2015, ARCH PHARM RES, V38, P1686, DOI 10.1007/s12272-015-0640-5
   MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P
   MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505
   Medigeshi GR, 2016, ANTIMICROB AGENTS CH, V60, P6709, DOI 10.1128/AAC.01367-16
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Micewicz ED, 2018, BIOORG MED CHEM LETT, V28, P452, DOI 10.1016/j.bmcl.2017.12.019
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Prasad S, 2016, TRENDS PHARMACOL SCI, V37, P435, DOI 10.1016/j.tips.2016.03.004
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   Rifaioglu AS, 2019, BRIEF BIOINFORM, V20, P1878, DOI 10.1093/bib/bby061
   Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Sanchez-Linares I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S13
   Schafer A, 2018, ANTIVIR RES, V157, P47, DOI 10.1016/j.antiviral.2018.07.003
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   Song CM, 2009, BRIEF BIOINFORM, V10, P579, DOI 10.1093/bib/bbp023
   Trott O, 2009, J COMPUT CHEM
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Xu HY, 2014, EUR ARCH PSY CLIN N, V264, P121, DOI 10.1007/s00406-013-0414-3
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
NR 68
TC 1
Z9 1
U1 3
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9596
EI 1549-960X
J9 J CHEM INF MODEL
JI J. Chem Inf. Model.
PD FEB
PY 2020
VL 60
IS 2
BP 731
EP 737
DI 10.1021/acs.jcim.9b00933
PG 7
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science,
   Information Systems; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Chemistry; Computer Science
GA KQ1BQ
UT WOS:000516665600031
PM 31850756
DA 2020-07-08
ER

PT J
AU Poveda-Cuevas, SA
   Etchebest, C
   da Silva, FLB
AF Poveda-Cuevas, Sergio A.
   Etchebest, Catherine
   Barroso da Silva, Fernando L.
TI Identification of Electrostatic Epitopes in Flavivirus by Computer
   Simulations: The PROCEEDpKa Method
SO JOURNAL OF CHEMICAL INFORMATION AND MODELING
LA English
DT Article
ID ZIKA VIRUS; MEMBRANE ASSOCIATION; COMPUTATIONAL DESIGN;
   MOLECULAR-DYNAMICS; DENGUE VIRUS; NS1; PREDICTION; SPECIFICITY;
   INSIGHTS; INFECTION
AB Viruses are enthusiastically studied due to the great impact that these organisms can have on human health. Computational approaches can contribute offering tools that can shed light on important molecular mechanisms that help to design new diagnostic procedures. Several cellular processes between the immune-host system and the pathogenic organism are dependent on specific intermolecular interactions. In this study, we evaluated theoretical approaches to understand some properties of the antigen antibody interactions considering the titratable properties of all ionizable residues of the nonstructural viral protein 1 (NSI) of the West Nile virus (WNV) and the Zika virus (ZIKV). Constant-pH Monte Carlo simulations were performed to estimate electrostatic properties such as the pK(a) shifts (Delta pK(a)). We proposed an alternative criterion for the discrimination of antigenic residues based on Delta pK(a)s. Our outcomes were analyzed by an evaluation of the sensitivity and specificity through a receiver operating characteristic (ROC). As a starting point, we used the known crystallographic structure for the complex of NS1(WNV(176-352)) and the specific antibody 22NS1 (PDB ID 4011) to differentiate the residues belonging to that interface. With an optimal threshold for the absolute value of the pKa shifts, we found that is possible to predict antigenic epitopes reproducing the interfaces as defined by the X-ray structure. After this validation, we evaluated theoretical predictions based on protein protein (PP) complexation simulations. From them, we observe amino acids with an antigenic potential and defined the optimum threshold that was applied for two strains of ZIKV (i.e., Uganda and Brazil). Several ionizable residues with antigenic capacity were identified. This is favorably related to some studies that show the high immunogenicity of secreted NS1. This approach opens up an important discussion about what are termed here "electrostatic epitopes" and how they work as an important reference in the paratope epitope interaction for viral systems.
C1 [Poveda-Cuevas, Sergio A.; Barroso da Silva, Fernando L.] Univ Sao Paulo, Programa Interunidades Bioinformat, Rua Matao 1010, BR-05508090 Sao Paulo, SP, Brazil.
   [Poveda-Cuevas, Sergio A.; Barroso da Silva, Fernando L.] Univ Sao Paulo, Dept Ciencias Biomol, Fac Ciencias Farmacaut Ribeirao Preto, Av Cafe S-N,Campus USP, BR-14040903 Ribeirao Preto, SP, Brazil.
   [Etchebest, Catherine] Univ Paris, Biol Integree Globule Rouge, UMR S1134, BIGR,INSERM, F-75015 Paris, France.
   [Etchebest, Catherine] Univ Paris Diderot Paris 7, Dynam Struct & Interact Mol, Equipe 2, INTS, 6 Rue Alexandre Cabanel, F-75015 Paris, France.
   [Etchebest, Catherine] Lab Excellence GR Ex, Paris, France.
   [Etchebest, Catherine; Barroso da Silva, Fernando L.] Univ Sao Paulo, Univ Sorbonne Paris Cite, Int Lab Struct Bioinformat, Av Cafe S-N FCFRP,Bloco B, BR-14040903 Ribeirao Preto, SP, Brazil.
   [Barroso da Silva, Fernando L.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
RP da Silva, FLB (corresponding author), Univ Sao Paulo, Programa Interunidades Bioinformat, Rua Matao 1010, BR-05508090 Sao Paulo, SP, Brazil.; da Silva, FLB (corresponding author), Univ Sao Paulo, Dept Ciencias Biomol, Fac Ciencias Farmacaut Ribeirao Preto, Av Cafe S-N,Campus USP, BR-14040903 Ribeirao Preto, SP, Brazil.; da Silva, FLB (corresponding author), Univ Sao Paulo, Univ Sorbonne Paris Cite, Int Lab Struct Bioinformat, Av Cafe S-N FCFRP,Bloco B, BR-14040903 Ribeirao Preto, SP, Brazil.; da Silva, FLB (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
EM fernando@fcfrp.usp.br
RI da Silva, Fernando Luis Barroso/B-9532-2009
OI da Silva, Fernando Luis Barroso/0000-0003-2526-2085
FU Fundacao de Amparo a Pesquisa do Estado de sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [Fapesp 2015/16116-3,
   2019/06139-7]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); "Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior" CAPESCAPES; University of sao Paulo (USP) through the
   NAP-CatSinQ (Research Core in Catalysis and Chemical Synthesis); Swedish
   National Infrastructure for Computing [SNIC 2019/1-32]; Print USP/Capes
   [88887.370314/2019]
FX This work has been supported in part by the "Fundacao de Amparo a
   Pesquisa do Estado de sao Paulo" [Grants Fapesp 2015/16116-3 and
   2019/06139-7 (F.L.B.d.S.)], the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) (F.L.B.d.S.), and the "Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior" CAPES (S.A.P.-C.).
   F.L.B.d.S. and S.A.P.-C. acknowledge the support of the University of
   sao Paulo (USP) through the NAP-CatSinQ (Research Core in Catalysis and
   Chemical Synthesis) and the computing hours at HPC/USP. F.L.B.d.S. is
   deeply thankful to the large use of computing hours at The Swedish
   National Infrastructure for Computing (Grant SNIC 2019/1-32). F.L.B.d.S.
   and C.E. acknowledge the mobility support from the joint Universite
   Sorbonne Paris Cite-USP Research Program and the Print USP/Capes
   (process 88887.370314/2019).
CR Adolf-Bryfogle J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006112
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Baran D, 2017, P NATL ACAD SCI USA, V114, P10900, DOI 10.1073/pnas.1707171114
   Barroso da Silva Fernando Luis, 2017, Biophysical Reviews, V9, P699, DOI 10.1007/s12551-017-0311-5
   da Silva FLB, 2019, J CHEM THEORY COMPUT, V15, P3875, DOI 10.1021/acs.jctc.9b00202
   da Silva FLB, 2018, BIOCHEM BIOPH RES CO, V498, P264, DOI 10.1016/j.bbrc.2017.07.027
   da Silva FLB, 2017, J CHEM THEORY COMPUT, V13, P2915, DOI 10.1021/acs.jctc.6b01114
   da Silva FLB, 2016, SOFT MATTER, V12, P5600, DOI 10.1039/c6sm00860g
   BERZOFSKY JA, 1981, MOL IMMUNOL, V18, P751, DOI 10.1016/0161-5890(81)90067-5
   Binder K, 1997, REP PROG PHYS, V60, P487, DOI 10.1088/0034-4885/60/5/001
   Borley DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061122
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Chen W, 2013, BIOPHYS J, V105, pL15, DOI 10.1016/j.bpj.2013.06.036
   Chen YJ, 2015, J CHEM THEORY COMPUT, V11, P3919, DOI 10.1021/acs.jctc.5b00261
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delboni LA, 2016, FOOD HYDROCOLLOID, V55, P89, DOI 10.1016/j.foodhyd.2015.11.010
   Dunbar J, 2016, NUCLEIC ACIDS RES, V44, pW474, DOI 10.1093/nar/gkw361
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ferre G, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4978623
   Fiorucci Sebastien, 2014, Methods Mol Biol, V1184, P365, DOI 10.1007/978-1-4939-1115-8_20
   Fischman S, 2018, CURR OPIN STRUC BIOL, V51, P156, DOI 10.1016/j.sbi.2018.04.007
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Hansen S, 2019, INT J INFECT DIS, V79, P33, DOI 10.1016/j.ijid.2018.11.094
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Hubbard S.J., 1993, NACCESS COMPUTER PRO
   Jespersen MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00298
   Jiang SB, 2019, CELL MOL IMMUNOL, V16, P96, DOI 10.1038/s41423-018-0043-x
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   King MT, 2018, METHODS MOL BIOL, V1785, P13, DOI 10.1007/978-1-4939-7841-0_2
   KNOWLES JR, 1970, PHILOS T R SOC B, V257, P135, DOI 10.1098/rstb.1970.0016
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kurut A, 2014, PROTEINS, V82, P657, DOI 10.1002/prot.24445
   Kurut A, 2013, FARADAY DISCUSS, V160, P271, DOI 10.1039/c2fd20073b
   Kurut A, 2012, J PHYS CHEM LETT, V3, P731, DOI 10.1021/jz201680m
   Leem J, 2016, MABS-AUSTIN, V8, P1259, DOI 10.1080/19420862.2016.1205773
   Li T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105954
   Liang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-302
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Long XY, 2019, PEERJ, V7, DOI 10.7717/peerj.6179
   Loyau J, 2015, J MOL BIOL, V427, P2647, DOI 10.1016/j.jmb.2015.05.016
   Lund M, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-1
   Machado MR, 2017, J CHEM THEORY COMPUT, V13, P5106, DOI 10.1021/acs.jctc.7b00659
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2018, DIAGN MICR INFEC DIS, V92, P284, DOI 10.1016/j.diagmicrobio.2018.06.019
   Marcatili P, 2014, NAT PROTOC, V9, P2771, DOI 10.1038/nprot.2014.189
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Mendonca DC, 2019, CYTOSKELETON, V76, P457, DOI 10.1002/cm.21569
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nimrod G, 2018, CELL REP, V25, P2121, DOI 10.1016/j.celrep.2018.10.081
   NOZAKI Y, 1967, METHOD ENZYMOL, V11, P715, DOI DOI 10.1016/S0076-6879(67)11088-4
   O'Kennedy R, 2017, TRAC-TREND ANAL CHEM, V89, P53, DOI 10.1016/j.trac.2017.01.009
   Ortiz-Baez AS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180251
   Pantazes RJ, 2010, PROTEIN ENG DES SEL, V23, P849, DOI 10.1093/protein/gzq061
   Persson BA, 2010, BIOPHYS CHEM, V151, P187, DOI 10.1016/j.bpc.2010.06.005
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Poveda-Cuevas SA, 2018, ACS OMEGA, V3, P16212, DOI 10.1021/acsomega.8b02081
   Prudkin-Silva C, 2020, J CHEM INF MODEL, V60, P854, DOI 10.1021/acs.jcim.9b00814
   Ramaraj T, 2012, BBA-PROTEINS PROTEOM, V1824, P520, DOI 10.1016/j.bbapap.2011.12.007
   Teixeira AAR, 2010, J CHEM THEORY COMPUT, V6, P3259, DOI 10.1021/ct1003093
   Reverberi Roberto, 2007, Blood Transfus, V5, P227, DOI 10.2450/2007.0047-07
   Rocha LB, 2017, ANTIBODIES, V6, DOI 10.3390/antib6040014
   Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sormanni P, 2018, CHEM SOC REV, V47, P9137, DOI 10.1039/c8cs00523k
   Srivastava D, 2017, LANGMUIR, V33, P11417, DOI 10.1021/acs.langmuir.7b02271
   Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054
   Van Regenmortel MHV, 2014, J MOL RECOGNIT, V27, P627, DOI 10.1002/jmr.2394
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Wade RC, 1998, P NATL ACAD SCI USA, V95, P5942, DOI 10.1073/pnas.95.11.5942
   Wang JX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24760-x
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weitzner BD, 2017, NAT PROTOC, V12, P401, DOI 10.1038/nprot.2016.180
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602
   Yoshida K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40461-5
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zhao J, 2018, ANTIBODIES, V7, DOI 10.3390/antib7030022
   Zhou C, 2019, NUCLEIC ACIDS RES, V47, pW388, DOI 10.1093/nar/gkz413
NR 93
TC 2
Z9 2
U1 6
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9596
EI 1549-960X
J9 J CHEM INF MODEL
JI J. Chem Inf. Model.
PD FEB
PY 2020
VL 60
IS 2
BP 944
EP 963
DI 10.1021/acs.jcim.9b00895
PG 20
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science,
   Information Systems; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Chemistry; Computer Science
GA KQ1BQ
UT WOS:000516665600051
PM 31774285
DA 2020-07-08
ER

PT J
AU Kozak, RA
   Goneau, LW
   DeLima, C
   Varsaneux, O
   Eshaghi, A
   Kristjanson, E
   Olsha, R
   Safronetz, D
   Perusini, S
   Frantz, C
   Gubbay, JB
AF Kozak, Robert A.
   Goneau, Lee W.
   DeLima, Cedric
   Varsaneux, Olivia
   Eshaghi, AliReza
   Kristjanson, Erik
   Olsha, Romy
   Safronetz, David
   Perusini, Stephen
   Frantz, Christine
   Gubbay, Jonathan B.
TI Presence of Flavivirus Antibodies Does Not Lead to a Greater Number of
   Symptoms in a Small Cohort of Canadian Travelers Infected with Zika
   Virus
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; dengue virus; viremia; antibodies; clinical disease
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; VIRAL LOAD; DIAGNOSTICS; OUTBREAK;
   DISEASE; PCR
AB Zika virus (ZIKV) is a mosquito-borne flavivirus associated with a febrile illness as well as severe complications, including microcephaly and Guillain-Barre Syndrome. Antibody cross-reactivity between flaviviruses has been documented, and in regions where ZIKV is circulating, dengue virus (DENV) is also endemic, leaving the potential that previous exposure to DENV could alter clinical features of ZIKV infection. To investigate this, we performed a retrospective case-control study in which we compared Canadian travellers who had been infected with ZIKV and had serological findings indicating previous DENV or other flavivirus exposure (n = 16) to those without any previous exposure (n = 44). Patient samples were collected between February 2016 and September 2017 and submitted to Public Health Ontario for testing. ZIKV infection was determined using real-time RT-PCR and antibodies against DENV were identified by the plaque-reduction neutralization test. The mean time from symptom onset to sample collection was 5 days for both groups; the magnitude of viremia was not statistically different (Ct values: 35.6 vs. 34.9, p-value = 0.2). Clinical scores were also similar. Our findings indicate that previous DENV or other flavivirus exposure did not result in greater viremia or a higher illness score.
C1 [Kozak, Robert A.] Sunnybrook Hlth Sci Ctr, Dept Lab Med & Mol Diagnost, Div Microbiol, Toronto, ON M4N 3M5, Canada.
   [Kozak, Robert A.; Gubbay, Jonathan B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.
   [Goneau, Lee W.; DeLima, Cedric; Eshaghi, AliReza; Kristjanson, Erik; Olsha, Romy; Perusini, Stephen; Frantz, Christine; Gubbay, Jonathan B.] Publ Hlth Ontario, Toronto, ON M5G 1V2, Canada.
   [Varsaneux, Olivia] Govt Canada, Ottawa, ON K1Z 8R9, Canada.
   [Safronetz, David] Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada.
   [Gubbay, Jonathan B.] Hosp Sick Children, Toronto, ON M5G 1V2, Canada.
RP Gubbay, JB (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.; Gubbay, JB (corresponding author), Publ Hlth Ontario, Toronto, ON M5G 1V2, Canada.; Gubbay, JB (corresponding author), Hosp Sick Children, Toronto, ON M5G 1V2, Canada.
EM rob.kozak@sunnybrook.ca; GoneauL@dynacare.ca; cedric.delima@oahpp.ca;
   Olivia.varsaneux@mail.mcgill.ca; alireza.eshaghi@oahpp.ca;
   erik.kristjanson@oahpp.ca; romy.olsha@oahpp.ca;
   david.safronetz@canada.ca; stephen.perusini@oahpp.ca;
   christine.frantz@oahpp.ca; jonathan.gubbay@oahpp.ca
OI Eshaghi, Alireza/0000-0001-5150-483X
FU Public Health Ontario
FX This study was supported by Public Health Ontario. Public Health Ontario
   has no role in study design, data collection or results interpretation.
CR Anderson T, 2019, B WORLD HEALTH ORGAN, V97, P6, DOI 10.2471/BLT.19.020119
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   de La Vega MA, 2015, J CLIN INVEST, V125, P4421, DOI 10.1172/JCI83162
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kass DE, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pongsiri P, 2012, ASIAN PAC J TROP MED, V5, P342, DOI 10.1016/S1995-7645(12)60055-8
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Read JS, 2018, JAMA PEDIATR, V172, P686, DOI 10.1001/jamapediatrics.2018.0870
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Santiago GA, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz320
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Ward MJ, 2018, AM J TROP MED HYG, V99, P780, DOI 10.4269/ajtmh.18-0237
NR 34
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2020
VL 12
IS 2
AR 140
DI 10.3390/v12020140
PG 9
WC Virology
SC Virology
GA KW6DX
UT WOS:000521256600115
PM 31991674
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zomosa-Signoret, VC
   Morales-Gonzalez, KR
   Estrada-Rodriguez, AE
   Rivas-Estilla, AM
   Deveze-Garcia, MC
   Galaviz-Aguilar, E
   Vidaltamayo, R
AF Zomosa-Signoret, Viviana C.
   Morales-Gonzalez, Karina R.
   Estrada-Rodriguez, Ana E.
   Rivas-Estilla, Ana M.
   Deveze-Garcia, M. Cristina
   Galaviz-Aguilar, Edgar
   Vidaltamayo, Roman
TI Alanine Substitution Inactivates Cross-Reacting Epitopes in Dengue Virus
   Recombinant Envelope Proteins
SO VIRUSES-BASEL
LA English
DT Article
DE epitope inactivation; dengue; Zika; serological methods
ID SWISS-MODEL; ZIKA VIRUS; GLYCOPROTEIN; ANTIBODY; ANTIGEN; ENVIRONMENT;
   STAGE
AB The expansion of the habitat of mosquitoes belonging to the Aedes genus puts nearly half of the world's population at risk of contracting dengue fever, and a significant fraction will develop its serious hemorrhagic complication, which can be fatal if not diagnosed properly and treated in a timely fashion. Although several diagnostic methods have been approved for dengue diagnostics, their applicability is limited in rural areas of developing countries by sample preparation costs and methodological requirements, as well as cross-reactivity among the different serotypes of the Dengue virus and other flavivirus, such as the Zika virus. For these reasons, it is necessary to generate more specific antigens to improve serological methods that could be cheaper and used in field operations. Here, we describe a strategy for the inactivation of cross-reacting epitopes on the surface of the Dengue virus envelope protein through the synthetic generation of recombinant peptide sequences, where key amino acid residues from Dengue virus serotype 1 (DENV-1) and 2 (DENV-2) are substituted by alanine residues. The proteins thus generated are recognized by 88% of sera from Dengue NS1+ patients and show improved serotype specificity because they do not react with the antibodies present in seroconverted, PCR-serotyped DEN-4 infected patients.
C1 [Zomosa-Signoret, Viviana C.; Estrada-Rodriguez, Ana E.; Rivas-Estilla, Ana M.] Univ Autonoma Nuevo Leon, Dept Bioquim & Med Mol, Fac Med, Monterrey 64460, NL, Mexico.
   [Morales-Gonzalez, Karina R.; Deveze-Garcia, M. Cristina; Galaviz-Aguilar, Edgar; Vidaltamayo, Roman] Univ Monterrey, Dept Basic Sci, Sch Med, Ave Ignacio Morones Prieto 4500 Pte, Garza Garcia 66238, NL, Mexico.
RP Zomosa-Signoret, VC (corresponding author), Univ Autonoma Nuevo Leon, Dept Bioquim & Med Mol, Fac Med, Monterrey 64460, NL, Mexico.; Vidaltamayo, R (corresponding author), Univ Monterrey, Dept Basic Sci, Sch Med, Ave Ignacio Morones Prieto 4500 Pte, Garza Garcia 66238, NL, Mexico.
EM viviana.zomosasg@uanl.edu.mx; karina.rubi@gmail.com;
   esrdzana@yahoo.com.mx; amrivas1@yahoo.ca; dra.deveze@gmail.com;
   dr_egalaviz@live.com; roman.vidaltamayo@udem.edu
OI Rivas-Estilla, Ana Maria/0000-0003-2311-2534; Zomosa,
   Viviana/0000-0002-0643-5318
FU Consejo Nacional de Ciencia y Tecnologia (CONACYT) of MexicoConsejo
   Nacional de Ciencia y Tecnologia (CONACyT) [CB-2014-22006,
   FOSISS-2011-161933, CB-2013-220342]; Division de Extension, Consultoria
   e Investigacion, Universidad de Monterrey; CONACyTConsejo Nacional de
   Ciencia y Tecnologia (CONACyT)
FX This work was supported by Consejo Nacional de Ciencia y Tecnologia
   (CONACYT) of Mexico [grant numbers: CB-2014-22006 to V.C.
   Zomosa-Signoret, FOSISS-2011-161933 and CB-2013-220342 to R.
   Vidaltamayo] and Division de Extension, Consultoria e Investigacion,
   Universidad de Monterrey grants (2017,2018) to R. Vidaltamayo. A.E.
   Rodriguez-Estrada was a recipient of a Doctoral fellowship from CONACyT.
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Chaudhury S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005395
   Chuansumrit A, 2008, PEDIATR INFECT DIS J, V27, P43, DOI 10.1097/INF.0b013e318150666d
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Gabaglia CR, 2017, CURR OPIN PEDIATR, V29, P107, DOI 10.1097/MOP.0000000000000446
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Granger D, 2017, DIAGN MICR INFEC DIS, V88, P120, DOI 10.1016/j.diagmicrobio.2017.03.015
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI 10.1586/ERV.09.139
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447
   Lourenco J, 2016, EPIDEMICS-NETH, V16, P40, DOI 10.1016/j.epidem.2016.05.003
   MASON PW, 1990, J GEN VIROL, V71, P2107, DOI 10.1099/0022-1317-71-9-2107
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Reddy MN, 2017, PEERJ, V5, DOI 10.7717/peerj.2970
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Serafin IL, 2001, ARCH VIROL, V146, P2469, DOI 10.1007/s007050170017
   Shukla MK, 2017, J MED VIROL, V89, P1146, DOI 10.1002/jmv.24764
   SIMANTINI E, 1995, ARCH VIROL, V140, P1257, DOI 10.1007/BF01322751
   Singla N, 2016, J CLIN DIAGN RES, V10, pDC12, DOI 10.7860/JCDR/2016/22482.9011
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Tripathi NK, 2011, BIOTECHNOL J, V6, P604, DOI 10.1002/biot.201000399
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Vivek R, 2017, DIAGN MICR INFEC DIS, V87, P229, DOI 10.1016/j.diagmicrobio.2016.09.020
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
NR 37
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2020
VL 12
IS 2
AR 208
DI 10.3390/v12020208
PG 13
WC Virology
SC Virology
GA KW6DX
UT WOS:000521256600029
PM 32069839
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gratton, R
   Tricarico, PM
   Agrelli, A
   da Silva, HVC
   Bernardo, LC
   Crovella, S
   Coelho, AVC
   de Moura, RR
   Brandao, LAC
AF Gratton, Rossella
   Tricarico, Paola Maura
   Agrelli, Almerinda
   Colaco da Silva, Heverton Valentim
   Bernardo, Lucas Coelho
   Crovella, Sergio
   Campos Coelho, Antonio Victor
   de Moura, Ronald Rodrigues
   Cavalcanti Brandao, Lucas Andre
TI In Vitro Zika Virus Infection of Human Neural Progenitor Cells:
   Meta-Analysis of RNA-Seq Assays
SO MICROORGANISMS
LA English
DT Review
DE congenital Zika syndrome; transcriptomics; genomics; apoptosis; gene
   ontology; pathway analysis; stem cells
ID GENE; BRAZIL; ROLES; TOOL
AB The Zika virus (ZIKV) is an emergent arthropod-borne virus (arbovirus) responsible for congenital Zika syndrome (CZS) and a range of other congenital malformations. Evidence shows that ZIKV infects human neural progenitor cells (hNPCs) in the fetal brain, prompting inflammation and tissue damage/loss. Despite recent advances, little is known about the pathways involved in CZS pathogenesis. We performed a meta-analysis, gene ontology (GO), and pathway analysis of whole transcriptome studies with the aim of clarifying the genes and pathways potentially altered during hNPCs infection with ZIKV. We selected three studies (17 samples of infected hPNCs compared to hPNCs uninfected controls) through a systematic search of the Gene Expression Omnibus (GEO) database. The raw reads were trimmed, counted, and normalized. Next, we performed a rank product meta-analysis to detect consistently differentially expressed genes (DEGs) in these independent experiments. We detected 13 statistically significant DEGs. GO ontology and reactome analysis showed an enrichment of interferon, pro-inflammatory, and chemokines signaling and apoptosis pathways in ZIKV-infected cells. Moreover, we detected three possible new candidate genes involved in hNPCs infection: APOL6, XAF1, and TNFRSF1. Our results confirm that interferon (IFN) signaling dominates the ZIKV response, and that a crucial contribution is given by apoptotic pathways, which might elicit the CZS phenotype.
C1 [Gratton, Rossella; Tricarico, Paola Maura; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Adv Translat Microbiol, Via Istria 65-1, I-34137 Trieste, Italy.
   [Gratton, Rossella] Univ Trieste, Dept Med Surg & Hlth Sci, Str Fiume 447, I-34129 Trieste, Italy.
   [Agrelli, Almerinda; Colaco da Silva, Heverton Valentim; Bernardo, Lucas Coelho; Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, LIKA, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Agrelli, Almerinda; Colaco da Silva, Heverton Valentim; Bernardo, Lucas Coelho; de Moura, Ronald Rodrigues; Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, Dept Pathol, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Crovella, Sergio; de Moura, Ronald Rodrigues] Fed Univ Pernambuco UFPE, Dept Genet, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Campos Coelho, Antonio Victor] Fed Univ Paraiba UFPB, Dept Mol Biol, Campus I Lot Cidade Univ, BR-58051900 Joao Pessoa, Paraiba, Brazil.
RP Gratton, R (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Adv Translat Microbiol, Via Istria 65-1, I-34137 Trieste, Italy.; Gratton, R (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Str Fiume 447, I-34129 Trieste, Italy.
EM rossella.gratton@gmail.com; tricaricopa@gmail.com;
   almerindaapimentel@hotmail.com; neto_pe6@live.com;
   lucascoelhobernardo.lb@gmail.com; crovelser@gmail.com;
   antoniocampos@dbm.ufpb.br; ronaldmoura1989@gmail.com;
   lucabrand@gmail.com
RI Coelho, Antonio Victor C/E-6795-2015
OI Coelho, Antonio Victor C/0000-0003-2143-9701; Agrelli,
   Almerinda/0000-0002-9908-742X; Colaco, Heverton/0000-0001-7169-4140;
   COELHO BERNARDO, LUCAS/0000-0003-4523-4276
FU Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES)CAPES
   [88881.130808/2016.1]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [440371/2016-3, 308540/2017-4]
FX This research was funded by Comissao de Aperfeicoamento de Pessoal do
   Nivel Superior (CAPES), grant number 88881.130808/2016.1, and by
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   from the Brazilian public notice Chamada 14/2016-Prevencao e Combate ao
   virus Zika, grant number 440371/2016-3, both granted to S.C and
   308540/2017-4 granted to L.A.C.B.
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Azar SR, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090867
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]
   Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008
   Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152
   Del Carratore F, 2017, BIOINFORMATICS, V33, P2774, DOI 10.1093/bioinformatics/btx292
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hammack C, 2019, J VIROL, V93, DOI 10.1128/JVI.00638-19
   Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476
   Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Lee SY, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0443-x
   Lima MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01928
   Liu ZH, 2005, MOL CANCER RES, V3, P21
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346
   Martinez-Cerdeno V, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00104
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   MORGAN M, 2016, R PACKAGE VERSION, V1, P677
   Morimoto K, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00916
   O'Rahilly R, 2010, CELLS TISSUES ORGANS, V192, P73, DOI 10.1159/000289817
   Plenchette S, 2007, CURR OPIN INVEST DR, V8, P469
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   R Core Team, R LANG ENV STAT COMP
   Rosa-Fernandes L, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00064
   Rue-Albrecht K., GOEXPRESS VISUALISE
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397
   Shui Jr-Wen, 2014, Immune Netw, V14, P67, DOI 10.4110/in.2014.14.2.67
   Siddique R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00319
   Siebert S, 2005, FEBS LETT, V579, P5193, DOI 10.1016/j.febslet.2005.08.037
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Urcuqui-Inchima S, 2017, ANTIVIR RES, V147, P47, DOI 10.1016/j.antiviral.2017.09.017
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang B, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00384
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Whelan JN, 2019, J VIROL, V93, DOI 10.1128/JVI.00313-19
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhu YL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-19
NR 49
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD FEB
PY 2020
VL 8
IS 2
AR 270
DI 10.3390/microorganisms8020270
PG 13
WC Microbiology
SC Microbiology
GA KU3NP
UT WOS:000519618200126
PM 32079323
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhu, XC
   Zhao, J
   Hu, AZ
   Pan, JY
   Deng, GQ
   Hua, CY
   Zhu, CC
   Liu, Y
   Yang, K
   Zhu, L
AF Zhu, Xinchao
   Zhao, Jun
   Hu, Anzhong
   Pan, Jingyu
   Deng, Guoqing
   Hua, Changyi
   Zhu, Cancan
   Liu, Yong
   Yang, Ke
   Zhu, Ling
TI A Novel Microfluidic Device Integrated with Chitosan-Modified
   Capillaries for Rapid ZIKV Detection
SO MICROMACHINES
LA English
DT Article
DE in situ PCR; molecular diagnosis; microfluidic chip; POC device; ZIKV
ID NUCLEIC-ACID EXTRACTION; WHOLE-BLOOD; AMPLIFICATION; DNA; CAPTURE;
   IDENTIFICATION; ADSORPTION; EFFICIENT; VIRUS
AB The outbreak of Zika virus (ZIKV) has posed a great challenge to public health in recent years. To address the urgent need of ZIKV RNA assays, we integrate the microfluidic chip embedded with chitosan-modified silicon dioxide capillaries, smartphone-based detection unit to be a C-3-system for the rapid extraction and detection of ZIKV RNA. The C-3-system is characterized by: (1) four chitosan-modified silicon dioxide capillaries integrated in the microfluidic chip for target ZIKV RNA enrichment and "in situ PCR" (polymerase chain reaction) amplification; (2) smartphone-based point of care (POC) device consisting of a pneumatic subsystem for controlling the nucleic acid extraction processes in the microfluidic chip, a heating subsystem for sample lysis and PCR amplification, and an optical subsystem for signal acquisition. The entire detection processes including sample lysis, ZIKV RNA enrichment, and reverse-transcription polymerase chain reaction (RT-PCR) is achieved in the microfluidic chip. Moreover, PCR buffers can be directly loaded into the chitosan-modified silicon dioxide capillaries for "in situ PCR", in which the captured ZIKV RNA is directly used for downstream PCR without any loss. ZIKV RNA extracted by the C-3-system can be successfully recovered at very low concentrations of 50 transducing units (TU)/mL from crude human saliva. This means that our method of detecting viremia in patients infected with ZIKV is reliable.
C1 [Zhu, Xinchao; Zhao, Jun; Hu, Anzhong; Pan, Jingyu; Deng, Guoqing; Hua, Changyi; Zhu, Cancan; Liu, Yong; Yang, Ke; Zhu, Ling] Chinese Acad Sci, Optoelect Applicat Technol Res Ctr, Inst Appl Technol, Hefei Inst Phys Sci, Hefei 230031, Peoples R China.
   [Zhu, Xinchao; Zhao, Jun] Univ Sci & Technol China, Hefei 230026, Peoples R China.
   [Pan, Jingyu] Anhui Normal Univ, Inst Opt Engn, 1 Beijing East Rd, Wuhu 241000, Peoples R China.
RP Yang, K; Zhu, L (corresponding author), Chinese Acad Sci, Optoelect Applicat Technol Res Ctr, Inst Appl Technol, Hefei Inst Phys Sci, Hefei 230031, Peoples R China.
EM zxc2014ustc@163.com; zhaojun@aiofm.ac.cn; anzhonghu620@163.com;
   panjy136@126.com; dgq@aiofm.ac.cn; xuehualang@aiofm.ac.cn;
   zhucancan@aiofm.ac.cn; liuyong@aiofm.ac.cn; keyang@rntek.cas.cn;
   zhul@aiofm.ac.cn
FU Class C talent fund project of Chinese Academy of Sciences
   [CXJJ-19-C03]; Dean's Fund of Hefei Institute of Physical Science, China
   [YZJJ2018QN22]; Open Subject of Key Laboratory of Optoelectronic
   Materials Science and Technology of Anhui [OMST201701]; Key Research and
   Development Program of Anhui [1804a09020051, 1804c04020335,
   201904c03020001]; Youth Innovation Promotion Association of the Chinese
   Academy of Sciences [2018489]
FX This research was funded by Class C talent fund project of Chinese
   Academy of Sciences (CXJJ-19-C03), Dean's Fund of Hefei Institute of
   Physical Science, China (YZJJ2018QN22); Open Subject of Key Laboratory
   of Optoelectronic Materials Science and Technology of Anhui
   (OMST201701); Key Research and Development Program of Anhui
   (1804a09020051, 1804c04020335, 201904c03020001); Youth Innovation
   Promotion Association of the Chinese Academy of Sciences (2018489).
CR Barbosa JDB, 2019, J APPL POLYM SCI, V136, DOI 10.1002/app.47479
   Cai P, 2006, SOIL BIOL BIOCHEM, V38, P471, DOI 10.1016/j.soilbio.2005.05.019
   Centers for Disease Control and Prevention, ZIK VIR
   Fu Y, 2017, LAB CHIP, V17, P4334, DOI 10.1039/c7lc01107e
   Gan WP, 2017, ANAL CHEM, V89, P3568, DOI 10.1021/acs.analchem.6b04882
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Hartman MR, 2013, NANOSCALE, V5, P10141, DOI 10.1039/c3nr04015a
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hui JH, 2018, LAB CHIP, V18, P2854, DOI 10.1039/c8lc00543e
   Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024
   Jangam SR, 2009, J CLIN MICROBIOL, V47, P2363, DOI 10.1128/JCM.r00092-09
   Kaur N, 2018, ANALYST, V143, P2213, DOI 10.1039/c7an01943b
   Trinh KTL, 2018, ANAL CHIM ACTA, V1040, P63, DOI 10.1016/j.aca.2018.06.042
   Kim J, 2010, ANALYST, V135, P2408, DOI 10.1039/c0an00288g
   Li BC, 2014, LAB CHIP, V14, P4085, DOI 10.1039/c4lc00227j
   Li J, 2018, J CLEAN PROD, V204, P896, DOI 10.1016/j.jclepro.2018.09.050
   Li J, 2018, J COLLOID INTERF SCI, V517, P61, DOI 10.1016/j.jcis.2018.01.112
   Li L, 2013, APPL MECH MATER, V263-266, P713, DOI 10.4028/www.scientific.net/AMM.263-266.713
   Li Z., 2019, BIOTECHNOL BIOTECHNO, V33, P223, DOI [10.1080/13102818.2018.1561211, DOI 10.1080/13102818.2018.1561211]
   Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a
   Mauk MG, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8010017
   Bravo-Anaya LM, 2019, INT J BIOL MACROMOL, V126, P1037, DOI 10.1016/j.ijbiomac.2019.01.008
   Nanayakkara IA, 2017, ANAL CHEM, V89, P3773, DOI 10.1021/acs.analchem.7b00274
   Oliveira DBL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110615
   Pandit KR, 2015, ANAL CHEM, V87, P11022, DOI 10.1021/acs.analchem.5b03006
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petralia S, 2017, ANALYST, V142, P140, DOI 10.1039/c6an02049f
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Schlappi TS, 2016, ANAL CHEM, V88, P7647, DOI 10.1021/acs.analchem.6b01485
   Nguyen T, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9080403
   Wand NIV, 2018, J GEN VIROL, V99, P1012, DOI 10.1099/jgv.0.001083
   Ward MJ, 2018, AM J TROP MED HYG, V99, P780, DOI 10.4269/ajtmh.18-0237
   Yamaguchi A, 2016, ANAL CHIM ACTA, V906, P1, DOI 10.1016/j.aca.2015.10.011
   Zarei M, 2017, TRAC-TREND ANAL CHEM, V91, P26, DOI 10.1016/j.trac.2017.04.001
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
   Zhang X, 2012, LANGMUIR, V28, P3896, DOI 10.1021/la205036p
   Zhu CC, 2019, CHINESE J ANAL CHEM, V47, P1751, DOI 10.19756/j.issn.0253-3820.191288
   Zhu CC, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10080537
   Zhu L, 2014, ANAL METHODS-UK, V6, P2628, DOI 10.1039/c3ay42126k
   Zou YP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003916
NR 40
TC 0
Z9 0
U1 11
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-666X
J9 MICROMACHINES-BASEL
JI Micromachines
PD FEB
PY 2020
VL 11
IS 2
AR 186
DI 10.3390/mi11020186
PG 17
WC Nanoscience & Nanotechnology; Instruments & Instrumentation
SC Science & Technology - Other Topics; Instruments & Instrumentation
GA KV1JR
UT WOS:000520181500075
PM 32054007
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alejo-Cancho, I
   Navero-Castillejos, J
   Peiro-Mestres, A
   Albarracin, R
   Barrachina, J
   Navarro, A
   Gonzalo, V
   Pastor, V
   Munoz, J
   Martinez, MJ
AF Alejo-Cancho, Izaskun
   Navero-Castillejos, Jessica
   Peiro-Mestres, Aida
   Albarracin, Rosa
   Barrachina, Josep
   Navarro, Alexander
   Gonzalo, Veronica
   Pastor, Victor
   Munoz, Jose
   Martinez, Miguel J.
TI Evaluation of a novel microfluidic immuno-magnetic agglutination assay
   method for detection of dengue virus NS1 antigen
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SEROTYPE
AB Background
   Dengue virus (DENV) is the most important arbovirus worldwide, causing infections in endemic countries and returning travellers from these areas. Rapid diagnostic tests are needed to improve patient management and monitor local transmission. The detection of DENV non-structural protein 1 (NS1) is a useful tool for the diagnosis, but the currently available methods can be time consuming or lack sensitivity. The objective of our study was to evaluate a new rapid and semi-quantitative microfluidic DENV NS1 immuno-magnetic agglutination assay based on aggregation of magnetic nanoparticles detected by an electronic reader (Virotrack Dengue Acute and Blubox, Blusense diagnostics, Copenhagen, Denmark).
   Methodology/Principal findings
   A panel of 135 serum samples from travelers returning from dengue endemic countries was analyzed (74 DENV positive samples including the four DENV serotypes, 26 Zika virus positive samples, 25 chikungunya virus positive samples, 5 malaria positive samples and 5 negative samples). Samples were tested by three different antigen detection methods: SD Dengue NS1 Ag ELISA, SD BIOLINE Dengue Duo and ViroTrack Dengue Acute. The sensitivity observed for SD Dengue NS1 Ag ELISA, ViroTrack Dengue Acute and SD BIOLINE Dengue Duo was 97.2%, 91.1% and 68.1%, respectively. All methods showed high specificity (98.4% for ViroTrack Dengue Acute and 100% for both SD Dengue NS1 Ag ELISA and SD BIOLINE Dengue Duo). SD Dengue NS1 Ag ELISA and ViroTrack Dengue Acute only failed to detect samples positive for DENV-2.
   Author summary
   Dengue virus is a human pathogen that causes millions of infections each year. It can be found in nearly all tropical areas, and people living in those regions and travelers who visit them are at risk of disease. The symptoms may vary from a mild flu-like disease to severe hemorrhagic symptoms. Accurate diagnosis of dengue is important for a better management of the disease and for epidemiological surveillance. Detection of DENV antigen is a useful tool to diagnose DENV infections. However, currently available techniques are not rapid (ELISA assays) or not accurate enough (immunochromatographic tests). Here, we evaluate a new antigen detection technique based on aggregation of magnetic nanoparticles. The method combines a short time to results (12 minutes) with a high diagnostic performance. We therefore conclude that this new technique could be a useful tool for the diagnosis of dengue.
C1 [Alejo-Cancho, Izaskun; Albarracin, Rosa; Barrachina, Josep; Navarro, Alexander; Gonzalo, Veronica; Pastor, Victor; Martinez, Miguel J.] Hosp Clin Barcelona, Dept Clin Microbiol, Barcelona, Spain.
   [Navero-Castillejos, Jessica; Peiro-Mestres, Aida; Munoz, Jose; Martinez, Miguel J.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Munoz, Jose] Hosp Clin Barcelona, Dept Trop Med, Barcelona, Spain.
RP Martinez, MJ (corresponding author), Hosp Clin Barcelona, Dept Clin Microbiol, Barcelona, Spain.; Martinez, MJ (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
EM myoldi@clinic.cat
RI Gutierrez, Jose Munoz/AAH-6954-2020
OI Gutierrez, Jose Munoz/0000-0002-0945-1735; Alejo Cancho,
   Izaskun/0000-0003-2488-7139; Martinez, Miguel Julian/0000-0002-0682-1075
FU Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Departament
   d'Empresa i Coneixement, Generalitat de Catalunya [2017 SGR 794]
FX This study was partially supported by grant 2017 SGR 794 to MJM from the
   Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Departament
   d'Empresa i Coneixement, Generalitat de Catalunya
   (http://agaur.gencat.cat). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2016, PEOPLES DAILY, V11, P4
   Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   European Centre for Disease Prevention and Control, LOC TRANSM DENG FEV
   Felix AC, 2012, CLIN VACCINE IMMUNOL, V19, P1972, DOI 10.1128/CVI.00535-12
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X
   Hermann LL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003193
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003
   Landis J.R., 2008, SOCIETY, V33, P159, DOI DOI 10.2307/2529310
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Mezger A, 2015, ACS NANO, V9, P7374, DOI 10.1021/acsnano.5b02379
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Newcombe RG, 1998, IMPROVED CONFIDENCE, P2650
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Park H, 2013, INT J NANOMED, V8, P4543, DOI 10.2147/IJN.S51893
   Schlagenhauf P, 2013, TRAVEL ASS INFECT PR, P55, DOI 10.1016/S1473-3099(14)71000-X
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Uddin R, 2016, BIOSENS BIOELECTRON, V85, P351, DOI 10.1016/j.bios.2016.05.023
   Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09
   World Health Organization, 2009, SPEC PROGRAM RES TRA, Vx, P147
NR 27
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2020
VL 14
IS 2
AR e0008082
DI 10.1371/journal.pntd.0008082
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KT7ZN
UT WOS:000519231700043
PM 32069280
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Luo, SX
   Zhao, W
   Ma, XR
   Zhang, PL
   Liu, BC
   Zhang, L
   Wang, WJ
   Wang, YZ
   Fu, YS
   Allain, JP
   Li, TT
   Li, CY
AF Luo, Shengxue
   Zhao, Wei
   Ma, Xiaorui
   Zhang, Panli
   Liu, Bochao
   Zhang, Ling
   Wang, Wenjing
   Wang, Yuanzhan
   Fu, Yongshui
   Allain, Jean-Pierre
   Li, Tingting
   Li, Chengyao
TI A high infectious simian adenovirus type 23 vector based vaccine
   efficiently protects common marmosets against Zika virus infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DNA VACCINE; CHIMPANZEE ADENOVIRUS; ANTIBODIES; TRANSMISSION; CHALLENGE;
   BIOLOGY; HUMANS; MODEL
AB Zika virus (ZIKV) has spread in many countries or territories causing severe neurologic complications with potential fatal outcomes. The small primate common marmosets are susceptible to ZIKV, mimicking key features of human infection. Here, a novel simian adenovirus type 23 vector-based vaccine expressing ZIKV pre-membrane-envelope proteins (Sad23L-prM-E) was produced in high infectious titer. Due to determination of immunogenicity in mice, a single-dose of 3x10(8) PFU Sad23L-prM-E vaccine was intramuscularly inoculated to marmosets. This vaccine raised antibody titers of 10(4.07) E-specific and 10(3.13) neutralizing antibody (NAb), as well as robust specific IFN-gamma secreting T-cell response (1,219 SFCs/10(6) cells) to E peptides. The vaccinated marmosets, upon challenge with a high dose of ZIKV (10(5) PFU) six weeks post prime immunization, reduced viremia by more than 100 folds, and the low level of detectable viral RNA (<10(3) copies/ml) in blood, saliva, urine and feces was promptly eliminated when the secondary NAb (titer >10(3.66)) and T-cell response (>726 SFCs/10(6) PBMCs) were acquired 1-2 weeks post exposure to ZIKV, while non-vaccinated control marmosets developed long-term high titer of ZIKV (10(5.73) copies/ml) (P<0.05). No significant pathological lesions were observed in marmoset tissues. Sad23L-prM-E vaccine was detectable in spleen, liver and PBMCs at least 4 months post challenge. In conclusion, a prime immunization with Sad23L-prM-E vaccine was able to protect marmosets against ZIKV infection when exposed to a high dose of ZIKV. This Sad23L-prM-E vaccine is a promising vaccine candidate for prevention of ZIKV infection in humans.
   Author summary
   Zika virus (ZIKV) is a member of the ) and causes severe neurologic diseases. The development of safe and effective vaccine is urgent need. In this study, we constructed a novel simian adenovirus type 23 vector-based vaccine expressing ZIKV pre-membrane-envelope proteins (Sad23L-prM-E). By vaccinating the common marmosets with prime immunization of vaccine, and upon challenge with a high dose of ZIKV to the vaccinated marmosets, the immune response and protective efficacy of vaccine were extensively evaluated. The data suggested that Sad23L-prM-E vaccine could protect marmosets against a high dose of ZIKV challenge, which provided a promising vaccine for preventing ZIKV infection in humans.
C1 [Luo, Shengxue; Ma, Xiaorui; Zhang, Panli; Liu, Bochao; Zhang, Ling; Wang, Wenjing; Allain, Jean-Pierre; Li, Tingting; Li, Chengyao] Southern Med Univ, Sch Lab Med & Biotechnol, Dept Transfus Med, Guangzhou, Peoples R China.
   [Zhao, Wei] Southern Med Univ, Sch Publ Hlth, Lab Biosafety, Guangzhou, Peoples R China.
   [Wang, Yuanzhan] Southern Med Univ, Nanfang Hosp, Expt Anim Ctr, Guangzhou, Peoples R China.
   [Fu, Yongshui] Guangzhou Blood Ctr, Guangzhou, Peoples R China.
   [Allain, Jean-Pierre] Univ Cambridge, Cambridge, England.
RP Li, TT; Li, CY (corresponding author), Southern Med Univ, Sch Lab Med & Biotechnol, Dept Transfus Med, Guangzhou, Peoples R China.
EM apple-ting-007@163.com; chengyaoli@hotmail.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31770185, 31970886, 81871655, 31500134]; National
   Key Research and Development Program [2017YFD0500305]; Guangdong
   Province Universities and Colleges Pearl River Scholar Funded Scheme
   (2017); Guangzhou major project of industry-universityresearch
   cooperation and collaborative innovation [201704020083]; Innovative R&D
   Team Introduction Program of Guangdong [2014ZT05S123]
FX This work was supported by the funding from the National Natural Science
   Foundation of China (No. 31770185, 31970886, 81871655 and 31500134) for
   CL and TL, the National Key Research and Development Program (No.
   2017YFD0500305) for CL, the Guangdong Province Universities and Colleges
   Pearl River Scholar Funded Scheme (2017) for TL, the Guangzhou major
   project of industry-universityresearch cooperation and collaborative
   innovation (No. 201704020083) for TL, and the Innovative R&D Team
   Introduction Program of Guangdong (No. 2014ZT05S123) for CL. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35755-z
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cervasi B, 2013, J VIROL, V87, P9420, DOI 10.1128/JVI.01456-13
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Cyranoski D, 2009, NATURE, V459, P492, DOI 10.1038/459492a
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Elong Ngono A, 2019, PLOS PATHOG, V15, DOI DOI 10.1371/J0URNAL.PPAT.1007474
   Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043
   Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001
   Ghaffar KA, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040077
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   Holkers M, 2014, METHODS, V69, P179, DOI 10.1016/j.ymeth.2014.02.017
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee CYP, 2018, MICROBES INFECT, V20, P635, DOI 10.1016/j.micinf.2018.02.009
   Li TT, 2014, HEPATOLOGY, V59, P789, DOI 10.1002/hep.26750
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   Luo SX, 2019, VIRUS RES, V268, P1, DOI 10.1016/j.virusres.2019.05.008
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Simoes M, 2012, BIOLOGICALS, V40, P399, DOI 10.1016/j.biologicals.2012.09.005
   Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   't Hart BA, 2012, DRUG DISCOV TODAY, V17, P1160, DOI 10.1016/j.drudis.2012.06.009
   Tatsis N, 2009, J IMMUNOL, V182, P6587, DOI 10.4049/jimmunol.0900317
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xiang ZQ, 2006, EMERG INFECT DIS, V12, P1596, DOI 10.3201/eid1210.060078
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhou DM, 2010, NAT PROTOC, V5, P1775, DOI 10.1038/nprot.2010.134
   Zhu SM, 2016, J VIROL, V90, P8198, DOI 10.1128/JVI.02653-15
NR 49
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2020
VL 14
IS 2
AR e0008027
DI 10.1371/journal.pntd.0008027
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KT7ZN
UT WOS:000519231700015
PM 32049958
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Malafa, S
   Medits, I
   Aberle, JH
   Aberle, SW
   Haslwanter, D
   Tsouchnikas, G
   Wolfel, S
   Huber, KL
   Percivalle, E
   Cherpillod, P
   Thaler, M
   Rossbacher, L
   Kundi, M
   Heinz, FX
   Stiasny, K
AF Malafa, Stefan
   Medits, Iris
   Aberle, Judith H.
   Aberle, Stephan W.
   Haslwanter, Denise
   Tsouchnikas, Georgios
   Woelfel, Silke
   Huber, Kristina L.
   Percivalle, Elena
   Cherpillod, Pascal
   Thaler, Melissa
   Rossbacher, Lena
   Kundi, Michael
   Heinz, Franz X.
   Stiasny, Karin
TI Impact of flavivirus vaccine-induced immunity on primary Zika virus
   antibody response in humans
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BORNE ENCEPHALITIS-VIRUS; ORIGINAL ANTIGENIC SIN; DENGUE VIRUS; ENVELOPE
   GLYCOPROTEIN; DEPENDENT ENHANCEMENT; MONOCLONAL-ANTIBODY;
   CRYSTAL-STRUCTURE; WESTERN SUBTYPE; IMMUNIZATION; NEUTRALIZATION
AB Author summary
   The explosive spread of Zika virus, a flavivirus, to South- and Central America underscores the potential threat of newly emerging arthropod-borne viruses. Zika virus infection can cause congenital birth defects and neurological complications. Many people at risk are flavivirus pre-immune because of prior infections with other flaviviruses (e.g. dengue virus, which co-circulates in Zika outbreak regions) or vaccinations (e.g. against yellow fever or tick-borne encephalitis) and have non-protective cross-reactive antibodies at the time of infection. Since pre-existing immunity can modulate the specificity and functional activity of antibody responses, and cross-reactive antibodies have been implicated in disease enhancement, we compared the specificities of serum samples from flavivirus-naive and vaccinated individuals after primary Zika virus infections. Prior immunity led to a strong booster of cross-reactive antibodies that did not neutralize Zika virus. Importantly, we could also show that newly formed IgM antibodies contributed significantly to virus neutralization and prevented infection enhancement by other antibodies. Our data thus show how pre-existing cross-reactive immunities can alter the specificities and functional activities of antibody responses in flavivirus infections, which may affect flavivirus-induced disease and the efficacy of vaccinations.
   Background
   Zika virus has recently spread to South- and Central America, causing congenital birth defects and neurological complications. Many people at risk are flavivirus pre-immune due to prior infections with other flaviviruses (e.g. dengue virus) or flavivirus vaccinations. Since pre-existing cross-reactive immunity can potentially modulate antibody responses to Zika virus infection and may affect the outcome of disease, we analyzed fine-specificity as well as virus-neutralizing and infection-enhancing activities of antibodies induced by a primary Zika virus infection in flavivirus-naive as well as yellow fever- and/or tick-borne encephalitis-vaccinated individuals.
   Methodology
   Antibodies in sera from convalescent Zika patients with and without vaccine-induced immunity were assessed by ELISA with respect to Zika virus-specificity and flavivirus cross-reactivity. Functional analyses included virus neutralization and infection-enhancement. The contribution of IgM and cross-reactive antibodies to these properties was determined by depletion experiments.
   Principal findings
   Pre-existing flavivirus immunity had a strong influence on the antibody response in primary Zika virus infections, resulting in higher titers of broadly flavivirus cross-reactive antibodies and slightly lower levels of Zika virus-specific IgM. Antibody-dependent enhancement (ADE) of Zika virus was mediated by sub-neutralizing concentrations of specific IgG but not by cross-reactive antibodies. This effect was potently counteracted by the presence of neutralizing IgM. Broadly cross-reactive antibodies were able to both neutralize and enhance infection of dengue virus but not Zika virus, indicating a different exposure of conserved sequence elements in the two viruses.
   Conclusions
   Our data point to an important role of flavivirus-specific IgM during the transient early stages of infection, by contributing substantially to neutralization and by counteracting ADE. In addition, our results highlight structural differences between strains of Zika and dengue viruses that are used for analyzing infection-enhancement by cross-reactive antibodies. These findings underscore the possible impact of specific antibody patterns on flavivirus disease and vaccination efficacy.
C1 [Malafa, Stefan; Medits, Iris; Aberle, Judith H.; Aberle, Stephan W.; Haslwanter, Denise; Tsouchnikas, Georgios; Thaler, Melissa; Rossbacher, Lena; Heinz, Franz X.; Stiasny, Karin] Med Univ Vienna, Ctr Virol, Vienna, Austria.
   [Woelfel, Silke] Bundeswehr Inst Microbiol, Munich, Germany.
   [Woelfel, Silke] Ctr Infect Res DZIF, Munich, Germany.
   [Huber, Kristina L.] Ludwig Maximilian Univ LMU, Div Infect Dis & Trop Med, Munich, Germany.
   [Percivalle, Elena] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Microbiol & Virol Dept, Pavia, Italy.
   [Cherpillod, Pascal] Geneva Univ Hosp, Lab Med Div, Lab Virol, Geneva, Switzerland.
   [Kundi, Michael] Med Univ Vienna, Ctr Publ Hlth, Vienna, Austria.
   [Haslwanter, Denise] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA.
   [Tsouchnikas, Georgios] Hookipa Pharma, Vienna, Austria.
   [Woelfel, Silke] Amedes MVZ Lab Med & Microbiol, Furstenfeldbruck, Germany.
   [Thaler, Melissa] LUMC, Dept Med Microbiol, Mol Virol Lab, Leiden, Netherlands.
RP Heinz, FX; Stiasny, K (corresponding author), Med Univ Vienna, Ctr Virol, Vienna, Austria.
EM franz.x.heinz@meduniwien.ac.at; karin.stiasny@meduniwien.ac.at
OI Aberle, Judith H/0000-0003-1197-3935; Haslwanter,
   Denise/0000-0003-2727-0468; Stiasny, Karin/0000-0002-1902-8674
FU Austrian Science Fund FWFAustrian Science Fund (FWF) [P27501-B21,
   P29928-B30]
FX The study has been funded by the Austrian Science Fund FWF
   (https://www.fwf.ac.at; grant P27501-B21 to FXH; grant P29928-B30 to
   KS). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Andersson CR, 2010, VACCINE, V28, P2827, DOI 10.1016/j.vaccine.2010.02.001
   Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Bradt V, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0133-5
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   CARDOSA MJ, 1983, J EXP MED, V158, P258, DOI 10.1084/jem.158.1.258
   Chanama S, 2004, J CLIN VIROL, V31, P185, DOI 10.1016/j.jcv.2004.03.005
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223
   Dowd KA, 2018, ANNU REV VIROL, V5, P185, DOI 10.1146/annurev-virology-092917-043300
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Haslwanter D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006643
   Hedman K, 1993, REV MED MICROBIOL, V4, P123, DOI DOI 10.1097/00013542-199307000-00001
   HEINZ FX, 1986, J BIOL STAND, V14, P133, DOI 10.1016/0092-1157(86)90032-6
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   Holzmann H, 1996, J MED VIROL, V48, P102, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;102::AID-JMV16&gt;3.0.CO;2-I
   Holzmann H, 1997, J GEN VIROL, V78, P31, DOI 10.1099/0022-1317-78-1-31
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   KAYSER M, 1985, J MED VIROL, V17, P35, DOI 10.1002/jmv.1890170106
   Kiermayr S, 2009, J VIROL, V83, P8482, DOI 10.1128/JVI.00660-09
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01196
   Koblischke M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09331-w
   LAEMMLI UK, 1973, J MOL BIOL, V80, P601, DOI 10.1016/0022-2836(73)90199-X
   Libraty DH, 2002, T ROY SOC TROP MED H, V96, P173, DOI 10.1016/S0035-9203(02)90294-4
   MANDL CW, 1988, VIROLOGY, V166, P197, DOI 10.1016/0042-6822(88)90161-4
   MANDL CW, 1989, VIROLOGY, V173, P291, DOI 10.1016/0042-6822(89)90246-8
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   MORENS DM, 1987, MICROB PATHOGENESIS, V3, P231, DOI 10.1016/0882-4010(87)90056-8
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pierson TC, 2013, FLAVIVIRUSES FIELDS, V2
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Puschnik A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002274
   Raut R, 2019, P NATL ACAD SCI USA, V116, P227, DOI 10.1073/pnas.1812055115
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Staples JE, 2018, PLOTKINS VACCINES, P1181
   Stiasny K, 2012, J CLIN VIROL, V54, P115, DOI 10.1016/j.jcv.2012.02.016
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069
   Tesh RB, 2002, EMERG INFECT DIS, V8, P245, DOI 10.3201/eid0803.010238
   Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilder-Smith A, 2018, CLIN MICROBIOL INFEC, V24, P680, DOI 10.1016/j.cmi.2018.03.024
   Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10
NR 69
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2020
VL 14
IS 2
AR e0008034
DI 10.1371/journal.pntd.0008034
PG 27
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KT7ZN
UT WOS:000519231700036
PM 32017766
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Manwill, PK
   Kalsi, M
   Wu, SJ
   Martinez-Rodriguez, EJ
   Cheng, XL
   Piermarini, PM
   Rakotondraibe, HL
AF Manwill, Preston K.
   Kalsi, Megha
   Wu, Sijin
   Martinez-Rodriguez, Erick J.
   Cheng, Xiaolin
   Piermarini, Peter M.
   Rakotondraibe, Harinantenaina L.
TI Semi-synthetic cinnamodial analogues: Structural insights into the
   insecticidal and antifeedant activities of drimane sesquiterpenes
   against the mosquito Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TRP CHANNEL ACTIVATION; COVALENT MODIFICATION; NORDRIMANE COMPOUNDS;
   LARVICIDAL ACTIVITY; BIOLOGICAL-ACTIVITY; VANILLOID RECEPTOR; VECTOR;
   INVOLVEMENT; PESTICIDES; RESISTANCE
AB Author summary
   Aedes mosquitoes are the primary carriers of Zika, dengue, chikungunya, and yellow fever viruses around the globe. Given the emergence of insecticide-resistance in this genus and unprecedented 'globalization' of mosquito-borne viruses, new chemicals to control these mosquitoes (e.g., insecticides, repellents) are urgently needed. In the continuation of our search for new and safe natural product derived insecticides, we generated semi-synthetic derivatives of cinnamodial (CDIAL), previously identified as an insect antifeedant, repellent and insecticide, to give insights into the important features of the molecule that can contribute to the observed activities. Since the antifeedant and repellent activity of CDIAL are found to be mediated by modulation of a sensory receptor (TRPA1) in the mosquito, we developed a structural model to understand how CDIAL interacts with TRPA1 and to explain the difference in activities of CDIAL and the prepared derivatives. Our findings aid in the development of plant-derived insecticides to control the Ae. aegypti mosquito and justify continued efforts using TRPA1 as a target for new mosquito repellents.
   The Aedes aegypti mosquito serves as a major vector for viral diseases, such as dengue, chikungunya, and Zika, which are spreading across the globe and threatening public health. In addition to increased vector transmission, the prevalence of insecticide-resistant mosquitoes is also on the rise, thus solidifying the need for new, safe and effective insecticides to control mosquito populations. We recently discovered that cinnamodial, a unique drimane sesquiterpene dialdehyde of the Malagasy medicinal plant Cinnamosma fragrans, exhibited significant larval and adult toxicity to Ae. aegypti and was more efficacious than DEET-the gold standard for insect repellents-at repelling adult female Ae. aegypti from blood feeding. In this study several semi-synthetic analogues of cinnamodial were prepared to probe the structure-activity relationship (SAR) for larvicidal, adulticidal and antifeedant activity against Ae. aegypti. Initial efforts were focused on modification of the dialdehyde functionality to produce more stable active analogues and to understand the importance of the 1,4-dialdehyde and the alpha,ss-unsaturated carbonyl in the observed bioactivity of cinnamodial against mosquitoes. This study represents the first investigation into the SAR of cinnamodial as an insecticide and antifeedant against the medically important Ae. aegypti mosquito.
C1 [Manwill, Preston K.; Wu, Sijin; Cheng, Xiaolin; Rakotondraibe, Harinantenaina L.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12Th Ave, Columbus, OH 43210 USA.
   [Manwill, Preston K.; Piermarini, Peter M.; Rakotondraibe, Harinantenaina L.] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA.
   [Kalsi, Megha; Martinez-Rodriguez, Erick J.; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.
RP Cheng, XL; Rakotondraibe, HL (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12Th Ave, Columbus, OH 43210 USA.; Piermarini, PM; Rakotondraibe, HL (corresponding author), Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA.; Piermarini, PM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.
EM cheng.1302@osu.edu; piermarini.1@osu.edu; rakotondraibe.1@osu.edu
RI Wu, Sijin/AAL-3482-2020
OI Rakotondraibe, L. Harinantenaina/0000-0003-2166-4992; Manwill, Preston
   K./0000-0002-6072-1067
FU National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; National
   Institute of Allergy and Infectious Diseases (NIAID)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [1R21AI129951-01]; Center for Applied Plant Sciences (CAPS)
FX This work was supported in part by the National Institute of Health
   (NIH) and National Institute of Allergy and Infectious Diseases (NIAID)
   grant #1R21AI129951-01 to P.M.P and H.L.R. P.K. M gratefully
   acknowledges support from a Center for Applied Plant Sciences (CAPS)
   graduate assistantship. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Andre E, 2004, NEUROPHARMACOLOGY, V46, P590, DOI 10.1016/j.neuropharm.2003.10.008
   [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9
   [Anonymous], 1996, MONTANA CROP HLTH RE, V9, P1
   ASAKAWA Y, 1988, J CHEM ECOL, V14, P1845, DOI 10.1007/BF01013481
   Baek M, 2017, NUCLEIC ACIDS RES, V45, pW320, DOI 10.1093/nar/gkx246
   Bahia PK, 2016, J GEN PHYSIOL, V147, P451, DOI 10.1085/jgp.201611581
   Beyenbach KW, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2015.1081861
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BLANEY WM, 1987, PHYSIOL ENTOMOL, V12, P281, DOI 10.1111/j.1365-3032.1987.tb00752.x
   CASIDA JE, 1980, ENVIRON HEALTH PERSP, V34, P189, DOI 10.2307/3428960
   Corfas RA, 2015, ELIFE, V4, DOI [10.7554/eLife.11751, 10.7554/eLife.11750]
   Coutsias EA, 2004, J COMPUT CHEM, V25, P510, DOI 10.1002/jcc.10416
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   Dasari R, 2015, CHEMMEDCHEM, V10, P2014, DOI 10.1002/cmdc.201500360
   Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046
   De Sousa DP, 2010, PARASITOL RES, V107, P741, DOI 10.1007/s00436-010-1942-7
   Derita M, 2013, MOLECULES, V18, P2029, DOI 10.3390/molecules18022029
   DISCHIA M, 1982, TETRAHEDRON LETT, V23, P3295, DOI 10.1016/S0040-4039(00)87596-6
   Escalera J, 2008, J BIOL CHEM, V283, P24136, DOI 10.1074/jbc.M710280200
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753
   FRITZ GL, 1989, J CHEM ECOL, V15, P2607, DOI 10.1007/BF01014720
   Fujita K, 2005, BIOORGAN MED CHEM, V13, P6742, DOI 10.1016/j.bmc.2005.07.023
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032
   Gols GJZ, 1996, ENTOMOL EXP APPL, V79, P69, DOI 10.1007/BF00333823
   Gordaliza M, 2010, MAR DRUGS, V8, P2849, DOI 10.3390/md8122849
   Govindarajan VS, 1979, ACS SYM SER, P53, DOI [10.1021/bk-1979-0115.ch003, DOI 10.1021/BK-1979-0115.CH003]
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   He DH, 2017, BIOORG MED CHEM LETT, V27, P1754, DOI 10.1016/j.bmcl.2017.02.067
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Inocente EA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006265
   Iwasaki Y, 2009, LIFE SCI, V85, P60, DOI 10.1016/j.lfs.2009.04.017
   Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104
   Jansen BJM, 2004, NAT PROD REP, V21, P449, DOI 10.1039/b311170a
   JANSEN BJM, 1991, NAT PROD REP, V8, P309, DOI 10.1039/np9910800309
   Karabelas AJ, 2009, ENVIRON INT, V35, P1096, DOI 10.1016/j.envint.2009.06.011
   Kim MG, 2013, J AGR FOOD CHEM, V61, P10741, DOI 10.1021/jf403679h
   Kornienko A, 2017, NAT PROD REP, V34, P1051, DOI 10.1039/c7np00024c
   KUBO I, 1977, TETRAHEDRON LETT, P4553
   KUBO I, 1981, EXPERIENTIA, V37, P1063, DOI 10.1007/BF02085009
   KUBO I, 1976, J CHEM SOC CHEM COMM, P1013, DOI 10.1039/c39760001013
   MA WC, 1977, PHYSIOL ENTOMOL, V2, P199, DOI 10.1111/j.1365-3032.1977.tb00104.x
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544
   MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620
   Mathie K, 2017, J AGR FOOD CHEM, V65, P5700, DOI 10.1021/acs.jafc.7b02356
   Matthews G, 2011, INTEGRATED VECTOR MA
   MEINWALD J, 1978, SCIENCE, V199, P1167, DOI 10.1126/science.199.4334.1167
   Montenegro I, 2014, MOLECULES, V19, P18993, DOI 10.3390/molecules191118993
   Montenegro I, 2013, MOLECULES, V18, P4192, DOI 10.3390/molecules18044192
   Moreno-Osorio L, 2008, Z NATURFORSCH C, V63, P215
   NAKANISHI K, 1977, ISRAEL J CHEM, V16, P28
   Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367
   Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097
   Piermarini PM, 2011, AM J PHYSIOL-REG I, V301, pR1318, DOI 10.1152/ajpregu.00223.2011
   Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219
   Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905
   Ribeiro KAL, 2009, ACTA TROP, V111, P44, DOI 10.1016/j.actatropica.2009.02.008
   Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056
   Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y
   SINGER G, 1975, NATURE, V256, P222, DOI 10.1038/256222a0
   Sparks TC, 2019, PEST MANAG SCI, V75, P309, DOI 10.1002/ps.5217
   Sterner O, 1999, TRENDS PHARMACOL SCI, V20, P459, DOI 10.1016/S0165-6147(99)01393-0
   Swale DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36954
   Szallasi A, 1998, EUR J PHARMACOL, V356, P81, DOI 10.1016/S0014-2999(98)00514-7
   Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745
   TANIGUCHI M, 1984, AGR BIOL CHEM TOKYO, V48, P73, DOI 10.1080/00021369.1984.10866095
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875
   Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, MOSQ BORN DIS
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x
   Zapata N, 2010, PHYTOPARASITICA, V38, P191, DOI 10.1007/s12600-010-0087-7
NR 80
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2020
VL 14
IS 2
AR e0008073
DI 10.1371/journal.pntd.0008073
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KT7ZN
UT WOS:000519231700030
PM 32101555
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sippy, R
   Farrell, DF
   Lichtenstein, DA
   Nightingale, R
   Harris, MA
   Toth, J
   Hantztidiamantis, P
   Usher, N
   Aponte, CC
   Aguilar, JB
   Puthumana, A
   Lupone, CD
   Endy, T
   Ryan, SJ
   Ibarra, ASM
AF Sippy, Rachel
   Farrell, Daniel F.
   Lichtenstein, Daniel A.
   Nightingale, Ryan
   Harris, Megan A.
   Toth, Joseph
   Hantztidiamantis, Paris
   Usher, Nicholas
   Cueva Aponte, Cinthya
   Barzallo Aguilar, Julio
   Puthumana, Anthony
   Lupone, Christina D.
   Endy, Timothy
   Ryan, Sadie J.
   Stewart Ibarra, Anna M.
TI Severity Index for Suspected Arbovirus (SISA): Machine learning for
   accurate prediction of hospitalization in subjects suspected of
   arboviral infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SUPPORT VECTOR MACHINE; CHIKUNGUNYA VIRUS; DENGUE INFECTION;
   RISK-FACTORS; MODELS
AB Author summary
   Patient triage is a critical decision for clinicians. Patients with suspected arbovirus infection are difficult to diagnose as symptoms can be vague and molecular testing can be expensive or unavailable. Determining whether these patients should be hospitalized or not can be challenging, especially in resource-limited settings. Our study included data from 543 subjects with a diagnosis of suspected dengue, chikungunya, or Zika infection. Using a machine learning approach, we tested the ability of seven algorithms to predict hospitalization status based on the signs, symptoms, and laboratory data that would be available to a clinician at patient intake. Using only signs and symptoms, we were able to predict hospitalization with high accuracy (94%). Including laboratory data also resulted in highly accurate prediction of hospitalization (92%). This tool should be tested in future studies with new subject data. Upon further development, we envision a simple mobile application to aid in the decision-making process for clinicians in areas with limited resources.
   Background
   Dengue, chikungunya, and Zika are arboviruses of major global health concern. Decisions regarding the clinical management of suspected arboviral infection are challenging in resource-limited settings, particularly when deciding on patient hospitalization. The objective of this study was to determine if hospitalization of individuals with suspected arboviral infections could be predicted using subject intake data.
   Methodology/Principal findings
   Two prediction models were developed using data from a surveillance study in Machala, a city in southern coastal Ecuador with a high burden of arboviral infections. Data were obtained from subjects who presented at sentinel medical centers with suspected arboviral infection (November 2013 to September 2017). The first prediction model-called the Severity Index for Suspected Arbovirus (SISA)-used only demographic and symptom data. The second prediction model-called the Severity Index for Suspected Arbovirus with Laboratory (SISAL)-incorporated laboratory data. These models were selected by comparing the prediction ability of seven machine learning algorithms; the area under the receiver operating characteristic curve from the prediction of a test dataset was used to select the final algorithm for each model. After eliminating those with missing data, the SISA dataset had 534 subjects, and the SISAL dataset had 98 subjects. For SISA, the best prediction algorithm was the generalized boosting model, with an AUC of 0.91. For SISAL, the best prediction algorithm was the elastic net with an AUC of 0.94. A sensitivity analysis revealed that SISA and SISAL are not directly comparable to one another.
C1 [Sippy, Rachel; Cueva Aponte, Cinthya; Lupone, Christina D.; Endy, Timothy; Stewart Ibarra, Anna M.] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Sippy, Rachel; Ryan, Sadie J.] Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat Lab, Gainesville, FL 32611 USA.
   [Sippy, Rachel; Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Farrell, Daniel F.; Lichtenstein, Daniel A.; Nightingale, Ryan; Harris, Megan A.; Toth, Joseph; Hantztidiamantis, Paris; Puthumana, Anthony] SUNY Upstate Med Univ, Coll Med, MD Program, Syracuse, NY 13210 USA.
   [Usher, Nicholas] Cornell Univ, Off Undergrad Biol, Ithaca, NY USA.
   [Barzallo Aguilar, Julio] Teofilo Davila Hosp, Minist Hlth, Machala, El Oro Province, Ecuador.
   [Endy, Timothy; Stewart Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Farrell, Daniel F.] Lancaster Gen Hlth, Penn Med Lancaster Gen Hlth Family & Community Re, Lancaster, PA USA.
   [Stewart Ibarra, Anna M.] Interamer Inst Global Change Res, Montevideo, Uruguay.
RP Sippy, R; Ibarra, ASM (corresponding author), SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.; Sippy, R (corresponding author), Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat Lab, Gainesville, FL 32611 USA.; Sippy, R (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.; Ibarra, ASM (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
EM sippyr@upstate.edu; astewart@dir.iai.int
OI Sippy, Rachel/0000-0003-3617-2093; Usher, Nicholas/0000-0001-8779-519X;
   Hantzidiamantis, Paris/0000-0002-7872-8355
FU Department of Defense Global Emerging Infection SurveillanceUnited
   States Department of Defense [P0220_13_OT]; Department of Medicine of
   SUNY Upstate Medical University; Ben Kean Fellowship from the American
   Society for Tropical Medicine and Hygeine; NSFNational Science
   Foundation (NSF) [DEB EEID 1518681, DEB RAPID 1641145]
FX This study was supported, in part, by the Department of Defense Global
   Emerging Infection Surveillance
   (https://health.mil/Military-Health-Topics/Combat-Support/Armed-Forces-H
   ealth-Surveillance-Branch/Global-Emerging-Infections-Surveillance-and-Re
   sponse) grant (P0220_13_OT) and the Department of Medicine of SUNY
   Upstate Medical University (http://www.upstate.edu/medicine/).D.F., M.H.
   and P.H. were supported by the Ben Kean Fellowship from the American
   Society for Tropical Medicine and Hygeine
   (https://www.astmh.org/awards-fellowships-medals/benjamin-h-keen-travel-
   fellowship-in-tropicalmedi).S.J.R and A.M.S-I were supported by NSF DEB
   EEID 1518681, NSF DEB RAPID 1641145 (https://www.nsf.gov/), A.M.S-I was
   additionally supported by the Prometeo program of the National Secretary
   of Higher Education, Science, Technology, and Innovation of Ecuador
   (http://prometeo.educacionsuperior.gob.ec/).The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agyeman-Duah JNA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-1
   Aronsky D, 1998, J AM MED INFORM ASSN, P632
   Azeredo EL, 2018, PLOS CURR, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Banerjee M, 1999, CAN J STAT, V27, P3, DOI 10.2307/3315487
   Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   Boillat-Blanco N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197982
   Boulesteix AL, 2014, BIOMETRICAL J, V56, P588, DOI 10.1002/bimj.201300226
   Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726
   Cabitza F, 2017, JAMA-J AM MED ASSOC, V318, P517, DOI 10.1001/jama.2017.7797
   Censos IN de E y, CENS ACT REC SAL
   Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004
   Dakappa PH, 2017, J HEALTHC ENG, DOI 10.1155/2017/5707162
   Davi C, 2019, IEEE T BIO-MED ENG, V66, P2861, DOI 10.1109/TBME.2019.2897285
   de la Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI 10.1016/j.jcv.2015.05.021
   Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593
   Er O, 2008, J MED SYST, V32, P429, DOI 10.1007/s10916-008-9148-6
   Farrell DF, 2018, AM J TROP MED HYG, V98, P838, DOI 10.4269/ajtmh.17-0781
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Goto T, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6937
   GREENLAND S, 1986, INT J EPIDEMIOL, V15, P413, DOI 10.1093/ije/15.3.413
   Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400
   Haddawy P, 2016, STUD HEALTH TECHNOL, V228, P773, DOI 10.3233/978-1-61499-678-1-773
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hastie T., 2009, ELEMENTS STAT LEARNI
   Hastie T., 2015, STAT LEARNING SPARSI
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   Karatzoglou A, 2004, J STAT SOFTW, V11, P9, DOI [DOI 10.18637/JSS.V011.I09, 10.18637/jss.v011.i09]
   Khan S, 2016, BIOMED OPT EXPRESS, V7, P2249, DOI 10.1364/BOE.7.002249
   Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05
   Kuhn Max, 2017, CARET CLASSIFICATION
   Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149
   Lee IK, 2009, AM J TROP MED HYG, V80, P651, DOI 10.4269/ajtmh.2009.80.651
   Lee VJ, 2012, PLOS NEGL TROP DIS, V6, DOI 10.1371/journal.pntd.0001786
   Liaw A, 2001, INT J FATIGUE, V23
   Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112
   Ministerio de Salud Publica Direccion Nacional de Vigilancia Epidemiologica, ENF TRASM VECT 1994
   Ministerio de Salud Publica Direccion Nacional de Vigilancia Epidemiologica, ENF TRASM VECT SE 52
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2018, CLIN MICROBIOL INFEC, V24, P827, DOI 10.1016/j.cmi.2018.05.001
   Nagori A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36586-8
   Melo CFOR, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00031
   Peters A., 2017, IPRED IMPROVED PREDI
   Raita Y, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2351-7
   Ridgeway G., 2017, GBM GEN BOOSTED REGR
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Sa-ngamuang C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006573
   Sartakhti JS, 2012, COMPUT METH PROG BIO, V108, P570, DOI 10.1016/j.cmpb.2011.08.003
   Sawasdivorn S, 2001, EFFICACY CLIN DIAGNO
   Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Stewart-Ibarra AM, 2018, AM J TROP MED HYG, V98, P1444, DOI 10.4269/ajtmh.17-0762
   Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207
   Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2
   Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060
   Venables W. N., 2002, MODERN APPL STAT S
   Wickham H., 2017, HAVEN IMPORT EXPORT
   Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x
   Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374
   World Health Organization (WHO) and the Special Programme for Research and Training in Tropical diseases (TDR), DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zou H, 2012, ELASTICNET ELASTIC N
NR 67
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2020
VL 14
IS 2
AR e0007969
DI 10.1371/journal.pntd.0007969
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KT7ZN
UT WOS:000519231700011
PM 32059026
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saavedra, LM
   Romanelli, GP
   Duchowicz, PR
AF Saavedra, Laura M.
   Romanelli, Gustavo P.
   Duchowicz, Pablo R.
TI A non-conformational QSAR study for plant-derived larvicides against
   Zika Aedes aegypti L. vector
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE QSAR analysis; MLR method; Larvicidal activity; Aedes aegypti vector;
   Freeware
ID MOLECULAR DESCRIPTORS; ESSENTIAL OILS; DERIVATIVES; ALGORITHM; MODELS;
   INHIBITORS; SELECTION; TOXICITY; SEARCH
AB A set of 263 plant-derived compounds with larvicidal activity against Aedes aegypti L. (Diptera: Culicidae) vector is collected from the literature, and is studied by means of a non-conformational quantitative structure-activity relationships (QSAR) approach. The balanced subsets method (BSM) is employed to split the complete dataset into training, validation and test sets. From 26,775 freely available molecular descriptors, the most relevant structural features of compounds affecting the bioactivity are taken. The molecular descriptors are calculated through four different freewares, such as PaDEL, Mold2, EPI Suite and QuBiLsMAS. The replacement method (RM) variable subset selection technique leads to the best linear regression models. A successful QSAR equation involves 7-conformation-independent molecular descriptors, fulfiling the evaluated internal (loo, l30 parts per thousand, VIF and Y-randomization) and external (test set with Ntest = 65 compounds) validation criteria. The practical application of this QSAR model reveals promising predicted values for some natural compounds with unknown experimental larvicidal activity. Therefore, the present model constitutes the first one based on a large molecular set, being a useful computational tool for identifying and guiding the synthesis of new active molecules inspired by natural products.
C1 [Saavedra, Laura M.; Duchowicz, Pablo R.] UNLP, CONICET, Inst Invest Fisicoquim Teor & Aplicadas INIFTA, Diag 113 & 64,CC 16,Sucursal 4, RA-1900 La Plata, Argentina.
   [Romanelli, Gustavo P.] UNLP, Ctr Invest & Desarrollo Ciencias Aplicadas Dr JJ, Fac Ciencias Exactas, CONICET,Dept Quim, Calle 47 257,B1900AJK, La Plata, Argentina.
   [Romanelli, Gustavo P.] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Ctr Invest Sanidad Vegetal CISaV, Catedra Quim Organ, Calles 60 & 119 S-N,B1904AAN, La Plata, Argentina.
RP Saavedra, LM; Duchowicz, PR (corresponding author), UNLP, CONICET, Inst Invest Fisicoquim Teor & Aplicadas INIFTA, Diag 113 & 64,CC 16,Sucursal 4, RA-1900 La Plata, Argentina.
EM laurasaa0913@gmail.com; pabloducho@gmail.com
FU National Scientific and Technical Research Council of Argentina
   (CONICET)Consejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET) [PIP11220130100311]
FX PRD acknowledges the financial support from the National Scientific and
   Technical Research Council of Argentina (CONICET) PIP11220130100311
   project and to the Ministerio de Ciencia, Tecnologia e Innovacion
   Productiva for the electronic library facilities. PRD and GPR are
   members of the scientific researcher career of CONICET.
CR Alencar EB, 2016, MED CHEM RES, V25, P2171, DOI 10.1007/s00044-016-1650-7
   [Anonymous], MATL 7 0
   Aranda JF, 2017, SAR QSAR ENVIRON RES, V28, P749, DOI [10.1080/1062936X.2017.1377765, 10.1080/1062936x.2017.1377765]
   Aranda JF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081247
   Benfenati E., 2012, THEORY GUIDANCE APPL
   Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1
   Canizares-Carmenate Y, 2017, J VECTOR DIS, V54, P164
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10
   da Silva JBP, 2015, EUR J MED CHEM, V100, P162, DOI 10.1016/j.ejmech.2015.04.061
   Department of control of neglected tropical diseases/WHO, 2017, 6 M VECT CONTR ADV G
   Devillers J, 2014, SAR QSAR ENVIRON RES, V25, P805, DOI 10.1080/1062936X.2014.958291
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Doucet JP, 2017, SAR QSAR ENVIRON RES, V28, P451, DOI [10.1080/1062936X.2017.1328855, 10.1080/1062936x.2017.1328855]
   Draper N.R., 1998, APPL REGRESSION ANAL
   Duchowicz PR, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7020013
   Duchowicz PR, 2017, CHEMISTRYSELECT, V2, P3725, DOI 10.1002/slct.201700436
   Duchowicz PR, 2006, MATCH-COMMUN MATH CO, V55, P179
   Duchowicz PR, 2005, CHEM PHYS LETT, V412, P376, DOI 10.1016/j.cplett.2005.07.016
   Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r
   Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758
   European Centre for Disease Prevention and Control, 2017, RAP RISK ASS ZIK VIR
   Geris R, 2012, STUD NAT PROD CHEM, V37, P277, DOI 10.1016/B978-0-444-59514-0.00010-9
   Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946
   Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151
   Hansch C, 1995, FUNDAMENTALS APPL CH, P139
   Hansch C, 2009, EUR J MED CHEM, V44, P260, DOI 10.1016/j.ejmech.2008.02.040
   Hawkins DM, 2003, J CHEM INF COMP SCI, V43, P579, DOI 10.1021/ci025626i
   Hong HX, 2008, J CHEM INF MODEL, V48, P1337, DOI 10.1021/ci800038f
   KATRITZKY AR, 1993, J CHEM INF COMP SCI, V33, P835, DOI 10.1021/ci00016a005
   Kim MG, 2013, J AGR FOOD CHEM, V61, P10741, DOI 10.1021/jf403679h
   Kishore N, 2014, PHYTOCHEM REV, V13, P587, DOI 10.1007/s11101-013-9316-2
   Lima TC, 2015, PARASITOL RES, V114, P2883, DOI 10.1007/s00436-015-4489-9
   Morales AH, 2006, CHEMOMETR INTELL LAB, V81, P180, DOI 10.1016/j.chemolab.2005.12.002
   Mullen LMA, 2011, CHEMOMETR INTELL LAB, V107, P269, DOI 10.1016/j.chemolab.2011.04.011
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   Rafiei H, 2016, EXCLI J, V15, P38, DOI 10.17179/excli2015-731
   Rojas C, 2015, CHEMOMETR INTELL LAB, V140, P126, DOI 10.1016/j.chemolab.2014.09.020
   Roy K., 2015, UNDERSTANDING BASICS
   Rucker C, 2007, J CHEM INF MODEL, V47, P2345, DOI 10.1021/ci700157b
   Saavedra LM, 2018, PEST MANAG SCI, V74, P1608, DOI 10.1002/ps.4850
   Saavedra LM, 2018, SCI TOTAL ENVIRON, V610, P937, DOI 10.1016/j.scitotenv.2017.08.119
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   Srinivasan R, 2015, IND CROP PROD, V76, P394, DOI 10.1016/j.indcrop.2015.07.032
   STANTON DT, 1993, QUANT STRUCT-ACT REL, V12, P239, DOI 10.1002/qsar.19930120304
   US EPA, 2016, EST PROGR INT SUIT M, P1
   Valdes-Martini JR, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0211-5
   Valdes-Martini JR, 2012, QUBILS MAS FREE SOFT
   WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005
   WHO, 1992, WHO TECHN REP SER
   WOLD S, 1995, STAT VALIDATION QSAR
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
   Yu KX, 2015, ASIAN PAC J TROP MED, V8, P981, DOI 10.1016/j.apjtm.2015.11.011
NR 53
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD FEB
PY 2020
VL 27
IS 6
BP 6205
EP 6214
DI 10.1007/s11356-019-06630-9
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA KU3UD
UT WOS:000519635800046
PM 31865579
DA 2020-07-08
ER

PT J
AU Cabral, S
   de Paula, A
   Samuels, R
   da Fonseca, R
   Gomes, S
   Silva, JR
   Mury, F
AF Cabral, Sara
   De Paula, Adriano
   Samuels, Richard
   Da Fonseca, Rodrigo
   Gomes, Simone
   Silva, Jose Roberto
   Mury, Flavia
TI Aedes aegypti (Diptera: Culicidae) Immune Responses with Different
   Feeding Regimes Following Infection by the Entomopathogenic Fungus
   Metarhizium anisopliae
SO INSECTS
LA English
DT Article
DE dengue; Zika; vector; immune response; gene expression
ID INSECT PESTS; ZIKA VIRUS; VECTOR; PATHWAY; GENES; TOLL; EXPRESSION;
   INTERACTS; HOMOLOG; DEFENSE
AB The mosquito Aedes aegypti is the most notorious vector of illness-causing viruses. The use of entomopathogenic fungi as bioinsecticides is a promising alternative for the development of novel mosquito control strategies. We investigate whether differences in immune responses could be responsible for modifications in survival rates of insects following different feeding regimes. Sucrose and blood-fed adult A. aegypti females were sprayed with M. anisopliae 1 x 10(6) conidia mL(-1), and after 48 h, the midgut and fat body were dissected. We used RT-qPCR to monitor the expression of Cactus and REL1 (Toll pathway), IMD, REL2, and Caspar (IMD pathway), STAT and PIAS (JAK-STAT pathway), as well as the expression of antimicrobial peptides (Defensin A, Attacin and Cecropin G). REL1 and REL2 expression in both the midgut and fat body were higher in blood-fed fungus-challenged A. aegypti than in sucrose-fed counterparts. Interestingly, infection of sucrose-fed insects induced Cactus expression in the fat body, a negative regulator of the Toll pathway. The IMD gene was upregulated in the fat body in response to fungal infection after a blood meal. Additionally, we observed the induction of antimicrobial peptides in the blood-fed fungus-challenged insects. This study suggests that blood-fed A. aegypti are less susceptible to fungal infection due to the rapid induction of Toll and IMD immune pathways.
C1 [Cabral, Sara; Silva, Jose Roberto] Univ Fed Rio de Janeiro, NUPEM, Inst Biodiversidade & Sustentabilidade, Lab Integrado Bioquim, BR-27965045 Macae, RJ, Brazil.
   [De Paula, Adriano; Samuels, Richard; Gomes, Simone] Univ Estadual Norte FluminenseDarcy Ribeiro, CCTA, Lab Entomol & Fitopatol, BR-28013603 Campos Dos Goytacazes, RJ, Brazil.
   [Da Fonseca, Rodrigo] Univ Fed Rio de Janeiro, NUPEM, Inst Biodiversidade & Sustentabilidade, Lab Integrado Ciencias Morfofuncionais, BR-27965045 Macae, RJ, Brazil.
   [Da Fonseca, Rodrigo; Silva, Jose Roberto; Mury, Flavia] INCT EM, BR-21941590 Rio De Janeiro, Brazil.
   [Mury, Flavia] Univ Fed Rio de Janeiro, NUPEM, Inst Biodiversidade & Sustentabilidade, Lab Integrado Biociencias Translacionais, BR-27965045 Macae, RJ, Brazil.
RP Samuels, R (corresponding author), Univ Estadual Norte FluminenseDarcy Ribeiro, CCTA, Lab Entomol & Fitopatol, BR-28013603 Campos Dos Goytacazes, RJ, Brazil.; Mury, F (corresponding author), INCT EM, BR-21941590 Rio De Janeiro, Brazil.; Mury, F (corresponding author), Univ Fed Rio de Janeiro, NUPEM, Inst Biodiversidade & Sustentabilidade, Lab Integrado Biociencias Translacionais, BR-27965045 Macae, RJ, Brazil.
EM sara_z_c@hotmail.com; biodepaulaarquivo@gmail.com;
   simoneazgomes@yahoo.com.br; rodrigo.nunes.da.fonseca@gmail.com;
   betocfrio@gmail.com; fbmury@macae.ufrj.br
RI Samuels, Richard/R-6042-2017
OI Samuels, Richard/0000-0003-1814-2456
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [RS: E26/102.353/2013,
   E-26/201.336/2016]
FX This research was funded by CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Brazil), FAPERJ (Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro) (RS: E26/102.353/2013;
   E-26/201.336/2016). Richard Samuels is a CNPq research fellow.
CR Alkhaibari AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005715
   Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007
   BarillasMury C, 1996, EMBO J, V15, P4691, DOI 10.1002/j.1460-2075.1996.tb00846.x
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Baverstock J, 2010, BIOCONTROL, V55, P89, DOI 10.1007/s10526-009-9238-5
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102
   Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010
   Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82
   Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985
   Butt TM, 2016, ADV GENET, V94, P307, DOI 10.1016/bs.adgen.2016.01.006
   Cherry AJ, 2005, J STORED PROD RES, V41, P295, DOI 10.1016/j.jspr.2004.04.002
   Dal Bello G, 2001, J STORED PROD RES, V37, P77, DOI 10.1016/S0022-474X(00)00009-6
   de Paula AR, 2008, BIOCONTROL SCI TECHN, V18, P1017, DOI 10.1080/09583150802509199
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dzaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43618
   EVERITT BS, 1994, STAT METHODS MED INV
   Fang WG, 2012, CURR OPIN MICROBIOL, V15, P232, DOI 10.1016/j.mib.2011.12.012
   Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Fukutani KF, 2018, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00084
   Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737
   Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Higgs S., 2004, BIOL DIS VECTORS, P167
   Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x
   Kumar A, 2010, MOL MICROBIOL, V75, P942, DOI 10.1111/j.1365-2958.2009.07033.x
   Kumar A, 2018, INSECTS, V9, DOI 10.3390/insects9030095
   LACEY LA, 1990, J AM MOSQUITO CONTR, P1
   Lavine MD, 2002, INSECT BIOCHEM MOLEC, V32, P1295, DOI 10.1016/S0965-1748(02)00092-9
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lord JC, 2001, J ECON ENTOMOL, V94, P367, DOI 10.1603/0022-0493-94.2.367
   Lovett B, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0001-2016
   Lu HL, 2016, ADV GENET, V94, P251, DOI 10.1016/bs.adgen.2015.11.002
   Luna C, 2006, INSECT MOL BIOL, V15, P721, DOI 10.1111/j.1365-2583.2006.00661.x
   Maina U.M., 2018, Journal of Entomology and Zoology Studies, V6, P27
   Manning JE, 2018, J INFECT DIS, V218, P7, DOI 10.1093/infdis/jiy179
   Marques AM, 2017, J VECTOR DIS, V54, P61
   Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102
   Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Paula AR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-91
   Paula AR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-8
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Ramirez JL, 2019, DEV COMP IMMUNOL, V95, P1, DOI 10.1016/j.dci.2018.12.010
   Ramirez JL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006433
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Rivera-Perez C, 2017, CURR OPIN INSECT SCI, V23, P112, DOI 10.1016/j.cois.2017.07.002
   Schneider D., 2009, INSECT INFECT IMMUNI
   SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200
   Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x
   Tawidian P, 2019, INSECT BIOCHEM MOLEC, V111, DOI 10.1016/j.ibmb.2019.103182
   Upton LM, 2015, J INNATE IMMUN, V7, P74, DOI 10.1159/000365331
   Wei G, 2017, P NATL ACAD SCI USA, V114, P5994, DOI 10.1073/pnas.1703546114
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, DENG SEV DENG
   Wrkato D., 1994, CELL, V76, P677
   Zhang RD, 2017, FRONT CELL INFECT MI, V7, DOI [10.3382/fcimb.2017.00022, 10.3389/fcimb.2017.00022]
NR 64
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4450
J9 INSECTS
JI Insects
PD FEB
PY 2020
VL 11
IS 2
AR 95
DI 10.3390/insects11020095
PG 15
WC Entomology
SC Entomology
GA KT6HZ
UT WOS:000519116600064
PM 32024202
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Jesus, CP
   Dias, FBS
   Villela, DMA
   Maciel-de-Freitas, R
AF de Jesus, Camila P.
   Dias, Fernando B. S.
   Villela, Daniel M. A.
   Maciel-de-Freitas, Rafael
TI Ovitraps Provide a Reliable Estimate of Wolbachia Frequency during
   wMelBr Strain Deployment in a Geographically Isolated Aedes aegypti
   Population
SO INSECTS
LA English
DT Article
DE ovitrap; Aedes aegypti; Wolbachia; surveillance; BG-Sentinel; sampling
ID DENGUE VECTOR CONTROL; RIO-DE-JANEIRO; ZIKA VIRUS; OVIPOSITION BEHAVIOR;
   SKIP-OVIPOSITION; BG-SENTINEL; DIPTERA; CULICIDAE; ALBOPICTUS; INFECTION
AB Deployment of Aedes aegypti mosquitoes carrying the endosymbiont bacterium Wolbachia has been identified as a promising strategy to reduce dengue, chikungunya, and Zika transmission. We investigated whether sampling larvae from ovitraps can provide reliable estimates on Wolbachia frequency during releases, as compared to the expensive adult-based BG-Sentinel. We conducted pilot releases in a semi-field system (SFS) divided into six cages of 21 m(2), each with five ovitraps. Five treatments were chosen to represent different points of a hypothetical invasion curve: 10%, 25%, 50%, 75%, and 90% of Wolbachia frequency. Collected eggs were counted and hatched, and the individuals from a net sample of 27% of larvae per treatment were screened for Wolbachia presence by RT-qPCR. Ovitrap positioning had no effect on egg hatching rate. Treatment strongly affected the number of eggs collected and also the hatching rate, especially when Wolbachia was at a 10% frequency. A second observation was done during the release of Wolbachia in Rio under a population replacement approach when bacterium frequency was estimated using 30 BG-Sentinel traps and 45 ovitraps simultaneously. By individually screening 35% (N = 3904) of larvae collected by RT-qPCR, we were able to produce a similar invasion curve to the one observed when all adults were individually screened. If sampling is reduced to 20%, monitoring Wolbachia frequency with 45 ovitraps would be roughly half the cost of screening all adult mosquitoes captured by 30 BG-Sentinels. Our findings support the scale-up of Wolbachia releases, especially in areas with limited resources to afford massive trapping with BG-Sentinel traps.
C1 [de Jesus, Camila P.; Maciel-de-Freitas, Rafael] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Dias, Fernando B. S.] Fiocruz MS, Gabinete Presidencia, BR-21040361 Rio De Janeiro, Brazil.
   [Villela, Daniel M. A.] Fiocruz MS, Programa Comp Cient, BR-21040361 Rio De Janeiro, Brazil.
RP Maciel-de-Freitas, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM kakabiogene@gmail.com; fbragasdias@gmail.com; daniel.villela@fiocruz.br;
   freitas@ioc.fiocruz.br
OI Maciel-de-Freitas, Rafael/0000-0002-2198-6492; Dias,
   Fernando/0000-0001-7747-6136; Villela, Daniel/0000-0001-8371-2959
FU CAPESCAPES [001]
FX This research was funded by CAPES grant number 001.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Chadee DD, 2010, J VECTOR ECOL, V35, P395, DOI 10.1111/j.1948-7134.2010.00098.x
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Colton YM, 2003, MED VET ENTOMOL, V17, P195, DOI 10.1046/j.1365-2915.2003.00424.x
   Daniel WW, 2009, BIOSTATISTICS FDN AN
   de Oliveira S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005947
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Farnesi LC, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3474-z
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fernandes JN, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0496
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Goncalves DD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-228
   Harrington LC, 2001, J MED ENTOMOL, V38, P641, DOI 10.1603/0022-2585-38.5.641
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Nazni WA, 2019, ESTABLISHMENT WOLBAC, DOI [10.1101/775965, DOI 10.1101/775965]
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988
   Roque RA, 2008, NEOTROP ENTOMOL, V37, P478, DOI 10.1590/S1519-566X2008000400018
   de Abreu FVS, 2015, MEM I OSWALDO CRUZ, V110, P669, DOI 10.1590/0074-02760140490
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x
   Turelli M, 2017, THEOR POPUL BIOL, V115, P45, DOI 10.1016/j.tpb.2017.03.003
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 44
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4450
J9 INSECTS
JI Insects
PD FEB
PY 2020
VL 11
IS 2
AR 92
DI 10.3390/insects11020092
PG 12
WC Entomology
SC Entomology
GA KT6HZ
UT WOS:000519116600063
PM 32024068
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vedovello, D
   Witkin, SS
   Silva, ACB
   Fajardo, TCG
   Mello, AS
   Bertozzi, APAP
   da Silva, AB
   Vieira, NF
   Rodrigues, MMD
   Gazeta, RE
   Moron, AF
   Sarmento, SGP
   Soriano-Arandes, A
   Passos, SD
AF Vedovello, Danila
   Witkin, Steven S.
   Botelho Silva, Andrea Cristina
   Gillo Fajardo, Thamirys Cosmo
   Mello, Alexandra Siqueira
   Antunes Pascalicchio Bertozzi, Ana Paula
   da Silva, Alify Bertoldo
   Vieira Filho, Nemesio Florence
   Duarte Rodrigues, Maria Manoela
   Gazeta, Rosa Estela
   Moron, Antonio Fernandes
   Pereira Sarmento, Stephanno Gomes
   Soriano-Arandes, Antonio
   Passos, Saulo Duarte
TI Detection of Zika virus in paired urine and amniotic fluid samples from
   symptomatic and asymptomatic women and their babies during a disease
   outbreak: association with neurological symptoms in newborns
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Pregnancy; Neurological symptoms; Urine; Amniotic fluid
ID INFECTION; TRANSMISSION; BLOOD
AB Paired maternal and newborn urine and amniotic fluid from 138 subjects collected during a Zika virus (ZIKV) outbreak was analyzed for ZIKV by gene amplification (RT-qPCR), and the findings were correlated with clinical symptoms and neurological anomalies in the babies. ZIKV was detected in 1 of 9 symptomatic women (11.1%) and in 19 of 129 asymptomatic women (14.7%). Neurological manifestations were present in 19 babies (13.7%), 10 of 20 (50%) positive and 9 of 119 (7.6%) negative (p < 0.001) for ZIKV. Twelve (8.6%) urines collected during gestation were ZIKV-positive; only 2 remained positive for ZIKV postpartum. Six (4.1%) newborn urines collected within 1 day of delivery were ZIKV-positive cases. In 3 of these cases, ZIKV was detected in mother's urine pre- and postpartum and in both mother's urine and babies' urine. Four of the amniotic fluid samples (2.9%) were ZIKV-positive. Among ZIKV-negative babies with neurological sequel, 87.5% were female; in contrast, 72.7% ZIKV-positive babies with neurological abnormalities were male (p = 0.019). We conclude that during a ZIKV outbreak, clinical symptoms and ZIKV detection in biological fluids are poor predictors of infection and adverse neurologic sequel in newborns.
C1 [Vedovello, Danila; Botelho Silva, Andrea Cristina; Gillo Fajardo, Thamirys Cosmo; Mello, Alexandra Siqueira; Antunes Pascalicchio Bertozzi, Ana Paula; Passos, Saulo Duarte] Jundiai Sch Med, Lab Pediat Infectol, Rua Francisco Telles 250, BR-13202550 Jundiai, SP, Brazil.
   [Witkin, Steven S.; Antunes Pascalicchio Bertozzi, Ana Paula; da Silva, Alify Bertoldo; Vieira Filho, Nemesio Florence; Duarte Rodrigues, Maria Manoela; Gazeta, Rosa Estela; Passos, Saulo Duarte] Univ Hosp, Jundiai Sch Med, Jundiai, SP, Brazil.
   [Witkin, Steven S.] Weill Cornell Med, New York, NY USA.
   [Moron, Antonio Fernandes] Paulista Fed Med Sch, Neonatal Perinatal Med Forum, Sao Paulo, SP, Brazil.
   [Pereira Sarmento, Stephanno Gomes] Paulista Fed Med Sch, Paulista Ctr Fetal Med, Sao Paulo, SP, Brazil.
   [Soriano-Arandes, Antonio] Hosp Univ Vall dHebron, Pediat Infect Dis Unit, Barcelona, Spain.
RP Vedovello, D (corresponding author), Jundiai Sch Med, Lab Pediat Infectol, Rua Francisco Telles 250, BR-13202550 Jundiai, SP, Brazil.
EM danvedo@hotmail.com
RI Arandes, Antonio Soriano/Q-3348-2016; Vedovello, Danila/M-5757-2014
OI Arandes, Antonio Soriano/0000-0001-9613-7228; Alexandrasmello@gmail.com,
   Alexandra/0000-0002-7996-873X; Vedovello, Danila/0000-0001-8585-8206;
   Passos, Saulo/0000-0002-0908-2677; FAJARDO, THAMIRYS/0000-0003-1096-1078
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/22007-8, 2016/08578-0]; World Health OrganizationWorld Health
   Organization [ZIKV100/2018]; LSHTM [PC0002/16]; MoH - Brazil
   [861306/2017 and 861307/2017]
CR Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos TD, 2018, INT J GENOMICS, DOI 10.1155/2018/6941735
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Jurado KA, 2017, NAT MICROBIOL, V2, P1460, DOI 10.1038/s41564-017-0049-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Papageorghiou AT, 2013, BJOG S2, V120, P1
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Walter LT, 2018, MOL NEUROBIOL, V55, P1620, DOI 10.1007/s12035-017-0442-5
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 42
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD FEB
PY 2020
VL 26
IS 1
BP 70
EP 76
DI 10.1007/s13365-019-00797-0
PG 7
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA KU0BZ
UT WOS:000519378600009
PM 31502209
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Rosa, RL
   Santi, L
   Berger, M
   Tureta, EF
   Quincozes-Santos, A
   Souza, DO
   Guimaraes, JA
   Beys-da-Silva, WO
AF Rosa, Rafael L.
   Santi, Lucelia
   Berger, Markus
   Tureta, Emanuela F.
   Quincozes-Santos, Andre
   Souza, Diogo O.
   Guimaraes, Jorge A.
   Beys-da-Silva, Walter O.
TI ZIKAVID-Zika virus infection database: a new platform to analyze the
   molecular impact of Zika virus infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Database; Host; Strains
ID RESOURCE; CELLS
AB The recent outbreak of Zika virus (ZIKV) in Brazil and other countries globally demonstrated the relevance of ZIKV studies. During and after this outbreak, there was an intense increase in scientific production on ZIKV infections, especially toward alterations promoted by the infection and related to clinical outcomes. Considering this massive amount of new data, mainly thousands of genes and proteins whose expression is impacted by ZIKV infection, the ZIKA Virus Infection Database (ZIKAVID) was created. ZIKAVID is an online database that comprises all genes or proteins, and associated information, for which expression was experimentally measured and found to be altered after ZIKV infection. The database, available at , contains 16,984 entries of gene expression measurements from a total of 7348 genes. It allows users to easily perform searches for different experimental hosts (cell lines, tissues, and animal models), ZIKV strains (African, Asian, and Brazilian), and target molecules (messenger RNA [mRNA] and protein), among others, used in differential expression studies regarding ZIKV infection. In this way, the ZIKAVID will serve as an additional and important resource to improve the characterization of the molecular impact and pathogenesis associated with ZIKV infection.
C1 [Rosa, Rafael L.; Santi, Lucelia; Tureta, Emanuela F.; Beys-da-Silva, Walter O.] Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752,Suit 709, Porto Alegre, RS, Brazil.
   [Rosa, Rafael L.; Santi, Lucelia; Berger, Markus; Guimaraes, Jorge A.; Beys-da-Silva, Walter O.] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.
   [Quincozes-Santos, Andre; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752,Suit 709, Porto Alegre, RS, Brazil.; Beys-da-Silva, WO (corresponding author), Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.
EM walter.beys@ufrgs.br
RI Beys-da-Silva, Walter O/M-3760-2018; Santi, Lucelia/AAK-9527-2020;
   Berger, Markus/U-7682-2019; Santi, Lucelia/AAB-8349-2020;
   Quincozes-Santos, Andre/AAO-2714-2020; Souza, Diogo/J-8894-2014
OI Beys-da-Silva, Walter O/0000-0001-8329-7839; Berger,
   Markus/0000-0001-7670-2584; Santi, Lucelia/0000-0002-5698-7006;
   Quincozes-Santos, Andre/0000-0001-8611-4890; Souza,
   Diogo/0000-0002-4322-0404
FU CAPES/MCTI/CNPq [440763/2016-9]
CR Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Beys-da-Silva WO, 2019, MOL NEUROBIOL, V56, P4708, DOI 10.1007/s12035-018-1417-x
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guirimand T, 2015, NUCLEIC ACIDS RES, V43, pD583, DOI 10.1093/nar/gku1121
   Gurumayum S, 2018, VIROLOGY, V514, P203, DOI 10.1016/j.virol.2017.11.007
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Hu T, 2019, VIROL SIN, V34, P1, DOI 10.1007/s12250-018-0078-2
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Jiang X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01067
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mishra A, 2017, INT REV IMMUNOL, V36, P89, DOI 10.1080/08830185.2017.1291640
   Mitchell RD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102104
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Papanikolaou NL, 2015, METHODS, V74, P47, DOI 10.1016/j.ymeth.2014.10.026
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Przybyla P, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw145
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Schuler-Faccini L, 2018, MOL NEUROBIOL, V55, P1551, DOI 10.1007/s12035-017-0429-2
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Yun SI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080422
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 38
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD FEB
PY 2020
VL 26
IS 1
BP 77
EP 83
DI 10.1007/s13365-019-00799-y
PG 7
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA KU0BZ
UT WOS:000519378600010
PM 31512145
DA 2020-07-08
ER

PT J
AU Bergren, NA
   Haller, S
   Rossi, SL
   Seymour, RL
   Huang, J
   Miller, AL
   Bowen, RA
   Hartman, DA
   Brault, AC
   Weaver, SC
AF Bergren, Nicholas A.
   Haller, Sherry
   Rossi, Shannan L.
   Seymour, Robert L.
   Huang, Jing
   Miller, Aaron L.
   Bowen, Richard A.
   Hartman, Daniel A.
   Brault, Aaron C.
   Weaver, Scott C.
TI "Submergence" of Western equine encephalitis virus: Evidence of positive
   selection argues against genetic drift and fitness reductions
SO PLOS PATHOGENS
LA English
DT Article
ID AMINO-ACID CHANGE; ENCEPHALOMYELITIS VIRUS; EXPERIMENTAL-INFECTION;
   PURIFYING SELECTION; RELATIVE FITNESS; SINDBIS VIRUS; HOST; ARBOVIRUS;
   POPULATIONS; CHIKUNGUNYA
AB Understanding the circumstances under which arboviruses emerge is critical for the development of targeted control and prevention strategies. This is highlighted by the emergence of chikungunya and Zika viruses in the New World. However, to comprehensively understand the ways in which viruses emerge and persist, factors influencing reductions in virus activity must also be understood. Western equine encephalitis virus (WEEV), which declined during the late 20(th) century in apparent enzootic circulation as well as equine and human disease incidence, provides a unique case study on how reductions in virus activity can be understood by studying evolutionary trends and mechanisms. Previously, we showed using phylogenetics that during this period of decline, six amino acid residues appeared to be positively selected. To assess more directly the effect of these mutations, we utilized reverse genetics and competition fitness assays in the enzootic host and vector (house sparrows and Culex tarsalis mosquitoes). We observed that the mutations contemporary with reductions in WEEV circulation and disease that were non-conserved with respect to amino acid properties had a positive effect on enzootic fitness. We also assessed the effects of these mutations on virulence in the Syrian-Golden hamster model in relation to a general trend of increased virulence in older isolates. However, no change effect on virulence was observed based on these mutations. Thus, while WEEV apparently underwent positive selection for infection of enzootic hosts, residues associated with mammalian virulence were likely eliminated from the population by genetic drift or negative selection. These findings suggest that ecologic factors rather than fitness for natural transmission likely caused decreased levels of enzootic WEEV circulation during the late 20(th) century.
   Author summary
   Equally important to understanding how arboviruses emerge is understanding the conditions in which they experience reductions in activity. Western equine encephalitis virus (WEEV) provides a unique case study due to its reduction in equine and human incidence and wildlife transmission activity during the second half of the twentieth century. Despite those reductions, we identified six amino acid substitutions that appeared to increase fitness in avian hosts and/or mosquito vectors. We also found no effect of these mutations on mammalian virulence. Our results suggest that ecological factors likely explain the reduction in WEEV activity, even in the face of adaptive evolution.
C1 [Bergren, Nicholas A.; Haller, Sherry; Rossi, Shannan L.; Seymour, Robert L.; Huang, Jing; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Bergren, Nicholas A.; Seymour, Robert L.; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Haller, Sherry; Rossi, Shannan L.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Miller, Aaron L.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.
   [Bowen, Richard A.; Hartman, Daniel A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.
   [Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
RP Bergren, NA (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Bergren, NA (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM Nicholas.Bergren@colostate.edu
OI Hartman, Daniel/0000-0001-9733-8355; Bergren,
   Nicholas/0000-0003-4496-447X
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [5T32AI060549-12, R24AI120942]
FX The research reported herein was supported by the National Institute of
   Allergy and Infectious Diseases of the National Institutes of Health
   (https://www.niaid.nih.gov/) under award numbers 5T32AI060549-12 and
   R24AI120942. NAB received the T32 award and SCW received the R24 award.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103
   [Anonymous], 1987, IEJ, V37, P18
   AVILES G, 1992, J MED ENTOMOL, V29, P850, DOI 10.1093/jmedent/29.5.850
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Beaty BJ, 1989, ARBOVIRUSES, P797
   BELLAMY R. E., 1958, MOSQUITO NEWS, V18, P132
   Bergren NA, 2014, J VIROL, V88, P9260, DOI 10.1128/JVI.01463-14
   Bowers JH, 1966, J MED ENTOMOLOGY, V6
   Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101
   BYRNE RJ, 1964, AM J VET RES, V25, P24
   CALISHER CH, 1985, AM J TROP MED HYG, V34, P956, DOI 10.4269/ajtmh.1985.34.956
   CDC, 2010, W EQ ENC VIR NEUR DI, P1964
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Disease Maps, 2016, DIS MAPS
   Dropulic LK, 1997, J VIROL, V71, P6100, DOI 10.1128/JVI.71.8.6100-6105.1997
   DUARTE E, 1992, P NATL ACAD SCI USA, V89, P6015, DOI 10.1073/pnas.89.13.6015
   Forrester NL, 2008, VIROLOGY, V380, P170, DOI 10.1016/j.virol.2008.08.012
   Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321
   Giltner LT, 1936, J AM VET MED ASSOC, V88, P363
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   HARDY JL, 1977, J WILDLIFE DIS, V13, P383, DOI 10.7589/0090-3558-13.4.383
   HARDY JL, 1974, INFECT IMMUN, V10, P553, DOI 10.1128/IAI.10.3.553-564.1974
   HARDY JL, 1976, AM J EPIDEMIOL, V103, P498, DOI 10.1093/oxfordjournals.aje.a112251
   Heise MT, 2000, J VIROL, V74, P4207, DOI 10.1128/JVI.74.9.4207-4213.2000
   HOLLAND JJ, 1991, J VIROL, V65, P2960, DOI 10.1128/JVI.65.6.2960-2967.1991
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   Kilby ER, 2007, STATE ANIMALS 4 2007
   Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998
   Lenth R., 2019, EMMEANS ESTIMATED MA
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lidbury BA, 2011, J VIROL, V85, P5651, DOI 10.1128/JVI.01189-10
   Logue CH, 2009, J GEN VIROL, V90, P1848, DOI 10.1099/vir.0.008656-0
   Losos J. B., 2013, PRINCETON GUIDE EVOL
   MARTINEZ MA, 1991, J VIROL, V65, P3954
   Medovy H, 1943, J PEDIATR-US, V22, P308, DOI 10.1016/S0022-3476(43)80169-4
   Meyer KF, 1931, SCIENCE, V74, P227, DOI 10.1126/science.74.1913.227
   Minke JM, 2004, VET RES, V35, P425, DOI 10.1051/vetres:2004019
   Mossel EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060427
   Neufeld J. L., 1982, Western equine encephalitis in Manitoba, P62
   Plante KS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004007
   Powers A, 2012, VIRUS TAXONOMY, P1103
   Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000
   Reisen WK, 2008, AM J TROP MED HYG, V78, P681, DOI 10.4269/ajtmh.2008.78.681
   Reisen WK, 2016, VECTOR-BORNE ZOONOT, V16, P264, DOI 10.1089/vbz.2015.1888
   Reisen WK, 1988, ARBOVIRUSES EPIDEMIO, P89
   Robb LL, 2018, CONTINUED EVIDENCE D
   Sekla L., 1991, Proceedings of the Entomological Society of Manitoba, V47, P30
   Snyder JE, 2013, J VIROL, V87, P8511, DOI 10.1128/JVI.00449-13
   SPONSELLER ML, 1966, AM J VET RES, V27, P1591
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999
   Weaver SC, 1997, J VIROL, V71, P613, DOI 10.1128/JVI.71.1.613-623.1997
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006
NR 60
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2020
VL 16
IS 2
AR e1008102
DI 10.1371/journal.ppat.1008102
PG 20
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA KS9NY
UT WOS:000518637800014
PM 32027727
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ramirez-Sanchez, LF
   Camargo, C
   Avila, FW
AF Felipe Ramirez-Sanchez, Luis
   Camargo, Carolina
   Avila, Frank W.
TI Male sexual history influences female fertility and re-mating incidence
   in the mosquito vector Aedes aegypti (Diptera: Culicidae)
SO JOURNAL OF INSECT PHYSIOLOGY
LA English
DT Article
DE Fertility; Fecundity; Re-mating; Reproduction; Seminal fluid proteins
ID SEMINAL FLUID PROTEINS; BODY-SIZE; FECUNDITY; OVIPOSITION; EXPRESSION;
   POLYANDRY; CAPACITY; BEHAVIOR
AB Aedes aegypti is the primary vector of several arboviruses that impact human health including the dengue, Zika, and yellow fever viruses. The potential of Ae. aegypti females to transmit viruses is enhanced by mating-induced behavioral and physiological changes that increase female host-seeking behaviors, blood-feeding frequency and longevity. The mating-induced changes are due to female receipt of male seminal fluid proteins (SFPs) during copulation. SFPs also inhibit female re-mating-re-mating incidence is significantly reduced in the initial hours after mating and nearly absent after 24 h. Males, however, are not limited in the number of females they can inseminate and are able to mate with multiple females in succession. As successive mating depletes SFPs, we examined parameters of fertility and re-mating incidence in females after mating with recently mated males. Males of two Ae. aegypti strains (Colombian and Thai) were mated five consecutive times and fecundity, resulting larvae and hatch percentage in each female of the mating sequence was assessed. In both strains, we found that males can mate three times in succession without impacting fertility in their mates. However, significant declines in fecundity, resulting larvae, and hatch percentage were observed after a third mating. Male size influenced female fecundity and fertility as mates of small males showed further reductions compared to mates of big males after mating consecutively. Seven days after the consecutive mating assays, the re-mating rate of females mated fifth in succession was significantly increased (Colombian strain: 33%; Thai strain: 48%) compared to females mated first (0% in both strains). Re-mating incidence was further increased in small, Thai strain males where 82% of fifth mated females re-mated compared to 0% of first mated females. Finally, we show that regardless of male size, mates of experimental males were similarly fertile to mates of control males when mated for a sixth time 48 h after the consecutive mating assays, showing that males recover fertility after 2 d. Our results show that male sexual history influences fertility and re-mating incidence of Ae. aegypti females.
C1 [Felipe Ramirez-Sanchez, Luis; Camargo, Carolina; Avila, Frank W.] Univ Antioquia, Max Planck Tandem Grp Mosquito Reprod Biol, Medellin 050010, Antioquia, Colombia.
RP Avila, FW (corresponding author), Complejo RutaN,Calle 67 52-20,Lab 4-166, Medellin 050010, Antioquia, Colombia.
EM grupotandem.mosquito@udea.edu.co
FU COLCIENCIASDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias; Universidad de Antioquia; Max Planck SocietyMax
   Planck SocietyFoundation CELLEX [566-1]
FX This work was supported by the COLCIENCIAS, Universidad de Antioquia and
   Max Planck Society cooperation grant 566-1 (2014) to FWA.
CR Alfonso-Parra C, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020049
   Alfonso-Parra C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004451
   Alfonso-Parra C, 2014, J INSECT PHYSIOL, V70, P117, DOI 10.1016/j.jinsphys.2014.07.004
   Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Carvalho DO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193164
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chippaux JP, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-018-0162-y
   CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499
   De Jesus CE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1734-8
   Degner EC, 2019, MOL CELL PROTEOMICS, V18, pS6, DOI 10.1074/mcp.RA118.001067
   Degner EC, 2016, AM J TROP MED HYG, V94, P780, DOI 10.4269/ajtmh.15-0893
   Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657
   Gligorov D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003395
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hardling R, 2008, AM NAT, V172, P259, DOI 10.1086/589452
   Hatala AJ, 2018, J MED ENTOMOL, V55, P1051, DOI 10.1093/jme/tjy040
   Helinski MEH, 2012, J INSECT PHYSIOL, V58, P1307, DOI 10.1016/j.jinsphys.2012.07.003
   Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225
   Helinski MEH, 2011, J MED ENTOMOL, V48, P202, DOI 10.1603/ME10071
   HISS EA, 1972, J INSECT PHYSIOL, V18, P2217, DOI 10.1016/0022-1910(72)90250-8
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   JONES JC, 1973, J INSECT PHYSIOL, V19, P435, DOI 10.1016/0022-1910(73)90118-2
   JUDSON CL, 1967, BIOL BULL, V133, P369, DOI 10.2307/1539832
   Kamal M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210122
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   LEAHY M. G., 1965, MOSQUITO NEWS, V25, P448
   Lee JJ, 1999, J AM MOSQUITO CONTR, V15, P4
   Liu-Helmersson J, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00148
   Mains JW, 2019, J MED ENTOMOL, V56, P1296, DOI 10.1093/jme/tjz051
   Meuti ME, 2019, INSECTS, V10, DOI 10.3390/insects10030074
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2
   Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395
   R Core Team, 2017, R LANG ENV STAT COMP
   RStudio Team, 2015, RSTUDIO INT DEV R
   Sirot LK, 2009, BEHAV ECOL SOCIOBIOL, V63, P1505, DOI 10.1007/s00265-009-0806-6
   Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x
   Turley A.P., 2017, PLOS BIOL, V15
   van den Heuvel M., 1963, T R ENT SOC LOND, V115, P197
   Villarreal SM, 2018, J INSECT PHYSIOL, V108, P1, DOI 10.1016/j.jinsphys.2018.05.001
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156
   Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897
NR 47
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-1910
EI 1879-1611
J9 J INSECT PHYSIOL
JI J. Insect Physiol.
PD FEB-MAR
PY 2020
VL 121
AR 104019
DI 10.1016/j.jinsphys.2020.104019
PG 8
WC Entomology; Physiology; Zoology
SC Entomology; Physiology; Zoology
GA KS7NR
UT WOS:000518493900017
PM 32032591
DA 2020-07-08
ER

PT J
AU Soh, JH
   Chan, HM
   Ying, JY
AF Soh, Jun Hui
   Chan, Hsi-Min
   Ying, Jackie Y.
TI Strategies for developing sensitive and specific nanoparticle-based
   lateral flow assays as point-of-care diagnostic device
SO NANO TODAY
LA English
DT Review
DE Lateral flow assays; Point-of-care diagnostic; Signal amplification;
   Rapid test
ID SINGLE-DOMAIN ANTIBODIES; ULTRASENSITIVE MULTIPLEXED DETECTION; ON-SITE
   DETECTION; ZIKA-VIRUS; RAPID DETECTION; IMMUNOCHROMATOGRAPHIC ASSAY;
   QUANTITATIVE DETECTION; COLORIMETRIC DETECTION; SILVER NANOPARTICLES;
   CERIA NANOPARTICLES
AB From a home-based pregnancy self-testing kit, lateral flow assays (LFAs) have proliferated and gained widespread utilization as point-of-care (POC) test kits. Their prevalence is due to their portability, rapid time-to-result, simplicity, stability, and cost-effectiveness. LFAs are well-suited for early detection of infectious diseases, which threatens public health and the economy, enabling timely medical intervention, and management of disease and treatment. This is vital for rural and resource-limited settings where well-equipped laboratories with well-trained personnel are scarce. Nevertheless, LFAs have certain limitations, such as moderate sensitivity and target throughput, as compared to lab-based technologies. Also, the development of LFA, although well-defined, is not straightforward. In this review article, we will elucidate the iterative process of LFA development, and discuss strategies for generating sensitive and specific capture/detector agents, multiplexed detection and signal amplification.
   An important starting point in LFA development is the clear definition/identification of design inputs and predicate. Newly engineered capture/detector agents, such as nanobodies and aptamers, should possess high binding affinity and functionality in body fluid samples for practical field application. Also, chemical methods, combined with engineering, have enabled multiplexing and signal amplification capabilities for higher target throughput and detection sensitivity. Furthermore, LFAs can be augmented or adapted to other platforms, such as smartphone, spectroscopy and electrochemistry, for quantitative measurements that can engender wider applications and adoption. Through these advances, LFA will transform into a genuinely versatile platform, capable of delivering accurate results that are similar to lab-based technologies, while retaining its advantage as a simple, portable, inexpensive and rapid test. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Soh, Jun Hui; Chan, Hsi-Min; Ying, Jackie Y.] Agcy Sci Technol & Res, Nanos, NanoBio Lab, 31 Biopolis Way, Singapore 138669, Singapore.
RP Ying, JY (corresponding author), Agcy Sci Technol & Res, Nanos, NanoBio Lab, 31 Biopolis Way, Singapore 138669, Singapore.
EM jyying@nbl.a-star.edu.sg
OI Chan, Hsi-Min/0000-0003-3880-0823
FU NanoBio Lab (Biomedical Research Council, Agency for Science, Technology
   and Research, Singapore)Agency for Science Technology & Research (ASTAR)
FX This work was supported by the NanoBio Lab (Biomedical Research Council,
   Agency for Science, Technology and Research, Singapore). The authors
   thank Dr. William Sun and team for providing ZIKV NS1 antibodies and
   full-length NS1 antigen.
CR Alvarez-Rueda N, 2007, MOL IMMUNOL, V44, P1680, DOI 10.1016/j.molimm.2006.08.007
   Anderson CE, 2019, LAB CHIP, V19, P885, DOI 10.1039/c8lc00691a
   Anfossi L, 2019, ANAL BIOANAL CHEM, V411, P1905, DOI 10.1007/s00216-018-1451-6
   Apple FS, 2009, CLIN CHEM, V55, P930, DOI 10.1373/clinchem.2008.114728
   Arbabi-Ghahroudi M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01589
   Bai LJ, 2017, BIOMATERIALS, V133, P11, DOI 10.1016/j.biomaterials.2017.04.010
   Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bertsch T, 2010, CLIN LAB, V56, P37
   Blanco-Covian L, 2017, NANOSCALE, V9, P2051, DOI 10.1039/c6nr08432j
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Boutal H, 2018, J ANTIMICROB CHEMOTH, V73, P909, DOI 10.1093/jac/dkx521
   Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a
   Bruno John G, 2012, BMC Res Notes, V5, P633, DOI 10.1186/1756-0500-5-633
   Carmona SJ, 2015, MOL CELL PROTEOMICS, V14, P1871, DOI 10.1074/mcp.M114.045906
   Carrio A, 2015, SENSORS-BASEL, V15, P29569, DOI 10.3390/s151129569
   Cazacu AC, 2004, J CLIN MICROBIOL, V42, P3661, DOI 10.1128/jcm.42.8.3661-3664.2004
   Chandra K, 2016, CHEM MATER, V28, P6763, DOI 10.1021/acs.chemmater.6b03242
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Chen AL, 2015, BIOSENS BIOELECTRON, V71, P230, DOI 10.1016/j.bios.2015.04.041
   Chen CX, 2012, SENSORS-BASEL, V12, P11684, DOI 10.3390/s120911684
   Chen WH, 2019, 2019 INTERNATIONAL CONFERENCE ON ARTS, MANAGEMENT, EDUCATION AND INNOVATION (ICAMEI 2019), P212, DOI 10.23977/icamei.2019.039
   Chinnasamy T, 2014, CLIN CHEM, V60, P1209, DOI 10.1373/clinchem.2014.223230
   Chiu RYT, 2014, LAB CHIP, V14, P3021, DOI 10.1039/c4lc00532e
   Choi DH, 2010, BIOSENS BIOELECTRON, V25, P1999, DOI 10.1016/j.bios.2010.01.019
   Chowdhury R, 2017, NANOSCALE, V9, P14074, DOI 10.1039/c7nr04062h
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Corstjens P, 2001, CLIN CHEM, V47, P1885
   Corstjens PLAM, 2007, ANN NY ACAD SCI, V1098, P437, DOI 10.1196/annals.1384.016
   Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847
   DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405
   Dalirirad S, 2019, SENSOR ACTUAT B-CHEM, V283, P79, DOI 10.1016/j.snb.2018.11.161
   De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103
   Kim DTH, 2018, THERANOSTICS, V8, P3629, DOI 10.7150/thno.25955
   Doerflinger SY, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00219-16
   Duan DM, 2015, BIOSENS BIOELECTRON, V74, P134, DOI 10.1016/j.bios.2015.05.025
   Duan H, 2017, ANAL CHEM, V89, P7062, DOI 10.1021/acs.analchem.7b00869
   Bao DT, 2017, THERANOSTICS, V7, P1835, DOI 10.7150/thno.18857
   Editoral, 2019, NAT MICROBIOL, V4, P1
   Fang CC, 2018, ANAL CHEM, V90, P2134, DOI 10.1021/acs.analchem.7b04411
   Fenton EM, 2009, ACS APPL MATER INTER, V1, P124, DOI 10.1021/am800043z
   Feraudet-Tarisse C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181013
   Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/nmeth.3170, 10.1038/NMETH.3170]
   Frohnmeyer E, 2019, ANALYST, V144, P1840, DOI [10.1039/C8AN01616J, 10.1039/c8an01616j]
   Fu E, 2011, ANAL CHEM, V83, P7941, DOI 10.1021/ac201950g
   Gandhi S, 2018, RSC ADV, V8, P1511, DOI 10.1039/c7ra12810j
   Gao XF, 2017, ANAL CHEM, V89, P10104, DOI 10.1021/acs.analchem.7b03015
   Gao ZQ, 2017, NANO LETT, V17, P5572, DOI 10.1021/acs.nanolett.7b02385
   Garner AL, 2013, J AM CHEM SOC, V135, P10014, DOI 10.1021/ja404180x
   Gasperino D, 2018, ANNU REV ANAL CHEM, V11, P219, DOI 10.1146/annurev-anchem-061417-125737
   Gole A, 2004, CHEM MATER, V16, P3633, DOI 10.1021/cm0492336
   Gomez-Martinez J, 2018, ANAL CHEM, V90, P7502, DOI 10.1021/acs.analchem.8b01078
   Gonzalez-Moa MJ, 2018, ACS INFECT DIS, V4, P912, DOI 10.1021/acsinfecdis.8b00031
   Graef RR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-86
   Granade TC, 2010, CLIN VACCINE IMMUNOL, V17, P1034, DOI 10.1128/CVI.00029-10
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Gray ER, 2017, ACS INFECT DIS, V3, P479, DOI 10.1021/acsinfecdis.6b00189
   Groff K, 2015, BIOTECHNOL ADV, V33, P1787, DOI 10.1016/j.biotechadv.2015.10.004
   Haushalter KJ, 2016, ACS OMEGA, V1, P586, DOI 10.1021/acsomega.6b00188
   Hou YF, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-2078-9
   Hsieh HV, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7020029
   Hu J, 2017, ANAL CHEM, V89, P13105, DOI 10.1021/acs.analchem.7b02222
   Hu QS, 2018, ANALYST, V143, P4646, DOI 10.1039/c8an00651b
   Hua F, 2015, SCI REP-UK, V5, DOI 10.1038/srep17178
   Hwang J, 2016, NANOSCALE, V8, P11418, DOI 10.1039/c5nr07243c
   JausetRubio M., 2017, TRENDS ANAL CHEM, P385
   JausetRubio M., 2018, DEV APTAMER BASED LA
   Jiao X, 2012, ANAL METHODS-UK, V4, P3261, DOI 10.1039/c2ay25511a
   Kaiser L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23963-6
   Kaur H, 2018, THERANOSTICS, V8, P4016, DOI 10.7150/thno.25958
   Kaur J, 2007, ENVIRON SCI TECHNOL, V41, P5028, DOI 10.1021/es070194j
   Khlebtsov BN, 2019, NANO RES, V12, P413, DOI 10.1007/s12274-018-2232-4
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Kogot JM, 2012, BIOTECHNIQUES, V52, P95, DOI 10.2144/000113810
   Kong XT, 2017, ADV OPT MATER, V5, DOI 10.1002/adom.201600594
   Kouzmitcheva GA, 2001, CLIN DIAGN LAB IMMUN, V8, P150, DOI 10.1128/CDLI.8.1.150-160.2001
   Kuttner C, 2018, ACS APPL MATER INTER, V10, P11152, DOI 10.1021/acsami.7b19081
   Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512
   Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18077
   Lee JH, 2015, BIOSENS BIOELECTRON, V69, P213, DOI 10.1016/j.bios.2015.02.033
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Lee S, 2016, ANAL CHEM, V88, P8359, DOI 10.1021/acs.analchem.6b01828
   Li CZ, 2011, BIOSENS BIOELECTRON, V26, P4342, DOI 10.1016/j.bios.2011.04.035
   Li J, 2016, LAB CHIP, V16, P242, DOI 10.1039/c5lc01323b
   Li TF, 2016, J CONTROL RELEASE, V243, P1, DOI 10.1016/j.jconrel.2016.09.019
   Liang JJ, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/49/495501
   Liu B, 2005, J PHYS CHEM B, V109, P15256, DOI 10.1021/jp051449n
   Liu DB, 2013, ANGEW CHEM INT EDIT, V52, P14065, DOI 10.1002/anie.201307952
   Liu FM, 2016, TALANTA, V161, P205, DOI 10.1016/j.talanta.2016.08.048
   Liu J, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-1944-9
   Lopez-Soriano P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176201
   Loynachan CN, 2018, ACS NANO, V12, P279, DOI 10.1021/acsnano.7b06229
   Lu WT, 2017, SCI REP-UK, V7, DOI 10.1038/srep42414
   Lu YD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13364
   Mak WC, 2016, TRAC-TREND ANAL CHEM, V79, P297, DOI 10.1016/j.trac.2015.10.017
   Makvandi-Nejad S, 2011, J IMMUNOL METHODS, V373, P8, DOI 10.1016/j.jim.2011.07.006
   Maneeprakorn W, 2016, RSC ADV, V6, P112079, DOI 10.1039/c6ra24418a
   McCoy LE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004552
   Mei ZL, 2013, BIOSENS BIOELECTRON, V49, P457, DOI 10.1016/j.bios.2013.06.006
   Melnik S, 2018, PLANT BIOTECHNOL J, V16, P27, DOI 10.1111/pbi.12746
   Mens PF, 2008, DIAGN MICR INFEC DIS, V61, P421, DOI 10.1016/j.diagmicrobio.2008.03.009
   Miedouge M, 2011, J CLIN VIROL, V50, P57, DOI 10.1016/j.jcv.2010.09.003
   Morales-Narvaez E, 2015, ACS NANO, V9, P7296, DOI 10.1021/acsnano.5b03097
   Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449
   Noguera P, 2011, ANAL BIOANAL CHEM, V399, P831, DOI 10.1007/s00216-010-4334-z
   Obishakin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115893
   Ozalp VC, 2016, ANALYST, V141, P2595, DOI 10.1039/c6an00273k
   Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036
   Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003
   Pan D, 2018, CHEM-EUR J, V24, P9869, DOI 10.1002/chem.201801202
   Panferov VG, 2018, FOOD AGR IMMUNOL, V29, P445, DOI 10.1080/09540105.2017.1401044
   Park JM, 2015, ANAL CHIM ACTA, V853, P360, DOI 10.1016/j.aca.2014.10.011
   Patris S, 2014, TALANTA, V130, P164, DOI 10.1016/j.talanta.2014.06.069
   Peng XY, 2018, FOOD AGR IMMUNOL, V29, P216, DOI 10.1080/09540105.2017.1365822
   Pereira SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108067
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pourreza N, 2015, BIOSENS BIOELECTRON, V74, P353, DOI 10.1016/j.bios.2015.06.041
   Raston NHA, 2017, BIOSENS BIOELECTRON, V93, P21, DOI 10.1016/j.bios.2016.11.061
   Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4
   Ren ML, 2014, ACS APPL MATER INTER, V6, P14215, DOI 10.1021/am503517s
   Renault C, 2014, LANGMUIR, V30, P7030, DOI 10.1021/la501212b
   Renault C, 2013, ANAL CHEM, V85, P7976, DOI 10.1021/ac401786h
   Richards DA, 2017, CHEM SCI, V8, P63, DOI 10.1039/c6sc02403c
   Rivas L, 2014, LAB CHIP, V14, P4406, DOI 10.1039/c4lc00972j
   Rong Z, 2019, ANAL CHIM ACTA, V1055, P140, DOI 10.1016/j.aca.2018.12.043
   Ruppert C, 2019, MICROCHIM ACTA, V186, DOI 10.1007/s00604-018-3195-6
   Russell TM, 2017, J CLIN MICROBIOL, V55, P3072, DOI [10.1128/JCM.00469-17, 10.1128/jcm.00469-17]
   Sanchez-Purra M, 2017, MOL SYST DES ENG, V2, P401, DOI [10.1039/C7ME00052A, 10.1039/c7me00052a]
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Sattlecker M, 2014, ALZHEIMERS DEMENT, V10, P724, DOI 10.1016/j.jalz.2013.09.016
   Sau TK, 2004, J AM CHEM SOC, V126, P8648, DOI 10.1021/ja047846d
   Savin M, 2018, TALANTA, V178, P910, DOI 10.1016/j.talanta.2017.10.045
   Scida K, 2014, ANAL CHEM, V86, P6501, DOI 10.1021/ac501004a
   Sharifzadeh Z, 2013, MOL BIOTECHNOL, V54, P590, DOI 10.1007/s12033-012-9601-0
   Shen GY, 2013, CLIN BIOCHEM, V46, P1734, DOI 10.1016/j.clinbiochem.2013.08.010
   Shirshahi V, 2019, J PHARMACEUT BIOMED, V164, P104, DOI 10.1016/j.jpba.2018.09.048
   Singh S, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4966535
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soh J.H., COLLABORATION W
   Soh J.H., 2012, COMPLEX SHAPED METAL, P477, DOI DOI 10.1002/9783527652570.CH15
   Soh JH, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201700523
   Soh JH, 2015, ANAL CHEM, V87, P7644, DOI 10.1021/acs.analchem.5b00875
   Sola L, 2018, ACS INFECT DIS, V4, P998, DOI 10.1021/acsinfecdis.8b00014
   Song LW, 2015, ANAL CHEM, V87, P5173, DOI 10.1021/ac504832c
   Stengaard C, 2013, AM J CARDIOL, V112, P1361, DOI 10.1016/j.amjcard.2013.06.026
   Takalkar S, 2017, BIOSENS BIOELECTRON, V98, P147, DOI 10.1016/j.bios.2017.06.045
   Tang RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01558-x
   Tang RH, 2016, TALANTA, V152, P269, DOI 10.1016/j.talanta.2016.02.017
   Tang XQ, 2017, ANAL CHEM, V89, P11520, DOI 10.1021/acs.analchem.7b02794
   Taranova NA, 2015, BIOSENS BIOELECTRON, V63, P255, DOI 10.1016/j.bios.2014.07.049
   Torres JEP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26732-7
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Valentini P, 2013, ACS NANO, V7, P5530, DOI 10.1021/nn401757w
   van Tienen C, 2018, SEX TRANSM INFECT, V94, P331, DOI 10.1136/sextrans-2016-052818
   Vanrell L, 2013, ANAL CHEM, V85, P1177, DOI 10.1021/ac3031114
   Tran V, 2019, ANGEW CHEM INT EDIT, V58, P442, DOI 10.1002/anie.201810917
   Wang GH, 2017, CHINESE J CHEM, V35, P791, DOI 10.1002/cjoc.201600845
   Wang J, 2014, ANAL CHEM, V86, P8296, DOI 10.1021/ac5017437
   Wang JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41419
   Wang JY, 2019, ACS OMEGA, V4, P6789, DOI 10.1021/acsomega.9b00657
   Wang SJ, 2017, J AGR FOOD CHEM, V65, P10107, DOI 10.1021/acs.jafc.7b03981
   Wang Y, 2018, BIOSENS BIOELECTRON, V107, P47, DOI 10.1016/j.bios.2018.02.012
   Wang YR, 2013, ANAL CHEM, V85, P8298, DOI 10.1021/ac4015885
   Wang ZZ, 2014, INT J NANOMED, V9, P1699, DOI 10.2147/IJN.S58942
   Wu SJ, 2018, J AGR FOOD CHEM, V66, P1949, DOI 10.1021/acs.jafc.7b05326
   Wu YF, 2014, BIOSENS BIOELECTRON, V52, P180, DOI 10.1016/j.bios.2013.08.039
   Wu YF, 2013, ANAL CHEM, V85, P8661, DOI 10.1021/ac401445a
   Xiao W, 2018, SENSOR ACTUAT B-CHEM, V266, P63, DOI 10.1016/j.snb.2018.03.110
   Xu Y, 2014, ANAL CHEM, V86, P5611, DOI 10.1021/ac5010458
   Yang M, 2015, J VIROL METHODS, V221, P119, DOI 10.1016/j.jviromet.2015.05.001
   Yang XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171376
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Yeo SJ, 2018, THERANOSTICS, V8, P6132, DOI 10.7150/thno.28027
   Yu L, 2017, TALANTA, V165, P167, DOI 10.1016/j.talanta.2016.12.042
   Yuan HK, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/7/075102
   Zare H, 2014, INT J BIOL MARKER, V29, pE169, DOI 10.5301/jbm.5000063
   Zhang J, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-2905-4
   Zhang XY, 2017, J AGR FOOD CHEM, V65, P8063, DOI 10.1021/acs.jafc.7b02827
   Zhang Y, 2015, LAB CHIP, V15, P1465, DOI 10.1039/c4lc01127a
   Zhu M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0352-5
   Zhu WJ, 2014, SENSOR ACTUAT B-CHEM, V190, P414, DOI 10.1016/j.snb.2013.09.007
NR 181
TC 0
Z9 0
U1 20
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-0132
EI 1878-044X
J9 NANO TODAY
JI Nano Today
PD FEB
PY 2020
VL 30
AR UNSP 100831
DI 10.1016/j.nantod.2019.100831
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA KS7NU
UT WOS:000518494200016
OA Bronze
DA 2020-07-08
ER

PT J
AU Beau, F
   Lastere, S
   Mallet, HP
   Mauguin, S
   Broult, J
   Laperche, S
AF Beau, F.
   Lastere, S.
   Mallet, H. -P.
   Mauguin, S.
   Broult, J.
   Laperche, S.
TI Impact on blood safety of the last arboviruses outbreaks in French
   Polynesia (2012-2018)
SO TRANSFUSION CLINIQUE ET BIOLOGIQUE
LA English
DT Article
DE Arboviruses; French Polynesia; Blood donors; Nucleic acid testing;
   Pathogen reduction
ID ZIKA VIRUS; TRANSFUSION; DENGUE; SEROPREVALENCE; TRANSMISSION; DONORS
AB Background. - Several successive arbovirus outbreaks have affected French Polynesia (FP) in the recent past years due to different dengue serotypes (DENV) present for several decades, Zika (ZIKV) (2013-2014) and chikungunya (CHIKV) (2014-2015) viruses with a potential impact on blood safety and blood supply due to the geographical isolation of these islands. This study reports an assessment of the impact of these outbreaks on blood products supply and infectious safety in FP and discuss the effectiveness of implemented preventive measures.
   Methods. - To ensure the infectious safety of blood products during outbreaks, several measures have successively been introduced as the selection of donors suspected of infection, the nucleic acid testing (NAT) and the pathogen reduction of platelets and plasmas.
   Results. - The donor deferral rate increased by 6% between 2012 and 2014 without changes in the number of collected donations. NAT excluded five blood donations reactive for DENV RNA, 42 for ZIKV and 34 for CHIKV. As Zika screening could not been implemented before the third month of the outbreak, 36 blood products from ZIKV-infected donors were transfused to 26 recipients. However, no transfusion-transmitted arbovirus has been reported.
   Conclusion. - The last past arboviruses outbreaks did not have a significant impact on blood supply in FP. The measures introduced to prevent arbovirus transmission by transfusion were able to maintain infectious safety for all blood products without impairing self-sufficiency. (C) 2019 Societe francaise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.
C1 [Beau, F.; Mallet, H. -P.; Broult, J.] Hop Taaone, Ctr Hosp Polynesie Francaise, Ctr Transfus Sanguine Polynesie Francaise, BP 4530, F-98713 Tahiti, French Polynesi, France.
   [Lastere, S.] Hop Taaone, Ctr Hosp Polynesie Francaise, Lab Biol, Tahiti, French Polynesi, France.
   [Mauguin, S.] Hop Taaone, Ctr Hosp Polynesie Francaise, Unite Hemovigilance, Tahiti, French Polynesi, France.
   [Laperche, S.] Ctr Natl Reference Risques Infectieux Transfus, Dept Agents Transmissibles Sang, Inst Natl Transfus Sanguine, Paris, France.
RP Beau, F (corresponding author), Hop Taaone, Ctr Hosp Polynesie Francaise, Ctr Transfus Sanguine Polynesie Francaise, BP 4530, F-98713 Tahiti, French Polynesi, France.
EM frederic.beau@cht.pf
CR Aubry M, 2018, EMERG INFECT DIS, V24, P558, DOI 10.3201/eid2403.171149
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Beau F, 2020, VOX SANG, V115, P124, DOI 10.1111/vox.12855
   Bierlaire D, 2014, TRANSFUS CLIN BIOL, V21, P234, DOI DOI 10.1016/J.TRACLI.2014.08.005
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Curlier E, 2017, MED MALADIES INFECT, V47, P596
   Daudens E., 2009, Bulletin Epidemiologique Hebdomadaire, P499
   Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493
   FDA, 2018, REV REC RED RISK ZIK
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Lanteri MC, 2012, TRANSFUSION, V52, P1634, DOI 10.1111/j.1537-2995.2012.03747.x
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Marks PW, 2016, J INFECT DIS, V213, P1676, DOI 10.1093/infdis/jiw089
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, TRANSFUS CLIN BIOL, V24, P301
   Musso D, 2018, LANCET INFECT DIS, V3099, P1
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
NR 31
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 1246-7820
J9 TRANSFUS CLIN BIOL
JI Transfu. Clin. Biol.
PD FEB
PY 2020
VL 27
IS 1
BP 4
EP 9
DI 10.1016/j.tracli.2019.12.001
PG 6
WC Hematology; Immunology
SC Hematology; Immunology
GA KS7QK
UT WOS:000518501000004
PM 31889619
OA Bronze
DA 2020-07-08
ER

PT J
AU Alexander, NDE
   Souza, WV
   Rodrigues, LC
   Braga, C
   Sa, A
   Bezerra, LCA
   Martelli, CMT
AF Alexander, Neal D. E.
   Souza, Wayner V.
   Rodrigues, Laura C.
   Braga, Cynthia
   Sa, Andre
   Albuquerque Bezerra, Luciana Caroline
   Turchi Martelli, Celina Maria
CA MERG
TI Spatiotemporal Analysis of the Population Risk of Congenital
   Microcephaly in Pernambuco State, Brazil
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE congenital microcephaly; Zika; Brazil; arbovirus
ID SURVEILLANCE
AB Since an outbreak in Brazil, which started in 2015, Zika has been recognized as an important cause of microcephaly. The highest burden of this outbreak was in northeast Brazil, including the state of Pernambuco. The prevalence of congenital microcephaly in Pernambuco state was estimated from the RESP (Registro de Eventos em Saude Publica) surveillance system, from August 2015 to August 2016 inclusive. The denominators were estimated at the municipality level from official demographic data. Microcephaly was defined as a neonatal head circumference below the 3rd percentile of the Intergrowth standards. Smoothed maps of the prevalence of microcephaly were obtained from a Bayesian model which was conditional autoregressive (CAR) in space, and first order autoregressive in time. A total of 742 cases were identified. Additionally, high and early occurrences were identified in the Recife Metropolitan Region, on the coast, and in a north-south band about 300 km inland. Over a substantial part of the state, the overall prevalence, aggregating over the study period, was above 0.5%. The reasons for the high occurrence in the inland area remain unclear.
C1 [Alexander, Neal D. E.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
   [Souza, Wayner V.; Braga, Cynthia; Sa, Andre; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50740465 Recife, PE, Brazil.
   [Albuquerque Bezerra, Luciana Caroline] State Hlth Dept Pernambuco, BR-50751530 Recife, PE, Brazil.
RP Alexander, NDE (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
EM neal.alexander@lshtm.ac.uk; wayner@cpqam.fiocruz.br;
   laura.rodrigues@lshtm.ac.uk; braga@cpqam.fiocruz.br;
   andre.sa@cpqam.fiocruz.br; lua_cad@yahoo.com.br; turchicm@gmail.com
OI Turchi Martelli, Celina Maria/0000-0002-2491-0688; Alexander,
   Neal/0000-0002-6707-7876
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308974/2018-2, 303661/2017-8]; ZikaPLAN [734584]; ZIKAlliance consortia
   - European Union's Horizon 2020 research and innovation programme
   [734548]; MRC UKMedical Research Council UK (MRC); DFID-MRC
   [MR/K012126/1]; UK Medical Research Council (MRC)Medical Research
   Council UK (MRC); UK Department for International Development (DFID);
   European UnionEuropean Union (EU)
FX C.M.T.M. receives CNPq scholarship #308974/2018-2. W.V.S. receives CNPq
   scholarship #303661/2017-8. This work was supported by the ZikaPLAN
   (Grant Agreement No. 734584) and ZIKAlliance (Grant Agreement No.
   734548) consortia, funded by European Union's Horizon 2020 research and
   innovation programme. N.D.E.A. receives support from the MRC UK and
   DFID-MRC Grant Reference MR/K012126/1: This award is jointly funded by
   the UK Medical Research Council (MRC) and the UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement
   and is also part of the EDCTP2 programme supported by the European
   Union.
CR Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Centers for Disease Control and Prevention, CONG ZIK SYNDR OTH B
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   deAraujo T.V.B, 2017, LANCET INFECT DIS
   DeSilva M, 2016, JAMA-J AM MED ASSOC, V316, P1823, DOI 10.1001/jama.2016.14432
   Elliott P, 1995, Stat Methods Med Res, V4, P137, DOI 10.1177/096228029500400204
   Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/s1679-49742018000200014
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Instituto de Pesquisa Economica Aplicada; Fundacao Joao Pinheiro; Programa das Nacoes Unidas para o Desenvolvimento, 2014, ATL DES HUM NAS REG
   Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#
   Lawson A.B., 2013, BAYESIAN DIS MAPPING
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, 2019, B EPIDEMIOLOGICO
   Ministerio da Saude, MIN SAUD INV AUM CAS
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Orioli IM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5018
   Paixao ES, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007721
   R Core Team, 2015, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vissoci JRN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006392
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 32
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB 1
PY 2020
VL 17
IS 3
AR 700
DI 10.3390/ijerph17030700
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KR7GF
UT WOS:000517783300025
PM 31973162
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, N
   Li, ZQ
   Fu, Y
   Cao, S
AF Li, Na
   Li, Zhiqiang
   Fu, Yan
   Cao, Sheng
TI Cryo-EM Studies of Virus-Antibody Immune Complexes
SO VIROLOGICA SINICA
LA English
DT Review
DE Cryo-electron microscopy (Cryo-EM); Icosahedral; Antigen; Virion; Immune
   complex
ID BROADLY NEUTRALIZING ANTIBODIES; DENGUE VIRUS; EBOLAVIRUS
   NEUTRALIZATION; MEDIATED NEUTRALIZATION; MONOCLONAL-ANTIBODIES;
   COXSACKIEVIRUS A6; RECEPTOR-BINDING; STRUCTURAL BASIS; INFLUENZA-VIRUS;
   ZIKA VIRUS
AB Antibodies play critical roles in neutralizing viral infections and are increasingly used as therapeutic drugs and diagnostic tools. Structural studies on virus-antibody immune complexes are important for better understanding the molecular mechanisms of antibody-mediated neutralization and also provide valuable information for structure-based vaccine design. Cryo-electron microscopy (cryo-EM) has recently matured as a powerful structural technique for studying bio-macromolecular complexes. When combined with X-ray crystallography, cryo-EM provides a routine approach for structurally characterizing the immune complexes formed between icosahedral viruses and their antibodies. In this review, recent advances in the structural understanding of virus-antibody interactions are outlined for whole virions with icosahedral T = pseudo 3 (picornaviruses) and T = 3 (flaviviruses) architectures, focusing on the dynamic nature of viral shells in different functional states. Glycoprotein complexes from pleomorphic enveloped viruses are also discussed as immune complex antigens. Improving our understanding of viral epitope structures using virus-based platforms would provide a fundamental road map for future vaccine development.
C1 [Li, Na; Li, Zhiqiang; Fu, Yan; Cao, Sheng] Wuhan Inst Virol, CAS Key Lab Special Pathogens, Biosafety, Wuhan, Peoples R China.
   [Li, Na; Li, Zhiqiang; Fu, Yan; Cao, Sheng] Chinese Acad Sciences, Ctr Biosafety Mega, Sci, Wuhan, Peoples R China.
   [Li, Na; Li, Zhiqiang] Univ Chinese Acad Sciences, Beijing, Beijing, Peoples R China.
RP Cao, S (corresponding author), Wuhan Inst Virol, CAS Key Lab Special Pathogens, Biosafety, Wuhan, Peoples R China.
EM caosheng@wh.iov.cn
CR Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Almeida J D, 1969, Adv Virus Res, V15, P307, DOI 10.1016/S0065-3527(08)60878-7
   Anasir MI, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00738
   Cao L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000229
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chuang GY, 2019, STRUCTURE, V27, P196, DOI 10.1016/j.str.2018.10.007
   Crowe JE, 2017, CELL HOST MICROBE, V22, P193, DOI 10.1016/j.chom.2017.07.013
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Danev R, 2019, TRENDS BIOCHEM SCI, V44, P837, DOI 10.1016/j.tibs.2019.04.008
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Domanska A, 2019, J VIROL, V93, DOI 10.1128/JVI.01597-18
   Dong YC, 2017, P NATL ACAD SCI USA, V114, P8017, DOI 10.1073/pnas.1707369114
   Earl LA, 2016, P NATL ACAD SCI USA, V113, P8903, DOI 10.1073/pnas.1609721113
   Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Finlay WJJ, 2017, METHODS MOL BIOL, V1485, P85, DOI 10.1007/978-1-4939-6412-3_6
   Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022
   Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Harris AK, 2013, P NATL ACAD SCI USA, V110, P4592, DOI 10.1073/pnas.1214913110
   HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126
   Hudalla GA, 2014, NAT MATER, V13, P829, DOI [10.1038/NMAT3998, 10.1038/nmat3998]
   Hume HKC, 2017, VACCINE, V35, P4480, DOI 10.1016/j.vaccine.2017.02.069
   Ilca SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9843
   Jiang W, 2017, CURR OPIN STRUC BIOL, V46, P122, DOI 10.1016/j.sbi.2017.07.002
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kimmis BD, 2018, CUTIS, V102, P353
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Lee H, 2013, J VIROL, V87, P11363, DOI 10.1128/JVI.01926-13
   Li ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07199-6
   Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159
   Liu YH, 2017, J MOL BIOL, V429, P1829, DOI 10.1016/j.jmb.2017.05.011
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Marcandalli J, 2019, CELL, V176, P1420, DOI 10.1016/j.cell.2019.01.046
   Meyerson JR, 2013, P NATL ACAD SCI USA, V110, P513, DOI 10.1073/pnas.1214810110
   Murin CD, 2018, CELL REP, V24, P2723, DOI 10.1016/j.celrep.2018.08.009
   Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010
   Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114
   Parent KN, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020067
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Plevka P, 2014, P NATL ACAD SCI USA, V111, P2134, DOI 10.1073/pnas.1320624111
   Rao GB, 2018, ACS APPL MATER INTER, V10, P25135, DOI 10.1021/acsami.8b07611
   Ren JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2889
   Rodenhuis-Zybert IA, 2011, TRENDS MICROBIOL, V19, P248, DOI 10.1016/j.tim.2011.02.002
   ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481
   Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002
   Shen PS, 2018, ANAL BIOANAL CHEM, V410, P2053, DOI 10.1007/s00216-018-0899-8
   Shingler KL, 2015, J VIROL, V89, P1900, DOI 10.1128/JVI.03098-14
   Shingler KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003240
   Snijder J, 2018, IMMUNITY, V48, P799, DOI 10.1016/j.immuni.2018.03.026
   Stephenson KE, 2016, CURR HIV-AIDS REP, V13, P31, DOI 10.1007/s11904-016-0299-7
   Stewart-Jones GBE, 2018, P NATL ACAD SCI USA, V115, P12265, DOI 10.1073/pnas.1811980115
   Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tran EEH, 2016, J VIROL, V90, P7618, DOI 10.1128/JVI.00406-16
   Tran EEH, 2016, MBIO, V7, DOI 10.1128/mBio.00257-16
   Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797
   Turner HL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000139
   Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang XX, 2017, P NATL ACAD SCI USA, V114, P770, DOI 10.1073/pnas.1616502114
   Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255
   Wang ZQ, 2013, J VIROL, V87, P8909, DOI 10.1128/JVI.00472-13
   Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507
   Wirawan M, 2019, STRUCTURE, V27, P253, DOI 10.1016/j.str.2018.10.009
   Xu LF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00477-9
   Yang CP, 2019, VIROL SIN, V34, P168, DOI 10.1007/s12250-019-00093-5
   Ye XH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005454
   Yu HJ, 2019, LANCET CHILD ADOLESC, V3, P373, DOI 10.1016/S2352-4642(19)30065-3
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041
   Zheng QB, 2019, NAT MICROBIOL, V4, P124, DOI 10.1038/s41564-018-0275-7
   Zhu DJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04051-9
   Zhu L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07531-0
   Zhu L, 2018, MBIO, V9, DOI 10.1128/mBio.01013-18
   Zhu R, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7459
NR 88
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD FEB
PY 2020
VL 35
IS 1
BP 1
EP 13
DI 10.1007/s12250-019-00190-5
PG 13
WC Virology
SC Virology
GA KO1TI
UT WOS:000515330700001
PM 31916022
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Wang, TY
   Zhan, Y
   Wu, D
   Chen, ZH
   Wu, W
   Deng, Y
   Wang, WL
   Tan, WJ
   Tang, SX
AF Wang, Tianyu
   Zhan, Ying
   Wu, De
   Chen, Zhihai
   Wu, Wei
   Deng, Yao
   Wang, Wenling
   Tan, Wenjie
   Tang, Shixing
TI Development and Evaluation of a Universal and Supersensitive NS1-Based
   Luciferase Immunosorbent Assay to Detect Zika Virus-Specific IgG
SO VIROLOGICA SINICA
LA English
DT Article
DE Zika virus (ZIKV); NS1; Luciferase immunosorbent assay; IgG; Detection
ID DENGUE VIRUS; INFECTION
AB Zika virus (ZIKV) causes rash, moderate fever, conjunctivitis, and arthralgia, and has serious connection with neurological complications; therefore, it is a major threat to public health. A rapid and supersensitive method for detecting anti-ZIKV antibodies in humans and animals is thus urgently required. Here, we report an NS1-based luciferase immunosorbent assay (LISA), developed to detect ZIKV-specific IgG. Fusion proteins including a reporter Nano-luciferase (NLuc) and various fragments of ZIKV NS1 protein were expressed in 293 T cells. LISA was performed using the above cell lysates containing the expressed fusion proteins. Sample panels of humans and animals infected with ZIKV were examined for sensitivity of LISA, relative to those of ZIKV RT-PCR, commercial NS1-based ELISA, and micro-neutralization (MN) assays. Specificity and potential cross-reactivity were also evaluated using various convalescent serum samples derived from patients infected with dengue virus (DENV), Japanese encephalitis virus (JEV), and hepatitis C virus (HCV). Results indicated the optimal antigenic domain for anti-ZIKV IgG detection was located within 172-352 amino acids (aa) of ZIKV NS1 protein. NS1-based LISA performs better than commercial ELISA in anti-ZIKV IgG detection. LISA was shown to be at least fourfold more sensitive than commercial ELISA, and could detect anti-ZIKV IgG in various animal hosts without the need of species-specific labeled antibody. This novel assay is potentially useful for the rapid and sensitive detection of anti-ZIKV IgG in human and animal samples.
C1 [Wang, Tianyu; Tang, Shixing] Southern Med Univ, Guangdong Prov Key Lab Trop Dis Res, Dept Epidemiol, Sch Publ Hlth, Guangzhou 510515, Peoples R China.
   [Wang, Tianyu; Zhan, Ying; Wu, Wei; Deng, Yao; Wang, Wenling; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 102206, Peoples R China.
   [Wu, De] Guangdong Prov Ctr Dis Control & Prevent, Key Lab Repository & Applicat Pathogen Microbiol, Res Ctr Pathogens Detect Technol Emerging Infect, Guangzhou 511430, Peoples R China.
   [Chen, Zhihai] Capital Med Univ, Beijing Ditan Hosp, Natl Clin Key Dept Infect Dis, Beijing 100015, Peoples R China.
RP Tang, SX (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Trop Dis Res, Dept Epidemiol, Sch Publ Hlth, Guangzhou 510515, Peoples R China.; Tan, WJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 102206, Peoples R China.
EM tanwj28@163.com; tamgshixing@smu.edu.cn
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Di Guardo G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00435
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gao XJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3173-y
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lee HJ, 2018, BIOCHEM BIOPH RES CO, V505, P1010, DOI 10.1016/j.bbrc.2018.10.024
   Ludolfs D, 2009, J CLIN VIROL, V45, P125, DOI 10.1016/j.jcv.2009.03.016
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Wang HY, 2019, VIRUS RES, V263, P9, DOI 10.1016/j.virusres.2018.12.017
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wiratsudakul A, 2018, PEERJ, V6, DOI 10.7717/peerj.4526
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zhong YB, 2016, CHINESE MED J-PEKING, V129, P2013, DOI 10.4103/0366-6999.187864
NR 24
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD FEB
PY 2020
VL 35
IS 1
BP 93
EP 102
DI 10.1007/s12250-019-00160-x
PG 10
WC Virology
SC Virology
GA KO1TI
UT WOS:000515330700010
PM 31552611
DA 2020-07-08
ER

PT J
AU Alaali, ZS
   Longcore, ND
   Santos, P
   Glaze, VH
   Ahmad, N
AF Alaali, Zahra S.
   Longcore, Nicole D.
   Santos, Pauline
   Glaze, Viola H.
   Ahmad, Nina
TI Methods of Tracking Newborns: New York State Zika Pregnancy and Infant
   Registry, 2015-2017
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID VIRUS-INFECTION; PUBLIC-HEALTH; SURVEILLANCE; BRAZIL
AB Objectives. To describe methods employed to track infants enrolled in the New York State Zika Pregnancy and Infant Registry (NYSZPIR) and demonstrate the benefits of population databases to improve the process.
   Methods. We used patient medical records and provider outreach, New York State Immunization Information System (NYSIIS), and New York State Early Hearing Detection and Intervention Information System (NYEHDI-IS) to gather medical information. We used descriptive statistics to summarize variables and the McNemar test to determine statistical significance (P <.05).
   Results. We identified 109 live births from NYSZPIR mothers. Provider information was documented for 106 (97.2%) infants in NYSIIS compared with 72 (66.1%) through chart review. Collected results of newborn hearing screening increased from 82 (75.2%) to 106 (97.2%) using NYEHDI-IS. The amount of data obtained was significantly higher (P <.001) when including NYSIIS and NYEHDI-IS compared with using medical records alone.
   Conclusions. Public health surveillance systems can be used to track infants using data sources such as NYSIIS and NYEHDI-IS in addition to traditional methods. Using medical records alone is inadequate for locating and tracking infants and may result in high lost to follow-up rates.
C1 [Alaali, Zahra S.; Longcore, Nicole D.; Santos, Pauline; Glaze, Viola H.; Ahmad, Nina] New York State Dept Hlth, Div Epidemiol, Zika Pregnancy & Infant Registry, Albany, NY 12237 USA.
RP Alaali, ZS (corresponding author), New York State Dept Hlth, Div Epidemiol, Corning Tower Room 584, Albany, NY 12237 USA.
EM zahra.alaali@health.ny.gov
FU Centers for Disease Control and Prevention (CDC)United States Department
   of Health & Human ServicesCenters for Disease Control & Prevention - USA
   [NU50CK000423]
FX This publication was supported with funds provided by the Centers for
   Disease Control and Prevention (CDC; cooperative agreement
   NU50CK000423).
CR Adachi K, 2018, CURR OPIN PEDIATR, V30, P105, DOI 10.1097/MOP.0000000000000582
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Bennett Trude A, 2002, Matern Child Health J, V6, P221, DOI 10.1023/A:1021153915360
   Birkhead GS, 2015, ANNU REV PUBL HEALTH, V36, P345, DOI 10.1146/annurev-publhealth-031914-122747
   Centers for Disease Control and Prevention, IMM INF SYST IIS DAS
   Centers for Disease Control and Prevention, DAT STAT ZIK PREGN
   Centers for Disease Control and Prevention, 2017, IMM INF SYST IIS
   Chandrasekaran N, 2017, CUREUS, V9, DOI 10.7759/cureus.1516
   DeSilva M, 2017, VACCINE, V35, P6472, DOI 10.1016/j.vaccine.2017.01.044
   Hall NB, 2017, MMWR-MORBID MORTAL W, V66, P835, DOI 10.15585/mmwr.mm6631a5
   Heisey-Grove D, 2015, MMWR-MORBID MORTAL W, V64, P439
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   International Fetal and Newborn Growth Consortium for the 21st Century, 2017, STAND NEWB REF VER P
   Milambo JPM, 2018, GLOB HEALTH RES POL, V3, DOI 10.1186/s41256-017-0057-4
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murthy N, 2017, MMWR-MORBID MORTAL W, V66, P1178, DOI 10.15585/mmwr.mm6643a4
   New York State, 2011, EARL HEAR DET INT PR
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Vogel J, 2014, AM J PUBLIC HEALTH, V104, P2265, DOI 10.2105/AJPH.2014.302103
   Watterberg KL, 2015, PEDIATRICS, V136, P819, DOI 10.1542/peds.2015-2651
NR 23
TC 0
Z9 0
U1 0
U2 0
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD FEB
PY 2020
VL 110
IS 2
BP 216
EP 221
DI 10.2105/AJPH.2019.305406
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KN4SV
UT WOS:000514829500030
PM 31855479
DA 2020-07-08
ER

PT J
AU Kelly, AH
   Lezaun, J
   Lowy, I
   Matta, GC
   Nogueira, CD
   Rabello, ET
AF Kelly, Ann H.
   Lezaun, Javier
   Lowy, Ilana
   Matta, Gustavo Correa
   Nogueira, Carolina de Oliveira
   Rabello, Elaine Teixeira
TI Uncertainty in times of medical emergency: Knowledge gaps and structural
   ignorance during the Brazilian Zika crisis
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Brazil; Zika; Uncertainty; Public health emergency; Emergency research
ID VIRUS OUTBREAK; CHALLENGES; CONSTRUCTION; SCIENCE
AB Uncertainty was a defining feature of the Brazilian Zika crisis of 2015-2016. The cluster of cases of neonatal microcephaly detected in the country's northeast in the second half of 2015, and the possibility that a new virus transmitted by Aedes mosquitoes was responsible for this new syndrome, created a deep sense of shock and confusion in Brazil and around the world. When in February 2016 the WHO declared a Public Health Emergency of International Concern (PHEIC), it noted that it did so on the basis of what was not known about the virus and its pathogenic potential. To better understand the role that non-knowledge played in the unfolding of the Brazilian Zika crisis we differentiate between three different kinds of uncertainty: global health uncertainty, public health uncertainty, and clinical uncertainty. While these three forms of uncertainty were difficult to disentangle in the early weeks of the crisis, very soon each one began to trace a distinct trajectory. Global health uncertainty centered on the question of the causative link between Zika virus infection and congenital malformations, and was declared resolved by the time the PHEIC was lifted in November 2016. Public health and clinical uncertainty, in contrast, persisted over a longer period of time and did, in some important ways, become entrenched. This taxonomy of uncertainties allows us to explore the systematic nonproduction of knowledge in times of medical emergency, and suggests structural limitations in the framework of "emergency research" that global health institutions have developed to deal with unexpected threats.
C1 [Kelly, Ann H.] Kings Coll London, Dept Global Hlth & Social Med, London, England.
   [Lezaun, Javier] Univ Oxford, Sch Anthropol & Museum Ethnog, Inst Sci Innovat & Soc, 64 Banbury Rd, Oxford OX2 6PN, England.
   [Lowy, Ilana] INSERM, CERMES 3, Paris, France.
   [Matta, Gustavo Correa] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Nogueira, Carolina de Oliveira] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Rabello, Elaine Teixeira] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Rabello, Elaine Teixeira] Wageningen Univ & Res, Publ Adm & Policy Grp, Wageningen, Netherlands.
RP Lezaun, J (corresponding author), Univ Oxford, Sch Anthropol & Museum Ethnog, Inst Sci Innovat & Soc, 64 Banbury Rd, Oxford OX2 6PN, England.
EM javier.lezaun@insis.ox.ac.uk
FU British Council/Newton Fund [280969145]; Wellcome TrustWellcome Trust
   [204939/Z/16/Z]; European CommissionEuropean Commission Joint Research
   Centre [734548]; European Research CouncilEuropean Research Council
   (ERC) [715450]; Oswaldo Cruz Foundation/VicePresidency of Research and
   Biological Collections
FX Our research was supported by the British Council/Newton Fund
   (Institutional Links Programme Grant Agreement no. 280969145: Acting in
   an Uncertain World), the Wellcome Trust (Ref. 204939/Z/16/Z: Zika Social
   Science Network: Sexual and Reproductive Health, Rights, and Justice).
   The European Commission's Horizon 2020 Research and Innovation Programme
   (ZIKAlliance Grant Agreement no. 734548), the European Research Council
   (Grant Agreement no. 715450: Investigating the Design and Use of
   Diagnostic Devices in Global Health, DiaDev), and the Oswaldo Cruz
   Foundation/VicePresidency of Research and Biological Collections.
CR Albuquerque MSV, 2019, HEALTH POLICY PLANN, V34, P499, DOI 10.1093/heapol/czz059
   [Anonymous], 2016, NATURE
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Borges A.L.V., 2018, PLOS ONE, V13
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C., 2017, VIRUS ZIKA BRASIL RE
   Brito C., 2016, LANCET NEUROL, V28, P679, DOI [10.1016/S1474-4422(16)00074-0, DOI 10.1016/S1474-4422(16)00074-0]
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carneiro R, 2018, INTERFACE-BOTUCATU, V22, P709, DOI 10.1590/1807-57622017.0857
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Castro MC, 2016, HEALTH SYST REFORM, V2, P119, DOI 10.1080/23288604.2016.1179085
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan M., 2017, ZIKA WE MUST BE READ
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Aradjo J.S.S., 2016, B WHO, V4
   de Figueiredo Carvalho K.K., 2019, THESIS
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECLAMC, 2015, ECLAMC FIN DOC 2015
   Faria NR, 2016, SCIENCE
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Frickel S, 2010, SCI TECHNOL HUM VAL, V35, P444, DOI 10.1177/0162243909345836
   Glopid-R, 2016, ZIK VIR ZIKV OUTBR O
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Goodridge K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183134
   Governo do Estado de Pernambuco, 2015, CIRC FEBR ZIK VIR OR
   Gross M., 2015, ROUTLEDGE INT HDB IG
   Harper A, 2008, ROUTL MEDIEVAL CASEB, P1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henriques C.M., 2017, VIRUS ZIKA BRASIL RE
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kelly AH, 2018, ECON SOC, V47, P135, DOI 10.1080/03085147.2018.1448557
   Kelly AH, 2013, SCI CULT-UK, V22, P86, DOI 10.1080/09505431.2013.776368
   KERWIN A, 1993, KNOWLEDGE, V15, P166, DOI 10.1177/107554709301500204
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuper H., 2018, WELLCOME OPEN RES, V3
   Lakoff A., 2017, UNPREPARED GLOBAL HL
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lowy I., 2018, TANGLED DIAGNOSES PR
   Lowy I, 2017, AM J PUBLIC HEALTH, V107, P517, DOI 10.2105/AJPH.2017.303652
   Mair J, 2012, CULT MIND SOC, P1
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   McGoey L, 2012, ECON SOC, V41, P1, DOI 10.1080/03085147.2011.637330
   McNeil D., 2016, ZIKA EMERGING EPIDEM
   McNeil D.G., 2016, NY TIMES        0304
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MERTON RK, 1987, ANNU REV SOCIOL, V13, P1, DOI 10.1146/annurev.so.13.080187.000245
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Ministerio da SaUde, 2015, MIN SAUD EP B, VNO2/2015
   Murphy M, 2006, SICK BUILDING SYNDRO
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Nunes J, 2016, THIRD WORLD Q, V37, P542, DOI 10.1080/01436597.2015.1124724
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PAHO, 2015, NEUR SYNDR CONG MALF
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rayner S, 2012, ECON SOC, V41, P107, DOI 10.1080/03085147.2011.637335
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   ROSENBERG C, 1992, EXPLAINING EPIDEMICS
   Sanabria E, 2010, ETHNOS, V75, P377, DOI 10.1080/00141844.2010.544393
   Santos R.H., 2016, CAD SAUDE PUBLICA, V32
   Schuler-Faccini L., 2016, MMWR-MORBID MORTAL W, P65
   Se M.R.C.D., 2019, CAD SAUDE PUBLICA, V35
   Siedner MJ, 2018, LANCET PUBLIC HEALTH, V3, pE109, DOI 10.1016/S2468-2667(18)30029-X
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Vasconcelos P.F. da C., 2017, VIRUS ZIKA BRASIL RE
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   WHO, 2016, ZIK VIR OUTBR GLOB R
   WHO, 2016, WHO DIR GEN ADDR MED
   WHO, 2016, WHO ZIK 2 EM COMM PR
   Will CM, 2020, SOCIOL REV, V68, P55, DOI 10.1177/0038026119887330
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 78
TC 1
Z9 1
U1 9
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD FEB
PY 2020
VL 246
AR 112787
DI 10.1016/j.socscimed.2020.112787
PG 9
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA KN9VG
UT WOS:000515194800045
PM 32004803
DA 2020-07-08
ER

PT J
AU Ciftci, S
   Neumann, F
   Abdurahman, S
   Appelberg, KS
   Mirazimi, A
   Nilsson, M
   Madaboosi, N
AF Ciftci, Sibel
   Neumann, Felix
   Abdurahman, Samir
   Appelberg, K. Sofia
   Mirazimi, Au
   Nilsson, Mats
   Madaboosi, Narayanan
TI Digital Rolling Circle Amplification-Based Detection of Ebola and Other
   Tropical Viruses
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Article
AB Emerging tropical viruses have caused serious outbreaks during the recent years, such as Ebola virus (EBOV) in 2014 and the most recent in 2018 to 2019 in Congo. Thus, immediate diagnostic attention is demanded at the point of care in resource-limited settings, because the performance and the operational parameters of conventional EBOV testing are Limited. Especially, their sensitivity, specificity, and coverage of other tropical disease viruses make them unsuitable for diagnostic at the point of care. Here, a padlock probe (PLP)-based rolling circle amplification (RCA) method for the detection of EBOV is presented. For this, a set of PLPs, separately targeting the viral RNA and complementary RNA of all seven EBOV genes, was used in the RCA assay and validated on virus isolates from cell culture. The assay was then translated for testing clinical samples, and simultaneous detection of both EBOV RNA types was demonstrated. For increased sensitivity, the RCA products were enriched on a simple and pump-free microfluidic chip. Because PLPs and RCA are inherently multiplexable, we demonstrate the extension of the probe panel for the simultaneous detection of the tropical viruses Ebola, Zika, and Dengue. The demonstrated high specificity, sensitivity, and multiplexing capability in combination with the digital quantification rendered the assay a promising diagnostic tool toward tropical virus detection at the point of care.
C1 [Ciftci, Sibel; Neumann, Felix; Nilsson, Mats; Madaboosi, Narayanan] Stockholm Univ, Sci Life Lab, Dept Biochem & Biophys, Solna, Sweden.
   [Abdurahman, Samir; Appelberg, K. Sofia; Mirazimi, Au] Publ Hlth Agcy Sweden, Solna, Sweden.
   [Mirazimi, Au] Karolinska Inst, LABMED, Solna, Sweden.
   [Mirazimi, Au] Karolinska Hosp Univ, Solna, Sweden.
   [Mirazimi, Au] Natl Vet Inst, Uppsala, Sweden.
RP Madaboosi, N (corresponding author), Stockholm Univ, Sci Life Lab, Dept Biochem & Biophys, Solna, Sweden.
EM narayanan.srinivasan@scilifelab.se
OI Neumann, Felix/0000-0003-3746-3693
FU Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics
   (EbolaMoDRAD) project under the Innovative Medicines Initiative 2 Joint
   Undertaking [115843]; European Union's Horizon 2020 research and
   innovation program New Diagnostics for Infectious Diseases [675412];
   Swedish Research CouncilSwedish Research Council
FX Supported by the Ebola Virus: Modern Approaches for developing bedside
   Rapid Diagnostics (EbolaMoDRAD) project under the Innovative Medicines
   Initiative 2 Joint Undertaking grant number 115843, European Union's
   Horizon 2020 research and innovation program New Diagnostics for
   Infectious Diseases grant number 675412, and the Swedish Research
   Council. This research study has been conducted using the Ebola Biobank,
   which is a partnership between the Ministry of Health and Sanitation of
   Sierra Leone and Public Health England (PHE). EbolaMoDRAD, an Innovative
   Medicines Initiatives project, received permission from PHE research
   ethics and governance group review number PHE R&D 336. Permission was
   received from the SL ethics committee on August 10, 2017.
CR Andersson C, 2012, VIROLOGY, V426, P87, DOI 10.1016/j.virol.2012.01.032
   Baner J, 1998, NUCLEIC ACIDS RES, V26, P5073, DOI 10.1093/nar/26.22.5073
   BEECHING NJ, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G7348
   Broadhurst MJ, 2016, CLIN MICROBIOL REV, V29, P773, DOI 10.1128/CMR.00003-16
   Carinelli S, 2017, BIOSENS BIOELECTRON, V93, P65, DOI 10.1016/j.bios.2016.09.099
   CASTANEDA SJ, 1989, J VIROL, V63, P2977, DOI 10.1128/JVI.63.7.2977-2986.1989
   Ciftci S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39854-3
   Coarsey CT, 2017, CRIT REV MICROBIOL, V43, P779, DOI [10.1080/1040841X.2017.1313814, 10.1080/1040841x.2017.1313814]
   Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101
   de La Vega MA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005221
   Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003
   Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202
   Heldt FS, 2012, J VIROL, V86, P7806, DOI 10.1128/JVI.00080-12
   Hernandez-Neuta I, 2019, J INTERN MED, V285, P19, DOI 10.1111/joim.12820
   Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916
   Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095
   Krzywkowski T, 2017, J VIROL, V91, DOI 10.1128/JVI.00166-17
   Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x
   Kuhnemund M, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1324
   Kuhnemund M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13913
   Kuhnemund M, 2014, LAB CHIP, V14, P2983, DOI 10.1039/c4lc00348a
   MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546
   Mbala-Kingebeni P, 2019, LANCET INFECT DIS, V19, P648, DOI 10.1016/S1473-3099(19)30118-5
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Neumann F, 2018, CLIN CHEM, V64, P1704, DOI 10.1373/clinchem.2018.292979
   Nyan DC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17925
   Ohimain EI, 2016, VIRUS RES, V211, P174, DOI 10.1016/j.virusres.2015.10.021
   Pujara P, 2016, INT J MED MICROBIOL, V2, P81
   Qiu Xusheng, 2014, ScientificWorldJournal, V2014, P934851, DOI 10.1155/2014/934851
   Song H, 2018, J VIROL METHODS, V256, P6, DOI 10.1016/j.jviromet.2018.02.013
   Troncoso Alcides, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P255, DOI 10.1016/S2221-1691(15)30340-3
   WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   Zhou HY, 2017, ARCH VIROL, V162, P1311, DOI 10.1007/s00705-017-3227-2
NR 33
TC 0
Z9 0
U1 6
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD FEB
PY 2020
VL 22
IS 2
BP 272
EP 283
DI 10.1016/j.jmoldx.2019.10.014
PG 12
WC Pathology
SC Pathology
GA KM6LG
UT WOS:000514249000015
PM 31837428
OA Other Gold
DA 2020-07-08
ER

PT J
AU Tokunaga, M
   Miyamoto, Y
   Suzuki, T
   Otani, M
   Inuki, S
   Esaki, T
   Nagao, C
   Mizuguchi, K
   Ohno, H
   Yoneda, Y
   Okamoto, T
   Oka, M
   Matsuura, Y
AF Tokunaga, Makoto
   Miyamoto, Yoichi
   Suzuki, Tatsuya
   Otani, Mayumi
   Inuki, Shinsuke
   Esaki, Tsuyoshi
   Nagao, Chioko
   Mizuguchi, Kenji
   Ohno, Hiroaki
   Yoneda, Yoshihiro
   Okamoto, Toru
   Oka, Masahiro
   Matsuura, Yoshiharu
TI Novel anti-flavivirus drugs targeting the nucleolar distribution of core
   protein
SO VIROLOGY
LA English
DT Article
DE Flavivirus; Nuclear transport; Nucleolus; High-throughput screening;
   Core protein
ID JAPANESE-ENCEPHALITIS-VIRUS; CYCLIN-DEPENDENT KINASES; DENGUE VIRUS;
   INHIBITOR; ZIKA; P53; REPLICATION; INFECTION; POLYMERASE; UBIQUITINATION
AB The risk of infectious diseases caused by Flavivirus is increasing globally. Here, we developed a novel high-throughput screening (HTS) system to evaluate the inhibitory effects of compounds targeting the nuclear localization of the flavivirus core protein. We screened 4000 compounds based on their ability to inhibit the nuclear localization of the core protein, and identified over 20 compounds including inhibitors for cyclin dependent kinase and glycogen synthase kinase. The efficacy of the identified compounds to suppress viral growth was validated in a cell-based infection system. Remarkably, the nucleolus morphology was affected by the treatment with the compounds, suggesting that the nucleolus function is critical for viral propagation. The present HTS system provides a useful strategy for the identification of antivirals against flavivirus by targeting the nucleolar localization of the core protein.
C1 [Tokunaga, Makoto; Suzuki, Tatsuya; Okamoto, Toru] Osaka Univ, Inst Adv Cocreat Studies, Res Inst Microbial Dis, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.
   [Miyamoto, Yoichi; Otani, Mayumi; Oka, Masahiro] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Nucl Transport Dynam, Osaka, Japan.
   [Inuki, Shinsuke; Ohno, Hiroaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan.
   [Esaki, Tsuyoshi; Mizuguchi, Kenji] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Artificial Intelligence Ctr Hlth & Biomed Res, Natl Inst Biomed Innovat, Lab Bioinformat, Osaka, Japan.
   [Esaki, Tsuyoshi] Shiga Univ, Ctr Data Sci Educ & Res, Hikone, Shiga, Japan.
   [Nagao, Chioko; Mizuguchi, Kenji] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Ctr Drug Design Res, Natl Inst Biomed Innovat, Lab In Silico Drug Design, Osaka, Japan.
   [Mizuguchi, Kenji] Osaka Univ, Inst Prot Res, Osaka, Japan.
   [Yoneda, Yoshihiro] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Osaka, Japan.
   [Matsuura, Yoshiharu] Osaka Univ, Res Inst Microbial Dis, Dept Mol Virol, Osaka, Japan.
RP Okamoto, T (corresponding author), Osaka Univ, Inst Adv Cocreat Studies, Res Inst Microbial Dis, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.; Oka, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Nucl Transport Dynam, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.
EM toru@biken.osaka-u.ac.jp; moka@nibiohn.go.jp
OI Mizuguchi, Kenji/0000-0003-3021-7078
FU Platform Project for Supporting Drug Discovery and Life Science Research
   (Basis for Supporting Innovative Drug Discovery and Life Science
   Research (BINDS)) from the Japan Agency for Medical Research and
   Development (AMED)Japan Agency for Medical Research and Development
   (AMED) [JP18am0101084]; Ministry of Education, Culture, Sports, Science
   and Technology, JapanMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT); AMED [JP19fk0108036, JP18fk0210010h003];
   Ministry of Education, Culture, Sports, Science and TechnologyMinistry
   of Education, Culture, Sports, Science and Technology, Japan (MEXT)
   [JP19H03479, JP16K19139, JP19K16669]; Takeda Science FoundationTakeda
   Science Foundation (TSF)
FX We are grateful to M. Tomiyama and K. Tanii for secretarial work. We
   thank T. Kurosu, M. Ikawa and M. Saijo for providing experimental
   materials. We also thank K. Tsujikawa, A. Tani, and K. Nunomura for
   their technical supports with the drug screening, and Y. Suenari for
   assistance with the structural similarity analysis of the identified
   compounds. This research was partially supported by the Platform Project
   for Supporting Drug Discovery and Life Science Research (Basis for
   Supporting Innovative Drug Discovery and Life Science Research (BINDS))
   from the Japan Agency for Medical Research and Development (AMED) under
   Grant Number JP18am0101084. SCADS Inhibitor Kit, Screening Committee of
   Anticancer Drugs supported by Grant-in-Aid for Scientific Research on
   Innovative Areas, Scientific Support Programs for Cancer Research, from
   The Ministry of Education, Culture, Sports, Science and Technology,
   Japan. This work was also supported in part by AMED (JP19&0108036 and
   JP18fk020010h003), the Ministry of Education, Culture, Sports, Science
   and Technology (JP19H03479, JP16K19139 and JP19K16669) and the Takeda
   Science Foundation.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bresnahan WA, 1997, VIROLOGY, V231, P239, DOI 10.1006/viro.1997.8489
   Burger K, 2013, J BIOL CHEM, V288, P21173, DOI 10.1074/jbc.M113.483719
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castro JEZ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/370872
   Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200
   Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200
   Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004
   David-Pfeuty T, 1999, ONCOGENE, V18, P7409, DOI 10.1038/sj.onc.1203103
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dorigatti I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06006-6
   Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r
   Fraser JE, 2016, ANTIVIR RES, V130, P1, DOI 10.1016/j.antiviral.2016.03.006
   Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777
   Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Jans DA, 2019, CURR OPIN CELL BIOL, V58, P50, DOI 10.1016/j.ceb.2019.01.001
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06
   Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280
   Perales C, 2015, VIRUSES-BASEL, V7, P5746, DOI 10.3390/v7112902
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Poordad F, 2012, J VIRAL HEPATITIS, V19, P449, DOI 10.1111/j.1365-2893.2012.01617.x
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rawlinson SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05354-7
   Rawlinson SM, 2015, CELL MICROBIOL, V17, P1108, DOI 10.1111/cmi.12465
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Rosa BR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-019368
   Salgado D, 2012, PEDIATR INFECT DIS J, V31, P771, DOI 10.1097/INF.0b013e3182575e6a
   Salvetti A, 2014, BBA-MOL BASIS DIS, V1842, P840, DOI 10.1016/j.bbadis.2013.12.010
   Schang LM, 2000, J VIROL, V74, P2107, DOI 10.1128/JVI.74.5.2107-2120.2000
   Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653
   Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024
   Suzuki T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007299
   Tanaka K, 2018, ORG BIOMOL CHEM, V16, P7530, DOI 10.1039/c8ob90140f
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Wang XD, 2012, J BIOL CHEM, V287, P18366, DOI 10.1074/jbc.M111.335422
   Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Whitlock JA, 2005, J CLIN ONCOL, V23, P9179, DOI 10.1200/JCO.2004.01.0660
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   Yang SNY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030281
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhang JJ, 2010, J VIROL, V84, P12619, DOI 10.1128/JVI.01696-10
   Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0
NR 62
TC 0
Z9 0
U1 3
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB
PY 2020
VL 541
BP 41
EP 51
DI 10.1016/j.virol.2019.11.015
PG 11
WC Virology
SC Virology
GA KM5ZX
UT WOS:000514219400005
PM 31826845
DA 2020-07-08
ER

PT J
AU Kesari, AS
   Heintz, VJ
   Poudyal, S
   Miller, AS
   Kuhn, RJ
   LaCount, DJ
AF Kesari, Aditi S.
   Heintz, Veronica J.
   Poudyal, Shishir
   Miller, Andrew S.
   Kuhn, Richard J.
   LaCount, Douglas J.
TI Zika virus NS5 localizes at centrosomes during cell division
SO VIROLOGY
LA English
DT Article
DE Zika virus; Flavivirus; Nonstructural protein NS5; RNA-Dependent RNA
   polymerase; Centrosome
ID BETA-CATENIN; CRYSTAL-STRUCTURE; PROTEIN; REVEALS; NINEIN; DENGUE;
   IDENTIFICATION; INSTABILITY; GMAP-210; NETWORK
AB Zika virus (ZIKV) nonstructural protein 5 (NS5) plays a critical role in viral RNA replication and mediates key virus-host cell interactions. As with other flavivirus NS5 proteins, ZIKV NS5 is primarily found in the nucleus. We previously reported that the NS5 protein of dengue virus, another flavivirus, localized to centrosomes during cell division. Here we show that ZIKV NS5 also relocalizes from the nucleus to centrosomes during mitosis. In infected cells with supernumerary centrosomes, NS5 was present at all centrosomes. Transient expression of NS5 in uninfected cells confirmed that centrosomal localization was independent of other viral proteins. Live-cell imaging demonstrated that NS5-GFP accumulated at centrosomes shortly after break down of nuclear membrane and remained there through mitosis. Cells expressing NS5-GFP took longer to complete mitosis than control cells. Finally, an analysis of ZIKV NS5 binding partners revealed several centrosomal proteins, providing potential direct links between NS5 and centrosomes.
C1 [Kesari, Aditi S.; Heintz, Veronica J.; LaCount, Douglas J.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.
   [Kesari, Aditi S.; Heintz, Veronica J.; LaCount, Douglas J.] Purdue Univ, Dept Mol Pharmacol, W Lafayette, IN 47907 USA.
   [Poudyal, Shishir; Miller, Andrew S.; Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Kesari, Aditi S.; Heintz, Veronica J.; Poudyal, Shishir; Miller, Andrew S.; Kuhn, Richard J.; LaCount, Douglas J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
RP LaCount, DJ (corresponding author), Purdue Univ, Dept Med Chem, DLR 442,207 South Martin Jischke Dr, W Lafayette, IN 47907 USA.
EM dlacount@purdue.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI114814, AI120943];
   Purdue Institute of Inflammation, Immunology and Infectious Disease
   (PI4D) Team Science Program [209263]
FX This work was supported by the National Institutes of Health [grant
   numbers AI114814 and AI120943] and the Purdue Institute of Inflammation,
   Immunology and Infectious Disease (PI4D) Team Science Program (grant
   number 209263).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166
   Arquint C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0464
   Aznar N, 2017, MOL BIOL CELL, V28, P3709, DOI 10.1091/mbc.E17-06-0405
   Baffet AD, 2015, DEV CELL, V33, P703, DOI 10.1016/j.devcel.2015.04.022
   Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BoucksonCastaing V, 1996, J CELL SCI, V109, P179
   Burgess SG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005345
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Coyaud E, 2015, MOL CELL PROTEOMICS, V14, P1781, DOI 10.1074/mcp.M114.045658
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fong CS, 2016, ELIFE, V5, DOI [10.7554/eLife.16270, 10.7554/eLite.16270]
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592
   Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217
   Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83
   Jayaraman D, 2018, ANNU REV GENOM HUM G, V19, P177, DOI 10.1146/annurev-genom-083117-021441
   Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Kobayashi A, 2015, CELL CYCLE, V14, P1447, DOI 10.1080/15384101.2015.1021518
   Kovanich D, 2019, J PROTEOME RES, V18, P3203, DOI 10.1021/acs.jproteome.9b00318
   LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104
   Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100
   Lambrus BG, 2016, J CELL BIOL, V214, P143, DOI 10.1083/jcb.201604054
   Lambrus BG, 2015, J CELL BIOL, V210, P63, DOI 10.1083/jcb.201502089
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu SL, 2014, ANAL CHEM, V86, P3902, DOI 10.1021/ac500640u
   Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104
   McDougall WM, 2019, ISCIENCE, V12, P270, DOI 10.1016/j.isci.2019.01.025
   Meitinger F, 2016, J CELL BIOL, V214, P155, DOI 10.1083/jcb.201604081
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Mogensen MM, 2000, J CELL SCI, V113, P3013
   Nakano H, 2010, J BIOL CHEM, V285, P10841, DOI 10.1074/jbc.M110.105890
   Ng IHW, 2019, ACS INFECT DIS, V5, P932, DOI 10.1021/acsinfecdis.8b00373
   Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ou YY, 2002, J CELL SCI, V115, P1825
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Petit C, 2003, J CELL SCI, V116, P3433, DOI 10.1242/jcs.00613
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Redwine WB, 2017, ELIFE, V6, DOI 10.7554/eLife.28257
   Rios RM, 2004, CELL, V118, P323
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sir JH, 2013, J CELL BIOL, V203, P747, DOI 10.1083/jcb.201309038
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Thakur HC, 2014, J BIOL CHEM, V289, P74, DOI 10.1074/jbc.M113.532333
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Wolf L, 2017, MUSIK BAYERN, P7
   Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhao B., 2017, NAT COMMUN, V8, P54
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
NR 74
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB
PY 2020
VL 541
BP 52
EP 62
DI 10.1016/j.virol.2019.11.018
PG 11
WC Virology
SC Virology
GA KM5ZX
UT WOS:000514219400006
PM 32056715
DA 2020-07-08
ER

PT J
AU Ji, W
   Luo, GX
AF Ji, Wei
   Luo, Guangxiang
TI Zika virus NS5 nuclear accumulation is protective of protein degradation
   and is required for viral RNA replication
SO VIROLOGY
LA English
DT Article
DE Zika virus; ZIKV; NS5; RdRp; NLS; Mutagenesis; Degradation; Replication;
   Nuclear accumulation
ID NONSTRUCTURAL PROTEIN; LOCALIZATION; INHIBITOR; REGION; INTERDOMAIN;
   POLYMERASE; SEQUENCES; CONTAINS; HELICASE; BINDING
AB Zika virus (ZIKV) nonstructural protein 5 (NS5) is a multifunctional protein possessing methyltransferase and RNA-dependent RNA polymerase activities. In the present study, we have carried out an extensive mutagenesis analysis to determine the importance of nuclear localization sequences (NLS) of NS5 in its nuclear accumulation and ZIKV replication. Deletion mutagenesis analysis demonstrated that the bipartite NLS consisting of importin beta 1 (beta NLS) and importin alpha/beta-recognized NLS (alpha/beta NLS) is required for NS5 nuclear accumulation. Deletion of beta NLS, alpha/beta NLS, or both as well as R(393)A and R393N mutations severely impaired NS5 nuclear import and consequently conferred NS5 degradation. The R(393)A and R393N mutations also ablated viral RNA replication and virus production. Treatment of ZIKV-infected cells with importin alpha/beta-NS5 interaction inhibitors ivermectin or 4-HPR resulted in a rapid degradation of NS5 similar to the R393 A/N mutations. Collectively, these findings suggest that NS5 nuclear accumulation protects NS5 from cytoplasmic degradation and therefore is required for viral RNA replication.
C1 [Ji, Wei; Luo, Guangxiang] Peking Univ, Dept Microbiol, Hlth Sci Ctr, Sch Basic Med Sci, Beijing, Peoples R China.
   [Luo, Guangxiang] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA.
RP Luo, GX (corresponding author), Peking Univ, Dept Microbiol, Hlth Sci Ctr, Sch Basic Med Sci, Beijing, Peoples R China.
EM gxluo@bjmu.edu.cn
CR Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125
   Cheng MJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050244
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   Fraser JE, 2014, METHODS MOL BIOL, V1138, P301, DOI 10.1007/978-1-4939-0348-1_19
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556
   Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Lopez-Denman AJ, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12848
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Ng IHW, 2019, ACS INFECT DIS, V5, P932, DOI 10.1021/acsinfecdis.8b00373
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 46
TC 1
Z9 1
U1 3
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB
PY 2020
VL 541
BP 124
EP 135
DI 10.1016/j.virol.2019.10.010
PG 12
WC Virology
SC Virology
GA KM5ZX
UT WOS:000514219400012
PM 32056710
DA 2020-07-08
ER

PT J
AU Garcell, HG
   Garcia, FG
   Nodal, MR
   Lozano, AR
   Diaz, CRP
   Valdes, AG
   Alvareza, LG
AF Guanche Garcell, Humberto
   Gutierrez Garcia, Francisco
   Ramirez Nodal, Manuel
   Ruiz Lozano, Alfredo
   Perez Diaz, Carlos R.
   Gonzalez Valdes, Anaika
   Gonzalez Alvareza, Luis
TI Clinical relevance of Zika symptoms in the context of a Zika Dengue
   epidemic
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Non-specific febrile syndrome; Zika; Infection; Clinical picture; Cuba
ID VIRUS-INFECTION
AB Background The clinical characteristics of the most frequent arbovirosis (Dengue, Zika, Chikungunya) are very similar, which is a diagnostic challenge for clinicians.
   Objective To identify the presence of clinical characteristics related to Zika virus infection confirmed by the laboratory in patients during an epidemic of co-infection with Zika and Dengue viruses.
   Method Cross-sectional descriptive study of patients with clinical - epidemiological suspicion of Zika virus infection, who were admitted in the Hospital Joaquin Albarran (La Habana, Cuba), during June 1 to October 31 of 2017. Demographic and symptoms and signs were recorded. By PCR for Zika virus (in blood or urine) the disease was confirmed.
   Results 1541 patients were studied. The most frequent symptoms and signs were rash (93.8%), pruritus (77.9%), arthralgia (60.0%), headache (50.8%), myalgia (46.1%), fever (34.7%), asthenia (31.7%), and conjunctivitis (27.9%). Zika virus infection was confirmed in 279 patients (18.1%). Greater frequency of arthralgia, asthenia, and diarrhea was demonstrated in Zika confirmed patients.
   Conclusion Minor clinical relevance was observed in the symptoms or signs of arboviral disease to support the clinical diagnosis of Zika virus infections by clinician during a Zika-Dengue epidemic. The assessment of the temporality of the onset of Zika andDengue symptoms of these infections is recommended to assist clinicians in the differential diagnosis. (c) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz Universityfor Health Sciences. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Guanche Garcell, Humberto; Gutierrez Garcia, Francisco; Gonzalez Valdes, Anaika; Gonzalez Alvareza, Luis] Hosp Docente Clin Quirurg Joaquin Albarran, Dept Epidemiol Hosp, Havana, Cuba.
   [Ramirez Nodal, Manuel] Hosp Docente Clin Quirurg Joaquin Albarran, Serv Med Interna, Havana, Cuba.
   [Ruiz Lozano, Alfredo] Hosp Docente Clin Quirurg Joaquin Albarran, Ctr Urgencias, Havana, Cuba.
   [Perez Diaz, Carlos R.] Hosp Docente Clin Quirurg Joaquin Albarran, Secc Gest Calidad, Havana, Cuba.
RP Garcell, HG (corresponding author), Ave 43 8411 84 & 84a, Havana, Cuba.
EM guanche@infomed.sld.cu; fcogutierrez@infomed.sld.cu;
   manuelramirez@infomed.sld.cu; vd.asistmedica@albarran.sld.cu;
   direccion@albarran.sld.cu; anaikagv@infomed.sld.cu;
   epidemiologia@albarran.sld.cu
RI Garcell, Humberto Guanche/AAB-7726-2020
OI Garcell, Humberto Guanche/0000-0001-7279-0062
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Brenciaglia M, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/4635647
   Cabezas C, 2017, AN FAC MED, V78, P89, DOI [10.15381/anales.v78i1.13028., DOI 10.15381/ANALES.V78I1.13028]
   Conner Gorry MA, 2019, MEDICC REV, V21, P6
   de Laval F, 2018, J CLIN VIROL, V109, P57, DOI 10.1016/j.jcv.2018.09.015
   El Sahly HM, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy352
   Guzman MG, 2016, DENGUE
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Sanchez O, 2018, REV CUBANA MED TROPI, V70
   Sanchez-Carbonel Jose, 2018, BMC Res Notes, V11, P175, DOI 10.1186/s13104-018-3290-0
   Stamm LV, 2016, JAMA DERMATOL, V152, P621, DOI 10.1001/jamadermatol.2016.1499
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tozetto-Mendoza TR, 2019, REV INST MED TROP SP, V61, DOI [10.1590/S1678-9946201961019, 10.1590/s1678-9946201961019]
   Woon YL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3786-9
NR 17
TC 3
Z9 3
U1 2
U2 2
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD FEB
PY 2020
VL 13
IS 2
BP 173
EP 176
DI 10.1016/j.jiph.2019.07.006
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KK7YD
UT WOS:000512953100004
PM 31399372
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Iqbal, A
   Colgrove, R
   Iacoviello, V
   Blair, BM
   Chen, LH
AF Iqbal, Aftab
   Colgrove, Robert
   Iacoviello, Vito
   Blair, Barbra M.
   Chen, Lin H.
TI Systematic Hospital-Based Travel Screening to Assess Exposure to Zika
   Virus
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; REPRODUCTIVE AGE; WOMEN
AB We queried hospital patients about international travel in the previous 30 days to assess potential importation of emerging infections. We used 12 months of deidentified data to analyze patient demographics, travel destinations, and diagnoses for exposure to Zika virus. Our approach could be used to analyze potential infectious disease exposures.
C1 [Iqbal, Aftab] Providence Community Hlth Ctr, Providence, RI USA.
   [Iqbal, Aftab; Colgrove, Robert; Iacoviello, Vito; Chen, Lin H.] Mt Auburn Hosp, Cambridge, MA USA.
   [Blair, Barbra M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Colgrove, Robert; Iacoviello, Vito; Blair, Barbra M.; Chen, Lin H.] Harvard Med Sch, Boston, MA 02115 USA.
RP Chen, LH (corresponding author), Mt Auburn Hosp, Div Infect Dis & Travel Med, 330 Mt Auburn St, Cambridge, MA 02138 USA.
EM lchen@hms.harvard.edu
FU Mount Auburn Hospital Medical Staff Executive Committee Research Grant
   2015
FX This project is supported in part by the Mount Auburn Hospital Medical
   Staff Executive Committee Research Grant 2015.
CR Council of State and Territorial Epidemiologists, ZIK VIR DIS CONG ZIK
   Graciaa DS, 2018, ANN INTERN MED, V169, P337, DOI 10.7326/M18-1112
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lammert S, 2017, EMERG INFECT DIS, V23, P324, DOI 10.3201/eid2302.161292
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Valle J, 2019, SOUTH MED J, V112, P45, DOI 10.14423/SMJ.0000000000000917
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, REPR HLTH IND GUID T
   World Health Organization, 2016, SITUATION REPORT ZIK
   World Health Organization, 2016, PREVENTION OF SEXUAL
NR 15
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2020
VL 26
IS 2
BP 315
EP 319
DI 10.3201/eid2602.190292
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA KH1WI
UT WOS:000510436500017
PM 31967538
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Taniguchi, M
AF Taniguchi, Masateru
TI Analysis Method of the Ion Current-Time Waveform Obtained from Low
   Aspect Ratio Solid-state Nanopores
SO ANALYTICAL SCIENCES
LA English
DT Review
DE Low aspect nanopores; solid-state nanopores; virus; bacteria;
   multiphysics; machine learning
ID DNA TRANSLOCATION; ZIKA VIRUS; H1N1 INFLUENZA; POLYMER TRANSLOCATION;
   SINGLE; GRAPHENE; IDENTIFICATION; MOLECULES; CHARGE; ELISA
AB Low aspect ratio nanopores are expected to be applied to the detection of viruses and bacteria because of their high spatial resolution. Multiphysics simulations have revealed that the ion current-time waveform obtained from low aspect ratio nanopores contains information on not only the volume of viruses and bacteria, but also the structure, surface charge, and flow dynamics. Analysis using machine learning extracts information about these analytes from the ion current-time waveform. The combination of low aspect ratio nanopores, multiphysics simulation, and machine learning has made it possible to distinguish different types of viruses and bacteria with high accuracy.
C1 [Taniguchi, Masateru] Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.
RP Taniguchi, M (corresponding author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.
EM taniguti@sanken.osaka-u.ac.jp
FU KAKENHIMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [19H00852]
FX This research was supported by KAKENHI Grant No. 19H00852.
CR Abgrall P, 2008, ANAL CHEM, V80, P2326, DOI 10.1021/ac702296u
   ALAMIYOUNSSI S, 1995, J MEMBRANE SCI, V102, P123, DOI 10.1016/0376-7388(94)00302-F
   Ando G, 2012, ACS NANO, V6, P10090, DOI 10.1021/nn303816w
   Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009
   Arima A, 2018, J AM CHEM SOC, V140, P16834, DOI 10.1021/jacs.8b10854
   Arima A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34665-4
   Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988
   Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495
   BULL BS, 1965, AM J CLIN PATHOL, V44, P678
   Chen P, 2004, NANO LETT, V4, P1333, DOI 10.1021/nl0494001
   CLARK MF, 1986, METHOD ENZYMOL, V118, P742
   Darvish A, 2019, ELECTROPHORESIS, V40, P776, DOI 10.1002/elps.201800311
   Davenport M, 2012, ACS NANO, V6, P8366, DOI 10.1021/nn303126n
   DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759
   DEBLOIS RW, 1970, REV SCI INSTRUM, V41, P909, DOI 10.1063/1.1684724
   Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27
   Dickinson EJF, 2014, ELECTROCHEM COMMUN, V40, P71, DOI 10.1016/j.elecom.2013.12.020
   Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103
   Elhoseny M, 2018, IEEE ACCESS, V6, P20596, DOI 10.1109/ACCESS.2018.2817615
   ENGVALL E, 1977, MED BIOL, V55, P193
   Farimani AB, 2014, ACS NANO, V8, P7914, DOI 10.1021/nn5029295
   Feng JD, 2015, NAT NANOTECHNOL, V10, P1070, DOI [10.1038/nnano.2015.219, 10.1038/NNANO.2015.219]
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155
   Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809
   Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Geisser Seymour, 1993, PREDICTIVE INFERENCE
   Ghosal S, 2019, BIOMICROFLUIDICS, V13, DOI 10.1063/1.5083913
   Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Goyal G, 2015, ANALYST, V140, P4865, DOI 10.1039/c5an00250h
   HALL JE, 1975, J GEN PHYSIOL, V66, P531, DOI 10.1085/jgp.66.4.531
   Haque F, 2013, NANO TODAY, V8, P56, DOI 10.1016/j.nantod.2012.12.008
   Hauer P, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4905874
   He YH, 2013, BIOPHYS J, V105, P776, DOI 10.1016/j.bpj.2013.05.065
   He YH, 2013, ACS NANO, V7, P538, DOI 10.1021/nn304914j
   He YH, 2011, ACS NANO, V5, P8391, DOI 10.1021/nn203186c
   He YH, 2011, ACS NANO, V5, P5509, DOI 10.1021/nn201883b
   Heerema SJ, 2016, NAT NANOTECHNOL, V11, P127, DOI [10.1038/nnano.2015.307, 10.1038/NNANO.2015.307]
   Holmes G., 1994, P ANZIIS 94 AUSTR NZ
   Hou X, 2011, CHEM SOC REV, V40, P2385, DOI 10.1039/c0cs00053a
   Hua BY, 2014, NAT METHODS, V11, P1233, DOI [10.1038/NMETH.3143, 10.1038/nmeth.3143]
   Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695
   Joshi O, 2009, APPL BIOCHEM BIOTECH, V152, P235, DOI 10.1007/s12010-008-8246-8
   Kumar R, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3264632
   Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037
   Li XQ, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4964117
   Liu K, 2014, ACS NANO, V8, P2504, DOI 10.1021/nn406102h
   Liu YX, 2012, CHEM SOC REV, V41, P2283, DOI 10.1039/c1cs15270j
   Lu B, 2013, NANO LETT, V13, P3048, DOI 10.1021/nl402052v
   Luo K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148102
   Luo KF, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2179792
   Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007
   McMullen A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5171
   Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t
   Miles BN, 2013, CHEM SOC REV, V42, P15, DOI 10.1039/c2cs35286a
   Muthukumar M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3429882
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
   Noto K, 2008, LECT NOTES ARTIF INT, V5360, P202, DOI 10.1007/978-3-540-89378-3_20
   Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rateni G, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061453
   Reineck P, 2010, ELECTROPHORESIS, V31, P279, DOI 10.1002/elps.200900505
   Riske KA, 2006, BIOPHYS J, V91, P1778, DOI 10.1529/biophysj.106.081620
   Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211
   Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/NMETH.1932, 10.1038/nmeth.1932]
   Ryuzaki S, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa5e66
   Sadik MM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066316
   Schneider GF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3619
   Schneider GF, 2010, NANO LETT, V10, P3163, DOI 10.1021/nl102069z
   Schoch RB, 2008, REV MOD PHYS, V80, P839, DOI 10.1103/RevModPhys.80.839
   Shen L, 2011, SURF SCI, V605, P494, DOI 10.1016/j.susc.2010.12.005
   Slater GW, 2009, ELECTROPHORESIS, V30, P792, DOI 10.1002/elps.200800673
   Smeets RMM, 2008, P NATL ACAD SCI USA, V105, P417, DOI 10.1073/pnas.0705349105
   Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Somerville JA, 2013, J COLLOID INTERF SCI, V394, P243, DOI 10.1016/j.jcis.2012.11.071
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901
   Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941
   Tabard-Cossa V, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/30/305505
   Tang ZP, 2014, SMALL, V10, P4332, DOI 10.1002/smll.201401091
   Taniguchi M, 2019, J PHYS CHEM C, V123, P15867, DOI 10.1021/acs.jpcc.9b03908
   Taniguchi M, 2015, ANAL CHEM, V87, P188, DOI 10.1021/ac504186m
   Tonomura W, 2019, LAB CHIP, V19, P1352, DOI 10.1039/c8lc01371c
   TOWNS JK, 1991, ANAL CHEM, V63, P1126, DOI 10.1021/ac00011a013
   Tsutsui M, 2018, ANAL CHEM, V90, P1511, DOI 10.1021/acs.analchem.7b04950
   Tsutsui M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17443-6
   Uram JD, 2008, ACS NANO, V2, P857, DOI 10.1021/nn700322m
   Van Rijsbergen C.J., 1979, INFORM RETRIEVAL
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Venkatesan BM, 2010, ADV FUNCT MATER, V20, P1266, DOI 10.1002/adfm.200902128
   Vogel R, 2012, ANAL CHEM, V84, P3125, DOI 10.1021/ac2030915
   VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wanunu M, 2012, PHYS LIFE REV, V9, P125, DOI 10.1016/j.plrev.2012.05.010
   Wanunu M, 2010, NAT NANOTECHNOL, V5, P160, DOI [10.1038/NNANO.2009.379, 10.1038/nnano.2009.379]
   Weatherall E, 2015, ANALYST, V140, P3318, DOI 10.1039/c4an02270j
   Weatherall E, 2015, J PHYS CHEM B, V119, P5328, DOI 10.1021/acs.jpcb.5b00344
   Wong CTA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2723088
   Wu HW, 2016, ANAL CHEM, V88, P2502, DOI 10.1021/acs.analchem.5b04905
   Yang H, 2016, J VIROL, V90, P5770, DOI 10.1128/JVI.00180-16
   Yusko EC, 2011, NAT NANOTECHNOL, V6, P253, DOI 10.1038/nnano.2011.12
   Zhang KH, 2013, SOFT MATTER, V9, P2069, DOI 10.1039/c2sm27370e
NR 107
TC 0
Z9 0
U1 3
U2 3
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0910-6340
EI 1348-2246
J9 ANAL SCI
JI Anal. Sci.
PD FEB
PY 2020
VL 36
IS 2
BP 161
EP 175
DI 10.2116/analsci.19R009
PG 15
WC Chemistry, Analytical
SC Chemistry
GA KJ8RC
UT WOS:000512322400004
PM 31813895
OA Bronze
DA 2020-07-08
ER

PT J
AU Sharma, V
   Sharma, M
   Dhull, D
   Sharma, Y
   Kaushik, S
   Kaushik, S
AF Sharma, Vikrant
   Sharma, Manisha
   Dhull, Divya
   Sharma, Yashika
   Kaushik, Sulochana
   Kaushik, Samander
TI Zika virus: an emerging challenge to public health worldwide
SO CANADIAN JOURNAL OF MICROBIOLOGY
LA English
DT Review
DE emerging infection; flaviviruses; microcephaly; Zika virus; ZIKV
ID SEXUAL TRANSMISSION; UNITED-STATES; CASE SERIES; INFECTION; BIOLOGY;
   DENGUE; BRAZIL; FEVER; ASSOCIATION; EPIDEMIC
AB Zika virus (ZIKV) is a mosquito-borne virus that was first isolated from Zika forest, Uganda, in 1947. Since its inception, major and minor outbreaks have been documented from several parts of world. Aedes spp. mosquitoes are the primary vectors of ZIKV, but the virus can also be transmitted through sexual practices, materno-fetal transmission, and blood transfusion. The clinical presentations of symptomatic ZIKV infections are similar to dengue and chikungunya, including fever, headache, arthralgia, retro-orbital pain, conjunctivitis, and rash. ZIKV often causes mild illness in the majority of cases, but in some instances, it is linked with congenital microcephaly and autoimmune disorders like Guillain-Barre syndrome. The recent Indian ZIKV outbreak suggests that the virus is circulating in the South East Asian region and may cause new outbreaks in future. At present, no specific vaccines or antivirals are available to treat ZIKV, so management and control of ZIKV infections rely mostly on preventive measures.
C1 [Sharma, Vikrant; Dhull, Divya; Sharma, Yashika; Kaushik, Samander] Maharshi Dayanand Univ, Ctr Biotechnol, Rohtak 124001, Haryana, India.
   [Sharma, Manisha] Himachal Pradesh Univ, Dept Biotechnol, Shimla 171005, Himachal Prades, India.
   [Kaushik, Sulochana] Maharshi Dayanand Univ, Dept Genet, Rohtak 124001, Haryana, India.
RP Kaushik, S (corresponding author), Maharshi Dayanand Univ, Ctr Biotechnol, Rohtak 124001, Haryana, India.
EM samanderkaushik@gmail.com
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhagat R, 2018, CELL DEATH DIFFER, V25, P1837, DOI 10.1038/s41418-018-0163-y
   Bhardwaj S, 2017, INDIAN J MED RES, V146, P572, DOI 10.4103/ijmr.IJMR_1160_17
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC, 2014, FRENCH POL
   Edupuganti S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx133
   FDA, 2019, EM PREP RESP
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.3290
   IDSP, 2018, WEEKLY OUTBREAK REPO
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McCarthy M., 2016, BMJ-BRIT MED J, V354, pi4235, DOI DOI 10.1136/BMJ.I4235.PMID:27480321
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Minhas AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1399
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO, 2017, TOOL DIAGN CAR PAT S
   PAHO, 2016, BRAZ CONF BLOOD TRAN
   Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sapkal GN, 2018, J INFECTION, V76, P314, DOI 10.1016/j.jinf.2017.09.020
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharma V, 2018, J VIROL METHODS, V253, P18, DOI 10.1016/j.jviromet.2017.12.005
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sloan A, 2018, DIAGN MICR INFEC DIS, V90, P264, DOI 10.1016/j.diagmicrobio.2017.11.018
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2017, DIS OUTBREAK NEWS
   WHO, 2018, DENG CONTR METH VECT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 104
TC 1
Z9 1
U1 4
U2 4
PU CANADIAN SCIENCE PUBLISHING
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4166
EI 1480-3275
J9 CAN J MICROBIOL
JI Can. J. Microbiol.
PD FEB
PY 2020
VL 66
IS 2
BP 87
EP 98
DI 10.1139/cjm-2019-0331
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology; Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology; Microbiology
GA KJ8OU
UT WOS:000512316100001
PM 31682478
OA Bronze
DA 2020-07-08
ER

PT J
AU Maertens, K
   Orije, MRP
   Van Damme, P
   Leuridan, E
AF Maertens, Kirsten
   Orije, Marjolein Rozemarie Paulien
   Van Damme, Pierre
   Leuridan, Elke
TI Vaccination during pregnancy: current and possible future
   recommendations
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Review
DE Immunization; Influenza; Maternal; Pregnancy; Pertussis
ID MATERNAL PERTUSSIS IMMUNIZATION; B STREPTOCOCCUS VACCINE; INFLUENZA
   VACCINATION; ANTIBODY-RESPONSES; TETANUS-DIPHTHERIA; IMMUNE-RESPONSE;
   INFANTS; MOTHERS; WOMEN; PROTECTION
AB Immunizing pregnant women to protect the mother, fetus and infant from infection has increasingly been used over the last decade. Protection against infectious diseases in neonates is mainly provided by maternal antibodies transferred from mother to infant during pregnancy through transplacental transport or after delivery via breastfeeding. Both the transplacental- and breast milk-derived maternal antibodies function as the primary source of protection against infectious diseases in neonates during the first vulnerable weeks of life. During recent infectious disease outbreaks (influenza, pertussis, Zika horizontal ellipsis ) and for other infectious diseases (CMV, GBS horizontal ellipsis ), pregnant women are increasingly identified as an important target for vaccination. For some of these diseases, vaccines are already on the market, and recommended during pregnancy. For others, vaccines are currently under development; furthermore, some are even specifically designed to be administered during pregnancy. Conclusion: This review article provides an overview on the rationale and main mechanism of the maternal vaccination strategy and gives a summary about the current and possible future recommendations for maternal vaccination.What is Known:center dot Maternal vaccination has a far-reaching potential in the protection of both women and offspring.center dot Currently, tetanus, pertussis and influenza vaccination during pregnancy is recommended in some countries. Several new vaccines specifically designed for use in pregnancy are currently under development.What is New:center dot Review providing a timely overview of the rationale and main mechanisms of the maternal vaccination strategy center dot Up-to-date summary of the current and possible future recommendations for maternal vaccination
C1 [Maertens, Kirsten; Orije, Marjolein Rozemarie Paulien; Van Damme, Pierre; Leuridan, Elke] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Univ Pl 1, B-2610 Antwerp, Belgium.
RP Maertens, K (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Univ Pl 1, B-2610 Antwerp, Belgium.
EM kirsten.maertens@uantwerp.be; marjolein.orije@uantwerp.be;
   pierre.vandamme@uantwerp.be; elke.leuridan@uantwerp.be
CR Abu Raya B, 2015, J INFECT DIS, V212, P1869, DOI 10.1093/infdis/jiv324
   Abu Raya B, 2014, VACCINE, V32, P5632, DOI 10.1016/j.vaccine.2014.08.006
   Abu-Raya B, 2019, JAMA-J AM MED ASSOC, V321, P935, DOI 10.1001/jama.2019.0703
   Abu-Raya B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00338
   Amirthalingam G, 2016, CLIN INFECT DIS, V63, pS236, DOI 10.1093/cid/ciw559
   Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3
   [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461
   Bergin N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050847
   Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027
   Calvert A, 2017, CURR OPIN INFECT DIS, V30, P268, DOI 10.1097/QCO.0000000000000372
   Campbell H, 2019, BORDETELLA2019 BRUSS
   Centers for Disease Control and Prevention, 2019, PREGN WOM INFL FLU
   Cuningham W, 2019, INFLUENZA OTHER RESP
   Dabrera G, 2015, CLIN INFECT DIS, V60, P333, DOI 10.1093/cid/ciu821
   De Schutter S, 2015, PEDIATR INFECT DIS J, V34, pE149, DOI 10.1097/INF.0000000000000675
   Demers-Mathieu V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050631
   Eberhardt CS, 2017, CLIN INFECT DIS, V64, P1129, DOI 10.1093/cid/cix046
   Eberhardt CS, 2016, CLIN INFECT DIS, V62, P829, DOI 10.1093/cid/ciw027
   ENGLUND JA, 1995, PEDIATRICS, V96, P580
   Faucette AN, 2015, HUM REPROD UPDATE, V21, P119, DOI 10.1093/humupd/dmu041
   Fell DB, 2017, BJOG-INT J OBSTET GY, V124, P48, DOI 10.1111/1471-0528.14143
   Giles ML, 2019, HUM VACC IMMUNOTHER, V15, P687, DOI 10.1080/21645515.2018.1540807
   Group B Streptococcus Vaccine Development Technology Roadmap, 2017, GROUP B STREPT VACC
   Hoang HTT, 2016, VACCINE, V34, P151, DOI 10.1016/j.vaccine.2015.10.098
   Halperin SA, 2018, CLIN INFECT DIS, V67, P1063, DOI 10.1093/cid/ciy244
   Hillier SL, 2019, CLIN INFECT DIS, V68, P2079, DOI 10.1093/cid/ciy838
   Horner I, 2014, NEW ENGL J MED, V371, P2340, DOI 10.1056/NEJMc1412050
   Huygen K, 2015, VACCINE, V33, P4117, DOI 10.1016/j.vaccine.2015.06.108
   Kachikis A, 2018, VIRAL IMMUNOL, V31, P184, DOI 10.1089/vim.2017.0135
   Kachikis A, 2016, J INFECTION, V72, pS83, DOI 10.1016/j.jinf.2016.04.027
   Kay AW, 2015, J INFECT DIS, V212, P861, DOI 10.1093/infdis/jiv138
   Ladhani SN, 2015, CLIN INFECT DIS, V61, P1637, DOI 10.1093/cid/civ695
   Leroux-Roels G, 2016, VACCINE, V34, P1786, DOI 10.1016/j.vaccine.2016.02.044
   Leuridan E, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1626
   Liang JL, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6702a1
   Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444
   Madhi SA, 2016, LANCET INFECT DIS, V16, P923, DOI 10.1016/S1473-3099(16)00152-3
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480
   Maertens K, 2017, PEDIATR INFECT DIS J, V36, P1186, DOI 10.1097/INF.0000000000001601
   Maertens K, 2016, CLIN INFECT DIS, V63, pS197, DOI 10.1093/cid/ciw551
   Maertens K, 2016, VACCINE, V34, P3613, DOI 10.1016/j.vaccine.2016.04.066
   Maertens K, 2016, VACCINE, V34, P142, DOI 10.1016/j.vaccine.2015.10.100
   Maertens K, 2014, VACCINE, V32, P1786, DOI 10.1016/j.vaccine.2014.01.083
   MALEK A, 1994, AM J REPROD IMMUNOL, V32, P8, DOI 10.1111/j.1600-0897.1994.tb00873.x
   Marchant A, 2017, LANCET INFECT DIS, V17, pE197, DOI 10.1016/S1473-3099(17)30229-3
   Masseria C, 2017, PEDIATR INFECT DIS J, V36, pE54, DOI 10.1097/INF.0000000000001440
   McHugh L, 2019, CLIN INFECT DIS, V68, P402, DOI 10.1093/cid/ciy517
   McMillan M, 2017, OBSTET GYNECOL, V129, P560, DOI 10.1097/AOG.0000000000001888
   Mertz D, 2017, VACCINE, V35, P521, DOI 10.1016/j.vaccine.2016.12.012
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Munoz FM, 2019, 37 ANN M EUR SOC PEA
   Naidu MA, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.002
   Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   Nunes MC, 2015, J INFECT DIS, V212, P1976, DOI 10.1093/infdis/jiv339
   Omer SB, 2017, NEW ENGL J MED, V376, P1256, DOI 10.1056/NEJMra1509044
   Orije MRP, 2020, VACCINE, V38, P20, DOI 10.1016/j.vaccine.2019.10.025
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131
   PATH, 2017, ADV MAT IMM COLL FOR
   PATH, 2018, ADV RSV MAT IMM GAP
   Psarris A, 2019, EUR J OBSTET GYN R B, V240, P29, DOI 10.1016/j.ejogrb.2019.06.019
   Public Health England, 2016, VACC PERT WHOOP COUG
   Rice TF, 2019, CLIN EXP IMMUNOL
   Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131
   Schlaudecker EP, 2018, VACCINE, V36, P4734, DOI 10.1016/j.vaccine.2018.05.117
   Schleiss MR, 2017, CLIN VACCINE IMMUNOL, V24
   Sealey KL, 2016, INFECT GENET EVOL, V40, P136, DOI 10.1016/j.meegid.2016.02.032
   STANFIELD JP, 1984, B WORLD HEALTH ORGAN, V62, P647
   Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599
   Sullivan Sheena G, 2019, Ther Adv Vaccines Immunother, V7, p2515135519826481, DOI 10.1177/2515135519826481
   Thwaites CL, 2015, LANCET, V385, P362, DOI 10.1016/S0140-6736(14)60236-1
   United Nations Children's Fund / World Health Organization / United Nations Population Fund, 2002, MAT NEON TET EL 2005
   Vilajeliu A, 2016, VACCINE, V34, P3719, DOI 10.1016/j.vaccine.2016.05.051
   Vornhagen J, 2017, TRENDS MICROBIOL, V25, P919, DOI 10.1016/j.tim.2017.05.013
   Voysey M, 2017, VACCINE, V35, P5850, DOI 10.1016/j.vaccine.2017.09.002
   Wanlapakorn N, 2019, CLIN INFECT DIS
   World Health Organization, 2018, GLOB HLTH OBS GHO DA
   World Health Organization, 2019, PROT ALL TET GUID SU
   World Health Organization Europe, 2014, EUR VACC ACT PLAN 20
NR 80
TC 0
Z9 0
U1 9
U2 9
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6199
EI 1432-1076
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD FEB
PY 2020
VL 179
IS 2
BP 235
EP 242
DI 10.1007/s00431-019-03563-w
PG 8
WC Pediatrics
SC Pediatrics
GA KJ3BO
UT WOS:000511932000005
PM 31912233
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Green, C
   Ntansah, C
   Frey, MT
   Krashin, JW
   Lathrop, E
   Romero, L
AF Green, Caitlin
   Ntansah, Charity
   Frey, Meghan T.
   Krashin, Jamie W.
   Lathrop, Eva
   Romero, Lisa
TI Assessment of Contraceptive Needs and Improving Access in the
   US-Affiliated Pacific Islands in the Context of Zika
SO JOURNAL OF WOMENS HEALTH
LA English
DT Article
DE Zika; contraception; preparedness; USAPI
ID ACTING REVERSIBLE CONTRACEPTIVES; FAMILY-PLANNING-SERVICES; PUERTO-RICO;
   INCREASING ACCESS; POSTPARTUM WOMEN; UNITED-STATES; PREPAREDNESS;
   STRATEGIES; NETWORK
AB Scientific evidence demonstrated a causal relationship between Zika virus infection during pregnancy and neurologic abnormalities and other congenital defects. The U.S. government's Zika Virus Disease Contingency Response Plan recognized the importance of preventing unintended pregnancy through access to high-quality family planning services as a primary strategy to reduce adverse Zika-related birth outcomes during the 2016-2017 Zika virus outbreak. The U.S.-affiliated Pacific Islands (USAPI) includes three U.S. territories: American Samoa, the Commonwealth of the Northern Mariana Islands, and Guam, and three independent countries in free association with the United States: the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. Aedes spp. mosquitoes, the primary vector that transmits Zika virus, are common across the Pacific Islands, and in 2016, laboratory-confirmed cases of Zika virus infection in USAPI were reported. CDC conducted a rapid assessment by reviewing available reproductive health data and discussing access to contraception with family planning providers and program staff in all six USAPI jurisdictions between January and May 2017. In this report, we summarize findings from the assessment; discuss strategies developed by jurisdictions to respond to identified needs; and describe a training that was convened to provide technical assistance to USAPI. Similar rapid assessments may be used to identify training and technical assistance needs in other emergency preparedness and response efforts that pose a risk to pregnant women and their infants.
C1 [Green, Caitlin; Frey, Meghan T.] CDC, Div Birth Defects & Infant Disorders, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway, Atlanta, GA 30341 USA.
   [Ntansah, Charity] Karna Contracting LLC, Atlanta, GA USA.
   [Krashin, Jamie W.; Lathrop, Eva; Romero, Lisa] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
   [Krashin, Jamie W.] Univ New Mexico, Sch Med, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA.
   [Lathrop, Eva] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA.
RP Green, C (corresponding author), CDC, Div Birth Defects & Infant Disorders, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway, Atlanta, GA 30341 USA.
EM lkj8@cdc.gov
CR Biggs MA, 2015, CONTRACEPTION, V91, P167, DOI 10.1016/j.contraception.2014.10.009
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Brittain AW, 2019, WOMEN HEALTH ISS, V29, P245, DOI 10.1016/j.whi.2019.01.007
   Centers for Disease Control and Prevention, 2016, 2016 CAS COUNTS US
   Centers for Disease Control and Prevention, 2017, PREV TRANSM
   Centers for Disease Control and Prevention, 2018, PREGN WOM AN LAB EV
   Central Intelligence Agency, 2016, WORLD FACTBOOK
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Curtis KM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6504a1
   Fowler CI, 2015, FAMILY PLANNING ANN
   Gavin L, 2014, MMWR RECOMM REP, V63, P1
   Kroelinger CD, 2019, J WOMENS HEALTH, V28, P346, DOI 10.1089/jwh.2018.7083
   Kroelinger CD, 2019, MMWR-MORBID MORTAL W, V68, P777, DOI 10.15585/mmwr.mm6836a1
   Kroelinger CD, 2017, MMWR-MORBID MORTAL W, V66, P1230, DOI 10.15585/mmwr.mm6644a6
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Martins SL, 2016, PERSPECT SEX REPRO H, V48, P9, DOI 10.1363/48e7116
   Office of the Assistant Secretary for Preparedness and Response, 2016, US GOV ZIK VIR DIS C
   Olson SM, 2019, BIRTH DEFECTS RES, V111, P938, DOI 10.1002/bdr2.1546
   Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]
   Ricketts S, 2014, PERSPECT SEX REPRO H, V46, P125, DOI 10.1363/46e1714
   Romero L, 2018, Z CAN INCREASING ACC
   Romero L, 2018, AM J PUBLIC HEALTH, V108, pS227, DOI 10.2105/AJPH.2018.304558
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x
   United Nations Department of Economic and Social Affairs Population Division, 2015, STESASERA349 UN
   Vaaler ML, 2012, WOMEN HEALTH ISS, V22, pE157, DOI 10.1016/j.whi.2011.11.004
NR 26
TC 0
Z9 0
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-9996
EI 1931-843X
J9 J WOMENS HEALTH
JI J. Womens Health
PD FEB 1
PY 2020
VL 29
IS 2
BP 139
EP 147
DI 10.1089/jwh.2020.8302
PG 9
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal; Obstetrics & Gynecology; Women's Studies
SC Public, Environmental & Occupational Health; General & Internal
   Medicine; Obstetrics & Gynecology; Women's Studies
GA KK1CG
UT WOS:000512487100004
PM 32045325
DA 2020-07-08
ER

PT J
AU Wijesooriya, SL
   Nguyen, CT
   Nguyen, TTT
   Vu, TBH
   Taichiro, T
   Morita, K
   Le, TQM
   Dang, DA
   Hasebe, F
   Moi, ML
AF Wijesooriya, Shashika Lavangi
   Co Thach Nguyen
   T Thi Thuy Nguyen
   Thi Bich Hau Vu
   Taichiro, Takemura
   Morita, Kouichi
   Thi Quynh Mai Le
   Duc Anh Dang
   Hasebe, Futoshi
   Meng Ling Moi
TI Long-term surveillance needed to detect Zika virus outbreaks in endemic
   regions
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Wijesooriya, Shashika Lavangi; Taichiro, Takemura; Morita, Kouichi; Hasebe, Futoshi; Meng Ling Moi] Nagasaki Univ, Inst Trop Med, WHO Collaborating Ctr Reference & Res Trop & Emer, Nagasaki 8528523, Japan.
   [Co Thach Nguyen; T Thi Thuy Nguyen; Thi Bich Hau Vu; Thi Quynh Mai Le; Duc Anh Dang] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam.
RP Hasebe, F; Moi, ML (corresponding author), Nagasaki Univ, Inst Trop Med, WHO Collaborating Ctr Reference & Res Trop & Emer, Nagasaki 8528523, Japan.
EM rainbow@nagasaki-u.ac.jp; sherry@nagasaki-u.ac.jp
FU Japan Agency for Medical Research and Development (AMED) (Japan
   Initiative for Global Research Network on Infectious Diseases), e-Asia
   Joint Research Program (e-Asia JRP) [JP19fm0108001, 19jm0210047h0004];
   AMED Research on Emerging and Re-emerging Infectious Diseases
   [19fk0108035j0003, 19fk0108109h0001]
FX We declare no competing interests. We thank health-care practitioners of
   the clinics and hospitals in Vietnam who supported the study. This
   research was supported by Japan Agency for Medical Research and
   Development (AMED) under grant number JP19fm0108001 (Japan Initiative
   for Global Research Network on Infectious Diseases), e-Asia Joint
   Research Program (e-Asia JRP, 19jm0210047h0004), and AMED Research on
   Emerging and Re-emerging Infectious Diseases (19fk0108035j0003 and
   19fk0108109h0001).
CR Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   World Health Organization, 2016, LAB TEST ZIK VIR INF
NR 5
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD FEB
PY 2020
VL 20
IS 2
BP 168
EP 169
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA KH2OB
UT WOS:000510486100024
PM 32006504
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, F
   Lee, EM
   Sun, X
   Wang, DC
   Tang, HL
   Zhou, GC
AF Li, Feng
   Lee, Emily M.
   Sun, Xia
   Wang, Decai
   Tang, Hengli
   Zhou, Guo-Chun
TI Design, synthesis and discovery of andrographolide derivatives against
   Zika virus infection
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE Zika virus; Antiviral; Andrographolide and derivative; Quinolyloxy; 14
   alpha-(8 '-quinolyloxy)
ID 14-ALPHA-LIPOYL ANDROGRAPHOLIDE; BIOLOGICAL-ACTIVITIES; ANTIVIRAL
   PROPERTIES; PANICULATA; DEHYDROANDROGRAPHOLIDE; INHIBITORS; OUTBREAK;
   ANALOGS; DRUG
AB The Zika endemic established by imported and local transmission is of significant concern and effective anti-ZIKV drugs remain an urgent unmet need. As andrographolide was identified to be an inhibitor of DENV and CHIKV and the importance of quinoline structure against infectious diseases was considered, we are interested in studying its andrographolide derivatives with quinoline moiety against Zika virus infection. In addition to screening eight in-house derivatives of andrographolide, sixteen new derivatives were designed, synthesized and tested against Zika virus infection. Among these compounds, two most potent anti-Zika compounds of 19-acetylated 14 alpha,-(5',7'-dichloro-8'-quinolyloxy) derivative 17b and 14 beta-(8'-quinolyloxy)-3,19- diol derivative 3 with the highest selectivity were discovered. The SAR analysis indicates that rational and optimal combined modification/s at 3-, 14-, or 19-positions can make derivatives less toxic and more potent against Zika infection, and both of 3 and 17b are suitable as leads for designing new generation of andrographolide derivatives with quinoline or its structure- and property related moieties against Zika virus and other arboviruses. (C) 2019 Elsevier Masson SAS. All rights reserved.
C1 [Li, Feng; Sun, Xia; Wang, Decai; Zhou, Guo-Chun] Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing 211800, Jiangsu, Peoples R China.
   [Lee, Emily M.; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
RP Zhou, GC (corresponding author), Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing 211800, Jiangsu, Peoples R China.; Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
EM tang@bio.fsu.edu; gczhou@njtech.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [30973621, U0632001]; National Institutes of Health,
   USAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19 AI131130]
FX The work was partially supported by the National Natural Science
   Foundation of China to GCZ (30973621 and U0632001) and National
   Institutes of Health, USA to HT (U19 AI131130).
CR Aromdee C, 2014, EXPERT OPIN THER PAT, V24, DOI 10.1517/13543776.2014.956084
   Aromdee C, 2012, EXPERT OPIN THER PAT, V22, P169, DOI 10.1517/13543776.2012.661718
   Banerjee M, 2017, FOLIA MICROBIOL, V62, P237, DOI 10.1007/s12223-017-0496-9
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Basak A, 1999, BIOCHEM J, V338, P107, DOI 10.1042/0264-6021:3380107
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calabrese C, 2000, PHYTOTHER RES, V14, P333, DOI 10.1002/1099-1573(200008)14:5&lt;333::AID-PTR584&gt;3.0.CO;2-D
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   CAVA MP, 1962, TETRAHEDRON, V18, P397, DOI 10.1016/S0040-4020(01)92685-7
   Chandramohan V, 2015, ADV VIROL, V2015, DOI 10.1155/2015/972067
   CHANG RS, 1991, P SOC EXP BIOL MED, V197, P59
   Chen H, 2014, BIOORG MED CHEM LETT, V24, P2353, DOI 10.1016/j.bmcl.2014.03.060
   Chen JX, 2009, BIOL PHARM BULL, V32, P1385, DOI 10.1248/bpb.32.1385
   Chinese Pharmacopoeia Commission, 2010, CHIN PHARMACOP, V2, P619
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng W L, 1980, Yao Xue Xue Bao, V15, P590
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   Goner M.K., 1911, NEES REC TRAV CHIM, V30, P151
   Gupta S, 2017, ARCH VIROL, V162, P611, DOI 10.1007/s00705-016-3166-3
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Han YS, 2019, J MED VIROL, V91, P1182, DOI 10.1002/jmv.25440
   Kishore V, 2017, CURR TOP MED CHEM, V17, P845, DOI 10.2174/1568026616666160927150452
   KLEIPOOL RJC, 1952, NATURE, V169, P33, DOI 10.1038/169033c0
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee EM, 2019, ASSAY DRUG DEV TECHN, V17, P128, DOI 10.1089/adt.2018.881
   Lee JC, 2014, BRIT J PHARMACOL, V171, P237, DOI 10.1111/bph.12440
   Li F, 2018, RSC ADV, V8, P9440, DOI 10.1039/c8ra01063c
   Lim JCW, 2012, CLIN EXP PHARMACOL P, V39, P300, DOI 10.1111/j.1440-1681.2011.05633.x
   Liu Xinjian, 2003, Zhong Yao Cai, V26, P135
   Ma L, 2012, ANTIMICROB AGENTS CH, V56, P6088, DOI 10.1128/AAC.01119-12
   Mishra Siddhartha Kumar, 2015, Front Biosci (Elite Ed), V7, P255
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nie X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04673-x
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Panraksa P, 2017, ANTIVIR RES, V139, P69, DOI 10.1016/j.antiviral.2016.12.014
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Saiz J., 2017, AGENTS CHEMOTHER, V61
   Shi Gao-Xiang, 2014, Zhongguo Zhong Yao Za Zhi, V39, P2924
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   WHO, ZIKA SIT REP
   Wiart C, 2005, PHYTOTHER RES, V19, P1069, DOI 10.1002/ptr.1765
   Wintachai P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14179
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yan Y.Y., 2013, ZHONGGUO ZHONGYAO ZA, P3819
   Yu B, 2014, CHIN J INTEGR MED, V20, P540, DOI 10.1007/s11655-014-1860-0
   Zeng XP, 2011, ANTIMICROB AGENTS CH, V55, P3015, DOI 10.1128/AAC.00575-10
   Zhang T, 2000, Zhong Yao Cai, V23, P366
   Zhou B, 2013, MINI-REV MED CHEM, V13, P298
NR 60
TC 1
Z9 1
U1 8
U2 8
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB 1
PY 2020
VL 187
AR UNSP 111925
DI 10.1016/j.ejmech.2019.111925
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA KH3CV
UT WOS:000510525000028
PM 31838328
DA 2020-07-08
ER

PT J
AU Shin, YS
   Jarhad, DB
   Jang, MH
   Kovacikova, K
   Kim, G
   Yoon, JS
   Kim, HR
   Hyun, YE
   Tipnis, AS
   Chang, TS
   van Hemert, MJ
   Jeong, LS
AF Shin, Young Sup
   Jarhad, Dnyandev B.
   Jang, Min Hwan
   Kovacikova, Kristina
   Kim, Gyudong
   Yoon, Ji-seong
   Kim, Hong-Rae
   Hyun, Young Eum
   Tipnis, Amol S.
   Chang, Tong-Shin
   van Hemert, Martijn J.
   Jeong, Lak Shin
TI Identification of 6 '-beta-fluoro-homoaristeromycin as a potent
   inhibitor of chikungunya virus replication
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE 6 '-fluorohomoaristeromycin; Anti-RNA virus; Chikungunya;
   S-adenosylhomocysteine hydrolase; Electrophilic fluorination
ID S-ADENOSYLHOMOCYSTEINE HYDROLASE; L-HOMOCYSTEINE HYDROLASE; CARBOCYCLIC
   ANALOG; NEPLANOCIN; ADENOSINE; (-)-ARISTEROMYCIN; INFECTION
AB We have reported on aristeromycin (1) and 6'-fluorinated-aristeromycin analogues (2), which are active against RNA viruses such as Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), Zika virus (ZIKV), and Chikungunya virus (CHIKV). However, these exhibit substantial cytotoxicity. As this cytotoxicity may be attributed to 5'-phosphorylation, we designed and synthesized one-carbon homologated 6'-fluorinated-aristeromycin analogues. This modification prevents 5'-phosphorlyation by cellular kinases, whereas the inhibitory activity towards S-adenosyk-homocysteine (SAH) hydrolase will be retained. The enantiomerically pure 6'-fluorinated-5'-homoaristeromycin analogues 3a-e were synthesized via the electrophilic fluorination of the silyl enol ether with Selectfluor, using a base-build up approach as the key steps. All synthesized compounds exhibited potent inhibitory activity towards SAH hydrolase, among which 6'-beta-fluoroadenosine analogue 3a was the most potent (IC50 = 0.36 mu M). Among the compounds tested, 6'-beta-fluoro-homoaristeromycin 3a showed potent antiviral activity (EC50 = 0.12 mu M) against the CHIKV, without noticeable cytotoxicity up to 250 mu M. Only 3a displayed anti-CHIKV activity, whereas both3a and 3b inhibited SAH hydrolase with similar IC50 values (0.36 and 0.37 mu M, respectively), which suggested that 3a's antiviral activity did not merely depend on the inhibition of SAH hydrolase. This is further supported by the fact that the antiviral effect was specific for CHIKV and some other alphaviruses and none of the homologated analogues inhibited other RNA viruses, such as SARS-CoV, MERS-CoV, and ZIKV. The potent inhibition and high selectivity index make 6'-beta-fluoro-homoaristeromycin (3a) a promising new template for the development of antivirals against CHIKV, a serious re-emerging pathogen that has infected millions of people over the past 15 years. (C) 2019 Elsevier Masson SAS. All rights reserved.
C1 [Shin, Young Sup; Jarhad, Dnyandev B.; Jang, Min Hwan; Kim, Gyudong; Yoon, Ji-seong; Kim, Hong-Rae; Hyun, Young Eum; Tipnis, Amol S.; Chang, Tong-Shin; Jeong, Lak Shin] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 08826, South Korea.
   [Kovacikova, Kristina; van Hemert, Martijn J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Albinusdreef 2, NL-2333ZA Leiden, Netherlands.
RP Jeong, LS (corresponding author), Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 08826, South Korea.
EM lakjeong@snu.ac.kr
RI Karabulut, Erman/G-6679-2011
OI Karabulut, Erman/0000-0002-0787-905X
FU National Research Foundation (NRF), Korea [NRF-2016R1A2B3010164]
FX This work was supported by a grant from the Mid-career Research program
   (NRF-2016R1A2B3010164) of National Research Foundation (NRF), Korea.
CR Agumadu VC, 2018, CUREUS, V10, DOI 10.7759/cureus.3025
   ARITA M, 1983, J AM CHEM SOC, V105, P4049, DOI 10.1021/ja00350a050
   BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971
   BENNETT LL, 1986, MOL PHARMACOL, V29, P383
   BENNETT LL, 1986, BIOCHEM PHARMACOL, V35, P4106, DOI 10.1016/0006-2952(86)90036-5
   Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292
   Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   CANTONI GL, 1986, BIOL METHYLATION DRU, P227
   Chambers TJ., 2003, FLAVIVIRUSES DETECTI, P3
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   Jarhad DB, 2019, ORG CHEM FRONT, V6, P959, DOI 10.1039/c9qo00099b
   Kim G, 2017, ORG LETT, V19, P5732, DOI 10.1021/acs.orglett.7b02470
   KUSAKA T, 1968, J ANTIBIOT, V21, P255, DOI 10.7164/antibiotics.21.255
   MADHAVAN GVB, 1986, J ORG CHEM, V51, P1287, DOI 10.1021/jo00358a023
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Payne S., 2018, INTRO RNA VIRUSES, P97
   SHEALY YF, 1980, CHEM PHARM BULL, V28, P3114
   SHEALY YF, 1969, J AM CHEM SOC, V91, P3075, DOI 10.1021/ja01039a042
   SHEALY YF, 1966, J AM CHEM SOC, V88, P3885, DOI 10.1021/ja00968a055
   SNOECK R, 1993, ANTIVIR RES, V21, P197, DOI 10.1016/0166-3542(93)90028-H
   Thiel V., 2007, CORONAVIRUSES MOL CE
   TSENG CKH, 1989, J MED CHEM, V32, P1442, DOI 10.1021/jm00127a007
   Turner MA, 2000, CELL BIOCHEM BIOPHYS, V33, P101, DOI 10.1385/CBB:33:2:101
   WOLFE MS, 1992, J MED CHEM, V35, P1782, DOI 10.1021/jm00088a013
   WOLFE MS, 1991, J MED CHEM, V34, P1521, DOI 10.1021/jm00109a001
   Yang MM, 2005, BIOORG MED CHEM LETT, V15, P149, DOI 10.1016/j.bmcl.2004.10.019
   Yang MM, 2004, J ORG CHEM, V69, P3993, DOI 10.1021/jo040119g
   Yoon JS, 2019, J MED CHEM, V62, P6346, DOI 10.1021/acs.jmedchem.9b00781
   YOSHIKAWA M, 1990, TETRAHEDRON, V46, P7459, DOI 10.1016/S0040-4020(01)89060-8
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 31
TC 1
Z9 1
U1 10
U2 10
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB 1
PY 2020
VL 187
AR UNSP 111956
DI 10.1016/j.ejmech.2019.111956
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA KH3CV
UT WOS:000510525000031
PM 31841728
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Faical, AVB
   de Oliveira, JMGC
   Andrade, NC
   Lucena, R
   Acosta, AX
   de Siqueira, IC
AF Barros Faical, Adriana Virginia
   Gomes Cabral de Oliveira, Juliana Menezes
   Andrade, Nara C.
   Lucena, Rita
   Acosta, Angelina Xavier
   de Siqueira, Isadora Cristina
TI Socioemotional Status of Children With Uterine Exposure to the Zika
   Virus
SO PEDIATRIC NEUROLOGY
LA English
DT Letter
DE Congenital Zika Infection; Neurodevelopment; Socioemotional status; Zika
   virus
C1 [Barros Faical, Adriana Virginia] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Gomes Cabral de Oliveira, Juliana Menezes; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz Fiocruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Andrade, Nara C.] Univ Catolica Salvador, Dept Psicol, Salvador, BA, Brazil.
   [Lucena, Rita; Acosta, Angelina Xavier] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [443875/2018-9, PPSUS/BA-FAPESB003/2017/SESAB/CNPq/MS
   (5125/2017)]
FX National Council for Scientific and Technological Development (CNPq)
   (443875/2018-9) and PPSUS/BA-FAPESB003/2017/SESAB/CNPq/MS (5125/2017).
CR Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Oliveira JV, 2018, ABSTRACT INT J INFEC, V73, P3
   Trentacosta CJ, 2007, EMOTION, V7, P77, DOI 10.1037/1528-3542.7.1.77
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Weiss LG, BAYLEY ILL CLIN USE
NR 6
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD FEB
PY 2020
VL 103
BP 86
EP 88
DI 10.1016/j.pediatrneurol.2019.07.020
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA KI3GT
UT WOS:000511237900016
PM 31735568
DA 2020-07-08
ER

PT J
AU Weaver, SC
AF Weaver, Scott C.
TI Incrimination of mosquito vectors
SO NATURE MICROBIOLOGY
LA English
DT Editorial Material
ID AEDES-AEGYPTI; ZIKA; ALBOPICTUS; BLOOD
AB Mosquitoes have been known for over a century to transmit viruses such as yellow fever. However, laboratory studies to identify the species capable of natural transmission still fail to explain some outbreaks, such as Zika. Now, this paradox is partially explained by a simple methodological shortcoming.
C1 [Weaver, Scott C.] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
CR Armstrong P. M, 2020, NAT MICROBIOL, DOI [10.1038/10.1038/s41564-019-0619-y, DOI 10.1038/10.1038/S41564-019-0619-Y]
   Azar SR, 2019, EMERG MICROBES INFEC, V8, P242, DOI 10.1080/22221751.2018.1561157
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
NR 10
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD FEB
PY 2020
VL 5
IS 2
BP 232
EP 233
DI 10.1038/s41564-019-0665-5
PG 2
WC Microbiology
SC Microbiology
GA KI2WR
UT WOS:000511211600003
PM 31992894
DA 2020-07-08
ER

PT J
AU Armstrong, PM
   Ehrlich, HY
   Magalhaes, T
   Miller, MR
   Conway, PJ
   Bransfield, A
   Misencik, MJ
   Gloria-Soria, A
   Warren, JL
   Andreadis, TG
   Shepard, JJ
   Foy, BD
   Pitzer, VE
   Brackney, DE
AF Armstrong, Philip M.
   Ehrlich, Hanna Y.
   Magalhaes, Tereza
   Miller, Megan R.
   Conway, Patrick J.
   Bransfield, Angela
   Misencik, Michael J.
   Gloria-Soria, Andrea
   Warren, Joshua L.
   Andreadis, Theodore G.
   Shepard, John J.
   Foy, Brian D.
   Pitzer, Virginia E.
   Brackney, Doug E.
TI Successive blood meals enhance virus dissemination within mosquitoes and
   increase transmission potential
SO NATURE MICROBIOLOGY
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; VECTOR COMPETENCE; ZIKA VIRUS; CHIKUNGUNYA-VIRUS;
   CULEX-TARSALIS; FEEDING PATTERNS; PUERTO-RICO; CULICIDAE; ALBOPICTUS;
   INFECTION
AB The recent Zika virus (ZIKV) and chikungunya virus epidemics highlight the explosive nature of arthropod-borne viruses (arboviruses) transmitted by Aedes spp. mosquitoes(1,2). Vector competence and the extrinsic incubation period (EIP) are two key entomological parameters used to assess the public health risk posed by arboviruses(3). These are typically measured empirically by offering mosquitoes an infectious blood meal and temporally sampling mosquitoes to determine the infection and transmission status. This approach has been used for the better part of a century; however, it does not accurately capture the biology and behaviour of many mosquito vectors that refeed frequently (every 2-3 d)(4). Here, we demonstrate that acquisition of a second non-infectious blood meal significantly shortens the EIP of ZIKV-infected Aedes aegypti by enhancing virus dissemination from the mosquito midgut. Similarly, a second blood meal increases the competence of this species for dengue virus and chikungunya virus as well as Aedes albopictus for ZIKV, suggesting that this phenomenon may be common among other virus-vector pairings and that A. albopictus might be a more important vector than once thought. Blood-meal-induced microperforations in the virus-impenetrable basal lamina that surrounds the midgut provide a mechanism for enhanced virus escape. Modelling of these findings reveals that a shortened EIP would result in a significant increase in the basic reproductive number, R-0, estimated from experimental data. This helps to explain how A. aegypti can sustain explosive epidemics such as ZIKV despite relatively poor vector competence in single-feed laboratory trials. Together, these data demonstrate a direct and unrecognized link between mosquito feeding behaviour, EIP and vector competence.
   This study reports that flavivirus transmission by mosquitoes to mice is increased if mosquitoes feed subsequently on non-infectious blood, possibly because feeding causes microperforations in the gut. Modelling shows this could explain how A. aegypti can sustain an explosive epidemic such as Zika virus despite its perceived poor vector competence.
C1 [Armstrong, Philip M.; Conway, Patrick J.; Bransfield, Angela; Misencik, Michael J.; Gloria-Soria, Andrea; Andreadis, Theodore G.; Shepard, John J.; Brackney, Doug E.] Ctr Vector, Dept Environm Sciences, Connecticut Agr Expt Stn, Zoonot Dis, New Haven, CT USA.
   [Armstrong, Philip M.; Ehrlich, Hanna Y.; Andreadis, Theodore G.; Pitzer, Virginia E.; Brackney, Doug E.] Yale Univ, Yale Sch Publ Hlth, Dept Epidmiol Microbial Dis, New Haven, CT USA.
   [Magalhaes, Tereza; Miller, Megan R.; Foy, Brian D.] Colorado State Univ, Dept MicroBiol, Immunol, Pathology, Ft Collins, CO USA.
   [Conway, Patrick J.] Quinnipiac Univ, Dept BioMed Sciences, Hamden, CT USA.
   [Warren, Joshua L.] Yale Univ, Yale Sch Publ Hlth, Dept BioStat, New Haven, CT USA.
RP Armstrong, PM; Brackney, DE (corresponding author), Ctr Vector, Dept Environm Sciences, Connecticut Agr Expt Stn, Zoonot Dis, New Haven, CT USA.; Armstrong, PM; Brackney, DE (corresponding author), Yale Univ, Yale Sch Publ Hlth, Dept Epidmiol Microbial Dis, New Haven, CT USA.
EM philip.armstrong@ct.gov; doug.brackney@ct.gov
RI Magalhaes, Tereza/V-6632-2019; Gloria-Soria, Andrea/AAJ-3304-2020
OI Gloria-Soria, Andrea/0000-0002-5401-3988
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR001863, KL2 TR001862]; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21 AI129464, R01 AI112970]; NCEZID CDC HHS
   [U01 CK000509]
CR Airs PM, 2019, ACTA TROP, V191, P221, DOI 10.1016/j.actatropica.2019.01.005
   Alm E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003416
   Anderson JF, 2008, J MED ENTOMOL, V45, P445, DOI 10.1603/0022-2585(2008)45[445:EIPFHA]2.0.CO;2
   [Anonymous], 2014, R LANG ENV STAT COMP
   Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769
   Baak-Baak CM, 2017, NEOTROP ENTOMOL, V46, P622, DOI 10.1007/s13744-017-0499-x
   Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965
   Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675
   Calvez E, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2319-x
   Carnell R., 2019, LHS LATIN HYPERCUBE
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298
   De Benedictis J, 2003, AM J TROP MED HYG, V68, P437, DOI 10.4269/ajtmh.2003.68.437
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Diagne CT, 2014, AM J TROP MED HYG, V91, P635, DOI 10.4269/ajtmh.13-0627
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Egizi A, 2013, INFECT GENET EVOL, V16, P122, DOI 10.1016/j.meegid.2013.01.008
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Haese NN, 2016, J INFECT DIS, V214, pS482, DOI 10.1093/infdis/jiw284
   HARDY JL, 1988, ARBOVIRUSES EPIDEMIO, V1, P87
   HOUK EJ, 1981, ACTA TROP, V38, P163
   HSIEH P, 1984, J BIOL CHEM, V259, P2375
   Kantor AM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100571
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   KRAMER LD, 1981, AM J TROP MED HYG, V30, P190, DOI 10.4269/ajtmh.1981.30.190
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   MEYER RP, 1983, AM J TROP MED HYG, V32, P305, DOI 10.4269/ajtmh.1983.32.305
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   Okuda K, 2007, J INSECT PHYSIOL, V53, P1307, DOI 10.1016/j.jinsphys.2007.07.005
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Plummer M, 2018, RJAGS BAYESIAN GRAPH
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   TURELL MJ, 1988, AM J TROP MED HYG, V39, P597, DOI 10.4269/ajtmh.1988.39.597
   Vazeille M, 2018, MED VET ENTOMOL, V32, P251, DOI 10.1111/mve.12284
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   WEAVER SC, 1988, J VIROL, V62, P2083, DOI 10.1128/JVI.62.6.2083-2090.1988
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 57
TC 2
Z9 2
U1 6
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD FEB
PY 2020
VL 5
IS 2
BP 239
EP +
DI 10.1038/s41564-019-0619-y
PG 22
WC Microbiology
SC Microbiology
GA KI2WR
UT WOS:000511211600007
PM 31819213
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Kikuti, M
   Tauro, LB
   Moreira, PSS
   Nascimento, LCJ
   Portilho, MM
   Soares, GC
   Weaver, SC
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Kikuti, Mariana
   Tauro, Laura B.
   Moreira, Patricia S. S.
   Nascimento, Leile Camila J.
   Portilho, Moyra M.
   Soares, Gubio C.
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
   Ribeiro, Guilherme S.
TI Evaluation of two commercially available chikungunya virus IgM
   enzyme-linked immunoassays (ELISA) in a setting of concomitant
   transmission of chikungunya, dengue and Zika viruses
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Accuracy; Sensitivity and specificity; Diagnostic performance;
   Chikungunya virus; Enzyme-linked immunosorbent assay ELISA
ID OUTBREAK
AB Objective: To evaluate the diagnostic performance of the Inbios (Seattle, US) and Euroimmun (Luebeck, Germany) chikungunya virus (CHIKV) IgM enzyme-linked immunoassays (ELISAs).
   Methods: We evaluated the tests' accuracy on sera from 372 patients enrolled in an acute febrile illness surveillance study performed in Salvador, Brazil from Sept/2014 to Jul/2016, a period of simultaneous CHIKV, dengue (DENV), and Zika (ZIKV) virus transmission. We assessed the sensitivity on acute and paired convalescent sera from RT-PCR-confirmed CHIKV cases (collected at median one and 19 days post-onset of symptoms, respectively), and the specificity on sera of RT-PCR-confirmed DENV and ZIKV cases, and on negative patients.
   Results: The Inbios and Euroimmun tests' sensitivities for acute samples were 4.0% and 10.3%, while for convalescent samples they were 92.4% and 96.9%, respectively. Overall, Inbios IgM ELISA specificities for acute and convalescent samples were 97.7% and 90.5%, respectively, and Euroimmun specificities were 88.5% and 83.9%, respectively.
   Conclusions: Both tests presented high sensitivity for convalescent samples. However, the Euroimmun test returned more equivocal results and presented a slightly lower specificity, which might result in a higher rate of false positives if the test is used in scenarios of low CHIKV transmission, when the chance of CHIKV infection is lower. (c) 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Kikuti, Mariana; Tauro, Laura B.; Moreira, Patricia S. S.; Nascimento, Leile Camila J.; Portilho, Moyra M.; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Kikuti, Mariana; Soares, Gubio C.; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Tauro, Laura B.] UNaM, CONICET, Inst Biol Subtrop Nodo Iguazu, Puerto Iguazu, Misiones, Argentina.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Reis, Mitermayer/AAO-9742-2020; Ribeiro, Guilherme/B-6624-2008; Kikuti,
   Mariana/G-2313-2017
OI Reis, Mitermayer/0000-0002-3051-9060; Ribeiro,
   Guilherme/0000-0002-6798-2059; Kikuti, Mariana/0000-0001-8119-7236
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [400830/2013-2, 440891/2016-7]; Bahia Foundation for Research
   Support [PET0026/2013, APP0044/2016, PET0022/2016]; Coordination for the
   Improvement of Higher Education Personnel, Brazilian Ministry of
   Education [88887.130746/2016-00]; Oswaldo Cruz Foundation; Federal
   University of Bahia; Department of Science and Technology, Secretariat
   of Science, Technology and Strategic Inputs, Brazilian Ministry of
   Health
FX This study was supported by the Brazilian National Council for
   Scientific and Technological Development (grants 400830/2013-2 and
   440891/2016-7 to GSR; and scholarships to UK, MGR, and GSR); the Bahia
   Foundation for Research Support (grants PET0026/2013, APP0044/2016, and
   PET0022/2016 to GSR); the Coordination for the Improvement of Higher
   Education Personnel, Brazilian Ministry of Education (grant
   88887.130746/2016-00 to GSR and scholarship to MK); the Oswaldo Cruz
   Foundation; the Federal University of Bahia; and the Department of
   Science and Technology, Secretariat of Science, Technology and Strategic
   Inputs, Brazilian Ministry of Health. The funding sources had no role in
   study design; in the collection, analysis and interpretation of data; in
   the writing of the paper; and in the decision to submit the article for
   publication.
CR [Anonymous], 2017, B EPIDEMIOLOGICO, V48
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Cardoso C.W., 2017, PLOS NEGLECT TROP D, V11, P1
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   PAHO, NUMB REP CAS CHIK FE
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   World Health Organisation, 2008, GUID CLIN MAN CHIK F
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 15
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2020
VL 91
BP 38
EP 43
DI 10.1016/j.ijid.2019.11.001
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA KH7YW
UT WOS:000510867100006
PM 31704226
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Marton, RM
   Pasca, SP
AF Marton, Rebecca M.
   Pasca, Sergiu P.
TI Organoid and Assembloid Technologies for Investigating Cellular
   Crosstalk in Human Brain Development and Disease
SO TRENDS IN CELL BIOLOGY
LA English
DT Review
ID ZIKA VIRUS-INFECTION; OLIGODENDROCYTE PROGENITOR CELLS;
   INITIATION-FACTOR EIF2B; PLURIPOTENT STEM-CELLS; VANISHING WHITE-MATTER;
   RADIAL GLIAL-CELLS; CEREBRAL ORGANOIDS; NEURAL PROGENITORS;
   BASIC-PROTEIN; ASTROCYTES
AB The biology of the human brain, and in particular the dynamic interactions between the numerous cell types and regions of the central nervous system, has been difficult to study due to limited access to functional brain tissue. Technologies to derive brain organoids and assembloids from human pluripotent stem cells are increasingly utilized to model, in progressively complex preparations, the crosstalk between cell types in development and disease. Here, we review the use of these human cellular models to study cell-cell interactions among progenitors, neurons, astrocytes, oligodendrocytes, cancer cells, and non-central nervous system cell types, as well as efforts to study connectivity between brain regions following controlled assembly of organoids. Ultimately, the promise of these patient-derived preparations is to uncover previously inaccessible features of brain function that emerge from complex cell-cell interactions and to improve our mechanistic understanding of neuropsychiatric disorders.
C1 [Marton, Rebecca M.; Pasca, Sergiu P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.
   [Marton, Rebecca M.; Pasca, Sergiu P.] Stanford Univ, Stanford Human Brain Organogenesis Program, Stanford, CA 94305 USA.
RP Pasca, SP (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Pasca, SP (corresponding author), Stanford Univ, Stanford Human Brain Organogenesis Program, Stanford, CA 94305 USA.
EM spasca@stanford.edu
OI Pasca, Sergiu/0000-0002-3216-3248
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Adamsky A, 2018, CELL, V174, P59, DOI 10.1016/j.cell.2018.05.002
   Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Balabanov R, 1998, J NEUROSCI RES, V53, P637, DOI 10.1002/(SICI)1097-4547(19980915)53:6<637::AID-JNR1>3.0.CO;2-6
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bian S., 2018, NAT MED, V9, P122
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Blair JD, 2018, NAT MED, V24, P1568, DOI 10.1038/s41591-018-0139-y
   Boisvert EM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1553-x
   Brancaccio M, 2019, SCIENCE, V363, P187, DOI 10.1126/science.aat4104
   Bugiani M, 2018, BRAIN PATHOL, V28, P408, DOI 10.1111/bpa.12606
   Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74
   Cakir B, 2019, NAT METHODS, V16, P1169, DOI 10.1038/s41592-019-0586-5
   Carson Monica J, 2008, Drug Discov Today Dis Models, V5, P19, DOI 10.1016/j.ddmod.2008.07.006
   Cederquist GY, 2019, NAT BIOTECHNOL, V37, P436, DOI 10.1038/s41587-019-0085-3
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055
   Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048
   Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003
   Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776
   Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva B., 2018, SLAS DISCOV
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Daviaud N, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0219-18.2018
   Davis B.A., 2019, XENOTRANSPLANTED HUM, DOI [10.1101/626218, DOI 10.1101/626218]
   Dermietzel R, 1998, BRAIN RES REV, V26, P176, DOI 10.1016/S0165-0173(97)00031-3
   Dezonne RS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45091
   Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007
   Dooves S, 2016, J CLIN INVEST, V126, P1512, DOI 10.1172/JCI83908
   Douvaras P, 2015, NAT PROTOC, V10, P1143, DOI 10.1038/nprot.2015.075
   Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063
   Ettle B, 2016, MOL NEUROBIOL, V53, P3046, DOI 10.1007/s12035-015-9205-3
   Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304
   Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841
   Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Kaitlin K.I., 2014, CNS DRUGS TAKE LONGE
   Kawaguchi K, 2017, NATURE, V545, P327, DOI 10.1038/nature22321
   Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983
   KIM SU, 1984, BRAIN RES, V300, P195, DOI 10.1016/0006-8993(84)91360-X
   Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9
   Krencik R, 2017, STEM CELL REP, V9, P1745, DOI 10.1016/j.stemcr.2017.10.026
   Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764
   Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424
   Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125
   Liebner S, 2018, ACTA NEUROPATHOL, V135, P311, DOI 10.1007/s00401-018-1815-1
   Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008
   Linkous A, 2019, CELL REP, V26, P3203, DOI 10.1016/j.celrep.2019.02.063
   Lu T.M., 2019, HUMAN INDUCED PLURIP, DOI [10.1101/699173, DOI 10.1101/699173]
   MACKLIN WB, 1986, J NEUROSCI RES, V16, P203, DOI 10.1002/jnr.490160118
   Madhavan M, 2018, NAT METHODS, V15, P700, DOI 10.1038/s41592-018-0081-4
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312
   Marton RM, 2019, NAT NEUROSCI, V22, P484, DOI 10.1038/s41593-018-0316-9
   McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483
   Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540
   Morel L, 2014, J NEUROSCI, V34, P10950, DOI 10.1523/JNEUROSCI.1167-14.2014
   MULLER CM, 1990, GLIA, V3, P487, DOI 10.1002/glia.440030607
   Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Nevin ZS, 2017, AM J HUM GENET, V100, P617, DOI 10.1016/j.ajhg.2017.03.005
   Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ogawa J, 2018, CELL REP, V23, P1220, DOI 10.1016/j.celrep.2018.03.105
   Ormel PR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06684-2
   Ostrom Q.T., 2018, NEUROONCOL, V20, piv
   Paolicelli R.C, 2014, SCIENCE, V1456, P10
   Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411
   Pasca AM, 2019, NAT MED, V25, P784, DOI 10.1038/s41591-019-0436-0
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pasca SP, 2019, SCIENCE, V363, P126, DOI 10.1126/science.aau5729
   Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032
   Phan DTT, 2017, EXP BIOL MED, V242, P1669, DOI 10.1177/1535370217694100
   Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3
   Renner M, 2017, EMBO J, V36, P1316, DOI 10.15252/embj.201694700
   REYNOLDS R, 1989, NEUROSCIENCE, V28, P181, DOI 10.1016/0306-4522(89)90242-X
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Song LQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47444-6
   Song LQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42439-9
   Stocker AM, 2009, DEV BIOL, V328, P66, DOI 10.1016/j.ydbio.2009.01.010
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699
   Tang-Schomer MD, 2018, BRAIN RES, V1678, P288, DOI 10.1016/j.brainres.2017.10.032
   Tani H, 2014, NEURON, V81, P888, DOI 10.1016/j.neuron.2013.12.026
   TAUBER H, 1980, NEUROSCI LETT, V16, P235, DOI 10.1016/0304-3940(80)90003-8
   THOMAS O, 2012, CELL STEM CELL, V21, DOI DOI 10.1088/0964-1726/21/1/015008
   van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112
   Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005
   Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998
   Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094
   Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954
   Xiang YF, 2019, CELL STEM CELL, V24, P487, DOI 10.1016/j.stem.2018.12.015
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Xiao L, 2016, NAT NEUROSCI, V19, P1210, DOI 10.1038/nn.4351
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010
   Yoon SJ, 2019, NAT METHODS, V16, P75, DOI 10.1038/s41592-018-0255-0
   Yu XZ, 2018, NEURON, V99, P1170, DOI 10.1016/j.neuron.2018.08.015
   Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980
   Zhou L, 2019, CNS NEUROSCI THER, V25, P759, DOI 10.1111/cns.13107
NR 124
TC 0
Z9 0
U1 16
U2 16
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0962-8924
EI 1879-3088
J9 TRENDS CELL BIOL
JI Trends Cell Biol.
PD FEB
PY 2020
VL 30
IS 2
BP 133
EP 143
DI 10.1016/j.tcb.2019.11.004
PG 11
WC Cell Biology
SC Cell Biology
GA KE9UI
UT WOS:000508895500004
PM 31879153
DA 2020-07-08
ER

PT J
AU Manet, C
   Simon-Loriere, E
   Jouvion, G
   Hardy, D
   Prot, M
   Conquet, L
   Flamand, M
   Panthier, JJ
   Sakuntabhai, A
   Montagutelli, X
AF Manet, Caroline
   Simon-Loriere, Etienne
   Jouvion, Gregory
   Hardy, David
   Prot, Matthieu
   Conquet, Laurine
   Flamand, Marie
   Panthier, Jean-Jacques
   Sakuntabhai, Anavaj
   Montagutelli, Xavier
TI Genetic Diversity of Collaborative Cross Mice Controls Viral
   Replication, Clinical Severity, and Brain Pathology Induced by Zika
   Virus Infection, Independently of Oas1b
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; flavivirus; mouse model; host genetics; genetic diversity;
   Collaborative Cross; Zika
ID MOUSE MODEL; SUSCEPTIBILITY; TRANSMISSION; ARCHITECTURE; RESISTANCE;
   RESOURCE; CELLS
AB The explosive spread of Zika virus (ZIKV) has been associated with major variations in severe disease and congenital afflictions among infected populations, suggesting an influence of host genes. We investigated how genome-wide variants could impact susceptibility to ZIKV infection in mice. We first describe that the susceptibility of Ifnar1-knockout mice is largely influenced by their genetic background. We then show that Collaborative Cross (CC) mice, which exhibit a broad genetic diversity, in which the type I interferon receptor (IFNAR) was blocked by an anti-IFNAR antibody expressed phenotypes ranging from complete resistance to severe symptoms and death, with large variations in the peak and the rate of decrease in the plasma viral load, in the brain viral load, in brain histopathology, and in the viral replication rate in infected cells. The differences in susceptibility to ZIKV between CC strains correlated with the differences in susceptibility to dengue and West Nile viruses between the strains. We identified highly susceptible and resistant mouse strains as new models to investigate the mechanisms of human ZIKV disease and other flavivirus infections. Genetic analyses revealed that phenotypic variations are driven by multiple genes with small effects, reflecting the complexity of ZIKV disease susceptibility in the human population. Notably, our results rule out the possibility of a role of the Oas1b gene in the susceptibility to ZIKV. Altogether, the findings of this study emphasize the role of host genes in the pathogeny of ZIKV infection and lay the foundation for further genetic and mechanistic studies.
   IMPORTANCE In recent outbreaks, ZIKV has infected millions of people and induced rare but potentially severe complications, including Guillain-Barre syndrome and encephalitis in adults. While several viral sequence variants were proposed to enhance the pathogenicity of ZIKV, the influence of host genetic variants in mediating the clinical heterogeneity remains mostly unexplored. We addressed this question using a mouse panel which models the genetic diversity of the human population and a ZIKV strain from a recent clinical isolate. Through a combination of in vitro and in vivo approaches, we demonstrate that multiple host genetic variants determine viral replication in infected cells and the clinical severity, the kinetics of blood viral load, and brain pathology in mice. We describe new mouse models expressing high degrees of susceptibility or resistance to ZIKV and to other flaviviruses. These models will facilitate the identification and mechanistic characterization of host genes that influence ZIKV pathogenesis.
C1 [Manet, Caroline; Conquet, Laurine; Panthier, Jean-Jacques; Montagutelli, Xavier] Inst Pasteur, Dept Genomes & Genet, Mouse Genet Lab, Paris, France.
   [Simon-Loriere, Etienne; Prot, Matthieu] Inst Pasteur, Dept Virol, Evolutionary Genom RNA Viruses, Paris, France.
   [Jouvion, Gregory] Sorbonne Univ, Hop Armand Trousseau, AP HP, INSERM,Pathophysiol Pediat Genet Dis,UF Genet Mol, Paris, France.
   [Jouvion, Gregory] Inst Pasteur, Expt Neuropathol Unit, Dept Global Hlth, Paris, France.
   [Flamand, Marie] Inst Pasteur, CNRS, UMR 3569, Struct Virol Unit,Dept Virol, Paris, France.
   [Sakuntabhai, Anavaj] Inst Pasteur, CNRS, UMR 2000, Funct Genet Infect Dis Unit,Dept Global Hlth, Paris, France.
RP Montagutelli, X (corresponding author), Inst Pasteur, Dept Genomes & Genet, Mouse Genet Lab, Paris, France.
EM xavier.montagutelli@pasteur.fr
FU French government's Investissement d'Avenir program, Laboratoire
   d'Excellence Integrative Biology of Emerging Infectious DiseasesFrench
   National Research Agency (ANR) [ANR-10-LABX-62-IBEID]
FX This work was supported by a grant from the French government's
   Investissement d'Avenir program, Laboratoire d'Excellence Integrative
   Biology of Emerging Infectious Diseases (grant no.
   ANR-10-LABX-62-IBEID). C.M. was supported by a fellowship from grant no.
   ANR-10-LABX-62-IBEID.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broman KW, 2019, GENETICS, V211, P495, DOI 10.1534/genetics.118.301595
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   do Valle TZ, 2010, J IMMUNOL, V185, P6146, DOI 10.4049/jimmunol.1000949
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Durrant C, 2011, GENOME RES, V21, P1239, DOI 10.1101/gr.118786.110
   Elbahesh H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26437
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Graham JB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005996
   Graham JB, 2015, MBIO, V6, DOI 10.1128/mBio.00493-15
   Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Green R, 2017, G3-GENES GENOM GENET, V7, P1665, DOI 10.1534/g3.117.041624
   HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910
   Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639
   Jaeger AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007343
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Julander JG, 2017, J INFECT DIS, V216, pS919, DOI 10.1093/infdis/jix465
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413
   Keele GR, 2019, G3-GENES GENOM GENET, V9, P1707, DOI 10.1534/g3.119.400194
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lore NI, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0260-6
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Manet C, 2019, BIORXIV, DOI [10.1101/677484, DOI 10.1101/677484]
   Manet C, 2018, MAMM GENOME, V29, P384, DOI 10.1007/s00335-018-9775-2
   Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009
   Noll KE, 2019, CELL HOST MICROBE, V25, P484, DOI 10.1016/j.chom.2019.03.009
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rutledge H, 2014, GENETICS, V198, P735, DOI 10.1534/genetics.114.168138
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Saul MC, 2019, TRENDS GENET, V35, P501, DOI 10.1016/j.tig.2019.04.003
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Shimizu S., 2004, LAB MOUSE, P527, DOI DOI 10.1016/B978-012336425-8/50085-6
   Simon-Loriere E, 2015, J INFECT DIS, V212, P2011, DOI 10.1093/infdis/jiv321
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Snyder-Keller A, 2019, J NEUROSCI, V39, P5393, DOI 10.1523/JNEUROSCI.2666-18.2019
   Srivastava A, 2017, GENETICS, V206, P537, DOI 10.1534/genetics.116.198838
   Talero-Gutierrez C, 2018, EPIDEMIOL INFECT, V146, P673, DOI 10.1017/S0950268818000419
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tokuda S, 2015, GENES IMMUN, V16, P206, DOI 10.1038/gene.2014.79
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Verdonk F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0614-7
   Le-Trilling VTK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174695
   Welsh CE, 2012, MAMM GENOME, V23, P706, DOI 10.1007/s00335-012-9410-6
   Winkler CW, 2018, IMMUNOLOGY, V153, P443, DOI 10.1111/imm.12883
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4667-0
NR 89
TC 1
Z9 1
U1 9
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2020
VL 94
IS 3
AR e01034-19
DI 10.1128/JVI.01034-19
PG 26
WC Virology
SC Virology
GA KD6WN
UT WOS:000508005900004
PM 31694939
DA 2020-07-08
ER

PT J
AU Melo, A
   Gama, GL
   Da Silva, RA
   De Assun?ao, PL
   Tavares, JS
   Da Silva, MB
   Costa, KNFS
   V?nia, ML
   Evangelista, MA
   De Amorim, MMR
AF Melo, Adriana
   Gama, Gabriela L.
   Da Silva Junior, Renan A.
   De Assuncao, Paula L.
   Tavares, Jousilene S.
   Da Silva, Mariana B.
   Costa, Kamila N. F. S.
   Vania, Mell L.
   Evangelista, Morgana A.
   De Amorim, Melania M. R.
TI Motor function in children with congenital Zika syndrome
SO DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
LA English
DT Article
ID CEREBRAL-PALSY; VIRUS-INFECTION; RELIABILITY; SYSTEM
AB Aim To evaluate gross motor function and associated factors in children with congenital Zika syndrome (CZS). Method Fifty-nine children (30 males, 29 females) with CZS at a mean (SD) age of 14.7 (3.9), months (range 5-29mo) were evaluated using the Gross Motor Function Measure (GMFM) and classified according to the Gross Motor Function Classification System (GMFCS). Neurological damage was evaluated by neuroimaging. The mothers' sociodemographic characteristics and general data on the children were obtained from interviews with the mothers and from the children's medical records. Correlational and multiple regression analyses were performed to identify factors associated with these children's motor function. Results In 81% of the children, motor function impairment was severe, classified as GMFCS level V. The overall GMFM score ranged from 5 to 210 (median 18; interquartile range 11), with only four children receiving scores in the D and E dimensions. The factors found to affect motor function were the presence of severe malformations of cortical development and small head circumference at birth. Interpretation Although motor impairment may be mild in some children, it is generally severe. Severe malformations of cortical development and small head circumference at birth were factors associated with poorer motor function, reflecting the greater severity of brain damage. What this paper adds
   Motor impairment is severe in most children with congenital Zika syndrome (CZS). Motor skills are adequate or close to adequate for age in 7% of children with CZS. Severe malformations of cortical development are associated with poor motor control. Small head circumference at birth is also associated with poor motor control.
C1 [Melo, Adriana; Gama, Gabriela L.; Da Silva Junior, Renan A.; De Assuncao, Paula L.; Tavares, Jousilene S.; Da Silva, Mariana B.; Costa, Kamila N. F. S.; Vania, Mell L.; Evangelista, Morgana A.; De Amorim, Melania M. R.] Inst Pesquisa Prof Joaqu Amor Neto IPESQ, Rua Salvino de Oliveira Neto 87, BR-58402040 Campina Grande, Paraiba, Brazil.
RP Melo, A (corresponding author), Inst Pesquisa Prof Joaqu Amor Neto IPESQ, Rua Salvino de Oliveira Neto 87, BR-58402040 Campina Grande, Paraiba, Brazil.
EM asomelo@gmail.com
RI Gama, Gabriela/AAD-1236-2020; Amorim, Melania/C-5807-2013
OI Amorim, Melania/0000-0003-1047-2514
CR Almeida KM, 2017, BRAZ J PHYS THER, V21, P307, DOI 10.1016/j.bjpt.2017.06.009
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Botelho Ana Carla Gomes, 2016, Rev. Bras. Saude Mater. Infant., V16, P39, DOI 10.1590/1806-9304201600s100004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Celikkiran S, 2015, NOROPSIKIYATRI ARS, V52, P180, DOI 10.5152/npa.2015.7230
   Chagas PSC, 2008, BRAZ J PHYS THER, V12, P409, DOI 10.1590/S1413-35552008000500011
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   De Kegel A, 2016, RES DEV DISABIL, V48, P253, DOI 10.1016/j.ridd.2015.11.014
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Durmazlar N, 1998, DEV MED CHILD NEUROL, V40, P411
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Odman P, 2005, J REHABIL MED, V37, P263, DOI 10.1080/16501970510032622
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   Palisano R, 2007, GMFCS E R GROSS MOT
   Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974
   RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341
   Russell DJ, 2000, PHYS THER, V80, P873, DOI 10.1093/ptj/80.9.873
   Soares-Marangoni DD, 2019, DEV NEUROREHABIL, V22, P71, DOI 10.1080/17518423.2018.1437843
   To T, 2004, ARCH PEDIAT ADOL MED, V158, P643, DOI 10.1001/archpedi.158.7.643
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wood E, 2000, DEV MED CHILD NEUROL, V42, P292, DOI 10.1017/S0012162200000529
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 2
Z9 2
U1 10
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0012-1622
EI 1469-8749
J9 DEV MED CHILD NEUROL
JI Dev. Med. Child Neurol.
PD FEB
PY 2020
VL 62
IS 2
BP 221
EP +
DI 10.1111/dmcn.14227
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA KB3TH
UT WOS:000506421700017
PM 30945276
DA 2020-07-08
ER

PT J
AU Gao, H
   Cui, CL
   Wang, LL
   Jacobs-Lorena, M
   Wang, SB
AF Gao, Han
   Cui, Chunlai
   Wang, Lili
   Jacobs-Lorena, Marcelo
   Wang, Sibao
TI Mosquito Microbiota and Implications for Disease Control
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID LIFE-SHORTENING WOLBACHIA; AEDES-AEGYPTI DIPTERA; GUT MICROBIOTA; VECTOR
   COMPETENCE; MALARIA TRANSMISSION; SYMBIOTIC BACTERIA; CHIKUNGUNYA VIRUS;
   MIDGUT BACTERIA; EGG-PRODUCTION; ZIKA VIRUS
AB Mosquito-transmitted diseases account for about 500 000 deaths every year. Blocking these pathogens in the mosquito vector before they are transmitted to humans is an effective strategy to prevent mosquito-borne diseases. Like most higher organisms, mosquitoes harbor a highly diverse and dynamic microbial flora that can be explored for prevention of pathogen transmission. Here we review the structure and function of the mosquito microbiota, including bacteria , fungi, and viruses, and discuss the potential of using components of the microbiota to thwart pathogen transmission.
C1 [Gao, Han; Cui, Chunlai; Wang, Lili; Wang, Sibao] Chinese Acad Sci, Inst Plant Physiol & Ecol, CAS Key Lab Insect Dev & Evolutionary Biol, CAS Ctr Excellence Mol Plant Sci, Shanghai 200032, Peoples R China.
   [Gao, Han; Cui, Chunlai; Wang, Lili; Wang, Sibao] Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing 100049, Peoples R China.
   [Jacobs-Lorena, Marcelo] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
RP Wang, SB (corresponding author), Chinese Acad Sci, Inst Plant Physiol & Ecol, CAS Key Lab Insect Dev & Evolutionary Biol, CAS Ctr Excellence Mol Plant Sci, Shanghai 200032, Peoples R China.; Wang, SB (corresponding author), Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing 100049, Peoples R China.; Jacobs-Lorena, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
EM ljacob13@jhu.edu; sbwang@sibs.ac.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31830086, 31772534, 31472044]; National Key R&D
   Program of China [2017YFD0200400, 2018YFA0900502]; Strategic Priority
   Research Program of Chinese Academy of Sciences [XDB11010500]; Key
   Research Program of the Chinese Academy of SciencesChinese Academy of
   Sciences [KFZD-SW-219]; National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI031478]; Bloomberg Philanthropies
FX This work was supported by grants from the National Natural Science
   Foundation of China (grants 31830086, 31772534, 31830086, 31472044), the
   National Key R&D Program of China (2017YFD0200400, 2018YFA0900502), the
   Strategic Priority Research Program of Chinese Academy of Sciences
   (grant XDB11010500), the Key Research Program of the Chinese Academy of
   Sciences (KFZD-SW-219), National Institutes of Health (NIH) grant
   R01AI031478, and the Bloomberg Philanthropies.
CR Altinli M, 2019, ENVIRON MICROBIOL, V21, P3284, DOI 10.1111/1462-2920.14511
   Anglero-Rodriguez YI, 2017, ELIFE, V6, DOI 10.7554/eLife.28844
   Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Bai L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01580
   Bando H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01641
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2
   Bukhari T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-23
   Capone A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-182
   Cappelli A, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3587-4
   Caragata EP, 2019, CURR OPIN VIROL, V37, P26, DOI 10.1016/j.coviro.2019.05.005
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   CASTRO AJ, 1967, NATURE, V213, P903, DOI 10.1038/213903a0
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chen HL, 2019, P NATL ACAD SCI USA, V116, P22314, DOI 10.1073/pnas.1914571116
   Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335
   Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Contreras E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10732-w
   Coon KL, 2017, P NATL ACAD SCI USA, V114, pE5362, DOI 10.1073/pnas.1702983114
   Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Correa MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07014-2
   Cui CL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12323-1
   de Oliveira SP, 2017, INSECT BIOCHEM MOLEC, V87, P65, DOI 10.1016/j.ibmb.2017.06.010
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Diaz-Nieto LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153133
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005
   Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274
   Dusfour I, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007615
   Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025
   Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Gaio AD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-105
   Gendrin M, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P525, DOI 10.5772/55107
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Hortnagl P, 2010, FEMS MICROBIOL ECOL, V73, P458, DOI 10.1111/j.1574-6941.2010.00904.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066
   Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   King JG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03981-8
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Silva JBL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181678
   Mancini MV, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1266-9
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Minard G, 2013, FEMS MICROBIOL ECOL, V83, P63, DOI 10.1111/j.1574-6941.2012.01455.x
   Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Muturi EJ, 2016, MOL ECOL, V25, P4075, DOI 10.1111/mec.13741
   Onchuru TO, 2016, INT J TROP INSECT SC, V36, P146, DOI 10.1017/S1742758416000096
   ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067
   Patil CD, 2011, PARASITOL RES, V109, P1179, DOI 10.1007/s00436-011-2365-9
   Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691
   Portugal S, 2011, EMBO REP, V12, P1233, DOI 10.1038/embor.2011.213
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Reeves WK, 2004, J VECTOR ECOL, V29, P159
   Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135
   Reveillaud J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08973-w
   Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004
   Ricci I, 2011, ENVIRON MICROBIOL, V13, P911, DOI 10.1111/j.1462-2920.2010.02395.x
   Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002
   Romoli O, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2784-x
   Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015
   Sazama EJ, 2019, ENVIRON ENTOMOL, V48, P127, DOI 10.1093/ee/nvy188
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639
   Scolari F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02036
   Shane JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06580-9
   Sharma A, 2013, ACTA TROP, V128, P41, DOI 10.1016/j.actatropica.2013.06.008
   Sharma P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-235
   Sheehan KB, 2016, MBIO, V7, DOI 10.1128/mBio.00622-16
   Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989
   Steyn A, 2016, MICROB ECOL, V71, P747, DOI 10.1007/s00248-015-0709-1
   Strand MR, 2018, CURR OPIN INSECT SCI, V28, P59, DOI 10.1016/j.cois.2018.05.008
   Tajedin L, 2009, IRAN J ARTHROPOD-BOR, V3, P36
   Tchioffo MT, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01500
   Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516
   Valzania L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006638
   Valzania L, 2018, P NATL ACAD SCI USA, V115, P457, DOI 10.1073/pnas.1719063115
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352
   Walker GM, 2011, ANTON LEEUW INT J G, V99, P25, DOI 10.1007/s10482-010-9491-8
   Wang HB, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0013-6
   Wang SB, 2017, ARTHROPOD VECTOR: CONTROLLER OF DISEASE TRANSMISSION, VOL 1: VECTOR MICROBIOME AND INNATE IMMUNITY OF ARTHROPODS, P219, DOI 10.1016/B978-0-12-805350-8.00013-1
   Wang SB, 2017, SCIENCE, V357, P1399, DOI 10.1126/science.aan5478
   Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001
   Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109
   Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495
   Wei G, 2017, P NATL ACAD SCI USA, V114, P5994, DOI 10.1073/pnas.1703546114
   WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Wu P, 2019, CELL HOST MICROBE, V25, P101, DOI 10.1016/j.chom.2018.11.004
   Yen PS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0011-5
   Yoshida S, 2001, MOL BIOCHEM PARASIT, V113, P89, DOI 10.1016/S0166-6851(00)00387-X
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
   Zhu YB, 2019, NAT MICROBIOL, V4, P2405, DOI 10.1038/s41564-019-0555-x
   Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x
NR 111
TC 1
Z9 1
U1 33
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD FEB
PY 2020
VL 36
IS 2
BP 98
EP 111
DI 10.1016/j.pt.2019.12.001
PG 14
WC Parasitology
SC Parasitology
GA JY8QJ
UT WOS:000504672700005
PM 31866183
DA 2020-07-08
ER

PT J
AU Simao, EP
   Silva, DBS
   Cordeiro, MT
   Gil, LHV
   Andrade, CAS
   Oliveira, MDL
AF Simao, Estefani P.
   Silva, Dammyres B. S.
   Cordeiro, Marli T.
   Gil, Laura H. V.
   Andrade, Cesar A. S.
   Oliveira, Maria D. L.
TI Nanostructured impedimetric lectin-based biosensor for arboviruses
   detection
SO TALANTA
LA English
DT Article
DE Concanavalin A; Nanoparticles; Arboviruses; Biosensor; Impedance
   spectroscopy
ID ZINC-OXIDE NANOPARTICLES; BORON-NITRIDE NANOSHEETS; GOLD NANOPARTICLES;
   SENSOR; DENGUE; CHIKUNGUNYA; DIAGNOSIS; SEROTYPE
AB Arboviruses have been emerging as a significant global health problem due to the recurrent epidemics. Arboviruses require the development of new diagnostic devices due to the nonspecific clinical manifestations. Herein, we report a biosensor based on cysteine (Cys), zinc oxide nanoparticles (ZnONp), and Concanavalin A (ConA) lectin to differentiate between arboviruses infections. ConA is capable of interacting with the saccharide components of the viral capsid. In this study, we evaluated the reproducibility, sensitivity, and specificity of the sensor for the virus of Dengue type 2 (DENV2), Zika (ZIKV), Chikungunya (CHIKV), and Yellow fever (YFV). Atomic force microscopy measurements confirmed the electrode surface modification and revealed a heterogeneous topography during the biorecognition process. Cyclic voltammetry (CV) and impedance spectroscopy (EIS) were used to characterize the biosensor. The blockage of the oxidation-reduction process is related to the formation of Cys-ZnONp-ConA system on the electroactive area and its subsequent interaction with viral glycoproteins. The sensor exhibited a linear response to different concentrations of the studied arboviruses. Our study demonstrates that ConA lectin recognizes the structural glycoproteins of the DENV2, ZIKV, CHIKV, and YFV. DENV2 is the most structurally similar to ZIKV. Our results have shown that the impedimetric response correlates with the structural glycoproteins, as follow: DENV2 (18.6 k Omega) > ZIKV (14.6 k Omega) > CHIKV (6.86 k Omega) > YFV (5.98 k Omega). The homologous structural regions contribute to ConA-arboviruses recognition. Our results demonstrate the use of the proposed system for the development of biosensors for arboviruses infections.
C1 [Simao, Estefani P.; Oliveira, Maria D. L.] Univ Fed Pernambuco, Programa Posgrad Ciencias Biol, BR-50670901 Recife, PE, Brazil.
   [Silva, Dammyres B. S.; Andrade, Cesar A. S.; Oliveira, Maria D. L.] Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
   [Cordeiro, Marli T.; Gil, Laura H. V.] Inst Aggeu Magalhaes Fiocruz, Dept Virol, BR-50670420 Recife, PE, Brazil.
RP Oliveira, MDL (corresponding author), Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
EM m_danielly@yahoo.com.br
RI Oliveira, Maria/AAM-4055-2020
OI Souza de Andrade, Cesar Augusto/0000-0002-3271-2817; Oliveira,
   Maria/0000-0002-8572-4846
FU Foundation for Science and Technology of the State of Pernambuco
   (FACEPE); FACEPE [APQ-0739-2.12/17]; CNPqNational Council for Scientific
   and Technological Development (CNPq) [314894/2018-7, 314756/2018-3]
FX E.P. Simao would like to thank Foundation for Science and Technology of
   the State of Pernambuco (FACEPE) for a Ph.D. scholarship. L.H.V. Gil
   would like to thank FACEPE (grant APQ-0739-2.12/17). M.D.L. Oliveira and
   C.A.S. Andrade would like to thank CNPq (grant 314894/2018-7 and
   314756/2018-3).
CR Akahata W, 2012, J VIROL, V86, P8879, DOI 10.1128/JVI.00370-12
   Andrade CAS, 2011, J COLLOID INTERF SCI, V362, P517, DOI 10.1016/j.jcis.2011.07.013
   Atar N, 2018, J ELECTROCHEM SOC, V165, pH255, DOI [10.1149/2.1311805JES, 10.1149/2.1311805jes]
   Bouckaert J, 1996, J BIOL CHEM, V271, P16144, DOI 10.1074/jbc.271.27.16144
   CDC (U.S. Centers for Disease Control and Prevention), 2016, TRIOPL REAL TIM RT P
   CDC (U.S. Centers for Disease Control and Prevention), 2016, TYP ZIK VIR TESTS
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   da Silva JSL, 2014, COLLOID SURFACE B, V117, P549, DOI 10.1016/j.colsurfb.2013.12.057
   Deeba F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv119
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Grasset F, 2003, J ALLOY COMPD, V360, P298, DOI 10.1016/S0925-8388(03)00371-2
   Grubhoffer L., 2009, LECTINS BIOL BIOCH C, V7, P313
   Gupta VK, 2013, SENSOR ACTUAT B-CHEM, V188, P1201, DOI 10.1016/j.snb.2013.08.034
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Khan R, 2008, ANAL CHIM ACTA, V616, P207, DOI 10.1016/j.aca.2008.04.010
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kurstack E.K.C., 1981, COMP DIAGNOSIS VIRAL
   Ma XH, 2017, SENSOR ACTUAT B-CHEM, V248, P201, DOI 10.1016/j.snb.2017.03.172
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nascimento HPO, 2011, COLLOID SURFACE B, V86, P414, DOI 10.1016/j.colsurfb.2011.04.028
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Oliveira MDL, 2011, J COLLOID INTERF SCI, V362, P194, DOI 10.1016/j.jcis.2011.06.042
   Oliveira MDL, 2011, SENSOR ACTUAT B-CHEM, V155, P789, DOI 10.1016/j.snb.2011.01.049
   Oliveira MDL, 2009, SYNTHETIC MET, V159, P2162, DOI 10.1016/j.synthmet.2009.09.022
   Oliveira MDL, 2009, BIOSENS BIOELECTRON, V25, P728, DOI 10.1016/j.bios.2009.08.009
   Oliveira N, 2015, SENSORS-BASEL, V15, P15562, DOI 10.3390/s150715562
   ORAM JD, 1971, NATURE-NEW BIOL, V233, P50
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Pereira EMA, 2008, COLLOID SURFACE B, V66, P45, DOI 10.1016/j.colsurfb.2008.05.013
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   Schwartz R.M., 2016, J CHROMATOGR B, V1032, P2
   Simao EP, 2016, J BRAZIL CHEM SOC, V27, P1040, DOI 10.5935/0103-5053.20150361
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Taylor P., 2008, ANAL LETT, V41, P37
   Volk DE, 2009, VIROLOGY, V394, P12, DOI 10.1016/j.virol.2009.09.001
   Yang HY, 2016, SENSOR ACTUAT B-CHEM, V229, P297, DOI 10.1016/j.snb.2015.08.034
   Yola ML, 2019, BIOSENS BIOELECTRON, V126, P418, DOI 10.1016/j.bios.2018.11.016
   Yola ML, 2018, APPL SURF SCI, V458, P648, DOI 10.1016/j.apsusc.2018.07.142
   Yola ML, 2015, SENSOR ACTUAT B-CHEM, V210, P149, DOI 10.1016/j.snb.2014.12.098
   Yola ML, 2014, ELECTROCHIM ACTA, V119, P24, DOI 10.1016/j.electacta.2013.12.028
   Yola ML, 2014, ELECTROCHIM ACTA, V125, P38, DOI 10.1016/j.electacta.2014.01.074
   Yumak T, 2011, COLLOID SURFACE B, V86, P397, DOI 10.1016/j.colsurfb.2011.04.030
   Zhao LZ, 2016, SENSOR ACTUAT B-CHEM, V235, P575, DOI 10.1016/j.snb.2016.05.136
NR 48
TC 0
Z9 0
U1 41
U2 41
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD FEB 1
PY 2020
VL 208
AR 120338
DI 10.1016/j.talanta.2019.120338
PG 7
WC Chemistry, Analytical
SC Chemistry
GA JW8RM
UT WOS:000503314200016
PM 31816752
DA 2020-07-08
ER

PT J
AU Oliveira, JH
   Bahia, AC
   Vale, PF
AF Oliveira, Jose Henrique
   Bahia, Ana Cristina
   Vale, Pedro F.
TI How are arbovirus vectors able to tolerate infection?
SO DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
LA English
DT Article
DE Mosquito; Arbovirus; Disease-tolerance
ID DISEASE TOLERANCE; GENETIC-VARIATION; RESISTANCE; DROSOPHILA; VIRULENCE;
   EVOLUTION; PATHWAY; GENOME; VIRUS; MICROBIOTA
AB One of the defining features of mosquito vectors of arboviruses such as Dengue and Zika is their ability to tolerate high levels of virus proliferation without suffering significant pathology. This adaptation is central to vector competence and disease spread. The molecular mechanisms, pathways, cellular and metabolic adaptations responsible for mosquito disease tolerance are still largely unknown and may represent effective ways to control mosquito populations and prevent arboviral diseases. In this review article, we describe the key link between disease tolerance and pathogen transmission, and how vector control methods may benefit by focusing efforts on dissecting the mechanisms underlying mosquito tolerance of arboviral infections. We briefly review recent work investigating tolerance mechanisms in other insects, describe the state of the art regarding the mechanisms of disease tolerance in mosquitos, and highlight the emerging role of gut microbiota in mosquito immunity and disease tolerance.
C1 [Oliveira, Jose Henrique] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.
   [Bahia, Ana Cristina] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Vale, Pedro F.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
RP Oliveira, JH (corresponding author), Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.; Bahia, AC (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.; Vale, PF (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
EM jose.oliveira@ufsc.br; anabahia@biof.ufrj.br; pedro.vale@ed.ac.uk
RI ; Bahia Nascimento, Ana Cristina/G-2372-2015
OI /0000-0003-3814-5312; Bahia Nascimento, Ana Cristina/0000-0002-4584-1888
FU Serrapilheira Institute [Serra-1812-26449]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [407312/20188];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); FINEPCiencia Tecnologia e Inovacao (FINEP);
   Branco Weiss fellowship (School of Biological Sciences, University of
   Edinburgh); Chancellor's Fellowship (School of Biological Sciences,
   University of Edinburgh)
FX J.H.O is supported by Serrapilheira Institute (Serra-1812-26449) and
   CNPq (407312/20188); A.C.B is supported by FAPERJ and FINEP; P.F.V. is
   supported by a Branco Weiss fellowship
   (https://brancoweissfellowship.org/) and a Chancellor's Fellowship
   (School of Biological Sciences, University of Edinburgh).
CR Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232
   Anglero-Rodriguez YI, 2017, ELIFE, V6, DOI 10.7554/eLife.28844
   Anglero-Rodriguez YI, 2016, SCI REP-UK, V6, DOI 10.1038/srep34084
   Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Ayres JS, 2016, CELL, V165, P1323, DOI 10.1016/j.cell.2016.05.049
   Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030
   Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305
   Bahia AC, 2014, ENVIRON MICROBIOL, V16, P2980, DOI 10.1111/1462-2920.12381
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Baucom RS, 2011, FUNCT ECOL, V25, P18, DOI 10.1111/j.1365-2435.2010.01742.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418
   Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260
   Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009
   Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49
   Clayton AM, 2013, DEV COMP IMMUNOL, V39, P323, DOI 10.1016/j.dci.2012.10.009
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   da Silveira ID, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03011
   Dharmarajan G., 2018, BIORXIV
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004
   Gaburro J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0069-2
   Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Grubaugh ND, 2017, CELL REP, V19, P709, DOI 10.1016/j.celrep.2017.03.076
   Gupta V, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170342
   Han C, 2014, NEURON, V81, P544, DOI 10.1016/j.neuron.2013.11.021
   Henschen A.E., 2019, INTEGR COMP BIOL, P1
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   Hongoh Y, 2008, SCIENCE, V322, P1108, DOI 10.1126/science.1165578
   Howick VM, 2017, MOL ECOL, V26, P1533, DOI 10.1111/mec.14017
   Hoze N, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006119
   Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632
   Janeh M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44594
   Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109
   Lambrechts L, 2019, CELL HOST MICROBE, V26, P309, DOI 10.1016/j.chom.2019.08.005
   Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709
   Lefevre T, 2011, P ROY SOC B-BIOL SCI, V278, P751, DOI 10.1098/rspb.2010.1479
   Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690
   Lissner MM, 2018, CURR OPIN INSECT SCI, V29, P133, DOI 10.1016/j.cois.2018.09.004
   Louie A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002435
   Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573
   Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8
   Martins R, 2019, ANNU REV IMMUNOL, V37, P405, DOI 10.1146/annurev-immunol-042718-041739
   Merkling SH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004692
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Miller MR, 2005, J THEOR BIOL, V236, P198, DOI 10.1016/j.jtbi.2005.03.005
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moreno-Garcia M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00451
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nag DK, 2017, J GEN VIROL, V98, P2731, DOI 10.1099/jgv.0.000945
   Nag DK, 2016, VIROLOGY, V498, P164, DOI 10.1016/j.virol.2016.08.022
   Nikoh N, 2011, GENOME BIOL EVOL, V3, P702, DOI 10.1093/gbe/evr064
   O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112
   Ocampo CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061187
   Olmo RP, 2018, NAT MICROBIOL, V3, P1385, DOI 10.1038/s41564-018-0268-6
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Petersen MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200766
   Ping LY, 2007, ENVIRON MICROBIOL, V9, P1572, DOI 10.1111/j.1462-2920.2007.01279.x
   Poirier EZ, 2018, CELL HOST MICROBE, V23, P353, DOI 10.1016/j.chom.2018.02.001
   Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184
   Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Rangan KJ, 2016, SCIENCE, V353, P1434, DOI 10.1126/science.aaf3552
   Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013
   Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198
   Regoes RR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001951
   Reiskind MH, 2010, J VECTOR ECOL, V35, P61, DOI 10.1111/j.1948-7134.2010.00029.x
   Ripert G, 2016, ANTIMICROB AGENTS CH, V60, P3445, DOI 10.1128/AAC.02815-15
   Rodgers FH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006391
   Sahoo M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004327
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Saraiva RG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006443
   Saraiva RG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24296-0
   Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Shaw DK, 2018, TRENDS IMMUNOL, V39, P862, DOI 10.1016/j.it.2018.09.003
   Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782
   Sirisena PDNN, 2018, J MED ENTOMOL, V55, P1580, DOI 10.1093/jme/tjy097
   Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136
   Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Sterkel M, 2017, TRENDS PARASITOL, V33, P633, DOI 10.1016/j.pt.2017.04.008
   Sternberg ED, 2013, AM NAT, V182, pE235, DOI 10.1086/673442
   Sternberg ED, 2012, EVOLUTION, V66, P3367, DOI 10.1111/j.1558-5646.2012.01693.x
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Taracena ML, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006498
   Teixeira L, 2012, BRIEF FUNCT GENOMICS, V11, P375, DOI 10.1093/bfgp/els043
   Testa B., 2018, PLOS NEGLECTED TROP, V12
   Thaker SK, 2019, CELL METAB, V29, P1206, DOI 10.1016/j.cmet.2019.01.024
   Troha K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006847
   Vale PF, 2012, J EVOLUTION BIOL, V25, P1888, DOI 10.1111/j.1420-9101.2012.02579.x
   Vale PF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001769
   Vale PF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1145
   Vale PF, 2011, AM NAT, V177, P510, DOI 10.1086/659002
   Wang H, 2012, J VIROL, V86, P6546, DOI 10.1128/JVI.00125-12
   Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Wu P, 2019, CELL HOST MICROBE, V25, P101, DOI 10.1016/j.chom.2018.11.004
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xiao XP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004848
NR 106
TC 0
Z9 0
U1 64
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0145-305X
EI 1879-0089
J9 DEV COMP IMMUNOL
JI Dev. Comp. Immunol.
PD FEB
PY 2020
VL 103
AR UNSP 103514
DI 10.1016/j.dci.2019.103514
PG 7
WC Fisheries; Immunology; Zoology
SC Fisheries; Immunology; Zoology
GA JS1CL
UT WOS:000500050700011
PM 31585195
DA 2020-07-08
ER

PT J
AU Wang, JL
   Chen, YM
AF Wang, Jinliang
   Chen, Yuming
TI Threshold dynamics of a vector-borne disease model with spatial
   structure and vector-bias
SO APPLIED MATHEMATICS LETTERS
LA English
DT Article
DE Spatial heterogeneity; Global asymptotic stability; Basic reproduction
   number; Threshold dynamics
ID TRANSMISSION DYNAMICS; ZIKA VIRUS
AB In this paper, we formulate and investigate a vector-borne disease model with vector-bias in a bounded spatial domain. The main result is a threshold dynamics characterized in terms of the basic reproduction number R-0 or equivalently in terms of the principal eigenvalue of the linearized system. Roughly speaking, R-0 < 1 then the semi-trivial equilibrium is globally asymptotically stable and the disease dies out; if R-0 > 1 then the disease persists. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Jinliang] Heilongjiang Univ, Sch Math Sci, Harbin 150080, Heilongjiang, Peoples R China.
   [Chen, Yuming] Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada.
RP Chen, YM (corresponding author), Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada.
EM jinliangwang@hlju.edu.cn; ychen@wlu.ca
OI Chen, Yuming/0000-0002-2896-5627
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11871179]; Natural Science Foundation of
   Heilongjiang ProvinceNatural Science Foundation of Heilongjiang Province
   [LC2018002]; Heilongjiang Provincial Key Laboratory of the Theory and
   Computation of Complex Systems; NSERC of CanadaNatural Sciences and
   Engineering Research Council of Canada
FX The research of Wang was supported by the National Natural Science
   Foundation of China (No. 11871179), Natural Science Foundation of
   Heilongjiang Province (No. LC2018002), and Heilongjiang Provincial Key
   Laboratory of the Theory and Computation of Complex Systems. The
   research of Chen was supported by NSERC of Canada.
CR Bai ZG, 2018, J MATH BIOL, V77, P201, DOI 10.1007/s00285-017-1193-7
   Cai YL, 2019, APPL MATH LETT, V92, P190, DOI 10.1016/j.aml.2019.01.015
   Cai YL, 2019, PHYSICA A, V514, P729, DOI 10.1016/j.physa.2018.09.100
   Cantrell R., 2003, SPATIAL ECOLOGY VIA
   DANIEL TL, 1983, J THEOR BIOL, V105, P661, DOI 10.1016/0022-5193(83)90226-6
   Fitzgibbon WE, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0051-z
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298
   Magal P, 2005, SIAM J MATH ANAL, V37, P251, DOI 10.1137/S0036141003439173
   Magal P, 2018, NONLINEARITY, V31, P5589, DOI 10.1088/1361-6544/aae1e0
   Smith HL, 2001, NONLINEAR ANAL-THEOR, V47, P6169, DOI 10.1016/S0362-546X(01)00678-2
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   Thieme HR, 2009, SIAM J APPL MATH, V70, P188, DOI 10.1137/080732870
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wang LP, 2019, PHYSICA A, V522, P248, DOI 10.1016/j.physa.2019.01.099
   Wang WD, 2012, SIAM J APPL DYN SYST, V11, P1652, DOI 10.1137/120872942
   Wang XN, 2017, SIAM J APPL MATH, V77, P181, DOI 10.1137/15M1046277
NR 17
TC 1
Z9 1
U1 8
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0893-9659
J9 APPL MATH LETT
JI Appl. Math. Lett.
PD FEB
PY 2020
VL 100
AR UNSP 106052
DI 10.1016/j.aml.2019.106052
PG 7
WC Mathematics, Applied
SC Mathematics
GA JJ3GA
UT WOS:000494048300033
DA 2020-07-08
ER

PT J
AU Ramos-Nino, ME
   Fitzpatrick, DM
   Tighe, S
   Eckstrom, KM
   Hattaway, LM
   Hsueh, AN
   Stone, DM
   Dragon, J
   Cheetham, S
AF Ramos-Nino, Maria E.
   Fitzpatrick, Daniel M.
   Tighe, Scott
   Eckstrom, Korin M.
   Hattaway, Lindsey M.
   Hsueh, Andy N.
   Stone, Diana M.
   Dragon, Julie
   Cheetham, Sonia
TI High prevalence of Phasi Charoen-like virus from wild-caught Aedes
   aegypti in Grenada, W. I. as revealed by metagenomic analysis
SO PLOS ONE
LA English
DT Article
ID REVERSE TRANSCRIPTION-PCR; EILAT VIRUS; FLAVIVIRUS; CHIKUNGUNYA;
   MECHANISMS; ALPHAVIRUS; EVOLUTION; DISCOVERY; TRANSMISSION; ARBOVIRUSES
AB Arboviruses cause diseases of significant global health concerns. Interactions between mosquitoes and their microbiota as well as the important role of this interaction in the mosquito's capacity to harbor and transmit pathogens have emerged as important fields of research. Aedes aegypti is one of the most abundant mosquitoes in many geographic locations, a vector capable of transmitting a number of arboviruses such as dengue and Zika. Currently, there are few studies on the metavirome of this mosquito particularly in the Americas. This study analyzes the metavirome of A. aegypti from Grenada, a Caribbean nation with tropical weather, abundant A. aegypti, and both endemic and arboviral pathogens transmitted by this mosquito. Between January and December 2018, 1152 mosquitoes were collected from six semi-rural locations near houses in St. George Parish, Grenada, by weekly trapping using BG-Sentinel traps. From these, 300 A. aegypti were selected for analysis. The metavirome was analyzed using the Illumina HiSeq 1500 for deep sequencing. The generation sequencing library construction protocol used was NuGEN Universal RNA with an average read length of 125 bp. Reads were mapped to the A. aegypti assembly. Non-mosquito reads were analyzed using the tools FastViromeExplorer. The NCBI total virus, RNA virus, and eukaryotic virus databases were used as references. The metagenomic comparison analysis showed that the most abundant virus-related reads among all databases and assemblies was Phasi Charoen-like virus. The Phasi Charoen-like virus results are in agreement to other studies in America, Asia and Australia. Further studies using wild-caught mosquitoes is needed to assess the impact of this insect-specific virus on the A. aegypti lifecycle and vector capacity.
C1 [Ramos-Nino, Maria E.] St Georges Univ, Sch Med, Dept Microbiol, St Georges, Grenada.
   [Fitzpatrick, Daniel M.; Hsueh, Andy N.; Stone, Diana M.; Cheetham, Sonia] St Georges Univ, Sch Vet Med, Dept Pathobiol, St Georges, Grenada.
   [Tighe, Scott; Eckstrom, Korin M.; Hattaway, Lindsey M.; Dragon, Julie] Univ Vermont, Massively Parallel Sequencing Facil, Burlington, VT USA.
RP Ramos-Nino, ME (corresponding author), St Georges Univ, Sch Med, Dept Microbiol, St Georges, Grenada.; Cheetham, S (corresponding author), St Georges Univ, Sch Vet Med, Dept Pathobiol, St Georges, Grenada.
EM mramosni@sgu.edu; scheetha@sgu.edu
RI Cheetham, Sonia/AAS-5409-2020
OI Cheetham, Sonia/0000-0002-0878-1222; Eckstrom,
   Korin/0000-0002-6941-7627; Ramos-Nino, Maria/0000-0002-4976-5333;
   Fitzpatrick, Daniel/0000-0002-1411-4178
FU Windward Islands Research and Education Foundation's One Health Research
   Initiative Grant [4-11-10]
FX This research was funded by The Windward Islands Research and Education
   Foundation's One Health Research Initiative Grant 4-11-10.
CR Aldridge RL, 2016, J AM MOSQUITO CONTR, V32, P282, DOI 10.2987/16-6609.1
   Atyame CM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2273
   Ballinger MJ, 2014, J VIROL, V88, P8783, DOI 10.1128/JVI.00531-14
   Beckmann JF, 2012, J MED ENTOMOL, V49, P1103, DOI 10.1603/ME12049
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0
   Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Darsie JR, 2005, IDENTIFICATION GEOGR, DOI [10.1017/s0031182005228834, DOI 10.1017/S0031182005228834]
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Dudas G, 2015, ELIFE, V4, DOI 10.7554/eLife.06837
   Fitzpatrick DM, 2019, J MED ENTOMOL, P1, DOI [10.1093/jme/tjy197, DOI 10.1093/JME/TJY197]
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Fredericks AC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007346
   Fujita R, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00736
   Gaffigan T, 2015, SYSTEMATIC CATALOG C
   Grywna K, 2010, J CLIN MICROBIOL, V48, P3386, DOI 10.1128/JCM.00317-10
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Hermanns K, 2017, J GEN VIROL, V98, P43, DOI 10.1099/jgv.0.000694
   Hill CL, 2014, ACTA TROP, V140, P151, DOI 10.1016/j.actatropica.2014.07.015
   Hobson-Peters J, 2016, VIROLOGY, DOI [10.1016/j.virol.2015.11.003, DOI 10.1016/J.VIR0L.2015.11.003]
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Jakob W, 1967, AEDES AEGYPTI HDB SE, V6
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johnson KN, 2015, CURR OPIN INSECT SCI, V8, P97, DOI 10.1016/j.cois.2015.01.008
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar Satish, 2015, Biotechnol Res Int, V2015, P121735, DOI 10.1155/2015/121735
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059
   Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14
   Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109
   Ohlund P, 2019, VIRUS GENES, V55, P127, DOI 10.1007/s11262-018-01629-9
   Olmo RP, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920190122
   Parry R, 2018, J VIROL, V92, DOI [10.1128/JVI.00224-18, 10.1128/jvi.00224-18]
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Plyusnin A, 2014, VIRUS RES, V187, P22, DOI 10.1016/j.virusres.2014.01.008
   Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Richard V, 2019, New Microbes and New Infections, V31, DOI 10.1016/j.nmni.2019.100569
   Romo H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0180-4
   Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1
   Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043
   Sangdee K, 2013, SE ASIAN J TROP MED
   Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Scolari F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02036
   Shi CY, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0734-2
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Sultan M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-675
   Talavera S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2887-4
   Tandina F, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3045-8
   Tithi SS, 2018, PEERJ, V6, DOI 10.7717/peerj.4227
   Vasilakis N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-97
   Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhang GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02347-2
   Zhang X, 2018, VIROLOGY, DOI [10.1016/j.virol.2018.07.021, DOI 10.1016/J.VIR0L.2018.07.021]
NR 78
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 31
PY 2020
VL 15
IS 1
AR e0227998
DI 10.1371/journal.pone.0227998
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP9CX
UT WOS:000534614600010
PM 32004323
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, YK
   Li, Y
   Wang, XH
   Zou, P
AF Chen, Yongkang
   Li, Yuan
   Wang, Xiaohuan
   Zou, Peng
TI Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by
   Disrupting Viral Integrity
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; flavivirus; montelukast; viral inactivator; viral integrity
ID SYNDROME CORONAVIRUS REPLICATION; SMALL-MOLECULE INHIBITORS; DENGUE
   VIRUS; IDENTIFICATION; VACCINE; BRAIN
AB The association of Zika virus (ZIKV) infection and severe complications including neurological sequelae especially fetal microcephaly has aroused global attentions since its outbreak in 2015. Currently, there are no vaccines or therapeutic drugs clinically approved for treatments of ZIKV infection, however. And the drugs used for treating ZIKV in pregnant women require a higher safety profile. Here, we identified an anti-asthmatic drug, montelukast, which is of safety profile for pregnant women and exhibited antiviral efficacy against ZIKV infection in vitro and in vivo. And we showed that montelukast could disrupt the integrity of the virions to release the viral genomic RNA, hence irreversibly inhibiting viral infectivity. In consideration of the neuro-protective activity that montelukast possessed, which was previously reported, it is promising that montelukast could be used for patients with ZIKV infection, particularly for pregnant women.
C1 [Chen, Yongkang; Li, Yuan; Wang, Xiaohuan; Zou, Peng] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
RP Zou, P (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
EM zoupeng@shphc.org.cn
RI Karabulut, Erman/G-6679-2011
OI Karabulut, Erman/0000-0002-0787-905X
FU Shanghai Public Health Clinical Center [2016-27, KY-GW-2017-17]
FX This work was supported by the funding from the Shanghai Public Health
   Clinical Center (2016-27 and KY-GW-2017-17).
CR Ahmad A, 2018, TROP BIOMED, V35, P1115
   Avelino-Silva VL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860064, 10.1590/s1678-9946201860064]
   Bakhireva LN, 2007, J ALLERGY CLIN IMMUN, V119, P618, DOI 10.1016/j.jaci.2006.12.618
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cavero-Carbonell C, 2017, BIRTH DEFECTS RES, V109, P452, DOI 10.1002/bdra.23621
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Fernandes-Monteiro AG, 2015, HUM VACC IMMUNOTHER, V11, P1865, DOI 10.4161/21645515.2014.990854
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131
   Gelosa P, 2019, PHARMACOL RES, V142, P223, DOI 10.1016/j.phrs.2019.02.025
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Hoxha M, 2017, EUR J CLIN PHARMACOL, V73, P799, DOI 10.1007/s00228-017-2242-2
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Lai JE, 2014, NEUROPHARMACOLOGY, V79, P707, DOI 10.1016/j.neuropharm.2014.01.011
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liu Q, 2015, ANTIMICROB AGENTS CH, V59, P742, DOI 10.1128/AAC.03977-14
   Lok SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050995
   Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Peixoto HM, 2019, T ROY SOC TROP MED H, V113, P252, DOI 10.1093/trstmh/trz010
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Si LL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau8408
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   St John AL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003783
   St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wang XH, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111064
   Wang XH, 2017, FRONT MED-PRC, V11, P449, DOI 10.1007/s11684-017-0589-5
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu NN, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008093
   Wu WH, 2018, J MED VIROL, V90, P1681, DOI 10.1002/jmv.25253
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan MC, 2018, VIROL J, V15, DOI 10.1186/s12985-017-0913-3
NR 57
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 30
PY 2020
VL 10
AR 3079
DI 10.3389/fmicb.2019.03079
PG 14
WC Microbiology
SC Microbiology
GA KN2GP
UT WOS:000514660100001
PM 32082265
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fernandez, E
   Dejnirattisai, W
   Cao, B
   Scheaffer, SM
   Supasa, P
   Wongwiwat, W
   Esakky, P
   Drury, A
   Mongkolsapaya, J
   Moley, KH
   Mysorekar, IU
   Screaton, GR
   Diamond, MS
AF Fernandez, Estefania
   Dejnirattisai, Wanwisa
   Cao, Bin
   Scheaffer, Suzanne M.
   Supasa, Piyada
   Wongwiwat, Wiyada
   Esakky, Prabagaran
   Drury, Andrea
   Mongkolsapaya, Juthathip
   Moley, Kelle H.
   Mysorekar, Indira U.
   Screaton, Gavin R.
   Diamond, Michael S.
TI Human antibodies to the dengue virus E-dimer epitope have therapeutic
   activity against Zika virus infection (vol 45, pg 917, 2020)
SO NATURE IMMUNOLOGY
LA English
DT Correction; Early Access
AB An amendment to this paper has been published and can be accessed via a link at the top of the paper.
EM g.screaton@imperial.ac.uk
CR FERNANDEZ E, 2020, NATURE IMMUNOLOGY, V45, P917
NR 1
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
DI 10.1038/s41590-019-0560-5
EA JAN 2020
PG 1
WC Immunology
SC Immunology
GA KH0HD
UT WOS:000510328100002
PM 32001822
OA Bronze
DA 2020-07-08
ER

PT J
AU Noguchi, KK
   Swiney, BS
   Williams, SL
   Huffman, JN
   Lucas, K
   Wang, SH
   Kapral, KM
   Li, A
   Dikranian, KT
AF Noguchi, Kevin K.
   Swiney, Brant S.
   Williams, Sasha L.
   Huffman, Jacob N.
   Lucas, Katherine
   Wang, Sophie H.
   Kapral, Kayla M.
   Li, Amber
   Dikranian, Krikor T.
TI Zika Virus Infection in the Developing Mouse Produces Dramatically
   Different Neuropathology Dependent on Viral Strain
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE apoptosis; congenital Zika syndrome; excitotoxicity; microcephaly;
   microencephaly; Zika virus
ID CENTRAL-NERVOUS-SYSTEM; BRAIN; INFANTS; BRAZIL; NEURODEGENERATION;
   APOPTOSIS; FETAL; MODEL; BIRTH; AGE
AB Zika virus (ZIKV) infection during pregnancy has been causally linked to a constellation of neurodevelopmental deformities in the fetus resulting in a disease termed congenital Zika syndrome (CZS). Here we detail how ZIKV infection produces extensive neuropathology in the developing mouse brain and spinal cord of both sexes. Surprisingly, neuropathology differs depending on viral strain with a French Polynesian isolate producing primarily excitotoxicity and a Brazilian isolate being almost exclusively apoptotic but occurring over a prolonged period that is more likely to produce severe hypoplasia. We also show exposure can produce a characteristic pattern of infection that mirrors neuropathology and ultimately results in gross morphological deformities strikingly similar to CZS. This research provides a valuable mouse model mirroring the clinical course of disease that can be used to test potential therapies to improve treatment and gain a better understanding of the disabilities associated with CZS.
C1 [Noguchi, Kevin K.; Swiney, Brant S.; Williams, Sasha L.; Huffman, Jacob N.; Lucas, Katherine; Wang, Sophie H.; Kapral, Kayla M.; Li, Amber] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA.
   [Dikranian, Krikor T.] Washington Univ, Dept Neurosci, St Louis, MO 63110 USA.
RP Noguchi, KK (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63110 USA.
EM noguchik@wustl.edu
FU Intellectual and Developmental Disabilities Research Center (IDDRC) at
   Washington University (IDDRC@WUSTL Research Program) [NICHD
   U54-HD087011]; St. Louis Children's Hospital [CDI-CORE-2015-505];
   Foundation for Barnes-Jewish Hospital [3770]; WashingtonUniversity
   School of Medicine; Children's DiscoveryInstitute of Washington
   University
FX This work was supported by Large Exploratory and PilotGrants (K.K.N.)
   from the Intellectual and Developmental Disabilities Research Center
   (IDDRC) at Washington University (IDDRC@WUSTL Research Program) in
   addition to a NIH Grant (NICHD U54-HD087011) for the IDDRC at Washington
   University. We thank Dr. Michael Diamond and his laboratory
   (particularly Jen Govero) for their support and advice in the design and
   implementation of thesestudies. Electron microscopic imagingwas
   performedattheWashingtonUniversity Center forCellularImaging supported
   by theWashingtonUniversity School of Medicine, The Children's
   DiscoveryInstitute of Washington University,St. Louis Children's
   Hospital (CDI-CORE-2015-505), and the Foundation for Barnes-Jewish
   Hospital (3770).
CR [Anonymous], 2011, GUIDE CARE USE LAB A
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Beck J., 2016, ATLANTIC
   Berngruber TW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003209
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cabrera OH, 2017, J MATERN-FETAL NEO M, V30, P2734, DOI 10.1080/14767058.2016.1261400
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173
   Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X
   de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0
   Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901
   Frieden T, 2016, TRANSCRIPT CDC TELEB
   Gaburro J, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0989-4
   Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ishimaru MJ, 1999, J COMP NEUROL, V408, P461
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Kidokoro H, 2017, J PERINATOL, V37, P1210, DOI 10.1038/jp.2017.114
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453
   LEWIS ML, 1989, OPHTHALMOLOGY, V96, P875
   Lindquist MA, 2015, PSYCHOSOM MED, V77, P114, DOI 10.1097/PSY.0000000000000148
   MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97
   Noguchi KK, 2005, DEV BRAIN RES, V158, P82, DOI 10.1016/j.devbrainres.2005.06.006
   Noguchi KK, 2001, HDB NEUROTOXICOLOGY, V2, P1582
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Sengul M, 2015, 2015 9TH INTERNATIONAL CONFERENCE ON ELECTRICAL AND ELECTRONICS ENGINEERING (ELECO), P115, DOI 10.1109/ELECO.2015.7394554
   TORVIK A, 1956, J NEUROPATH EXP NEUR, V15, P119, DOI 10.1097/00005072-195604000-00001
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Trumpy J H, 1971, Ergeb Anat Entwicklungsgesch, V44, P3
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 63
TC 0
Z9 0
U1 5
U2 5
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD JAN 29
PY 2020
VL 40
IS 5
BP 1145
EP 1161
DI 10.1523/JNEUROSCI.1376-19.2019
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA KG5UA
UT WOS:000510014900016
PM 31836659
DA 2020-07-08
ER

PT J
AU Dodero-Rojas, E
   Ferreira, LG
   Leite, VBP
   Onuchic, JN
   Contessoto, VG
AF Dodero-Rojas, Esteban
   Ferreira, Luiza G.
   Leite, Vitor B. P.
   Onuchic, Jose N.
   Contessoto, Vinicius G.
TI Modeling Chikungunya control strategies and Mayaro potential outbreak in
   the city of Rio de Janeiro
SO PLOS ONE
LA English
DT Article
ID BASIC REPRODUCTION NUMBER; VIRUS-INFECTION; AEDES-AEGYPTI; YELLOW-FEVER;
   SAO-PAULO; DENGUE; EPIDEMIC; RISK; TRANSMISSION; MOSQUITO
AB Mosquito-borne diseases have become a significant health issue in many regions around the world. For tropical countries, diseases such as Dengue, Zika, and Chikungunya, became epidemic in the last decades. Health surveillance reports during this period were crucial in providing scientific-based information to guide decision making and resources allocation to control outbreaks. In this work, we perform data analysis of the last Chikungunya epidemics in the city of Rio de Janeiro by applying a compartmental mathematical model. Sensitivity analyses were performed in order to describe the contribution of each parameter to the outbreak incidence. We estimate the "basic reproduction number" for those outbreaks and predict the potential epidemic outbreak of the Mayaro virus. We also simulated several scenarios with different public interventions to decrease the number of infected people. Such scenarios should provide insights about possible strategies to control future outbreaks.
C1 [Dodero-Rojas, Esteban; Onuchic, Jose N.; Contessoto, Vinicius G.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.
   [Dodero-Rojas, Esteban] Univ Costa Rica, Theoret & Computat Phys Lab, San Jose, Costa Rica.
   [Ferreira, Luiza G.; Onuchic, Jose N.] Rice Univ, Dept Chem, Houston, TX USA.
   [Leite, Vitor B. P.] Sao Paulo State Univ, Inst Biosci Letters & Exact Sci, Dept Phys, UNESP, Sao Jose Do Rio Preto, SP, Brazil.
   [Onuchic, Jose N.] Rice Univ, Dept Phys & Astron, Houston, TX USA.
   [Onuchic, Jose N.] Rice Univ, Dept Biosci, Houston, TX USA.
   [Contessoto, Vinicius G.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biorenewables Natl Lab LNBR, Campinas, SP, Brazil.
RP Contessoto, VG (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.; Contessoto, VG (corresponding author), Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biorenewables Natl Lab LNBR, Campinas, SP, Brazil.
EM contessoto@rice.edu
FU Center for Theoretical Biological Physics - NSF [PHY-1427654];
   NSF-CHENational Science Foundation (NSF) [1614101]; FAPESP (Sao Paulo
   Research Foundation)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2016/13998-8, 2017/09662-7]; CAPESCAPES; Higher Education
   Personnel Improvement Coordination; FAPESPFundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) [2018/18668-1]
FX This work was supported by the Center for Theoretical Biological Physics
   sponsored by the NSF (https://www.nsf.gov) (Grant PHY-1427654) and by
   NSF-CHE 1614101. JNO is a Cancer Prevention and Research Institute of
   Texas (CPRIT) Scholar in Cancer Research. VGC was funded by Grant
   2016/13998-8 and 2017/09662-7, FAPESP (Sao Paulo Research Foundation and
   Higher Education Personnel -http://www.fapesp.br) and CAPES and (Higher
   Education Personnel Improvement Coordination
   -http://www.capes.gov.br/).VBPL also acknowledges FAPESP Grant
   2018/18668-1. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   ANDERSON R M, 1991
   Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540
   Brustolin M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006895
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Coordenacao de Vigilancia Epidemiologica, 2018, INF EP
   Coordenacao de Vigilancia Epidemiologica, 2019, INF EP
   Coordenaco de Vigilancia Epidemiologica, 2016, INF EP
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   de Vigilancia em Saude Secretaria, 2019, B EPIDEMIOLOGICO, V50
   Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Erguler K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174293
   Fitzgibbon WE, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0051-z
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013
   Izurieta RO, 2011, J GLOB INFECT DIS, V3, P317, DOI 10.4103/0974-777X.91049
   Kantor AM, 2019, J MED ENTOMOL, V56, P832, DOI 10.1093/jme/tjy241
   Kantor AM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100571
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   MACDONAL.G, 1965, T ROY SOC TROP MED H, V59, P489, DOI 10.1016/0035-9203(65)90152-5
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI 10.1590/s0034-89102003000400013
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Nsubuga P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P997
   Pan American Health Organization & World Health Organization, 2019, EP AL MAY FEV
   Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561
   Pego PN, 2014, J HUMAN VIROLOGY RET
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339
   Samsuzzoha M, 2013, APPL MATH MODEL, V37, P903, DOI 10.1016/j.apm.2012.03.029
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wearing HJ, 2016, PARASITOLOGY, V143, P860, DOI 10.1017/S0031182016000421
   Wiggins K, 2018, MED VET ENTOMOL, V32, P436, DOI 10.1111/mve.12322
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 45
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 28
PY 2020
VL 15
IS 1
AR e0222900
DI 10.1371/journal.pone.0222900
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP8ZJ
UT WOS:000534605400005
PM 31990920
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Colucci, F
AF Colucci, Francesco
TI Sharing Knowledge With Young and Established Students of Immunology by
   the Neapolitan Gulf at the Ruggero Ceppellini Advanced School
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE pregnancy; immunity; transplantation; cancer; collaborations
ID ZIKA VIRUS; PREGNANCY; KIR; RECEPTORS; LIGANDS; WOMEN
C1 [Colucci, Francesco] Univ Cambridge, Sch Clin Med, Dept Obstet & Gynaecol, Natl Inst Hlth Res,Cambridge Biomed Res Ctr, Cambridge, England.
   [Colucci, Francesco] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England.
RP Colucci, F (corresponding author), Univ Cambridge, Sch Clin Med, Dept Obstet & Gynaecol, Natl Inst Hlth Res,Cambridge Biomed Res Ctr, Cambridge, England.; Colucci, F (corresponding author), Univ Cambridge, Ctr Trophoblast Res, Cambridge, England.
EM fc287@medschl.cam.ac.uk
FU  [200841/Z/16/Z]
FX Work in the Colucci laboratory is funded by theWellcome Trust (Grant
   Number 200841/Z/16/Z).
CR Aghaeepour N, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan2946
   Bodmer W, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01280
   Colucci F, 2019, EUR J IMMUNOL, V49, P2123, DOI 10.1002/eji.201970125
   Colucci F, 2019, SCIENCE, V365, P862, DOI 10.1126/science.aaw1300
   Colucci F, 2014, EUR J IMMUNOL, V44, P1883, DOI 10.1002/eji.201470065
   de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5
   Di Giacomo A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01494
   Doisne JM, 2015, J IMMUNOL, V195, P3937, DOI 10.4049/jimmunol.1500689
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Filipovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06918-3
   Huhn O, 2019, NAT COMMUN, DOI [10.17863/CAM.47154, DOI 10.17863/CAM.47154]
   Jiang W, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0358-0
   Jiang XX, 2018, CELL MOL IMMUNOL, V15, P1027, DOI 10.1038/s41423-018-0008-0
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Le Gars M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02469
   Lei YM, 2016, J CLIN INVEST, V126, P2736, DOI 10.1172/JCI85295
   Luty AJF, 2016, LANCET INFECT DIS, V16, P137, DOI 10.1016/S1473-3099(15)00379-5
   McIntosh CM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0474-8
   Moffett A, 2015, IMMUNOL REV, V267, P283, DOI 10.1111/imr.12323
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Nakimuli A, 2015, P NATL ACAD SCI USA, V112, P845, DOI 10.1073/pnas.1413453112
   Nakimuli A, 2014, AM J OBSTET GYNECOL, V210, P510, DOI 10.1016/j.ajog.2013.10.879
   Namara B, 2017, PEDIAT ALLERG IMM-UK, V28, P784, DOI 10.1111/pai.12804
   Norman PJ, 2016, AM J HUM GENET, V99, P375, DOI 10.1016/j.ajhg.2016.06.023
   Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Salvany-Celades M, 2019, CELL REP, V27, P2537, DOI 10.1016/j.celrep.2019.04.109
   Sharkey AM, 2015, J IMMUNOL, V195, P3026, DOI 10.4049/jimmunol.1501229
   Shreeve N, 2019, IMMUNITY, DOI [10.2139/ssrn.3477575, DOI 10.2139/SSRN.3477575]
   Surani MA, 2002, NATURE, V416, P491, DOI 10.1038/416491a
   Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3
   Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6
   Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918
NR 33
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JAN 28
PY 2020
VL 11
AR 43
DI 10.3389/fimmu.2020.00043
PG 4
WC Immunology
SC Immunology
GA KM8FS
UT WOS:000514376600001
PM 32047501
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, SB
   Zhang, Q
   Tiwari, SK
   Lichinchi, G
   Yau, EH
   Hui, H
   Li, WY
   Furnari, F
   Rana, TM
AF Wang, Shaobo
   Zhang, Qiong
   Tiwari, Shashi Kant
   Lichinchi, Gianluigi
   Yau, Edwin H.
   Hui, Hui
   Li, Wanyu
   Furnari, Frank
   Rana, Tariq M.
TI Integrin alpha v beta 5 Internalizes Zika Virus during Neural Stem Cells
   Infection and Provides a Promising Target for Antiviral Therapy
SO CELL REPORTS
LA English
DT Article
ID WIDE CRISPR SCREEN; WEST-NILE-VIRUS; CEREBRAL ORGANOIDS; MOUSE MODEL;
   RECEPTOR; GENOME; ENTRY; AXL; IDENTIFICATION; ANTAGONISTS
AB We perform a CRISPR-Cas9 genome-wide screen in glioblastoma stem cells and identify integrin alpha v beta 5 as an internalization factor for Zika virus (ZIKV). Expression of alpha v beta 5 is correlated with ZIKV susceptibility in various cells and tropism in developing human cerebral cortex. A blocking antibody against integrin alpha v beta 5, but not alpha v beta 3, efficiently inhibits ZIKV infection. ZIKV binds to cells but fails to internalize when treated with integrin alpha v beta 5-blocking antibody. alpha v beta 5 directly binds to ZIKV virions and activates focal adhesion kinase, which is required for ZIKV infection. Finally, alpha v beta 5 blocking antibody or two inhibitors, SB273005 and cilengitide, reduces ZIKV infection and alleviates ZIKV-induced pathology in human neural stem cells and in mouse brain. Altogether, our findings identify integrin alpha v beta 5 as an internalization factor for ZIKV, providing a promising therapeutic target, as well as two drug candidates for prophylactic use or treatments for ZIKV infections.
C1 [Wang, Shaobo; Zhang, Qiong; Tiwari, Shashi Kant; Lichinchi, Gianluigi; Yau, Edwin H.; Hui, Hui; Li, Wanyu; Rana, Tariq M.] Univ Calif San Diego, Sch Med, Div Genet, Dept Pediat,Inst Genom Med,Program Immunol, 9500 Gilman Dr MC 0762, La Jolla, CA 92093 USA.
   [Yau, Edwin H.] Univ Calif San Diego, Sch Med, Dept Internal Med, Div Hematol Oncol, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Hui, Hui; Li, Wanyu; Rana, Tariq M.] Univ Calif San Diego, Sch Med, Dept Biol, Bioinformat Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Furnari, Frank] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Furnari, Frank] Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Furnari, Frank; Rana, Tariq M.] Univ Calif San Diego, Sch Med, Moores Canc Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.
RP Rana, TM (corresponding author), Univ Calif San Diego, Sch Med, Div Genet, Dept Pediat,Inst Genom Med,Program Immunol, 9500 Gilman Dr MC 0762, La Jolla, CA 92093 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Sch Med, Dept Biol, Bioinformat Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Sch Med, Moores Canc Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM trana@ucsd.edu
OI Zhang, Qiong/0000-0001-9790-3625
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI125103, CA177322, DA039562,
   DA046171, DA049524]
FX We thank Dr. Andres Merits at University of Tartu, Tartu, Estonia, for
   providing ZIKV-ZsGreen and ZIKV-replicon clones. We thank Michael
   Diamond, David Cheresh, and David Schlaepfer for sharing their insight
   into the integrin and ZIKV receptors mechanisms. We also thank the
   support from Dr. Kristen Jepsen of IGM at UCSD for her help with the
   HT-seq and Dr. Celsa Spina and Tara Rambaldo at UCSD CFAR for cell
   sorting. We thank members of the Rana lab for helpful discussions and
   advice. This work was supported in part by grants from the NIH
   (AI125103, CA177322, DA039562, DA046171, and DA049524).
CR Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1
   Macedo JKA, 2015, CURR PROTEIN PEPT SC, V16, P532, DOI 10.2174/1389203716666150515125002
   Badger AM, 2001, ARTHRITIS RHEUM-US, V44, P128, DOI 10.1002/1529-0131(200101)44:1<128::AID-ANR17>3.0.CO;2-M
   Benitez JA, 2018, NAT COMMUN, V9, DOI 10.1038/ncomms16217
   BERGELSON JM, 1992, SCIENCE, V255, P1718, DOI 10.1126/science.1553561
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Cseke G, 2009, P NATL ACAD SCI USA, V106, P1566, DOI 10.1073/pnas.0801433106
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui XY, 2018, ANTIVIR RES, V155, P20, DOI 10.1016/j.antiviral.2018.04.018
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748
   Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goffart Nicolas, 2013, Cancers (Basel), V5, P1049, DOI 10.3390/cancers5031049
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hussein HAM, 2015, ARCH VIROL, V160, P2669, DOI 10.1007/s00705-015-2579-8
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510
   Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004
   Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Larson RS, 2005, J VIROL, V79, P7319, DOI 10.1128/JVI.79.12.7319-7326.2005
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li Y, 2019, P NATL ACAD SCI USA, V116, P9527, DOI 10.1073/pnas.1900867116
   Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Luo P, 2012, NEUROCHEM INT, V61, P731, DOI 10.1016/j.neuint.2012.06.014
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miller WH, 2000, J MED CHEM, V43, P22, DOI 10.1021/jm990446u
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011
   Moodbidri MS, 2006, CELL BIOL INT, V30, P210, DOI 10.1016/j.cellbi.2005.10.022
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001
   Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899
   Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001
   Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tancioni I, 2014, MOL CANCER THER, V13, P2050, DOI 10.1158/1535-7163.MCT-13-1063
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tanner SM, 2001, P NATL ACAD SCI USA, V98, P13901, DOI 10.1073/pnas.241525498
   Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000
   Wells M.F., 2018, BIORXIV, DOI [10.1101/476440, DOI 10.1101/476440]
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E
   Youssef M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40868-0
   Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43303-6
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 77
TC 2
Z9 2
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JAN 28
PY 2020
VL 30
IS 4
BP 969
EP +
DI 10.1016/j.celrep.2019.11.020
PG 19
WC Cell Biology
SC Cell Biology
GA KG2LZ
UT WOS:000509775700004
PM 31956073
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Henderson, AD
   Aubry, M
   Kama, M
   Vanhomwegen, J
   Teissier, A
   Mariteragi-Helle, T
   Paoaafaite, T
   Teissier, Y
   Manuguerra, JC
   Edmunds, J
   Whitworth, J
   Watson, CH
   Lau, CL
   Cao-Lormeau, VM
   Kucharski, AJ
AF Henderson, Alasdair D.
   Aubry, Maite
   Kama, Mike
   Vanhomwegen, Jessica
   Teissier, Anita
   Mariteragi-Helle, Teheipuaura
   Paoaafaite, Tuterarii
   Teissier, Yoann
   Manuguerra, Jean-Claude
   Edmunds, John
   Whitworth, Jimmy
   Watson, Conall H.
   Lau, Colleen L.
   Cao-Lormeau, Van-Mai
   Kucharski, Adam J.
TI Zika seroprevalence declines and neutralizing antibodies wane in adults
   following outbreaks in French Polynesia and Fiji
SO ELIFE
LA English
DT Article
ID VIRUS-INFECTION; BLOOD-DONORS; BRAZIL
AB It has been commonly assumed that Zika virus (ZIKV) infection confers long-term protection against reinfection, preventing ZIKV from re-emerging in previously affected areas for several years. However, the long-term immune response to ZIKV following an outbreak remains poorly documented. We compared results from eight serological surveys before and after known ZIKV outbreaks in French Polynesia and Fiji, including cross-sectional and longitudinal studies. We found evidence of a decline in seroprevalence in both countries over a two-year period following first reported ZIKV transmission. This decline was concentrated in adults, while high seroprevalence persisted in children. In the Fiji cohort, there was also a significant decline in neutralizing antibody titres against ZIKV, but not against dengue viruses that circulated during the same period.
C1 [Henderson, Alasdair D.; Edmunds, John; Whitworth, Jimmy; Watson, Conall H.; Kucharski, Adam J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Aubry, Maite; Teissier, Anita; Mariteragi-Helle, Teheipuaura; Paoaafaite, Tuterarii; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, French Polynesi, France.
   [Kama, Mike] Fiji Ctr Communicable Dis Control, Suva, Fiji.
   [Kama, Mike] Univ South Pacific, Suva, Fiji.
   [Vanhomwegen, Jessica; Manuguerra, Jean-Claude] Inst Pasteur, Paris, France.
   [Teissier, Yoann] Direct Sante Polynesie Francaise, Papeete, French Polynesi, France.
   [Lau, Colleen L.] Australian Natl Univ, Canberra, ACT, Australia.
RP Kucharski, AJ (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.; Cao-Lormeau, VM (corresponding author), Inst Louis Malarde, Papeete, French Polynesi, France.
EM mlormeau@ilm.pf; adam.kucharski@lshtm.ac.uk
RI Lau, Colleen L/F-5974-2012; Cao-Lormeau, Van-Mai/H-4879-2018
OI Lau, Colleen L/0000-0001-8288-4169; Cao-Lormeau,
   Van-Mai/0000-0001-5606-7480; Aubry, Maite/0000-0002-9913-5794
FU Ministry for Europe and Foreign Affairs [04917-19/07/17]; Horizon 2020 -
   Research and Innovation Framework Programme [734548]; Investissement
   d'Avenir Program Labex IBEID grantFrench National Research Agency (ANR)
   [ANR-10-LABX-62-IBEID]; Wellcome [107778/Z/15/Z, 206250/Z/17/Z]; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/J003999/1,
   MR/N013638/1]; National Health and Medical Research CouncilNational
   Health and Medical Research Council of Australia [1109035]; Ministry of
   Europe and Foreign AffairsMinistry of Europe and Foreign Affairs
   [02918-18/06/18]; French and French Polynesia government MA'I'ORE
   program [03298/MTF/REC-17/05/18, HC/372/DIE/BPT- 18/05/18,
   HC/245/DIE/BPT-16/05/19]
FX Ministry for Europe and Foreign Affairs Pacific funds 04917-19/07/17
   Van-Mai Cao-Lormeau; Horizon 2020 - Research and Innovation Framework
   Programme ZIKAlliance grant 734548 Van-Mai Cao-Lormeau; Investissement
   d'Avenir Program Labex IBEID grant ANR-10-LABX-62-IBEID Jessica
   Vanhomwegen Jean-Claude Manuguerra; Wellcome 107778/Z/15/Z Jimmy
   Whitworth; Wellcome 206250/Z/17/Z Adam J Kucharski; Medical Research
   Council MR/J003999/1 Conall H Watson; National Health and Medical
   Research Council 1109035 Colleen L Lau; Medical Research Council
   MR/N013638/1 Alasdair D Henderson; Ministry of Europe and Foreign
   Affairs Pacific funds 02918-18/06/18 Van-Mai Cao-Lormeau; French and
   French Polynesia government MA'I'ORE program 03298/MTF/REC-17/05/18
   Van-Mai Cao-Lormeau; French and French Polynesia government MA'I'ORE
   program HC/372/DIE/BPT- 18/05/18 Van-Mai Cao-Lormeau; French and French
   Polynesia government MA'I'ORE program HC/245/DIE/BPT-16/05/19 Van-Mai
   Cao-Lormeau
CR Aubry M, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.29.1900407
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Clapham HE, 2016, J INFECT DIS, V213, P1428, DOI 10.1093/infdis/jiv759
   Cohen J, 2018, SCIENCE, V361, P1055, DOI 10.1126/science.361.6407.1055
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Griffin I, 2019, EMERG INFECT DIS, V25, P299, DOI 10.3201/eid2502.181286
   Henderson AD, 2019, ZIKA SERO PACIFIC
   Kama M, 2019, EMERG INFECT DIS, V25, P1535, DOI 10.3201/eid2508.180524
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Kucharski AJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004974
   Kucharski AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34848
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Mallet HP, 2015, B INFORM SANITAIRES, V13
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Watson CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005786
   World Health Organisation, 2015, PAC SYNDR SURV REP W
   World Health Organisation, 2019, PAC PUBL HLTH SURV N
   World Health Organization, 2019, WEEKL PAC SYNDR REP
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 37
TC 2
Z9 2
U1 0
U2 0
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JAN 28
PY 2020
VL 9
AR e48460
DI 10.7554/eLife.48460
PG 17
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KH1BF
UT WOS:000510380800001
PM 31987069
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ledur, PF
   Karmirian, K
   Pedrosa, CDG
   Souza, LRQ
   Assis-de-Lemos, G
   Martins, TM
   Ferreira, JDCG
   Reis, GFD
   Silva, ES
   Silva, D
   Salerno, JA
   Ornelas, IM
   Devalle, S
   da Costa, RFM
   Goto-Silva, L
   Higa, LM
   Melo, A
   Tanuri, A
   Chimelli, L
   Murata, MM
   Garcez, PP
   Filippi-Chiela, EC
   Galina, A
   Borges, HL
   Rehen, SK
AF Ledur, Pitia Flores
   Karmirian, Karina
   Gouveia Pedrosa, Carolina da Silva
   Quintino Souza, Leticia Rocha
   Assis-de-Lemos, Gabriela
   Martins, Thiago Martino
   Cavalheiro Gomes Ferreira, Jessica de Cassia
   de Azevedo Reis, Gabriel Ferreira
   Silva, Eduardo Santos
   Silva, Debora
   Salerno, Jose Alexandre
   Ornelas, Isis Moraes
   Devalle, Sylvie
   Madeiro da Costa, Rodrigo Furtado
   Goto-Silva, Livia
   Higa, Luiza Mendonca
   Melo, Adriana
   Tanuri, Amilcar
   Chimelli, Leila
   Murata, Marcos Massao
   Garcez, Patricia Pestana
   Filippi-Chiela, Eduardo Cremonese
   Galina, Antonio
   Borges, Helena Lobo
   Rehen, Stevens Kastrup
TI Zika virus infection leads to mitochondrial failure, oxidative stress
   and DNA damage in human iPSC-derived astrocytes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL-CELLS; BREAK REPAIR; STEM-CELLS;
   BRAIN; GENERATION; DYSFUNCTION; ORGANOIDS; GROWTH
AB Zika virus (ZIKV) has been extensively studied since it was linked to congenital malformations, and recent research has revealed that astrocytes are targets of ZIKV. However, the consequences of ZIKV infection, especially to this cell type, remain largely unknown, particularly considering integrative studies aiming to understand the crosstalk among key cellular mechanisms and fates involved in the neurotoxicity of the virus. Here, the consequences of ZIKV infection in iPSC-derived astrocytes are presented. Our results show ROS imbalance, mitochondrial defects and DNA breakage, which have been previously linked to neurological disorders. We have also detected glial reactivity, also present in mice and in post-mortem brains from infected neonates from the Northeast of Brazil. Given the role of glia in the developing brain, these findings may help to explain the observed effects in congenital Zika syndrome related to neuronal loss and motor deficit.
C1 [Ledur, Pitia Flores; Karmirian, Karina; Gouveia Pedrosa, Carolina da Silva; Quintino Souza, Leticia Rocha; Salerno, Jose Alexandre; Ornelas, Isis Moraes; Devalle, Sylvie; Madeiro da Costa, Rodrigo Furtado; Goto-Silva, Livia; Rehen, Stevens Kastrup] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Karmirian, Karina; Martins, Thiago Martino; Cavalheiro Gomes Ferreira, Jessica de Cassia; Salerno, Jose Alexandre; Garcez, Patricia Pestana; Borges, Helena Lobo; Rehen, Stevens Kastrup] Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [Assis-de-Lemos, Gabriela; Galina, Antonio] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo De Meis, Rio De Janeiro, RJ, Brazil.
   [de Azevedo Reis, Gabriel Ferreira; Silva, Eduardo Santos; Murata, Marcos Massao] State Univ Rio de Janeiro UERJ, Dept Biophys & Biometr, Insitute Biol, Rio De Janeiro, RJ, Brazil.
   [Silva, Debora; Chimelli, Leila] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, RJ, Brazil.
   [Higa, Luiza Mendonca; Tanuri, Amilcar] Fed Univ Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil.
   [Filippi-Chiela, Eduardo Cremonese] Fed Univ Rio Grande do Sul UFRGS, Inst Hlth Sci, Porto Alegre, RS, Brazil.
   [Melo, Adriana] Res Inst Prof Joaquim Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
RP Rehen, SK (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, Brazil.; Rehen, SK (corresponding author), Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
EM srehen@lance-ufrj.org
RI ; Garcez, Patricia/F-8026-2012; Borges, Helena/E-5044-2013
OI Salerno, Jose Alexandre/0000-0003-0511-7083; Rehen,
   Stevens/0000-0003-4216-9501; Garcez, Patricia/0000-0002-9107-1335;
   Borges, Helena/0000-0003-2866-4223
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440909/2016-3, 441096/2016-6]; CAPESCAPES [440909/2016-3,
   88887.116625/2016-01]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.340/2016,
   E-26/201.319/2016]; FINEPCiencia Tecnologia e Inovacao (FINEP)
   [01.08.0657.00, 01.12.0161.00]; BNDES [10.2.0051.1]; D'Or Institute for
   Research and Education
FX This project was supported by grants from CNPq (grant numbers
   440909/2016-3 and 441096/2016-6), CAPES (grant numbers
   88887.116625/2016-01 and 440909/2016-3), FAPERJ (grant numbers
   E-26/201.340/2016 and E-26/201.319/2016), FINEP (grant numbers
   01.08.0657.00 and 01.12.0161.00) and BNDES (grant number 10.2.0051.1),
   in addition to intramural grants from D'Or Institute for Research and
   Education. We thank Ismael Carlos da Silva Gomes, Marcelo do Nascimento
   Costa, Gabriela Lopes Vitoria and Severino Galdino from D'Or Institute
   for Research and Education for technical support, and Daniel Cadilhe,
   Pablo Trindade, Pablo Leal Cardozo and Erick Correia Loiola for
   scientific discussions and input.
CR Bender C., 2012, ASTROCYTES STRUCTURE, P109, DOI 10.13140/2.1.4745.8243
   Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Casas BS, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0095-9
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chandler AL, 2012, BIRTH DEFECTS RES A, V94, P864, DOI 10.1002/bdra.23068
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Filippi-Chiela EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042522
   Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Gnaiger E., 2012, MITOCHONDRIAL PATHWA
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Jorgacevski J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44559-8
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuo LJ, 2008, IN VIVO, V22, P305
   Lambrus BG, 2016, J CELL BIOL, V214, P143, DOI 10.1083/jcb.201604054
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Madigan CA, 2017, CELL, V170, P973, DOI 10.1016/j.cell.2017.07.030
   Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018
   Medvedev R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9012580
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112
   Morgan WF, 1998, MUTAT RES-FUND MOL M, V404, P125, DOI 10.1016/S0027-5107(98)00104-3
   Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204
   Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475
   Nigg EA, 2018, NAT REV MOL CELL BIO, V19, P297, DOI 10.1038/nrm.2017.127
   O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI 10.1016/j.mito.2010.10.007
   Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719
   Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628
   Potokar M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030691
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3339/fnhum.2016.00566
   Reid CR, 2015, VIRUSES-BASEL, V7, P4385, DOI 10.3390/v7082825
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002
   Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129
   Schreiner B, 2015, CELL REP, V12, P1377, DOI 10.1016/j.celrep.2015.07.051
   Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870
   Sher AA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00596
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Sochacki J, 2016, STEM CELL RES, V17, P107, DOI 10.1016/j.scr.2016.05.018
   Sochacki J, 2016, STEM CELL RES, V17, P97, DOI 10.1016/j.scr.2016.05.017
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Trindade P., 2019, BIORXIV, P1, DOI [10.1101/722017, DOI 10.1101/722017]
   van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049
   Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145
   Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5
   Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106
   Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689
NR 86
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 27
PY 2020
VL 10
IS 1
AR 1218
DI 10.1038/s41598-020-57914-x
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LY2JT
UT WOS:000540347100001
PM 31988337
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Smoots, AN
   Olson, SM
   Cragan, J
   Delaney, A
   Roth, NM
   Godfred-Cato, S
   Jones, AM
   Nahabedian, JF
   Fornoff, J
   Sandidge, T
   Yazdy, MM
   Higgins, C
   Olney, RS
   Eckert, V
   Forkner, A
   Fox, DJ
   Stolz, A
   Crawford, K
   Cho, SJ
   Knapp, M
   Ahmed, MF
   Lake-Burger, H
   Elmore, AL
   Langlois, P
   Breidenbach, R
   Nance, A
   Denson, L
   Caton, L
   Forestieri, N
   Bergman, K
   Humphries, BK
   Leedom, VO
   Tran, T
   Johnston, J
   Valencia-Prado, M
   Perez-Gonzalez, S
   Romitti, PA
   Fall, C
   Bryan, JM
   Barton, J
   Arias, W
   St John, K
   Mann, S
   Kimura, J
   Orantes, L
   Martin, B
   de Wilde, L
   Ellis, EM
   Song, Z
   Akosa, A
   Goodroe, C
   Ellington, SR
   Tong, V
   Gilboa, SM
   Moore, CA
   Honein, MA
AF Smoots, Ashley N.
   Olson, Samantha M.
   Cragan, Janet
   Delaney, Augustina
   Roth, Nicole M.
   Godfred-Cato, Shana
   Jones, Abbey M.
   Nahabedian, John F., III
   Fornoff, Jane
   Sandidge, Theresa
   Yazdy, Mahsa M.
   Higgins, Cathleen
   Olney, Richard S.
   Eckert, Valorie
   Forkner, Allison
   Fox, Deborah J.
   Stolz, Amanda
   Crawford, Katherine
   Cho, Sook Ja
   Knapp, Mary
   Ahmed, Muhammad Farooq
   Lake-Burger, Heather
   Elmore, Amanda L.
   Langlois, Peter
   Breidenbach, Rebecca
   Nance, Amy
   Denson, Lindsay
   Caton, Lisa
   Forestieri, Nina
   Bergman, Kristin
   Humphries, Brian K.
   Leedom, Vinita Oberoi
   Tran, Tri
   Johnston, Julie
   Valencia-Prado, Miguel
   Perez-Gonzalez, Stephany
   Romitti, Paul A.
   Fall, Carrie
   Bryan, J. Michael
   Barton, Jerusha
   Arias, William
   St John, Kristen
   Mann, Sylvia
   Kimura, Jonathan
   Orantes, Lucia
   Martin, Brennan
   de Wilde, Leah
   Ellis, Esther M.
   Song, Ziwei
   Akosa, Amanda
   Goodroe, Caroline
   Ellington, Sascha R.
   Tong, Van T.
   Gilboa, Suzanne M.
   Moore, Cynthia A.
   Honein, Margaret A.
TI Population-Based Surveillance for Birth Defects Potentially Related to
   Zika Virus Infection-22 States and Territories, January 2016-June 2017
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID PREGNANCY
C1 [Smoots, Ashley N.; Olson, Samantha M.; Cragan, Janet; Delaney, Augustina; Roth, Nicole M.; Godfred-Cato, Shana; Jones, Abbey M.; Nahabedian, John F., III; Song, Ziwei; Akosa, Amanda; Goodroe, Caroline; Tong, Van T.; Gilboa, Suzanne M.; Moore, Cynthia A.; Honein, Margaret A.] CDC, Div Birth Defects & Infant Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Fornoff, Jane; Sandidge, Theresa] Illinois Dept Publ Hlth, Springfield, IL 62761 USA.
   [Yazdy, Mahsa M.; Higgins, Cathleen] Massachusetts Dept Publ Hlth, Boston, MA 02111 USA.
   [Olney, Richard S.; Eckert, Valorie] Calif Dept Publ Hlth, Fresno, CA USA.
   [Forkner, Allison] Indiana State Dept Hlth, Indianapolis, IN 46202 USA.
   [Fox, Deborah J.; Stolz, Amanda] New York State Dept Hlth, Albany, NY 12237 USA.
   [Crawford, Katherine] Virginia Dept Hlth, Richmond, VA USA.
   [Cho, Sook Ja] Minnesota Dept Hlth, Minneapolis, MN 55414 USA.
   [Knapp, Mary; Ahmed, Muhammad Farooq] New Jersey Dept Hlth, Trenton, NJ USA.
   [Lake-Burger, Heather; Elmore, Amanda L.] Florida Dept Hlth, Tallahassee, FL USA.
   [Langlois, Peter; Breidenbach, Rebecca] Texas Dept State Hlth Serv, Austin, TX USA.
   [Nance, Amy] Utah Dept Hlth, Salt Lake City, UT 84116 USA.
   [Denson, Lindsay; Caton, Lisa] Oklahoma Dept Hlth, Oklahoma City, OK 73117 USA.
   [Forestieri, Nina; Bergman, Kristin] North Carolina Dept Hlth & Human Serv, Raleigh, NC USA.
   [Humphries, Brian K.; Leedom, Vinita Oberoi] South Carolina Dept Hlth & Environm Control, Columbia, SC USA.
   [Tran, Tri; Johnston, Julie] Louisiana Dept Hlth, Baton Rouge, LA USA.
   [Valencia-Prado, Miguel; Perez-Gonzalez, Stephany] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Romitti, Paul A.; Fall, Carrie] Univ Iowa, Iowa City, IA USA.
   [Bryan, J. Michael; Barton, Jerusha] Georgia Dept Publ Hlth, Atlanta, GA USA.
   [Arias, William; St John, Kristen] Rhode Isl Dept Hlth, Providence, RI 02908 USA.
   [Mann, Sylvia; Kimura, Jonathan] Hawaii Dept Hlth, Honolulu, HI USA.
   [Orantes, Lucia; Martin, Brennan] Vermont Dept Hlth, Burlington, VT 05402 USA.
   [de Wilde, Leah; Ellis, Esther M.] US Virgin Isl Dept Hlth, Christiansted, VI USA.
   [Ellington, Sascha R.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
RP Olson, SM (corresponding author), CDC, Div Birth Defects & Infant Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM ylz8@cdc.gov
CR Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Gilboa SM, 2017, BIRTH DEFECTS RES, V109, P372, DOI 10.1002/bdr2.1007
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Olson SM, 2019, BIRTH DEFECTS RES, V111, P938, DOI 10.1002/bdr2.1546
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
NR 8
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JAN 24
PY 2020
VL 69
IS 3
BP 67
EP 71
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LR9CY
UT WOS:000535994400003
PM 31971935
OA Bronze
DA 2020-07-08
ER

PT J
AU Trus, I
   Udenze, D
   Berube, N
   Wheler, C
   Martel, MJ
   Gerdts, V
   Karniychuk, U
AF Trus, Ivan
   Udenze, Daniel
   Berube, Nathalie
   Wheler, Colette
   Martel, Marie-Jocelyne
   Gerdts, Volker
   Karniychuk, Uladzimir
TI CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation
   of Infection With Protection Against Lethal Heterologous Challenge in
   Mice
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE CpG dinucleotide; Zika virus; neonate; adult; age; vaccine; ZAP
ID CODON PAIR; RNA VIRUSES; DINUCLEOTIDE; VACCINE; FREQUENCIES;
   IMMUNIZATION; REPLICATION; STRAINS; FITNESS; BIAS
AB Experimental increase of CpG dinucleotides in an RNA virus genome impairs infection providing a promising approach for vaccine development. While CpG recoding is an emerging and promising vaccine approach, little is known about infection phenotypes caused by recoded viruses in vivo. For example, infection phenotypes, immunogenicity, and protective efficacy induced by CpG-recoded viruses in different age groups were not studied yet. This is important, because attenuation of infection phenotypes caused by recoded viruses may depend on the population-based expression of cellular components targeting viral CpG dinucleotides. In the present study, we generated several Zika virus (ZIKV) variants with the increasing CpG content and compared infection in neonatal and adult mice. Increasing the CpG content caused host-age-dependent attenuation of infection with considerable attenuation in neonates and high attenuation in adults. Expression of the zinc-finger antiviral protein (ZAP)-the host protein targeting viral CpG dinucleotides-was also age-dependent. Similar to the wild-type virus, ZIKV variants with the increased CpG content evoked robust cellular and humoral immune responses and protection against lethal challenge. Collectively, the host age should be accounted for in future studies on mechanisms targeting viral CpG dinucleotides, development of safe dinucleotide recoding strategies, and applications of CpG-recoded vaccines.
C1 [Trus, Ivan; Udenze, Daniel; Berube, Nathalie; Wheler, Colette; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK, Canada.
   [Udenze, Daniel; Karniychuk, Uladzimir] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.
   [Martel, Marie-Jocelyne] Univ Saskatchewan, Coll Med, Dept Obstet & Gynecol, Saskatoon, SK, Canada.
   [Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK, Canada.
RP Karniychuk, U (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK, Canada.; Karniychuk, U (corresponding author), Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.; Karniychuk, U (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK, Canada.
EM u.karniychuk@usask.ca
OI Trus, Ivan/0000-0003-2849-5140
FU Genome Canada Emerging Issue Program grantGenome Canada [418402];
   Natural Sciences & Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada [420249];
   Saskatchewan Health Research Foundation Research Fellowship [422027]
FX This work was supported by Genome Canada Emerging Issue Program grant
   #418402, Natural Sciences & Engineering Research Council of Canada
   Discovery Grants Program #420249, and Saskatchewan Health Research
   Foundation Research Fellowship #422027. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   [Anonymous], 2006, JAX NOTES ISSUE 201
   Antzin-Anduetza I, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0374-1
   Atieh T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14522-6
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109
   Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Ficarelli M, 2019, ELIFE, V8, DOI 10.7554/eLife.46767
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Fros JJ, 2017, ELIFE, V6, DOI 10.7554/eLife.29112
   Futcher B, 2015, P NATL ACAD SCI USA, V112, pE3635, DOI 10.1073/pnas.1507710112
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gaunt E, 2016, ELIFE, V5, DOI 10.7554/eLife.12735
   Georges A, 2019, NUCLEIC ACIDS RES, V47, P8988, DOI 10.1093/nar/gkz598
   GUILLOT S, 1994, VACCINE, V12, P503, DOI 10.1016/0264-410X(94)90307-7
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   JOSSE J, 1961, J BIOL CHEM, V236, P864
   KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994
   Karniychuk UU, 2009, PLACENTA, V30, P497, DOI 10.1016/j.placenta.2009.03.016
   Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842
   Kunec D, 2016, CELL REP, V14, P55, DOI 10.1016/j.celrep.2015.12.011
   Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635
   Le Nouen C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01250
   Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Mapletoft JW, 2008, J GEN VIROL, V89, P250, DOI 10.1099/vir.0.83300-0
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McFadden N, 2013, NUCLEIC ACIDS RES, V41, P6316, DOI 10.1093/nar/gkt334
   McIntosh CJ, 2012, REPRODUCTION, V143, P195, DOI 10.1530/REP-11-0336
   McKinstry SU, 2014, J NEUROSCI, V34, P9455, DOI 10.1523/JNEUROSCI.4699-13.2014
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Odon V, 2019, NUCLEIC ACIDS RES, V47, P8061, DOI 10.1093/nar/gkz581
   Ostrand-Rosenberg S, 2017, J LEUKOCYTE BIOL, V101, P1091, DOI 10.1189/jlb.1HI1016-306RR
   Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Sexton NR, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070643
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Simmonds P, 2015, P NATL ACAD SCI USA, V112, pE3633, DOI 10.1073/pnas.1507339112
   Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50
   Stern A, 2017, CELL, V169, P35, DOI 10.1016/j.cell.2017.03.013
   Sugiyama T, 2005, J IMMUNOL, V175, P2026, DOI 10.4049/jimmunol.175.3.2026
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039
   Troyer RM, 2008, VIRUS RES, V137, P179, DOI 10.1016/j.virusres.2008.07.018
   Trus I, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008038
   Trus I, 2018, VIRULENCE, V9, P1338, DOI 10.1080/21505594.2018.1504558
   Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Wu YH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006848
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
NR 68
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JAN 24
PY 2020
VL 10
AR 3077
DI 10.3389/fimmu.2019.03077
PG 21
WC Immunology
SC Immunology
GA KJ1YU
UT WOS:000511855900001
PM 32038625
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, S
   Wang, M
   Zhou, JM
AF Li, Shuang
   Wang, Min
   Zhou, Junmei
TI Brain Organoids: A Promising Living Biobank Resource for Neuroscience
   Research
SO BIOPRESERVATION AND BIOBANKING
LA English
DT Article
DE living biobank; brain organoids; neurological disorders
ID PLURIPOTENT STEM-CELLS; ZIKA VIRUS-INFECTION; IN-VITRO EXPANSION;
   CEREBRAL ORGANOIDS; CORTICAL DEVELOPMENT; MODELING DEVELOPMENT; NEURAL
   PROGENITORS; HELA-CELLS; CULTURE; CRYOPRESERVATION
AB Biobanking plays an important role between clinical practice and translational research. In addition to the traditional biomolecular-based biobanks, there is a growing interest in establishing living biobanks, including organoid biobanks that can collect and store viable and functional tissues and proliferative cell types for long periods of time. An organoid is a three-dimensional cell complex derived by self-organization of small tissue blocks or stem cells, which can recapitulate the phenotypic and genetic characteristics of targeted human organs. Publications on brain organoids have increased recently, and several types of brain organoids have been reported to model normal and abnormal neural development, as well as different neurodegenerative diseases, neuropsychiatric disorders, and other neural conditions. Based on the current status of research, more exploration on brain organoids is needed, through technical advancements, to improve the reproducibility and scalability, as well as to decrease the diversity. Moreover, given their natural characteristics, more attention to ethical considerations is needed, considering the extent of maturation and complexity of brain organoids. Living biobanks that are engaged in collecting categories of brain organoids possessing different genetic backgrounds, and with spatial and temporal characteristics, will eventually contribute to the understanding of neural conditions and ultimately facilitate innovative treatment development.
C1 [Li, Shuang; Wang, Min; Zhou, Junmei] Shanghai Jiao Tong Univ, Dept Cent Lab, Shanghai Childrens Hosp, 1400 Beijing Rd West, Shanghai 200040, Peoples R China.
   [Wang, Min] Shanghai Jiao Tong Univ, Dept Pediat Hematol & Oncol, Shanghai Childrens Med Ctr, Sch Med, Shanghai, Peoples R China.
RP Zhou, JM (corresponding author), Shanghai Jiao Tong Univ, Dept Cent Lab, Shanghai Childrens Hosp, 1400 Beijing Rd West, Shanghai 200040, Peoples R China.
EM junmei_zhou@139.com
FU Shanghai Municipal Commission of Health and Family Planning [201940204];
   Shanghai Collaborative Innovation Center for Translational Medicine
   [TM201827]
FX This work was supported by the Shanghai Municipal Commission of Health
   and Family Planning (Grant No. 201940204) and the Shanghai Collaborative
   Innovation Center for Translational Medicine (Grant No. TM201827).
CR Aitman TJ, 2011, NAT REV GENET, V12, P575, DOI 10.1038/nrg3047
   Andrade RD, 2019, NATURE, V569, P318
   Asslaber Martin, 2007, Briefings in Functional Genomics & Proteomics, V6, P193, DOI 10.1093/bfgp/elm023
   Baker M, 2017, NATURE, V541, P269, DOI 10.1038/541269a
   Barber K, 2019, NAT PROTOC, V14, P1261, DOI 10.1038/s41596-019-0141-y
   Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a
   Beglyarova N, 2016, CLIN CANCER RES, V22, P6153, DOI 10.1158/1078-0432.CCR-16-0149
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bishop D, 2019, NATURE, V568, P435, DOI 10.1038/d41586-019-01307-2
   Boers SN, 2016, EMBO REP, V17, P938, DOI 10.15252/embr.201642613
   Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021
   Border R, 2019, AM J PSYCHIAT, V176, P376, DOI 10.1176/appi.ajp.2018.18070881
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Brown KS, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010117
   Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a
   Coppola L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1922-3
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   De Souza YG, 2013, AIDS, V27, P303, DOI 10.1097/QAD.0b013e32835c1244
   Fahy GM, 2013, XENOBIOTICA, V43, P113, DOI 10.3109/00498254.2012.728300
   Farahany NA, 2018, NATURE, V556, P429, DOI 10.1038/d41586-018-04813-x
   Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051
   Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x
   Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016
   Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0
   Giwa S, 2017, NAT BIOTECHNOL, V35, P530, DOI 10.1038/nbt.3889
   Golab Karolina, 2018, Oncotarget, V9, P9728, DOI 10.18632/oncotarget.23887
   Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708
   Han SH, 2017, WORLD J GASTROENTERO, V23, P964, DOI 10.3748/wjg.v23.i6.964
   Harati Mitra D, 2019, Methods Mol Biol, V1897, P7, DOI 10.1007/978-1-4939-8935-5_2
   Hartman V, 2019, BIOPRESERV BIOBANK, V17, P264, DOI 10.1089/bio.2018.0120
   Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kim JH, 2019, STEM CELLS, DOI 10.1002/stem.3003
   Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lavazza A, 2018, J MED ETHICS, V44, P606, DOI 10.1136/medethics-2017-104555
   Lee CT, 2017, NEUROPSYCHOPHARMACOL, V42, P774, DOI 10.1038/npp.2016.156
   Li M, 2019, NEW ENGL J MED, V380, P1982, DOI 10.1056/NEJMc1903253
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008
   Lisanti MP, 2012, AM J PATHOL, V180, P1334, DOI 10.1016/j.ajpath.2012.02.003
   Liu XF, 2017, NAT PROTOC, V12, P439, DOI 10.1038/nprot.2016.174
   Lu YC, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201700165
   Lucey BP, 2009, ARCH PATHOL LAB MED, V133, P1463, DOI 10.1043/1543-2165-133.9.1463
   Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109
   Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017
   Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775
   McCullough ME, 2014, NATURE, V508, P319, DOI 10.1038/508319c
   Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526
   Meyer K, 2019, CELL REP, V26, P1112, DOI 10.1016/j.celrep.2019.01.023
   Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153
   Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Nuciforo S, 2018, CELL REP, V24, P1363, DOI 10.1016/j.celrep.2018.07.001
   OCONNOR NE, 1981, LANCET, V1, P75
   Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4
   Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032
   Perkel JM, 2018, NATURE, V560, P513, DOI 10.1038/d41586-018-05990-5
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Roberts JN, 2015, ADV EXP MED BIOL, V864, P95, DOI 10.1007/978-3-319-20579-3_8
   Robles V, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9050181
   Roschke AV, 2003, CANCER RES, V63, P8634
   Rowe RG, 2019, NAT REV GENET, V20, P377, DOI 10.1038/s41576-019-0100-z
   Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010
   Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112
   Simeon-Dubach D, 2014, CLIN BIOCHEM, V47, P300, DOI 10.1016/j.clinbiochem.2013.12.018
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015
   Taylor MJ, 2019, TRANSFUS MED HEMOTH, V46, P197, DOI 10.1159/000499453
   Thirumala S, 2009, ORGANOGENESIS, V5, P143, DOI 10.4161/org.5.3.9811
   Topfer E, 2019, TOXICOL IN VITRO, V61, DOI 10.1016/j.tiv.2019.104606
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x
   Wang YQ, 2018, LAB CHIP, V18, P851, DOI 10.1039/c7lc01084b
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wilding JL, 2014, CANCER RES, V74, P2377, DOI 10.1158/0008-5472.CAN-13-2971
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang HHN, 2018, CELL STEM CELL, V23, P882, DOI 10.1016/j.stem.2018.09.016
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu YJ, 2017, INTEGR BIOL-UK, V9, P968, DOI 10.1039/c7ib00105c
NR 99
TC 0
Z9 0
U1 9
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1947-5535
EI 1947-5543
J9 BIOPRESERV BIOBANK
JI Biopreserv. Biobank.
PD APR 1
PY 2020
VL 18
IS 2
BP 136
EP 143
DI 10.1089/bio.2019.0111
EA JAN 2020
PG 8
WC Cell Biology; Chemistry, Applied; Medical Laboratory Technology
SC Cell Biology; Chemistry; Medical Laboratory Technology
GA LC5EM
UT WOS:000509272400001
PM 31977235
DA 2020-07-08
ER

PT J
AU Koblischke, M
   Spitzer, FS
   Florian, DM
   Aberle, SW
   Malafa, S
   Fae, I
   Cassaniti, I
   Jungbauer, C
   Knapp, B
   Laferl, H
   Fischer, G
   Baldanti, F
   Stiasny, K
   Heinz, FX
   Aberle, JH
AF Koblischke, Maximilian
   Spitzer, Felicia S.
   Florian, David M.
   Aberle, Stephan W.
   Malafa, Stefan
   Fae, Ingrid
   Cassaniti, Irene
   Jungbauer, Christof
   Knapp, Bernhard
   Laferl, Hermann
   Fischer, Gottfried
   Baldanti, Fausto
   Stiasny, Karin
   Heinz, Franz X.
   Aberle, Judith H.
TI CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic
   Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE West Nile virus; flavivirus; CD4 T cell; immunodominance; epitope; West
   Nile patients
ID BORNE ENCEPHALITIS-VIRUS; MHC CLASS-II; ENVELOPE GLYCOPROTEIN;
   3-DIMENSIONAL STRUCTURE; EPITOPE DOMINANCE; HIV ENVELOPE;
   MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HLA-DR
AB West Nile (WN) virus infection of humans is frequently asymptomatic, but can also lead to WN fever or neuroinvasive disease. CD4 T cells and B cells are critical in the defense against WN virus, and neutralizing antibodies, which are directed against the viral glycoprotein E, are an accepted correlate of protection. For the efficient production of these antibodies, B cells interact directly with CD4 helper T cells that recognize peptides from E or the two other structural proteins (capsid-C and membrane-prM/M) of the virus. However, the specific protein sites yielding such helper epitopes remain unknown. Here, we explored the CD4 T cell response in humans after WN virus infection using a comprehensive library of overlapping peptides covering all three structural proteins. By measuring T cell responses in 29 individuals with either WN virus disease or asymptomatic infection, we showed that CD4 T cells focus on peptides in specific structural elements of C and at the exposed surface of the pre- and postfusion forms of the E protein. Our data indicate that these immunodominant epitopes are recognized in the context of multiple different HLA molecules. Furthermore, we observed that immunodominant antigen regions are structurally conserved and similarly targeted in other mosquito-borne flaviviruses, including dengue, yellow fever, and Zika viruses. Together, these findings indicate a strong impact of virion protein structure on epitope selection and antigenicity, which is an important issue to consider in future vaccine design.
C1 [Koblischke, Maximilian; Spitzer, Felicia S.; Florian, David M.; Aberle, Stephan W.; Malafa, Stefan; Stiasny, Karin; Heinz, Franz X.; Aberle, Judith H.] Med Univ Vienna, Ctr Virol, Vienna, Austria.
   [Fae, Ingrid; Fischer, Gottfried] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria.
   [Cassaniti, Irene; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy.
   [Cassaniti, Irene; Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
   [Jungbauer, Christof] Austrian Red Cross, Blood Serv Vienna Lower Austria & Burgenland, Vienna, Austria.
   [Knapp, Bernhard] Symptoma GmbH, Data Sci Sect, Vienna, Austria.
   [Laferl, Hermann] Kaiser Franz Josef Spita, Sozialmed Zentrum Sud, Vienna, Austria.
RP Aberle, JH (corresponding author), Med Univ Vienna, Ctr Virol, Vienna, Austria.
EM judith.aberle@meduniwien.ac.at
RI ; Cassaniti, Irene/Y-9946-2019
OI Aberle, Judith H/0000-0003-1197-3935; Cassaniti,
   Irene/0000-0002-3385-2088; Stiasny, Karin/0000-0002-1902-8674;
   Koblischke, Maximilian/0000-0003-1223-4990
FU Austrian Science Fund FWFAustrian Science Fund (FWF) [P29881-B30,
   P29928-B30]
FX This study was funded by research grants from the Austrian Science Fund
   FWF (JA: P29881-B30; KS: P29928-B30).
CR Aberle JH, 2018, J CLIN VIROL, V108, P126, DOI 10.1016/j.jcv.2018.09.020
   Aberle JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140545
   Aberle SW, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.43.1800545
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890
   Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0
   Barba-Spaeth G, 2016, NATURE, V539, DOI 10.1038/nature19780
   Barrett ADT, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay096
   Bradt V, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0133-5
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   Brown SA, 2003, J IMMUNOL, V171, P4140, DOI 10.4049/jimmunol.171.8.4140
   Carmicle S, 2007, MOL IMMUNOL, V44, P1159, DOI 10.1016/j.molimm.2006.06.014
   Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101
   Chaves FA, 2012, J IMMUNOL, V188, P4235, DOI 10.4049/jimmunol.1103640
   Chen ZM, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1092-6
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Eisenlohr LC, 2011, IMMUNOL RES, V51, P237, DOI 10.1007/s12026-011-8257-3
   Fae I, 2019, HLA, V93, P89, DOI 10.1111/tan.13439
   Gould LH, 2004, J CLIN INVEST, V113, P1102, DOI 10.1172/JCI21623
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   James EA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005375
   Kaiser JA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090823
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kim A, 2015, CURR OPIN IMMUNOL, V34, P9, DOI 10.1016/j.coi.2014.12.005
   Klitz W, 2003, TISSUE ANTIGENS, V62, P296, DOI 10.1034/j.1399-0039.2003.00103.x
   Knapp B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-241
   Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02083
   Koblischke M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09331-w
   Kufareva Irina, 2012, Methods Mol Biol, V857, P231, DOI 10.1007/978-1-61779-588-6_10
   Landry SJ, 2008, J VIROL, V82, P1238, DOI 10.1128/JVI.02026-07
   Landry SJ, 2017, VIRAL IMMUNOL, V30, P479, DOI 10.1089/vim.2017.0008
   Landry SJ, 2000, J THEOR BIOL, V203, P189, DOI 10.1006/jtbi.1999.1056
   Lanteri MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022948
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   Luca VC, 2013, J VIROL, V87, P818, DOI 10.1128/JVI.01950-12
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mehlhop E, 2008, CURR TOP MICROBIOL, V317, P125
   Mettu RR, 2016, J IMMUNOL METHODS, V432, P72, DOI 10.1016/j.jim.2016.02.013
   Miller MA, 2015, NAT MED, V21, P1216, DOI 10.1038/nm.3958
   Mirano-Bascos D, 2008, EUR J IMMUNOL, V38, P1231, DOI 10.1002/eji.200738011
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405
   PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209
   Paul S, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0204-1
   Paul S, 2015, J IMMUNOL, V194, P6164, DOI 10.4049/jimmunol.1403074
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2017, CRYSTAL STRUCTURE PR
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Sarri CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205557
   Sarri CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165952
   Schwaiger J, 2014, J VIROL, V88, P7828, DOI 10.1128/JVI.00196-14
   Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stiasny K, 2013, EUROSURVEILLANCE, V18, P26, DOI 10.2807/1560-7917.ES2013.18.43.20614
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069
   Surman S, 2001, P NATL ACAD SCI USA, V98, P4587, DOI 10.1073/pnas.071063898
   Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
NR 76
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JAN 23
PY 2020
VL 11
AR 16
DI 10.3389/fimmu.2020.00016
PG 14
WC Immunology
SC Immunology
GA KJ2CZ
UT WOS:000511867100001
PM 32038660
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bernatchez, JA
   Tran, LT
   Li, J
   Luan, YP
   Siqueira-Neto, JL
   Li, RS
AF Bernatchez, Jean A.
   Tran, Lana T.
   Li, Jerry
   Luan, Yepeng
   Siqueira-Neto, Jair L.
   Li, Rongshi
TI Drugs for the Treatment of Zika Virus Infection
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID POTENTIAL ANTIBIOTIC AGENTS; FDA-APPROVED DRUG; NS2B-NS3 PROTEASE;
   DENGUE VIRUS; IN-VITRO; MARINOPYRROLE DERIVATIVES; ANTIVIRAL ACTIVITY;
   CRYSTAL-STRUCTURE; FLAVIVIRAL PROTEASES; SEXUAL TRANSMISSION
AB Zika virus is an emerging flavivirus that causes the neurodevelopmental congenital Zika syndrome and that has been linked to the neuroinflammatory Guillain Barre syndrome. The absence of a vaccine or a clinically approved drug to treat the disease combined with the likelihood that another outbreak will occur in the future defines an unmet medical need. Several promising drug candidate molecules have been reported via repurposing studies, high-throughput compound library screening, and de novo design in the short span of a few years. Intense research activity in this area has occurred in response to the World Health Organization declaration of a Public Health Emergency of International Concern on February 1, 2016. In this Perspective, the authors review the emergence of Zika virus, the biology of its replication, targets for therapeutic intervention, target product profile, and current drug development initiatives.
C1 [Luan, Yepeng; Li, Rongshi] Qingdao Univ, Sch Pharm, Dept Med Chem, Qingdao 266071, Shandong, Peoples R China.
   [Bernatchez, Jean A.; Li, Jerry; Siqueira-Neto, Jair L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Bernatchez, Jean A.; Siqueira-Neto, Jair L.] Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Tran, Lana T.] Univ N Carolina, UNS Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA.
   [Li, Rongshi] Univ Nebraska Med Ctr, Coll Pharm, UNMC Ctr Drug Discovery, Fred & Pamela Buffett Canc Ctr,Dept Pharmaceut Sc, Omaha, NE 68198 USA.
   [Li, Rongshi] Univ Nebraska Med Ctr, Ctr Staphylococcal Res, Omaha, NE 68198 USA.
RP Li, RS (corresponding author), Qingdao Univ, Sch Pharm, Dept Med Chem, Qingdao 266071, Shandong, Peoples R China.; Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Li, RS (corresponding author), Univ Nebraska Med Ctr, Coll Pharm, UNMC Ctr Drug Discovery, Fred & Pamela Buffett Canc Ctr,Dept Pharmaceut Sc, Omaha, NE 68198 USA.; Li, RS (corresponding author), Univ Nebraska Med Ctr, Ctr Staphylococcal Res, Omaha, NE 68198 USA.
EM jairlage@ucsd.edu; rongshi.li@unmc.edu
RI Siqueira-Neto, Jair L/D-6040-2012
OI Siqueira-Neto, Jair L/0000-0001-9574-8174; Bernatchez,
   Jean/0000-0002-8309-1627; Li, Jerry/0000-0002-8774-826X
FU Clinical and Translational (CTRI) Pilot Grant [UL1TR001442]; National
   Science Foundation for Young Scientists of China (NSFC) [81602947];
   University of Nebraska Medical Center
FX This work is partially supported by Clinical and Translational (CTRI)
   Pilot Grant UL1TR001442 to J.L.S.-N. We gratefully acknowledge the
   financial support from the National Science Foundation for Young
   Scientists of China to Y.L. (NSFC Grant 81602947). This work is
   partially supported by startup funds to R.L. provided by the University
   of Nebraska Medical Center.
CR Aguiar M, 2017, EXPERT REV VACCINES, V16, P301, DOI 10.1080/14760584.2017.1276831
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Arredondo-Garcia JL, 2018, CLIN MICROBIOL INFEC, V24, P755, DOI 10.1016/j.cmi.2018.01.018
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Batista MN, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010049
   Beck S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040338
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Bernatchez JA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040365
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cheng CW, 2013, MAR DRUGS, V11, P2927, DOI 10.3390/md11082927
   Cheng CW, 2010, J COMB CHEM, V12, P541, DOI 10.1021/cc100052j
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Martinez JD, 2019, DERMATOL CLIN, V37, P95, DOI 10.1016/j.det.2018.07.008
   de Leuw P, 2018, EXPERT OPIN PHARMACO, V19, P577, DOI 10.1080/14656566.2018.1454428
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Ferrero DS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007656
   Fischer MA, 2013, J VIROL, V87, P9411, DOI 10.1128/JVI.00101-13
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2018, HUM VACC IMMUNOTHER, V14, P2158, DOI 10.1080/21645515.2018.1445448
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hernandez J, 2019, EUR J MED CHEM, V161, P323, DOI 10.1016/j.ejmech.2018.09.056
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kaptein SJF, 2018, CHEMMEDCHEM, V13, P1371, DOI 10.1002/cmdc.201800178
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lee JL, 2019, ANTIVIR RES, V167, P13, DOI 10.1016/j.antiviral.2019.04.003
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li RS, 2016, MED RES REV, V36, P169, DOI 10.1002/med.21359
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Liu Y, 2014, MAR DRUGS, V12, P2458, DOI 10.3390/md12052458
   Liu Y, 2012, MAR DRUGS, V10, P953, DOI 10.3390/md10040953
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Lv ZT, 2015, HIV AIDS-RES PALLIAT, V7, P95, DOI 10.2147/HIV.S79956
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Majerova T, 2019, BIOCHIMIE, V166, P132, DOI 10.1016/j.biochi.2019.05.004
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mayberry J, 2019, MED CLIN N AM, V103, P43, DOI 10.1016/j.mcna.2018.08.007
   McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Menendez-Arias L, 2017, VIRUS RES, V234, P1, DOI 10.1016/j.virusres.2017.02.003
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Ngono AE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01316
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Ortiz-Lopez FJ, 2015, J NAT PROD, V78, P468, DOI 10.1021/np500854j
   Palanichamy K, 2019, J MED CHEM, V62, P4110, DOI 10.1021/acs.jmedchem.9b00142
   Patil VM, 2019, VIRAL POLYMERASES: STRUCTURES, FUNCTIONS, AND ROLES AS ANTIVIRAL DRUG TARGETS, P357, DOI 10.1016/B978-0-12-815422-9.00013-9
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pinkham AM, 2018, CHEM COMMUN, V54, P12357, DOI 10.1039/c8cc07448h
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tao ZY, 2018, EUR J MED CHEM, V157, P994, DOI 10.1016/j.ejmech.2018.08.057
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Vannice KS, 2018, VACCINE, V36, P3411, DOI 10.1016/j.vaccine.2018.02.062
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Vincetti P, 2019, ACS MED CHEM LETT, V10, P558, DOI 10.1021/acsmedchemlett.8b00583
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
   Yang YQ, 2019, J MED CHEM, V62, P4056, DOI 10.1021/acs.jmedchem.9b00091
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00402
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zasloff M, 2011, P NATL ACAD SCI USA, V108, P15978, DOI 10.1073/pnas.1108558108
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 146
TC 1
Z9 1
U1 20
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD JAN 23
PY 2020
VL 63
IS 2
BP 470
EP 489
DI 10.1021/acs.jmedchem.9b00775
PG 20
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA KF7SL
UT WOS:000509438800002
PM 31549836
DA 2020-07-08
ER

PT J
AU Wang, JL
   Zhu, SM
   Lin, YY
   Svanberg, S
   Zhao, GY
AF Wang, Jinlei
   Zhu, Shiming
   Lin, Yueyu
   Svanberg, Sune
   Zhao, Guangyu
TI Mosquito counting system based on optical sensing
SO APPLIED PHYSICS B-LASERS AND OPTICS
LA English
DT Article
ID NUMBER
AB Mosquitos, sometimes carrying deadly diseases such as malaria, zika, and dengue fever, cause much concern. To control mosquitos, it is important to effectively monitor their presence and behavioral trends. We have constructed two optical sensing systems for insects based on light attenuation and light backscattering, respectively. The systems, which were tested with the potentially dangerous Aedes albopictus and Culex pipiens, were able to extract the wing-beat frequency, when they passed impinging light, derived from light-emitting diodes. We could achieve distinction between the sexes of A. albopictus and C. pipiens based on the wing-beat frequency. Finally, we propose a statistical method suitable for the system to improve the accuracy of counting.
C1 [Wang, Jinlei; Zhu, Shiming; Lin, Yueyu; Svanberg, Sune; Zhao, Guangyu] South China Normal Univ, South China Acad Adv Optoelect, Ctr Opt & Electromagnet Res, Univ City Campus, Guangzhou 510006, Peoples R China.
   [Svanberg, Sune] Lund Univ, Dept Phys, SE-22100 Lund, Sweden.
RP Svanberg, S; Zhao, GY (corresponding author), South China Normal Univ, South China Acad Adv Optoelect, Ctr Opt & Electromagnet Res, Univ City Campus, Guangzhou 510006, Peoples R China.; Svanberg, S (corresponding author), Lund Univ, Dept Phys, SE-22100 Lund, Sweden.
EM sune.svanberg@fysik.lth.se; guangyu.zhao@coer-scnu.org
FU Lund University; Guangdong Province Innovation Research Team Program
   [2010001D0104799318]; National Science Foundation of ChinaNational
   Natural Science Foundation of China [61705069]; Chinese Ministry of
   Science and Technology through the National Key Research and Development
   Program of China [2018YFC1407503]
FX Open access funding provided by Lund University. The authors thank
   Professors Sailing He and Guofu Zhou for support. We are also grateful
   to Xinghua Su and Professor Xiaodong Chen of Southern Medical University
   for providing well-classified insects, and to Dr Mikkel Brydegaard for
   discussions on electronic circuitry. We would also like to thank Zheng
   Duan, Ying Li, and Lingna Hu for assistance. This work was supported by
   the Guangdong Province Innovation Research Team Program
   (2010001D0104799318), the National Science Foundation of China
   (61705069), and the Chinese Ministry of Science and Technology through
   the National Key Research and Development Program of China
   (2018YFC1407503).
CR Beeson JG, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau1458
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brydegaard M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135231
   Brydegaard M, 2014, PROG ELECTROMAGN RES, V147, P141, DOI 10.2528/PIER14101001
   Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058
   Gibson G, 2010, PHYSIOL ENTOMOL, V20, P224
   Hawkes F, 2016, PARASITE VECTOR, V9, P1
   Hongtao Zhang, 2013, Advanced Materials Research, V756-759, P4063, DOI 10.4028/www.scientific.net/AMR.756-759.4063
   Huang S. G., 2009, INT C IM AN SIGN PRO
   Jansson S, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2018.2859225
   Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092
   Malmqvist E, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172303
   Meyer G. E., 1991, P SPIE INT SOC OPTIC, V1379
   Mharakurwa S, 2012, ACTA TROP, V121, P202, DOI 10.1016/j.actatropica.2011.06.012
   Potamitis I, 2018, J SENSORS, V2018, DOI 10.1155/2018/3949415
   Potamitis I, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010110
   Potamitis I, 2016, IEEE SENS J, V16, P6053, DOI 10.1109/JSEN.2016.2574762
   Potamitis I, 2016, APPL ACOUST, V109, P54, DOI 10.1016/j.apacoust.2016.03.005
   Raman DR, 2007, T ASABE, V50, P1481, DOI 10.13031/2013.23606
   Santos DAA, 2019, J CLEAN PROD, V217, P767, DOI 10.1016/j.jclepro.2019.01.187
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Song ZW, 2020, J APPL ENTOMOL, V144, P161, DOI 10.1111/jen.12714
   Spitzen J, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2735-6
   Tian YouWen, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P325, DOI 10.3969/j.issn.1002-6819.2015.04.046
   Weber M., 2019, 85 ANCA C ORL
   Zhu SM, 2017, APPL PHYS B-LASERS O, V123, DOI 10.1007/s00340-017-6784-x
NR 26
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0946-2171
EI 1432-0649
J9 APPL PHYS B-LASERS O
JI Appl. Phys. B-Lasers Opt.
PD JAN 22
PY 2020
VL 126
IS 2
AR 28
DI 10.1007/s00340-019-7361-2
PG 10
WC Optics; Physics, Applied
SC Optics; Physics
GA KO5FS
UT WOS:000515575800001
OA Other Gold
DA 2020-07-08
ER

PT J
AU Ma, XC
   Luo, X
   Zhou, SL
   Huang, YX
   Chen, CC
   Huang, CB
   Shen, L
   Zhang, P
   Liu, C
AF Ma, Xiaocao
   Luo, Xin
   Zhou, Shili
   Huang, Yanxia
   Chen, Cancan
   Huang, Changbai
   Shen, Li
   Zhang, Ping
   Liu, Chao
TI Hydroxycarboxylic Acid Receptor 2 Is a Zika Virus Restriction Factor
   That Can Be Induced by Zika Virus Infection Through the IRE1-XBP1
   Pathway
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE ZIKV; HCAR2; IRE1-XBP1; CRISPR; Cas9; restriction factor; viral
   replication
ID NICOTINIC-ACID; MOLECULAR-IDENTIFICATION; MESSENGER-RNA; PUMA-G;
   GPR109A; PROTEIN; DENGUE; CELLS; EXPRESSION; EMERGENCE
AB Zika virus (ZIKV) is an emerging arthropod-borne virus and belongs to the Flaviviridae family. The infection of ZIKV has become the global health crisis because of its rapid spread and association with severe neurological disorders, including congenital microcephaly and Guillain-Barre Syndrome. To identify host factors contributing to ZIKV pathogenesis, transcriptomic landscape in ZIKV-infected cells was examined with mRNA microarray analysis and we observed that the expression of hydroxycarboxylic acid receptor 2 (HCAR2) could be significantly induced by ZIKV infection. By utilizing two IRE1 inhibitors and XBP1-specific shRNAs, we revealed that the up-regulation of HCAR2 expression induced by ZIKV was dependent on the IRE1-XBP1 pathway. Through the CRISPR/Cas9 system, we generated HCAR2-deficient cell clones in two cell types (human lung carcinoma epithelial A549 cell and human hepatoma Huh7.5 cell). We found that the depletion of HCAR2 significantly increased the replication level of ZIKV, including RNA levels, protein expression levels, and viral titers. In addition, our data demonstrated that the antiviral effect of HCAR2 was not involved in viral entry process and was not dependent on its antilipolytic effect on nicotinic acid/HCAR2-mediated signaling pathway. Taken together, our results indicated that HCAR2 could function as a restriction factor in control of ZIKV replication, potentially providing a novel molecular target for anti-ZIKV therapeutics.
C1 [Ma, Xiaocao; Luo, Xin; Zhou, Shili; Huang, Yanxia; Huang, Changbai; Shen, Li; Zhang, Ping; Liu, Chao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Immunol, Guangzhou, Peoples R China.
   [Ma, Xiaocao; Luo, Xin; Zhou, Shili; Huang, Yanxia; Huang, Changbai; Shen, Li; Zhang, Ping; Liu, Chao] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Peoples R China.
   [Chen, Cancan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China.
RP Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Immunol, Guangzhou, Peoples R China.; Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Peoples R China.
EM liuchao9@mail.sysu.edu.cn
FU Guangdong Science and Technology Department [2018A050506029,
   2017A050501012]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31970887, 81471935]; Natural
   Science Foundation of Guangdong provinceNational Natural Science
   Foundation of Guangdong Province [2019A1515011336]
FX This work was supported by Guangdong Science and Technology Department
   (Nos. 2018A050506029 and 2017A050501012), National Natural Science
   Foundation of China (Nos. 31970887 and 81471935), and Natural Science
   Foundation of Guangdong province (No. 2019A1515011336).
CR Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen CC, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0382-1
   Concha NO, 2015, MOL PHARMACOL, V88, P1011, DOI 10.1124/mol.115.100917
   Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045
   Feingold KR, 2014, J LIPID RES, V55, P2501, DOI 10.1194/jlr.M050955
   Osuna-Ramos JF, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00388
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gao HX, 2019, VIROLOGY, V529, P91, DOI 10.1016/j.virol.2019.01.019
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213
   Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651
   Martin PM, 2009, MOL VIS, V15, P362
   Martin-Acebes MA, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020097
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martins AS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01951
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Montecucco F, 2010, EXPERT REV CARDIOVAS, V8, P1457, DOI [10.1586/erc.10.116, 10.1586/ERC.10.116]
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pombo JP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01276
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01398
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schaub A, 2001, EUR J IMMUNOL, V31, P3714, DOI 10.1002/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1
   Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5
   Soto-Acosta R, 2018, ELIFE, V7, DOI 10.7554/eLife.39023
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750
   Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Wanders D, 2012, BIOCHEM BIOPH RES CO, V425, P278, DOI 10.1016/j.bbrc.2012.07.082
   Wang Y, 2019, J VIROL, V93, DOI 10.1128/JVI.01306-18
   Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zandi-Nejad K, 2013, FASEB J, V27, P4366, DOI 10.1096/fj.12-223933
   Zellner C, 2005, HUM MUTAT, V25, P18, DOI 10.1002/humu.20121
   Zhang JS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02286
NR 48
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JAN 22
PY 2020
VL 9
AR 480
DI 10.3389/fcimb.2019.00480
PG 14
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KI5DR
UT WOS:000511370600001
PM 32039055
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bryden, SR
   Pingen, M
   Lefteri, DA
   Miltenburg, J
   Delang, L
   Jacobs, S
   Abdelnabi, R
   Neyts, J
   Pondeville, E
   Major, J
   Muller, M
   Khalid, H
   Tuplin, A
   Varjak, M
   Merits, A
   Edgar, J
   Graham, GJ
   Shams, K
   McKimmie, CS
AF Bryden, Steven R.
   Pingen, Marieke
   Lefteri, Daniella A.
   Miltenburg, Janne
   Delang, Leen
   Jacobs, Sofie
   Abdelnabi, Rana
   Neyts, Johan
   Pondeville, Emilie
   Major, Jack
   Mueller, Marietta
   Khalid, Henna
   Tuplin, Andrew
   Varjak, Margus
   Merits, Andres
   Edgar, Julia
   Graham, Gerard J.
   Shams, Kave
   McKimmie, Clive S.
TI Pan-viral protection against arboviruses by activating skin macrophages
   at the inoculation site
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID SEMLIKI-FOREST-VIRUS; FULL-LENGTH CDNA; JAPANESE ENCEPHALITIS; DENDRITIC
   CELLS; CHIKUNGUNYA; INTERFERON; DENGUE; INFECTION; ZIKA; PATHOGENESIS
AB Arthropod-borne viruses (arboviruses) are important human pathogens for which there are no specific antiviral medicines. The abundance of genetically distinct arbovirus species, coupled with the unpredictable nature of their outbreaks, has made the development of virus-specific treatments challenging. Instead, we have defined and targeted a key aspect of the host innate immune response to virus at the arthropod bite that is common to all arbovirus infections, potentially circumventing the need for virus-specific therapies. Using mouse models and human skin explants, we identify innate immune responses by dermal macrophages in the skin as a key determinant of disease severity. Post-exposure treatment of the inoculation site by a topical TLR7 agonist suppressed both the local and subsequent systemic course of infection with a variety of arboviruses from the Alphavirus, Flavivirus, and Orthobunyavirus genera. Clinical outcome was improved in mice after infection with a model alphavirus. In the absence of treatment, antiviral interferon expression to virus in the skin was restricted to dermal dendritic cells. In contrast, stimulating the more populous skin-resident macrophages with a TLR7 agonist elicited protective responses in key cellular targets of virus that otherwise proficiently replicated virus. By defining and targeting a key aspect of the innate immune response to virus at the mosquito bite site, we have identified a putative new strategy for limiting disease after infection with a variety of genetically distinct arboviruses.
C1 [Bryden, Steven R.; Pingen, Marieke; Lefteri, Daniella A.; Miltenburg, Janne; Major, Jack; McKimmie, Clive S.] Univ Leeds, Leeds Inst Med Res, Sch Med, Fac Med & Hlth,Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.
   [Bryden, Steven R.; Pingen, Marieke; Pondeville, Emilie; Major, Jack; Varjak, Margus; Edgar, Julia; Graham, Gerard J.] Univ Glasgow, Inst Infect Immunol & Inflammat, Glasgow G12 8TA, Lanark, Scotland.
   [Delang, Leen; Jacobs, Sofie; Abdelnabi, Rana; Neyts, Johan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, B-3000 Leuven, Belgium.
   [Mueller, Marietta; Khalid, Henna; Tuplin, Andrew] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.
   [Mueller, Marietta; Khalid, Henna; Tuplin, Andrew] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
   [Merits, Andres] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia.
   [Shams, Kave] Univ Leeds, Fac Med & Hlth, Sch Med, Inflammatory Skin Dis Grp,Inst Rheumat & Musculos, Leeds LS9 7TF, W Yorkshire, England.
RP McKimmie, CS (corresponding author), Univ Leeds, Leeds Inst Med Res, Sch Med, Fac Med & Hlth,Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.
EM c.s.mckimmie@leeds.ac.uk
RI abdelnabi, rana/D-9526-2018; NEYTS, Johan/U-8267-2017; McKimmie,
   Clive/C-9208-2013
OI abdelnabi, rana/0000-0001-9771-7312; Jacobs, Sofie/0000-0001-8657-6841;
   Lefteri, Daniella/0000-0002-9985-4254; NEYTS, Johan/0000-0002-0033-7514;
   Major, Jack/0000-0002-8018-1512; Bryden, Steven/0000-0001-5408-6047;
   McKimmie, Clive/0000-0002-7694-9509; Miltenburg,
   Janne/0000-0001-6624-7215
FU BBSRC DTP PhD fellowship; Wellcome Trust Seed Award in ScienceWellcome
   Trust [108227/B/15/Z]; Royal Society research grantRoyal Society of
   London [RGS\R1\191390]; University of Leeds UAF; Wellcome Trust
   investigator awardWellcome Trust; MRC ProgrammeMedical Research Council
   UK (MRC); Wolfson Royal Society Merit AwardRoyal Society of London; MRC
   core funding [MC_UU_12014/8]; Fund for Scientific Research (FWO)FWO
   [1522918N]; FWO PhD fellowshipFWO [1S21918N]; MRCMedical Research
   Council UK (MRC) [MR/NO1054X/1]
FX Funding was provided by BBSRC DTP PhD fellowship to S.R.B. and C.S.M.;
   Wellcome Trust Seed Award in Science (108227/B/15/Z), The Royal Society
   research grant (RGS\R1\191390), and the University of Leeds UAF to
   C.S.M.; Wellcome Trust investigator award, MRC Programme, and a Wolfson
   Royal Society Merit Award to G.J.G.; MRC core funding MC_UU_12014/8 to
   E.P.; Fund for Scientific Research (FWO) Flanders individual credit
   (1522918N) to L.D. and FWO PhD fellowship (1S21918N) to S.J.; and an MRC
   grant MR/NO1054X/1 to A.T.
CR 3M, 2004, ALDARA PHARM
   Abdelnabi R, 2018, ANTIVIR RES, V149, P113, DOI 10.1016/j.antiviral.2017.09.016
   Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007
   Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664
   Carpentier KS, 2018, CURR OPIN VIROL, V28, P53, DOI 10.1016/j.coviro.2017.11.006
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Ferguson MC, 2015, J VIROL, V89, P7536, DOI 10.1128/JVI.03645-14
   Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017
   Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Handfield C, 2018, TRENDS IMMUNOL, V39, P328, DOI 10.1016/j.it.2018.02.003
   Iversen MB, 2016, NAT IMMUNOL, V17, P150, DOI 10.1038/ni.3319
   Jetter N, 2018, AM J CLIN DERMATOL, V19, P543, DOI 10.1007/s40257-018-0348-7
   Rodriguez-Lopez MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033064
   Kan YJ, 2012, J VIROL, V86, P10338, DOI 10.1128/JVI.01196-12
   Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516
   LILJESTROM P, 1991, J VIROL, V65, P4107
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Lukaszewski RA, 2000, J VIROL, V74, P5006, DOI 10.1128/JVI.74.11.5006-5015.2000
   Michlmayr D, 2014, J VIROL, V88, P9553, DOI 10.1128/JVI.03421-13
   Morrey John D., 2004, Antiviral Chemistry & Chemotherapy, V15, P101
   Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880
   Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Pagni S, 2012, IMMUNOL RES, V54, P152, DOI 10.1007/s12026-012-8334-2
   Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862
   Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Sali TM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005324
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007
   Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Werneke SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002322
   Zhang LJ, 2016, IMMUNITY, V45, P119, DOI 10.1016/j.immuni.2016.06.021
NR 54
TC 1
Z9 1
U1 1
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JAN 22
PY 2020
VL 12
IS 527
AR eaax2421
DI 10.1126/scitranslmed.aax2421
PG 16
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA KE6JE
UT WOS:000508659500001
PM 31969486
OA Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Okar, SV
   Bekircan-Kurt, CE
   Hacioglu, S
   Erdem-Ozdamar, S
   Ozkul, A
   Ergunay, K
AF Okar, Serhat Vahip
   Bekircan-Kurt, Can Ebru
   Hacioglu, Sabri
   Erdem-Oezdamar, Sevim
   Oezkul, Aykut
   Erguenay, Koray
TI Toscana virus associated with Guillain-Barre syndrome: a case-control
   study
SO ACTA NEUROLOGICA BELGICA
LA English
DT Article; Early Access
DE Toscana virus; Guillain-Barre syndrome; West Nile virus
ID WEST-NILE-VIRUS; INFECTION; DIAGNOSIS; ZIKA; IDENTIFICATION
AB Guillain-Barre syndrome (GBS) is an acute-onset, immune-mediated polyradiculoneuropathy, often precipitated by an antecedent infection. An association of GBS with vector-borne viral infections has been suggested, with evidence for the involvement of Zika, Dengue, Chikungunya and West Nile virus (WNV). This prospective case-control study was conducted to identify vector-borne viral infections in GBS. Thirteen individuals newly diagnosed as GBS were enrolled. Disease severity, prognostic factors and nerve conduction patterns were assessed. Eleven individuals with non-infectious conditions requiring cerebrospinal fluid (CSF) analysis were included as controls. Plasma, CSF and urine specimens were evaluated via nucleic acid amplification assays aimed to detect a broad spectrum of viruses. WNV and Toscana virus (TOSV) IgM/IgG antibodies were screened using commercial immunofluorescence assays and confirmed via virus neutralization tests (VNT). Partial TOSV nucleocapsid and genotype 1 polymerase sequences were detected in CSF of a patient with normal pressure hydrocephalus. Two control subjects had VNT-confirmed TOSV IgM in plasma. VNT-confirmed WNV and TOSV IgG were detected in 15.4% and 61.5% of GBS patients, respectively. Variations in WNV IgG and TOSV IgM detection rates were not statistically significant among study cohorts. However, TOSV IgG was significantly more frequent in GBS patients. No difference was observed for disease form or prognostic scores for virus markers. Follow-up serological profiles were identical to the initial findings. We have identified TOSV as a potential precipitating agent in GBS, with some rare clinical presentations of symptomatic TOSV infections.
C1 [Okar, Serhat Vahip; Bekircan-Kurt, Can Ebru; Erdem-Oezdamar, Sevim] Hacettepe Univ, Hacettepe Univ Hosp, Dept Neurol, Fac Med, Floor A, TR-06100 Ankara, Turkey.
   [Hacioglu, Sabri; Oezkul, Aykut] Ankara Univ, Dept Virol, Fac Vet Med, TR-06110 Ankara, Turkey.
   [Erguenay, Koray] Hacettepe Univ, Dept Med Microbiol, Virol Unit, Fac Med, TR-06100 Ankara, Turkey.
RP Okar, SV (corresponding author), Hacettepe Univ, Hacettepe Univ Hosp, Dept Neurol, Fac Med, Floor A, TR-06100 Ankara, Turkey.
EM okarserhat@gmail.com
RI Ergunay, Koray/I-8368-2013; Ozkul, Aykut/A-1973-2016
OI Ergunay, Koray/0000-0001-5422-1982; Ozkul, Aykut/0000-0001-5008-9443
FU Hacettepe University Scientific Research Projects Coordination Unit
   fundsHacettepe University [:15364: THD-2017-15364]
FX The study was supported by the Hacettepe University Scientific Research
   Projects Coordination Unit funds (Project ID:15364: THD-2017-15364).
CR Martinez-Garcia FA, 2008, MED CLIN-BARCELONA, V130, P639
   Baldelli F, 2004, CLIN INFECT DIS, V38, P515, DOI 10.1086/381201
   Bartels S, 2012, J NEUROL, V259, P175, DOI 10.1007/s00415-011-6121-y
   Charrel RN, 2007, EMERG INFECT DIS, V13, P465, DOI 10.3201/eid1303.061086
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1657, DOI 10.3201/eid1111.050869
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   Ergunay K, 2011, CLIN MICROBIOL INFEC, V17, P575, DOI 10.1111/j.1469-0691.2010.03346.x
   Ergunay K, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1898
   Ergunay K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003028
   Ergunay K, 2011, VECTOR-BORNE ZOONOT, V11, P781, DOI 10.1089/vbz.2010.0224
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6
   Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Johnson DJ, 2001, EMERG INFECT DIS, V7, P739
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lynch RM, 2019, J INFECT DIS, V219, P26, DOI 10.1093/infdis/jiy466
   Magurano F, 1999, CLIN DIAGN LAB IMMUN, V6, P55, DOI 10.1128/CDLI.6.1.55-60.1999
   Mancera-Paez O, 2018, J NEUROL SCI, V395, P47, DOI 10.1016/j.jns.2018.09.028
   Mosnier E, 2013, MED MALADIES INFECT, V43, P208, DOI 10.1016/j.medmal.2013.04.002
   Ocal M, 2014, ZOONOSES PUBLIC HLTH, V61, P480, DOI 10.1111/zph.12096
   Oechtering J, 2012, NEUROLOGY, V79, P829, DOI 10.1212/WNL.0b013e3182661f1a
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rota E, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008081
   Sahu R, 2014, NEUROLOGY, V83, P1601, DOI 10.1212/WNL.0000000000000935
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sanbonmatsu-Gamez S, 2009, EMERG INFECT DIS, V15, P347, DOI 10.3201/eid1502.081001
   Sanchez-Seco MP, 2003, J MED VIROL, V71, P140, DOI 10.1002/jmv.10465
   Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8
   Serata D, 2011, INT J NEUROSCI, V121, P165, DOI 10.3109/00207454.2010.537412
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Van den Bergh PYK, 2018, MUSCLE NERVE, V58, P23, DOI 10.1002/mus.26056
   van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Willison Hugh J, 2012, J Peripher Nerv Syst, V17 Suppl 3, P3, DOI 10.1111/j.1529-8027.2012.00423.x
   Zanelli G, 2013, INFECTION, V41, P735, DOI 10.1007/s15010-012-0368-9
NR 41
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-9009
EI 2240-2993
J9 ACTA NEUROL BELG
JI Acta Neurol. Belg.
DI 10.1007/s13760-020-01279-5
EA JAN 2020
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA KE6YT
UT WOS:000508700100002
PM 31970702
DA 2020-07-08
ER

PT J
AU Pramanik, S
   Thaker, M
   Perumal, AG
   Ekambaram, R
   Poondla, N
   Schmidt, M
   Kim, PS
   Kutzner, A
   Heese, K
AF Pramanik, Subrata
   Thaker, Manisha
   Perumal, Ananda Gopu
   Ekambaram, Rajasekaran
   Poondla, Naresh
   Schmidt, Markus
   Kim, Pok-Son
   Kutzner, Arne
   Heese, Klaus
TI Proteomic Atomics Reveals a Distinctive Uracil-5-Methyltransferase
SO MOLECULAR INFORMATICS
LA English
DT Article
DE Apicoplast; Bioinformatics; Cross species; Malaria; Methyltransferase
ID PLASMODIUM-FALCIPARUM; FUNCTIONAL-SIGNIFICANCE; PHYSICAL REALISM; ZIKA
   VIRUS; WEB SERVER; METHYLTRANSFERASE; PROTEINS; TARGET; APICOPLAST;
   GENOME
AB Carbon (C), hydrogen (H), nitrogen (N), oxygen (O), and sulfur (S) atoms intrigue as they are the foundation for amino acid (AA) composition and the folding and functions of proteins and thus define and control the survival of a cell, the smallest unit of life. Here, we calculated the proteomic atom distribution in >1500 randomly selected species across the entire current phylogenetic tree and identified uracil-5-methyltransferase (U5MTase) of the protozoan parasite Plasmodium falciparum (Pf, strain Pf3D7), with a distinct atom and AA distribution pattern. We determined its apicoplast location and in silico 3D protein structure to refocus attention exclusively on U5MTase with tremendous potential for therapeutic intervention in malaria. Around 300 million clinical cases of malaria occur each year in tropical and subtropical regions of the world, resulting in over one million deaths annually, placing malaria among the most serious infectious diseases. Genomic and proteomic research of the clades of parasites containing Pf is progressing slowly and the functions of most of the similar to 5300 genes are still unknown. We applied a 'bottom-up' comparative proteomic atomics analysis across the phylogenetic tree to visualize a protein molecule on its actual basis - i. e., its atomic level. We identified a protruding Pf3D7-specific U5MTase, determined its 3D protein structure, and identified potential inhibitory drug molecules through in silico drug screening that might serve as possible remedies for the treatment of malaria. Besides, this atomic-based proteome map provides a unique approach for the identification of parasite-specific proteins that could be considered as novel therapeutic targets.
C1 [Pramanik, Subrata; Poondla, Naresh; Heese, Klaus] Hanyang Univ, Grad Sch Biomed Sci & Engn, 222 Wangsimni Ro, Seoul 133791, South Korea.
   [Pramanik, Subrata] Rhein Westfal TH Aachen, Inst Biotechnol, Worringerweg 3, D-52074 Aachen, Germany.
   [Thaker, Manisha] Harvard Med Sch, Dept Med, 3 Blackfan Circle, Boston, MA 02115 USA.
   [Perumal, Ananda Gopu] Periyar Maniammai Inst Sci & Technol, Technol Business Incubator, Thanjavur 613403, Tamil Nadu, India.
   [Ekambaram, Rajasekaran] VSB Engn Coll, Dept Chem, 67 Covai Rd, Karur 639111, Tamil Nadu, India.
   [Schmidt, Markus; Kutzner, Arne] Hanyang Univ, Coll Engn, Dept Informat Syst, 222 Wangsimni Ro, Seoul 133791, South Korea.
   [Kim, Pok-Son] Kookmin Univ, Dept Math, 77 Jeongneung Ro, Seoul 136702, South Korea.
RP Heese, K (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, 222 Wangsimni Ro, Seoul 133791, South Korea.
EM klaus@hanyang.ac.kr
RI Ekambaram, Rajasekaran/W-2192-2018; Heese, Klaus/H-3128-2013
OI Ekambaram, Rajasekaran/0000-0002-9317-3984; Heese,
   Klaus/0000-0002-0027-6993; Perumal, Anandagopu/0000-0002-0228-1745;
   Pramanik, Subrata/0000-0003-3328-6239; Kutzner, Arne/0000-0001-5061-6936
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [2015R1D1A1A01057243]
FX This study was supported by the Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (2015R1D1A1A01057243).
CR Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332
   Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052
   Bennett MR, 2017, CURR OPIN CHEM BIOL, V37, P97, DOI 10.1016/j.cbpa.2017.01.020
   Bragg JG, 2007, P ROY SOC B-BIOL SCI, V274, P1063, DOI 10.1098/rspb.2006.0290
   Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270
   Carlton JM, 2018, NAT MICROBIOL, V3, P642, DOI 10.1038/s41564-018-0170-2
   Chakraborty A, 2016, LIFE SCI, V158, P104, DOI 10.1016/j.lfs.2016.06.030
   Cilingir G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036598
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Davies HM, 2017, FEMS MICROBIOL REV, V41, P923, DOI 10.1093/femsre/fux046
   Draper SJ, 2018, CELL HOST MICROBE, V24, P43, DOI 10.1016/j.chom.2018.06.008
   Druart X, 2013, J PROTEOMICS, V91, P13, DOI 10.1016/j.jprot.2013.05.029
   Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302
   Hamdane D, 2016, J MOL BIOL, V428, P4867, DOI 10.1016/j.jmb.2016.10.031
   Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634
   Ikehara K, 2007, CURR MED CHEM, V14, P3221, DOI 10.2174/092986707782793853
   Jamal S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-55
   Jiang C, 2018, SCIENCE, V359, DOI 10.1126/science.aas8953
   Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570
   Labbe CM, 2015, NUCLEIC ACIDS RES, V43, pW448, DOI 10.1093/nar/gkv306
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li HM, 2014, SCI CHINA LIFE SCI, V57, P287, DOI 10.1007/s11427-014-4617-2
   Li N, 2009, J MOL EVOL, V68, P248, DOI 10.1007/s00239-009-9199-4
   Ludin P, 2012, INT J PARASITOL-DRUG, V2, P191, DOI 10.1016/j.ijpddr.2012.07.002
   Lutgen P., 2018, PHARM PHARM INT J, V6, P176
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   McFadden GI, 2017, INT J PARASITOL, V47, P137, DOI 10.1016/j.ijpara.2016.08.005
   Mishanina TV, 2012, BIOORG CHEM, V43, P37, DOI 10.1016/j.bioorg.2011.11.005
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Moura A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077319
   Otto TD, 2018, NAT MICROBIOL, V3, P687, DOI 10.1038/s41564-018-0162-2
   Palanisamy B, 2014, BIOINFORMATICS, V30, P597, DOI 10.1093/bioinformatics/btt587
   Palanisamy B, 2014, FEMS MICROBIOL LETT, V351, P59, DOI 10.1111/1574-6968.12355
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phillips MA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.50
   Podvinec M, 2010, J MED CHEM, V53, P1483, DOI 10.1021/jm900776m
   Pramanik S, 2016, MOL INFORM, V35, P99, DOI 10.1002/minf.201500035
   Pramanik S, 2015, TUMOR BIOL, V36, P239, DOI 10.1007/s13277-014-2620-7
   Rajasekaran E, 2012, BIOINFORMATION, V8, P508, DOI 10.6026/97320630008508
   Rout S, 2015, J MICROBIOL METH, V109, P1, DOI 10.1016/j.mimet.2014.11.016
   Schwartz R, 2006, PROTEIN SCI, V15, P102, DOI 10.1110/ps.051741806
   Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409
   Shemesh Ronen, 2010, Genomics Proteomics & Bioinformatics, V8, P180, DOI 10.1016/S1672-0229(10)60020-4
   Singh J, 2016, J PHARM BIOALLIED SC, V8, P188, DOI 10.4103/0975-7406.171682
   Struck AW, 2012, CHEMBIOCHEM, V13, P2642, DOI 10.1002/cbic.201200556
   Sundararaman SA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11078
   Wang X, 2017, NUCLEIC ACIDS RES, V45, pW356, DOI 10.1093/nar/gkx374
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024
   Yadav MK, 2012, BIOINFORMATION, V8, P1230, DOI 10.6026/97320630081230
   Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
NR 56
TC 0
Z9 0
U1 1
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1868-1743
EI 1868-1751
J9 MOL INFORM
JI Mol. Inf.
PD MAY
PY 2020
VL 39
IS 5
DI 10.1002/minf.201900135
EA JAN 2020
PG 9
WC Chemistry, Medicinal; Computer Science, Interdisciplinary Applications;
   Mathematical & Computational Biology
SC Pharmacology & Pharmacy; Computer Science; Mathematical & Computational
   Biology
GA LS2ZU
UT WOS:000508453700001
PM 31943843
DA 2020-07-08
ER

PT J
AU Ropidi, MIM
   Khazali, AS
   Rashid, NN
   Yusof, R
AF Mohd Ropidi, Muhammad Izzuddin
   Khazali, Ahmad Suhail
   Nor Rashid, Nurshamimi
   Yusof, Rohana
TI Endoplasmic reticulum: a focal point of Zika virus infection
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Review
DE Zika virus; Endoplasmic reticulum; Unfolded protein response; Stress
   granules; Reticulophagy; Paraptosis; Cytoplasmic vacuolization
ID UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR CHOP; ER STRESS;
   MISFOLDED PROTEINS; ALPHA-SUBUNIT; APOPTOSIS; AUTOPHAGY; PATHWAY;
   BINDING; DENGUE
AB Zika virus (ZIKV) belongs to the Flavivirus genus of the Flaviviridae family. It is an arbovirus that can cause congenital abnormalities and is sexually transmissible. A series of outbreaks accompanied by unexpected severe clinical complications have captured medical attention to further characterize the clinical features of congenital ZIKV syndrome and its underlying pathophysiological mechanisms. Endoplasmic reticulum (ER) and ER-related proteins are essential in ZIKV genome replication. This review highlights the subcellular localization of ZIKV to the ER and ZIKV modulation on the architecture of the ER. This review also discusses ZIKV interaction with ER proteins such as signal peptidase complex subunit 1 (SPCS1), ER membrane complex (EMC) subunits, and ER translocon for viral replication. Furthermore, the review covers several important resulting effects of ZIKV infection to the ER and cellular processes including ER stress, reticulophagy, and paraptosis-like death. Pharmacological targeting of ZIKV-affected ER-resident proteins and ER-associated components demonstrate promising signs of combating ZIKV infection and rescuing host organisms from severe neurologic sequelae.
C1 [Mohd Ropidi, Muhammad Izzuddin; Khazali, Ahmad Suhail; Nor Rashid, Nurshamimi; Yusof, Rohana] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.
RP Rashid, NN (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.
EM nurshamimi@um.edu.my
FU Ministry of Higher Education, MalaysiaMinistry of Education, Malaysia
   [FRGS FP007-2017A]
FX This work was supported by the grant [FRGS FP007-2017A] from the
   Ministry of Higher Education, Malaysia.
CR Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055
   Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Barreto-Vieira DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184397
   Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423
   BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9
   Bonenfant G, 2019, J VIROL, V93, DOI [10.1128/JVI.00520-19, 10.1128/jvi.00520-19]
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836
   Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2018, ANTIVIR RES, V160, P38, DOI 10.1016/j.antiviral.2018.10.007
   Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   de Sousa JR, 2018, AM J PATHOL, V188, P2644, DOI [10.1016/j.ajpath.2018.07.009, 10.1016/j.ajpat]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169
   Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2019, ISCIENCE, V13, P339, DOI 10.1016/j.isci.2019.03.003
   He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hoenen A, 2007, J GEN VIROL, V88, P3013, DOI 10.1099/vir.0.83125-0
   Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Hu H, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03083
   JFE T, 2019, CROSSTALK ENDOPLASMI
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Liu J, 2018, INT J BIOL SCI, V14, P1099, DOI 10.7150/ijbs.26400
   Liu J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0071-8
   Maier HJ, 2013, MBIO, V4, DOI 10.1128/mBio.00801-13
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McCormick C, 2017, NAT REV IMMUNOL, V17, P647, DOI 10.1038/nri.2017.63
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008
   Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Pan American Health Organization / World Health Organization, 2015, EP AL INCR MICR NE B
   Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Prischi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4554
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rawle RJ, 2018, ACS CENTRAL SCI, V4, P1503, DOI 10.1021/acscentsci.8b00494
   Romero-Brey I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060160
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Sager G, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100559
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   Sari FR, 2011, CELL PHYSIOL BIOCHEM, V27, P487, DOI 10.1159/000329970
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716
   Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074
   Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6
   Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010
   Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961
   Ubeda M, 1996, MOL CELL BIOL, V16, P1479
   Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI 10.1089/ARS.2009.2485
   Wang P, 2018, J BIOL CHEM, V293, P4110, DOI 10.1074/jbc.RA117.001294
   Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09
   Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347
   Xing HP, 2020, VIRUS RES, V275, DOI 10.1016/j.virusres.2019.197793
   Xu S, 2019, NUCLEIC ACIDS RES, V47, P8693, DOI 10.1093/nar/gkz650
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
   Zhang Q, 2019, VIROL SIN, V34, P175, DOI 10.1007/s12250-019-00122-3
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang XW, 2019, MBIO, V10, DOI 10.1128/mBio.02375-19
NR 94
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD JAN 20
PY 2020
VL 27
IS 1
AR 27
DI 10.1186/s12929-020-0618-6
PG 13
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA KL6RX
UT WOS:000513549400001
PM 31959174
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cordeiro, MTA
   Garcia, JE
   Gonzalez-Lopez, VA
   Londono, SLM
AF Cordeiro, Marcos Tadeu A.
   Garcia, Jesus Enrique
   Gonzalez-Lopez, Veronica Andrea
   Mercado Londono, Sergio Luis
TI Partition Markov model for multiple processes
SO MATHEMATICAL METHODS IN THE APPLIED SCIENCES
LA English
DT Article; Early Access
DE Bayesian information criterion; metric between stochastic processes;
   parsimonious model; stochastic processes
ID ZIKA VIRUS
AB In this paper, we analyze the model proposed in Garcia and Londono(1) in which a set of p-independent sequences of discrete time Markov chains is considered, over a finite alphabet A and with finite order o. The model is obtained identifying the states on the state space A(o) where two or more sequences share the same transition probabilities (see also Garcia and Gonzalez-Lopez(2)). This identification establishes a partition on {1, horizontal ellipsis ,p}xA(o), the set of sequences, and the state space. We show that by means of the Bayesian information criterion (BIC), the partition can be estimated eventually almost surely. Also, in Garcia and Londono,(1) it is given a notion of divergence, derived from the BIC, which serves to identify the proximity/discrepancy between elements of {1, horizontal ellipsis ,p}xA(o) (see also Garcia et al(3)). In the present article, we prove that this notion is a metric in the space where the model is built and that it is statistically consistent to determine proximity/discrepancy between the elements of the space {1, horizontal ellipsis ,p}xA(o). We apply the notions discussed here for the construction of a parsimonious model that represents the common stochastic structure of 153 complete genomic Zika sequences, coming from tropical and subtropical regions.
C1 [Cordeiro, Marcos Tadeu A.] Fed Univ Technol, Dept Math, Ponta Grossa, Parana, Brazil.
   [Garcia, Jesus Enrique; Gonzalez-Lopez, Veronica Andrea; Mercado Londono, Sergio Luis] Univ Estadual Campinas, Dept Stat, Rua Sergio Buarque de Holanda 651, BR-13083859 Campinas, SP, Brazil.
RP Garcia, JE (corresponding author), Univ Estadual Campinas, Dept Stat, Rua Sergio Buarque de Holanda 651, BR-13083859 Campinas, SP, Brazil.
EM jg@ime.unicamp.br
RI Gonzalez-Lopez, Veronica Andrea/I-2844-2012
OI Gonzalez-Lopez, Veronica Andrea/0000-0002-3514-4130
FU CAPESCAPES; PhD Graduate Program in Statistics-University of Campinas
FX M. Cordeiro and S. Londono gratefully acknowledge the financial support
   provided by CAPES with fellowships from the PhD Graduate Program in
   Statistics-University of Campinas.
CR Cordeiro MTA, 2019, 4OPEN, V2, DOI [10.1051/fopen/2019020, DOI 10.1051/FOPEN/2019020]
   Csiszar I, 2006, IEEE T INFORM THEORY, V52, P1007, DOI 10.1109/TIT.2005.864431
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Galves A, 2012, ANN APPL STAT, V6, P186, DOI 10.1214/11-AOAS511
   Garcia B, 2018, 2018 11TH INTERNATIONAL CONFERENCE ON THE QUALITY OF INFORMATION AND COMMUNICATIONS TECHNOLOGY (QUATIC), P143, DOI 10.1109/QUATIC.2018.00029
   Garcia J, 2016, REV UNISCI, P217, DOI 10.5209/RUNI.53794
   Garcia JE, 2019, AIP CONF PROC, V2116, DOI 10.1063/1.5114125
   Garcia JE, 2018, APPL STOCH MODEL BUS, V34, P868, DOI 10.1002/asmb.2346
   Garcia JE, 2018, AIP CONF PROC, V1978, DOI 10.1063/1.5043823
   Garcia JE, 2017, AIP CONF PROC, V1863, DOI 10.1063/1.4992383
   Garcia JE, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19040160
   Garcia JE, 2017, CAD ESTUD LINGUIST, V59, P617, DOI 10.20396/cel.v59i3.8651002
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
NR 14
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0170-4214
EI 1099-1476
J9 MATH METHOD APPL SCI
JI Math. Meth. Appl. Sci.
DI 10.1002/mma.6079
EA JAN 2020
PG 15
WC Mathematics, Applied
SC Mathematics
GA KD9FB
UT WOS:000508166000001
DA 2020-07-08
ER

PT J
AU Girard, YA
   Santa Maria, F
   Lanteri, MC
AF Girard, Yvette A.
   Santa Maria, Felicia
   Lanteri, Marion C.
TI Inactivation of yellow fever virus with amotosalen and ultraviolet A
   light pathogen-reduction technology
SO TRANSFUSION
LA English
DT Article
ID CHIKUNGUNYA VIRUS; ZIKA VIRUS; COMPONENTS; DISEASES; PLASMA; STRAIN
AB BACKGROUND The reemergence of yellow fever virus (YFV) in Africa and Brazil, and massive vaccine campaigns triggered to contain the outbreaks, have raised concerns over blood transfusion safety and availability with increased risk of YFV transfusion-transmitted infections (TTIs) by native and vaccine-acquired YFV. Blood donor deferral for 2 to 4 weeks following live attenuated YFV vaccination, and deferral for travel to endemic/epidemic areas, may result in blood donor loss and impact platelet component (PC) stocks. This study investigated the efficacy of INTERCEPT Blood System pathogen reduction (PR) with use of amotosalen and ultraviolet A (UVA) light to inactivate high levels of YFV in PCs. MATERIALS Four units of apheresis platelets prepared in 35% plasma/65% platelet additive solution (PC-PAS) and 4 units of PC in 100% human plasma (PC-Plasma) were spiked with high infectious titers of YFV (YFV-17D vaccine strain). YFV-17D infectious titers were measured by plaque assay and expressed as plaque-forming units (PFU) before and after amotosalen/UVA treatment to determine log reduction. RESULTS The mean YFV-17D infectious titers in PC before inactivation were 5.5 +/- 0.1 log PFU/mL in PC-PAS and 5.3 +/- 0.1 log PFU/mL in PC-Plasma. No infectivity was detected immediately after amotosalen/UVA treatment. CONCLUSION The amotosalen/UVA PR system inactivated high titers of infectious YFV-17D in PC. This PR technology could reduce the risk of YFV TTI and help secure PC supplies in areas experiencing YFV outbreaks where massive vaccination campaigns are required.
C1 [Girard, Yvette A.; Santa Maria, Felicia] Cerus Corp, Dept Microbiol, Concord, CA USA.
   [Lanteri, Marion C.] Cerus Corp, Dept Sci Affairs, Concord, CA USA.
RP Lanteri, MC (corresponding author), 1220 Concord Ave,Suite 600, Concord, CA 94520 USA.
EM mlanteri@cerus.com
CR [Anonymous], 2009, MMWR-MORBID MORTAL W, V59, P34
   [Anonymous], 2018, INTERCEPT BLOOD SYST
   [Anonymous], 2012, WHO LIB CATALOGUING
   [Anonymous], 2015, INTERCEPT BLOOD SYST
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Calvert AE, 2016, ANTIVIR RES, V131, P92, DOI 10.1016/j.antiviral.2016.04.013
   Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391
   Croce E, 2017, VACCINE, V35, P1216, DOI 10.1016/j.vaccine.2017.01.048
   Cunha MS, 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2
   Faddy HM, 2019, TRANSFUSION, V59, P2223, DOI 10.1111/trf.15332
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015
   Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092
   Laughhunn A, 2018, TRANSFUSION, V58, P748, DOI 10.1111/trf.14442
   Lindsey NP, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw045
   Lopert P, 2018, AABB ANN M BOST
   Maria FS, 2018, TRANSFUSION, V58, p24A
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   McElroy KL, 2006, J GEN VIROL, V87, P2993, DOI 10.1099/vir.0.82023-0
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Moreno-Madrinan MJ, 2018, EMERG INFECT DIS, V24, P821, DOI 10.3201/eid2405.171609
   Muller-Steinhardt M, 2017, TRANSFUS MED HEMOTH, V44, P217, DOI 10.1159/000479192
   Musso D, 2018, LANCET, V392, P2347, DOI 10.1016/S0140-6736(18)32520-0
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Pierelli L, 2018, TRANSFUSION, V58, P3027, DOI 10.1111/trf.14892
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Rajbhandary S, 2018, 2014 2015 AABB BLOOD
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   U.S Department of Health and Human Services, 2016, FEB REC DON SCREEN D
   U.S. Department of Health and Human Services, 2016, AUG REV REC RED RISK
   US Department of Health and Human Services, 2019, REC RED RISK TRANSF
   Waggoner JJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00827-18
NR 40
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2020
VL 60
IS 3
BP 622
EP 627
DI 10.1111/trf.15673
EA JAN 2020
PG 6
WC Hematology
SC Hematology
GA KR7VW
UT WOS:000508030100001
PM 31957887
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khade, PM
   Kumar, A
   Jernigan, RL
AF Khade, Pranav M.
   Kumar, Ambuj
   Jernigan, Robert L.
TI Characterizing and Predicting Protein Hinges for Mechanistic Insight
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE Protein hinge prediction; Alpha shape; Zika virus hinges; Flexible
   peptide linkers; Domain identification
ID DNA-POLYMERASE-BETA; DOMAIN MOVEMENTS; ATP HYDROLYSIS; DYNAMICS;
   MOTIONS; INHIBITION; CALMODULIN; HELICASE; MODELS
AB The functioning of proteins requires highly specific dynamics, which depend critically on the details of how amino acids are packed. Hinge motions are the most common type of large motion, typified by the opening and closing of enzymes around their substrates. The packing and geometries of residues are characterized here by graph theory. This characterization is sufficient to enable reliable hinge predictions from a single static structure, and notably, this can be from either the open or the closed form of a structure. This new method to identify hinges within protein structures is called PACKMAN. The predicted hinges are validated by using permutation tests on B-factors. Hinge prediction results are compared against lists of manually curated hinge residues, and the results suggest that PACKMAN is robust enough to reproduce the known conformational changes and is able to predict hinge regions equally well from either the open or the closed forms of a protein. A group of 167 protein pairs with open and closed structures has been investigated Examples are shown for several additional proteins, including Zika virus nonstructured (NS) proteins where there are 6 hinge regions in the NS5 protein, 5 hinge regions in the NS2B bound in the NS3 protease complex and 5 hinges in the NS3-helicase protein. Results obtained from this method can be important for generating conformational ensembles of protein targets for drug design. PACKMAN is freely accessible at (https://PACKMAN.bb.iastate. edu/). (C) 2019 Published by Elsevier Ltd.
C1 [Khade, Pranav M.; Kumar, Ambuj; Jernigan, Robert L.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Bioinformat & Computat Biol Program, Ames, IA 50011 USA.
RP Jernigan, RL (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Bioinformat & Computat Biol Program, Ames, IA 50011 USA.
EM jernigan@iastate.edu
RI Khade, Pranav/AAR-7082-2020
OI Khade, Pranav/0000-0002-0756-9828
FU NSFNational Science Foundation (NSF) [DBI-1661391]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01-GM127701, R01-GM127701-01S1]
FX This research has been supported by NSF grant DBI-1661391 and by NIH
   grants R01-GM127701 and R01-GM127701-01S1. The authors also thank
   Research IT@ Iowa State University for helping with many aspects of the
   computing.
CR Ahn S, 2001, J MOL BIOL, V313, P797, DOI 10.1006/jmbi.2001.5070
   Bahar I, 2015, BIOPHYS J, V109, P1101, DOI 10.1016/j.bpj.2015.06.004
   Bahar I, 2010, J GEN PHYSIOL, V135, P563, DOI 10.1085/jgp.200910368
   Ban YEA, 2006, J ACM, V53, P361, DOI 10.1145/1147954.1147957
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   BINNIE RA, 1992, PROTEIN SCI, V1, P1642, DOI 10.1002/pro.5560011212
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Chopra N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004826
   Cregut D, 1998, PROTEIN ENG, V11, P891, DOI 10.1093/protein/11.10.891
   DeLano W.L., 2002, CCP4 NEWSLETTER PROT, V40, P82, DOI DOI 10.1038/S41598-017-03842-2
   Delaunay B., 1934, SPHERE VIDE, V7, P793
   EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635
   Eyal E, 2007, BIOINFORMATICS, V23, pI175, DOI 10.1093/bioinformatics/btm186
   Flores SC, 2008, PROTEINS, V73, P299, DOI 10.1002/prot.22060
   Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-215
   Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167
   Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280
   Girdlestone C, 2016, J COMPUT BIOL, V23, P21, DOI 10.1089/cmb.2015.0143
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Isin Basak, 2012, Methods Mol Biol, V914, P285, DOI 10.1007/978-1-62703-023-6_17
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Katebi AR, 2015, METHODS MOL BIOL, V1215, P213, DOI 10.1007/978-1-4939-1465-4_10
   Keating KS, 2009, PROTEIN SCI, V18, P359, DOI 10.1002/pro.38
   Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002
   Lakowski TM, 2007, PROTEIN SCI, V16, P1119, DOI 10.1110/ps.072777107
   Liu J, 2017, BIOPHYS J, V112, P1561, DOI 10.1016/j.bpj.2017.03.004
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Ozer N, 2015, EVOL APPL, V8, P185, DOI 10.1111/eva.12241
   Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987
   Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Poupon A, 2004, CURR OPIN STRUC BIOL, V14, P233, DOI 10.1016/j.sbi.2004.03.010
   Sankar K, 2018, J PHYS CHEM B, V122, P5409, DOI 10.1021/acs.jpcb.7b11668
   Sankar K, 2017, P NATL ACAD SCI USA, V114, P2928, DOI 10.1073/pnas.1613331114
   Sankar K, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4937940
   SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581
   Shatsky M, 2004, J COMPUT BIOL, V11, P83, DOI 10.1089/106652704773416902
   Song G, 2006, PROTEINS, V63, P197, DOI 10.1002/prot.20836
   Starcevic D, 2005, J BIOL CHEM, V280, P28388, DOI 10.1074/jbc.M502178200
   Sun Y, 2011, BIOCHEMISTRY-US, V50, P10724, DOI 10.1021/bi201572g
   Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003
   Wong I, 2002, J BIOL CHEM, V277, P19424, DOI 10.1074/jbc.M201198200
   Wriggers W, 1998, BIOPHYS J, V74, P1622, DOI 10.1016/S0006-3495(98)77876-2
   Wriggers W, 1997, PROTEINS, V29, P1
   Yang L, 2007, BIOPHYS J, V93, P920, DOI 10.1529/biophysj.106.095927
   Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Zhao BT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14586
   Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017
   ZHOU W, 2012, BRIEF BIOINFORM, V15, P54, DOI DOI 10.1093/BIB/BBS077
NR 53
TC 0
Z9 0
U1 2
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 17
PY 2020
VL 432
IS 2
BP 508
EP 522
DI 10.1016/j.jmb.2019.11.018
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KJ7EE
UT WOS:000512220300016
PM 31786268
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Diamos, AG
   Hunter, JGL
   Pardhe, MD
   Rosenthal, SH
   Sun, HY
   Foster, BC
   DiPalma, MP
   Chen, Q
   Mason, HS
AF Diamos, Andrew G.
   Hunter, Joseph G. L.
   Pardhe, Mary D.
   Rosenthal, Sun H.
   Sun, Haiyan
   Foster, Bonnie C.
   DiPalma, Michelle P.
   Chen, Qiang
   Mason, Hugh S.
TI High Level Production of Monoclonal Antibodies Using an Optimized Plant
   Expression System
SO FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
LA English
DT Article
DE plant-based biopharmaceuticals; pharming; transient expression;
   glycosylation; monoclonal antibodies; Zika virus; transient expression;
   heteromultimeric proteins
ID RECOMBINANT IMMUNE-COMPLEXES; ENZYME REPLACEMENT THERAPY; TECHNOECONOMIC
   ANALYSIS; RAPID PRODUCTION; VIRUS-INFECTION; GLUCOCEREBROSIDASE; TRIAL;
   MICE; ZIKA
AB Biopharmaceuticals are a large and fast-growing sector of the total pharmaceutical market with antibody-based therapeutics accounting for over 100 billion USD in sales yearly. Mammalian cells are traditionally used for monoclonal antibody production, however plant-based expression systems have significant advantages. In this work, we showcase recent advances made in plant transient expression systems using optimized geminiviral vectors that can efficiently produce heteromultimeric proteins. Two, three, or four fluorescent proteins were coexpressed simultaneously, reaching high yields of 3-5 g/kg leaf fresh weight or similar to 50% total soluble protein. As a proof-of-concept for this system, various antibodies were produced using the optimized vectors with special focus given to the creation and production of a chimeric broadly neutralizing anti-flavivirus antibody. The variable regions of this murine antibody, 2A10G6, were codon optimized and fused to a human IgG1. Analysis of the chimeric antibody showed that it was efficiently expressed in plants at 1.5 g of antibody/kilogram of leaf tissue, can be purified to near homogeneity by a simple one-step purification process, retains its ability to recognize the Zika virus envelope protein, and potently neutralizes Zika virus. Two other monoclonal antibodies were produced at similar levels (1.2-1.4 g/kg). This technology will be a versatile tool for the production of a wide spectrum of pharmaceutical multi-protein complexes in a fast, powerful, and cost-effective way.
C1 [Diamos, Andrew G.; Hunter, Joseph G. L.; Pardhe, Mary D.; Rosenthal, Sun H.; Sun, Haiyan; DiPalma, Michelle P.; Chen, Qiang; Mason, Hugh S.] Arizona State Univ, Biodesign Inst, Ctr Immunotherapy Vaccines & Virotherapy, Tempe, AZ 85281 USA.
   [Diamos, Andrew G.; Hunter, Joseph G. L.; Pardhe, Mary D.; Rosenthal, Sun H.; Sun, Haiyan; Foster, Bonnie C.; DiPalma, Michelle P.; Chen, Qiang; Mason, Hugh S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.
RP Diamos, AG; Mason, HS (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Immunotherapy Vaccines & Virotherapy, Tempe, AZ 85281 USA.; Diamos, AG; Mason, HS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.
EM adiamos@asu.edu; hugh.mason@asu.edu
OI chen, qiang/0000-0003-1498-7013
FU ASU School of Life Sciences and Biodesign Institute at ASU; National
   Institute of Allergy and Infectious Diseases (NIAID)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R33AI101329]
FX This work was supported by funds from ASU School of Life Sciences and
   Biodesign Institute at ASU. This work was also supported in part through
   a grant from the National Institute of Allergy and Infectious Diseases
   (NIAID) #R33AI101329 to QC.
CR Alam A, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00102
   Baeg K, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.36
   Buyel JF, 2012, BIOTECHNOL BIOENG, V109, P2575, DOI 10.1002/bit.24523
   Buyel JF, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01893
   Castilho A, 2012, J BIOL CHEM, V287, P36518, DOI 10.1074/jbc.M112.402685
   Castilho A, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200032
   Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401
   Chargelegue D, 2005, INFECT IMMUN, V73, P5915, DOI 10.1128/IAI.73.9.5915-5922.2005
   Chen Qiang, 2016, F1000Res, V5, DOI 10.12688/f1000research.8010.1
   Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Logu A, 1998, J CLIN MICROBIOL, V36, P3198, DOI 10.1128/JCM.36.11.3198-3204.1998
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Diamos AG, 2019, J GEN VIROL, V100, P1038, DOI 10.1099/jgv.0.001275
   Diamos AG, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01974
   Diamos AG, 2019, VACCINE, V37, P137, DOI 10.1016/j.vaccine.2018.11.021
   Diamos AG, 2018, PROTEIN EXPRES PURIF, V151, P86, DOI 10.1016/j.pep.2018.06.011
   Diamos AG, 2018, PLANT BIOTECHNOL J, V16, P1971, DOI 10.1111/pbi.12931
   Diamos AG, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00200
   Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042
   Fischer R, 2015, CURR OPIN BIOTECH, V32, P156, DOI 10.1016/j.copbio.2014.12.018
   Fox J. L., 2012, Nature Biotechnology, V30, P472, DOI 10.1038/nbt0612-472
   Gengenbach BB, 2018, PROTEIN EXPRES PURIF, V151, P46, DOI 10.1016/j.pep.2018.06.003
   Gengenbach BB, 2019, BIOTECHNOL BIOENG, V116, P2236, DOI 10.1002/bit.27076
   Geyer BC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-27
   Geyer BC, 2010, PLANT BIOTECHNOL J, V8, P873, DOI 10.1111/j.1467-7652.2010.00515.x
   Grilo AL, 2019, TRENDS BIOTECHNOL, V37, P9, DOI 10.1016/j.tibtech.2018.05.014
   Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652
   Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299
   Hunter J. G., 2018, PEERJ PREPRINTS, V6, pe27390v, DOI [10.7287/peerj.preprints.27390v1, DOI 10.7287/PEERJ.PREPRINTS.27390V1]
   Hurtado J, 2020, PLANT BIOTECHNOL J, V18, P266, DOI 10.1111/pbi.13194
   Jeske H, 2009, CURR TOP MICROBIOL, V331, P185
   Kim MY, 2015, VACCINE, V33, P1830, DOI 10.1016/j.vaccine.2015.02.036
   Lai HF, 2018, VACCINE, V36, P1846, DOI 10.1016/j.vaccine.2018.02.073
   Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724
   Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838
   Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416
   Ma JKC, 2013, PLANT BIOTECHNOL J, V11, P1029, DOI 10.1111/pbi.12127
   Marusic C, 2018, BIOTECHNOL BIOENG, V115, P565, DOI 10.1002/bit.26503
   Mason HS, 2016, HUM VACC IMMUNOTHER, V12, P988, DOI 10.1080/21645515.2015.1116655
   Mastrangeli R, 2019, GLYCOBIOLOGY, V29, P199, DOI 10.1093/glycob/cwy092
   Mathew LG, 2011, PLANT MOL BIOL, V75, P263, DOI 10.1007/s11103-010-9725-1
   Mir-Artigues P, 2019, BIOTECHNOL BIOENG, V116, P2526, DOI 10.1002/bit.27093
   Montero-Morales L, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00081
   Nandi S, 2016, MABS-AUSTIN, V8, P1456, DOI 10.1080/19420862.2016.1227901
   Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109
   Palaci J, 2019, PLANT BIOTECHNOL J, V17, P1760, DOI 10.1111/pbi.13098
   Pepponi I, 2014, PLANT BIOTECHNOL J, V12, P840, DOI 10.1111/pbi.12185
   Pillet S, 2016, CLIN IMMUNOL, V168, P72, DOI 10.1016/j.clim.2016.03.008
   Pillet S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216533
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Rosenthal SH, 2018, PLANT MOL BIOL, V96, P429, DOI 10.1007/s11103-018-0708-y
   Sack M, 2015, PLANT BIOTECHNOL J, V13, P1094, DOI 10.1111/pbi.12438
   Sack M, 2015, CURR OPIN BIOTECH, V32, P163, DOI 10.1016/j.copbio.2014.12.008
   Schroeder HA, 2018, MUCOSAL IMMUNOL, V11, P1477, DOI 10.1038/s41385-018-0054-z
   Shaaltiel Y, 2015, PLANT BIOTECHNOL J, V13, P1033, DOI 10.1111/pbi.12366
   Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x
   Sun HY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010054
   Thuenemann EC, 2013, PLANT BIOTECHNOL J, V11, P839, DOI 10.1111/pbi.12076
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Walwyn DR, 2015, APPL BIOCHEM BIOTECH, V175, P841, DOI 10.1007/s12010-014-1320-5
   Webster GR, 2018, PLANT BIOTECHNOL J, V16, P1983, DOI 10.1111/pbi.12932
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Zeitlin L, 1996, VIROLOGY, V225, P213, DOI 10.1006/viro.1996.0589
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
   Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955
   Zischewski J, 2016, BIOTECHNOL J, V11, P107, DOI 10.1002/biot.201500255
NR 69
TC 0
Z9 0
U1 6
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-4185
J9 FRONT BIOENG BIOTECH
JI Front. Bioeng. Biotechnol.
PD JAN 17
PY 2020
VL 7
AR 472
DI 10.3389/fbioe.2019.00472
PG 15
WC Biotechnology & Applied Microbiology; Multidisciplinary Sciences
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA KH5KY
UT WOS:000510689800001
PM 32010680
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sadeghieh, T
   Waddell, LA
   Ng, V
   Hall, A
   Sargeant, J
AF Sadeghieh, Tara
   Waddell, Lisa A.
   Ng, Victoria
   Hall, Alexandra
   Sargeant, Jan
TI A scoping review of importation and predictive models related to
   vector-borne diseases, pathogens, reservoirs, or vectors (1999-2016)
SO PLOS ONE
LA English
DT Review
ID CLIMATE-CHANGE; ZIKA VIRUS; DENGUE TRANSMISSION; POTENTIAL IMPACT;
   LYME-DISEASE; RISK; INVASION; AFRICA; SPREAD
AB Background
   As globalization and climate change progress, the expansion and introduction of vector-borne diseases (VBD) from endemic regions to non-endemic regions is expected to occur. Mathematical and statistical models can be useful in predicting when and where these changes in distribution may happen. Our objective was to conduct a scoping review to identify and characterize predictive and importation models related to vector-borne diseases that exist in the global literature.
   Methods
   A literature search was conducted to identify publications published between 1999 and 2016 from five scientific databases using relevant keywords. All publications had to be in English or French, and include a predictive or importation model on VBDs, pathogens, reservoirs and/or vectors. Relevance screening and data characterization were performed by two reviewers using pretested forms. The data were analyzed using descriptive statistics.
   Results
   The search initially identified 19 710 unique articles, reports, and conference abstracts. This was reduced to 428 relevant documents after relevance screening and data charting. About half of the models used mathematical techniques, and the remainder were statistical. Most of the models were predictive (87%), rather than importation (5%). The most commonly investigated diseases were malaria and dengue fever. Around 12% of the publications did not report all the parameters used in their model. Only 29% of the models incorporated the impacts of climate change.
   Conclusions
   A wide variety of mathematical and statistical models on vector-borne diseases exist. Researchers creating their own mathematical and/or statistical models may be able to use this scoping review to be informed about the diseases and/or regions, parameters, model types, and methodologies used in published models.
C1 [Sadeghieh, Tara; Waddell, Lisa A.; Ng, Victoria; Hall, Alexandra] Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, Guelph, ON, Canada.
   [Sadeghieh, Tara; Hall, Alexandra; Sargeant, Jan] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.
   [Sargeant, Jan] Univ Guelph, Ontario Vet Coll, Ctr Publ Hlth & Zoonoses, Guelph, ON, Canada.
RP Sadeghieh, T (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, Guelph, ON, Canada.; Sadeghieh, T (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.
EM tsadeghi@uoguelph.ca
FU Public Health Agency of Canada
FX This study was funded through the Public Health Agency of Canada
   (http://www.phac-aspc.gc.ca).The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abeyrathna MPAR, 2016, 2ND INTERNATIONAL MERCON 2016 MORATUWA ENGINEERING RESEARCH CONFERENCE, P156, DOI 10.1109/MERCon.2016.7480132
   Addawe J, 2016, AIP CONF PROC, V1782, DOI 10.1063/1.4966069
   Arsevska E, 2016, TRANSBOUND EMERG DIS, V63, P658, DOI 10.1111/tbed.12331
   Baeza A, 2014, ACTA TROP, V129, P42, DOI 10.1016/j.actatropica.2013.04.001
   Banu S, 2014, ENVIRON INT, V63, P137, DOI 10.1016/j.envint.2013.11.002
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brauer Fred, 2017, Infect Dis Model, V2, P113, DOI 10.1016/j.idm.2017.02.001
   Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729
   Butterworth MK, 2017, ENVIRON HEALTH PERSP, V125, P579, DOI 10.1289/EHP218
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4
   Egger Matthias, 2017, F1000Res, V6, P1584, DOI 10.12688/f1000research.12367.2
   Fischer D, 2014, EUROSURVEILLANCE
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Gardner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072129
   Hanafi-Bojd AA, 2015, J MED ENTOMOL, V52, P557, DOI 10.1093/jme/tjv058
   Intergovernmental Panel on Climate Change, 2014, CLIMATE CHANGE 2014
   Kaga T, 2012, INT J ENV RES PUB HE, V9, P4704, DOI 10.3390/ijerph9124704
   Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710
   Kursah MB, 2017, GEOJOURNAL, V82, P1101, DOI 10.1007/s10708-016-9732-0
   Luz PM, 2011, MEM I OSWALDO CRUZ, V106, P755, DOI 10.1590/S0074-02762011000600017
   Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5
   Martins-Bede FT, 2010, MEM I OSWALDO CRUZ, V105, P541, DOI 10.1590/S0074-02762010000400033
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   McCreesh N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0617-0
   McCullagh P, 2002, ANN STAT, V30, P1225
   Mishra S, 2011, J EPIDEMIOL COMMUN H, V65, P87, DOI 10.1136/jech.2009.097113
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Musa MI, 2012, GEOSPATIAL HEALTH, V7, P27, DOI 10.4081/gh.2012.102
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Ogden NH, 2008, J THEOR BIOL, V254, P621, DOI 10.1016/j.jtbi.2008.06.020
   Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/, 10.1111/1365-2664.12050]
   Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148
   Parham PE, 2010, ADV EXP MED BIOL, P284
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Peters MDJ, 2015, METHOLODY JBI SCOPIN
   Peterson AT, 2015, J VECTOR ECOL, V40, P191, DOI 10.1111/jvec.12151
   Poncon N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-147
   Riley S, 2012, Hong Kong Med J, V18 Suppl 2, P45
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Tan Kah Bee, 2009, Proceedings of the 2009 Sixth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2009), P61, DOI 10.1109/FSKD.2009.761
   Tavecchia G, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0217-x
   von Elm E, 2007, BMJ-BRIT MED J, V335, P806
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 48
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 15
PY 2020
VL 15
IS 1
AR e0227678
DI 10.1371/journal.pone.0227678
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP5OV
UT WOS:000534368000089
PM 31940405
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Puerta-Guardo, H
   Tabata, T
   Petitt, M
   Dimitrova, M
   Glasner, DR
   Pereira, L
   Harris, E
AF Puerta-Guardo, Henry
   Tabata, Takako
   Petitt, Matthew
   Dimitrova, Milena
   Glasner, Dustin R.
   Pereira, Lenore
   Harris, Eva
TI Zika Virus Nonstructural Protein 1 Disrupts Glycosaminoglycans and
   Causes Permeability in Developing Human Placentas
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus NS1; heparan sulfate; cytotrophoblast; Hofbauer cells;
   hyaluronic acid
ID ENDOTHELIAL GLYCOCALYX; HOFBAUER CELLS; CD44; LYMPHANGIOGENESIS;
   TROPHOBLASTS; HYALURONAN; PROTECTION; INFECTION; INVASION; SULFATE
AB Background. During pregnancy, the Zika flavivirus (ZIKV) infects human placentas, inducing defects in the developing fetus. The flavivirus nonstructural protein 1 (NS1) alters glycosaminoglycans on the endothelium, causing hyperpermeability in vitro and vascular leakage in vivo in a tissue-dependent manner. The contribution of ZIKV NS1 to placental dysfunction during ZIKV infection remains unknown.
   Methods. We examined the effect of ZIKV NS1 on expression and release of heparan sulfate (HS), hyaluronic acid (HA), and sialic acid on human trophoblast cell lines and anchoring villous explants from first-trimester placentas infected with ZIKV ex vivo. We measured changes in permeability in trophoblasts and stromal cores using a dextran-based fluorescence assay and changes in HA receptor expression using immunofluorescent microscopy.
   Results. ZIKV NS1 in the presence and absence of ZIKV increased the permeability of anchoring villous explants. ZIKV NS1 induced shedding of HA and HS and altered expression of CD44 and lymphatic endothelial cell HA receptor-I, HA receptors on stromal fibroblasts and Hofbauer macrophages in villous cores. Hyaluronidase was also stimulated in NS1-treated trophoblasts.
   Conclusions. These findings suggest that ZIKV NS1 contributes to placental dysfunction via modulation of glycosaminoglycans on trophoblasts and chorionic villi, resulting in increased permeability of human placentas.
C1 [Puerta-Guardo, Henry; Dimitrova, Milena; Glasner, Dustin R.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Tabata, Takako; Petitt, Matthew; Pereira, Lenore] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
RP Pereira, L (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave, San Francisco, CA 94143 USA.
EM lenore.pereira@ucsf.edu
OI Glasner, Dustin/0000-0001-9821-6683
FU National Institutes of Health Institute for Allergy and Infectious
   Diseases [R01AI04667, R21 AI129508, R01AI124493]
FX This work was funded by grants from the National Institutes of Health
   Institute for Allergy and Infectious Diseases: R01AI04667 (to L. P.),
   R21 AI129508 (to L. P. and E. H.), and R01AI124493 (to E. H.).
CR Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gao HX, 2019, VIROLOGY, V529, P91, DOI 10.1016/j.virol.2019.01.019
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6
   Hromatka BS, 2013, GLYCOBIOLOGY, V23, P593, DOI 10.1093/glycob/cws162
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Kim Youn-Hyun, 2017, Curr Heart Fail Rep, V14, P117, DOI 10.1007/s11897-017-0320-5
   Kim Y, 2014, MOL CANCER RES, V12, P1416, DOI 10.1158/1541-7786.MCR-13-0629
   Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X
   Lim HY, 2018, IMMUNITY, V49, P1191, DOI 10.1016/j.immuni.2018.12.009
   Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Red-Horse K, 2006, J CLIN INVEST, V116, P2643, DOI 10.1172/JC127306
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rothbauer M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06364-z
   Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003
   Seval Y, 2007, PLACENTA, V28, P841, DOI 10.1016/j.placenta.2007.01.010
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025
   Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suwarto S, 2017, J INFECT DIS, V215, P992, DOI 10.1093/infdis/jix041
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2012, AM J PATHOL, V181, P1540, DOI 10.1016/j.ajpath.2012.08.003
   Tang THC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46191
   Toti P, 2011, AM J REPROD IMMUNOL, V65, P470, DOI 10.1111/j.1600-0897.2010.00927.x
   Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629
   Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086
   Xu X, 2016, PLOS CURR, V8
   YAMADA M, 1977, J BIOCHEM, V81, P485, DOI 10.1093/oxfordjournals.jbchem.a131482
   Zhu R, 2013, PLACENTA, V34, P784, DOI 10.1016/j.placenta.2013.05.009
   Zhu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074812
NR 50
TC 3
Z9 3
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JAN 15
PY 2020
VL 221
IS 2
BP 313
EP 324
DI 10.1093/infdis/jiz331
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KW7AP
UT WOS:000521334500020
PM 31250000
DA 2020-07-08
ER

PT J
AU Ortega-Lopez, LD
   Pondeville, E
   Kohl, A
   Leon, R
   Betancourth, MP
   Almire, F
   Torres-Valencia, S
   Saldarriaga, S
   Mirzai, N
   Ferguson, HM
AF Ortega-Lopez, Leonardo D.
   Pondeville, Emilie
   Kohl, Alain
   Leon, Renato
   Betancourth, Mauro Pazmino
   Almire, Floriane
   Torres-Valencia, Sergio
   Saldarriaga, Segundo
   Mirzai, Nosrat
   Ferguson, Heather M.
TI The mosquito electrocuting trap as an exposure-free method for measuring
   human-biting rates by Aedes mosquito vectors
SO PARASITES & VECTORS
LA English
DT Article
DE Zika; Dengue; Chikungunya; Arbovirus; Host-seeking; Aedes aegypti;
   Mosquito electrocuting trap; BG sentinel trap; Vector surveillance;
   Ecuador
ID CHIKUNGUNYA VIRUS; ANOPHELES-ARABIENSIS; DENGUE TRANSMISSION; AEGYPTI
   DIPTERA; CARBON-DIOXIDE; 1ST REPORT; SURVEILLANCE; HOST; ALBOPICTUS;
   MALARIA
AB Background Entomological monitoring of Aedes vectors has largely relied on surveillance of larvae, pupae and non-host-seeking adults, which have been poorly correlated with human disease incidence. Exposure to mosquito-borne diseases can be more directly estimated using human landing catches (HLC), although this method is not recommended for Aedes-borne arboviruses. We evaluated a new method previously tested with malaria vectors, the mosquito electrocuting trap (MET) as an exposure-free alternative for measuring landing rates of Aedes mosquitoes on people. Aims were to (i) compare the MET to the BG-sentinel (BGS) trap gold standard approach for sampling host-seeking Aedes vectors; and (ii) characterize the diel activity of Aedes vectors and their association with microclimatic conditions. Methods The study was conducted over 12 days in Quininde (Ecuador) in May 2017. Mosquito sampling stations were set up in the peridomestic area of four houses. On each day of sampling, each house was allocated either a MET or a BGS trap, which were rotated amongst the four houses daily in a Latin square design. Mosquito abundance and microclimatic conditions were recorded hourly at each sampling station between 7:00-19:00 h to assess variation between vector abundance, trapping methods, and environmental conditions. All Aedes aegypti females were tested for the presence of Zika (ZIKV), dengue (DENV) and chikungunya (CHIKV) viruses. Results A higher number of Ae. aegypti females were found in MET than in BGS collections, although no statistically significant differences in mean Ae. aegypti abundance between trapping methods were found. Both trapping methods indicated female Ae. aegypti had bimodal patterns of host-seeking, being highest during early morning and late afternoon hours. Mean Ae. aegypti daily abundance was negatively associated with daily temperature. No infection by ZIKV, DENV or CHIKV was detected in any Aedes mosquitoes caught by either trapping method. Conclusion We conclude the MET performs at least as well as the BGS standard and offers the additional advantage of direct measurement of per capita human-biting rates. If detection of arboviruses can be confirmed in MET-collected Aedes in future studies, this surveillance method could provide a valuable tool for surveillance and prediction on human arboviral exposure risk.
C1 [Ortega-Lopez, Leonardo D.; Ferguson, Heather M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.
   [Ortega-Lopez, Leonardo D.; Pondeville, Emilie; Kohl, Alain; Almire, Floriane] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
   [Leon, Renato; Torres-Valencia, Sergio; Saldarriaga, Segundo] Univ San Francisco Quito, LEMMT, Quito 170901, Ecuador.
   [Betancourth, Mauro Pazmino] Univ Glasgow, Sch Engn, Glasgow G12 8QQ, Lanark, Scotland.
   [Mirzai, Nosrat] Univ Glasgow, Bioelect Unit, Glasgow G12 8QQ, Lanark, Scotland.
RP Ortega-Lopez, LD (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.
EM leinfloyd@yahoo.com
OI Pazmino Betancourth, Mauro/0000-0003-4259-0611
FU Government of Ecuador through SENESCYT [AR2Q-9554]; Medical Research
   Council from the UK [MC_PC_15081, MC_UU_12014/8]
FX Funding for LDOL to develop this research as part of his PhD studies was
   provided by the Government of Ecuador through SENESCYT (AR2Q-9554) under
   the programme "Primera Convocatoria Abierta 2013". Funding for this
   research work was provided by the Medical Research Council from the UK
   under the Grant Number MC_PC_15081 (to AK, HMF, LDOL and RL) and
   MC_UU_12014/8 (to EP and AK).
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Achee NL, 2015, VECTOR-BORNE ZOONOT, V15, P89, DOI 10.1089/vbz.2014.1628
   Akaratovic KI, 2017, J AM MOSQUITO CONTR, V33, P108, DOI 10.2987/16-6596.1
   [Anonymous], 2017, ETH ISS ASS VECT BOR
   Arimoto H, 2015, J AM MOSQUITO CONTR, V31, P384, DOI 10.2987/moco-31-04-384-387.1
   ATMOSOEDJONO S, 1972, MOSQ NEWS, V32, P467
   Barrera R, 2006, AM J TROP MED HYG, V74, P290, DOI 10.4269/ajtmh.2006.74.290
   Barrera R, 2019, MED VET ENTOMOL, V33, P68, DOI 10.1111/mve.12338
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109
   Beier John C, 2002, Methods Mol Med, V72, P3
   Beserra EB, 2009, IHERINGIA SER ZOOL, V99, P142, DOI 10.1590/S0073-47212009000200004
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Braack L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0677-9
   Carver S, 2009, VECTOR-BORNE ZOONOT, V9, P51, DOI 10.1089/vbz.2008.0040
   Centers for Disease Control and Prevention, 2017, SURV CONTR AED AEG A
   Chadee DD, 2000, J VECTOR ECOL, V25, P158
   CHAMBERS JM, 1992, STAT MODELS S
   Charlwood JD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-324
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429
   de Lima-Camara Tamara Nunes, 2010, Oecologia Australis, V14, P737
   DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925
   Dekker T, 1998, ENTOMOL EXP APPL, V87, P295, DOI 10.1023/A:1003278228021
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   Dickens BL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000801
   Direccion Nacional de Vigilancia Epidemiologica Ministerio de Salud Publica Ecuador, 2016, GAC 2 2016 VIR CHIK
   Direccion Nacional de Vigilancia Epidemiologica Ministerio de Salud Publica Ecuador, 2017, GAC 52 2017 ENF VECT
   Direccion Nacional de Vigilancia Epidemiologica Ministerio de Salud Publica Ecuador, 2016, GAC 52 2016 VIR ZIK
   Direccion Nacional de Vigilancia Epidemiologica Ministerio de Salud Publica Ecuador, 2016, GAC 52 2016 VIR DENG
   Dzul-Manzanilla F, 2015, J AM MOSQUITO CONTR, V31, P275, DOI 10.2987/moco-31-03-275-277.1
   Eder M, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0475-7
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   FAY RW, 1970, MOSQ NEWS, V30, P20
   FAY RW, 1968, MOSQ NEWS, V28, P1
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   FOCKS DA, 2003, REV ENTOMOLOGICAL SA
   FREIER JE, 1991, J AM MOSQUITO CONTR, V7, P73
   Gao Q, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3053-8
   Gimnig JE, 2013, AM J TROP MED HYG, V88, P301, DOI 10.4269/ajtmh.2012.12-0209
   Govella NJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1513-1
   Govella NJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-40
   Gubler DJ, 2011, EXPERT REV VACCINES, V10, P563, DOI [10.1586/ERV.11.35, 10.1586/erv.11.35]
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Harwood JF, 2015, J AM MOSQUITO CONTR, V31, P242, DOI 10.2987/moco-31-03-242-247.1
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Irish SR, 2008, J AM MOSQUITO CONTR, V24, P393, DOI 10.2987/5682.1
   Kamal M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210122
   Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19
   Knols BGJ, 1998, MED VET ENTOMOL, V12, P116, DOI 10.1046/j.1365-2915.1998.00087.x
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Krajacich BJ, 2014, J MED ENTOMOL, V51, P253, DOI 10.1603/ME13090
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   LANE J., 1953, NEOTROPICAL CULICIDA
   LUMSDEN WHR, 1947, J EXP BIOL, V24, P361
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   Maliti DV, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1025-4
   Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1
   Meza FC, 2019, MALARIA J, V10, P1
   Ndebele P, 2012, MALAWI MED J, V24, P65
   Ong Song-Quan, 2017, Serangga, V22, P179
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   Rezza G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006919
   Rivas GBS, 2018, J BIOL RHYTHM, V33, P272, DOI 10.1177/0748730418772175
   Roiz D, 2016, J MED ENTOMOL, V53, P460, DOI 10.1093/jme/tjv184
   Sallam MF, 2019, J MED ENTOMOL, V56, P609, DOI 10.1093/jme/tjy230
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184
   Setbon M, 2012, EMERGING HLTH THREAT, V2, P7083, DOI [10.3402/ehtj.v2i0.7083, DOI 10.3402/EHTJ.V2I0.7083]
   Shirai Y, 2002, J AM MOSQUITO CONTR, V18, P97
   Sivagnaname N, 2012, INDIAN J MED RES, V136, P739
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Sukumaran D, 2016, INDIAN J NAT PROD RE, V7, P207
   Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203
   Torr S, 2008, MED VET ENTOMOL, V22, P93, DOI 10.1111/j.1365-2915.2008.00723.x
   Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   User:Rei-artur, 2006, USER REI ARTUR LARGE
   VALE GA, 1974, T ROY SOC TROP MED H, V68, P11, DOI 10.1016/0035-9203(74)90234-X
   Vale GA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004169
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   WHO, 2018, EFF TEST TRAPS CONTR
   WHO, 2017, GLOB ACT PLAN PUBL H, P2
   WHO, 2013, MAL ENT VECT CONTR G
   Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212688
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P641, DOI 10.2987/8756-971X(2006)22[641:LAFAOS]2.0.CO;2
   WILTON DP, 1985, J MED ENTOMOL, V22, P113, DOI 10.1093/jmedent/22.1.113
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   2018, VACCINE, V37, P4848
NR 95
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 15
PY 2020
VL 13
IS 1
AR 31
DI 10.1186/s13071-020-3887-8
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KW6FL
UT WOS:000521260600001
PM 31941536
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Lindsey, NP
   Porse, CC
   Potts, E
   Hyun, J
   Sandhu, K
   Schiffman, E
   Cervantes, KB
   White, JL
   Mason, K
   Owens, K
   Holsinger, C
   Fischer, M
   Staples, JE
   Jilek, W
   Brown, J
   Stevens, T
   Tonzel, J
   Scott-Waldron, C
   Simonson, S
   Feldman, K
   Brooks, R
   Galvin, M
   Scotland, S
   Brown, C
   Garafalo, K
   Ojo, M
   Worthington, K
   Thomas, N
   Jamro, E
   Long, J
   Miller, B
   Arshadmansab, S
   Broussard, K
   Evert, N
   Broyhill, J
   Mircoff, E
AF Lindsey, Nicole P.
   Porse, Charsey C.
   Potts, Emily
   Hyun, Judie
   Sandhu, Kayleigh
   Schiffman, Elizabeth
   Cervantes, Kimberly B.
   White, Jennifer L.
   Mason, Krystal
   Owens, Kamesha
   Holsinger, Caroline
   Fischer, Marc
   Staples, J. Erin
   Jilek, Wendy
   Brown, Jennifer
   Stevens, Taryn
   Tonzel, Julius
   Scott-Waldron, Christine
   Simonson, Sean
   Feldman, Katherine
   Brooks, Richard
   Galvin, Megan
   Scotland, Sarah
   Brown, Catherine
   Garafalo, Kristin
   Ojo, Mojisola
   Worthington, Karen
   Thomas, Nadia
   Jamro, Erica
   Long, Jonah
   Miller, Barry
   Arshadmansab, Sepehr
   Broussard, Kelly
   Evert, Nicole
   Broyhill, Jim
   Mircoff, Elena
CA Zika Virus Dis Enhanced Surveillan
TI Postnatally Acquired Zika Virus Disease Among Children, United States,
   2016-2017
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pediatric; Zika; epidemiology
ID INFECTION; CHIKUNGUNYA; OUTBREAK; DENGUE
AB Background. The clinical findings among children with postnatally acquired Zika virus disease are not well characterized. We describe and compare clinical signs and symptoms for children aged <18 years.
   Methods. Zika virus disease cases were included if they met the national surveillance case definition, had illness onset in 2016 or 2017, resided in a participating state, and were reported to the Centers for Disease Control and Prevention. Pediatric cases were aged <18 years; congenital and perinatal infections were excluded. Pediatric cases were matched to adult cases (1849 years). Clinical information was compared between younger and older pediatric cases and between children and adults.
   Results. A total of 141 pediatric Zika virus disease cases were identified; none experienced neurologic disease. Overall, 28 (20%) were treated in an emergency department, 1 (<1%) was hospitalized; none died. Of the 4 primary clinical signs and symptoms associated with Zika virus disease, 133 (94%) children had rash, 104 (74%) fever, 67 (48%) arthralgia, and 51 (36%) conjunctivitis. Fever, arthralgia, and myalgia were more common in older children (1217 years) than younger children (111 years). Arthralgia, arthritis, edema, and myalgia were more common in adults compared to children.
   Conclusions. This report supports previous findings that Zika virus disease is generally mild in children. The most common symptoms are similar to other childhood infections, and clinical findings and outcomes are similar to those in adults. Healthcare providers should consider a diagnosis of Zika virus infection in children with fever, rash, arthralgia, or conjunctivitis, who reside in or have traveled to an area where Zika virus transmission is occurring.
C1 [Lindsey, Nicole P.; Fischer, Marc; Staples, J. Erin] Ctr Dis Control & Prevent, Arboviral Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Porse, Charsey C.; Jilek, Wendy] Calif Dept Publ Hlth, Sacramento, CA USA.
   [Potts, Emily; Brown, Jennifer; Stevens, Taryn] Indiana State Dept Hlth, Indianapolis, IN 46202 USA.
   [Hyun, Judie; Feldman, Katherine; Brooks, Richard; Galvin, Megan] Maryland Dept Hlth, Baltimore, MD USA.
   [Sandhu, Kayleigh; Scotland, Sarah; Brown, Catherine] Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA.
   [Schiffman, Elizabeth] Minnesota Dept Hlth, St Paul, MN USA.
   [Cervantes, Kimberly B.; Garafalo, Kristin; Ojo, Mojisola; Worthington, Karen] New Jersey Dept Hlth, Trenton, NJ USA.
   [White, Jennifer L.; Thomas, Nadia; Jamro, Erica] New York State Dept Hlth, Albany, NY 12237 USA.
   [Mason, Krystal; Long, Jonah; Miller, Barry] Penn Dept Hlth, Harrisburg, PA 17108 USA.
   [Owens, Kamesha; Arshadmansab, Sepehr; Broussard, Kelly; Evert, Nicole] Texas Dept State Hlth Serv, Austin, TX USA.
   [Holsinger, Caroline; Broyhill, Jim; Mircoff, Elena] Virginia Dept Hlth, Richmond, VA USA.
   [Tonzel, Julius; Scott-Waldron, Christine; Simonson, Sean] Louisiana Dept Hlth, Baton Rouge, LA USA.
RP Lindsey, NP (corresponding author), Ctr Dis Control & Prevent, Arboviral Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM nplindsey@cdc.gov
FU Epidemiology and Laboratory Capacity Cooperative Agreement - Centers for
   Disease Control and Prevention [CK14-14105PPHF18]
FX This work was supported in part by the Epidemiology and Laboratory
   Capacity Cooperative Agreement funded by the Centers for Disease Control
   and Prevention (CK14-14105PPHF18).
CR Ball JD, 2019, CLIN INFECT DIS, V68, P919, DOI 10.1093/cid/ciy582
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Griffin I, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2044
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Pastula DM, 2017, NEUROCRIT CARE, V26, P457, DOI 10.1007/s12028-016-0333-z
   Read JS, 2018, JAMA PEDIATR, V172, P686, DOI 10.1001/jamapediatrics.2018.0870
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Slavov S, 2017, PEDIATRIC REP, V9, P78, DOI 10.4081/pr.2017.7341
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
NR 16
TC 4
Z9 4
U1 3
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 15
PY 2020
VL 70
IS 2
BP 227
EP 231
DI 10.1093/cid/ciz195
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KB9IY
UT WOS:000506801400009
PM 30855072
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Marra, RKF
   Kummerle, AE
   Guedes, GP
   Barros, CD
   Gomes, RSP
   Cirne-Santos, CC
   Paixao, ICNP
   Neves, AP
AF Marra, Roberta K. F.
   Kummerle, Arthur E.
   Guedes, Guilherme P.
   Barros, Caroline de S.
   Gomes, Rafaela S. P.
   Cirne-Santos, Claudio C.
   Paixao, Izabel Christina N. P.
   Neves, Amanda P.
TI Quinolone-N-acylhydrazone hybrids as potent Zika and Chikungunya virus
   inhibitors
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Quinolone-N-acylhydrazones; Arbovirus; Zika; Chikungunya; Antiviral
   activity
ID IN-VITRO; COMPLEXES; INFECTION
AB This work reports the synthesis of quinolone-N-acylhydrazone hybrids, namely 6-R-N'-(2 hydxoxybenzylidene)-4-oxo-1,4-dihydroquinoline-3-carbohydrazide (R = H: 5a, F: 5b, Cl: 5c and Br: 5d), which exhibited excellent activity against arbovirus Zika (ZIKV) and Chikungunya (CHIKV). In vitro screening towards ZIKV and CHIKV inhibition revealed that all substances have significant antiviral activity, most of them being more potent than standard Ribavirin (5a-d: EC50 = 0.75-0.81 mu M, Ribavirin: EC50 = 3.95 mu M for ZIKV and 5a-d: 1.16-2.85 mu M, Ribavirin: EC50 = 2.42 mu M for CHIKV). The quinolone-N-acylhydrazone hybrids were non-toxic against Vero cells, in which compounds 5c and 5d showed the best selectivities (SI = 1410 and 630 against ZIKV and CHIKV, respectively). Antiviral activity was identified by inhibition of viral RNA production in a dose-dependent manner. In the evaluation of the time of addition of the compounds, we observed that 5b and 5c remain with strong effect even in the addition for 12 h after infection. The above results indicate that quinolone-N-acylhydrazones represent a new and promising class to be further investigated as anti-ZIKV and anti-CHIKV agents.
C1 [Marra, Roberta K. F.; Kummerle, Arthur E.; Neves, Amanda P.] Univ Fed Rural Rio de Janeiro, Inst Quim, BR-23897000 Seropedica, RJ, Brazil.
   [Guedes, Guilherme P.] Univ Fed Fluminense, Inst Quim, BR-24020141 Niteroi, RJ, Brazil.
   [Barros, Caroline de S.; Gomes, Rafaela S. P.; Cirne-Santos, Claudio C.; Paixao, Izabel Christina N. P.] Univ Fed Fluminense, Inst Biol, BR-24020141 Niteroi, RJ, Brazil.
RP Neves, AP (corresponding author), Univ Fed Rural Rio de Janeiro, Inst Quim, BR-23897000 Seropedica, RJ, Brazil.
EM amandanevess@ufrrj.br
RI Paixao, Izabel/AAM-1668-2020; Barros, Caroline/S-7840-2019; Guedes,
   Guilherme/G-8610-2014
OI Guedes, Guilherme/0000-0001-6138-9943; Barros,
   Caroline/0000-0002-4678-3093
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [443930/2014-7]; FAPERJ (Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/201.442/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - Brazil (CAPES)CAPES [001]
FX The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) for financial support and for Productivity
   Fellowship to ICNPP (443930/2014-7). ICNPP (E-26/201.442/2014) also
   thank the FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro) for the Cientista do Nosso Estado Fellowship. This study was
   financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior -Brazil (CAPES) - Finance Code 001. We also thank
   LDRX-UFF (www.ldrx.uff.br/) for the X-ray diffraction analysis and
   PPGQ-UFRRJ (http://cursos.ufrrj.br/posgraduacao/ppgq/) for the
   facilities.
CR Ahmed A, 2012, J PHARM PHARM SCI, V15, P52
   Ampudial A, 2018, FRONT MOL NEUROSC, V11, P116
   Areas ES, 2017, SPECTROCHIM ACTA A, V187, P130, DOI 10.1016/j.saa.2017.06.031
   Barbosa IR, 2018, TRANSIT METAL CHEM, V43, P739, DOI 10.1007/s11243-018-0262-0
   Borges JC, 2007, J BRAZIL CHEM SOC, V18, P1571, DOI 10.1590/S0103-50532007000800019
   da Silva GS, 2016, J ENZYM INHIB MED CH, V31, P1464, DOI 10.3109/14756366.2016.1144597
   de Almeida PSVB, 2019, POLYHEDRON, V171, P20, DOI 10.1016/j.poly.2019.06.053
   Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209
   Delogu I, 2011, ANTIVIR RES, V90, P99, DOI 10.1016/j.antiviral.2011.03.182
   Ehteshami M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02395-16
   Ferreira NC, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01441-17
   Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023
   Gonzaga DTG, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00261
   Khachatoorian R, 2019, BIOORG MED CHEM LETT, V29, DOI 10.1016/j.bmcl.2019.126626
   Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663
   Kouznetsov VV, 2005, CURR ORG CHEM, V9, P141, DOI 10.2174/1385272053369196
   Kovaleva KS, 2018, MEDCHEMCOMM, V9, P2072, DOI 10.1039/c8md00442k
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030
   Perez-Perez MJ, 2019, EXPERT OPIN DRUG DIS, V14, P855, DOI 10.1080/17460441.2019.1629413
   Pham TDM, 2019, MEDCHEMCOMM, V10, P1079
   Richter Sara, 2004, Current Drug Targets - Infectious Disorders, V4, P111, DOI 10.2174/1568005043340920
   Rodriguez JC, 2002, INT J ANTIMICROB AG, V20, P464, DOI 10.1016/S0924-8579(02)00239-X
   Bernardino AMR, 2006, BIOORGAN MED CHEM, V14, P5765, DOI 10.1016/j.bmc.2006.03.013
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Scholte FEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071047
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Wang R, 2019, ARCH PHARM, V352, DOI 10.1002/ardp.201900045
   Zmurko J, 2016, J INFECT DIS, V214, P707
NR 33
TC 1
Z9 1
U1 12
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD JAN 15
PY 2020
VL 30
IS 2
AR 126881
DI 10.1016/j.bmcl.2019.126881
PG 4
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA JZ1OE
UT WOS:000504873300036
PM 31843348
DA 2020-07-08
ER

PT J
AU Maciel, LG
   Oliveira, AA
   Romao, TP
   Leal, LLL
   Guido, RVC
   Silva, MHNL
   dos Anjos, JV
   Soares, TA
AF Maciel, Larissa G.
   Oliveira, Andrew A.
   Romao, Tatiany P.
   Leal, Laylla L. L.
   Guido, Rafael V. C.
   Silva-Filha, Maria Helena N. L.
   dos Anjos, Janaina V.
   Soares, Thereza A.
TI Discovery of 1,2,4-oxadiazole derivatives as a novel class of
   noncompetitive inhibitors of 3-hydroxykynurenine transaminase (HKT) from
   Aedes aegypti
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article
DE Kinetic constants; New HKT recombinant; Expression in Escherichia coli;
   Xanthurenic acid detection
ID MAJOR BRANCH PATHWAY; XANTHURENIC ACID; GLYOXYLATE TRANSAMINASE;
   INSECTICIDE RESISTANCE; CRYSTAL-STRUCTURE; FORCE-FIELD; ZIKA VIRUS;
   AMINOTRANSFERASE; PROTEIN; CHIKUNGUNYA
AB The mosquito Aedes aegypti is the vector of arboviruses such as Zika, Chikungunya, dengue and yellow fever. These infectious diseases have a major impact on public health. The unavailability of effective vaccines or drugs to prevent or treat most of these diseases makes vector control the main form of prevention. One strategy to promote mosquito population control is the use of synthetic insecticides to inhibit key enzymes in the metabolic pathway of these insects, particularly during larval stages. One of the main targets of the kynurenine detoxification pathway in mosquitoes is the enzyme 3-hydroxykynurenine transaminase (HKT), which catalyzes the conversion of 3-hydroxykynurenine (3-HK) into xanthurenic acid (XA). In this work, we report eleven newly synthesized oxadiazole derivatives and demonstrate that these compounds are potent noncompetitive inhibitors of HKT from Ae. aegypti. The present data provide direct evidence that HKT can be explored as a molecular target for the discovery of novel larvicides against Ae. aegypti. More importantly, it ensures that structural information derived from the HKT 3D-structure can be used to guide the development of more potent inhibitors.
C1 [Maciel, Larissa G.; Leal, Laylla L. L.; dos Anjos, Janaina V.; Soares, Thereza A.] Univ Fed Pernambuco, Dept Fundamental Chem, Ave Jornalista Anibal Fernandes S-N Cidade Univ, BR-50740560 Recife, PE, Brazil.
   [Oliveira, Andrew A.; Guido, Rafael V. C.] Univ Sao Paulo, Sao Carlos Inst Phys, Ave Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, SP, Brazil.
   [Romao, Tatiany P.; Silva-Filha, Maria Helena N. L.] Fiocruz MS, IAM, Ave Prof Moraes Rego S-N, BR-50740560 Recife, PE, Brazil.
RP dos Anjos, JV; Soares, TA (corresponding author), Univ Fed Pernambuco, Dept Fundamental Chem, Ave Jornalista Anibal Fernandes S-N Cidade Univ, BR-50740560 Recife, PE, Brazil.
EM janaina.anjos@ufpe.br; thereza.soares@ufpe.br
RI Maciel, Larissa Goncalves/AAC-9423-2020; Anjos, Janaina V
   dos/E-6785-2013; Romao, Tatiany Patricia/F-6957-2015; Guido,
   Rafael/A-7450-2009
OI Romao, Tatiany/0000-0002-5296-0543; Guido, Rafael/0000-0002-7187-0818;
   Versiani dos Anjos, Janaina/0000-0002-8842-8284
FU FACEPE [APQ-0732-1.06/14]; BioMol/CAPES [BioComp 23038.004630/2014-35];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/07600-3]; INCT-Fx/CNPq [465259/2014-6]
FX We thank Dr. Roberto D. Lins for using the AKTA to perform HKT
   purifications at the Dept. of Virology, IAM-FIOCRUZ. We also thank for
   the insectarium support from IAM-FIOCRUZ and the Program for
   Technological Development in Tools for Health (PDTIS-FIOCRUZ) for the
   use of its automatic sequencing facilities. Financial support for this
   research project was provided by the Brazilian funding agencies FACEPE
   (APQ-0732-1.06/14), BioMol/CAPES (BioComp 23038.004630/2014-35),
   INCT-Fx/CNPq (465259/2014-6) and FAPESP (2013/07600-3). Molecular
   docking calculations were performed and included in the manuscript as
   requested by one of the Reviewers.
CR Almeida RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030062
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Callender DM, 2019, GLOB PUBLIC HEALTH, V14, P445, DOI 10.1080/17441692.2018.1512144
   Canavesi R, 2019, J PHARMACEUT BIOMED, V173, P154, DOI 10.1016/j.jpba.2019.05.025
   Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637
   Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1
   da Silva-Alves DCB, 2013, BIOORGAN MED CHEM, V21, P940, DOI 10.1016/j.bmc.2012.12.006
   de Araujo AP, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez054
   ELOY F, 1962, CHEM REV, V62, P155, DOI 10.1021/cr60216a003
   Garcia GE, 1998, J BIOL CHEM, V273, P12003, DOI 10.1074/jbc.273.20.12003
   George Sarah L, 2014, Mo Med, V111, P337
   Giles GI, 2003, BIOCHEM BIOPH RES CO, V300, P719, DOI 10.1016/S0006-291X(02)02917-0
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002
   Goyal M, 2018, DRUG DES DEV THER, V12, P4195, DOI 10.2147/DDDT.S181574
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Han Q, 2002, J BIOL CHEM, V277, P15781, DOI 10.1074/jbc.M201202200
   Han Q, 2002, FEBS LETT, V527, P199, DOI 10.1016/S0014-5793(02)03229-5
   Han Q, 2008, BIOSCIENCE REP, V28, P205, DOI 10.1042/BSR20080085
   Han Q, 2007, J INSECT PHYSIOL, V53, P254, DOI 10.1016/j.jinsphys.2006.09.004
   Han Q, 2006, BIOCHEM J, V397, P473, DOI 10.1042/BJ20060469
   Han Q, 2009, J MED CHEM, V52, P2786, DOI 10.1021/jm9000874
   Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634
   Huhtiniemi T, 2008, J MED CHEM, V51, P4377, DOI 10.1021/jm800639h
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Lepkovsky S, 1943, J BIOL CHEM, V149, P195
   Lepkovsky S, 1942, J BIOL CHEM, V144, P135
   Li JY, 1997, INSECT BIOCHEM MOLEC, V27, P859, DOI 10.1016/S0965-1748(97)00068-4
   Li JY, 1999, INSECT BIOCHEM MOLEC, V29, P329, DOI 10.1016/S0965-1748(99)00007-7
   Lima VLA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038349
   Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lueg C, 2013, BIOORGAN MED CHEM, V21, P7481, DOI 10.1016/j.bmc.2013.09.040
   Matthews BJ, 2017, IMPROVED AEDES AEGYP, DOI [10.1101/240747, DOI 10.1101/240747]
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   MEHLER EL, 1991, PROTEIN ENG, V4, P903, DOI 10.1093/protein/4.8.903
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nadvi NA, 2017, PROTEIN SCI, V26, P727, DOI 10.1002/pro.3119
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Oliveira VS, 2013, BIOORGAN MED CHEM, V21, P6996, DOI 10.1016/j.bmc.2013.09.020
   PAHO/WHO, 2018, CUMULATIVE CASES
   Pavia DL, 1996, INTRO SPECTROSCOPY, P267
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Romao TP, 2006, FEBS J, V273, P1556, DOI 10.1111/j.1742-4658.2006.05177.x
   Rossi F, 2006, P NATL ACAD SCI USA, V103, P5711, DOI 10.1073/pnas.0510233103
   Rossi F, 2005, FEBS J, V272, P5653, DOI 10.1111/j.1742-4658.2005.04961.x
   Rossi F, 2008, J BIOL CHEM, V283, P3559, DOI 10.1074/jbc.M707925200
   Rossi F, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00007
   Rossi F, 2008, CURR OPIN STRUC BIOL, V18, P748, DOI 10.1016/j.sbi.2008.09.009
   Sathyasaikumar KV, 2017, NEUROSCIENCE, V367, P85, DOI 10.1016/j.neuroscience.2017.10.006
   Schwarcz R, 2017, NEUROPHARMACOLOGY, V112, P237, DOI 10.1016/j.neuropharm.2016.08.003
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Soares TA, 2000, J MOL RECOGNIT, V13, P146, DOI 10.1002/1099-1352(200005/06)13:3<146::AID-JMR497>3.0.CO;2-4
   Soares TA, 1999, BIOPOLYMERS, V50, P319, DOI 10.1002/(SICI)1097-0282(199909)50:3<319::AID-BIP7>3.0.CO;2-8
   Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314
   STOUTEN PFW, 1993, MOL SIMULAT, V10, P97, DOI 10.1080/08927029308022161
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Sukhralia S, 2019, EUR J CLIN MICROBIOL, V38, P3, DOI 10.1007/s10096-018-3375-7
   Tale R. H., 2011, Journal of Chemical and Pharmaceutical Research, V3, P496
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   Vazquez S, 2000, FREE RADICAL RES, V32, P11, DOI 10.1080/10715760000300021
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viana-Medeiros PF, 2017, MED VET ENTOMOL, V31, P340, DOI 10.1111/mve.12241
   Neves RAW, 2009, CHEM PHARM BULL, V57, P819, DOI 10.1248/cpb.57.819
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051
   Wieten RW, 2016, J INFECTION, V72, P713, DOI 10.1016/j.jinf.2016.02.017
   World Health Organization, 2017, SITUATION REPORT ZIK
NR 76
TC 0
Z9 0
U1 12
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
EI 1464-3391
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD JAN 15
PY 2020
VL 28
IS 2
AR 115252
DI 10.1016/j.bmc.2019.115252
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA JY8GV
UT WOS:000504647600018
PM 31864777
DA 2020-07-08
ER

PT J
AU Steinbach, RJ
   Haese, NN
   Smith, JL
   Colgin, LMA
   MacAllister, RP
   Greene, JM
   Parkins, CJ
   Kempton, JB
   Porsov, E
   Wang, XJ
   Renner, LM
   McGill, TJ
   Dozier, BL
   Kreklywich, CN
   Andoh, TF
   Grafe, MR
   Pecoraro, HL
   Hodge, T
   Friedman, RM
   Houser, LA
   Morgan, TK
   Stenzel, P
   Lindner, JR
   Schelonka, RL
   Sacha, JB
   Roberts, VHJ
   Neuringer, M
   Brigande, JV
   Kroenke, CD
   Frias, AE
   Lewis, AD
   Kelleher, MA
   Hirsch, AJ
   Streblow, DN
AF Steinbach, Rosemary J.
   Haese, Nicole N.
   Smith, Jessica L.
   Colgin, Lois M. A.
   MacAllister, Rhonda P.
   Greene, Justin M.
   Parkins, Christopher J.
   Kempton, J. Beth
   Porsov, Edward
   Wang, Xiaojie
   Renner, Lauren M.
   McGill, Trevor J.
   Dozier, Brandy L.
   Kreklywich, Craig N.
   Andoh, Takeshi F.
   Grafe, Marjorie R.
   Pecoraro, Heidi L.
   Hodge, Travis
   Friedman, Robert M.
   Houser, Lisa A.
   Morgan, Terry K.
   Stenzel, Peter
   Lindner, Jonathan R.
   Schelonka, Robert L.
   Sacha, Jonah B.
   Roberts, Victoria H. J.
   Neuringer, Martha
   Brigande, John V.
   Kroenke, Christopher D.
   Frias, Antonio E.
   Lewis, Anne D.
   Kelleher, Meredith A.
   Hirsch, Alec J.
   Streblow, Daniel Neal
TI A neonatal nonhuman primate model of gestational Zika virus infection
   with evidence of microencephaly, seizures and cardiomyopathy
SO PLOS ONE
LA English
DT Article
ID DILATED CARDIOMYOPATHY; CARDIOTHORACIC RATIO; BIRTH-WEIGHT; FETAL;
   GROWTH; REGISTRATION; INFANTS; ROBUST; BRAZIL; COMPLICATIONS
AB Zika virus infection during pregnancy is associated with miscarriage and with a broad spectrum of fetal and neonatal developmental abnormalities collectively known as congenital Zika syndrome (CZS). Symptomology of CZS includes malformations of the brain and skull, neurodevelopmental delay, seizures, joint contractures, hearing loss and visual impairment. Previous studies of Zika virus in pregnant rhesus macaques (Macaca mulatta) have described injury to the developing fetus and pregnancy loss, but neonatal outcomes following fetal Zika virus exposure have yet to be characterized in nonhuman primates. Herein we describe the presentation of rhesus macaque neonates with a spectrum of clinical outcomes, including one infant with CZS-like symptoms including cardiomyopathy, motor delay and seizure activity following maternal infection with Zika virus during the first trimester of pregnancy. Further characterization of this neonatal nonhuman primate model of gestational Zika virus infection will provide opportunities to evaluate the efficacy of pre- and postnatal therapeutics for gestational Zika virus infection and CZS.
C1 [Steinbach, Rosemary J.; Roberts, Victoria H. J.; Frias, Antonio E.; Kelleher, Meredith A.] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR USA.
   [Haese, Nicole N.; Smith, Jessica L.; Greene, Justin M.; Parkins, Christopher J.; Kreklywich, Craig N.; Andoh, Takeshi F.; Sacha, Jonah B.; Hirsch, Alec J.; Streblow, Daniel Neal] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.
   [Haese, Nicole N.; Greene, Justin M.; Sacha, Jonah B.; Hirsch, Alec J.; Streblow, Daniel Neal] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR 97006 USA.
   [Colgin, Lois M. A.; Lewis, Anne D.] Oregon Natl Primate Res Ctr, Div Comparat Med, Pathol Serv Unit, Beaverton, OR USA.
   [MacAllister, Rhonda P.; Dozier, Brandy L.] Oregon Natl Primate Res Ctr, Div Comparat Med, Clin Med Unit, Beaverton, OR USA.
   [Kempton, J. Beth; Porsov, Edward; Brigande, John V.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Oregon Hearing Res Ctr, Portland, OR 97201 USA.
   [Wang, Xiaojie; Kroenke, Christopher D.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA.
   [Renner, Lauren M.; McGill, Trevor J.; Friedman, Robert M.; Neuringer, Martha] Oregon Natl Primate Res Ctr, Dept Neurosci, Beaverton, OR USA.
   [McGill, Trevor J.; Neuringer, Martha] Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA.
   [Grafe, Marjorie R.; Morgan, Terry K.; Stenzel, Peter] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA.
   [Pecoraro, Heidi L.] North Dakota State Univ, Vet Diagnost Serv Dept, Fargo, ND USA.
   [Hodge, Travis] Oregon Natl Primate Res Ctr, Div Comparat Med, Time Mated Breeding Serv Unit, Beaverton, OR USA.
   [Houser, Lisa A.] Oregon Natl Primate Res Ctr, Div Comparat Med, Behav Serv Unit, Beaverton, OR USA.
   [Morgan, Terry K.; Frias, Antonio E.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Lindner, Jonathan R.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA.
   [Schelonka, Robert L.] Oregon Hlth & Sci Univ, Dept Pediat, Div Neonatol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.
RP Streblow, DN (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.; Streblow, DN (corresponding author), Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR 97006 USA.
EM streblow@ohsu.edu
OI Steinbach, Rosemary/0000-0003-0257-7308; Wang,
   Xiaojie/0000-0001-5557-6048; Kelleher, Meredith/0000-0002-5313-004X
FU Bill and Melinda Gates FoundationGates Foundation [OPP1131710]; Oregon
   National Primate Research Center (ONPRC) [P51-ODO11092]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K01-OD026561,
   R21-HD091032, R01-HD096741-01]
FX The work presented in this manuscript was supported by the Bill and
   Melinda Gates Foundation (OPP1131710) the Pilot Program and Base grant
   support from the Oregon National Primate Research Center (ONPRC)
   P51-ODO11092 as well as K01-OD026561, R21-HD091032 and R01-HD096741-01
   awarded by the National Institutes of Health. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the National Institutes of Health.
CR Abend NS, 2018, VOLPES NEUROLOGY NEW
   Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Angelidou A, 2018, NEONATOLOGY, V113, P177, DOI 10.1159/000484656
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cakirer Sinan, 2003, Curr Probl Diagn Radiol, V32, P194, DOI 10.1016/S0363-0188(03)00026-4
   Carta KG, 2019, J AM COLL CARDIOL, V73, P719, DOI 10.1016/S0735-1097(19)31327-0
   Centers for Disease Control and Prevention, 2018, OUTC PREGN LAB EV PO
   Centers for Disease Control and Prevention, 2019, ZIK TRANSM 2019
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Di Cavalcanti D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175065
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   EDWARDS DK, 1981, AM J ROENTGENOL, V136, P907, DOI 10.2214/ajr.136.5.907
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Esposito DL, 2017, ABORTION RATE IS MUC
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goldberger AL, 2018, GOLDBERGERS CLIN ELE, P50
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Greene JM, 2017, MUCOSAL IMMUNOL, V10, P802, DOI 10.1038/mi.2016.91
   Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hopper KJ, 2008, COMPARATIVE MED, V58, P597
   Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132
   Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6
   Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x
   Kattwinkel J, 2011, TXB NEONATAL RESUSCI
   Kearney MT, 2001, POSTGRAD MED J, V77, P4, DOI 10.1136/pmj.77.903.4
   Kelleher MA, 2017, PEDIATR RES, V82, P244, DOI 10.1038/pr.2017.57
   KERR GR, 1969, GROWTH, V33, P201
   Knutsen AK, 2013, CEREB CORTEX, V23, P488, DOI 10.1093/cercor/bhs042
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu Z, 2019, NEUROIMAGE, V184, P372, DOI 10.1016/j.neuroimage.2018.09.015
   Lo JO, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.016
   Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Maslen CL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00735
   Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Minhas AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1399
   Mirvis DM, 2018, BRAUNWALDS HEART DIS
   Mitchell C, 2019, J AM SOC ECHOCARDIOG, V32, P1, DOI 10.1016/j.echo.2018.06.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   O'Connor M, 2008, AM J EMERG MED, V26, P506, DOI 10.1016/j.ajem.2008.03.030
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020
   Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Peloggia A, 2018, INT J GYNECOL OBSTET, V143, P277, DOI 10.1002/ijgo.12663
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Resiere D, 2018, J CLIN VIROL, V98, P8, DOI 10.1016/j.jcv.2017.11.002
   Rohlfing T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00027
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   RUPPENTHAL GC, 1992, RES PROTOCOL TECHNIC
   Sackett G, 2006, DEV PSYCHOBIOL, V48, P243, DOI 10.1002/dev.20132
   Santana MB, 2019, CLIN MICROBIOL INFEC, V25, P1043, DOI 10.1016/j.cmi.2019.03.020
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI 10.1016/S0025-6196(11)60670-8
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Slotkin TA, 2011, NEUROTOXICOL TERATOL, V33, P431, DOI 10.1016/j.ntt.2011.02.001
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007
   Tarantal AF, 1995, GROWTH REGULAT, V5, P190
   Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9
   Trevathan E, 2016, BIRTH DEFECTS RES A, V106, P869, DOI 10.1002/bdra.23582
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang XJ, 2017, J NEUROSCI, V37, P1971, DOI 10.1523/JNEUROSCI.3157-16.2017
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Wozniak LJ, 2006, J PERINATOL, V26, P769, DOI 10.1038/sj.jp.7211605
   Ohki CMY, 2019, EXPERT OPIN DRUG DIS, V14, P577, DOI 10.1080/17460441.2019.1597050
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 102
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 14
PY 2020
VL 15
IS 1
AR e0227676
DI 10.1371/journal.pone.0227676
PG 32
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP5JP
UT WOS:000534354100041
PM 31935257
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, P
   Nie, KX
   Zhu, YB
   Liu, Y
   Wu, P
   Liu, ZW
   Du, SY
   Fan, HH
   Chen, CH
   Zhang, RL
   Wang, PH
   Cheng, G
AF Sun, Peng
   Nie, Kaixiao
   Zhu, Yibin
   Liu, Yang
   Wu, Pa
   Liu, Ziwen
   Du, Senyan
   Fan, Huahao
   Chen, Chun-Hong
   Zhang, Renli
   Wang, Penghua
   Cheng, Gong
TI A mosquito salivary protein promotes flavivirus transmission by
   activation of autophagy
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ZIKA VIRUS-INFECTION; DENGUE VIRUS; AEDES-AEGYPTI; IMMUNE-RESPONSE;
   SHIGA TOXIN; BECLIN 1; LRPPRC; COMPLEX; ASSOCIATION; CELLS
AB Transmission from an infected mosquito to a host is an essential process in the life cycle of mosquito-borne flaviviruses. Numerous studies have demonstrated that mosquito saliva facilitates viral transmission. Here we find that a saliva-specific protein, named Aedes aegypti venom allergen-1 (AaVA-1), promotes dengue and Zika virus transmission by activating autophagy in host immune cells of the monocyte lineage. The AG6 mice (ifnar1(-/-)ifngr1(-/-)) bitten by the virus-infected AaVA-1-deficient mosquitoes present a lower viremia and prolonged survival. AaVA-1 intracellularly interacts with a dominant negative binder of Beclin-1, known as leucine-rich pentatricopeptide repeat-containing protein (LRPPRC), and releases Beclin-1 from LRPPRC-mediated sequestration, thereby enabling the initialization of downstream autophagic signaling. A deficiency in Beclin-1 reduces viral infection in mice and abolishes AaVA-1-mediated enhancement of ZIKV transmission by mosquitoes. Our study provides a mechanistic insight into saliva-aided viral transmission and could offer a potential prophylactic target for reducing flavivirus transmission. Mosquito saliva affects transmission of flaviviruses, but underlying mechanisms are incompletely understood. Here, the authors show that Aedes aegypti venom allergen-1 (AaVA-1) promotes dengue and Zika virus transmission by activating autophagy in host immune cells of the monocyte lineage.
C1 [Sun, Peng; Nie, Kaixiao; Zhu, Yibin; Liu, Yang; Wu, Pa; Du, Senyan; Fan, Huahao; Cheng, Gong] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Beijing 100084, Peoples R China.
   [Sun, Peng; Zhu, Yibin; Zhang, Renli; Cheng, Gong] Shenzhen Ctr Dis Control & Prevent, Inst Pathogen Organisms, Shenzhen 518055, Guangdong, Peoples R China.
   [Zhu, Yibin; Liu, Yang; Liu, Ziwen] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Chen, Chun-Hong] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli 35053, Taiwan.
   [Wang, Penghua] Univ Connecticut, Sch Med, Dept Immunol, Hlth Ctr, Farmington, CT 06030 USA.
RP Cheng, G (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Beijing 100084, Peoples R China.; Cheng, G (corresponding author), Shenzhen Ctr Dis Control & Prevent, Inst Pathogen Organisms, Shenzhen 518055, Guangdong, Peoples R China.
EM gongcheng@mail.tsinghua.edu.cn
OI CHEN, CHUN-HONG/0000-0002-3028-5508
FU National Key Research and Development Plan of China [2019YFC1200201,
   2018YFA0507202, 2018ZX09711003-004-003, 2016ZX10004001-008,
   2016YFC1201000, 2016YFD0500400]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81730063, 31825001,
   815719754]; Shenzhen San-Ming Project for prevention and research on
   vector-borne diseases [SZSM201611064]
FX We thank Professor Liang Ge from Tsinghua University School of Life
   Sciences to provide suggestions for the autophagy studies. We thank
   Professor Qiyong Liu from China CDC to donate the A. albopictus Jiangsu
   strain. This work was funded by the grants from the National Key
   Research and Development Plan of China (2019YFC1200201, 2018YFA0507202,
   2018ZX09711003-004-003, 2016ZX10004001-008, 2016YFC1201000, and
   2016YFD0500400), the National Natural Science Foundation of China
   (81730063, 31825001, and 815719754), and Shenzhen San-Ming Project for
   prevention and research on vector-borne diseases (SZSM201611064). We
   thank the core facilities of the Center for Life Sciences and Center of
   Biomedical Analysis for technical assistance (Tsinghua University).
CR Baillie JK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006641
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906
   Cunha LD, 2018, CELL, V175, P429, DOI 10.1016/j.cell.2018.08.061
   El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54
   Fong SW, 2018, J VIROL, V92, DOI [10.1128/JVI.01004-17, 10.1128/jvi.01004-17]
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Galluzzi L, 2019, CELL, V177, P1682, DOI 10.1016/j.cell.2019.05.026
   Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0
   Hastings AK, 2019, J VIROL, V93, DOI 10.1128/JVI.00395-19
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248
   Huang YJS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005038
   Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080
   Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864
   Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lightowlers RN, 2013, RNA BIOL, V10, P1433, DOI 10.4161/rna.24770
   Lin MG, 2016, CURR OPIN CELL BIOL, V39, P61, DOI 10.1016/j.ceb.2016.02.010
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Machain-Williams C, 2012, PARASITE IMMUNOL, V34, P15, DOI 10.1111/j.1365-3024.2011.01339.x
   Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973
   Mauthe M, 2016, J CELL BIOL, V214, P619, DOI 10.1083/jcb.201602046
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nastasi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16148
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039
   Refolo G, 2019, HEPATOLOGY, V69, P34, DOI 10.1002/hep.30149
   Ribeiro JMC, 2001, J EXP BIOL, V204, P3887
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0
   Sasarman F, 2015, HUM MOL GENET, V24, P480, DOI 10.1093/hmg/ddu468
   Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171
   Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009
   Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085
   Sowa-Rogozinska N, 2019, TOXINS, V11, DOI 10.3390/toxins11060350
   St John AL, 2013, NAT REV MICROBIOL, V11, P420, DOI 10.1038/nrmicro3030
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Tan CW, 2019, EMERG MICROBES INFEC, V8, P426, DOI 10.1080/22221751.2019.1590130
   Uraki R, 2019, NAT MICROBIOL, V4, P948, DOI 10.1038/s41564-019-0385-x
   Vogt MB, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006439
   Volpon L, 2017, RNA, V23, P927, DOI 10.1261/rna.060137.116
   Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x
   Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33
   Zou J, 2015, J BIOL CHEM, V290, P7269, DOI 10.1074/jbc.M114.627679
   Zou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094903
   Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306
NR 70
TC 2
Z9 2
U1 5
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 14
PY 2020
VL 11
IS 1
AR 260
DI 10.1038/s41467-019-14115-z
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LH6OL
UT WOS:000528903400003
PM 31937766
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Olawoyin, O
   Kribs, C
AF Olawoyin, Omomayowa
   Kribs, Christopher
TI Coinfection, Altered Vector Infectivity, and Antibody-Dependent
   Enhancement: The Dengue-Zika Interplay
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Invasion reproductive number; Copersistence; Zika; Dengue
ID CROSS-REACTIVITY; AEDES-AEGYPTI; VIRUS; CHIKUNGUNYA; TRANSMISSION;
   VACCINATION; POPULATION; PREVENTION; DISEASE; IMPACT
AB Although dengue and Zika cocirculation has increased within the past 5 years, very little is known about its epidemiological consequences. To investigate the effect of dengue and Zika cocirculation on the spread of both pathogens, we create a deterministic dengue and Zika coinfection model, the first to incorporate altered infectivity of mosquitoes (due to coinfection). The model also addresses increased infectivity due to antibody-dependent enhancement (ADE) within the human population. Central to our analysis is the derivation and interpretation of the basic reproductive number and invasion reproductive number of both pathogens. In addition, we investigate how model parameters impact the persistence of each disease. Our results identify threshold conditions under which one disease facilitates the spread of the other and show that ADE has a greater impact on disease persistence than altered vector infectivity. This work highlights the importance of ADE and illustrates that while the endemic presence of dengue facilitates the spread of Zika, it is possible for high Zika prevalence to prevent the establishment of dengue.
C1 [Olawoyin, Omomayowa; Kribs, Christopher] Univ Texas Arlington, Dept Math, 411 South Nedderman Dr,Box 19408, Arlington, TX 76019 USA.
RP Olawoyin, O (corresponding author), Univ Texas Arlington, Dept Math, 411 South Nedderman Dr,Box 19408, Arlington, TX 76019 USA.
EM omomayowa.olawoyin@mavs.uta.edu; kribs@uta.edu
FU National Science FoundationNational Science Foundation (NSF); National
   Science Foundation Graduate Research Fellowship ProgramNational Science
   Foundation (NSF) [1746052]
FX The authors acknowledge the National Science Foundation as this material
   is based upon work supported by the National Science Foundation Graduate
   Research Fellowship Program under Grant No. 1746052. Any opinions,
   findings, and conclusions or recommendations expressed in this material
   are those of the authors and do not necessarily reflect the views of the
   National Science Foundation.
CR Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Braselton J, 2015, J COMPUT SCI SYST BI, V8, P255
   Chaudhuri AA, 2016, CUREUS, V8, DOI 10.7759/cureus.484
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Crawford B, 2009, DISCRETE CONT DYN-B, V12, P279, DOI 10.3934/dcdsb.2009.12.279
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Isea Raul, 2016, AM J MODERN PHYS APP, V3, P11
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kumar K, 2010, ASIAN PAC J TROP MED, V3, P997, DOI 10.1016/S1995-7645(11)60017-5
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Martcheva Maia, 2009, Journal of Biological Dynamics, V3, P235, DOI 10.1080/17513750802638712
   Mitchell C, 2019, INFECT DIS MODEL, V4, P124, DOI 10.1016/j.idm.2019.04.002
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Okuneye KO, 2017, J BIOL SYST, V25, P545, DOI 10.1142/S0218339017400046
   Olawoyin O, 2018, INFECT DIS MODEL, V3, P331, DOI 10.1016/j.idm.2018.11.003
   PAHO, 2016, PROV REM ZIK VIR INF
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Porco TC, 1998, INTERFACES, V28, P167, DOI 10.1287/inte.28.3.167
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wang LP, 2019, PHYSICA A, V522, P248, DOI 10.1016/j.physa.2019.01.099
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Wiratsudakul A, 2018, PEERJ, V6, DOI 10.7717/peerj.4526
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 39
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD JAN 14
PY 2020
VL 82
IS 1
AR UNSP 13
DI 10.1007/s11538-019-00681-2
PG 20
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA KM9LV
UT WOS:000514463600003
PM 31933003
OA Green Published
DA 2020-07-08
ER

PT J
AU Schanoski, AS
   Le, TT
   Kaiserman, D
   Rowe, C
   Prow, NA
   Barboza, DD
   Santos, CA
   Zanotto, PMA
   Magalhaes, KG
   Aurelio, L
   Muller, D
   Young, P
   Zhao, PS
   Bird, PI
   Suhrbier, A
AF Schanoski, Alessandra S.
   Le, Thuy T.
   Kaiserman, Dion
   Rowe, Caitlin
   Prow, Natalie A.
   Barboza, Diego D.
   Santos, Cliomar A.
   Zanotto, Paolo M. A.
   Magalhaes, Kelly G.
   Aurelio, Luigi
   Muller, David
   Young, Paul
   Zhao, Peishen
   Bird, Phillip I.
   Suhrbier, Andreas
TI Granzyme A in Chikungunya and Other Arboviral Infections
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE chikungunya; granzyme A; NK cell; arthritis; arbovirus
ID PROTEINASE-ACTIVATED RECEPTOR-2; NATURAL-KILLER-CELLS; CD4(+) T-CELLS;
   NEUTROPHIL ELASTASE; VIRUS-INFECTION; MOUSE GRANZYME; EXTRACELLULAR
   GRANZYME; PROTEASE GRANZYME; ARTHRITIS; INFLAMMATION
AB Granzyme A (GzmA) is secreted by cytotoxic lymphocytes and has traditionally been viewed as a mediator of cell death. However, a growing body of data suggests the physiological role of GzmA is promotion of inflammation. Here, we show that GzmA is significantly elevated in the sera of chikungunya virus (CHIKV) patients and that GzmA levels correlated with viral loads and disease scores in these patients. Serum GzmA levels were also elevated in CHIKV mouse models, with NK cells the likely source. Infection of mice deficient in type I interferon responses with CHIKV, Zika virus, or dengue virus resulted in high levels of circulating GzmA. We also show that subcutaneous injection of enzymically active recombinant mouse GzmA was able to mediate inflammation, both locally at the injection site as well as at a distant site. Protease activated receptors (PARs) may represent targets for GzmA, and we show that treatment with PAR antagonist ameliorated GzmA- and CHIKV-mediated inflammation.
C1 [Schanoski, Alessandra S.] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
   [Le, Thuy T.; Prow, Natalie A.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Kaiserman, Dion; Rowe, Caitlin; Bird, Phillip I.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.
   [Prow, Natalie A.; Suhrbier, Andreas] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
   [Santos, Cliomar A.] Hlth Fdn Parreiras Horta, Cent Publ Hlth Lab, State Secretary Hlth, Aracaju, Brazil.
   [Zanotto, Paolo M. A.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.
   [Magalhaes, Kelly G.] Univ Brasilia, Lab Immunol & Inflammat, Brasilia, DF, Brazil.
   [Aurelio, Luigi] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia.
   [Muller, David] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic, Australia.
   [Muller, David; Young, Paul] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
RP Schanoski, AS (corresponding author), Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.; Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Suhrbier, A (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
EM alessandra.schanoki@butantan.gov.br;
   Andreas.Suhrbier@qimrberghofer.edu.au
RI de A. Zanotto, Paolo M./B-9286-2019; Magalhaes, Kelly Grace/A-6966-2010;
   Soares Schanoski, Alessandra/H-8144-2014
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Magalhaes, Kelly
   Grace/0000-0002-7435-5272; Soares Schanoski,
   Alessandra/0000-0002-6514-8458
FU Butantan Foundation; CNPqNational Council for Scientific and
   Technological Development (CNPq) [443371/2016-4]; FAPDF/PPSUS
   [193.001.621/2016]; National Health and Medical Research Council (NHMRC)
   of AustraliaNational Health and Medical Research Council of Australia
   [APP1078468]; Australian Infectious Disease Research Center; Advance
   Queensland Research Fellowship from the Queensland Government,
   Australia; National Health and Medical Research Council of
   AustraliaNational Health and Medical Research Council of Australia
FX The work in Brazil was supported by Butantan Foundation, CNPq (Grant
   443371/2016-4) and FAPDF/PPSUS #193.001.621/2016. The work in Australia
   was supported by a project grant from the National Health and Medical
   Research Council (NHMRC) of Australia (APP1078468) and intramural seed
   funding from the Australian Infectious Disease Research Center. NP was
   supported by an Advance Queensland Research Fellowship from the
   Queensland Government, Australia. AS holds a Principal Research
   Fellowship from the National Health and Medical Research Council of
   Australia.
CR Arias MA, 2014, CELL REP, V8, P419, DOI 10.1016/j.celrep.2014.06.012
   Bengsch B, 2018, J IMMUNOL METHODS, V453, P3, DOI 10.1016/j.jim.2017.03.009
   Brilot F, 2008, FRONT BIOSCI-LANDMRK, V13, P6443, DOI 10.2741/3165
   BRUNNER G, 1990, FEBS LETT, V260, P141, DOI 10.1016/0014-5793(90)80087-Y
   Burrack KS, 2015, J IMMUNOL, V194, P678, DOI 10.4049/jimmunol.1401833
   Campbell RA, 2018, J IMMUNOL, V200, P295, DOI 10.4049/jimmunol.1700885
   Chemin K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00353
   Cheuk S, 2017, EXP DERMATOL, V26, P824, DOI 10.1111/exd.13284
   Cook LE, 2020, J VIROL, V94, DOI 10.1128/JVI.00841-19
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   de Jong HK, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005823
   Della-Torre E, 2018, ARTHRITIS RHEUMATOL, V70, P1133, DOI 10.1002/art.40469
   Engin A, 2019, J MED VIROL, V91, P1385, DOI 10.1002/jmv.25467
   Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010
   Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913
   Garcia-Laorden MI, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4137563
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gasque P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam6567
   Golstein P, 2018, NAT REV IMMUNOL, V18, P526, DOI 10.1038/s41577-018-0009-3
   Gordy LE, 2011, J IMMUNOL, V187, P6335, DOI 10.4049/jimmunol.1003965
   Gryka RJ, 2017, DRUGS R&D, V17, P65, DOI 10.1007/s40268-016-0158-4
   Hammer Q, 2018, NAT IMMUNOL, V19, P800, DOI 10.1038/s41590-018-0163-6
   Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102
   Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x
   Heuberger DM, 2019, THROMB J, V17, DOI 10.1186/s12959-019-0194-8
   Hildebrand D, 2014, CELL REP, V9, P910, DOI 10.1016/j.celrep.2014.10.003
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544
   Jaime P, 2017, OSTEOARTHR CARTILAGE, V25, P1708, DOI 10.1016/j.joca.2017.06.007
   Jimenez-Vargas NN, 2018, P NATL ACAD SCI USA, V115, pE7438, DOI 10.1073/pnas.1721891115
   Joeckel LT, 2014, BIOL CHEM, V395, P181, DOI 10.1515/hsz-2013-0238
   Jose RJ, 2015, J IMMUNOL, V194, P6024, DOI 10.4049/jimmunol.1500124
   Juno JA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00019
   Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073
   Kaiserman D, 2014, J BIOL CHEM, V289, P9408, DOI 10.1074/jbc.M113.525808
   Kelso EB, 2006, J PHARMACOL EXP THER, V316, P1017, DOI 10.1124/jpet.105.093807
   Kiniry BE, 2018, J IMMUNOL, V200, P1876, DOI 10.4049/jimmunol.1701532
   La Linn M, 1998, J VIROL, V72, P5146, DOI 10.1128/JVI.72.6.5146-5153.1998
   Lauw FN, 2000, J INFECT DIS, V182, P206, DOI 10.1086/315642
   Liesche C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01840
   Liu J, 2019, IMMUNOL CELL BIOL, V97, P586, DOI 10.1111/imcb.12248
   Lochhead RB, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12992
   Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004
   Mandrup-Poulsen T, 2017, DIABETES, V66, P2937, DOI 10.2337/dbi17-0037
   Martin-Antonio B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091868
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014
   Michlmayr D, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177862
   Mihara K, 2013, J BIOL CHEM, V288, P32979, DOI 10.1074/jbc.M113.483123
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Mollah ZUA, 2017, DIABETES, V66, P3041, DOI 10.2337/db17-0517
   Mpande CAM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00324
   Muley MM, 2016, BRIT J PHARMACOL, V173, P766, DOI 10.1111/bph.13237
   Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783
   Muraro E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00197
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Petitdemange C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004499
   Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268
   Plasman K, 2014, J PROTEOME RES, V13, P6067, DOI 10.1021/pr500968d
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Prow NA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02736
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111
   Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Santiago L, 2017, ARTHRITIS RHEUMATOL, V69, P320, DOI 10.1002/art.39857
   Setoh YX, 2019, NAT MICROBIOL, V4, P876, DOI 10.1038/s41564-019-0399-4
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Sharma M, 2016, FEBS J, V283, P1734, DOI 10.1111/febs.13699
   Shields CA, 2018, AM J PHYSIOL-REG I, V315, pR336, DOI 10.1152/ajpregu.00061.2018
   Shimizu K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01450
   Silveira GF, 2018, J VIROL, V92, DOI [10.1128/JVI.02181-17, 10.1128/jvi.02181-17]
   Soares-Schanoski A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007880
   Sower LE, 1996, J IMMUNOL, V156, P2585
   Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610
   Spaeny-Dekking EHA, 2000, BLOOD, V95, P1465
   Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330
   Stewart SE, 2012, BBA-PROTEINS PROTEOM, V1824, P59, DOI 10.1016/j.bbapap.2011.05.020
   Suen JY, 2012, BRIT J PHARMACOL, V165, P1413, DOI 10.1111/j.1476-5381.2011.01610.x
   SUHRBIER A, 1991, J IMMUNOL METHODS, V145, P43, DOI 10.1016/0022-1759(91)90309-4
   Suhrbier A, 2019, NAT REV RHEUMATOL, V15, P597, DOI 10.1038/s41584-019-0276-9
   Suidan HS, 1996, BIOCHEM J, V315, P939, DOI 10.1042/bj3150939
   SUIDAN HS, 1994, P NATL ACAD SCI USA, V91, P8112, DOI 10.1073/pnas.91.17.8112
   Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989
   SUN JR, 1995, BBA-PROTEIN STRUCT M, V1252, P28, DOI 10.1016/0167-4838(95)00108-7
   Susanto O, 2013, CELL DEATH DIFFER, V20, P1183, DOI 10.1038/cdd.2013.59
   Teo TH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1333
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Thanapati S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188342
   Thanapati S, 2017, HUM IMMUNOL, V78, P370, DOI 10.1016/j.humimm.2017.02.006
   TRICE JM, 1985, SEMIN ARTHRITIS RHEU, V15, P45, DOI 10.1016/0049-0172(85)90009-5
   Triggianese P, 2016, INT J IMMUNOPATH PH, V29, P65, DOI 10.1177/0394632015615130
   van den Boogaard FE, 2016, AM J PHYSIOL-LUNG C, V311, pL507, DOI 10.1152/ajplung.00116.2016
   van Eck JA, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.56
   Velaga S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124927
   Waasdorp M, 2019, FASEB J, V33, P10966, DOI 10.1096/fj.201900516R
   Webster B, 2018, ELIFE, V7, DOI 10.7554/eLife.34273
   Wensink AC, 2015, J IMMUNOL, V194, P491, DOI 10.4049/jimmunol.1401214
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
   Wu CH, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1588538
   Xue ML, 2012, ARTHRITIS RHEUM-US, V64, P88, DOI 10.1002/art.33323
   Yamin R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37448-z
   Yang YH, 2005, ARTHRITIS RHEUM-US, V52, P1325, DOI 10.1002/art.21001
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736
   Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712
   Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067
NR 110
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JAN 14
PY 2020
VL 10
AR 3083
DI 10.3389/fimmu.2019.03083
PG 14
WC Immunology
SC Immunology
GA KG5XF
UT WOS:000510024400001
PM 31993061
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yeh, YT
   Gulino, K
   Zhanga, YH
   Sabestien, A
   Chou, TW
   Zhou, B
   Lin, Z
   Albert, I
   Lu, HG
   Swaminathan, V
   Ghedin, E
   Terrones, M
AF Yeh, Yin-Ting
   Gulino, Kristen
   Zhanga, YuHe
   Sabestien, Aswathy
   Chou, Tsui-Wen
   Zhou, Bin
   Lin, Zhong
   Albert, Istvan
   Lu, Huaguang
   Swaminathan, Venkataraman
   Ghedin, Elodie
   Terrones, Mauricio
TI A rapid and label-free platform for virus capture and identification
   from clinical samples
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE carbon nanotube; microfabrication; infectious disease; sequencing; virus
   isolation
ID REAL-TIME PCR; RESPIRATORY-SYNCYTIAL-VIRUS; LOGISTIC-REGRESSION;
   INFLUENZA-VIRUS; ASSAY; DIVERSITY; ALIGNMENT; GENOMICS; ZIKA
AB Emerging and reemerging viruses are responsible for a number of recent epidemic outbreaks. A crucial step in predicting and controlling outbreaks is the timely and accurate characterization of emerging virus strains. We present a portable microfluidic platform containing carbon nanotube arrays with differential filtration porosity for the rapid enrichment and optical identification of viruses. Different emerging strains (or unknown viruses) can be enriched and identified in real time through a multivirus capture component in conjunction with surface-enhanced Raman spectroscopy. More importantly, after viral capture and detection on a chip, viruses remain viable and get purified in a microdevice that permits subsequent in-depth characterizations by various conventional methods. We validated this platform using different subtypes of avian influenza A viruses and human samples with respiratory infections. This technology successfully enriched rhinovirus, influenza virus, and parainfluenza viruses, and maintained the stoichiometric viral proportions when the samples contained more than one type of virus, thus emulating coinfection. Viral capture and detection took only a few minutes with a 70-fold enrichment enhancement; detection could be achieved with as little as 10(2) EID50/mL (50% egg infective dose per microliter), with a virus specificity of 90%. After enrichment using the device, we demonstrated by sequencing that the abundance of viral-specific reads significantly increased from 4.1 to 31.8% for parainfluenza and from 0.08 to 0.44% for influenza virus. This enrichment method coupled to Raman virus identification constitutes an innovative system that could be used to quickly track and monitor viral outbreaks in real time.
C1 [Yeh, Yin-Ting; Zhanga, YuHe; Lin, Zhong; Swaminathan, Venkataraman; Terrones, Mauricio] Penn State Univ, Dept Phys, University Pk, PA 16802 USA.
   [Gulino, Kristen; Chou, Tsui-Wen; Zhou, Bin; Ghedin, Elodie] NYU, Dept Biol, New York, NY 10003 USA.
   [Sabestien, Aswathy; Albert, Istvan] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
   [Lu, Huaguang] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.
RP Yeh, YT; Terrones, M (corresponding author), Penn State Univ, Dept Phys, University Pk, PA 16802 USA.
EM yxy155@psu.edu; mut11@psu.edu
OI Yeh, Yin-Ting/0000-0002-1512-9267
FU National Science Foundation's Growing Convergence Research Big Idea
   [1934977]; Thrasher Research Fund [TRF13731]; Princeton
   UniversityPrinceton University; Pennsylvania State University [402854
   UP1001 ST-YEH]
FX We thank the National Science Foundation's Growing Convergence Research
   Big Idea (under Grant 1934977), The Thrasher Research Fund (TRF13731),
   Infectious Disease Research Exchanges Grant from Princeton University,
   and the start-up fund (402854 UP1001 ST-YEH) from The Pennsylvania State
   University.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Beigel H, 2005, NEW ENGL J MED, V353, P1374
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Cheung CL, 2002, J PHYS CHEM B, V106, P2429, DOI 10.1021/jp0142278
   Claesson MJ, 2017, NAT REV GASTRO HEPAT, V14, P585, DOI 10.1038/nrgastro.2017.97
   Datta Sibnarayan, 2015, World J Virol, V4, P265, DOI 10.5501/wjv.v4.i3.265
   Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1
   Ding SY, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.21
   Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0
   Feldmann H, 2018, ANNU REV MICROBIOL, V72, P423, DOI 10.1146/annurev-micro-090817-062414
   Firth C, 2013, ANNU REV GENOM HUM G, V14, P281, DOI 10.1146/annurev-genom-091212-153446
   Flint SJ, 2000, PRINCIPLES VIROLOGY
   Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Greninger AL, 2018, EXPERT REV MOL DIAGN, V18, P605, DOI 10.1080/14737159.2018.1487292
   Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16
   Hardwick SA, 2017, NAT REV GENET, V18, P473, DOI 10.1038/nrg.2017.44
   Kost GJ, 2018, EXPERT REV MOL DIAGN, V18, P657, DOI 10.1080/14737159.2018.1491793
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lim JY, 2015, ANAL CHEM, V87, P11652, DOI 10.1021/acs.analchem.5b02661
   Lipkin WI, 2015, VIROLOGY, V479, P194, DOI 10.1016/j.virol.2015.02.006
   Lu HU, 2003, AVIAN DIS, V47, P361, DOI 10.1637/0005-2086(2003)047[0361:ALSOAN]2.0.CO;2
   Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07
   Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359
   Metcalf CJE, 2017, SCIENCE, V357, P149, DOI 10.1126/science.aam8335
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Pappas G, 2013, CLIN MICROBIOL INFEC, V19, P605, DOI 10.1111/1469-0691.12262
   Parras-Molto M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0507-3
   Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Reyes M, 2017, ANAL CHEM, V89, P5373, DOI 10.1021/acs.analchem.7b00066
   Saphire EO, 2018, NAT IMMUNOL, V19, P1169, DOI 10.1038/s41590-018-0233-9
   Schlucker S, 2014, ANGEW CHEM INT EDIT, V53, P4756, DOI 10.1002/anie.201205748
   Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Scholkopf B., 2002, LEARNING KERNELS SUP
   Shao F, 2014, ACS APPL MATER INTER, V6, P6281, DOI 10.1021/am4045212
   She R, 2011, BIOINFORMATICS, V27, P2141, DOI 10.1093/bioinformatics/btr342
   Simner PJ, 2018, CLIN INFECT DIS, V66, P778, DOI 10.1093/cid/cix881
   Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002
   Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107
   Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238
   Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160
   Tan B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01027
   Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004
   Terrones M, 2002, APPL PHYS A-MATER, V74, P355, DOI 10.1007/s003390201278
   Toh SY, 2015, BIOSENS BIOELECTRON, V64, P392, DOI 10.1016/j.bios.2014.09.026
   Vincent AT, 2017, J MICROBIOL METH, V138, P60, DOI 10.1016/j.mimet.2016.02.016
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Woolhouse MEJ, 2013, FUTURE VIROL, V8, P159, DOI [10.2217/FVL.12.129, 10.2217/fvl.12.129]
   World Health Organization, 2014, INF PREV CONTR EP PA
   World Health Organization, 2004, WORLD HLTH REPORT 20
   Yamada T, 2006, NAT NANOTECHNOL, V1, P131, DOI 10.1038/nnano.2006.95
   Yeh YT, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601026
   Zhang YZ, 2018, CURR OPIN VIROL, V31, P9, DOI 10.1016/j.coviro.2018.07.017
NR 58
TC 3
Z9 3
U1 21
U2 21
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 14
PY 2020
VL 117
IS 2
BP 895
EP 901
DI 10.1073/pnas.1910113117
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KF0XT
UT WOS:000508976200021
PM 31882450
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Xiao, J
   Li, WY
   Zheng, X
   Qi, LL
   Wang, H
   Zhang, C
   Wan, XP
   Zheng, YX
   Zhong, RY
   Zhou, X
   Lu, Y
   Li, ZQ
   Qiu, Y
   Liu, C
   Zhang, F
   Zhang, YB
   Xu, XY
   Yang, ZZ
   Chen, HL
   Zhai, QW
   Wei, B
   Wang, HY
AF Xiao, Jun
   Li, Weiyun
   Zheng, Xin
   Qi, Linlin
   Wang, Hui
   Zhang, Chi
   Wan, Xiaopeng
   Zheng, Yuxiao
   Zhong, Ruiyue
   Zhou, Xin
   Lu, Yao
   Li, Zhiqi
   Qiu, Ying
   Liu, Chang
   Zhang, Fang
   Zhang, Yanbo
   Xu, Xiaoyan
   Yang, Zhongzhou
   Chen, Hualan
   Zhai, Qiwei
   Wei, Bin
   Wang, Hongyan
TI Targeting 7-Dehydrocholesterol Reductase Integrates Cholesterol
   Metabolism and IRF3 Activation to Eliminate Infection
SO IMMUNITY
LA English
DT Article
ID LEMLI-OPITZ-SYNDROME; IMMUNE-RESPONSE; IN-VITRO; REVEALS;
   25-HYDROXYCHOLESTEROL; INTERFERES; MODEL
AB Recent work suggests that cholesterol metabolism impacts innate immune responses against infection. However, the key enzymes or the natural products and mechanisms involved are not well elucidated. Here, we have shown that upon DNA and RNA viral infection, macrophages reduced 7-dehydrocholesterol reductase (DHCR7) expression. DHCR7 deficiency or treatment with the natural product 7-dehydrocholesterol (7-DHC) could specifically promote phosphorylation of IRF3 (not TBK1) and enhance type I interferon (IFN-I) production in macrophages. We further elucidated that viral infection or 7-DHC treatment enhanced AKT3 expression and activation. AKT3 directly bound and phosphorylated IRF3 at Ser385, together with TBK1-induced phosphorylation of IRF3 Ser386, to achieve IRF3 dimerization. Deletion of DHCR7 and the DHCR7 inhibitors including AY9944 and the chemotherapy drug tamoxifen promoted clearance of Zika virus and multiple viruses in vitro or in vivo. Taken together, we propose that the DHCR7 inhibitors and 7-DHC are potential therapeutics against emerging or highly pathogenic viruses.
C1 [Xiao, Jun; Li, Weiyun; Zheng, Xin; Zhang, Chi; Zheng, Yuxiao; Zhong, Ruiyue; Zhou, Xin; Lu, Yao; Qiu, Ying; Liu, Chang; Zhang, Yanbo; Xu, Xiaoyan; Wang, Hongyan] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,Innovat Ctr Cel, State Key Lab Cell Biol,Key Lab Syst Biol,CAS Ctr, Shanghai 200031, Peoples R China.
   [Qi, Linlin; Zhang, Fang; Wei, Bin] Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.
   [Qi, Linlin; Zhang, Fang; Wei, Bin] Shanghai Univ, Sch Life Sci, Shangda Rd, Shanghai, Peoples R China.
   [Wang, Hui; Zhai, Qiwei] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai, Peoples R China.
   [Wan, Xiaopeng; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.
   [Li, Zhiqi] Fudan Univ, Huashan Hosp, Shanghai, Peoples R China.
   [Zhang, Yanbo] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Xu, Xiaoyan] NCI, Expt Immunol Branch, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.
   [Yang, Zhongzhou] Nanjing Univ, Model Anim Res Ctr, Nanjing Biomed Res Inst, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Peoples R China.
   [Yang, Zhongzhou] Nanjing Univ, Model Anim Res Ctr, Nanjing Biomed Res Inst, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China.
   [Wei, Bin; Wang, Hongyan] Tongji Univ, Shanghai Peoples Hosp 10, Canc Ctr, Sch Med, Shanghai 200072, Peoples R China.
RP Wang, HY (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,Innovat Ctr Cel, State Key Lab Cell Biol,Key Lab Syst Biol,CAS Ctr, Shanghai 200031, Peoples R China.; Wei, B (corresponding author), Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.; Wei, B (corresponding author), Shanghai Univ, Sch Life Sci, Shangda Rd, Shanghai, Peoples R China.; Wei, B; Wang, HY (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Canc Ctr, Sch Med, Shanghai 200072, Peoples R China.
EM weibinwhy@shu.edu.cn; hongyanwang@sibcb.ac.cn
RI Zhang, Yanbo/B-3047-2011; , 肖俊/AAO-9118-2020; Xiao, Jun/AAH-5238-2020
OI Zhang, Yanbo/0000-0002-6201-7970; 
FU Strategic Priority Research Program of the Chinese Academy of
   SciencesChinese Academy of Sciences [XDB19000000]; Ministry of Science
   and Technology of ChinaMinistry of Science and Technology, China
   [2016YFD0500207, 2016YFD0500407, 2018YFA0800702, 2016YFC0905902];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81930038, 81825011, 81630043, 81671572, 81571552,
   81701569, 31700781, 81801575]
FX We thank the Strategic Priority Research Program of the Chinese Academy
   of Sciences (XDB19000000) for support. We thank Dr. Zhong Zhou Yang for
   providing Akt2<SUP>-/-</SUP> and Akt3<SUP>-/-</SUP> mice, Dr. Xiaolong
   Liu for CD45.1 mice, Drs. Qibin Leng and Jin Zhong for AG6 mice, and Dr.
   Deyin Guo, Daming Gao, and Bing Sun for providing the plasmids. We thank
   the staff, especially Chao Peng, Yue Yin, and Chaohua Zheng from the
   National Centre for Protein Science, Shanghai for MS analysis and mice
   irradiance. This work was supported by grants from the Ministry of
   Science and Technology of China (2016YFD0500207, 2016YFD0500407,
   2018YFA0800702, and 2016YFC0905902), National Natural Science Foundation
   of China (81930038, 81825011, 81630043, 81671572, 81571552, 81701569,
   31700781, and 81801575). We thank the Genome Tagging Project (GTP)
   Centre and Shanghai Institute of Biochemistry and Cell Biology, CAS for
   technical support.
CR Achour A, 1998, ANTIMICROB AGENTS CH, V42, P2482, DOI 10.1128/AAC.42.10.2482
   Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487
   Babovic-Vuksanovic D, 2005, J INHERIT METAB DIS, V28, P181, DOI 10.1007/s10545-005-5515-3
   Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031
   Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004
   Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598
   Boland MR, 2016, PHARMACOGENOMICS J, V16, P411, DOI 10.1038/tpj.2016.48
   Bonneau L, 2010, BBA-BIOMEMBRANES, V1798, P2150, DOI 10.1016/j.bbamem.2010.07.026
   Corriden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9369
   Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029
   Ezella SA, 2012, P NATL ACAD SCI USA, V109, pE613, DOI 10.1073/pnas.1115029109
   Francis KR, 2016, NAT MED, V22, P388, DOI 10.1038/nm.4067
   Gerrick KY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208602
   Hiscott J, 2004, NAT STRUCT MOL BIOL, V11, P1028, DOI 10.1038/nsmb1104-1028
   Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892
   Kandasamy RK, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.27
   Keller RK, 2004, J LIPID RES, V45, P347, DOI 10.1194/jlr.M300232-JLR200
   Khodabandehlou N, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5286-0
   Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015
   Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001
   Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899
   OSTERGAARD GZ, 1992, EUR J PEDIATR, V151, P291, DOI 10.1007/BF02072232
   Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911
   Phung TL, 2015, CANCER RES, V75, P40, DOI 10.1158/0008-5472.CAN-13-2961
   Ramstedt B, 1999, BIOPHYS J, V77, P1498, DOI 10.1016/S0006-3495(99)76997-3
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790
   Rodgers MA, 2012, J AM CHEM SOC, V134, P6896, DOI 10.1021/ja207391q
   Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007
   Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025
   Sonnino S, 2013, CURR MED CHEM, V20, P4
   Sponne I, 2004, FASEB J, V18, P836, DOI 10.1096/fj.03-0372fje
   Sunshine H, 2017, CURR OPIN LIPIDOL, V28, P408, DOI 10.1097/MOL.0000000000000443
   TEO CC, 1992, J MED CHEM, V35, P1330, DOI 10.1021/jm00086a002
   Wang Q, 2016, CANCER CELL, V29, P523, DOI 10.1016/j.ccell.2016.02.008
   Watashi K, 2007, J BIOL CHEM, V282, P32765, DOI 10.1074/jbc.M704418200
   Wu SY, 2019, NAT CELL BIOL, V21, P1027, DOI 10.1038/s41556-019-0352-z
   Xu LB, 2011, J LIPID RES, V52, P1810, DOI 10.1194/jlr.M018366
   Xu XY, 2017, J EXP MED, V214, P209, DOI 10.1084/jem.20160068
   York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045
   Zhang YB, 2014, IMMUNITY, V40, P501, DOI 10.1016/j.immuni.2014.01.013
   Zhong CQ, 2015, CELL STEM CELL, V17, P221, DOI 10.1016/j.stem.2015.06.005
NR 49
TC 2
Z9 2
U1 16
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD JAN 14
PY 2020
VL 52
IS 1
BP 109
EP +
DI 10.1016/j.immuni.2019.11.015
PG 20
WC Immunology
SC Immunology
GA KC7WX
UT WOS:000507384600012
PM 31882361
DA 2020-07-08
ER

PT J
AU Guo, XX
   Li, CX
   Deng, YQ
   Jiang, YT
   Sun, AJ
   Liu, QM
   Dong, YD
   Xing, D
   Cao, WC
   Qin, CF
   Zhao, TY
AF Guo, Xiaoxia
   Li, Chunxiao
   Deng, Yongqiang
   Jiang, Yuting
   Sun, Aijuan
   Liu, Qinmei
   Dong, Yande
   Xing, Dan
   Cao, Wuchun
   Qin, Chengfeng
   Zhao, Tongyan
TI Vector Competence and Vertical Transmission of Zika Virus in Aedes
   albopictus (Diptera: Culicidae)
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article; Early Access
DE ZIKV; vector competence; Aedes albopictus; vertical transmission
ID GENOMIC CHARACTERIZATION; GEOGRAPHIC STRAINS; AEGYPTI MOSQUITOS;
   YELLOW-FEVER; SUSCEPTIBILITY; INFECTION
AB Zika virus (ZIKV) is an emerging mosquito-borne pathogen belonging to the genus Flavivirus of the family Flaviviridae. Aedes albopictus is widely distributed in China. However, little is known about the vector competence of Ae. albopictus in China. The present study presents the oral susceptibility and vector competence of Ae. albopictus Guangzhou strain to ZIKV. Additionally, vertical transmission of ZIKV is described. The results demonstrated the susceptibility of local Ae. albopictus mosquitoes to ZIKV with an extrinsic incubation period of 6 days. Disseminated infection was observed in Ae. albopictus starting on day 2 postinfection (PI). Starting on day 6 PI, the saliva of Ae. albopictus exhibited ZIKV infection, and the transmission rate was 36.4%. Vertical transmission was observed during the first gonotrophic cycle. The minimum infection rate was observed in third-to-fourth instar larvae.
C1 [Guo, Xiaoxia; Li, Chunxiao; Jiang, Yuting; Sun, Aijuan; Liu, Qinmei; Dong, Yande; Xing, Dan; Zhao, Tongyan] Inst Microbiol & Epidemiol, Dept Vector Biol & Control, State Key Lab Pathogen & Biosecur, Beijing Key Lab Vector Borne & Nat Focus Infect D, Beijing, Peoples R China.
   [Deng, Yongqiang; Qin, Chengfeng] Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Cao, Wuchun] Inst Microbiol & Epidemiol, Dept Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
RP Qin, CF (corresponding author), Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Zhao, TY (corresponding author), Inst Microbiol & Epidemiol, Dept Vector Biol & Control, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM chengfeng_qin@126.com; tongyanzhao@126.com
FU Infective Diseases Prevention and Cure Project of China [2017ZX
   1000303404]; National Key Technology Support ProgramNational Key
   Technology R&D Program [2014BAI13B01]; Zika Prevention and Control
   Project of China
FX This work was funded by grants from the Infective Diseases Prevention
   and Cure Project of China (no. 2017ZX 1000303404), the National Key
   Technology Support Program (no. 2014BAI13B01), and the Zika Prevention
   and Control Project of China.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Anderson JF, 2012, AM J TROP MED HYG, V86, P134, DOI 10.4269/ajtmh.2012.11-0473
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lu BL, 1990, VECTOR DENGUE FEVER
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 33
TC 0
Z9 0
U1 5
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
DI 10.1089/vbz.2019.2492
EA JAN 2020
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KC9LN
UT WOS:000507492900001
PM 31934825
DA 2020-07-08
ER

PT J
AU Deng, XD
   Achari, A
   Federman, S
   Yu, GX
   Somasekar, S
   Bartolo, I
   Yagi, S
   Mbala-Kingebeni, P
   Kapetshi, J
   Ahuka-Mundeke, S
   Muyembe-Tamfum, JJ
   Ahmed, AA
   Ganesh, V
   Tamhankar, M
   Patterson, JL
   Ndembi, N
   Mbanya, D
   Kaptue, L
   McArthur, C
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Lopez, S
   Arias, CF
   Arevalo, S
   Miller, S
   Stone, M
   Busch, M
   Hsieh, K
   Messenger, S
   Wadford, DA
   Rodgers, M
   Cloherty, G
   Faria, NR
   Theze, J
   Pybus, OG
   Neto, Z
   Morais, J
   Taveira, N
   Hackett, JR
   Chiu, CY
AF Deng, Xianding
   Achari, Asmeeta
   Federman, Scot
   Yu, Guixia
   Somasekar, Sneha
   Bartolo, Ines
   Yagi, Shigeo
   Mbala-Kingebeni, Placide
   Kapetshi, Jimmy
   Ahuka-Mundeke, Steve
   Muyembe-Tamfum, Jean-Jacques
   Ahmed, Asim A.
   Ganesh, Vijay
   Tamhankar, Manasi
   Patterson, Jean L.
   Ndembi, Nicaise
   Mbanya, Dora
   Kaptue, Lazare
   McArthur, Carole
   Munoz-Medina, Jose E.
   Gonzalez-Bonilla, Cesar R.
   Lopez, Susana
   Arias, Carlos F.
   Arevalo, Shaun
   Miller, Steve
   Stone, Mars
   Busch, Michael
   Hsieh, Kristina
   Messenger, Sharon
   Wadford, Debra A.
   Rodgers, Mary
   Cloherty, Gavin
   Faria, Nuno R.
   Theze, Julien
   Pybus, Oliver G.
   Neto, Zoraima
   Morais, Joana
   Taveira, Nuno
   Hackett, John R.
   Chiu, Charles Y.
TI Metagenomic sequencing with spiked primer enrichment for viral
   diagnostics and genomic surveillance
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ZIKA VIRUS; EBOLA-VIRUS; REAL-TIME; TRANSMISSION; DIVERSITY; DEPLETION;
   IMPACT; BRAZIL; BAHIA; AIDS
AB Metagenomic next-generation sequencing (mNGS), the shotgun sequencing of RNA and DNA from clinical samples, has proved useful for broad-spectrum pathogen detection and the genomic surveillance of viral outbreaks. An additional target enrichment step is generally needed for high-sensitivity pathogen identification in low-titre infections, yet available methods using PCR or capture probes can be limited by high cost, narrow scope of detection, lengthy protocols and/or cross-contamination. Here, we developed metagenomic sequencing with spiked primer enrichment (MSSPE), a method for enriching targeted RNA viral sequences while simultaneously retaining metagenomic sensitivity for other pathogens. We evaluated MSSPE for 14 different viruses, yielding a median tenfold enrichment and mean 47% (+/- 16%) increase in the breadth of genome coverage over mNGS alone. Virus detection using MSSPE arboviral or haemorrhagic fever viral panels was comparable in sensitivity to specific PCR, demonstrating 95% accuracy for the detection of Zika, Ebola, dengue, chikungunya and yellow fever viruses in plasma samples from infected patients. Notably, sequences from re-emerging and/or co-infecting viruses that have not been specifically targeted a priori, including Powassan and Usutu, were successfully enriched using MSSPE. MSSPE is simple, low cost, fast and deployable on either benchtop or portable nanopore sequencers, making this method directly applicable for diagnostic laboratory and field use.
   This study describes a new method that improves the sensitivity of viral detection compared with next-generation sequencing and enables the detection of emerging flaviviruses not specifically targeted a priori. Metagenomic sequencing with spiked primer enrichment is simple, low cost, fast and deployable on either benchtop or portable nanopore sequencers, making it applicable for diagnostic laboratory and field use.
C1 [Deng, Xianding; Achari, Asmeeta; Federman, Scot; Yu, Guixia; Somasekar, Sneha; Arevalo, Shaun; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Deng, Xianding; Achari, Asmeeta; Federman, Scot; Yu, Guixia; Somasekar, Sneha; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 91407 USA.
   [Bartolo, Ines] Univ Lisbon, Med Res Inst, Fac Pharm, Lisbon, Portugal.
   [Yagi, Shigeo; Hsieh, Kristina; Messenger, Sharon; Wadford, Debra A.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA USA.
   [Mbala-Kingebeni, Placide; Kapetshi, Jimmy; Ahuka-Mundeke, Steve; Muyembe-Tamfum, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Ahmed, Asim A.] Boston Childrens Hosp, Boston, MA USA.
   [Ahmed, Asim A.] Harvard Med Sch, Boston, MA 02115 USA.
   [Ganesh, Vijay] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Tamhankar, Manasi; Patterson, Jean L.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA.
   [Ndembi, Nicaise] Inst Human Virol Nigeria, Abuja, Nigeria.
   [Ndembi, Nicaise] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
   [Mbanya, Dora] Univ Yaounde I, Yaounde, Cameroon.
   [Mbanya, Dora] Univ Bamenda, Bamenda, Cameroon.
   [Kaptue, Lazare] Univ Montagnes, Bangangte, Cameroon.
   [McArthur, Carole] Univ Missouri, Kansas City, MO 64110 USA.
   [Munoz-Medina, Jose E.; Gonzalez-Bonilla, Cesar R.] Inst Mexicano Seguro Social, Mexico City, DF, Mexico.
   [Lopez, Susana; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Stone, Mars; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA.
   [Rodgers, Mary; Cloherty, Gavin; Hackett, John R.] Abbott Labs, Abbott Pk, IL 60064 USA.
   [Faria, Nuno R.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Neto, Zoraima; Morais, Joana] Angolan Natl Inst Hlth Res, Luanda, Angola.
   [Taveira, Nuno] IUEM, Monte De Caparica, Portugal.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 91407 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.
EM charles.chiu@ucsf.edu
RI NDEMBI, Nicaise/AAE-4383-2020; Bartolo, Ines/A-7477-2014; Taveira,
   Nuno/A-6252-2014
OI Bartolo, Ines/0000-0002-2022-8921; Taveira, Nuno/0000-0003-0176-5585
FU Abbott LaboratoriesAbbott Laboratories; NIH from the NIAID
   [R33-AI129455]; NIH from the National Heart, Lung, and Blood
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01-HL105704]; California Initiative to Advance
   Precision Medicine; Charles and Helen Schwab Foundation; Steven and
   Alexandra Cohen Foundation; United States Department of DefenseUnited
   States Department of Defense [W81XWH-17-1-0681]; Wellcome TrustWellcome
   Trust; Royal Society/Sir Henry Dale Fellowship [204311/Z/16/Z]; Global
   Challenges Research Fund [005073]; Oxford John Fell Research Fund
   [005166]; Africa Oxford grant [AfiOx-48]
FX We thank N. Loman and J. Quick at the University of Birmingham for
   providing ZIKV tiling multiplex PCR primers. The following viral RNA
   extracts were obtained through Biodefense and Emerging Infections
   Resources, the National Institute of Allergy and Infectious Diseases
   (NIAID) and the National Institutes of Health (NIH): CCHFV, IbAr10200,
   NR-37382; LASV, Josiah, NR-31821; Rift Valley Fever Virus, ZH501,
   NR-37379; MeV, Edmonston strain, NR-44104. This work was also funded in
   part by Abbott Laboratories (C.Y.C.), NIH grant no. R33-AI129455
   (C.Y.C.) from the NIAID, NIH grant no. R01-HL105704 (C.Y.C.) from the
   National Heart, Lung, and Blood Institute, the California Initiative to
   Advance Precision Medicine (C.Y.C.), the Charles and Helen Schwab
   Foundation (C.Y.C.), the Steven and Alexandra Cohen Foundation (C.Y.C.),
   United States Department of Defense award W81XWH-17-1-0681 (C.Y.C.), the
   Wellcome Trust and Royal Society/Sir Henry Dale Fellowship grant no.
   204311/Z/16/Z (N.R.F.), the Global Challenges Research Fund grant no.
   005073 (N.R.F.), the Oxford John Fell Research Fund grant no. 005166
   (N.R.F.) and Africa Oxford grant no. AfiOx-48 (N.R.F.).
CR Nguyen AT, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0580-9
   Berg Michael G, 2016, J Clin Microbiol, V54, P868, DOI 10.1128/JCM.02479-15
   Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Cherpillod P, 2016, J CLIN VIROL, V77, P9, DOI 10.1016/j.jcv.2016.01.017
   Chiu CY, 2019, NAT REV GENET, V20, P341, DOI 10.1038/s41576-019-0113-7
   Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064
   Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5
   Hasan MR, 2016, J CLIN MICROBIOL, V54, P919, DOI 10.1128/JCM.03050-15
   Kafetzopoulou LE, 2019, SCIENCE, V363, P74, DOI 10.1126/science.aau9343
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Koehler JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107007
   Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lorenz TC, 2012, JOVE-J VIS EXP, DOI 10.3791/3998
   Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219
   Metsky HC, 2019, NAT BIOTECHNOL, V37, P160, DOI 10.1038/s41587-018-0006-x
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miller S, 2019, GENOME RES, V29, P831, DOI 10.1101/gr.238170.118
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Pollock NR, 2017, J CLIN MICROBIOL, V55, P1255, DOI [10.1128/JCM.00053-17, 10.1128/jcm.00053-17]
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rasmussen AL, 2016, CELL HOST MICROBE, V19, P611, DOI 10.1016/j.chom.2016.04.016
   Reperant LA, 2017, VACCINE, V35, P4470, DOI 10.1016/j.vaccine.2017.04.082
   ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Shorten RJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004948
   Simner PJ, 2018, CLIN INFECT DIS, V66, P778, DOI 10.1093/cid/cix881
   Song HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04217-5
   Sovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11307
   Sozhamannan S, 2015, VIRUSES-BASEL, V7, P3130, DOI 10.3390/v7062763
   Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005
   Strong MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004437
   Temmam S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139810
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5
   Wilson MR, 2019, NEW ENGL J MED, V380, P2327, DOI 10.1056/NEJMoa1803396
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
NR 54
TC 5
Z9 5
U1 11
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD MAR
PY 2020
VL 5
IS 3
BP 443
EP 454
DI 10.1038/s41564-019-0637-9
EA JAN 2020
PG 12
WC Microbiology
SC Microbiology
GA KQ0XE
UT WOS:000508513600001
PM 31932713
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Guo, YM
   Li, TT
AF Guo, Youming
   Li, Tingting
TI Optimal control and stability analysis of an online game addiction model
   with two stages
SO MATHEMATICAL METHODS IN THE APPLIED SCIENCES
LA English
DT Article; Early Access
DE forward and backward sweep method; game addiction model; Lyapunov
   function; optimal control; two stages
ID COST-EFFECTIVENESS ANALYSIS; ZIKA VIRUS
AB In this paper, we establish a mathematical model of online game addiction with two stages to research the dynamic properties of it. The existence of all equilibria is obtained, and the basic reproduction number is calculated by the method of next-generation matrix. The global asymptotic stability of disease-free equilibrium (DFE) is proved by comparison principle, and the global asymptotic stability of endemic equilibrium (EE) is proved by constructing an appropriate Lyapunov function. Then we use the Pontryagin's maximum principle to find the optimal solution of the model, so that the number of infected people can be minimized. In numerical simulation, firstly, we validate the global stability of DFE and EE. Secondly, we consider three kind of control measures (treatment, isolation, and education) and divide them into four cases. The models with control and without control are solved numerically by using forward and backward sweep Runge-Kutta method. In order to achieve the best control effect, we suggest that three kind of measures should be used simultaneously according to the optimal control strategy.
C1 [Guo, Youming; Li, Tingting] Guilin Univ Technol, Coll Sci, Guilin 541004, Guangxi, Peoples R China.
RP Li, TT (corresponding author), Guilin Univ Technol, Coll Sci, Guilin 541004, Guangxi, Peoples R China.
EM wsltt0621@163.com
FU Basic Competence Promotion Project for Young and Middle-aged Teachers in
   Guangxi, China [2018KY0262, 2019KY0269]
FX Basic Competence Promotion Project for Young and Middle-aged Teachers in
   Guangxi, China, Grant/Award Number: 2018KY0262 and 2019KY0269
CR Agusto FB, 2018, MATH BIOSCI, V305, P102, DOI 10.1016/j.mbs.2018.09.007
   [Anonymous], 2018, WORLD HLTH STAT
   [Anonymous], 2019, STAT CLASSIFICATION
   Bonyah E, 2019, OPTIM CONTR APPL MET, V40, P394, DOI 10.1002/oca.2483
   Bonyah E, 2019, MATH BIOSCI, V309, P1, DOI 10.1016/j.mbs.2018.12.015
   Bonyah E, 2018, CHAOS SOLITON FRACT, V117, P150, DOI 10.1016/j.chaos.2018.10.025
   Fleming W. H., 1975, DETERMINISTIC STOCHA
   Hattaf K, 2012, ISRN BIOMATHEMATICS, V2012
   Huo HF, 2016, APPL MATH MODEL, V40, P9474, DOI 10.1016/j.apm.2016.06.029
   JIANG X, 2016, MATH PRACTICE THEORY, V46, P277
   Khan MA, 2019, NONLINEAR ANAL-REAL, V50, P144, DOI 10.1016/j.nonrwa.2019.04.006
   LaSalle j. P., 1976, REGIONAL C SERIES AP
   Li TT, 2019, FILOMAT, V33, P5691, DOI 10.2298/FIL1917691L
   Lukes DL, 1982, DIFFERENTIAL EQUATIO
   Mathews CL, 2019, AM J DRUG ALCOHOL AB, V45, P67, DOI 10.1080/00952990.2018.1472269
   McAsey M, 2012, COMPUT OPTIM APPL, V53, P207, DOI 10.1007/s10589-011-9454-7
   Momoh AA, 2018, OPER RES HEALTH CARE, V18, P99, DOI 10.1016/j.orhc.2017.08.004
   Mulone G, 2012, INT J BIOMATH, V5, DOI 10.1142/S1793524511001453
   Sana M, 2015, SCI INT LABORE, V27, P839
   Sharomi O, 2008, APPL MATH COMPUT, V195, P475, DOI 10.1016/j.amc.2007.05.012
   Tang CSK, 2017, ASIA-PAC J PUBLIC HE, V29, P673, DOI 10.1177/1010539517739558
   Ullah S, 2019, OPTIM CONTR APPL MET, V40, P529, DOI 10.1002/oca.2493
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Viriyapong R, 2018, MATH METHOD APPL SCI, V1, P1
   Wang X, 2019, APPL MATH COMPUT, V359, P165, DOI 10.1016/j.amc.2019.04.026
   Zhao Q, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0473-x
   Zhou WK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213898
NR 27
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0170-4214
EI 1099-1476
J9 MATH METHOD APPL SCI
JI Math. Meth. Appl. Sci.
DI 10.1002/mma.6200
EA JAN 2020
PG 18
WC Mathematics, Applied
SC Mathematics
GA KB9UG
UT WOS:000506832300001
DA 2020-07-08
ER

PT J
AU Shao, T
   Pan, JH
   Zhang, SW
   Xin, ZY
   Wang, GQ
AF Shao, Tong
   Pan, Jiahui
   Zhang, Shiwei
   Xin, Zhuoyuan
   Wang, Guoqing
TI Application of MCMC-Based Bayesian Modeling for Genetic Evolutionary and
   Dynamic Change Analysis of Zika Virus
SO FRONTIERS IN GENETICS
LA English
DT Article
DE zika virus; NS5; evolution; dynamic changes; Bayesian method
ID PROTEIN; GLYCOSYLATION; INFECTIVITY; STATE
AB Zika virus was first discovered in 1947. For a long time afterward, no large-scale outbreaks occurred. However, more recently, in 2007 and 2016, there were two episodes of ZIKV outbreak that have produced serious public health problems. By analyzing the evolution of the viral genome, we can understand the potential for its outbreak. In this study, we constructed a maximum clade credibility (MCC) tree for the ZIKV non-structural protein 5 (NS5) gene using the Bayesian method. A total of 108 whole-NS5 sequences were retrieved from the GeneBank. We carried out an analysis of potential glycosylation and phosphorylation sites of the ZIKV virus NS5 gene and dynamic analysis of the evolutionary characteristics of the gene. Phylogenetic analysis revealed the presence of two sequence lineages: African and Asian. The sequence of the strains obtained from GeneBank has high homology of 85% to 100%. There are 35 potential phosphorylation sites and glycosylation sites in the ZIKV-NS5 sequences. This article analyzes the possible causes of ZIKV virus outbreaks from the perspective of genetic evolution and analyzes the dynamic trends of virus outbreaks to provide a theoretical basis for predicting the outbreak of the virus.
C1 [Shao, Tong; Pan, Jiahui; Zhang, Shiwei; Xin, Zhuoyuan; Wang, Guoqing] Jilin Univ, Coll Basic Med Sci, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun, Peoples R China.
   [Wang, Guoqing] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Peoples R China.
RP Wang, GQ (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun, Peoples R China.; Wang, GQ (corresponding author), Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Peoples R China.
EM qing@jlu.edu.cn
FU Epidemiology, Early Warning and Response Techniques of Major Infectious
   Diseases in the Belt and Road Initiative [2018ZX10101002]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81871699]; Foundation of Jilin Province Science and Technology
   Department [172408GH010234983]
FX This work was supported by grants from Epidemiology, Early Warning and
   Response Techniques of Major Infectious Diseases in the Belt and Road
   Initiative (#2018ZX10101002), the National Natural Science Foundation of
   China (#81871699), and the Foundation of Jilin Province Science and
   Technology Department (#172408GH010234983).
CR Battaglia V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00208
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boon L, 2016, BIOCHEM J, V473, P1471, DOI 10.1042/BJ20151154
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Koh PO, 2014, NEUROSCI LETT, V574, P36, DOI 10.1016/j.neulet.2014.05.006
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Mazeaud C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00595
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Shi H, 2019, GENOMICS, V111, P1839, DOI 10.1016/j.ygeno.2018.12.007
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yuan L, 2015, NEUROCHEM RES, V40, P1232, DOI 10.1007/s11064-015-1586-1
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
NR 30
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JAN 10
PY 2020
VL 10
AR 1319
DI 10.3389/fgene.2019.01319
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA KF4XQ
UT WOS:000509247300001
PM 31998372
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcia, GA
   Hoffmann, AA
   Maciel-de-Freitas, R
   Villela, DAM
AF Garcia, Gabriela A.
   Hoffmann, Ary A.
   Maciel-de-Freitas, Rafael
   Villela, Daniel A. M.
TI Aedes aegypti insecticide resistance underlies the success (and failure)
   of Wolbachia population replacement
SO SCIENTIFIC REPORTS
LA English
DT Article
ID KNOCKDOWN RESISTANCE; ZIKA VIRUS; DENGUE; INFECTION; MUTATIONS;
   CULICIDAE; DIPTERA; BRAZIL
AB Mosquitoes that carry Wolbachia endosymbionts may help control the spread of arboviral diseases, such as dengue, Zika and chikungunya. Wolbachia frequencies systematically increase only when the frequency-dependent advantage due to cytoplasmic incompatibility exceeds frequency-independent costs, which may be intrinsic to the Wolbachia and/or can be associated with the genetic background into which Wolbachia are introduced. Costs depend on field conditions such as the environmental pesticide load. Introduced mosquitoes need adequate protection against insecticides to ensure survival after release. We model how insecticide resistance of transinfected mosquitoes determines the success of local Wolbachia introductions and link our theoretical results to field data. Two Ae. aegypti laboratory strains carrying Wolbachia were released in an isolated district of Rio de Janeiro, Brazil: wMelBr (susceptible to pyrethroids) and wMelRio (resistant to pyrethroids). Our models elucidate why releases of the susceptible strain failed to result in Wolbachia establishment, while releases of the resistant strain led to Wolbachia transforming the native Ae. aegypti population. The results highlight the importance of matching insecticide resistance levels in release stocks to those in the target natural populations during Wolbachia deployment.
C1 [Garcia, Gabriela A.; Maciel-de-Freitas, Rafael] Fundacao Oswaldo Cruz FIOCRUZ, IOC, Lab Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Hoffmann, Ary A.] Univ Melbourne, Parkville, Vic, Australia.
   [Villela, Daniel A. M.] Fundacao Oswaldo Cruz FIOCRUZ, Programa Computacao Cient PROCC, Rio De Janeiro, Brazil.
RP Villela, DAM (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Programa Computacao Cient PROCC, Rio De Janeiro, Brazil.
EM daniel.villela@fiocruz.br
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX We thank Dr. Michael Turelli for stimulating discussions about the
   formulation presented here and also about our results. We are grateful
   for support from CAPES, CNPq and Program Print-Fiocruz-CAPES.
CR Diniz DFA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1276-5
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Brito L. P, 2018, BIOMED RES INT, V2018, P1
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Chevillon C, 1999, BIOL J LINN SOC, V68, P147, DOI 10.1111/j.1095-8312.1999.tb01163.x
   David M.R, 2018, BIOMED RES INT, V2018, P1
   de Oliveira CD, 2015, B ENTOMOL RES, V105, P305, DOI 10.1017/S0007485315000085
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   de Oliveira S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005947
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285
   Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Garcia GD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160196
   Hancock P, 2016, J APPL ECOLOGY, V53
   Hancock PA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0319-5
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hoffmann AA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0371
   Jaramillo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096379
   Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395
   Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343
   LAVEN H, 1959, COLD SPRING HARB SYM, V24, P166, DOI 10.1101/SQB.1959.024.01.017
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Maciel-De-Freitas R, 2007, MEM I O CRUZ RIO DE, V102
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Martins AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037435
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   Schechtman H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123961
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Turelli M, 2017, THEOR POPUL BIOL, V115, P45, DOI 10.1016/j.tpb.2017.03.003
   Turley AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-36
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
NR 56
TC 0
Z9 0
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 9
PY 2020
VL 10
IS 1
AR 63
DI 10.1038/s41598-019-56766-4
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KS0GI
UT WOS:000517989900014
PM 31919396
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Musso, D
   Ko, AI
   Baud, D
AF Musso, Didier
   Ko, Albert I.
   Baud, David
TI Zika Virus Infection - After the Pandemic REPLY
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Musso, Didier] Lab Eurofins Labazur Guyane, Cayenne, French Guiana.
   [Ko, Albert I.] Yale Sch Publ Hlth, New Haven, CT USA.
   [Baud, David] CHU Vaudois, Lausanne, Switzerland.
RP Musso, D (corresponding author), Lab Eurofins Labazur Guyane, Cayenne, French Guiana.
EM dmusso12345@gmail.com
RI Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Baud, David/0000-0001-9914-6496
CR Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ximenes RAD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007763
NR 3
TC 0
Z9 0
U1 1
U2 1
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JAN 9
PY 2020
VL 382
IS 2
BP E3
EP +
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA KB6CS
UT WOS:000506581500003
PM 31914252
DA 2020-07-08
ER

PT J
AU Pacheco, LD
   Weaver, SC
   Saade, GR
AF Pacheco, Luis D.
   Weaver, Scott C.
   Saade, George R.
TI Zika Virus Infection - After the Pandemic
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Pacheco, Luis D.; Weaver, Scott C.; Saade, George R.] Univ Texas Med Branch, Galveston, TX 77555 USA.
RP Pacheco, LD (corresponding author), Univ Texas Med Branch, Galveston, TX 77555 USA.
EM ldpachec@utmb.edu
RI Ko, Albert Icksang/P-2343-2015; Musso, Didier/P-7809-2016; Musso,
   Didier/AAO-8178-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR [Anonymous], 2019, OBSTET GYNECOL, V134, pe64
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
NR 3
TC 0
Z9 0
U1 3
U2 3
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JAN 9
PY 2020
VL 382
IS 2
BP E3
EP E3
DI 10.1056/NEJMc1914974
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA KB6CS
UT WOS:000506581500002
PM 31914251
DA 2020-07-08
ER

PT J
AU de Jesus, JG
   Wallau, GD
   Maia, ML
   Xavier, J
   Lima, MAO
   Fonseca, V
   de Abreu, AS
   Tosta, SFD
   do Amaral, HR
   Lima, IAB
   Silva, PV
   dos Santos, DC
   de Oliveira, AS
   de Souza, SC
   Falcao, MB
   Cerqueira, E
   Machado, LC
   Sobral, MC
   Rezende, TMT
   Pereira, MR
   Pereira, FM
   Maia, ZPG
   Franca, RFD
   de Abreu, AL
   Melo, CFCDE
   Faria, NR
   da Cunha, RV
   Giovanetti, M
   Alcantara, LCJ
AF de Jesus, Jaqueline Goes
   Wallau, Gabriel da Luz
   Maia, Maricelia Lima
   Xavier, Joilson
   Oliveira Lima, Maria Aparecida
   Fonseca, Vagner
   de Abreu, Alvaro Salgado
   de Oliveira Tosta, Stephane Fraga
   do Amaral, Helineide Ramos
   Barbosa Lima, Italo Andrade
   Silva, Paloma Viana
   dos Santos, Daiana Carlos
   de Oliveira, Aline Sousa
   de Souza, Siane Campos
   Falcao, Melissa Barreto
   Cerqueira, Erenilde
   Machado, Lais Ceschini
   Sobral, Mariana Carolina
   Teodoro Rezende, Tatiana Maria
   Pereira, Mylena Ribeiro
   Pereira, Felicidade Mota
   Gusmao Maia, Zuinara Pereira
   de Oliveira Franca, Rafael Freitas
   de Abreu, Andre Luiz
   de Albuquerque e Melo, Carlos Frederico Campelo
   Faria, Nuno Rodrigues
   da Cunha, Rivaldo Venancio
   Giovanetti, Marta
   Junior Alcantara, Luiz Carlos
TI Persistence of chikungunya ECSA genotype and local outbreak in an upper
   medium class neighborhood in Northeast Brazil
SO PLOS ONE
LA English
DT Article
ID INDIAN-OCEAN; VIRUS; REEMERGENCE; POPULATION; GENOME; ZIKA
AB The chikungunya East/Central/South/Africa virus lineage (CHIKV-ECSA) was first detected in Brazil in the municipality of Feira de Santana (FS) by mid 2014. Following that, a large number of CHIKV cases have been notified in FS, which is the second-most populous city in Bahia state, northeastern Brazil, and plays an important role on the spread to other Brazilian states due to climate conditions and the abundance of competent vectors. To better understand CHIKV dynamics in Bahia state, we generated 5 complete genome sequences from a local outbreak raised in Serraria Brasil, a neighbourhood in FS, by next-generation sequencing using Illumina approach. Phylogenetic reconstructions revealed that the new FS genomes belongs to the ECSA genotype and falls within a single strongly supported monophyletic clade that includes other older CHIKV sequences from the same location, suggesting the persistence of the virus during distinct epidemic seasons. We also performed minor variants analysis and found a small number of SNPs per sample (b_29L and e_45SR = 16 SNPs, c_29SR = 29 and d_45PL and f_45FL = 21 SNPs). Out of the 93 SNPs found, 71 are synonymous, 21 are non-synonymous and one generated a stop codon. Although those mutations are not related to the increase of virus replication and/or infectivity, some SNPs were found in non-structural proteins which may have an effect on viral evasion from the mammal immunological system. These findings reinforce the needing of further studies on those variants and of continued genomic surveillance strategies to track viral adaptations and to monitor CHIKV epidemics for improved public health control.
C1 [de Jesus, Jaqueline Goes; Barbosa Lima, Italo Andrade; Silva, Paloma Viana; dos Santos, Daiana Carlos; de Oliveira, Aline Sousa; de Souza, Siane Campos] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Wallau, Gabriel da Luz; Machado, Lais Ceschini; Sobral, Mariana Carolina; Teodoro Rezende, Tatiana Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
   [Maia, Maricelia Lima; Oliveira Lima, Maria Aparecida; do Amaral, Helineide Ramos; Cerqueira, Erenilde] Univ Estadual Feira De Santana, Feira De Santana, BA, Brazil.
   [Maia, Maricelia Lima; Falcao, Melissa Barreto] Minist Saude, Secretaria Sande Feira De Santana, Feira De Santana, BA, Brazil.
   [Xavier, Joilson; Fonseca, Vagner; de Abreu, Alvaro Salgado; de Oliveira Tosta, Stephane Fraga; Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Pereira, Mylena Ribeiro; de Oliveira Franca, Rafael Freitas] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Pereira, Felicidade Mota; Gusmao Maia, Zuinara Pereira] Lab Cent Saude Publ Bahia, Salvador, BA, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, Coordenacao Geral Labs Saude Publ, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [de Albuquerque e Melo, Carlos Frederico Campelo] Org Mundial Sande OPAS OMS, Org Pan Amer Saude, Brasilia, DF, Brazil.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Dept Clin Medica, Fac Med, Campo Grande, MS, Brazil.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
RP Giovanetti, M; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.; Giovanetti, M; Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
EM giovanetti.marta@gmail.com; luiz.alcantara@ioc.fiocruz.br
RI ; Wallau, Gabriel/B-5911-2008
OI Fonseca, Vagner/0000-0001-5521-6448; Wallau,
   Gabriel/0000-0002-1419-5713; Andrade Barbosa Lima,
   Italo/0000-0002-7113-7579
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440685/2016-8]; CAPESCAPES [88887.130716/2016-00]; Horizon 2020
   [PRES-005-FEX-17-4-2-33]
FX This research was funded by CNPq grant number (440685/2016-8); CAPES
   grant number (88887.130716/2016-00), and by Horizon 2020
   (PRES-005-FEX-17-4-2-33) to LCJA. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   [Anonymous], 2016, B EP MON CAS DENG FE, V47, P7
   [Anonymous], 2017, B EP MON CAS DENG FE, V48
   [Anonymous], 2019, B EP ARB BAH 2019
   [Anonymous], 2017, IBGE CID FEIR SANT
   Brasil. Ministerio da Saude. OPAS, 2015, OPAS DIV DAD LEV
   Brasil. Ministerio da Saude. Secretaria de Vigilacia em Saude, 2017, SECR VIG SAUD SECR A
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   European Centre for Disease Prevention and Control, 2014, GUID SURV NAT MOSQ E, DOI [10.2900/37227, DOI 10.2900/37227]
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Fonseca V, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007231
   Fros JJ, 2013, J VIROL, V87, P10394, DOI 10.1128/JVI.00884-13
   Fu JYL, 2019, J GEN VIROL, V100, P1541, DOI 10.1099/jgv.0.001338
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Huits R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196630
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lima MM, 2018, ORG YVANNA CARLA SOU, V2
   Morrison CR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0017-2016
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Pathak H, 2019, CLIN MED, V19, P381, DOI 10.7861/clinmed.2019-0035
   Peres RC, 2013, J VECTOR ECOL, V38, P190, DOI 10.1111/j.1948-7134.2013.12027.x
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rodas JD, 2016, AM J TROP MED HYG, V95, P639, DOI 10.4269/ajtmh.16-0091
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Xavier J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217871
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
NR 49
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 8
PY 2020
VL 15
IS 1
AR e0226098
DI 10.1371/journal.pone.0226098
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP5DK
UT WOS:000534337700012
PM 31914137
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yadav, R
   Selvaraj, C
   Aarthy, M
   Kumar, P
   Kumar, A
   Singh, SK
   Giri, R
AF Yadav, Rakhi
   Selvaraj, Chandrabose
   Aarthy, Murali
   Kumar, Prateek
   Kumar, Ankur
   Singh, Sanjeev Kumar
   Giri, Rajanish
TI Investigating into the molecular interactions of flavonoids targeting
   NS2B-NS3 protease from ZIKA virus through in-silico approaches
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE ZIKA virus; NS2B-NS3 protease; flavonoids; MD simulations; non
   structural proteins; flavivirus
ID HEPATITIS-C VIRUS; NS3 PROTEASE; INHIBITS ZIKA; KIX DOMAIN; BINDING;
   RECOGNITION; MECHANISM; PROTEINS; DOCKING; REPLICATION
AB Zika virus (ZIKV), belongs to the flavivirus genus and Flaviviridae family that associated with serious diseased conditions like microcephaly and other neurological disorders (Guillan-Barre syndrome). As there is no vaccine or therapies available against ZIKV to date. Hence, it is an unmet need to find potential drug candidates and target sites against Zika virus infection. NS2B-NS3 protease making an attractive target for therapeutic intervention in ZIKV infections because of its critical role in hydrolysis of a single polyprotein encoded by Zika virus. Recently, there are some experimental evidence about the flavonoids as Zika virus NS2B-NS3 protease inhibitors. However, molecular interaction between protease complex and inhibitors at atomic levels has not been explored. Here, we have taken the experimentally validated thirty-eight flavonoids inhibitors against NS2B-NS3 protease to examine the molecular interaction using molecular docking and molecular dynamics simulations. We found out few flavonoids such as EGCG and its two derivatives, isoquercetin, rutin and sanggenon O showing interaction with catalytic triad (His51, Asp75, and Ser135) of the active site of NS2B-NS3 protease and found to be stable throughout the simulation. Therefore it is evident that interaction with the catalytic triad playing a vital role in the inhibition of the enzyme activity as a result inhibition of the virus propagation. However these compounds can be explored further for understanding the mechanism of action of these compounds targeting NS2B-NS3 protease for inhibition of Zika virus. Investigating into the Molecular Interactions of Flavonoids targeting NS2B-NS3 protease from ZIKA virus through in-silico approaches
   [GRAPHICS]
   ZIKA virus protease (NS2B-NS3pro) is essential for ZIKA virus replication and maturation. Therefore targeting this protein complex with potential inhibitors will block the viral replication. Here we revealed the interaction of the flavonoids, a successful ZIKA NS2B-NS3pro inhibitors through Molecular modeling and Simulation studies.
C1 [Yadav, Rakhi; Selvaraj, Chandrabose; Kumar, Prateek; Kumar, Ankur; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India.
   [Selvaraj, Chandrabose; Aarthy, Murali; Singh, Sanjeev Kumar] Alagappa Univ, Comp Aided Drug Design & Mol Modeling Lab, Dept Bioinformat, Karaikkudi, Tamil Nadu, India.
RP Giri, R (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India.
EM rajanishgiri@iitmandi.ac.in
RI Selvaraj, Chandrabose/F-4168-2012; Singh, Kumar/AAP-1954-2020; Giri,
   Rajanish/Q-6530-2018
OI Selvaraj, Chandrabose/0000-0002-8115-0486; Singh,
   Kumar/0000-0003-4153-6437; Giri, Rajanish/0000-0002-2046-836X; Kumar,
   Prateek/0000-0001-7392-5045
FU DBT grant, India [BT/11/IYBA/2018/06]
FX This work was partially supported by the DBT grant, India
   (BT/11/IYBA/2018/06) to RG.
CR Aarthy M, 2018, GENE, V658, P159, DOI 10.1016/j.gene.2018.03.026
   Aguilera-Pesantes D, 2017, BIOCHEM BIOPH RES CO, V492, P659, DOI 10.1016/j.bbrc.2017.02.035
   Bachmetov L, 2012, J VIRAL HEPATITIS, V19, pE81, DOI 10.1111/j.1365-2893.2011.01507.x
   Ekins Sean, 2002, J Mol Graph Model, V20, P305, DOI 10.1016/S1093-3263(01)00127-9
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Frimayanti N, 2011, INT J MOL SCI, V12, P1089, DOI 10.3390/ijms12021089
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garg N, 2019, PROG MOL BIOL TRANSL, V166, P371, DOI 10.1016/bs.pmbts.2019.05.006
   Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110
   Gupta S, 2017, INT J BIOL MACROMOL, V98, P357, DOI 10.1016/j.ijbiomac.2017.01.098
   HUNKAPILLER MW, 1976, BIOCHEMISTRY-US, V15, P5581, DOI 10.1021/bi00670a024
   Ioakimidis L, 2008, QSAR COMB SCI, V27, P445, DOI 10.1002/qsar.200730051
   Joshi P, 2015, ADV EXP MED BIOL, V870, P383, DOI 10.1007/978-3-319-20164-1_13
   Katzenmeier G., 2004, Dengue Bulletin, V28, P58
   Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019
   Kim YJ, 2010, ANTIVIR RES, V88, P227, DOI 10.1016/j.antiviral.2010.08.016
   Klinski E., 2013, J NANOMEDICINE BIOTH, V3, P2
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kumar D, 2020, INT J BIOL MACROMOL, V144, P892, DOI 10.1016/j.ijbiomac.2019.09.166
   Kumar D, 2019, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1689851
   Kumar D, 2017, CANCER INFORM, V16, DOI 10.1177/1176935117699408
   Kumar P, 2019, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1696231
   Kumar P, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030128
   Lambert JD, 2006, DRUG METAB DISPOS, V34, P2111, DOI 10.1124/dmd.106.011460
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lo K., 2007, J GEN VIROL, V88, P2223, DOI [10.1099/vir.0.82735-0, DOI 10.1099/VIR.0.82735-0]
   Lohr K, 2007, J GEN VIROL, V88, P2223, DOI 10.1099/vir.0.82735-0
   Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215
   Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Mulakala C, 2013, J MOL GRAPH MODEL, V46, P41, DOI 10.1016/j.jmgm.2013.09.005
   Nutho B, 2019, PHYS CHEM CHEM PHYS, V21, P14945, DOI 10.1039/c9cp02377a
   Perez-Perez MJ, 2019, EXPERT OPIN DRUG DIS, V14, P855, DOI 10.1080/17460441.2019.1629413
   Raza Saad, 2019, IEEE/ACM Trans Comput Biol Bioinform, DOI 10.1109/TCBB.2019.2911081
   Rimmert B, 2014, J BIOMOL STRUCT DYN, V32, P950, DOI 10.1080/07391102.2013.800001
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Samanta PN, 2017, J MOL GRAPH MODEL, V75, P294, DOI 10.1016/j.jmgm.2017.06.011
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Seniya C, 2013, BIOINFORMATION, V9, P54, DOI 10.6026/97320630009054
   Senthilvel P, 2013, BIOINFORMATION, V9, P889, DOI 10.6026/97320630009889
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Singh A, 2018, RSC ADV, V8, P27293, DOI 10.1039/c8ra04760j
   Singh A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23969-0
   Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994
   Toto A, 2014, PROTEIN SCI, V23, P962, DOI 10.1002/pro.2480
   Uversky VN, 2012, EXPERT OPIN DRUG DIS, V7, P475, DOI 10.1517/17460441.2012.686489
   Zhang C, 2016, ONCOTARGET, V7, P83755, DOI 10.18632/oncotarget.13194
   Zhou H, 2006, PROTEINS, V65, P692, DOI 10.1002/prot.21129
NR 58
TC 3
Z9 3
U1 2
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2019.1709546
EA JAN 2020
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KB5DP
UT WOS:000506516200001
PM 31920173
DA 2020-07-08
ER

PT J
AU Zimmerman, MG
   Wrammert, J
   Suthar, MS
AF Zimmerman, Matthew G.
   Wrammert, Jens
   Suthar, Mehul S.
TI Cross-Reactive Antibodies during Zika Virus Infection: Protection,
   Pathogenesis, and Placental Seeding
SO CELL HOST & MICROBE
LA English
DT Review
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; DISEASE SEVERITY; MOUSE;
   REPLICATION; RECEPTORS; PATHOLOGY; RESPONSES; JANUARY; INFANTS
AB Humoral immunity is in essential component of the protective immune response to flavivirus infection. Typically, primary infection generates a robust neutralizing antibody response that mediates viral control and protection. It is becoming increasingly apparent that secondary infection with a closely related flavivirus strain can result in immunological cross-reactivity; however, the consequences to infection outcome remain controversial. Since its introduction to Brazil in 2015, Zika virus (ZIKV) has caused an epidemic of fetal congenital malformations within the Americas. Because ZIKV is a mosquito-borne flavivirus with a high degree of sequence and structural homology to Dengue virus (DENV), the role of immunological cross-reactivity in ZIKV and DENV infections has become a great concern. In this review, we highlight contemporary findings that implicate a role for flavivirus antibodies in mediating protection, contributing to pathogenesis, and seeding the human placenta.
C1 [Zimmerman, Matthew G.; Wrammert, Jens; Suthar, Mehul S.] Emory Univ, Dept Pediat, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA.
   [Zimmerman, Matthew G.; Wrammert, Jens; Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
RP Suthar, MS (corresponding author), Emory Univ, Dept Pediat, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA.; Suthar, MS (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM msuthar@emory.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19AI083019,
   U01AI131566, 2U19AI057266, 5U19AI057266-13]; National Institutes of
   Health's Office of the Director, Office of Research Infrastructure
   Programs [P51OD011132]; Children's Healthcare of Atlanta; Emory Vaccine
   Center; Georgia Research Alliance
FX This research is funded in part by National Institutes of Health grants
   U19AI083019 (M.S.S), U01AI131566 (M.S.S.), 2U19AI057266 (M.S.S.), and
   5U19AI057266-13REVIS Supplement (M.S.S and J.W); the National Institutes
   of Health's Office of the Director, Office of Research Infrastructure
   Programs, P51OD011132; Children's Healthcare of Atlanta (M.S.S.); Emory
   Vaccine Center (M.S.S. and J.W.); and the Georgia Research Alliance
   (M.S.S). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Ander SE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat6114
   Andrade P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08845-3
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Cardoso TF, 2019, ARCH DIS CHILD, V104, P199, DOI 10.1136/archdischild-2018-314782
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005926
   Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006
   Collins MH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124588
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Figueiredo CP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11866-7
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gossner CM, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.24.1800268
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P804, DOI 10.1093/aje/152.9.804
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Heald-Sargent T, 2017, PEDIATR ANN, V46, pE428, DOI 10.3928/19382359-20171025-01
   Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Larocca RA, 2019, CELL HOST MICROBE, V26, P591, DOI 10.1016/j.chom.2019.10.001
   Latvala S, 2017, J HISTOCHEM CYTOCHEM, V65, P321, DOI 10.1369/0022155417705095
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   MARCHETTE NJ, 1979, INFECT IMMUN, V24, P47, DOI 10.1128/IAI.24.1.47-50.1979
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Robbiani DF, 2019, J EXP MED, V216, P2302, DOI 10.1084/jem.20191061
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   Rodenhuis-Zybert IA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003564
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 99
TC 0
Z9 0
U1 8
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JAN 8
PY 2020
VL 27
IS 1
BP 14
EP 24
DI 10.1016/j.chom.2019.12.003
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA KB0TM
UT WOS:000506213900006
PM 31917957
DA 2020-07-08
ER

PT J
AU Lin, SC
   Carey, BD
   Callahan, V
   Lee, JH
   Bracci, N
   Patnaik, A
   Smith, AK
   Narayanan, A
   Lepene, B
   Kehn-Hall, K
AF Lin, Shih-Chao
   Carey, Brian D.
   Callahan, Victoria
   Lee, Ji-Hyun
   Bracci, Nicole
   Patnaik, Anurag
   Smith, Amy K.
   Narayanan, Aarthi
   Lepene, Benjamin
   Kehn-Hall, Kylene
TI Use of Nanotrap particles for the capture and enrichment of Zika,
   chikungunya and dengue viruses in urine
SO PLOS ONE
LA English
DT Article
ID HYDROGEL PARTICLES; PCR
AB Nanotrap (R) (NT) particles are hydrogel microspheres developed for target analyte separation and discovery applications. NT particles consist of cross-linked N-isopropylacrylamide (NIPAm) copolymers that are functionalized with a variety of chemical affinity baits to enable broad-spectrum collection and retention of target proteins, nucleic acids, and pathogens. NT particles have been previously shown to capture and enrich arboviruses including Rift Valley fever and Venezuelan equine encephalitis viruses. Yet, there is still a need to enhance the detection ability for other re-emerging viruses such as Zika (ZIKV), chikungunya (CHIKV), and dengue (DENV) viruses. In this study, we exploited NT particles with different affinity baits, including cibacron blue, acrylic acid, and reactive red 120, to evaluate their capturing and enrichment capability for ZIKV, DENV and CHIKV in human fluids. Our results demonstrate that CN1030, a NT particle conjugated with reactive red 120, can recover between 8-16-fold greater genomic copies of ZIKV, CHIKV and DENV in virus spiked urine samples via RT-qPCR, superior to the other chemical baits. Also, we observed that CN1030 simultaneously enriched ZIKV, CHIKV and DENV in co-infection-based settings and could stabilize ZIKV, but not CHIKV infectivity in saliva spiked samples. CN1030 enriched viral detection at various viral concentrations, with significant enhancement observed at viral titers as low as 100 PFU/mL for ZIKV and 10 PFU/mL for CHIKV. The detection of ZIKV was further enhanced with NT particles by processing of larger volume urine samples. Furthermore, we developed a magnetic NT particle, CN3080, based on the same backbone of CN1030, and demonstrated that CN3080 could also capture and enrich ZIKV and CHIKV in a dose-dependent manner. Finally, in silico docking predictions support that the affinity between reactive red 120 and ZIKV or CHIKV envelope proteins appeared to be greater than acrylic acid. Overall, our data show that NT particles along with reactive red 120 can be utilized as a pre-processing technology for enhancement of detecting febrile-illness causing viruses.
C1 [Lin, Shih-Chao; Carey, Brian D.; Callahan, Victoria; Lee, Ji-Hyun; Bracci, Nicole; Narayanan, Aarthi; Kehn-Hall, Kylene] George Mason Univ, Sch Syst Biol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.
   [Patnaik, Anurag; Lepene, Benjamin] Ceres Nanosci Inc, Manassas, VA USA.
   [Smith, Amy K.] George Mason Univ, Sch Syst Biol, Manassas, VA USA.
   [Smith, Amy K.] George Mason Univ, Computat Mat Sci Ctr, Manassas, VA USA.
RP Kehn-Hall, K (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.
EM kkehnhal@gmu.edu
OI Bracci, Nicole/0000-0002-7298-4796; Kehn-Hall,
   Kylene/0000-0001-8036-7213
FU Defense Advanced Research Projects AgencyUnited States Department of
   DefenseDefense Advanced Research Projects Agency (DARPA)
   [W911NF-16-C-0060]
FX Support for this work was provided by the Defense Advanced Research
   Projects Agency: Contract No. W911NF-16-C-0060. DARPA does not have any
   role in the design of the study and collection, analysis, and
   interpretation of data and nor in writing the manuscript. Authors AP and
   BL are employed by the company Ceres Nanosciences, Inc. Ceres
   Nanosciences provided support in the form of salaries for authors AP and
   BL, but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   `author contributions' section.
CR Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778
   Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2
   Kanbara A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-39
   Khurshid Z, 2019, J INFECT PUBLIC HEAL, V12, P601, DOI 10.1016/j.jiph.2019.05.004
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lin SC, 2019, INT J ANTIMICROB AG, V54, P80, DOI 10.1016/j.ijantimicag.2019.03.017
   Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Musso D, 2016, VIROL J, V13
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   PAIXAO ES, 2018, BMJ GLOB HEALTH, V3, DOI DOI 10.1136/BMJGH-2017-000530.
   Patanarut A, 2010, COLLOID SURFACE A, V362, P8, DOI 10.1016/j.colsurfa.2010.03.023
   Paul J, 2013, CHEMOSPHERE, V90, P1348, DOI 10.1016/j.chemosphere.2012.07.049
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Prevention CfDCa, 2018, ZIK VIR TEST GUID SY
   Prevention CfDCa, 2017, EST POT RANG AED AEG
   Rahman N, 2018, ENVIRON SCI POLLUT R, V25, P26114, DOI 10.1007/s11356-018-2566-1
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Salam N, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5626-z
   Shafagati N, 2016, VIRULENCE, V7, P756, DOI 10.1080/21505594.2016.1185585
   Shafagati N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128215
   Shafagati N, 2014, PATHOG DIS, V71, P162, DOI 10.1111/2049-632X.12136
   Shafagati N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002296
   SMITH TJ, 1970, J VIROL, V5, P524, DOI 10.1128/JVI.5.4.524-532.1970
   Suwanmanee S, 2018, ACTA TROP, V188, P244, DOI 10.1016/j.actatropica.2018.09.012
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
NR 38
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 7
PY 2020
VL 15
IS 1
AR e0227058
DI 10.1371/journal.pone.0227058
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP5BZ
UT WOS:000534333800025
PM 31910225
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Grifoni, A
   Tian, Y
   Sette, A
   Weiskopf, D
AF Grifoni, Alba
   Tian, Yuan
   Sette, Alessandro
   Weiskopf, Daniela
TI Transcriptomic immune profiles of human flavivirus-specific T-cell
   responses
SO IMMUNOLOGY
LA English
DT Review
DE Dengue virus; T cells; transcriptomic; yellow fever virus; Zika virus
ID JAPANESE ENCEPHALITIS-VIRUS; ORIGINAL ANTIGENIC SIN; DENGUE VIRUS;
   PROTECTIVE ROLE; ZIKA VIRUS; CD4(+); INFECTION; CD8; DETERMINANTS; BLOOD
AB The Flavivirus genus of viruses includes dengue (DENV), Zika (ZIKV), yellow fever (YFV), Japanese encephalitis (JEV), and West Nile (WNV) viruses. Infections with these species combined are prevalent in tropical and sub-tropical areas, affecting millions of people and ranging from asymptomatic to severe forms of the disease. They therefore pose a serious threat to global public health. Several studies imply a role for T cells in the protection but also pathogenesis against the different flavivirus species. Identifying flavivirus-specific T-cell immune profiles and determining how pre-exposure of one species might affect the immune response against subsequent infections from other species is important to further define the role of T cells in the immune response against infection. Understanding the immune profiles of the flavivirus-specific T-cell response in natural infection is important to understand the T-cell response in the context of vaccination. In this review, we summarize the current knowledge on human immune profiles of flavivirus-specific T-cell reactivity, comparing natural infection with the acute form of the disease and vaccination in different flavivirus infections.
C1 [Grifoni, Alba; Tian, Yuan; Sette, Alessandro; Weiskopf, Daniela] La Jolla Inst Immunol, Div Vaccine Discovery, 9420 Athena Cir, La Jolla, CA 92037 USA.
   [Sette, Alessandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Grifoni, A; Weiskopf, D (corresponding author), La Jolla Inst Immunol, Div Vaccine Discovery, 9420 Athena Cir, La Jolla, CA 92037 USA.
EM agrifoni@lji.org; dweiskopf@lji.org
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19 AI118626]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [HHSN272200900042C, HHSN27220140045C]; American Association of
   Immunologists Intersect Fellowship Program for Computational Scientists
   and Immunologists
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases grants U19 AI118626 as well as National Institutes
   of Health contracts HHSN272200900042C and HHSN27220140045C. YT was
   supported through The American Association of Immunologists Intersect
   Fellowship Program for Computational Scientists and Immunologists.
CR Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BURKE DS, 2001, FIELDS VIROLOGY, P1043
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Chandele A, 2016, J VIROL, V90, P11259, DOI 10.1128/JVI.01424-16
   Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Collins ND, 2018, MBIO, V9, DOI 10.1128/mBio.01871-18
   Cong Y, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004709
   Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Graham JB, 2019, J INFECT DIS, V219, P1162, DOI 10.1093/infdis/jiy623
   GRIFONI A, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01469-17
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309
   Guarner J, 2019, SEMIN DIAGN PATHOL, V36, P170, DOI 10.1053/j.semdp.2019.04.009
   Guy B, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029462
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Hassert M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01045
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003673
   Khetarpal N, 2016, J IMMUNOL RES, DOI 10.1155/2016/6803098
   Kumar P, 2004, J GEN VIROL, V85, P1131, DOI 10.1099/vir.0.19698-0
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   Loke P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000710
   Long HT, 2009, J INFECT DIS, V199, P537, DOI 10.1086/596507
   Long TH, 2010, J VIROL, V84, P12982, DOI 10.1128/JVI.01224-10
   Malavige GN, 2012, CLIN EXP IMMUNOL, V168, P215, DOI 10.1111/j.1365-2249.2012.04566.x
   Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023
   Malavige GN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002409
   Mladinich KM, 2012, IMMUNOGENETICS, V64, P111, DOI 10.1007/s00251-011-0566-0
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardy RD, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080820
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Patil VS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8664
   Popper SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001966
   Rivino L, 2018, ADV EXP MED BIOL, V1062, P241, DOI 10.1007/978-981-10-8727-1_17
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Rivino L, 2013, J IMMUNOL, V191, P4010, DOI 10.4049/jimmunol.1301507
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Robinson M, 2019, CELL REP, V26, P1104, DOI 10.1016/j.celrep.2019.01.033
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Saron WAA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4297
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sharma M, 2020, J INFECT DIS, V221, P867, DOI 10.1093/infdis/jiz081
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Tian Y, 2019, CELL REP, V29, P4482, DOI 10.1016/j.celrep.2019.11.098
   Tian Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02125
   Tian Y, 2019, J CLIN INVEST, V129, P1727, DOI 10.1172/JCI123726
   Tian Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01728-5
   Tian Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00531
   Tsang TK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09193-y
   Turtle L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005263
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   van de Weg CAMV, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003522
   Waickman AT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11634-7
   Watson AM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040077
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, J INTERF CYTOK RES, V37, P475, DOI 10.1089/jir.2017.0106
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wertheimer AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015514
   Wijeratne DT, 2019, IMMUN INFLAMM DIS, V7, P276, DOI 10.1002/iid3.271
   Wijeratne DT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006540
NR 78
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD MAY
PY 2020
VL 160
IS 1
BP 3
EP 9
DI 10.1111/imm.13161
EA JAN 2020
PG 7
WC Immunology
SC Immunology
GA LD2ML
UT WOS:000505924600001
PM 31778581
OA Bronze
DA 2020-07-08
ER

PT J
AU Spizzichino, S
   Mattedi, G
   Lauder, K
   Valle, C
   Aouadi, W
   Canard, B
   Decroly, E
   Kaptein, SJF
   Neyts, J
   Graham, C
   Sule, Z
   Barlow, DJ
   Silvestri, R
   Castagnolo, D
AF Spizzichino, Sharon
   Mattedi, Giulio
   Lauder, Kate
   Valle, Coralie
   Aouadi, Wahiba
   Canard, Bruno
   Decroly, Etienne
   Kaptein, Suzanne J. F.
   Neyts, Johan
   Graham, Carl
   Sule, Zakary
   Barlow, David J.
   Silvestri, Romano
   Castagnolo, Daniele
TI Design, Synthesis and Discovery of N,N'-Carbazoyl-aryl-urea Inhibitors
   of Zika NS5 Methyltransferase and Virus Replication
SO CHEMMEDCHEM
LA English
DT Article
DE Zika; flavivirus; methyltransferase; antiviral agents; urea
ID SMALL-MOLECULE INHIBITORS; DENGUE VIRUS; IDENTIFICATION; PROTEASE;
   INFECTION
AB The recent outbreaks of Zika virus (ZIKV) infection worldwide make the discovery of novel antivirals against flaviviruses a research priority. This work describes the identification of novel inhibitors of ZIKV through a structure-based virtual screening approach using the ZIKV NS5-MTase. A novel series of molecules with a carbazoyl-aryl-urea structure has been discovered and a library of analogues has been synthesized. The new compounds inhibit ZIKV MTase with IC50 between 23-48 mu M. In addition, carbazoyl-aryl-ureas also proved to inhibit ZIKV replication activity at micromolar concentration.
C1 [Spizzichino, Sharon; Mattedi, Giulio; Lauder, Kate; Graham, Carl; Sule, Zakary; Barlow, David J.; Castagnolo, Daniele] Kings Coll London, Sch Canc & Pharmaceut Sci, London SE1 9NH, England.
   [Spizzichino, Sharon; Silvestri, Romano] Sapienza Univ Rome, Dept Drug Chem & Technol, Inst Pasteur Italia, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Valle, Coralie; Aouadi, Wahiba; Canard, Bruno; Decroly, Etienne] Aix Marseille Univ, AFMB, CNRS, UMR 7257, Case 925,163 Ave Luminy, F-13288 Marseille 09, France.
   [Kaptein, Suzanne J. F.; Neyts, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol Immunol & Transplantat, Lab Virol & Chemotherapy, Minderbroedersstr 10, B-3000 Leuven, Belgium.
RP Castagnolo, D (corresponding author), Kings Coll London, Sch Canc & Pharmaceut Sci, London SE1 9NH, England.
EM daniele.castagnolo@kcl.ac.uk
RI ; Castagnolo, Daniele/C-2796-2014; NEYTS, Johan/U-8267-2017
OI DECROLY, Etienne/0000-0002-6046-024X; Castagnolo,
   Daniele/0000-0002-7517-5732; NEYTS, Johan/0000-0002-0033-7514
FU European program H2020 under the ZIKAlliance project [734548]; EVAg
   Research Infrastructure [653316]; French research agency ANR
   (VMTaseIn)French National Research Agency (ANR) [ANR-ST14-ASTR-0026];
   EPSRC (Global Challenges Competition King's College London)Engineering &
   Physical Sciences Research Council (EPSRC); Royal SocietyRoyal Society
   of London [RG160870]; National Research Agency ANR under the program
   RAB-CapFrench National Research Agency (ANR); infectiopole Sud
FX This work was supported by the European program H2020 under the
   ZIKAlliance project (grant agreement 734548), the EVAg Research
   Infrastructure (grant agreement 653316) and by the French research
   agency ANR (VMTaseIn, grant ANR-ST14-ASTR-0026). DC gratefully
   acknowledges EPSRC (Global Challenges Competition King's College London)
   and Royal Society (RG160870) for research funding and financial support.
   We thank Caroline Collard, Charlotte Vanderheydt and Elke Maas for their
   assistance in the acquisition of the antiviral data. C.V. get a
   fellowship from the National Research Agency ANR under the program
   RAB-Cap and W.A. from the infectiopole Sud.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Botta L, 2018, FRONT BIOSCI-LANDMRK, V23, P997, DOI 10.2741/4630
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Decroly E, 2017, CURR OPIN VIROL, V24, P87, DOI 10.1016/j.coviro.2017.04.003
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   European Centre for Disease Prevention and Control, ZIK VIR DIS
   European Medicines Agency, DENGV
   Hajra A, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12607
   Hernandez J, 2019, EUR J MED CHEM, V161, P323, DOI 10.1016/j.ejmech.2018.09.056
   Kaptein SJF, 2018, CHEMMEDCHEM, V13, P1371, DOI 10.1002/cmdc.201800178
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Micewicz ED, 2018, BIOORG MED CHEM LETT, V28, P452, DOI 10.1016/j.bmcl.2017.12.019
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Tian YS, 2018, CHEM PHARM BULL, V66, P191, DOI 10.1248/cpb.c17-00794
   Varshney D, 2016, NUCLEIC ACIDS RES, V44, P10423, DOI 10.1093/nar/gkw637
   Vincetti P, 2019, ACS MED CHEM LETT, V10, P558, DOI 10.1021/acsmedchemlett.8b00583
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 29
TC 0
Z9 0
U1 5
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1860-7179
EI 1860-7187
J9 CHEMMEDCHEM
JI ChemMedChem
PD FEB 17
PY 2020
VL 15
IS 4
BP 385
EP 390
DI 10.1002/cmdc.201900533
EA JAN 2020
PG 6
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KM9OH
UT WOS:000505817500001
PM 31805205
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Melo, N
   Wolff, GH
   Costa-da-Silva, AL
   Arribas, R
   Triana, MF
   Gugger, M
   Riffell, JA
   DeGennaro, M
   Stensmyr, MC
AF Melo, Nadia
   Wolff, Gabriella H.
   Costa-da-Silva, Andre Luis
   Arribas, Robert
   Triana, Merybeth Fernandez
   Gugger, Muriel
   Riffell, Jeffrey A.
   DeGennaro, Matthew
   Stensmyr, Marcus C.
TI Geosmin Attracts Aedes aegypti Mosquitoes to Oviposition Sites
SO CURRENT BIOLOGY
LA English
DT Article
ID ZIKA VIRUS; DROSOPHILA; IDENTIFICATION; BIOSYNTHESIS; RECEPTORS; DIPTERA
AB Geosmin is one of the most recognizable and common microbial smells on the planet. Some insects, like mosquitoes, require microbial-rich environments for their progeny, whereas for other insects such microbes may prove dangerous. In the vinegar fly Drosophila melanogaster, geosmin is decoded in a remarkably precise fashion and induces aversion, presumably signaling the presence of harmful microbes [1]. We have here investigated the effect of geosmin on the behavior of the yellow fever mosquito Aedes aegypti. In contrast to flies, geosmin is not aversive but mediates egg-laying site selection. Female mosquitoes likely associate geosmin with microbes, including cyanobacteria consumed by larvae [2], who also find geosmin-as well as geosmin-producing cyanobacteria-attractive. Using in vivo multiphoton calcium imaging from transgenic PUb-GCaMP6s mosquitoes, we show that Ae. aegypti code geosmin in a qualitatively similar fashion to flies, i.e., through a single olfactory channel with a high degree of sensitivity for this volatile. We further demonstrate that geosmin can be used as bait under field conditions, and finally, we show that geosmin, which is both expensive and difficult to obtain, can be substituted by beetroot peel extract, providing a cheap and viable potential mean for mosquito control and surveillance in developing countries.
C1 [Melo, Nadia; Triana, Merybeth Fernandez; Stensmyr, Marcus C.] Lund Univ, Dept Biol, S-22362 Lund, Sweden.
   [Wolff, Gabriella H.; Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA.
   [Costa-da-Silva, Andre Luis; Arribas, Robert; DeGennaro, Matthew] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.
   [Costa-da-Silva, Andre Luis; Arribas, Robert; DeGennaro, Matthew] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.
   [Triana, Merybeth Fernandez] Univ Fed Alagoas, Inst Quim & Biotecnol, BR-5702970 Maceio, Alagoas, Brazil.
   [Gugger, Muriel] Inst Pasteur, Collect Cyanobacteria, F-75015 Paris, France.
RP Stensmyr, MC (corresponding author), Lund Univ, Dept Biol, S-22362 Lund, Sweden.
EM marcus.stensmyr@biol.lu.se
RI Triana, Merybeth Fernandez/AAJ-6879-2020; DeGennaro, Matthew/H-4975-2015
OI Triana, Merybeth Fernandez/0000-0001-6132-0436; DeGennaro,
   Matthew/0000-0003-3837-4430; Gugger, Muriel/0000-0001-6728-1976
FU Crafoord Foundation; Carl Tryggers Foundation; Swedish Research
   CouncilSwedish Research Council; Florida Department of Agriculture and
   Consumer Services ("Highly attractive biological insecticide trap
   (HABIT) to reduce mosquito populations''); Centers for Disease Control
   and Prevention (CDC), Southeastern Center of Excellence in Vector-borne
   DiseaseUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA; National Science FoundationNational
   Science Foundation (NSF) [IOS-1354159]; Air Force Office of Scientific
   ResearchUnited States Department of DefenseAir Force Office of
   Scientific Research (AFOSR) [FA9550-16-1-0167]; University of Washington
   Innovation Award; Pasteur Institute
FX We thank Christopher Potter for valuable comments on the manuscript and
   members of our respective labs for critical feedback during the project.
   We thank Elisabeth Barane for expert assistance with growing
   cyanobacteria and Prof. Antonio Euzebio Goulart Sant'ana for support
   with the Brazilian fieldwork. N.M. and M.C.S. were supported by the
   Crafoord Foundation, Carl Tryggers Foundation, and the Swedish Research
   Council. A.L.C., R.A., and M.D. were supported by The Florida Department
   of Agriculture and Consumer Services ("Highly attractive biological
   insecticide trap (HABIT) to reduce mosquito populations'') and The
   Centers for Disease Control and Prevention (CDC), Southeastern Center of
   Excellence in Vector-borne Disease. We would like to thank the entire
   DeGennaro laboratory for their help in obtaining the field collections
   of mosquito eggs. G.H.W. and J.A.R. were supported by awards from the
   National Science Foundation (IOS-1354159), Air Force Office of
   Scientific Research (FA9550-16-1-0167), and University of Washington
   Innovation Award. M.G. and the Pasteur Collection of Cyanobacteria is
   funded by the Pasteur Institute. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of respective employers or the CDC.
CR Afify A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103765
   Afify A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-315
   Baak-Baak CM, 2013, J VECTOR ECOL, V38, P175, DOI 10.1111/j.1948-7134.2013.12024.x
   BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153
   Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001
   Beyenbach KW, 2002, J INSECT PHYSIOL, V48, P375, DOI 10.1016/S0022-1910(02)00057-4
   Blanksteen J., 1974, NOTHING BEETS BORSCH
   Bui M, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0511-y
   Calteau A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-977
   CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x
   Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Huang J, 2006, J MED ENTOMOL, V43, P498, DOI 10.1603/0022-2585(2006)43[498:AGDCOI]2.0.CO;2
   Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800
   Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104
   KIVIRANTA J, 1994, WORLD J MICROB BIOT, V10, P517, DOI 10.1007/BF00367656
   KNIGHT JC, 1991, J AM MOSQUITO CONTR, V7, P37
   Krivosheina M, 2008, PALEONTOL J+, V42, P596, DOI 10.1134/S003103010806004X
   Lahondere C, 2019, OLFACTORY BASIS ORCH, DOI [10.1101/643510, DOI 10.1101/643510]
   Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019
   Lu GP, 2003, J AGR FOOD CHEM, V51, P1026, DOI 10.1021/jf020905r
   Lu GP, 2003, J AGR FOOD CHEM, V51, P1021, DOI 10.1021/jf020806d
   Lutz E.K., 2019, BIORXIV, DOI [10.1101/585075, DOI 10.1101/585075]
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   Mazmouz R, 2010, APPL ENVIRON MICROB, V76, P4943, DOI 10.1128/AEM.00717-10
   Mejean A, 2009, J AM CHEM SOC, V131, P7512, DOI 10.1021/ja9024353
   POLAK EH, 1992, CHEM SENSES, V17, P23, DOI 10.1093/chemse/17.1.23
   Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105
   Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409
   Prieto-Godino LL, 2017, NEURON, V93, P661, DOI 10.1016/j.neuron.2016.12.024
   Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046
   THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991
   Vazquez-Martinez MG, 2002, J MED ENTOMOL, V39, P825, DOI 10.1603/0022-2585-39.6.825
   Vinauger C, 2018, CURR BIOL, V28, P333, DOI 10.1016/j.cub.2017.12.015
   Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6
   Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495
NR 40
TC 2
Z9 2
U1 3
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD JAN 6
PY 2020
VL 30
IS 1
BP 127
EP +
DI 10.1016/j.cub.2019.11.002
PG 13
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA KA3IK
UT WOS:000505692200028
PM 31839454
OA Green Accepted, Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ticconi, C
   Rezza, G
AF Ticconi, Carlo
   Rezza, Giovanni
TI Defining Zika virus infection in pregnant women
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Editorial Material
C1 [Ticconi, Carlo] Univ Tor Vergata, Dept Surg Sci, Rome, Italy.
   [Rezza, Giovanni] Ist Super Sanita, Dept Infect Dis, Rome, Italy.
RP Ticconi, C (corresponding author), Univ Tor Vergata, Dept Surg Sci, Rome, Italy.
EM ticconi@med.uniroma2.it
OI Ticconi, Carlo/0000-0003-1923-2744
CR Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Ximenes RAD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007763
NR 3
TC 0
Z9 0
U1 3
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PD OCT 3
PY 2019
VL 113
IS 7
BP 290
EP 290
DI 10.1080/20477724.2019.1706712
EA JAN 2020
PG 1
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA KC5UW
UT WOS:000505849100001
PM 31905106
DA 2020-07-08
ER

PT J
AU Pierson, J
   Yeruva, RR
   El-Mallakh, RS
AF Pierson, Johnathan
   Yeruva, Rajashekar Reddy
   El-Mallakh, Rif S.
TI Can in utero Zika virus exposure be a risk factor for schizophrenia in
   the offspring?
SO WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
LA English
DT Review
DE Schizophrenia; Zika; congenital infection; neurotropic; pathogenesis
ID ALBOPICTUS DIPTERA-CULICIDAE; AEDES STEGOMYIA AEGYPTI;
   TOXOPLASMA-GONDII; IMMUNE ACTIVATION; BRAIN-DEVELOPMENT; PRENATAL
   INFECTION; BORNE TRANSMISSION; BIRTH-DEFECTS; INFLUENZA; PSYCHOSIS
AB Objectives: Schizophrenia is a severe psychiatric illness that has been purported to be causally related to in utero infection of neurotropic organisms. For obvious ethical reasons, this hypothesis has never been tested prospectively in humans. However, with the recent introduction of Zika virus into the New World offers the opportunity to test the hypothesis of infection in schizophrenia. Methods: This is a directed review examining the hypothesis. The literature relevant to Zika virus transmission in the New World, its biology and neurotropy is reviewed. Results: Zika virus has been associated with a wide variety of neural tube and neuroanatomical abnormalities. In its original range, Zika is only infrequently associated with congenital anomalies, but in the New World, where the majority of the population has not developed immunity, infections are associated with a wide range of neurologic abnormalities. Conclusions: The current outbreak of Zika virus in the Western Hemisphere, offers the opportunity to prospectively examine the congenital infection hypothesis of the pathogenesis of schizophrenia.
C1 [Pierson, Johnathan; Yeruva, Rajashekar Reddy; El-Mallakh, Rif S.] Univ Louisville, Dept Psychiat & Behav Sci, Sch Med, 401 East Chestnut St,Suite 610, Louisville, KY 40202 USA.
RP El-Mallakh, RS (corresponding author), Univ Louisville, Dept Psychiat & Behav Sci, Sch Med, 401 East Chestnut St,Suite 610, Louisville, KY 40202 USA.
EM rselma01@louisville.edu
CR Addington J, 2012, ANNU REV CLIN PSYCHO, V8, P269, DOI 10.1146/annurev-clinpsy-032511-143146
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Anacker C, 2013, NEUROPSYCHOPHARMACOL, V38, P872, DOI 10.1038/npp.2012.253
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P1304
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Ayhan Y, 2016, PROG NEUROBIOL, V136, P1, DOI 10.1016/j.pneurobio.2015.10.002
   Bagalkote H, 2000, INT J MENT HEALTH, V29, P3, DOI 10.1080/00207411.2000.11449500
   Bakhshi K, 2015, NEUROSCIENCE, V303, P82, DOI 10.1016/j.neuroscience.2015.06.028
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2016, EUROSURVEILLANCE, V21, P4
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767
   Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774
   Brown AS, 2001, BIOL PSYCHIAT, V49, P473, DOI 10.1016/S0006-3223(01)01068-X
   Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers of Disease Control, 2017, OUTC COMPL PREGN US
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   CHESS S, 1971, PSYCHIAT DISORDERS C
   Cohen J, 2017, SCIENCE, DOI [10.1126/science.aao6984, DOI 10.1126/SCIENCE.AAO6984]
   Corey L, 1989, LANCET, V331, P1
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davis J, 2016, NEUROSCI BIOBEHAV R, V65, P185, DOI 10.1016/j.neubiorev.2016.03.017
   Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Evans AK, 2014, BRAIN BEHAV IMMUN, V37, P122, DOI 10.1016/j.bbi.2013.11.012
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fuller R, 2002, AM J PSYCHIAT, V159, P1183, DOI 10.1176/appi.ajp.159.7.1183
   Gage SH, 2015, LANCET PSYCHIAT, V2, P778, DOI 10.1016/S2215-0366(15)00333-8
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Giovanoli S, 2014, BRAIN BEHAV IMMUN, V40, P48, DOI 10.1016/j.bbi.2014.04.005
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Green MJ, 2014, J PSYCHIATR RES, V49, P43, DOI 10.1016/j.jpsychires.2013.10.018
   Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Haroon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035516
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Holub D, 2013, ACTA PSYCHIAT SCAND, V127, P227, DOI 10.1111/acps.12031
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Joyce EM, 2007, CURR OPIN PSYCHIATR, V20, P268
   Keshavan MS, 2014, LANCET PSYCHIAT, V1, P549, DOI 10.1016/S2215-0366(14)00081-9
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kusbeci OY, 2011, ALZ DIS ASSOC DIS, V25, P1, DOI 10.1097/WAD.0b013e3181f73bc2
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Labouesse MA, 2015, AM J PHYSIOL-REG I, V309, pR1, DOI 10.1152/ajpregu.00087.2015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lewandowski KE, 2011, PSYCHOL MED, V41, P225, DOI 10.1017/S0033291710001042
   Lieberman JA, 2001, BIOL PSYCHIAT, V50, P884, DOI 10.1016/S0006-3223(01)01303-8
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Ribeiro BMM, 2013, SCHIZOPHR RES, V151, P12, DOI 10.1016/j.schres.2013.10.040
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138
   Martines Roosecelis Brasil, 2016, MMWR Morb Mortal Wkly Rep, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005
   McGrath J, 2011, SCHIZOPHRENIA BULL, V37, P272, DOI 10.1093/schbul/sbq121
   McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101
   MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011
   Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Monteleone P, 2014, PSYCHIAT RES, V215, P263, DOI 10.1016/j.psychres.2013.12.016
   Mortensen PB, 2007, SCHIZOPHRENIA BULL, V33, P741, DOI 10.1093/schbul/sbm009
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reisinger S, 2015, PHARMACOL THERAPEUT, V149, P213, DOI 10.1016/j.pharmthera.2015.01.001
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schulz J, 2014, SCHIZOPHRENIA BULL, V40, P143, DOI 10.1093/schbul/sbs157
   Selten JP, 2010, BIPOLAR DISORD, V12, P753, DOI 10.1111/j.1399-5618.2010.00849.x
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   SOUTH MA, 1985, TERATOLOGY, V31, P297, DOI 10.1002/tera.1420310216
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Susser ES, 2000, SCHIZOPHRENIA BULL, V26, P257, DOI 10.1093/oxfordjournals.schbul.a033451
   Sutterland AL, 2015, ACTA PSYCHIAT SCAND, V132, P161, DOI 10.1111/acps.12423
   Taboas W, 2012, PSYCHIAT RES, V198, P176, DOI 10.1016/j.psychres.2011.05.029
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012
   World Health Organization, 2015, NEUR SYNDR CONG MALF
   Young GR, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-59
   Yung AR, 1996, AUST NZ J PSYCHIAT, V30, P587, DOI 10.3109/00048679609062654
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 149
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1562-2975
EI 1814-1412
J9 WORLD J BIOL PSYCHIA
JI World J. Biol. Psychiatry
PD JAN 2
PY 2020
VL 21
IS 1
BP 2
EP 11
DI 10.1080/15622975.2018.1500027
PG 10
WC Psychiatry
SC Psychiatry
GA LE0QU
UT WOS:000526430400002
PM 30051738
DA 2020-07-08
ER

PT J
AU Mwale, PF
   Lee, CH
   Lin, LT
   Leu, SJ
   Huang, YJ
   Chiang, LC
   Mao, YC
   Yang, YY
AF Mwale, Pharaoh Fellow
   Lee, Chi-Hsin
   Lin, Liang-Tzung
   Leu, Sy-Jye
   Huang, Yun-Ju
   Chiang, Liao-Chun
   Mao, Yan-Chiao
   Yang, Yi-Yuan
TI Expression, Purification, and Characterization of Anti-Zika virus
   Envelope Protein: Polyclonal and Chicken-Derived Single Chain Variable
   Fragment Antibodies
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Zika virus (ZIKV); envelope protein; phage display technology; single
   chain variable fragments (scFv); immunoglobulin yolk (IgY); chicken
   immunization
ID LINKED-IMMUNOSORBENT-ASSAY; EGG-YOLK; MONOCLONAL-ANTIBODY; IGY
   ANTIBODIES; EMERGENCE; BIOLOGY
AB Zika virus (ZIKV) is a new and emerging virus that has caused outbreaks worldwide. The virus has been linked to congenital neurological malformations in neonates and Guillain-Barre syndrome in adults. Currently there are no effective vaccines available. As a result, there is a great need for ZIKV treatment. In this study, we developed single chain variable fragment (scFv) antibodies that target the ZIKV envelope protein using phage display technology. We first induced an immune response in white leghorn laying hens against the ZIKV envelope (E) protein. Chickens were immunized and polyclonal immunoglobulin yolk (IgY) antibodies were extracted from egg yolks. A high-level titer of anti-ZIKV_E IgY antibodies was detected using enzyme-linked immunosorbent assay (ELISA) after the third immunization. The titer persisted for at least 9 weeks. We constructed two antibody libraries that contained 5.3 x 10(6) and 4.5 x 10(6) transformants. After biopanning, an ELISA phage assay confirmed the enrichment of specific clones. We randomly selected 26 clones that expressed ZIKV scFv antibodies and classified them into two groups, short-linker and long-linker. Of these, four showed specific binding activities toward ZIKV_E proteins. These data suggest that the polyclonal and monoclonal scFv antibodies have the diagnostic or therapeutic potential for ZIKV.
C1 [Mwale, Pharaoh Fellow; Lee, Chi-Hsin; Yang, Yi-Yuan] Taipei Med Univ, Coll Med Sci & Technol, Med Biotechnol, Taipei 11031, Taiwan.
   [Mwale, Pharaoh Fellow; Lee, Chi-Hsin; Huang, Yun-Ju; Yang, Yi-Yuan] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei 11031, Taiwan.
   [Lin, Liang-Tzung; Leu, Sy-Jye] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan.
   [Lin, Liang-Tzung; Leu, Sy-Jye] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei 11031, Taiwan.
   [Chiang, Liao-Chun] Natl Tsing Hua Univ, Coll Life Sci, Hsinchu 30013, Taiwan.
   [Mao, Yan-Chiao] Taichung Vet Gen Hosp, Dept Emergency Med, Div Clin Toxicol, Taichung 40705, Taiwan.
   [Yang, Yi-Yuan] Taipei Med Univ, Core Lab Antibody Generat & Res, Taipei 11031, Taiwan.
RP Yang, YY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Med Biotechnol, Taipei 11031, Taiwan.; Yang, YY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei 11031, Taiwan.; Yang, YY (corresponding author), Taipei Med Univ, Core Lab Antibody Generat & Res, Taipei 11031, Taiwan.
EM pmwale@medcol.mw; chihsine@msn.com; ltlin@tmu.edu.tw;
   cmbsycl@tmu.edu.tw; jonsauwi@tmu.edu.tw; axe956956@gmail.com;
   doc1385e@gmail.com; yangyuan@tmu.edu.tw
RI ; Lee, Chi-Hsin/C-9783-2014
OI Mwale, Pharaoh/0000-0001-9260-8467; Lee, Chi-Hsin/0000-0002-3412-7400;
   Lin, Liang-Tzung/0000-0001-7374-7234
FU Ministry of Science and Technology [MOST108-2622-B-038-003-CC2];
   Ministry of Health and Welfare surcharge of tobacco products grant
   [MOHW107-TDU-B-212-114014, MOHW108-TDU-B-212-124014]; Taipei Medical
   University
FX This research was funded by the Ministry of Science and Technology grant
   number [MOST108-2622-B-038-003-CC2], the Ministry of Health and Welfare
   surcharge of tobacco products grant number [MOHW107-TDU-B-212-114014,
   and MOHW108-TDU-B-212-124014]. The APC was funded by Taipei Medical
   University through Yi-Yuan Yang.
CR AKITA EM, 1993, J IMMUNOL METHODS, V162, P155, DOI 10.1016/0022-1759(93)90380-P
   AKITA EM, 1992, J FOOD SCI, V57, P629, DOI 10.1111/j.1365-2621.1992.tb08058.x
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Andris-Widhopf J, 2000, J IMMUNOL METHODS, V242, P159, DOI 10.1016/S0022-1759(00)00221-0
   Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978
   Bird CR, 2009, SPRINGER PROTOC HAND, P1779, DOI 10.1007/978-1-59745-198-7_189
   Cabezas S, 2008, J VIROL METHODS, V147, P235, DOI 10.1016/j.jviromet.2007.09.001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   da Silva AD, 2012, MEM I OSWALDO CRUZ, V107, P960, DOI 10.1590/S0074-02762012000700022
   da Silva MC, 2018, J IMMUNOL METHODS, V461, P100, DOI 10.1016/j.jim.2018.06.023
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Du XJ, 2010, FOOD AGR IMMUNOL, V21, P81, DOI 10.1080/09540100903414106
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ENGVALL E, 1971, BIOCHIM BIOPHYS ACTA, V251, P427, DOI 10.1016/0005-2795(71)90132-2
   FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879
   Jara-Acevedo Ricardo, 2018, Methods Mol Biol, V1701, P365, DOI 10.1007/978-1-4939-7447-4_20
   Jara-Acevedo R, 2016, CURR PHARM DESIGN, V22, P6490, DOI 10.2174/1381612822666161007153127
   Knipe D., 2013, FIELDS VIROLOGY KNIP
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee CH, 2018, TOXINS, V10, DOI 10.3390/toxins10100383
   Lee CH, 2016, APPL ENVIRON MICROB, V82, P6973, DOI 10.1128/AEM.01876-16
   Li TW, 2016, ARCH VIROL, V161, P19, DOI 10.1007/s00705-015-2625-6
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Michael A, 2010, INDIAN J SCI TECHNOL, V3, P468
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Munhoz LS, 2014, CIENC RURAL, V44, P153, DOI 10.1590/S0103-84782014000100025
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nilvebrant Johan, 2018, Methods Mol Biol, V1701, P45, DOI 10.1007/978-1-4939-7447-4_3
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Palmieri M, 2013, ANAL BIOANAL CHEM, V405, P6365, DOI 10.1007/s00216-013-7045-4
   Paul RE, 2016, EBIOMEDICINE, V9, P17, DOI 10.1016/j.ebiom.2016.06.020
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Rahman S, 2013, HUM VACC IMMUNOTHER, V9, P1039, DOI 10.4161/hv.23383
   Sager G, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100559
   Scott J., 2001, PHAGE DISPLAY VECTOR
   Siegel DL, 2002, TRANSFUS CLIN BIOL, V9, P15, DOI 10.1016/S1246-7820(01)00210-5
   Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8
   Van Coillie E, 2004, J AGR FOOD CHEM, V52, P4975, DOI 10.1021/jf049593d
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
NR 54
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 2
PY 2020
VL 21
IS 2
AR 492
DI 10.3390/ijms21020492
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA KO2KZ
UT WOS:000515380000122
PM 31940993
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Radaelli, G
   Nunes, ML
   Soder, RB
   de Oliveira, JM
   Bruzzo, FTK
   Neto, FK
   Leal-Conceicao, E
   Portuguez, MW
   da Costa, JC
AF Radaelli, Graciane
   Nunes, Magda Lahorgue
   Soder, Ricardo Bernardi
   de Oliveira, Julia Monteiro
   Bruzzo, Fernanda Thays Konat
   Neto, Felipe Kalil
   Leal-Conceicao, Eduardo
   Portuguez, Mirna Wetters
   da Costa, Jaderson Costa
TI Review of neuroimaging findings in congenital Zika virus syndrome and
   its relation to the time of infection
SO NEURORADIOLOGY JOURNAL
LA English
DT Review
DE Zika virus; microcephaly; tomography; magnetic resonance
ID OUTBREAK; FETUSES
AB Background Many original articles and case series have been published emphasizing the neuroimaging findings of congenital Zika virus (ZIKV) infection. The majority of these studies do not follow a neuroradiological methodology to describe malformations and brain abnormalities resulting from ZIKV infection. The cause-and-effect correlation between the gestational period of maternal infection and the severity of encephalic changes at birth has rarely been reported. A systematic literature review was conducted on the neuroimaging findings in children affected with microcephaly due to ZIKV. Methods PubMed, Cochrane Library and Web of Science were searched for full-text articles published up to July 2019. Duplicate entries were removed. Two independent reviewers performed a quality assessment of all the studies included. Results A total of 2214 publications were identified. Of these 2170 were excluded by analysis of titles and abstracts, resulting in the inclusion of only eight articles. Chi-square and Fisher's exact tests were performed with a 95% confidence interval to verify the statistically significant differences in the neuroradiological findings between the cases of ZIKV infection in the first or second trimester of gestation. The studies published so far have described image abnormalities at random, without utilizing any pre-established neuroradiological criteria, and imaging modalities with different sensitivity and accuracy have been used, which jeopardizes a reliable and adequate statistical analysis. Conclusions Neuroimaging abnormalities are much more prevalent and severe when the infection by ZIKV is contracted in the first or second trimester of pregnancy.
C1 [Radaelli, Graciane; Nunes, Magda Lahorgue; Soder, Ricardo Bernardi; de Oliveira, Julia Monteiro; Bruzzo, Fernanda Thays Konat; Neto, Felipe Kalil; Leal-Conceicao, Eduardo; Portuguez, Mirna Wetters; da Costa, Jaderson Costa] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande do Sul BraIns, Porto Alegre, RS, Brazil.
   [Nunes, Magda Lahorgue; da Costa, Jaderson Costa] CNPq, Brasilia, DF, Brazil.
   [Nunes, Magda Lahorgue; Soder, Ricardo Bernardi; Portuguez, Mirna Wetters; da Costa, Jaderson Costa] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.
RP da Costa, JC (corresponding author), Brain Inst Rio Grande do Sul BraIns, Av Ipiranga 6690, BR-90610000 Porto Alegre, RS, Brazil.
EM jcc@pucrs.br
RI DaCosta, Jaderson/C-4968-2015
OI DaCosta, Jaderson/0000-0001-6776-1515; Radaelli,
   Graciane/0000-0002-1208-362X
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: Our study was
   supported by the following grants: CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). J.C.C. and M.L.N.
   were funded by CNPq (bolsa de produtividade em pesquisa). J.C.C. and
   M.L.N. are researchers 1A and 1D, respectively, from CNPq, Brazil.
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   da Silva NA, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012602
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Desai SK, 2017, AM J STEM CELLS, V6, P13
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Pires P, 2018, CHILD NERV SYST, V34, P957, DOI 10.1007/s00381-017-3682-9
   Pool KL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8124
   Rothan HA, 2018, MOL NEUROBIOL, P1
   Paiva MHS, 2017, GENET MOL BIOL, V40, P597, DOI [10.1590/1678-4685-GMB-2016-0312, 10.1590/1678-4685-gmb-2016-0312]
   Van Der Linden V, 2016, MMWR MORB MORTAL WKL, V65
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   de Castro JDV, 2017, ARQ NEURO-PSIQUIAT, V75, P703, DOI [10.1590/0004-282X20170134, 10.1590/0004-282x20170134]
NR 22
TC 1
Z9 1
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1971-4009
EI 2385-1996
J9 NEURORADIOL J
JI Neuradiology J.
PD APR
PY 2020
VL 33
IS 2
BP 152
EP 157
AR UNSP 1971400919896264
DI 10.1177/1971400919896264
EA JAN 2020
PG 6
WC Neuroimaging
SC Neurosciences & Neurology
GA LA1RS
UT WOS:000506992500001
PM 31896285
DA 2020-07-08
ER

PT J
AU Correa-Morales, F
   Gonzalez-Acosta, C
   Mejia-Zuniga, D
   Huerta, H
   Perez-Renteria, C
   Vazquez-Pichardo, M
   Ortega-Morales, AI
   Hernandez-Triana, LM
   Salazar-Bueyes, VM
   Moreno-Garcia, M
AF Correa-Morales, Fabian
   Gonzalez-Acosta, Cassandra
   Mejia-Zuniga, David
   Huerta, Heron
   Perez-Renteria, Crescencio
   Vazquez-Pichardo, Mauricio
   Ortega-Morales, Aldo, I
   Hernandez-Triana, Luis M.
   Salazar-Bueyes, Victor M.
   Moreno-Garcia, Miguel
TI Surveillance for Zika in Mexico: naturally infected mosquitoes in urban
   and semi-urban areas
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Arbovirus; Culicidae; mosquito-borne diseases; vector control
ID CULEX-QUINQUEFASCIATUS; VERTICAL TRANSMISSION; CULISETA-PARTICEPS;
   DIPTERA-CULICIDAE; AEDES-AEGYPTI; VIRUS; AMERICA
AB Zika cases have been reported in 29 out of the 32 states of Mexico. Information regarding which mosquito species might be driving Zika virus transmission/maintenance in nature must be regularly updated. From January 2017 to November 2018, mosquitoes were collected indoors and outdoors using the CDC backpack aspirator in urban and semi-urban areas with evidence of mosquito-borne disease transmission. 3873 mosquito pools were tested for Zika infection using the CDC Trioplex real-time RT-PCR. For each collected specie, maximum likelihood estimator of infection rate (MLE) was estimated. Results showed 492 mosquito pools positive for Zika virus RNA. The majority of the positive pools were Aedes (Stegomyia) aegypti (Linnaeus) (54.6%, MLE = 19) (males and females) and Culex (Culex) quinquefasciatus (Say) (19.5%, MLE = 16.8). For the first time, ZIKV infection was detected in Ae. (Georgecraigius) epactius (Dyar and Knab) (MLE = 17.1), Cx. (Melanoconion) erraticus (Dyar and Knab) (MLE = non-estimable), Culiseta (Culiseta) inornata (Williston) (MLE = non estimable), and Cs (Cs.) particeps (Adams) (MLE = 369.5). Other detected species were: Ae. (Stg.) albopictus (Skuse) (MLE = 90.5), Cx. (Cx.) coronator s.l. (Dyar and Knab) (MLE = 102.8) and Cx. (Cx.) tarsalis (Coquillett) (MLE = 117.2). However, our results do not allow for the incrimination of these species as vectors of ZIKV. Routine surveillance should start to consider other mosquito species across the taxonomic spectrum of the Culicidae.
C1 [Correa-Morales, Fabian; Salazar-Bueyes, Victor M.] Ctr Nacl Programas Prevent & Control Enfermedades, Subdirecc Programa Enfermedades Transmitidas Vect, Ciudad De Mexico, Mexico.
   [Gonzalez-Acosta, Cassandra] Serv Salud Morelos, Coordinac Enfermedades Transmitidas Vector & Zoon, Cuernavaca, Morelos, Mexico.
   [Mejia-Zuniga, David] Serv Salud Chihuahua, Unidad Invest Entomol & Bioensayos, Chihuahua, Chihuahua, Mexico.
   [Huerta, Heron; Perez-Renteria, Crescencio; Vazquez-Pichardo, Mauricio] Inst Diagnost & Referencia Epidemiol Dr Manuel Ma, Lab Entomol, Ciudad De Mexico, Mexico.
   [Ortega-Morales, Aldo, I] Univ Autonoma Agr Antonio Narro, Unidad Laguna, Dept Parasitol, Torreon, Mexico.
   [Hernandez-Triana, Luis M.] Anim & Plant Hlth Agcy, Virol Dept, Wildlife Zoonoses & Vector Borne Dis Res Grp, Addlestone, Surrey, England.
   [Moreno-Garcia, Miguel] Ctr Reg Control Vectores Panchimalco, Serv Salud Morelos, Unidad Invest Entomol & Bioensayos, Emiliano Zapata 95, Jojutla 62900, Mexico.
RP Moreno-Garcia, M (corresponding author), Ctr Reg Control Vectores Panchimalco, Serv Salud Morelos, Unidad Invest Entomol & Bioensayos, Emiliano Zapata 95, Jojutla 62900, Mexico.
EM miguelmoga2000@yahoo.com.mx
OI Huerta, Heron/0000-0002-7935-9758; Correa Morales,
   Fabian/0000-0002-6193-1242; MORENO-GARCIA, MIGUEL/0000-0001-6733-9007
FU European Virus Archive (EVAg) [653316]; Welsh Government [SV3045,
   SE4113]; UK Department for Environment and Rural Affairs
   (DEFRA)Department for Environment, Food & Rural Affairs (DEFRA) [SV3045,
   SE4113]; Scottish Government [SV3045, SE4113]
FX We would like to thank all the staff from each of the Mexican
   Specialized Bioassay Units of in the surveyed states for their
   assistance with field work. We are grateful to all the staff of in the
   Department of Virology InDRE and to the Red Nacional de Laboratorios de
   Salud Publica (RNLSP) for molecular work. Luis M. Hernandez-Triana would
   like to thank the EU Framework Horizon 2020 Innovation Grant, European
   Virus Archive (EVAg, grant no. 653316) and the UK Department for
   Environment and Rural Affairs (DEFRA), Scottish Government and Welsh
   Government (grant nos. SV3045, SE4113) for travel expenses. We thank
   Selene Garcia-Luna for assisting us with the MLE analysis. We are
   extremely grateful to Audrey Lenhart for her comments, suggestions and
   proofreading this paper for the use of English. We thank two anonymous
   reviewers for invaluable comments.
CR Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Biggerstaff BJ, 2012, POOLEDINFRATE VERSIO
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Burkett-Cadena ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017681
   Campos SS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2543-4
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CARPENTER SJ, 1955, MOSQUITOES N AM N ME
   CDC, 2012, MOSQ SPEC WHICH W NI
   CDC, 2018, TRIOPL REAL TIM RT P
   CENAPRECE, 2018, GUIA MET VIG ENT SUB
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Davalos-Becerril E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212987
   Diaz-Badillo A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-70
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Elizondo-Quiroga D, 2016, SCI REP, V8, P809
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1
   Foster Woodbridge A., 2002, P203, DOI 10.1016/B978-012510451-7/50014-1
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   HAMMON WM, 1945, JAMA-J AM MED ASSOC, V128, P1133, DOI 10.1001/jama.1945.02860330001001
   HARDY JL, 1980, AM J TROP MED HYG, V29, P963, DOI 10.4269/ajtmh.1980.29.963
   HEARD PB, 1991, J AM MOSQUITO CONTR, V7, P94
   Huerta H, 2017, T ROY SOC TROP MED H, V111, P328, DOI 10.1093/trstmh/trx056
   Ibanez-Bernal Sergio, 1994, Folia Entomologica Mexicana, V0, P43
   Jackson M, 2013, CAN ENTOMOL, V145, P115, DOI 10.4039/tce.2012.99
   Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Lozano-Fuentes S, 2012, J MED ENTOMOL, V49, P1244, DOI 10.1603/ME12067
   Martnez Palacios A., 1952, Revista de la Sociedad Mexicana de Historia Natural, V13, P75
   Mendenhall IH, 2012, J MED ENTOMOL, V49, P1092, DOI 10.1603/ME11260
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   SCHREIBER ET, 1989, J AM MOSQUITO CONTR, V5, P434
   Secretaria de Salud de Mexico, 2018, CAS CONF INF VIR ZIK
   Secretaria de Salud de Mexico, 2015, B EP SEM, V47
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
NR 45
TC 0
Z9 0
U1 4
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PD OCT 3
PY 2019
VL 113
IS 7
BP 309
EP 314
DI 10.1080/20477724.2019.1706291
EA JAN 2020
PG 6
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA KC5UW
UT WOS:000505655500001
PM 31902313
DA 2020-07-08
ER

PT J
AU Xing, HP
   Xu, S
   Jia, FF
   Yang, Y
   Xu, CM
   Qin, CF
   Shi, L
AF Xing, Huaipeng
   Xu, Shan
   Jia, Fangfei
   Yang, Yang
   Xu, Caimin
   Qin, Chengfeng
   Shi, Lei
TI Zika NS2B is a crucial factor recruiting NS3 to the ER and activating
   its protease activity
SO VIRUS RESEARCH
LA English
DT Article
DE Zika virus; NS2B; NS3 protease; Recruitment
ID FLAVIVIRAL REPLICATION COMPLEX; CRYSTAL-STRUCTURE; MEMBRANE TOPOLOGY;
   RNA-SYNTHESIS; VIRUS; DENGUE; BIOLOGY; INHIBITORS; HELICASE
AB Zika virus (ZIKV) is an emergent flavivirus associated with severe neurological disorders. ZIKV NS3 protein is a viral protease that cleaves the ZIKV polyprotein precursor into individual viral proteins. In this study, we found that ZIKV NS3 by itself exhibited mitochondrial localization, which was quite different from its endoplasmic reticulum (ER) localization in ZIKV-infected cells. We screened viral proteins and identified NS2B as the bona fide recruiter of NS3 to the ER. The NS2B C-terminal tail interacted with NS3 protease domain to retain NS3 on the ER. beta-Sheet motifs that formed between NS2B and the NS3 protease domain played important roles in their interaction, while mutation in the beta-strand of NS2B attenuated NS2B-NS3 interaction and impaired the ability of NS3 protease to cleave the polyprotein precursor into multiple viral proteins. Consequently, NS2B mutations led to severe inhibition of ZIKV replication and production due to insufficient NS3 protease activity. In summary, our study reveals the critical role of NS2B in NS3 recruitment and protease function and provides mechanistic insight into ZIKV replication.
C1 [Xing, Huaipeng; Xu, Shan; Jia, Fangfei; Yang, Yang; Xu, Caimin; Shi, Lei] Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.
   [Xing, Huaipeng; Xu, Shan; Jia, Fangfei; Yang, Yang; Xu, Caimin; Shi, Lei] Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China.
   [Xing, Huaipeng; Xu, Shan; Jia, Fangfei; Yang, Yang; Xu, Caimin; Shi, Lei] Chinese Acad Med Sci, Dept Biochem & Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.
   [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100005, Peoples R China.
RP Shi, L (corresponding author), Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.; Shi, L (corresponding author), Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100005, Peoples R China.
EM qincf@bmi.ac.cn; shilei@ibms.pumc.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470813, 81622028]; 1000 Talents Plan Youth
   program; CAMS Innovation Fund for Medical Sciences (CIFMS)
   [2016-I2M-3-020]; Chinese Academy of Medical Sciences [2016ZX310192,
   2016RC310037, 2016RC310031]
FX This work was supported by National Natural Science Foundation of China
   [31470813 and 81622028 to L.S.], the 1000 Talents Plan Youth program to
   L.S., CAMS Innovation Fund for Medical Sciences (CIFMS)
   [2016-I2M-3-020], Chinese Academy of Medical Sciences [2016ZX310192,
   2016RC310037, 2016RC310031].
CR Aktepe TE, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12884
   Anderson CJ, 2017, CHANDOS INF PROF SER, P89
   Ash Caroline, 2017, Science, V357, P43, DOI 10.1126/science.357.6346.43-b
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Giulietti M, 2018, VIRUS RES, V255, P133, DOI 10.1016/j.virusres.2018.07.010
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2016, ANGEW CHEM INT EDIT, V55, P12068, DOI 10.1002/anie.201606609
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Reddy SBG, 2018, BIOCHEM PHARMACOL, V154, P54, DOI 10.1016/j.bcp.2018.04.008
   Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007
   Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Swarbrick CMD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1127
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Weinert T, 2015, NAT METHODS, V12, P131, DOI 10.1038/nmeth.3211
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   ZHANG LW, 1992, J VIROL, V66, P7549, DOI 10.1128/JVI.66.12.7549-7554.1992
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 46
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JAN 2
PY 2020
VL 275
AR 197793
DI 10.1016/j.virusres.2019.197793
PG 11
WC Virology
SC Virology
GA JS5VI
UT WOS:000500373700004
PM 31676367
OA Bronze
DA 2020-07-08
ER

PT J
AU Ophir, Y
   Jamieson, KH
AF Ophir, Yotam
   Jamieson, Kathleen Hall
TI The Effects of Zika Virus Risk Coverage on Familiarity, Knowledge and
   Behavior in the US - A Time Series Analysis Combining Content Analysis
   and a Nationally Representative Survey
SO HEALTH COMMUNICATION
LA English
DT Article
ID NEWS COVERAGE; UNITED-STATES; INTERPERSONAL-COMMUNICATION;
   FAMILY/FRIENDS INCREASES; SOCIAL AMPLIFICATION; INFORMATION-SEEKING;
   HEALTH; MEDIA; EXPOSURE; CRISIS
AB This study assessed the effects of the February through September 2016 American news media's coverage of Zika Virus (ZIKV) risk on the U.S. public's familiarity, knowledge and behavior in the form of interpersonal discussions. A content analysis (N = 2,782 pieces) revealed that the Rio Olympic Games elicited a spike in coverage of Zika. We also found that newsworthy and easy- to- depict aspects of the disease, specifically its transmission by mosquitoes and its relation to microcephaly were covered more extensively than its sexual transmission and transmissibility from an infected person who is asymptomatic. Nevertheless, survey data over the same period of time (N = 37,180 respondents) revealed that the general amount of coverage, rather than the specifics about Zika transmission and its consequences, influenced the public's familiarity, knowledge, and behavior.
C1 [Ophir, Yotam; Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
RP Ophir, Y (corresponding author), Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
EM yophir@asc.upenn.edu
RI Ophir, Yotam/J-8397-2019
OI Ophir, Yotam/0000-0001-5049-7906
FU Science of Science Communication endowment of the Annenberg Public
   Policy Center of the University of Pennsylvania
FX The study was funded by the Science of Science Communication endowment
   of the Annenberg Public Policy Center of the University of Pennsylvania.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Allison PD, 2001, MISSING DATA
   Almeling R, 2013, GENDER SOC, V27, P821, DOI 10.1177/0891243213484510
   Alter A., 2017, NY TIMES
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Bennett WL, 2008, J COMMUN, V58, P707, DOI 10.1111/j.1460-2466.2008.00410.x
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan MPS, 2018, SOC SCI MED, V212, P50, DOI 10.1016/j.socscimed.2018.07.007
   Chang CC, 2012, HEALTH COMMUN, V27, P111, DOI 10.1080/10410236.2011.569004
   Chau J, 2009, AUST NZ J PUBL HEAL, V33, P189, DOI 10.1111/j.1753-6405.2009.00368.x
   Conway BA, 2015, J COMPUT-MEDIAT COMM, V20, P363, DOI 10.1111/jcc4.12124
   Coombs W.T., 2009, HDB RISK CRISIS COMM, P99
   Covello VT, 2001, J URBAN HEALTH, V78, P382, DOI 10.1093/jurban/78.2.382
   D'Angelo P., 2010, DOING NEWS FRAMING A, P1
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dayan Daniel, 1994, MEDIA EVENTS
   Dunlop S, 2013, AM J PUBLIC HEALTH, V103, pE66, DOI 10.2105/AJPH.2012.301079
   Ekblad N., 2013, NEWSWORTHINESS SCI C
   ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   GALTUNG J, 1965, J PEACE RES, P64
   Gans H. J., 1979, DECIDING WHATS NEWS
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Golan G., 2006, JOURNALISM STUD, V7, P323, DOI DOI 10.1080/14616700500533643
   Golding P., 1979, MAKING THE NEWS
   Green J., 1985, EXPOSITORY SCI FORMS, P139, DOI DOI 10.1007/978-94-009-5239-3_7
   GREENBERG MR, 1989, RISK ANAL, V9, P119, DOI 10.1111/j.1539-6924.1989.tb01227.x
   Hart W, 2009, PSYCHOL BULL, V135, P555, DOI 10.1037/a0015701
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   HEWLETT B.S., 2007, EBOLA CULTURE POLITI
   Hindman M. S., 2008, MYTH DIGITAL DEMOCRA
   Hornik RC, 2002, SOCIAL MARKETING Q, V8, P30, DOI DOI 10.1080/15245000214135
   Joffe H, 2008, DIOGENES, V55, P84, DOI 10.1177/0392192107087919
   Johnson B., 1993, RISK HLTH SAFETY ENV, V4
   Jones KO, 2006, J APPL COMMUN RES, V34, P94, DOI 10.1080/00909880500420242
   Kasperson RE, 1996, ANN AM ACAD POLIT SS, V545, P95, DOI 10.1177/0002716296545001010
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Kennedy MG, 2004, J COMMUN, V54, P287, DOI 10.1093/joc/54.2.287
   Lang A, 2000, J COMMUN, V50, P46, DOI 10.1093/joc/50.1.46
   Len-Rios ME, 2005, J COMMUN, V55, P152, DOI 10.1111/j.1460-2466.2005.tb02664.x
   Levis DM, 2013, AM J HEALTH PROMOT, V27, pS36, DOI 10.4278/ajhp.120113-QUAL-19
   Lewis N., 2017, INT ENCY MEDIA EFFEC, P1, DOI [10.1002/9781118783764.wbieme0156, DOI 10.1002/9781118783764.WBIEME0156]
   Lewis N, 2012, HEALTH COMMUN, V27, P380, DOI 10.1080/10410236.2011.586990
   Lundgren R.E., 2013, RISK COMMUNICATION H
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   MAZUR A, 1984, MINERVA, V22, P45, DOI 10.1007/BF02207556
   MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990
   McNeil D., 2016, ZIKA EMERGING EPIDEM
   Mebane F, 2003, J HEALTH COMMUN, V8, P50, DOI 10.1080/1081730390224875
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MORGAN MG, 1992, ENVIRON SCI TECHNOL, V26, P2048
   Moyer-Guse E, 2011, J COMMUN, V61, DOI 10.1111/j.1460-2466.2011.01551.x
   Mueller D., 2003, YOUTH VIOLENCE JUV J, V1, P330, DOI DOI 10.1177/1541204003255842
   Niederdeppe J, 2008, MILBANK Q, V86, P481, DOI 10.1111/j.1468-0009.2008.00530.x
   O'Neill D, 2009, INT COMMUN ASSOC HAN, P161
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Ophir Y, 2018, HEALTH SECUR, V16, P147, DOI 10.1089/hs.2017.0106
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   Pellechia MG, 1997, PUBLIC UNDERST SCI, V6, P49, DOI 10.1088/0963-6625/6/1/004
   Petts J., 2010, RISK COMMUNICATION P, P81
   Pidgeon N., 2010, RISK COMMUNICATION P, P53, DOI DOI 10.1093/ACPROF:OSO/9780199562848.001.0001
   Pokharel S., 2015, THESIS
   Price M., 2009, OWNING OLYMPICS NARR
   Ramirez AS, 2013, J HEALTH COMMUN, V18, P527, DOI 10.1080/10810730.2012.743632
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Renn O., 1991, COMMUNICATING RISKS, V4, P287, DOI DOI 10.1007/978-94-009-1952-5
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Reynolds B., 2014, CRISIS EMERGENCY RIS
   Rimal RN, 1999, COMMUN RES, V26, P322, DOI 10.1177/009365099026003003
   ROSENTHAL U, 2001, MANAGING CRISES THRE, P5
   Ross K, 2011, MEDIA CULT SOC, V33, P1148, DOI 10.1177/0163443711418272
   Rowan K. E., 1991, J APPLIED COMMUNICAT, V19, P300, DOI DOI 10.1080/00909889109365311
   Sandman P., 1987, EPA J, V13, P21, DOI DOI 10.1177/0893318988002002006
   Sandman PM, 1993, RESPONDING COMMUNITY
   Shih TJ, 2008, MASS COMMUN SOC, V11, P141, DOI 10.1080/15205430701668121
   SHOEMAKER PJ, 1991, JOURNALISM QUART, V68, P781, DOI 10.1177/107769909106800419
   SHOEMAKER PJ, 1996, MEDIATING MESSAGE TH
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Srinivasan R, 2010, J ROY SOC MED, V103, P340, DOI 10.1258/jrsm.2010.100118
   Stroud N. J., 2011, NICHE NEWS POLITICS
   Stryker JE, 2002, PREV MED, V35, P519, DOI 10.1006/pmed.2002.1102
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tesler M., 2014, OXFORD HDB POLITICAL, P69, DOI [10.1093/oxfordhb/9780199793471.013.003, DOI 10.1093/OXFORDHB/9780199793471.013.003]
   Thompson EL, 2017, MATERN CHILD HLTH J, V21, P1147, DOI 10.1007/s10995-016-2213-8
   TUCHMAN G, 1973, AM J SOCIOL, V79, P110, DOI 10.1086/225510
   Vasterman P, 2008, EUR J COMMUN, V23, P319, DOI 10.1177/0267323108092538
   Veil S, 2008, HEALTH PROMOT PRACT, V9, p26S, DOI 10.1177/1524839908322113
   WANTA W, 1992, JOURNALISM QUART, V69, P847, DOI 10.1177/107769909206900405
NR 91
TC 4
Z9 4
U1 12
U2 15
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1041-0236
EI 1532-7027
J9 HEALTH COMMUN
JI Health Commun.
PD JAN 2
PY 2020
VL 35
IS 1
BP 35
EP 45
DI 10.1080/10410236.2018.1536958
PG 11
WC Communication; Health Policy & Services
SC Communication; Health Care Sciences & Services
GA JQ2HC
UT WOS:000498771100005
PM 30358431
OA Other Gold
DA 2020-07-08
ER

PT J
AU Mata, VE
   de Andrade, CAF
   Passos, SRL
   Hokerberg, YHM
   Fukuoka, LVB
   da Silva, SA
AF Mata, Veronica Elizabeth
   Ferreira de Andrade, Carlos Augusto
   Lambert Passos, Sonia Regina
   Marques Hokerberg, Yara Hahr
   Boas Fukuoka, Levy Vilas
   da Silva, Suzana Alves
TI Rapid immunochromatographic tests for the diagnosis of dengue: a
   systematic review and meta-analysis
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Review
DE Dengue; Diagnosis; Sensitivity and Specificity; Systematic Review;
   Meta-Analysis
ID NS1 ANTIGEN; ZIKA VIRUS; ANTIBODY DETECTION; SUSPECTED DENGUE;
   LABORATORY TESTS; INFECTION; ASSAYS; ACCURACY; IGA; PERFORMANCE
AB Dengue is an important arthropod-borne viral disease in terms of morbidity, mortality, economic impact and challenges in vector control. Benchmarks are expensive, time consuming and require trained personnel. Preventing dengue complications with rapid diagnosis has been based on the testing of easy-to-perform optimized immunochromatographic methods (ICT). This is a systematic meta-analysis review of the diagnostic accuracy of IgA, NS1, IgM and/or IgG ICT studies in suspected cases of acute or convalescent dengue, using a combination of RT-PCR, ELISA NS1, IgM IgG or viral isolation as a reference standard. This protocol was registered in PROSPERO (CRD42014009885). Two pairs of reviewers searched the PubMed, BIREME, Science Direct, Scopus, Web of Science, Ovid MEDLINE JBrigs, SCIRUS and EMBASE databases, selected, extracted, and quality-assessed by QUADAS 2 Of 3,783 studies, we selected 57, of which 40 in meta-analyses according to the analyte tested, with high heterogeneity (I-2 > 90%), as expected for diagnostic tests. We detected higher pooled sensitivity in acute phase IgA (928%) with excellent (90%) specificity. ICT meta-analysis with NS1/IgM/IgG showed 91% sensitivity and 96% specificity. Poorer screening performance was for IgM/IgG ICT (sensitivity = 56%). Thus, the studies with NS1/IgM/IgG ICT showed the best combined performance in the acute phase of the disease.
C1 [Mata, Veronica Elizabeth; Ferreira de Andrade, Carlos Augusto; Lambert Passos, Sonia Regina; Marques Hokerberg, Yara Hahr; Boas Fukuoka, Levy Vilas] Fundacao Oswaldo Cruz, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [da Silva, Suzana Alves] Hosp Coracao, Sao Paulo, Brazil.
RP Mata, VE (corresponding author), Fundacao Oswaldo Cruz, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM veronica.elizabeth.mata@gmail.com
RI hokerberg, yara/K-2880-2016
OI hokerberg, yara/0000-0001-7140-7172
FU Rio de Janeiro State Research Foundation - FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-25/110.188/2014]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [221354 E_01/2016];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [310765/2016-1]; Brazilian National Graduate Studies Board - CAPES
   [001]; Brazilian National Research Council - CNPqNational Council for
   Scientific and Technological Development (CNPq) [401396/2013-4];
   Brazilian Network for Technological and Health Assessment - REBRATS
FX The study received funding from the Brazilian National Research Council
   - CNPq (grant n. 401396/2013-4; Brazilian Network for Technological and
   Health Assessment - REBRATS), and Rio de Janeiro State Research
   Foundation - FAPERJ (grant n. E-25/110.188/2014). Scholarship from
   FAPERJ (grant n. 221354 E_01/2016] to V.E.M. Grant from CNPq (n.
   310765/2016-1) to S.R.L.P. This study was financed in part by the
   Brazilian National Graduate Studies Board - CAPES (Finance Code 001).
CR Ahmed F, 2010, DIAGN MICR INFEC DIS, V68, P339, DOI 10.1016/j.diagmicrobio.2010.07.007
   Aikat Aditi, 2011, J Indian Med Assoc, V109, P543
   Alagarasu K, 2016, EPIDEMIOL INFECT, V144, P876, DOI 10.1017/S0950268815001922
   Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   [Anonymous], 2020, CAD SAUDE PUBLICA, V36
   Martinez-Vega RA, 2009, BIOMEDICA, V29, P616, DOI 10.7705/biomedica.v29i4.139
   Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358
   Blacksell SD, 2006, T ROY SOC TROP MED H, V100, P775, DOI 10.1016/j.trstmh.2005.10.018
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Branch SL, 1999, CLIN DIAGN LAB IMMUN, V6, P555, DOI 10.1128/CDLI.6.4.555-557.1999
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carter MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003424
   Chaiyaratana W, 2009, DIAGN MICR INFEC DIS, V64, P83, DOI 10.1016/j.diagmicrobio.2009.01.004
   Cohen AL, 2007, TROP MED INT HEALTH, V12, P47, DOI 10.1111/j.1365-3156.2006.01752.x
   Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799
   Colonetti T, 2018, AN ACAD BRAS CIENC, V90, P3147, DOI 10.1590/0001-3765201820170989
   Congpuong K, 2008, ASIAN BIOMED, V2, P289
   da Costa VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094655
   Hernandez SIDC, 2012, DIAGN MICR INFEC DIS, V72, P150, DOI 10.1016/j.diagmicrobio.2011.11.002
   Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Garg A, 2019, J LAB PHYS, V11, P63, DOI 10.4103/JLP.JLP_140_18
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hartono A, 2012, INT J INFECT DIS, V16, pE394, DOI 10.1016/j.ijid.2012.05.522
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Huits R, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw273
   Hunsperger EA, 2016, J CLIN MICROBIOL, V54, P2090, DOI 10.1128/JCM.00521-16
   Jang WS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213451
   Jusoh TNAM, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/4687182
   Kikuti M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213301
   Krishnananthasivam S, 2015, SE ASIAN J TROP MED, V46, P602
   Kyaw AK, 2019, J VIROL METHODS, V273, DOI 10.1016/j.jviromet.2019.113724
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lee H, 2019, ANN LAB MED, V39, P566, DOI 10.3343/alm.2019.39.6.566
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136
   Lim JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2789-8
   Liu LT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202304
   Lubell Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152420
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mata VE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2679-z
   Mitra S, 2014, INT J INFECT DIS, V21, P450, DOI 10.1016/j.ijid.2014.03.1348
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Najioullah F, 2011, DIAGN MICR INFEC DIS, V69, P172, DOI 10.1016/j.diagmicrobio.2010.09.021
   Naz A, 2014, PAK J MED SCI, V30, P166, DOI 10.12669/pjms.301.4173
   Nga TTT, 2007, CLIN VACCINE IMMUNOL, V14, P799, DOI 10.1128/CVI.00483-06
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Pan-ngum W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050765
   Parham LA, 2014, AM J TROP MED HYG  S, V91, P429
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176
   Prado PS, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170433
   Pun R, 2012, Kathmandu Univ Med J (KUMJ), V10, P7
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022
   Sanchez-Vargas LA, 2014, DIAGN MICR INFEC DIS, V78, P368, DOI 10.1016/j.diagmicrobio.2013.12.019
   Shih HI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158437
   Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Shukla MK, 2017, J MED VIROL, V89, P1146, DOI 10.1002/jmv.24764
   Simonnet C, 2017, EUR J CLIN MICROBIOL, V36, P2441, DOI 10.1007/s10096-017-3083-8
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tan YY, 2011, J GLOB INFECT DIS, V3, P233, DOI 10.4103/0974-777X.83528
   Tontulawat P, 2011, SE ASIAN J TROP MED, V42, P570
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Valdez Sandoval JJ, 2012, REV CUBA MED TROP, V64, P27
   Vaughn DW, 1998, J CLIN MICROBIOL, V36, P2795
   Vickers I, 2017, DIAGN MICR INFEC DIS, V89, P271, DOI 10.1016/j.diagmicrobio.2017.08.019
   Vickers IE, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0164-9
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yusuf Noshin Wasim, 2008, J Ayub Med Coll Abbottabad, V20, P26
   Zainah S, 2009, J VIROL METHODS, V155, P157, DOI 10.1016/j.jviromet.2008.10.016
   Zhang H, 2014, INT J INFECT DIS, V26, P57, DOI 10.1016/j.ijid.2014.02.002
NR 84
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2020
VL 36
IS 6
AR e00225618
DI 10.1590/0102-311X00225618
PG 24
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LZ9RP
UT WOS:000541556400001
PM 32520127
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Yang, L
   Norris, EJ
   Jiang, SY
   Bernier, UR
   Linthicum, KJ
   Bloomquist, JR
AF Yang, Liu
   Norris, Edmund J.
   Jiang, Shiyao
   Bernier, Ulrich R.
   Linthicum, Kenneth J.
   Bloomquist, Jeffrey R.
TI Reduced effectiveness of repellents in a pyrethroid-resistant strain of
   Aedes aegypti (Diptera: culicidae) and its correlation with olfactory
   sensitivity
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE cross-resistance; DEET; IR3535; pyrethroids; 2-undecanone; 1-octen-3-ol
ID INSECTICIDE; DENGUE
AB BACKGROUND: The mosquito, Aedes aegypti (Diptera: Culicidae), is a vector of dengue fever, zika, chikungunya, and yellow fever viruses, and in many areas possesses significant levels of resistance to pyrethroids. Behavioral performance was assessed in 15, 30, and 60min exposures in a high throughput vapor phase spatial repellency assay to three contact repellent standards: N,N-diethyl-3-methylbenzamide (DEET), ethyl 3-[acetyl(butyl)amino] propanoate (IR3535), and 2-undecanone, as well as pyrethrum extract, transfluthrin, and metofluthrin in susceptible (Orlando) and a pyrethroid-resistant Puerto Rico strain of Aedes aegypti. Additionally, electroantennographic studies were used to investigate the antennal sensitivities to these compounds in both strains.
   RESULTS: Resistance was found to all tested insect repellents in the Puerto Rico strain of Ae. aegypti. Resistance ratios at the different time points were about 2 for DEET, 3 for 2-undecanone, and 12 for IR3535. Resistance was also observed to pyrethrum extract (similar to 9-fold), transfluthrin (similar to 5-fold), and metofluthrin (similar to 48-fold) in repellent behavioral response. Electrophysiological analysis found decreased antennal sensitivity to all repellents tested, consistent with their behavioral effects.
   CONCLUSION: The reduced sensitivity to these repellents may represent a fitness cost arising from the kdr mutation present in Puerto Rico Aedes aegypti. This work highlights the need for understanding collateral effects from the evolution of pesticide resistance in mosquitoes, and the importance of finding alternative strategies to control resistance development. (c) 2019 Society of Chemical Industry
C1 [Yang, Liu; Norris, Edmund J.; Jiang, Shiyao; Bloomquist, Jeffrey R.] Univ Florida, Emerging Pathogens Inst, Dept Entomol & Nematol, 2055 Mowry Rd, Gainesville, FL 32610 USA.
   [Bernier, Ulrich R.; Linthicum, Kenneth J.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA.
RP Bloomquist, JR (corresponding author), Univ Florida, Emerging Pathogens Inst, Dept Entomol & Nematol, 2055 Mowry Rd, Gainesville, FL 32610 USA.
EM jbquist@epi.ufl.edu
OI yang, liu/0000-0002-0746-3433; Bloomquist, Jeff/0000-0002-9136-4998
FU Department of Defense, Deployed War Fighter Research Program, under USDA
   [58-6615-4-023, 58-0208-5-001]
FX This project was funded by the Department of Defense, Deployed War
   Fighter Research Program, under USDA Specific Cooperative Agreements
   58-6615-4-023 and 58-0208-5-001 to J.R.B. Drs. Daniel L. Kline and James
   J. Becnel of the USDA CMAVE provided the Orlando and Puerto Rico Ae.
   aegypti mosquitoes, respectively.
CR Agramonte NM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005954
   Bibbs CS, 2017, J INTEGR PEST MANAG, V8, DOI 10.1093/jipm/pmx016
   Bowman NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196410
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   CRAMPTON JM, 1994, ANN TROP MED PARASIT, V88, P3, DOI 10.1080/00034983.1994.11812828
   Estep AS, 2017, J MED ENTOMOL, V54, P1643, DOI 10.1093/jme/tjx143
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Frances SP, 2005, J AM MOSQUITO CONTR, V21, P1, DOI 10.2987/8756-971X(2005)21[1:RPPAF]2.0.CO;2
   Gautam R, 2017, CURR TOP MED CHEM, V17, P2199, DOI 10.2174/1568026617666170130122921
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   IBM Corp, IBM SPSS STAT WIND V
   Jiang S, 2019, MED VET ENTOMOL, V33, P388, DOI 10.1111/mve.12377
   Kandel Y, 2019, PLOS ONE, P14
   Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208
   Lin YH, 2013, PESTIC BIOCHEM PHYS, V107, P266, DOI 10.1016/j.pestbp.2013.08.004
   Liu F, 2013, J INSECT PHYSIOL, V59, P1169, DOI 10.1016/j.jinsphys.2013.08.016
   Mengoni SL, 2018, J ECON ENTOMOL, V111, P836, DOI 10.1093/jee/toy009
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007
   Pennetier C, 2005, AM J TROP MED HYG, V72, P739, DOI 10.4269/ajtmh.2005.72.739
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Rapley LP, 2009, AM J TROP MED HYG, V81, P94, DOI 10.4269/ajtmh.2009.81.94
   Reid WR, 2014, J MED ENTOMOL, V51, P605, DOI 10.1603/ME13228
   Ritchie SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-262
   Rozendaal J.A., 1997, VECTOR CONTROL METHO
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Sfara V, 2006, MEM I OSWALDO CRUZ, V101, P89, DOI 10.1590/S0074-02762006000100017
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soko W, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0076-7
   Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107
   Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105
   Vassena CV, 2019, J ECON ENTOMOL, V112, P997, DOI 10.1093/jee/toy387
   Wagman JM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003726
   WHO, 2017, DENG SEV DENG
   WHO, 2018, IMM VACC BIOL
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   World Health Organization, 2011, GLOB INS US VECT BOR
NR 38
TC 3
Z9 3
U1 11
U2 20
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JAN
PY 2020
VL 76
IS 1
BP 118
EP 124
DI 10.1002/ps.5562
PG 7
WC Agronomy; Entomology
SC Agriculture; Entomology
GA LY3YE
UT WOS:000540464500014
PM 31338960
DA 2020-07-08
ER

PT J
AU Cardenas, DM
   Jaimes, MA
   Vega, LD
   Oliveros, NL
   Soto, JA
   ChUa, CR
   Osorio, JE
   Ciuoderis, KA
AF Cardenas, Denny M.
   Jaimes, Miguel A.
   Vega, Leidy D.
   Oliveros, Nicolas L.
   Soto, Javier A.
   Chia, Claudia R.
   Osorio, Jorge E.
   Ciuoderis, Karl A.
TI Immunological Memory to Zika Virus in a University Community in
   Colombia, South America
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE cytokines; flavivirus infection; immunological memory; seroepidemiologic
   studies; Zika virus
ID T-CELL RESPONSES; DENGUE; INFECTION; TRANSMISSION; OUTBREAK; KINETICS;
   ANTIBODY; CD4(+); SPREAD; BRAZIL
AB Zika virus appeared in South America in 2015, generating alarm worldwide as it causes microcephaly and autoimmunity. This study aims to determine the serological footprint of the incoming epidemic in a student community and to characterize the memory functional cell response during post convalescence. In a cross-sectional study, Zika-specific IgG using LIA immunoassay was found in 328 university students (CI=95%), while in the second phase, the functional cellular memory response for IFN-gamma and IL-2 was quantified using post-stimulus ELISpot with inactivated virus, starting with individuals seropositive for Zika and control individuals (seropositive only for Dengue and seronegative for Zika-Dengue). Depending on the antigen used, memory humoral response (IgG) against Zika Virus was observed in >60% of the population; seropositivity for NS1 was 21.1% higher than E antigen with high intensity. The analysis of cell functionality in 22 individuals seropositive for Zika virus revealed either IFN-gamma+ or IL-2+ cells in 86.3% of cases (Th1 profile), presenting multifunctionality in 50% (11 individuals), 64% of which presented > 6 SFC/10(4) PBMCs (>600 SFC/10(6) PBMC), reflecting memory circulating cells. A good agreement (Kappa = 0.754) was observed between the coexistence of both cellular and humoral responses but not in their intensity.
C1 [Cardenas, Denny M.; Jaimes, Miguel A.; Vega, Leidy D.; Oliveros, Nicolas L.; Soto, Javier A.; Chia, Claudia R.] Univ Santander, Fac Hlth Sci, Biogen Res Grp, 4E Ave 10N-61St, Cucuta 540003, Colombia.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, 119 Hanson Biomed Sci Bldg,1656 Linden Dr, Madison, WI 53706 USA.
   [Ciuoderis, Karl A.] Univ Nacl Colombia, Ctr Res & Surveillance Trop & Infect Dis, CRS TID Res Grp, 75th St 79a-51 Block M15, Medellin 050034, Colombia.
RP Cardenas, DM (corresponding author), Univ Santander, Fac Hlth Sci, Biogen Res Grp, 4E Ave 10N-61St, Cucuta 540003, Colombia.
EM dennymileycardenas@gmail.com
FU Universidad de Santander; University of Wisconsin and Corpotropica
   (CRS-TID) in Universidad Nacional de Colombia-Medellin
FX The authors of this study acknowledge the Universidad de Santander for
   the corresponding funding; to University of Wisconsin and Corpotropica
   (CRS-TID) in Universidad Nacional de Colombia-Medellin, as well as each
   of the volunteer students who participated in the study, the support to
   conduct this research.
CR Adam A, 2018, J IMMUNOL, V201, P3804, DOI 10.4049/jimmunol.1800892
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bhaumik SK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010019
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bozza FA, 2019, EMERG INFECT DIS, V25, P311, DOI 10.3201/eid2502.180166
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardenas D, 2015, CLIN EXP IMMUNOL, V182, P173, DOI 10.1111/cei.12682
   Cárdenas Denny, 2015, Rev Med Hered, V26, P230
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CIMINI E, 2017, SCI REP, V7, P1
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Barros JBD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00821
   DELGADO F, 2018, VIRUSES, V10, P1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   FLAMAND C, 2017, EUROSURVEILLANCE, V22, P17
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   GRIFONI A, 2017, J VIROL, V91, P1
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Hobbs SJ, 2018, CURR OPIN VIROL, V28, P12, DOI 10.1016/j.coviro.2017.10.001
   Holbrook M. R., 2017, VIRUSES, V9, P1
   Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   LIM MQ, 2018, FRONT IMMUNOL, V9, P1
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Ngono AE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01316
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ning RJ, 2011, IMMUNOLOGY, V134, P161, DOI 10.1111/j.1365-2567.2011.03476.x
   OLIVEIRA RA, 2019, MEM I O CRUZ, V114, P1
   ORTIZ OGP, 2016, REV CIENTIFICA DEP M, V2, P7
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   REYNOLDS C, 2018, SCI REP, V8, P1
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   ROTH C, 2018, INT J ENV RES PUB HE, V15, P1
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Schreiner D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02394
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   SIVIGILA NPHSS, 2018, EP B WEEK, V52
   SIVIGILA NPHSS, 2016, B WEEK, V52
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   TIAN Y, 2019, FRONT IMMUNOL, V10, P1
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   TURTLE L, 2017, PLOS NEGLECT TROP D, V11, P1
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WANG WN, 2018, NAT COMMUN, V9, DOI DOI 10.1515/NPF-2017-0032
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, J INTERF CYTOK RES, V37, P475, DOI 10.1089/jir.2017.0106
   WHO, 2016, SAUDI MED J, V37, P332
   Wilder-Smith A., 2018, J TRAVEL MED, V25, P1, DOI DOI 10.1093/JTM/TAY057
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   WORLD HEALTH ORGANIZATION WHO, 2016, CUM ZIK SUSP CONF CA
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 79
TC 0
Z9 0
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PY 2020
VL 92
IS 1
AR e20190883
DI 10.1590/0001-3765202020190883
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LV4QQ
UT WOS:000538422200001
PM 32491129
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Biswas, SK
   Ghosh, U
   Sarkar, S
AF Biswas, Sudhanshu Kumar
   Ghosh, Uttam
   Sarkar, Susmita
TI Mathematical model of zika virus dynamics with vector control and
   sensitivity analysis
SO INFECTIOUS DISEASE MODELLING
LA English
DT Article
DE Zika virus; Vector transmission; Sexual transmission; Basic reproduction
   number; Stability analysis; Backward bifurcation; Sensitivity analysis
ID SEXUAL TRANSMISSION
AB In this paper, we have developed and analyzed a deterministic Zika model considering both vector and sexual transmission route with the effect of human awareness and vector control in the absence of disease induce death. To formulate the model, we assume that the Zika virus is being first transmitted to human by mosquito bite, and then it is being transmitted to his or her sexual partner. The system contains at most three equilibrium points among them one is the disease free and other two are endemic equilibrium points, exists under certain conditions. The theoretical analysis shows that the diseases-free equilibrium is locally and globally asymptotically stable if the basic reproduction number is less than one. Theatrically we have established that endemic equilibrium point which is locally asymptotically stable if the basic reproduction number is greater than one. The system exhibits backward bifurcation when the transmission probability per biting of susceptible mosquito with infected humans crosses the critical value. We estimate the model parameters and validate the model by fitting the model with the reported Zika infected human data from 1 to 36 week of 2016 Zika outbreak in Colombia. Furthermore, using the normalised forward sensitivity index method we have established that the model parameter mosquito biting rate, recruitment rate of mosquito, transmission probability per biting of Susceptible (infected) humans with infected (susceptible) mosquito, rate of awareness in host population, recovery rates of infected human are most sensitive parameters of the considered Zika model. Lastly, some conclusions are given to control the spreading of the Zika disease. (c) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Biswas, Sudhanshu Kumar] Sripat Singh Coll, Dept Math, Murshidabad, W Bengal, India.
   [Ghosh, Uttam; Sarkar, Susmita] Univ Calcutta, Dept Appl Math, Kolkata, India.
RP Ghosh, U (corresponding author), Univ Calcutta, Dept Appl Math, Kolkata, India.
EM sudhanshukumarbiswas207@gmail.com; uttam_math@yahoo.co.in;
   susmita62@yahoo.co.in
CR Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   [Anonymous], 2016, TORONTO STAR
   [Anonymous], 2017, ZIK EP REP
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361
   Castillo-Chavez C., 2002, MATH APPROACHES EMER
   Cauchemez S., 2016, LANCET, V15
   Centers for Disease Control and Prevention (CDC), 2016, UPD INT GUID PREV SE
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Dallas County Health Human Services (DCHHS), 2016, DCHHS REP 1 ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Esteva L, 2000, MATH BIOSCI, V167, P51, DOI 10.1016/S0025-5564(00)00024-9
   Esteva L, 2009, MATH COMPUT MODEL, V50, P611, DOI 10.1016/j.mcm.2009.02.012
   European Centre for Disease Control and Prevention (CDC), 2015, ZIK VIR INF
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gakkhar Sunita, 2013, APPL MATH, V4, P142
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   HETHCOTE HW, 1985, MATH BIOSCI, V75, P205, DOI 10.1016/0025-5564(85)90038-0
   Imran M., 2017, DIFFER EQU DYN SYST, DOI [10.1007/s12591-017-0374-6, DOI 10.1007/S12591-017-0374-6]
   Kucharski A. J., 2016, PLOS NEGLECTED TROPI, V10
   Lakshmikantham V., 1989, STABILITY ANAL NONLI
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manore C, SIAM NEWS
   Mishra A, 2014, APPL MATH COMPUT, V246, P159, DOI 10.1016/j.amc.2014.07.115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Perkins T. A., 2016, BIORXIV PREPRINT
   Pontryagin L., 1986, MATH THEORY OPTIMAL, V4
   Powell D. R., 2005, P INT SYST DYN C BOS
   Shah NH, 2017, APPL MATH, V8, P500
   Shapshak P., 2015, ZIKA VIRUS GLOBAL VI
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   World Health Organization, 2016, ZIK VIR
NR 38
TC 0
Z9 0
U1 0
U2 0
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717,
   PEOPLES R CHINA
EI 2468-0427
J9 INFECT DIS MODEL
JI Infect. Dis. Model.
PY 2020
VL 5
BP 23
EP 41
DI 10.1016/j.idm.2019.12.001
PG 19
WC Mathematical & Computational Biology; Infectious Diseases
SC Mathematical & Computational Biology; Infectious Diseases
GA LV8LM
UT WOS:000538690300003
PM 31911957
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, H
   Lui, R
AF Zhang, Hong
   Lui, Roger
TI Releasing Wolbachia-infected Aedes aegypti to prevent the spread of
   dengue virus: A mathematical study
SO INFECTIOUS DISEASE MODELLING
LA English
DT Article
DE Mathematical modeling; Steady-states; Bistability; Optimal control;
   Uncertainty analysis; Sensitivity analysis
ID SENSITIVITY-ANALYSIS; ZIKA VIRUS; TRANSMISSION; DYNAMICS; DISEASE;
   MODEL; UNCERTAINTY
AB Wolbachia is a bacterium that is present in 60% of insects but it is not generally found in Aedes aegypti, the primary vector responsible for the transmission of dengue virus, Zika virus, and other human diseases caused by RNA viruses. Wolbachia has been shown to stop the growth of a variety of RNA viruses in Drosophila and in mosquitoes. Wolbachia-infected Ae. aegypti have both reproductive advantages and disadvantages over wild types. If Wolbachia-infected females are fertilized by either normal or infected males, the offspring are healthy and Wolbachia-positive. On the other hand, if Wolbachia-negative females are fertilized by Wolbachia-positive males, the offspring do not hatch. This phenomenon is called cytoplasmic incompatibility. Thus, Wolbachia-positive females have a reproductive advantage, and the Wolbachia is expanded in the population. On the other hand, Wolbachia-infected mosquitoes lay fewer eggs and generally have a shorter lifespan. In recent years, scientists have successfully released these Wolbachia-adapted mosquitoes into the wild in several countries and have achieved a high level of replacement with Wolbachia-positive mosquitoes. Here, we propose a minimal mathematical model to investigate the feasibility of such a release method. The model has five steady-states two of which are locally asymptotically stable. One of these stable steady-states has no Wolbachia-infected mosquitoes while for the other steady-state, all mosquitoes are infected with Wolbachia. We apply optimal control theory to find a release method that will drive the mosquito population close to the steady-state with only Wolbachia-infected mosquitoes in a two-year time period. Because some of the model parameters cannot be accurately measured or predicted, we also perform uncertainty and sensitivity analysis to quantify how variations in our model parameters affect our results. (c) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Zhang, Hong] Merck Res Labs, Rahway, NJ 07065 USA.
   [Lui, Roger] Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA.
RP Lui, R (corresponding author), Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA.
EM hong.zhang8@merck.com; rlui@wpi.edu
OI Zhang, Hong/0000-0002-8869-8671
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Agusto FB, 2018, MATH BIOSCI, V305, P102, DOI 10.1016/j.mbs.2018.09.007
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Antonelli T. D., 2015, POPULATION DYNAMICS
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Campo-Duarte DE, 2018, J MATH BIOL, V76, P1907, DOI 10.1007/s00285-018-1213-2
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Chung KW, 2016, J MATH BIOL, V73, P1467, DOI 10.1007/s00285-016-1000-x
   Derouich M, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-4
   Dorigatti I, 2018, TRENDS PARASITOL, V34, P102, DOI 10.1016/j.pt.2017.11.002
   Edelstein-Keshet L., 2005, MATH MODELS BIOL
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fisher RA, 1924, METRON, V3, P329
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   Kamtchum-Tatuene J, 2017, CURR OPIN INFECT DIS, V30, P108, DOI 10.1097/QCO.0000000000000342
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kendall MG, 1942, BIOMETRIKA, V32, P277, DOI 10.1093/biomet/32.3-4.277
   Labbe GMC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001724
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522
   Ndii MZ, 2016, EPIDEMIOL INFECT, V144, P2874, DOI 10.1017/S0950268816000753
   Ndii MZ, 2016, THEOR POPUL BIOL, V111, P9, DOI 10.1016/j.tpb.2016.05.003
   Ndii MZ, 2015, MATH BIOSCI, V262, P157, DOI 10.1016/j.mbs.2014.12.011
   O'Neill S. L., 2018, GATES OPEN RES, V2
   Saltelli A, 2008, GLOBAL SENSITIVITY A
   Sanches Rosangela Peregrina, 2016, Infect Dis Model, V1, P88, DOI 10.1016/j.idm.2016.08.002
   Smith H, 2011, TEXTS APPL MATH, V57, P1, DOI 10.1007/978-1-4419-7646-8
   Supriatna AK, 2012, PROCEDIA ENGINEER, V50, P12, DOI 10.1016/j.proeng.2012.10.002
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   WHO, 2016, DENG CONTR
   World Health Organization, 2019, DENG SEV DENG
   Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   2016, B WORLD HEALTH ORGAN, V94, P562
NR 44
TC 0
Z9 0
U1 0
U2 0
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717,
   PEOPLES R CHINA
EI 2468-0427
J9 INFECT DIS MODEL
JI Infect. Dis. Model.
PY 2020
VL 5
BP 142
EP 160
DI 10.1016/j.idm.2019.12.004
PG 19
WC Mathematical & Computational Biology; Infectious Diseases
SC Mathematical & Computational Biology; Infectious Diseases
GA LV8LM
UT WOS:000538690300009
PM 31956742
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mello, MVP
   Domingos, TFS
   Ferreira, DF
   Ribeiro, MMJ
   Ribeiro, TP
   Rodrigues, CR
   Souza, AMT
AF Mello, Marcos V. P.
   Domingos, Thaisa F. S.
   Ferreira, Davis F.
   Ribeiro, Mariana M. J.
   Ribeiro, Thayssa P.
   Rodrigues, Carlos R.
   Souza, Alessandra M. T.
TI Antiviral Drug Discovery and Development for Mayaro Fever - What do we
   have so far?
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Mayaro virus; mayaro fever; alphavirus; antivirals; tropical infectious;
   arboviruses
ID LOUIS-ENCEPHALITIS-VIRUS; HUMAN-DISEASE AGENT; MATO-GROSSO; BIOLOGICAL
   EVALUATION; PROSTAGLANDIN A(1); ZIKA VIRUS; SAO-PAULO; DERIVATIVES;
   INFECTION; BRAZIL
AB Tropical infectious diseases cause millions of deaths every year in developing countries, with about half of the world population living at risk. Mayaro virus (MAYV) is an emerging arbovirus that causes Mayaro fever, which is characterized by fever, headache, diarrhea, arthralgia, and rash. These symptoms can be clinically indistinguishable from other arboviruses, such as Dengue, Zika, and Chikungunya, which makes the diagnosis and treatment of the disease more difficult. Though, the Mayaro virus is a potential candidate to cause large-scale epidemics on the scale of ZIKV and CHIKV. Despite this, there is no licensed vaccine or antiviral for the treatment of Mayaro fever and most arboviruses, so the design and development of candidates for antiviral drugs are urgently needed. In this context, this mini-review aims to provide an overview of studies of anti-MAYV derivatives and highlight the importance of the discovery and development of promising drug candidates for Mayaro fever.
C1 [Mello, Marcos V. P.; Domingos, Thaisa F. S.; Ribeiro, Mariana M. J.; Ribeiro, Thayssa P.; Rodrigues, Carlos R.; Souza, Alessandra M. T.] Univ Fed Rio de Janeiro, Fac Pharm, Lab Mol Modeling & QSAR ModMolQSAR, Rio De Janeiro, RJ, Brazil.
   [Mello, Marcos V. P.] Fed Fluminense Univ, Chem Inst, Niteroi, RJ, Brazil.
   [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Paulo de Goes Microbiol Inst, Dept Virol, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Davis F.] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC USA.
RP Souza, AMT (corresponding author), Univ Fed Rio de Janeiro, Fac Pharm, Lab Mol Modeling & QSAR ModMolQSAR, Rio De Janeiro, RJ, Brazil.
EM amtsouza2@yahoo.com.br
RI Palmeira-Mello, Marcos V./M-3659-2014
OI Palmeira-Mello, Marcos V./0000-0003-2550-5315
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   Aly HM, 2011, EUR J MED CHEM, V46, P4566, DOI 10.1016/j.ejmech.2011.07.035
   Amorim R, 2017, ARCH VIROL, V162, P1577, DOI 10.1007/s00705-017-3261-0
   Anderson R., 1957, ISOLATION BLOOD OFPA, V6, DOI DOI 10.4269/AJTMH.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Bernardino Alice Mr, 2012, Org Med Chem Lett, V2, P3, DOI 10.1186/2191-2858-2-3
   Burlandy FM, 2001, INTERVIROLOGY, V44, P344, DOI 10.1159/000050069
   Caldas LA, 2018, REV SOC BRAS MED TRO, V51, P584, DOI 10.1590/0037-8682-0235-2018
   Camini FC, 2018, ANTIVIR RES, V158, P8, DOI 10.1016/j.antiviral.2018.07.023
   Carvalho CAM, 2014, VIROLOGY, V452, P297, DOI 10.1016/j.virol.2014.01.022
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   Heinen LBD, 2015, REV INST MED TROP SP, V57, P215, DOI 10.1590/S0036-46652015000300006
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   DEMELLO H, 2004, ANTILEISHMANIAL PYRA, V47, P5427, DOI DOI 10.1021/JM0401006
   dos Santos AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-130
   FARIA NR, 2016, PLOS CURR, V8, DOI DOI 10.1186/S13073-016-0356-2
   Ferraz AC, 2019, ANTIVIR RES, V168, P76, DOI 10.1016/j.antiviral.2019.05.008
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hayakawa I, 2004, BIOORG MED CHEM LETT, V14, P3411, DOI 10.1016/j.bmcl.2004.04.079
   Ishimaru D, 1998, BRAZ J MED BIOL RES, V31, P1119, DOI 10.1590/S0100-879X1998000900003
   Kim NC, 2003, ORG BIOMOL CHEM, V1, P1684, DOI 10.1039/b300099k
   Leal B, 2008, BIOORGAN MED CHEM, V16, P8196, DOI 10.1016/j.bmc.2008.07.035
   Lin Liang-Tzung, 2014, J Tradit Complement Med, V4, P24, DOI 10.4103/2225-4110.124335
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   Lourenco AL, 2017, EUR J MED CHEM, V135, P213, DOI 10.1016/j.ejmech.2017.04.023
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Michailidou M, 2016, EUR J MED CHEM, V121, P143, DOI 10.1016/j.ejmech.2016.05.035
   Ministerio da Saude, SIT EP DAD
   Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/S0037-86822011005000041, 10.1590/s0037-86822011005000041]
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Navarrete-Espinosa Joel, 2006, Rev Med Inst Mex Seguro Soc, V44, P347
   Orlikova B, 2014, EUR J MED CHEM, V85, P450, DOI 10.1016/j.ejmech.2014.08.008
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Parvez MK, 2017, INTERVIROLOGY, V60, P1, DOI 10.1159/000478729
   Pauvolid-Correa A, 2010, MEM I OSWALDO CRUZ, V105, P829, DOI 10.1590/S0074-02762010000600017
   Pena-Garcia VH, 2017, CURR CLIN MICROBIOL, V4, P208, DOI 10.1007/s40588-017-0076-4
   Pinheiro F. P., 1988, The arboviruses: epidemiology and ecology. Volume III., P137
   Pinheiro L, 2012, J MICROBIOL ANTIMICR, V4, P32, DOI DOI 10.5897/JMA11.109
   Queiroz MJRP, 2010, EUR J MED CHEM, V45, P5628, DOI 10.1016/j.ejmech.2010.09.014
   Redwan EM, 2014, CR BIOL, V337, P581, DOI 10.1016/j.crvi.2014.08.003
   Bernardino AMR, 2007, MED CHEM RES, V16, P352, DOI 10.1007/s00044-007-9035-6
   Bernardino AMR, 2006, BIOORGAN MED CHEM, V14, P5765, DOI 10.1016/j.bmc.2006.03.013
   Saito MS, 2016, J ENZYM INHIB MED CH, V31, P1591, DOI 10.3109/14756366.2016.1158712
   SANTORO M G, 1990, P27
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva TB, 2016, BIOORGAN MED CHEM, V24, P4492, DOI 10.1016/j.bmc.2016.07.049
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Spindola KCW, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0537-z
   Fantinato FFST, 2016, EPIDEMIOL SERV SAUDE, V25, P683, DOI [10.5123/S1679-49742016000400002, 10.5123/s1679-49742016000400002]
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Torres JR, 2004, EMERG INFECT DIS, V10, P1304
   Weaver S., 2005, 8 INT COMM TAX VIR L, P999
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 71
TC 0
Z9 0
U1 1
U2 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PY 2020
VL 20
IS 10
BP 921
EP 928
DI 10.2174/1389557520666200316160425
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA LU0BK
UT WOS:000537428600008
PM 32178610
DA 2020-07-08
ER

PT J
AU de Jesus, JG
   Dutra, KR
   Sales, FCD
   Claro, IM
   Terzian, AC
   Candido, DD
   Hill, SC
   Theze, J
   Torres, C
   D'Agostini, TL
   Felix, AC
   Reis, AFN
   Alcantar, LC
   de Abreu, AL
   Croda, JHR
   de Oliveira, WK
   de Filipis, AMB
   Camis, MDRD
   Romano, CM
   Loman, NJ
   Pybus, OG
   Sabino, EC
   Nogueira, ML
   Faria, NR
AF de Jesus, Jaqueline Goes
   Dutra, Karina Rocha
   da Silva Sales, Flavia Cristina
   Claro, Ingra Morales
   Terzian, Ana Carolina
   Candido, Darlan da Silva
   Hill, Sarah C.
   Theze, Julien
   Torres, Celeste
   D'Agostini, Tatiana Lang
   Felix, Alvina Clara
   Negri Reis, Andreia F.
   Alcantar, Luiz Carlos Junior
   de Abreu, Andre L.
   Croda, Julio H. R.
   de Oliveira, Wanderson K.
   Bispo de Filipis, Ana Maria
   Rodrigues dos Santos Camis, Maria do Carmo
   Romano, Camila Malta
   Loman, Nick J.
   Pybus, Oliver G.
   Sabino, Ester Cerdeira
   Nogueira, Mauricio L.
   Faria, Nuno Rodrigues
TI Genomic detection of a virus lineage replacement event of dengue virus
   serotype 2 in Brazil, 2019
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue 2; outbreak; genomic surveillance; lineage replacement; Brazil
ID ZIKA VIRUS; CIRCULATION
AB BACKGROUND Despite efforts to mitigate the impact of dengue virus (DENV) epidemics, the virus remains a public health problem in tropical and subtropical regions around the world. Most DENV cases in the Americas between January and July 2019 were reported in Brazil. Sao Paulo State in the southeast of Brazil has reported nearly half of all DENV infections in the country.
   OBJECTIVES To understand the origin and dynamics of the 2019 DENV outbreak.
   METHODS Here using portable nanopore sequencing we generated20 new DENV genome sequences from viremic patients with suspected dengue infection residing in two of the most-affected municipalities of Sao Paulo State, Araraquara and Sao Jose do Rio Preto. We conducted a comprehensive phylogenetic analysis with 1,630 global DENV strains to better understand the evolutionary history of the DENV lineages that currently circulate in the region.
   FINDINGS The new outbreak strains were classified as DENV2 genotype III (American/Asian genotype). Our analysis shows that the 2019 outbreak is the result of a novel DENV lineage that was recently introduced to Brazil from the Caribbean region. Dating phylogeographic analysis suggests that DENV2-III BR-4 was introduced to Brazil in or around early 2014, possibly from the Caribbean region.
   MAIN CONCLUSIONS Our study describes the early detection of a newly introduced and rapidly-expanding DENV2 virus lineage in Brazil.
C1 [de Jesus, Jaqueline Goes; da Silva Sales, Flavia Cristina; Claro, Ingra Morales; Felix, Alvina Clara; Romano, Camila Malta; Sabino, Ester Cerdeira; Faria, Nuno Rodrigues] Univ Sao Paulo, Inst Med Trop, Sao Paulo, SP, Brazil.
   [Dutra, Karina Rocha; Terzian, Ana Carolina; Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Sao Jose Do Rio Preto, SP, Brazil.
   [Candido, Darlan da Silva; Hill, Sarah C.; Theze, Julien; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Torres, Celeste; Alcantar, Luiz Carlos Junior; Bispo de Filipis, Ana Maria] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [D'Agostini, Tatiana Lang; Rodrigues dos Santos Camis, Maria do Carmo] Coordenadoria Controle Doencas Sao Paulo, Ctr Vigilancia Epidemiol Prof Alexandre Vranjac, Secretaria Estado Saude, Sao Paulo, SP, Brazil.
   [Negri Reis, Andreia F.] Secretaria Municipal Saude, Sao Jose Do Rio Preto, SP, Brazil.
   [Alcantar, Luiz Carlos Junior] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [de Abreu, Andre L.; Croda, Julio H. R.; de Oliveira, Wanderson K.] Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Minist Saude, Brasilia, DF, Brazil.
   [Croda, Julio H. R.] Fundacao Univ Fed Grande Dourados, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.
   [Croda, Julio H. R.] Fiocruz MS, Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.
   [Romano, Camila Malta] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, SP, Brazil.
   [Loman, Nick J.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
RP Faria, NR (corresponding author), Univ Sao Paulo, Inst Med Trop, Sao Paulo, SP, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM nuno.faria@zoo.ox.ac.uk
OI Hill, Sarah/0000-0002-2995-2596
FU FAPESP-MRC grant (CADDE) [FAPESP 2018/14389-0]; Wellcome TrustWellcome
   Trust; Royal Society Sir Henry Dale Fellowship [204311/Z/16/Z];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [400354/2016-0, 440685/2016-8, 440856/2016-7]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/01735-2, 13/21719-3,
   15/12295-0, 15/14313-6]; Oxford Martin School; Decit/SCTIE/MoH;
   CAPESCAPES [88887.130716/201600, 88881.130825/2016-00,
   88887.130823/2016-00]; EU's Horizon 2020 Programme through ZIKAlliance
   [PRES-005-FEX-17-4-2-33]
FX Financial support: The research was supported by the FAPESP-MRC grant
   (CADDE, FAPESP 2018/14389-0), a Wellcome Trust and Royal Society Sir
   Henry Dale Fellowship (grant 204311/Z/16/Z), and by a CNPq
   #400354/2016-0 and FAPESP #2016/01735-2, and by the Oxford Martin
   School; Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7);
   CAPES (88887.130716/201600, 88881.130825/2016-00 and
   88887.130823/2016-00); EU's Horizon 2020 Programme through ZIKAlliance
   (PRES-005-FEX-17-4-2-33).; MLN is supported by FAPESP (grant
   #13/21719-3); ACBT and KRD receive FAPESP Scholarships (grants
   #15/12295-0 and 15/14313-6, respectively); MLN and ECS are CNPq Research
   Fellows (PQ).
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   de Bruycker-Nogueira F, 2016, INFECT GENET EVOL, V45, P454, DOI 10.1016/j.meegid.2016.09.025
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fonseca V, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007231
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Nunes PCG, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6641-4
   Hill SC, 2019, EMERG INFECT DIS, V25, P784, DOI 10.3201/eid2504.180958
   Kanakaratne N, 2009, EMERG INFECT DIS, V15, P192, DOI 10.3201/eid1502.080926
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Mir D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098519
   MS-Ministerio da Saude, 2019, MON CAS ARB ROS URB
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Ortiz-Baez AS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180251
   PAHO /WHO-Pan American Health Organization/World Health Organization, 2019, EP UPD YELL FEV
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
NR 28
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e190423
DI 10.1590/0074-02760190423
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LT4TX
UT WOS:000537066200001
PM 32428189
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barbosa, RMR
   de Melo-Santos, MAV
   Silveira , JC
   Silva, MHNL
   Souza, WV
   de Oliveira, CMF
   Ayres, CFJ
   Xavier, MD
   Rodrigues, MP
   dos Santos, SA
   Nakazawa, MM
   Regis, LN
AF Rodrigues Barbosa, Rosangela Maria
   Varjal de Melo-Santos, Maria Alice
   Silveira Jr, Jose Constantino
   Lobo Silva-Filha, Maria Helena Neves
   Souza, Wayner Vieira
   Fontes de Oliveira, Claudia Maria
   Junqueira Ayres, Constancia Flavia
   Xavier, Morgana do Nascimento
   Rodrigues, Marina Praxedes
   dos Santos, Suzane Alves
   Nakazawa, Mitsue Maia
   Regis, Leda Narcisa
TI Infestation of an endemic arbovirus area by sympatric populations of
   Aedes aegypti and Aedes albopictus in Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE vectors; arboviruses; egg monitoring; surveillance; ovitraps; dengue
ID DENGUE; CULICIDAE; DIPTERA; VECTOR; ZIKA
AB BACKGROUND Aedes aegypti and Aedes albopictus are the most important arbovirus vectors in the world.
   OBJECTIVES This study aimed to investigate and compare the infestation pattern of these species in a neighbourhood of Recife, Brazil, endemic for arboviruses in 2005 (T1) and 2013 (T2). METHODS Infestation, distribution and relative abundance of these sympatric species were recorded by egg collection using a network of 59 sentinel ovitraps (s-ovt) at fixed sampling stations for 12 months in T1 and T2.
   FINDINGS A permanent occupation pattern was detected which was characterised by the presence of egg-laying females of one or both species with a high ovitrap positivity index (94.3 to 100%) throughout both years analysed. In terms of abundance, the total of eggs collected was lower (p < 0.005) in T2 (146,153) than in T1 (281,103), although ovitraps still displayed a high index of positivity. The spatial distribution showed the presence of both species in 65.1% of the 148 s-ovt assessed, while a smaller number of traps exclusively contained Ae. aegypti (22%) or Ae. albopictus (13.2%) eggs.
   MAIN CONCLUSIONS Our comparative analysis demonstrated the robustness of the spatial occupation and permanence of Ae. aegypti and Ae. albopictus populations in this endemic urban area.
C1 [Rodrigues Barbosa, Rosangela Maria; Varjal de Melo-Santos, Maria Alice; Lobo Silva-Filha, Maria Helena Neves; Fontes de Oliveira, Claudia Maria; Junqueira Ayres, Constancia Flavia; Xavier, Morgana do Nascimento; Rodrigues, Marina Praxedes; dos Santos, Suzane Alves; Nakazawa, Mitsue Maia; Regis, Leda Narcisa] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
   [Silveira Jr, Jose Constantino; Souza, Wayner Vieira] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Dept Saude Colet, Recife, PE, Brazil.
RP Barbosa, RMR (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
EM barbosar@cpqam.fiocruz.br
OI Barbosa, Rosangela Maria/0000-0002-1171-598X
FU Brazilian Swiss Joint Research Programme [BJRP 0112-08]; FACEPE-PROEP
   (APQ) [1630-2.01/15]
FX This study received funds from the Brazilian Swiss Joint Research
   Programme (Grant no. BJRP 0112-08), FACEPE-PROEP (APQ 1630-2.01/15).
CR Bailey T.C., 1995, INTERACTIVE SPATIAL
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   de Albuquerque C M, 2000, Rev Saude Publica, V34, P314
   Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x
   Forattini OP, 1965, CULICINI CULEX AEDES, VII
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Ayres CFJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3461-4
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Morato VCG, 2005, REV SAUDE PUBL, V39, P553, DOI [10.1590/S0034-89102005000400006, 10.1590/s0034-89102005000400006]
   MS-Ministerio da Saude, 2002, PROGR NAC CONTR DENG
   MS-Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2009, SECR VIG SAUD
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   REGIS L, 1995, MEM I OSWALDO CRUZ, V90, P115, DOI 10.1590/S0074-02761995000100022
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Regis LN, 2014, ACTA TROP, V137, P80, DOI 10.1016/j.actatropica.2014.04.010
   Regis LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067682
   Santos S. R. A., 2003, Dengue Bulletin, V27, P156
   Suter T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2364-5
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e190437
DI 10.1590/0074-02760190437
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LT4TY
UT WOS:000537066300001
PM 32428083
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nunes, BTD
   Fontes-Garfias, CR
   Shan, C
   Muruato, AE
   Nunes, JGC
   Burbano, RMR
   Vasconcelos, PFC
   Shi, PY
   Medeiros, DBA
AF Nunes, Bruno T. D.
   Fontes-Garfias, Camila R.
   Shan, Chao
   Muruato, Antonio E.
   Nunes, Jannyce G. C.
   Burbano, Rommel M. R.
   Vasconcelos, Pedro F. C.
   Shi, Pei-Yong
   Medeiros, Daniele B. A.
TI Zika structural genes determine the virulence of African and Asian
   lineages
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika; virulence; lineages; African; Asian
ID CENTRAL-NERVOUS-SYSTEM; VIRUS-INFECTION; MOUSE MODEL; STRAINS;
   TRANSMISSION; MECHANISMS; VACCINE; BRAZIL; DAMAGE
AB The Asian lineage of Zika virus (ZIKV) is responsible for the recent epidemics in the Americas and severe disease, whereas the African lineage of ZIKV has not been reported to cause epidemics or severe disease. We constructed a cDNA infectious clone (IC) of an African ZIKV strain, which, together with our previously developed Asian ZIKV strain IC, allowed us to engineer chimeric viruses by swapping the structural and non-structural genes between the two lineages. Recombinant parental and chimeric viruses were analyzed in A129 and newborn CD1 mouse models. In the A129 mice, the African strain developed higher viremia, organ viral loading, and mortality rate. In CD1 mice, the African strain exhibited a higher neurovirulence than the Asian strain. A chimeric virus containing the structural genes from the African strain is more virulent than the Asian strain, whereas a chimeric virus containing the non-structural genes from the African strain exhibited a virulence comparable to the Asian strain. These results suggest that (i) African strain is more virulent than Asian strain and (ii) viral structural genes primarily determine the virulence difference between the two lineages in mouse models. Other factors may contribute to the discrepancy between the mouse and epidemic results.
C1 [Nunes, Bruno T. D.; Vasconcelos, Pedro F. C.; Medeiros, Daniele B. A.] Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Brazil.
   [Nunes, Bruno T. D.; Fontes-Garfias, Camila R.; Shan, Chao; Muruato, Antonio E.; Nunes, Jannyce G. C.; Shi, Pei-Yong; Medeiros, Daniele B. A.] Dept Biochem & Mol Biol, Galveston, TX USA.
   [Muruato, Antonio E.] Dept Microbiol & Immunol, Galveston, TX USA.
   [Shi, Pei-Yong] Inst Human Infect & Immun, Galveston, TX USA.
   [Shi, Pei-Yong] Inst Translat Sci, Galveston, TX USA.
   [Shi, Pei-Yong] Sealy Inst Vaccine Sci, Galveston, TX USA.
   [Shi, Pei-Yong] Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA.
   [Vasconcelos, Pedro F. C.] Para State Univ Belem, Dept Pathol, Belem, Para, Brazil.
   [Medeiros, Daniele B. A.] Minist Hlth, Evandro Chagas Inst, Post Grad Program Virol, Ananindeua, Brazil.
   [Nunes, Bruno T. D.; Nunes, Jannyce G. C.; Burbano, Rommel M. R.; Medeiros, Daniele B. A.] Hlth Sci Inst, Belem, Para, Brazil.
   [Burbano, Rommel M. R.] Fed Univ Para, Biol Sci Inst ICS, Belem, Para, Brazil.
RP Shi, PY (corresponding author), 301 Univ Blvd, Galveston, TX 77555 USA.; Medeiros, DBA (corresponding author), Rodovia BR-316 Km 7 S-N, BR-67030000 Ananindeua, PA, Brazil.
EM peshi@utmb.edu; danielemedeiros@iec.pa.gov.br
FU Amon G. Carter Foundation; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [303999/2016-0,440405/2016-5];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; John
   S. Dunn Foundation; Gilson Longenbaugh Foundation; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI127744, AI136126, AI142759]; PAHO [SCON2016-01353]; Summerfield
   Robert Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg
   Foundation; Sealy & Smith Foundation
FX This work was supported by Amon G. Carter Foundation; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico: [Grant Number
   303999/2016-0,440405/2016-5]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior: [Grant Number Zika fast track project]; John S. Dunn
   Foundation; Gilson Longenbaugh Foundation; NIH: [Grant Number
   AI127744,AI136126,AI142759]; PAHO: [Grant Number SCON2016-01353];
   Summerfield Robert Foundation; Robert J. Kleberg, Jr. and Helen C.
   Kleberg Foundation; Sealy & Smith Foundation.
CR Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   de Sousa JR, 2018, CYTOKINE, V111, P255, DOI 10.1016/j.cyto.2018.08.008
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontaine KA, 2018, MBIO, V9, DOI [10.1128/mBio.02126-18, 10.1128/mbio.02126-18]
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Jaeger AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007343
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li P, 2018, CELL HOST MICROBE, V24, P875, DOI 10.1016/j.chom.2018.10.011
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shi PY, 2002, VIROLOGY, V296, P219, DOI 10.1006/viro.2002.1453
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Slomnicki LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16952-8
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 47
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 1023
EP 1033
DI 10.1080/22221751.2020.1753583
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA LT7WC
UT WOS:000537275800001
PM 32419649
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Queiroz, JTM
   Silva, PN
   Heller, L
AF Matos de Queiroz, Josiane Teresinha
   Silva, Priscila Neves
   Heller, Leo
TI New premises for sanitation in arbovirus infections control in Brazil
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
ID RIO-DE-JANEIRO; DENGUE-FEVER; WATER; STATE; EMERGENCE; BURDEN; URBAN;
   ZIKA
C1 [Matos de Queiroz, Josiane Teresinha; Silva, Priscila Neves; Heller, Leo] Fundacao Oswaldo Cruz, Inst Rene Rachou, Av Augusto de Lima 1715, BR-31190009 Belo Horizonte, MG, Brazil.
RP de Queiroz, JTM (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Av Augusto de Lima 1715, BR-31190009 Belo Horizonte, MG, Brazil.
EM josiane.matosqueiroz@yahoo.com.br
OI QUEIROZ, JOSIANE/0000-0002-5773-6006; Neves-Silva,
   Priscila/0000-0001-8909-4477
CR Agencia Nacional de Aguas, ODS 6 BRAS VIAS AN I
   Aleixo B, 2019, SCI TOTAL ENVIRON, V652, P1445, DOI 10.1016/j.scitotenv.2018.10.202
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brown C, 2016, CIENC SAUDE COLETIVA, V21, P661, DOI 10.1590/1413-81232015213.20142015
   Buss Paulo Marchiori, 2007, Physis, V17, P77, DOI 10.1590/S0103-73312007000100006
   Carlton EJ, 2012, B WORLD HEALTH ORGAN, V90, P578, DOI 10.2471/BLT.11.098343
   Costa JV, 2013, CAD SAUDE PUBLICA, V29, P1522, DOI [10.1590/S0102-311X2013001200005, 10.1590/0102-311X00110912]
   de Almeida AS, 2009, REV SAUDE PUBL, V43, P666, DOI 10.1590/s0034-89102009000400013
   Teixeira TRD, 2008, CAD SAUDE PUBLICA, V24, P2160, DOI 10.1590/S0102-311X2008000900022
   de Oliveira R M, 2001, Cad Saude Publica, V17 Suppl, P77, DOI 10.1590/S0102-311X2001000700016
   Flauzino RF, 2011, SAUDE SOC-SAO PAULO, V20, P225, DOI 10.1590/S0104-12902011000100023
   Heller L., MELHORAMENTO SERVICO
   Johansen Igor Cavallini, 2018, Rev. salud pública, V20, P346, DOI [10.15446/rsap.v20n3.54315, 10.15446/rsap.V20n3.54315]
   Lenzi M F, 2000, Cad Saude Publica, V16, P851
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Neves-Silva P, 2016, CIENC SAUDE COLETIVA, V21, P1861, DOI 10.1590/1413-81232015216.03422016
   Pedrosa CDG, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008060
   Pina MF, 2000, CONCEITOS BASICOS SI, P13
   Rey JR, 2010, INTERCIENCIA, V35, P800
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Secretaria de Vigilancia em Saude Ministerio da Saude, B EPIDEMIOLOGICO, V51
   Secretaria Nacional de Saneamento Ambiental Ministerio das Cidades, PLAN NAC SAN BAS
   Silva PN, 2018, SANEAMENTO ENTRE OS, V6
   Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055
   Thammapalo S, 2008, EPIDEMIOL INFECT, V136, P135, DOI 10.1017/S0950268807008126
   United Nations Human Right Council, 2015, REP SPEC RAPP HUM RI
   Vilani RM, 2014, VIGIL SANIT DEBATE, V2, P18, DOI 10.3395/vd.v2i3.163
   Vilcarromero Stalin, 2015, Rev. perú. med. exp. salud publica, V32, P172
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   World Health Organization; United Nations Children's Fund, 2017, JOINT MON PROGR WAT
   World Helth Organization, GLOB STRAT DENG PREV
NR 32
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2020
VL 36
IS 5
AR e00233719
DI 10.1590/0102-311X00223719
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LQ7WL
UT WOS:000535209500001
PM 32402002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wang, T
   Li, PH
   Zhang, Y
   Liu, Y
   Tan, ZY
   Sun, JH
   Ke, XL
   Miao, YJ
   Luo, D
   Hu, QX
   Xu, FQ
   Wang, HZ
   Zheng, ZH
AF Wang, Ting
   Li, Penghui
   Zhang, Yuan
   Liu, Yan
   Tan, Zhongyuan
   Sun, Jianhong
   Ke, Xianliang
   Miao, Yuanjiu
   Luo, Dan
   Hu, Qinxue
   Xu, Fuqiang
   Wang, Hanzhong
   Zheng, Zhenhua
TI In vivo imaging of Zika virus reveals dynamics of viral invasion in
   immune-sheltered tissues and vertical propagation during pregnancy
SO THERANOSTICS
LA English
DT Article
DE Zika virus; Bioluminescence imaging; Viscera dissemination; Tissue
   localization; Vertical transmission; Pooled immune sera
ID ILEOCECAL SEGMENT TRANSPOSITION; WHOLE GUT TRANSIT; REPORTER VIRUSES;
   DENGUE VIRUS; INFECTION; TRANSMISSION; REPLICATION; INTERFERONS;
   PROTECTION; PARALYSIS
AB Rationale: Zika virus (ZIKV) is a pathogenic virus known to cause a wide range of congenital abnormalities, including microcephaly, Guillain-Barre syndrome, meningoencephalitis, and other neurological complications, in humans. This study investigated the noninvasive detection of ZIKV infection in vivo, which is necessary for elucidating the virus's mechanisms of viral replication and pathogenesis, as well as to accelerate the development of anti-ZIKV therapeutic strategies.
   Methods: In this study, a recombinant ZIKV harbouring Nluc gene (ZIKV-Nluc) was designed, recovered, and purified. The levels of bioluminescence were directly correlated with viral loads in vitro and in vivo. The dynamics of ZIKV infection in A129 (interferon (IFN)-alpha/beta receptor deficient), AG6 (IFN)-alpha/beta and IFN-gamma receptor deficient), and C57BL/6 mice were characterized. Pregnant dams were infected with ZIKV-Nluc at E10 via intra footpad injection. Then, the pooled immune sera (anti-ZIKV neutralizing antibodies) #22-1 in ZIKV-Nluc virus-infected mice were visualized.
   Results: ZIKV-Nluc showed a high genetic stability and replicated well in cells with similar properties to the wild-type ZIKV (ZIKVwt). Striking bioluminescence signals were consistently observed in animal organs, including spleen, intestine, testis, uterus/ovary, and kidney. The ileocecal junction was found to be the crucial visceral target. Infection of pregnant dams with ZIKV-Nluc showed that ZIKV was capable of crossing the maternal-fetal barrier to infect the fetuses via vertical transmission. Furthermore, it was visualized that treatment with the pooled immune sera was found to greatly restrict the spread of the ZIKV-Nluc virus in mice.
   Conclusions: This study is the first to report the real-time noninvasive tracking of the progression of ZIKV invading immune-sheltered tissues and propagating vertically during pregnancy. The results demonstrate that ZIKV-Nluc represents a powerful tool for the study of the replication, dissemination, pathogenesis, and treatment of ZIKV in vitro and in vivo.
C1 [Wang, Ting; Zhang, Yuan; Liu, Yan; Tan, Zhongyuan; Sun, Jianhong; Ke, Xianliang; Miao, Yuanjiu; Luo, Dan; Wang, Hanzhong; Zheng, Zhenhua] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
   [Wang, Ting; Xu, Fuqiang] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Key Lab Magnet Resonance Biol Syst,Ctr Brain Sci, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China.
   [Li, Penghui] Hebei Univ Engn, Coll Life Sci & Food Engn, Handan 056038, Peoples R China.
   [Hu, Qinxue] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
   [Hu, Qinxue] St Georges Univ London, Inst Infect & Immun, London SW17 0RE, England.
RP Zheng, ZH (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
EM zhengzh@wh.iov.cn
OI Hu, Qinxue/0000-0002-4594-9215
FU National Key R&D Program of China [2016YFD0500406]; National Natural
   Science Foundation of China (NSFC)National Natural Science Foundation of
   China [31800155, 81871665]; Youth Innovation Promotion Association of
   CAS [2016302]
FX The authors thank Prof. Qibin Leng of the Institute Pasteur of Shanghai,
   Chinese Academy of Sciences for providing the AG6 mice. We would also
   like to thank the Core Facility and Technical Support, Wuhan Institute
   of Virology, Chinese Academy of Sciences for Xuefang An's and Fan
   Zhang's help in the animal experiments. This work was supported by the
   National Key R&D Program of China (2016YFD0500406 to Hanzhong Wang),
   National Natural Science Foundation of China (NSFC) (31800155 to Ting
   Wang, 81871665 to Yuan Zhang), and Youth Innovation Promotion
   Association of CAS (2016302 to Zhenhua Zheng).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Barreto SG, 2017, DIGEST DIS SCI, V62, P319, DOI 10.1007/s10620-016-4402-0
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cai H, 2018, J VIROL, V92, DOI 10.1128/JVI.00593-18
   Caine EA, 2017, J VIROL, V91, DOI 10.1128/JVI.01759-16
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Czako R, 2017, MBIO, V8, DOI 10.1128/mBio.00714-17
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daniels BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005096
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Degen LP, 1997, ANN SURG, V226, P746, DOI 10.1097/00000658-199712000-00011
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112
   Falendysz EA, 2014, J WILDLIFE DIS, V50, P524, DOI 10.7589/2013-07-171
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478
   Hawley P, 1997, ANN SURG, V226, P751
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Jia F, 2016, VIROLOGY, V490, P109, DOI 10.1016/j.virol.2016.01.001
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Lasfar A, 2014, IMMUNOLOGY, V142, P442, DOI 10.1111/imm.12273
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li P, 2018, J VIROL, V92, DOI 10.1128/JVI.00209-18
   Li XF, 2017, THERANOSTICS, V7, P912, DOI 10.7150/thno.16615
   Li XF, 2013, APPL MICROBIOL BIOT, V97, P4589, DOI 10.1007/s00253-013-4799-8
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Pan WQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3369
   Patterson CE, 2002, J VIROL, V76, P4497, DOI 10.1128/JVI.76.9.4497-4506.2002
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Rameix-Welti MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6104
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang LC, 2010, ANTIVIR RES, V87, P50, DOI 10.1016/j.antiviral.2010.04.010
   White JP, 2018, CELL, V175, P1198, DOI 10.1016/j.cell.2018.08.069
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yuan L, 2017, SCIENCE
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zaitseva M, 2009, J VIROL, V83, P10437, DOI 10.1128/JVI.01296-09
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 67
TC 0
Z9 0
U1 1
U2 1
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2020
VL 10
IS 14
BP 6430
EP 6447
DI 10.7150/thno.43177
PG 18
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA LP9DC
UT WOS:000534615100023
PM 32483462
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT S
AU Yu, Z
   Cowan, JA
AF Yu, Zhen
   Cowan, James A.
BE Sadler, PJ
   VanEldik, R
TI Design and applications of catalytic metallodrugs containing the ATCUN
   motif
SO MEDICINAL CHEMISTRY
SE Advances in Inorganic Chemistry
LA English
DT Review; Book Chapter
ID VIRUS NS2B/NS3 PROTEASE; CELLULAR SENESCENCE; COPPER(II) BINDING;
   CRYSTAL-STRUCTURE; MOLECULAR DESIGN; ZIKA VIRUS; DNA; COMPLEXES;
   PEPTIDES; SITE
AB The aim of this chapter is to provide a brief account of the discovery and application of catalytic metallodrugs, and specifically those cases that include a catalytic metal-ATCUN motif. The concepts and design strategies for catalytic metallodrugs are illustrated through recent examples that target G-quadruplex telomeric DNA, H2-antigen, Flavivirus NS2B/NS3 proteases, and lipid bilayers of bacteria. The distinct advantages of the tripeptide ATCUN metal chelate are described and well illustrated through these examples, and longstanding challenges in metallodrug design and use are discussed, including the potential for metal toxicity, applications as "prodrugs," and metal lability.
C1 [Yu, Zhen; Cowan, James A.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.
RP Cowan, JA (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.
EM cowan.2@osu.edu
FU National Science FoundationNational Science Foundation (NSF)
   [CHE-1800239]
FX We wish to convey our thanks to the many coworkers (named in our cited
   publications) who have contributed to the catalytic metallodrug research
   program. This material is based upon work supported by the National
   Science Foundation under CHE-1800239.
CR Agbale CM, 2016, METALLOMICS, V8, P1159, DOI 10.1039/c6mt00133e
   Alexander JL, 2019, ACS CHEM BIOL, V14, P449, DOI 10.1021/acschembio.8b01087
   Alexander JL, 2018, ACS CHEM BIOL, V13, P844, DOI 10.1021/acschembio.7b00989
   Alexander JL, 2017, J MED CHEM, V60, P10047, DOI 10.1021/acs.jmedchem.7b01117
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Alonso-de Castro S, 2019, CHEM-EUR J, V25, P6651, DOI 10.1002/chem.201806341
   Balgir R S, 2007, Indian J Hum Genet, V13, P109, DOI 10.4103/0971-6866.38985
   Best SL, 1997, J CHEM SOC DALTON, P2587, DOI 10.1039/a701395g
   Bianchi E, 2002, BIOPOLYMERS, V66, P101, DOI 10.1002/bip.10230
   Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Bras NF, 2012, CARBOHYDRATES - COMPREHENSIVE STUDIES ON GLYCOBIOLOGY AND GLYCOTECHNOLOGY, P117, DOI 10.5772/52019
   CAMERMAN N, 1976, CAN J CHEM, V54, P1309, DOI 10.1139/v76-185
   Campisi J, 1999, ALFRED BENZON SYMP S, V44, P112
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cao HN, 2014, J BIOL CHEM, V289, P25624, DOI 10.1074/jbc.M114.583286
   Catherman AD, 2014, BIOCHEM BIOPH RES CO, V445, P683, DOI 10.1016/j.bbrc.2014.02.041
   Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804
   Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249
   COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900
   Das D, 2018, MINI-REV MED CHEM, V18, P584, DOI 10.2174/1389557517666170913111930
   Dawson RM, 2009, DRUG DEVELOP RES, V70, P481, DOI 10.1002/ddr.20329
   Dean L, 2005, BLOOD GROUPS RED CEL
   DIXON JW, 1972, BIOCHEM BIOPH RES CO, V48, P197, DOI 10.1016/0006-291X(72)90362-2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Engelmann MD, 2003, BIOMETALS, V16, P519, DOI 10.1023/A:1023480617038
   Fernandes Heloise Pöckel, 2011, Rev. Bras. Hematol. Hemoter., V33, P297, DOI 10.5581/1516-8484.20110080
   Fry DC, 2006, BIOPOLYMERS, V84, P535, DOI 10.1002/bip.20608
   Garcia-Bella J, 2018, EUR J OPHTHALMOL, V28, P32, DOI 10.5301/ejo.5001028
   Gokhale NH, 2008, J AM CHEM SOC, V130, P2388, DOI 10.1021/ja0778038
   Grogan J, 2001, FEBS LETT, V491, P76, DOI 10.1016/S0014-5793(01)02157-3
   Harford C, 1997, ACCOUNTS CHEM RES, V30, P123, DOI 10.1021/ar9501535
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   Hayes Curtis G., 2001, V951, P25
   Heinisch T, 2016, ACCOUNTS CHEM RES, V49, P1711, DOI 10.1021/acs.accounts.6b00235
   Hilpert K, 2010, ANTIMICROB AGENTS CH, V54, P4480, DOI 10.1128/AAC.01664-09
   Hocharoen L, 2013, J MED CHEM, V56, P9826, DOI 10.1021/jm4009345
   Hocharoen L, 2009, CHEM-EUR J, V15, P8670, DOI 10.1002/chem.200900821
   Joyner JC, 2011, J AM CHEM SOC, V133, P15613, DOI 10.1021/ja2052599
   Kalfa VC, 2001, ANTIMICROB AGENTS CH, V45, P3256, DOI 10.1128/AAC.45.11.3256-3261.2001
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004
   KELLY RJ, 1994, P NATL ACAD SCI USA, V91, P5843, DOI 10.1073/pnas.91.13.5843
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kolozsi A, 2009, J INORG BIOCHEM, V103, P940, DOI 10.1016/j.jinorgbio.2009.04.006
   Kreig A, 2015, NUCLEIC ACIDS RES, V43, P7961, DOI 10.1093/nar/gkv749
   Kulprachakarn K, 2016, J BIOL INORG CHEM, V21, P329, DOI 10.1007/s00775-016-1342-2
   Li JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002381
   Li J, 2014, NAT CHEM, V6, P352, DOI [10.1038/NCHEM.1887, 10.1038/nchem.1887]
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1
   Lv ZT, 2015, HIV AIDS-RES PALLIAT, V7, P95, DOI 10.2147/HIV.S79956
   Maji B, 2014, CHEM COMMUN, V50, P6422, DOI 10.1039/c4cc00611a
   Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065
   Mania D, 2010, APPL ENVIRON MICROB, V76, P7102, DOI 10.1128/AEM.01560-10
   MASUOKA J, 1994, J BIOL CHEM, V269, P25557
   MEHLE C, 1994, CANCER RES, V54, P236
   Miller MA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15906
   Miyamoto T, 2016, DALTON T, V45, P9436, DOI 10.1039/c6dt01387b
   Miyamoto T, 2013, CHEM LETT, V42, P1099, DOI 10.1246/cl.130405
   Mlynarz P, 2000, J CHEM SOC DALTON, P1033, DOI 10.1039/a909354k
   Molphy Z, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00028
   Nagaj J, 2013, J INORG BIOCHEM, V119, P85, DOI 10.1016/j.jinorgbio.2012.11.002
   Ngo AH, 2018, CHEM-EUR J, V24, P10584, DOI 10.1002/chem.201800504
   Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153
   Okamoto Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04440-0
   Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755
   Pinkham AM, 2018, CHEM COMMUN, V54, P12357, DOI 10.1039/c8cc07448h
   Pinkham AM, 2018, J MED CHEM, V61, P980, DOI 10.1021/acs.jmedchem.7b01409
   Prieto PA, 1997, J BIOL CHEM, V272, P2089
   PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301
   Reid M. E., 2012, BLOOD GROUP ANTIGEN, p745 S
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Saiman L, 2001, ANTIMICROB AGENTS CH, V45, P2838, DOI 10.1128/AAC.45.10.2838-2844.2001
   Sakurama H, 2012, BIOSCI BIOTECH BIOCH, V76, P1022, DOI 10.1271/bbb.111004
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Sankararamakrishnan R, 2005, PROTEINS, V58, P211, DOI 10.1002/prot.20265
   Sanman LE, 2014, ANNU REV BIOCHEM, V83, P249, DOI 10.1146/annurev-biochem-060713-035352
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29
   Shahshahani Hayedeh Javadzadeh, 2013, Asian J Transfus Sci, V7, P86, DOI 10.4103/0973-6247.106754
   Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001
   Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410
   Soldevila-Barreda JJ, 2015, CURR OPIN CHEM BIOL, V25, P172, DOI 10.1016/j.cbpa.2015.01.024
   Soldevila-Barreda JJ, 2019, CHEM REV, V119, P829, DOI 10.1021/acs.chemrev.8b00493
   Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200
   Tong L, 2002, CHEM REV, V102, P4609, DOI 10.1021/cr010184f
   Torcato IM, 2013, CHEMBIOCHEM, V14, P2013, DOI 10.1002/cbic.201300274
   VANQUICKENBORNE LG, 1981, INORG CHEM, V20, P796, DOI 10.1021/ic50217a033
   Wiloch MZ, 2017, J ELECTROCHEM SOC, V164, pG77, DOI 10.1149/2.1191706jes
   Woodfield G, 2004, Immunohematology, V20, P244
   Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370
   YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0
   Yu LC, 1997, VOX SANG, V72, P36, DOI 10.1046/j.1423-0410.1997.00036.x
   Yu Z, 2019, J MED CHEM, V62, P5040, DOI 10.1021/acs.jmedchem.9b00215
   Yu Z, 2018, CURR OPIN CHEM BIOL, V43, P37, DOI 10.1016/j.cbpa.2017.10.029
   Yu Z, 2017, CHEM-EUR J, V23, P14113, DOI 10.1002/chem.201701714
   Yu Z, 2017, ANGEW CHEM INT EDIT, V56, P2763, DOI 10.1002/anie.201612079
   Yu Z, 2015, ANGEW CHEM INT EDIT, V54, P1901, DOI 10.1002/anie.201410434
   ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026
NR 103
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0898-8838
BN 978-0-12-819197-2; 978-0-12-819196-5
J9 ADV INORG CHEM
JI Adv. Inorg. Chem.
PY 2020
VL 75
BP 361
EP 391
DI 10.1016/bs.adioch.2019.10.005
PG 31
WC Chemistry, Medicinal; Chemistry, Inorganic & Nuclear
SC Pharmacology & Pharmacy; Chemistry
GA BP0GZ
UT WOS:000534290000012
DA 2020-07-08
ER

PT J
AU Mata, VE
   Passos, SRL
   dos Santos, MAB
   Buonora, SN
   de Andrade, CAF
   Lima, MDQ
   Costa, BM
   Hokerberg, YHM
AF Mata, Veronica Elizabeth
   Lambert Passos, Sonia Regina
   Borges dos Santos, Maria Angelica
   Buonora, Sibelle Nogueira
   Ferreira de Andrade, Carlos Augusto
   Queiroz Lima, Monique da Rocha
   Costa, Betina Moreira
   Marques Hokerberg, Yara Hahr
TI Diagnostic parameters and reliability of four rapid
   immunochromatographic tests for dengue 4
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Immunochromatographic tests; Sensitivity and specificity;
   Reproducibility of tests; Diagnosis
ID NS1 ANTIGEN; ZIKA VIRUS
AB Background: Although performance of rapid immunochromatographic tests (RITs) for dengue virus (DENY) serotypes 1, 2 and 3 is relatively settled, evidence on accuracy of RITs for DENV-4 are based on studies with small sample sizes and with discrepant results.
   Objectives: To assess accuracy and inter-observer agreement of RITs targeting dengue nonstructural protein-1 (NS1) antigen - Dengue NS1-Bioeasy (TM), Dengue NS1 Ag Strip-Bio-Rad (TM), IVB Dengue Ag NS1-Orangelife (TM) and Dengue NS1-K130-Bioclin (TM) in DENV-4 samples.
   Methods: Study sample (n = 324) included adults presenting at an emergency unit in Rio de Janeiro, Brazil, with fever of <= 72 h and two or more dengue symptoms. A serum sample from each patient was tested by each RIT. A positive reverse-transcription polymerase chain reaction was considered as the reference standard for dengue diagnosis. The diagnostic parameters analyzed for each RIT were sensitivity, specificity, positive and negative predictive values, and likelihood ratios. Each RIT was read by homogeneous (two junior nurses) or heterogeneous (one junior nurse and one senior biologist) pairs. Agreement was estimated by simple kappa with 95% confidence interval, positive (Ppos) and negative (Pneg) proportion concordance and prevalence and bias adjusted kappa, rated from poor (k < 0.0) to almost perfect (0.8 < k < 1.0), and perfect (k= 1).
   Results: NS1 RITs for DENV-4 diagnosis showed high specificity (95.9%-99.4%), but low sensitivity (14.7%-45.4%). BioeasyTM had the best performance, with a positive likelihood ratio of 26.0 (95% CI: 8.4;81.0). Inter-observer agreement was almost perfect for all evaluated RITs. Mismatches in confirmed dengue were more common for the BioclinTM (Ppos 88.3-90.0 %) and Orangelife (TM) (Ppos 91.7-94.1 %) tests.
   Conclusions: For DENV-4, the tested RITs had high specificity, but lower sensitivity compared to published results for other serotypes. They should not be used for screening purposes. Different brands may have very different performances. This should be considered upon deciding of using RITs in DENV-4 outbreaks. (C) 2020 Sociedade Brasileira de Infectologia. Published by Elsevier Espana, S.L.U.
C1 [Mata, Veronica Elizabeth; Lambert Passos, Sonia Regina; Buonora, Sibelle Nogueira; Marques Hokerberg, Yara Hahr] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, RJ, Brazil.
   [Borges dos Santos, Maria Angelica] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth ENSP, Rio De Janeiro, RJ, Brazil.
   [Queiroz Lima, Monique da Rocha] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Ferreira de Andrade, Carlos Augusto; Costa, Betina Moreira] Univ Estacio Sa, Rio De Janeiro, RJ, Brazil.
RP Passos, SRL (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, RJ, Brazil.
EM sonia.lambert@ini.fiocruz.br
RI ; hokerberg, yara/K-2880-2016
OI Borges dos Santos, Maria Angelica/0000-0002-7547-3537; Buonora,
   Sibelle/0000-0002-0843-1783; hokerberg, yara/0000-0001-7140-7172
FU Conselho Nacional de Desenvolvimen to Cientifico (CNPq)National Council
   for Scientific and Technological Development (CNPq) [402068/2012-2];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [3107665/2016-1]; UNESA Produtividade em Pesquisa; FaperjCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [221.354E 01/2016]
FX This study was supported by the Conselho Nacional de Desenvolvimen to
   Cientifico (CNPq) grant numbers. 402068/2012-2. SRLP had a fellowship
   from CNPq [grant number 3107665/2016-1] and UNESA Produtividade em
   Pesquisa. VEM hada doctoral fellowship from Faperj [grant number
   221.354E 01/2016]. The funding source had no involvement in the
   collection, analysis and interpretation of data or in the writing of the
   report.
CR [Anonymous], 2014, MEDCALC STAT SOFTW V
   [Anonymous], 2008, PLATELIA DENGUE NS1
   Martinez-Vega RA, 2009, BIOMEDICA, V29, P616, DOI 10.7705/biomedica.v29i4.139
   Barde PV, 2012, INDIAN J MED RES, V136, P491
   Bio-Rad Laboratories Inc, 2014, DENG NS1 AG STRIP BI
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Colombo TE, 2013, J CLIN VIROL, V58, P710, DOI 10.1016/j.jcv.2013.10.021
   DUSSART P, 2008, PLOS NEGLECT TROP D, V2, DOI DOI 10.1371/J0URNALTNTD.0000280
   Sea VRF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064056
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LIMA MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI DOI 10.1371/JOURNALPNTD.0000738
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191
   MATA VE, 2017, BMC INFECT DIS, V17, DOI DOI 10.1186/S17879-017-7679-Z
   Orangelife comercio e indUstria Ltda. Brazil, 2016, IVB DENG AG NS1 OR
   Osorio L, 2015, MEM I OSWALDO CRUZ, V110, P510, DOI 10.1590/0074-02760140359
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Quibasa Quimica Basica Ltda Brazil, 2017, DENG NS1 K130 BIOCL
   Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022
   Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Trajman A, 2008, SCAND J CLIN LAB INV, V68, P77, DOI 10.1080/00365510701666031
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Vazquez S, 2010, DIAGN MICR INFEC DIS, V68, P46, DOI 10.1016/j.diagmicrobio.2010.04.006
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang H, 2014, INT J INFECT DIS, V26, P57, DOI 10.1016/j.ijid.2014.02.002
NR 42
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JAN-FEB
PY 2020
VL 24
IS 1
BP 58
EP 64
DI 10.1016/j.bjid.2019.12.004
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA LG3SA
UT WOS:000528023500009
PM 31954721
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Charlier, C
   Lecuit, M
AF Charlier, Caroline
   Lecuit, Marc
TI Maternal-fetal infections: Why do they matter?
SO VIRULENCE
LA English
DT Editorial Material
ID ZIKA VIRUS-INFECTION; PREGNANCY; MEASLES
C1 [Charlier, Caroline; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France.
   INSERM, U1117, Paris, France.
   Inst Pasteur, French Natl Reference Ctr, Paris, France.
   Inst Pasteur, WHO Collaborating Ctr Listeria, Paris, France.
   Necker Enfants Malad Univ Hosp, APHP, Dept Infect Dis & Trop Med, Inst Imagine, Paris, France.
   Univ Paris, Paris, France.
RP Charlier, C; Lecuit, M (corresponding author), Inst Pasteur, Biol Infect Unit, Paris, France.
EM caroline.charlier@pasteur.fr; marc.lecuit@pasteur.fr
RI Lecuit, Marc/J-4073-2013
OI Lecuit, Marc/0000-0002-4491-1063
CR ATMAR RL, 1992, CLIN INFECT DIS, V14, P217, DOI 10.1093/clinids/14.1.217
   Blanche S, 2020, VIRULENCE, V11, P14, DOI 10.1080/21505594.2019.1697136
   Charlier C, 2020, VIRULENCE, V11, P391, DOI 10.1080/21505594.2020.1759287
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Charlier C, 2017, LANCET INFECT DIS, V17, P510, DOI [10.1016/S1473-3099(16)30521-7, 10.1016/s1473-3099(16)30521-7]
   Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303
   DYER I., 1940, SOUTHERN MED JOUR, V33, P601, DOI 10.1097/00007611-194006000-00007
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101
   Liang B, 2019, VIRULENCE, V10, P768, DOI 10.1080/21505594.2019.1656503
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007
   Ogbuanu IU, 2014, CLIN INFECT DIS, V58, P1086, DOI 10.1093/cid/ciu037
   Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667
NR 17
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2150-5594
EI 2150-5608
J9 VIRULENCE
JI Virulence
PD JAN 1
PY 2020
VL 11
IS 1
BP 398
EP 399
DI 10.1080/21505594.2020.1759288
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA LK7EP
UT WOS:000531025700001
PM 32363994
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hurtado, J
   Acharya, D
   Lai, HF
   Sun, HY
   Kallolimath, S
   Steinkellner, H
   Bai, FW
   Chen, Q
AF Hurtado, Jonathan
   Acharya, Dhiraj
   Lai, Huafang
   Sun, Haiyan
   Kallolimath, Somanath
   Steinkellner, Herta
   Bai, Fengwei
   Chen, Qiang
TI In vitro and in vivo efficacy of anti-chikungunya virus monoclonal
   antibodies produced in wild-type and glycoengineered Nicotiana
   benthamiana plants
SO PLANT BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE monoclonal antibody; chikungunya virus; plant-made therapeutics;
   glycosylation; neutralization; glycoengineering; plant-made antibody
ID NEUTRALIZING IMMUNE-RESPONSES; ZIKA VIRUS; GLYCOSYLATION; INFECTION;
   VACCINES; PARTICLES; APPROVAL; VARIANT; TRIAL
AB Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus, and its infection can cause long-term debilitating arthritis in humans. Currently, there are no licensed vaccines or therapeutics for human use to combat CHIKV infections. In this study, we explored the feasibility of using an anti-CHIKV monoclonal antibody (mAb) produced in wild-type (WT) and glycoengineered (Delta XFT) Nicotiana benthamiana plants in treating CHIKV infection in a mouse model. CHIKV mAb was efficiently expressed and assembled in plant leaves and enriched to homogeneity by a simple purification scheme. While mAb produced in Delta XFT carried a single N-glycan species at the Fc domain, namely GnGn structures, WT produced mAb exhibited a mixture of N-glycans including the typical plant GnGnXF(3) glycans, accompanied by incompletely processed and oligomannosidic structures. Both WT and Delta XFT plant-produced mAbs demonstrated potent in vitro neutralization activity against CHIKV. Notably, both mAb glycoforms showed in vivo efficacy in a mouse model, with a slight increased efficacy by the Delta XFT-produced mAbs. This is the first report of the efficacy of plant-produced mAbs against CHIKV, which demonstrates the ability of using plants as an effective platform for production of functionally active CHIKV mAbs and implies optimization of in vivo activity by controlling Fc glycosylation.
C1 [Hurtado, Jonathan; Lai, Huafang; Sun, Haiyan; Chen, Qiang] Arizona State Univ, Biodesign Inst & Sch Life Sci, Tempe, AZ 85281 USA.
   [Acharya, Dhiraj; Bai, Fengwei] Univ Southern Mississippi, Dept Cell & Mol Biol, Hattiesburg, MS 39406 USA.
   [Kallolimath, Somanath; Steinkellner, Herta] Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.
RP Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst & Sch Life Sci, Tempe, AZ 85281 USA.
EM qiang.chen.4@asu.edu
RI ; Steinkellner, Herta/N-4267-2016
OI chen, qiang/0000-0003-1498-7013; Steinkellner, Herta/0000-0003-4823-1505
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R33AI101329, R15A113706, R15AI135893]
FX The authors wish to thank Drs. Friedrich Altmann and Clemens Gruber at
   University of Natural Resources and Applied Life Sciences for N-glycan
   analyses. The authors also acknowledge Dr. Robert B. Tesh at University
   of Texas Medical Branch for providing CHIKV strain and Collin Jugler for
   the critical reading of the manuscript. All authors declare no conflict
   of interest for the publication of this manuscript. This work was
   supported in part by grants from National Institute of Allergy and
   Infectious Diseases (NIAID) #R33AI101329 to QC and #R15A113706 and
   R15AI135893 to FB.
CR Acharya D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004139
   Arntzen C, 2015, PLANT BIOTECHNOL J, V13, P1013, DOI 10.1111/pbi.12460
   Beck A, 2012, MABS-AUSTIN, V4, P419, DOI 10.4161/mabs.20996
   Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256
   Broeckel R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005637
   Cardona-Ospina Jaime A, 2016, F1000Res, V5, P2121
   Chen Q., 2016, F1000RES, V5
   Chen Q, 2013, ADV TECH BIOL MED, V1, DOI [10.4172/atbm.1000103, DOI 10.4172/ATBM.1000103]
   Chen Q, 2016, P NATL ACAD SCI USA, V113, P9404, DOI 10.1073/pnas.1610803113
   Chen Q, 2014, CABI BIOTECH SER, P42, DOI 10.1079/9781780643434.0042
   Chen Q, 2014, BIOMED RES INT, DOI 10.1155/2014/418064
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600
   Garber K, 2018, NAT BIOTECHNOL, V36, P1025, DOI 10.1038/nbt1118-1025
   Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103
   He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541
   He JY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/106783
   Hiatt A, 2014, P NATL ACAD SCI USA, V111, P5992, DOI 10.1073/pnas.1402458111
   Holtz BR, 2015, PLANT BIOTECHNOL J, V13, P1180, DOI 10.1111/pbi.12469
   Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j
   Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021
   Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   Lai HF, 2018, VACCINE, V36, P1846, DOI 10.1016/j.vaccine.2018.02.073
   Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217
   Lai HF, 2012, PLANT CELL REP, V31, P573, DOI 10.1007/s00299-011-1196-6
   Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521
   Lim J, 2011, BIOPHARM INT, V24, P54
   Lomonossoff GP, 2016, SCIENCE, V353, P1237, DOI 10.1126/science.aaf6638
   Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416
   Moldt B, 2012, J VIROL, V86, P6189, DOI 10.1128/JVI.00491-12
   Montero-Morales L, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00081
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Salazar-Gonzalez JA, 2015, VACCINE, V33, P3650, DOI 10.1016/j.vaccine.2015.05.104
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009
   Strasser R, 2014, CURR OPIN BIOTECH, V30, P95, DOI 10.1016/j.copbio.2014.06.008
   Sun HY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010054
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Zeitlin L., 2015, SOC MOL FARM, P1
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
NR 51
TC 5
Z9 5
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7644
EI 1467-7652
J9 PLANT BIOTECHNOL J
JI Plant Biotechnol. J.
PD JAN
PY 2020
VL 18
IS 1
BP 266
EP 273
DI 10.1111/pbi.13194
PG 8
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA LJ7VZ
UT WOS:000530370800026
PM 31207008
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aljofan, M
   Gaipov, A
AF Aljofan, Mohamad
   Gaipov, Abduzhappar
TI Chloroquine and COVID-19: A Light at the End of the Tunnel, or is it
   Another Train?
SO ELECTRONIC JOURNAL OF GENERAL MEDICINE
LA English
DT Editorial Material
DE COVID-19
ID INFECTION; VIRUS
AB Over the last a few decades, the world has faced several viral disease outbreaks including Hendra, Nipah, severe acute respiratory syndrome (SARS), Influenza (H1N1), Middle East respiratory syndrome (MERS), Zika and most recently coronavirus disease 2019 (COVID-19). The economical and health impacts of the outbreaks were limited to certain affected areas only, but the recent outbreak of COVID-19 seems to have a global impact on human health, health resources and global economy.
C1 [Aljofan, Mohamad; Gaipov, Abduzhappar] Nazarbayev Univ, Sch Med, Nur Sultan, Kazakhstan.
RP Aljofan, M (corresponding author), Nazarbayev Univ, Sch Med, Nur Sultan, Kazakhstan.
EM m.aljofan@gmail.com
RI Gaipov, Abduzhappar/G-3059-2012; Karabulut, Erman/G-6679-2011
OI Gaipov, Abduzhappar/0000-0002-9844-8772; Karabulut,
   Erman/0000-0002-0787-905X
CR Colson P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105923
   COOMBS K, 1981, J VIROL, V37, P1060, DOI 10.1128/JVI.37.3.1060-1065.1981
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gorbalenya A, 2020, NATURE MICROBIOLOGY
   Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Yan YW, 2013, CELL RES, V23, P300, DOI 10.1038/cr.2012.165
NR 7
TC 2
Z9 2
U1 3
U2 3
PU MODESTUM LTD
PI LONDON
PA STE 124 CHALLENGE HOUSE 616 MITCHAM RD, CROYDON, LONDON, CRO 3AA,
   ENGLAND
SN 2516-3507
J9 ELECTRON J GEN MED
JI Electron. J. Gen. Med.
PY 2020
VL 17
IS 4
AR em207
DI 10.29333/ejgm/7863
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA LJ2SY
UT WOS:000530020800002
OA Other Gold
DA 2020-07-08
ER

PT J
AU de Castro, MCR
   Ramos-e-Silva, M
AF Ribeiro de Castro, Maria Cristina
   Ramos-e-Silva, Marcia
TI The rash with mucosal ulceration
SO CLINICS IN DERMATOLOGY
LA English
DT Article
ID ZIKA; MANIFESTATIONS; ARBOVIRUSES
AB A rash is a disseminated eruption of cutaneous lesions with great variation in appearance, cause, and severity. When the physician is facing a rash, the history and physical examination of the patient are extremely important for the identification of the disease and its causal agent.
   There are various causes for a rash, which may be infectious, allergic, or rheumatologic, besides many others. Rashes associated with mucosal ulcers may have causes related to viral and bacterial infections or drug reactions. They may be associated with measles; erythema infectiosum; roseola infantum; rubella; hand, foot, and mouth disease; pityriasis rosea; dengue fever; chikungunya; zika; scarlet fever; meningococcal diseases; syphilis; and exanthematous drug eruptions. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Ramos-e-Silva, Marcia] Univ Fed Rio de Janeiro, Univ Hosp, Sect Dermatol, Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Postgrad Course Dermatol, Univ Hosp, Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Sch Med, Rio De Janeiro, RJ, Brazil.
RP Ramos-e-Silva, M (corresponding author), Univ Fed Rio de Janeiro, Univ Hosp, Sect Dermatol, Rio De Janeiro, RJ, Brazil.
EM ramos.e.silva@dermato.med.br
CR Allmon A, 2015, AM FAM PHYSICIAN, V92, P211
   Bian LL, 2015, EXPERT REV ANTI-INFE, V13, P1061, DOI 10.1586/14787210.2015.1058156
   Biesbroeck L, 2013, DERMATOL THER, V26, P433, DOI 10.1111/dth.12107
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Centers for Disease Control and Prevention, CLIN GUID DENG VIR
   Centers for Disease Control and Prevention, UPD EP PREV VACC PRE
   Centers for Disease Control and Prevention, SYPHILIS
   Centers for Disease Control and Prevention, DENG VIR INF 2015 CA
   Centers for Disease Control and Prevention, 2016, UPD NONC ZIK VIR DIS
   Cho YT, 2017, J IMMUNOL RES, DOI 10.1155/2017/1503709
   Drage LA, 1999, MAYO CLIN PROC, V74, P68, DOI 10.4065/74.1.68
   Fernandez-Salas I, 2016, CURR OPIN INFECT DIS, V29, P467, DOI 10.1097/QCO.0000000000000304
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Mancini AJ, 2018, DERMATOLOGY, P1425
   Nawas ZY, 2016, J AM ACAD DERMATOL, V75, P1, DOI 10.1016/j.jaad.2016.04.033
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Schadt C, 2018, JAMA DERMATOL, V154, P1496, DOI 10.1001/jamadermatol.2018.3290
   Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8
   Stary G, 2018, DERMATOLOGY, P1447
   Vleyne-Allanore L, 2018, DERMATOLOGY, P348
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0738-081X
EI 1879-1131
J9 CLIN DERMATOL
JI Clin. Dermatol.
PD JAN-FEB
PY 2020
VL 38
IS 1
BP 35
EP 41
DI 10.1016/j.clindermatol.2019.10.019
PG 7
WC Dermatology
SC Dermatology
GA LG2CY
UT WOS:000527916700004
PM 32197747
OA Bronze
DA 2020-07-08
ER

PT J
AU Zheng, QL
   Duan, T
   Jin, LP
AF Zheng, Qing-Liang
   Duan, Tao
   Jin, Li-Ping
TI Single-cell RNA expression profiling of ACE2 and AXL in the human
   maternal-Fetal interface
SO REPRODUCTIVE AND DEVELOPMENTAL MEDICINE
LA English
DT Review
ID ZIKA VIRUS
AB 2019 novel coronavirus disease has resulted in thousands of critically ill patients in China, which is a serious threat to people's life and health. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) was reported to share the same receptor, angiotensin-converting enzyme 2 (ACE2), with SARS-CoV. Here, based on the public single-cell RNA-sequencing database, we analyzed the mRNA expression profile of putative receptor ACE2 and AXL receptor tyrosine kinase (AXL) in the early maternal-fetal interface. The result indicates that the ACE2 has very low expression in the different cell types of early maternal-fetal interface, except slightly high in decidual perivascular cells cluster 1 (PV1). Interestingly, we found that the Zika virus (ZIKV) receptor AXL expression is concentrated in perivascular cells and stromal cells, indicating that there are relatively more AXL-expressing cells in the early maternal-fetal interface. This study provides a possible infection route and mechanism for the SARS-CoV-2- or ZIKV-infected mother-to-fetus transmission disease, which could be informative for future therapeutic strategy development.
C1 [Zheng, Qing-Liang; Duan, Tao; Jin, Li-Ping] Tongji Univ, Sch Med, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Shanghai 201204, Peoples R China.
RP Duan, T; Jin, LP (corresponding author), Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Shanghai 201204, Peoples R China.
EM tduan@yahoo.com; jinlpa1@l63.com
RI Karabulut, Erman/G-6679-2011
OI Karabulut, Erman/0000-0002-0787-905X
FU Key Program of the National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81730039]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [81671460, 81871167]; National Key Research and Development Program of
   China [2017YFC 1001401]; Shanghai Municipal Medical and Health
   Discipline Construction Projects [2017ZZ02015]; National Basic Research
   Program of ChinaNational Basic Research Program of China [2015CB943300];
   Program for Shanghai leaders; Natural Science Foundation of
   ShanghaiNatural Science Foundation of Shanghai [18ZR1430000]
FX This study was supported by the Key Program of the National Natural
   Science Foundation of China (81730039), the National Natural Science
   Foundation of China (81671460, 81871167), the National Key Research and
   Development Program of China (2017YFC 1001401), Shanghai Municipal
   Medical and Health Discipline Construction Projects (2017ZZ02015), the
   National Basic Research Program of China (2015CB943300), the Program for
   Shanghai leaders to Li-Ping Jin, and the Natural Science Foundation of
   Shanghai (18ZR1430000) to Qingliang Zheng.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Ferreira LMR, 2017, TRENDS IMMUNOL, V38, P272, DOI 10.1016/j.it.2017.01.009
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li WH, 2007, VIROLOGY, V367, P367, DOI 10.1016/j.virol.2007.04.035
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Zuo W., 2020, SINGLE CELL RNA EXPR, DOI [10.1101/2020.01.26.919985., DOI 10.1101/2020.01.26.919985]
NR 14
TC 7
Z9 7
U1 5
U2 5
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2096-2924
EI 2589-8728
J9 REPROD DEV MED
JI Reprod. Dev. Med.
PD JAN-MAR
PY 2020
VL 4
IS 1
BP 7
EP 10
DI 10.4103/2096-2924.278679
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LE7WK
UT WOS:000526934300002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rojas, A
   Stittleburg, V
   Cardozo, F
   Bopp, N
   Cantero, C
   Lopez, S
   Bernal, C
   Mendoza, L
   Aguilar, P
   Pinsky, BA
   Guillen, Y
   Paez, M
   Waggoner, JJ
AF Rojas, Alejandra
   Stittleburg, Victoria
   Cardozo, Fatima
   Bopp, Nathen
   Cantero, Cesar
   Lopez, Sanny
   Bernal, Cynthia
   Mendoza, Laura
   Aguilar, Patricia
   Pinsky, Benjamin A.
   Guillen, Yvalena
   Paez, Malvina
   Waggoner, Jesse J.
TI Real-time RT-PCR for the detection and quantitation of Oropouche virus
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Oropouche virus; Orthobunyavirus; Reverse transcriptase PCR;
   Quantitative real-time PCR
ID INFECTION; CHIKUNGUNYA; DIAGNOSIS; ZIKA
AB Oropouche virus (OROV) causes an acute, systemic febrile illness, and in certain regions of South America, this represents the second most common human arboviral infection after dengue virus. A new real-time RT-PCR was developed for OROV and reassortant species. The new OROV rRT-PCR proved linear across 6-7 orders of magnitude with a lower limit of 95% detection of 5.6-10.8 copies/mu L. Upon testing dilutions of OROV and Iquitos virus reference genomic RNA, all dilutions with >10 copies/mu L were detected in both the OROV rRT-PCR and a comparator molecular assay, but the OROV rRT-PCR detected more samples with <= 10 copies/mu L (8/14 vs 0/13, respectively, P = 0.002). In a set of 100 acute-phase clinical samples from Paraguay patients with a suspected arboviral illness, no patients tested positive for OROV RNA using either assay. The OROV rRT-PCR provides a sensitive molecular assay for the study of this important yet neglected tropical arboviral infection. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Rojas, Alejandra; Cantero, Cesar; Lopez, Sanny; Bernal, Cynthia; Guillen, Yvalena] Univ Nacl Asuncion, Inst Invest Ciencias & Salud, Dept Prod, Asuncion, Paraguay.
   [Stittleburg, Victoria; Waggoner, Jesse J.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Cardozo, Fatima; Mendoza, Laura; Paez, Malvina] Univ Nacl Asuncion, Inst Invest Ciencias & Salud, Dept Salud Publ, Asuncion, Paraguay.
   [Bopp, Nathen; Aguilar, Patricia] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Dept Med, Stanford, CA 94305 USA.
   [Waggoner, Jesse J.] Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA USA.
RP Waggoner, JJ (corresponding author), 1760 Haygood Dr NE,Room E 132, Atlanta, GA 30322 USA.
EM jjwaggo@emory.edu
OI Pinsky, Benjamin/0000-0001-8751-4810
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [K08 AI110528]; Consejo Nacional de
   Ciencia y Tecnologia (CONACYT) in ParaguayConsejo Nacional de Ciencia y
   Tecnologia (CONACyT)
FX Researchwas supported by NIH grants K08 AI110528 (JJW). In addition, the
   development of this collaboration was supported by funding from the
   Consejo Nacional de Ciencia y Tecnologia (CONACYT) in Paraguay (ARS and
   JJW).
CR Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Alva-Urcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187897
   Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Cardozo-Segovia Fátima María, 2017, Mem. Inst. Investig. Cienc. Salud, V15, P7, DOI 10.18004/mem.iics/1812-9528/2017.015(01)07-015
   FIGUEIREDO L T M, 1988, Memorias do Instituto Oswaldo Cruz, V83, P161
   Ladner JT, 2014, J GEN VIROL, V95, P1055, DOI 10.1099/vir.0.061309-0
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Navarro JC, 2016, AM J TROP MED HYG, V95, P328, DOI 10.4269/ajtmh.15-0679
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Pan American Health Organization, 2018, DENGUE
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P172, DOI 10.4269/ajtmh.1981.30.172
   PINHEIRO FP, 1982, SCIENCE, V215, P1251, DOI 10.1126/science.6800036
   Romero-Alvarez D, 2018, MICROBES INFECT, V20, P135, DOI 10.1016/j.micinf.2017.11.013
   Saeed MF, 2001, J CLIN MICROBIOL, V39, P2445, DOI 10.1128/JCM.39.7.2445-2452.2001
   Saeed MF, 2001, VIRUS RES, V77, P25, DOI 10.1016/S0168-1702(01)00262-3
   Silva-Caso W, 2019, INT J INFECT DIS IJI
   Nunes MRT, 2019, INFECT GENET EVOL, V68, P16, DOI 10.1016/j.meegid.2018.11.020
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Weidmann M, 2003, J CLIN MICROBIOL, V41, P3299, DOI 10.1128/JCM.41.7.3299-3305.2003
   Wise EL, 2018, EMERG INFECT DIS, V24, P935, DOI 10.3201/eid2405.171569
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD JAN
PY 2020
VL 96
IS 1
AR UNSP 114894
DI 10.1016/j.diagmicrobio.2019.114894
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA LE0LQ
UT WOS:000526416900011
PM 31727377
OA Bronze
DA 2020-07-08
ER

PT J
AU Santana, LS
   Braga, JU
AF Santana, Lais Santos
   Braga, Jose Ueleres
TI Spatial diffusion of Zika fever epidemics in the Municipality of
   Salvador-Bahia, Brazil, in 2015-2016: does Zika fever have the same
   spread pattern as Dengue and Chikungunya fever epidemics?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Zika; Chikungunya; Dengue; Arboviruses; Spatial diffusion
ID VIRUS OUTBREAK
AB Introduction: The recent emergence and rapid spread of Zika and Chikungunya fevers in Brazil, occurring simultaneously to a Dengue fever epidemic, together represent major challenges to public health authorities. This study aimed to identify and compare the 2015-2016 spatial diffusion pattern of Zika, Chikungunya, and Dengue epidemics in Salvador-Bahia. Methods: We used two study designs comprising a cross-sectional-to-point pattern and an ecological analysis of lattice data. Residential addresses involving notified cases were geocoded. We used four spatial diffusion analysis techniques: (i) visual inspection of the sequential kernel and choropleth map. (ii) spatial correlogram analysis, (iii) spatial local autocorrelation (LISA) changes analysis and, (iv) nearest neighbor index (NNI) modeling. Results: Kernel and choropleth maps indicated that arboviruses spread to neighboring areas near the first reported cases and occupied these new areas, suggesting a diffusion expansion pattern. A greater case density occurred in central and western areas. In 2015 and 2016, the NNI best-fit model had an S-curve compatible with an expansion pattern for Zika (R-2 = 0.94; 0.95), Chikungunya (R-2 = 0.99; 0.98) and Dengue (R-2 = 0.93; 0.99) epidemics, respectively. Spatial correlograms indicated a decline in spatial lag autocorrelations for the three diseases (expansion pattern). Significant LISA changes suggested different diffusion patterns, although a small number of changes were detected. Conclusions: These findings indicate diffusion expansion, a unique spatial diffusion pattern of Zika, Chikungunya, and Dengue epidemics in Salvador-Bahia, namely. Knowing how and where arboviruses spread in Salvador-Bahia can help improve subsequent specific epidemic control interventions.
C1 [Santana, Lais Santos] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Programa Posgrad Stricto Sensu Epidemiol Saude Pu, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitativos, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
RP Braga, JU (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitativos, Rio De Janeiro, RJ, Brazil.; Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
EM ueleres@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES).
CR Andrade Ana Lúcia Sampaio Sgambatti de, 2004, Cad. Saúde Pública, V20, P411, DOI 10.1590/S0102-311X2004000200008
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Anselin L., 2017, GEODA USERS GUIDE
   Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cliff A. D., 1981, SPATIAL DIFFUSION
   Cohen J, 1999, J QUANT CRIMINOL, V15
   Cromley EK, 2012, GIS PUBLIC HLTH, P234
   Gatrell AC, 1996, SOC SCI MED, V42, P843, DOI 10.1016/0277-9536(95)00183-2
   Gubler DJ, 2016, NOVART FDN SYMP, V277, P3
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   IBGE, 2016, POP MUN SALV 2016
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lam NS, 1996, SPATIAL TEMPORAL SPR, V28
   Lee J, 2014, INT J APPL GEOSPAT R, V5, P1, DOI 10.4018/ijagr.2014010101
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006245, 10.1590/s1518-8787.2016050006245]
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Ministerio da Saude ( MS), 2014, SIST NAC VIG SAUD RE, V45
   Ministerio da Saude ( MS), 2017, SIST NAC VIG SAUD VI, V48
   Ministerio da Saude ( MS), 2015, SIST NAC VIG SAUD PL
   Morato DG, 2015, MEM I OSWALDO CRUZ, V110, P528, DOI 10.1590/0074-0276140388
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1
   R Core Team, 2016, R FDN STAT COMP
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Sant-Julien T, 2010, MODEL SPAT ANAL, P127, DOI 10.1002/9780470612255
   SEDUR, 2016, PLAN DIR DES URB MUN
   Team Qgis Development, 2016, QGIS GEOGR INF SYST
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 32
TC 0
Z9 0
U1 1
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2020
VL 53
AR e20190563
DI 10.1590/0037-8682-0563-2019
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LC6AV
UT WOS:000525414000001
PM 32267460
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mudele, O
   Bayer, FM
   Zanandrez, LFR
   Eiras, AE
   Gamba, P
AF Mudele, Oladimeji
   Bayer, Fabio M.
   Zanandrez, Lucas F. R.
   Eiras, Alvaro E.
   Gamba, Paolo
TI Modeling the Temporal Population Distribution of Ae. aegypti Mosquito
   Using Big Earth Observation Data
SO IEEE ACCESS
LA English
DT Article
DE Ae. aegypti; machine learning; random forest; remote sensing
ID AEDES-AEGYPTI; LANDSCAPE EPIDEMIOLOGY; URBAN-GROWTH; LANDSAT; DISEASE;
   IMAGES
AB Over 50% of the world population is at risk of mosquito-borne diseases. Female Ae. aegypti mosquito species transmit Zika, Dengue, and Chikungunya. The spread of these diseases correlate positively with the vector population, and this population depends on biotic and abiotic environmental factors including temperature, vegetation condition, humidity and precipitation. To combat virus outbreaks, information about vector population is required. To this aim, Earth observation (EO) data provide fast, efficient and economically viable means to estimate environmental features of interest. In this work, we present a temporal distribution model for adult female Ae. aegypti mosquitoes based on the joint use of the Normalized Difference Vegetation Index, the Normalized Difference Water Index, the Land Surface Temperature (both at day and night time), along with the precipitation information, extracted from EO data. The model was applied separately to data obtained during three different vector control and field data collection condition regimes, and used to explain the differences in environmental variable contributions across these regimes. To this aim, a random forest (RF) regression technique and its nonlinear features importance ranking based on mean decrease impurity (MDI) were implemented. To prove the robustness of the proposed model, other machine learning techniques, including support vector regression, decision trees and k-nearest neighbor regression, as well as artificial neural networks, and statistical models such as the linear regression model and generalized linear model were also considered. Our results show that machine learning techniques perform better than linear statistical models for the task at hand, and RF performs best. By ranking the importance of all features based on MDI in RF and selecting the subset comprising the most informative ones, a more parsimonious but equally effective and explainable model can be obtained. Moreover, the results can be empirically interpreted for use in vector control activities.
C1 [Mudele, Oladimeji; Gamba, Paolo] Univ Pavia, Dept Elect Comp & Biomed Engn, Telecommun & Remote Sensing Lab, I-27100 Pavia, Italy.
   [Bayer, Fabio M.] Univ Fed Santa Maria, Dept Stat, BR-97105900 Santa Maria, RS, Brazil.
   [Bayer, Fabio M.] Univ Fed Santa Maria, LACESM, BR-97105900 Santa Maria, RS, Brazil.
   [Zanandrez, Lucas F. R.] Ecovec Ltda, BR-31310260 Belo Horizonte, MG, Brazil.
   [Eiras, Alvaro E.] Univ Fed Minas Gerais, Lab Technol Innovat & Entrepreneurship Vector Con, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Mudele, O (corresponding author), Univ Pavia, Dept Elect Comp & Biomed Engn, Telecommun & Remote Sensing Lab, I-27100 Pavia, Italy.
EM oladimeji.mudele01@universitadipavia.it
RI Bayer, Fabio M/G-4513-2012; Gamba, Paolo/G-1959-2010
OI Bayer, Fabio M/0000-0002-1464-0805; Gamba, Paolo/0000-0002-9576-6337;
   Mudele, Oladimeji/0000-0001-7131-6334
FU European Commission through Horizon 2020 Research and Innovation
   Programme (Project EOXPOSURE) [734541]; CNPq/MCTI, Brazil;
   CAPES/MECCAPESSpanish Government; CNPq/MCTI; Decit/SCTIE/MS
   [440358/2016-7]
FX The work of Oladimeji Mudele was supported by the European Commission
   through Horizon 2020 Research and Innovation Programme (Project
   EOXPOSURE) under Grant 734541. The work of Fabio M. Bayer was supported
   by the CNPq/MCTI, Brazil. The work of Alvaro E. Eiras was supported in
   part by the CAPES/MEC, in part by the CNPq/MCTI, and in part by the
   Decit/SCTIE/MS under Grant 440358/2016-7.
CR Angiuli E, 2014, IEEE GEOSCI REMOTE S, V11, P661, DOI 10.1109/LGRS.2013.2274327
   Antonio FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180715
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Bagan H, 2012, REMOTE SENS ENVIRON, V127, P210, DOI 10.1016/j.rse.2012.09.011
   Barsante L., 2014, ARXIV14097942
   Biau G, 2016, TEST-SPAIN, V25, P197, DOI 10.1007/s11749-016-0481-7
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Breiman L., 1984, CLASSIFICATION REGRE
   Chen SC, 2010, SCI TOTAL ENVIRON, V408, P4069, DOI 10.1016/j.scitotenv.2010.05.021
   Cheong YL, 2013, INT J ENV RES PUB HE, V10, P6319, DOI 10.3390/ijerph10126319
   Christopher M., 1996, NEURAL NETWORKS PATT
   Costa EMD, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000400007, 10.5123/s1679-49742018000400007]
   Doll CNH, 2006, ECOL ECON, V57, P75, DOI 10.1016/j.ecolecon.2005.03.007
   Donnay J.-P., 2012, REMOTE SENSING URBAN, V9
   dos Santos AR, 2017, SCI TOTAL ENVIRON, V605, P946, DOI 10.1016/j.scitotenv.2017.05.275
   Eiras A. E., 2018, LOCAL GLOBAL IMPACT
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1
   Fornace KM, 2014, TRENDS PARASITOL, V30, P514, DOI 10.1016/j.pt.2014.09.001
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3
   German A., 2018, Remote Sensing Applications: Society and Environment, V11, P231, DOI 10.1016/j.rsase.2018.07.006
   Hollander M., 2013, NONPARAMETRIC STAT M
   Jamison A, 2015, APPL GEOGR, V63, P418, DOI 10.1016/j.apgeog.2015.08.001
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Jiang Z., 2017, SPATIAL BIG DATA SCI
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6
   Kamimura Kiyoshi, 2002, Medical Entomology and Zoology, V53, P53
   Karpatne A, 2019, IEEE T KNOWL DATA EN, V31, P1544, DOI 10.1109/TKDE.2018.2861006
   Krzywinksi M, 2017, NAT METHODS, V14, P757, DOI 10.1038/nmeth.4370
   Lary DJ, 2016, GEOSCI FRONT, V7, P3, DOI 10.1016/j.gsf.2015.07.003
   Lary DJ, 2010, GEOSCIENCE AND REMOTE SENSING, NEW ACHIEVEMENTS, P105
   Linard C, 2013, APPL GEOGR, V44, P23, DOI 10.1016/j.apgeog.2013.07.009
   Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337
   Louppe G, 2013, ADV NEURAL INFORM PR, V2013, P431
   Marinoni A, 2017, IEEE T COMPUT IMAG, V3, P243, DOI 10.1109/TCI.2017.2669731
   Markham BL, 2012, REMOTE SENS ENVIRON, V122, P30, DOI 10.1016/j.rse.2011.06.026
   McCullagh P., 1989, GEN LINEAR MODELS
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   de Melo DPO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042125
   Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009
   Patel NN, 2015, INT J APPL EARTH OBS, V35, P199, DOI 10.1016/j.jag.2014.09.005
   Porcasi X., 2014, GEOSPATIAL HEALTH, V6, P31
   R Core Team, 2018, R LANG ENV STAT COMP
   Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419
   Riedmiller M., 1994, TECH REP
   Ritchie S. A., 1984, MOSQUITO NEWS
   Rossi JP, 2018, INFECT GENET EVOL, V63, P307, DOI 10.1016/j.meegid.2017.10.006
   Rotela C, 2017, GEOSPATIAL HEALTH, V12, P226, DOI 10.4081/gh.2017.564
   Sammut C., 2017, ENCY MACHINE LEARNIN
   Scavuzzo JM, 2018, ACTA TROP, V185, P167, DOI 10.1016/j.actatropica.2018.05.003
   Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235
   Skofronick-Jackson G, 2017, B AM METEOROL SOC, V98, P1679, DOI [10.1175/BAMS-D-15-00306.1, 10.1175/bams-d-15-00306.1]
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Tran A, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11091024
   TRPIS M, 1972, B WORLD HEALTH ORGAN, V47, P433
   Turyahikayo A., 2015, P IEEE INT GEOSC REM
   Wan Z, 2004, INT J REMOTE SENS, V25, P261, DOI 10.1080/0143116031000116417
   Weng P. E. G. Qihao, 2018, URBAN REMOTE SENSING
   Weng Q., 2014, GLOBAL URBAN MONITOR
   While A, 2013, URBAN STUD, V50, P1325, DOI 10.1177/0042098013480963
   World Health Organization, 2016, MOSQ BORN DIS
   Yao Q., 2009, P INT C ENG COMP
   Young SG, 2013, APPL GEOGR, V45, P241, DOI 10.1016/j.apgeog.2013.09.022
   Zhang LP, 2016, IEEE GEOSC REM SEN M, V4, P22, DOI 10.1109/MGRS.2016.2540798
NR 66
TC 0
Z9 0
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2169-3536
J9 IEEE ACCESS
JI IEEE Access
PY 2020
VL 8
BP 14182
EP 14194
DI 10.1109/ACCESS.2020.2966080
PG 13
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA LB6HQ
UT WOS:000524735300016
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Brito, J
   Louback-Franco, N
   Mendoza, C
   Nonato, F
   Juen, L
   Michelan, T
AF Brito, Joas
   Louback-Franco, Nayara
   Mendoza, Cristion
   Nonato, Flavia
   Juen, Leandro
   Michelan, Thaisa
TI After 10 years the myth of Crotalaria spp. and dragonflies remains alive
SO BIOTA NEOTROPICA
LA English
DT Article
DE Mosquitoes; tropical diseases; zika; invasive species
ID MOSQUITO LARVAE; AQUATIC INSECTS; ODONATA
AB The struggle to control insect-borne diseases can lead to make rash decisions. For instance, the controversial method of planting of Crotalaria spp. to attract predatory dragonflies can be used to control insect vectors of dengue fever and several other medically significant insect-borne diseases. Nevertheless, there is no scientific support for this assumption. Despite the lack of evidence, in Brazil, there remains a multitude of online articles and grey literature sources still promote Crotalaria planting as a means to prevent dengue fever. Here we discuss the reasons why Odonata would not be attracted by Crotalaria and, therefore, it cannot not be considered as an efficient method for vector control. Finally, the best practice to avoid the spread of insect-borne diseases in the tropics is to avoid the accumulation of standing water in urban areas.
C1 [Brito, Joas; Louback-Franco, Nayara; Nonato, Flavia; Michelan, Thaisa] Univ Fed Para, EMBRAPA, Programa Posgrad Ecol, Belem, Para, Brazil.
   [Brito, Joas; Louback-Franco, Nayara; Mendoza, Cristion; Nonato, Flavia; Juen, Leandro] Univ Fed Para, Lab Ecol & Conservacao, Belem, Para, Brazil.
   [Mendoza, Cristion] Univ Fed Para, Museu Paraense Emilio Goeldi, Programa Posgrad Zool, Belem, Para, Brazil.
   [Michelan, Thaisa] Univ Fed Para, Lab Ecol Prod Primarios, Belem, Para, Brazil.
   [Juen, Leandro] Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil.
RP Juen, L (corresponding author), Rua Augusto Correa, Belem, Para, Brazil.
EM leandrojuen@ufpa.br
RI ; Sala Michelan, Thaisa/I-5255-2012
OI Juen, Leandro/0000-0002-6188-4386; Louback-Franco,
   Nayara/0000-0002-1986-9465; Brito, Joas/0000-0002-9682-7429; Nonato,
   Flavia Alessandra/0000-0001-8208-5877; Sala Michelan,
   Thaisa/0000-0001-9416-0758
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [433125/2018-7, 428961/2018-5]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES)CAPES [001]; CAPESCAPES
   [307597/2016-4]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [307597/2016-4]; BRC (Brazilian Research Consortium)
   [0005]; Hydro Alunorte company
FX This study was financed by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq (processes: 433125/2018-7 and
   428961/2018-5) and the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) - Finance Code 001. We acknowledge CAPES
   and CNPq for granting scholarship and productivity grant to NLF, CCM and
   LJ (process #307597/2016-4). We are also grateful to BRC (Brazilian
   Research Consortium -this paper is number 0005 in the publication series
   of the BRC) and Hydro Alunorte company for providing scholarship to JSB
   and FASN. The authors are grateful to Dr. Alistair John Campbell for
   English's revising the text and for the review/suggestions from two
   anonymous reviewers. We are also thankful to MSc. Ricardo Ribeiro da
   Silva to draw the figure 01.
CR Acquah-Lamptey D, 2018, WEB ECOL, V18, P81, DOI 10.5194/we-18-81-2018
   ANDRADE C.F.S., 2011, 7 INT C URB PESTS OU
   De Oliveira-Jr JMB, 2015, AUSTRAL ECOL, V40, P733, DOI 10.1111/aec.12242
   Carvalho FG, 2018, ANIM CONSERV, V21, P526, DOI 10.1111/acv.12427
   Clausnitzer V, 2009, BIOL CONSERV, V142, P1864, DOI 10.1016/j.biocon.2009.03.028
   Corbet P.S., 1999, DRAGONFLIES BEHAV EC
   De Marco Jr P., 2005, LUNDIANA S, V6, P13
   Fernandes GW, 2015, PLANTA DANINHA, V33, P463, DOI 10.1590/S0100-83582015000300009
   Fincke O.M., 1984, Advances in Odonatology, V2, P13
   Fincke OM, 1997, OECOLOGIA, V112, P244, DOI 10.1007/s004420050307
   Fonseca RL, 2006, WEED SCI, V54, P458, DOI 10.1614/WS-05-059R4.1
   Harris WE, 2011, INT J ODONATOL, V14, P281, DOI 10.1080/13887890.2011.623981
   Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0
   Kriska G, 2006, P ROY SOC B-BIOL SCI, V273, P1667, DOI 10.1098/rspb.2006.3500
   KUSTER A., 2010, AGROECOLOGIA MANEJO
   MATTOS E.C.A, 2017, 1 ENC INT GEST DES I
   MENDES T.P., NEOTROP ENTOMOL, V6, P631
   Miguel TB, 2017, INT J ODONATOL, V20, P27, DOI 10.1080/13887890.2017.1286267
   Mitterboeck TF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1128
   Nam VS, 2000, AM J TROP MED HYG, V62, P5, DOI 10.4269/ajtmh.2000.62.5
   Oliveira JMB, 2019, NEOTROP ENTOMOL, V48, P552, DOI 10.1007/s13744-019-00672-x
   Piersanti S, 2014, J INSECT PHYSIOL, V70, P49, DOI 10.1016/j.jinsphys.2014.09.003
   POLHILL RM, 1982, CROTALARIA AFRICA MA
   Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548
   Quiroz-Martinez H, 2007, J AM MOSQUITO CONTR, V23, P110, DOI 10.2987/8756-971X(2007)23[110:AIAPOM]2.0.CO;2
   Remsburg AJ, 2009, J N AM BENTHOL SOC, V28, P44, DOI 10.1899/08-004.1
   Roberts D, 2012, ENTOMOL EXP APPL, V145, P23, DOI 10.1111/j.1570-7458.2012.01300.x
   ROOM PM, 1981, NATURE, V294, P78, DOI 10.1038/294078a0
   Sheppard A. W., 2003, Biocontrol News and Information, V24, p91N
   Stevani CV, 2000, POLYM DEGRAD STABIL, V68, P61, DOI 10.1016/S0141-3910(99)00165-2
   Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557
   Suhling F, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P893, DOI 10.1016/B978-0-12-385026-3.00035-8
   Venkatesh A., 2015, International Journal of Mosquito Research, V2, P98
   VIEIRA C.M., 2001, RODRIGUESIA, V52, P17, DOI DOI 10.1590/2175-78602001528002
   Wildermuth Hansruedi, 2005, International Journal of Odonatology, V8, P97
   World Health Organization, 2019, DENG SEV DENG
   WUTKE E.B., 2015, AEDES AEGYPTI CONTRO
   Yaser SA, 2010, ASIAN PAC J TROP MED, V3, P276, DOI 10.1016/S1995-7645(10)60067-3
NR 38
TC 0
Z9 0
U1 1
U2 1
PU REVISTA BIOTA NEOTROPICA
PI CAMPINAS
PA AV. DR. ROMEU TORTIMA, 388 - BARAO GERALDO, CEP 13084-520, CAMPINAS, SP,
   BRAZIL
SN 1676-0603
J9 BIOTA NEOTROP
JI Biota Neotrop.
PY 2020
VL 20
IS 2
AR e20190907
DI 10.1590/1676-0611-BN-2019-0907
PG 6
WC Biodiversity Conservation
SC Biodiversity & Conservation
GA LA5WM
UT WOS:000524017900001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zhang, X
   Chu, H
   Wen, L
   Shuai, HP
   Yang, D
   Wang, YX
   Hou, YX
   Zhu, Z
   Yuan, SF
   Yin, FF
   Chan, JFW
   Yuen, WY
AF Zhang, Xi
   Chu, Hin
   Wen, Lei
   Shuai, Huiping
   Yang, Dong
   Wang, Yixin
   Hou, Yuxin
   Zhu, Zheng
   Yuan, Shuofeng
   Yin, Feifei
   Chan, Jasper Fuk-Woo
   Yuen, Kwok-Yung
TI Competing endogenous RNA network profiling reveals novel host dependency
   factors required for MERS-CoV propagation
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE KEYWORDS; MERS-CoV; competing endogenous RNA; circRNA; miRNA; mRNA
ID RESPIRATORY SYNDROME CORONAVIRUS; PAPAIN-LIKE PROTEASE; PDZ-BINDING
   MOTIF; CIRCULAR RNAS; DOWN-REGULATION; VIRUS-INFECTION; ZIKA VIRUS;
   REPLICATION; ROLES; BIOGENESIS
AB Circular RNAs (circRNAs) are an integral component of the host competitive endogenous RNA (ceRNA) network. These noncoding RNAs are characterized by their unique splicing reactions to form covalently closed loop structures and play important RNA regulatory roles in cells. Recent studies showed that circRNA expressions were perturbed in viral infections and circRNAs might serve as potential antiviral targets. We investigated the host ceRNA network changes and biological relevance of circRNAs in human lung adenocarcinoma epithelial (Calu-3) cells infected with the highly pathogenic Middle East respiratory syndrome coronavirus (MERS-CoV). A total of >= 49337 putative circRNAs were predicted. Among the 7845 genes which generated putative circRNAs, 147 (1.9%) of them each generated >= 30 putative circRNAs and were involved in various biological, cellular, and metabolic processes, including viral infections. Differential expression (DE) analysis showed that the proportion of DE circRNAs significantly (P < 0.001) increased at 24 h-post infection. These DE circRNAs were clustered into 4 groups according to their time-course expression patterns and demonstrated inter-cluster and intra-cluster variations in the predicted functions of their host genes. Our comprehensive circRNA-miRNA-mRNA network identified 7 key DE circRNAs involved in various biological processes upon MERS-CoV infection. Specific siRNA knockdown of two selected DE circRNAs (circFNDC3B and circCNOT1) significantly reduced MERS-CoV load and their target mRNA expression which modulates various biological pathways, including the mitogen-activated protein kinase (MAPK) and ubiquitination pathways. These results provided novel insights into the ceRNA network perturbations, biological relevance of circRNAs, and potential host-targeting antiviral strategies for MERS-CoV infection.
C1 [Zhang, Xi; Chu, Hin; Shuai, Huiping; Yuan, Shuofeng; Chan, Jasper Fuk-Woo] Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Zhang, Xi; Chu, Hin; Wen, Lei; Shuai, Huiping; Yang, Dong; Wang, Yixin; Hou, Yuxin; Zhu, Zheng; Yuan, Shuofeng; Chan, Jasper Fuk-Woo] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.
   [Yin, Feifei; Chan, Jasper Fuk-Woo] Hainan Med Univ, Hainan Med Univ Univ Hong Kong Joint Lab Trop Inf, Haikou, Hainan, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Dept Pathogen Biol, Haikou, Hainan, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Key Lab Translat Trop Med, Minist Educ, Haikou, Hainan, Peoples R China.
   [Chan, Jasper Fuk-Woo] Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Dept Clin Microbiol & Infect Control, Shenzhen Hosp, Shenzhen, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
RP Chan, JFW (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.; Chan, JFW (corresponding author), Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.; Chan, JFW (corresponding author), Hainan Med Univ, Hainan Med Univ Univ Hong Kong Joint Lab Trop Inf, Haikou, Hainan, Peoples R China.; Chan, JFW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.; Chan, JFW; Yuen, WY (corresponding author), Univ Hong Kong, Dept Clin Microbiol & Infect Control, Shenzhen Hosp, Shenzhen, Peoples R China.; Yuen, WY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
FU Theme-Based Research Scheme [T11/707/15]; NSFC/RGC Joint Research Scheme
   of the Research Grants Council [N_HKU728/14, 81461168030]; Hong Kong
   Health and Medical Research Fund of the Food and Health Bureau, Hong
   Kong Special Administrative Region [16150572]; Sanming Project of
   Medicine in Shenzhen, China [SZSM201911014]; High Level-Hospital
   Program, Health Commission of Guangdong Province, China; Collaborative
   Innovation Center for Diagnosis and Treatment of Infectious Diseases,
   the Ministry of Education of ChinaMinistry of Education, China
FX This study was partly supported by the donations of Michael Seak-Kan
   Tong, Respiratory Viral Research Foundation Limited, Hui Ming, Hui Hoy
   and Chow Sin Lan Charity Fund Limited, Chan Yin Chuen Memorial
   Charitable Foundation, Marina Man-Wai Lee, and the Hong Kong Hainan
   Commercial Association South China Microbiology Research Fund; and
   funding from the Theme-Based Research Scheme (T11/707/15) and the
   NSFC/RGC Joint Research Scheme (N_HKU728/14 and 81461168030) of the
   Research Grants Council; the Hong Kong Health and Medical Research Fund
   (16150572) of the Food and Health Bureau, Hong Kong Special
   Administrative Region; Sanming Project of Medicine in Shenzhen, China
   (No. SZSM201911014); the High Level-Hospital Program, Health Commission
   of Guangdong Province, China; and the Collaborative Innovation Center
   for Diagnosis and Treatment of Infectious Diseases, the Ministry of
   Education of China. The funding sources had no role in the study design,
   data collection, analysis, interpretation, or writing of the report.
CR Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644
   Bernier A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080440
   Chan CM, 2016, J VIROL, V90, P9114, DOI 10.1128/JVI.01133-16
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002
   Chan JFW, 2018, ANTIVIR RES, V160, P38, DOI 10.1016/j.antiviral.2018.10.007
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123
   Chen BJ, 2016, J NEUROCHEM, V139, P485, DOI 10.1111/jnc.13752
   Chen JN, 2019, VIROLOGY, V527, P169, DOI 10.1016/j.virol.2018.11.014
   Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32
   Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560
   Chiang C, 2018, J VIROL, V92, DOI 10.1128/JVI.01737-17
   Chu H, 2018, J BIOL CHEM, V293, P11709, DOI 10.1074/jbc.RA118.001897
   Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380
   Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018
   Cui SC, 2018, ONCOL LETT, V15, P423, DOI 10.3892/ol.2017.7265
   Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793
   Dudekulay DB, 2016, RNA BIOL, V13, P34, DOI 10.1080/15476286.2015.1128065
   Enright AJ, 2004, GENOME BIOL, V5
   Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881
   Gao Y, 2018, BRIEF BIOINFORM, V19, P803, DOI 10.1093/bib/bbx014
   Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11
   Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993
   Holdt LM, 2018, CELL MOL LIFE SCI, V75, P1071, DOI 10.1007/s00018-017-2688-5
   Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890
   Kindrachuk J, 2015, ANTIMICROB AGENTS CH, V59, P1088, DOI 10.1128/AAC.03659-14
   Kusakabe S, 2019, J VIROL, V93, DOI 10.1128/JVI.01708-18
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li SF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0699-2
   Lopez-Jimenez E, 2018, ADV EXP MED BIOL, V1087, P17, DOI 10.1007/978-981-13-1426-1_2
   Ma XL, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5128-5
   Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928
   Pauli EK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004577
   Pyeon D, 2016, VIRUS RES, V223, P161, DOI 10.1016/j.virusres.2016.07.009
   Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470
   Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103
   Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027
   Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014
   Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777
   Shi JD, 2017, ONCOTARGET, V8, P98609, DOI 10.18632/oncotarget.21694
   Tagawa T, 2018, P NATL ACAD SCI USA, V115, P12805, DOI 10.1073/pnas.1816183115
   Tao P, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00076
   Thomas LF, 2014, BIOINFORMATICS, V30, P2243, DOI 10.1093/bioinformatics/btu257
   Wang C, 2019, J VIROL, V93, DOI 10.1128/JVI.00513-19
   Wang ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00479
   Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   Yeung ML, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.4, 10.1038/nmicrobiol.2016.4]
   Yoshimatsu Y, 2017, CANCER SCI, V108, P1303, DOI 10.1111/cas.13264
   Yu TQ, 2019, VET MICROBIOL, V231, P238, DOI 10.1016/j.vetmic.2019.03.012
   Yuan SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08015-x
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115
   Zhang XH, 2017, ONCOTARGET, V8, P34961, DOI 10.18632/oncotarget.16442
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 59
TC 0
Z9 0
U1 7
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 733
EP 746
DI 10.1080/22221751.2020.1738277
PG 14
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KY0FA
UT WOS:000522248400001
PM 32223537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Korzeniewski, K
AF Korzeniewski, Krzysztof
TI Eye diseases in travelers
SO INTERNATIONAL MARITIME HEALTH
LA English
DT Review
DE eye diseases; travelers; treatment; prevention
ID DRY EYE; EXPOSURE; RADIATION
AB Travelling has been growing in popularity over the last several decades. Eye diseases, e.g. decreased visual acuity, inflammatory or degenerative lesions, chronic diseases or eye trauma, affect all groups of travelers. The main risk factors contributing to the manifestation or exacerbation of common ocular diseases include exposure to dry air (inside the airplane cabin or in air-conditioned hotel rooms), exposure to chlorinated or salty water (swimming/bathing in swimming pools or in the sea), and sudden changes in the weather conditions. In addition, travelers to tropical destinations are at risk of ocular diseases which are rarely seen in temperate climate, e.g. onchocerciasis, loiasis, gnatostomosis, African trypanosomosis, or trachoma. The most common condition of the eye seen in travelers is conjunctivitis; it may be either of cosmopolitan (bacterial or viral infections, allergic inflammation) or tropical etiology, e.g. arboviral infections (zika, chikungunya). Given the fact that a large proportion of the general population have decreased visual acuity and many of them wear contact lenses rather than glasses, keratitis has become a common health problem among travelers as well; the major risk factors in such cases include sleeping in contact lenses, prolonged exposure to air-conditioning, working with a computer or swimming/bathing in microbiologically contaminated water (e.g. Acanthoamoeba protozoa). Conditions affecting the cornea, conjunctiva or lens may also occur due to excessive exposure to solar radiation, especially if travelers wear glasses without a UV protection.
C1 [Korzeniewski, Krzysztof] Mil Inst Med, Dept Epidemiol & Trop Med, Szaserow St 128, PL-04141 Warsaw, Poland.
   [Korzeniewski, Krzysztof] Polish Soc Maritime Trop & Travel Med, Powstania Styczniowego St 98, PL-81519 Gdynia, Poland.
RP Korzeniewski, K (corresponding author), Mil Inst Med, Dept Epidemiol & Trop Med, Szaserow St 128, PL-04141 Warsaw, Poland.; Korzeniewski, K (corresponding author), Polish Soc Maritime Trop & Travel Med, Powstania Styczniowego St 98, PL-81519 Gdynia, Poland.
EM kkorzeniewski@wim.mil.pl
RI Korzeniewski, Krzysztof/C-8309-2015
CR ANTONIAK K, 2009, FARM POL, V65, P124
   Das D, 2016, INDIAN J OPHTHALMOL, V64, P794, DOI 10.4103/0301-4738.195590
   Diaz James H, 2015, J La State Med Soc, V167, P172
   Diaz JH, 2013, J TRAVEL MED, V20, P108, DOI 10.1111/j.1708-8305.2012.00667.x
   Ezuddin NS, 2015, DRUG AGING, V32, P505, DOI 10.1007/s40266-015-0277-6
   Gadaria-Rathod N, 2013, EXPERT OPIN EMERG DR, V18, P121, DOI 10.1517/14728214.2013.791676
   Hessen Michelle, 2014, J Ophthalmic Vis Res, V9, P240
   Izadi M, 2018, J POSTGRAD MED, V64, P40, DOI 10.4103/jpgm.JPGM_52_17
   Izadi M, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_161_18
   Kanski JJ, 2008, INFLAMMATORY EYE DIS
   Khairallah M, 2013, CURR OPIN OPHTHALMOL, V24, P574, DOI 10.1097/ICU.0b013e3283654e09
   Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789
   Korzeniewski K., 2019, TRAVEL MED, P111
   Korzeniewski Krzysztof, 2008, Pol Merkur Lekarski, V25, P161
   Leggat PA, 1999, J TRAVEL MED, V6, P45, DOI 10.1111/j.1708-8305.1999.tb00866.x
   Leibowitz HM, 2000, NEW ENGL J MED, V343, P345, DOI 10.1056/NEJM200008033430507
   Marshall Leisa L, 2016, Consult Pharm, V31, P96, DOI 10.4140/TCP.n.2016.96
   Messmer EM, 2015, DTSCH ARZTEBL INT, V112, P71, DOI 10.3238/arztebl.2015.0071
   Moshirfar M, 2014, CLIN OPHTHALMOL, V8, P1419, DOI 10.2147/OPTH.S65263
   Omulecki W, 2015, OPHTHALMOLOGY RETINA
   Partyka O, 2015, PRZEGL EPIDEMIOL, V69, P905
   Pleyer U, 2016, OPHTHALMOLOGE, V113, P35, DOI 10.1007/s00347-015-0176-6
   Raciborski F, 2016, EYE DIS HLTH SOCIAL
   Ryan ET, 2006, TROPICAL INFECT DIS, P1554
   Sasaki H, 2011, EYE CONTACT LENS, V37, P191, DOI 10.1097/ICL.0b013e31821fbf29
   Stankewicz A, 2013, FAM MED PRIM CARE RE, V15, P477
   Statistics Poland, 2016, HLTH COND POL POP 20
   Szmurlo D, 2013, ACCESS OPHTHALMOLOGI
   Torkildsen G, 2017, CLIN OPHTHALMOL, V11, P1883, DOI 10.2147/OPTH.S144369
   Tuchinda C, 2006, J AM ACAD DERMATOL, V54, P845, DOI 10.1016/j.jaad.2005.11.1082
   Walsh JE, 2011, EYE CONTACT LENS, V37, P267, DOI 10.1097/ICL.0b013e3182235777
   Wang F, 2014, PHOTOCHEM PHOTOBIOL, V90, P1174, DOI 10.1111/php.12287
   Yorston DH, 2009, MANSONS TROPICAL DIS, P283
   Zhou L, 2012, PROG RETIN EYE RES, V31, P527, DOI 10.1016/j.preteyeres.2012.06.002
NR 34
TC 0
Z9 0
U1 0
U2 0
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 1641-9251
EI 2081-3252
J9 INT MARIT HEALTH
JI Int. Marit. Health
PY 2020
VL 71
IS 1
BP 78
EP 84
DI 10.5603/IMH.2020.0015
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KX8WH
UT WOS:000522155800015
PM 32212152
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Anwar, S
   Mourosi, JT
   Khan, MF
   Hosen, MJ
AF Anwar, Saeed
   Mourosi, Jarin T.
   Khan, Md Fahim
   Hosen, Mohammad J.
TI Prediction of Epitope-based Peptide Vaccine Against the Chikungunya
   Virus by Immuno-informatics Approach
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Article
DE Chikungunya virus; immunoinformatics; T cell epitopes; B-cell epitopes
   glycoprotein; vaccine; Zika viruses
ID ANTIGENIC DETERMINANTS; CELL EPITOPES; PROTEINS; SEQUENCE; DESIGN;
   SELECTION; ANTIBODY; DOCKING; REGIONS; MODELS
AB Background: Chikungunya is an arthropod-borne viral disease characterized by abrupt onset of fever frequently accompanied by joint pain, which has been identified in over 60 countries in Africa, the Americas, Asia, and Europe.
   Methods: Regardless of the availability of molecular knowledge of this virus, no definite vaccine or other remedial agents have been developed yet. In the present study, a combination of B-cell and T-cell epitope predictions, followed by molecular docking simulation approach has been carried out to design a potential epitope-based peptide vaccine, which can trigger a critical immune response against the viral infections.
   Results: A total of 52 sequences of El glycoprotein from the previously reported isolates of Chikungunya outbreaks were retrieved and examined through in silico methods to identify a potential B-cell and T-cell epitope. From the two separate epitope prediction servers, five potential B-cell epitopes were selected, among them "NTQLSEAHVEKS" was found highly conserved across strains and manifests high antigenicity with surface accessibility, flexibility, and hydrophilicity. Similarly, two highly conserved, non-allergenic, non-cytotoxic putative T-cell epitopes having maximum population coverage were screened to bind with the HLA-C 12*03 molecule. Molecular docking simulation revealed potential T-cell based epitope "KTEFASAYR" as a vaccine candidate for this virus.
   Conclusion: A combination of these B-cell and T-cell epitope-based vaccine can open up a new skyline with broader therapeutic application against Chikungunya virus with further experimental and clinical investigation.
C1 [Anwar, Saeed; Mourosi, Jarin T.; Khan, Md Fahim; Hosen, Mohammad J.] Shahjalal Univ Sci & Technol, Sch Life Sci, Dept Genet Engn & Biotechnol, Sylhet 3114, Bangladesh.
   [Anwar, Saeed] Univ Alberta, Fac Med & Dent, Dept Med Genet, Maternal & Child Hlth Program, 8440 112 St NW, Edmonton, AB T6G 2R7, Canada.
   [Mourosi, Jarin T.] Catholic Univ Amer, Dept Biol, Microbial & Cellular Biol Program, 620 Michigan Ave NE, Washington, DC 20064 USA.
RP Hosen, MJ (corresponding author), Shahjalal Univ Sci & Technol, Sch Life Sci, Dept Genet Engn & Biotechnol, Sylhet 3114, Bangladesh.
EM jakir-gen@sust.edu
RI Hosen, Mohammad Jakir/AAR-2710-2020; Anwar, Saeed/AAR-3114-2020
OI Hosen, Mohammad Jakir/0000-0001-6444-0214; Anwar,
   Saeed/0000-0003-3688-5923
CR Adhikari UK, 2018, J IMMUNOL RES, DOI 10.1155/2018/6718083
   Andreatta M, 2018, BIOINFORMATICS, V34, P1522, DOI 10.1093/bioinformatics/btx820
   Basu A, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55060236
   Ben-Yedidia T, 2007, EXPERT REV VACCINES, V6, P939, DOI 10.1586/14760584.6.6.939
   Benson DA, 2012, NUCLEIC ACIDS RES, V40, pD48, DOI 10.1093/nar/gkr1202
   Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451
   Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380
   Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361
   Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Bussiere Jeanine L., 1995, P61
   Caoili S.E. C., 2010, BIOMED RES INT, V2010
   Chen JS, 2013, BIOINFORMATICS, V29, P420, DOI 10.1093/bioinformatics/bts715
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916
   Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19
   Dash Raju, 2017, Adv Appl Bioinform Chem, V10, P11, DOI 10.2147/AABC.S115859
   Dimitrov I, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S4
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985
   Erasmus JH, 2016, J INFECT DIS, V214, pS488, DOI 10.1093/infdis/jiw271
   Fenwick A, 2012, PUBLIC HEALTH, V126, P233, DOI 10.1016/j.puhe.2011.11.015
   Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313
   Gao C., 2010, THESIS
   Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211
   Gauci PJ, 2010, CLIN VACCINE IMMUNOL, V17, P176, DOI 10.1128/CVI.00377-09
   Kozlova EEG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33298-x
   Gupta S., 2013, PLOS ONE, V8
   Hasan MA, 2013, BIOINFORM BIOL INSIG, V7, P347, DOI 10.4137/BBI.S13402
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Ingale AG, 2014, BIOCH PHYSL OPEN ACC, V3, P1
   Islam R, 2012, FUTURE VIROL, V7, P1029, DOI 10.2217/FVL.12.95
   Jadoon M.H., 2019, INFECT DISORD DRUG T
   Jain M, 2008, TROP DOCT, V38, P70, DOI 10.1258/td.2007.070019
   Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075
   Khan MA, 2015, SCAND J IMMUNOL, V82, P25, DOI 10.1111/sji.12302
   Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829
   Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329
   Lapelosa M, 2009, J MOL BIOL, V385, P675, DOI 10.1016/j.jmb.2008.10.089
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Laskowski R, 2006, PROCHECK VALIDATION
   Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546
   Li X., 2012, COMPLETE GENOME SEQU
   Lin SYH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S10
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146
   Mobbs JI, 2017, J BIOL CHEM, V292, P17203, DOI 10.1074/jbc.M117.806976
   Moreau V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-71
   Mourya DT, 2006, LANCET, V368, P186, DOI 10.1016/S0140-6736(06)69017-X
   Narula A, 2018, INFECT GENET EVOL, V61, P4, DOI 10.1016/j.meegid.2018.03.007
   NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226
   Pandey RK, 2018, J CELL BIOCHEM, V119, P7631, DOI 10.1002/jcb.27110
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132
   Plemper RK, 2005, ANTIMICROB AGENTS CH, V49, P3755, DOI 10.1128/AAC.49.9.3755-3761.2005
   Rahman M, 2019, EMERG INFECT DIS, V25, P370, DOI 10.3201/eid2502.180188
   Ravichandran L, 2019, J CELL BIOCHEM, V120, P7082, DOI 10.1002/jcb.27979
   Reddy CS, 2006, COMPUT BIOL CHEM, V30, P120, DOI 10.1016/j.compbiolchem.2005.12.002
   Rezza G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006919
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Runowska M, 2018, CLIN EXP RHEUMATOL, V36, P494
   Sabetian S, 2019, J BIOMOL STRUCT DYN, V37, P2546, DOI 10.1080/07391102.2018.1491890
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Sala M, 2000, J MOL EVOL, V51, P12, DOI 10.1007/s002390010062
   Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886
   Schneider FS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002826
   Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6
   Shah P, 2018, MOL IMMUNOL, V97, P56, DOI 10.1016/j.molimm.2018.03.007
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404
   Smith JL, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00003-18, 10.1128/msphere.00003-18]
   Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800
   Spurgers K.B., 2011, J BIOTERR BIODEF
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Starr-Spires LD, 2002, CLIN LAB MED, V22, P681, DOI 10.1016/S0272-2712(02)00011-2
   STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C
   Subudhi BB, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050235
   Swayze RD, 2011, VACCINE, V29, P813, DOI 10.1016/j.vaccine.2010.11.009
   Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Trolle T, 2015, BIOINFORMATICS, V31, P2174, DOI 10.1093/bioinformatics/btv123
   ul Qamar MT, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1672-7
   Vani J, 2006, MICROBES INFECT, V8, P738, DOI 10.1016/j.micinf.2005.09.012
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Vrtala S, 2004, METHODS, V32, P313, DOI 10.1016/j.ymeth.2003.08.016
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Weaver S.C., 2011, TROPICAL INFECT DIS
   Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1
   Weger-Lucarelli J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004163
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 99
TC 0
Z9 0
U1 0
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
EI 1873-4316
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PY 2020
VL 21
IS 4
BP 325
EP 340
DI 10.2174/1389201020666191112161743
PG 16
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA KX4CP
UT WOS:000521828200006
PM 31721709
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika and spontaneous abortion
SO BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO
LA English
DT Letter
C1 [Joob, Beuy] Acad Med Ctr, Instalac Sanit, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Acad Med Ctr, Instalac Sanit, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Rivadeneyra-Espinar PG, 2019, B MED HOSP INFANT M, V76, P193, DOI 10.24875/BMHIM.19000116
   Santos GR, 2020, INT J GYNECOL PATHOL, V39, P157, DOI 10.1097/PGP.0000000000000586
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 6
TC 0
Z9 0
U1 0
U2 0
PU HOSPITAL INFANTIL MEXICO
PI MEXICO CITY
PA FEDERICO GOMEZ, DEPT EDICIONES  MEDICAS, CALLE DR MARQUEZ 162 COL
   DOCTORES, DELEG CUAUHTEMOC, MEXICO CITY 06720, MEXICO
SN 0539-6115
EI 1665-1146
J9 B MED HOSP INFANT M
JI Bol. Med. Hosp. Infant. Mex.
PD JAN-FEB
PY 2020
VL 77
IS 1
BP 46
EP 46
DI 10.24875/BMHIM.19000114
PG 1
WC Pediatrics
SC Pediatrics
GA KW3NB
UT WOS:000521072600008
PM 32115581
OA Bronze
DA 2020-07-08
ER

PT J
AU Cavalcanti, AL
   de Arruda, TD
   Fernandes, LHF
   Leal, JIBD
   Aguiar, YPC
   Cavalcanti, SDLB
   Cavalcanti, AFC
AF Cavalcanti, Alessandro Leite
   de Arruda, Taynna Dantas
   Freitas Fernandes, Liege Helena
   Bezerra de Freitas Leal, Jeime Iara
   Costa Aguiar, Yeska Paola
   Lins Bezerra Cavalcanti, Sergio D'Avila
   Cabral Cavalcanti, Alidianne Fabia
TI Use of Medicines by Infants with Microcephaly Caused by Congenital Zika
   Virus Infection and Implications to Oral Health
SO PESQUISA BRASILEIRA EM ODONTOPEDIATRIA E CLINICA INTEGRADA
LA English
DT Article
DE Microcephaly; Child; Prescription Drugs; Oral Health
ID DENTAL-CARIES; CHILDREN; RISK
AB Objective: To analyze the use of continued-use medications by Brazilian children with microcephaly caused by Congenital Zika Virus Infection. Material and Methods: Cross-sectional study with 76 children of both genders. Information on age, use of continued-use medications, number and type of drugs used was collected. Data were analyzed using descriptive statistics. Results: Continued-use medications were used by 89.4% of the children, anticonvulsants / antiepileptics (88.1%), and those indicated for behavioral disorders (27.1%) were the most frequent. Sodium saccharin, sucrose, and sorbitol are the most common sugars in the composition of these drugs. Conclusion: The use of medicines is high, predominantly anticonvulsants and antiepileptics, which contain sugars in their composition. These drugs can lead to irreversible dental problems, such as tooth decay if proper oral hygiene is not present. Therefore, parents/guardians should be advised about adopting healthy oral hygiene habits after the administration of these drugs.
C1 [Cavalcanti, Alessandro Leite; Freitas Fernandes, Liege Helena; Costa Aguiar, Yeska Paola; Lins Bezerra Cavalcanti, Sergio D'Avila] State Univ Paraiba, Dept Dent, Postgrad Program Dent, Campina Grande, Paraiba, Brazil.
   [de Arruda, Taynna Dantas] State Univ Paraiba, Sch Dent, Araruna, PB, Brazil.
   [Bezerra de Freitas Leal, Jeime Iara] Specialized Rehabil Ctr, Campina Grande, Paraiba, Brazil.
   [Cabral Cavalcanti, Alidianne Fabia] State Univ Paraiba, Dept Dent, Campina Grande, Paraiba, Brazil.
RP Cavalcanti, AL (corresponding author), Univ Estadual Paraiba, Dept Odontol, Rua Baraunas 351, BR-58429500 Campina Grande, Paraiba, Brazil.
EM alessandrouepb@gmail.com
RI ; d'Avila, Sergio/I-9093-2014; LEITE CAVALCANTI, ALESSANDRO/A-2828-2010
OI Cavalcanti, Alidianne Fabia Cabral/0000-0002-7779-2478; d'Avila,
   Sergio/0000-0002-7836-896X; LEITE CAVALCANTI,
   ALESSANDRO/0000-0003-3572-3332
FU Brazilian National Council for Scientific and Technological Development
   (CNPq) - Research Productivity GrantNational Council for Scientific and
   Technological Development (CNPq) [302850/2016-3]
FX Brazilian National Council for Scientific and Technological Development
   (CNPq) - Research Productivity Grant (Process 302850/2016-3).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cavalcanti AFC, 2019, INT J PAEDIATR DENT, V29, P74, DOI 10.1111/ipd.12431
   Xavier AFC, 2015, PESQUI BRAS ODONTOPE, V15, P279, DOI 10.4034/PBOCI.2015.151.30
   Cavalcanti AL, 2013, PESQUI BRAS ODONTOPE, V13, P69, DOI 10.4034/PBOCI.2013.131.10a
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   COLLUCCI C, 2016, BMJ-BRIT MED J, V355, DOI DOI 10.1136/BMJ.I6157
   Aguiar YPC, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.16
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Hartwig AD, 2016, PESQUI BRAS ODONTOPE, V16, P59, DOI 10.4034/PBOCI.2016.161.07
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   LAPINSKI M, 2019, PESQUI BRAS ODONTOPE, V19, DOI DOI 10.4034/PBOCI.2019.191.139
   Nirmala SVSG, 2015, J INT SOC PREV COMMU, V5, P35, DOI 10.4103/2231-0762.151973
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Siqueira RMP, 2018, INT J PAEDIATR DENT, V28, P523, DOI 10.1111/ipd.12402
   Shellis RP, 2014, MONOGR ORAL SCI, V25, P32, DOI 10.1159/000359936
   Valinoti AC, 2016, OPEN DENT J, V10, P420, DOI 10.2174/1874210601610010420
   Wiegand A, 2007, CARIES RES, V41, P56, DOI 10.1159/000096106
   Xavier AFC, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-71
NR 18
TC 0
Z9 0
U1 2
U2 2
PU ASSOC APOIO PESQUISA & SAUDE BUCAL-APESB
PI JOAO PESSOA
PA AGENCIA CIDADE UNIV, UNIV FEDERAL PARAIBA, CAMPUS I, JOAO PESSOA, PB
   58051-970, BRAZIL
SN 1519-0501
EI 1983-4632
J9 PESQUI BRAS ODONTOPE
JI Pesqui. Bras. Odontopediatria Clin. Integr.
PY 2020
VL 20
AR e5565
DI 10.1590/pboci.2020.048
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA KW6ZN
UT WOS:000521331400001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Amrun, SN
   Yee, WX
   Abu Bakar, F
   Lee, BN
   Kam, YW
   Lum, FM
   Tan, JJL
   Lim, VWX
   Watthanaworawit, W
   Ling, CR
   Nosten, F
   Renia, L
   Leo, YS
   Ng, LFP
AF Amrun, Siti Naqiah
   Yee, Wearn-Xin
   Abu Bakar, Farhana
   Lee, Bernett
   Kam, Yiu-Wing
   Lum, Fok-Moon
   Tan, Jeslin J. L.
   Lim, Vanessa W. X.
   Watthanaworawit, Wanitda
   Ling, Clare
   Nosten, Francois
   Renia, Laurent
   Leo, Yee-Sin
   Ng, Lisa F. P.
TI Novel differential linear B-cell epitopes to identify Zika and dengue
   virus infections in patients (vol 8, e1066, 2019)
SO CLINICAL & TRANSLATIONAL IMMUNOLOGY
LA English
DT Correction
DE flavivirus; epitopes; patients; diagnostic
AB Objectives Recent Zika virus (ZIKV) outbreaks challenged existing laboratory diagnostic standards, especially for serology-based methods. Because of the genetic and structural similarity of ZIKV with other flaviviruses, this results in cross-reactive antibodies, which confounds serological interpretations. Methods Plasma from Singapore ZIKV patients was screened longitudinally for antibody responses and neutralising capacities against ZIKV. Samples from healthy controls, ZIKV patients and DENV patients were further assessed using ZIKV and DENV peptides of precursor membrane (prM), envelope (E) or non-structural 1 (NS1) viral proteins in a peptide-based ELISA for epitope identification. Identified epitopes were re-validated and diagnostically evaluated using sera of patients with DENV, bacteria or unknown infections from Thailand. Results Long-lasting ZIKV-neutralising antibodies were elicited during ZIKV infection. Thirteen potential linear B-cell epitopes were identified, and of these, four common flavivirus, three ZIKV-specific and one DENV-specific differential epitopes had more than 50% sensitivity and specificity. Notably, ZIKV-specific peptide 26 on domain I/II of E protein (amino acid residues 271-288) presented 80% sensitivity and 85.7% specificity. Importantly, the differential epitopes also showed significance in differentiating non-flavivirus patient samples. Conclusion Linear B-cell epitope candidates to differentiate between ZIKV and DENV infections were identified, providing the first step towards the design of a much-needed serology-based assay.
EM lisa_ng@immunol.a-star.edu.sg
FU Biomedical Research Council (BMRC), A*ccelerate GAP
   [ETPL/18-GAP054-R20H]; BMRC A*STAR-led Zika Virus Consortium FundAgency
   for Science Technology & Research (ASTAR) [15/1/82/27/001]; Agency for
   Science, Technology and Research (A*STAR), SingaporeAgency for Science
   Technology & Research (ASTAR); BMRCAgency for Science Technology &
   Research (ASTAR) [IAF 311006, H16/99/b0/011]
FX This work was supported by core research grants provided to the
   Singapore Immunology Network (SIgN) by the Biomedical Research Council
   (BMRC), A*ccelerate GAP funding [project number: ETPL/18-GAP054-R20H],
   and also partially supported by the BMRC A*STAR-led Zika Virus
   Consortium Fund [project number: 15/1/82/27/001], Agency for Science,
   Technology and Research (A*STAR), Singapore. SIgN Immunomonitoring and
   Flow Cytometry platforms are supported by BMRC IAF 311006 grant and BMRC
   transition funds #H16/99/b0/011.
CR Amrun SN, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1066
NR 1
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2050-0068
J9 CLIN TRANSL IMMUNOL
JI Clin. Transl. Immunol.
PY 2020
VL 9
IS 2
AR e01118
DI 10.1002/cti2.1118
PG 1
WC Immunology
SC Immunology
GA KU5JY
UT WOS:000519748300010
PM 32099653
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fernandez, CMM
   Lorenzetti, FB
   Lima, MMD
   Kleinubing, SA
   Bortolucci, WD
   de Andrade, JPP
   Romagnolo, MB
   Cortez, DAG
   Gazim, ZC
   Dias, BP
AF Mariano Fernandez, Carla Maria
   Lorenzetti, Fabiana Brusco
   de Souza Lima, Marli Miriam
   Kleinubing, Sirlene Adriana
   Bortolucci, Wanessa de Campos
   Pinguello de Andrade, Joao Paulo
   Romagnolo, Mariza Barion
   Garcia Cortez, Diogenes Aparicio
   Gazim, Zilda Cristiani
   Dias Filho, Benedito Prado
TI Larvicidal activity of piperovatine and dichloromethane extract from
   Piper corcovadensis roots against mosquitoes Aedes aegypti L.
SO BOLETIN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMATICAS
LA English
DT Article
DE Piper corcovadensis; Piperovatine; Aedes aegypti; Larvicidal; Mosquito
ID ESSENTIAL OILS; CHEMICAL-COMPOSITION; MEDICINAL-PLANTS; PHYTOCHEMISTRY;
   AMIDES
AB The research of new substances capable of controlling the Aedes aegypti mosquito is urgent due to the increase in the transmission of the diseases such as dengue, chikungunya and Zika virus by the vector. Thus, the aim of this study was to evaluate the larvicidal activity of crude extract of Piper corcovadensis roots, a native plant from Brazil, and of the isolated compound piperovatine against larvae of A. aegypti by the larval immersion test. The lethal concentration that killed 50% (LC50) and 99% (LC99) of larvae was determined by Probit analysis. The results indicated high larvicidal activity on A. aegypti larvae for crude extract of Piper corcovadensis roots with LC50 of 4.86 mu g/mL and LC99 of 15.50 mu g/mL and piperovatine with LC50 of 17.78 mu g/mL and LC99 of 48.55 mu g/mL. This work opens new perspectives to the development of future products with crude extract of Piper corcovadensis roots and piperovatine that can be applied to mosquito control.
C1 [Mariano Fernandez, Carla Maria; Lorenzetti, Fabiana Brusco; de Souza Lima, Marli Miriam; Kleinubing, Sirlene Adriana; Garcia Cortez, Diogenes Aparicio; Dias Filho, Benedito Prado] Univ Estadual Maringa, Postgrad Program Pharmaceut Sci, Maringa, Parana, Brazil.
   [Bortolucci, Wanessa de Campos; Gazim, Zilda Cristiani] Univ Paranaense, Postgrad Program Biotechnol Appl Agr, Umuarama, Brazil.
   [Pinguello de Andrade, Joao Paulo] State Univ Western Parana, Postgrad Program Chem Engn, Toledo, Brazil.
   [Romagnolo, Mariza Barion] Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil.
RP Fernandez, CMM (corresponding author), Univ Estadual Maringa, Postgrad Program Pharmaceut Sci, Maringa, Parana, Brazil.
EM carla.mfernandez@hotmail.com
OI Mariano Fernandez de Andrade, Carla Maria/0000-0001-7324-5533; Gazim,
   Zilda Cristiani/0000-0003-0392-5976
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors thank the financial support of Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   Costa J.G.M., 2005, Rev. bras. farmacogn., V15, P304, DOI 10.1590/S0102-695X2005000400008
   COSTA SS, 1981, PHYTOCHEMISTRY, V20, P1305, DOI 10.1016/0031-9422(81)80027-1
   Cunico MM, 2015, AN ACAD BRAS CIENC, V87, P1991, DOI 10.1590/0001-3765201520140090
   Facundo VA, 2004, QUIM NOVA, V27, P79, DOI 10.1590/S0100-40422004000100017
   GREGER H, 1984, PLANTA MED, V50, P366, DOI 10.1055/s-2007-969741
   Hari I, 2018, ENVIRON SCI POLLUT R, V25, P9176, DOI 10.1007/s11356-018-1515-3
   Kanis LA, 2013, IND CROP PROD, V50, P816, DOI 10.1016/j.indcrop.2013.08.034
   Lija-Escaline J, 2015, PARASITOL RES, V114, P4239, DOI 10.1007/s00436-015-4662-1
   Maciel MAM, 2002, QUIM NOVA, V25, P429, DOI 10.1590/S0100-40422002000300016
   Cavalca PAM, 2010, BRAZ ARCH BIOL TECHN, V53, P835, DOI 10.1590/S1516-89132010000400012
   Fernandez CMM, 2018, VET PARASITOL, V263, P5, DOI 10.1016/j.vetpar.2018.10.002
   Marques AM, 2017, J VECTOR DIS, V54, P61
   Marques JV, 2007, J NAT PROD, V70, P2036, DOI 10.1021/np070347g
   McFerren MA, 1998, J ETHNOPHARMACOL, V60, P183, DOI 10.1016/S0378-8741(97)00154-2
   Mendes LA, 2017, IND CROP PROD, V108, P684, DOI 10.1016/j.indcrop.2017.07.034
   Mgbeahuruike EE, 2017, S AFR J BOT, V112, P54, DOI 10.1016/j.sajb.2017.05.007
   Mitic ZS, 2018, IND CROP PROD, V111, P55, DOI 10.1016/j.indcrop.2017.10.004
   Nunes RKV, 2018, ENVIRON SCI POLLUT R, V25, P31165, DOI 10.1007/s11356-018-2809-1
   PAHO, 2017, TOOL DIAGN CAR PAT S
   Park IK, 2002, J AGR FOOD CHEM, V50, P1866, DOI 10.1021/jf011457a
   Parmar VS, 1997, PHYTOCHEMISTRY, V46, P597, DOI 10.1016/S0031-9422(97)00328-2
   Pinto CCC, 2016, B LATINOAM CARIBE PL, V15, P122
   da Silva MFR, 2016, EXP PARASITOL, V165, P64, DOI 10.1016/j.exppara.2016.03.017
   Rodrigues-Silva D, 2009, ACTA PROTOZOOL, V48, P73
   Scott Ian M., 2008, Phytochemistry Reviews, V7, P65, DOI 10.1007/s11101-006-9058-5
   Silva DR, 2009, MOLECULES, V14, P1171, DOI 10.3390/molecules14031171
   Veiga-Santos P, 2013, ACTA TROP, V125, P349, DOI 10.1016/j.actatropica.2012.11.014
NR 29
TC 0
Z9 0
U1 0
U2 0
PU MS-EDITIONS
PI SANTIAGO
PA  AV GENERAL SAN MARTIN 305-25 VALLE GRANDE, LAMPA, SANTIAGO, CHILE
SN 0717-7917
J9 B LATINOAM CARIBE PL
JI Bol. Latinoam. Caribe Plantas M.
PD JAN
PY 2020
VL 19
IS 1
BP 142
EP 148
PG 7
WC Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Integrative & Complementary Medicine; Pharmacology & Pharmacy
GA KU5RB
UT WOS:000519768100007
DA 2020-07-08
ER

PT J
AU Niu, W
   Parent, JM
AF Niu, Wei
   Parent, Jack M.
TI Modeling genetic epilepsies in a dish
SO DEVELOPMENTAL DYNAMICS
LA English
DT Review
DE brain organoid; epilepsy; genome editing; human pluripotent stem cells;
   neurological disorder; seizure disorder
ID PLURIPOTENT STEM-CELLS; FUNCTIONAL CORTICAL-NEURONS; IN-VITRO
   DIFFERENTIATION; NEURAL PROGENITOR CELLS; HUMAN BRAIN-DEVELOPMENT; ZIKA
   VIRUS-INFECTION; CEREBRAL ORGANOIDS; RETT-SYNDROME; DIRECTED
   DIFFERENTIATION; HUMAN ES
AB Human pluripotent stem cells (hPSCs), including embryonic and induced pluripotent stem cells, provide a powerful platform for mechanistic studies of disorders of neurodevelopment and neural networks. hPSC models of autism, epilepsy, and other neurological disorders are also advancing the path toward designing and testing precision therapies. The field is evolving rapidly with the addition of genome-editing approaches, expanding protocols for the two-dimensional (2D) differentiation of different neuronal subtypes, and three-dimensional (3D) human brain organoid cultures. However, the application of these techniques to study complex neurological disorders, including the epilepsies, remains a challenge. Here, we review previous work using both 2D and 3D hPSC models of genetic epilepsies, as well as recent advances in the field. We also describe new strategies for applying these technologies to disease modeling of genetic epilepsies, and discuss current challenges and future directions.
C1 [Niu, Wei; Parent, Jack M.] Univ Michigan, Med Ctr, Dept Neurol, 5021 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
   [Niu, Wei; Parent, Jack M.] Univ Michigan, Med Ctr, Grad Program Neurosci, 5021 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
   [Niu, Wei; Parent, Jack M.] VA Ann Arbor Healthcare Syst, 5021 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
RP Parent, JM (corresponding author), Univ Michigan, Med Ctr, Dept Neurol, 5021 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.; Parent, JM (corresponding author), Univ Michigan, Med Ctr, Grad Program Neurosci, 5021 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.; Parent, JM (corresponding author), VA Ann Arbor Healthcare Syst, 5021 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
EM parent@umich.edu
OI Parent, Jack/0000-0002-2972-1528
CR Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007
   An KS, 2007, GENET MED, V9, P88, DOI 10.1097/GIM.0b013e31803068c7
   Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Bamba Y, 2017, J NEUROSCI METH, V289, P57, DOI 10.1016/j.jneumeth.2017.07.004
   Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112
   Berkovic F, 2015, LANCET NEUROL, V14, P1219, DOI 10.1016/S1474-4422(15)00199-4
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Binley KE, 2014, J NEUROSCI METH, V225, P65, DOI 10.1016/j.jneumeth.2014.01.017
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Blair JD, 2019, DEV DYN
   Blair JD, 2018, NAT MED, V24, P1568, DOI 10.1038/s41591-018-0139-y
   Brazovskaja A, 2019, CURR OPIN BIOTECH, V55, P167, DOI 10.1016/j.copbio.2018.11.002
   Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19
   Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646
   Camarena V, 2014, EMBO MOL MED, V6, P1003, DOI 10.15252/emmm.201404044
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Canals I, 2018, NAT METHODS, V15, P693, DOI 10.1038/s41592-018-0103-2
   Cao J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw660
   Cavaliere F, 2017, NEUROBIOL DIS, V103, P101, DOI 10.1016/j.nbd.2017.04.011
   Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chandrasekaran A, 2017, STEM CELL RES, V25, P139, DOI 10.1016/j.scr.2017.10.010
   Chen G, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00317
   Chen HI, 2019, DEV DYNAM, V248, P53, DOI 10.1002/dvdy.24662
   Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001
   Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Collier TJ, 2017, NEUROBIOL DIS, V106, P191, DOI 10.1016/j.nbd.2017.07.007
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Costa V, 2016, CELL REP, V15, P86, DOI 10.1016/j.celrep.2016.02.090
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3
   de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505
   DeRosa BA, 2012, NEUROSCI LETT, V516, P9, DOI 10.1016/j.neulet.2012.02.086
   Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Dolce A, 2013, PEDIATR NEUROL, V48, P337, DOI 10.1016/j.pediatrneurol.2012.11.001
   Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175
   Dravet Charlotte, 2005, Adv Neurol, V95, P71
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011
   Favero M, 2018, J NEUROSCI, V38, P7912, DOI 10.1523/JNEUROSCI.0193-18.2018
   Featherstone C, 1999, CURR BIOL, V9, pR759, DOI 10.1016/S0960-9822(00)80005-6
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   Flaherty EK, 2017, BRAIN RES, V1655, P283, DOI 10.1016/j.brainres.2015.11.009
   Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Giandomenico SL, 2019, NAT NEUROSCI, V22, P669, DOI 10.1038/s41593-019-0350-2
   Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029
   Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587
   Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011
   Griffin A, 2016, PROG BRAIN RES, V226, P195, DOI 10.1016/bs.pbr.2016.03.012
   Grone BP, 2015, NAT NEUROSCI, V18, P339, DOI 10.1038/nn.3934
   Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107
   Hasbani Daphne M, 2018, Handb Clin Neurol, V148, P813, DOI 10.1016/B978-0-444-64076-5.00052-1
   Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290
   Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013
   Howden SE, 2015, STEM CELL REP, V5, P1109, DOI 10.1016/j.stemcr.2015.10.009
   Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127
   Hwang B, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0071-8
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Ip JPK, 2018, NAT REV NEUROSCI, V19, P368, DOI 10.1038/s41583-018-0006-3
   Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740
   Jin M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05068-w
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31
   Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037
   Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1
   Kim H, 2019, STEM CELL REP, V12, P890, DOI 10.1016/j.stemcr.2019.04.011
   Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108
   Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113
   Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014
   Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li X, 2018, STEM CELL REP, V11, P998, DOI 10.1016/j.stemcr.2018.08.019
   Li XJ, 2006, METH MOL B, V331, P169
   Li YQ, 2017, STEM CELL REP, V8, P883, DOI 10.1016/j.stemcr.2017.02.020
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766
   Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207
   Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9
   Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106
   Liu Y, 2013, ANN NEUROL, V74, P128, DOI 10.1002/ana.23897
   Livide G, 2015, EUR J HUM GENET, V23, P195, DOI 10.1038/ejhg.2014.81
   Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Mack CM, 2014, NEUROTOXICOLOGY, V40, P75, DOI 10.1016/j.neuro.2013.11.008
   Madhavan M, 2018, NAT METHODS, V15, P700, DOI 10.1038/s41592-018-0081-4
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P772, DOI 10.1038/nbt0818-772e
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Marchese M, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-26
   Marchetto MC, 2011, HUM MOL GENET, V20, pR109, DOI 10.1093/hmg/ddr336
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008
   Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030178
   Marton RM, 2019, NAT NEUROSCI, V22, P484, DOI 10.1038/s41593-018-0316-9
   Matarese CA, 2009, PEDIATR NEUROL, V40, P324, DOI 10.1016/j.pediatrneurol.2008.11.008
   Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466
   Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335
   Mellios N, 2018, MOL PSYCHIATR, V23, P1051, DOI 10.1038/mp.2017.86
   Miller DJ, 2019, CURR OPIN NEUROBIOL, V56, P117, DOI 10.1016/j.conb.2018.12.005
   Mirzaa GM, 2013, AM J MED GENET C, V163C, P122, DOI 10.1002/ajmg.c.31361
   Mistry AM, 2014, NEUROBIOL DIS, V65, P1, DOI 10.1016/j.nbd.2014.01.006
   Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549
   Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Muratore CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105807
   Nadadhur AG, 2019, STEM CELL REP, V12, P42, DOI 10.1016/j.stemcr.2018.11.019
   Nagamani SCS, 2009, J MED GENET, V46, P825, DOI 10.1136/jmg.2009.067637
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005
   Noebels J, 2015, NAT NEUROSCI, V18, P344, DOI 10.1038/nn.3933
   Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423
   Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007
   Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104
   Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293
   Olsen Thale Kristin, 2018, Curr Protoc Mol Biol, V122, pe57, DOI 10.1002/cpmb.57
   Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011
   Ozone C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10351
   Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017
   Parent JM, 2015, NAT NEUROSCI, V18, P360, DOI 10.1038/nn.3944
   Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Pastula DM, 2017, JAMA NEUROL, V74, P631, DOI 10.1001/jamaneurol.2017.0215
   Patzke C, 2016, RARE DIS, V4, DOI 10.1080/21675511.2015.1131884
   Patzke C, 2015, J CLIN INVEST, V125, P3560, DOI 10.1172/JCI78612
   Peron S, 2015, CURR OPIN NEUROBIOL, V32, P115, DOI 10.1016/j.conb.2015.03.016
   Picelli S, 2017, RNA BIOL, V14, P637, DOI 10.1080/15476286.2016.1201618
   PINE J, 1980, J NEUROSCI METH, V2, P19, DOI 10.1016/0165-0270(80)90042-4
   Prykhozhij SV, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky512
   Qi YC, 2017, NAT BIOTECHNOL, V35, P154, DOI 10.1038/nbt.3777
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Rana P, 2017, TOXICOL IN VITRO, V45, P111, DOI 10.1016/j.tiv.2017.08.014
   Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252
   Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566
   Roberts B, 2017, MOL BIOL CELL, V28, P2854, DOI 10.1091/mbc.E17-03-0209
   Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73
   Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425
   Santos DP, 2016, CURR PROTOC STEM CEL, V38, p5B 6 1
   Sarkar A, 2018, CELL STEM CELL, V22, P684, DOI 10.1016/j.stem.2018.04.009
   Savic D, 2015, GENOME RES, V25, P1581, DOI 10.1101/gr.193540.115
   Schafer ST, 2019, NAT NEUROSCI, V22, P243, DOI 10.1038/s41593-018-0295-x
   SCHOLL AJ, 1954, SURG CLIN N AM, V34, P1719
   Scholvin J, 2016, IEEE T BIO-MED ENG, V63, P120, DOI 10.1109/TBME.2015.2406113
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203
   Sherman SP, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.031906
   Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011
   Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019
   Soliman MA, 2017, MOL PSYCHIATR, V22, P1241, DOI 10.1038/mp.2017.40
   Srikanth P, 2014, J NEUROGENET, V28, P5, DOI 10.3109/01677063.2014.881358
   Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035
   Sun AX, 2016, CELL REP, V16, P1942, DOI 10.1016/j.celrep.2016.07.035
   Sun Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.25
   Sundberg M, 2018, MOL PSYCHIATR, V23, P2167, DOI 10.1038/s41380-018-0018-4
   Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016
   Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002
   Tchieu J, 2019, NAT BIOTECHNOL, V37, P267, DOI 10.1038/s41587-019-0035-0
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tidball AM, 2017, STEM CELL REP, V9, P725, DOI 10.1016/j.stemcr.2017.07.003
   Tidball AM, 2016, STEM CELLS, V34, P27, DOI 10.1002/stem.2203
   Tortoriello G, 2014, EMBO J, V33, P668, DOI 10.1002/embj.201386035
   Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005
   Vangipuram M, 2013, JOVE-J VIS EXP, DOI 10.3791/3779
   Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x
   Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020
   Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019
   Wang H, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00015
   Wang LH, 2013, NAT METHODS, V10, P84, DOI [10.1038/NMETH.2283, 10.1038/nmeth.2283]
   Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002
   Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wen ZX, 2016, CURR OPIN NEUROBIOL, V36, P118, DOI 10.1016/j.conb.2015.11.003
   Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008
   Xiang YF, 2019, CELL STEM CELL, V24, P487, DOI 10.1016/j.stem.2018.12.015
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Xiong X, 2017, ACS SYNTH BIOL, V6, P1034, DOI 10.1021/acssynbio.6b00358
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129
   Yamashita S, 2016, EPILEPSIA, V57, pE81, DOI 10.1111/epi.13338
   Yang N, 2017, NAT METHODS, V14, P621, DOI [10.1038/nmeth.4291, 10.1038/NMETH.4291]
   Yeyeodu Susan T, 2010, Curr Chem Genomics, V4, P74, DOI 10.2174/1875397301004010074
   Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003
   Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009
   Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754
   Zack MM, 2015, MMWR-MORBID MORTAL W, V66, P821
   Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052
   Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029
   Zhang Z, 2017, MOL THER-NUCL ACIDS, V9, P230, DOI 10.1016/j.omtn.2017.09.009
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106
   Zucco AJ, 2018, MOL CELL NEUROSCI, V92, P149, DOI 10.1016/j.mcn.2018.08.004
NR 227
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1058-8388
EI 1097-0177
J9 DEV DYNAM
JI Dev. Dyn.
PD JAN
PY 2020
VL 249
IS 1
SI SI
BP 56
EP 75
DI 10.1002/dvdy.79
PG 20
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA JZ7GW
UT WOS:000505277700004
PM 31241228
OA Bronze
DA 2020-07-08
ER

PT J
AU do Nascimento, VA
   Santos, JHA
   Monteiro, DCD
   Pessoa, KP
   Cardoso, AJL
   de Souza, VC
   Abdalla, LF
   Naveca, FG
AF do Nascimento, Valdinete Alves
   Abdalla Santos, Joao Hugo
   da Silva Monteiro, Dana Cristina
   Pessoa, Karina Pinheiro
   Leao Cardoso, Antonio Jose
   de Souza, Victor Costa
   Abdalla, Ligia Fernandes
   Naveca, Felipe Gomes
TI Oropouche virus detection in saliva and urine
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE arboviruses; orthobunyavirus; Oropouche virus; saliva; urine; real-time
   polymerase chain reaction
ID ZIKA VIRUS; FEVER; PATIENT; STATE
AB Oropouche virus (OROV) is an arthropod-borne virus of the Peribunyaviridae family, transmitted to humans primarily by Culicoides paraensis. It is one of the main arboviruses infecting humans in Brazil, primarily in the Amazon Region. Here, we report the detection of OROV in the saliva and urine of a patient whose samples were collected five days after the onset of symptoms. Nucleotide sequencing and phylogenetic analysis further confirmed the results. To our knowledge, this is the first study reporting the detection of OROV in the saliva and urine of an infected patient. In addition, the results of our study expand the current knowledge pertaining to the natural history of Oropouche fever.
C1 [do Nascimento, Valdinete Alves; da Silva Monteiro, Dana Cristina; Pessoa, Karina Pinheiro; Leao Cardoso, Antonio Jose; de Souza, Victor Costa; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, AM, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Inst Oswald Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, RJ, Brazil.
   [Abdalla Santos, Joao Hugo] Univ Fed Amazonas, Manaus, AM, Brazil.
   [Abdalla Santos, Joao Hugo] Hosp Adventista Manaus, Manaus, AM, Brazil.
   [Pessoa, Karina Pinheiro; Leao Cardoso, Antonio Jose; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogeno Hospedei, Manaus, AM, Brazil.
   [Abdalla, Ligia Fernandes] Univ Estado Amazonas, Manaus, AM, Brazil.
RP Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, AM, Brazil.; Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswald Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, RJ, Brazil.; Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogeno Hospedei, Manaus, AM, Brazil.
EM felipe.naveca@fiocruz.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060
CR Abdalla LF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0938-2
   Alva-Urcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187897
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Luna LKD, 2017, J MED VIROL, V89, P1108, DOI 10.1002/jmv.24722
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Naveca FG, 2018, PLOS CURR, V10
   Romero-Alvarez D, 2018, MICROBES INFECT, V20, P135, DOI 10.1016/j.micinf.2017.11.013
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Nunes MRT, 2019, INFECT GENET EVOL, V68, P16, DOI 10.1016/j.meegid.2018.11.020
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Wise EL, 2018, EMERG INFECT DIS, V24, P935, DOI 10.3201/eid2405.171569
NR 29
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e190338
DI 10.1590/0074-02760190338
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KT1YW
UT WOS:000518810200001
PM 32130368
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lima, LHDS
   Monteiro, EMLM
   Coriolano, MWD
   Linhares, FMP
   Cavalcanti, AMTD
AF de Souza Soares Lima, Lais Helena
   Leite Meirelles Monteiro, Estela Maria
   de Lavor Coriolano, Maria Wanderleya
   Pereira Linhares, Francisca Marcia
   Tenorio de Souza Cavalcanti, Ana Marcia
TI Family fortresses in Zika Congenital Syndrome according to Betty Neuman
SO REVISTA BRASILEIRA DE ENFERMAGEM
LA English
DT Article
DE Family; Family Relations; Microcephaly; Zika Virus; Nursing Theory
ID SOCIAL SUPPORT; CHILDREN
AB Objectives: to identify elements that contribute to strengthen the family system of children with Zika virus congenital syndrome according to Betty Neuman's theory. Methods: qualitative research, carried out in the outpatient service of a public hospital in the city of Recife, Brazil, with 13 mothers, by semi-structured interviews. The IRAMUTEQ software was used for data analysis and the interpretation was carried out according to Betty Neuman's Systems Model Theory. Results: the dendrogram originated five categories, which we named: Family Routine, Health Service Assistance, Changes in Lifestyle, Support Network, and Social Repercussions of Care for the the Family Context. Final considerations: nursing actions based on Betty Neuman's theory provide subsidies for the recognition of elements that strengthen the defense lines of the family system. These resources can be explored, aiming to maintaining the well-being and balance in the context of the family system.
C1 [de Souza Soares Lima, Lais Helena; Leite Meirelles Monteiro, Estela Maria; de Lavor Coriolano, Maria Wanderleya; Pereira Linhares, Francisca Marcia; Tenorio de Souza Cavalcanti, Ana Marcia] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Lima, LHDS (corresponding author), Univ Fed Pernambuco, Recife, PE, Brazil.
EM laishelena18@gmail.com
OI de Lavor Coriolano-Marinus, Maria Wanderleya/0000-0001-7531-2605;
   Cavalcanti, Ana Marcia/0000-0001-6468-8826; Monteiro,
   Estela/0000-0002-5736-0133
CR Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Barbosa TA, 2016, REV RENE, V17, P60, DOI 10.15253/2175-6783.2016000100009
   Bolla Bruna Aparecida, 2013, Esc. Anna Nery, V17, P284, DOI 10.1590/S1414-81452013000200012
   CAMARGO BV, 2013, TEMAS PSICOL, V21, P513, DOI DOI 10.9788/TP2013.2-16
   Falqueto J, 2016, CIAIQ, V1, P560
   Figueiredo SV, 2016, REV BRAS ENFERM, V69, P79, DOI 10.1590/0034-7167.2016690112i
   FLICK Uwe, 2009, DESENHO PESQUISA QUA
   Guerini IC, 2012, TEXTO CONTEXTO ENFER, V21, P348, DOI 10.1590/S0104-07072012000200012
   Martins TSS, 2010, COGITARE ENFERM, V15, P340, DOI [10.5380/ce.v15i2.17873, DOI 10.5380/CE.V15I2.17873]
   McEwen M, 2015, BASES TEORICAS ENFER
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Ministerio da Saude Brasil, 2016, PROT AT SAUD RESP OC
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Marques AKMC, 2011, CIENC SAUDE COLETIVA, V16, P945, DOI 10.1590/S1413-81232011000700026
   Neuman B, 1995, NEUMAN SYSTEMS MODEL
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Polidori MM, 2014, REV COMPET, V4, P11, DOI [10.24936/2177-4986.v4n2.2011.69, DOI 10.24936/2177-4986.V4N2.2011.69]
   Rodrigues DRS, 2013, INDAG DIDACT, V5, P978
   Santos AD, 2012, TEXTO CONTEXTO ENFER, V21, P879, DOI 10.1590/S0104-07072012000400019
   Silva CCB, 2014, CAD BRAS TER OCUP, V22, P15
   Silva ML, 2012, MUDANCAS, V20, P13, DOI DOI 10.15603/2176-1019/MUD.V20N1-2P13-21
   World Health Organization, 2015, EP AL NEUR SYNDR CON
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRASILEIRA ENFERMAGEM
PI BRASILIA DF
PA SGA NORTE QUADRA 603 CONJ B AV L2 NORTE, BRASILIA DF, 70830-030, BRAZIL
SN 0034-7167
EI 1984-0446
J9 REV BRAS ENFERM
JI Rev. Bras. Enferm.
PY 2020
VL 73
IS 2
AR UNSP e20180578
DI 10.1590/0034-7167-2018-0578
PG 8
WC Nursing
SC Nursing
GA KT2AD
UT WOS:000518813800001
PM 32074238
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Morelli, F
   Souza, RP
   da Cruz, TE
   Damke, GMZF
   Damke, E
   Suehiro, TT
   da Silva, VRS
   Consolaro, MEL
AF Morelli, Fabricio
   Souza, Raquel Pantarotto
   da Cruz, Tais Elisangela
   Ferreira Damke, Gabrielle Marconi Zago
   Damke, Edilson
   Suehiro, Tamy Tuani
   Sela da Silva, Vania Ramos
   Lopes Consolaro, Marcia Edilaine
TI Zika virus infection in the genital tract of non-pregnant females: a
   systematic review
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Review
DE Zika virus; Female; Non-pregnant; Genital tract
ID MALE SEXUAL TRANSMISSION; VAGINAL SECRETIONS; MOUSE MODEL
AB This review provides a general overview on the positivity and persistence of Zika virus (ZIKV) in female genital tract (FGT) of non-pregnant women and animals, as well as in cell cultures, and its influence on FGT health. We performed a systematic review based on the PRISMA statement to identify studies focused on "Zika virus" and "non-pregnant female" in PubMed, Embase. Scopus Scholar and Web of Knowledge databases of full-text papers and abstracts published in English, with no restrictions regarding the initial date of publication, up to August 2019. Our search terms yielded 625 records, that were 108 after removal of duplicates, leaving 517 items for title and abstract reviews. Of these, 475 did not meet the inclusion criteria, leaving 42 records for full-text review and resulting in the exclusion of 6 additional records. The remaining 36 met our inclusion criteria. Variations were observed regarding the presence and persistence of ZIKV in lower and upper genital samples. However, the FGT was the place in which ZIKV RNA has been detected, sometimes for relatively long periods, even after the clearance from blood and urine. In addition to the vagina and cervix, the endometrium, uterus and ovary (oocytes and follicles) could also be involved in persistent ZIKV infections. Further prospective studies are needed to assess the effect of ZIKV on FGT health.
C1 [Morelli, Fabricio; Souza, Raquel Pantarotto; da Cruz, Tais Elisangela; Ferreira Damke, Gabrielle Marconi Zago; Damke, Edilson; Suehiro, Tamy Tuani; Sela da Silva, Vania Ramos; Lopes Consolaro, Marcia Edilaine] Univ Estadual Maringa, Dept Anal Clin & Biomed, Programa Posgrad Biociencias & Fisiopatol, Av Colombo 5790, BR-87020900 Maringa, Parana, Brazil.
RP Consolaro, MEL (corresponding author), Univ Estadual Maringa, Dept Anal Clin & Biomed, Programa Posgrad Biociencias & Fisiopatol, Av Colombo 5790, BR-87020900 Maringa, Parana, Brazil.
EM melconsolaro@gmail.com
RI Consolaro, Marcia Edilaine Lope/I-4932-2014
OI Consolaro, Marcia Edilaine Lope/0000-0001-9102-4865
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES,
   Brazilian GovernmentCAPES [88881.130822/201601]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/CNPq, Brazilian
   GovernmentNational Council for Scientific and Technological Development
   (CNPq) [440521/2016-5]; Departamento de Ciencia e Tecnologia da
   Secretaria de Ciencia, Tecnologia e Insumos Estrategicos do Ministerio
   da Saude/DECIT/SCTIE/MS
FX This work was supported by grants from Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior/CAPES, Brazilian Government (Grant No
   88881.130822/201601), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPq, Brazilian Government (Grant No 440521/2016-5) and
   Departamento de Ciencia e Tecnologia da Secretaria de Ciencia,
   Tecnologia e Insumos Estrategicos do Ministerio da Saude/DECIT/SCTIE/MS.
CR American Society for Reproductive Medicine, GUID PROV CAR WOM ME
   Amerson-Brown MH, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03340
   Araujo E, 2019, J BRAS REPROD ASSIST, V23, P172, DOI 10.5935/1518-0557.20180081
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broughton DE, 2017, FERTIL STERIL, V108, pE35
   Cagno V, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.04.016
   Caine EA, 2019, J INFECT DIS, V220, P1904, DOI 10.1093/infdis/jiz239
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005926
   Cordeiro CN, 2017, CURR OPIN OBSTET GYN, V29, P175, DOI 10.1097/GCO.0000000000000366
   Cruz TE, 2019, AM J TROP MED HYG, V100, P183
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva SR, 2019, J MED VIROL, V91, P179, DOI 10.1002/jmv.25306
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li L, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030093
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MANDL AM, 1951, J ENDOCRINOL, V7, P112, DOI 10.1677/joe.0.0070112
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Muller JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04442-y
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Pan American Health Organization; World Health Organization, 2018, ZIK CAS CONG SYNDR A
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Prisant N, 2019, REPROD BIOMED ONLINE, V39, P624, DOI 10.1016/j.rbmo.2019.05.013
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Reyes Y, 2019, EMERG INFECT DIS, V25, P808, DOI 10.3201/eid2504.180977
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tobar P, 2018, P R HEALTH SCI J, V37, pS96
   Tozetto-Mendoza TR, 2019, REV INST MED TROP SP, V61, DOI [10.1590/S1678-9946201961019, 10.1590/s1678-9946201961019]
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   WHO, 2016, PREV SEX TRANSM ZIK
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
NR 77
TC 0
Z9 0
U1 0
U2 0
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2020
VL 62
AR e16
DI 10.1590/S1678-9946202062016
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KT1ZM
UT WOS:000518812000001
PM 32130356
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Villanueva-Segura, OK
   Ontiveros-Zapata, KA
   Lopez-Monroy, B
   Ponce-Garcia, G
   Gutierrez-Rodriguez, SM
   Davila-Barboza, JA
   Mora-Jasso, ED
   Flores, AE
AF Villanueva-Segura, Olga K.
   Ontiveros-Zapata, Kevin A.
   Lopez-Monroy, Beatriz
   Ponce-Garcia, Gustavo
   Gutierrez-Rodriguez, Selene M.
   Davila-Barboza, Jesus A.
   Mora-Jasso, Esteban de J.
   Flores, Adriana E.
TI Distribution and Frequency of the kdr Mutation V410L in Natural
   Populations of Aedes aegypti (L.) (Diptera: Culicidae) From Eastern and
   Southern Mexico
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; kdr mutation; V410L; pyrethroids; vector control
ID SODIUM-CHANNEL GENE; RESISTANCE; EVOLUTION; DDT
AB Aedes aegypti (L.) is the primary vector of the viruses that cause dengue, Zika, and chikungunya, for which effective vaccines and drugs are still lacking. Current strategies for suppressing arbovirus outbreaks based on insecticide use pose a challenge because of the rapid increase in resistance. The widespread and excessive use of pyrethroid-based insecticides has created a large selection pressure for a kdr-type resistance, caused by mutations in the para gene of the voltage-gated sodium channel (vgsc). Our objective was to evaluate the allelic frequency of natural populations of Ae. aegypti of Mexico at codon 410 of the para gene. Twenty-six Ae. aegypti populations from east and southern Mexico were genotyped for the codon 410 using allele-specific PCR. The frequencies of the L410 allele in Ae. aegypti ranged from 0.10 to 0.99; however, most of the frequencies were in the range of 0.36 to 0.64.The highest frequencies were found in three populations from the state of Veracruz, namely, Minatitlan with 0.99, Poza Rica with 0.82, and Jose Cardel with 0.97, along with populations from Cancun in Quintana Roo with 0.93, Frontera in Tabasco with 0.91, and Ciudad del Carmen in Campeche with 0.86. The frequency of the L410 allele was high in all populations of Ae. aegypti with higher values in populations of the southeast of the country. The knowledge of specific substitutions in vgsc and their interaction to confer resistance is essential to predict and develop future strategies for resistance management in Ae. aegypti in Mexico.
C1 [Villanueva-Segura, Olga K.; Ontiveros-Zapata, Kevin A.; Lopez-Monroy, Beatriz; Ponce-Garcia, Gustavo; Gutierrez-Rodriguez, Selene M.; Davila-Barboza, Jesus A.; Mora-Jasso, Esteban de J.; Flores, Adriana E.] UANL, Fac Ciencias Biol, Av Univ S-N Cd Univ, San Nicolas De Los Garza 66455, Nuevo Leon, Mexico.
RP Flores, AE (corresponding author), UANL, Fac Ciencias Biol, Av Univ S-N Cd Univ, San Nicolas De Los Garza 66455, Nuevo Leon, Mexico.
EM adriana.floressr@uanl.edu.mx
RI Flores, Adriana E./AAM-4478-2020
OI Flores, Adriana E./0000-0001-8554-8865; Davila-Barboza,
   Jesus/0000-0003-1686-4738; Ponce-Garcia, Gustavo/0000-0003-0654-006X;
   Villanueva-Segura, Karina/0000-0002-1976-8277
FU Consejo Nacional de Ciencia y TecnologiaConsejo Nacional de Ciencia y
   Tecnologia (CONACyT) [PN-2016-2134]
FX Research funded by Consejo Nacional de Ciencia y Tecnologia
   (PN-2016-2134).
CR Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001
   COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X
   Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117
   DOF, 2015, NAT FISH WEEK COMP, P1
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Granada Y, 2018, INSECTS, V9, DOI 10.3390/insects9010023
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Imam Hashmat, 2014, Trop Parasitol, V4, P53, DOI 10.4103/2229-5070.129167
   Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032
   Kushwah RBS, 2015, J VECTOR DIS, V52, P95
   Lopez-Monroy B, 2018, PEST MANAG SCI, V74, P2176, DOI 10.1002/ps.4916
   Pan American Health Organization / World Health Organization, 2018, EP AL DENG
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2019, INSECT MOL BIOL, V28, P591, DOI 10.1111/imb.12575
   Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0
   Scott JG, 2019, ANNU REV ENTOMOL, V64, P243, DOI 10.1146/annurev-ento-011118-112420
   Siller Q, 2011, J AM MOSQUITO CONTR, V27, P357, DOI 10.2987/11-6149.1
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   (SS). Secretaria de Salud, 2014, PREV CONTR DENG PROG
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 25
TC 2
Z9 2
U1 4
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2020
VL 57
IS 1
BP 218
EP 223
DI 10.1093/jme/tjz148
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA KS8JN
UT WOS:000518553000024
PM 31504686
DA 2020-07-08
ER

PT J
AU Bishop, C
   Parry, R
   Asgari, S
AF Bishop, Cameron
   Parry, Rhys
   Asgari, Sassan
TI Effect of Wolbachia wAlbB on a positive-sense RNA negev-like virus: a
   novel virus persistently infecting Aedes albopictus mosquitoes and cells
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Wolbachia; RNA-Seq; negevirus; insect-specific viruses; Aedes aegypti
ID CYTOPLASMIC INCOMPATIBILITY; DENGUE; TRANSMISSION; DENSITY;
   QUANTIFICATION; REPLICATION; CHIKUNGUNYA; PIPIENTIS; PROTEIN; BLOCKS
AB The Aedes aegypti mosquito is the primary vector of several medically important arboviruses. The endosymbiotic bacterium, Wolbachia pipientis, has emerged as a means of blocking transmission of arboviruses such as dengue and Zika viruses. One Wolbachia strain that has shown potential in field trials is wAlbB, a naturally occurring Wolbachia strain of the Asian tiger mosquito Aedes albopictus. When transinfected into Ae. aegypti, wAlbB exhibits strong virus inhibition. In addition to modulating arboviruses, Wolbachia also modulates some insect-specific viruses. Here, we explored the effect of Wolbachia on the virome of the Ae. albopictus cell line Aa23 naturally infected with wAlbB and also a stably transinfected recipient Ae. aegypti cell line (Aag2.wAlbB). RNA sequencing and bioinformatic analysis on both cell lines revealed an 11 kb genome of a single-stranded positive-sense RNA negev-like virus related to the recently proposed negevirus taxon. We denoted this novel virus as Aedes albopictus negev-like virus (AalNLV). Tetracycline clearance of Wolbachia from Aa23 cells did not significantly affect AalNLV levels, while in Aag2.wAlbB cells, a significant increase in virus genome RNA copies was observed. We further investigated the inhibitory effect of wAlbB on AalNLV and another positive-sense RNA virus, cell fusing agent virus, which is present in Aag2 cells and known to be suppressed by Wolbachia. wAlbB suppressed both viruses, with the effect on AalNLV being more striking. The findings from this study further supplement our understanding of the complex interaction between Wolbachia, host and virome.
C1 [Bishop, Cameron; Parry, Rhys; Asgari, Sassan] Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld 4072, Australia.
RP Asgari, S (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld 4072, Australia.
EM s.asgari@uq.edu.au
RI Asgari, Sassan/G-2678-2011
OI Asgari, Sassan/0000-0001-7885-6544; Parry, Rhys/0000-0001-9238-1952
FU Australian Research CouncilAustralian Research Council [DP150101782];
   University of Queensland scholarships
FX This project was funded by the Australian Research Council grant
   (DP150101782) to S.A. and the University of Queensland scholarships to
   C.B. and R.P.
CR Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bigot D, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex040
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bonizzoni M, 2018, PLOS NEGL TROP DIS, V12
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Cock PJA, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0080-7
   Dobson SL, 2003, TRENDS PARASITOL, V19, P128, DOI 10.1016/S1471-4922(03)00002-3
   Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fattouh N, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007218
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Kallies R, 2014, VIRUSES-BASEL, V6, P4346, DOI 10.3390/v6114346
   Kuchibhatla DB, 2014, J VIROL, V88, P10, DOI 10.1128/JVI.02595-13
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   LOURENCODEOLIVEIRA, 2017, PLOS NEGLECT TROP D, V11, DOI DOI 10.1371/JOURNAL.PNTD.0005511
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   O'Brien CA, 2017, EVOL BIOINFORM, V13, DOI 10.1177/1176934317691269
   ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174
   Parry R, 2019, VIROLOGY, V528, P89, DOI 10.1016/j.virol.2018.12.006
   Parry R, 2018, J VIROL, V92, DOI [10.1128/JVI.00224-18, 10.1128/jvi.00224-18]
   PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pudney M., 1979, TCA (TISSUE CULTURE ASSOCIATION) MANUAL, V5, P997, DOI 10.1007/BF00919719
   Rambaut A., 2014, FIGTREE V1 4 2 GRAPH
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Raquin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125066
   Ridley AW, 2016, J ECON ENTOMOL, V109, P2561, DOI 10.1093/jee/tow226
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Shi M, 2017, J VIROL, V91
   Sicard M, 2019, CURR OPIN INSECT SCI, V34, P12, DOI 10.1016/j.cois.2019.02.005
   Siozios S, 2008, INSECT SCI, V15, P89, DOI 10.1111/j.1744-7917.2008.00189.x
   Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164
   Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12
   Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249
   White PM, 2017, GENETICS, V205, P1473, DOI 10.1534/genetics.116.198903
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Xiao PP, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00359
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhang GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02347-2
NR 59
TC 0
Z9 0
U1 1
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PY 2020
VL 101
IS 2
BP 216
EP 225
DI 10.1099/jgv.0.001361
PG 10
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA KS5YQ
UT WOS:000518384700009
PM 31846415
OA Bronze
DA 2020-07-08
ER

PT J
AU Arcanjo, DBMC
   Vidal, PO
   dos Santos, JYG
   Venancio, LPR
   Suesdek, L
   Amorim, JH
AF Marques Campos Arcanjo, Danielle Beatriz
   Vidal, Paloma Oliveira
   Gomes dos Santos, Jose Yure
   Rodrigues Venancio, Larissa Paola
   Suesdek, Lincoln
   Amorim, Jaime Henrique
TI Geometric morphometrics of Aedes aegypti populations and study of
   transmission of arboviral diseases in Barreiras, Brazil
SO REVISTA BRASILEIRA DE ENTOMOLOGIA
LA English
DT Article
DE A.aegypti; geometric morphometrics; transmission; barriers; segregation
ID RAINFALL; DYNAMICS; STATE
AB Aedes (Stegontyia) aegypti (A. aegypti) transmits arboviral diseases of high public health importance, including those caused by Zika virus(ZIKV), Dengue virus(DENV), Chikungunya virus (CHIKV) and Yellow fever virus(YFV). Barreiras is a city with 157,638 inhabitants in the West of the State of Bahia, Northeast of Brazil. The climate is dry, with well-determined and concentrated seasons of rains. The city is crossed by a Federal Highway and by the Rio Grande river. In this study, we aimed to understand the dynamics of mosquito vectors and arboviral diseases in Barreiras. We used correlation statistics to investigate a possible relationship among rains, mosquito abundance and transmission of diseases. In addition, as a preliminary population genetics estimate, we used geometric morphometrics to compare mosquitoes from areas limited by a highway and a river. We found that i) infestation occurs in rain-dependent cycles and that ii) both, the river and the highway segregate populations of A. aegypti in different areas of the studied city. Our results indicate that it is necessary to treat anthropic containers with mosquito breading capacity during both, the dry and rain seasons in urban areas similar to Barreiras.
C1 [Marques Campos Arcanjo, Danielle Beatriz; Vidal, Paloma Oliveira; Rodrigues Venancio, Larissa Paola; Amorim, Jaime Henrique] Univ Fed Oeste Bahia, Ctr Ciencias Biol & Saude, Lab Agentes Infecciosos & Verores, Barreiros, BA, Brazil.
   [Gomes dos Santos, Jose Yure] Univ Fed Oeste Bahia, Ctr Humanidades, Lab Geoproc, Barreiros, BA, Brazil.
   [Suesdek, Lincoln] Inst Butantan, Lab Parasitol, Sao Paulo, SP, Brazil.
   [Suesdek, Lincoln] Univ Sao Paulo, Inst Med Trop, Sao Paulo, SP, Brazil.
RP Amorim, JH (corresponding author), Univ Fed Oeste Bahia, Ctr Ciencias Biol & Saude, Lab Agentes Infecciosos & Verores, Barreiros, BA, Brazil.
EM jaime.amorim@ufob.edu.br
RI Santos, Jose Yure Gomes dos/AAK-8651-2020
OI Santos, Jose Yure Gomes dos/0000-0001-9840-8132
FU International Society for Infectious Diseases; Fundacao de Amparo a
   Pesquisa do Estado da Bahia (FAPESB) [PET 0024/2016]; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [311805/2014-0]; FAPESB;
   Center of Control of Zoonotic and Endemic Diseases of Barreiras, Bahia,
   Brazil
FX We appreciate the financial support of the International Society for
   Infectious Diseases, Fundacao de Amparo a Pesquisa do Estado da Bahia
   (FAPESB) (PET 0024/2016) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Grant #311805/2014-0. We are thankful
   to FAPESB by providing undergraduate research fellowship for Danielle
   Beatriz Marques Campos Arcanjo. We are also thankful to the support of
   Center of Control of Zoonotic and Endemic Diseases of Barreiras, Bahia,
   Brazil. We are thankful to Karina Zanatta and Fernanda Almeida Lopes for
   technical assistance.
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, 2017, ZIK VIR TRANSM
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Demirci B, 2012, J VECTOR ECOL, V37, P197, DOI 10.1111/j.1948-7134.2012.00217.x
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Lagrotta MT, 2008, CAD SAUDE PUBLICA, V24, P70, DOI 10.1590/S0102-311X2008000100007
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634
   Lorenz C, 2017, INFECT GENET EVOL, V54, P205, DOI 10.1016/j.meegid.2017.06.029
   Lorenz C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0581-8
   Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851
   Lozano-Fuentes S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000468
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Pongsumpun P, 2008, TROP MED INT HEALTH, V13, P1180, DOI 10.1111/j.1365-3156.2008.02124.x
   Silva FD, 2016, CIENC SAUDE COLETIVA, V21, P641, DOI 10.1590/1413-81232015212.09592015
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536
   Vicente JL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-5
   Vidal PO, 2012, MEM I OSWALDO CRUZ, V107, P1030, DOI 10.1590/S0074-02762012000800011
   Wee LK, 2013, SE ASIAN J TROP MED, V44, P157
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA ENTOMOLOGIA
PI CURITIBA
PA CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL
SN 0085-5626
EI 1806-9665
J9 REV BRAS ENTOMOL
JI Rev. Bras. Entomol.
PY 2020
VL 64
IS 1
AR UNSP e201960
DI 10.1590/1806-9665-RBENT-2019-60
PG 7
WC Entomology
SC Entomology
GA KT1MZ
UT WOS:000518777000001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Crespillo-Andujar, C
   Diaz-Menendez, M
   Trigo, E
   Arsuaga, M
   De la Calle, F
   Lago, M
   de Guevara, MCL
   Barreiro, P
   Montero, D
   Garcia-Bujalance, S
   Alvarado, EA
   de la Calle, M
   Sanchez-Seco, MP
   de Ory, F
   Vazquez, A
   Arribas, JR
   La Paz-Carlos III
   Garcia, J
   Martin-Boado, E
   Martinez-Sanchez, N
   Rodriguez, R
   Herrero, B
   Lopez, F
   Bartha, JL
   Elorza, MD
   Lafuente, MC
   Hortelano, MG
AF Crespillo-Andujar, Clara
   Diaz-Menendez, Marta
   Trigo, Elena
   Arsuaga, Marta
   De la Calle, Fernando
   Lago, Mar
   Ladron de Guevara, Maria Concepcion
   Barreiro, Pablo
   Montero, Dolores
   Garcia-Bujalance, Silvia
   Antolin Alvarado, Eugenia
   de la Calle, Maria
   Paz Sanchez-Seco, Maria
   de Ory, Fernando
   Vazquez, Ana
   Arribas, Jose R.
   La Paz-Carlos, III
   Garcia, Julio
   Martin-Boado, Elena
   Martinez-Sanchez, Nuria
   Rodriguez, Roberto
   Herrero, Beatriz
   Lopez, Francisco
   Luis Bartha, Jose
   Dolores Elorza, Maria
   Cabrera Lafuente, Marta
   Garcia Hortelano, Milagros
CA Hosp Multidisciplinary Working Grp
TI Characteristics of Zika virus infection among international travelers: A
   prospective study from a Spanish referral unit
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Arbovirus infections; Endemic disease; Travel medicine
ID SEXUAL TRANSMISSION; ARBOVIRUSES; EXPOSURE; STATES; SEMEN
AB Background: From the first Zika virus (ZIKV) description, it has progressively widespread worldwide. We analyzed demographic, clinical, microbiologic and travel-related characteristic from returned patients from a ZIKV endemic country in a referral Tropical Medicine Unit.
   Method: A prospective cohort study performed in a Spanish referral center with the aim of determining the significant factors associated with confirmed Zika virus (ZIKV) infection.
   Results: 817 patients, (56% women, median age 36 [IQR, Interquartile Range: 32-42]) were enrolled. Most had returned from Latin America (n = 486; 59.4%), travelled for tourism (n = 404; 49.4%) and stayed a median of 18 days (IQR: 10-30). 602 (73.6%) presented symptoms, but only 25 (4%) were finally diagnosed with confirmed ZIKV infection (including two pregnant women, without adverse fetal outcomes), 88% (n:22) presented with fever and 92% (n:23) with rash. 56% (n:14) arthralgia and/or myalgia and 28% (n:7) conjunctivitis. The presence of conjunctivitis, fever and rash were associated with an 8.9 (95% CI: 2.2-34.9), 6.4 (95% CI: 1.2-33.3) and 72.3 (95% CI: 9.2-563.5) times greater probability of confirmed ZIKV infection, respectively.
   Conclusion: Travel characteristics and clinical presentation may help clinicians to optimize requests for microbiological testing. Diagnosis of arboviriasis in travellers arriving form endemic areas remains a challenge for clinicians, but must be detected for the possible transmission outside endemic areas, where the vector is present.
C1 [Crespillo-Andujar, Clara; Diaz-Menendez, Marta; Trigo, Elena; Arsuaga, Marta; De la Calle, Fernando; Lago, Mar; Ladron de Guevara, Maria Concepcion; Barreiro, Pablo] Hosp Univ La Paz Carlos III, IdiPAZ, Natl Referral Unit Trop & Travel Med, Dept Internal Med, Madrid, Spain.
   [Montero, Dolores; Garcia, Julio] Hosp Univ La Paz Carlos III, Microbiol, IdiPAZ, Madrid, Spain.
   [Garcia-Bujalance, Silvia] Hosp Univ La Paz Carlos III, Microbiol & Parasitol, IdiPAZ, Madrid, Spain.
   [Antolin Alvarado, Eugenia; de la Calle, Maria; Martin-Boado, Elena; Martinez-Sanchez, Nuria] Hosp Univ La Paz Carlos III, Dept Gynecol & Obstet, IdiPAZ, Madrid, Spain.
   [Paz Sanchez-Seco, Maria] Inst Hlth Carlos III, Natl Microbiol Ctr, Madrid, Spain.
   [de Ory, Fernando; Vazquez, Ana] Inst Hlth Carlos III, Biomed Res Networking Ctr Publ Hlth CiberESP, Natl Microbiol Ctr, Madrid, Spain.
   [Arribas, Jose R.] Inst Invest Hosp La Paz IdiPaz, Dept Internal Med, Infect Dis Unit, Madrid, Spain.
   [Rodriguez, Roberto; Herrero, Beatriz; Lopez, Francisco] Dept Gynecol & Obstet, Ultrasound & Fetal Med Sect, Madrid, Spain.
   [Luis Bartha, Jose] Dept Gynecol & Obstet, Madrid, Spain.
   [Dolores Elorza, Maria; Cabrera Lafuente, Marta] Pediat Dept, Neonatol Unit, Madrid, Spain.
   [Garcia Hortelano, Milagros] Pediat Dept, Natl Referral Unit Trop & Travel Med, Madrid, Spain.
   [Diaz-Menendez, Marta] IdiPAZ, C Sinesio Delgado 10, Madrid 28029, Spain.
RP Diaz-Menendez, M (corresponding author), Hosp Univ La Paz Carlos III, IdiPAZ, Natl Referral Unit Trop & Travel Med, Dept Internal Med, Madrid, Spain.; Diaz-Menendez, M (corresponding author), IdiPAZ, C Sinesio Delgado 10, Madrid 28029, Spain.
EM clara.crespillo@gmail.com; marta.diaz@salud.madrid.org;
   elena.trigo@salud.madrid.org; marta.arsuaga@salud.madrid.org;
   fercalleprieto@gmail.com; mariamar.lago@salud.madrid.org;
   mconcepcion.ladron@salud.madrid.org; pablo.barreiro@salud.madrid.org;
   mdolores.montero@salud.madrid.org; sgbujalance@salud.madrid.org;
   eantolin@salud.madrid.org; mcallefm@gmail.com; paz.sanchez@isciii.es;
   fory@isciii.es; A.VAZQUEZ@isciii.es; joser.arribas@salud.madrid.org
OI SANCHEZ-SECO, MARIA PAZ/0000-0001-9033-7704; Barreiro,
   Pablo/0000-0002-3819-5371
FU Network of Tropical Diseases Research RICET [RD16/0027/0002];
   FEDEREuropean Union (EU)
FX This work was supported by the Network of Tropical Diseases Research
   RICET (RD16/0027/0002) and FEDER.
CR [Anonymous], ZIK VIR ZIKV VACC TA
   [Anonymous], 2019, EM PREP RESP
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2017, TRIOPL REAL TIM RT P
   Centers for Disease Control and Prevention, ZIK VIR TEST GUID SY
   Centers for Disease Control and Prevention, 2019, ZIK VIR TEST GUID
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2016, ZIK VIR DIS ZIK VIR
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gonzalez R, 2017, REV ESP SALUD PUBLIC, V91
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Huits R, 2019, TRAVEL MED INFECT DI, V27, P107, DOI 10.1016/j.tmaid.2018.08.007
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Millet JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01319
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2014, POTENTIAL ZIKA VIRUS, V19
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Petridou C, 2019, TRAVEL MED INFECT DI, V29, P21, DOI 10.1016/j.tmaid.2019.03.001
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Protocolo consenso de seguimiento por virus zika, 2017, PROTOCOLO CONSENSO S
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Valero N, 2017, EMERG INFECT DIS, V23, P1426, DOI 10.3201/eid2308.170415
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Spiteri G, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.41.17-00254
   Succo T, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.21.30240., DOI 10.2807/1560-7917.ES.2016.21.21.30240.]
   Sulleiro E, 2019, TRAVEL MED INFECT DI, V29, P69, DOI 10.1016/j.tmaid.2019.03.006
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   World Health Organization, 2018, ZIK CAS CONG SYNDR A
   World Health Organization, 2017, EM ZIK SIT REP
   Yan G, 2018, EMERG INFECT DIS, V24, P1565, DOI 10.3201/eid2408.171883
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 43
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2020
VL 33
AR 101543
DI 10.1016/j.tmaid.2019.101543
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KR7EL
UT WOS:000517778600003
PM 31805400
OA Bronze
DA 2020-07-08
ER

PT J
AU Luo, XS
   Imai, N
   Dorigatti, I
AF Luo, Xue Shi
   Imai, Natsuko
   Dorigatti, Ilaria
TI Quantifying the risk of Zika virus spread in Asia during the 2015-16
   epidemic in Latin America and the Caribbean: A modeling study
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Asia; Southeastern; Latin America; Epidemics; Disease
   transmission; Infectious
ID TRANSMISSION; DENGUE; OUTBREAK; INFECTION; COUNTRIES; SINGAPORE;
   IMMUNITY; CHINA
AB Background: No large-scale Zika epidemic has been observed to date in Southeast Asia following the 2015-16 Latin American and the Caribbean epidemic. One hypothesis is Southeast Asian populations' partial immunity to Zika.
   Method: We estimated the two conditions for a Zika outbreak emergence in Southeast Asia: (i) the risk of Zika introduction from Latin America and the Caribbean and, (ii) the risk of autochthonous transmission under varying assumptions on population immunity. We also validated the model used to estimate the risk of introduction by comparing the estimated number of Zika seeds introduced into the United States with case counts reported by the Centers for Disease Control and Prevention (CDC).
   Results: There was good agreement between our estimates and case counts reported by the CDC. We thus applied the model to Southeast Asia and estimated that, on average, 1-10 seeds were introduced into Indonesia, Malaysia, the Philippines, Singapore, Thailand and Vietnam. We also found increasing population immunity levels from 0 to 90% reduced probability of autochthonous transmission by 40% and increasing individual variation in transmission further reduced the outbreak probability.
   Conclusions: Population immunity, combined with heterogeneity in transmission, can explain why no large-scale outbreak was observed in Southeast Asia during the 2015-16 epidemic.
C1 [Luo, Xue Shi] Imperial Coll London, St Marys Campus,Norfolk Pl, London W2 1PG, England.
   [Imai, Natsuko; Dorigatti, Ilaria] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.
   [Luo, Xue Shi] Minist Hlth Singapore, Agcy Care Effectiveness, 16 Coll Rd,Coll Med Bldg, Singapore 169854, Singapore.
RP Luo, XS (corresponding author), Imperial Coll London, St Marys Campus,Norfolk Pl, London W2 1PG, England.
EM luoxueshi8@gmail.com; n.imai@imperial.ac.uk; i.dorigatti@imperial.ac.uk
RI Imai, Natsuko/J-5817-2017
OI Imai, Natsuko/0000-0002-4218-9716
FU UK Medical Research Council (MRC)Medical Research Council UK (MRC); UK
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement; European UnionEuropean Union (EU); Imperial College
   Junior Research Fellowship; Wellcome TrustWellcome Trust
   [213494/Z/18/Z]; Sir Henry Dale Fellowship - Royal Society
FX This work is jointly funded by the UK Medical Research Council (MRC) and
   the UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement and is also part of the EDCTP2 programme
   supported by the European Union. I.D. also acknowledges research funding
   from an Imperial College Junior Research Fellowship and a Sir Henry Dale
   Fellowship funded by the Royal Society and Wellcome Trust [grant
   213494/Z/18/Z].
CR [Anonymous], 2016, GLOBAL TIMES
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blumberg S, 2013, EPIDEMICS-NETH, V5, P131, DOI 10.1016/j.epidem.2013.05.002
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Centers for Disease Control and Prevention, 2016, CAS COUNTS US 2016
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dorigatti I, 2017, EUROSURVEILLANCE, V22, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917]
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Dyer O, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5577
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI [10.2471/BLT.17.201541, DOI 10.2471/BLT.17.201541.402-13D]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   ITB Academy, 2017, ITB WORLD TRAV TREND
   Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Ministry of Health Brunei Darussalam, 2017, NUMB ZIKA CAS BRUN D
   Moraga Paula, 2018, F1000Res, V7, P1374, DOI 10.12688/f1000research.16032.2
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Oag Aviation Worldwide Ltd, 2018, OAG TRAFF AN VERS 2
   Ogden N H, 2015, Can Commun Dis Rep, V41, P11
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pan American Health Organization, 2018, ZIK CUM CAS
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   R Core Team, 2018, R LANG ENV STAT COMP
   Reuters, 2016, REUTERS
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Ryu S, 2019, TRAVEL MED INFECT DI, V29, P72, DOI 10.1016/j.tmaid.2018.11.008
   Seidahmed OME, 2018, GEOHEALTH, V2, P54, DOI 10.1002/2017GH000080
   The Straits Times, 2016, STRAITS TIMES
   Dinh TC, 2019, EUR J CLIN MICROBIOL, V38, P1585, DOI 10.1007/s10096-019-03563-6
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   U.S. Department of Commerce, 2016, PROF US RES TRAV VIS
   U.S. Department of Commerce, 2015, MARK PROF US OUTB OV
   Uraki R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006350
   World Health Organization Myanmar, 1 CAS ZIK VIR INF DE
   Xiang B, 2017, J INFECTION, V74, P328, DOI 10.1016/j.jinf.2017.01.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 54
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2020
VL 33
AR 101562
DI 10.1016/j.tmaid.2020.101562
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KR7EL
UT WOS:000517778600024
PM 31996323
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wilson, ME
AF Wilson, Mary E.
TI What goes on board aircraft? Passengers include Aedes, Anopheles,
   2019-nCoV, dengue, Salmonella, Zika, et al
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
C1 [Wilson, Mary E.] Univ Calif San Francisco, Sch Med, Epidemiol & Biostat, San Francisco, CA USA.
   [Wilson, Mary E.] Harvard TH Chan Sch Publ Hlth, Global Hlth & Populat, Boston, MA USA.
RP Wilson, ME (corresponding author), 171 Ripley St, San Francisco, CA 94110 USA.
EM mewilson@hsph.harvard.edu
CR Bitzegeio J, TRAV MED INFECT DIS
   Chan JF-W, 2020, LANCET
   Grout A, 2020, PLOS NEGLECTED TROP
   Mier-Y-Teran-Romero L, PLOS NEGLECTED TROP, V217
   Moore Melinda, 2017, Rand Health Q, V6, P5
   Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349
   Pang AM, 2020, TRAV MED INFECT DIS
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Zhao B, 2019, TRAVEL MED INFECT DI, V28, P6, DOI 10.1016/j.tmaid.2018.07.011
   Zhu N., 2019, N ENGL J MED, P2020
NR 10
TC 2
Z9 2
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2020
VL 33
AR 101572
DI 10.1016/j.tmaid.2020.101572
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KR7EL
UT WOS:000517778600036
PM 32035269
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kum, DB
   Boudewijns, R
   Ma, J
   Mishra, N
   Schols, D
   Neyts, J
   Dallmeier, K
AF Kum, Dieudonne Buh
   Boudewijns, Robbert
   Ma, Ji
   Mishra, Niraj
   Schols, Dominique
   Neyts, Johan
   Dallmeier, Kai
TI A chimeric yellow fever-Zika virus vaccine candidate fully protects
   against yellow fever virus infection in mice
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE YFV-17D; chimeric flavivirus vaccine; CD8(+) T cells; live-attenuated
   vaccines; non-neutralizing antibodies
ID T-CELL RESPONSE; 17D; IMMUNIZATION; CHALLENGE; DENGUE; MODEL;
   ENCEPHALITIS; ACTIVATION; ANTIBODY; IMMUNITY
AB The recent Zika virus (ZIKV) epidemic in the Americas, followed by the yellow fever virus (YFV) outbreaks in Angola and Brazil highlight the urgent need for safe and efficient vaccines against the ZIKV as well as much greater production capacity for the YFV-17D vaccine. Given that the ZIKV and the YFV are largely prevalent in the same geographical areas, vaccines that would provide dual protection against both pathogens may obviously offer a significant benefit. We have recently engineered a chimeric vaccine candidate (YF-ZIKprM/E) by swapping the sequences encoding the YFV-17D surface glycoproteins prM/E by the corresponding sequences of the ZIKV. A single vaccine dose of YF-ZIKprM/E conferred complete protection against a lethal challenge with wild-type ZIKV strains. Surprisingly, this vaccine candidate also efficiently protected against lethal YFV challenge in various mouse models. We demonstrate that CD8(+) but not CD4(+) T cells, nor ZIKV neutralizing antibodies are required to confer protection against YFV. The chimeric YF-ZIKprM/E vaccine may thus be considered as a dual vaccine candidate efficiently protecting mice against both the ZIKV and the YFV, and this following a single dose immunization. Our finding may be particularly important in the rational design of vaccination strategies against flaviviruses, in particular in areas where YFV and ZIKV co-circulate.
C1 [Kum, Dieudonne Buh; Boudewijns, Robbert; Ma, Ji; Mishra, Niraj; Schols, Dominique; Neyts, Johan; Dallmeier, Kai] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Rega Inst, Lab Virol & Chemotherapy, Leuven, Belgium.
   [Kum, Dieudonne Buh] Aligos Belgium, Leuven, Belgium.
   [Mishra, Niraj] Intas Pharmaceut Ltd, Gene Therapy Div, Biopharma Plant, Ahmadabad, Gujarat, India.
RP Neyts, J; Dallmeier, K (corresponding author), Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Rega Inst, Lab Virol & Chemotherapy, Leuven, Belgium.
EM johan.neyts@kuleuven.be; kai.dallmeier@kuleuven.be
RI NEYTS, Johan/U-8267-2017; Boudewijns, Robbert/Y-2904-2018; Mishra,
   Niraj/T-1375-2018; Schols, Dominique/S-9057-2017
OI NEYTS, Johan/0000-0002-0033-7514; Boudewijns,
   Robbert/0000-0002-5984-7279; Kum, Dieudonne Buh/0000-0001-8251-8230;
   Mishra, Niraj/0000-0002-8679-8847; Schols, Dominique/0000-0003-3256-5850
FU European UnionEuropean Union (EU) [733176, 734584, 734548]; FRNS/FWO-EOS
   action under EOS [30981113]
FX This project has received funding from the European Union's Horizon 2020
   Research and Innovation Framework programme under grant agreement No
   733176 (RABYD-VAX consortium), No 734584 (ZikaPLAN) and No 734548
   (ZIKAlliance), and was supported by the FRNS/FWO-EOS action under EOS ID
   30981113 (VirEOS research project).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234
   de Melo AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001938
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Harenberg A, 2013, HUM VACC IMMUNOTHER, V9, P2317, DOI 10.4161/hv.25562
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034
   Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10
   Kum DB, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0092-2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee YH, 2016, J GEN VIROL, V97, P3103, DOI 10.1099/jgv.0.000637
   Malavige GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050387
   Nasveld PE, 2010, HUM VACCINES, V6, P906, DOI 10.4161/hv.6.11.12854
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   World Health Organization, 2013, WHOIVB1301
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 35
TC 0
Z9 0
U1 3
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 520
EP 533
DI 10.1080/22221751.2020.1730709
PG 14
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KR3MO
UT WOS:000517522700001
PM 32116148
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Forster, D
   Schwarz, JH
   Brosinski, K
   Kalinke, U
   Sutter, G
   Volz, A
AF Forster, Dominik
   Schwarz, Jan Hendrik
   Brosinski, Katrin
   Kalinke, Ulrich
   Sutter, Gerd
   Volz, Asisa
TI Obstetric Ultrasonography to Detect Fetal Abnormalities in a Mouse Model
   for Zika Virus Infection
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; uteroplacental infection; viral pathogenesis; pregnancy;
   ultrasound
ID TRANSMISSION; REPLICATION; INTERFERONS; PROTECTION; MOSQUITOS; PLACENTA;
   BRAZIL
AB In 2015 Zika virus (ZIKV) emerged for the first time in South America. The following ZIKV epidemic resulted in the appearance of a clinical phenotype with microcephaly and other severe malformations in newborns. So far, mechanisms of ZIKV induced damage to the fetus are not completely understood. Previous data suggest that ZIKV may bypass the placenta to reach the fetus. Thus, animal models for ZIKV infection are important to facilitate studies about ZIKV infection during pregnancy. Here, we used ultrasound based imaging (USI) to characterize ZIKV induced pathogenesis in the pregnant Type I interferon receptor-deficient (IFNAR-/-) mouse model. Based on USI we suggest the placenta to be a primary target organ of ZIKV infection enabling ZIKV spreading to the fetus. Moreover, in addition to direct infection of the fetus, the placental ZIKV infection may cause an indirect damage to the fetus through reduced uteroplacental perfusion leading to intrauterine growth retardation (IUGR) and fetal complications as early as embryonic day (ED) 12.5. Our data confirmed the capability of USI to characterize ZIKV induced modifications in mouse fetuses. Data from further studies using USI to monitor ZIKV infections will contribute to a better understanding of ZIKV infection in pregnant IFNAR-/- mice.
C1 [Forster, Dominik; Schwarz, Jan Hendrik; Brosinski, Katrin; Sutter, Gerd; Volz, Asisa] Ludwig Maximilians Univ Munchen, Inst Infect Dis & Zoonoses, D-80539 Munich, Germany.
   [Kalinke, Ulrich] Ctr Expt & Clin Infect Res Joint Venture Helmholt, Inst Expt Infect Res, TWINCORE, D-30625 Hannover, Germany.
   [Sutter, Gerd; Volz, Asisa] German Ctr Infect Res DZIF, Partner Site Munich, D-80539 Munich, Germany.
RP Volz, A (corresponding author), Ludwig Maximilians Univ Munchen, Inst Infect Dis & Zoonoses, D-80539 Munich, Germany.; Volz, A (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, D-80539 Munich, Germany.
EM dominik.forster@micro.vetmed.uni-muenchen.de;
   jan.schwarz@micro.vetmed.uni-muenchen.de;
   katrin.printz@micro.vetmed.uni-muenchen.de;
   Kalinke.Ulrich@mh-hannover.de; gerd.sutter@lmu.de;
   asisa.volz@micro.vetmed.uni-muenchen.de
OI Sutter, Gerd/0000-0001-6143-082X
FU Federal Ministry of Education and Research (BMBF; "ZOOVAC"-project),
   Research Network Zoonotic Infectious DiseasesFederal Ministry of
   Education & Research (BMBF) [01KI1718]
FX The work was funded by the Federal Ministry of Education and Research
   (BMBF; "ZOOVAC"-project number 01KI1718 to A.V.) as part of the Research
   Network Zoonotic Infectious Diseases.
CR Agbulos D.S., 2016, CURR PROTOC MICROBIO, V43, p15D41
   Alkirav C, 2005, PLACENTA, V26, P129, DOI 10.1016/j.placenta.2004.05.010
   Ang ESBC, 2006, P NATL ACAD SCI USA, V103, P12903, DOI 10.1073/pnas.0605294103
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Browne VA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0068
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen K-H, 2012, Pregnancy Hypertens, V2, P292, DOI 10.1016/j.preghy.2012.04.207
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daud WMW, 2017, CLIN TER, V168, pE283, DOI 10.7417/T.2017.2021
   de Carvalho Leal Mariana, 2019, Top Magn Reson Imaging, V28, P19, DOI 10.1097/RMR.0000000000000191
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Grazel R, 2018, ADV NEONAT CARE, V18, P350, DOI 10.1097/ANC.0000000000000557
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joob Beuy, 2017, Pediatr Neurol, V68, pe1, DOI 10.1016/j.pediatrneurol.2016.11.009
   Kim WJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50994
   Lang U, 2000, AM J PHYSIOL-REG I, V279, pR53
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McClintic AM, 2014, AUTISM RES, V7, P295, DOI 10.1002/aur.1349
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nishimura M, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00257-17
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petitt M, 2017, CURR OPIN VIROL, V27, P48, DOI 10.1016/j.coviro.2017.11.008
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sepulveda W, 2003, ULTRASOUND OBST GYN, V21, P564, DOI 10.1002/uog.132
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 57
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2020
VL 12
IS 1
AR 72
DI 10.3390/v12010072
PG 19
WC Virology
SC Virology
GA KP0JM
UT WOS:000515930700019
PM 31936159
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, JK
   Oh, SJ
   Park, H
   Shin, OS
AF Lee, Jae Kyung
   Oh, Soo-Jin
   Park, Hosun
   Shin, Ok Sarah
TI Recent Updates on Research Models and Tools to Study Virus-Host
   Interactions at the Placenta
SO VIRUSES-BASEL
LA English
DT Review
DE placenta; congenital infection; immunity; trophoblasts; Hofbauer cells
ID MESENCHYMAL STEM-CELLS; PRIMARY CYTOMEGALOVIRUS-INFECTION; ADENOVIRUS
   RECEPTOR CAR; ZIKA VIRUS; GUINEA-PIG; TROPHOBLAST INVASION;
   ENDOTHELIAL-CELLS; VIRAL-INFECTIONS; CHORIONIC VILLI; C19MC MICRORNAS
AB The placenta is a unique mixed organ, composed of both maternal and fetal tissues, that is formed only during pregnancy and serves as the key physiological and immunological barrier preventing maternal-fetal transmission of pathogens. Several viruses can circumvent this physical barrier and enter the fetal compartment, resulting in miscarriage, preterm birth, and birth defects, including microcephaly. The mechanisms underlying viral strategies to evade the protective role of placenta are poorly understood. Here, we reviewed the role of trophoblasts and Hofbauer cells in the placenta and have highlighted characteristics of vertical and perinatal infections caused by a wide range of viruses. Moreover, we explored current progress and future opportunities in cellular targets, pathogenesis, and underlying biological mechanisms of congenital viral infections, as well as novel research models and tools to study the placenta.
C1 [Lee, Jae Kyung; Oh, Soo-Jin; Shin, Ok Sarah] Korea Univ, Coll Med, Dept Biomed Sci, Guro Hosp, Seoul 08308, South Korea.
   [Park, Hosun] Yeungnam Univ, Coll Med, Dept Microbiol, 170 Hyeonchung Ro, Namgu 42415, Daegu, South Korea.
RP Shin, OS (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Guro Hosp, Seoul 08308, South Korea.; Park, H (corresponding author), Yeungnam Univ, Coll Med, Dept Microbiol, 170 Hyeonchung Ro, Namgu 42415, Daegu, South Korea.
EM jae.lee0321@gmail.com; sj0000h@gmail.com; hspark@ynu.ac.kr;
   oshin@korea.ac.kr
OI Lee, Jae Kyung/0000-0002-9641-8473
FU Basic Science Research Program of the National Research Foundation of
   Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2019R1A2C1005961]
FX This research was supported by the Basic Science Research Program of the
   National Research Foundation of Korea (NRF) and was funded by the
   Ministry of Science, ICT & Future Planning (NRF-2019R1A2C1005961).
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abrahams VM, 2006, HUM REPROD, V21, P2432, DOI 10.1093/humrep/del178
   Abumaree MH, 2013, STEM CELL REV REP, V9, P16, DOI 10.1007/s12015-012-9385-4
   Adams AP, 2001, BIOL REPROD, V64, P753, DOI 10.1095/biolreprod64.3.753
   Agboeze J, 2019, INT J INFECT DIS, V89, P84, DOI 10.1016/j.ijid.2019.08.023
   Anzivino E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-40
   Asher DR, 2005, GENESIS, V42, P77, DOI 10.1002/gene.20127
   AXELSSON C, 1993, J MED VIROL, V39, P282, DOI 10.1002/jmv.1890390405
   BALOGH A, 1985, ACTA PHYSIOL HUNG, V65, P275
   Barrila J, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00282-18
   Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bebell LM, 2017, BIRTH DEFECTS RES, V109, P353, DOI 10.1002/bdra.23558
   Bebell LM, 2015, OBSTET GYNECOL, V125, P1293, DOI 10.1097/AOG.0000000000000853
   Bendig JWA, 2003, J MED VIROL, V70, P606, DOI 10.1002/jmv.10437
   Benirschke K., 2012, PATHOLOGY HUMAN PLAC, P157
   BENIRSCHKE K, 1995, PATHOLOGY HUMAN PLAC
   Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590
   BIA FJ, 1983, REV INFECT DIS, V5, P177
   Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BROWN GC, 1967, J AMER MED ASSOC, V199, P183, DOI 10.1001/jama.199.3.183
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002
   Carter AM, 2006, PLACENTA, V27, pS30, DOI 10.1016/j.placenta.2006.01.008
   Carter AM, 2011, REPRODUCTION, V141, P391, DOI 10.1530/REP-10-0530
   Casazza RL, 2020, VIRAL IMMUNOL, V33, P3, DOI 10.1089/vim.2019.0076
   CASTELLUCCI M, 1982, PLACENTA, V3, P269, DOI 10.1016/S0143-4004(82)80004-0
   Castellucci M., 2006, PATHOLOGY HUMAN PLAC, P50, DOI [10.1007/0-387-26742-5_6., DOI 10.1007/0-387-26742-5_6]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001
   CHOI YC, 1978, J INFECT DIS, V138, P197, DOI 10.1093/infdis/138.2.197
   Comiskey M, 2006, MED INTELL UNIT, P130
   CROY BA, 1990, J REPROD FERTIL, V88, P231, DOI 10.1530/jrf.0.0880231
   Daiminger A, 2005, BJOG-INT J OBSTET GY, V112, P166, DOI 10.1111/j.1471-0528.2004.00328.x
   DALSGAARD AM, 1995, PLACENTA, V16, P137, DOI 10.1016/0143-4004(95)90002-0
   Darland N W, 1985, J Obstet Gynecol Neonatal Nurs, V14, P212, DOI 10.1111/j.1552-6909.1985.tb02229.x
   de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5
   de Jong EP, 2006, J CLIN VIROL, V36, P1, DOI 10.1016/j.jcv.2006.01.004
   de Mestre AM, 2009, BIOL REPROD, V80, P227, DOI 10.1095/biolreprod.108.070920
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013
   Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dyson RM, 2012, PEDIATR RES, V71, P20, DOI 10.1038/pr.2011.9
   Emery Vincent C, 2017, F1000Res, V6, P138, DOI 10.12688/f1000research.10276.1
   Enders AC, 2006, PLACENTA, V27, pS11, DOI 10.1016/j.placenta.2005.10.013
   Enders AC, 1997, HUM REPROD UPDATE, V3, P561, DOI 10.1093/humupd/3.6.561
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Euscher E, 2001, OBSTET GYNECOL, V98, P1019, DOI 10.1016/S0029-7844(01)01625-8
   Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Fortner KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083338
   Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060
   Genen L, 2004, J PEDIATR-US, V144, P316, DOI 10.1016/j.jpeds.2003.12.015
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Geyer H, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0475-9
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   GRIFFITH BP, 1985, J VIROL, V55, P402, DOI 10.1128/JVI.55.2.402-409.1985
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038
   Hall OJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02160-16
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Hwang JY, 2014, EXP ANIM TOKYO, V63, P63, DOI 10.1538/expanim.63.63
   Hwang JH, 2014, YONSEI MED J, V55, P1562, DOI 10.3349/ymj.2014.55.6.1562
   Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1
   in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058
   Ingman K, 2010, PLACENTA, V31, P535, DOI 10.1016/j.placenta.2010.03.003
   JANSSON T, 1990, PEDIATR RES, V28, P203, DOI 10.1203/00006450-199009000-00007
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson EL, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-101
   Jordan JA, 1999, PLACENTA, V20, P103, DOI 10.1053/plac.1998.0353
   KAUFMANN P, 2004, COMP PLACENTATION
   Khan S, 2000, BIOL REPROD, V62, P1075, DOI 10.1095/biolreprod62.4.1075
   KINNEY JS, 1988, CLIN PERINATOL, V15, P727
   Kliman H.J., 1999, ENCY REPROD
   Knipe D., 2007, FIELDS VIROLOGY, V1, P1001
   Konstantinidou A, 2007, J MED VIROL, V79, P754, DOI 10.1002/jmv.20887
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   KUMAR ML, 1978, J INFECT DIS, V138, P650, DOI 10.1093/infdis/138.5.650
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lazar M, 2016, EBIOMEDICINE, V3, P86, DOI 10.1016/j.ebiom.2015.11.050
   Lee JK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051101
   Lee J, 2016, J MATERN-FETAL NEO M, V29, P707, DOI 10.3109/14767058.2015.1020293
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Leoon-Juarez M., 2017, PATHOG DIS, V75, P7
   Littauer EQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02455
   Littauer EQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006757
   Liu YW, 2018, CELL RES, V28, P819, DOI 10.1038/s41422-018-0066-y
   Loewendorf AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096723
   Luan XY, 2013, TISSUE CELL, V45, P32, DOI 10.1016/j.tice.2012.09.002
   Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481
   Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Megli C, 2016, AM J OBSTET GYNECOL, V214, pS271, DOI 10.1016/j.ajog.2015.10.540
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mendelson E, 2006, REPROD TOXICOL, V21, P350, DOI 10.1016/j.reprotox.2006.02.001
   Mess A, 2007, PLACENTA, V28, P812, DOI 10.1016/j.placenta.2007.02.005
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Miki T, 2006, STEM CELL REV, V2, P133, DOI 10.1007/s12015-006-0020-0
   Mustonen K, 2001, J Perinatol, V21, P141, DOI 10.1038/sj.jp.7200508
   Nikkels AF, 2005, J INFECT DIS, V191, P540, DOI 10.1086/426942
   Nishiguchi A, 2019, BIOMATERIALS, V192, P140, DOI 10.1016/j.biomaterials.2018.08.025
   Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272
   Noronha LE, 2010, AM J REPROD IMMUNOL, V64, P231, DOI 10.1111/j.1600-0897.2010.00895.x
   Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002
   Ouyang YS, 2016, PLACENTA, V47, P86, DOI 10.1016/j.placenta.2016.09.008
   Park SE, 2019, SCIENCE, V364, P960, DOI 10.1126/science.aaw7894
   Pasquinelli G, 2009, J CLIN VIROL, V44, P33, DOI 10.1016/j.jcv.2008.10.008
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Perez-Garcia V, 2018, NATURE, V555, P463, DOI 10.1038/nature26002
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Prescott JB, 2017, NAT REV IMMUNOL, V17, P195, DOI 10.1038/nri.2016.138
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Racicot K, 2017, J CLIN INVEST, V127, P1591, DOI 10.1172/JCI87490
   REDMAN CWG, 1984, IMMUNOLOGY, V52, P457
   Reyes L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02628
   Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Sarah A., 2015, KNOBIL NEILLS PHYSL
   Saraswathy TS, 2013, SE ASIAN J TROP MED, V44, P429
   Schmidt A, 2015, J REPROD IMMUNOL, V108, P65, DOI 10.1016/j.jri.2015.03.001
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90
   Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221
   Takahashi K, 2004, CELL TRANSPLANT, V13, P337, DOI 10.3727/000000004783983918
   TONDURY G, 1966, J PEDIATR-US, V68, P867, DOI 10.1016/S0022-3476(66)80204-4
   Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317
   Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128
   Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6
   Wang Y.Z.S., 2010, CELL TYPES PLACENTA
   Wetzka B, 1997, HUM REPROD, V12, P847, DOI 10.1093/humrep/12.4.847
   Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9
   WOOD G, 1978, CELL IMMUNOL, V35, P205, DOI 10.1016/0008-8749(78)90140-5
   Woods L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00570
   Yin FC, 2019, TOXICOL IN VITRO, V54, P105, DOI 10.1016/j.tiv.2018.08.014
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
NR 149
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2020
VL 12
IS 1
AR 5
DI 10.3390/v12010005
PG 20
WC Virology
SC Virology
GA KP0JM
UT WOS:000515930700105
PM 31861492
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Perez-Olmeda, M
   Sanchez-Seco, MP
   Vazquez, A
   Balfagon, P
   de la Fuente, J
   Murillo, MA
   Minguito, T
   de Ory, F
AF Perez-Olmeda, Mayte
   Paz Sanchez-Seco, Maria
   Vazquez, Ana
   Balfagon, Pilar
   de la Fuente, Jesus
   Angeles Murillo, Maria
   Minguito, Teodora
   de Ory, Fernando
TI Evaluation of the LIAISON XL Zika Capture IgM II for the Diagnosis of
   Zika Virus Infections
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; chemiluminescent immunoassay; enzyme immunoassay; dengue
   viruses; chikungunya virus
AB The aim of this study is to evaluate the performance characteristics of the LIAISON XL Zika Capture IgM II. For this purpose we tested 128 samples obtained from recent infections caused by the Zika (ZIKV; 74 samples), dengue (DENV; 10 samples), chikungunya (CHIK V; 11 samples), rubella (RUBV; 10 samples) and measles (MeV; 10 samples) viruses, as well as human parvovirus B19 (HPVB19; 13 samples). The results of the assay under evaluation are compared with those obtained from an indirect immunofluorescence (IIF) assay, and the discrepancies are resolved by considering other laboratory results (PCR and a plaque-reduction neutralization test). The LIAISON showed excellent sensitivity (100%). The specificity (91.25%) was hampered by some false-positive results in recent dengue virus, chikungunya virus, measles virus and human parvovirus B19 infections. The method evaluated is adequate, but the low specificity makes it necessary to consider the clinical and epidemiological contexts of patients, as well as other laboratory results.
C1 [Perez-Olmeda, Mayte; Paz Sanchez-Seco, Maria; Vazquez, Ana; Balfagon, Pilar; de la Fuente, Jesus; Angeles Murillo, Maria; Minguito, Teodora; de Ory, Fernando] Inst Salud Carlos III, Ctr Nacl Microbiol, Lab Serol & Arbovirus, Majadahonda 28220, Spain.
   [Vazquez, Ana; de Ory, Fernando] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid 28029, Spain.
RP de Ory, F (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Lab Serol & Arbovirus, Majadahonda 28220, Spain.; de Ory, F (corresponding author), Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid 28029, Spain.
EM mayteperez@isciii.es; paz.sanchez@isciii.es; a.vazquez@isciii.es;
   pbalfagon@isciii.es; jfuentel@isciii.es; mariam.murillo@isciii.es;
   teodoraminguito@gmail.com; fory@isciii.es
RI ; Perez-olmeda, Mayte/C-7687-2014
OI SANCHEZ-SECO, MARIA PAZ/0000-0001-9033-7704; Perez-olmeda,
   Mayte/0000-0003-4553-5423
FU Instituto de Salud Carlos IIIInstituto de Salud Carlos III [MVP280/18];
   Diasorin Iberia [MVP280/18]
FX This work has been financed by a contract between the Instituto de Salud
   Carlos III and Diasorin Iberia (MVP280/18).
CR Amaro F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020179
   Basile AJ, 2018, J VIROL METHODS, V260, P26, DOI 10.1016/j.jviromet.2018.06.018
   De Ory F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070379
   Diasorin, 2019, LIAIS XL ZIK CAPT IG
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2009, DIAGN MICR INFEC DIS, V65, P42, DOI 10.1016/j.diagmicrobio.2009.05.004
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcell HG, 2020, J INFECT PUBLIC HEAL, V13, P173, DOI 10.1016/j.jiph.2019.07.006
   Houe V, 2019, EMERG MICROBES INFEC, V8, P542, DOI 10.1080/22221751.2019.1599302
   Muzumdar S, 2019, CLIN DERMATOL, V37, P109, DOI 10.1016/j.clindermatol.2018.12.004
   Sloan A, 2018, DIAGN MICR INFEC DIS, V90, P264, DOI 10.1016/j.diagmicrobio.2017.11.018
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Van der Beken Y, 2019, DIAGN MICR INFEC DIS, V95, P144, DOI 10.1016/j.diagmicrobio.2019.05.004
   World Health Organization, COUNTR TERR CURR PRE
NR 16
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2020
VL 12
IS 1
AR 69
DI 10.3390/v12010069
PG 8
WC Virology
SC Virology
GA KP0JM
UT WOS:000515930700025
PM 31936013
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silva, SJR
   Pardee, K
   Pena, L
AF Ribeiro da Silva, Severino Jefferson
   Pardee, Keith
   Pena, Lindomar
TI Loop-Mediated Isothermal Amplification (LAMP) for the Diagnosis of Zika
   Virus: A Review
SO VIRUSES-BASEL
LA English
DT Review
DE diagnostic; point-of-care; loop-mediated isothermal amplification
   (LAMP); Zika virus (ZIKV)
ID AEDES-AEGYPTI; ASSAY; TRANSMISSION; EPIDEMIC; STATE; PCR; DNA
AB The recent outbreak of Zika virus (ZIKV) in the Americas and its devastating developmental and neurological manifestations has prompted the development of field-based diagnostics that are rapid, reliable, handheld, specific, sensitive, and inexpensive. The gold standard molecular method for lab-based diagnosis of ZIKV, from either patient samples or insect vectors, is reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The method, however, is costly and requires lab-based equipment and expertise, which severely limits its use as a point-of-care (POC) tool in resource-poor settings. Moreover, given the lack of antivirals or approved vaccines for ZIKV infection, a POC diagnostic test is urgently needed for the early detection of new outbreaks and to adequately manage patients. Loop-mediated isothermal amplification (LAMP) is a compelling alternative to RT-qPCR for ZIKV and other arboviruses. This low-cost molecular system can be freeze-dried for distribution and exhibits high specificity, sensitivity, and efficiency. A growing body of evidence suggests that LAMP assays can provide greater accessibility to much-needed diagnostics for ZIKV infections, especially in developing countries where the ZIKV is now endemic. This review summarizes the different LAMP methods that have been developed for the virus and summarizes their features, advantages, and limitations.
C1 [Ribeiro da Silva, Severino Jefferson; Pena, Lindomar] Oswaldo Cruz Fdn Fiocruz, Aggeu Magalhaes Inst, Dept Virol, BR-50670420 Recife, PE, Brazil.
   [Pardee, Keith] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada.
RP Pena, L (corresponding author), Oswaldo Cruz Fdn Fiocruz, Aggeu Magalhaes Inst, Dept Virol, BR-50670420 Recife, PE, Brazil.
EM jeffersonbiotecviro@gmail.com; keith.pardee@utoronto.ca;
   lindomar.pena@cpqam.fiocruz.br
OI Silva, Severino Jefferson Ribeiro da/0000-0002-3779-4727
FU Canadian International Development Research Centre [IDRC-108410-001];
   Foundation for Science and Technology of Pernambuco
   [FACEPE-APQ-0154-2.12/16]
FX This work was supported by the Canadian International Development
   Research Centre (IDRC-108410-001) and Foundation for Science and
   Technology of Pernambuco (FACEPE-APQ-0154-2.12/16). The funders had no
   role in study design, decision to publish, or preparation of the
   manuscript.
CR Abd El Wahed Ahmed, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.a7f1db2c7d66c3fc0ea0a774305d319e
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Balasuriya UBR, 2014, J VIROL METHODS, V207, P66, DOI 10.1016/j.jviromet.2014.06.016
   Bartolone SN, 2018, JOVE-J VIS EXP, DOI 10.3791/58436
   Bui Thu Thuy, 2020, Jpn J Infect Dis, V73, P153, DOI 10.7883/yoken.JJID.2019.073
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos TD, 2018, INT J GENOMICS, DOI 10.1155/2018/6941735
   Castro T, 2018, J ORAL MICROBIOL, V10, DOI 10.1080/20002297.2018.1510712
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chander Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00395
   Chen Hua-Wei, 2015, Int J Bacteriol, V2015, P147173, DOI 10.1155/2015/147173
   Chen HW, 2016, MIL MED, V181, P227, DOI 10.7205/MILMED-D-15-00149
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Fischbach J, 2015, BIOTECHNIQUES, V58, P189, DOI 10.2144/000114275
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Guo XG, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0591-6
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hong M, 2012, WORLD J MICROB BIOT, V28, P523, DOI 10.1007/s11274-011-0843-y
   Hsieh K, 2014, CHEM COMMUN, V50, P3747, DOI 10.1039/c4cc00540f
   Inoshima Y, 2016, J VET MED SCI, V78, P1841, DOI 10.1292/jvms.16-0268
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9
   Karthik K, 2014, METHODSX, V1, P137, DOI 10.1016/j.mex.2014.08.009
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lau YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138694
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Lee SH, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02166
   Liang C, 2013, J NANOSCI NANOTECHNO, V13, P3999, DOI 10.1166/jnn.2013.6497
   Lopez-Jimena B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006381
   Lopez-Jimena B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006448
   Lucchi NW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151437
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mwendwa Fridah, 2017, BMC Research Notes, V10, P142, DOI 10.1186/s13104-017-2466-3
   Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415
   Nemoto M, 2010, J VET MED SCI, V72, P823, DOI 10.1292/jvms.09-0446
   Estrela PFN, 2019, J VIROL METHODS, V271, DOI 10.1016/j.jviromet.2019.113675
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Niessen L, 2015, APPL MICROBIOL BIOT, V99, P553, DOI 10.1007/s00253-014-6196-3
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Nzelu CO, 2014, ACTA TROP, V132, P1, DOI 10.1016/j.actatropica.2013.12.016
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oscorbin IP, 2016, BIOTECHNIQUES, V61, P20, DOI 10.2144/000114432
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   da Silva SJR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40960-5
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Salinas Nelson R, 2012, ISRN Bioinform, V2012, P696758, DOI 10.5402/2012/696758
   Sanchez-Carbonel Jose, 2018, BMC Res Notes, V11, P175, DOI 10.1186/s13104-018-3290-0
   Santiago-Felipe S, 2016, BIOSENS BIOELECTRON, V79, P300, DOI 10.1016/j.bios.2015.12.045
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stranieri A, 2017, J VIROL METHODS, V243, P105, DOI 10.1016/j.jviromet.2017.01.009
   Tanner NA, 2012, BIOTECHNIQUES, V53, P81, DOI 10.2144/0000113902
   Tao ZY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-115
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Wassermann M, 2014, VET PARASITOL, V200, P97, DOI 10.1016/j.vetpar.2013.12.012
   Watts MR, 2014, AM J TROP MED HYG, V90, P306, DOI 10.4269/ajtmh.13-0583
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong YP, 2018, J APPL MICROBIOL, V124, P626, DOI 10.1111/jam.13647
   Woniakowski G., 2013, AVIAN DIS, V57, P539
   Wu RN, 2014, CURR MICROBIOL, V69, P839, DOI 10.1007/s00284-014-0661-1
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zhao JT, 2019, VIRUS GENES, V55, P43, DOI 10.1007/s11262-018-1612-x
   Zhou DG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04912
NR 93
TC 0
Z9 0
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2020
VL 12
IS 1
AR 19
DI 10.3390/v12010019
PG 20
WC Virology
SC Virology
GA KP0JM
UT WOS:000515930700068
PM 31877989
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Volkova, E
   Tsetsarkin, KA
   Sippert, E
   Assis, F
   Liu, GP
   Rios, M
   Pletnev, AG
AF Volkova, Evgeniya
   Tsetsarkin, Konstantin A.
   Sippert, Emilia
   Assis, Felipe
   Liu, Guangping
   Rios, Maria
   Pletnev, Alexander G.
TI Novel Approach for Insertion of Heterologous Sequences into Full-Length
   ZIKV Genome Results in Superior Level of Gene Expression and Insert
   Stability
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; flaviviruses; heterologous gene expression; bioluminescence;
   reverse genetics
ID WEST-NILE-VIRUS; REPORTER VIRUSES; RNA; REPLICATION; TRANSMISSION;
   ATTENUATION; CYCLIZATION; INFECTION; MOSQUITO; REPLICON
AB Zika virus (ZIKV) emerged in the Americas in 2015, presenting unique challenges to public health. Unlike other arboviruses of the Flaviviridae family, it is transmissible by sexual contact, which facilitates the spread of the virus into new geographic areas. Additionally, ZIKV can be transmitted from mother to fetus, causing microcephaly and other severe developmental abnormalities. Reliable and easy-to-work-with clones of ZIKV expressing heterologous genes will significantly facilitate studies aimed at understanding the virus pathogenesis and tissue tropism. Here, we developed and characterized two novel approaches for expression of heterologous genes of interest in the context of full-length ZIKV genome and compared them to two previously published strategies for ZIKV-mediated gene expression. We demonstrated that among the four tested viruses expressing nLuc gene, the virus constructed using a newly developed approach of partial capsid gene duplication (PCGD) attained the highest titer in Vero cells and resulted in the highest level of nLuc expression. Suitability of the PCGD approach for expression of different genes of interest was validated by replacing nLuc sequence with that of eGFP gene. The generated constructs were further characterized in cell culture. Potential applications of ZIKV clones stably expressing heterologous genes include development of detection assays, antivirals, therapeutics, live imaging systems, and vaccines.
C1 [Volkova, Evgeniya; Sippert, Emilia; Assis, Felipe; Rios, Maria] US FDA, Ctr Biol Evaluat & Res, Off Blood Res & Review, Silver Spring, MD 20993 USA.
   [Tsetsarkin, Konstantin A.; Liu, Guangping; Pletnev, Alexander G.] NIAID, Lab Infect Dis, NIH, Bethesda, MD 20892 USA.
RP Rios, M (corresponding author), US FDA, Ctr Biol Evaluat & Res, Off Blood Res & Review, Silver Spring, MD 20993 USA.; Pletnev, AG (corresponding author), NIAID, Lab Infect Dis, NIH, Bethesda, MD 20892 USA.
EM evgeniya.volkova@fda.hhs.gov; konstantin.tsetsarkin@nih.gov;
   emilia.sippert@fda.hhs.gov; felipe.assis@fda.hhs.gov;
   guangping.liu@nih.gov; maria.rios@fda.hhs.gov; apletnev@niaid.nih.gov
RI Sippert, Emilia Angela/B-3033-2013
OI Sippert, Emilia Angela/0000-0002-6341-3879; Volkova,
   Evgeniya/0000-0002-3564-3423
FU Division of Intramural Research Program of the National Institute of
   Allergy and Infectious Diseases, National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID); CBER/OBRR (U.S. FDA)United States Department of Health
   & Human Services; U.S. Department of EnergyUnited States Department of
   Energy (DOE); FDAUnited States Department of Health & Human Services
FX This research was supported by the Division of Intramural Research
   Program of the National Institute of Allergy and Infectious Diseases,
   National Institutes of Health and by intramural funds from CBER/OBRR
   (U.S. FDA). Postdoctoral fellows E.S. and F.A. were supported by
   appointments to the ORISE Research Fellowship Program at the Center for
   Biologics Evaluation and Research. The fellowship was administered by
   the Oak Ridge Institute for Science and Education through an interagency
   agreement between the U.S. Department of Energy and the FDA.
CR Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Frese M, 2014, J VIROL, V88, P2056, DOI 10.1128/JVI.03051-13
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Grabowski JM, 2017, MBIO, V8, DOI [10.1128/mBio.01255-17, 10.1128/mbio.01255-17]
   Groat-Carmona AM, 2012, VIROLOGY, V432, P511, DOI 10.1016/j.virol.2012.06.028
   Huang H V, 1989, Virus Genes, V3, P85, DOI 10.1007/BF00301989
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.3290
   Knipe D., 2007, FLAVIVIRIDAE VIRUSES
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Li XF, 2017, THERANOSTICS, V7, P912, DOI 10.7150/thno.16615
   Li YF, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050127
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lundstrom K, 2009, VIRUSES-BASEL, V1, P13, DOI 10.3390/v1010013
   McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   Mortimer CL, 2015, CURR OPIN BIOTECH, V32, P85, DOI 10.1016/j.copbio.2014.11.009
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Reid S, 2018, NEUROL CLIN, V36, P767, DOI 10.1016/j.ncl.2018.06.003
   Sambrook J., 1989, MOL CLONING LAB MANU
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shustov AV, 2007, J VIROL, V81, P11737, DOI 10.1128/JVI.01112-07
   Smith SM, 1997, J VIROL, V71, P9713, DOI 10.1128/JVI.71.12.9713-9721.1997
   Tamura T, 2018, J VIROL, V92, DOI 10.1128/JVI.01582-17
   Tsetsarkin KA, 2019, MBIO, V10, DOI [10.1128/mBio.02904-18, 10.1128/mbio.02904-18]
   Tsetsarkin KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07782-x
   Tsetsarkin KA, 2017, MBIO, V8, DOI [10.1128/mBio.02326-16, 10.1128/mbio.02326-16]
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Tsetsarkin KA, 2016, NUCLEIC ACIDS RES, V44, P3330, DOI 10.1093/nar/gkw061
   Tuplin A, 2011, NUCLEIC ACIDS RES, V39, P7034, DOI 10.1093/nar/gkr237
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 39
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2020
VL 12
IS 1
AR 61
DI 10.3390/v12010061
PG 17
WC Virology
SC Virology
GA KP0JM
UT WOS:000515930700035
PM 31947825
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tonnerre, P
   Melgaco, JG
   Torres-Cornejo, A
   Pinto, MA
   Yue, C
   Blumel, J
   de Sousa, PSF
   de Mello, VD
   Moran, J
   de Filippis, AMB
   Wolski, D
   Grifoni, A
   Sette, A
   Barouch, DH
   Hoogeveen, RC
   Baylis, SA
   Lauer, GM
   Lewis-Ximenez, LL
AF Tonnerre, Pierre
   Melgaco, Juliana G.
   Torres-Cornejo, Almudena
   Pinto, Marcelo A.
   Yue, Constanze
   Bluemel, Johannes
   Fonseca de Sousa, Paulo Sergio
   de Mello, Vinicius da Motta
   Moran, Julio
   Bispo de Filippis, Ana M.
   Wolski, David
   Grifoni, Alba
   Sette, Alessandro
   Barouch, Dan H.
   Hoogeveen, Ruben C.
   Baylis, Sally A.
   Lauer, Georg M.
   Lewis-Ximenez, Lia L.
TI Evolution of the innate and adaptive immune response in women with acute
   Zika virus infection
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; T-CELL RESPONSES; CROSS-REACTIVITY;
   DENGUE VIRUS; TRANSMISSION; RHESUS; MONOCYTES; TARGET; BRAZIL
AB Zika virus (ZIKV) is a flavivirus that is closely related to other human pathogens, such as dengue virus (DENV)(1). Primary transmission usually involves Aedes aegypti, which has expanded its distribution range considerably(2), although rarer infection routes, including mother-to-fetus transmission, sexual contact and blood transfusion, have also been observed(3-7). Primary ZIKV infection is usually asymptomatic or mild in adults, with quickly resolved blood viraemia, but ZIKV might persist for months in saliva, urine, semen, breast milk and the central nervous system(8-12). During a recent ZIKV outbreak in South America, substantial numbers of neurological complications, such as Guillain-Barre syndrome, were reported(13,14) together with cases of microcephaly and associated developmental problems in infants born to women infected with ZIKV during pregnancy(15-20), highlighting the clinical importance of this infection. Analyses of the human immune response to ZIKV are lacking(21-28), but the recent outbreak has provided an opportunity to assess ZIKV immunity using current immunological methods. Here, we comprehensively assess the acute innate and adaptive immune response to ZIKV infection in ten women who were recruited during early infection and followed through reconvalescence. We define a cascade of events that lead to immunological control of ZIKV, with previous exposure to DENV impacting some, but not all, mediators of antiviral immunity.
C1 [Tonnerre, Pierre; Melgaco, Juliana G.; Torres-Cornejo, Almudena; Wolski, David; Hoogeveen, Ruben C.; Lauer, Georg M.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.
   [Melgaco, Juliana G.; Pinto, Marcelo A.; Fonseca de Sousa, Paulo Sergio; de Mello, Vinicius da Motta; Bispo de Filippis, Ana M.; Lewis-Ximenez, Lia L.] Harvard Med Sch, Boston, MA 02115 USA.
   [Yue, Constanze; Bluemel, Johannes; Lewis-Ximenez, Lia L.] Fiocruz MS, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [Moran, Julio] Paul Ehrlich Inst, Div Virol, Langen, Germany.
   [Grifoni, Alba; Sette, Alessandro] Dr Julio Moran Labs, Zurich, Switzerland.
   [Sette, Alessandro] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA USA.
   [Barouch, Dan H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA.
   [Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Tonnerre, Pierre] Inst Pasteur, Biodivers & Epidemiol Bacterial Pathogens, Paris, France.
   [Melgaco, Juliana G.] Fiocruz MS, Immunobiol Technol Inst, Biomanguinhos, Rio De Janeiro, Brazil.
RP Lauer, GM (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Lewis-Ximenez, LL (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Lewis-Ximenez, LL (corresponding author), Fiocruz MS, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
EM glauer@mgh.harvard.edu; lialewis.fiocruz@gmail.com
RI Melgaco, Juliana/AAQ-6084-2020; Tonnerre, Pierre/AAA-1631-2020
OI Melgaco, Juliana/0000-0003-0087-6531; Tonnerre,
   Pierre/0000-0002-1719-9736; Mello, Vinicius/0000-0001-7705-5921
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U01 AI131314, U19
   AI066345, HHSN27220140045C, 1PO1AI106695-01A1, U19AI118626-01,
   75N9301900065]; EUEuropean Union (EU) [734584]; Conselho Nacional de
   Desenvolvimento TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [CNPq 470092/2014-9, 200099/2016-7];
   Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [Faperj E-26/202.930/2016]; 'Sicherheit von Blut(produkten) und
   Geweben hinsichtlich der Abwesenheit von Zikaviren' from the German
   Ministry of Health
FX We thank the patients as well as the physicians and medical staff of the
   Viral Hepatitis Clinic in Brazil who provided care to the patients; the
   Flavivirus Laboratory staff at FIOCRUZ as well as J. Quick and N. Loman
   from the University of Birmingham for their assistance in analysing
   patient samples for ZIKV; B. da Silva Baptista as well as the
   Massachusetts General Hospital HSCI CRM flow cytometry core facility
   members for their technical assistance. This work was supported in part
   by National Institutes of Health grants U01 AI131314 (to G.M.L. and
   L.L.L.-X.), U19 AI066345 (to G.M.L. and L.L.L.-X.), HHSN27220140045C (to
   A.S.), 1PO1AI106695-01A1 (to A.S.), U19AI118626-01 (to A.S.),
   75N9301900065 (to A.S.), the EU grant 734584 (to A.S.), Conselho
   Nacional de Desenvolvimento Tecnologico (CNPq 470092/2014-9;
   200099/2016-7), Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (Faperj E-26/202.930/2016) and 'Sicherheit von Blut(produkten)
   und Geweben hinsichtlich der Abwesenheit von Zikaviren' from the German
   Ministry of Health.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Carlin AF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0007053
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Crosby EJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003970
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kim J, 2018, IMMUNITY, V48, P161, DOI 10.1016/j.immuni.2017.11.025
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lannuzel A, 2019, NEUROLOGY, V92, pE2406, DOI 10.1212/WNL.0000000000007536
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tian Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00531
   Trosemeier J. H., 2016, GENOME ANNOUNC, V4, P00917
   Wang C, 2017, J IMMUNOL, V199, P3094, DOI 10.4049/jimmunol.1700671
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 54
TC 1
Z9 1
U1 4
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JAN
PY 2020
VL 5
IS 1
BP 76
EP +
DI 10.1038/s41564-019-0618-z
PG 18
WC Microbiology
SC Microbiology
GA KQ8GL
UT WOS:000517158800015
PM 31792427
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Zavattoni, M
   Rovida, F
   Percivalle, E
   Cassaniti, I
   Sarasini, A
   Arossa, A
   Tassis, B
   Bollani, L
   Lombardi, G
   Orcesi, S
   Baldanti, F
AF Zavattoni, Maurizio
   Rovida, Francesca
   Percivalle, Elena
   Cassaniti, Irene
   Sarasini, Antonella
   Arossa, Alessia
   Tassis, Beatrice
   Bollani, Lina
   Lombardi, Giuseppina
   Orcesi, Simona
   Baldanti, Fausto
TI Zika Virus Infection in Pregnancy: Advanced Diagnostic Approaches in
   Dengue-Naive and Dengue-Experienced Pregnant Women and Possible
   Implication for Cross-Reactivity and Cross-Protection
SO MICROORGANISMS
LA English
DT Article
DE Zika virus; congenital infection; flavivirus; cross-reactivity;
   cross-protection
ID ANTIBODY-DEPENDENT ENHANCEMENT; NEUTRALIZATION TEST; INTERIM GUIDANCE;
   RESPONSES; BRAZIL; INFORMATION; TRAVELERS; FETUSES; CD4(+); MEMORY
AB Zika virus (ZIKV) infection has been linked to congenital defects in fetuses and infants, as exemplified by the microcephaly epidemic in Brazil. Given the overlapping presence of Dengue virus (DENV) in the majority of ZIKV epidemic regions, advanced diagnostic approaches need to be evaluated to establish the role of pre-existing DENV immunity in ZIKV infection. From 2015 to 2017, five pregnant women with suspected ZIKV infection were investigated in Pavia, Italy. Among the five pregnant women, three were DENV-ZIKV immunologically cross-reactive, and two were DENV-naive. Advanced diagnosis included the following: (i) NS1 blockade-of-binding (BOB) ELISA assay for ZIKV specific antibodies and (ii) ELISpot assay for the quantification of effector memory T cells for DENV and ZIKV. These novel assays allowed to distinguish between related flavivirus infections. The three DENV-experienced mothers did not transmit ZIKV to the fetus, while the two DENV-naive mothers transmitted ZIKV to the fetus. Pre-existing immunity in DENV experienced mothers might play a role in cross-protection.
C1 [Zavattoni, Maurizio; Rovida, Francesca; Percivalle, Elena; Cassaniti, Irene; Sarasini, Antonella; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, I-27100 Pavia, Italy.
   [Arossa, Alessia] Fdn IRCCS Policlin San Matteo, Dept Obstet, I-27100 Pavia, Italy.
   [Arossa, Alessia] Fdn IRCCS Policlin San Matteo, Dept Gynecol, I-27100 Pavia, Italy.
   [Tassis, Beatrice] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Obstet & Gynecol Unit, I-20122 Milan, Italy.
   [Bollani, Lina; Lombardi, Giuseppina] Fdn IRCCS Policlin San Matteo, Neonatal Intens Care Unit, I-27100 Pavia, Italy.
   [Orcesi, Simona] IRCCS Mondino Fdn, Child Neurol & Psychiat Unit, I-27100 Pavia, Italy.
   [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Sect Microbiol, I-27100 Pavia, Italy.
RP Baldanti, F (corresponding author), Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, I-27100 Pavia, Italy.; Baldanti, F (corresponding author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Sect Microbiol, I-27100 Pavia, Italy.
EM m.zavattoni@smatteo.pv.it; f.rovida@smatteo.pv.it;
   e.percivalle@smatteo.pv.it; i.cassaniti@smatteo.pv.it;
   a.sarasini@smatteo.pv.it; alessia.arossa@yahoo.it;
   beatrice.tassis@tin.it; l.bollani@smatteo.pv.it;
   g.lombardi@smatteo.pv.it; simona.orcesi@mondino.it;
   fausto.baldanti@unipv.it
RI Cassaniti, Irene/Y-9946-2019; Percivalle, Elena/K-7994-2016
OI Cassaniti, Irene/0000-0002-3385-2088; Percivalle,
   Elena/0000-0002-3355-1410
FU Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca
   CorrenteMinistry of Health, Italy [80206]
FX The work was supported by Ministero della Salute, Fondazione IRCCS
   Policlinico San Matteo, Ricerca Corrente (grant no. 80206).
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Calarota SA, 2014, J CLIN VIROL, V61, P65, DOI 10.1016/j.jcv.2014.05.017
   Calarota SA, 2013, IMMUNOLOGY, V139, P533, DOI 10.1111/imm.12106
   Cassaniti I, 2020, VECTOR-BORNE ZOONOT, V20, P295, DOI 10.1089/vbz.2019.2515
   Cauchemez S, 2016, LANCET, V388, P338, DOI 10.1016/S0140-6736(16)31017-0
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, OV ZIK VIR TEST GUID
   Chanama S, 2004, J CLIN VIROL, V31, P185, DOI 10.1016/j.jcv.2004.03.005
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grubaugh ND, 2019, TRENDS MICROBIOL, V27, P381, DOI 10.1016/j.tim.2019.02.004
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Hay JA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006991
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pereira JP, 2019, CLIN INFECT DIS, V69, P713, DOI 10.1093/cid/ciz013
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
NR 48
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD JAN
PY 2020
VL 8
IS 1
AR 56
DI 10.3390/microorganisms8010056
PG 16
WC Microbiology
SC Microbiology
GA KN2DE
UT WOS:000514650700110
PM 31905661
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Golubeva, VA
   Nepomuceno, TC
   de Gregoriis, G
   Mesquita, RD
   Li, XL
   Dash, S
   Garcez, PP
   Suarez-Kurtz, G
   Izumi, V
   Koomen, J
   Carvalho, MA
   Monteiro, ANA
AF Golubeva, Volha A.
   Nepomuceno, Thales C.
   de Gregoriis, Giuliana
   Mesquita, Rafael D.
   Li, Xueli
   Dash, Sweta
   Garcez, Patricia P.
   Suarez-Kurtz, Guilherme
   Izumi, Victoria
   Koomen, John
   Carvalho, Marcelo A.
   Monteiro, Alvaro N. A.
TI Network of Interactions between ZIKA Virus Non-Structural Proteins and
   Human Host Proteins
SO CELLS
LA English
DT Article
DE ZIKV; protein-protein interaction; non-structural viral proteins;
   network
ID INTERACTION MAP; CENTROSOME; DENGUE; PIAS1; INHIBITOR; COMPLEXES;
   CYTOSCAPE; INFECTION; GENOME; STRAIN
AB The Zika virus (ZIKV) is a mosquito-borne Flavivirus and can be transmitted through an infected mosquito bite or through human-to-human interaction by sexual activity, blood transfusion, breastfeeding, or perinatal exposure. After the 2015-2016 outbreak in Brazil, a strong link between ZIKV infection and microcephaly emerged. ZIKV specifically targets human neural progenitor cells, suggesting that proteins encoded by ZIKV bind and inactivate host cell proteins, leading to microcephaly. Here, we present a systematic annotation of interactions between human proteins and the seven non-structural ZIKV proteins corresponding to a Brazilian isolate. The interaction network was generated by combining tandem-affinity purification followed by mass spectrometry with yeast two-hybrid screens. We identified 150 human proteins, involved in distinct biological processes, as interactors to ZIKV non-structural proteins. Our interacting network is composed of proteins that have been previously associated with microcephaly in human genetic disorders and/or animal models. Further, we show that the protein inhibitor of activated STAT1 (PIAS1) interacts with NS5 and modulates its stability. This study builds on previously published interacting networks of ZIKV and genes related to autosomal recessive primary microcephaly to generate a catalog of human cellular targets of ZIKV proteins implicated in processes related to microcephaly in humans. Collectively, these data can be used as a resource for future characterization of ZIKV infection biology and help create a basis for the discovery of drugs that may disrupt the interaction and reduce the health damage to the fetus.
C1 [Golubeva, Volha A.; Nepomuceno, Thales C.; Li, Xueli; Dash, Sweta; Monteiro, Alvaro N. A.] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA.
   [Nepomuceno, Thales C.; de Gregoriis, Giuliana; Suarez-Kurtz, Guilherme; Carvalho, Marcelo A.] Inst Nacl Canc, Div Pesquisa Clin, BR-20230130 Rio De Janeiro, Brazil.
   [Mesquita, Rafael D.] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, BR-21941909 Rio De Janeiro, Brazil.
   [Dash, Sweta] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA.
   [Garcez, Patricia P.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-20230130 Rio De Janeiro, Brazil.
   [Izumi, Victoria] H Lee Moffitt Canc Ctr & Res Inst, Prote & Metabol Core, Tampa, FL 33612 USA.
   [Koomen, John] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA.
   [Carvalho, Marcelo A.] Inst Fed Rio De Janeiro IFRJ, BR-20270021 Rio De Janeiro, Brazil.
RP Monteiro, ANA (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA.; Carvalho, MA (corresponding author), Inst Nacl Canc, Div Pesquisa Clin, BR-20230130 Rio De Janeiro, Brazil.; Carvalho, MA (corresponding author), Inst Fed Rio De Janeiro IFRJ, BR-20270021 Rio De Janeiro, Brazil.
EM golubeva.3@osu.edu; thales.cn@gmail.com; gregoriis@gmail.com;
   rdmesquita@iq.ufrj.br; xueli.li@moffitt.org; sweta.dash@moffitt.org;
   ppgarcez@gmail.com; Kurtz@inca.gov.br; victoria.izumi@moffitt.org;
   john.koomen@moffitt.org; marcelo.carvalho@ifrj.edu.br;
   alvaro.monteiro@moffitt.org
RI Suarez-Kurtz, Guilherme/J-6648-2012; Monteiro, Alvaro N. A./A-7566-2009;
   Nepomuceno, Thales/Y-8018-2019; Carvalho, Marcelo A/J-7144-2012; Garcez,
   Patricia/F-8026-2012
OI Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Monteiro, Alvaro N.
   A./0000-0002-8448-4801; Nepomuceno, Thales/0000-0002-1171-1030;
   Carvalho, Marcelo A/0000-0002-7053-0053; Garcez,
   Patricia/0000-0002-9107-1335
FU Florida Department of Health Zika Research Grant Initiative pilot award
   [7ZK29]; Proteomics and Metabolomics Core at the Moffitt Cancer Center
   through its NCI CCSG [P30-CA76292]; Moffitt's Center for Immunization
   and Infection Research in Cancer (CIIRC)
FX This work was supported by Florida Department of Health Zika Research
   Grant Initiative pilot award 7ZK29 and in part by the Proteomics and
   Metabolomics Core at the Moffitt Cancer Center through its NCI CCSG
   grant (P30-CA76292), and by Moffitt's Center for Immunization and
   Infection Research in Cancer (CIIRC). T.C.N. is a Fulbright Scholar.
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Barbelanne M, 2014, BIOMED RES INT, DOI 10.1155/2014/547986
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brown JR, 2016, J VIROL, V90, P5939, DOI 10.1128/JVI.00426-16
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Craig AT, 2017, B WORLD HEALTH ORGAN, V95, P69, DOI 10.2471/BLT.16.171892
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Eckhardt M, 2018, CANCER DISCOV, V8, P1474, DOI 10.1158/2159-8290.CD-17-1018
   Firat-Karalar EN, 2014, CURR BIOL, V24, P664, DOI 10.1016/j.cub.2014.01.067
   Freund A, 2014, CELL, V159, P1389, DOI 10.1016/j.cell.2014.10.059
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289
   Golemis E.A., 1994, CURRENT PROTOCOLS MO, P131411
   Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019
   Goodfellow FT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100550
   GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039
   Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   Jaeger AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007343
   Joukov V, 2014, MOL CELL, V55, P578, DOI 10.1016/j.molcel.2014.06.016
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuenzi BM, 2016, J PROTEOME RES, V15, P4747, DOI 10.1021/acs.jproteome.6b00660
   Lafarga M, 2017, RNA BIOL, V14, P712, DOI 10.1080/15476286.2016.1231360
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403
   Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13
   Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91
   Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Naveed M, 2018, GENET RES, V100, DOI 10.1017/S0016672318000046
   Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/NMETH.1938, 10.1038/nmeth.1938]
   Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rabellino A, 2012, CANCER RES, V72, P2275, DOI 10.1158/0008-5472.CAN-11-3159
   Rajagopala SV, 2012, METHODS, V58, P392, DOI 10.1016/j.ymeth.2012.07.015
   Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sprinzak E, 2003, J MOL BIOL, V327, P919, DOI 10.1016/S0022-2836(03)00239-0
   Su CI, 2016, J VIROL, V90, P4308, DOI 10.1128/JVI.00223-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Woods NT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002255
   Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684
   Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055
   Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j
NR 62
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JAN
PY 2020
VL 9
IS 1
AR 153
DI 10.3390/cells9010153
PG 18
WC Cell Biology
SC Cell Biology
GA KO2RZ
UT WOS:000515398200153
PM 31936331
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martinez-Rojas, PP
   Quiroz-Garcia, E
   Monroy-Martinez, V
   Agredano-Moreno, LT
   Jimenez-Garcia, LF
   Ruiz-Ordaz, BH
AF Pablo Martinez-Rojas, Pedro
   Quiroz-Garcia, Elizabeth
   Monroy-Martinez, Veronica
   Teresa Agredano-Moreno, Lourdes
   Felipe Jimenez-Garcia, Luis
   Ruiz-Ordaz, Blanca H.
TI Participation of Extracellular Vesicles from Zika-Virus-Infected
   Mosquito Cells in the Modification of Naive Cells' Behavior by Mediating
   Cell-to-Cell Transmission of Viral Elements
SO CELLS
LA English
DT Article
DE extracellular vesicles; Zika virus; cellular communication; C6; 36
   cells; human monocytes; endothelial vascular cells
ID RT-PCR; EPIDEMIOLOGY; PATHOGENESIS; EXOSOMES; PHOSPHATIDYLSERINE;
   COAGULATION; HISTORY
AB To date, no safe vaccine or antivirals for Zika virus (ZIKV) infection have been found. The pathogenesis of severe Zika, where host and viral factors participate, remains unclear. For the control of Zika, it is important to understand how ZIKV interacts with different host cells. Knowledge of the targeted cellular pathways which allow ZIKV to productively replicate and/or establish prolonged viral persistence contributes to novel vaccines and therapies. Monocytes and endothelial vascular cells are the main ZIKV targets. During the infection process, cells are capable of releasing extracellular vesicles (EVs). EVs are mediators of intercellular communication. We found that mosquito EVs released from ZIKV-infected (C6/36) cells carry viral RNA and ZIKV-E protein and are able to infect and activate naive mosquito and mammalian cells. ZIKV C6/36 EVs promote the differentiation of naive monocytes and induce a pro-inflammatory state with tumor necrosis factor-alpha (TNF-alpha) mRNA expression. ZIKV C6/36 EVs participate in endothelial vascular cell damage by inducing coagulation (TF) and inflammation (PAR-1) receptors at the endothelial surface of the cell membranes and promote a pro-inflammatory state with increased endothelial permeability. These data suggest that ZIKV C6/36 EVs may contribute to the pathogenesis of ZIKV infection in human hosts.
C1 [Pablo Martinez-Rojas, Pedro; Quiroz-Garcia, Elizabeth; Monroy-Martinez, Veronica; Ruiz-Ordaz, Blanca H.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Av Univ 3000,Ciudad Univ, Mexico City 04510, DF, Mexico.
   [Teresa Agredano-Moreno, Lourdes; Felipe Jimenez-Garcia, Luis] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Celular, Av Univ 3000,Ciudad Univ, Mexico City 04510, DF, Mexico.
RP Ruiz-Ordaz, BH (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Av Univ 3000,Ciudad Univ, Mexico City 04510, DF, Mexico.
EM pedropablo.martinezrojas@gmail.com; geliqg@gmail.com;
   vmonroy@iibiomedicas.unam.mx; agredano-moreno@ciencias.unam.mx;
   luisfelipe_jimenez@ciencias.unam.mx; bhro@unam.mx
OI Martinez-Rojas, Pedro Pablo/0000-0001-9560-1340
FU Consejo Nacional de Ciencia y Tecnologia (CONACYT), MexicoConsejo
   Nacional de Ciencia y Tecnologia (CONACyT); CONACYTConsejo Nacional de
   Ciencia y Tecnologia (CONACyT); PAPIIT-UNAM Program
FX Pedro Pablo Martinez-Rojas is a doctoral student from Programa de
   Doctorado en Ciencias Bioquimicas, Universidad Nacional Autonoma de
   Mexico (UNAM), and was supported by Consejo Nacional de Ciencia y
   Tecnologia (CONACYT), Mexico. Elizabeth Quiroz-Garcia is a doctoral
   student from Programa de Doctorado en Ciencias Biomedicas, UNAM and was
   supported by CONACYT. We thank the PAPIIT-UNAM Program for partially
   funding support. We also thank LabNalCit-UNAM (CONACYT) for the
   technical support in the acquisition of flow cytometry samples and
   Miguel Tapia Rodriguez, from Unidad de Microscopia, Instituto de
   Investigaciones Biomedicas UNAM, for his support in the use of the
   Olympus IX71 microscope.
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Anfasa F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00817
   Bello-Morales R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02572
   Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397
   Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309
   Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770
   Chavez ASO, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224212
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Cime-Castillo J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504187
   Cosset FL, 2014, J HEPATOL, V60, P674, DOI 10.1016/j.jhep.2013.10.015
   De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203
   Delatorre E, 2018, J GEN VIROL, V99, P913, DOI 10.1099/jgv.0.001080
   Dogrammatzis C, 2019, J VIROL, V93, DOI 10.1128/JVI.01850-18
   EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006
   Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Iraci N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020171
   Isermann B, 2017, J THROMB HAEMOST, V15, P1273, DOI 10.1111/jth.13721
   Jurado KA, 2017, NAT MICROBIOL, V2, P1460, DOI 10.1038/s41564-017-0049-7
   Kaminski VD, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02355
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Karkhah A, 2018, EUR J CLIN MICROBIOL, V37, P2035, DOI 10.1007/s10096-018-3354-z
   Kay JG, 2011, SENSORS-BASEL, V11, P1744, DOI 10.3390/s110201744
   Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Reyes-Ruiz JM, 2019, VIRUS RES, V266, P1, DOI 10.1016/j.virusres.2019.03.015
   Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x
   Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880
   Naranjo-Gomez JS, 2019, IMMUNOLOGY, V156, P147, DOI 10.1111/imm.13011
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Oksvold MP, 2015, METHODS MOL BIOL, V1218, P465, DOI 10.1007/978-1-4939-1538-5_27
   Patnaik BB, 2013, INT J MOL SCI, V14, P20744, DOI 10.3390/ijms141020744
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Quesenberry PJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0150-x
   Raab-Traub N, 2017, NAT REV MICROBIOL, V15, P559, DOI 10.1038/nrmicro.2017.60
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Schwab A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01132
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750
   van Dongen HM, 2016, MICROBIOL MOL BIOL R, V80, P369, DOI 10.1128/MMBR.00063-15
   Van Dyne EA, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy325
   van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125
   Vora A, 2018, P NATL ACAD SCI USA, V115, pE6604, DOI 10.1073/pnas.1720125115
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519
   World Health Organization (WHO), VECT BORN DIS
   Yoshikawa FSY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060611
   Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066
   Yang CF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003885
   Zhang L, 2019, EMERG MICROBES INFEC, V8, P232, DOI 10.1080/22221751.2018.1559707
   Zhou WS, 2019, EMERG MICROBES INFEC, V8, P307, DOI 10.1080/22221751.2019.1578188
   Zhou WS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006764
NR 68
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JAN
PY 2020
VL 9
IS 1
AR 123
DI 10.3390/cells9010123
PG 32
WC Cell Biology
SC Cell Biology
GA KO2RZ
UT WOS:000515398200123
PM 31947958
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yang, SNY
   Atkinson, SC
   Audsley, MD
   Heaton, SM
   Jans, DA
   Borg, NA
AF Yang, Sundy N. Y.
   Atkinson, Sarah C.
   Audsley, Michelle D.
   Heaton, Steven M.
   Jans, David A.
   Borg, Natalie A.
TI RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA
   Helicase DDX3X
SO CELLS
LA English
DT Article
DE DDX3X; DEAD-box helicase; RK-33; viral infection; small molecule
   inhibitor
ID HEPATITIS-C VIRUS; EXPANDED FAT NUCLEOSIDE; ANALOGS EXHIBIT POTENT;
   WEST-NILE VIRUS; REPLICATION; INHIBITOR; HIV-1; NUCLEOTIDE; EFFICIENT
AB Viral disease is one of the greatest burdens for human health worldwide, with an urgent need for efficacious antiviral strategies. While antiviral drugs are available, in many cases, they are prone to the development of drug resistance. A way to overcome drug resistance associated with common antiviral therapies is to develop antivirals targeting host cellular co-factors critical to viral replication, such as DEAD-box helicase 3 X-linked (DDX3X), which plays key roles in RNA metabolism and the antiviral response. Here, we use biochemical/biophysical approaches and infectious assays to show for the first time that the small molecule RK-33 has broad-spectrum antiviral action by inhibiting the enzymatic activities of DDX3X. Importantly, we show that RK-33 is efficacious at low micromolar concentrations in limiting infection by human parainfluenza virus type 3 (hPIV-3), respiratory syncytial virus (RSV), dengue virus (DENV), Zika virus (ZIKV) or West Nile virus (WNV)-for all of which, no Food and Drug Administration (FDA)-approved therapeutic is widely available. These findings establish for the first time that RK-33 is a broad-spectrum antiviral agent that blocks DDX3X's catalytic activities in vitro and limits viral replication in cells.
C1 [Yang, Sundy N. Y.; Jans, David A.] Monash Univ, Monash Biomed Discovery Inst, Nucl Signaling Lab, Clayton, Vic 3800, Australia.
   [Yang, Sundy N. Y.; Atkinson, Sarah C.; Audsley, Michelle D.; Heaton, Steven M.; Jans, David A.; Borg, Natalie A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.
   [Atkinson, Sarah C.; Audsley, Michelle D.; Heaton, Steven M.; Borg, Natalie A.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.
   [Atkinson, Sarah C.; Audsley, Michelle D.; Borg, Natalie A.] RMIT Univ, Sch Hlth & Biomed Sci, Chron Infect & Inflammatory Dis Res, Bundoora, Vic 3083, Australia.
RP Jans, DA (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Nucl Signaling Lab, Clayton, Vic 3800, Australia.; Jans, DA; Borg, NA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Borg, NA (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Borg, NA (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Chron Infect & Inflammatory Dis Res, Bundoora, Vic 3083, Australia.
EM sundyniyenyang@gmail.com; sarah.atkinson@monash.edu;
   michelle.audsley@monash.edu; steven.heaton@monash.edu;
   david.jans@monash.edu; natalie.borg@rmit.edu.au
RI Heaton, Steven/N-1676-2017
OI Heaton, Steven/0000-0003-3323-8691; Jans, David/0000-0001-5115-4745
FU BioCurate Pty Ltd.; Australian National Health and Medical Research
   Council (NHMRC)National Health and Medical Research Council of Australia
   [APP1157053]; Australian Research Council Discovery Early Career
   Research AwardAustralian Research Council [DE190100304]; NHMRC Senior
   Principal Research FellowshipNational Health and Medical Research
   Council of Australia [APP1103050]
FX We gratefully acknowledge financial support from BioCurate Pty Ltd. and
   the Australian National Health and Medical Research Council (NHMRC,
   APP1157053). S.C.A. is supported by an Australian Research Council
   Discovery Early Career Research Award (DE190100304) and D.A.J. by an
   NHMRC Senior Principal Research Fellowship (APP1103050).
CR Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094
   Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07
   Bajorek M, 2014, J VIROL, V88, P6380, DOI 10.1128/JVI.03856-13
   Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368
   Brai A, 2019, J MED CHEM, V62, P2333, DOI 10.1021/acs.jmedchem.8b01403
   Brai A, 2016, P NATL ACAD SCI USA, V113, P5388, DOI 10.1073/pnas.1522987113
   Caly L, 2017, BIOCHEM BIOPH RES CO, V483, P64, DOI 10.1016/j.bbrc.2017.01.005
   Chen HM, 1999, NUCLEOS NUCLEOT, V18, P331, DOI 10.1080/15257779908043079
   Epling LB, 2015, J MOL BIOL, V427, P1779, DOI 10.1016/j.jmb.2015.02.015
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050
   Irwin KK, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew014
   Ishaq M, 2008, MOL BIOTECHNOL, V39, P231, DOI 10.1007/s12033-008-9040-0
   Kim Jeong-Hoon, 2009, V521, P361, DOI [10.1007/978-1-60327-815-7_20, 10.1007/978-1-60327-817-5_20]
   Kondaskar A, 2011, ACS MED CHEM LETT, V2, P252, DOI 10.1021/ml100281b
   Kumar R, 2008, ORG LETT, V10, P4681, DOI 10.1021/ol8020176
   LAUE TM, 1992, ANAL ULTRACENTRIFUGA, P90, DOI DOI 10.1007/S00249-009-0425-1
   Li C, 2014, VIROLOGY, V449, P70, DOI 10.1016/j.virol.2013.11.008
   Mitsakos V, 2008, BIOORG MED CHEM LETT, V18, P842, DOI 10.1016/j.bmcl.2007.11.026
   Putnam AA, 2013, BBA-GENE REGUL MECH, V1829, P884, DOI 10.1016/j.bbagrm.2013.02.002
   Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Sharma D, 2017, J MOL BIOL, V429, P3730, DOI 10.1016/j.jmb.2017.10.008
   Song H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11083-2
   Sood RK, 2002, ANTIVIR RES, V53, P159, DOI 10.1016/S0166-3542(01)00204-2
   Soto-Rifo R, 2013, WIRES RNA, V4, P369, DOI 10.1002/wrna.1165
   Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s
   van Voss MRH, 2018, ONCOGENE, V37, P63, DOI 10.1038/onc.2017.308
   van Voss MRH, 2015, ONCOTARGET, V6, P28312, DOI 10.18632/oncotarget.4873
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Wilky BA, 2016, ONCOGENE, V35, P2574, DOI 10.1038/onc.2015.336
   Xie Min, 2016, Cancer Res, V76, P6340
   Yang SNY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030281
   Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m
   Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029
   Zhang N, 2003, J MED CHEM, V46, P4149, DOI 10.1021/jm030842j
   Zhang N, 2003, J MED CHEM, V46, P4776, DOI 10.1021/jm030277k
NR 38
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JAN
PY 2020
VL 9
IS 1
AR 170
DI 10.3390/cells9010170
PG 13
WC Cell Biology
SC Cell Biology
GA KO2RZ
UT WOS:000515398200170
PM 31936642
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Viveiros-Rosa, SG
   Regis, EG
   Santos, WC
AF Viveiros-Rosa, Sandro G.
   Regis, Eduardo G.
   Santos, Wilson C.
TI Vector competence of Culex mosquitoes (Diptera: Culicidae) in Zika virus
   transmission: an integrative review
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Review
DE Public health; Zika virus; mosquito vectors; Culex
ID AEDES-AEGYPTI; QUINQUEFASCIATUS; INFECTION; AMERICA; PIPIENS
AB Objective. To identify studies on the competence of Culex mosquitoes as vectors for the transmission of Zika virus (ZIKV) around the globe.
   Methods. We performed an integrative review to identify relevant articles on specific experiments to determine whether Culex mosquitoes are vectors for ZIKV. The sources we used for our research were the Brazilian Periodicos CAPES electronic portal (MEDLINE/PubMed, ScienceDirect Journals, Nature Publishing Group, SciELO, Springer Link, and 250 other databases) and gray literature.
   Results. We identified 344 studies, of which 36 were considered for this review. In 8 studies, infection in salivary glands of Culex quinquefasciatus, Culex restuans, Culex tarsals, and Culex coronator was detected. Cx. quinquefasciatus was the most studied among those confirmed as potential ZIKV vectors, and only strains of Asian lineages (THA/2014/SV0127-14; SZO1 (2016)) and American lineages (BRPE243 (2015); PRVABC59 (2015)) can infect the salivary glands of Culex mosquitoes. The tested African strains (MR766 and DAK AR 41525) were unable to infect salivary glands.
   Conclusions. There is still a lack of compelling evidence that indicates Culex spp. are a competent ZIKV vector, but they should remain a target for further monitoring studies, especially regarding ZIKV transmission to other species. Furthermore, studies should not be limited to studying whether their salivary glands are infected.
C1 [Viveiros-Rosa, Sandro G.; Santos, Wilson C.] Univ Fed Fluminense, Fac Farm, Programa Posgrad Ciencias Aplicadas Prod Saude, Niteroi, RJ, Brazil.
   [Regis, Eduardo G.] Inst Nacl Propriedade Ind, Div Biofarmacos, Rio De Janeiro, RJ, Brazil.
RP Viveiros-Rosa, SG (corresponding author), Univ Fed Fluminense, Fac Farm, Programa Posgrad Ciencias Aplicadas Prod Saude, Niteroi, RJ, Brazil.
EM sandrogvr@gmail.com
RI Santos, Wilson C./R-2595-2019
OI Santos, Wilson C./0000-0001-9971-094X
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Barnett HC, 1962, P 11 INT C ENT, P341
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dibernardo A, 2017, J AM MOSQUITO CONTR, V33, P276, DOI 10.2987/17-6664.1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2018, PEERJ, V6, DOI 10.7717/peerj.4324
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duchemin JB, 2017, VIROL J, V14, P1
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Foxi C, 2018, VET ITAL, V54, P243, DOI 10.12834/VetIt.1303.7208.2
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Fu SH, 2017, SCI CHINA LIFE SCI, V60, P1364, DOI 10.1007/s11427-017-9196-8
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Heitmann A, 2018, JOVE-J VIS EXP, DOI 10.3791/57980
   Hery L, 2019, EMERG MICROBES INFEC, V8, P699, DOI 10.1080/22221751.2019.1615849
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Ayres CFJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3461-4
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Khaklang S, 2014, J VECTOR ECOL, V39, P448, DOI 10.1111/jvec.12122
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Phumee A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41727-8
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2
   Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Tien WP, 2017, PARASITE VECTOR, V10, P1
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   World Health Organization, 2017, INF TRAV VIS ZIK INF
   Yee DA, 2018, MED VET ENTOMOL, V32, P255, DOI 10.1111/mve.12289
NR 53
TC 0
Z9 0
U1 2
U2 2
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2020
VL 44
AR e7
DI 10.26633/RPSP.2020.7
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KO2QT
UT WOS:000515395000001
PM 32025230
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU CastilhoS, W
   Almeida, C
AF CastilhoS, Washington
   Almeida, Carla
TI Discourses on abortion amid the Zika epidemic: analysis of the coverage
   by newspapers O Globo and Folha de S.Paulo
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Abortion; Zika Virus; Microcephaly; Address; Press
AB The objective of this study was to analyze the national press coverage of abortion in cases of Zika infection and examine whether it reinforced discourses already associated with the practice or broadened and qualified the discussion of the subject. It is a qualitative study based on the analysis of 43 news stories on Zika/microcephaly/abortion published in the newspapers O Globo and Folha de S.Paulo between November 2015 and December 2016. Based on concepts from Journalism and Discourse Analysis, we identified the sources present in the coverage and analyzed the arguments they used in order to justify their positions, in addition to the strategies, types of knowledge and values they mobilized in the argumentation. We found that both newspapers privileged specialized sources - physicians in Folha de S.Paulo and lawyers and legal scholars in O Globo - and silenced the voices of women directly affected by the epidemic. As for the argumentation, sources that were favorable to the right to have an abortion in cases of Zika infection mainly denounced social injustices, while those who oppose it used a defense-of-life discourse. We observed the predominance of knowledge derived from beliefs and moral values in the discursive arena we analyzed, which was further marked by analogies loaded with negative meaning on both sides of the debate. Comparing our data with those from other studies on abortion in the media, we consider that the media coverage of Zika/microcephaly/abortion played a relevant role in reconfiguring the media discourse on the subject, characterized by a more technical focus, by a plurality of voices and positions and by a greater attention afforded to favorable arguments based on constitutional principles.
C1 [CastilhoS, Washington; Almeida, Carla] Fundacao Oswaldo Cruz, Casa Oswaldo Cruz, Rio De Janeiro, Brazil.
   [CastilhoS, Washington] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
RP CastilhoS, W (corresponding author), Rua Dona Cara 15,Apto 101, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM wcastilhos@gmail.com
OI da Silva Almeida, Carla/0000-0003-3139-0331
CR Almeida C, 2013, HIST CIENC SAUDE-MAN, V20, P1203, DOI 10.1590/S0104-59702013000400007
   [Anonymous], 2015, IDENTIFICADO VIRUS C
   [Anonymous], 2016, FOLHA DE S PAULO
   Baima C., 2016, GLOBO
   BRASIL. Ministerio da Saude, 2015, DIARIO OFICIAL UNIAO
   Charaudeau P., 2016, REV VIRTUAL ESTUDOS, V14, P8
   Charaudeau Patrick, 2010, DISCURSO DAS MIDIAS
   CHARAUDEAU Patrick, 2008, LINGUAGEM E DISCURSO
   Collucci C., 2016, FOLHA DE S PAULO
   Colluci C., 2016, FOLHA DE S PAULO
   Diniz Debora, 2008, Rev. Estud. Fem., V16, P647, DOI 10.1590/S0104-026X2008000200019
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   Alessio RLD, 2008, PSICOL-REFLEX CRIT, V21, P455, DOI 10.1590/S0102-79722008000300014
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grillo M, 2016, GLOBO
   Lage N., 2003, REPORTAGEM TEORIA TE
   LEITE ER, 2012, REV BRASILEIRA CIENC, P83, DOI DOI 10.1007/978-1-4614-1308-0_6
   Maisonnave F., 2016, FOLHA DE S PAULO
   Mariz R., 2016, GLOBO
   Mascarenhas G., 2016, FOLHA DE S PAULO
   ORLANDI EP, 2009, ANALISE DISCURSO PRI
   Pazello M, 2002, OLHAR MIDIA, P147
   Pecheux Michel, 1975, VERITES PALICE
   Rocha Maria Isabel Baltar da, 2006, Rev. bras. estud. popul., V23, P369, DOI 10.1590/S0102-30982006000200011
   Senra R., 2016, FOLHA DE S PAULO
   Souto L., 2016, GLOBO
   Souza A., 2016, GLOBO
   Tuchman G., 1978, MAKING NEWS STUDY CO
NR 28
TC 0
Z9 0
U1 2
U2 2
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2020
VL 36
SU 1
AR e00190518
DI 10.1590/0102-311X00190518
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KM4XI
UT WOS:000514134300010
PM 32049123
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Liew, CH
AF Liew, Chee H.
TI The first case of sexual transmission of dengue in Spain
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Editorial Material
DE semen; non-vector transmission; male to male transmission; flaviviruses;
   Zika; persistence
C1 [Liew, Chee H.] Natl Univ Ireland Galway, Sch Med, Galway, Ireland.
   [Liew, Chee H.] Trinity Coll Dublin, Sch Med, Dublin, Ireland.
   [Liew, Chee H.] Natl Inst Prevent & Cardiovasc Hlth, Galway, Ireland.
RP Liew, CH (corresponding author), Natl Univ Ireland Galway, Sch Med, Galway, Ireland.; Liew, CH (corresponding author), Trinity Coll Dublin, Sch Med, Dublin, Ireland.; Liew, CH (corresponding author), Natl Inst Prevent & Cardiovasc Hlth, Galway, Ireland.
EM cliew@tcd.ie
OI Liew, Chee Hwui/0000-0002-4287-019X
CR European Centre for Disease Prevention and Control, 2019, COMM DIS THREATS REP
   Lee C, 2019, INFECT DIS-NOR, V51, P150, DOI 10.1080/23744235.2018.1521004
   Molton JS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay023
   Redondo-Bravo L, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz072
   Wilder-Smith A, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay157
NR 5
TC 0
Z9 0
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD JAN
PY 2020
VL 27
IS 1
AR taz087
DI 10.1093/jtm/taz087
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA KN8UD
UT WOS:000515119600009
PM 31776571
DA 2020-07-08
ER

PT J
AU Monteiro, FJC
   Mourao, FRP
   Ribeiro, ESD
   Rego, MOD
   Frances, PAD
   Souto, RNP
   Facanha, MD
   Tahmasebi, R
   da Costa, AC
AF Costa Monteiro, Fred Julio
   Paixao Mourao, Fabio Rodrigo
   D'Athaide Ribeiro, Edicelha Soares
   da Silva Rego, Marlisson Octavio
   da Costa Frances, Pablo Abdon
   Picanco Souto, Raimundo Nonato
   Facanha, Marlucia dos Santos
   Tahmasebi, Roozbeh
   da Costa, Antonio Charlys
TI Prevalence of dengue, Zika and chikungunya viruses in Aedes (Stegomyia)
   aegypti (Diptera: Culicidae) in a medium-sized city, Amazon, Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Arboviruses; Chikungunya; Dengue; Entomology; Infectivity; Infestation;
   Prevention; Surveillance in public health; Zika
ID MOSQUITOS; PCR
AB Aedes aegypti is associated with epidemic diseases in Brazil. such as urban yellow fever, dengue. and more recently, chikungunya and Zika viruses infections. More information about Ae. aegypti infestation is fundamental to virological surveillance in order to ensure the effectiveness of control measures in use. Thus, the present study aims to identify and compare infestation and infectivity of Ae. aegypti females in Macapa city, Amapa State (Amazon region), Brazil, between the epidemiological weeks 2017/02 and 2018/20. A total number of 303 Ae. aegypti females were collected at 21 fixed collection points, 171 at the 10 collection points in the Marabaixo neighborhood and 132 at the 11 collection points in the Central neighborhood. Among the collected samples. only two were positive for dengue virus, with a 2.08% (2/96 pools) infectivity rate for Marabaixo. The difference between the medians of Ae. aegypti females captured in Central and Marabaixo sites was not statistically significant. The findings indicate similar mosquito infestation levels between the neighborhoods, and a low-level of mosquito infectivity, although dengue virus was found only in Marabaixo. Virological surveillance of Ae. aegypti was important to identify sites of infection and determine possible routes of transmission to enable health surveillance teams to adopt preventive strategies where infected mosquitoes are present and act faster.
C1 [Costa Monteiro, Fred Julio; Paixao Mourao, Fabio Rodrigo; Facanha, Marlucia dos Santos] Superintendencia Vigilancia Saude Amapa, Lab Vetores, Rua Tancredo Neves 1118, BR-68908530 Macapa, Amapa, Brazil.
   [D'Athaide Ribeiro, Edicelha Soares; da Silva Rego, Marlisson Octavio] Superintendencia Vigilancia Saude Amapa, Lab Virol, Macapa, Amapa, Brazil.
   [da Costa Frances, Pablo Abdon] Policia Tecn Cient Amapa, Dept Labs Forenses, Macapa, Amapa, Brazil.
   [Picanco Souto, Raimundo Nonato] Univ Fed Amapa, Lab Arthropoda, Macapa, Amapa, Brazil.
   [Tahmasebi, Roozbeh] Univ Sao Paulo, Programa Posgrad Engn Eletr, Escola Politecn, Sao Paulo, SP, Brazil.
   [da Costa, Antonio Charlys] Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Virol, Sao Paulo, SP, Brazil.
RP Monteiro, FJC (corresponding author), Superintendencia Vigilancia Saude Amapa, Lab Vetores, Rua Tancredo Neves 1118, BR-68908530 Macapa, Amapa, Brazil.
EM fredjulio@gmail.com
OI FACANHA, MARLUCIA DOS SANTOS/0000-0003-0264-059X; Julio Costa Monteiro,
   Fred/0000-0002-1989-7810; Souto, Raimundo/0000-0002-8795-1217
FU FAPEAP (Fundacao de Amparo a Pesquisa do Estado do Amapa); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico),
   PPSUSNational Council for Scientific and Technological Development
   (CNPq) [250.203.0333/2016]
FX This research was funding by FAPEAP (Fundacao de Amparo a Pesquisa do
   Estado do Amapa) and CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico), PPSUS No 250.203.0333/2016.
CR Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Ayres M, 2007, BIOESTAT APLICACOES
   Azevedo Filho WS, 2005, TECNICAS COLETA IDEN
   Baak-Baak CM, 2019, REV INST MED TROP SP, V61, DOI [10.1590/S1678-9946201961009, 10.1590/s1678-9946201961009]
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2013, LEV RAP IND AED AEGP
   Brasil. Ministerio da Saude. Secretaria de Vigiliancia em Saude. Departamento de Vigilancia Epidemiologica, 2009, DIR NAC PREV CONTR E
   Chen LH, 2019, CLIN INFECT DIS, V68, P1761, DOI 10.1093/cid/ciy777
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Costa Monteiro Fred Julio, 2014, EntomoBrasilis, V7, P188, DOI 10.12741/ebrasilis.v7i3.419
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   CRUZ LCT, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   Cunha AC, 2010, TEMPO CLIMA RECURSOS
   Eiras AE, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2883-8
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Instituto Brasileiro de Geografia e Estatistica, IBGE DIVUL EST POP M
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Michlmayr D, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177862
   NATAL D, 1984, REV SAUDE PUBL, V18, P418, DOI 10.1590/S0034-89101984000500013
   Natal Delsio, 2002, Biologico (Sao Paulo), V64, P205
   Pena-Garcia V. H., 2016, INT J ENV RES PUB HE, V13, P1
   Perez Rodriguez AE, 2018, REV PANAM ENF INF, V1, P33
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Perez-Perez J, 2017, BIOMEDICA, V37, DOI [10.7705/biomedica.v37i0.3467, 10.7705/biomedica.v34i2.3467]
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
NR 32
TC 0
Z9 0
U1 1
U2 1
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2020
VL 62
AR e10
DI 10.1590/S1678-9946202062010
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA KM5AJ
UT WOS:000514146500007
PM 32049261
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cabrera, CVP
   Selvaraj, JJ
AF Portilla Cabrera, Cristiam Victoriano
   Josephraj Selvaraj, John
TI Geographic shifts in the bioclimatic suitability for Aedes aegypti under
   climate change scenarios in Colombia
SO HELIYON
LA English
DT Article
DE Mathematical modeling; Climate change; Viral vector; Public health;
   Environmental change; Aedes aegypti; Environmental suitability;
   Geographical distribution; MaxEnt; Colombia
ID SPECIES DISTRIBUTIONS; DISEASE VECTORS; SAMPLING BIAS; MODELS; DENGUE;
   MAXENT; PREDICTION; IMPACTS; TEMPERATURE; PERFORMANCE
AB The Dengue, Chikungunya and Zika viruses are arboviruses predominantly transmitted to humans through the bite of the female mosquito Aedes aegypti. Currently, the vector represents a potential epidemiological risk in several Latin American and Pacific countries. However, little is known about the geographical distribution and bioclimatic suitability of this mosquito in the projected climate change scenarios in Colombia. Using a species distribution model of maximum entropy (MaxEnt) based on presence-only records obtained from Global Biodiversity Information Facility (GBIF), land elevation obtained from Shuttle Radar Topography Mission (SRTM) and bioclimatic variables (WorldClim), we produced environmental suitability maps of this mosquito vector for present and future geographic distribution. The future distribution were constructed based on the Community Climate System Model (CCSM4) for the years 2050 and 2070, projected according to the Representative Concentration Pathways (RCP) 2.6, 4.5 and 8.5 described by the Intergovernmental Panel on Climate Change (IPCC). For the current conditions, Colombia has similar to 140,612.8 square km of areas with the possible presence of the vector; however, for the future, this will be reduced by more than 30%. For the future conditions, the suitable areas for A. aegypti decreased compared to the present, mainly for the year 2070 under RCP scenarios 4.5 and 8.5, however, the probability of mosquito occurrence increases in some departments of Colombia. Areas susceptible to the presence of A. aegypti are affected by climate change. The Caribbean and Andean regions have a high probability of mosquito distribution; therefore, control and epidemiological surveillance are required in these areas. The results can serve as an input to define preventive and control measures, especially in areas with a higher risk of contracting the virus.
C1 [Portilla Cabrera, Cristiam Victoriano; Josephraj Selvaraj, John] Univ Nacl Colombia, Fac Engn & Adm, Dept Engn, Palmira Campus,Cra 32 12-00, Palmira 763533, Colombia.
RP Selvaraj, JJ (corresponding author), Univ Nacl Colombia, Fac Engn & Adm, Dept Engn, Palmira Campus,Cra 32 12-00, Palmira 763533, Colombia.
EM jojselvaraj@unal.edu.co
OI Portilla Cabrera, Cristiam Victoriano/0000-0003-4346-3972
CR Alaniz AJ, 2017, INT J EPIDEMIOL, V46, P966, DOI 10.1093/ije/dyw366
   Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264
   Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011
   Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x
   Andriamifidy RF, 2019, EMERG TOP LIFE SCI, V3, P115, DOI 10.1042/ETLS20180125
   Attaway DF, 2016, ACTA TROP, V158, P248, DOI 10.1016/j.actatropica.2016.02.018
   Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x
   Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011
   Beckham JL, 2017, PEERJ, V5, DOI 10.7717/peerj.3612
   Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012
   Brown JL, 2017, PEERJ, V5, DOI 10.7717/peerj.4095
   Brown JL, 2015, ECOL EVOL, V5, P1131, DOI 10.1002/ece3.1418
   Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200
   Cardoso-Leite R, 2014, T ROY SOC TROP MED H, V108, P99, DOI 10.1093/trstmh/trt115
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Castrillon JC, 2015, REV CHIL INFECTOL, V32, P142, DOI 10.4067/S0716-10182015000300002
   Danis-Lozano R., 2015, PHILOS T R SOC BIOL, V370, P20140135
   Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Escobar LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep39150
   Fatima SH, 2016, TROP MED INT HEALTH, V21, P427, DOI 10.1111/tmi.12664
   Feilhauer H, 2012, REMOTE SENS-BASEL, V4, P2057, DOI 10.3390/rs4072057
   Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   GILLIES M. T., 1953, EAST AFRICAN MED JOUR, V30, P129
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Goberville E, 2015, ECOL EVOL, V5, P1100, DOI 10.1002/ece3.1411
   Gomes VHF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18927-1
   Grillet ME, 2010, AM J TROP MED HYG, V82, P194, DOI 10.4269/ajtmh.2010.09-0040
   Haines A, 2006, PUBLIC HEALTH, V120, P585, DOI 10.1016/j.puhe.2006.01.002
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1
   Hosmer D.W., 2000, WILEY SER PROBAB SAT
   IDEAM, 2005, ATL CLIM NAC
   Instituto Nacional de la salud, 2018, VIG RUT
   Kantor I.N., 2016, MEDICINA B AIRES, P1
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kouri Gustavo, 2007, Rev Cubana Med Trop, V59, P177
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Ministerio de Asuntos Exteriores y de Cooperacion, 2017, REP COL
   Nelson M.J., 1986, AEDES AEGYPTI BIOL E
   Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205
   Osborne PE, 2002, ECOL MODEL, V157, P249, DOI 10.1016/S0304-3800(02)00198-9
   Pachauri R.K., 2014, CONTRIBUCI GRUPOS TR
   Palomino-Lemus Reiner, 2015, Revista Biodiversidad Neotropical, V5, P16
   PEARSON R G, 2010, LESSONS CONSERVATION, V3, P54, DOI DOI 10.1016/S0140-6736(10)61462-6
   Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x
   Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x
   Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004
   Phillips S., 2010, AM MUSEUM NAT HIST
   Phillips S.J., 2016, SAMPLE SELECTION BIA, V19, P181
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x
   Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227
   Rodriguez A., 2012, IDEAM METEO, V34
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Samy A.M., 2016, PLOS ONE, V11
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   SHAH FT, 2016, ELIFE, V5, P1
   Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018
   Suarez M. F., 1981, Biomedica, V1, P225
   Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Tognelli MF, 2009, REV CHIL HIST NAT, V82, P347, DOI 10.4067/S0716-078X2009000300003
   VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010
   Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   Wilby RL, 2010, WEATHER, V65, P180, DOI 10.1002/wea.543
   Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x
   Wiwanitkit Viroj, 2006, Journal of Vector Borne Diseases, V43, P73
   Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004
   Zeng YW, 2016, ECOL MODEL, V341, P5, DOI 10.1016/j.ecolmodel.2016.09.019
NR 79
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD JAN
PY 2020
VL 6
IS 1
AR e03101
DI 10.1016/j.heliyon.2019.e03101
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KH1BC
UT WOS:000510380200063
PM 31909268
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kabir, MA
   Zilouchian, H
   Sher, M
   Asghar, W
AF Kabir, Md Alamgir
   Zilouchian, Hussein
   Sher, Mazhar
   Asghar, Waseem
TI Development of a Flow-Free Automated Colorimetric Detection Assay
   Integrated with Smartphone for Zika NS1
SO DIAGNOSTICS
LA English
DT Article
DE Zika NS1; point of care; colorimetric; smartphone; microfluidic
ID SENSITIVE DETECTION; VIRUS; DIAGNOSIS; DENGUE; IMMUNOASSAY; PLATFORM;
   ANTIGEN
AB The Zika virus (ZIKV) is an emerging flavivirus transmitted to humans by Aedes mosquitoes that can potentially cause microcephaly, Guillain-Barre Syndrome, and other birth defects. Effective vaccines for Zika have not yet been developed. There is a necessity to establish an easily deployable, high-throughput, low-cost, and disposable point-of-care (POC) diagnostic platform for ZIKV infections. We report here an automated magnetic actuation platform suitable for a POC microfluidic sandwich enzyme-linked immunosorbent assay (ELISA) using antibody-coated superparamagnetic beads. The smartphone integrated immunoassay is developed for colorimetric detection of ZIKV nonstructural protein 1 (NS1) antigen using disposable chips to accommodate the reactions inside the chip in microliter volumes. An in-house-built magnetic actuator platform automatically moves the magnetic beads through different aqueous phases. The assay requires a total of 9 min to automatically control the post-capture washing, horseradish peroxidase (HRP) conjugated secondary antibody probing, washing again, and, finally, color development. By measuring the saturation intensity of the developed color from the smartphone captured video, the presented assay provides high sensitivity with a detection limit of 62.5 ng/mL in whole plasma. These results advocate a great promise that the platform would be useful for the POC diagnosis of Zika virus infection in patients and can be used in resource-limited settings.
C1 [Kabir, Md Alamgir; Sher, Mazhar; Asghar, Waseem] Florida Atlantic Univ, Dept Comp & Elect Engn & Comp Sci, Boca Raton, FL 33431 USA.
   [Kabir, Md Alamgir; Zilouchian, Hussein; Sher, Mazhar; Asghar, Waseem] Coll Engn & Comp Sci, Asghar Lab, Micro & Nanotechnol Med, Boca Raton, FL 33431 USA.
   [Asghar, Waseem] Florida Atlantic Univ, Dept Biol Sci Courtesy Appointment, Boca Raton, FL 33431 USA.
RP Asghar, W (corresponding author), Florida Atlantic Univ, Dept Comp & Elect Engn & Comp Sci, Boca Raton, FL 33431 USA.; Asghar, W (corresponding author), Coll Engn & Comp Sci, Asghar Lab, Micro & Nanotechnol Med, Boca Raton, FL 33431 USA.; Asghar, W (corresponding author), Florida Atlantic Univ, Dept Biol Sci Courtesy Appointment, Boca Raton, FL 33431 USA.
EM mkabir2016@fau.edu; hzilouchi@gmail.com; msher2015@fau.edu;
   wasghar@fau.edu
RI Kabir, Alamgir/M-4273-2019
OI Kabir, Alamgir/0000-0002-1659-3125
FU National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R56AI138659];
   Florida Department of Health Zika grant [7ZK10]
FX This research was funded by National Institute of Health (NIH) grant
   number R15AI127214, and R56AI138659, and Florida Department of Health
   Zika grant 7ZK10. The APC was funded by National Institute of Health
   (NIH) grant number R56AI138659.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Asghar W, 2019, ACS OMEGA, V4, P7474, DOI 10.1021/acsomega.9b00499
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Chen YN, 2015, NANOSCALE, V7, P16381, DOI 10.1039/c5nr04987c
   Choi JR, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201600920
   Coarsey C, 2019, RSC ADV, V9, P8159, DOI [10.1039/c8ra07607c, 10.1039/C8RA07607C]
   Coleman B, 2019, ANALYST, V144, P1935, DOI 10.1039/c8an02521e
   Coleman B, 2019, SENSOR ACTUAT B-CHEM, V282, P225, DOI 10.1016/j.snb.2018.11.036
   Herrada CA, 2018, J MED DEVICES, V12, DOI 10.1115/1.4041086
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PAHO, CAS
   Peeling RW, 2006, NAT REV MICROBIOL, V4, P909, DOI 10.1038/nrmicro1555
   Rong Z, 2019, ANAL CHIM ACTA, V1055, P140, DOI 10.1016/j.aca.2018.12.043
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Sher M, 2019, BIOSENS BIOELECTRON, V142, DOI 10.1016/j.bios.2019.111490
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Song SQ, 2014, ANAL CHEM, V86, P4995, DOI 10.1021/ac500540z
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Theillet G, 2018, ARCH VIROL, V163, P1757, DOI 10.1007/s00705-018-3776-z
   Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09
   Wang SQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03796
   Wang SQ, 2011, LAB CHIP, V11, P3411, DOI 10.1039/c1lc20479c
   WHO, ZIK EP UPD
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   Zhang L, 2015, LANGMUIR, V31, P5537, DOI 10.1021/acs.langmuir.5b00592
   Zhang LD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110634
NR 30
TC 1
Z9 1
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD JAN
PY 2020
VL 10
IS 1
AR 42
DI 10.3390/diagnostics10010042
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA KL0NM
UT WOS:000513129500023
PM 31947549
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, L
   Wong, WY
   Yang, HT
   Huber, RG
   Bond, PJ
   Ng, LC
   Maurer-Stroh, S
   Hapuarachchi, HC
AF Tan, Li Kiang
   Wong, Wing Yan
   Yang, Hui Ting
   Huber, Roland G.
   Bond, Peter J.
   Ng, Lee Ching
   Maurer-Stroh, Sebastian
   Hapuarachchi, Hapuarachchige Chanditha
TI Flavivirus Cross-Reactivity to Dengue Nonstructural Protein 1 Antigen
   Detection Assays
SO DIAGNOSTICS
LA English
DT Article
DE flavivirus; diagnostics; nonstructural protein 1; cross-reactivity;
   false positives
ID ZIKA VIRUS; LABORATORY DIAGNOSIS; NS1; SPECIFICITY; ANTIBODIES; HISTORY;
   VIREMIA; PHASE
AB Dengue virus (DENV) and Zika virus (ZIKV) are flaviviruses of public health relevance. Both viruses circulate in the same endemic settings and acute infections generally manifest similar symptoms. This highlights the importance of accurate diagnosis for clinical management and outbreak control. One of the commonly used acute diagnostic markers for flaviviruses is nonstructural protein 1 (NS1). However, false positives due to antigenic cross-reactivity have been reported between DENV and ZIKV infections when using DENV NS1 antigen (NS1 Ag) detection assays in acute cases. Therefore, we investigated the lowest detectable virus titres and cross-reactivity of three commercial dengue NS1 Ag rapid assays and two ELISAs for different flaviviruses. Our results showed that substantially high viral titres of ZIKV, Kunjin virus (KUNV) and yellow fever virus (YFV) are required to give false-positive results when using DENV NS1 rapid detection assays. Commercial DENV NS1 ELISAs did not react with ZIKV and YFV. In comparison, tested assays detected DENV at a significantly low virus titre. Given the relatively low viral loads reported in clinical samples, our findings suggest that commercially available dengue NS1 Ag detection assays are less likely to generate false-positive results among clinical samples in areas where multiple flaviviruses cocirculate.
C1 [Tan, Li Kiang; Wong, Wing Yan; Yang, Hui Ting; Ng, Lee Ching; Hapuarachchi, Hapuarachchige Chanditha] Natl Environm Agcy, Environm Hlth Inst, Singapore 38667, Singapore.
   [Huber, Roland G.; Bond, Peter J.; Maurer-Stroh, Sebastian] Agcy Sci Technol & Res, Bioinformat Inst, Singapore 138671, Singapore.
   [Bond, Peter J.; Maurer-Stroh, Sebastian] Natl Univ Singapore, Dept Biol Sci, Singapore 117558, Singapore.
   [Ng, Lee Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.
RP Hapuarachchi, HC (corresponding author), Natl Environm Agcy, Environm Hlth Inst, Singapore 38667, Singapore.
EM Tan_li_kiang@nea.gov.sg; Wong_Wing_yan@nea.gov.sg;
   YANG_Huiting@nea.gov.sg; rghuber@bii.a-star.edu.sg;
   peterjb@bii.a-star.edu.sg; Ng_Lee_Ching@nea.gov.sg;
   sebastianms@bii.a-star.edu.sg; chanditha_hapuarachchi@nea.gov.sg
OI Maurer-Stroh, Sebastian/0000-0003-0813-9640; Bond,
   Peter/0000-0003-2900-098X; Hapuarachchi, Hapuarachchige
   Chanditha/0000-0001-7079-8538; Huber, Roland/0000-0001-5093-5988
FU National Environment Agency (NEA), Singapore; A*STAR HEIDI programme
   [H1699f0013]
FX This study was supported by the internal funds from the National
   Environment Agency (NEA), Singapore. S.M.-S. was partially supported by
   the A*STAR HEIDI programme (grant number: H1699f0013).
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Alcon-LePoder S, 2006, Novartis Found Symp, V277, P233, DOI 10.1002/0470058005.ch17
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Ding X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095307
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Grell L, 2006, BIOCHEM MOL BIOL EDU, V34, P402, DOI 10.1002/bmb.2006.494034062672
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kumar JS, 2011, J MED VIROL, V83, P1063, DOI 10.1002/jmv.22097
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lau SM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2091-y
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rocha LB, 2017, ANTIBODIES, V6, DOI 10.3390/antib6040014
   SCOTT MG, 1985, TRENDS BIOTECHNOL, V3, P170, DOI 10.1016/0167-7799(85)90117-9
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tan CH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010044
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Tan L.K., 2013, ADV INFECT DIS, V3, P9, DOI 10.4236/aid.2013.31001
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wee S, 2019, P NATL ACAD SCI USA, V116, P6754, DOI 10.1073/pnas.1817867116
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Zhang L, 2009, BIOINFORMATICS, V25, P650, DOI 10.1093/bioinformatics/btn663
NR 39
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD JAN
PY 2020
VL 10
IS 1
AR 11
DI 10.3390/diagnostics10010011
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA KL0NM
UT WOS:000513129500004
PM 31878299
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Williams, AE
   Franz, AWE
   Reid, WR
   Olson, KE
AF Williams, Adeline E.
   Franz, Alexander W. E.
   Reid, William R.
   Olson, Ken E.
TI Antiviral Effectors and Gene Drive Strategies for Mosquito Population
   Suppression or Replacement to Mitigate Arbovirus Transmission by Aedes
   aegypti
SO INSECTS
LA English
DT Review
DE Aedes aegypti; gene drive; arbovirus; population suppression; population
   replacement
ID YELLOW-FEVER MOSQUITO; RNA INTERFERENCE; TRANSPOSABLE ELEMENT; VECTOR
   COMPETENCE; WOLBACHIA STRAIN; DENGUE-2 VIRUS; TRANSFORMATION;
   ENDONUCLEASE; SYSTEMS; MUTAGENESIS
AB The mosquito vector Aedes aegypti transmits arthropod-borne viruses (arboviruses) of medical importance, including Zika, dengue, and yellow fever viruses. Controlling mosquito populations remains the method of choice to prevent disease transmission. Novel mosquito control strategies based on genetically manipulating mosquitoes are being developed as additional tools to combat arbovirus transmission. Genetic control of mosquitoes includes two basic strategies: population suppression and population replacement. The former aims to eliminate mosquito populations while the latter aims to replace wild populations with engineered, pathogen-resistant mosquitoes. In this review, we outline suppression strategies being applied in the field, as well as current antiviral effector genes that have been characterized and expressed in transgenic Ae. aegypti for population replacement. We discuss cutting-edge gene drive technologies that can be used to enhance the inheritance of effector genes, while highlighting the challenges and opportunities associated with gene drives. Finally, we present currently available models that can estimate mosquito release numbers and time to transgene fixation for several gene drive systems. Based on the recent advances in genetic engineering, we anticipate that antiviral transgenic Ae. aegypti exhibiting gene drive will soon emerge; however, close monitoring in simulated field conditions will be required to demonstrate the efficacy and utility of such transgenic mosquitoes.
C1 [Williams, Adeline E.; Olson, Ken E.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Franz, Alexander W. E.; Reid, William R.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
RP Olson, KE (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM adeline.williams@colostate.edu; franza@missouri.edu;
   reidwi@missouri.edu; kenneth.olson@colostate.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI130085-02]
FX This research was funded by the NIH, grant number R01 AI130085-02.
CR Adelman Z, 2017, NAT BIOTECHNOL, V35, P716, DOI 10.1038/nbt.3926
   Adelman ZN, 2017, PATHOG GLOB HEALTH, V111, P436, DOI 10.1080/20477724.2018.1424514
   Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2
   Akbari OS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03954
   Aryan A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01603
   Bargielowski I, 2012, VECTOR-BORNE ZOONOT, V12, P1053, DOI 10.1089/vbz.2012.0994
   Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699
   Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112
   Benedict MQ, 2018, VECTOR-BORNE ZOONOT, V18, P2, DOI 10.1089/vbz.2017.2121
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bier E, 2018, GENETICS, V208, P1, DOI 10.1534/genetics.117.1113
   Blair CD, 2019, CURR ISSUES MOL BIOL, V34, P13, DOI 10.21775/cimb.034.013
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Bosio CF, 2000, GENETICS, V156, P687
   Buchman A., 2019, SSRN ELECT J, DOI [10.2139/ssrn.3398490, DOI 10.2139/SSRN.3398490]
   Buchman A, 2019, P NATL ACAD SCI USA, V116, P3656, DOI 10.1073/pnas.1810771116
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Burt A., 2008, GENES CONFLICT BIOL
   Carter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139899
   CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7
   Cha SJ, 2006, AM J TROP MED HYG, V74, P62, DOI 10.4269/ajtmh.2006.74.62
   Champer J, 2018, P NATL ACAD SCI USA, V115, P5522, DOI 10.1073/pnas.1720354115
   Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748
   CRAIG GB, 1960, SCIENCE, V132, P1887, DOI 10.1126/science.132.3443.1887
   Criscione F, 2015, CURR OPIN INSECT SCI, V10, P90, DOI 10.1016/j.cois.2015.04.012
   Crow JF, 1999, SCIENCE, V283, P1651, DOI 10.1126/science.283.5408.1651
   Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3
   de Andrade PP, 2016, B WORLD HEALTH ORGAN, V94, P766, DOI 10.2471/BLT.16.173377
   Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037
   Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353
   Drury DW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601910
   Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001
   Ford SA, 2019, NAT MICROBIOL, V4, P1832, DOI 10.1038/s41564-019-0533-3
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gould F, 2008, EVOLUTION, V62, P500, DOI 10.1111/j.1558-5646.2007.00298.x
   Haller BC, 2019, MOL BIOL EVOL, V36, P632, DOI 10.1093/molbev/msy228
   Haller BC, 2017, MOL BIOL EVOL, V34, P230, DOI 10.1093/molbev/msw211
   Hammond AM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007039
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   HICKEY WA, 1966, GENETICS, V53, P1177
   Houe V, 2019, EMERG MICROBES INFEC, V8, P542, DOI 10.1080/22221751.2019.1599302
   JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8
   James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004
   Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5
   Konet DS, 2007, INSECT MOL BIOL, V16, P199, DOI 10.1111/j.1365-2583.2006.00714.x
   Lambrechts L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2437
   Li M, 2020, ELIFE, V9, DOI 10.7554/eLife.51701
   Li M, 2017, P NATL ACAD SCI USA, V114, pE10540, DOI 10.1073/pnas.1711538114
   Lilley DMJ, 2005, CURR OPIN STRUC BIOL, V15, P313, DOI 10.1016/j.sbi.2005.05.002
   Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525
   Luckhart S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000566
   Magalhaes T, 2019, INSECT BIOCHEM MOLEC, V111, DOI 10.1016/j.ibmb.2019.05.004
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   MEDHORA M, 1991, GENETICS, V128, P311
   MILLER BR, 1991, AM J TROP MED HYG, V45, P399, DOI 10.4269/ajtmh.1991.45.399
   Mishra P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060163
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Nawtaisong P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-73
   ONEILL SL, 2019, GATES OPEN RES, V2, P36, DOI DOI 10.12688/GATESOPENRES.12844.3
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Sanchez CHM, 2020, METHODS ECOL EVOL, V11, P229, DOI 10.1111/2041-210X.13318
   Sethuraman N, 2007, INSECT BIOCHEM MOLEC, V37, P941, DOI 10.1016/j.ibmb.2007.05.004
   Shin D, 2019, INSECTS, V10, DOI 10.3390/insects10010025
   Sicard M, 2019, CURR OPIN INSECT SCI, V34, P12, DOI 10.1016/j.cois.2019.02.005
   Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Tassetto M, 2019, ELIFE, V8, DOI 10.7554/eLife.41244
   Traver BE, 2009, INSECT MOL BIOL, V18, P623, DOI 10.1111/j.1365-2583.2009.00905.x
   Turley AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-36
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Ward CM, 2011, EVOLUTION, V65, P1149, DOI 10.1111/j.1558-5646.2010.01186.x
   WARREN WD, 1994, GENET RES, V64, P87, DOI 10.1017/S0016672300032699
   Werren JH, 2011, P NATL ACAD SCI USA, V108, P10863, DOI 10.1073/pnas.1102343108
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632
   Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937
   Yen PS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0011-5
NR 92
TC 0
Z9 0
U1 9
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4450
J9 INSECTS
JI Insects
PD JAN
PY 2020
VL 11
IS 1
AR 52
DI 10.3390/insects11010052
PG 18
WC Entomology
SC Entomology
GA KL0NT
UT WOS:000513130200019
PM 31940960
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alshehri, MA
   Aziz, A
   Trivedi, S
   Alanazi, NA
   Panneerselvam, C
   Baeshen, R
   Alatawi, A
AF Alshehri, Mohammed Ali
   Aziz, Al Thbiani
   Trivedi, Subrata
   Alanazi, Naimah A.
   Panneerselvam, Chellasamy
   Baeshen, Rowida
   Alatawi, Aishah
TI One-Step Synthesis of Ag Nanoparticles Using Aqueous Extracts from
   Sundarbans Mangroves Revealed High Toxicity on Major Mosquito Vectors
   and Microbial Pathogens
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Mosquito control; Antibacterial activity; Arbovirus; Heritiera fomes;
   Green synthesis
ID MEDIATED GREEN SYNTHESIS; SILVER NANOPARTICLES; AEDES-AEGYPTI; DENGUE
   VECTOR; CULEX-QUINQUEFASCIATUS; PREDATION EFFICIENCY; GOLD
   NANOPARTICLES; SONNERATIA-APETALA; HERITIERA-FOMES; PLANT-EXTRACT
AB Mosquitoes act as vectors for several deadly diseases that have devastating effect on millions of people throughout the world. Controlling the spread of these mosquito vectors is a challenging task. Here, we propose a mangrove-mediated production of AgNPs from cheap aqueous extracts of Heritiera fomes from the Sundarbans UNESCO World Heritage Site against mosquito vectors and bacterial pathogen. The bio-fabricated AgNPs were analyzed using UV-vis spectroscopy, Transmission electron microscopy, Fourier transform infrared spectroscopy, energy-dispersive X-ray spectroscopy, and X-ray diffraction. The fabricated Ag nanocomposites were crystalline and spherical shaped. Our experimental results indicated that minimal doses of H. fomes extract and H. fomes-AgNPs exhibited excellent toxicity against Anopheles stephensi as well as the Aedes aegypti with the LC50 of AgNPs ranging from 7.44 ppm (I instar) to 15.61 ppm (pupae) for A. stephensi and 8.39 ppm (I instar) to 17.66 ppm for A. aegypti. In antibacterial assays, then mangrove fabricated-AgNPs also highly inhibited the growth of B. subtilis, K. pneumoniae, and S. typhi in low doses. Overall, this study highlighted that H. fomes extracts and H. fomes-mediated Ag nanomaterials could be potentially applied for dengue, Zika and malaria vector control operations.
C1 [Alshehri, Mohammed Ali; Aziz, Al Thbiani; Trivedi, Subrata; Panneerselvam, Chellasamy; Baeshen, Rowida; Alatawi, Aishah] Univ Tabuk, Fac Sci, Biol Dept, Tabuk, Saudi Arabia.
   [Alanazi, Naimah A.] Univ Hail, Fac Sci, Biol Dept, Hail, Saudi Arabia.
RP Trivedi, S; Panneerselvam, C (corresponding author), Univ Tabuk, Fac Sci, Biol Dept, Tabuk, Saudi Arabia.
EM trivedi.subrata@gmail.com; cpselva@ymail.com
OI Panneerselvam, Chellasamy/0000-0003-3994-8141
CR Ali M, 2011, ADV NAT APPL SCI, V5, P116
   Ali M. S. Syed, 2013, J COASTAL LIFE MED, V1, P36
   Ali MS, 2015, INT J NANO DIMENS, V6, P197, DOI 10.7508/ijnd.2015.02.011
   Anila PA, 2017, J CLUST SCI, V28, P205
   Anon, 2000, REP IMPR PROJ PLANN
   Arjunan NK, 2012, VECTOR-BORNE ZOONOT, V12, P262, DOI 10.1089/vbz.2011.0661
   Balakrishnan S., 2014, J PARASIT DIS, V12, P233
   Balakrishnan Srinivasan, 2016, J Parasit Dis, V40, P991, DOI 10.1007/s12639-014-0621-5
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Bar H, 2009, COLLOID SURFACE A, V339, P134, DOI 10.1016/j.colsurfa.2009.02.008
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   Finney J, 1971, PROBIT ANAL, P68
   Ghosh A, 2012, LIVING CHANGING CLIM
   Gnanadesigan M, 2012, APPL NANOSCI, V2, P143, DOI 10.1007/s13204-011-0048-6
   Gnanadesigan M, 2011, ASIAN PAC J TROP MED, V4, P799, DOI 10.1016/S1995-7645(11)60197-1
   Govindaraju K, 2009, J NANOSCI NANOTECHNO, V9, P5497, DOI 10.1166/jnn.2009.1199
   Hossain M.A., 2013, J PORPHYR PHTHALOCYA, V2, P95
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Kalimuthu K, 2017, HYDROBIOLOGIA, V785, P359, DOI 10.1007/s10750-016-2943-z
   Kannan RRR, 2013, APPL NANOSCI, V3, P229, DOI 10.1007/s13204-012-0125-5
   Kathiraven T, 2015, APPL NANOSCI, V5, P499, DOI 10.1007/s13204-014-0341-2
   Kumar SA, 2007, BIOTECHNOL LETT, V29, P439, DOI 10.1007/s10529-006-9256-7
   Kumar SD, 2017, J CLUST SCI, V28, P359, DOI 10.1007/s10876-016-1100-1
   Kumar VA, 2017, J PHOTOCH PHOTOBIO B, V171, P1, DOI 10.1016/j.jphotobiol.2017.04.022
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Madhiyazhagan P, 2017, J APPL PHYCOL, V29, P649, DOI 10.1007/s10811-016-0953-x
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   MAHMOODI MR, 2014, IEEE INFORM TECHNOL, V2014, P1
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Malaikozhundan B, 2016, BIOCATAL AGR BIOTECH, V8, P189, DOI 10.1016/j.bcab.2016.09.007
   Mitra A, 2016, INDIAN J GEO-MAR SCI, V45, P1598
   Murugan K, 2017, J CLUST SCI, V28, P437, DOI 10.1007/s10876-016-1115-7
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P4087, DOI 10.1007/s00436-015-4638-1
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Nicoletti M, 2012, PARASITOL RES, V111, P205, DOI 10.1007/s00436-012-2819-8
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Panneerselvam C, 2013, PARASITOL RES, V112, P679, DOI 10.1007/s00436-012-3185-2
   Patel Vijay, 2015, Biotechnol Rep (Amst), V5, P112, DOI 10.1016/j.btre.2014.12.001
   Patil S., 2014, AM J ETHNOMED, V1, P174
   Patra JK, 2013, ORIENTAL PHARM EXP M, V13, P133, DOI 10.1007/s13596-013-0113-7
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Ramkumar Vijayan Sri, 2017, Biotechnol Rep (Amst), V14, P1, DOI 10.1016/j.btre.2017.02.001
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Sangeetha A., 2014, INT J PHARM SCI INVE, V3, P54
   Simlai Aritra, 2013, Pharmacogn Rev, V7, P170, DOI 10.4103/0973-7847.120518
   Singh M, 2008, DIG J NANOMATER BIOS, V3, P115
   Song JY, 2009, PROCESS BIOCHEM, V44, P1133, DOI 10.1016/j.procbio.2009.06.005
   Sujitha V, 2017, AQUAT TOXICOL, V188, P100, DOI 10.1016/j.aquatox.2017.04.015
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Suresh U, 2018, PHYSIOL MOL PLANT P, V101, P225, DOI 10.1016/j.pmpp.2017.01.002
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Susanto H, 2009, J FOOD ENG, V91, P333, DOI 10.1016/j.jfoodeng.2008.09.011
   Thatoi P, 2016, J PHOTOCH PHOTOBIO B, V163, P311, DOI 10.1016/j.jphotobiol.2016.07.029
   Trivedi S, 2016, BARCODING MARINE PER, P3
   Trivedi S, 2016, SAUDI J BIOL SCI, V23, P161, DOI 10.1016/j.sjbs.2015.01.001
   Umashankari Jaganathan, 2012, Aquat Biosyst, V8, P11, DOI 10.1186/2046-9063-8-11
   UNESCO, 2017, WORLD HERITAGE SITES
   United Nation, 2015, UN MILLENNIUM GOALS
   Velusamy P, 2015, IND CROP PROD, V66, P103, DOI 10.1016/j.indcrop.2014.12.042
   Vijayakumar S, 2016, J ENVIRON CHEM ENG, V4, P2076, DOI 10.1016/j.jece.2016.03.036
   Wangensteen H, 2009, ADV PHYTOTHERAPY RES, V1, P59
   Wangensteen H, 2009, NAT PROD COMMUN, V4, P371
   WHO, 2015, WORLD MALARIA REPORT
NR 78
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD JAN
PY 2020
VL 31
IS 1
BP 177
EP 184
DI 10.1007/s10876-019-01631-7
PG 8
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA KL2ER
UT WOS:000513242600014
DA 2020-07-08
ER

PT J
AU Sotcheff, S
   Routh, A
AF Sotcheff, Stephanea
   Routh, Andrew
TI Understanding Flavivirus Capsid Protein Functions: The Tip of the
   Iceberg
SO PATHOGENS
LA English
DT Review
DE flavivirus; capsid protein; antivirals; vaccines
ID VIRUS CORE PROTEIN; ROUND INFECTIOUS PARTICLES; N-TERMINAL REGION; MHC
   CLASS-I; DENGUE VIRUS; ZIKA VIRUS; DNA VACCINE; ULTRASTRUCTURAL
   CHARACTERIZATION; 3-DIMENSIONAL ARCHITECTURE; UP-REGULATION
AB Flaviviruses are enveloped positive-sense single-stranded RNA arboviruses, infectious to humans and many other animals and are transmitted primarily via tick or mosquito vectors. Capsid is the primary structural protein to interact with viral genome within virus particles and is therefore necessary for efficient packaging. However, in cells, capsid interacts with many proteins and nucleic acids and we are only beginning to understand the broad range of functions of flaviviral capsids. It is known that capsid dimers interact with the membrane of lipid droplets, aiding in both viral packaging and storage of capsid prior to packaging. However, capsid dimers can bind a range of nucleic acid templates in vitro, and likely interact with a range of targets during the flavivirus lifecycle. Capsid may interact with host RNAs, resulting in altered RNA splicing and RNA transcription. Capsid may also bind short interfering-RNAs and has been proposed to sequester these species to protect flaviviruses from the invertebrate siRNA pathways. Capsid can also be found in the nucleolus, where it wreaks havoc on ribosome biogenesis. Here we review flavivirus capsid structure, nucleic acid interactions and how these give rise to multiple functions. We also discuss how these features might be exploited either in the design of effective antivirals or novel vaccine strategies.
C1 [Sotcheff, Stephanea; Routh, Andrew] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77550 USA.
   [Routh, Andrew] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77550 USA.
RP Routh, A (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77550 USA.; Routh, A (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77550 USA.
EM slsotche@utmb.edu; alrouth@utmb.edu
RI Routh, Andrew/J-7486-2019
OI Routh, Andrew/0000-0002-2874-5990
FU University of Texas Medical Branch at Galveston
FX A.R. is supported by start-up funds from the University of Texas Medical
   Branch at Galveston.
CR Aggarwal M, 2017, ANTIVIR RES, V146, P102, DOI 10.1016/j.antiviral.2017.08.015
   ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Armstrong PM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005623
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Barrett ADT, 2008, NAT BIOTECHNOL, V26, P525, DOI 10.1038/nbt0508-525
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Bartlow A.W., 2019, VET SCI, V6
   Beck A, 2014, J INFECT DIS, V209, P334, DOI 10.1093/infdis/jit546
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Bocanegra R, 2012, VIRUS RES, V169, P388, DOI 10.1016/j.virusres.2012.06.016
   Boon P.L.S., 2019, BIORXIV
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Chang DC, 2008, NAT BIOTECHNOL, V26, P571, DOI 10.1038/nbt1400
   Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272
   Collins N., 2017, THESIS
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   DYER O, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5759
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Fontaine KA, 2018, MBIO, V9, DOI [10.1128/mBio.02126-18, 10.1128/mbio.02126-18]
   Galler R, 1997, BRAZ J MED BIOL RES, V30, P157, DOI 10.1590/S0100-879X1997000200002
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Huang J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040180
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Ishida K., 2019, J VIROL, V93
   Jelinek T, 2009, EXPERT REV VACCINES, V8, P1501, DOI 10.1586/ERV.09.112
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Lobigs M, 2004, IMMUNOL CELL BIOL, V82, P184, DOI 10.1046/j.0818-9641.2004.01218.x
   Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Machara A, 2016, J MED CHEM, V59, P545, DOI 10.1021/acs.jmedchem.5b01089
   Mandl CW, 2004, VIRAL IMMUNOL, V17, P461, DOI 10.1089/vim.2004.17.461
   Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Momburg F, 2001, J VIROL, V75, P5663, DOI 10.1128/JVI.75.12.5663-5671.2001
   MULLBACHER A, 1995, IMMUNITY, V3, P207, DOI 10.1016/1074-7613(95)90090-X
   Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Ostlund EN, 2001, EMERG INFECT DIS, V7, P665
   Patkar CG, 2007, J VIROL, V81, P6471, DOI 10.1128/JVI.02120-06
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   PHELPS DK, 1995, J MOL BIOL, V254, P544, DOI 10.1006/jmbi.1995.0637
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Poonsiri T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070623
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   Requiao R.D., 2019, BIORXIV
   Roby JA, 2014, J GEN VIROL, V95, P2176, DOI 10.1099/vir.0.064121-0
   ROSSMANN MG, 1988, P NATL ACAD SCI USA, V85, P4625, DOI 10.1073/pnas.85.13.4625
   Ryu W.S., 2017, MOL VIROLOGY HUMAN P
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schlick P, 2010, VACCINE, V28, P5903, DOI 10.1016/j.vaccine.2010.06.045
   Seino KK, 2007, CLIN VACCINE IMMUNOL, V14, P1465, DOI 10.1128/CVI.00249-07
   Sessions OM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002107
   Shan C, 2018, J VIROL, V92, DOI 10.1128/JVI.01002-18
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Slomnicki LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16952-8
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4
   Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009
   Touret F, 2019, ANTIVIR RES, V168, P109, DOI 10.1016/j.antiviral.2019.05.005
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   Urbanowski MD, 2008, CELL SIGNAL, V20, P1227, DOI 10.1016/j.cellsig.2007.12.018
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WHO, 2018, GLOB STRAT EL YELL F
   Xie XP, 2019, CELL HOST MICROBE, V26, P606, DOI 10.1016/j.chom.2019.09.015
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10
   Yang JS, 2002, EMERG INFECT DIS, V8, P1379, DOI 10.3201/eid0812.020224
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   Yoshii K, 2019, J VET MED SCI, V81, P343, DOI 10.1292/jvms.18-0373
   Zhang XW, 2019, MBIO, V10, DOI 10.1128/mBio.02375-19
NR 104
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD JAN
PY 2020
VL 9
IS 1
AR 42
DI 10.3390/pathogens9010042
PG 18
WC Microbiology
SC Microbiology
GA KL0NU
UT WOS:000513130300056
PM 31948047
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carey, JM
   Chi, V
   Flynn, DJ
   Nyhan, B
   Zeitzoff, T
AF Carey, John M.
   Chi, Victoria
   Flynn, D. J.
   Nyhan, Brendan
   Zeitzoff, Thomas
TI The effects of corrective information about disease epidemics and
   outbreaks: Evidence from Zika and yellow fever in Brazil
SO SCIENCE ADVANCES
LA English
DT Article
ID MISINFORMATION; BEHAVIOR; HEALTH; IMPACT; NEWS
AB Disease epidemics and outbreaks often generate conspiracy theories and misperceptions that mislead people about the risks they face and how best to protect themselves. We investigate the effectiveness of interventions aimed at combating false and unsupported information about the Zika epidemic and subsequent yellow fever outbreak in Brazil. Results from a nationally representative survey show that conspiracy theories and other misperceptions about Zika are widely believed. Moreover, results from three preregistered survey experiments suggest that efforts to counter misperceptions about diseases during epidemics and outbreaks may not always be effective. We find that corrective information not only fails to reduce targeted Zika misperceptions but also reduces the accuracy of other beliefs about the disease. In addition, although corrective information about the better-known threat from yellow fever was more effective, none of these corrections affected support for vector control policies or intentions to engage in preventive behavior.
C1 [Carey, John M.; Nyhan, Brendan] Dartmouth Coll, Dept Govt, Hanover, NH 03755 USA.
   [Chi, Victoria] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Flynn, D. J.] IE Univ, Sch Int Relat, Segovia, Spain.
   [Zeitzoff, Thomas] Amer Univ, Sch Publ Affairs, Washington, DC 20016 USA.
RP Nyhan, B (corresponding author), Dartmouth Coll, Dept Govt, Hanover, NH 03755 USA.
EM nyhan@dartmouth.edu
FU Decision, Risk and Management Sciences program at the NSF [1659128];
   Global Health Initiative of the John Sloan Dickey Center for
   International Understanding at Dartmouth College
FX This study was supported by the Decision, Risk and Management Sciences
   program at the NSF (award 1659128) and the Global Health Initiative of
   the John Sloan Dickey Center for International Understanding at
   Dartmouth College.
CR Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057
   Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Carneiro J., 2016, BBC BRASIL      0218
   CHAMPION VL, 2008, HLTH BEHAV HLTH ED T, V4, P45
   Chan MPS, 2017, PSYCHOL SCI, V28, P1531, DOI 10.1177/0956797617714579
   Clayton K., 2019, POLIT BEHAV
   Coppock A, 2019, POLIT SCI RES METH, V7, P613, DOI 10.1017/psrm.2018.10
   Dantas C., 2018, FEBRE AMARELA VACINA
   Darlington Shasta, 2018, NY TIMES
   Echterhoff G, 2007, SOC COGNITION, V25, P367, DOI 10.1521/soco.2007.25.3.367
   Feuer A., 2014, NY TIMES
   Flynn DJ, 2017, POLIT PSYCHOL, V38, P127, DOI 10.1111/pops.12394
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Ingram M., 2018, COLUMBIA JOURNALISM
   Jacobs A., 2016, NY TIMES
   JOHNSON HM, 1994, J EXP PSYCHOL LEARN, V20, P1420, DOI 10.1037/0278-7393.20.6.1420
   Johnson R., 2016, WALL STREET J
   Jolley D, 2014, BRIT J PSYCHOL, V105, P35, DOI 10.1111/bjop.12018
   Macedo J., 2016, TEORIAS CONSPIRACAO
   Miller JM, 2016, AM J POLIT SCI, V60, P824, DOI 10.1111/ajps.12234
   Ministerio da Saude, 2019, MON PER SAZ FEBR AM
   Nyhan B., 2015, J EXPT POLITICAL SCI, V2, P81, DOI DOI 10.1017/XPS.2014.22
   Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Pennycook G., MANAG SCI
   Petty RE, 2002, J PERS SOC PSYCHOL, V82, P722, DOI 10.1037//0022-3514.82.5.722
   Pingree RJ, 2011, J COMMUN, V61, P22, DOI 10.1111/j.1460-2466.2010.01525.x
   Raude J, 2019, SOC SCI MED, V230, P184, DOI 10.1016/j.socscimed.2019.04.009
   Salm A, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3546-0
   Scheufele DA, 2019, P NATL ACAD SCI USA, V116, P7662, DOI 10.1073/pnas.1805871115
   Schwarz N, 2007, ADV EXP SOC PSYCHOL, V39, P127, DOI 10.1016/S0065-2601(06)39003-X
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Spinney L, 2019, SCIENCE, V363, P213, DOI 10.1126/science.363.6424.213
   Sunstein C.R, 2014, CONSPIRACY THEORIES
   van der Meer TGLA, 2020, HEALTH COMMUN, V35, P560, DOI 10.1080/10410236.2019.1573295
   Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5
   Walter N, 2018, COMMUN MONOGR, V85, P423, DOI 10.1080/03637751.2018.1467564
   Whitson JA, 2008, SCIENCE, V322, P115, DOI 10.1126/science.1159845
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363
   World Health Organization, 2018, SIT REP ZIK VIR MICR
NR 43
TC 1
Z9 1
U1 8
U2 8
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD JAN
PY 2020
VL 6
IS 5
AR eaaw7449
DI 10.1126/sciadv.aaw7449
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KK7FS
UT WOS:000512904600004
PM 32064329
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jones, ST
   Cagno, V
   Janecek, M
   Ortiz, D
   Gasilova, N
   Piret, J
   Gasbarri, M
   Constant, DA
   Han, YX
   Vukovi, L
   Kral, P
   Kaiser, L
   Huang, S
   Constant, S
   Kirkegaard, K
   Boivin, G
   Stellacci, F
   Tapparel, C
AF Jones, Samuel T.
   Cagno, Valeria
   Janecek, Matej
   Ortiz, Daniel
   Gasilova, Natalia
   Piret, Jocelyne
   Gasbarri, Matteo
   Constant, David A.
   Han, Yanxiao
   Vukovi, Lela
   Kral, Petr
   Kaiser, Laurent
   Huang, Song
   Constant, Samuel
   Kirkegaard, Karla
   Boivin, Guy
   Stellacci, Francesco
   Tapparel, Caroline
TI Modified cyclodextrins as broad-spectrum antivirals
SO SCIENCE ADVANCES
LA English
DT Article
ID TOPICAL MICROBICIDES; SULFATE; HIV; INHIBITORS; CANDIDATE; VIRUSES; GEL;
   PREVENTION; DYNAMICS; AGENT
AB Viral infections kill millions of people and new antivirals are needed. Nontoxic drugs that irreversibly inhibit viruses (virucidal) are postulated to be ideal. Unfortunately, all virucidal molecules described to date are cytotoxic. We recently developed nontoxic, broad-spectrum virucidal gold nanoparticles. Here, we develop further the concept and describe cyclodextrins, modified with mercaptoundecane sulfonic acids, to mimic heparan sulfates and to provide the key nontoxic virucidal action. We show that the resulting macromolecules are broad-spectrum, biocompatible, and virucidal at micromolar concentrations in vitro against many viruses [including herpes simplex virus (HSV), respiratory syncytial virus (RSV), dengue virus, and Zika virus]. They are effective ex vivo against both laboratory and clinical strains of RSV and HSV-2 in respiratory and vaginal tissue culture models, respectively. Additionally, they are effective when administrated in mice before intravaginal HSV-2 inoculation. Lastly, they pass a mutation resistance test that the currently available anti-HSV drug (acyclovir) fails.
C1 [Jones, Samuel T.; Cagno, Valeria; Janecek, Matej; Gasbarri, Matteo; Stellacci, Francesco] Ecole Polytech Fed Lausanne, Inst Mat, CH-1015 Lausanne, Switzerland.
   [Jones, Samuel T.] Univ Manchester, Dept Mat, Manchester M13 9PL, Lancs, England.
   [Cagno, Valeria; Tapparel, Caroline] Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.
   [Ortiz, Daniel; Gasilova, Natalia] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland.
   [Piret, Jocelyne; Boivin, Guy] Laval Univ, CHU Quebec, Quebec City, PQ, Canada.
   [Constant, David A.; Kirkegaard, Karla] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.
   [Han, Yanxiao; Kral, Petr] Univ Illinois, Dept Chem, Chicago, IL 60607 USA.
   [Vukovi, Lela] Univ Texas El Paso, Dept Chem & Biochem, El Paso, TX 79966 USA.
   [Kral, Petr] Univ Illinois, Dept Phys, Chicago, IL 60612 USA.
   [Kral, Petr] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA.
   [Kaiser, Laurent] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland.
   [Huang, Song; Constant, Samuel] Epithelix Sarl, Geneva, Switzerland.
   [Stellacci, Francesco] Ecole Polytech Fed Lausanne, Dept Bionengn, CH-1015 Lausanne, Switzerland.
RP Stellacci, F (corresponding author), Ecole Polytech Fed Lausanne, Inst Mat, CH-1015 Lausanne, Switzerland.; Tapparel, C (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.; Stellacci, F (corresponding author), Ecole Polytech Fed Lausanne, Dept Bionengn, CH-1015 Lausanne, Switzerland.
EM francesco.stellacci@epfl.ch; caroline.tapparel@unige.ch
RI Han, Yanxiao/AAM-7379-2020
OI Jones, Samuel/0000-0002-3907-0810
FU Dame Kathleen Ollerenshaw Fellowship; Firmenich Foundation for
   EPFL-Stanford Exchange; Canadian Institutes of Health ResearchCanadian
   Institutes of Health Research (CIHR) [148361]; NIAID of the NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R03AI142553]; Leenaards Foundation [4390]; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [CRSII5_180323]; National Center of Competence in Research (NCCR)
   Bio-Inspired MaterialsSwiss National Science Foundation (SNSF)
FX S.T.J. was supported by Dame Kathleen Ollerenshaw Fellowship. V.C. was
   supported by Firmenich Foundation for EPFL-Stanford Exchange. J.P. and
   G.B. were financed by the Canadian Institutes of Health Research (grant
   no. 148361 to G.B.). L.V. was supported by the NIAID of the NIH under
   award number R03AI142553. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   NIH. We thank the reviewers for their useful feedback on additional
   experiments especially the DNase experiment that strengthened the
   message in our manuscript. The work was supported by the Leenaards
   Foundation (grant 4390 to C.T. and F.S.) and the Swiss National Science
   Foundation (via a Sinergia grant CRSII5_180323 to F.S. and C.T.), and
   the National Center of Competence in Research (NCCR) Bio-Inspired
   Materials that supported M.G.
CR Abe M, 2007, JPN J INFECT DIS, V60, P342
   Anand R, 1990, ANTIVIR CHEM CHEMOTH, V1, P41, DOI 10.1177/095632029000100107
   Baram-Pinto D, 2010, SMALL, V6, P1044, DOI 10.1002/smll.200902384
   Bergstrom Donald E, 2002, Antivir Chem Chemother, V13, P185
   Cagno V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070596
   Cagno V, 2018, NAT MATER, V17, P195, DOI [10.1038/NMAT5053, 10.1038/nmat5053]
   Constant DA, 2018, P NATL ACAD SCI USA, V115, P10136, DOI 10.1073/pnas.1805195115
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9
   Donalisio M, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-266
   Essaidi-Laziosi M, 2018, J ALLERGY CLIN IMMUN, V141, P2074, DOI 10.1016/j.jaci.2017.07.018
   Essaidi-Laziosi M, 2016, J VIROL METHODS, V235, P9, DOI 10.1016/j.jviromet.2016.05.004
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09
   Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jansze SM, 2018, CHEM COMMUN, V54, P9529, DOI 10.1039/c8cc04870c
   Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395
   Leydet A, 1998, J MED CHEM, V41, P4927, DOI 10.1021/jm970661f
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0
   MORIYA T, 1993, J MED CHEM, V36, P1674, DOI 10.1021/jm00063a018
   MORIYA T, 1991, J MED CHEM, V34, P2301, DOI 10.1021/jm00111a055
   Nishijo J, 2003, CHEM PHARM BULL, V51, P1253, DOI 10.1248/cpb.51.1253
   OTAKE T, 1994, ANTIVIR CHEM CHEMOTH, V5, P155, DOI 10.1177/095632029400500303
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176
   Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874
   Putnam F. W., 1995, ALL ALBUMIN, pxi
   Roy S, 2001, ANTIMICROB AGENTS CH, V45, P1671, DOI 10.1128/AAC.45.6.1671-1681.2001
   Royston L, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006962
   Rusnati M, 2009, PHARMACOL THERAPEUT, V123, P310, DOI 10.1016/j.pharmthera.2009.05.001
   Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845
   van Buuren N, 2018, ELIFE, V7, DOI 10.7554/eLife.32579
   Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957
   Van Haute D, 2017, THER DELIV, V8, P763, DOI 10.4155/tde-2017-0057
   Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367
   Zeev-Ben-Mordehai T, 2016, P NATL ACAD SCI USA, V113, P4176, DOI 10.1073/pnas.1523234113
NR 42
TC 4
Z9 4
U1 13
U2 13
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD JAN
PY 2020
VL 6
IS 5
AR eaax9318
DI 10.1126/sciadv.aax9318
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KK7FS
UT WOS:000512904600016
PM 32064341
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hung, NH
   Huong, LT
   Chung, NT
   Thuong, NTH
   Satyal, P
   Dung, NA
   Tai, TA
   Setzer, WN
AF Nguyen Huy Hung
   Le Thi Huong
   Nguyen Thanh Chung
   Nguyen Thi Hoai Thuong
   Satyal, Prabodh
   Nguyen Anh Dung
   Thieu Anh Tai
   Setzer, William N.
TI Callicarpa Species from Central Vietnam: Essential Oil Compositions and
   Mosquito Larvicidal Activities
SO PLANTS-BASEL
LA English
DT Article
DE Lamiaceae; Callicarpa candicans; Callicarpa rubella; Aedes aegypti;
   atractylone; beta-bisabolene; germacrone
ID AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; INSECTICIDE RESISTANCE;
   CHEMICAL-COMPOSITION; ZIKA VIRUS; MEDICINAL-PLANTS; YELLOW-FEVER;
   DENGUE; CHALLENGES; TOXICITY
AB There are around 140 species in the genus Callicarpa, with 23 species occurring in Vietnam. The Vietnamese Callicarpa species have been poorly studied. In this work, the leaf essential oils of C. bodinieri, C. candicans, C. formosana, C. longifolia, C. nudiflora, C. petelotii, C. rubella, and C. sinuata, have been obtained from plants growing in central Vietnam. The chemical compositions of the essential oils were determined using gas chromatography - mass spectrometry. Mosquito larvicidal activities of the essential oils were carried out against Aedes aegypti. All of the Callicarpa leaf essential oils showed larvicidal activity, but two samples of C. candicans were particularly active with 48-h LC50 values of 2.1 and 3.8 mu g/mL. Callicarpacandicans essential oil should be considered as a potential alternative mosquito control agent.
C1 [Nguyen Huy Hung] Duy Tan Univ, Inst Res & Dev, Ctr Adv Chem, 03 Quang Trung, Da Nang 50000, Vietnam.
   [Le Thi Huong; Nguyen Thi Hoai Thuong; Nguyen Anh Dung] Vinh Univ, Sch Nat Sci Educ, 182 Le Duan, Vinh City 43000, Nghe An Provinc, Vietnam.
   [Nguyen Thanh Chung] Grad Univ Sci & Technol, Vietnam Acad Sci & Technol, 18 Hoang Quoc Viet, Hanoi 10072, Vietnam.
   [Satyal, Prabodh; Setzer, William N.] Aromat Plant Res Ctr, 230 N 1200 E,Suite 102, Lehi, UT 84043 USA.
   [Thieu Anh Tai] Duy Tan Univ, Dept Pharm, 03 Quang Trung, Da Nang 50000, Vietnam.
   [Setzer, William N.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
RP Hung, NH (corresponding author), Duy Tan Univ, Inst Res & Dev, Ctr Adv Chem, 03 Quang Trung, Da Nang 50000, Vietnam.; Setzer, WN (corresponding author), Aromat Plant Res Ctr, 230 N 1200 E,Suite 102, Lehi, UT 84043 USA.; Setzer, WN (corresponding author), Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
EM nguyenhuyhung@duytan.edu.vn; lehuong223@gmail.com;
   chungpuhoat@gmail.com; hoaithuongnguyen468@gmail.com;
   psatyal@aromaticplant.org; nadungch8@gmail.com; anhtai0808qn@gmail.com;
   wsetzer@chemistry.uah.edu
OI Setzer, William N./0000-0002-3639-0528
FU NAFOSTED (Vietnam)National Foundation for Science & Technology
   Development (NAFOSTED) [106.03-2019.25]
FX The authors thank the NAFOSTED (Vietnam) for financial support of this
   study through Project No. 106.03-2019.25.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Albuquerque CMR, 1999, MEM I OSWALDO CRUZ, V94, P591, DOI 10.1590/S0074-02761999000500005
   [Anonymous], 2017, NIST17
   Au DT, 2008, J ETHNOPHARMACOL, V117, P41, DOI 10.1016/j.jep.2008.01.016
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bramley GLC, 2013, KEW BULL, V68, P369, DOI 10.1007/s12225-013-9456-y
   Bramley Gemma L. C., 2011, Gardens' Bulletin (Singapore), V63, P287
   Buot I.E., 2009, J NAT STUD, V8, P1
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   Chu SS, 2011, PEST MANAG SCI, V67, P1253, DOI 10.1002/ps.2180
   Chusri S., 2012, Journal of Medicinal Plants Research, V6, P5616
   Dan Yang, 2010, Chinese Herbal Medicines, V2, P272
   de Morals SM, 2007, BIOCHEM SYST ECOL, V35, P670, DOI 10.1016/j.bse.2007.05.002
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Dua VK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-30
   Quyen DL, 2018, AM J TROP MED HYG, V98, P402, DOI 10.4269/ajtmh.17-0630
   Finney D., 2009, PROBIT ANAL
   Gao JB, 2018, J NAT PROD, V81, P998, DOI 10.1021/acs.jnatprod.7b01082
   Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Ho P.H, 2000, ILLUSTRATED FLORA VI, V3
   Jawale C.S., 2018, TRENDS FISH RES, V7, P33
   Jones William P, 2008, Curr Bioact Compd, V4, P15, DOI 10.2174/157340708784533393
   Kamrin M.A, 1997, PESTICIDE PROFILES T
   Kim HK, 2007, J AGR FOOD CHEM, V55, P6027, DOI 10.1021/jf0708802
   Le V.T.T., 2018, VIETNAM J CHEM, V56, P341
   Lee C, 2019, J ETHNOPHARMACOL, V231, P283, DOI 10.1016/j.jep.2018.11.006
   LEERATIWONG C, 2009, THAI FOREST B BOT, V37, P36
   Liang JJ, 2009, CHEM NAT COMPD+, V45, P267, DOI 10.1007/s10600-009-9279-0
   [林朝展 LIN Chao-zhan], 2009, [热带亚热带植物学报, Journal of Tropical and Subtropical Botany], V17, P401
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lopes RP, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3850-8
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Mabberley D.J., 2008, MABBERLEYS PLANT BOO
   Masetti A, 2016, B INSECTOL, V69, P307
   Mondello L., 2016, 3 FFNSC
   Muensaen S., 2019, AGR NAT RESOUR, V53, P251
   MUNIR A A, 1982, Journal of the Adelaide Botanic Gardens, V6, P5
   Nandwani D., 2008, Journal of Applied Biosciences, V8, P323
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Ntalli N, 2019, PHYTOCHEM REV, V18, P1255, DOI 10.1007/s11101-019-09647-7
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Perumalsamy H, 2009, J MED ENTOMOL, V46, P1420, DOI 10.1603/033.046.0624
   Phuong V.X., 2007, FLORA VIETNAM, V6
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Satyal P., 2015, THESIS
   Scalerandi E, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01579
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Su X., 2008, J JINGMEN TECH COLL, V23, P7
   Tu YH, 2013, J ETHNOPHARMACOL, V146, P465, DOI 10.1016/j.jep.2012.12.051
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Vo V.C., 2012, DICT MED PLANTS VIET
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   Yadouleton A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0638-3
   Zhang W, 2017, CHEM NAT COMPD+, V53, P976, DOI 10.1007/s10600-017-2175-0
   Zheng XL, 2009, J ETHNOPHARMACOL, V124, P197, DOI 10.1016/j.jep.2009.04.042
NR 63
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2223-7747
J9 PLANTS-BASEL
JI Plants-Basel
PD JAN
PY 2020
VL 9
IS 1
AR 113
DI 10.3390/plants9010113
PG 32
WC Plant Sciences
SC Plant Sciences
GA KL2DE
UT WOS:000513238700113
PM 31963227
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reis, MCD
   Carvalho, ACA
   Tavares, CSS
   Santos, VS
   Santos, HP
   Martins, PRS
AF da Silva Reis, Monique Carla
   Araujo Carvalho, Aline Carla
   Souza Tavares, Carolina Santos
   Santos, Victor Santana
   Santos, Hudson P., Jr.
   Saquete Martins-Filho, Paulo Ricardo
TI Changes in Occupational Roles and Common Mental Disorders in Mothers of
   Children With Congenital Zika Syndrome
SO AMERICAN JOURNAL OF OCCUPATIONAL THERAPY
LA English
DT Article
ID QUALITY-OF-LIFE; MATERNAL EMPLOYMENT; VIRUS-INFECTION; ROLE CHECKLIST;
   DEPRESSION; HEALTH; NEWBORNS; INFANTS; ANXIETY; IMPACT
AB Importance: The functional limitations and long-term dependence of children with congenital Zika syndrome (CZS) may lead to changes H maternal occupational roles. which can have a negative impact on mothers' well-being and mental health.
   Objective: To investigate changes in occupational roles and their effects on the mental health of mothers who have a child with CZS.
   Design: Cross-sectional study.
   Setting: Rehabilitation centers of the Brazilian Unified Health System in Alagoas. Northeast Brazil.
   Participants: Forty mothers of children with CZS.
   Outcomes and Measures: The Role Checklist and the Self-Reporting Questionnaire-20 were used to assess the mothers' involvement H occupational roles and common mental disorders (CMDs), respectively. The relationship between changes H occupational roles and CMDs was analyzed using a logistic regression model.
   Results: Our study showed that loss of paid work (p = .026) is associated with poor mental health of mothers of children with CZS.
   Conclusions and Relevance: Strengthening public policies to reduce the economic impact of CZS on families. offering multidisciplinary counseling. and implementing psychoeducational strategies for promoting maternal psychological adjustment are needed.
C1 [da Silva Reis, Monique Carla; Araujo Carvalho, Aline Carla; Souza Tavares, Carolina Santos; Saquete Martins-Filho, Paulo Ricardo] Univ Fed Sergipe, Investigat Pathol Lab, Aracaju, Brazil.
   [da Silva Reis, Monique Carla; Araujo Carvalho, Aline Carla] Alagoas State Univ Hlth Sci, Maceio, Alagoas, Brazil.
   [Santos, Victor Santana] Univ Fed Alagoas, Ctr Epidemiol & Publ Hlth, Arapiraca, Brazil.
   [Santos, Hudson P., Jr.] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27515 USA.
RP Martins, PRS (corresponding author), Univ Fed Sergipe, Investigat Pathol Lab, Aracaju, Brazil.
EM martins-filho@ufs.br
RI Santos, Victor S/B-8738-2014
OI Santos, Victor S/0000-0003-0194-7397; Martins-Filho, Paulo
   Ricardo/0000-0001-8779-0727
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Barlow J., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002020.PUB2
   Beusenberg M, 1994, USERS GUIDE SELF REP
   Brasil. Ministerio da Saude, 2019, B EPIDEMIOLOGICO, V50
   Brazilian Institute of Geography and Statistics, 2012, CENS DEM 2010 CAR UR
   Brehaut JC, 2004, PEDIATRICS, V114, P182
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Cordeiro JR, 2007, AM J OCCUP THER, V61, P33, DOI 10.5014/ajot.61.1.33
   Crowe TK, 1997, AM J OCCUP THER, V51, P651, DOI 10.5014/ajot.51.8.651
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Oliveira SJGD, 2017, ARCH WOMEN MENT HLTH, V20, P473, DOI 10.1007/s00737-017-0724-y
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993
   HEARD C, 1977, AM J OCCUP THER, V31, P243
   Hope S, 2017, EUR J PUBLIC HEALTH, V27, P48, DOI 10.1093/eurpub/ckw132
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889
   Kagee A, 2013, INT HEALTH, V5, P11, DOI 10.1093/inthealth/ihs004
   KIELHOFNER G, 1980, AM J OCCUP THER, V34, P572, DOI 10.5014/ajot.34.9.572
   MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23
   Ribeiro MFM, 2014, REV LAT-AM ENFERM, V22, P440, DOI 10.1590/0104-1169.3409.2435
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   OAKLEY F, 1986, OCCUP THER J RES, V6, P157, DOI 10.1177/153944928600600303
   Sawyer MG, 2011, DEV MED CHILD NEUROL, V53, P338, DOI 10.1111/j.1469-8749.2010.03848.x
   Scott S, 2017, STUD SOC HARM, P3
   Shearn J, 2000, J APPL RES INTELLECT, V13, P109, DOI 10.1046/j.1468-3148.2000.00021.x
   Singer GHS, 2006, AM J MENT RETARD, V111, P155, DOI 10.1352/0895-8017(2006)111[155:MOCSOD]2.0.CO;2
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   2015, B WORLD HEALTH ORGAN, V93, P516, DOI DOI 10.1037/E360882004-001
NR 29
TC 0
Z9 0
U1 1
U2 1
PU AMER OCCUPATIONAL THERAPY ASSOC, INC
PI BETHESDA
PA 4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA
SN 0272-9490
EI 1943-7676
J9 AM J OCCUP THER
JI Am. J. Occup. Ther.
PD JAN-FEB
PY 2020
VL 74
IS 1
AR 7401345010
DI 10.5014/ajot.2019.035972
PG 6
WC Rehabilitation
SC Rehabilitation
GA KK8KH
UT WOS:000512984700017
PM 32078520
OA Green Published
DA 2020-07-08
ER

PT J
AU Huong, L
   Huong, TT
   Huong, NTT
   Hung, NH
   Dat, PTT
   Luong, NX
   Ogunwande, IA
AF Huong, Le T.
   Huong, Trinh T.
   Huong, Nguyen T. T.
   Hung, Nguyen H.
   Dat, Pham T. T.
   Luong, Ngo X.
   Ogunwande, Isiaka A.
TI Mosquito Larvicidal Activity of the Essential Oil of Zingiber collinsii
   against Aedes albopictus and Culex quinquefasciatus
SO JOURNAL OF OLEO SCIENCE
LA English
DT Article
DE Zingiber collinsii; essential oil composition; monoterpenes;
   sesquiterpenes; larvicidal activity
ID CHEMICAL-COMPOSITION; ZIKA VIRUS; AEGYPTI; CONSTITUENTS; REPELLENCY
AB The chemical composition and larvicidal activity of essential oils from the leaves and rhizomes of Zingiber collinsii Mood & Theilade (Zingiberaceae) were reported. The main compounds in the leaf oil were alpha-pinene (25.6%), beta-caryophyllene (16.8%), beta-pinene (16.1%) and bicyclogermacrene (6.9%) while the rhizome oil consist mainly of camphene (22.5%), beta-pinene (16.3%), alpha-pinene (9.0%) and humulene oxide II (9.0%). The rhizome oil demonstrated larvicidal effects towards fourth instant larvae of mosquito vectors. The highest mortality (100%) was observed at 24 h exposure against Aedes albopictus (concentration 100 mu g/mL) and 48 h (concentration of 50 and 100 mu g/mL), while the highest mortality (100%) was observed for Culex quinquefasciatus at 24 h and 48 h at concentration of 100 mu g/mL. The 24 h mosquito larvicidal activity of the rhizome oil against Ae. albopictus were LC50 = 25.51 mu g/mL; LC90 = 40.22 mu g/mL and towards Cx. quinquefasciatus with LC50 = 50.11 mu g/mL and LC90 = 71.53 mu g/mL). However, the 48 h larvicidal activity were LC50 = 20.03 mu g/mL and LC90 = 24.51 mu g/mL (Ae. albopictus), as well as LC50 = 36.18 mu g/mL and LC90 = 55.11 mu g/mL (Cx. quinquefasciatus). On the other hand, no appreciable mortality and larvicidal activity was observed for the leaf oil. The larvicidal activity of the essential oils of Z. collinsii was being reported for the first time.
C1 [Huong, Le T.] Vinh Univ, Sch Nat Sci Educ, 182 Le Duan, Vinh City, Nghe An Provinc, Vietnam.
   [Huong, Trinh T.; Huong, Nguyen T. T.] Grad Univ Sci & Technol, Vietnam Acad Sci & Technol, 18 Hoang Quoc Viet, Hanoi, Vietnam.
   [Huong, Trinh T.; Luong, Ngo X.] Hong Duc Univ, Fac Nat Sci, 565 Quang Trung, Thanh Hoa City, Thanh Hoa Provi, Vietnam.
   [Huong, Nguyen T. T.] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, 18 Hoang Quoc Viet, Hanoi, Vietnam.
   [Hung, Nguyen H.] Duy Tan Univ, Ctr Adv Chem, Inst Res & Dev, 03 Quang Trung, Da Nang, Vietnam.
   [Dat, Pham T. T.] Nong Lam Univ, Dept Biotechnol, Ho Chi Minh City, Vietnam.
   [Dat, Pham T. T.] Ctr Sci Res & Practice, Thu Dau Mot, Binh Duong Prov, Vietnam.
   [Ogunwande, Isiaka A.] 7 Univ Dr, Aleku Area, Osogbo, Nigeria.
RP Huong, L (corresponding author), Vinh Univ, Sch Nat Sci Educ, 182 Le Duan, Vinh City, Nghe An Provinc, Vietnam.; Ogunwande, IA (corresponding author), 7 Univ Dr, Aleku Area, Osogbo, Nigeria.
EM lehuong233@gmail.com; isiakaogunwande@gmail.com
RI Dat, Pham Thi Thanh/AAN-9898-2020
FU Vietnam National Foundation for Science and Technology
   Development(NAFOSTED)National Foundation for Science & Technology
   Development (NAFOSTED) [106.03-2017.328]
FX This research was funded by Vietnam National Foundation for Science and
   Technology Development(NAFOSTED)under grant number 106.03-2017.328.
CR Ali A, 2014, J MED ENTOMOL, V51, P824, DOI 10.1603/ME13249
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Bedini S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36158-w
   Boonyuan W, 2014, J VECTOR ECOL, V39, P112, DOI 10.1111/j.1948-7134.2014.12077.x
   Chau L. T. M., 2014, American Journal of Plant Sciences, V5, P760
   Chau L. T. M., 2016, J SCI TECHNOL, V54, P283
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dai D., J OLEO SCI
   Dias CN, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/490765
   Finney D., 2009, PROBIT ANAL
   Hung ND, 2019, CHEM NAT COMPD+, V55, P361, DOI 10.1007/s10600-019-02691-x
   Huong LT, 2018, NAT PROD COMMUN, V13, P763
   Isman M. B., 2007, ESSENTIAL OIL BASED
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   Komalamisra Narumon, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1412
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Magalhaes LAM, 2010, MOLECULES, V15, P5734, DOI 10.3390/molecules15085734
   Mahardika RW, 2017, TROP BIOMED, V34, P375
   Hung NH, 2019, INSECTS, V10, DOI 10.3390/insects10020047
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Lien PTK, 2016, ASIAN PAC J TROP MED, V9, P36, DOI 10.1016/j.apjtm.2015.12.008
   Phukerd U, 2014, PARASITOL RES, V113, P3333, DOI 10.1007/s00436-014-3996-4
   Phukerd Ubol, 2013, Southeast Asian J Trop Med Public Health, V44, P761
   Rabha P., 2016, E3 J MED RES, V1
   Seo SM, 2015, J AGR FOOD CHEM, V63, P9977, DOI 10.1021/acs.jafc.5b03586
   Sutthanont N, 2019, INSECTS, V10, DOI 10.3390/insects10010027
   Theillade I, 2000, NORD J BOT, V20, P32, DOI 10.1111/j.1756-1051.2000.tb00728.x
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Vietnamese Pharmacopoeia, 2009, VIETNAMESE PHARMACOP
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
NR 31
TC 1
Z9 1
U1 0
U2 0
PU JAPAN OIL CHEMISTS SOC
PI TOKYO
PA YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO,
   103-0027, JAPAN
SN 1345-8957
EI 1347-3352
J9 J OLEO SCI
JI J. Oleo Sci.
PY 2020
VL 69
IS 2
BP 153
EP 160
DI 10.5650/jos.ess19175
PG 8
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA KK3QS
UT WOS:000512661400008
PM 32023580
OA Bronze
DA 2020-07-08
ER

PT J
AU Welton, M
   Vega, CMV
   Murphy, CB
   Rosario, Z
   Torres, H
   Russell, E
   Brown, P
   Huerta-Montanez, G
   Watkins, D
   Meeker, JD
   Alshawabkeh, A
   Cordero, JF
AF Welton, Michael
   Velez Vega, Carmen M.
   Murphy, Colleen B.
   Rosario, Zaira
   Torres, Hector
   Russell, Elle
   Brown, Phil
   Huerta-Montanez, Gredia
   Watkins, Deborah
   Meeker, John D.
   Alshawabkeh, Akram
   Cordero, Jose F.
TI Impact of Hurricanes Irma and Maria on Puerto Rico Maternal and Child
   Health Research Programs
SO MATERNAL AND CHILD HEALTH JOURNAL
LA English
DT Article
DE Maternal and child health; Natural disaster response; Hurricane; Puerto
   Rico; Disaster preparedness
ID AMBIENT-TEMPERATURE; NATURAL DISASTER; MENTAL-HEALTH; BIRTH; PREGNANCY;
   CONSEQUENCES; OUTCOMES; STRESS
AB Puerto Rico was hit by two major hurricanes in September 2017 causing great devastation, losing over 90% of the power grid, wireless communication and access to potable water, and destroying many homes. Our research programs: Puerto Rico Testsite for Exploring Contamination Threats (PROTECT), Center for Research on Early Childhood Exposure and Development in Puerto Rico (CRECE), Zika in Infants and Pregnancy (ZIP), and Environmental Influences on Child Health Outcomes (ECHO) are ongoing observational cohort studies that have been investigating environmental risk factors for perinatal health outcomes among Puerto Rican mothers and infants. Our projects paused operations for about two weeks, to begin recovery process and become a source of assistance, retaining 95% of study participants across all research programs. We joined with various groups to ensure the safety and welfare of team members, study participants, community health center partners, and members of the surrounding communities. We learned important lessons about the impact of these hurricanes and the difficulties of the recovery. Major challenges post-hurricanes were access to care and nutrition, maternal stress, and environmental damage. We understood the need to integrate disaster preparedness into our programs' operating procedures and future applications, recognizing that these events will recur. We will grow resilience among our staff, maternal and child health partners, and participants by building on the experience of these two storms.
C1 [Welton, Michael; Cordero, Jose F.] Univ Georgia, Dept Epidemiol & Biostat, Coll Publ Hlth, Hlth Sci Campus,101 Buck Rd, Athens, GA 30602 USA.
   [Velez Vega, Carmen M.; Murphy, Colleen B.; Rosario, Zaira; Torres, Hector] Univ Puerto Rico, Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.
   [Russell, Elle; Huerta-Montanez, Gredia; Alshawabkeh, Akram] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA.
   [Brown, Phil] Northeastern Univ, Social Sci Environm Hlth Res Inst, Boston, MA 02115 USA.
   [Watkins, Deborah; Meeker, John D.] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
RP Welton, M (corresponding author), Univ Georgia, Dept Epidemiol & Biostat, Coll Publ Hlth, Hlth Sci Campus,101 Buck Rd, Athens, GA 30602 USA.
EM mdwelton@uga.edu; carmen.velez2@upr.edu; colleen.murphy@upr.edu;
   zaira.rosario@upr.edu; hector.torres26@upr.edu;
   e.russell@northeastern.edu; p.brown@neu.edu; grediamd@gmail.com;
   debjwat@umich.edu; meekerj@umich.edu; a.alshawabkeh@northeastern.edu;
   jcordero@uga.edu
FU NIEHS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [R21 ES029751, P50 ES026049, P42 ES017198]; NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [UG3 OD023251, UH3 OD023251]; NIMHD NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Minority
   Health & Health Disparities (NIMHD) [U54 MD007600, R21 MD013709]; NIOSH
   CDC HHS [T42 OH008455]
CR American Red Cross, 2017, PREP EM
   [Anonymous], 2017, NEW YORK POST
   [Anonymous], 2018, NBC NEWS
   [Anonymous], 2017, NY TIMES
   Brown P, 2018, HURRICANES EJ ISLAND
   Buekens P, 2006, BIRTH-ISS PERINAT C, V33, P91, DOI 10.1111/j.0730-7659.2006.00084.x
   Carballo M, 2005, J ROY SOC MED, V98, P400, DOI 10.1258/jrsm.98.9.400
   Carrera JS, 2018, SOC SCI MED, V196, P175, DOI 10.1016/j.socscimed.2017.11.028
   Centers for Disease Control and Prevention (CDC), 2016, WOM HLTH STAT PUERT
   Chang HL, 2002, PSYCHIAT CLIN NEUROS, V56, P139, DOI 10.1046/j.1440-1819.2002.00948.x
   Cohan CL, 2002, J FAM PSYCHOL, V16, P14, DOI 10.1037//0893-3200.16.1.14
   CORDERO JF, 1993, ENVIRON HEALTH PERSP, V101, P131, DOI 10.2307/3431386
   Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452
   Erikson Kai T., 1976, EVERYTHING ITS PATH
   Ewing B, 2008, MCN-AM J MATERN-CHIL, V33, P98, DOI 10.1097/01.NMC.0000313417.66742.ce
   Ha S, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP945
   Ha SD, 2017, ENVIRON RES, V155, P394, DOI 10.1016/j.envres.2017.02.021
   Ha SD, 2017, ENVIRON HEALTH PERSP, V125, P453, DOI 10.1289/EHP97
   Hapsari ED, 2009, CONTRACEPTION, V79, P316, DOI 10.1016/j.contraception.2008.10.015
   Harville EW, 2018, ENVIRON RES, V161, P153, DOI 10.1016/j.envres.2017.11.012
   Kishore N, 2018, NEW ENGL J MED, V379, P162, DOI [10.1056/NEJMsa1803972, 10.1056/nejmsa1803972]
   Knutson TR, 2015, J CLIMATE, V28, P7203, DOI 10.1175/JCLI-D-15-0129.1
   March of Dimes, 2016, PER STAT DAT PUERT R
   Morland L, 2007, PSYCHOSOMATICS, V48, P304, DOI 10.1176/appi.psy.48.4.304
   Mosher William D, 2012, Natl Health Stat Report, P1
   National Hurrican Center: National Oceanic and Atmosheric Administration (NHC-NOAA), 2017, ABNT30 NHCNOAA
   National Institutes of Health (NIH), 2016, NIH LAUNCH LARG STUD
   Northeastern University (NU), 2018, CTR RES EARL CHILDH
   Northeastern University (NU), 2018, PUERT RIC TESTS EXPL
   RICHTER R, 2008, AM J DISASTER MED, V3, P31, DOI DOI 10.5055/ajdm.2008.0004
   Rodriguez-Diaz CE, 2018, AM J PUBLIC HEALTH, V108, P30, DOI 10.2105/AJPH.2017.304198
   Salazar MA, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31320
   Tees MT, 2010, MATERN CHILD HLTH J, V14, P511, DOI 10.1007/s10995-009-0486-x
   Than More, 2017, CBS NEWS
   Ulrich F, 2016, GEBURTSH FRAUENHEILK, V76, P1136, DOI 10.1055/s-0042-118180
   United States Breast Feeding Committee U, 2011, STAT INF YOUNG CHILD
   United States Census Bureau (USCB), 2010, QUICK FACTS PUERT RI
   United States Census Bureau (USCB), 1931, NUMB DISTR INH TOT P
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
   Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779
   Williams D, 2004, J MIDWIFERY WOM HEAL, V49, P48, DOI 10.1016/j.jmwh.2004.04.030
NR 41
TC 0
Z9 0
U1 4
U2 5
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1092-7875
EI 1573-6628
J9 MATERN CHILD HLTH J
JI Matern. Child Health J.
PD JAN
PY 2020
VL 24
IS 1
BP 22
EP 29
DI 10.1007/s10995-019-02824-2
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KJ2GK
UT WOS:000511876000002
PM 31728717
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Tao, J
   Yao, HP
AF Tao, Jun
   Yao, Huipeng
TI Comprehensive analysis of the codon usage patterns of polyprotein of
   Zika virus
SO PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
LA English
DT Review
DE Zika virus; Codon usage; Evolutionary; Mutation pressure; Natural
   selection
ID TRANSLATIONAL SELECTION; BIAS; PRESSURE; GENE
AB Zika virus (ZIKV) is a mosquito-borne virus in the family Flaviviridae, and the massive outbreak of ZIKV has endangered public health. Codon usage patterns of viruses reflect a series of evolutionary changes that enable viruses to shape their survival rates and fitness toward the external environment and, most importantly, their hosts. In this study, 90 ZIKV isolates were used for a comprehensive analysis on the codon usage patterns. The overall codon usage among ZIKV strains is similar and slightly biased. The value of effective number of codons (ENC) showed that the overall extent of codon usage bias in ZIKV is relatively low. Nucleotide analysis showed that the overall codon usage is biased toward A- and G-ending codons. The phylogenetic analysis indicated that their independent evolutionary origins from a common ancestor. The RSCU analysis showed that the codon usage pattern of ZIKV is more similar to that of Homo sapiens. Correlation analysis, Correspondence analysis, ENC-GC(3s) plot, and PR2 plot indicated that the codon usage patterns of the viruses are not only influenced by mutational pressure but also by natural selection, but neutrality plot analysis showed that the latter plays a major role. These results built the base for further research on the molecular evolution of ZIKV. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Tao, Jun; Yao, Huipeng] Sichuan Agr Univ, Coll Life Sci, Yaan 625014, Sichuan, Peoples R China.
RP Yao, HP (corresponding author), Sichuan Agr Univ, Coll Life Sci, Yaan 625014, Sichuan, Peoples R China.
EM yaohuipeng0921@163.com
OI Huipeng, Yao/0000-0001-5078-6492
FU Discipline construction Double Support Project of Sichuan Agriculture
   University [00770114]
FX This work was supported by the research grants from the Discipline
   construction Double Support Project of Sichuan Agriculture University
   (00770114), in china.
CR Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Chen L, 2013, GENET MOL RES, V12, P587, DOI 10.4238/2013.February.27.8
   Chen Youhua, 2014, VirusDisease, V25, P285, DOI 10.1007/s13337-014-0191-2
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Kawabe A, 2003, GENES GENET SYST, V78, P343, DOI 10.1266/ggs.78.343
   Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154376
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68
   LOBRY JR, 1994, NUCLEIC ACIDS RES, V22, P3174, DOI 10.1093/nar/22.15.3174
   Ma YP, 2014, ARCH VIROL, V159, P1841, DOI 10.1007/s00705-014-2000-z
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Maurer-Stroh S., 2016, EUROPEAN COMMUNICABL, V21
   McLean E, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1304505
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4
   Peixoto L, 2003, GENE, V320, P109, DOI 10.1016/S0378-1119(03)00815-1
   Rao YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110381
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948
   Singh NK, 2017, ARCH VIROL, V162, P1963, DOI 10.1007/s00705-017-3324-2
   Singh Ravi K, 2017, Methods Mol Biol, V1640, P267, DOI 10.1007/978-1-4939-7165-7_20
   Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0
   SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z
   Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0
   Waterkeyn JG, 1998, EXP PARASITOL, V88, P76, DOI 10.1006/expr.1998.4215
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Yang X, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0527-1
   Zang MH, 2017, INFECT GENET EVOL, V54, P54, DOI 10.1016/j.meegid.2017.06.013
   Zhang YQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-174
NR 42
TC 0
Z9 1
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6107
J9 PROG BIOPHYS MOL BIO
JI Prog. Biophys. Mol. Biol.
PD JAN
PY 2020
VL 150
BP 43
EP 49
DI 10.1016/j.pbiomolbio.2019.05.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KH9GQ
UT WOS:000510957500003
PM 31054849
DA 2020-07-08
ER

PT J
AU Buchman, A
   Gamez, S
   Li, M
   Antoshechkin, I
   Li, HH
   Wang, HW
   Chen, CH
   Klein, MJ
   Duchemin, JB
   Crowe, JE
   Paradkar, PN
   Akbari, OS
AF Buchman, Anna
   Gamez, Stephanie
   Li, Ming
   Antoshechkin, Igor
   Li, Hsing-Han
   Wang, Hsin-Wei
   Chen, Chun-Hong
   Klein, Melissa J.
   Duchemin, Jean-Bernard
   Crowe, James E., Jr.
   Paradkar, Prasad N.
   Akbari, Omar S.
TI Broad dengue neutralization in mosquitoes expressing an engineered
   antibody
SO PLOS PATHOGENS
LA English
DT Article
ID INAPPROPRIATE SUBGROUP ANALYSES; YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI;
   GENE DRIVE; CAUSE HARM; VIRUS; WOLBACHIA; TRANSMISSION; STRAIN;
   CONTROVERSY
AB Author summary With limited success of traditional vector control methods to curb dengue infections and more than half of the world's population still at risk, there is a need for novel strategies to reduce its impact on public health. Recent advances in genetic technologies has allowed for precise modifications of mosquito genome to make them resistant to infections, thus breaking the transmission cycle. Here we generated engineered Ae. aegypti mosquitoes efficiently expressing a DENV-targeting single-chain variable fragment (scFv) derived from a previously characterized broadly neutralizing human antibody, which blocked infection and transmission in these mosquitoes. To our knowledge, this is the first example of an engineered transgene capable of rendering Ae. aegypti mosquitoes 100% refractory to all four serotypes of DENV. The engineered mosquitoes, in future, could easily be paired with a gene drive, capable of spreading the transgene throughout wild disease-transmitting mosquito populations and preventing further DENV transmission. Since a number of diverse and well-characterized antibodies exist against other arboviruses (eg chikungunya and Zika, this work also provides a proof-of-concept principle for developing similar genetic strategies for reducing the impact of these arboviruses.
   With dengue virus (DENV) becoming endemic in tropical and subtropical regions worldwide, there is a pressing global demand for effective strategies to control the mosquitoes that spread this disease. Recent advances in genetic engineering technologies have made it possible to create mosquitoes with reduced vector competence, limiting their ability to acquire and transmit pathogens. Here we describe the development of Aedes aegypti mosquitoes synthetically engineered to impede vector competence to DENV. These mosquitoes express a gene encoding an engineered single-chain variable fragment derived from a broadly neutralizing DENV human monoclonal antibody and have significantly reduced viral infection, dissemination, and transmission rates for all four major antigenically distinct DENV serotypes. Importantly, this is the first engineered approach that targets all DENV serotypes, which is crucial for effective disease suppression. These results provide a compelling route for developing effective genetic-based DENV control strategies, which could be extended to curtail other arboviruses.
C1 [Buchman, Anna; Gamez, Stephanie; Li, Ming; Akbari, Omar S.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.
   [Antoshechkin, Igor] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Li, Hsing-Han] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.
   [Li, Hsing-Han; Wang, Hsin-Wei; Chen, Chun-Hong] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.
   [Li, Hsing-Han; Wang, Hsin-Wei; Chen, Chun-Hong] Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Zhunan, Taiwan.
   [Klein, Melissa J.; Duchemin, Jean-Bernard; Paradkar, Prasad N.] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA.
   [Akbari, Omar S.] Tata Inst Genet & Soc UCSD, La Jolla, CA 92093 USA.
   [Duchemin, Jean-Bernard] Inst Pasteur, Cayenne, French Guiana.
RP Akbari, OS (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.; Paradkar, PN (corresponding author), CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.; Akbari, OS (corresponding author), Tata Inst Genet & Soc UCSD, La Jolla, CA 92093 USA.
EM Prasad.Paradkar@csiro.au; oakbari@ucsd.edu
RI Crowe, James E./B-5549-2009; Duchemin, Jean-Bernard/AAE-8077-2020
OI Crowe, James E./0000-0002-0049-1079; Duchemin,
   Jean-Bernard/0000-0001-5044-4855; CHEN, CHUN-HONG/0000-0002-3028-5508;
   Gamez, Stephanie/0000-0003-0665-0066
FU Defense Advanced Research Project Agency (DARPA) Safe Genes
   ProgramUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA) [HR0011-17-2-0047]; NIH
   Exploratory/Developmental Research Grant AwardUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [1R21AI123937]; CSIROCommonwealth Scientific & Industrial Research
   Organisation (CSIRO)
FX This work was supported in part by a Defense Advanced Research Project
   Agency (DARPA) Safe Genes Program Grant (HR0011-17-2-0047) awarded to
   O.S.A. and a NIH Exploratory/Developmental Research Grant Award
   (1R21AI123937) awarded to O.S.A and CSIRO internal funding to P.N.P. The
   funders had no role in study design, data collection, analysis, the
   decision to publish, nor the preparation of the manuscript
CR Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15
   [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y
   [Anonymous], 2018, VOX             0919
   [Anonymous], 2006, AM J KIDNEY DIS, V2006, pS176
   Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463
   Bhadauria V, 2017, NEXT GENERATION SEQU, DOI [10.1016/j.plantsci.2017.01.016, DOI 10.1016/J.PLANTSCI.2017.01.016]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Budigi Y, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006209
   Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chen ZJ, 2015, CELL REP, V13, P573, DOI 10.1016/j.celrep.2015.09.018
   Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]
   Dans AL, 2018, J CLIN EPIDEMIOL, V95, P137, DOI 10.1016/j.jclinepi.2017.11.019
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Edwards MJ, 2000, INSECT MOL BIOL, V9, P33, DOI 10.1046/j.1365-2583.2000.00159.x
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fernandez E, 2018, MBIO, V9, DOI [10.1128/mBio.00008-18, 10.1128/mbio.00008-18]
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Goo L, 2019, NAT MICROBIOL, V4, P71, DOI 10.1038/s41564-018-0283-7
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hadinegoro SRS, 2018, J CLIN EPIDEMIOL, V95, P140, DOI 10.1016/j.jclinepi.2017.12.024
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hudson PJ, 1999, J IMMUNOL METHODS, V231, P177, DOI 10.1016/S0022-1759(99)00157-X
   Imler J-L, 2018, F1000 POST PUBLICATI, DOI [10.3410/f.732369982.793541519, DOI 10.3410/F.732369982.793541519]
   Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109
   Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kandul NP, 2019, ASSESSMENT SPLIT HOM, DOI [10.1101/706929, DOI 10.1101/706929]
   Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07
   Li M., 2019, DEV CONFINABLE GENE, DOI [10.1101/645440, DOI 10.1101/645440]
   Li M, 2017, GERMLINE CAS9 EXPRES, DOI [10.1101/156778, DOI 10.1101/156778]
   Long F, 2019, P NATL ACAD SCI USA
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Macias VM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091006
   Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x
   Matthews BJ, 2017, IMPROVED AEDES AEGYP, DOI [10.1101/240747, DOI 10.1101/240747]
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   O'Neill SL, 2018, ADV EXP MED BIOL, V1062, P355, DOI 10.1007/978-981-10-8727-1_24
   Rajapakse Senaka, 2011, J Emerg Trauma Shock, V4, P120, DOI 10.4103/0974-2700.76835
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Selck FW, 2014, VECTOR-BORNE ZOONOT, V14, P824, DOI 10.1089/vbz.2013.1528
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870
   Smith SA, 2015, CELL HOST MICROBE, V18, P382, DOI 10.1016/j.chom.2015.08.002
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Sumitani M, 2013, INSECT MOL BIOL, V22, P41, DOI 10.1111/j.1365-2583.2012.01168.x
   Van P., 2009, J STAT MECH THEORY E, V2009, pP0254
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Whitehorn J, 2001, DENGUE FEVER VIRUSES
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yamanaka A, 2013, J VIROL, V87, P12828, DOI 10.1128/JVI.01874-13
   Yusakul G, 2016, BIOSCI BIOTECH BIOCH, V80, P1306, DOI 10.1080/09168451.2016.1156482
   Zou G, 2012, ANTIVIR RES, V95, P216, DOI 10.1016/j.antiviral.2012.06.010
   2017, COLORECTAL DIS, V19
NR 79
TC 2
Z9 2
U1 8
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JAN
PY 2020
VL 16
IS 1
AR e1008103
DI 10.1371/journal.ppat.1008103; 10.1371/journal.ppat.1008103.r001;
   10.1371/journal.ppat.1008103.r002; 10.1371/journal.ppat.1008103.r003;
   10.1371/journal.ppat.1008103.r004
PG 20
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA KH6FM
UT WOS:000510746400037
PM 31945137
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Meng, YJ
   Zhang, YZ
   Wang, SW
   Wu, SY
   Zhou, HN
   Ke, CW
   Qi, XP
   Rainey, JJ
AF Meng, Yujie
   Zhang, Yuzhi
   Wang, Songwang
   Wu, Shuyu
   Zhou, Hongning
   Ke, Changwen
   Qi, Xiaopeng
   Rainey, Jeanette J.
TI Lessons Learned in the Development of a Web-based Surveillance Reporting
   System and Dashboard to Monitor Acute Febrile Illnesses in Guangdong and
   Yunnan Provinces, China, 2017-2019
SO HEALTH SECURITY
LA English
DT Article
DE Web-based surveillance; Surveillance; Dashboard; Acute febrile
   illnesses; Zika; China
AB Global spread of Zika virus in 2015 and 2016 highlighted the importance of surveillance to rapidly detect, report, and respond to emerging infections. We describe the lessons learned from the development and deployment of a web-based surveillance reporting system for Zika virus and other acute febrile illnesses (AFI) in Guangdong and Yunnan provinces, China. In less than 2 months, we customized the China Epidemiologic Dynamic Data Collection (EDDC) platform to collect, manage, and visualize data in close to real time. According to provincial and sentinel hospital staff requirements, the customized platform provided specific user authorization management, online/offline data collection, data quality control, and secure data transmission and protection and visualization tools. AFI case data and laboratory test results were entered through a web-based interface by hospital and provincial-level staff and saved on a China CDC server in Beijing. The dashboard visualized aggregate data by hospital, age, onset date, and laboratory test results. From June 2017 to December 2018, data from 768 patients with AFI were entered into the web-based surveillance system and visualized by hospital and provincial-level decision makers. Input from provincial and hospital staff was essential for developing the AFI case-reporting and feedback tools appropriate for specific settings and decision-making requirements. Web-based systems (eg, EDDC, data collection, and visualization tools that can be easily adapted to meet local surveillance needs) can help shorten time for system deployment, thereby strengthening global health security to rapidly detect and respond to emerging infections and outbreaks.
C1 [Meng, Yujie; Wang, Songwang] Chinese Ctr Dis Control & Prevent, Informat Ctr, Beijing, Peoples R China.
   [Qi, Xiaopeng] Chinese Ctr Dis Control & Prevent, Ctr Global Publ Hlth, 155 Changbai Rd, Beijing 102206, Peoples R China.
   [Zhang, Yuzhi; Wu, Shuyu; Rainey, Jeanette J.] Country Off China, US Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Beijing, Peoples R China.
   [Zhou, Hongning] Yunnan Inst Parasit Dis, Puer, Peoples R China.
   [Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Inst Pathogen Microbiol, Guangzhou, Peoples R China.
RP Qi, XP (corresponding author), Chinese Ctr Dis Control & Prevent, Ctr Global Publ Hlth, 155 Changbai Rd, Beijing 102206, Peoples R China.
EM qixp@chinacdc.cn
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012
   Kamadjeu Raoul, 2017, Pan Afr Med J, V27, P22, DOI 10.11604/pamj.supp.2017.27.3.11062
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Liu J, 2016, J CLIN MICROBIOL, V54, P49, DOI 10.1128/JCM.02257-15
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Qi XP, 2014, STUD HEALTH TECHNOL, V204, P123, DOI 10.3233/978-1-61499-427-5-123
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Revere Debra, 2014, EGEMS (Wash DC), V2, P1082, DOI 10.13063/2327-9214.1082
   Richards CL, 2017, PUBLIC HEALTH REP, V132, P403, DOI 10.1177/0033354917709542
   Robertson C, 2010, EMERG INFECT DIS, V16, P1524, DOI 10.3201/eid1610.100249
   Sacks JA, 2015, GLOB HEALTH-SCI PRAC, V3, P646, DOI 10.9745/GHSP-D-15-00207
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   WHO, 2017, ZIK SIT REP
NR 14
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD JAN 1
PY 2020
VL 18
SU 1
BP S14
EP S22
DI 10.1089/hs.2019.0079
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KH0HS
UT WOS:000510329600004
PM 32004129
OA Bronze
DA 2020-07-08
ER

PT J
AU Chumsri, A
   Tina, FW
   Jaroensutasinee, M
   Jaroensutasinee, K
AF Chumsri, Anantanit
   Tina, Fahmida Wazed
   Jaroensutasinee, Mullica
   Jaroensutasinee, Krisanadej
TI Seasons and water container types affecting Culex spp. in southern
   Thailand
SO JOURNAL OF ANIMAL BEHAVIOUR AND BIOMETEOROLOGY
LA English
DT Article
DE dry and wet seasons; Lansaka district; mosquito larvae; Nakhon Si
   Thammarat; positive containers
ID AEDES-AEGYPTI DIPTERA; BREEDING MOSQUITOS; PREVALENCE; VECTOR; LARVAE;
   ALBOPICTUS; CULICIDAE; DISTRICT; STATE
AB Usually, Culex mosquitoes are responsible for spreading several human diseases such as malaria, Japanese encephalitis, yellow fever, filariasis, and Zika. Lymphatic filariasis and Zika cases are increasing in Thailand with more prevalent in southern Thailand. In this study, our aim is to examine how seasons and water container types affect Culex spp. larvae numbers in Lansaka district, Nakhon Si Thammarat province, southern Thailand. This study was conducted in five sub-districts (Lansaka, Khaokaew, Thadi, Kamlon, and Khunthale) in Lansaka district. In each sub-district, 120 houses were randomly selected to study the breeding sites of Culex mosquito in dry (March-May, 2018) and wet (October-December, 2018) seasons. Mosquito larvae were collected from indoor, outdoor, natural, artificial, dark-coloured, light-coloured, with lid, and without lid containers. It was observed that in all sub-districts, Culex larvae numbers were higher in dry season compared to wet season. In both seasons, outdoor, without lid, dark-coloured, and artificial containers contained more Culex larvae than inside, with lid, light-coloured, and natural containers, respectively. This study shows that seasons and water container types affect Culex mosquito larvae. Since the larvae numbers are higher in dry season, as well as in outdoor, without lid, dark-coloured, and artificial containers, people should reduce the usage of these containers, especially in the dry season, to prevent Culex borne diseases.
C1 [Chumsri, Anantanit; Jaroensutasinee, Mullica; Jaroensutasinee, Krisanadej] Walailak Univ, Sch Sci, Ctr Excellence Ecoinformat, Thai Buri 80161, Nakhon Si Thamm, Thailand.
   [Tina, Fahmida Wazed] Nakhon Si Thammarat Rajabhat Univ, Tha Ngio 80280, Nakhon Si Thamm, Thailand.
RP Jaroensutasinee, M (corresponding author), Walailak Univ, Sch Sci, Ctr Excellence Ecoinformat, Thai Buri 80161, Nakhon Si Thamm, Thailand.
EM mullica.jn@gmail.com
OI Tina, Fahmida Wazed/0000-0001-9040-8947
FU Centre of Excellence for Ecoinformatics, Walailak University, Thailand
FX We sincerely thank Mr. John Barker for improving the English text of
   this manuscript. The authors are grateful to the Centre of Excellence
   for Ecoinformatics, Walailak University, Thailand for financial
   supports.
CR Ahmed Tauhid U., 2007, Bangladesh Journal of Zoology, V35, P205
   [Anonymous], 2018, ANN EP SURV REP
   Aziz Al Thabiany, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P849, DOI 10.1016/S2221-1691(12)60242-1
   Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031
   Chandra G, 2013, BIOLOGICAL AND ENVIRONMENTAL CONTROL OF DISEASE VECTORS, P25, DOI 10.1079/9781845939861.0025
   Chen Chee Dhang, 2005, Trop Biomed, V22, P39
   Chumsri A, 2018, TROP BIOMED, V35, P111
   Collins LE, 2000, J VECTOR ECOL, V25, P127
   Dass K, 2014, INT J MOSQ RES, V1, P25
   Dom NC, 2013, PROCD SOC BEHV, V85, P100, DOI 10.1016/j.sbspro.2013.08.342
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Govoetchan R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-79
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hirzel A, 2002, ECOL MODEL, V157, P331, DOI 10.1016/S0304-3800(02)00203-X
   Hribar LJ, 2007, J WATER HEALTH, V5, P97, DOI 10.2166/wh.2006.053
   Idowu OA, 2012, J ENV HLTH RES, V12, P25
   Kiarie-Makara MW, 2015, IOSR J PHARM BIOMEDI, V10, P1
   Kumar R, 2014, PEDIATR HEALTH MED T, V5, P99, DOI 10.2147/PHMT.S49049
   Lalubin F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-307
   Lambdin BH, 2009, AM J TROP MED HYG, V81, P1013, DOI 10.4269/ajtmh.2009.09-0115
   Loetti V, 2011, NEOTROP ENTOMOL, V40, P138, DOI 10.1590/S1519-566X2011000100021
   Mahadev PVM, 2004, INDIAN J MED RES, V120, P173
   Manyi M.M., 2014, International Journal of Mosquito Research, V1, P1
   Nadeeka PVJ, 2014, J EXP BIOL AGRIC SCI, V2, P157
   Panigrahi SK, 2014, J INSECTS, V2014, DOI DOI 10.1155/2014/207489
   Perea NO, 2017, PEERJ, V5, DOI 10.7717/peerj.3361
   Phuanukoonnon S, 2005, TROP MED INT HEALTH, V10, P755, DOI 10.1111/j.1365-3156.2005.01452.x
   Preechaporn W., 2007, WORLD ACAD SCI ENG T, V36, P23
   Promprou S., 2005, Dengue Bulletin, V29, P41
   Promprou S, 2007, WALAILAK J SCI TECHN, V4, P9
   RAJESH K, 2013, J ENTOMOL ZOOL STU B, V1, P88
   Rattanarithikul R, 1996, AM J TROP MED HYG, V54, P114, DOI 10.4269/ajtmh.1996.54.114
   Rattanarithikul Rampa, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P1
   Shad Amitabh, 2016, International Journal of Mosquito Research, V3, P52
   Thete K. D., 2013, Biological Forum, V5, P124
   Vijayakumar K, 2014, J VECTOR DIS, V51, P27
   Webb C, 2016, GUIDE MOSQUITOES AUS
   Williams RE, 1962, THESIS
   Wongkoon S., 2007, Dengue Bulletin, V31, P141
   Wongkoon S, 2007, WORLD ACAD SCI ENG T, V33, P5
NR 43
TC 0
Z9 0
U1 1
U2 1
PU MALQUE PUBLISHING
PI MOSSORO
PA RUA DA PITOMBA, 703, MOSSORO, 59630-830, BRAZIL
EI 2318-1265
J9 J ANIM BEHAV BIOMETE
JI J. Anim. Behav. Biometeorol.
PD JAN
PY 2020
VL 8
IS 1
BP 55
EP 62
DI 10.31893/jabb.20008
PG 8
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA KG5KK
UT WOS:000509987300008
OA Bronze
DA 2020-07-08
ER

PT J
AU Montes-Grajales, D
   Puerta-Guardo, H
   Espinosa, DA
   Harris, E
   Caicedo-Torres, W
   Olivero-Verbel, J
   Martinez-Romero, E
AF Montes-Grajales, Diana
   Puerta-Guardo, Henry
   Espinosa, Diego A.
   Harris, Eva
   Caicedo-Torres, William
   Olivero-Verbel, Jesus
   Martinez-Romero, Esperanza
TI In silico drug repurposing for the identification of potential candidate
   molecules against arboviruses infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Dengue; Zika; Chikungunya; Virtual screening; Antiviral; Virus entry
ID VIRUS ENVELOPE PROTEIN; ANTIFUNGAL ACTIVITY; DENGUE; CHIKUNGUNYA;
   REPLICATION; ENTRY; GLYCOPROTEIN; INHIBITORS; DISCOVERY; TARGETS
AB Arboviral diseases caused by dengue (DENV), Zika (ZIKV) and chikungunya (CHIKV) viruses represent a major public health problem worldwide, especially in tropical areas where millions of infections occur every year. The aim of this research was to identify candidate molecules for the treatment of these diseases among the drugs currently available in the market, through in silico screening and subsequent in vitro evaluation with cell culture models of DENV and ZIKV infections. Numerous pharmaceutical compounds from antibiotics to chemotherapeutic agents presented high in silico binding affinity for the viral proteins, including ergotamine, antrafenine, natamycin, pranlukast, nilotinib, itraconazole, conivaptan and novobiocin. These five last compounds were tested in vitro, being pranlukast the one that exhibited the best antiviral activity. Further in vitro assays for this compound showed a significant inhibitory effect on DENV and ZIKV infection of human monocytic cells and human hepatocytes (Huh-7 cells) with potential abrogation of virus entry. Finally, intrinsic fluorescence analyses suggest that pranlukast may have some level of interaction with three viral proteins of DENV: envelope, capsid, and NS1. Due to its promising results, suitable accessibility in the market and reduced restrictions compared to other pharmaceuticals; the anti-asthmatic pranlukast is proposed as a drug candidate against DENV, ZIKV, and CHIKV, supporting further in vitro and in vivo assessment of the potential of this and other lead compounds that exhibited good affinity scores in silico as therapeutic agents or scaffolds for the development of new drugs against arboviral diseases.
C1 [Montes-Grajales, Diana; Olivero-Verbel, Jesus] Univ Cartagena, Sch Pharmaceut Sci, Environm & Computat Chem Grp, Zaragocilla Campus, Cartagena 130015, Colombia.
   [Puerta-Guardo, Henry; Espinosa, Diego A.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Caicedo-Torres, William] Univ Tecnol Bolivar, Sch Engn, Grp Invest Tecnol Aplicadas & Sistemas Informac, Cartagena 130010, Colombia.
   [Martinez-Romero, Esperanza] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, 565-A, Cuernavaca, Morelos, Mexico.
RP Montes-Grajales, D (corresponding author), Univ Cartagena, Sch Pharmaceut Sci, Environm & Computat Chem Grp, Zaragocilla Campus, Cartagena 130015, Colombia.
EM dmontesg@unicartagena.edu.co
FU Administrative Department of Science, Technology and Innovation of
   Colombia [Grant: Colciencias] [811-2018]; Universidad Nacional Autonoma
   de Mexico [Grant: Programa de Becas Posdoctorales en la UNAM 2016];
   Universidad Tecnologica de Bolivar [TRFCI-1P2016]; National Institutes
   of Health [NIH]United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI24493]
FX The authors wish to thank the Administrative Department of Science,
   Technology and Innovation of Colombia [Grant: Colciencias No. 811-2018],
   Universidad Nacional Autonoma de Mexico [Grant: Programa de Becas
   Posdoctorales en la UNAM 2016], Universidad Tecnologica de Bolivar
   [Grant: TRFCI-1P2016] and the National Institutes of Health [NIH grant
   R01 AI24493] for their financial support.
CR Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478
   Afzal O, 2015, EUR J MED CHEM, V97, P871, DOI 10.1016/j.ejmech.2014.07.044
   Aguiar M, 2018, LANCET INFECT DIS, V18, P245, DOI 10.1016/S1473-3099(17)30752-1
   Ahola T., 2016, CHIKUNGUNYA VIRUS AD, P75, DOI [10.1007/978-3-319-42958-8_6, DOI 10.1007/978-3-319-42958-8]
   Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Annane D, 2009, AM J MED SCI, V337, P28, DOI 10.1097/MAJ.0b013e31817b8148
   Balaguer MP, 2014, INT J FOOD MICROBIOL, V173, P62, DOI 10.1016/j.ijfoodmicro.2013.12.013
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   CarriloMunoz AJ, 1996, J ANTIMICROB CHEMOTH, V37, P815, DOI 10.1093/jac/37.4.815
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   CHANT C, 1995, ANN PHARMACOTHER, V29, P1022, DOI 10.1177/106002809502901013
   Chen YP, 1996, J VIROL, V70, P8765, DOI 10.1128/JVI.70.12.8765-8772.1996
   Cholo MC, 2017, J ANTIMICROB CHEMOTH, V72, P338, DOI 10.1093/jac/dkw426
   Oliveira AFCD, 2017, MOLECULES, V22, DOI 10.3390/molecules22030505
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Silva AM, 2018, ADV EXP MED BIOL, V1062, P107, DOI 10.1007/978-981-10-8727-1_8
   DEGARA C, 1982, POSTGRAD MED J, V58, P489, DOI 10.1136/pgmj.58.682.489
   Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   Eglen R.M., 2000, VIRTUAL SCREENING BI, V10, P59
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FINLAY AC, 1951, AM REV TUBERC PULM, V63, P1
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Fros JJ, 2015, J GEN VIROL, V96, P580, DOI 10.1099/vir.0.071845-0
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Garoff H, 2004, VIRUS RES, V106, P103, DOI 10.1016/j.virusres.2004.08.008
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Gonzalez-Molleda L, 2012, ANTIMICROB AGENTS CH, V56, P893, DOI 10.1128/AAC.05274-11
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Henss L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0607-2
   Iakovlev V P, 1994, Antibiot Khimioter, V39, P56
   Keam SJ, 2003, DRUGS, V63, P991, DOI 10.2165/00003495-200363100-00005
   Kielian M, 2010, VIRUSES-BASEL, V2, P796, DOI 10.3390/v2040796
   Kim Seo W, 2016, Open Respir Med J, V10, P36, DOI 10.2174/1874306401610010036
   Klumpp K, 2014, CURR OPIN VIROL, V5, P63, DOI 10.1016/j.coviro.2014.02.002
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Langedijk J., 2016, CONTINUOUS INNOVATIO
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Ma DL, 2013, CHEM SOC REV, V42, P2130, DOI 10.1039/c2cs35357a
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3
   MARSH M, 1993, REV MED VIROL, V3, P173, DOI 10.1002/rmv.1980030307
   Mas Vicente, 2013, Subcell Biochem, V68, P467, DOI 10.1007/978-94-007-6552-8_16
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   MAZZOLA EP, 1980, J PHARM SCI-US, V69, P229, DOI 10.1002/jps.2600690236
   Mehndiratta M. M., 2016, INT J EPILEPSY, V3, P91, DOI DOI 10.1016/J.IJEP.2016.09.002
   Meyers CLF, 2003, BIOCHEMISTRY-US, V42, P4179, DOI 10.1021/bi0340088
   Mishra P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20122
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Montes-Grajales D., 2013, J BRAZILIAN CHEM SOC
   Montes-Grajales D, 2016, CHEM RES TOXICOL, V29, P150, DOI 10.1021/acs.chemrestox.5b00342
   Montes-Grajales D, 2013, TOXICOL LETT, V222, P312, DOI 10.1016/j.toxlet.2013.08.010
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nolting A, 1996, PHARM RES-DORDR, V13, P91, DOI 10.1023/A:1016085402278
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   O'Connor KA, 2005, NAT REV DRUG DISCOV, V4, P1005, DOI 10.1038/nrd1900
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Patil R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012029
   Calvo EP, 2016, BIOMEDICA, V36, P35, DOI 10.7705/biomedica.v36i0.2982
   Pfaller MA, 2017, DIAGN MICR INFEC DIS, V88, P177, DOI 10.1016/j.diagmicrobio.2017.02.020
   Pu SY, 2018, ANTIVIR RES, V155, P67, DOI 10.1016/j.antiviral.2018.05.001
   Puerta-Guardo H, 2020, J INFECT DIS, V221, P313, DOI 10.1093/infdis/jiz331
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   R Core Team, 2016, LANG ENV STAT COMP
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Schneider M, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.06.001
   Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6
   Sekiguchi JA, 1997, VIROLOGY, V235, P129, DOI 10.1006/viro.1997.8684
   Bastos LFS, 2014, CNS DRUGS, V28, P45, DOI 10.1007/s40263-013-0128-0
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003
   STEIN CA, 1989, J CLIN ONCOL, V7, P499, DOI 10.1200/JCO.1989.7.4.499
   Subudhi BB, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050235
   Tfelt-Hansen PC, 2008, CEPHALALGIA, V28, P877, DOI 10.1111/j.1468-2982.2008.01578.x
   Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Walker T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-382
   Warnes GR, 2009, GPLOTS VARIOUS R PRO
   WEAVER SC, 2014, TROP DIS, V8, DOI DOI 10.1371/JOURNAL.PNTD.0002921
   WEBER C, 2017, TROP DIS, V11, DOI DOI 10.1371/JOURNAL.PNTD.0005318
   Whitehead SS, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028811
   WHO, 2018, ZIK VIR
   Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e
   Wolf D., 2012, AM SOC HEMATOL, V120, P4666
   World Health Organization, 2016, FACSH DENG SEV DENG
   World Health Organization, 2017, CHIK
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104
   Zhang J, 2017, EXPERT SYST APPL, V84, P281, DOI 10.1016/j.eswa.2017.05.004
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   ZUCKERMAN JM, 1994, INFECT CONT HOSP EP, V15, P397, DOI 10.1086/646938
NR 115
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2020
VL 173
AR 104668
DI 10.1016/j.antiviral.2019.104668
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KH6JO
UT WOS:000510757900010
PM 31786251
OA Bronze
DA 2020-07-08
ER

PT J
AU Bahk, YY
   Jun, H
   Jegal, S
   Kim-Jeon, MD
   Roh, JY
   Lee, WG
   Park, SH
   Ahn, SK
   Lee, J
   Gong, YW
   Kwon, MJ
   Kim, TS
AF Bahk, Young Yil
   Jun, Hojong
   Jegal, Seung
   Kim-Jeon, Myung-Deok
   Roh, Jong Yul
   Lee, Wook-Gyo
   Park, Seo Hye
   Ahn, Seong Kyu
   Lee, Jinyoung
   Gong, Young Woo
   Kwon, Mun Ju
   Kim, Tong-Soo
TI Flaviviral disease mosquito vector surveillance in Incheon Metropolitan
   City and the Hwaseong area, Gyeonggi-Do, Republic of Korea, in 2015
SO ENTOMOLOGICAL RESEARCH
LA English
DT Article
DE climate change; Flavivirus; Hwaseong; Incheon; mosquito; surveillance;
   vector-borne diseases
ID JAPANESE ENCEPHALITIS-VIRUS; CLIMATE-CHANGE; DIPTERA-CULICIDAE; CHAOYANG
   VIRUS; SOUTH-KOREA; EVOLUTION; MALARIA; ZIKA
AB Owing to global climate change, the global resurgence of vector-borne infectious diseases and their potential to inflict widespread casualties among human populations has emerged as a pivotal burden on public health systems. In this study, the prevalence of flaviviral diseases transmitted by mosquitoes, and their target vector diversity, abundance, and distribution was investigated to enable the mapping of hotspots for these diseases. For the surveillance of the vector mosquitoes carrying flaviviruses during April to November 2015, female mosquitoes were collected to study whether they carried pathogens from abroad at seven locations in Incheon Metropolitan City (Incheon) as a typical urban area and Hwaseong-si (= city, Hwaseong) of Gyeonggi-do (= province) as a rural area. A total of 15 species belonging to seven genera (29,102 female mosquitoes) were collected with black-light and BG-Sentinel (TM) traps at a collection rate of 260 per trap/night from whole collection locations. The most collected mosquito species in Incheon were Aedes vexans nipponii (species ratio (SR), 29.9%) and the Culex pipiens complex (SR, 28.8%), followed by Anopheles sinensis s.l. (SR, 27.9%) and Ochlerotatus koreicus (SR, 7.1%). From the results of viral RNA detection, five flaviviruses were found in 20,981 individuals (excluding An. sinensis; 696 pools) in the Cx. pipiens complex and Ae. vexans nipponii. Three Japanese encephalitis virus (JEV)-positive pools were from the Cx. pipiens complex, a Chaoyang virus pool was found from Ae. vexans nipponii, and the remaining unidentified flavivirus pool was from Cx. pipiens. The three JEV-positive pools were phylogenetically grouped as genotype V. The results of our study demonstrate that enhanced monitoring and long-term surveillance of these vector viruses are of great public health importance.
C1 [Bahk, Young Yil] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea.
   [Jun, Hojong; Park, Seo Hye; Ahn, Seong Kyu; Lee, Jinyoung; Kim, Tong-Soo] Inha Univ, Coll Med, Dept Trop Med, Incheon, South Korea.
   [Jegal, Seung; Kim-Jeon, Myung-Deok; Gong, Young Woo; Kwon, Mun Ju] Incheon Metropolitan City Inst Public Hlth & Envi, Dept Infect Dis Diag, Incheon, South Korea.
   [Roh, Jong Yul; Lee, Wook-Gyo] Korea Ctr Dis Control & Prevent, Div Vectors & Parasit Dis, Osong, South Korea.
RP Kim, TS (corresponding author), Inha Univ, Sch Med, Dept Parasitol & Trop Med, Incheon 22212, South Korea.
EM tongsookim@inha.ac.kr
CR Bahk YY, 2018, KOREAN J PARASITOL, V56, P205, DOI [10.3347/kjp.2018.56.2.205, 10.3347/kjp.2018.56.6.531]
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Braks M, 2014, INT J ENV RES PUB HE, V11, P13, DOI 10.3390/ijerph110100013
   Wilke ABB, 2017, ACTA TROP, V166, P343, DOI 10.1016/j.actatropica.2016.10.025
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang KS, 2018, AM J TROP MED HYG, V98, P166, DOI 10.4269/ajtmh.17-0587
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x
   Chen WR, 1990, J GEN VIROL, V71, P61
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Honnen AC, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex086
   KCDC, 2016, DIS WEB STAT SYST
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kim H. C., 2004, Entomological Research, V34, P177, DOI 10.1111/j.1748-5967.2004.tb00111.x
   Kim HC, 2015, MIL MED, V180, P158, DOI 10.7205/MILMED-D-14-00206
   Kim HC, 2011, J MED ENTOMOL, V48, P1250, DOI 10.1603/ME11091
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Kovats S, 1995, Med War, V11, P168, DOI 10.1080/07488009508409236
   Lee H.Y., 2015, PUBLIC HLTH WKLY REP, V8, P433
   Lee H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199205
   Lee JS, 2013, VIROLOGY, V435, P220, DOI 10.1016/j.virol.2012.10.020
   Lee KW, 1999, REVISION ILLUSTRATED, P40
   Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087
   Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Min SK, 2013, J CLIMATE, V26, P7430, DOI 10.1175/JCLI-D-12-00551.1
   Ogden NH, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx186
   Park S, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014030
   Reinert JF, 2001, J AM MOSQUITO CONTR, V17, P51
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143
   Sohn YM, 2000, EMERG INFECT DIS, V6, P17
   Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003
   Sunwoo JS, 2016, EMERG INFECT DIS, V22, P1841, DOI 10.3201/eid2210.160288
   Takhampunya R, 2014, J MED ENTOMOL, V51, P464, DOI 10.1603/ME13033
   Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449
   Tanaka K, 1979, REVISION ADULT LARVA, V16
   Wang Z.S., 2009, CHIN J PUBLIC HLTH, V25, P769
   WATSON RT, 1998, REGIONAL IMPACTS CLI
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Yang CF, 2010, J VIROL METHODS, V168, P147, DOI 10.1016/j.jviromet.2010.05.006
   Yeom JS, 2017, J KOREAN MED ASSOC, V60, P468, DOI 10.5124/jkma.2017.60.6.468
   Yun SM, 1994, VIROL J, V145, P93
NR 47
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1738-2297
EI 1748-5967
J9 ENTOMOL RES
JI Entomol. Res.
PD JAN
PY 2020
VL 50
IS 1
BP 3
EP 13
DI 10.1111/1748-5967.12417
PG 11
WC Entomology
SC Entomology
GA KF4LF
UT WOS:000509215000001
OA Bronze
DA 2020-07-08
ER

PT J
AU Pereira, AM
   Araujo, E
   Werner, H
   Monteiro, DLM
AF Pereira, Alessandra Mendelski
   Araujo Junior, Edward
   Werner, Heron
   Maia Monteiro, Denise Leite
TI Zika Virus and Pregnancy: Association between Acute Infection and
   Microcephaly in Newborns in the State of Rio de Janeiro, Brazil
SO GEBURTSHILFE UND FRAUENHEILKUNDE
LA English
DT Article
DE congenital infection; Zika virus; microcephaly; low birth weight; first
   trimester of pregnancy
ID NEUROIMAGING FINDINGS; OUTBREAK; FETAL
AB Introduction Aim of the study was to evaluate the association between microcephaly and acute infection with Zika virus (ZIKV) in pregnant women in the state of Rio de Janeiro, Brazil. Infection was confirmed by laboratory testing. Materials and Methods A cross-sectional retrospective study of pregnant women with symptoms occurring between 2015 and 2016 suggestive of acute ZIKV infection was carried out, with confirmation of infection done by blood or urine RT-PCR. The relative proportions of categorical variables were calculated for two distinct groups: pregnant women whose newborns had microcephaly and pregnant women who gave birth to infants without microcephaly. Confidence intervals with a 95% level of agreement were estimated for the relative ratios. Results A total of 1609 pregnant women with a mean age of 26.4 +/- 6.5 years were evaluated. As regards the time of acute infection, 19.6% (316) of cases occurred in the first trimester of pregnancy. Nineteen (76%) of the 25 cases with microcephaly (1.5%) were associated with an infection contracted in the first trimester of pregnancy (p < 0.001, OR = 13.7, 95% CI: 5.6 - 37.7). 48% (12/25) of the newborns with microcephaly had a birth weight of < 2500 grams, while only 7% (116/1597) of the group of newborns without microcephaly had a similarly low birth weight (p < 0.001, OR = 11.7, 95% CI: 5.2 - 26.2). Logistic regression showed that a birth weight of < 2500 g (OR = 12.54) and ZIKV infection in the first trimester of pregnancy (OR = 14.05) were associated with microcephaly (area under ROC curve = 0.86). Conclusion Acute ZIKV infection in the first trimester of pregnancy and low birth weight are associated with microcephaly.
C1 [Pereira, Alessandra Mendelski; Maia Monteiro, Denise Leite] State Univ Rio De Janeiro UERJ, Perinatal Unit, Rio De Janeiro, RJ, Brazil.
   [Araujo Junior, Edward] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Sao Paulo, SP, Brazil.
   [Araujo Junior, Edward] Municipal Univ Sao Caetano USCS, Med Course, Sao Paulo, SP, Brazil.
   [Werner, Heron] Clin Diagnost Imagem CPDI, Dept Radiol, Rio De Janeiro, RJ, Brazil.
RP Araujo, E (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Obstet, Rua Belchior Azevedo,156 Apto,111 Torre Vitoria, BR-05089030 Sao Paulo, SP, Brazil.
EM araujojred@terra.com.br
CR Araujo E, 2017, CURR OPIN OBSTET GYN, V29, P95, DOI 10.1097/GCO.0000000000000345
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carvalho-Sauer R, 2019, INT J INFECT DIS, V82, P44, DOI 10.1016/j.ijid.2019.02.040
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ximenes ASFC, 2019, J MATERN-FETAL NEO M, V32, P493, DOI 10.1080/14767058.2017.1384459
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pereira AM, 2018, J TURK-GER GYNECOL A, V19, P39, DOI 10.4274/jtgga.2017.0072
   Pires P, 2018, CHILD NERV SYST, V34, P957, DOI 10.1007/s00381-017-3682-9
   Ramalho Rocha Yuri Raoni, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.e854dbf51b8075431a05b39042c00244
   Rick AM, 2017, GLOB HEALTH-SCI PRAC, V5, P686, DOI 10.9745/GHSP-D-17-00116
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
NR 25
TC 0
Z9 0
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0016-5751
EI 1438-8804
J9 GEBURTSH FRAUENHEILK
JI Geburtshilfe Frauenheilkd.
PD JAN
PY 2020
VL 80
IS 1
BP 60
EP 65
DI 10.1055/a-0972-2052
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KF0PI
UT WOS:000508953300010
PM 31949320
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Halani, S
   Tombindo, P
   O'Reilly, R
   Bielecki, JM
   Boyle, J
   Erdman, L
   Miranda, RN
   Morris, S
   Murphy, K
   Ramsay, L
   Whitehead, C
   Ximenes, R
   Sander, B
AF Halani, Sheliza
   Tombindo, Panashe
   O'Reilly, Ryan
   Bielecki, Joanna M.
   Boyle, Justin
   Erdman, Laura
   Miranda, Rafael N.
   Morris, Shaun
   Murphy, Kellie
   Ramsay, Lauren
   Whitehead, Clare
   Ximenes, Raphael
   Sander, Beate
TI CLINICAL MANIFESTATIONS AND HEALTH OUTCOMES ASSOCIATED WITH ZIKA VIRUS
   INFECTIONS IN ADULTS: A SYSTEMATIC REVIEW
SO MEDICAL DECISION MAKING
LA English
DT Meeting Abstract
C1 [Halani, Sheliza; Tombindo, Panashe; Boyle, Justin; Ramsay, Lauren] Univ Toronto, Toronto, ON, Canada.
   [O'Reilly, Ryan] Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Bielecki, Joanna M.; Miranda, Rafael N.; Ximenes, Raphael] Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada.
   [Erdman, Laura; Morris, Shaun] Hosp Sick Children, Toronto, ON, Canada.
   [Murphy, Kellie; Whitehead, Clare] Mt Sinai Hosp, Toronto, ON, Canada.
   [Ximenes, Raphael] Univ Hlth Network, Toronto, ON, Canada.
   [Sander, Beate] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Sander, Beate] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada.
   [Sander, Beate] Inst Clin Evaluat Sci, Toronto, ON, Canada.
   [Sander, Beate] Publ Hlth Ontario, Toronto, ON, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0272-989X
EI 1552-681X
J9 MED DECIS MAKING
JI Med. Decis. Mak.
PD JAN
PY 2020
VL 40
IS 1
MA PS 4-31
BP E231
EP E232
PG 2
WC Health Care Sciences & Services; Health Policy & Services; Medical
   Informatics
SC Health Care Sciences & Services; Medical Informatics
GA KF5IM
UT WOS:000509275600199
DA 2020-07-08
ER

PT J
AU Barbeito-Andres, J
   Pezzuto, P
   Higa, LM
   Dias, AA
   Vasconcelos, JM
   Santos, TMP
   Ferreira, JCCG
   Ferreira, RO
   Dutra, FF
   Rossi, AD
   Barbosa, RV
   Amorim, CKN
   De Souza, MPC
   Chimelli, L
   Aguiar, RS
   Gonzalez, PN
   Lara, FA
   Castro, MC
   Molnar, Z
   Lopes, RT
   Bozza, MT
   Vianez, JLSG
   Barbeito, CG
   Cuervo, P
   Bellio, M
   Tanuri, A
   Garcez, PP
AF Barbeito-Andres, J.
   Pezzuto, P.
   Higa, L. M.
   Dias, A. A.
   Vasconcelos, J. M.
   Santos, T. M. P.
   Ferreira, J. C. C. G.
   Ferreira, R. O.
   Dutra, F. F.
   Rossi, A. D.
   Barbosa, R., V
   Amorim, C. K. N.
   De Souza, M. P. C.
   Chimelli, L.
   Aguiar, R. S.
   Gonzalez, P. N.
   Lara, F. A.
   Castro, M. C.
   Molnar, Z.
   Lopes, R. T.
   Bozza, M. T.
   Vianez, J. L. S. G.
   Barbeito, C. G.
   Cuervo, P.
   Bellio, M.
   Tanuri, A.
   Garcez, P. P.
TI Congenital Zika syndrome is associated with maternal protein
   malnutrition
SO SCIENCE ADVANCES
LA English
DT Article
ID INFECTION; NUTRITION; GROWTH; MODEL; MICE
AB Zika virus (ZIKV) infection during pregnancy is associated with a spectrum of developmental impairments known as congenital Zika syndrome (CZS). The prevalence of this syndrome varies across ZIKV endemic regions, suggesting that its occurrence could depend on cofactors. Here, we evaluate the relevance of protein malnutrition for the emergence of CZS. Epidemiological data from the ZIKV outbreak in the Americas suggest a relationship between undernutrition and cases of microcephaly. To experimentally examine this relationship, we use immunocompetent pregnant mice, which were subjected to protein malnutrition and infected with a Brazilian ZIKV strain. We found that the combination of protein restriction and ZIKV infection leads to severe alterations of placental structure and embryonic body growth, with offspring displaying a reduction in neurogenesis and postnatal brain size. RNA-seq analysis reveals gene expression deregulation required for brain development in infected low-protein progeny. These results suggest that maternal protein malnutrition increases susceptibility to CZS.
C1 [Barbeito-Andres, J.; Ferreira, J. C. C. G.; Ferreira, R. O.; Garcez, P. P.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Barbeito-Andres, J.; Gonzalez, P. N.] Consejo Nacl Invest Cient & Tecn, Inst Studies Neurosci & Complex Syst ENyS, Buenos Aires, DF, Argentina.
   [Pezzuto, P.; Higa, L. M.; Rossi, A. D.; Aguiar, R. S.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Dias, A. A.; Dutra, F. F.; Bozza, M. T.; Bellio, M.] Univ Fed Rio de Janeiro, Microbiol Inst Paulo de Goes, Rio De Janeiro, Brazil.
   [Vasconcelos, J. M.] Fed Univ Para, Biol Sci Inst, Belem, Para, Brazil.
   [Santos, T. M. P.; Lopes, R. T.] Univ Fed Rio de Janeiro, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
   [Barbosa, R., V] CENABIO Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Amorim, C. K. N.; De Souza, M. P. C.; Vianez, J. L. S. G.] Evandro Chagas Inst, Technol Innovat Ctr, Ananindeua, Brazil.
   [Chimelli, L.] State Inst Brain Paulo Niemeyer, Rio De Janeiro, Brazil.
   [Lara, F. A.; Cuervo, P.] Fiocruz MS, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [Castro, M. C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.
   [Molnar, Z.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.
   [Barbeito, C. G.] Natl Univ La Plata, Fac Vet Sci, Buenos Aires, DF, Argentina.
RP Garcez, PP (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
EM ppgarcez@icb.ufrj.br
RI Higa, Luiza/W-2698-2019; Cuervo, Patricia/Y-6048-2019; Aguiar, Renato
   S/G-3542-2015; Barbeito, Claudio/AAM-5227-2020; BELLIO,
   MARIA/N-8525-2018; Garcez, Patricia/F-8026-2012
OI Cuervo, Patricia/0000-0002-6245-4185; Aguiar, Renato
   S/0000-0001-5180-3717; Barbeito, Claudio/0000-0001-9459-138X; BELLIO,
   MARIA/0000-0002-3360-2740; Alves Dias, Andre/0000-0002-6437-2773;
   Garcez, Patricia/0000-0002-9107-1335
FU MRC Zika Rapid Response Grant [MC_PC_15102]; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_03/2017E_03/2017]; Brazilian Ministry of Health [DSAST/SVS
   25380.001612/2017-70]; AAPA Professional Development Grant
FX This work was funded by the MRC Zika Rapid Response Grant (MC_PC_15102),
   FAPERJ (E_03/2017E_03/2017), the Brazilian Ministry of Health (DSAST/SVS
   25380.001612/2017-70), and the AAPA Professional Development Grant.
CR Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Carvalho-Sauer R, 2019, INT J INFECT DIS, V82, P44, DOI 10.1016/j.ijid.2019.02.040
   CHANDRA RK, 1992, J NUTR, V122, P754, DOI 10.1093/jn/122.suppl_3.754
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Dobin A., 2015, CURRENT PROTOCOLS BI
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gonzalez PN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152227
   Hedrich A, 2007, VER SALUS GAURAUPUA, V1, P139
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Institute of Medicine, 2005, DIETARY REFERENCE IN
   Instituto Brasileiro de Geografia e Estatistica, 2015, IND SOC POP BRAS
   Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Losada-Barragan M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45991
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Luo HC, 2017, ONCOTARGET, V8, P81295, DOI 10.18632/oncotarget.18333
   Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mourao Junior C. A., 2016, REV EXTENDERE, V4, P85
   Moussaud S, 2010, J NEUROSCI METH, V187, P243, DOI 10.1016/j.jneumeth.2010.01.017
   Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Prata-Barbos A, 2019, J PEDIAT-BRAZIL, V95, pS30, DOI 10.1016/j.jped.2018.10.016
   R Foundation for Statistical Computing, 2013, LANG ENV STAT COMP
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   REVILLARD JP, 1990, FOOD ADDIT CONTAM, V7, pS82, DOI 10.1080/02652039009373853
   Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543
   Rosen S., 2008, FOOD SECURITY ASSESS
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3
   Silva Gomes V. T., 2015, REV INTERDISCIP, V8, P127
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
   Weger-Lucarelli J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006247
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
NR 47
TC 0
Z9 0
U1 1
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD JAN
PY 2020
VL 6
IS 2
AR eaaw6284
DI 10.1126/sciadv.aaw6284
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KD0JH
UT WOS:000507557500004
PM 31950075
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Thorson, A
   Aslanyan, G
   Brizuela, V
   Perez, F
   de Leon, RGP
   Reeder, JC
   Serruya, SJ
   Espinal, M
   Askew, I
AF Thorson, Anna
   Aslanyan, Garry
   Brizuela, Vanessa
   Perez, Freddy
   Ponce de Leon, Rodolfo Gomez
   Reeder, John C.
   Serruya, Suzanne J.
   Espinal, Marcos
   Askew, Ian
TI Research and research capacity strengthening in the context of an
   emerging epidemic: Zika virus in Latin America
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Editorial Material
C1 [Thorson, Anna; Brizuela, Vanessa; Askew, Ian] WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland.
   [Aslanyan, Garry; Reeder, John C.] WHO, UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland.
   [Perez, Freddy; Espinal, Marcos] PAHO, Communicable Dis & Environm Determinants Hlth Dep, Washington, DC USA.
   [Ponce de Leon, Rodolfo Gomez; Serruya, Suzanne J.] PAHO, Ctr Perinatol Womens Hlth & Reprod CLAP, Montevideo, Uruguay.
RP Thorson, A (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland.
EM thorsona@who.int
RI Perez, Freddy/AAN-3893-2020; Aslanyan, Garry/AAI-6646-2020; Brizuela,
   Vanessa/O-6279-2019
OI Brizuela, Vanessa/0000-0002-4860-0828
FU HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization; WHO Headquarters
FX The authors would like to thank all the contributors to this Supplement,
   particularly Jose Guilherme Cecatti as Guest Editor, as well as the
   researchers whose projects did not make it to this publication, for
   their work and efforts in the Zika virus outbreak response. They also
   wish to thank the team at CEMICAMP in Brazil, particularly Luis
   Bahamondes, Jose Guilherme Cecatti, and Vilma Zotareli! for the support
   provided to the research teams during manuscript preparation. The work
   in this Supplement was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by WHO.
   Funding was also provided from WHO Headquarters, within the frame of the
   coordinated Zika research response. The Pan American Health Organization
   provided technical support throughout project implementation.
CR Angelo JR, 2020, INT J GYNECOL OBSTET, V148, P70, DOI 10.1002/ijgo.13050
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Florez-Lozano K, 2020, INT J GYNECOL OBSTET, V148, P55, DOI 10.1002/ijgo.13048
   Forero-Martinez LJ, 2020, INT J GYNECOL OBSTET, V148, P15, DOI 10.1002/ijgo.13043
   Freitas PSS, 2020, INT J GYNECOL OBSTET, V148, P20, DOI 10.1002/ijgo.13044
   Gomez HM, 2020, INT J GYNECOL OBSTET, V148, P29, DOI 10.1002/ijgo.13045
   Iguiniz-Romero R, 2020, INT J GYNECOL OBSTET, V148, P45, DOI 10.1002/ijgo.13047
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   Mocelin HJS, 2020, INT J GYNECOL OBSTET, V148, P61, DOI 10.1002/ijgo.13049
   Canas JAO, 2020, INT J GYNECOL OBSTET, V148, P4, DOI 10.1002/ijgo.13041
   Oliveira JV, 2020, INT J GYNECOL OBSTET, V148, P9, DOI 10.1002/ijgo.13042
   de Leon RGP, 2019, LANCET GLOB HEALTH, V7, pE227, DOI 10.1016/S2214-109X(18)30481-9
   TDR HRP PAHO WHO Americas, CALL APPL HRP TDR PA
   Tirado V, 2020, INT J GYNECOL OBSTET, V148, P36, DOI 10.1002/ijgo.13046
   World Health Organization, 2016, WHOZIKVMOC162REV1
   World Health Organization, 2016, WHOZIKVPHR161
NR 16
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 1
EP 3
DI 10.1002/ijgo.13040
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700001
PM 31975399
OA Other Gold
DA 2020-07-08
ER

PT J
AU Canas, JAO
   Combita, DC
   Leon, HFM
   Sierra, AMG
   Florez, LJH
AF Ocampo Canas, Jovana A.
   Caviedes Combita, David
   Molina Leon, Helvert F.
   Garcia Sierra, Andres M.
   Hernandez Florez, Luis J.
TI Patient characteristics and pregnancy outcomes among Zika-infected
   pregnant women: Epidemiologic surveillance data from two cities in
   Colombia, 2015-2016
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Colombia; Epidemiologic surveillance; Low birthweight; Pregnancy
   outcomes; Preterm birth; Zika virus
ID VIRUS-INFECTION
AB Objectives To describe the characteristics of pregnant women infected with Zika virus in two representative regions of Colombia, examine their pregnancy outcomes, and outline findings of the epidemiologic surveillance program established during the peak of the 2015-2016 epidemic. Methods A cohort study conducted in the municipalities of Cali and Villavicencio using data from the National Public Health Surveillance System (SIVIGILA) and clinical follow-up data from pregnant women. We describe sociodemographic characteristics, health insurance status, Zika virus, pregnancy-related characteristics, and pregnancy outcomes. Results A total of 1259 Zika-infected pregnant women were identified in Cali; of these, 2.3% (n=27) experienced pregnancy loss, 9.5% (n=113) had preterm birth, and 7.9% (n=91) had a low birthweight neonate. In Villavicencio, 3.0% (n=13) experienced pregnancy loss, 6.9% (n=30) had preterm birth, and 6.7% (n=28) had a low birthweight neonate. Compared with the general population, this population of Zika-infected pregnant women did not experience an increased frequency of preterm birth or low birthweight (relative risk of prematurity and low birthweight infant <1). Conclusions Epidemiologic surveillance data showed that most neonates of Zika-infected pregnant women were born at term, and that the frequency of low birthweight neonates was low. Good quality data were obtained from the surveillance registries.
C1 [Ocampo Canas, Jovana A.; Caviedes Combita, David; Molina Leon, Helvert F.; Garcia Sierra, Andres M.; Hernandez Florez, Luis J.] Univ Andes, Sch Med, Publ Hlth Med Educ & Professionalism Res Grp, Bogota, Colombia.
RP Canas, JAO (corresponding author), Cra 1 18A-12,Edificio Q,Piso 8,Oficina Q812, Bogota, Colombia.
EM ja.ocampo@uniandes.edu.co
OI Garcia Sierra, Andres Mauricio/0000-0001-9873-1570
FU HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation. We
   are grateful to the public health and epidemiologic surveillance teams
   at the health departments of Villavicencio and Cali, particularly with
   Dr Alexandra Pardo and Dr Javier Colorado, and for the support of the
   epidemiologic surveillance and vector-borne diseases teams of the
   National Institute of Health of Colombia. We also thank Bianca M.
   Stifani for translating the article.
CR Boillat-Blanco N, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3549-z
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calle-Giraldo JP, 2019, PEDIATR INFECT DIS J, V38, P735, DOI [10.1097/INF.0000000000002307, 10.1097/inf.0000000000002307]
   Chacon-Duque JC, 2014, INFECT GENET EVOL, V27, P89, DOI 10.1016/j.meegid.2014.07.003
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Lebov JF, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2430-4
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Noticias Caracol, 2018, NOTICIAS CARACOL MIN
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pacheco O, 2016, N ENGL J MED
   R Core Team, 2014, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rees EE, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2867-8
   Schirmer DA, 2016, SEMIN REPROD MED, V34, P261, DOI 10.1055/s-0036-1592069
NR 18
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 4
EP 8
DI 10.1002/ijgo.13041
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700002
PM 31975396
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Oliveira, JV
   Carvalho, TCX
   Giovanetti, M
   de Jesus, JG
   Santos, CS
   Pessoa, LB
   Magalhaes, CFQ
   Lima, JGS
   Carvalho, DAX
   Figueiredo, EM
   Biron, AC
   dos Santos, DC
   Viana, P
   Duarte, AO
   Pessoa, R
   Souza, GB
   Calcagno, JI
   Lima, FWM
   Alcantara, LCJ
   de Siqueira, IC
AF Oliveira, Joao, V
   Carvalho, Tereza C. X.
   Giovanetti, Marta
   de Jesus, Jaqueline G.
   Santos, Cleiton S.
   Pessoa, Lorena B.
   Magalhaes Filho, Claudio F. Q.
   Lima, Jessica G. S.
   Carvalho, Daniel A. X.
   Figueiredo, Eduardo M.
   Biron, Ana Carolina
   dos Santos, Daiana C.
   Viana, Paloma
   Duarte, Alan O.
   Pessoa, Rosana
   Souza, Gloryane B.
   Calcagno, Juan, I
   Lima, Fernanda W. M.
   Alcantara, Luiz C. J.
   de Siqueira, Isadora C.
TI Neonatal surveillance for congenital Zika infection during the 2016
   microcephaly outbreak in Salvador, Brazil: Zika virus detection in
   asymptomatic newborns
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brazil; Congenital infection; Microcephaly; Neonatal surveillance; Zika
   virus
AB Objective To identify newborns with congenital Zika infection (CZI) at a maternity hospital in Salvador, Brazil, during the 2016 microcephaly outbreak. Methods A prospective study enrolled microcephalic and normocephalic newborns with suspected CZI between January and December 2016. Serology (immunoglobulins IgM and IgG) and quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) for the Zika virus were performed. Demographic and clinical characteristics of newborns with and without microcephaly were compared. Results Of the 151 newborns enrolled, 32 (21.2%) were classified as microcephalic. The majority of these cases were born between January and May 2016. IgM and IgG Zika virus antibodies were detected in 5 (23.8%) and 17 (80.9%) microcephalic newborn blood samples, respectively. Six (24%) microcephalic newborns tested positive for Zika virus by RT-qPCR in urine or placenta samples. Thirteen (11.8%) normocephalic newborns also tested positive for Zika virus by PCR in urine, plasma, or placenta samples, while IgM antibodies against Zika were detected in 4 (4.2%) others. Conclusions Identification of 17 normocephalic CZI cases, confirmed by IgM serology or RT-qPCR for Zika virus, provides evidence that CZI can present asymptomatically at birth. This finding highlights the need for prenatal and neonatal screening for Zika virus in endemic regions.
C1 [Oliveira, Joao, V; de Jesus, Jaqueline G.; Santos, Cleiton S.; Pessoa, Lorena B.; Magalhaes Filho, Claudio F. Q.; Lima, Jessica G. S.; Carvalho, Daniel A. X.; dos Santos, Daiana C.; Viana, Paloma; de Siqueira, Isadora C.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Minist Hlth, Salvador, BA, Brazil.
   [Carvalho, Tereza C. X.; Figueiredo, Eduardo M.; Biron, Ana Carolina; Pessoa, Rosana; Souza, Gloryane B.; Calcagno, Juan, I] Jose Maria de Magalhaes Netto Matern Hosp, Salvador, BA, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz C. J.] Fiocruz MS, Flavivirus Lab, Oswald Cruz Inst, Rio De Janeiro, RJ, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz C. J.] Univ Fed Minas Gerais, ICB, Cell & Mol Genet Lab, Belo Horizonte, MG, Brazil.
   [Duarte, Alan O.; Lima, Fernanda W. M.] Univ Fed Bahia, Fac Pharm, Immunol Infect Dis Lab, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Alcantara,
   Luiz/0000-0002-6769-9931
FU HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq) [425380/2016, 440685/2016-8, 443875/2018];
   Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES [88887.130716/2016-00, 88881.130825/2016-00]
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation.
   Financial support was also provided by the National Council for
   Scientific and Technological Development (CNPq) (425380/2016,
   440685/2016-8, and 443875/2018) and by Coordination for the Improvement
   of Higher Education Personnel (CAPES) (88887.130716/2016-00 and
   88881.130825/2016-00). The authors are grateful to the physicians and
   nurses charged with the patients' clinical care and would also like to
   thank the Arboviral Diseases Branch Diagnostic and Reference Team
   (Vector-Borne Diseases Division of the Centers for Disease Control and
   Prevention) for kindly providing the reagents necessary for MAC-ELISA
   serological testing. Andris K. Walter provided English language revision
   and manuscript copyediting assistance.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Centers for Disease Control and Prevention C, 2018, ZIK MAC ELISA INSTR, P101
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Onis M, 1996, ZIK MAC ELISA INSTR, V64, P650
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Giovanetti M, 2018, CLIN MICROBIOL INFEC, V24, P1111, DOI 10.1016/j.cmi.2018.06.008
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministry of Health, 2015, SURV RESP PROT OCC M
   Ministry of Health, 2016, EP B MON MICR CAS BR, V47
   Ministry of Health, 2018, EP B INT MON GROWTH, V49
   Ministry of Health, 2017, INT SURV HLTH CAR GU, P158
   Ministry of Health, 2015, PROT VIG RESP OC MIC, P55
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL INCR MICR NE B
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 9
EP 14
DI 10.1002/ijgo.13042
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700003
PM 31975394
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Forero-Martinez, LJ
   Murad, R
   Calderon-Jaramillo, M
   Rivillas-Garcia, JC
AF Forero-Martinez, Luz J.
   Murad, Rocio
   Calderon-Jaramillo, Mariana
   Rivillas-Garcia, Juan C.
TI Zika and women's sexual and reproductive health: Critical first steps to
   understand the role of gender in the Colombian epidemic
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Climate change; Colombia; Gender; Sexual and reproductive health;
   Sustainable Development Goals; Zika virus
ID VIRUS; OUTBREAK; RIGHTS
AB Objectives To describe the mechanisms of implementation of Zika virus diagnosis, prevention, and management guidelines in Colombia, and to characterize their influence on efforts to defend sexual and reproductive rights. Methods A qualitative study performed between February and April 2018 in three municipalities in Colombia. We conducted 30 semistructured interviews and five focus groups with key informants who played a role during the epidemic. These included decision-makers, program coordinators, healthcare providers, pregnant women diagnosed with Zika virus, and members of affected communities. Results We identified barriers to and facilitators for the implementation of the national Zika virus response plan. Barriers included a lack of coordination between vector control efforts and in the realms of sexual and reproductive rights. Facilitators included healthcare providers' response to the epidemic, the development of technical skills, and the establishment of coordination and referral networks across different institutions. Conclusion A multidimensional approach that considers healthcare services, gender issues, and the environment is crucial. We highlight the epidemic's effects on women's sexual and reproductive rights, mainly related to inequalities in sexual and reproductive health such as the increased risk of sexually transmitted infections experienced by the poorest and most vulnerable women.
C1 [Forero-Martinez, Luz J.; Murad, Rocio; Calderon-Jaramillo, Mariana; Rivillas-Garcia, Juan C.] Asociac Profamilia, Bogota, DC, Colombia.
RP Calderon-Jaramillo, M (corresponding author), Profamilia, Calle 34 14-52, Bogota, DC, Colombia.
EM mariana.calderon@profamilia.org.co
FU HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation. The
   authors are grateful to the women and men who were willing to share
   their experience, to PAHO, to the Ministry of Health, and the National
   Health Institute in Colombia, especially Martha Lucia Ospina and Marcela
   Mercado. We would also like to thank Marilyn Ibarguen and Linda Ciro of
   Profamilia, who supported the fieldwork in Barranquilla and Cucuta, and
   Bianca M. Stifani for translating the article.
CR Adamski A, 2018, J INFECTION, V76, P529, DOI 10.1016/j.jinf.2018.02.010
   Candelo E, 2018, BIOMEDICA, V38, P127, DOI 10.7705/biomedica.v38i0.4413
   Centers for Disease Control and Prevention, 2019, ZIK PREGN UND IMP ZI
   Centers for Disease Control and Prevention, 2019, ZIK VIR SEX TRANSM P
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   International Planned Parenthood Federation, 2016, IMAP STAT ZIK VIR SE
   Larson E, 2016, HEALTH POLICY PLANN, V31, P964, DOI 10.1093/heapol/czw020
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Means AR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006681
   Ministry of Health and Social Protection, 2013, 10 YEAR PUBL HLTH PL
   Ministry of Health and Social Protection, 2016, PLAN ADDR ZIK VIR CO
   Ministry of Health and Social Protection National Institute of Health, 2016, PROT EP SURV ZIK VIR
   National Institute of Health, 2017 WEEK 52 EP B
   Pacheco O, 2016, N ENGL J MED
   Profamilia UNFPA International Organization for Migration Ministry of Health and Social Protection, 2014, NAT POL SEX RIGHTS R
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Scott Jennifer, 2013, Confl Health, V7, P24, DOI 10.1186/1752-1505-7-24
   United Nations, 2015, SUST DEV GOALS KNOWL
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
   World Health Organization, 2014, GEND CLIM CHANG HLTH
NR 21
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 15
EP 19
DI 10.1002/ijgo.13043
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700004
PM 31975403
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Freitas, PSS
   Soares, GB
   Mocelin, HJS
   Lamonato, LCXL
   Sales, CMM
   Linde-Arias, AR
   Bussinger, ECA
   Maciel, ELN
AF Freitas, Paula S. S.
   Soares, Gabriella B.
   Mocelin, Helaine J. S.
   Lamonato, Larissa C. X. L.
   Sales, Carolina M. M.
   Linde-Arias, Ana R.
   Bussinger, Elda C. A.
   Maciel, Ethel L. N.
TI How do mothers feel? Life with children with congenital Zika syndrome
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brazil; Children with disabilities; Congenital Zika syndrome;
   Microcephaly; Mother-child relationships; Public Health; Zika virus
ID BRAZIL; VIRUS
AB Objective To describe the repercussions, from the perspectives of caregiver mothers, of confirmed congenital Zika syndrome (CZS) in their offspring. Methods A descriptive-exploratory study with a qualitative approach was carried out in the state of Espirito Santo in southeastern Brazil, with 25 women who had a child diagnosed with CZS. Results Emerging themes from the content analysis were grouped into two categories: (1) inequalities experienced by mothers, including social inequality, poverty, and gender inequality; (2) the impact of a child with CZS on mothering, including feelings at the time of diagnosis, maternal isolation and mental health, experiences of stigma and prejudice, and exhausting itineraries searching for therapeutic care. Conclusion The repercussions of CZS were a huge burden on already vulnerable women, and social inequalities and poverty were important markers in the mothers' reports. Many of the families affected by CZS already lived in precarious social conditions and these conditions were exacerbated further. Robust public and social policies to support these mothers need effective implementation given that babies born with CZS need long-term care and support.
C1 [Freitas, Paula S. S.; Mocelin, Helaine J. S.; Sales, Carolina M. M.; Maciel, Ethel L. N.] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Freitas, Paula S. S.; Mocelin, Helaine J. S.; Sales, Carolina M. M.; Maciel, Ethel L. N.] Univ Fed Espirito Santo, Grad Program Collect Hlth, Vitoria, ES, Brazil.
   [Soares, Gabriella B.] Univ Fed Paraiba, Med Sci Ctr, Dept Hlth Promot, Joao Pessoa, Paraiba, Brazil.
   [Lamonato, Larissa C. X. L.] Univ Fed Espirito Santo, Hlth Sci Dept, Sao Mateus, ES, Brazil.
   [Linde-Arias, Ana R.] Univ Massachusetts, Mauricio Gaston Inst, Boston, MA 02125 USA.
   [Bussinger, Elda C. A.] Grad Sch Law, Fac Law, Vitoria, ES, Brazil.
RP Freitas, PSS (corresponding author), Univ Fed Espirito Santo, Vitoria, ES, Brazil.
EM paulassfreitas@gmail.com
OI Maciel, Ethel Leonor/0000-0003-4826-3355
FU HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation.
CR Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Brazil. Presidency of the Republic. Policy Secretariat for Women, 2018, WOM SOC ANN REP, P227
   Brazilian Institute of Geography and Statistics (IGBE), 2018, PAN CIT
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Carvalho LP, 2017, CAD GENERO DIVERS, V3, P134
   Costa AM, 2016, SOCIAL DETERMINATION, V3, P44
   Leite FMC, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006815, 10.1590/s1518-8787.2017051006815]
   de Mello DF, 2007, REV LAT-AM ENFERM, V15, P820, DOI 10.1590/S0104-11692007000700017
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Freitas AAF, 2019, REV ENFERMAGEM ATUAL, V87, P1
   Gondim Kamilla de Mendonça, 2012, Esc. Anna Nery, V16, P11, DOI 10.1590/S1414-81452012000100002
   Guerra SC, 2015, TEXT CONTEXT NURS, V24, P459
   Human Rights Watch, 2017, FORG UNPR IMP ZIK VI
   Kotzky K, 2019, J DEV BEHAV PEDIATR, V40, P344, DOI 10.1097/DBP.0000000000000666
   Machado MEC, 2012, REV SBPH, V15, P86
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Rezende JMM, 2010, REV PESQUI-CUID FUND, P22
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Minayo MCS, SOCIAL RES METHOD TH
   Ministry of Health, 2017, ZIK VIR BRAZ SUS RES
   Ministry of Health, 2017, INT GUID IMPR HLTH C
   Ministry of Health Health Surveillance Secretariat, EP B INT MON GROWTH
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira MC, 2017, REV PESQ FISIO, V7, P511, DOI DOI 10.17267/2238-2704RPF.V7I4.1602
   Osorio LC, 2009, FAMILY THERAPY MANUA
   Pimentel PLB, 2018, P 1 MICR HEAR C CESM, P28
   Pinheiro DAJP, 2017, CAD GENERO DIVERS, V3, P113
   Pinto JMM, 2013, THESIS
   Ramos LW, 2015, MONOGRAPH UNDERGRADU
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Santos JHA, 2017, P 2 BRAZ C HLTH SCI, V1, P1
   Silva A. S. F, 2016, THESIS
   Freitas PDS, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.24
   State Secretariat of Health of Espirito Santo, 2017, SESA REL ZIK MICR NE
   UNICEF Brazil Altino Ventura Foundation, 2018, INCL NETW SEC RIGHTS
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 20
EP 28
DI 10.1002/ijgo.13044
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700005
PM 31975400
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gomez, HM
   Arbelaez, CM
   Canas, JAO
AF Gomez, Hector M.
   Mejia Arbelaez, Carlos
   Ocampo Canas, Jovana A.
TI A qualitative study of the experiences of pregnant women in accessing
   healthcare services during the Zika virus epidemic in Villavicencio,
   Colombia, 2015-2016
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Access; Colombia; Experience; Healthcare services; Pregnant women;
   Qualitative; Zika virus
ID INFECTION
AB Objective To explore the perceptions and experiences of pregnant women in accessing healthcare services during the epidemic in Colombia during 2015-2016. Methods A qualitative study using semistructured interviews was conducted in Villavicencio. Six women who had been diagnosed with Zika virus infection during their pregnancies and whose fetus had suspected microcephaly participated in the investigation. Grounded theory was used and thematic content analysis was made for each category identified. Results Three main themes affecting access to healthcare services were identified: (1) women knew basic information about the virus, but it was limited; (2) access to services was delayed due to their lack of availability or limited supply in the municipality; and (3) most of the participants made out-of-pocket payments to get access to services that were not provided. Conclusions Several gaps were identified in the provision of healthcare services to pregnant women during the Zika epidemic. Policy makers need to utilize the results from affected communities to develop and implement public policies that adapt and respond to their priorities and needs.
C1 [Gomez, Hector M.; Mejia Arbelaez, Carlos; Ocampo Canas, Jovana A.] Univ los Andes, Sch Med, Publ Hlth Med Educ & Professionalism, Bogota, Colombia.
RP Canas, JAO (corresponding author), Cra 1 18A-12 Edificio Q,Piso 8,Oficina 812, Bogota 111711, Colombia.
EM ja.ocampo@uniandes.edu.co
RI Canas, Jovana Alexandra Ocampo/AAG-1554-2020
FU HRP Alliance part of UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme
   of Research, Development and Research Training in Human Reproduction
   (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for Research and
   Training in Tropical Diseases (TDR)World Health Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation. We
   are grateful to the public health and epidemiologic surveillance teams
   at the health department of Villavicencio, particularly Dr Alexandra
   Pardo, and Janeth Pinilla, from the SEP group, for her support and
   assistance.
CR [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875
   Baird K, 2016, HEALTH SERV RES, V51, P1467, DOI 10.1111/1475-6773.12444
   Carabali JM, 2012, GLOB HEALTH PROMOT, V19, P45, DOI 10.1177/1757975912464250
   Centers for Disease Control and Prevention, CONG ZIK SYNDR OTH B
   David AM, 2007, J URBAN HEALTH, V84, pI65, DOI 10.1007/s11524-007-9183-5
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Luiza A, 2018, PLOS NEGLECT TROP D, V12, pe0190024
   Ministry of Health and Social Protection, 2016, PROV GUID CLIN APPR
   Ministry of Health and Social Protection, 2016, RESP PLAN ZIK VIR FE
   National Institute of Health, 2018, WEEKL EP B, V29, P1
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pan American Health Organisation, NEUR SYNDR CONG MALF
   Pan American Health Organization, 2016, ZIK CUM CAS 29 DEC
   Perera N, 2016, PEOPLE'S SPACES: COPING, FAMILIARIZING, CREATING, P1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sharma S, 2017, J MED VIROL, V89, P1693, DOI 10.1002/jmv.24822
   United Nations Development Programme, 2017, SOC IMP ASS ZIK VIR
   Vargas Lorenzo I, 2009, THESIS
   Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4
   WHO, 2016, PREGN MAN CONT ZIK V
   World Health Organization, 2015, ZIK VIR INF BRAZ COL
NR 31
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 29
EP 35
DI 10.1002/ijgo.13045
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700006
PM 31975397
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tirado, V
   Mesa, SAM
   Kinsman, J
   Ekstrom, AM
   Jaramillo, BNR
AF Tirado, Veronika
   Morales Mesa, Santiago A.
   Kinsman, John
   Ekstrom, Anna Mia
   Restrepo Jaramillo, Berta N.
TI Women's reluctance for pregnancy: Experiences and perceptions of Zika
   virus in Medellin, Colombia
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Colombia; Family planning; Perceptions; Pregnancy; Zika virus
AB Objective To explore how being infected with the Zika virus during pregnancy was experienced by affected women, and how it influenced their family relationships and future family planning. Methods We conducted a qualitative study, including 19 semistructured interviews with women of reproductive age and confirmed Zika infection during 2015-2018 in Medellin, Colombia. Purposeful sampling was applied, and participants were identified through National Public Health Surveillance System records. Interviews were recorded, transcribed verbatim, and analyzed using content analysis with inductive and deductive approaches. Results Of 19 women interviewed, eight women identified the pregnancy as unexpected and two women had undergone permanent sterilization. Women had mixed views about decision-making related to family planning, and not having an abortion in a future pregnancy was influenced by religious beliefs. Women knew about vector-borne transmission but were not well informed about sexual transmission of the virus. Women desired better support and guidance to ease concerns about Zika virus. Conclusion All interviewed women expressed a need for more information about Zika virus and continuous support, specifically after delivery, from healthcare professionals. Communication strategies to enhance culturally sensitive messages and for accurate perception of information are recommended during Zika outbreaks.
C1 [Tirado, Veronika; Kinsman, John; Ekstrom, Anna Mia] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.
   [Morales Mesa, Santiago A.] Univ Medellin, CES Univ, Inst Hlth Sci, Fac Psychol, Medellin, Colombia.
   [Morales Mesa, Santiago A.] Catholic Univ Luis Amigo, Fac Law & Polit Sci, Medellin, Colombia.
   [Kinsman, John] Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden.
   [Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.
   [Restrepo Jaramillo, Berta N.] CES Univ, Inst Hlth Sci, Colombian Inst Trop Med, Dept Virol, Medellin, Colombia.
RP Tirado, V (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.
EM Veronika.Tirado@ki.se
FU HRP Alliance part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation. We
   thank all the women interviewed, many of whom expressed gratitude to be
   able to share their experiences of Zika virus. We also thank the Swedish
   Foundation for International Cooperation in Research and Higher
   Education (STINT). We are grateful to Katerine Marin Velasquez for her
   assistance during the process of qualitative data collection and members
   of the Secretariat of Health in Medellin, in particular Carlos Julio
   Montes for his collaboration providing information on reported Zika
   virus cases in SIVIGILA.
CR Adamski A, 2018, J INFECTION, V76, P529, DOI 10.1016/j.jinf.2018.02.010
   [Anonymous], 2017, COMM ACT ZIK CAZ PRO
   [Anonymous], 2017, ZIK EP REP
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Center for Reproductive Rights, 2018, UNH VOIC WOM EXP ZIK
   Centers for Disease Control and Prevention, 2019, ZIK PREGN CONG ZIK S
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Gomez EJ, 2018, BMJ GLOB HEALTH, V19, P3
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Human Rights Watch, 2017, NEGL UNPR IMP ZIK OU
   Cordova-Pozo KL, 2017, REV PANAM SALUD PUBL, V41, DOI 10.26633/RPSP.2017.140
   Mayor of Medellin, TECHN SUPP DOC POT M
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Ministry of Health and Social Protection, PROV GUID CLIN APPR
   Murray LR, 2011, SOC SCI MED, V72, P945, DOI 10.1016/j.socscimed.2011.01.004
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pacheco O, 2016, N ENGL J MED
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Public Health Surveillance, DENG ZIK VIR CHIK CO
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Weldon Caroline T, 2018, PLoS Negl Trop Dis, V12, pe0006708, DOI 10.1371/journal.pntd.0006708
NR 24
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 36
EP 44
DI 10.1002/ijgo.13046
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700007
PM 31975395
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Iguiniz-Romero, R
   Guerra-Reyes, L
AF Iguiniz-Romero, Ruth
   Guerra-Reyes, Lucia
TI On the front line: Health professionals and system preparedness for Zika
   virus in Peru
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Congenital Zika syndrome; Health personnel; Peru; Surveillance; Zika
   virus
ID RIGHTS
AB Objectives To analyze the initial healthcare response to the Zika virus in Piura, Peru, and assess the perceptions of midwives and nurses regarding their role in prevention of Zika virus and management of congenital Zika syndrome (CZS). Methods This ethnographic study used a rapid qualitative assessment design. Data were collected through a focus group with midwives and in-depth interviews with midwives (n=11) and nurses (n=5). Results The focus of the early Zika virus response in Piura was on pregnant women and vector control. Midwives received some training on Zika-related care during the early response. Nurses did not receive any Zika-specific training. Neither nurses nor midwives were trained in neonatal CZS surveillance. Midwives were clear about the value and feasibility of incorporating Zika virus surveillance in their daily work, however nurses were not. They referred to lack of training and appropriate tools as limitations. Confusion about Zika virus and CZS symptomatology and effects persisted in both groups. Concerns about their own personal risk influenced the ways they engaged with Zika virus prevention in the community. Conclusion Long-term management of endemic Zika virus in Piura will require the engagement of both nurses and midwives as primary care providers.
C1 [Iguiniz-Romero, Ruth] Cayetano Heredia Univ, Sch Publ Hlth & Adm, Lima, Peru.
   [Guerra-Reyes, Lucia] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA.
RP Iguiniz-Romero, R (corresponding author), Av Armendariz 445, Lima, Peru.
EM Ruth.iguinizs@upch.pe
FU HRP Alliance part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation. We
   thank the Piura Regional Directorate of Health authorities for
   facilitating entry in lower Piura, our fieldwork assistants Catherine
   Munoz and Boris Lazo, and all midwives and nurses who participated in
   the study.
CR Olortegui RA, 2017, REV PERU GINECOL OBS, V63, P71
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Beare S, 2019, GLOB HEALTH-SCI PRAC, V7, P116, DOI 10.9745/GHSP-D-18-00356
   Beebe J., 2014, RAPID QUALITATIVE IN
   Brissett DI, 2018, AM J TROP MED HYG, V99, P211, DOI 10.4269/ajtmh.18-0014
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   General Directorate of Epidemiology, EP SURV SYST
   General Directorate of Epidemiology, EP SURV SYST ZIK SUR
   Gray D, 2019, GLOB PUBLIC HEALTH, V14, P9, DOI 10.1080/17441692.2018.1471146
   Jamrozik E, 2018, J MED ETHICS, V44, P343, DOI 10.1136/medethics-2017-104389
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   National Institute of Statistics and Informatics (INEI), 2017, STAT COMP PIUR 2017
   National Institute of Statistics and Informatics (INEI), 2018, CHILD HLTH PER END 2
   Obregon J, 2017, PIURA DEATHS DENGUE
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quinn C, 2018, HEALTH SECUR, V16, P252, DOI 10.1089/hs.2018.0026
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Sharma S, 2018, J INT SOC PREV COMMU, V8, P41, DOI 10.4103/jispcd.JISPCD_371_17
   Valente PK, 2017, AM J PUBLIC HEALTH, V107, P1376, DOI 10.2105/AJPH.2017.303924
   World Health Organization, ZIK VIR FACTSH
NR 22
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 45
EP 54
DI 10.1002/ijgo.13047
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700008
PM 31975393
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Florez-Lozano, K
   Navarro-Lechuga, E
   Llinas-Solano, H
   Tuesca-Molina, R
   Sisa-Camargo, A
   Mercado-Reyes, M
   Ospina-Martinez, M
   Prieto-Alvarado, F
   Acosta-Reyes, J
AF Florez-Lozano, Karen
   Navarro-Lechuga, Edgar
   Llinas-Solano, Humberto
   Tuesca-Molina, Rafael
   Sisa-Camargo, Augusto
   Mercado-Reyes, Marcela
   Ospina-Martinez, Martha
   Prieto-Alvarado, Franklyn
   Acosta-Reyes, Jorge
TI Spatial distribution of the relative risk of Zika virus disease in
   Colombia during the 2015-2016 epidemic from a Bayesian approach
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Bayes theorem; Colombia; Spatial analysis; Temporal Analysis; Zika virus
ID OUTBREAK; MORTALITY
AB Objective To determine the spatial distribution of the risk of Zika virus disease in each region of Colombia during the 2015-2016 epidemic. Methods An ecological study was designed to estimate the risks for each Colombian region using first-order neighbors, covariate effects, and three adjacent periods of time (beginning, development, and end of the epidemic) to analyze the spatial distribution of the disease based on a Bayesian hierarchical model. Results Spatial distribution of the estimated risks of Zika virus disease showed that it increased in a strip that crosses the central area of the country from west to east. Analysis of the three time periods showed greater risk of the disease in the central and southern zones-Arauca and Santander-where the increase in risk was four times higher during the peak phase compared with the initial phase of the outbreak. Conclusion In the identified high-risk areas, integrated surveillance systems for Zika virus disease and its complications must be strengthened to provide up-to-date and accurate epidemiological information. This information would allow those involved in policy and decision making to identify new outbreaks and risk clusters, enabling more focused and accurate measures to target at-risk populations.
C1 [Florez-Lozano, Karen; Llinas-Solano, Humberto] Univ Norte, Dept Math & Stat, Barranquilla, Colombia.
   [Navarro-Lechuga, Edgar; Tuesca-Molina, Rafael; Acosta-Reyes, Jorge] Univ Norte, Dept Publ Hlth, Barranquilla, Colombia.
   [Sisa-Camargo, Augusto] Univ Norte, Dept Civil & Environm Engn, Barranquilla, Colombia.
   [Mercado-Reyes, Marcela; Ospina-Martinez, Martha; Prieto-Alvarado, Franklyn] Natl Inst Hlth, Dept Publ Hlth Res, Bogota, Colombia.
RP Florez-Lozano, K (corresponding author), Univ Norte, Dept Math & Stat, Barranquilla, Colombia.
EM lozanok@uninorte.edu.co
RI Acosta-Reyes, Jorge/D-1906-2011
OI Acosta-Reyes, Jorge/0000-0003-4303-3243
FU HRP Alliance part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation.
CR Barcelo MA, 2008, GAC SANIT, V22, P596, DOI 10.1016/S0213-9111(08)75362-7
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   BERNARDINELLI L, 1995, STAT MED, V14, P2433, DOI 10.1002/sim.4780142112
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231
   FERRANDIZ J, 1995, BIOMETRICS, V51, P665, DOI 10.2307/2532953
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Jet propulsion Laboratory, SHUTTL RAD TOP MISS
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lawson A.B., 2013, BAYESIAN DIS MAPPING
   Lawson AB, 2014, WIRES COMPUT STAT, V6, P405, DOI 10.1002/wics.1315
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2170-2
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011
   Mollie A, 1996, MARKOV CHAIN MONTE C, V1, P359
   National Institute of Health, 2016, EP WEEK 52
   Pacheco O, 2016, N ENGL J MED
   QGIS Development Team, QGIS GEOGR INF SYST
   R Core Team, 2013, R LANG ENV STAT COMP
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 28
TC 1
Z9 1
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 55
EP 60
DI 10.1002/ijgo.13048
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700009
PM 31975401
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Mocelin, HJS
   Catao, RC
   Freitas, PSS
   Prado, TN
   Bertolde, AI
   Castro, MC
   Maciel, ELN
AF Mocelin, Helaine J. S.
   Catao, Rafael C.
   Freitas, Paula S. S.
   Prado, Thiago N.
   Bertolde, Adelmo, I
   Castro, Marcia C.
   Maciel, Ethel L. N.
TI Analysis of the spatial distribution of cases of Zika virus infection
   and congenital Zika virus syndrome in a state in the southeastern region
   of Brazil: Sociodemographic factors and implications for public health
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brazil; Congenital Zika virus syndrome; Public health; Spatial
   distribution; Zika virus infection
AB Objective To perform spatial distribution analysis of reported cases of Zika virus and congenital Zika syndrome (CZS) in the state of Espirito Santo, Brazil, by neighborhood, and relate the results to sociodemographic indicators and implications for the health process. Methods An ecological study using data from the 2016 National Notifiable Diseases Surveillance System, epidemiological records, and information on neighborhoods of families confirmed with CZS from qualitative field research. Results Sociodemographic indicators were analyzed in three distinct groups: general population with Zika virus, pregnant women with Zika virus, and cases of CZS visited. For the three groups, average literacy rates were 71.1%, 71.0%, and 68.3%; the average income per minimum wage was 1.4, 1.1, and 1.4; sanitary sewage coverage was 75.6%, 76.1%, and 71.4%; garbage coverage was 90.8%, 91.2%, and 89.2%; and water supply was 93.8%, 94.1% and 93.8%, respectively. Socioeconomic indicators showed no significant differences between groups, although they were above the national average. A nonsignificant variation of 68.3%-71.1% was seen in the average literacy level above 15 years of age. Conclusion Socioeconomic and demographic indicators of cases of Zika virus infection and CZS may indicate that the outbreak had different impacts according to class, social group, or gender, reflecting the persistence and social geography of inequality in Brazil.
C1 [Mocelin, Helaine J. S.; Freitas, Paula S. S.; Prado, Thiago N.; Bertolde, Adelmo, I; Maciel, Ethel L. N.] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Mocelin, Helaine J. S.; Freitas, Paula S. S.; Prado, Thiago N.; Maciel, Ethel L. N.] Univ Fed Espirito Santo, Grad Program Collect Hlth, Vitoria, ES, Brazil.
   [Catao, Rafael C.] Univ Fed Espirito Santo, Dept Geog, Vitoria, ES, Brazil.
   [Bertolde, Adelmo, I] Univ Fed Espirito Santo, Dept Stat, Vitoria, ES, Brazil.
   [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.
RP Freitas, PSS (corresponding author), Univ Fed Espirito Santo, Vitoria, ES, Brazil.
EM paulassfreitas@gmail.com
OI Maciel, Ethel Leonor/0000-0003-4826-3355
FU HRP Alliance part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Institute of Geography and Statistics, 2017, SUMM SOC IND AN LIV
   Brazilian Institute of Geography and Statistics, 2016, IBGE DISCL CAP HOUS
   Brazilian Instiute of Geography and Statistics, 2018, RES DIR WORK INC COO
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V63, P143, DOI 10.33588/rn.6303.2016274
   Centers for Disease Control and Prevention, ZIK VIR
   Closs EV, 2014, GERIATRICS GERONTOLO
   Costa AM, 2016, SOCIAL DETERMINATION
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duarte E, 2016, EPIDEMIOL SERV SAUDE, V25, P231, DOI 10.5123/S1679-49742016000200001
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Garcia LP, 2018, ZIKA VIRUS EPIDEMIC
   Human Rights Watch, 2017, FORG UNPR IMP ZIK VI
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Ministry of Citizenship, 2017, SOC ASS MICR CAR
   Ministry of Health. Health Care Secretariat, 2015, HLTH CAR PROT RESP O
   Ministry of Health . Health Surveillance Secretariat, 2017, HLTH SURV SECR EP B
   Ministry of Health Health Surveillance Secretariat, 2017, EPIDEMIOLOGICAL B
   Ministry of Health . Health Surveillance Secretariat, HLTH SURV SECR ZIK V
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan-American Health Organization, 2019, COMM DIS HLTH SIT AN
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pimenta Mariana, 2016, Acta Obstet Ginecol Port, V10, P92
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Quinn SC, 2014, BIOSECUR BIOTERROR, V12, P263, DOI 10.1089/bsp.2014.0032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Freitas PDS, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.24
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Soares FCA, 2017, EVALUATING IMPACT BR
   Stevens P, 2004, DIS POVERTY 10 90 GA
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   UN News, 2017, UN NEWS
   United Nations Development Program, 2017, INT FED RED CROSS RE
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 44
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 61
EP 69
DI 10.1002/ijgo.13049
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700010
PM 31975398
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Angelo, JR
   Fuller, TL
   Leandro, BBS
   Praca, HLF
   Marques, RD
   Ferreira, JMC
   Pupe, CCB
   Perez, OC
   Nielsen-Saines, K
   Nascimento, OJM
   Sabroza, PC
AF Angelo, Jussara R.
   Fuller, Trevon L.
   Leandro, Bianca B. S.
   Praca, Heitor L. F.
   Marques, Renata D.
   Ferreira, Joao M. C.
   Pupe, Camila C. B.
   Perez, Olivia C.
   Nielsen-Saines, Karin
   Nascimento, Osvaldo J. M.
   Sabroza, Paulo C.
TI Neurological complications associated with emerging viruses in Brazil
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Arboviruses; Guillain-Barre syndrome; Human influenza; Peripheral
   nervous system diseases; Polyneuropathies; Public hospitals; Sentinel
   surveillance
ID GUILLAIN-BARRE-SYNDROME; ZIKA VIRUS; INFECTION
AB Objective To test the hypotheses that emerging viruses are associated with neurological hospitalizations and that statistical models can be used to predict neurological sequelae from viral infections. Methods An ecological study was carried out to observe time trends in the number of hospitalizations with inflammatory polyneuropathy and Guillain-Barre syndrome (GBS) in the state of Rio de Janeiro from 1997 to 2017. Increases in GBS from month to month were assessed using a Farrington test. In addition, a cross-sectional study was conducted analyzing 50 adults hospitalized for inflammatory polyneuropathies from 2015 to 2017. The extent to which Zika virus symptoms explained GBS hospitalizations was evaluated using a calibration test. Results There were significant increases (Farrington test, P<0.001) in the incidence of GBS following the introduction of influenza A/H1N1 in 2009, dengue virus type 4 in 2013, and Zika virus in 2015. Of 50 patients hospitalized, 14 (28.0%) were diagnosed with arboviruses, 9 (18.0%) with other viruses, and the remainder with other causes of such neuropathies. Statistical models based on cases of emerging viruses accurately predicted neurological sequelae, such as GBS. Conclusion The introduction of novel viruses increases the incidence of inflammatory neuropathies.
C1 [Angelo, Jussara R.; Praca, Heitor L. F.; Marques, Renata D.; Sabroza, Paulo C.] Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Samuel Pessoa Dept Endem Dis, Rio De Janeiro, Brazil.
   [Fuller, Trevon L.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA USA.
   [Leandro, Bianca B. S.] Fundacao Oswaldo Cruz, Joaquim Venancio Natl Hlth Polytech Sch, Rio De Janeiro, Brazil.
   [Ferreira, Joao M. C.; Pupe, Camila C. B.; Nascimento, Osvaldo J. M.] Fed Fluminense Univ, Dept Neurol, Niteroi, RJ, Brazil.
   [Perez, Olivia C.] Univ Fed Piaui, Dept Polit Sci, Teresina, Brazil.
   [Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Pediat Infect Dis, Los Angeles, CA USA.
RP Angelo, JR (corresponding author), Rua Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, Brazil.
EM jussara.angelo@ensp.fiocruz.br
OI Duarte Marques, Renata/0000-0001-6168-3827
FU TDR, WHOWorld Health Organization
FX HRP, TDR, WHO
CR Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Heringer M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2488-4
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Keesen TSL, 2017, LANCET INFECT DIS, V17, P693, DOI 10.1016/S1473-3099(17)30333-X
   Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Meyer S, 2017, J STAT SOFTW, V77, DOI 10.18637/jss.v077.i11
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Salinas JL, 2017, J NEUROL SCI, V377, P102, DOI 10.1016/j.jns.2017.04.006
   Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330
   Souza TML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014158
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Leeuwen N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143837
   Wachira VK, 2019, TROP MED INT HEALTH, V24, P132, DOI 10.1111/tmi.13181
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 26
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 70
EP 75
DI 10.1002/ijgo.13050
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700011
PM 31975402
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, JH
   Zhang, WP
   Tan, ZY
   Zheng, CS
   Tang, Y
   Ke, XL
   Zhang, Y
   Liu, Y
   Li, PH
   Hu, QX
   Wang, HZ
   Mao, PY
   Zheng, ZH
AF Sun, Jianhong
   Zhang, Wanpo
   Tan, Zhongyuan
   Zheng, Caishang
   Tang, Yan
   Ke, Xianliang
   Zhang, Yuan
   Liu, Yan
   Li, Penghui
   Hu, Qinxue
   Wang, Hanzhong
   Mao, Panyong
   Zheng, Zhenhua
TI Zika virus promotes CCN1 expression via the CaMKII alpha-CREB pathway in
   astrocytes
SO VIRULENCE
LA English
DT Article
DE Zika virus; connective tissue growth factor/Nephroblastoma overexpressed
   (CCN) gene family 1(CCN1); ca2+/calmodulin-dependent protein kinase II;
   cAMP-responsive element-binding protein (CREB); cAMP response element;
   ns3 protein
ID KINASE-II; INFECTION; CYR61; DIFFERENTIATION; INFLAMMATION; ACTIVATION;
   CCN1/CYR61; PROTEINS; INTEGRIN; CANCER
AB Zika virus (ZIKV) infection in the human central nervous system (CNS) causes Guillain-Barre syndrome, cerebellum deformity, and other diseases. Astrocytes are immune response cells in the CNS and an important component of the blood-brain barrier. Consequently, any damage to astrocytes facilitates the spread of ZIKV in the CNS. Connective tissue growth factor/Nephroblastoma overexpressed gene family 1 (CCN1), an important inflammatory factor secreted by astrocytes, is reported to regulate innate immunity and viral infection. However, the mechanism by which astrocyte viral infection affects CCN1 expression remains undefined. In this study, we demonstrate that ZIKV infection up-regulates CCN1 expression in astrocytes, thus promoting intracellular viral replication. Other studies revealed that the cAMP response element (CRE) in the CCN1 promoter is activated by the ZIKV NS3 protein. The cAMP-responsive element-binding protein (CREB), a transacting factor of the CRE, is also activated by NS3 or ZIKV. Furthermore,a specific inhibitor of CREB, i.e. SGC-CBP30, reduced ZIKV-induced CCN1 up-regulation and ZIKV replication. Moreover, co-immunoprecipitation, overexpression, and knockdown studies confirmed that the interaction between NS3 and the regulatory domain of CaMKII alpha could activate the CREB pathway, thus resulting in the up-regulation of CCN1 expression and enhancement of virus replication. In conclusion, the findings of our investigations on the NS3-CaMKII alpha-CREB-CCN1 pathway provide a foundation for understanding the infection mechanism of ZIKV in the CNS.
C1 [Sun, Jianhong; Tan, Zhongyuan; Zheng, Caishang; Tang, Yan; Ke, Xianliang; Zhang, Yuan; Liu, Yan; Li, Penghui; Wang, Hanzhong; Zheng, Zhenhua] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China.
   [Sun, Jianhong] Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Wuhan, Peoples R China.
   [Zhang, Wanpo] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.
   [Hu, Qinxue] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.
   [Mao, Panyong] Mil Hosp China, Beijing Inst Infect Dis, Beijing, Peoples R China.
RP Zheng, ZH (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China.
EM zhengzh@wh.iov.cn
OI Hu, Qinxue/0000-0002-4594-9215
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81672036]; Youth Innovation Promotion Association
   of Chinese Academy of Sciences [2016302]; National Key R&D Program of
   China [2018YFA0507201]
FX This work was supported by the National Natural Science Foundation of
   China [81672036]; Youth Innovation Promotion Association of Chinese
   Academy of Sciences [2016302]; National Key R&D Program of China
   [2018YFA0507201].
CR Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Almad A, 2018, NAT REV NEUROL, V14, P351, DOI 10.1038/s41582-018-0010-2
   Baek A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00285
   Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594
   Borkham-Kamphorst E, 2016, CELL SIGNAL, V28, P34, DOI 10.1016/j.cellsig.2015.10.013
   Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3
   CESARE D, 1999, TRENDS BIOCHEM SCI, V24, P281
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Detje CN, 2015, J VIROL, V89, P2731, DOI 10.1128/JVI.02044-14
   Du F, 2006, BIOCHEM BIOPH RES CO, V347, P814, DOI 10.1016/j.bbrc.2006.06.162
   Emre Y, 2014, SEMIN IMMUNOPATHOL, V36, P253, DOI 10.1007/s00281-014-0420-1
   Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200
   Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870
   Gueugnon F, 2016, GENE, V586, P176, DOI 10.1016/j.gene.2016.04.022
   Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x
   Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228
   Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118
   Johnsen IB, 2013, CELL SIGNAL, V25, P1804, DOI 10.1016/j.cellsig.2013.05.014
   Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599
   Kallfass C, 2012, J VIROL, V86, P11223, DOI 10.1128/JVI.01093-12
   Katano T, 2011, NEUROPHARMACOLOGY, V60, P609, DOI 10.1016/j.neuropharm.2010.12.005
   Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004
   Kim SM, 2004, J VIROL, V78, P13479, DOI 10.1128/JVI.78.24.13479-13488.2004
   Kok SH, 2011, ARTHRITIS RHEUM-US, V63, P1010, DOI 10.1002/art.27433
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kurozumi K, 2008, MOL THER, V16, P1382, DOI 10.1038/mt.2008.112
   LATINKIC BV, 1991, NUCLEIC ACIDS RES, V19, P3261, DOI 10.1093/nar/19.12.3261
   Leu SJJ, 2013, BIOCHEM BIOPH RES CO, V434, P885, DOI 10.1016/j.bbrc.2013.04.045
   Li F, 2014, J VIROL, V88, P4328, DOI 10.1128/JVI.03628-13
   Li J, 2012, ACTA PHARMACOL SIN, V33, P1030, DOI 10.1038/aps.2012.61
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753
   Liu XY, 2018, MOL PAIN, V14, DOI 10.1177/1744806918778490
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   LOTHROP D, 1974, J VIROL, V14, P485, DOI 10.1128/JVI.14.3.485-492.1974
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Miletic G, 2002, PAIN, V99, P493, DOI 10.1016/S0304-3959(02)00242-7
   Moon HG, 2015, MUCOSAL IMMUNOL, V8, P243, DOI 10.1038/mi.2014.62
   NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001
   Perbal B, 2018, J CELL COMMUN SIGNAL, V12, P1, DOI 10.1007/s12079-018-0460-8
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Potokar M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030691
   Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893
   Retallack H, 2016, ZIKA VIRUS HUMAN PLA
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shi L, 2018, CELL BIOL TOXICOL, V34, P39, DOI 10.1007/s10565-017-9401-1
   Singh MV, 2011, J MOL MED, V89, P537, DOI 10.1007/s00109-011-0727-5
   Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122
   Sun J, 2018, MOL CELL BIOCHEM, V441, P1, DOI 10.1007/s11010-017-3170-2
   Sun Y, 2015, J INVEST DERMATOL, V135, P2666, DOI 10.1038/jid.2015.231
   Tan TW, 2009, CARCINOGENESIS, V30, P258, DOI 10.1093/carcin/bgn284
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tangsongcharoen C, 2019, BBA-PROTEINS PROTEOM, V1867, P89, DOI 10.1016/j.bbapap.2018.10.016
   Tsai MS, 2000, CANCER RES, V60, P5603
   Wei G, 2013, J ALZHEIMERS DIS, V33, P863, DOI 10.3233/JAD-2012-120865
   Wu PR, 2017, CLIN IMMUNOL, V174, P53, DOI 10.1016/j.clim.2016.11.003
   Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666
   Yan LL, 2013, J CELL COMMUN SIGNAL, V7, P253, DOI 10.1007/s12079-013-0206-6
   Yang R, 2018, MOL MED REP, V17, P3, DOI 10.3892/mmr.2017.7880
   Zhang XS, 2016, PETROL SCI, V13, P18, DOI 10.1007/s12182-015-0075-0
   Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013
NR 66
TC 0
Z9 0
U1 2
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2150-5594
EI 2150-5608
J9 VIRULENCE
JI Virulence
PD JAN 1
PY 2020
VL 11
IS 1
BP 113
EP 131
DI 10.1080/21505594.2020.1715189
PG 19
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KE9MA
UT WOS:000508872800001
PM 31957543
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Dinesh, DC
   Tamilarasan, S
   Rajaram, K
   Boura, E
AF Dinesh, Dhurvas Chandrasekaran
   Tamilarasan, Selvaraj
   Rajaram, Kaushik
   Boura, Evzen
TI Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic
   Human Diseases
SO CURRENT DRUG TARGETS
LA English
DT Review
DE RNA viruses; chronic diseases; drug targets; inhibitors; antivirals;
   HIV; hepatitis; flaviviruses; protein structures
ID RESPIRATORY SYNCYTIAL VIRUS; SMALL-MOLECULE INHIBITOR; HEPATITIS-C; ZIKA
   VIRUS; BROAD-SPECTRUM; CRYSTAL-STRUCTURE; EBOLA-VIRUS; PROTEASE
   INHIBITORS; MEASLES-VIRUS; ENTRY INHIBITORS
AB Ribonucleic acid (RNA) viruses associated with chronic diseases in humans are major threats to public health causing high mortality globally. The high mutation rate of RNA viruses helps them to escape the immune response and also is responsible for the development of drug resistance. Chronic infections caused by human immunodeficiency virus (HIV) and hepatitis viruses (HBV and HCV) lead to acquired immunodeficiency syndrome (AIDS) and hepatocellular carcinoma respectively, which are one of the major causes of human deaths. Effective preventative measures to limit chronic and re-emerging viral infections are absolutely necessary. Each class of antiviral agents targets a specific stage in the viral life cycle and inhibits them from its development and proliferation. Most often, antiviral drugs target a specific viral protein, therefore only a few broad-spectrum drugs are available. This review will be focused on the selected viral target proteins of pathogenic viruses containing single-stranded (ss) RNA genome that causes chronic infections in humans (e.g. HIV, HCV, Flaviviruses). In the recent past, an exponential increase in the number of available three-dimensional protein structures (>150000 in Protein Data Bank), allowed us to better understand the molecular mechanism of action of protein targets and antivirals. Advancements in the in silico approaches paved the way to design and develop several novels, highly specific small-molecule inhibitors targeting the viral proteins.
C1 [Dinesh, Dhurvas Chandrasekaran; Boura, Evzen] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.
   [Tamilarasan, Selvaraj] Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Ctr, Sect Microbial Biotechnol, Halle, Saale, Germany.
   [Rajaram, Kaushik] Cent Univ Tamil Nadu, Dept Microbiol, Thiruvarur, India.
RP Dinesh, DC; Boura, E (corresponding author), Czech Acad Sci, Dept Mol Biol & Biochem, Inst Organ Chem & Biochem, Flemingovo Namesti 542-2,POB 16000, Prague, Czech Republic.
EM dinesh@uochb.cas.cz; boura@uochb.cas.cz
RI Dinesh, Dhurvas Chandrasekaran/AAR-1948-2020
OI Dinesh, Dhurvas Chandrasekaran/0000-0001-9125-4775; Boura,
   Evzen/0000-0002-9652-4065
FU European Regional Development Fund; OP RDE; Project: "IOCB Mobility"
   [CZ.02.2.69/0.0/0.0/16_027/0008477]; European Regional Development Fund;
   OP RDE; Project: "Chemical biology for drugging undruggable targets
   (ChemBioDrug)" [CZ.02.1.01/0.0/0.0/16_019/0000729]; Czech Academy of
   SciencesCzech Academy of Sciences [RVO:61388963]; (Programu podpory
   perspektivnich lidskych zdroju) of the Czech Academy of Sciences;
   University Grant Commission (UGC) of IndiaUniversity Grants Commission,
   India
FX The work was supported by European Regional Development Fund; OP RDE;
   Project: "IOCB Mobility" (No. CZ.02.2.69/0.0/0.0/16_027/0008477), and OP
   RDE; Project: "Chemical biology for drugging undruggable targets
   (ChemBioDrug)" (No. CZ.02.1.01/0.0/0.0/16_019/0000729), The Czech
   Academy of Sciences (RVO:61388963) and (Programu podpory perspektivnich
   lidskych zdroju) of the Czech Academy of Sciences is also acknowledged.
   The authors also thank the University Grant Commission (UGC) of India
   for the support.
CR Aguado LC, 2018, P NATL ACAD SCI USA, V115, pE9211, DOI 10.1073/pnas.1810229115
   Al Olaby RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111333
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Alidjinou EK, 2015, ANTIVIR RES, V116, P51, DOI 10.1016/j.antiviral.2015.01.010
   Anasir MI, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00738
   [Anonymous], 2016, TRANSFUS MED HEMOTH, V43, P203, DOI DOI 10.1159/000445852
   Atoom AM, 2014, VIROLOGY, V462, P377, DOI 10.1016/j.virol.2014.04.018
   Atta MG, 2019, CLIN J AM SOC NEPHRO, V14, P435, DOI 10.2215/CJN.02240218
   Axley P, 2018, J CLIN TRANSL HEPATO, V6, P79, DOI 10.14218/JCTH.2017.00067
   Balasubramaniam M, 2019, J VIROL, V93, DOI 10.1128/JVI.01741-18
   Balmith M, 2017, CHEM BIOL DRUG DES, V89, P297, DOI 10.1111/cbdd.12870
   Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132
   Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506
   Basu A, 2015, J INFECT DIS, V212, pS425, DOI 10.1093/infdis/jiv223
   Battles MB, 2019, NAT REV MICROBIOL, V17, P233, DOI 10.1038/s41579-019-0149-x
   Bauer L, 2017, CURR OPIN VIROL, V24, P1, DOI 10.1016/j.coviro.2017.03.009
   Behmard E, 2018, BIOPHYS CHEM, V233, P47, DOI 10.1016/j.bpc.2017.11.002
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9
   Brecher M, 2015, ACS INFECT DIS, V1, P340, DOI 10.1021/acsinfecdis.5b00070
   Bukh J, 2016, J HEPATOL, V65, pS2, DOI 10.1016/j.jhep.2016.07.035
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Campagnola G, 2008, J VIROL, V82, P9458, DOI 10.1128/JVI.00647-08
   Carrillo-Infante C, 2007, INT J ONCOL, V30, P1521
   Challa S, 2015, ANTIMICROB AGENTS CH, V59, P1080, DOI 10.1128/AAC.04119-14
   Chu C, 2017, AM FAM PHYSICIAN, V96, P161
   Coey AT, 2018, J MOL BIOL, V430, P5137, DOI 10.1016/j.jmb.2018.08.029
   Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cox R, 2016, EXPERT OPIN DRUG DIS, V11, P543, DOI 10.1517/17460441.2016.1174212
   Das K, 2019, P NATL ACAD SCI USA, V116, P7308, DOI 10.1073/pnas.1814170116
   Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   De Clercq E, 2009, REV MED VIROL, V19, P287, DOI 10.1002/rmv.624
   de Leuw Philipp, 2017, GMS Infect Dis, V5, pDoc08, DOI 10.3205/id000034
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009
   Dubankova A, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104536
   Dube M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004530
   Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003
   Dufner-Beattie J, 2014, ANTIMICROB AGENTS CH, V58, P3399, DOI 10.1128/AAC.00113-14
   Duke T, 2003, LANCET, V361, P763, DOI 10.1016/S0140-6736(03)12661-X
   Einav S, 2010, J INFECT DIS, V202, P65, DOI 10.1086/653080
   Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747
   Esbjornsson J, 2018, LANCET HIV
   Espinosa M, 2015, KIDNEY BLOOD PRESS R, V40, P258, DOI 10.1159/000368501
   Fearns R, 2016, ANTIVIR RES, V134, P63, DOI 10.1016/j.antiviral.2016.08.006
   Ferreira LG, 2015, MOLECULES, V20, P13384, DOI 10.3390/molecules200713384
   Fontana J, 2007, CELL MICROBIOL, V9, P875, DOI 10.1111/j.1462-5822.2006.00837.x
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Garmaroudi FS, 2015, FUTURE MICROBIOL, V10, P629, DOI [10.2217/FMB.15.5, 10.2217/fmb.15.5]
   Gilani U, 2019, J MED VIROL, V91, P1, DOI 10.1002/jmv.25292
   Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060272
   Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x
   Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16
   Gruez A, 2008, J VIROL, V82, P9577, DOI 10.1128/JVI.00631-08
   Gu WG, 2014, AAPS J, V16, P674, DOI 10.1208/s12248-014-9604-9
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hashiguchi T, 2018, P NATL ACAD SCI USA, V115, P2496, DOI 10.1073/pnas.1718957115
   Hassan AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210559
   Heo YA, 2018, DRUGS, V78, P577, DOI 10.1007/s40265-018-0895-5
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hernandez J, 2019, EUR J MED CHEM, V161, P323, DOI 10.1016/j.ejmech.2018.09.056
   Heylen E, 2017, BIOCHEM PHARMACOL, V127, P1, DOI 10.1016/j.bcp.2016.09.014
   Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882
   Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9
   Hviid A, 2019, MEASLES MUMPS RUBELL
   ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136
   JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320
   Jayappa Kallesh Danappa, 2012, Int J Biochem Mol Biol, V3, P70
   Jiang YT, 2014, J MED CHEM, V57, P1753, DOI 10.1021/jm400164c
   Jinno-Oue A, 2013, AIDS RES HUM RETROV, V29, P621, DOI [10.1089/aid.2012.0156, 10.1089/AID.2012.0156]
   Kaaijk P, 2018, HUM VACC IMMUNOTHER, V14, P337, DOI 10.1080/21645515.2017.1389363
   Kalayanarooj Siripen, 2011, Trop Med Health, V39, P83, DOI 10.2149/tmh.2011-S10
   Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002
   Karr JP, 2016, BIOCHEMISTRY-US, V55, P3995, DOI 10.1021/acs.biochem.6b00467
   Kloc A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00485
   KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Kota S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032207
   Kowalzik F, 2018, VACCINE, V36, P5402, DOI 10.1016/j.vaccine.2017.07.051
   Kuhnert M, 2014, J MED CHEM, V57, P6266, DOI 10.1021/jm500402c
   Lai SH, 2008, MOL THER, V16, P1120, DOI 10.1038/mt.2008.81
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Larsen KP, 2018, NATURE, V557, P118, DOI 10.1038/s41586-018-0055-9
   Lavorgna A, 2014, VIRUSES-BASEL, V6, P3925, DOI 10.3390/v6103925
   Lee M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44676
   Leligdowicz A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1325-2
   Li Darrick K, 2019, Methods Mol Biol, V1911, P3, DOI 10.1007/978-1-4939-8976-8_1
   Li GD, 2016, MICROBIOL MOL BIOL R, V80, P679, DOI 10.1128/MMBR.00065-15
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liao KC, 2018, RNA, V24, P803, DOI 10.1261/rna.064006.117
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lu L, 2016, CURR TOP MED CHEM, V16, P1074, DOI 10.2174/1568026615666150901114527
   Lv ZT, 2015, HIV AIDS-RES PALLIAT, V7, P95, DOI 10.2147/HIV.S79956
   Mahadevia Parthiv J, 2012, J Med Econ, V15, P987, DOI 10.3111/13696998.2012.690013
   Malvy D, 2019, LANCET, V393, P936, DOI 10.1016/S0140-6736(18)33132-5
   Marino-Merlo F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00925
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Martinez-Cajas JL, 2007, ANTIVIR RES, V76, P203, DOI 10.1016/j.antiviral.2007.06.010
   Mason S, 2018, ANTIVIR RES, V158, P103, DOI 10.1016/j.antiviral.2018.07.020
   McCarthy MK, 2017, CURR OPIN VIROL, V23, P8, DOI 10.1016/j.coviro.2017.01.003
   McElroy AK, 2014, J INFECT DIS, V210, P558, DOI 10.1093/infdis/jiu088
   McGivern DR, 2015, J VIROL, V89, P5362, DOI 10.1128/JVI.03188-14
   Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a
   Mejdrova I, 2017, J MED CHEM, V60, P100, DOI 10.1021/acs.jmedchem.6b01465
   Mejdrova I, 2015, J MED CHEM, V58, P3767, DOI 10.1021/acs.jmedchem.5b00499
   Mitchell JK, 2015, CURR OPIN VIROL, V14, P101, DOI 10.1016/j.coviro.2015.09.003
   Moss WJ, 2006, NAT REV MICROBIOL, V4, P900, DOI 10.1038/nrmicro1550
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Ndungu JM, 2012, J MED CHEM, V55, P4220, DOI 10.1021/jm201699w
   Nitsche C, 2018, ADV EXP MED BIOL, V1062, P175, DOI 10.1007/978-981-10-8727-1_13
   Noton SL, 2015, J VIROL, V89, P7786, DOI 10.1128/JVI.00530-15
   Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014
   Ohimain EI, 2016, VIRUS RES, V211, P174, DOI 10.1016/j.virusres.2015.10.021
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pancera M, 2017, NAT CHEM BIOL, V13, P1115, DOI [10.1038/nchembio.2460, 10.1038/NCHEMBIO.2460]
   Petrova EK, 2016, VACCINE, V34, P1006, DOI 10.1016/j.vaccine.2016.01.010
   Phillips AN, 2019, LANCET HIV, V6, pE116, DOI 10.1016/S2352-3018(18)30317-5
   Phillips B, 2014, J MED CHEM, V57, P2161, DOI 10.1021/jm401646w
   Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024
   Plemper RK, 2009, CURR OPIN INVEST DR, V10, P811
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Prasad VM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006377
   Prasad VM, 2013, P NATL ACAD SCI USA, V110, P20105, DOI 10.1073/pnas.1316681110
   Quan XB, 2019, PHYS CHEM CHEM PHYS, V21, P10300, DOI 10.1039/c9cp01543d
   Rai MA, 2018, EXPERT OPIN EMERG DR, V23, P149, DOI 10.1080/14728214.2018.1474202
   Randall RE, 2017, CURR OPIN VIROL, V23, P35, DOI 10.1016/j.coviro.2017.03.001
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Ren JS, 2018, J MED CHEM, V61, P724, DOI 10.1021/acs.jmedchem.7b01249
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   RHIM H, 1991, J VIROL, V65, P4555, DOI 10.1128/JVI.65.9.4555-4564.1991
   Rice WG, 1997, NAT MED, V3, P341, DOI 10.1038/nm0397-341
   Romano KP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002832
   Rota PA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.49
   Ruigrok RWH, 2010, VIRUSES-BASEL, V2, P27, DOI 10.3390/v2010027
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, P6, DOI DOI 10.1128/AAC.00411-17.E00411-17
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Sancineto L, 2015, J MED CHEM, V58, P9601, DOI 10.1021/acs.jmedchem.5b01183
   Schlabe S, 2018, EXPERT OPIN PHARMACO, V19, P49, DOI 10.1080/14656566.2017.1419185
   Sebera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29459-7
   Shameer K, 2018, BIORXIV
   Shaw J, 2015, ANTIVIR RES, V117, P20, DOI 10.1016/j.antiviral.2015.02.005
   Sheldon J, 2007, EXPERT OPIN INV DRUG, V16, P1171, DOI 10.1517/13543784.16.8.1171
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Shortridge MD, 2019, NUCLEIC ACIDS RES, V47, P1523, DOI 10.1093/nar/gky1197
   Sin J, 2015, VIROLOGY, V484, P288, DOI 10.1016/j.virol.2015.06.006
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Skorenski M MA, 2017, INHIBITORS COMPOUNDS, V14, P95
   Soltani A, 2019, BIOMED PHARMACOTHER, V109, P770, DOI 10.1016/j.biopha.2018.10.139
   Tahamtan A, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2026
   Tang W, 2019, FASEB J, V33, P4287, DOI 10.1096/fj.201800579R
   Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634
   Taylor JG, 2019, BIOORG MED CHEM LETT, V29, P2428, DOI 10.1016/j.bmcl.2019.03.037
   Thenin-Houssier S, 2016, ANTIMICROB AGENTS CH, V60, P2195, DOI 10.1128/AAC.02574-15
   Thenin-Houssier S, 2016, CURR HIV RES, V14, P270, DOI 10.2174/1570162X14999160224103555
   Nguyen TH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01541
   Tripp RA, 2018, J VIROL, V92, DOI 10.1128/JVI.01302-17
   Tyor W, 2014, HAND CLINIC, V123, P591, DOI 10.1016/B978-0-444-53488-0.00028-6
   Ulferts R, 2016, ANTIMICROB AGENTS CH, V60, P2627, DOI 10.1128/AAC.02182-15
   van Montfort RLM, 2017, ESSAYS BIOCHEM, V61, P431, DOI 10.1042/EBC20170052
   WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Wei L, 2019, LANCET GASTROENTEROL, V4, P127, DOI 10.1016/S2468-1253(18)30343-1
   White JP, 2018, CELL, V175, P1198, DOI 10.1016/j.cell.2018.08.069
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Xing Y, 2019, EUR J PEDIATR, V178, P131, DOI 10.1007/s00431-018-03310-7
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15576
   Xue WW, 2014, J CHEM INF MODEL, V54, P621, DOI 10.1021/ci400060j
   Yang Y, 2018, ELIFE, P7
   Yavuz B, 2018, ADV THER
   Yen PS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0011-5
   Yi HA, 2016, CURR HIV RES, V14, P283, DOI 10.2174/1570162X14999160224103908
   Yuan S, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0055-z
   Zanella L, 2012, J VIROL, V86, P12451, DOI 10.1128/JVI.02258-12
   Zentner I, 2013, CHEMMEDCHEM, V8, P426, DOI 10.1002/cmdc.201200577
   Zhan P, 2016, J MED CHEM, V59, P2849, DOI 10.1021/acs.jmedchem.5b00497
   Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615
   Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226
NR 182
TC 0
Z9 0
U1 8
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-4501
EI 1873-5592
J9 CURR DRUG TARGETS
JI Curr. Drug Targets
PY 2020
VL 21
IS 2
SI SI
BP 105
EP 124
DI 10.2174/1389450119666190920153247
PG 20
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KE6EL
UT WOS:000508647100002
PM 31538891
DA 2020-07-08
ER

PT J
AU Cranston, JS
   Tiene, SF
   Nielsen-Saines, K
   Moreira, M
   Vasconcelos, Z
   Da Costa, A
AF Cranston, J. S.
   Tiene, S. F.
   Nielsen-Saines, K.
   Moreira, M.
   Vasconcelos, Z.
   Da Costa, A.
TI CHARACTERIZING CLINICAL MANIFESTATIONS OF CONGENITAL ZIKA SYNDROME IN
   NON-MICROCEPHALIC INFANTS
SO JOURNAL OF INVESTIGATIVE MEDICINE
LA English
DT Meeting Abstract
CT Western Medical Research Conference (WMRC)
CY JAN 23-25, 2020
CL Carmel, CA
C1 [Cranston, J. S.; Tiene, S. F.; Nielsen-Saines, K.] David Geffen Sch Med, Los Angeles, CA USA.
   [Moreira, M.; Vasconcelos, Z.; Da Costa, A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1081-5589
EI 1708-8267
J9 J INVEST MED
JI J. Invest. Med.
PD JAN
PY 2020
VL 68
SU 1
MA 330
BP A142
EP A143
DI 10.1136/jim-2019-WMRC.330
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA KC9SZ
UT WOS:000507513300330
DA 2020-07-08
ER

PT J
AU Tiene, SF
   Cranston, JS
   Nielsen-Saines, K
   Moreira, M
   Vasconcelos, Z
   Da Costa, A
AF Tiene, S. F.
   Cranston, J. S.
   Nielsen-Saines, K.
   Moreira, M.
   Vasconcelos, Z.
   Da Costa, A.
TI EARLY PREDICTORS OF NEURODEVELOPMENT IN INFANTS ANTENATALLY EXPOSED TO
   ZIKA
SO JOURNAL OF INVESTIGATIVE MEDICINE
LA English
DT Meeting Abstract
CT Western Medical Research Conference (WMRC)
CY JAN 23-25, 2020
CL Carmel, CA
C1 [Tiene, S. F.; Cranston, J. S.; Nielsen-Saines, K.] David Geffen Sch Med, Los Angeles, CA USA.
   [Moreira, M.; Vasconcelos, Z.; Da Costa, A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Moreira, M.; Vasconcelos, Z.; Da Costa, A.] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1081-5589
EI 1708-8267
J9 J INVEST MED
JI J. Invest. Med.
PD JAN
PY 2020
VL 68
SU 1
MA 331
BP A143
EP A143
DI 10.1136/jim-2019-WMRC.331
PG 1
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA KC9SZ
UT WOS:000507513300331
DA 2020-07-08
ER

PT J
AU Slavov, SN
   Machado, RRG
   Ferreira, AR
   Soares, CP
   Araujo, DB
   Oliveira, DBL
   Covas, DT
   Durigon, EL
   Kashima, S
AF Slavov, Svetoslav Nanev
   Guaragna Machado, Rafael Rahal
   Ferreira, Alexander Rodrigo
   Soares, Camila Pereira
   Araujo, Danielle Bastos
   Leal Oliveira, Danielle Bruna
   Covas, Dimas Tadeu
   Durigon, Edison Luiz
   Kashima, Simone
TI Zika virus seroprevalence in blood donors from the Northeastern region
   of Sao Paulo State, Brazil, between 2015 and 2017
SO JOURNAL OF INFECTION
LA English
DT Article
DE Seroprevalence; Zika virus; Blood donors; PRNT; Brazil
ID TRANSMISSION; OUTBREAK
AB Objectives: Although primarily transmitted by Aedes aegypti mosquitos, Zika virus (ZIKV) can also be transmitted by blood transfusion, due to the fact that some of the infected donors can establish asymptomatic viremia. ZIKV seroprevalence in Brazilian blood donors is unknown. The main reason for this gap in the knowledge originates from the difficulty in evaluating ZIKV humoral immunity due to antigenic cross-reactivity between the different Brazilian flaviviruses and, in particular, dengue virus (DENV). The objective of this study was to evaluate the anti-ZIKV IgG prevalence in blood donors from the Northeast region of the Sao Paulo State, Brazil, which experienced a ZIKV outbreak in 2016.
   Methods: We evaluated the ZIKV seroprevalence using the NS1 anti-ZIKV IgG test (Euroimmun), followed by confirmation of the positive and borderline results using the Plaque Reduction Neutralization Test (PRNT). ZIKV seroprevalence was estimated by testing plasma samples collected in 2015 (before the ZIKV outbreak), 2016 (during the outbreak) and 2017 (after the outbreak). In order to investigate possible antigenic cross - reactivity between ZIKV and DENV we also included samples that were taken well before the ZIKV outbreak, in years 2010 and 2013.
   Results: The results obtained by the Euroimmun anti-ZIKV IgG test demonstrated ZIKV seroreactivity in 2015, 2016, and 2017 with prevalences of 5.3%, 12.8% and 13.2%, respectively. The inclusion of blood donor samples from 2010 to 2013, demonstrated anti-ZIKV IgG reactivity only for 2013 (1.7%). The PRNT testing of the ZIKV positive and borderline ELISA reacting samples generated positive results only for the years of 2016 and 2017 (prevalences of 5.6% and 9.1%) which coincided with the introduction of ZIKV in our region.
   Conclusions: Our results estimate for the first time the ZIKV seroprevalence among Brazilian blood donors from a region with apparently extensive ZIKV circulation and which, at the same time, is highly endemic for DENV. We detected relatively low ZIKV seroprevalence in blood donors from the studied region probably due to the lower intensity of the outbreak compared to other Brazilian locations. Our study adds to the global understanding of ZIKV circulation and the herd immunity of the exposed population. (C) 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Slavov, Svetoslav Nanev; Ferreira, Alexander Rodrigo; Covas, Dimas Tadeu; Kashima, Simone] Univ Sao Paulo, Fac Med Ribeirao Preto, Blood Ctr Ribeirao Preto, Lab Mol Biol, 2501 Tenente Catao Roxo St, BR-14051140 Ribeirao Preto, SP, Brazil.
   [Slavov, Svetoslav Nanev] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Guaragna Machado, Rafael Rahal; Soares, Camila Pereira; Araujo, Danielle Bastos; Leal Oliveira, Danielle Bruna; Durigon, Edison Luiz] Univ Sao Paulo, Inst Biomed Sci, Lab Clin & Mol Virol, BR-05508000 Sao Paulo, SP, Brazil.
RP Slavov, SN (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Blood Ctr Ribeirao Preto, Lab Mol Biol, 2501 Tenente Catao Roxo St, BR-14051140 Ribeirao Preto, SP, Brazil.
EM svetoslav.slavov@hemocentro.fmrp.usp.br
RI Ferreira, Alexander/R-1439-2017
OI Ferreira, Alexander/0000-0003-1175-8127; Rahal Guaragna Machado,
   Rafael/0000-0001-6974-5092
FU Fundacao de Amparo e Pesquisa do Estado de Sao Paulo-FAPESP, Brazil
   [CTC-2013/081352, 2017/23205-8, INCTC-FAPESP-2014/50947-7, 2016/08727-5,
   2016/20045-7, PPSUS 2016/15049-3, 17/23205-8]; Conselho Nacional do
   Desenvolvimento Cientifico e Tecnologico, Brazil [INCTC-465539/2014-9];
   FINEP, BrazilCiencia Tecnologia e Inovacao (FINEP) [245/2016]
FX We are grateful to Sandra Navarro Bresciani for the artwork. This study
   was supported by grants provided by the Fundacao de Amparo e Pesquisa do
   Estado de Sao Paulo-FAPESP, Brazil (CTC-2013/081352, 2017/23205-8,
   INCTC-FAPESP-2014/50947-7, 2016/08727-5, No 2016/20045-7, PPSUS
   2016/15049-3, 17/23205-8), Conselho Nacional do Desenvolvimento
   Cientifico e Tecnologico, Brazil (INCTC-465539/2014-9), and FINEP,
   Brazil (245/2016).
CR [Anonymous], 2017, B EPIDEMIOLOGICO
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Britt WJ, 2018, SEMIN PERINATOL, V42, P155, DOI 10.1053/j.semperi.2018.02.003
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Karkhah A, 2018, EUR J CLIN MICROBIOL, V37, P2035, DOI 10.1007/s10096-018-3354-z
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Langerak T, 2019, J INFECT DIS, V220, P28, DOI 10.1093/infdis/jiz063
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Massad E, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000712, 10.1017/s0950268819000712]
   Ministerio da Saude, 2017, B EPIDEMIOLOGICO, V48
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Maia FGM, 2014, INT J INFECT DIS, V26, P96, DOI 10.1016/j.ijid.2014.05.018
   Neto RJP, 2005, BRAZ J MED BIOL RES, V38, P843, DOI 10.1590/S0100-879X2005000600005
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Oliveira DBL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110615
   Pastorino B, 2019, AM J TROP MED HYG, V100, P639, DOI 10.4269/ajtmh.18-0439
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Seruyange E, 2018, J MED VIROL, V90, P1290, DOI 10.1002/jmv.25198
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Souza NCSE, 2019, INT J INFECT DIS
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   World Health, 2007, GUID PLAQ RED NEUTR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 0
Z9 0
U1 1
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JAN
PY 2020
VL 80
IS 1
BP 111
EP 115
DI 10.1016/j.jinf.2019.10.002
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KC8ZF
UT WOS:000507459600013
PM 31738944
OA Bronze
DA 2020-07-08
ER

PT J
AU Miller, EA
   Sung, KJ
   Kongsuphol, P
   Baniya, S
   Aw-Yong, HQ
   Tay, V
   Tan, YX
   Kabir, FM
   Pang-Yeo, K
   Kaspriskie, IG
   Sikes, HD
AF Miller, Eric A.
   Sung, Ki-Joo
   Kongsuphol, Patthara
   Baniya, Subha
   Aw-Yong, Hui Qi
   Tay, Vivian
   Tan, Yuxuan
   Kabir, Farah M.
   Pang-Yeo, Karl
   Kaspriskie, Isabel G.
   Sikes, Hadley D.
TI Beyond Epitope Binning: Directed in Vitro Selection of Complementary
   Pairs of Binding Proteins
SO ACS COMBINATORIAL SCIENCE
LA English
DT Article
DE binding pairs; epitope binning; protein engineering; yeast surface
   display; sandwich immunoassay
ID PHAGE DISPLAY SELECTION; YEAST SURFACE DISPLAY; NONOVERLAPPING EPITOPES;
   EFFICIENT SELECTION; PICOMOLAR AFFINITY; ANTIBODIES; IDENTIFICATION;
   DISCOVERY; CAPTURE; ASSAYS
AB Many biotechnological applications require the simultaneous binding of affinity reagents to nonoverlapping target epitopes, the most prominent example being sandwich immunoassays. Typically, affinity pairs are identified via post facto functional analysis of clones that were not selected for complementarity. Here, we developed the Rapid Affinity Pair Identification via Directed Selection (RAPIDS) process, which enables the efficient identification of affinity reagents that function together as complementary pairs, from in vitro libraries of similar to 10(9) variants. We used RAPIDS to develop highly specific affinity pairs against biomarkers of tuberculosis, Zika virus, and sepsis. Without additional trial-and-error screening, these affinity pairs exhibited utility in multiple assay formats. The RAPIDS process applies selective pressure to hundreds of thousands of potential affinity pairs to efficiently identify complementary pairs that bind to separate epitopes without binding to one another or nontargets, yielding diagnostic assays that are sensitive and specific by design.
C1 [Miller, Eric A.; Sung, Ki-Joo; Kabir, Farah M.; Kaspriskie, Isabel G.; Sikes, Hadley D.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Kongsuphol, Patthara; Aw-Yong, Hui Qi; Tay, Vivian; Tan, Yuxuan; Pang-Yeo, Karl; Sikes, Hadley D.] Singapore MIT Alliance Res & Technol SMART Ctr, 1 CREATE Way, Singapore 138602, Singapore.
   [Baniya, Subha] Wellesley Coll, Dept Biochem, Wellesley, MA 02481 USA.
RP Sikes, HD (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Sikes, HD (corresponding author), Singapore MIT Alliance Res & Technol SMART Ctr, 1 CREATE Way, Singapore 138602, Singapore.
EM sikes@mit.edu
FU MIT Tata Center for Technology and Design; National Research Foundation
   of SingaporeSingapore National Research Foundation; MIT Deshpande Center
   for Technological Innovation; National Science Foundation Graduate
   Research FellowshipNational Science Foundation (NSF) [1122374]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [2 T32 GM008334 26];
   MIT's UROP Program; National Cancer InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [NIH S10 OD016326, NIH P3OCCA14051]
FX This work was supported by the MIT Tata Center for Technology and
   Design, the National Research Foundation of Singapore, and MIT Deshpande
   Center for Technological Innovation. K.-J.S. acknowledges a National
   Science Foundation Graduate Research Fellowship (1122374). E.A.M.
   acknowledges a training grant from the National Institutes of Health (2
   T32 GM008334 26). H.D.S. acknowledges the Esther and Harold E. Edgerton
   chair at MIT. F.M.K. and I.G.K. acknowledge support from MIT's UROP
   Program. The Octet Bio-Layer Interferometry System (NIH S10 OD016326)
   and flow cytometry equipment provided by a Cancer Center Core Grant (NIH
   P3OCCA14051) from the National Cancer Institute are gratefully
   acknowledged.
CR Abdiche YN, 2012, J IMMUNOL METHODS, V382, P101, DOI 10.1016/j.jim.2012.05.010
   Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038
   Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451
   Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174
   Anderson GP, 2017, J IMMUNOL METHODS, V442, P42, DOI 10.1016/j.jim.2017.01.005
   Badu-Tawiah AK, 2015, LAB CHIP, V15, P655, DOI 10.1039/c4lc01239a
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200
   Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3
   Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382
   Carlin KB, 2016, ACS SYNTH BIOL, V5, P1348, DOI 10.1021/acssynbio.6b00034
   Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94
   Chen WZ, 2012, MOL CANCER THER, V11, P1400, DOI 10.1158/1535-7163.MCT-12-0172
   Cho M, 2015, ANAL CHEM, V87, P821, DOI 10.1021/ac504076k
   Cruz-Teran CA, 2017, ACS SYNTH BIOL, V6, P2096, DOI 10.1021/acssynbio.7b00144
   Dong JX, 2019, ELIFE, V8, DOI 10.7554/eLife.48750
   EKINS R, 1980, NATURE, V284, P13, DOI 10.1038/284014a0
   Even-Desrumeaux K, 2014, MOL CELL PROTEOMICS, V13, P653, DOI 10.1074/mcp.O112.025486
   Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12
   Fleetwood F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07518
   Galan A, 2016, MOL BIOSYST, V12, P2342, DOI 10.1039/c6mb00219f
   Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020
   Gorman KT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx688
   Gray AC, 2016, TRENDS BIOTECHNOL, V34, P960, DOI 10.1016/j.tibtech.2016.05.017
   Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051
   Hou TY, 2015, INT J CLIN EXP MED, V8, P15238
   Institute for Laboratory Animal Research, 1999, MONOCLONAL ANTIBODY, DOI 10.17226/9450
   Itoh Kunihiko, 2002, Methods Mol Biol, V178, P195
   Juncker D, 2014, CURR OPIN CHEM BIOL, V18, P29, DOI 10.1016/j.cbpa.2013.11.012
   Kashino SS, 2008, CLIN EXP IMMUNOL, V153, P56, DOI 10.1111/j.1365-2249.2008.03672.x
   Ki MK, 2010, BIOTECHNOL BIOPROC E, V15, P152, DOI 10.1007/s12257-009-3080-6
   Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269
   Li JY, 2016, CANCER CELL, V29, P117, DOI 10.1016/j.ccell.2015.12.008
   McMahon C, 2018, NAT STRUCT MOL BIOL, V25, P289, DOI 10.1038/s41594-018-0028-6
   Miller EA, 2016, MOL SYST DES ENG, V1, P377, DOI [10.1039/c6me00032k, 10.1039/C6ME00032K]
   Miller EA, 2018, BIOSENS BIOELECTRON, V102, P456, DOI 10.1016/j.bios.2017.11.050
   Nag A, 2013, ANGEW CHEM INT EDIT, V52, P13975, DOI 10.1002/anie.201305882
   Napolitano DR, 2008, CLIN VACCINE IMMUNOL, V15, P638, DOI 10.1128/CVI.00010-08
   Nelson PN, 2000, J CLIN PATHOL-MOL PA, V53, P111
   Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x
   Ochsner UA, 2014, BIOTECHNIQUES, V56, P125, DOI 10.2144/000114134
   Puri V, 2013, MABS-AUSTIN, V5, P533, DOI 10.4161/mabs.25211
   Qin SY, 2017, ACS SENSORS, V2, P308, DOI 10.1021/acssensors.6b00836
   Rossotti MA, 2015, ANAL CHEM, V87, P11907, DOI 10.1021/acs.analchem.5b03561
   Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166
   Sivasubramanian A, 2017, MABS-AUSTIN, V9, P29, DOI 10.1080/19420862.2016.1246096
   Skerra A, 2000, BBA-PROTEIN STRUCT M, V1482, P337, DOI 10.1016/S0167-4838(00)00145-X
   Sung KJ, 2018, MOL SYST DES ENG, V3, P877, DOI 10.1039/c8me00049b
   Traxlmayr MW, 2016, J BIOL CHEM, V291, P22496, DOI 10.1074/jbc.M116.741314
   Van Deventer JA, 2015, PROTEIN ENG DES SEL, V28, P317, DOI 10.1093/protein/gzv043
   Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028
   Zhang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09928
   Zhao N, 2016, FEBS J, V283, P1351, DOI 10.1111/febs.13674
NR 53
TC 1
Z9 1
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2156-8952
EI 2156-8944
J9 ACS COMB SCI
JI ACS Comb. Sci.
PD JAN
PY 2020
VL 22
IS 1
BP 49
EP 60
DI 10.1021/acscombsci.9b00176
PG 12
WC Chemistry, Applied; Chemistry, Medicinal; Chemistry, Multidisciplinary
SC Chemistry; Pharmacology & Pharmacy
GA KC8NW
UT WOS:000507429300007
PM 31769955
OA Bronze
DA 2020-07-08
ER

PT J
AU Nascimento, KLC
   da Silva, JFM
   Zequi, JAC
   Lopes, J
AF Campana Nascimento, Kauani Larissa
   Marques da Silva, Joao Fernando
   Cyrino Zequi, Joao Antonio
   Lopes, Jose
TI Comparison Between Larval Survey Index and Positive Ovitrap Index in the
   Evaluation of Populations of Aedes (Stegomyia) aegypti (Linnaeus, 1762)
   North of Parana, Brazil
SO ENVIRONMENTAL HEALTH INSIGHTS
LA English
DT Article
DE Dengue; mosquito vectors; oviposition
ID 1ST REPORT; DENGUE; ALBOPICTUS; SURVEILLANCE; CULICIDAE; DIPTERA; STATE;
   TRANSMISSION; INFESTATION; VIRUS
AB Aedes (Stegomyia) aegypti (Linnaeus, 1762) is one of the world's most widely distributed mosquitoes and is the vector of the dengue virus, one of the most important reemerging diseases. Besides dengue, A. aegypti can also transmit urban yellow fever, chikungunya, and Zika virus, making it of great medical importance. Thus, it is of extreme importance to find reliable methods to evaluate the presence of A. aegypti in urban areas. In Brazil, rapid index surveys of Aedes aegypti by means of larval survey (LIRAa) is the official method to estimate the Breteau (BI) and property infestation (PII) indexes, which indicates how many infested containers with larvae of A. aegypti were found by the total number of properties surveyed and the proportion of houses infested, respectively. As the LIRAa requires access to private residences and trained personal to find breeding sites and do not reveal the mosquito's presence when in low density, it has not demonstrated efficacy in determining the presence of A. aegypti. To evaluate an alternative method, the LIRAa method was compared with an oviposition trap, made with hay infusion and a hardboard pallet, to evaluate the BI and the PII. The 2 methods were carried out simultaneously through 4 surveys, sampling 60 homes per survey. To evaluate the best configuration of ovitraps for surveillance of A. aegypti, the ovitraps were installed in intradomicile and peridomicile areas, with 1 to 5 traps per residence and with 1 to 3 pallets per trap, and these different configurations were compared using the positive ovitrap index (POI) and egg density index (EDI). The ovitraps showed greater sensitivity for detecting the presence of A. aegypti, with a BI of 72.5% and PII of 54.2%, whereas the LIRAa revealed only 2.1% for the BI and 1.3% for the PII. Therefore, the use of sentinel traps can provide information in a more rapid and precise manner. As there were no differences in the ovitraps distributions patterns, the ovitraps can be installed in the peridomicile area, with 2 traps per surveillance point and 1 pallet per trap, making their installation easier and more cost-efficient, facilitating the work of health agents in future surveillances complementing LIRAa's actions for efficient monitoring.
C1 [Campana Nascimento, Kauani Larissa] Univ Estadual Londrina, Programa Posgrad Ciencias Biol, Dept Biol Anim & Vegetal, Ctr Ciencias Biol, Londrina, Parana, Brazil.
   [Marques da Silva, Joao Fernando; Cyrino Zequi, Joao Antonio; Lopes, Jose] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Biol Anim & Vegetal, Londrina, Parana, Brazil.
RP Zequi, JAC (corresponding author), Univ Estadual Londrina, Caixa Postal 6001, BR-86051970 Londrina, Parana, Brazil.
EM zequi@uel.br
RI zequi, joao/J-1714-2012
OI zequi, joao/0000-0002-1480-7660; Marques Silva, Joao
   Fernando/0000-0002-6559-9312
FU Capes (Coordination for the Improvement of Higher Education
   Personnel-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -
   Brasil) [001]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the Capes (Coordination for the Improvement of Higher
   Education Personnel-Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - Brasil (CAPES) - Finance Code 001).
CR Acioli RV., 2006, THESIS
   Ai-leen Ginny Tan, 2000, Dengue Bulletin, V24, P110
   [Anonymous], 2002, VISION 2020 RIGHT SI, V1, p[1, 1]
   [Anonymous], 2005, FUNCTIONAL FOODS OPP, V1, P1
   Balestra RAM, 2008, NEOTROP ENTOMOL, V37, P233, DOI 10.1590/S1519-566X2008000200020
   Barcellos C, 2005, REV SOC BRAS MED TRO, V38, P246, DOI 10.1590/S0037-86822005000300008
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Braga Ima Aparecida, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P347, DOI 10.1590/S0037-86822000000400003
   Brasil, CAS DENG BRAS GRAND
   Cardoso Junior R P, 1997, Rev Soc Bras Med Trop, V30, P37, DOI 10.1590/S0037-86821997000100007
   CHADEE DD, 1995, MED VET ENTOMOL, V9, P66, DOI 10.1111/j.1365-2915.1995.tb00118.x
   Chen Chee Dhang, 2005, Trop Biomed, V22, P39
   CHENG ML, 1982, B WORLD HEALTH ORGAN, V60, P291
   Chiaravalloti-Neto F, 1998, CAD SAUDE PUBLICA SU, V14, pS101
   da Silva VC, 2006, REV SAUDE PUBL, V40, P1106, DOI [10.1590/S0034-89102006000700021, 10.1590/s0034-89102006000700021]
   Da Silva Vieira GS, 2006, CAMINHOS GEOG, V11, P107
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   Forattini OP., 2002, CULICIDOLOGIA MED
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Glasser CM, 2002, REV SAUDE PUBL, V36, P166, DOI 10.1590/s0034-89102002000200008
   Gomes AC., 1998, IESUS, V1, P49
   Gomes AD, 2005, REV SAUDE PUBL, V39, P206, DOI 10.1590/S0034-89102005000200010
   Ipardes, PERF MUN CAMB PAR
   MARCONDES C. B., 2001, ENTOMOLOGIA MED VET
   MARQUES CCD, 1993, REV SAUDE PUBL, V27, P237, DOI 10.1590/S0034-89101993000400002
   Marten GG, 2012, J MED ENTOMOL, V49, P640, DOI 10.1603/ME10284
   Masuh H, 2008, PARASITOL RES, V103, P167, DOI 10.1007/s00436-008-0945-0
   Ministerio da Saude, LEV RAP IND AED AEG
   Morato VCG, 2005, REV SAUDE PUBL, V39, P553, DOI [10.1590/S0034-89102005000400006, 10.1590/s0034-89102005000400006]
   Nogueira RMR, 1999, MEM I OSWALDO CRUZ, V94, P297, DOI 10.1590/S0074-02761999000300004
   Nunes LS, 2011, BIOTA AMAZONIA, V1, P26
   Ordonez-Gonzalez JG, 2001, J AM MOSQUITO CONTR, V17, P93
   Polson K. A., 2002, Dengue Bulletin, V26, P178
   R Core Team, 2019, R LANG ENV STAT COMP
   Rawlins SC, 1998, J AM MOSQUITO CONTR, V14, P131
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Resende MC., 2009, THESIS
   RIBEIRO C. S., 2010, THESIS
   Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076
   Rueda BZ., 2009, THESIS
   Santos Roseli La Corte dos, 2003, Rev. Saúde Pública, V37, P671, DOI 10.1590/s0034-89102003000500019
   Secretaria de Vigilancia em Saude (SVS), 2016, INF EP NO 27 MON CAS, V46
   Secretaria de Vigilancia em Saude (SVS), 2015, B EP MON CAS DENG FE, V46
   Secretaria de Vigilancia em Saude (SVS), 2019, B EPIDEMIOLOGICO, V50
   Secretaria de Vigilancia em Saude (SVS), 2016, B EP MON CAS DENG FE, V47
   Secretaria de Vigilancia em Saude (SVS), 2014, PLAN CONT NAC FEBR C
   Silva JCS, 2010, MONOGRAFIA ESPECIALI
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002
   Wan Norafikah O, 2011, HLTH ENV J, V2, P15
   World Health Organization (WHO), DENG SEV DENG
   WRBU, MOSQ ID RES
   Wu HH, 2013, J MED ENTOMOL, V50, P261, DOI 10.1603/ME11263
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 55
TC 0
Z9 0
U1 2
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1178-6302
J9 ENVIRON HEALTH INSIG
JI Environ. Health Insights
PD JAN
PY 2020
VL 14
AR 1178630219886570
DI 10.1177/1178630219886570
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KA8BF
UT WOS:000506023600001
PM 31933523
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Prochnow, H
   Rox, K
   Birudukota, NVS
   Weichert, L
   Hotop, SK
   Klahn, P
   Mohr, K
   Franz, S
   Banda, DH
   Blockus, S
   Schreiber, J
   Haid, S
   Oeyen, M
   Martinez, JP
   Sussmuth, RD
   Wink, J
   Meyerhans, A
   Goffinet, C
   Messerle, M
   Schulz, TF
   Kroger, A
   Schols, D
   Pietschmann, T
   Bronstrup, M
AF Prochnow, Hans
   Rox, Katharina
   Birudukota, N. V. Suryanarayana
   Weichert, Loreen
   Hotop, Sven-Kevin
   Klahn, Philipp
   Mohr, Kathrin
   Franz, Sergej
   Banda, Dominic H.
   Blockus, Sebastian
   Schreiber, Janine
   Haid, Sibylle
   Oeyen, Merel
   Martinez, Javier P.
   Suessmuth, Roderich D.
   Wink, Joachim
   Meyerhans, Andreas
   Goffinet, Christine
   Messerle, Martin
   Schulz, Thomas F.
   Kroeger, Andrea
   Schols, Dominique
   Pietschmann, Thomas
   Broenstrup, Mark
TI Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through
   Lipid-Binding-Mediated Virolysis
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE lanthipeptides; antivirals; drug discovery; mechanism of action;
   phosphatidylethanolamine; lipids; drug synergism; dengue virus; DENV;
   Zika virus; ZIKV
ID CYCLOTIDE KALATA B1; VIRUS; DENGUE; ENVELOPE; ENTRY; BIOSYNTHESIS;
   INFECTIONS; METABOLISM; INHIBITORS; FLAVIVIRUS
AB To counteract the serious health threat posed by known and novel viral pathogens, drugs that target a variety of viruses through a common mechanism have attracted recent attention due to their potential in treating (re)emerging infections, for which direct-acting antivirals are not available. We found that labyrinthopeptins A1 and A2, the prototype congeners of carbacyclic lanthipeptides, inhibit the proliferation of diverse enveloped viruses, including dengue virus, Zika virus, West Nile virus, hepatitis C virus, chikungunya virus, Kaposi's sarcoma-associated herpesvirus, cytomegalovirus, and herpes simplex virus, in the low micromolar to nanomolar range. Mechanistic studies on viral particles revealed that labyrinthopeptins induce a virolytic effect through binding to the viral membrane lipid phosphatidylethanolamine (PE). These effects are enhanced by a combined equimolar application of both labyrinthopeptins, and a clear synergism was observed across a concentration range corresponding to 10% to 90% inhibitory concentrations of the compounds. Time-resolved experiments with large unilamellar vesicles (LUVs) reveal that membrane lipid raft compositions (phosphatidylcholine [PC]/PE/cholesterol/sphingomyelin at 17:10:33:40) are particularly sensitive to labyrinthopeptins in comparison to PC/PE (90:10) LUVs, even though the overall PE amount remains constant. Labyrinthopeptins exhibited low cytotoxicity and had favorable pharmacokinetic properties in mice (half-life [t(1/2)] = 10.0 h), which designates them promising antiviral compounds acting by an unusual viral lipid targeting mechanism.
   IMPORTANCE For many viral infections, current treatment options are insufficient. Because the development of each antiviral drug is time-consuming and expensive, the prospect of finding broad-spectrum antivirals that can fight multiple, diverse viruses-well-known viruses as well as (re)emerging species- has gained attention, especially for the treatment of viral coinfections. While most known broad-spectrum agents address processes in the host cell, we found that targeting lipids of the free virus outside the host cell with the natural products labyrinthopeptin A1 and A2 is a viable strategy to inhibit the proliferation of a broad range of viruses from different families, including chikungunya virus, dengue virus, Zika virus, Kaposi's sarcoma-associated herpesvirus, and cytomegalovirus. Labyrinthopeptins bind to viral phosphatidylethanolamine and induce virolysis without exerting cytotoxicity on host cells. This represents a novel and unusual mechanism to tackle medically relevant viral infections.
C1 [Prochnow, Hans; Rox, Katharina; Birudukota, N. V. Suryanarayana; Hotop, Sven-Kevin; Klahn, Philipp; Schreiber, Janine; Broenstrup, Mark] Helmholtz Ctr Infect Res, Dept Chem Biol, Braunschweig, Germany.
   [Rox, Katharina; Schreiber, Janine; Schulz, Thomas F.; Pietschmann, Thomas; Broenstrup, Mark] Partner Site Hannover Braunschweig, German Ctr Infect Res DZIF, Hannover, Germany.
   [Weichert, Loreen] Helmholtz Ctr Infect Res, Innate Immun & Infect, Braunschweig, Germany.
   [Mohr, Kathrin] Helmholtz Ctr Infect Res, Dept Microbial Drugs, Braunschweig, Germany.
   [Franz, Sergej; Banda, Dominic H.; Blockus, Sebastian; Haid, Sibylle; Goffinet, Christine; Pietschmann, Thomas] TWINCORE, Inst Expt Virol, Hannover, Germany.
   [Oeyen, Merel] Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium.
   [Martinez, Javier P.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Infect Biol Lab, Barcelona, Spain.
   [Suessmuth, Roderich D.] Tech Univ Berlin, Inst Chem, Berlin, Germany.
   [Wink, Joachim] Helmholtz Ctr Infect Res, Microbial Strain Collect, Braunschweig, Germany.
   [Meyerhans, Andreas] ICREA, Barcelona, Spain.
   [Goffinet, Christine] Charite Univ Med Berlin, Campus Charite Mitte, Inst Virol, Berlin, Germany.
   [Goffinet, Christine] Berlin Inst Hlth, Berlin, Germany.
   [Messerle, Martin; Schulz, Thomas F.] Hannover Med Sch, Inst Virol, Hannover, Germany.
   [Kroeger, Andrea] Otto von Guericke Univ, Inst Med Microbiol, Magdeburg, Germany.
   [Broenstrup, Mark] Leibniz Univ Hannover, Biomol Drug Res Ctr BMWZ, Hannover, Germany.
RP Bronstrup, M (corresponding author), Helmholtz Ctr Infect Res, Dept Chem Biol, Braunschweig, Germany.; Bronstrup, M (corresponding author), Partner Site Hannover Braunschweig, German Ctr Infect Res DZIF, Hannover, Germany.; Bronstrup, M (corresponding author), Leibniz Univ Hannover, Biomol Drug Res Ctr BMWZ, Hannover, Germany.
EM Mark.Broenstrup@helmholtz-hzi.de
RI Oeyen, Merel/G-3415-2018; Goffinet, Christine/L-4878-2019; Schols,
   Dominique/S-9057-2017
OI Oeyen, Merel/0000-0002-7173-6651; Goffinet,
   Christine/0000-0002-3959-004X; Schulz, Thomas/0000-0001-8792-5345;
   Klahn, Philipp/0000-0003-4713-2345; Rox, Katharina/0000-0002-8020-1384;
   Schols, Dominique/0000-0003-3256-5850
FU Helmholtz Alberta initiative of infectious disease research (HAI-IDR);
   Spanish Ministry of Economy, Industry and Competitiveness; FEDER
   (AEI/MINEICO/FEDER, UE) [SAF2016-75505-R]; DZIF [07.802];
   Innovationsfonds der HelmholtzZentren; DFGGerman Research Foundation
   (DFG) [GO2153/3-1]; Helmholtz Center for Infection Research (HZI);
   Berlin Institute of Health (BIH); Infection Biology international Ph.D.
   program of Hannover Biomedical Research School
FX Thomas Pietschmann was supported by funds from the Helmholtz Alberta
   initiative of infectious disease research (HAI-IDR). Andreas Meyerhans
   and Javier P. Martinez were supported by a grant from the Spanish
   Ministry of Economy, Industry and Competitiveness and FEDER grant no.
   SAF2016-75505-R (AEI/MINEICO/FEDER, UE). Mark Bronstrup, Andreas
   Meyerhans, and Javier P. Martinez acknowledge a networking contribution
   from the COST Action CM1407 "Challenging organic syntheses inspired by
   nature-from natural products chemistry to drug discovery." Martin
   Messerle and Thomas F. Schulz were supported by funding from DZIF
   (project 07.802 TTU IICH). Christine Goffinet, Thomas Pietschmann, and
   Mark Bronstrup were supported by a grant provided by Innovationsfonds
   der HelmholtzZentren. Christine Goffinet was supported by a DFG grant
   within German-African Cooperation Projects in Infectiology (GO2153/3-1)
   and by funding from the Helmholtz Center for Infection Research (HZI)
   and the Berlin Institute of Health (BIH). Sergej Franz was supported by
   the Infection Biology international Ph.D. program of Hannover Biomedical
   Research School.
CR Alen MMF, 2012, ANTIVIR RES, V96, P280, DOI 10.1016/j.antiviral.2012.10.007
   Alen MMF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021658
   ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Borst EM, 2005, J VIROL, V79, P3615, DOI 10.1128/JVI.79.6.3615-3626.2005
   Bronstrup M, 2016, Patent application, Patent No. [WO2017085257A1, 2017085257]
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v
   Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003
   Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10
   Dikmans A, 2006, QSAR COMB SCI, V25, P1069, DOI 10.1002/qsar.200640130
   Ferir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064010
   Gerold G, 2017, MOL CELL PROTEOMICS, V16, pS75, DOI 10.1074/mcp.R116.065649
   Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011
   Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393
   Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384
   Huarte N, 2016, SCI REP-UK, V6, DOI 10.1038/srep34190
   Hullin-Matsuda F, 2016, BIOCHIMIE, V130, P81, DOI 10.1016/j.biochi.2016.09.020
   Huo LJ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02698-16
   Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886
   Kati S, 2015, J VIROL METHODS, V217, P79, DOI 10.1016/j.jviromet.2015.02.022
   Koutsoudakis G, 2015, J HEPATOL, V63, P813, DOI 10.1016/j.jhep.2015.06.002
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lindholm P, 2002, MOL CANCER THER, V1, P365
   Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108
   Lok SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050995
   Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   LUUKKONEN A, 1973, BIOCHIM BIOPHYS ACTA, V326, P256, DOI 10.1016/0005-2760(73)90251-8
   Makino A, 2003, J BIOL CHEM, V278, P3204, DOI 10.1074/jbc.M210347200
   Marston HD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009872
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Meindl K, 2010, ANGEW CHEM INT EDIT, V49, P1151, DOI 10.1002/anie.200905773
   Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Muller WM, 2010, ANGEW CHEM INT EDIT, V49, P2436, DOI 10.1002/anie.200905909
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   Neris RLS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27855-7
   Nieto-Garai JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01983
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Petruzielo RS, 2013, BBA-BIOMEMBRANES, V1828, P1302, DOI 10.1016/j.bbamem.2013.01.007
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321
   Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v
   Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z
   Tongluan N, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0685-9
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Weber C, 2014, J VIROL METHODS, V201, P7, DOI 10.1016/j.jviromet.2014.02.001
   Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107
   Xin BY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01115
   Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007
   Zhao M, 2011, AMINO ACIDS, V41, P1071, DOI 10.1007/s00726-009-0386-9
NR 65
TC 2
Z9 2
U1 12
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2020
VL 94
IS 2
AR e01471-19
DI 10.1128/JVI.01471-19
PG 24
WC Virology
SC Virology
GA KA4SO
UT WOS:000505787400019
PM 31666384
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Bolte, E
   Seferovic, M
   Valentine, GC
   Jochum, M
   Chu, D
   Pace, R
   Fowler, S
   Swennes, A
   Versalovic, J
   Aagaard, KM
AF Bolte, Erin
   Seferovic, Maxim
   Valentine, Gregory C.
   Jochum, Michael
   Chu, Derrick
   Pace, Ryan
   Fowler, Stephanie
   Swennes, Alton
   Versalovic, James
   Aagaard, Kjersti M.
TI Maternal microbial conventionalization fails to normalize Zika Virus
   transmission compared to conventional mouse
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 40th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY FEB 03-08, 2020
CL Grapevine, TX
SP Soc Maternal Fetal Med
C1 [Bolte, Erin; Seferovic, Maxim; Jochum, Michael; Chu, Derrick; Pace, Ryan; Fowler, Stephanie; Swennes, Alton; Versalovic, James; Aagaard, Kjersti M.] Baylor Coll Med, Houston, TX 77030 USA.
   [Valentine, Gregory C.] Univ Washington, Tacoma, WA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2020
VL 222
IS 1
SU S
MA 945
BP S586
EP S586
DI 10.1016/j.ajog.2019.11.956
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JZ3JD
UT WOS:000504997301267
OA Bronze
DA 2020-07-08
ER

PT J
AU Stephens, A
   Haese, N
   Mani, A
   Steinbach, R
   Roberts, VH
   Frias, AE
   Hirsch, A
   Strewblow, D
   Goetzl, L
AF Stephens, Angela
   Haese, Nicole
   Mani, Arunmani
   Steinbach, Rosemary
   Roberts, Victoria H.
   Frias, Antonio E.
   Hirsch, Alec
   Strewblow, Daniel
   Goetzl, Laura
TI Fetal neural exosomes for non-invasive assessment of zika-mediated
   injury in a primate model
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 40th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY FEB 03-08, 2020
CL Grapevine, TX
SP Soc Maternal Fetal Med
C1 [Stephens, Angela; Mani, Arunmani; Goetzl, Laura] Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Obstet Gynecol & Reprod Sci, McGovern Med Sch, Houston, TX USA.
   [Haese, Nicole; Hirsch, Alec; Strewblow, Daniel] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Div Pathobiol & Immunol, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA.
   [Steinbach, Rosemary] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Portland, OR USA.
   [Roberts, Victoria H.; Frias, Antonio E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
RI Haese, Nicole/AAN-4551-2020
NR 0
TC 0
Z9 0
U1 1
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2020
VL 222
IS 1
SU S
MA 52
BP S44
EP S44
DI 10.1016/j.ajog.2019.11.068
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JZ3JD
UT WOS:000504997300053
OA Bronze
DA 2020-07-08
ER

PT J
AU Wong, T
   Pereira, JP
   Sobhani, N
   Cardozo, RF
   Valle, HA
   Dutra, BRT
   Gama, HD
   Gaw, SL
AF Wong, Thalia
   Pereira, Jose Paulo, Jr.
   Sobhani, Nasim
   Cardozo, Renan Fonseca
   Valle, Helena Abreu
   Torres Dutra, Beatriz Ribeiro
   Gama, Helder Dotta
   Gaw, Stephanie L.
TI Middle cerebral artery Dopplers and adverse neonatal outcomes among
   pregnant women with Zika virus infection
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 40th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY FEB 03-08, 2020
CL Grapevine, TX
SP Soc Maternal Fetal Med
C1 [Wong, Thalia] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Pereira, Jose Paulo, Jr.; Cardozo, Renan Fonseca; Valle, Helena Abreu; Torres Dutra, Beatriz Ribeiro; Gama, Helder Dotta] Fiocruz MS, Inst Fernandez Figueira, Rio De Janeiro, Brazil.
   [Sobhani, Nasim; Gaw, Stephanie L.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2020
VL 222
IS 1
SU S
MA 694
BP S439
EP S439
DI 10.1016/j.ajog.2019.11.708
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JZ3JD
UT WOS:000504997301021
OA Bronze
DA 2020-07-08
ER

PT J
AU Maia, ZPG
   Pereira, FM
   Said, RFD
   Fonseca, V
   Graf, T
   Nogueira, FD
   Nardy, VB
   Xavier, J
   Maia, ML
   Abreu, AL
   de Albuquerque, CFC
   Oliveira, WK
   Croda, J
   de Filippis, AMB
   Cunha, RV
   Lourenco, J
   de Oliveira, T
   Faria, NR
   Alcantara, LCJ
   Giovanetti, M
AF Pereira Gusmao Maia, Zuinara
   Mota Pereira, Felicidade
   do Carmo Said, Rodrigo Fabiano
   Fonseca, Vagner
   Graef, Tiago
   de Bruycker Nogueira, Fernanda
   Brandao Nardy, Vanessa
   Xavier, Joilson
   Lima Maia, Maricelia
   Abreu, Andre L.
   Campelo de Albuquerque, Carlos F.
   Kleber Oliveira, Wanderson
   Croda, Julio
   de Filippis, Ana Maria Bispo
   Venancio Cunha, Rivaldo
   Lourenco, Jose
   de Oliveira, Tulio
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
   Giovanetti, Marta
TI Return of the founder Chikungunya virus to its place of introduction
   into Brazil is revealed by genomic characterization of exanthematic
   disease cases
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Chikungunya; East-Central-South-African genotype; Northeast Brazil;
   surveillance; portable genome sequencing
ID ZIKA
AB Between June 2017 and August 2018, several municipalities located in Bahia state (Brazil) reported a large increase in the number of patients presenting with febrile illness similar to that of arboviral infections. Using a combination of portable whole genome sequencing, molecular clock and epidemiological analyses, we revealed the return of the CHIKV-ECSA genotype into Bahia. Our results show local persistence of lineages in some municipalities and the re-introduction of new epidemiological strains from different Brazilian regions, highlighting a complex dynamic of transmission between epidemic seasons and sampled locations. Estimated climate-driven transmission potential of CHIKV remained at similar levels throughout the years, such that large reductions in the total number of confirmed cases suggests a slow, but gradual accumulation of herd-immunity over the 4 years of the epidemic in Bahia after its introduction in 2014. Bahia remains a reservoir of the genetic diversity of CHIKV in the Americas, and genomic surveillance strategies are essential to assist in monitoring and understanding arboviral transmission and persistence both locally and over large distances.
C1 [Pereira Gusmao Maia, Zuinara; Mota Pereira, Felicidade; Brandao Nardy, Vanessa] Dept Virol, Lab Cent Saude Publ, Salvador, BH, Brazil.
   [do Carmo Said, Rodrigo Fabiano; Giovanetti, Marta] Univ Fed Minas Gerais, Inst Ciencias Biol, Coordenacao Geral Vigilancia Arboviroses CGARB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Graef, Tiago] Fiocruz MS, Lab Patol Expt, Inst Goncalo Moniz, Salvador, BH, Brazil.
   [de Bruycker Nogueira, Fernanda; de Filippis, Ana Maria Bispo; Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Lima Maia, Maricelia] Univ Estadual Feira de Santana, Feira De Santana, BA, Brazil.
   [Lima Maia, Maricelia] Secretaria Saude Feira de Santana, Feira De Santana, BA, Brazil.
   [Abreu, Andre L.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, CGLAB SVS MS, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Kleber Oliveira, Wanderson] Minist Saude SVS MS, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Venancio Cunha, Rivaldo] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil.
   [Venancio Cunha, Rivaldo] Fundacao Oswaldo Cruz, Coordinat Hlth Surveillance & Reference Labs, Rio De Janeiro, RJ, Brazil.
   [Lourenco, Jose; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Giovanetti, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Coordenacao Geral Vigilancia Arboviroses CGARB, Belo Horizonte, MG, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Alcantara, LCJ; Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
EM luiz.alcantara@ioc.fiocruz.br; giovanetti.marta@gmail.com
RI Graf, Tiago/S-8535-2019; Giovanetti, Marta/AAK-7408-2020; Fonseca,
   Vagner/R-5813-2019; Maia, Zuinara Pereira Gusmao/AAA-6737-2020
OI Graf, Tiago/0000-0003-4921-7975; Fonseca, Vagner/0000-0001-5521-6448;
   Maia, Zuinara Pereira Gusmao/0000-0003-0224-4335; Alcantara,
   Luiz/0000-0002-6769-9931
FU ZiBRA2 project - Brazilian Ministry of Health (SVS-MS); Pan American
   Organization (OPAS); CNPqNational Council for Scientific and
   Technological Development (CNPq) [440685/2016-8, 440856/2016-7];
   CAPESCAPES [88887.130716/2016-00, 88881.130825/2016-00,
   88887.130823/2016-00]; Horizon 2020 Framework Programme
   [PRES-005-FEX-17-4-2-33]; Faperj (Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]; International Development Research Centre (IDRC)
   Canada [108411-001]; EU's Horizon 2020 Framework Programme through
   ZikaPlan [734584, 734857]; EU's Horizon 2020 Framework Programme through
   ZikAction [734584, 734857]; Department of Zoology, University of Oxford;
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX This work was supported by the ZiBRA2 project, supported by the
   Brazilian Ministry of Health (SVS-MS) and the Pan American Organization
   (OPAS) and founded by CNPq [grant number 440685/2016-8 and
   440856/2016-7]; by CAPES [grant number 88887.130716/2016-00,
   88881.130825/2016-00 and 88887.130823/2016-00]; by Horizon 2020
   Framework Programme [grant number PRES-005-FEX-17-4-2-33]. The
   Flavivirus Laboratory activities were also supported by Faperj (Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)
   under the [grant number E-26/2002.930/2016], by the International
   Development Research Centre (IDRC) Canada over the [grant number
   108411-001] and EU's Horizon 2020 Framework Programme through ZikaPlan
   and ZikAction under the [grant number 734584 and 734857]. JL was
   supported by a lectureship from the Department of Zoology, University of
   Oxford. MG is supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro - FAPERJ; Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior.
CR Brasil, 2019, B EPIDEMIOLOGICO MON
   Fonseca V, 2019, PLOS NEGLECT TROP D, V8, P13
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lourenco J, 2017, ELIFE, V9, P6
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Naveca FG, 2019, PLOS NEGLECT TROP D, V7, P13
   Obolski U., 2019, METHODS ECOL EVOL, V1, P1
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Xavier J, 2019, PLOS ONE, V11, P14
NR 14
TC 0
Z9 0
U1 6
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 53
EP 57
DI 10.1080/22221751.2019.1701954
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA JZ6DG
UT WOS:000505191100001
PM 31880218
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Niu, XF
   Yan, QH
   Yao, ZP
   Zhang, F
   Qu, LB
   Wang, CL
   Wang, CR
   Lei, H
   Chen, CM
   Liang, RS
   Luo, J
   Wang, Q
   Zhaog, LZ
   Zhang, YD
   Luo, K
   Wang, LY
   Wu, HK
   Liu, TT
   Li, PC
   Zheng, ZQ
   Tan, YJ
   Feng, LQ
   Zhang, ZH
   Han, J
   Zhang, FC
   Chen, L
AF Niu, Xuefeng
   Yan, Qihong
   Yao, Zhipeng
   Zhang, Fan
   Qu, Linbing
   Wang, Chunlin
   Wang, Chengrui
   Lei, Hui
   Chen, Chaoming
   Liang, Renshan
   Luo, Jia
   Wang, Qian
   Zhaog, Lingzhai
   Zhang, Yudi
   Luo, Kun
   Wang, Longyu
   Wu, Hongkai
   Liu, Tingting
   Li, Pingchao
   Zheng, Zhiqiang
   Tan, Yee Joo
   Feng, Liqiang
   Zhang, Zhenhai
   Han, Jian
   Zhang, Fuchun
   Chen, Ling
TI Longitudinal analysis of the antibody repertoire of a Zika
   virus-infected patient revealed dynamic changes in antibody response
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika virus; antibody; repertoire; monoclonal antibody; next-generation
   sequencing
ID TRANSMISSION
AB The Zika virus (ZIKV) is a mosquito-borne flavivirus that causes neonatal abnormalities and other disorders. Antibodies to the ZIKV envelope (E) protein can block infection. In this study, next-generation sequencing (NGS) of immunoglobulin heavy chain (IgH) mRNA transcripts was combined with single-cell PCR cloning of E-binding monoclonal antibodies for analysing antibody response in a patient from the early stages of infection to more than one year after the clearance of the virus. The patient's IgH repertoire 14 and 64 days after symptom onset showed dramatic dominant clonal expansion but low clonal diversity. IgH repertoire 6 months after disease-free status had few dominant clones but increased diversity. E-binding antibodies appeared abundantly in the repertoire during the early stages of infection but quickly declined after clearance of the virus. Certain VH genes such as VH5-10-1 and VH4-39 appeared to be preferentially enlisted for a rapid antibody response to ZIKV infection. Most of these antibodies require relatively few somatic hypermutations to acquire the ability to bind to the E protein, pointing to a possible mechanism for rapid defence against ZIKV infection. This study provides a unique and holistic view of the dynamic changes and characteristics of the antibody response to ZIKV infection.
C1 [Niu, Xuefeng; Lei, Hui; Liang, Renshan; Wu, Hongkai; Liu, Tingting; Chen, Ling] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China.
   [Yan, Qihong; Yao, Zhipeng; Zhang, Fan; Qu, Linbing; Chen, Chaoming; Luo, Jia; Wang, Qian; Zhang, Yudi; Luo, Kun; Wang, Longyu; Li, Pingchao; Feng, Liqiang; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Lab Computat Biomed, Guangzhou 510530, Guangdong, Peoples R China.
   [Yan, Qihong; Wang, Qian; Zhang, Yudi; Luo, Kun] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Yao, Zhipeng; Zhang, Fan; Wang, Longyu] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei, Anhui, Peoples R China.
   [Wang, Chunlin; Han, Jian] HudsonAlpha Inst Biotechnol, Huntsville, AL USA.
   [Wang, Chengrui; Zhang, Zhenhai] Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.
   [Zhaog, Lingzhai; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
   [Zheng, Zhiqiang; Tan, Yee Joo] Natl Univ Singapore, NUHS, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.
RP Chen, L (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China.; Chen, L (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Lab Computat Biomed, Guangzhou 510530, Guangdong, Peoples R China.; Zhang, FC (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
EM gz8hzfc@126.com; chen_ling@gibh.ac.cn
OI Zheng, Zhiqiang/0000-0003-1028-3246
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81661148056]; National Science and Technology Major
   Project [2017ZX10304401]; National Key Research and Development Program
   [2016YFC0903700]; Guangzhou Health Care and Cooperative Innovation Major
   Project [20174020229]; Guangzhou Science and Technology Program Key
   Projects [201904020037]; Guangdong Science and Technology Department
   [2016A020250001, 2016A02048001]; Key Research and Development Program of
   Guangdong Province [2019B020218004]
FX This study was partly supported by the National Natural Science
   Foundation of China [grant number 81661148056], National Science and
   Technology Major Project [grant number 2017ZX10304401], National Key
   Research and Development Program [grant number 2016YFC0903700],
   Guangzhou Health Care and Cooperative Innovation Major Project [grant
   number 20174020229], Guangzhou Science and Technology Program Key
   Projects [grant number 201904020037], Guangdong Science and Technology
   Department [grant numbers 2016A020250001 and 2016A02048001], the Key
   Research and Development Program of Guangdong Province [grant number
   2019B020218004].
CR Aouinti S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00339
   Boyd SD, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0017-2014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Bourcy CFA, 2017, P NATL ACAD SCI USA, V114, P1105, DOI 10.1073/pnas.1617959114
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782
   Goodwin E, 2018, IMMUNITY, V48, P339, DOI 10.1016/j.immuni.2018.01.005
   Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hou DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep33843
   JIANG N, 1944, SCI TRANSL MED, V5
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kwong PD, 2017, IMMUNOL REV, V275, P108, DOI 10.1111/imr.12480
   Laserson U, 2014, P NATL ACAD SCI USA, V111, P4928, DOI 10.1073/pnas.1323862111
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Meng WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066276
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   NADLER SB, 1962, SURGERY, V51, P224
   Niu PH, 2018, J INFECT DIS, V218, P1249, DOI 10.1093/infdis/jiy311
   Niu XF, 2019, EMERG MICROBES INFEC, V8, P749, DOI 10.1080/22221751.2019.1614885
   Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Rayichandran S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09914-3
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Seifert M, 2009, J EXP MED, V206, P2659, DOI 10.1084/jem.20091087
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352
   Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6
   [杨媛媛 Yang Yuanyuan], 2015, [护理学杂志, Journal of Nursing Science], V30, P4
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhao LZ, 2019, J MED VIROL, V91, P872, DOI 10.1002/jmv.25366
NR 43
TC 0
Z9 0
U1 5
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 111
EP 123
DI 10.1080/22221751.2019.1701953
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KA7AQ
UT WOS:000505949200001
PM 31906823
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Onyango, MG
   Bialosuknia, SM
   Payne, AF
   Mathias, N
   Kuo, LL
   Vigneron, A
   DeGennaro, M
   Ciota, AT
   Kramer, LD
AF Onyango, Maria Gorreti
   Bialosuknia, Sean M.
   Payne, Anne F.
   Mathias, Nicholas
   Kuo, Lili
   Vigneron, Aurelien
   DeGennaro, Matthew
   Ciota, Alexander T.
   Kramer, Laura D.
TI Increased temperatures reduce the vectorial capacity of Aedes mosquitoes
   for Zika virus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Climate change; Aedes mosquitoes; Zika virus; vectorial capacity;
   transmission potential
ID CLIMATE-CHANGE; ENVIRONMENTAL-TEMPERATURE; AEGYPTI DIPTERA; DENGUE;
   CULICIDAE; COMPETENCE; ALBOPICTUS; AMERICA; TRANSMISSION; ENHANCEMENT
AB Rapid and significant range expansion of both Zika virus (ZIKV) and its Aedes vector species has resulted in ZIKV being declared a global health threat. Mean temperatures are projected to increase globally, likely resulting in alterations of the transmission potential of mosquito-borne pathogens. To understand the effect of diurnal temperature range on the vectorial capacity of Ae. aegypti and Ae. albopictus for ZIKV, longevity, blood-feeding and vector competence were assessed at two temperature regimes following feeding on infectious blood meals. Higher temperatures resulted in decreased longevity of Ae. aegypti [Log-rank test, chi 2, df 35.66, 5, P < 0.001] and a decrease in blood-feeding rates of Ae. albopictus [Fisher's exact test, P < 0.001]. Temperature had a population and species-specific impact on ZIKV infection rates. Overall, Ae. albopictus reared at the lowest temperature regime demonstrated the highest vectorial capacity (0.53) and the highest transmission efficiency (57%). Increased temperature decreased vectorial capacity across groups yet more significant effects were measured with Ae. aegypti relative to Ae. albopictus. The results of this study suggest that future increases in temperature in the Americas could significantly impact vector competence, blood-feeding and longevity, and potentially decrease the overall vectorial capacity of Aedes mosquitoes in the Americas.
C1 [Onyango, Maria Gorreti; Bialosuknia, Sean M.; Payne, Anne F.; Mathias, Nicholas; Kuo, Lili; Ciota, Alexander T.; Kramer, Laura D.] New York State Dept Hlth, Griffin Lab, 5668 State Farm Rd, Slingerlands, NY 12159 USA.
   [Bialosuknia, Sean M.; Ciota, Alexander T.; Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Albany, NY USA.
   [Vigneron, Aurelien] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [DeGennaro, Matthew] Florida Int Univ, Dept Biol Sci, Biomol Sci Inst, Miami, FL 33199 USA.
RP Kramer, LD (corresponding author), New York State Dept Hlth, Griffin Lab, 5668 State Farm Rd, Slingerlands, NY 12159 USA.
EM laura.kramer@health.ny.gov
RI Vigneron, Aurelien/G-7268-2011; DeGennaro, Matthew/H-4975-2015
OI Vigneron, Aurelien/0000-0003-4986-6465; DeGennaro,
   Matthew/0000-0003-3837-4430
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U01CK000509]
FX This work was supported by Centers for Disease Control and Prevention
   [Cooperative Agreement Number U01CK000509].
CR Adelman ZN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002239
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Black WI, 1996, POPULATION BIOL TOOL, P393
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110538
   Ciota AT, 2018, AM J TROP MED HYG, V99, P417, DOI 10.4269/ajtmh.18-0097
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2014, J MED ENTOMOL, V51, P55, DOI 10.1603/ME13003
   Ciota AT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-71
   Ciota Alexander T., 2011, BMC Ecology, V11, P23, DOI 10.1186/1472-6785-11-23
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gloria-Soria A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1506
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   HUEY RB, 1979, AM ZOOL, V19, P357
   IPCC, 2007, 3 ASS REP
   Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782
   Kay BH, 2002, J MED ENTOMOL, V39, P99, DOI 10.1603/0022-2585-39.1.99
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LILES J. N., 1960, ANN ENT SOC AMER, V53, P277, DOI 10.1093/aesa/53.2.277
   LILES JAMES N., 1965, MOSQUITO NEWS, V25, P434
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Murdock CC, 2012, P ROY SOC B-BIOL SCI, V279, P3357, DOI 10.1098/rspb.2012.0638
   Muttis E, 2018, J MED ENTOMOL, V20, P1
   Pachauri Rajendra, 2006, AVOIDING DANGEROUS C, P3
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Romero-Lankao P, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1439
   Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Tramonte AR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214306
   TURELL MJ, 1993, AM J TROP MED HYG, V49, P672, DOI 10.4269/ajtmh.1993.49.672
   Villarreal SM, 2018, J INSECT PHYSIOL, V108, P1, DOI 10.1016/j.jinsphys.2018.05.001
   Vose R. S., 2017, CLIM SCI SPEC REP 4, VI, P185, DOI DOI 10.7930/J0N29V45
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
NR 56
TC 1
Z9 1
U1 20
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 67
EP 77
DI 10.1080/22221751.2019.1707125
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA JZ6PC
UT WOS:000505224900001
PM 31894724
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yakass, MB
   Franco, D
   Quaye, O
AF Yakass, Michael Bright
   Franco, David
   Quaye, Osbourne
TI Suppressors of Cytokine Signaling and Protein Inhibitors of Activated
   Signal Transducer and Activator of Transcriptions As Therapeutic Targets
   in Flavivirus Infections
SO JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
LA English
DT Review
DE suppressors of cytokine signaling; protein inhibitors of activated STAT;
   flavivirus infections
ID WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; CHRONIC HEPATITIS-C; JAPANESE
   ENCEPHALITIS; UP-REGULATION; YELLOW-FEVER; GLOBAL DISTRIBUTION;
   ANTIVIRAL IMMUNITY; PREDICTIVE FACTORS; SOCS3 EXPRESSION
AB Flaviviruses cause significant human diseases putting more than 400 million people at risk annually worldwide. Because of migration and improved transportation, these viruses can be found on all continents (except Antarctica). Although a majority of the viruses are endemic in the tropics, a few [West Nile virus (WNV) and tick-borne encephalitis virus (TBEV)] have shown endemicity in Europe and North America. Currently, there are vaccines for the Yellow fever virus, Japanese encephalitis virus, and TBEV, but there is no effective vaccine and/or therapy against all other flaviviruses. Although there are intensive efforts to develop vaccines for Zika viruses, dengue viruses, and WNVs, there is the need for alternative or parallel antiviral therapeutic approaches. Suppressors of cytokine signaling (SOCS) and protein inhibitors of activated signal transducer and activator of transcription (STATs; PIAS), both regulatory proteins of the Janus kinase/STAT signaling pathway, have been explored as therapeutic targets in herpes simplex and vaccinia viruses, as well as in cancer therapy. In this review, we briefly describe the function of SOCS and PIAS and their therapeutic potential in flaviviral infections.
   [GRAPHICS]
   .
C1 [Yakass, Michael Bright; Quaye, Osbourne] Univ Ghana, WACCBIP, Volta Rd, Legon, Accra, Ghana.
   [Yakass, Michael Bright; Quaye, Osbourne] Univ Ghana, Dept Biochem Cell & Mol Biol, Accra, Ghana.
   [Franco, David] GSK Vaccines, Rixensart, Belgium.
RP Quaye, O (corresponding author), Univ Ghana, WACCBIP, Volta Rd, Legon, Accra, Ghana.
EM oquaye@ug.edu.gh
OI Quaye, Osbourne/0000-0002-0621-876X
FU WACCBIP-World Bank ACE PhD fellowship; World Bank African Centres of
   Excellence grant [ACE02-WACCBIP: Awandare]; DELTAS Africa grant
   [107755/Z/15/Z: Awandare]; New Partnership for Africa's Development
   Planning and Coordinating Agency (NEPAD Agency); Wellcome TrustWellcome
   Trust [107755/Z/15/Z: Awandare]; United Kingdom government
FX M.B.Y. was supported by a WACCBIP-World Bank ACE PhD fellowship with
   funds from a World Bank African Centres of Excellence grant
   (ACE02-WACCBIP: Awandare) and a DELTAS Africa grant (107755/Z/15/Z:
   Awandare). The DELTAS Africa Initiative is an independent funding scheme
   of the African Academy of Sciences (AAS)'s Alliance for Accelerating
   Excellence in Science in Africa (AESA) and supported by the New
   Partnership for Africa's Development Planning and Coordinating Agency
   (NEPAD Agency) with funding from the Wellcome Trust (107755/Z/15/Z:
   Awandare) and the United Kingdom government. The views expressed in this
   publication are those of the author(s) and not necessarily those of
   World Bank, AAS, NEPAD Agency, Wellcome Trusts, or the United Kingdom
   government.
CR Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545
   Ahmed CM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00574
   Ahmed CMI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00183
   Ahmed CMI, 2010, J IMMUNOL, V185, P1103, DOI 10.4049/jimmunol.0902895
   Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10
   Akhtar LN, 2010, J IMMUNOL, V185, P2393, DOI 10.4049/jimmunol.0903563
   Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411
   Arleevskaya MI, 2020, CLIN REV ALLERG IMMU, V58, P172, DOI 10.1007/s12016-019-08742-z
   Arora T, 2003, J BIOL CHEM, V278, P21327, DOI 10.1074/jbc.C300119200
   Aslam R, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3506-5
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Bautista D, 2007, J PATHOL, V213, P347, DOI 10.1002/path.2214
   Baz M, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030101
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016
   Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618
   Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654
   Brown JR, 2016, J VIROL, V90, P5939, DOI 10.1128/JVI.00426-16
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcante LN, 2015, WORLD J HEPATOL, V7, P1617, DOI 10.4254/wjh.v7.i12.1617
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chang PC, 2010, J BIOL CHEM, V285, P5266, DOI 10.1074/jbc.M109.088088
   Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493
   Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chen RF, 2014, J INFECTION, V69, P366, DOI 10.1016/j.jinf.2014.05.013
   Chugh PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104770
   Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803
   Collins AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069090
   Conn KL, 2016, J VIROL, V90, P4807, DOI 10.1128/JVI.03055-15
   Connor Bradley, 2017, Trop Dis Travel Med Vaccines, V3, P14, DOI 10.1186/s40794-017-0057-x
   Crampon E, 2010, BIOPHYS J, V98, p759A, DOI 10.1016/j.bpj.2009.12.4166
   Sousa LFD, 2016, BRAIN RES BULL, V127, P164, DOI 10.1016/j.brainresbull.2016.09.011
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x
   Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024
   Dolasia K, 2018, INT REV IMMUNOL, V37, P3, DOI 10.1080/08830185.2017.1397656
   Du LY, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-51
   Duechting A, 2008, J VIROL, V82, P7942, DOI 10.1128/JVI.00891-08
   Ehrmann J Jr, 2006, Vnitr Lek, V52, P167
   El-Saadany S, 2013, CAN J GASTROENTEROL, V27, pE13, DOI 10.1155/2013/562765
   Estrada-Jimenez T, 2016, VIRAL IMMUNOL, V29, P95, DOI 10.1089/vim.2014.0136
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Fatima K, 2018, J GLOB HEALTH, V8, DOI [10.7189/jogh.08-020312, 10.7189/jogh.08.020312]
   Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201
   Flowers LO, 2004, J IMMUNOL, V172, P7510, DOI 10.4049/jimmunol.172.12.7510
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Frey KG, 2009, J IMMUNOL, V183, P1253, DOI 10.4049/jimmunol.0900570
   Fu XH, 2016, 2016 INTERNATIONAL CONFERENCE ON ENERGY DEVELOPMENT AND ENVIRONMENTAL PROTECTION (EDEP 2016), P1
   Gao DN, 2015, ANTIVIR RES, V118, P20, DOI 10.1016/j.antiviral.2015.03.001
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Getts DR, 2007, J NEUROCHEM, V103, P1019, DOI 10.1111/j.1471-4159.2007.04798.x
   Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898
   Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527
   Guo J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100285
   Hashimoto K, 2009, VIROLOGY, V391, P162, DOI 10.1016/j.virol.2009.06.026
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Higginbotham JM, 2015, J VIROL, V89, P10260, DOI 10.1128/JVI.01091-15
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Hunter FW, 2016, BRIT J CANCER, V114, P1071, DOI 10.1038/bjc.2016.79
   Imanaka K, 2005, J VIRAL HEPATITIS, V12, P130, DOI 10.1111/j.1365-2893.2005.00576.x
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jiang MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00070
   Karkhah A, 2018, EUR J CLIN MICROBIOL, V37, P2035, DOI 10.1007/s10096-018-3354-z
   Khaiboullina S. F, 2017, SCI REPORTS, V7, P1
   Kim ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103308
   Kim KA, 2009, J HEPATOL, V50, P705, DOI 10.1016/j.jhep.2008.12.021
   Koeberlein B, 2010, VIRUS RES, V148, P51, DOI 10.1016/j.virusres.2009.12.003
   Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002
   Kubota T, 2011, J BIOL CHEM, V286, P8165, DOI 10.1074/jbc.M110.195255
   Kundu K, 2013, CELL IMMUNOL, V285, P100, DOI 10.1016/j.cellimm.2013.09.005
   Lafferty MK, 2014, PATHOG DIS, V71, P81, DOI 10.1111/2049-632X.12117
   Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909
   Li R, 2013, ANTIVIR RES, V100, P546, DOI 10.1016/j.antiviral.2013.09.001
   Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008
   Li XM, 2014, VIRUSES-BASEL, V6, P4280, DOI 10.3390/v6114280
   Linossi EM, 2013, CYTOKINE GROWTH F R, V24, P241, DOI 10.1016/j.cytogfr.2013.03.005
   Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104
   Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626
   Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005
   Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598
   Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Lowrey AJ, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0183-0
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Mahony R, 2016, CELL MOL LIFE SCI, V73, P3323, DOI 10.1007/s00018-016-2234-x
   Majoros A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00029
   Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299
   Mansfield KL, 2017, VET MICROBIOL, V201, P85, DOI 10.1016/j.vetmic.2017.01.014
   Mansfield KL, 2010, VECTOR-BORNE ZOONOT, V10, P649, DOI 10.1089/vbz.2009.0259
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murphy J.M., 2010, HDB CELL SIGNALING, P467
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24
   Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200
   Oliveira LG, 2019, J LEUKOCYTE BIOL, V106, P695, DOI 10.1002/JLB.MR1118-460R
   Palma-Ocampo HK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0383-4
   Pan YJ, 2017, PHARMAZIE, V72, P550, DOI 10.1691/ph.2017.7594
   Paul AM, 2016, J IMMUNOL, V197, P4425, DOI 10.4049/jimmunol.1600902
   Pedroso JAB, 2019, HORM-INT J ENDOCRINO, V18, P127, DOI 10.1007/s42000-018-0078-5
   Pennella MA, 2010, J VIROL, V84, P12210, DOI 10.1128/JVI.01442-10
   Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302
   Quicke KM, 2017, EUR J IMMUNOL, V47, P615, DOI 10.1002/eji.201646484
   Qvit N, 2017, DRUG DISCOV TODAY, V22, P454, DOI 10.1016/j.drudis.2016.11.003
   Ran MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0845-x
   Randolph SE, 2011, TICKS TICK-BORNE DIS, V2, P179, DOI 10.1016/j.ttbdis.2011.07.004
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Root JJ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050459
   Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8
   Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105
   Sabouri AH, 2014, BRAIN RES, V1574, P84, DOI 10.1016/j.brainres.2014.05.049
   Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801
   Scheller EL, 2011, J CELL BIOCHEM, V112, P3364, DOI 10.1002/jcb.23267
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Sharma N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27685
   Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035
   Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027
   Slovak M, 2014, TICKS TICK-BORNE DIS, V5, P962, DOI 10.1016/j.ttbdis.2014.07.019
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Steffen R., 2016, J TRAVEL MED, V23
   Sugase T, 2017, INT J CANCER, V140, P2608, DOI 10.1002/ijc.30666
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Ullah MO, 2016, J LEUKOCYTE BIOL, V100, P27, DOI 10.1189/jlb.2RI1115-531R
   Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009
   Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004
   Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Weng YH, 2019, BIOTECHNOL ADV, V37, P801, DOI 10.1016/j.biotechadv.2019.04.012
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Worst BC, 2016, EUR J CANCER, V65, P91, DOI 10.1016/j.ejca.2016.06.009
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Xu G, 2014, VIROLOGY, V462, P343, DOI 10.1016/j.virol.2014.06.024
   Ying J, 2019, PATHOL ONCOL RES, V25, P1295, DOI 10.1007/s12253-019-00612-5
   Yokota S, 2005, VIROLOGY, V338, P173, DOI 10.1016/j.virol.2005.04.028
   Yokota S, 2004, J VIROL, V78, P6282, DOI 10.1128/JVI.78.12.6282-6286.2004
   Yoshikawa Akira, 2016, Trop Med Health, V44, P8, DOI 10.1186/s41182-016-0010-0
   Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zhang J, 2008, VIROLOGY, V379, P306, DOI 10.1016/j.virol.2008.06.035
   Zhang LK, 2013, J PROTEOME RES, V12, P2666, DOI 10.1021/pr400011k
   Zhang X, 2014, J VIRAL HEPATITIS, V21, P264, DOI 10.1111/jvh.12137
   Zhao DM, 2017, J VIROL, V91, DOI [10.1128/JVI.02215, 10.1128/jvi.02215-16]
   Zhu ZX, 2015, J PROTEOME RES, V14, P4194, DOI 10.1021/acs.jproteome.5b00310
NR 160
TC 1
Z9 1
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1079-9907
EI 1557-7465
J9 J INTERF CYTOK RES
JI J. Interferon Cytokine Res.
PD JAN 1
PY 2020
VL 40
IS 1
BP 1
EP 18
DI 10.1089/jir.2019.0097
PG 18
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA JZ5JD
UT WOS:000505137100001
PM 31436502
OA Bronze
DA 2020-07-08
ER

PT J
AU Kuadkitkan, A
   Wikan, N
   Sornjai, W
   Smith, DR
AF Kuadkitkan, Atichat
   Wikan, Nitwara
   Sornjai, Wannapa
   Smith, Duncan R.
TI Zika virus and microcephaly in Southeast Asia: A cause for concern?
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Review
DE Flavivirus; Zika virus; Birth defects; Southeast Asia
ID INFECTION
AB Zika virus (ZIKV), a mosquito transmitted virus in the family Flaviviridae, genus Flavivirus, recently emerged to cause infections in more than 70 countries and territories around the world. While human infection is normally asymptomatic, it can also result in a mild febrile disease similar to dengue fever. However, when a pregnant woman is infected, ZIKV can cause fetal abnormalities including microcephaly. Evidence has suggested that ZIKV has circulated in Southeast Asia for more than a decade and yet cases of ZIKV associated microcephaly remain sparsely documented. This review seeks to collate the information currently existing on ZIKV associated microcephaly in Southeast Asia, and assess the potential future risk posed by this virus. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Kuadkitkan, Atichat; Wikan, Nitwara; Sornjai, Wannapa; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Pathom, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Mol Pathol Lab, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonthon Sai 4, Salaya 73170, Nakhon Pathom, Thailand.
EM duncan_r_smith@hotmail.com
FU National Science and Technology Development Agency [P-16-50685,
   FDA-CO-2559-1569-TH, FDACO-2561-6820-TH]; Thailand Research FundThailand
   Research Fund (TRF) [BRG6080006, IRN58W0002]; Mahidol University
   [BRG6080006, IRN58W0002]
FX DRS is supported by the National Science and Technology Development
   Agency (P-16-50685, FDA-CO-2559-1569-TH and FDACO-2561-6820-TH) and the
   Thailand Research Fund andMahidol University (BRG6080006 and IRN58W0002)
   and Mahidol University. The funders had no role in the design or
   interpretation of this work, or in the decision to submit for
   publication.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Barzon L, 2016, EUROSURVEILL, V21
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Bui TC, 2018, INT J GYNECOL OBSTET, V141, P390, DOI 10.1002/ijgo.12456
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Davila-Castrodad NM, 2018, P R HEALTH SCI J, V37, pS81
   DeSilva M, 2017, VACCINE, V35, P6472, DOI 10.1016/j.vaccine.2017.01.044
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hernandez-Avila JE, 2018, B WORLD HEALTH ORGAN, V96, P306, DOI 10.2471/BLT.17.201004
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Grubaugh ND, 2019, TRENDS MICROBIOL, V27, P381, DOI 10.1016/j.tim.2019.02.004
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hoen B, 2016, N ENGL J MED, V201-9
   Khongwichit S, 2018, MICROBES INFECT
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lan PT, 2017, PLOS CURR, V9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lourenco M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060327
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nawathe A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2232
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Nitatpattana N, 2018, MICROBIOL RESOUR ANN, V6, DOI [10.1128/genomeA.00121-18, 10.1128/genomea.00121-18]
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pacheco O, 2016, N ENGL J MED
   Parens R, 2017, PLOS CURR, V9
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodrigues LC, 2016, LANCET INFECT DIS
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Su X, 2016, SCI REP-UK, V6, DOI 10.1038/srep26741
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   Tang H, 2016, CELL STEM CELL
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Triunfol M, 2016, LANCET INFECT DIS, V16, P1008, DOI 10.1016/S1473-3099(16)30281-X
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   WHO, 2007, GUID PLAQ RED NEUTR
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization Regional Office for South-East Asia, 2013, BIRTH DEF S E AS PUB
   Xia H, 2018, VIROL SIN, V33, P5, DOI 10.1007/s12250-018-0002-9
   Zanluca C, 2015, MEM I O CRUZ
NR 65
TC 2
Z9 2
U1 6
U2 6
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN
PY 2020
VL 13
IS 1
BP 11
EP 15
DI 10.1016/j.jiph.2019.09.012
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JY8FL
UT WOS:000504643900002
PM 31669035
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Clinical relevance of Zika symptoms in the context of a Zika Dengue
   epidemic
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Bagno FF, 2019, J CLIN VIROL, V113, P27, DOI 10.1016/j.jcv.2019.02.006
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Garcell HG, 2020, J INFECT PUBLIC HEAL, V13, P173, DOI 10.1016/j.jiph.2019.07.006
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN
PY 2020
VL 13
IS 1
BP 158
EP 158
DI 10.1016/j.jiph.2019.10.001
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JY8FL
UT WOS:000504643900026
PM 31653571
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Becker-Dreps, S
   Stringer, EM
   Bucardo, F
   Bowman, NM
   Boivin, MJ
AF Becker-Dreps, Sylvia
   Stringer, Elizabeth M.
   Bucardo, Filemon
   Bowman, Natalie M.
   Boivin, Michael J.
TI Is there a silver lining to the Zika virus epidemic in the Americas?
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Becker-Dreps, Sylvia] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA.
   [Becker-Dreps, Sylvia] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.
   [Stringer, Elizabeth M.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA.
   [Bowman, Natalie M.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27599 USA.
   [Bucardo, Filemon] Univ Nacl Autonoma Nicaragua, Dept Microbiol, Leon, Nicaragua.
   [Boivin, Michael J.] Michigan State Univ, Dept Psychiat & Neurol, E Lansing, MI 48824 USA.
   [Boivin, Michael J.] Michigan State Univ, Dept Ophthalmol, E Lansing, MI 48824 USA.
   [Boivin, Michael J.] Univ Michigan, Psychol, E Lansing, MI USA.
   [Boivin, Michael J.] Univ Michigan, Dept Psychiat, E Lansing, MI USA.
RP Becker-Dreps, S (corresponding author), Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA.; Becker-Dreps, S (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.
EM sbd@unc.edu
FU US National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI137902, R21AI129532]; US National Institute of Child Health and
   Human DevelopmentUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [R01HD094009]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [K24AI141744]; Emerging Challenges in
   Biomedical Research and Explorations in Global Health Awards from the
   University of North Carolina at Chapel Hill
FX SB-D, NMB, and FB are supported by the US National Institute of Allergy
   and Infectious Diseases (R21AI137902 and R21AI129532). FB, EMS, and MJB
   are supported by the US National Institute of Child Health and Human
   Development (R01HD094009). SB-D is supported by an award from the
   National Institute of Allergy and Infectious Diseases (K24AI141744).
   This work received support from the Emerging Challenges in Biomedical
   Research and Explorations in Global Health Awards from the University of
   North Carolina at Chapel Hill. The funder of the study had no role in
   the writing of this comment. The authors had final responsibility for
   the decision to submit the comment for publication.
CR Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Beare S, 2019, GLOB HEALTH-SCI PRAC, V7, P116, DOI 10.9745/GHSP-D-18-00356
   Boivin M, 2016, CURR HIV-AIDS REP, V13, P318, DOI 10.1007/s11904-016-0342-8
   Boivin MJ, 2015, NATURE, V527, pS155, DOI 10.1038/nature16029
   Gilboa SM, 2017, BIRTH DEFECTS RES, V109, P372, DOI 10.1002/bdr2.1007
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Richter L, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001302
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 9
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2020
VL 20
IS 1
BP 14
EP 15
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA JX8UZ
UT WOS:000504005300018
PM 31876484
OA Bronze
DA 2020-07-08
ER

PT J
AU Bujan, L
   Mansuy, JM
   Hamdi, S
   Pasquier, C
   Joguet, G
AF Bujan, Louis
   Mansuy, Jean-Michel
   Hamdi, Safouane
   Pasquier, Christophe
   Joguet, Guillaume
TI 1 year after acute Zika virus infection in men
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Bujan, Louis; Hamdi, Safouane] Univ Paul Sabatier Toulouse III, EA 3694, Res Grp Human Fertil, Toulouse, France.
   [Bujan, Louis] CHU Toulouse, Hop Paule de Viguier, Reprod Med Unit, CECOS, F-31059 Toulouse, France.
   [Mansuy, Jean-Michel; Pasquier, Christophe] CHU Toulouse, Inst Federatif Biol, Lab Virol, Toulouse, France.
   [Hamdi, Safouane] CHU Toulouse, Inst Federatif Biol, Dept Biochim & Hormonol, Toulouse, France.
   [Joguet, Guillaume] CHU Pointe A Pitre, Ctr Caribeen Med Reprod CECOS CARAIBES, Pointe A Pitre, Guadeloupe, France.
RP Bujan, L (corresponding author), Univ Paul Sabatier Toulouse III, EA 3694, Res Grp Human Fertil, Toulouse, France.; Bujan, L (corresponding author), CHU Toulouse, Hop Paule de Viguier, Reprod Med Unit, CECOS, F-31059 Toulouse, France.
EM bujan.l@chu-toulouse.fr
FU Agence de la Biomedecine; Agence Regionale de Sante de la Guadeloupe;
   University Hospital of Toulouse
FX This study was supported by a grant from the Agence de la Biomedecine
   and from the Agence Regionale de Sante de la Guadeloupe and was
   sponsored by the University Hospital of Toulouse for regulatory and
   ethical submission. We declare no competing interests.
CR Avelino-Silva VL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860064, 10.1590/s1678-9946201860064]
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2020
VL 20
IS 1
BP 25
EP 26
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA JX8UZ
UT WOS:000504005300028
PM 31876496
OA Bronze
DA 2020-07-08
ER

PT J
AU Chuang, FK
   Huang, SM
   Liao, CL
   Lee, AR
   Lien, SP
   Chiu, YL
   Chang, TH
   Tsai, PL
   Lin, RJ
   Shih, CC
   Tsai, YJ
   Lin, GJ
   Yen, LC
AF Chuang, Fu-Kai
   Huang, Shih-Ming
   Liao, Ching-Len
   Lee, An-Rong
   Lien, Shu-Pei
   Chiu, Yu-Lung
   Chang, Tsung-Hsien
   Tsai, Pei-Ling
   Lin, Ren-Jye
   Shih, Chih-Chin
   Tsai, Yi-Jing
   Lin, Gu-Jiun
   Yen, Li-Chen
TI Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against
   Flavivirus Infection
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE anti-inflammatory compound; antiviral agents; dengue virus; flavivirus
ID DENGUE VIRUS; INFLAMMATORY CYTOKINES; REPLICATION; MECHANISM; COX-2
AB Flaviviruses comprise several medically important viruses, including Japanese encephalitis virus, West Nile virus, dengue virus (DENV), yellow fever virus, and Zika virus (ZIKV). A large outbreak of DENV and ZIKV occurred recently, leading to many cases of illness and death. However, despite decades of effort, we have no clinically specific therapeutic drugs against DENV and ZIKV. Previous studies showed that inflammatory responses play a critical role in dengue and Zika virus pathogenesis. Thus, in this study, we examined a series of novel anti-inflammatory compounds and found that treatment with compound 2d could dose dependently reduce viral protein expression and viral progeny production in HEK-293 and Raw264.7 cells infected with four serotypes of DENV and ZIKV. In addition, considering medication safety, compound 2d could not suppress cyclooxygenase-1 (COX-1) enzymatic activities and thus could prevent the side effect of bleeding. Moreover, compound 2d significantly inhibited COX-2 enzymatic activities and prostaglandin E-2 levels, associated with viral replication, compared to results with a selective COX-2 inhibitor, celecoxib. Furthermore, administering 5 mg/kg compound 2d to DENV-2-infected AG129 mice prolonged survival and reduced viremia and serum cytokine levels. Overall, compound 2d showed therapeutic safety and efficacy in vitro and in vivo and could be further developed as a potential therapeutic agent for flavivirus infection.
C1 [Chuang, Fu-Kai] Triserv Gen Hosp, Penghu Bran H, Penghu, Taiwan.
   [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.
   [Liao, Ching-Len; Lien, Shu-Pei; Tsai, Pei-Ling] Natl & Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan.
   [Liao, Ching-Len; Chang, Tsung-Hsien; Tsai, Pei-Ling; Tsai, Yi-Jing; Yen, Li-Chen] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan.
   [Lee, An-Rong] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan.
   [Chiu, Yu-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.
   [Lin, Ren-Jye] Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Miaoli, Taiwan.
   [Shih, Chih-Chin] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.
   [Lin, Gu-Jiun] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan.
RP Yen, LC (corresponding author), Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan.
EM yenlichen1030@gmail.com
RI Chang, Tsung-Hsien/AAG-9384-2019
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST 104-2320-B-016-002, MOST
   105-2628-B-016-002-MY2]; Ministry of National Defense Medical Affairs
   Bureau [MAB-105-015, MAB-107-078, MAB-108-054]; Tri-Service General
   Hospital [TSGH-PH-106-02, TSGH-PH-107-01]
FX This research was funded by grants from the Ministry of Science and
   Technology, Taiwan (MOST 104-2320-B-016-002 and MOST
   105-2628-B-016-002-MY2), Ministry of National Defense Medical Affairs
   Bureau (MAB-105-015, MAB-107-078, and MAB-108-054), and Tri-Service
   General Hospital (TSGH-PH-106-02 and TSGH-PH-107-01).
CR Arias J, 2014, VIROLOGY, V452, P42, DOI 10.1016/j.virol.2013.12.027
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baz M, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030101
   Chiang CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002432
   Chung ST, 2016, RES CHEM INTERMEDIAT, V42, P1195, DOI 10.1007/s11164-015-2081-7
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0
   D'Elia RV, 2013, CLIN VACCINE IMMUNOL, V20, P319, DOI 10.1128/CVI.00636-12
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Gan Victor C, 2014, Curr Treat Options Infect Dis, V6, P208
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Hsieh MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188170
   Kellstein D, 2019, POSTGRAD MED, V131, P109, DOI 10.1080/00325481.2019.1561916
   Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948
   Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499
   Lin CK, 2017, SCI REP-UK, V7, DOI 10.1038/srep44701
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liou JT, 2008, EUR J PHARMACOL, V589, P288, DOI 10.1016/j.ejphar.2008.04.056
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Rothan HA, 2013, TROP BIOMED, V30, P681
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Seynhaeve ALB, 2006, CELL BIOCHEM BIOPHYS, V44, P157, DOI 10.1385/CBB:44:1:157
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029
   Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283
   Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021
   van de Weg CAM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002236
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wu WL, 2009, EUR J IMMUNOL, V39, P3413, DOI 10.1002/eji.200939306
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
NR 39
TC 0
Z9 0
U1 4
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JAN
PY 2020
VL 64
IS 1
AR e00941-19
DI 10.1128/AAC.00941-19
PG 11
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA JX6JU
UT WOS:000503839600007
PM 31636070
OA Green Published
DA 2020-07-08
ER

PT J
AU Vilar, WTS
   Barbosa, MF
   Pinto, L
   de Araujo, MCU
   Pontes, MJC
AF Silva Vilar, Welma Thaise
   Barbosa, Mayara F.
   Pinto, Licarion
   Ugulino de Araujo, Mario Cesar
   Coelho Pontes, Marcio Jose
TI Determination of N, N-diethyl-3-methylbenzamide and
   ethyl-butyl-acetylaminopropionate in insect repellent using near
   infrared spectroscopy and multivariate calibration
SO MICROCHEMICAL JOURNAL
LA English
DT Article
DE Insect repellent; DEBT; IR 3535; Near infrared spectroscopy;
   Multivariate calibration
ID VALIDATION; EFFICACY; LAVENDER
AB Aedes aegypti mosquitoes are vectors of diseases such as dengue, chikungunya, zika and yellow fever. With the increase in the incidence of these diseases the population has resorted to the use of repellents searching to protect themselves from mosquito attack. The Brazilian market offers a wide variety of products with different active principles in varying levels of concentration, times of action and different prices, where DEET (N, N-diethyl-3-methylbenzamide) and 1R3535 (ethyl-butyl-acetylarninopropionate) based repellents are suitable for use around adults and children, respectively. The action time of these repellents depends, among other factors, on the concentration of their active ingredients. Chromatographic methods are recommended to quantify these compounds in different samples. However, these methods require long analysis time, and use reagents that are expensive and generate toxic waste. Near Infrared Spectroscopy (NIBS) has been applied in several areas of research on this subject and is characterized by its rapid, low cost, non-destructive characteristics no sample treatment is required. The present work proposes the development of a methodology based on NIR spectroscopy and multivariate calibration for determination of DEFT and IR 3535 in samples from commercial repellents. A PerkinElmer FT-NIR spectrometer equipped with a 0.1 cm quartz cell was used to obtain the NIR spectra in the range of 750-2500 nm, with a resolution of 0.1 nm and an average of 16 scans. The reference analysis for the determination of DEET and IR3535 was performed using high performance liquid chromatography with diode array ultraviolet detection (HPLC-DAD). Calibration models based on partial least squares (PIS) regression across spectral bands, the same algorithm using intervals (iPLS), and multiple linear regression (MLR) with previous selected of variables by successive projections algorithm (SPA), stepwise (SW) and genetic algorithm (GA) were developed and compared. Satisfactory prediction results were obtained for all models with RMSEP values ranging from 0.70 to 1.18% (m m(-1)) and 0.64 to 1.12% (m m(-1)) for DEET and IR3535, respectively. In addition, no systematic error was observed and no significant differences were found between predicted and reference values obtained by HPLC analysis for 178 samples, according to a t-paired test at the 95% confidence level.
C1 [Silva Vilar, Welma Thaise; Barbosa, Mayara F.; Ugulino de Araujo, Mario Cesar; Coelho Pontes, Marcio Jose] Univ Fed Paraiba, Dept Quim, BR-58005197 Joao Pessoa, PB, Brazil.
   [Pinto, Licarion] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.
RP Pontes, MJC (corresponding author), Univ Fed Paraiba, Dept Quim, BR-58005197 Joao Pessoa, PB, Brazil.
EM marciocoelho@quimica.ufpb.br
RI BARBOSA, MAYARA FERREIRA/C-3308-2017; Pinto, Licarion/N-8953-2013;
   Araujo, Mario C.U./H-6553-2013
OI Pinto, Licarion/0000-0002-8682-6174; Araujo, Mario
   C.U./0000-0002-7976-3494
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [420400/2016-8, 303649/2015-1, 304752/2018-5, 423601/2016.4,
   302349/2016-2]
FX The authors acknowledge CNPq (420400/2016-8, 303649/2015-1,
   304752/2018-5, 423601/2016.4, 302349/2016-2). The authors are also
   grateful to Thiago de Andrade Marinho Freire (in memoriam) for his
   valuable contribuiton, as well as the Merle Company that kindly donated
   the standard of insect repellent of IR 3535. The Fuel Laboratory
   situated at the Federal University of Pernambuco (LACUFPE) for their
   support with the infrared analysis and technical support. The English
   text of this paper has been revised by Sidney Pratt, Canadian, MAT (The
   Johns Hopkins University), RSAdip - TESL (Cambridge University).
CR Barr DB, 2010, SCI TOTAL ENVIRON, V408, P790, DOI 10.1016/j.scitotenv.2009.10.007
   Brito ALB, 2013, FOOD RES INT, V51, P924, DOI 10.1016/j.foodres.2013.02.014
   Briassoulis G, 2001, HUM EXP TOXICOL, V20, P8, DOI 10.1191/096032701676731093
   Broschard TH, 2013, TOXICOL LETT, V218, P246, DOI 10.1016/j.toxlet.2013.02.002
   Cascant M, 2011, TALANTA, V85, P1721, DOI 10.1016/j.talanta.2011.06.040
   Pontes MJC, 2011, MICROCHEM J, V98, P254, DOI 10.1016/j.microc.2011.02.010
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Galvao RKH, 2005, TALANTA, V67, P736, DOI 10.1016/j.talanta.2005.03.025
   Goicoechea HC, 2002, ANAL CHIM ACTA, V453, P289, DOI 10.1016/S0003-2670(01)01232-6
   Lafhal S, 2015, J RAMAN SPECTROSC, V46, P577, DOI 10.1002/jrs.4697
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Marselos SC, 2002, J CHROMATOGR A, V946, P295, DOI 10.1016/S0021-9673(01)01525-4
   McEachran AD, 2018, ENVIRON SCI POLLUT R, V25, P12451, DOI 10.1007/s11356-018-1505-5
   Norgaard L, 2000, APPL SPECTROSC, V54, P413, DOI 10.1366/0003702001949500
   Oliveri AC, 2004, CHEMOMETR INTELL LAB, V73, P189, DOI 10.1016/j.chemolab.2004.03.004
   Pasquini C, 2018, ANAL CHIM ACTA, V1026, P8, DOI 10.1016/j.aca.2018.04.004
   Sanches FAC, 2012, TALANTA, V92, P84, DOI 10.1016/j.talanta.2012.01.045
   Schwartz KL, 2018, TROP DIS TRAVEL MED, V4, DOI 10.1186/s40794-018-0062-8
   Semmler M, 2014, PARASITOL RES, V113, P185, DOI 10.1007/s00436-013-3641-7
   Silva V.H., 2015, J PHARM BIOMED ANAL, V115, P587, DOI DOI 10.1016/J.JPBA.2015.08.018
   Tankeu SY, 2014, IND CROP PROD, V59, P234, DOI 10.1016/j.indcrop.2014.05.005
   Tavares M, 2018, INT J PHARMACEUT, V539, P190, DOI 10.1016/j.ijpharm.2018.01.046
   Vilar WTS, 2018, ANAL METHODS-UK, V10, P1911, DOI 10.1039/c8ay00486b
   WHO. World Health Organization, 2019, WHOSRPT1R2
   Wickerham EL, 2012, ENVIRON INT, V47, P80, DOI 10.1016/j.envint.2012.06.007
   Workman JJ, 1996, APPL SPECTROSC REV, V31, P251, DOI 10.1080/05704929608000571
   World Health Organization, 2019, ETH BUT ALS KNOW IR3
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Yiin LM, 2015, ENVIRON SCI POLLUT R, V22, P7062, DOI 10.1007/s11356-014-3915-3
NR 29
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0026-265X
EI 1095-9149
J9 MICROCHEM J
JI Microchem J.
PD JAN
PY 2020
VL 152
AR 104285
DI 10.1016/j.microc.2019.104285
PG 7
WC Chemistry, Analytical
SC Chemistry
GA JW8RX
UT WOS:000503315300074
OA Bronze
DA 2020-07-08
ER

PT J
AU El Sahili, A
   Soh, TS
   Schiltz, J
   Gharbi-Ayachi, A
   Seh, CC
   Shi, PY
   Lim, SP
   Lescar, J
AF El Sahili, Abbas
   Soh, Tingjin Sherryl
   Schiltz, Jonas
   Gharbi-Ayachi, Aicha
   Seh, Cheah Chen
   Shi, Pei-Yong
   Lim, Siew Pheng
   Lescar, Julien
TI NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to
   That of Its Zika Virus and Japanese Encephalitis Virus Homologues
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE flaviviruses; dengue virus; nonstructural protein; RNA
   methyltransferase; RNA-dependent RNA polymerase; X-ray crystallography;
   nonstructural protein 5
ID CRYSTAL-STRUCTURE; RNA CAP; POLYMERASE; PROTEIN; INITIATION;
   METHYLATIONS; FLEXIBILITY; COMPOUND; INSIGHTS; FEATURES
AB Flavivirus nonstructural protein 5 (NS5) contains an N-terminal methyltransferase (MTase) domain and a C-terminal polymerase (RNA-dependent RNA polymerase [RdRp]) domain fused through a 9-amino-acid linker. While the individual NS5 domains are structurally conserved, in the full-length protein, their relative orientations fall into two classes: the NS5 proteins from Japanese encephalitis virus (JEV) and Zika virus (ZIKV) adopt one conformation, while the NS5 protein from dengue virus serotype 3 (DENV3) adopts another. Here, we report a crystallographic structure of NS5 from DENV2 in a conformation similar to the extended one seen in JEV and ZIKV NS5 crystal structures. Replacement of the DENV2 NS5 linker with DENV1, DENV3, DENV4, JEV, and ZIKV NS5 linkers had modest or minimal effects on in vitro DENV2 MTase and RdRp activities. Heterotypic DENV NS5 linkers attenuated DENV2 replicon growth in cells, while the JEV and ZIKV NS5 linkers abolished replication. Thus, the JEV and ZIKV linkers likely hindered essential DENV2 NS5 interactions with other viral or host proteins within the virus replicative complex. Overall, this work sheds light on the dynamics of the multifunctional flavivirus NS5 protein and its interdomain linker. Targeting the NS5 linker is a possible strategy for producing attenuated flavivirus strains for vaccine design.
   IMPORTANCE Flaviviruses include important human pathogens, such as dengue virus and Zika virus. NS5 is a nonstructural protein essential for flavivirus RNA replication with dual MTase and RdRp enzyme activities and thus constitutes a major drug target. Insights into NS5 structure, dynamics, and evolution should inform the development of antiviral inhibitors and vaccine design. We found that NS5 from DENV2 can adopt a conformation resembling that of NS5 from JEV and ZIKV. Replacement of the DENV2 NS5 linker with the JEV and ZIKV NS5 linkers abolished DENV2 replication in cells, without significantly impacting in vitro DENV2 NS5 enzymatic activities. We propose that heterotypic flavivirus NS5 linkers impede DENV2 NS5 protein-protein interactions that are essential for virus replication.
C1 [El Sahili, Abbas; Soh, Tingjin Sherryl; Gharbi-Ayachi, Aicha; Lescar, Julien] Nanyang Technol Univ, NTU Inst Struct Biol, Sch Biol Sci, Singapore, Singapore.
   [Soh, Tingjin Sherryl; Schiltz, Jonas; Seh, Cheah Chen; Shi, Pei-Yong; Lim, Siew Pheng] Novartis Inst Trop Dis, Singapore, Singapore.
   [Schiltz, Jonas] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, Lubeck, Germany.
   [Lescar, Julien] Singapore MIT Alliance Res & Technol, Antimicrobial Resistance Interdisciplinary Res Gr, Singapore, Singapore.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Lim, Siew Pheng] Denka Life Innovat Res Pte Ltd, Nucl, Singapore, Singapore.
RP Lescar, J (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, Sch Biol Sci, Singapore, Singapore.; Lim, SP (corresponding author), Novartis Inst Trop Dis, Singapore, Singapore.; Lescar, J (corresponding author), Singapore MIT Alliance Res & Technol, Antimicrobial Resistance Interdisciplinary Res Gr, Singapore, Singapore.
EM siewpheng-lim@denka.com.sg; julien@ntu.edu.sg
OI Lim, Siew Pheng/0000-0002-7377-5662; El Sahili,
   Abbas/0000-0003-3973-686X
FU  [NRF20016NRF-CRP001-063]
FX This work was supported by grant NRF20016NRF-CRP001-063 to the J. Lescar
   lab.
CR Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Ferrero DS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007656
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lim SP, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.132.132
   Lim SP, 2019, ANTIVIR RES, V163, P156, DOI 10.1016/j.antiviral.2018.12.016
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   Niyomrattanakit P, 2015, ANTIVIR RES, V119, P36, DOI 10.1016/j.antiviral.2015.04.007
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   WHO, 2017, YELLOW FEVER
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
NR 40
TC 1
Z9 1
U1 6
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2020
VL 94
IS 1
AR e01294-19
DI 10.1128/JVI.01294-19
PG 14
WC Virology
SC Virology
GA JX6LP
UT WOS:000503844300008
PM 31597763
OA Green Published
DA 2020-07-08
ER

PT J
AU Giovanetti, M
   de Mendonca, MCL
   Fonseca, V
   Mares-Guia, MA
   Fabri, A
   Xavier, J
   de Jesus, JG
   Graf, T
   Rodrigues, CDD
   dos Santos, CC
   Sampaio, SA
   Chalhoub, FLL
   Nogueira, FD
   Theze, J
   Romano, APM
   Ramos, DG
   de Abreu, AL
   Oliveira, WK
   Said, RFD
   de Alburque, CFC
   de Oliveira, T
   Fernandes, CA
   Aguiar, SF
   Chieppe, A
   Sequeira, PC
   Faria, NR
   Cunha, RV
   Alcantara, LCJ
   de Filippis, AMB
AF Giovanetti, Marta
   Lima de Mendonca, Marcos Cesar
   Fonseca, Vagner
   Mares-Guia, Maria Angelica
   Fabri, Allison
   Xavier, Joilson
   de Jesus, Jaqueline Goes
   Graf, Tiago
   dos Santos Rodrigues, Cintia Damasceno
   dos Santos, Carolina Cardoso
   Sampaio, Simone Alves
   Levy Chalhoub, Flavia Lowen
   Nogueira, Fernanda de Bruycker
   Theze, Julien
   Martins Romano, Alessandro Pecego
   Ramos, Daniel Garkauskas
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   do Carmo Said, Rodrigo Fabiano
   Campelo de Alburque, Carlos F.
   de Oliveira, Tulio
   Fernandes, Carlos Augusto
   Aguiar, Shirlei Ferreira
   Chieppe, Alexandre
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Cunha, Rivaldo Venancio
   Junior Alcantara, Luiz Carlos
   Bispo de Filippis, Ana Maria
TI Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016-2019
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE yellow fever; outbreak; Southeast Brazil; genomic surveillance; outbreak
   response
ID PHYLOGENETIC ANALYSIS; DENGUE; ZIKA
AB The recent reemergence of yellow fever virus (YFV) in Brazil has raised serious concerns due to the rapid dissemination of the virus in the southeastern region. To better understand YFV genetic diversity and dynamics during the recent outbreak in southeastern Brazil, we generated 18 complete and nearly complete genomes from the peak of the epidemic curve from nonhuman primates (NHPs) and human infected cases across the Espirito Santo and Rio de Janeiro states. Genomic sequencing of 18 YFV genomes revealed the estimated timing, source, and likely routes of yellow fever virus transmission and dispersion during one of the largest outbreaks ever registered in Brazil. We showed that during the recent epidemic, YFV was reintroduced from Minas Gerais to the Espirito Santo and Rio de Janeiro states multiple times between 2016 and 2019. The analysis of data from portable sequencing could identify the corridor of spread of YFV. These findings reinforce the idea that continued genomic surveillance strategies can provide information on virus genetic diversity and transmission dynamics that might assist in understanding arbovirus epidemics.
   IMPORTANCE Arbovirus infections in Brazil, including yellow fever, dengue, zika, and chikungunya, result in considerable morbidity and mortality and are pressing public health concerns. However, our understanding of these outbreaks is hampered by the limited availability of genomic data. In this study, we investigated the genetic diversity and spatial distribution of YFV during the current outbreak by analyzing genomic data from areas in southeastern Brazil not covered by other previous studies. To gain insights into the routes of YFV introduction and dispersion, we tracked the virus by sequencing YFV genomes sampled from nonhuman primates and infected patients from the southeastern region. Our study provides an understanding of how YFV initiates transmission in new Brazilian regions and illustrates that genomics in the field can augment traditional approaches to infectious disease surveillance and control.
C1 [Giovanetti, Marta; Lima de Mendonca, Marcos Cesar; Mares-Guia, Maria Angelica; Fabri, Allison; dos Santos Rodrigues, Cintia Damasceno; dos Santos, Carolina Cardoso; Sampaio, Simone Alves; Levy Chalhoub, Flavia Lowen; Nogueira, Fernanda de Bruycker; Sequeira, Patricia Carvalho; Junior Alcantara, Luiz Carlos; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [de Jesus, Jaqueline Goes; Graf, Tiago] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Theze, Julien] Univ Oxford, Dept Zool, Oxford, England.
   [Martins Romano, Alessandro Pecego; Ramos, Daniel Garkauskas] Minist Saude, Coordenacao Geral Vigilancia Arboviroses CGARB, CGLAB SVS MS, Brasilia, DF, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Minist Saude,CGLAB SVS MS, Brasilia, DF, Brazil.
   [Oliveira, Wanderson Kleber] Minist Saude, SVS, Brasilia, DF, Brazil.
   [Campelo de Alburque, Carlos F.] Lab Cent Saude Publ Noel Nutels LACEN RJ, Rio De Janeiro, Brazil.
   [Fernandes, Carlos Augusto] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Chieppe, Alexandre] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Cunha, Rivaldo Venancio] Univ Fed Mato Grosso, Fac Med, Campo Grande, MS, Brazil.
RP Giovanetti, M (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Giovanetti, M (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
EM giovanetti.marta@gmail.com
RI Graf, Tiago/S-8535-2019; Giovanetti, Marta/AAK-7408-2020; Fonseca,
   Vagner/R-5813-2019
OI Graf, Tiago/0000-0003-4921-7975; Fonseca, Vagner/0000-0001-5521-6448;
   Alcantara, Luiz/0000-0002-6769-9931
FU ZiBRA2 project - Brazilian Ministry of Health (SVS-MS); Pan American
   Organization (OPAS); CNPqNational Council for Scientific and
   Technological Development (CNPq) [440685/2016-8, 440856/2016-7];
   CAPESCAPES [88887.130716/2016-00, 88881.130825/2016-00,
   88887.130823/2016-00]; EU's Horizon 2020 program through ZIKAlliance
   [PRES-005-FEX-17-4-2-33]; Faperj (Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]; International Development Research Centre (IDRC)
   Canada [108411-001]; Horizon 2020 through ZikaPlan [734584, 734857];
   Horizon 2020 through ZikAction [734584, 734857]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX We thank all personnel from Health Surveillance System in Rio de Janeiro
   that coordinated surveillance and helped with data collection and
   assembly. We also thank Ronaldo Lapa e Solange Regina Conceicao from the
   Instituto Oswaldo Cruz (Fiocruz, Rio de Janeiro) for their support.;
   This work was supported by the ZiBRA2 project supported by the Brazilian
   Ministry of Health (SVS-MS) and the Pan American Organization (OPAS) and
   founded by Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7);
   by CAPES (88887.130716/2016-00, 88881.130825/2016-00, and
   88887.130823/2016-00); and by EU's Horizon 2020 program through
   ZIKAlliance (PRES-005-FEX-17-4-2-33). The Flavivirus Laboratory
   activities was also supported by Faperj (Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro) under grant number
   E-26/2002.930/2016, by the International Development Research Centre
   (IDRC) Canada over the grant 108411-001 and Horizon 2020 through
   ZikaPlan and ZikAction under the grant's agreement numbers 734584 and
   734857. M.G. is supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ).
CR Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Brazilian Ministry of Health, 2017, EP UPD YELL FEV
   Brazilian Ministry of Health, 2018, EP UPD YELL FEV
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   Degallier Nicolas, 1992, Ciencia e Cultura (Sao Paulo), V44, P143
   Delatorre E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01079
   deSouza RP, 2019, BIORXIV, DOI [10.1101/645341, DOI 10.1101/645341]
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Giovanetti M, 2019, BIORXIV, DOI [10.1101/711994, DOI 10.1101/711994]
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mondet B, 1996, B SOC PATHOL EXOT, V89, P107
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Ribeiro AF, 2019, AM J TROP MED HYG, V101, P180, DOI 10.4269/ajtmh.18-0882
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   Secretaria de Vigilancia em Saude, 2019, MON PER SAZ FEBR AM
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Souza Renato Pereira de, 2011, Rev. Inst. Med. trop. S. Paulo, V53, P133, DOI 10.1590/S0036-46652011000300004
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
NR 36
TC 3
Z9 3
U1 14
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2020
VL 94
IS 1
AR e01623-19
DI 10.1128/JVI.01623-19
PG 12
WC Virology
SC Virology
GA JX6LP
UT WOS:000503844300009
PM 31597773
OA Green Published
DA 2020-07-08
ER

PT J
AU Peregrine, J
   Gurung, S
   Lindgren, MC
   Husain, S
   Zavy, MT
   Myers, DA
   Papin, JF
AF Peregrine, Jamie
   Gurung, Sunam
   Lindgren, Mark C.
   Husain, Sanam
   Zavy, Michael T.
   Myers, Dean A.
   Papin, James F.
TI Zika Virus Infection, Reproductive Organ Targeting, and Semen
   Transmission in the Male Olive Baboon
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; nonhuman primate; semen; testes; olive baboon; baboon;
   immune modulation; West Nile; Zika; humoral immunity; male reproduction;
   seminal vesicles; spermatogenesis
ID VECTOR-BORNE TRANSMISSION; WEST-NILE-VIRUS; SEXUAL TRANSMISSION; DENGUE
   VIRUS; PATHOGENESIS; ENHANCEMENT; RHESUS
AB Zika virus (ZIKV) infection in pregnant women is a serious threat to the development and viability of the fetus. The primary mode of ZIKV transmission to humans is through mosquito bites, but sexual transmission has also been well documented in humans. However, little is known of the short- and long-term effects of ZIKV infection on the human male reproductive system. This study examines the effects of ZIKV infection on the male reproductive organs and semen and the immune response of the olive baboon (Papio anubis). Nine mature male baboons were infected with ZIKV (French Polynesian strain) subcutaneously. Six animals were euthanized at 41 days, while three animals were euthanized at 10 or 11 days postinfection (dpi). Viremia and clinical evidence of infection were present in all nine baboons. ZIKV RNA was present in the semen of five of nine baboons. ZIKV was present in the testes of two of three males euthanized at 10 or 11 dpi, but in none of six males at 41 dpi. Immunofluorescence of testes suggested the presence of ZIKV in sperm progenitor cells, macrophage penetration of seminiferous tubules, and increased tumor necrosis factor alpha (TNF-alpha), particularly in vascular walls. These data demonstrate that male olive baboons approximate the male human ZIKV response, including viremia, the adaptive immune response, and persistent ZIKV in semen. Although gross testicular pathology was not seen, the demonstrated breach of the testes-blood barrier and targeting of spermatogenic precursors suggest possible long-term implications in ZIKV-infected primates.
   IMPORTANCE Zika virus (ZIKV) is an emerging flavivirus spread through mosquitoes and sexual contact. ZIKV infection during pregnancy can lead to severe fetal outcomes, including miscarriage, fetal death, preterm birth, intrauterine growth restriction, and fetal microcephaly, collectively known as congenital Zika syndrome. Therefore, it is important to understand how this virus spreads, as well as the resulting pathogenesis in translational animal models that faithfully mimic ZIKV infection in humans. Such models will contribute to the future development of efficient therapeutics and prevention mechanisms. Through our previous work in olive baboons, we developed a nonhuman primate model that is permissive to ZIKV infection and transfers the virus vertically from mother to fetus, modeling human observations. The present study contributes to understanding of ZIKV infection in male baboon reproductive tissues and begins to elucidate how this may affect fertility, reproductive capacity, and sexual transmission of the virus.
C1 [Peregrine, Jamie; Zavy, Michael T.] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Sect Reprod Endocrinol & Infertil, Oklahoma City, OK 73190 USA.
   [Gurung, Sunam; Myers, Dean A.] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Sect Maternal Fetal Med, Oklahoma City, OK 73190 USA.
   [Lindgren, Mark C.] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK USA.
   [Husain, Sanam; Papin, James F.] Univ Oklahoma, Hlth Sci Ctr, Div Comparat Med, Dept Pathol & Lab, Oklahoma City, OK 73106 USA.
RP Papin, JF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Div Comparat Med, Dept Pathol & Lab, Oklahoma City, OK 73106 USA.
EM James-Papin@ouhsc.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21 AI129560];
   American Board of Obstetrics and Gynecology; American College of
   Obstetricians and Gynecologists; American Society for Reproductive
   Medicine; Society for Reproductive Endocrinology and Infertility
FX These studies were supported in part by National Institutes of Health
   grant R21 AI129560 and a grant from the American Board of Obstetrics and
   Gynecology, the American College of Obstetricians and Gynecologists, the
   American Society for Reproductive Medicine, and the Society for
   Reproductive Endocrinology and Infertility. The funders had no role in
   study design, data collection and analysis, the decision to publish, or
   preparation of the manuscript.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Centers for Disease Control and Prevention, 2018, ZIK CAS US
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   DE SK, 1993, ENDOCRINOLOGY, V133, P389, DOI 10.1210/en.133.1.389
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Gurung S, 2018, J VIROL, V92, DOI 10.1128/JVI.00186-18
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Wolf RF, 2006, VIROLOGY, V355, P44, DOI 10.1016/j.virol.2006.06.033
   Zafer M, 2016, FERTIL STERIL, V105, P645, DOI 10.1016/j.fertnstert.2015.11.028
NR 36
TC 2
Z9 2
U1 4
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2020
VL 94
IS 1
AR e01434-19
DI 10.1128/JVI.01434-19
PG 16
WC Virology
SC Virology
GA JX6LP
UT WOS:000503844300024
PM 31597777
OA Green Published
DA 2020-07-08
ER

PT J
AU Salgado, DM
   Vega, R
   Rodriguez, JA
   Nino, A
   Rodriguez, R
   Ortiz, A
   DeLaura, I
   Bosch, I
   Narvaez, CF
AF Salgado, Doris M.
   Vega, Rocio
   Antonio Rodriguez, Jairo
   Nino, Angela
   Rodriguez, Rocio
   Ortiz, Angela
   DeLaura, Isabel
   Bosch, Irene
   Narvaez, Carlos F.
TI Clinical, laboratory and immune aspects of Zika virus-associated
   encephalitis in children
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Viral encephalitis; Dengue virus; Pediatric; Neurological
   surveillance
ID GUILLAIN-BARRE-SYNDROME; INFECTION; DENGUE; ILLNESS; COMPLICATIONS;
   CYTOKINES
AB Objective: To evaluate the clinical, laboratory, and immune characteristics of Zika virus (ZIKV)-associated encephalitis in pediatric patients after the epidemic in Huila, southern Colombia.
   Methods: A pediatric neuro-surveillance hospital study was conducted in a referral health center in southern Colombia, from October 2016 to October 2017. Cases of encephalitis were confirmed by nucleic acid amplification tests and serological methods in cerebrospinal fluid (CSF), plasma, and/or urine. Levels of six cytokines were evaluated by flow cytometry. Patients underwent daily clinical and laboratory follow-up.
   Results: Twenty children with probable encephalitis were included for further studies and 16 of them were confirmed. Four cases of bacterial meningoencephalitis (Streptococcus pneumoniae, group B Streptococcus, Staphylococcus epidermidis, and Escherichia coli) and 12 cases of viral encephalitis were identified, six of them associated with ZIKV infection. Other viral encephalitis cases were caused by herpes viruses (n = 3), enterovirus (n = 2), and dengue virus type 2 (DENV-2; n = 1) infections. ZIKV-associated encephalitis symptoms subsided faster than those of patients with encephalitis caused by other agents. CSF analysis revealed lymphocytic pleocytosis. Compared to healthy controls, children with ZIKV-associated encephalitis presented modest plasma interleukin (IL)-10 but not IL-2, IL-4, IL-6, interferon gamma (IFN-gamma), or tumor necrosis factor alpha (TNF-alpha). Cytokine expression was differentially regulated, as dramatically elevated IL-6, IL-10, and IFN-gamma levels were observed in CSF but not in paired plasma samples in one of the patients with ZIKV detectable in CSF.
   Conclusions: This study provides evidence that ZIKV is responsible for pediatric encephalitis in endemic areas, and the local presence of the virus may induce cephalic but not systemic expression of cytokines. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Salgado, Doris M.; Vega, Rocio; Antonio Rodriguez, Jairo; Nino, Angela; Rodriguez, Rocio; Ortiz, Angela; DeLaura, Isabel; Narvaez, Carlos F.] Univ Surcolombiana, Programa Med, Fac Salud, Calle 9 14-02, Neiva, Huila, Colombia.
   [Salgado, Doris M.; Vega, Rocio; Antonio Rodriguez, Jairo; Nino, Angela; Rodriguez, Rocio; Ortiz, Angela] Hosp Univ Neiva, Dept Pediat, Neiva, Huila, Colombia.
   [Salgado, Doris M.; Vega, Rocio; Antonio Rodriguez, Jairo; Nino, Angela; Rodriguez, Rocio; Ortiz, Angela; Narvaez, Carlos F.] Univ Surcolombiana, Fac Salud, Especializac Med Pediat, Postgrad Clin, Neiva, Huila, Colombia.
   [DeLaura, Isabel] Harvard Univ, Cambridge, MA 02138 USA.
   [Bosch, Irene] E25Bio Inc, Engine MIT, 501 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Bosch, Irene] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.
RP Salgado, DM (corresponding author), Univ Surcolombiana, Programa Med, Fac Salud, Calle 9 14-02, Neiva, Huila, Colombia.; Narvaez, CF (corresponding author), Univ Surcolombiana, I&I Lab, Programa Med, Fac Salud, Calle 9 14-02, Neiva, Huila, Colombia.
EM dpanqueba@gmail.com; cfnarvaez@usco.edu.co
FU Vicerrectoria de Investigacion y Proyeccion Social -Universidad
   Surcolombiana [1946]; Fulbright scholarship
FX This study was financed by the Vicerrectoria de Investigacion y
   Proyeccion Social -Universidad Surcolombiana (Grant Number 1946, to
   CFN). IDL was funded by a Fulbright scholarship.
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   AURELIUS E, 1994, J INFECT DIS, V170, P678, DOI 10.1093/infdis/170.3.678
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   De Broucker T, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0590-9
   Barros JBD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00821
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leber AL, 2016, J CLIN MICROBIOL, V54, P2251, DOI 10.1128/JCM.00730-16
   Mansuy JM, 2019, EMERG INFECT DIS, V25, P823, DOI 10.3201/eid2504.171886
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Pacheco O, 2016, N ENGL J MED
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perdomo-Celis F, 2015, BIOMARK INSIGHTS, V10, P125, DOI [10.4137/BMIMI.S35005, 10.4137/BMI.S35005]
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Tyson J, 2018, J CLIN MICROBIOL
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 35
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JAN
PY 2020
VL 90
BP 104
EP 110
DI 10.1016/j.ijid.2019.10.030
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA JW1FD
UT WOS:000502803300016
PM 31678190
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU August, EM
   Rosenthal, J
   Torrez, R
   Romero, L
   Berry-Bibee, EN
   Frey, MT
   Torres, R
   Rivera-Garc?a, B
   Honein, MA
   Jamieson, DJ
   Lathrop, E
AF August, Euna M.
   Rosenthal, Jackie
   Torrez, Ruben
   Romero, Lisa
   Berry-Bibee, Erin N.
   Frey, Meghan T.
   Torres, Ricardo
   Rivera-Garcia, Brenda
   Honein, Margaret A.
   Jamieson, Denise J.
   Lathrop, Eva
TI Community Understanding of Contraception During the Zika Virus Outbreak
   in Puerto Rico
SO HEALTH PROMOTION PRACTICE
LA English
DT Article
DE contraception; birth control; Zika virus; Puerto Rico; qualitative;
   focus groups
ID HEALTH-CARE PROVIDERS; INTERNET USE; PREGNANCY; IMPACT; COMMUNICATION;
   ACCESS; TRUST; BIRTH; WOMEN; COST
AB In response to the Zika virus outbreak in Puerto Rico (2015-2016), the Zika Contraception Access Network (Z-CAN) was established to provide same-day access to the full range of reversible contraception at no cost to women. Formative research was conducted to inform the development of a communication campaign about Z-CAN. Ten focus groups with women and men, aged 18 to 49 years, in Puerto Rico were conducted to collect data on contraception awareness, use, and decision making during the Zika outbreak, as well as culturally appropriate messaging and outreach strategies. Thematic analysis was conducted using the constant comparative method. Data showed that there was community awareness regarding Zika in Puerto Rico. However, it was not a motivating factor in contraception decision making; instead, economic factors were the major drivers. Most participants preferred to receive information on contraception, potential side effects, and where to access contraceptive services via Internet-based channels and health care providers. Based on these findings, the Ante La Duda, Pregunta [When in Doubt, Ask] campaign was launched to promote awareness of Z-CAN services among those who chose to prevent pregnancy during the Zika outbreak. Our results underscore the importance of conducting formative research to develop communication initiatives, while also demonstrating that it is feasible to perform these activities as part of an emergency response.
C1 [August, Euna M.; Rosenthal, Jackie; Romero, Lisa; Frey, Meghan T.; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.
   [Torrez, Ruben] MarketVision, San Antonio, TX USA.
   [Berry-Bibee, Erin N.; Jamieson, Denise J.; Lathrop, Eva] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Torres, Ricardo; Rivera-Garcia, Brenda] Emory Univ, Sch Med, Atlanta, GA USA.
RP August, EM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, 1600 Clifton Rd NE,Mail Stop E-49, Atlanta, GA 30329 USA.
EM eaugust@cdc.gov
RI ; August, Euna/G-9273-2011
OI Jamieson, Denise/0000-0003-2597-1201; August, Euna/0000-0002-0345-9728
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Akers AY, 2010, J WOMENS HEALTH, V19, P1163, DOI 10.1089/jwh.2009.1735
   Andreasen AR, 1995, MARKETING SOCIAL CHA
   Bethune G R, 2009, Public Health, V123 Suppl 1, pe17, DOI 10.1016/j.puhe.2009.06.006
   Burke HM, 2014, INT PERSPECT SEX R H, V40, P56, DOI 10.1363/4005614
   Centers for Disease Control and Prevention, 2016, ZIK VIR 2016 CAS COU
   Centers for Disease Control and Prevention (CDC), 2016, WOM HLTH STAT PUERT
   Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1
   Eisenberg D, 2013, J ADOLESCENT HEALTH, V52, pS59, DOI 10.1016/j.jadohealth.2013.01.012
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Firestone R, 2017, HEALTH POLICY PLANN, V32, P110, DOI 10.1093/heapol/czw088
   Fraze J L, 2009, Public Health, V123 Suppl 1, pe23, DOI 10.1016/j.puhe.2009.08.006
   GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070
   Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618
   Hopkins Brooke, 2017, Nurs Womens Health, V21, P122, DOI 10.1016/j.nwh.2017.02.007
   Hornik R. C, 2002, PUBLIC HLTH COMMUNIC
   Hou JR, 2010, J HEALTH COMMUN, V15, P186, DOI 10.1080/10810730.2010.522691
   Iverson SA, 2008, J AM OSTEOPATH ASSOC, V108, P699
   JANOWITZ B, 1992, STUD FAMILY PLANN, V23, P110, DOI 10.2307/1966540
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Malave L., 1999, STERILIZATION PUERTO
   MarketVision, 2016, ANT DUD PREG
   McNeil Jr Donald G., 2016, NY TIMES
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Ochako R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1483-1
   Patton MQ, 2002, QUALITATIVE RES EVAL
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   RTI International, 2016, DET ZIK
   Sable MR, 2000, FAM PLANN PERSPECT, V32, P124, DOI 10.2307/2648161
   Snyder LB, 2007, J NUTR EDUC BEHAV, V39, pS32, DOI 10.1016/j.jneb.2006.09.004
   Stead M, 2007, HEALTH EDUC, V107, P126, DOI 10.1108/09654280710731548
   STYCOS JM, 1956, MILBANK FUND Q, V34, P150, DOI 10.2307/3348414
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   THIMMESCH N, 1968, J MARRIAGE FAM, V30, P252, DOI 10.2307/349251
   WARREN CW, 1987, STUD FAMILY PLANN, V18, P42, DOI 10.2307/1966420
   Wright E, 2011, AIDS CARE, V23, P534, DOI 10.1080/09540121.2010.524190
NR 38
TC 0
Z9 0
U1 3
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1524-8399
EI 1552-6372
J9 HEALTH PROMOT PRACT
JI Health Promot. Pract.
PD JAN
PY 2020
VL 21
IS 1
BP 133
EP 141
DI 10.1177/1524839919850764
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JW2ES
UT WOS:000502871600017
PM 31142152
DA 2020-07-08
ER

PT J
AU Dowall, SD
   Graham, VA
   Hewson, R
AF Dowall, Stuart D.
   Graham, Victoria A.
   Hewson, Roger
TI Lineage-dependent differences of Zika virus infection in a susceptible
   mouse model are associated with different profiles of cytokines,
   chemokines, growth factors and acute phase proteins
SO CYTOKINE
LA English
DT Article
DE Zika virus; Cytokine; Chemokine; Growth factors; Acute phase proteins;
   Pathogenicity
ID BRAIN; PREGNANCY; OUTBREAK; AFRICAN; SYSTEM
AB Zika virus (ZIKV) is phylogenetically divided into two lineages comprising African (ZIKV(AF)) and Asian (ZIKV(AS)) genotypes. In the type-I interferon receptor deficient mouse model, ZIKV(AF) causes severe disease with all mice meeting humane endpoints with doses as low as 10 plaque-forming units (pfu) whereas a much milder infection is seen after challenge with ZIKV(AS), including with doses as high as 10(6) pfu. Using this mouse model, the elucidation of cytokine, chemokine, growth factor and acute phase protein responses over the course of infection were studied to determine whether these analytes contributed to the stark difference in clinical outcome. Results demonstrated some significant differences, with the ZIKV(AF) infection being associated with increases in a higher number of biomarkers than ZIKV(AS). When low (10 pfu) and high (10(6) pfu) challenge doses were compared, animals given the lower virus inoculum showed a wider range of responses, indicating a different disease progression compared to those challenged with high doses. These results aid with elucidating the different outcomes with the two lineages of ZIKV and with future work to assess pathogenicity of virus infection.
C1 [Dowall, Stuart D.; Graham, Victoria A.; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England.
RP Dowall, SD (corresponding author), Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England.
EM stuart.dowall@phe.gov.uk
FU Public Health England
FX Work was funded through the Public Health England grant-in-aid
   programmes.
CR Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chiang S, 2013, MUSCLE NERVE, V48, P320, DOI 10.1002/mus.23829
   Colavita F, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2450540
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Barros JBD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00821
   de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2019, METHODS, V158, P17, DOI 10.1016/j.ymeth.2019.02.008
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foo SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124152
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Ginsberg Y., 2017, RAMBAM MAIMONIDES ME, V8
   HALLORAN PF, 1993, TRANSPLANT P, V25, P10
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jain S, 2011, J PHARM BIOALLIED SC, V3, P118, DOI 10.4103/0975-7406.76489
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3
   Restrepo BN, 2008, AM J TROP MED HYG, V79, P673, DOI 10.4269/ajtmh.2008.79.673
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sathupan P, 2007, ANN TROP PAEDIATR, V27, P179, DOI 10.1179/146532807X220280
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Tanaka T, 2016, ADV EXP MED BIOL, V941, P79, DOI 10.1007/978-94-024-0921-5_4
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 52
TC 1
Z9 1
U1 4
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD JAN
PY 2020
VL 125
AR 154864
DI 10.1016/j.cyto.2019.154864
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA JU0TJ
UT WOS:000501391800049
PM 31577989
OA Bronze
DA 2020-07-08
ER

PT J
AU Zaidi, MB
   Cedillo-Barron, L
   Almeida, MEGY
   Garcia-Cordero, J
   Campos, FD
   Namorado-Tonix, K
   Perez, F
AF Zaidi, Mussaret Bano
   Cedillo-Barron, Leticia
   Gonzalez y Almeida, Maria Elena
   Garcia-Cordero, Julio
   Campos, Freddy D.
   Namorado-Tonix, Karime
   Perez, Freddy
TI Serological tests reveal significant cross-reactive human antibody
   responses to Zika and Dengue viruses in the Mexican population
SO ACTA TROPICA
LA English
DT Article
DE Enzyme-linked immunosorbent assay; NS1 protein; EDIII protein;
   Sensitivity; Specificity; Cross-reactivity
ID INFECTIONS; IGM; SPECIFICITY; ASSAY
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has caused recent large outbreaks in the Americas. Given its association with severe congenital defects including microcephaly, distinguishing infections caused by ZIKV from those caused by dengue virus (DENV) is of primordial importance. The objectives of this study were to evaluate the recombinant proteins rEIII-ZIKV (Envelope protein domain III) and rNS1 beta-leader-ZIKV (nonstructural protein 1) for the serological diagnosis of ZIKV in the Mexican population. We also evaluated potential cross-reactivity in commercial enzyme-linked immunosorbent assays (ELISA) based on the ZIKV NS1 and DENV NS1 proteins. rEIII-ZIKV and rNS1 beta-leader-ZIKV proteins were tested with sera from 30 PCR-confirmed ZIKV cases, 50 ZIKV-naive, DENV-exposed subjects with no acute febrile disease, (asymptomatic subjects, AS), and 50 ZIKV-naive and DENV naive AS. Commercial ELISA tests were evaluated with sera from 57 ZIKV and 20 DENV PCR-confirmed cases, and 50 ZIKV-naive, DENV-exposed AS. In-house ELISA assays showed that IgM antibody levels against rEIII-ZIKV and rNS1 beta-ZIKV were higher in ZIKV naive, DENV-exposed AS than in acutely infected ZIKV individuals. IgG reactivity was highest for rEIII-ZIKV, and indistinguishable between acutely infected ZIKV cases and DENV exposed AS. Positivity for the Euroimmun Zika IgM assay at 7-10 days was considerably higher in DENV-naive ZIKV patients (86%) than in DENV-exposed ZIKV patients (33%), while 39% of the latter had false-negative anti-ZIKV IgG before 7 days of onset. DENV-exposed ZIKV patients presented lower anti-ZIKV IgM and higher IgG responses similar to a secondary dengue response. Forty-four percent of DENV- exposed acute ZIKV patients were DENV IgM positive with the Panbio Dengue assay, and two (15%) of the DENV-naive ZIKV patients presented false DENV IgG conversion. Given the extensive cross-reactivity to both the NS1 and EDIII proteins in current serological methods, the development of sensitive and specific serological tests to distinguish ZIKV from DENV infections is an urgent priority.
C1 [Zaidi, Mussaret Bano; Gonzalez y Almeida, Maria Elena; Campos, Freddy D.] Hosp Gen OHoran, Infect Dis Res Unit, Merida, Yucatan, Mexico.
   [Zaidi, Mussaret Bano] Michigan State Univ, Dept Epidemiol & Biostat, Lansing, MI USA.
   [Cedillo-Barron, Leticia; Garcia-Cordero, Julio; Namorado-Tonix, Karime] IPN, Dept Mol Biomed, CINVESTAV, Mexico City, DF, Mexico.
   [Perez, Freddy] Panamer Hlth Org, Communicable Dis & Environm Determinants Hlth Dep, Washington, DC USA.
RP Zaidi, MB (corresponding author), Hosp Gen OHoran, Unidad Invest, Av Itzaes X Jacinto Canek, Merida 97000, Yucatan, Mexico.
EM zaidimus@msu.edu; lcedillo@cinvestav.mx; maria.gonzalez@ssy.gob.mx;
   leebeydengue@yahoo.com.mx; fcampos26@hotmail.com;
   namorado93@hotmail.com; perezf@paho.org
RI Perez, Freddy/AAN-3893-2020
FU HRP/TDR/PAHO Joint Small Grants Programme [2017-03-0030]; Fundacion
   Mexicana para la Salud, Capitulo Peninsular; CINVESTAV-IPN
FX This work was supported by the HRP/TDR/PAHO Joint Small Grants Programme
   [Project 2017-03-0030] and intramural funds from the Fundacion Mexicana
   para la Salud, Capitulo Peninsular and the CINVESTAV-IPN.; We wish to
   thank Dr. Leopoldo Flores-Romo for critical review of the manuscript and
   Dr. Martha Valtierra-Rosales, Dr. Karla EscobedoRodriguez and Dr. Yania
   Alvarado-Rodriguez for generously providing the samples from Zacatecas.
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   CHAMPSAUR H, 1988, J CLIN MICROBIOL, V26, P328, DOI 10.1128/JCM.26.2.328-332.1988
   Chanama S, 2004, J CLIN VIROL, V31, P185, DOI 10.1016/j.jcv.2004.03.005
   Corzo-Gomez J., 2019, PROTEIN EXPR PURIF
   Direccion General de Epidemiologia SS, 2016, B EPIDEMIOLOGICO
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pavia-Ruz N, 2018, AM J TROP MED HYG, V98, P1202, DOI 10.4269/ajtmh.17-0382
   Priyamvada L., 2016, PNAS, V113, P785
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tate Jill, 2004, Clin Biochem Rev, V25, P105
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
NR 21
TC 2
Z9 2
U1 2
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JAN
PY 2020
VL 201
AR UNSP 105201
DI 10.1016/j.actatropica.2019.105201
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JS3CL
UT WOS:000500186700008
PM 31562846
OA Bronze
DA 2020-07-08
ER

PT J
AU Fridell, M
   Edwin, S
   von Schreeb, J
   Saulnier, DD
AF Fridell, My
   Edwin, Sanna
   von Schreeb, Johan
   Saulnier, Dell D.
TI Health System Resilience: What Are We Talking About? A Scoping Review
   Mapping Characteristics and Keywords
SO INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT
LA English
DT Review
DE Health System Resilience; Scoping Review; Shocks; Health System
ID ZIKA VIRUS; EBOLA; GOVERNANCE
AB Background: Health systems are based on 6 functions that need to work together at all times to effectively deliver safe and quality health services. These functions are vulnerable to shocks and changes; if a health system is unable to withstand the pressure from a shock, it may cease to function or collapse. The concept of resilience has been introduced with the goal of strengthening health systems to avoid disruption or collapse. The concept is new within health systems research, and no common description exists to describe its meaning. The aim of this study is to summarize and characterize the existing descriptions of health system resilience to improve understanding of the concept.
   Methods and Analysis: A scoping review was undertaken to identify the descriptions and characteristics of health system resilience. Four databases and gray literature were searched using the keywords "health system" and "resilience" for published documents that included descriptions, frameworks or characteristics of health system resilience. Additional documents were identified from reference lists. Four expert consultations were conducted to gain a broader perspective. Descriptions were analysed by studying the frequency of key terms and were characterized by using the World Health Organization (WHO) health system framework. The scoping review identified eleven sources with descriptions and 24 sources that presented characteristics of health system resilience. Frequently used terms that were identified in the literature were shock, adapt, maintain, absorb and respond. Change and learning were also identified when combining the findings from the descriptions, characteristics and expert consultations. Leadership and governance were recognized as the most important building block for creating health system resilience.
   Discussion: No single description of health system resilience was used consistently. A variation was observed on how resilience is described and to what depth it was explained in the existing literature. The descriptions of health system resilience primarily focus on major shocks. Adjustments to long-term changes and the element of learning should be considered for a better understating of health system resilience.
C1 [Fridell, My; Edwin, Sanna; von Schreeb, Johan; Saulnier, Dell D.] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
RP Fridell, M (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
EM myfridell@hotmail.com
OI Saulnier, Dell/0000-0001-7761-0737
CR Abimbola S, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000758
   Alexander DE, 2013, NAT HAZARD EARTH SYS, V13, P2707, DOI 10.5194/nhess-13-2707-2013
   Ammar W, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020704
   [Anonymous], 2016, GLOBAL HLTH RISK FRA, DOI [10.17226/21856, DOI 10.17226/21856]
   [Anonymous], 2013, RES INN HLTH SYST EU
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Baggio JA, 2015, ECOL SOC, V20, DOI 10.5751/ES-07484-200202
   Barasa E, 2018, INT J HEALTH POLICY, V7, P491, DOI 10.15171/ijhpm.2018.06
   Barasa EW, 2017, HEALTH POLICY PLANN, V32, P91, DOI 10.1093/heapol/czx118
   Blanchet K, 2017, INT J HEALTH POLICY, V6, P431, DOI 10.15171/ijhpm.2017.36
   Blanchet K, 2013, INT J HEALTH POLICY, V1, P177, DOI 10.15171/ijhpm.2013.31
   Campbell J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4148
   Castro MC, 2016, HEALTH SYST REFORM, V2, P119, DOI 10.1080/23288604.2016.1179085
   Du Pisani J.A., 2006, ENV SCI, V3, P83, DOI DOI 10.1080/15693430600688831
   European Commission, 2014, COMM COMM EFF ACC RE
   Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002
   Folke C, 2010, ECOL SOC, V15
   Gilson L, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000224
   Godin K, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0125-0
   Haimes YY, 2009, RISK ANAL, V29, P498, DOI 10.1111/j.1539-6924.2009.01216.x
   Haldane V, 2017, LANCET, V389, P1513, DOI 10.1016/S0140-6736(17)30946-7
   Hallegatte S, 2014, EC RESILIENCE DEFINI, DOI [10.1596/1813-9450-6852, DOI 10.1596/1813-9450-6852]
   Hanefeld J, 2018, HEALTH POLICY PLANN, V33, P355, DOI 10.1093/heapol/czx183
   Ho K, 2016, STUD HEALTH TECHNOL, V231, P54, DOI 10.3233/978-1-61499-712-2-54
   Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245
   Hudson CG, 2013, BIOMED RES INT, DOI 10.1155/2013/801614
   Kamal-Yanni M, 2015, NEVER BUILDING RESIL, P38
   Khan FN, 2017, BIOMED PHARMACOTHER, V96, P1513, DOI 10.1016/j.biopha.2017.11.103
   Kieny MP, 2015, LANCET, V385, P91, DOI 10.1016/S0140-6736(14)62479-X
   Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3
   Lama PD, 2017, INT J DISAST RISK RE, V23, P193, DOI 10.1016/j.ijdrr.2017.04.010
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
   Ling EJ, 2017, HEALTH POLICY PLANN, V32, P40, DOI 10.1093/heapol/czx109
   M8 Alliance Kyoto, 2015, M EM CHALL RESP RES
   Martineau FP, 2016, INT HEALTH, V8, P307, DOI 10.1093/inthealth/ihw029
   McKenzie A, 2015, BUILDING RESILIENT H
   Mfutso-Bengo J, 2017, MALAWI MED J, V29, P317, DOI 10.4314/mmj.v29i4.7
   Moore JE, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0637-1
   Musgrove P, 2000, WORLD HLTH REPORT IM
   Olafsdottir AE, 2013, SCAND J PUBLIC HEALT, V41, P198, DOI 10.1177/1403494812470038
   Olmen J. van, 2012, Health, Culture and Society, V2, P1
   Olu O, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00263
   Ozawa S, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1867-7
   Pendall R, 2010, CAMB J REG ECON SOC, V3, P71, DOI 10.1093/cjres/rsp028
   Senkubuge F, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23568
   SHARACHCHANDRA M, 1991, WORLD DEV, V19, P607, DOI DOI 10.1016/0305750X(91)90197P
   Sochas L, 2017, HEALTH POLICY PLANN, V32, P32, DOI 10.1093/heapol/czx108
   Thomas S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-450
   Tomson G, 2014, UPSALA J MED SCI, V119, P117, DOI 10.3109/03009734.2014.902879
   van de Pas R, 2017, HEALTH POLICY PLANN, V32, P88, DOI 10.1093/heapol/czx110
   Viens AM, 2015, PUBLIC HEALTH ETH-UK, V8, P255, DOI 10.1093/phe/phv015
   Walker B., 2004, ECOLOGY SOC, P5, DOI DOI 10.5751/ES-00650-090205
   Witter S, 2017, HEALTH POLICY PLANN, V32, P3, DOI 10.1093/heapol/czx112
   World Health Organization, 2007, EV BUS STRENGTH HLTH
   World Health Organization, 2015, OP FRAM BUILD CLIM R
NR 57
TC 0
Z9 0
U1 7
U2 8
PU KERMAN UNIV MEDICAL SCIENCES
PI KERMAN
PA JAHAD BLVD, KERMAN, 7619813159, IRAN
EI 2322-5939
J9 INT J HEALTH POLICY
JI Int. J. Health Policy Manag.
PD JAN
PY 2020
VL 9
IS 1
BP 6
EP 16
DI 10.15171/ijhpm.2019.71
PG 11
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA JS5QK
UT WOS:000500360400002
PM 31902190
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Huber, C
   Rinner, C
AF Huber, Carmen
   Rinner, Claus
BE Kyriakidis, P
   Hadjimitsis, D
   Skarlatos, D
   Mansourian, A
TI Market Area Delineation for Airports to Predict the Spread of Infectious
   Disease
SO GEOSPATIAL TECHNOLOGIES FOR LOCAL AND REGIONAL DEVELOPMENT
SE Lecture Notes in Geoinformation and Cartography
LA English
DT Proceedings Paper
CT 22nd AGILE Conference on Geographic Information Science
CY JUN 17-20, 2019
CL Limassol, CYPRUS
SP Assoc Geog Informat Labs Europe
DE Airport catchments; Huff model; Infectious disease; Public health;
   Retail geography
ID ZIKA VIRUS; AMERICA; CHOICE; MODEL; SARS; SET
AB Air travel facilitates the international spread of infectious disease. While global air travel data represent the volume of travel between airports, identifying which airport an infected individual might use, or where a disease might spread after an infected passenger deplanes, remains a largely unexplored area of research and public health practice. This gap can be addressed by estimating airport catchment areas. This research aims to determine how existing market area delineation techniques estimate airport catchments differently, and which techniques are best suited to anticipate where infectious diseases may spread. Multiple techniques were tested for airports in the Province of Ontario, Canada: circular buffers, drive-time buffers, Thiessen polygons, and the Huff model, with multiple variations tested for some techniques. The results were compared qualitatively and quantitatively based on spatial patterns as well as area and population of each catchment area. There were notable differences, specifically between deterministic and probabilistic approaches. Deterministic techniques may only be suitable if all airports in a study area are similar in terms of attractiveness. The probabilistic Huff model appeared to produce more realistic results because it accounted for variation in airport attractiveness. Additionally, the Huff model requires few inputs and therefore would be efficient to execute in situations where time, resources, and data are limited.
C1 [Huber, Carmen; Rinner, Claus] Ryerson Univ, Dept Geog & Environm Studies, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
RP Rinner, C (corresponding author), Ryerson Univ, Dept Geog & Environm Studies, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
EM crinner@ryerson.ca
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada
FX Partial funding of this research from the Natural Sciences and
   Engineering Research Council of Canada is gratefully acknowledged.
CR Augustyniak W., 2014, J INT STUDIES, V7, P144, DOI [10.14254/2071-8330.2014/7-3/13, DOI 10.14254/2071-8330.2014/7-3/13]
   Basar G, 2004, TRANSPORT RES B-METH, V38, P889, DOI 10.1016/j.trb.2004.01.001
   Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729
   Bilotkach V, 2012, J REGUL ECON, V42, P73, DOI 10.1007/s11149-011-9172-1
   Bird BH, 2016, ANTIVIR RES, V132, P274, DOI 10.1016/j.antiviral.2016.07.005
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boots B, 1997, J RETAILING, V73, P519, DOI 10.1016/S0022-4359(97)90033-6
   BOOTS BN, 1980, ECON GEOGR, V56, P248, DOI 10.2307/142716
   Brent SE, 2018, B WORLD HEALTH ORGAN, V96, P343, DOI 10.2471/BLT.17.205658
   Centers for Disease Control and Prevention, 2017, S FLOR MAPS
   Cervero R, 1995, BART 20 SERIES RAIL
   Debrezion G, 2009, TRANSPORT RES E-LOG, V45, P270, DOI 10.1016/j.tre.2008.07.001
   Dolega L, 2016, J RETAIL CONSUM SERV, V28, P78, DOI 10.1016/j.jretconser.2015.08.013
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Golnar AJ, 2018, TRANSBOUND EMERG DIS, V65, P85, DOI 10.1111/tbed.12608
   Hatcher MJ, 2012, FUNCT ECOL, V26, P1275, DOI 10.1111/j.1365-2435.2012.02031.x
   Hernandez T, 2004, WHATS TRADE AREA
   Hess S, 2005, J AIR TRANSP MANAG, V11, P59, DOI 10.1016/j.jairtraman.2004.09.001
   Huff D., 1997, APPL GEOGR STUD, V1, P83
   Huff D.L., 2003, ARC USER, P34
   HUFF DL, 1963, LAND ECON, V39, P81, DOI 10.2307/3144521
   Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x
   Leon S., 2011, J TRANSPORT RES FORU, V50, P5, DOI DOI 10.5399/0SU/JTRF.50.2.2711
   Levitt P, 2007, ANNU REV SOCIOL, V33, P129, DOI 10.1146/annurev.soc.33.040406.131816
   Lieshout R, 2012, J TRANSP GEOGR, V25, P27, DOI 10.1016/j.jtrangeo.2012.07.004
   Lin T, 2016, J TRANSP GEOGR, V54, P336, DOI 10.1016/j.jtrangeo.2016.06.011
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   McLay P, 2006, TRANSPORT RES A-POL, V40, P181, DOI 10.1016/j.tra.2005.06.002
   Muller MP, 2006, EUR J CLIN MICROBIOL, V25, P230, DOI 10.1007/s10096-006-0127-x
   Ontario Ministry of Natural Resources, 2010, ONT ROAD NETW SEGM A
   Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0
   Reilly WJ, 1931, LAW RETAIL GRAVITATI
   Sanko N, 2009, 11 C COMP OWN LAND P
   SARS Commission, 2006, SPRING FEAR, V2
   Summers A, 2013, EMERG NURSE, V17, P16
   Suzuki Y, 2007, TRANSPORT RES E-LOG, V43, P1, DOI 10.1016/j.tre.2005.05.005
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Upchurch C., 2004, J TRANSP GEOGR, V1, P23, DOI [DOI 10.1016/J.JTRANGEO.2003.10.001, 10.1016/j.jtrangeo.2003.10.001]
   Wang FH, 2000, PROF GEOGR, V52, P120, DOI 10.1111/0033-0124.00210
   WHO, 2018, EB VIR DIS DEM REP C
   Wittman MD, 2014, ASSESSMENT AIR SERVI
   Yamada I., 2016, INT ENCY GEOGRAPHY, P1, DOI DOI 10.1002/9781118786352.WBIEG0157
NR 43
TC 0
Z9 0
U1 5
U2 8
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1863-2246
EI 1863-2351
BN 978-3-030-14745-7; 978-3-030-14744-0
J9 LECT NOTES GEOINF CA
PY 2020
BP 263
EP 289
DI 10.1007/978-3-030-14745-7_15
PG 27
WC Geography; Remote Sensing
SC Geography; Remote Sensing
GA BO0TW
UT WOS:000493377700015
DA 2020-07-08
ER

PT J
AU Serpa, SC
   de Melo, ACMG
   Lins, OG
   van der Linden, V
   Rolim, E
   dos Santos, ACO
AF Serpa, Sarah Costa
   de Melo, Ana Claudia M. G.
   Gomes Lins, Otavio
   van der Linden, Vanessa
   Leite Rolim Filho, Epitacio
   Oliveira dos Santos, Ana Celia
TI Orthopedic findings in arthrogryposis and congenital Zika syndrome: A
   case series
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE arthrogryposis; clubfoot; congenital anomalies; congenital Zika
   syndrome; talipes
ID VIRUS-INFECTION; ETIOLOGY; UPDATE
AB Background Congenital arthrogryposis (CA) consists of congenital joint contractures that affect at least two joints in different parts of the body. Approximately, 80% of CA cases are neurogenic, with changes to the formation, structure or functioning of the central and/or peripheral nervous systems. Most abnormalities are triggered either by motoneurons decreased activation in the corticospinal tract or by direct motoneurons injury. There had been few reports in the literature correlating congenital infection in humans with arthrogryposis until 2015. CA has recently been described associated with congenital Zika syndrome (CZS). Methods The objective of this study was to investigate and describe accurately the arthrogrypotic alterations in infants diagnosed with CZS and thus, suggest a possible pattern of orthopedic impairment. A total of 198 medical records of infants with CZS were evaluated. According to inclusion and exclusion criteria, 17 infants were included in the present study. Arthrogrypotic joints were orthopedically evaluated in four segments: right, left, upper, and lower limbs. All the four segments were assessed independently. Results Flexed wrists were the most frequently observed manifestation, associated with ulnar deviation (35.29%). Deformities were also commonly found in the third and fourth fingers (64.70%). Hip dislocation was found in 58.82% of the patients and talipes equinovarus and equinovalgus ankles were found in 29.41 and 23.52%. Conclusion There was a particular pattern of joint impairment related to CZS and arthogrypotic alterations of infants evaluated in this study.
C1 [Serpa, Sarah Costa; Gomes Lins, Otavio] SOS Neuro Clin, Dept Pediat Neurol, Recife, PE, Brazil.
   [de Melo, Ana Claudia M. G.] Hosp Restauracao, Dept Pediat Neurol, Recife, PE, Brazil.
   [van der Linden, Vanessa] Hosp Barao Lucena, Dept Pediat Neurol, Recife, PE, Brazil.
   [Leite Rolim Filho, Epitacio] Hosp Getulio Vargas, Dept Pediat Orthoped, Recife, PE, Brazil.
   [Oliveira dos Santos, Ana Celia] Univ Pernambuco, Postgrad Program Hlth Sci, Recife, PE, Brazil.
RP Serpa, SC (corresponding author), SOS Neuro, Dept Pediat Neurol, Rua Gen Joaquim Inacio 830,Emp Plaza,Sala 1810, BR-50070495 Recife, PE, Brazil.
EM sarah_serpa@hotmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil
   (CAPES)CAPES
FX The authors thank to the support of Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior-Brazil (CAPES).
CR Alencar Junior C. A., 1998, REV BRAS GINECOL OBS, V20, P481, DOI [10.1590/S0100-72031998000800009, DOI 10.1590/S0100-72031998000800009]
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Almeida Saulo Fontes, 2014, Rev. bras. ortop., V49, P134, DOI 10.1016/j.rboe.2014.03.002
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Aucourt J, 2012, SEMIN MUSCULOSKEL R, V16, P146, DOI 10.1055/s-0032-1311766
   Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281
   Bevan WP, 2007, J PEDIATR ORTHOPED, V27, P594, DOI 10.1097/BPO.0b013e318070cc76
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Rocha NACF, 2017, INFANT BEHAV DEV, V49, P70, DOI 10.1016/j.infbeh.2017.07.002
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   Del Carpio-Orantes Luis, 2019, J Matern Fetal Neonatal Med, P1, DOI 10.1080/14767058.2019.1582627
   Dimitraki M, 2011, J MATERN-FETAL NEO M, V24, P32, DOI 10.3109/14767058.2010.482615
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Gibbons PJ, 2013, J PAEDIATR CHILD H, V49, pE434, DOI 10.1111/jpc.12167
   Guarniero Roberto, 2010, Rev. bras. ortop., V45, P116, DOI [10.1016/S2255-4971(15)30279-2, 10.1590/S0102-36162010000200002]
   Gupta Babita, 2014, Acta Anaesthesiol Taiwan, V52, P88, DOI 10.1016/j.aat.2014.04.003
   Haaker G, 2013, APPL CLIN GENET, V6, P113, DOI 10.2147/TACG.S53615
   Hall JG, 2016, MOL SYNDROMOL, V7, P101, DOI 10.1159/000446617
   Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008
   Hermanson M., 2017, PREVENTION HIP DISLO
   Jones RM, 2008, RESP MED CME, V1, P219
   Kalampokas Emmanouil, 2012, ISRN Obstet Gynecol, V2012, P264918, DOI 10.5402/2012/264918
   Konstantinidou A, 2007, J MED VIROL, V79, P754, DOI 10.1002/jmv.20887
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Pavone V, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0913-z
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seringe R, 2014, ORTHOP TRAUMATOL-SUR, V100, P59, DOI 10.1016/j.otsr.2013.12.006
   Skaria P, 2019, J MATERN-FETAL NEO M, V32, P502, DOI 10.1080/14767058.2017.1381683
   Sucuoglu H, 2015, CASE REP MED, DOI 10.1155/2015/379730
   Tse R., 2014, CONGENIT ANOM, P209
   Valdes-Flores M, 2016, J PEDIAT-BRAZIL, V92, P58, DOI 10.1016/j.jped.2015.04.008
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 35
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAR
PY 2020
VL 112
IS 5
BP 385
EP 392
DI 10.1002/bdr2.1641
EA DEC 2019
PG 8
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA KS8ZD
UT WOS:000504934300001
PM 31891236
DA 2020-07-08
ER

PT J
AU Braz-De-Melo, HA
   Pasquarelli-do-Nascimento, G
   Correa, R
   Almeida, RD
   Santos, ID
   Prado, PS
   Picolo, V
   de Bem, AF
   Pizato, N
   Magalhaes, KG
AF Braz-De-Melo, Heloisa Antoniella
   Pasquarelli-do-Nascimento, Gabriel
   Correa, Rafael
   Almeida, Raquel das Neves
   Santos, Igor de Oliveira
   Prado, Paulo Sousa
   Picolo, Victor
   de Bem, Andreza Fabro
   Pizato, Nathalia
   Magalhaes, Kelly Grace
TI Potential neuroprotective and anti-inflammatory effects provided by
   omega-3 (DHA) against Zika virus infection in human SH-SY5Y cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DOCOSAHEXAENOIC ACID; STEM-CELLS; BRAIN; OMEGA-3-FATTY-ACIDS;
   INFLAMMATION; APOPTOSIS; RETINA; IMPACT
AB Zika virus (ZIKV) has a strong tropism for the nervous system and has been related to post-infection neurological syndromes. Once neuronal cells are infected, the virus is capable of modulating cell metabolism, leading to neurotoxicity and cellular death. The negative effect of ZIKV in neuron cells has been characterized. However, the description of molecules capable of reversing these cytotoxic effects is still under investigation. In this context, it has been largely demonstrated that docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid, is highly neuroprotective. Here, we hypothesized that DHA's neuroprotective proprieties could have an influence on ZIKV-induced neurotoxicity in SH-SY5Y cells. Our data showed that pre-treatment of SH-SY5Y cells with DHA increased the cell viability and proliferation in ZIKV-infected cells. Moreover, DHA triggered an anti-inflammatory response in those infected cells. Besides, DHA was capable of restoring mitochondria function and number in ZIKV-infected SH-SY5Y cells. In addition, cells pre-treated with DHA prior to ZIKV infection presented a lower viral load at different times of infection. Taking together, these results demonstrated that DHA has a potential anti-inflammatory and neuroprotective effect against ZIKV infection in these neuron-like cells and could be a useful tool in the treatment against this virus.
C1 [Braz-De-Melo, Heloisa Antoniella; Pasquarelli-do-Nascimento, Gabriel; Correa, Rafael; Almeida, Raquel das Neves; Santos, Igor de Oliveira; Magalhaes, Kelly Grace] Univ Brasilia UnB, Dept Cell Biol, Lab Immunol & Inflammat, BR-70910900 Brasilia, DF, Brazil.
   [Prado, Paulo Sousa] Cent Lab Fed Dist LACEN, BR-70830010 Brasilia, DF, Brazil.
   [Picolo, Victor; de Bem, Andreza Fabro] Univ Brasilia UnB, Dept Physiol Sci, BR-70910900 Brasilia, DF, Brazil.
   [Pizato, Nathalia] Univ Brasilia UnB, Dept Nutr, BR-70910900 Brasilia, DF, Brazil.
RP Magalhaes, KG (corresponding author), Univ Brasilia UnB, Dept Cell Biol, Lab Immunol & Inflammat, BR-70910900 Brasilia, DF, Brazil.
EM kellymagalhaes@unb.br
RI ; Magalhaes, Kelly Grace/A-6966-2010
OI Fabro de Bem, Andreza/0000-0003-1090-5244; Braz de Melo, Heloisa
   Antoniella/0000-0003-3327-4633; Magalhaes, Kelly
   Grace/0000-0002-7435-5272; Correa, Rafael/0000-0003-2989-2383; Pizato,
   Nathalia/0000-0001-5858-7076
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [312359/2016-0]; Fundacao de Amparo a Pesquisa do Distrito
   Federal (FapDF/PPSUS) [193.001.621/2016]; Welcome TrustWellcome Trust
   [24076*1*014]
FX We would like to thank our financial support provided by National
   Council for Scientific and Technological Development (CNPq
   #312359/2016-0), Fundacao de Amparo a Pesquisa do Distrito Federal
   (FapDF/PPSUS #193.001.621/2016) and Welcome Trust (24076*1*014).
CR Agapite J., 2009, AM PHYS SOC, V98, P813
   Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531
   Alpuche-Lazcano S. P., 2018, VIRUSES, V10, P1
   Anil E, 2007, P NUTR SOC, V66, P60, DOI 10.1017/S0029665107005307
   Bazan NG, 2005, BRAIN PATHOL, V15, P159
   Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030
   Bazan NG, 2013, NESTLE NUTR WORKS SE, V77, P121, DOI 10.1159/000351395
   Bennett M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0035-2016
   Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355
   Croset M., 1996, AM SOC CLI NUT, V64, P577
   Culshaw A., 2018, F1000RESEARCH, V7, P1
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Du XL, 2015, MOL MED REP, V12, P953, DOI 10.3892/mmr.2015.3482
   Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052
   Florent S, 2006, J NEUROCHEM, V96, P385, DOI 10.1111/j.1471-4159.2005.03541.x
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Husson M., 2016, J INFECTION, V4453, P1
   Jones G. J. B., 2017, SCI REPORTS, V159, P1
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kim HY, 2014, MIL MED, V179, P106, DOI 10.7205/MILMED-D-14-00162
   Kim Hee-Young, 2010, PROSTAGLANDINS LEUKO, V5, P379
   Kim HY, 2003, LIPIDS, V38, P453, DOI 10.1007/s11745-003-1083-z
   Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Leonelli M, 2011, BRAZ J MED BIOL RES, V44, P1088, DOI [10.1590/S0100-879X2011007500124, 10.1590/S0100-879X2011001100003]
   Li GB, 2017, J LIPID RES, V58, P1080, DOI [10.1194/jlr.m072587, 10.1194/jlr.M072587]
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Losev Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39218-x
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Luplertlop N, 2017, J VECTOR DIS, V54, P207, DOI 10.4103/0972-9062.217611
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Muench Reed, 2018, AM J HYG, V27, P493
   Ojha CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02340
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Prado PS, 2018, MEM I O CRUZ, V113, P1
   Querques G, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/748361
   Quicke KM, 2013, VIRUSES-BASEL, V5, P2643, DOI 10.3390/v5112643
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Sakai C., 2017, PLOS ONE, V12, P1
   Souza B. S. F., 2016, SCI REPORTS, V6, P1
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Suphioglu C, 2010, FEBS LETT, V584, P612, DOI 10.1016/j.febslet.2009.12.013
   Xicoy H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0149-0
   Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015
NR 49
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 27
PY 2019
VL 9
AR 20119
DI 10.1038/s41598-019-56556-y
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KF6GA
UT WOS:000509337000027
PM 31882804
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fernandes, RS
   Bersot, MI
   Castro, MG
   Telleria, EL
   Ferreira-de-Brito, A
   Raphael, LM
   Bonaldo, MC
   Lourenco-de-Oliveira, R
AF Fernandes, Rosilainy S.
   Bersot, Maria I.
   Castro, Marcia G.
   Telleria, Erich Loza
   Ferreira-de-Brito, Anielly
   Raphael, Lidiane M.
   Bonaldo, Myrna C.
   Lourenco-de-Oliveira, Ricardo
TI Low vector competence in sylvatic mosquitoes limits Zika virus to
   initiate an enzootic cycle in South America
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INFECTION; TRANSMISSION; EMERGENCE; OUTBREAK; HISTORY; BRAZIL; ISLAND
AB Zika virus (ZIKV) has spread in the Americas since 2015 and the potential establishment of a sylvatic transmission cycle in the continent has been hypothesized. We evaluated vector competence of five sylvatic Neotropical mosquito species to two ZIKV isolates. Distinct batches of Haemagogus leucoceleanus, Sabethes albiprivus, Sabethes identicus, Aedes terrens and Aedes scapularis females were respectively orally challenged and inoculated intrathoracically with ZIKV. Orally challenged mosquitoes were refractory or exhibited low infection rates. Viral dissemination was detected only in Hg. leucocelaenus, but with very low rates. Virus was not detected in saliva of any mosquito orally challenged with ZIKV, regardless of viral isolate and incubation time. When intrathoracically injected, ZIKV disseminated in high rates in Hg. leucocelaenus, Sa. identicus and Sa. albpiprivus, but low transmission was detected in these species; very low dissemination and no transmission was detected in Ae. terrens and Ae. scapularis. Together these results suggest that genetically determined tissue barriers, especially in the midgut, play a vital role in inhibiting ZIKV for transmission in the tested sylvatic mosquito species. Thus, an independent enzootic transmission cycle for ZIKV in South America is very unlikely.
C1 [Fernandes, Rosilainy S.; Bersot, Maria I.; Castro, Marcia G.; Ferreira-de-Brito, Anielly; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Telleria, Erich Loza] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, Rio De Janeiro, Brazil.
   [Raphael, Lidiane M.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Telleria, Erich Loza] Charles Univ Prague, Fac Sci, Dept Parasitol, Vinicna 7, CR-12844 Prague 2, Czech Republic.
RP Lourenco-de-Oliveira, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM lourenco@ioc.fiocruz.br
RI Telleria, Erich L/F-1580-2015
OI Telleria, Erich L/0000-0003-0006-0057; Lourenco-de-Oliveira,
   Ricardo/0000-0003-0423-5694
CR Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Amraoui F, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006997
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Espinal MA, 2019, AM J PUBLIC HEALTH, V109, P387, DOI 10.2105/AJPH.2018.304849
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gerberg EJ, 1970, AM MOSQ CONTROL ASS, V5, P109
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Karna AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080434
   LOURENCODEOLIVEIRA, 2017, PLOS NEGLECT TROP D, V11, DOI DOI 10.1371/JOURNAL.PNTD.0005698
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Obara MT, 2012, EPIDEMIOL SERV SAUDE, V21, P457, DOI 10.5123/S1679-49742012000300011
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Terzian ACB, 2017, EMERG INFECT DIS, V23, P1891, DOI 10.3201/eid2311.170078
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 3
Z9 3
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 27
PY 2019
VL 9
AR 20151
DI 10.1038/s41598-019-56669-4
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KF6HI
UT WOS:000509340400030
PM 31882976
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Avila-Perez, G
   Nogales, A
   Park, JG
   Marquez-Jurado, S
   Iborra, FJ
   Almazan, F
   Martinez-Sobrido, L
AF Avila-Perez, Gines
   Nogales, Aitor
   Park, Jun-Gyu
   Marquez-Jurado, Silvia
   Iborra, Francisco J.
   Almazan, Fernando
   Martinez-Sobrido, Luis
TI A natural polymorphism in Zika virus NS2A protein responsible of
   virulence in mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; IN-VITRO; NONSTRUCTURAL PROTEINS; MOUSE MODEL;
   INFECTION; TRANSMISSION; APOPTOSIS; OUTBREAK; MUTATIONS; INDUCTION
AB Zika virus (ZIKV) infection is currently one of the major concerns in human public health due to its association with neurological disorders. Intensive effort has been implemented for the treatment of ZIKV, however there are not currently approved vaccines or antivira Is available to combat ZIKV infection. In this sense, the identification of virulence factors associated with changes in ZIKV virulence could help to develop safe and effective countermeasures to treat ZIKV or to prevent future outbreaks. Here, we have compared the virulence of two related ZIKV strains from the recent outbreak in Brazil (2015), Rio Grande do Norte Natal (RGN) and Paraiba. In spite of both viruses being identified in the same period of time and region, significant differences in virulence and replication were observed using a validated mouse model of ZIKV infection. While ZIKV-RGN has a 50% mouse lethal dose (MLD50) of similar to 10(5) focus forming units (FFUs), ZIKV-Paraiba infection resulted in 100% of lethality with less than 10 FFUs. Combining deep-sequencing analysis and our previously described infectious ZIKV-RGN cDNA clone, we identified a natural polymorphism in the non-structural protein 2A (NS2A) that increase the virulence of ZIKV. Moreover, results demonstrate that the single amino acid a lanine to valine substitution at position 117 (A117V) in the NS2A was sufficient to convert the attenuated rZIKV-RGN in a virulent Paraiba-like virus (MLD50 < 10 FFU). The mechanism of action was also evaluated and data indicate that substitution A117V in ZIKV NS2A protein reduces host innate immune responses and viral-induced apoptosis in vitro. Therefore, amino acid substitution A117V in ZIKV NS2A could be used as a genetic risk-assessment marker for future ZIKV outbreaks.
C1 [Avila-Perez, Gines; Nogales, Aitor; Park, Jun-Gyu; Martinez-Sobrido, Luis] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.
   [Nogales, Aitor] INIA CISA, Ctr Anim Hlth Res, Madrid 28130, Spain.
   [Marquez-Jurado, Silvia; Iborra, Francisco J.; Almazan, Fernando] Univ Autonoma Madrid, CSIC, CNB, Dept Mol & Cell Biol, 3 Darwin St, E-28049 Madrid, Spain.
RP Martinez-Sobrido, L (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.; Almazan, F (corresponding author), Univ Autonoma Madrid, CSIC, CNB, Dept Mol & Cell Biol, 3 Darwin St, E-28049 Madrid, Spain.
EM falmazan@cnb.csic.es; luis_martinez@urmc.rochester.edu
OI NOGALES, AITOR/0000-0002-2424-7900; iborra,
   francisco/0000-0002-0692-3696
FU National Institute of Allergy and Infectious Disease (NIAID), National
   Institute of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21 AI130500]; Spanish
   Ministry of Economy and Competitiveness (MINECO) [BFU2016-79127-R]
FX We are grateful to Stephen Dewhurst (University of Rochester Medical
   Center) for providing the ZIKV-Paraiba. We thank Snezhana Dimitrova for
   technical assistance in the mouse care and maintenance. This research
   project was funded by the National Institute of Allergy and Infectious
   Disease (NIAID), National Institute of Health (NIH) (grant number R21
   AI130500) to L. M.-S. and F. A. and the Spanish Ministry of Economy and
   Competitiveness (MINECO) (grant number BFU2016-79127-R) to FAT.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   AVILAPEREZ G, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10110597
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Council NR, 2011, GUIDE CARE USE LAB A
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DeDiego ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002315
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Friedrich MJ, 2017, JAMA-J AM MED ASSOC, V317, P246, DOI 10.1001/jama.2016.20447
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Itoh M, 1998, J VIROL, V72, P2927, DOI 10.1128/JVI.72.4.2927-2934.1998
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marquez-Jurado S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100547
   Martinez-Sobrido L, 2016, METHODS MOL BIOL, V1403, P313, DOI 10.1007/978-1-4939-3387-7_17
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Nogales A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010020
   Oehler E., 2013, EURO SURVEILL, V19
   Ojosnegros S, 2011, VIRUS RES, V162, P203, DOI 10.1016/j.virusres.2011.09.018
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Partidos CD, 2011, VACCINE, V29, P3067, DOI 10.1016/j.vaccine.2011.01.076
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Rossi SL, 2007, VIROLOGY, V364, P184, DOI 10.1016/j.virol.2007.02.009
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Taylor G, 2014, J GEN VIROL, V95, P1244, DOI 10.1099/vir.0.064931-0
   Tham HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01040
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 85
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 27
PY 2019
VL 9
AR 19968
DI 10.1038/s41598-019-56291-4
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KG1DY
UT WOS:000509683000001
PM 31882898
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zani, A
   Zhang, LZ
   McMichael, TM
   Kenney, AD
   Chemudupati, M
   Kwiek, JJ
   Liu, SL
   Yount, JS
AF Zani, Ashley
   Zhang, Lizhi
   McMichael, Temet M.
   Kenney, Adam D.
   Chemudupati, Mahesh
   Kwiek, Jesse J.
   Liu, Shan-Lu
   Yount, Jacob S.
TI Interferon-induced transmembrane proteins inhibit cell fusion mediated
   by trophoblast syncytins
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE interferon; virus; trophoblast; membrane fusion; fusion protein; IFITM;
   IFITM1; IFITM2; IFITM3; influenza virus; restriction factor; Zika virus;
   interferon-induced transmembrane protein; syncytin; placenta; cell
   fusion
ID IN-VITRO DEVELOPMENT; ZIKA VIRUS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION;
   HERV-W; GLYCOPROTEIN; EXPRESSION; PROTECTION; RESISTANCE; INFECTION
AB Type I interferon (IFN) induced by virus infections during pregnancy can cause placental damage, but the mechanisms and identities of IFN-stimulated genes that are involved in this damage remain under investigation. The IFN-induced transmembrane proteins (IFITMs) inhibit virus infections by preventing virus membrane fusion with cells and by inhibiting fusion of infected cells (syncytialization). Fusion of placental trophoblasts via expression of endogenous retroviral fusogens known as syncytins forms the syncytiotrophoblast, a multinucleated cell structure essential for fetal development. We found here that IFN blocks fusion of BeWo human placental trophoblasts. Stably expressed IFITM1, -2, and -3 also blocked fusion of these trophoblasts while making them more resistant to virus infections. Conversely, stable IFITM knockdowns in BeWo trophoblasts increased their spontaneous fusion and allowed fusion in the presence of IFN while also making the cells more susceptible to virus infection. We additionally found that exogenous expression of IFITMs in HEK293T cells blocked fusion with cells expressing syncytin-1 or syncytin-2, confirming the ability of IFITMs to block individual syncytin-mediated fusion. Overall, our data indicate that IFITMs inhibit trophoblast fusion and suggest that there may be a critical balance between these antifusogenic effects and the beneficial antiviral effects of IFITMs in virus infections during pregnancy.
C1 [Zani, Ashley; Zhang, Lizhi; McMichael, Temet M.; Kenney, Adam D.; Chemudupati, Mahesh; Yount, Jacob S.] Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,BRT 790, Columbus, OH 43210 USA.
   [Kwiek, Jesse J.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.
   [Liu, Shan-Lu] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.
   [Zani, Ashley; Zhang, Lizhi; McMichael, Temet M.; Kenney, Adam D.; Chemudupati, Mahesh; Kwiek, Jesse J.; Liu, Shan-Lu; Yount, Jacob S.] Ohio State Univ, Infect Dis Inst, Columbus, OH 43210 USA.
RP Yount, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,BRT 790, Columbus, OH 43210 USA.
EM jacob.yount@osumc.edu
OI Kwiek, Jesse/0000-0003-4277-8315
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI130110, AI142256,
   AI112542]; National Science Foundation Graduate Research Fellowship
   ProgramNational Science Foundation (NSF); NIGMS, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM068412]
FX This work was supported by National Institutes of Health Grants AI130110
   and AI142256 (to J. S. Y.). The authors declare that they have no
   conflicts of interest with the contents of this article. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.;
   Supported by the National Science Foundation Graduate Research
   Fellowship Program.; Supported by National Institutes of Health Training
   Grant AI112542 administered by the Ohio State University Infectious
   Diseases Institute.; Supported by NIGMS, National Institutes of Health,
   Training Grant GM068412 administered by the Ohio State University
   Biomedical Sciences Graduate Program.
CR Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/NCHEMBIO.1982, 10.1038/nchembio.1982]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100
   Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000
   Borges M, 2003, PLACENTA, V24, P959, DOI 10.1016/S0143-4004(03)00173-5
   Buchrieser J, 2019, SCIENCE, V365, P176, DOI 10.1126/science.aaw7733
   Cameo M, 1999, HUM REPROD, V14, P959, DOI 10.1093/humrep/14.4.959
   Casazza RL, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3446
   Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765
   Chesarino NM, 2017, EMBO REP, V18, P1740, DOI 10.15252/embr.201744100
   Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095
   Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   COUTIFARIS C, 1991, DEVELOPMENT, V113, P767
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108
   Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106
   Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003
   Gauster M, 2010, PLACENTA, V31, P82, DOI 10.1016/j.placenta.2009.12.007
   Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011
   Gresser I, 1980, Ann N Y Acad Sci, V350, P12, DOI 10.1111/j.1749-6632.1980.tb20602.x
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Ihara Toshio, 1999, Congenital Anomalies, V39, P223, DOI 10.1111/j.1741-4520.1999.tb00562.x
   Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12
   Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029
   Kudo Y, 2002, PLACENTA, V23, P536, DOI 10.1053/plac.2002.0839
   Lavialle C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0507
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033
   McMichael TM, 2018, J INFECT DIS, V218, P1582, DOI 10.1093/infdis/jiy361
   McMichael TM, 2017, J BIOL CHEM, V292, P21517, DOI 10.1074/jbc.M117.800482
   Melvin WJ, 2015, VIRUSES-BASEL, V7, P3035, DOI 10.3390/v7062759
   Mi S, 2000, NATURE, V403, P785
   Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345
   Ozog S, 2019, BLOOD, V134, P1298, DOI 10.1182/blood.2019000040
   Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Shi GL, 2018, P NATL ACAD SCI USA, V115, pE10069, DOI 10.1073/pnas.1811892115
   Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321
   Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095
   Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]
   Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055
   ZUSMAN I, 1984, TERATOLOGY, V29, P405, DOI 10.1002/tera.1420290311
NR 46
TC 3
Z9 3
U1 8
U2 9
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 27
PY 2019
VL 294
IS 52
BP 19844
EP 19851
DI 10.1074/jbc.AC119.010611
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JZ3MK
UT WOS:000505005800002
PM 31735710
DA 2020-07-08
ER

PT J
AU Avelino-Silva, VI
   Mayaud, P
   Tami, A
   Miranda, MC
   Rosenberger, KD
   Alexander, N
   Nacul, L
   Segurado, A
   Pohl, M
   Bethencourt, S
   Villar, LA
   Viana, IFT
   Rabello, R
   Soria, C
   Salgado, SP
   Gotuzzo, E
   Guzman, MG
   Martinez, PA
   Lopez-Gatell, H
   Hegewisch-Taylor, J
   Borja-Aburto, VH
   Gonzalez, C
   Netto, EM
   Villarroel, PMS
   Hoen, B
   Brasil, P
   Marques, ETA
   Rockx, B
   Koopmans, M
   de Lamballerie, X
   Jaenisch, T
   Jaenisch, T
   Rosenberger, KD
   Morales, I
   Tobian, F
   Uhlmann, L
   Pohl, M
   Schretzmann, J
   Leege, A
   Marques, ETA
   Marques, ETA
   Viana, IFT
   Lins, RD
   de Filippis, AMB
   Duarte, ACM
   Espindola, OD
   Bonaldo, M
   Rabello, R
   Damasceno, L
   Mendes-Correa, MC
   Mayaud, P
   Nacul, L
   Alexander, N
   Netto, EM
   Tami, A
   Bethencourt, S
   Tinedo, MJ
   La Rosa, Y
   Murillo, M
   Villar, LA
   Miranda, MC
   Lozano, A
   Herrera, VM
   Gomez, A
   Gelvez, RM
   Ortiz, R
   Herrera, VM
   Soria, C
   Dimitrakis, L
   Salgado, SP
   Arrata, MR
   Gotuzzo, E
   Allison, HG
   Talledo, M
   Villarroel, PMS
   Torres, EM
   Guzman, MG
   Rodriguez, PAM
   Vera, MA
   Santana, BG
   Reyes, A
   Alvarez, SS
   Dorticos, DF
   Hegewisch-Taylor, J
   Alpuche-Aranda, C
   Lopez-Gatell, H
   Gonzalez-Diaz, E
   Pavia-Ruz, N
   Borja-Aburto, VH
   Gonzalez, C
   Grajales, C
   Rojas, T
   Arriaga, L
   Vallejos, A
   Tynevez, D
   Thirion, L
   Drexler, JF
   Rockx, B
   van Gorp, E
   Koopmans, M
AF Avelino-Silva, Vivian I.
   Mayaud, Philippe
   Tami, Adriana
   Miranda, Maria C.
   Rosenberger, Kerstin D.
   Alexander, Neal
   Nacul, Luis
   Segurado, Aluisio
   Pohl, Moritz
   Bethencourt, Sarah
   Villar, Luis A.
   Viana, Isabelle F. T.
   Rabello, Renata
   Soria, Carmen
   Salgado, Silvia P.
   Gotuzzo, Eduardo
   Guzman, Maria G.
   Martinez, Pedro A.
   Lopez-Gatell, Hugo
   Hegewisch-Taylor, Jennifer
   Borja-Aburto, Victor H.
   Gonzalez, Cesar
   Netto, Eduardo M.
   Villarroel, Paola M. Saba
   Hoen, Bruno
   Brasil, Patricia
   Marques, Ernesto T. A.
   Rockx, Barry
   Koopmans, Marion
   de Lamballerie, Xavier
   Jaenisch, Thomas
   Jaenisch, Thomas
   Rosenberger, Kerstin Daniela
   Morales, Ivonne
   Tobian, Frank
   Uhlmann, Lorenz
   Pohl, Moritz
   Schretzmann, Julius
   Leege, Annika
   Marques, Ernesto T. A.
   Marques, Ernesto T. A.
   Viana, Isabelle F. T.
   Lins, Roberto D.
   Bispo de Filippis, Ana Maria
   Machado Duarte, Ana Claudia
   Espindola, Otavio de Melo
   Bonaldo, Myrna
   Rabello, Renata
   Damasceno, Luana
   Mendes-Correa, Maria Cassia
   Mayaud, Philippe
   Nacul, Luis
   Alexander, Neal
   Netto, Eduardo Martins
   Tami, Adriana
   Bethencourt, Sarah
   Tinedo, Maria Jose
   La Rosa, Yenifer
   Murillo, Marianela
   Angel Villar, Luis
   Consuelo Miranda, Maria
   Lozano, Anyela
   Mauricio Herrera, Victor
   Gomez, Adriana
   Margarita Gelvez, Rosa
   Ortiz, Ricardo
   Mauricio Herrera, Victor
   Soria, Carmen
   Dimitrakis, Lady
   Paola Salgado, Silvia
   Regato Arrata, Mary
   Gotuzzo, Eduardo
   Guerra Allison, Humberto
   Talledo, Michael
   Saba Villarroel, Paola Mariela
   Torres, Eric Martinez
   Guzman, Maria G.
   Martinez Rodriguez, Pedro A.
   Alvarez Vera, Mayling
   Galindo Santana, Belkis
   Reyes, Alicia
   Serrano Alvarez, Silvia
   Ferriol Dorticos, Diana
   Hegewisch-Taylor, Jennifer
   Alpuche-Aranda, Celia
   Lopez-Gatell, Hugo
   Gonzalez-Diaz, Esteban
   Pavia-Ruz, Norma
   Hugo Borja-Aburto, Victor
   Gonzalez, Cesar
   Grajales, Concepcion
   Rojas, Teresita
   Arriaga, Lumumba
   Vallejos, Alfonso
   Tynevez, Dominique
   Thirion, Laurence
   Drexler, Jan Felix
   Rockx, Barry
   van Gorp, Eric
   Koopmans, Marion
CA ZIKAlliance Clinical Study Grp
TI Study protocol for the multicentre cohorts of Zika virus infection in
   pregnant women, infants, and acute clinical cases in Latin America and
   the Caribbean: the ZIKAlliance consortium
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Pregnant women; Children; Cohort; Latin America; Caribbean; Risk;
   Congenital abnormalities; Natural history; Arboviruses; Mosquito-borne
   viruses; Vector-borne viruses
ID EXTERNAL QUALITY ASSESSMENT; GUILLAIN-BARRE-SYNDROME; BIRTH-DEFECTS;
   SEXUAL TRANSMISSION; MOLECULAR-DETECTION; BRAZIL; EPIDEMIC;
   LABORATORIES; TERRITORIES; OUTCOMES
AB Background: The European Commission (EC) Horizon 2020 (H2020)-funded ZIKAlliance Consortium designed a multicentre study including pregnant women (PW), children (CH) and natural history (NH) cohorts. Clinical sites were selected over a wide geographic range within Latin America and the Caribbean, taking into account the dynamic course of the ZIKV epidemic.
   Methods: Recruitment to the PW cohort will take place in antenatal care clinics. PW will be enrolled regardless of symptoms and followed over the course of pregnancy, approximately every 4 weeks. PW will be revisited at delivery (or after miscarriage/abortion) to assess birth outcomes, including microcephaly and other congenital abnormalities according to the evolving definition of congenital Zika syndrome (CZS). After birth, children will be followed for 2 years in the CH cohort. Follow-up visits are scheduled at ages 1-3, 4-6, 12, and 24 months to assess neurocognitive and developmental milestones. In addition, a NH cohort for the characterization of symptomatic rash/fever illness was designed, including follow-up to capture persisting health problems.
   Blood, urine, and other biological materials will be collected, and tested for ZIKV and other relevant arboviral diseases (dengue, chikungunya, yellow fever) using RT-PCR or serological methods. A virtual, decentralized biobank will be created. Reciprocal clinical monitoring has been established between partner sites. Substudies of ZIKV seroprevalence, transmission clustering, disabilities and health economics, viral kinetics, the potential role of antibody enhancement, and co-infections will be linked to the cohort studies.
   Discussion: Results of these large cohort studies will provide better risk estimates for birth defects and other developmental abnormalities associated with ZIKV infection including possible co-factors for the variability of risk estimates between other countries and regions. Additional outcomes include incidence and transmission estimates of ZIKV during and after pregnancy, characterization of short and long-term clinical course following infection and viral kinetics of ZIKV.
C1 [Jaenisch, Thomas; Rosenberger, Kerstin Daniela; Morales, Ivonne; Tobian, Frank; Uhlmann, Lorenz; Pohl, Moritz; Schretzmann, Julius; Leege, Annika] Univ Heidelberg Hosp, Heidelberg, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Viana, Isabelle F. T.; Lins, Roberto D.; Bispo de Filippis, Ana Maria; Machado Duarte, Ana Claudia; Espindola, Otavio de Melo; Bonaldo, Myrna; Rabello, Renata; Damasceno, Luana] Aggeu Magalhaes Inst, Oswaldo Cruz Fdn, Recife, PE, Brazil.
   [Avelino-Silva, Vivian I.; Segurado, Aluisio; Angel Villar, Luis; Consuelo Miranda, Maria] Univ Sao Paulo, Sao Paulo, Brazil.
   [Mayaud, Philippe; Alexander, Neal; Angel Villar, Luis] LSHTM, London, England.
   [Gotuzzo, Eduardo] Fed Univ Bahia UFB, Salvador, BA, Brazil.
   [Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Marques, Ernesto T. A.] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Tami, Adriana] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Consuelo Miranda, Maria; Lozano, Anyela] Ciudad Hosp Enrique Tejera, Valencia, Spain.
   [La Rosa, Yenifer] Ctr Policlin Valencia Vina, Lab Clin Vina, Valencia, Venezuela.
   [Murillo, Marianela] Inst Especialidades Quirurg Ios Mangos, Valencia, Venezuela.
   [Angel Villar, Luis; Consuelo Miranda, Maria; Lozano, Anyela; Mauricio Herrera, Victor; Gomez, Adriana; Margarita Gelvez, Rosa] Univ Ind Santander, Bucaramanga, Colombia.
   [Ortiz, Ricardo; Mauricio Herrera, Victor] Univ Autonoma Bucaramanga UNAB Hosp Local Norte I, Bucaramanga, Colombia.
   [Soria, Carmen; Dimitrakis, Lady] Univ Catolica Santiago Guayaquil, SOSECALI C Ltda, Guayaquil, Ecuador.
   [Paola Salgado, Silvia; Regato Arrata, Mary] Inst Nacl Invest Salud Publ Dr Leopoldo Izquieta, Guayaquil, Ecuador.
   [Gotuzzo, Eduardo; Guerra Allison, Humberto; Talledo, Michael] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Humboldt, Humboldt, Germany.
   [Saba Villarroel, Paola Mariela] Ctr Nacl Enfermedades Trop CENETROP, Santa Cruz, CA, Bolivia.
   [Torres, Eric Martinez; Guzman, Maria G.; Martinez Rodriguez, Pedro A.; Alvarez Vera, Mayling; Galindo Santana, Belkis; Reyes, Alicia; Serrano Alvarez, Silvia] Pedro Kouri Trop Med Inst IPK, Havana, Cuba.
   [Ferriol Dorticos, Diana] MINSAP, Secc Materno Infantil, Cienfuegos, Cuba.
   [Hegewisch-Taylor, Jennifer; Alpuche-Aranda, Celia; Lopez-Gatell, Hugo] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas Inst, Cuernavaca, Morelos, Mexico.
   [Gonzalez-Diaz, Esteban] Hosp Civil Guadalajara, Unidad Vigilancia Epidemiol Hosp Med Prevent, Fray Antonio Alcalde O P, Mexico.
   [Pavia-Ruz, Norma] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Mexico City, DF, Mexico.
   [Gonzalez, Cesar; Grajales, Concepcion; Rojas, Teresita; Arriaga, Lumumba; Vallejos, Alfonso; Tynevez, Dominique] INSERM, Concepcion, Chile.
   [de Lamballerie, Xavier; Thirion, Laurence] AixMarseille Univ, Inserm 1207, INSERM Gouadelo, IRD 190,Unite Virus Emergents, Marseille, France.
   [Drexler, Jan Felix] Charite Univ Med Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Rockx, Barry; van Gorp, Eric; Koopmans, Marion] Erasmus MC, Rotterdam, Netherlands.
   [Avelino-Silva, Vivian I.; Segurado, Aluisio] Univ Sao Paulo, Fac Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil.
   [Avelino-Silva, Vivian I.; Segurado, Aluisio] Univ Sao Paulo, Fac Med, Inst Med Trop, Sao Paulo, Brazil.
   [Avelino-Silva, Vivian I.] Hosp Sirio Libanes, Sao Paulo, Brazil.
   [Mayaud, Philippe; Alexander, Neal; Nacul, Luis] London Sch Hyg & Trop Med, London, England.
   [Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Tami, Adriana; Bethencourt, Sarah] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Miranda, Maria C.; Villar, Luis A.] Univ Ind Santander, Bucaramanga, Colombia.
   [Rosenberger, Kerstin D.; Jaenisch, Thomas] Heidelberg Univ Hosp, Sect Clin Trop Med, Dept Infect Dis, INF 324, D-69120 Heidelberg, Germany.
   [Rosenberger, Kerstin D.; Jaenisch, Thomas] German Ctr Infect Res DZIF, Heidelberg Site, Cologne, Germany.
   [Pohl, Moritz] Heidelberg Univ Hosp, Inst Med Biometry & Informat, Heidelberg, Germany.
   [Viana, Isabelle F. T.] Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Rabello, Renata; Brasil, Patricia] Fundacao Oswaldo Cruz, FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Soria, Carmen] Univ Catolic Santiago Guayaquil, Guayaquil, Ecuador.
   [Soria, Carmen] SOSECALI C Ltda, Guayaquil, Ecuador.
   [Salgado, Silvia P.] Inst Nacl Invest Salud Publ Dr Leopold Izquieta P, Guayaquil, Ecuador.
   [Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Guzman, Maria G.; Martinez, Pedro A.] Pedro Kouri Trop Med Inst IPK, Havana, Cuba.
   [Lopez-Gatell, Hugo; Hegewisch-Taylor, Jennifer] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.
   [Borja-Aburto, Victor H.; Gonzalez, Cesar] Mexican Inst Social Secur, Mexico City, Mexico.
   [Netto, Eduardo M.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Villarroel, Paola M. Saba] Ctr Nacl Enfermedades Trop CENETROP, Santa Cruzde SierraBoliv, Bolivia.
   [Hoen, Bruno] Ctr Hosp Univ Pointe A Pitre, Ctr Invest Clin 1424, INSERM, Pointe A Pitre, France.
   [Hoen, Bruno] Ctr Hosp Univ Pointe A Pitre, Serv Malad Infect & Trop, Dermatol, Med Interne, Pointe A Pitre, France.
   [Hoen, Bruno] Univ Antilles Guyane, Fac Med Hyacinthe Bastaraud, F-4537 Pointe A Pitre, EA, France.
   [Rockx, Barry; Koopmans, Marion] Erasmus MC, WHO CC Arbovirus & Hemorrhag Fever Viruses Refere, Dept Virosci, Rotterdam, Netherlands.
   [de Lamballerie, Xavier] Aix Marseille Univ, Marseille, France.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Jaenisch, T (corresponding author), Heidelberg Univ Hosp, Sect Clin Trop Med, Dept Infect Dis, INF 324, D-69120 Heidelberg, Germany.; Jaenisch, T (corresponding author), German Ctr Infect Res DZIF, Heidelberg Site, Cologne, Germany.
EM thomas.jaenisch@urz.uni-heidelberg.de
RI Avelino-Silva, Vivian I/L-2640-2013; Uhlmann, Lorenz/AAL-9839-2020
OI Avelino-Silva, Vivian I/0000-0002-6660-3088; Tami,
   Adriana/0000-0002-1918-9144
FU European Union's Horizon 2020 Research and Innovation Program under
   ZIKAlliance [734548]; Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG); Ruprecht-Karls-Universitat Heidelberg;
   Baden-Wurttemberg Ministry of Science, Research and the Arts
FX This work is supported by the European Union's Horizon 2020 Research and
   Innovation Program under ZIKAlliance Grant Agreement no. 734548; the
   study also received partial funding from Deutsche Forschungsgemeinschaft
   funding programme Open Access Publishing, Baden-Wurttemberg Ministry of
   Science, Research and the Arts and by Ruprecht-Karls-Universitat
   Heidelberg. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bayley N, 2006, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECLAMC, 2015, FREQ MICR AO NASC BR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   International Committee of Journal Medical Editors (ICMJE), DEF ROL AUTH CONTR
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mogling R, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.36.30609
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Squires J., 2009, AGES STAGES QUESTION
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, ZIK VIR INF UPD EV C
NR 85
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD DEC 26
PY 2019
VL 19
IS 1
AR 1081
DI 10.1186/s12879-019-4685-9
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA KI2EP
UT WOS:000511160500003
PM 31878895
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gerzson, LR
   de Almeida, CS
   da Silva, JH
   Feitosa, MMA
   de Oliveira, LN
   Schuler-Faccini, L
AF Gerzson, Lais Rodrigues
   de Almeida, Carla Skilhan
   da Silva, Juliana Herrero
   Feitosa, Michelle Mirttes Albuquerque
   de Oliveira, Lucia Nunes
   Schuler-Faccini, Lavinia
TI Neurodevelopment of Nonmicrocephalic Children, After 18 Months of Life,
   Exposed Prenatally to Zika Virus
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE ZIKV; child development; physiotherapy; Bayley III
ID GENERAL MOVEMENTS; INFECTION; BRAZIL; BORN
AB The aim of this work was to evaluate the cognitive, language, and motor development, after 18 months of life, of nonmicrocephalic children born to mothers with Zika virus infection during pregnancy. Participants were 37 children aged 18-29 months divided into 2 groups: 17 nonmicrocephalic children born to mothers who had Zika virus infection during pregnancy (ZIKVG) and 20 nonmicrocephalic children with no maternal history of infection matched by sex and age (control group). A semistructured interview and the Bayley Scale of Infant and Toddler Development (Bayley III) were used for their evaluation. One child in the ZIKVG presented low cognitive score, the same in the control group. There were no statistical differences between the 2 groups regarding cognitive, language, and motor development. This sample, although small, showed that a significant proportion of nonmicrocephalic children exposed prenatally to Zika virus had normal development. A longer follow-up is necessary to observe if no other adverse outcomes will appear in the future.
C1 [Gerzson, Lais Rodrigues] Univ Fed Rio Grande do Sul, Grad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil.
   [de Almeida, Carla Skilhan] Univ Fed Rio Grande do Sul, Dept Physiotherapy Phys Educ & Dance, Porto Alegre, RS, Brazil.
   [da Silva, Juliana Herrero] Univ Fed Rio Grande do Sul, Grad Program Genet & Mol Biol, Porto Alegre, RS, Brazil.
   [Feitosa, Michelle Mirttes Albuquerque] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [de Oliveira, Lucia Nunes] Univ Fed Rio Grande do Sul, Grad Program Sci Informat, Porto Alegre, RS, Brazil.
   [Schuler-Faccini, Lavinia] Hosp Clin Porto Alegre, SIAT, Informat Serv Teratogen Agents, Med Genet Serv, Porto Alegre, RS, Brazil.
RP Schuler-Faccini, L (corresponding author), Dept Genet, Ave Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM lavinia.faccini@ufrgs.br
RI SCHULER-FACCINI, LAVINIA/C-8309-2013
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
FU INAGEMP-National Institute of Population Medical Genetics grant CNPq
   [465549/2014-4]; INAGEMP-National Institute of Population Medical
   Genetics grant CAPES [88887.136366/2017-00]; INAGEMP-National Institute
   of Population Medical Genetics grant FAPERGS [17/2551-0000521-0];
   Project: Zika virus: Uma abordagem translacional (CNPq grant)
   [440763/2016-9]; Project: "A Historia Natural do Zika Virus" (Ministry
   of Health) [929698560001160-02]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This study was
   funded by INAGEMP-National Institute of Population Medical Genetics
   grant CNPq (465549/2014-4), CAPES (88887.136366/2017-00) and FAPERGS
   (17/2551-0000521-0); Project: Zika virus: Uma abordagem translacional
   (CNPq grant 440763/2016-9); and Project: "A Historia Natural do Zika
   Virus" (Ministry of Health grant 929698560001160-02).
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Botelho Ana Carla Gomes, 2016, Rev. Bras. Saude Mater. Infant., V16, P39, DOI 10.1590/1806-9304201600s100004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cabral J, 2018, INT J INFECT DIS, V73, P48, DOI 10.1016/j.ijid.2018.04.3533
   Carvalho A, 2019, BRAIN DEV-JPN, V41, P587, DOI 10.1016/j.braindev.2019.03.005
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Einspieler C, 2005, MENT RETARD DEV D R, V11, P61, DOI 10.1002/mrdd.20051
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Faical AV, 2019, BMJ PAEDIAT OPEN, V3, pe
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Flor CJDRV, 2017, FISIOTER, V7, P313
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hadders-Algra M, 2018, DEV MED CHILD NEUROL, V60, P39, DOI 10.1111/dmcn.13540
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleber de Oliveira W, 2015, MMWR-MORBID MORTAL W, V2016, P242
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Ministerio da Saude . Secretaria de AtencAo a Saude. Departamento de AtencAo Basica, 2012, SAUD CRIANC CRESC DE, P272
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Soares-Marangoni D, 2018, DEV NEUROREHABIL, V16, P1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 28
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR
PY 2020
VL 35
IS 4
BP 278
EP 282
AR 0883073819892128
DI 10.1177/0883073819892128
EA DEC 2019
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA KI3OH
UT WOS:000507197900001
PM 31878830
DA 2020-07-08
ER

PT J
AU Millies, B
   von Hammerstein, F
   Gellert, A
   Hammerschmidt, S
   Barthels, F
   Goppel, U
   Immerheiser, M
   Elgner, F
   Jung, N
   Basic, M
   Kersten, C
   Kiefer, W
   Bodem, J
   Hildt, E
   Windbergs, M
   Hellmich, UA
   Schirmeister, T
AF Millies, Benedikt
   von Hammerstein, Franziska
   Gellert, Andrea
   Hammerschmidt, Stefan
   Barthels, Fabian
   Goeppel, Ulrike
   Immerheiser, Melissa
   Elgner, Fabian
   Jung, Nathalie
   Basic, Michael
   Kersten, Christian
   Kiefer, Werner
   Bodem, Jochen
   Hildt, Eberhard
   Windbergs, Maike
   Hellmich, Ute A.
   Schirmeister, Tanja
TI Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3
   Proteases
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID MOLECULAR-DYNAMICS; NS2B-NS3 PROTEASE; BROAD-SPECTRUM; FORCE-FIELD;
   DISCOVERY; PREDICTION; PARAMETERIZATION; ACTIVATION; PROTEINS; HELICASE
AB The NS2B/NS3 serine proteases of the Zika and Dengue flaviviruses are attractive targets for the development of antiviral drugs. We report the synthesis and evaluation of a new, proline-based compound class that displays allosteric inhibition of both proteases. The structural features relevant for protease binding and inhibition were determined to establish them as new lead compounds for flaviviral inhibitors. Based on our structure-activity relationship studies, the molecules were further optimized, leading to inhibitors with submicromolar IC50 values and improved lipophilic ligand efficiency. The allosteric binding site in the proteases was probed using mutagenesis and covalent modification of the obtained cysteine mutants with maleimides, followed by computational elucidation of the possible binding modes. In infected cells, antiviral activity against Dengue virus serotype 2 using prodrugs of the inhibitors was observed. In summary, a novel inhibitor scaffold targeting an allosteric site shared between flaviviral NS2B/NS3 proteases is presented whose efficacy is demonstrated in vitro and in cellulo.
C1 [Millies, Benedikt; von Hammerstein, Franziska; Gellert, Andrea; Hammerschmidt, Stefan; Barthels, Fabian; Goeppel, Ulrike; Kersten, Christian; Kiefer, Werner; Schirmeister, Tanja] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Staudinger Weg 5, D-55128 Mainz, Germany.
   [Immerheiser, Melissa; Bodem, Jochen] Julius Maximilians Univ Wurzburg, Inst Virol & Immunbiol, Versbacher Str 7, D-97078 Wurzburg, Germany.
   [Elgner, Fabian; Basic, Michael; Hildt, Eberhard] Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
   [Hellmich, Ute A.] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becherweg 30, D-55128 Mainz, Germany.
   [Hellmich, Ute A.] Goethe Univ, Ctr Biomol Magnet Resonance BMRZ, D-60438 Frankfurt, Germany.
   [Jung, Nathalie; Windbergs, Maike] Goethe Univ, Inst Pharmaceut Technol, Max von Laue Str 15, D-60438 Frankfurt, Germany.
   [Jung, Nathalie; Windbergs, Maike] Goethe Univ, Buchmann Inst Mol Life Sci, Max von Laue Str 15, D-60438 Frankfurt, Germany.
RP Schirmeister, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Staudinger Weg 5, D-55128 Mainz, Germany.; Hellmich, UA (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becherweg 30, D-55128 Mainz, Germany.; Hellmich, UA (corresponding author), Goethe Univ, Ctr Biomol Magnet Resonance BMRZ, D-60438 Frankfurt, Germany.
EM U.Hellmich@uni-mainz.de; schirmei@uni-mainz.de
RI Faculty of Biochemistry, Chemistry/AAR-2127-2020; Hildt,
   Eberhard/A-1040-2015
OI Kersten, Christian/0000-0001-9976-7639
FU Carl Zeiss Foundation; Centre for Biomolecular Magnetic Resonance
   (BMRZ), Goethe University Frankfurt - the State of Hesse; LOEWE Center
   DRUID (Novel Drug Targets against Povertry-Related and Neglected
   Tropical Diseases)
FX U.A.H. acknowledges support by the Carl Zeiss Foundation and the Centre
   for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt,
   funded by the State of Hesse. E.H. obtained a grant by the LOEWE Center
   DRUID (Novel Drug Targets against Povertry-Related and Neglected
   Tropical Diseases).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   [Anonymous], 2019, MOL OP ENV MOE 2019
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   BioSolveIT, 2017, LEADIT VERS 2 3 2
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Case D. A., 2018, AMBER
   Cavalli A, 2004, J MED CHEM, V47, P3991, DOI 10.1021/jm040787u
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Frisch M.J., 2009, GAUSSIAN 09 REVISION
   Green T. J, QUESTIONABLE LIGAND
   Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759
   Grinter R, QUESTIONABLE LIGAND
   Guo HC, 2005, SYNTHESIS-STUTTGART, P1061, DOI 10.1055/s-2005-861857
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:6<490::AID-JCC1>3.3.CO;2-V
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heller B, 2002, J ORG CHEM, V67, P4414, DOI 10.1021/jo011032n
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hill ME, 2019, BIOCHEMISTRY-US, V58, P776, DOI 10.1021/acs.biochem.8b00978
   Hukkanen J, 2000, AM J RESP CELL MOL, V22, P360, DOI 10.1165/ajrcmb.22.3.3845
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liu K, 2017, J COMPUT AID MOL DES, V31, P201, DOI 10.1007/s10822-016-0005-2
   Ludewig S, 2010, CURR TOP MED CHEM, V10, P368, DOI 10.2174/156802610790725498
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Mehrotra S, 2016, CRYSTENGCOMM, V18, P4438, DOI 10.1039/c6ce00496b
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MORGAN MS, 1948, J AM CHEM SOC, V70, P375, DOI 10.1021/ja01181a116
   Mukhametov A, 2014, J MOL GRAPH MODEL, V52, P103, DOI 10.1016/j.jmgm.2014.06.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nepali K, 2019, J MED CHEM, V62, P2851, DOI 10.1021/acs.jmedchem.8b00147
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477
   Rieutord A, 1995, XENOBIOTICA, V25, P1345, DOI 10.3109/00498259509061922
   Steuer C, 2009, J BIOMOL SCREEN, V14, P1102, DOI 10.1177/1087057109344115
   Trapani G, 2001, EUR J PHARM SCI, V14, P209, DOI 10.1016/S0928-0987(01)00173-7
   Ullmann F, 1909, BER DTSCH CHEM GES, V42, P2057, DOI 10.1002/cber.19090420287
   Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v
   Volkamer A, 2010, J CHEM INF MODEL, V50, P2041, DOI 10.1021/ci100241y
   von Hammerstein F, 2019, FEBS LETT, V593, P2204, DOI 10.1002/1873-3468.13507
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005
   Wildman SA, 1999, J CHEM INF COMP SCI, V39, P868, DOI 10.1021/ci990307l
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Ye Y, 2019, J PROTEOME RES, V18, P1623, DOI 10.1021/acs.jproteome.8b00897
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
NR 75
TC 4
Z9 4
U1 5
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD DEC 26
PY 2019
VL 62
IS 24
BP 11359
EP 11382
DI 10.1021/acs.jmedchem.9b01697
PG 24
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA KA2NE
UT WOS:000505633400026
PM 31769670
DA 2020-07-08
ER

PT J
AU Akaberi, D
   Chinthakindi, PK
   Bahlstrom, A
   Palanisamy, N
   Sandstrom, A
   Lundkvist, A
   Lennerstrand, J
AF Akaberi, Dario
   Chinthakindi, Praveen K.
   Bahlstrom, Amanda
   Palanisamy, Navaneethan
   Sandstrom, Anja
   Lundkvist, Ake
   Lennerstrand, Johan
TI Identification of a C2-symmetric diol based human immunodeficiency virus
   protease inhibitor targeting Zika virus NS2B-NS3 protease
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE In silico screening; structure-based drug discovery; Zika virus (ZIKV);
   NS2B-NS3 protease; protease inhibitors
ID CRYSTAL-STRUCTURE; FRENCH-POLYNESIA; NS3 PROTEASE; FORCE-FIELD; BINDING;
   FLAVIVIRUS; DISCOVERY; EFFICIENT; ACCURACY
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus and infection by ZIKV Asian lineage is known to cause fetal brain anomalies and Guillain-Barres syndrome. The WHO declared ZIKV a global public health emergency in 2016. However, currently neither vaccines nor antiviral prophylaxis/treatments are available. In this study, we report the identification of a C2-symmetric diol-based Human immunodeficiency virus type-1 (HIV) protease inhibitor active against ZIKV NS2B-NS3 protease. The compound, referred to as 9b, was identified by in silico screening of a library of 6265 protease inhibitors. Molecular dynamics (MD) simulation studies revealed that compound 9b formed a stable complex with ZIKV protease. Interaction analysis of compound 9b's binding pose from the cluster analysis of MD simulations trajectories predicted that 9b mostly interacted with ZIKV NS3. Although designed as an aspartyl protease inhibitor, compound 9b was found to inhibit ZIKV serine protease in vitro with IC50 = 143.25 +/- 5.45 mu M, in line with the in silico results. Additionally, linear interaction energy method (LIE) was used to estimate binding affinities of compounds 9b and 86 (a known panflavivirus peptide hybrid with IC50 = 1.64 +/- 0.015 mu M against ZIKV protease). The LIE method correctly predicted the binding affinity of compound 86 to be lower than that of 9b, proving to be superior to the molecular docking methods in scoring and ranking compounds. Since most of the reported ZIKV protease inhibitors are positively charged peptide-hybrids, with our without electrophilic warheads, compound 9b represents a less polar and more drug-like non-peptide hit compound useful for further optimization. Communicated by Ramaswamy Sarma
C1 [Akaberi, Dario; Lennerstrand, Johan] Uppsala Univ, Univ Uppsala Hosp, Dept Med Sci, Clin Microbiol, Uppsala, Sweden.
   [Akaberi, Dario; Lundkvist, Ake] Uppsala Univ, Dept Med Biochem & Microbiol, Zoonosis Sci Ctr, Uppsala, Sweden.
   [Chinthakindi, Praveen K.; Bahlstrom, Amanda; Sandstrom, Anja] Uppsala Univ, Beijer Lab, Dept Med Chem Drug Design & Discovery, Uppsala, Sweden.
   [Palanisamy, Navaneethan] Heidelberg Univ, HBIGS, Heidelberg, Germany.
   [Palanisamy, Navaneethan] Univ Freiburg, Inst Biol 2, Freiburg, Germany.
RP Lennerstrand, J (corresponding author), Uppsala Univ, Clin Microbiol Sect, Dept Med Sci, Dag Hammarskjold Vag 38, SE-75237 Uppsala, Sweden.
EM johan.lennerstrand@medsci.uu.se
RI Navaneethan, Palanisamy/AAL-1462-2020
OI Navaneethan, Palanisamy/0000-0003-0369-2316
FU Scandinavian Society for Antimicrobial Chemotherapy [SLS-787601,
   SLS-886221]; Kjell and Marta Beijer Foundation
FX J.Lennerstrand received financial support for this study from the
   Scandinavian Society for Antimicrobial Chemotherapy (SLS-787601 and
   SLS-886221). A. Sandstrom received financial support from the Kjell and
   Marta Beijer Foundation.
CR Akaberi Dario, 2018, Infection Ecology & Epidemiology, V8, P1528117, DOI 10.1080/20008686.2018.1528117
   Almlof M, 2007, J CHEM THEORY COMPUT, V3, P2162, DOI 10.1021/ct700106b
   Bauer P, 2018, SOFTWAREX, V7, P388, DOI 10.1016/j.softx.2017.12.001
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Leuw P, 2018, EXPERT OPIN PHARMACO, V19, P577, DOI 10.1080/14656566.2018.1454428
   Dodda LS, 2017, NUCLEIC ACIDS RES, V45, pW331, DOI 10.1093/nar/gkx312
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:6<490::AID-JCC1>3.3.CO;2-V
   Hansson T, 1998, J COMPUT AID MOL DES, V12, P27, DOI 10.1023/A:1007930623000
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lv ZT, 2015, HIV AIDS-RES PALLIAT, V7, P95, DOI 10.2147/HIV.S79956
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Palanisamy N, 2018, MOL PHYLOGENET EVOL, V118, P58, DOI 10.1016/j.ympev.2017.09.015
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pyring D, 2001, J MED CHEM, V44, P3083, DOI 10.1021/jm001134q
   Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sandeep Gaddam, 2011, BMC Res Notes, V4, P445, DOI 10.1186/1756-0500-4-445
   Simmonds P, 2011, CURR OPIN VIROL, V1, P410, DOI 10.1016/j.coviro.2011.10.021
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 44
TC 4
Z9 4
U1 5
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2019.1704882
EA DEC 2019
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA JY6YP
UT WOS:000504558200001
PM 31880199
OA Other Gold
DA 2020-07-08
ER

PT J
AU Jesus, T
   Wanner, E
   Cardoso, R
AF Jesus, Tales
   Wanner, Elizabeth
   Cardoso, Rodrigo
TI A receding horizon control approach for integrated vector management of
   Aedes aegypti using chemical and biological control: A mono and a
   multiobjective approach
SO MATHEMATICAL METHODS IN THE APPLIED SCIENCES
LA English
DT Article; Early Access
DE control problems; cost-effectiveness analysis; epidemiology;
   mono-objective and multiobjective optimization; receding horizon control
AB This paper addresses an integrated vector management (IVM) approach for combating Aedes aegypti, the transmission vector of dengue, zika, and chikungunya diseases, some of the most important viral epidemics worldwide. In order to tackle this problem, a receding horizon control (RHC) strategy is adopted, considering a mono-objective and a multiobjective version of the optimal control model of combating the mosquito using chemical and biological control. RHC is essentially a suboptimal scheme of classical optimal control strategies considering discrete-time approximations. The integrated vector control actions used in this work consist in applying insecticides and inserting sterile males produced by irradiation in the population of mosquitoes. The cost function is defined in terms of social and economic costs, in order to quantify the effectiveness of the proposed epidemiological control throughout a time window of 4 months. Numerical simulations show that the obtained results are better than those from the optimal control strategies found in literature. Furthermore, through the application of the multiobjetive approach, varying the scenarios in the mono-objective formulation is no longer necessary and a set of optimal strategies can be obtained at once. Finally, in order to help health authorities in the choice of the best solution of the Pareto-optimal set to be implemented in practice, a cost-effectiveness analysis is performed and a strategy representing the most cost-effective control policy is obtained.
C1 [Jesus, Tales; Wanner, Elizabeth] CEFET MG, Dept Comp, Belo Horizonte, MG, Brazil.
   [Wanner, Elizabeth] Aston Univ, EASS, Birmingham, W Midlands, England.
   [Cardoso, Rodrigo] CEFET MG, Dept Phys & Math, Belo Horizonte, MG, Brazil.
RP Jesus, T (corresponding author), CEFET MG, Dept Comp, Belo Horizonte, MG, Brazil.
EM tales@cefetmg.br
RI ; Wanner, Elizabeth/F-4927-2016
OI Jesus, Tales/0000-0001-9279-1249; Cardoso, Rodrigo/0000-0002-6784-2929;
   Wanner, Elizabeth/0000-0001-6450-3043
FU Centro Federal de Educacao Tecnologica de Minas Gerais (CEFET-MG);
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo
   a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG)
FX Centro Federal de Educacao Tecnologica de Minas Gerais (CEFET-MG);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais
CR Barsante LS, 2011, P 43 BRAZ S OP RES U
   Brown VL, 2011, MATH BIOSCI, V231, P126, DOI 10.1016/j.mbs.2011.02.009
   Cela A, 2013, OPTIMAL DESIGN DISTR
   Clarke J, 2013, B MATH BIOL, V75, P1747, DOI 10.1007/s11538-013-9867-9
   David J, 2011, OPTIM CONTR APPL MET, V32, P681, DOI 10.1002/oca.969
   Deb K., 2001, MULTIOBJECTIVE OPTIM
   Dias WO, 2015, MATH BIOSCI, V269, P37, DOI 10.1016/j.mbs.2015.08.019
   Dias WO, 2013, BIOMAT, P136
   Du Toit NE, 2012, IEEE T ROBOT, V28, P101, DOI 10.1109/TRO.2011.2166435
   Elhia M, 2012, APPL MATH SCI, V6, P4057
   Esteva L, 2006, MAT APL COMPUT, V7, P259
   Fiorentino HO, 2014, MATH BIOSCI, V258, P77, DOI 10.1016/j.mbs.2014.08.013
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Joshi HR, 2002, OPTIM CONTR APPL MET, V23, P199, DOI 10.1002/oca.710
   Keviczky T., 2005, DECENTRALIZED RECEDI
   Kim N, 2012, P I MECH ENG D-J AUT, V226, P1160, DOI 10.1177/0954407012438304
   Kirk D. E., 1998, OPTIMAL CONTROL THEO
   Mohseni F, 2016, IEEE SYST J, V10, P198, DOI 10.1109/JSYST.2014.2325219
   Ohtsuka T, 2004, AUTOMATICA, V40, P563, DOI 10.1016/j.automatica.2003.11.005
   Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008
   Peng HJ, 2016, ISA T, V60, P38, DOI 10.1016/j.isatra.2015.10.015
   Peng HJ, 2013, ADV SPACE RES, V51, P2093, DOI 10.1016/j.asr.2013.01.013
   Peng H, 2018, IEEE T AERO ELEC SYS, V54, P144, DOI 10.1109/TAES.2017.2739938
   Rafikov  M., 2015, J APPL MATH, V9, P1, DOI [10.1155/2015/918194, DOI 10.1155/2015/918194]
   Rawlings J., 2009, MODEL PREDICTIVE CON
   Rodrigues HS, 2014, MATH BIOSCI, V247, P1, DOI 10.1016/j.mbs.2013.10.006
   Rodrigues HS, 2010, MATH COMPUT MODEL, V52, P1667, DOI 10.1016/j.mcm.2010.06.034
   Rodrigues HSF, 2012, OPTIMAL CONTROL NUME
   Selley F., 2014, RECEDING HORIZON CON
   Selley F, 2015, SIAM J APPL DYN SYST, V14, P168, DOI 10.1137/130947039
   Sepulveda LS, 2016, MATH METHOD APPL SCI, V39, P5475, DOI 10.1002/mma.3932
   Sharomi Oluwaseun, 2017, Annals of Operations Research, V251, P55, DOI 10.1007/s10479-015-1834-4
   SHIM H, 2003, INT J CONTROL AUTOM, V1, P401
   Thome RCA, 2010, MATH BIOSCI, V223, P12, DOI 10.1016/j.mbs.2009.08.009
   Tian BL, 2011, ACTA ASTRONAUT, V68, P1176, DOI 10.1016/j.actaastro.2010.10.010
   World Health Organization, 2016, WAT REL DIS DENG DEN
   World Health Organization, 2014, STAT ART PREV CONTR
   Yusuf T.J., 2012, WORLD J MODEL SIMUL, V8, P194
   Zurakowski R, 2006, J THEOR BIOL, V238, P368, DOI 10.1016/j.jtbi.2005.05.004
NR 39
TC 1
Z9 1
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0170-4214
EI 1099-1476
J9 MATH METHOD APPL SCI
JI Math. Meth. Appl. Sci.
DI 10.1002/mma.6115
EA DEC 2019
PG 18
WC Mathematics, Applied
SC Mathematics
GA JX5JX
UT WOS:000503772200001
DA 2020-07-08
ER

PT J
AU Morrey, JD
   Oliveira, ALR
   Wang, H
   Zukor, K
   de Castro, MV
   Siddharthan, V
AF Morrey, John D.
   Oliveira, Alexandre L. R.
   Wang, Hong
   Zukor, Katherine
   de Castro, Mateus Vidigal
   Siddharthan, Venkatraman
TI Zika virus infection causes temporary paralysis in adult mice with motor
   neuron synaptic retraction and evidence for proximal peripheral
   neuropathy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; I EXPRESSION; SPINAL-CORD; MOUSE MODEL;
   PLASTICITY; DEATH; ENCEPHALITIS; PATHOGENESIS; REPLICATION; CONTRIBUTES
AB Clinical evidence is mounting that Zika virus can contribute to Guillain-Barre syndrome which causes temporary paralysis, yet the mechanism is unknown. We investigated the mechanism of temporary acute flaccid paralysis caused by Zika virus infection in aged interferon alpha beta-receptor knockout mice used for their susceptibility to infection. Twenty-five to thirty-five percent of mice infected subcutaneously with Zika virus developed motor deficits including acute flaccid paralysis that peaked 8-10 days after viral challenge. These mice recovered within a week. Despite Zika virus infection in the spinal cord, motor neurons were not destroyed. We examined ultrastructures of motor neurons and synapses by transmission electron microscopy. The percent coverage of motor neurons by boutons was reduced by 20%; more specifically, flattened-vesicle boutons were reduced by 46%, and were normalized in recovering mice. Using electromyographic procedures employed in people to help diagnose Guillain-Barre syndrome, we determined that nerve conduction velocities between the sciatic notch and the gastrocnemius muscle were unchanged in paralyzed mice. However, F-wave latencies were increased in paralyzed mice, which suggests that neuropathy may exist between the sciatic notch to the nerve rootlets. Reversible synaptic retraction may be a previously unrecognized cofactor along with peripheral neuropathy for the development of Guillain-Barre syndrome during Zika virus outbreaks.
C1 [Morrey, John D.; Wang, Hong; Zukor, Katherine; Siddharthan, Venkatraman] Utah State Univ, Inst Antiviral Res, Dept Anim Dairy & Vet Sci, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Oliveira, Alexandre L. R.; de Castro, Mateus Vidigal] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
RP Morrey, JD (corresponding author), Utah State Univ, Inst Antiviral Res, Dept Anim Dairy & Vet Sci, 5600 Old Main Hill, Logan, UT 84322 USA.
EM john.morrey@usu.edu
OI Ditton, Thomas/0000-0003-4622-2613; Castro, Mateus Vidigal
   de/0000-0002-8895-652X
FU Public Health Service (PHS) research grants from the National Institute
   of Neurological Disorders and Stroke (NINDS), National Institutes of
   Health (NIH) [1R21NS090133]; PHS grant from the Virology Branch,
   National Institute of Allergy and Infectious Diseases (NIAID), NIH, Utah
   Agricultual Experiment Station, Utah State University [5R33AI101483,
   HHSN272201000039I/HHSN27200004]; Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo - FAPESP, BrazilFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2014/06892-3]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq, BrazilNational Council for Scientific
   and Technological Development (CNPq) [303085/2017-7]
FX We thank the following individuals from the Institute for Antiviral
   Research at Utah State University for their excellent technical
   assistance: Mitch Stevens for help with viral paresis scale assay and
   immunohistofluorescent staining; Dallan Blotter for help with hanging
   wire assay; Marvin Joe Burger with Illustrator neuron coloration; Heidi
   Julander, Brittney Downs, Nicole Anderson, and Parker Webber for help
   with IFNAR-/-mouse colony management; Skot Neilson and Ashley Dagley for
   overseeing animal studies; Abbey Thomas, Carlee Frank, Dallan Blotter,
   Kade Roberts, Nicole Anderson, and Ryden Crowther for assisting with
   animal studies; Neil Motter and Rich Albrechtsen for maintenance and
   design of electrophysiological instruments, and Thomas Ditton, Nicole
   Anderson, and Matthew McKinnon for proof-reading the manuscript. We also
   thank Arnaud Vanwettere for pathology (Certified-board pathologist, Utah
   Veterinary Diagnostic Laboratory) and YoungMin Lee (Utah State
   University) for critique of electron micrographs. The work was supported
   by Public Health Service (PHS) research grants 1R21NS090133 to J.D. M.
   from the National Institute of Neurological Disorders and Stroke
   (NINDS), National Institutes of Health (NIH), and PHS grant 5R33AI101483
   and contract HHSN272201000039I/HHSN27200004 to J.D.M. from the Virology
   Branch, National Institute of Allergy and Infectious Diseases (NIAID),
   NIH, Utah Agricultual Experiment Station, Utah State University to
   J.D.M. and approved as journal paper number UAES #9274, Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil, proc.
   2014/06892-3; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq, Brazil, proc. 303085/2017-7, A.R. L. de O. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   ALBERS JW, 1985, MUSCLE NERVE, V8, P528, DOI 10.1002/mus.880080609
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   [Anonymous], 2009, ATL MOUS SPIN CORD
   [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Barbizan R, 2014, INT J MOL SCI, V15, P19535, DOI 10.3390/ijms151119535
   Barbizan R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-29
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Blakely PK, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00344
   Bombeiro AL, 2017, NEUROSCI LETT, V647, P97, DOI 10.1016/j.neulet.2017.03.038
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CONRADI S, 1969, ACTA PHYSIOL SCAND, P65
   CONRADI S, 1969, ACTA PHYSIOL SCAND, P5
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dai CS, 2014, BASIC CLIN PHARMACOL, V115, P577, DOI 10.1111/bcpt.12272
   Dhiman G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46389-0
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Freria CM, 2010, J COMP NEUROL, V518, P990, DOI 10.1002/cne.22259
   Gabriel CM, 1998, BRAIN, V121, P1895, DOI 10.1093/brain/121.10.1895
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923
   Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   JOHNSON RT, 1987, J INFECT DIS, V155, P359, DOI 10.1093/infdis/155.3.359
   Koma T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20185-8
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee KM, 2014, J NEUROVIROL, V20, P474, DOI 10.1007/s13365-014-0267-1
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Marques KB, 2006, EUR J NEUROSCI, V24, P3053, DOI 10.1111/j.1460-9568.2006.05184.x
   Marques KB, 2009, BRAZ J MED BIOL RES, V42, P179, DOI 10.1590/S0100-879X2009000200006
   MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082
   Mesrati F, 2004, NEUROPHYSIOL CLIN, V34, P217, DOI 10.1016/j.neucli.2004.09.005
   Michaelis M, 2007, J ANTIMICROB CHEMOTH, V60, P981, DOI 10.1093/jac/dkm307
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Morrey JD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010033
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677
   Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06
   Santerre M, 2019, J BIOL CHEM, V294, P3618, DOI 10.1074/jbc.RA118.003744
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schulz KS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00498
   Scorisa JM, 2009, NEUROSCI LETT, V451, P34, DOI 10.1016/j.neulet.2008.12.017
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09
   Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859
   Sugiyama K, 2017, J NEUROSCI, V37, P8830, DOI 10.1523/JNEUROSCI.0730-17.2017
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Volpi VG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28257-5
   WAKSMAN BH, 1955, J EXP MED, V102, P213, DOI 10.1084/jem.102.2.213
   Wang H, 2014, CLIN AUTON RES, V24, P15, DOI 10.1007/s10286-013-0213-y
   Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P308, DOI 10.1016/B978-0-12-374247-6.50020-1
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Yan WX, 2014, J NEUROIMMUNOL, V277, P13, DOI 10.1016/j.jneuroim.2014.09.012
   Yang M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-5
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zukor K, 2018, J NEUROVIROL, V24, P273, DOI 10.1007/s13365-017-0595-z
   Zukor K, 2017, J NEUROVIROL, V23, P186, DOI 10.1007/s13365-016-0488-6
NR 65
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 20
PY 2019
VL 9
AR 19531
DI 10.1038/s41598-019-55717-3
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KE9LD
UT WOS:000508870500006
PM 31862897
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rault, LC
   Johnson, EJ
   O'Neal, ST
   Chen, R
   McComic, SE
   Swale, DR
   Anderson, TD
AF Rault, Leslie C.
   Johnson, Ellis J.
   O'Neal, Scott T.
   Chen, Rui
   McComic, Sarah E.
   Swale, Daniel R.
   Anderson, Troy D.
TI Age- and sex-related ABC transporter expression in
   pyrethroid-susceptible and - resistant Aedes aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ATP-BINDING CASSETTE; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE;
   DETOXIFICATION GENES; DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; INSECTICIDE;
   DEXAMETHASONE; VERAPAMIL; STRAIN
AB Resistance mechanisms to synthetic insecticides often include point mutations and increased expression of genes encoding detoxification enzymes. Since pyrethroids are the main adulticides used against Aedes aegypti, which vectors pathogens such as Zika virus, understanding resistance to this insecticide class is of significant relevance. We focused on adenosine triphosphate (ATP)-binding cassette (ABC) transporters in the pyrethroid-resistant Puerto Rico (PR) strain of Ae. aegypti. We investigated the expression patterns of six ABC transporters previously characterized as differentially expressed in insecticide-challenged mosquitoes, or increased mRNA expression in pyrethroid-resistant Ae. aegypti, by comparing PR to the Rockefeller (Rock) susceptible strain. No constitutive differential expression between strains was detected, but expression differences for these genes was influenced by sex and age, suggesting that their role is independent from resistance in PR. Instead, ABC transporters may be induced after insecticide exposure. Challenging mosquitoes with deltamethrin, with or without ABC transporter modulators, showed that Rock and PR responded differently, but a contribution of ABC transporters to deltamethrin toxicity is suspected. Moreover, the effect of dexamethasone, which enhanced the inhibition of nerve firing by deltamethrin, was observed using a Drosophila central nervous system preparation, showing synergy of these two compounds through the potential inhibition of ABC transporters.
C1 [Rault, Leslie C.; Johnson, Ellis J.; O'Neal, Scott T.; Anderson, Troy D.] Univ Nebraska, Dept Entomol, 103 Entomol Hall, Lincoln, NE 68583 USA.
   [Chen, Rui; McComic, Sarah E.; Swale, Daniel R.] Louisiana State Univ, Dept Entomol, AgCtr, Baton Rouge, LA 70803 USA.
RP Rault, LC (corresponding author), Univ Nebraska, Dept Entomol, 103 Entomol Hall, Lincoln, NE 68583 USA.
EM lrault2@unl.edu
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Belpomme D, 2000, ANN ONCOL, V11, P1471, DOI 10.1023/A:1026556119020
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bergson P, 2011, MOL PHARMACOL, V79, P411, DOI 10.1124/mol.110.069492
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001
   Buss DS, 2002, MED VET ENTOMOL, V16, P218, DOI 10.1046/j.1365-2915.2002.00365.x
   Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08
   Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   CHATTERJEE M, 1990, CANCER RES, V50, P2818
   Chen R, 2019, ACS CHEM NEUROSCI, V10, P2765, DOI 10.1021/acschemneuro.8b00697
   Chen RY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18489-2
   Chouaibou M, 2014, ACTA TROP, V130, P108, DOI 10.1016/j.actatropica.2013.10.020
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   De Marco L., 2017, SCI REP, V7, P1
   Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Dzaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43618
   Epel D, 2008, ENVIRON SCI TECHNOL, V42, P3914, DOI 10.1021/es087187v
   Epis S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07435
   Epis S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-349
   Estep AS, 2017, J MED ENTOMOL, V54, P1643, DOI 10.1093/jme/tjx143
   Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052
   Francis SAM, 2017, INSECTS, V8, DOI 10.3390/insects8010002
   Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007
   HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435
   Hougard JM, 2003, B WORLD HEALTH ORGAN, V81, P324
   JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7
   Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389
   Koehn LM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42402-8
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kusuhara H, 2007, PFLUG ARCH EUR J PHY, V453, P735, DOI 10.1007/s00424-006-0134-x
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lima EP, 2014, MEM I OSWALDO CRUZ, V109, P964, DOI 10.1590/0074-0276140164
   Manceau S, 2012, J CHEMOTHERAPY, V24, P48, DOI 10.1179/1120009X12Z.00000000010
   Manjarres-Suarez Alejandra, 2013, Rev. costarric. salud pública, V22, P68
   Marquez B., 2011, ABC MULTIDRUG TRANSP, V12
   Mastrantonio V, 2017, ACTA TROP, V171, P37, DOI 10.1016/j.actatropica.2017.03.012
   Matz MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071448
   Merzendorfer H, 2014, ADV INSECT PHYSIOL, V46, P1, DOI 10.1016/B978-0-12-417010-0.00001-X
   Muktar Y., 2016, J TROP DIS PUBLIC HL, V4
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Narang VS, 2008, AM J PHYSIOL-CELL PH, V295, pC440, DOI 10.1152/ajpcell.00491.2007
   Podsiadlowski L, 1998, COMP BIOCHEM PHYS B, V121, P443, DOI 10.1016/S0305-0491(98)10137-2
   Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x
   Porretta D, 2016, ACTA TROP, V157, P131, DOI 10.1016/j.actatropica.2016.02.002
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   R Core Team, 2013, R LANG ENV STAT COMP
   Ranson H., 2010, TROP ONLINE, V1
   Rault LC, 2019, PESTIC BIOCHEM PHYS, V156, P96, DOI 10.1016/j.pestbp.2019.02.007
   Reid WR, 2014, J MED ENTOMOL, V51, P605, DOI 10.1603/ME13228
   Rozen S, 2000, Methods Mol Biol, V132, P365
   SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Strycharz JP, 2013, PESTIC BIOCHEM PHYS, V107, P207, DOI 10.1016/j.pestbp.2013.06.010
   Suzuki T, 2006, LIFE SCI, V79, P455, DOI 10.1016/j.lfs.2006.01.024
   Swale DR, 2018, JOVE-J VIS EXP, DOI 10.3791/58375
   Swale DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103713
   Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   TSURUO T, 1981, CANCER RES, V41, P1967
   UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004
   Ueda K, 1997, SEMIN CANCER BIOL, V8, P151, DOI 10.1006/scbi.1997.0066
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Xu J, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01692-17
   Yoon KS, 2011, INSECT MOL BIOL, V20, P687, DOI 10.1111/j.1365-2583.2011.01097.x
   Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x
NR 72
TC 0
Z9 0
U1 4
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 20
PY 2019
VL 9
AR 19551
DI 10.1038/s41598-019-56134-2
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KE9LD
UT WOS:000508870500026
PM 31862982
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Trammell, CE
   Goodman, AG
AF Trammell, Chasity E.
   Goodman, Alan G.
TI Emerging Mechanisms of Insulin-Mediated Antiviral Immunity in Drosophila
   melanogaster
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE innate immunity; RNA interference; JAK; STAT; insulin; STING; West Nile
   virus; Zika virus; dengue virus
ID RIG-I; VIRUS-INFECTION; FLAVIVIRUS RNA; STING REVEALS; AEDES-AEGYPTI;
   INTERFERENCE; INSECT; REPLICATION; RECEPTOR; PATHWAY
AB Arboviruses (arthropod-borne viruses), such as Zika (ZIKV), West Nile (WNV), and dengue (DENV) virus, include some of the most significant global health risks to human populations. The steady increase in the number of cases is of great concern due to the debilitating diseases associated with each viral infection. Because these viruses all depend on the mosquito as a vector for disease transmission, current research has focused on identifying immune mechanisms used by insects to effectively harbor these viruses and cause disease in humans and other animals. Drosophila melanogaster are a vital model to study arboviral infections and host responses as they are a genetically malleable model organism for experimentation that can complement analysis in the virus' natural vectors. D. melanogaster encode a number of distinct mechanisms of antiviral defense that are found in both mosquito and vertebrate animal systems, providing a viable model for study. These pathways include canonical antiviral modules such as RNA interference (RNAi), JAK/STAT signaling, and the induction of STING-mediated immune responses like autophagy. Insulin signaling plays a significant role in host-pathogen interactions. The exact mechanisms of insulin-mediated immune responses vary with each virus type, but nevertheless ultimately demonstrates that metabolic and immune signaling are coupled for antiviral immunity in an arthropod model. This mini review provides our current understanding of antiviral mechanisms in D. melanogaster, with a focus on insulin-mediated antiviral signaling, and how such immune responses pertain to disease models in vertebrate and mosquito species.
C1 [Trammell, Chasity E.; Goodman, Alan G.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.
   [Trammell, Chasity E.] Washington State Univ, NIH Biotechnol Grad Training Program, Pullman, WA 99164 USA.
   [Goodman, Alan G.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
RP Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.; Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
EM alan.goodman@wsu.edu
RI Goodman, Alan/AAQ-1108-2020
OI Goodman, Alan/0000-0001-6394-332X
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI139051]; NIH/NIGMSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [T32
   GM008336]
FX Research in the Goodman lab was supported by NIH/NIAID Grant R01
   AI139051 to AG. CT was supported by NIH/NIGMS pre-doctoral fellowship
   T32 GM008336.
CR Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2
   Ahlers LRH, 2019, CELL REP, V29, P1946, DOI 10.1016/j.celrep.2019.10.029
   Akhrymuk I, 2016, VIROLOGY, V487, P230, DOI 10.1016/j.virol.2015.09.023
   Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874
   BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300
   Boisvert MEL, 2008, CURR TOP MICROBIOL, V320, P21
   Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8
   Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109
   Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429
   Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022
   Cucunawangsih, 2017, Virology (Auckl), V8, p1178122X17695836, DOI 10.1177/1178122X17695836
   Cullen BR, 2014, J VIROL, V88, P12934, DOI 10.1128/JVI.01179-14
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106
   DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Goto A, 2018, IMMUNITY, V49, P225, DOI 10.1016/j.immuni.2018.07.013
   Hagan RW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24893-z
   Harsh S, 2018, J IMMUNOL, V201, P3058, DOI 10.4049/jimmunol.1800597
   Herrera SC, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.167643
   Hillyer JF, 2016, DEV COMP IMMUNOL, V58, P102, DOI 10.1016/j.dci.2015.12.006
   Hua XT, 2018, J BIOL CHEM, V293, P11878, DOI 10.1074/jbc.RA117.000194
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022
   Lamiable O, 2016, J VIROL, V90, P5415, DOI 10.1128/JVI.00238-16
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Martin M, 2018, CELL REP, V23, P3537, DOI 10.1016/j.celrep.2018.05.029
   Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034
   Muttis E, 2018, J MED ENTOMOL, V55, P1105, DOI 10.1093/jme/tjy057
   Nielsen MD, 2008, AGING CELL, V7, P688, DOI 10.1111/j.1474-9726.2008.00420.x
   Paradkar PN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005143
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Pean CB, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14642
   Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505
   Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703
   Riedl W, 2019, CELL HOST MICROBE, V26, P493, DOI 10.1016/j.chom.2019.09.012
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Sansone CL, 2015, CELL HOST MICROBE, V18, P571, DOI 10.1016/j.chom.2015.10.010
   Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuster S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050448
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Spellberg MJ, 2015, P NATL ACAD SCI USA, V112, P14587, DOI 10.1073/pnas.1517124112
   Stone AEL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11250-5
   Taracena ML, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006498
   Uraki R, 2019, NAT MICROBIOL, V4, P948, DOI 10.1038/s41564-019-0385-x
   van Cleef KWR, 2011, METHODS MOL BIOL, V721, P201, DOI 10.1007/978-1-61779-037-9_12
   WHO, 2019, 10 HLTH ISS WHO WILL
   Wittes J, 2019, G3-GENES GENOM GENET, V9, P47, DOI 10.1534/g3.118.200786
   Wright VM, 2011, CELL SIGNAL, V23, P920, DOI 10.1016/j.cellsig.2011.01.020
   Xu J, 2013, P NATL ACAD SCI USA, V110, P15025, DOI 10.1073/pnas.1303193110
NR 66
TC 0
Z9 0
U1 3
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD DEC 20
PY 2019
VL 10
AR 2973
DI 10.3389/fimmu.2019.02973
PG 7
WC Immunology
SC Immunology
GA KA3ZR
UT WOS:000505737300001
PM 31921210
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silva, PAN
   Ito, CRM
   Barbosa, MS
   Santos, MD
   Carneiro, LC
AF da Silva, Paulo Alex Neves
   Ito, Celia Regina Malveste
   Barbosa, Monica Santiago
   de Oliveira Santos, Monica
   Carneiro, Lilian Carla
TI Arboviruses (chikungunya, dengue, and Zika) associated with ophthalmic
   changes: a focus on aqueous fluid and vitreous humor
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Review
DE Arboviruses; Chikungunya; Dengue; Zika; Transplantation; Eyes
ID VIRUS-INFECTION; OPTIC NEURITIS; TRAVELERS; EPIDEMIC; FEVER; RISK
AB The aim of this study was to conduct a bibliographic survey and correlates the presence of arboviroses in the eyeball with the main eye changes presented by the population under study. This study is a systematic review of journals and indexed articles, carried out between January 2019 and June 2019, in which there was a query in the Pubmed/Medline and Scielo databases without temporal restriction. In addition to the aforementioned databases, the Brazilian Association of Organ Transplantation Association database, which provides epidemiological data on organ and tissue transplants in Brazil, was used as a research source. The Midwest region contributed to the increase in the number of organ transplants in Brazil. The number of corneal transplants in Brazil surpassed the number of organ transplants by four times. Several ophthalmic changes associated with Chikungunya, Dengue, and Zika virus infections have been diagnosed; however, few studies have identified the presence of the virus in the eyeball. Arboviruses are of great relevance to public health due to a number of factors, ranging from the diversity of infectious agents involved and the plurality of clinical manifestations because the absence of efficient laboratory support, leading to delayed disease confirmation due to lack of differential diagnostics available. Added to these difficulties is the lack of specific therapy, leaving only the symptomatic control of clinical manifestations as the only treatment option. However, the manifestations are directly associated with the decreased quality of vision and consequently the quality of life of patients.
C1 [da Silva, Paulo Alex Neves; Ito, Celia Regina Malveste; Barbosa, Monica Santiago; de Oliveira Santos, Monica; Carneiro, Lilian Carla] Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Biotecnol, Goiania, Go, Brazil.
RP Carneiro, LC (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Biotecnol, Goiania, Go, Brazil.
EM carlacarneirolilian@gmail.com
RI Carneiro, Lilian Carla/D-3079-2013
OI Carneiro, Lilian Carla/0000-0003-4067-1506
CR Cardona-Ospina JA, 2018, INT J INFECT DIS, V76, P126, DOI 10.1016/j.ijid.2018.08.022
   Appassakij H, 2014, TRANSFUSION, V54, P1945, DOI 10.1111/trf.12575
   Bawankar P, 2018, INDIAN J OPHTHALMOL, V66, P1631, DOI 10.4103/ijo.IJO_387_18
   Carrillo-Soto M A, 2018, Arch Soc Esp Oftalmol, V93, P329, DOI 10.1016/j.oftal.2018.02.005
   Chanana B, 2007, EYE, V21, P1020, DOI 10.1038/sj.eye.6702863
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Darrigo LG, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0612-2
   Farnon E., 2007, Morbidity and Mortality Weekly Report, V56, P276
   Foresto Renato Demarchi, 2019, Braz. J. Nephrol., V41, P575, DOI [10.1590/2175-8239-JBN-2018-0196, 10.1590/2175-8239-jbn-2018-0196]
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Giacomin Natalia Torres, 2018, Rev. bras.oftalmol., V77, P222, DOI 10.5935/0034-7280.20180049
   Heck E, 2017, AM J TRANSPLANT, V17, P2227, DOI 10.1111/ajt.14334
   Janani MK, 2018, CORNEA, V37, P1586, DOI 10.1097/ICO.0000000000001706
   Kamoi K, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011875
   Koundanya VV, 2019, J OPHTHALMIC INFLAMM, V9, DOI 10.1186/s12348-019-0175-x
   Kumar A, 2019, TURK OFTALMOL DERG, V49, P51, DOI 10.4274/tjo.galenos.2018.94103
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Levi ME, 2017, CURR OPIN INFECT DIS, V30, P340, DOI 10.1097/QCO.0000000000000384
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Mahesh G, 2009, INDIAN J OPHTHALMOL, V57, P148, DOI 10.4103/0301-4738.45508
   de Aragao REM, 2010, ARQ BRAS OFTALMOL, V73, P175, DOI 10.1590/S0004-27492010000200015
   Merle H, 2018, J FR OPHTALMOL, V41, pE235, DOI 10.1016/j.jfo.2018.05.002
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Murthy KR, 2008, INDIAN J OPHTHALMOL, V56, P329
   Nair AG, 2012, J OPHTHALMIC INFLAMM, V2, P39, DOI 10.1007/s12348-011-0038-6
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Cruz GKP, 2017, REV LAT-AM ENFERM, V25, P1, DOI 10.1590/1518-8345.1537.2897
   Rose N, 2011, INT J INFECT DIS, V15, pE147, DOI 10.1016/j.ijid.2010.10.004
   Rosso F, 2018, BRAZ J INFECT DIS, V22, P63, DOI 10.1016/j.bjid.2018.01.001
   Veloso CE, 2015, CASE REP OPHTHALM, V6, P18, DOI 10.1159/000371791
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WHO, 1985, TECHNICAL REPORT
   Zaidi Mussaret B, 2018, JMM Case Rep, V5, pe005152, DOI 10.1099/jmmcr.0.005152
NR 36
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD MAY
PY 2020
VL 39
IS 5
BP 827
EP 833
DI 10.1007/s10096-019-03792-9
EA DEC 2019
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA LG8YY
UT WOS:000503955800002
PM 31863236
DA 2020-07-08
ER

PT J
AU Palacios, R
   Shah, SK
AF Palacios, Ricardo
   Shah, Seema K.
TI When could human challenge trials be deployed to combat emerging
   infectious diseases? Lessons from the case of a Zika virus human
   challenge trial
SO TRIALS
LA English
DT Article
DE Human challenge trials; Research ethics; Ethics in emergencies; Zika
   virus
ID SOCIAL VALUE; PARTICIPATION; TRANSMISSION; PAYMENT; ETHICS; UNDUE;
   WOMEN; RISK
AB Human challenge trials (HCTs) deliberately infect participants in order to test vaccines and treatments in a controlled setting, rather than enrolling individuals with natural exposure to a disease. HCTs are therefore potentially powerful tools to prepare for future outbreaks of emerging infectious diseases. Yet when an infectious disease is emerging, there is often substantial risk and uncertainty about its complications, and few available interventions, making an HCT ethically complex. In light of the need to consider ethical issues proactively as a part of epidemic preparedness, we use the case of a Zika virus HCT to explore whether and when HCTs might be ethically justified to combat emerging infectious diseases. We conclude that emerging infectious diseases could be appropriate candidates for HCTs and we identify relevant considerations and provide a case example to illustrate when they might be ethically acceptable.
C1 [Palacios, Ricardo] Inst Butantan, Div Clin Trials & Pharmacovigilance, Sao Paulo, SP, Brazil.
   [Palacios, Ricardo] Univ Sao Paulo, Sch Philosophy Literature & Human Sci, Sao Paulo, SP, Brazil.
   [Shah, Seema K.] Ann & Robert H Lurie Childrens Hosp Chicago, Mary Ann & J Milburn Smith Child Hlth Res Outreac, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA.
   [Shah, Seema K.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Palacios, R (corresponding author), Inst Butantan, Div Clin Trials & Pharmacovigilance, Sao Paulo, SP, Brazil.; Palacios, R (corresponding author), Univ Sao Paulo, Sch Philosophy Literature & Human Sci, Sao Paulo, SP, Brazil.
EM ricardo.palacios@butantan.gov.br
RI Palacios, Ricardo/AAN-7606-2020
OI Palacios, Ricardo/0000-0002-1410-8579
FU Global Forum on Bioethics in Research (GFBR); Wellcome TrustWellcome
   Trust; Bill & Melinda Gates FoundationGates Foundation [OPP1151904];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; UK Medical Research
   CouncilMedical Research Council UK (MRC)
FX Funds were provided by the Global Forum on Bioethics in Research (GFBR).
   GFBR funding is provided by the Wellcome Trust, the Bill & Melinda Gates
   Foundation [OPP1151904], the National Institutes of Health, and the UK
   Medical Research Council. The GFBR and its funders had no role in the
   conception of the research or in writing the manuscripts.
CR Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   [Anonymous], 2018, 2018 ANN REV DIS PRI
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405
   Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594
   Butler D, 2016, NATURE, V529, P263, DOI 10.1038/nature.2016.19189
   Clements AN, 2017, J VECTOR ECOL, V42, P208, DOI 10.1111/jvec.12261
   Cohen J., 2018, SCIENCE, DOI [10.1126/science.aav3996, DOI 10.1126/SCIENCE.AAV3996]
   Council for International Organizations of Medical Sciences, 2016, INT ETH GUID HLTH RE
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Cryder CE, 2010, SOC SCI MED, V70, P455, DOI 10.1016/j.socscimed.2009.10.047
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dennehy JJ, 2017, ANN NY ACAD SCI, V1389, P124, DOI 10.1111/nyas.13304
   Dickert N, 1999, NEW ENGL J MED, V341, P198, DOI 10.1056/NEJM199907153410312
   Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709
   Emanuel EJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3271
   Ghooi Ravindra B, 2011, Perspect Clin Res, V2, P72, DOI 10.4103/2229-3485.80371
   Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kraft SA, 2019, J EMPIR RES HUM RES, V14, P49, DOI 10.1177/1556264618820219
   Miller FG, 2009, J MED ETHICS, V35, P445, DOI 10.1136/jme.2008.026062
   Mitchell PK, 2019, AM J EPIDEMIOL, V188, P206, DOI 10.1093/aje/kwy189
   Mngadi KT, 2017, J MED ETHICS, V43, P824, DOI 10.1136/medethics-2016-103414
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nayak R, 2017, BIOETHICS, V31, P116, DOI 10.1111/bioe.12322
   Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28
   Njue Maureen, 2018, Wellcome Open Res, V3, P39, DOI [10.12688/wellcomeopenres.14439.1, 10.12688/wellcomeopenres.14439.2]
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Presidential Commission for the Study of Bioethical Issues, STD RES GUAT 1946 19
   Roestenberg M, 2018, LANCET INFECT DIS, V18, pE312, DOI 10.1016/S1473-3099(18)30177-4
   Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577
   Selgelid Michael J, 2018, Indian J Med Ethics, V3, P263, DOI 10.20529/IJME.2018.073
   Shah SK, 2018, SCIENCE, V360, P158, DOI 10.1126/science.aaq0917
   Shah SK, ETHICAL CONSIDERATIO
   Spring M, 2014, J INFECT DIS, V209, P540, DOI 10.1093/infdis/jiu063
   Stunkel L, 2011, CONTEMP CLIN TRIALS, V32, P342, DOI 10.1016/j.cct.2010.12.003
   Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   WHO Statement, 2016, 5 M EM COMM INT HLTH
NR 43
TC 1
Z9 1
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6215
J9 TRIALS
JI Trials
PD DEC 19
PY 2019
VL 20
IS 1
SU 2
AR 702
DI 10.1186/s13063-019-3843-0
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA KC0PN
UT WOS:000506890000002
PM 31852506
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Van Rompay, KKA
   Keesler, RI
   Ardeshir, A
   Watanabe, J
   Usachenko, J
   Singapuri, A
   Cruzen, C
   Bliss-Moreau, E
   Murphy, AM
   Yee, JL
   Webster, H
   Dennis, M
   Singh, T
   Heimsath, H
   Lemos, D
   Stuart, J
   Morabito, KM
   Foreman, BM
   Burgomaster, KE
   Noe, AT
   Dowd, KA
   Ball, E
   Woolard, K
   Presicce, P
   Kallapur, SG
   Permar, SR
   Foulds, KE
   Coffey, LL
   Pierson, TC
   Graham, BS
AF Van Rompay, Koen K. A.
   Keesler, Rebekah I.
   Ardeshir, Amir
   Watanabe, Jennifer
   Usachenko, Jodie
   Singapuri, Anil
   Cruzen, Christina
   Bliss-Moreau, Eliza
   Murphy, Ashley M.
   Yee, Joann L.
   Webster, Helen
   Dennis, Maria
   Singh, Tulika
   Heimsath, Holly
   Lemos, Danilo
   Stuart, Jackson
   Morabito, Kaitlyn M.
   Foreman, Bryant M.
   Burgomaster, Katherine E.
   Noe, Amy T.
   Dowd, Kimberly A.
   Ball, Erin
   Woolard, Kevin
   Presicce, Pietro
   Kallapur, Suhas G.
   Permar, Sallie R.
   Foulds, Kathryn E.
   Coffey, Lark L.
   Pierson, Theodore C.
   Graham, Barney S.
TI DNA vaccination before conception protects Zika virus-exposed pregnant
   macaques against prolonged viremia and improves fetal outcomes
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID ANTIGEN; DISEASE
AB Zika virus (ZIKV) infection of pregnant women is associated with congenital Zika syndrome (CZS) and no vaccine is available, although several are being tested in clinical trials. We tested the efficacy of ZIKV DNA vaccine VRC5283 in a rhesus macaque model of congenital ZIKV infection. Most animal vaccine experiments have a set pathogen exposure several weeks or months after vaccination. In the real world, people encounter pathogens years or decades after vaccination, or may be repeatedly exposed if the virus is endemic. To more accurately mimic how this vaccine would be used, we immunized macaques before conception and then exposed them repeatedly to ZIKV during early and mid-gestation. In comparison to unimmunized animals, vaccinated animals had a significant reduction in peak magnitude and duration of maternal viremia, early fetal loss, fetal infection, and placental and fetal brain pathology. Vaccine-induced neutralizing antibody titers on the day of first ZIKV exposure were negatively associated with the magnitude of maternal viremia, and the absence of prolonged viremia was associated with better fetal outcomes. These data support further clinical development of ZIKV vaccine strategies to protect against negative fetal outcomes.
C1 [Van Rompay, Koen K. A.; Keesler, Rebekah I.; Ardeshir, Amir; Watanabe, Jennifer; Usachenko, Jodie; Cruzen, Christina; Bliss-Moreau, Eliza; Murphy, Ashley M.; Yee, Joann L.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Van Rompay, Koen K. A.; Singapuri, Anil; Lemos, Danilo; Stuart, Jackson; Ball, Erin; Woolard, Kevin; Coffey, Lark L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Bliss-Moreau, Eliza; Murphy, Ashley M.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.
   [Webster, Helen; Dennis, Maria; Singh, Tulika; Heimsath, Holly; Permar, Sallie R.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA.
   [Morabito, Kaitlyn M.; Noe, Amy T.; Foulds, Kathryn E.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Foreman, Bryant M.; Burgomaster, Katherine E.; Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Presicce, Pietro; Kallapur, Suhas G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol, Los Angeles, CA 90095 USA.
   [Presicce, Pietro; Kallapur, Suhas G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Dev Biol, Los Angeles, CA 90095 USA.
RP Van Rompay, KKA (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.; Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM kkvanrompay@ucdavis.edu; bgraham@nih.gov
RI Presicce, Pietro/AAN-8719-2020; ARDESHIR, AMIR/Q-1258-2017
OI Presicce, Pietro/0000-0002-2690-1814; Van Rompay,
   Koen/0000-0002-7375-1337; ARDESHIR, AMIR/0000-0002-4330-4659
FU Office of Research Infrastructure Program/OD (CNPRC) [P510D11107];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32 CA009111]; Intramural Research
   Program of the National Institute of Allergy and Infectious Diseases,
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID);  [R21AI129479-S];  [R21NS104692]; 
   [R21HD090856];  [R01HD098389]
FX This work was supported by R21AI129479-S (to K.K.A. V.R.), the Office of
   Research Infrastructure Program/OD (P510D11107; CNPRC), R21NS104692
   (E.B.-M.), R21HD090856 and R01HD098389 (to S.G. K.), NIH T32 CA009111
   (to T.S.), and the Intramural Research Program of the National Institute
   of Allergy and Infectious Diseases, NIH (to K.M.M., B.M.F., K.E.B.,
   A.T.N., K.A.D., K. E. F., T.C.P., and B.S.G.).
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Azevedo RSS, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120496
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Bedda M, 2016, J IMMUNOL METHODS, V439, P74, DOI 10.1016/j.jim.2016.08.009
   Bialas KM, 2015, P NATL ACAD SCI USA, V112, P13645, DOI 10.1073/pnas.1511526112
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cohen J, 2018, SCIENCE, V361, P1055, DOI 10.1126/science.361.6407.1055
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Forootan Amin, 2017, Biomol Detect Quantif, V12, P1, DOI 10.1016/j.bdq.2017.04.001
   Foulds KE, 2012, CYTOM PART A, V81A, P360, DOI 10.1002/cyto.a.22008
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reader JR, 2016, COMPARATIVE MED, V66, P162
   Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Vannuccini S, 2016, HUM REPROD UPDATE, V22, P104, DOI 10.1093/humupd/dmv044
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 35
TC 1
Z9 1
U1 2
U2 3
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD DEC 18
PY 2019
VL 11
IS 523
AR eaay2736
DI 10.1126/scitranslmed.aay2736
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA JW9ZV
UT WOS:000503405100005
PM 31852797
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wedell, N
   Price, TAR
   Lindholm, AK
AF Wedell, N.
   Price, T. A. R.
   Lindholm, A. K.
TI Gene drive: progress and prospects
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Editorial Material
DE vector control; population control; invasive species; synthetic biology;
   genetic management; Wolbachia
ID SELFISH GENES; DISTORTION; WOLBACHIA; EVOLUTION; SYSTEM
AB Gene drive is a naturally occurring phenomenon in which selfish genetic elements manipulate gametogenesis and reproduction to increase their own transmission to the next generation. Currently, there is great excitement about the potential of harnessing such systems to control major pest and vector populations. If synthetic gene drive systems can be constructed and applied to key species, they may be able to rapidly spread either modifying or eliminating the targeted populations. This approach has been lauded as a revolutionary and efficient mechanism to control insect-borne diseases and crop pests. Driving endosymbionts have already been deployed to combat the transmission of dengue and Zika virus in mosquitoes. However, there are a variety of barriers to successfully implementing gene drive techniques in wild populations. There is a risk that targeted organisms will rapidly evolve an ability to suppress the synthetic drive system, rendering it ineffective. There are also potential risks of synthetic gene drivers invading non-target species or populations. This Special Feature covers the current state of affairs regarding both natural and synthetic gene drive systems with the aim to identify knowledge gaps. By understanding how natural drive systems spread through populations, we may be able to better predict the outcomes of synthetic drive release.
C1 [Wedell, N.] Univ Exeter, Dept Biosci, Penryn Campus, Penryn TR10 9FE, England.
   [Price, T. A. R.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
   [Lindholm, A. K.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
RP Wedell, N (corresponding author), Univ Exeter, Dept Biosci, Penryn Campus, Penryn TR10 9FE, England.
EM n.wedell@exeter.ac.uk
RI ; Lindholm, Anna/E-5207-2012
OI Wedell, Nina/0000-0003-1170-8613; Lindholm, Anna/0000-0001-8460-9769
CR Anders KL, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2670-z
   Babcock CS, 1996, MOL BIOL EVOL, V13, P297, DOI 10.1093/oxfordjournals.molbev.a025589
   Backus GA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1589
   Barrett LG, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1515
   Bastide H, 2013, MOL ECOL, V22, P5352, DOI 10.1111/mec.12492
   Bastide H, 2011, MOL BIOL EVOL, V28, P2461, DOI 10.1093/molbev/msr074
   Beaghton AK, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1586
   BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060
   Buchman A, 2018, P NATL ACAD SCI USA, V115, P4725, DOI 10.1073/pnas.1713139115
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Burt A, 2006, GENES CONFLICT BIOL
   Callaway E, 2018, NATURE, V563, P454, DOI 10.1038/d41586-018-07436-4
   Charlat S, 2007, SCIENCE, V317, P214, DOI 10.1126/science.1143369
   Courret C, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1430
   Dearden PK, 2018, J ROY SOC NEW ZEAL, V48, P225, DOI 10.1080/03036758.2017.1385030
   Dyer KA, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.2529
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   Finnegan SR, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1414
   Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   George DR, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1484
   Gerber R, 2016, SCI TOTAL ENVIRON, V550, P522, DOI 10.1016/j.scitotenv.2016.01.129
   Godwin J, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1606
   Grunwald HA, 2019, NATURE, V566, P105, DOI [10.1038/s41586-019-0875-2, 10.1038/s41586-019-1861-4]
   HAMMERBERG C, 1975, NATURE, V253, P137, DOI 10.1038/253137a0
   Herrmann BG, 2019, EVOLUTION HOUSE MOUS
   Holman L, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1070
   Jaenike J, 2008, J EVOLUTION BIOL, V21, P1570, DOI 10.1111/j.1420-9101.2008.01607.x
   Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958
   Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064
   Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245
   Larner W, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.2038
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Lea JK, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1534
   Ledford H, 2019, NATURE, V572, P15, DOI 10.1038/d41586-019-02162-x
   Leitschuh CM, 2018, J RESPONSIBLE INNOV, V5, pS121, DOI 10.1080/23299460.2017.1365232
   Lindholm A, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1927
   Lohr MT, 2018, SCI TOTAL ENVIRON, V634, P1372, DOI 10.1016/j.scitotenv.2018.04.069
   Macias VM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091006
   Mallapaty Smriti, 2019, Nature, DOI 10.1038/d41586-019-01282-8
   Manser A, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0852
   National Academies of Sciences Engineering and Medicine, 2016, GEN DRIV HOR ADV SCI
   Oberhofer G, 2018, P NATL ACAD SCI USA, V115, pE9343, DOI 10.1073/pnas.1805278115
   Price TAR, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.2267
   Ritchie SA, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0973
   Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379
   Sheppard A, 2017, SYNTHETIC GENE DRIVE
   Taylor ML, 2014, TRENDS ECOL EVOL, V29, P376, DOI 10.1016/j.tree.2014.04.005
   The Royal Society, 2018, GEN DRIV RES WHY IT, P1
   Tsutsui ND, 2003, CONSERV BIOL, V17, P48, DOI 10.1046/j.1523-1739.2003.02018.x
   Wang J, 2013, NATURE, V493, P664, DOI 10.1038/nature11832
   Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114
   Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937
   WOOD RJ, 1991, AM NAT, V137, P379, DOI 10.1086/285171
NR 54
TC 0
Z9 0
U1 10
U2 11
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD DEC 18
PY 2019
VL 286
IS 1917
AR 20192709
DI 10.1098/rspb.2019.2709
PG 7
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA JY3IW
UT WOS:000504313100013
PM 31847764
OA Green Published, Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Hefferon, KL
AF Hefferon, Kathleen L.
TI The role of plant expression platforms in biopharmaceutical development:
   possibilities for the future
SO EXPERT REVIEW OF VACCINES
LA English
DT Review
DE Transgenic plant; virus expression vector; HIV/AIDS; influenza virus;
   Ebola virus; monoclonal antibody; vaccine
ID VACCINE PROTECTS MICE; WEST NILE VIRUS; HIGH-LEVEL EXPRESSION; VIRAL
   VECTORS; MADE VACCINES; MULTICOMPONENT VACCINE; IMMUNE-RESPONSES;
   MOSAIC-VIRUS; NANOPARTICLES; PARTICLES
AB Introduction: Plant-made vaccines have been in the pipeline for nearly thirty years. Generated stably in transgenic plants or transiently using virus expression systems, pharmaceuticals have been developed to address global pandemics as well as several emerging One Health Diseases. Areas covered: This review describes the generation of plant-made vaccines to address some of the world's most growing health concerns, including both infectious and non-communicable diseases, such as cancer. The review provides an overview of the research taking place in this field over the past three to five years. The PubMed database was searched under the topic of plant-made vaccine between the periods of 2014 and 2019. Expert opinion: While vaccines and other biologics have been shown to be cheap safe and efficacious, they have not yet entered the marketplace largely due to regulatory constraints. The lack of an appropriate regulatory structure to guide plant-made vaccines through to commercial development has stalled efforts to provide life-saving medicines to low- and middle-income families. In my opinion, it is paramount that regulatory hurdles are mitigated to address emerging infectious diseases such as Ebola and Zika in a timely manner.
C1 [Hefferon, Kathleen L.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.
RP Hefferon, KL (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.
EM kathleen.hefferon@alumni.utoronto.ca
OI Hefferon, Kathleen/0000-0003-3550-0366
CR Boehm R, 2007, ANN NY ACAD SCI, V1102, P121, DOI 10.1196/annals.1408.009
   Bruckman MA, 2018, METHODS MOL BIOL, V1776, P425, DOI 10.1007/978-1-4939-7808-3_28
   Cardona-Ospina Jaime A, 2016, F1000Res, V5, P2121
   Cervera L, 2019, APPL MICROBIOL BIOT, V103, P7367, DOI 10.1007/s00253-019-10038-3
   Chan HT, 2016, PLANT BIOTECHNOL J, V14, P2190, DOI 10.1111/pbi.12575
   Chan HT, 2015, PLANT BIOTECHNOL J, V13, P1056, DOI 10.1111/pbi.12471
   Chen Q, 2015, BIOTECHNOL J, V10, P671, DOI 10.1002/biot.201400428
   Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297
   Czapar AE, 2017, CURR OPIN CHEM BIOL, V38, P108, DOI 10.1016/j.cbpa.2017.03.013
   D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x
   Eiben S, 2019, ADV DRUG DELIVER REV, V145, P96, DOI 10.1016/j.addr.2018.08.011
   Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007
   Gleba YY, 2014, CURR TOP MICROBIOL, V375, P155, DOI 10.1007/82_2013_352
   Grubaugh ND, 2016, CURR OPIN VIROL, V21, P132, DOI 10.1016/j.coviro.2016.09.007
   HAQ TA, 1995, SCIENCE, V268, P714, DOI 10.1126/science.7732379
   Hefferon KL, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010011
   Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P344, DOI 10.1111/tbed.12401
   Hoelscher M, 2018, PLANT MOL BIOL, V97, P357, DOI 10.1007/s11103-018-0744-7
   Holtz BR, 2015, PLANT BIOTECHNOL J, V13, P1180, DOI 10.1111/pbi.12469
   Ishiura S, 2019, P JPN ACAD B-PHYS, V95, P290, DOI 10.2183/pjab.95.020
   Kalbina I, 2016, PROTEIN EXPRES PURIF, V127, P61, DOI 10.1016/j.pep.2016.07.003
   Karaman S, 2012, PLANT CELL REP, V31, P527, DOI 10.1007/s00299-011-1146-3
   Kim HS, 2014, BIOMED RES INT, DOI 10.1155/2014/249519
   Klimyuk V, 2014, CURR TOP MICROBIOL, V375, P127, DOI 10.1007/82_2012_212
   Lai HF, 2018, VACCINE, V36, P1846, DOI 10.1016/j.vaccine.2018.02.073
   Lindsay BJ, 2018, VACCINE, V36, P2147, DOI 10.1016/j.vaccine.2018.02.106
   Lizotte PH, 2016, NAT NANOTECHNOL, V11, P295, DOI [10.1038/NNANO.2015.292, 10.1038/nnano.2015.292]
   Lossl AG, 2011, PLANT BIOTECHNOL J, V9, P527, DOI 10.1111/j.1467-7652.2011.00615.x
   Loh HS, 2017, CURR OPIN VIROL, V26, P81, DOI 10.1016/j.coviro.2017.07.019
   Lotter-Stark HCT, 2012, BIOTECHNOL ADV, V30, P1614, DOI 10.1016/j.biotechadv.2012.06.002
   Madden AJ, 2017, NANOMEDICINE-UK, V12, P2519, DOI 10.2217/nnm-2016-0421
   Makarkov AI, 2017, VACCINE, V35, P4629, DOI 10.1016/j.vaccine.2017.07.012
   Margolin E, 2018, PLANT BIOTECHNOL J, V16, P1531, DOI 10.1111/pbi.12963
   Marquez-Escobar VA, 2017, EXPERT REV VACCINES, V16, P137, DOI 10.1080/14760584.2017.1232167
   Marsian J, 2016, CURR OPIN BIOTECH, V37, P201, DOI 10.1016/j.copbio.2015.12.007
   Mbewana S, 2018, BMC BIOTECHNOL, V18, DOI 10.1186/s12896-018-0489-z
   McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5488
   Mechtcheriakova IA, 2006, J VIROL METHODS, V131, P10, DOI 10.1016/j.jviromet.2005.06.020
   Monreal-Escalante E, 2017, PLANTA, V246, P123, DOI 10.1007/s00425-017-2689-5
   Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108
   Pillet S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216533
   Pniewski T, 2017, PLANT CELL REP, V36, P49, DOI 10.1007/s00299-016-2056-1
   Posgai AL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42372
   Roder J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01125
   Rosales-Mendoza S, 2018, J BIOTECHNOL, V266, P124, DOI 10.1016/j.jbiotec.2017.12.012
   Rosales-Mendoza S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00252
   Rosales-Mendoza S, 2012, PLANT CELL REP, V31, P495, DOI 10.1007/s00299-011-1194-8
   Rybicki EP, 2017, HUM VACC IMMUNOTHER, V13, P2912, DOI 10.1080/21645515.2017.1356497
   Salazar-Gonzalez JA, 2015, VACCINE, V33, P3650, DOI 10.1016/j.vaccine.2015.05.104
   Saldana S, 2006, VIRAL IMMUNOL, V19, P42, DOI 10.1089/vim.2006.19.42
   Saxena P, 2016, METHODS MOL BIOL, V1385, P39, DOI 10.1007/978-1-4939-3289-4_3
   Schmidt JA, 2019, NAT PLANTS, V5, P715, DOI 10.1038/s41477-019-0467-z
   Scotti N, 2009, PLANTA, V229, P1109, DOI 10.1007/s00425-009-0898-2
   Shukla S, 2017, BIOMATERIALS, V121, P15, DOI 10.1016/j.biomaterials.2016.12.030
   Takeyama Natsumi, 2015, Ther Adv Vaccines, V3, P139, DOI 10.1177/2051013615613272
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002
   Vamvaka E, 2018, P NATL ACAD SCI USA, V115, pE7854, DOI 10.1073/pnas.1806022115
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yoshimura K, 2017, J INFECT CHEMOTHER, V23, P12, DOI 10.1016/j.jiac.2016.10.002
   Yu J, 2001, NAT BIOTECHNOL, V19, P548, DOI 10.1038/89297
   Yusibov V, 2015, EXPERT REV VACCINES, V14, P519, DOI 10.1586/14760584.2015.989988
   Yusibov V, 2013, CURR PHARM DESIGN, V19, P5574, DOI 10.2174/13816128113199990335
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
NR 64
TC 0
Z9 0
U1 8
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD DEC 2
PY 2019
VL 18
IS 12
BP 1301
EP 1308
DI 10.1080/14760584.2019.1704264
EA DEC 2019
PG 8
WC Immunology
SC Immunology
GA KB7UB
UT WOS:000504386900001
PM 31829081
OA Bronze
DA 2020-07-08
ER

PT J
AU Khor, CS
   Mohd-Rahim, NF
   Hassan, H
   Tan, KK
   Zainal, N
   Teoh, BT
   Sam, SS
   Khoo, JJ
   Lee, HY
   Lim, YAL
   Abubakar, S
AF Khor, Chee-Sieng
   Mohd-Rahim, Nurul-Farhana
   Hassan, Habibi
   Tan, Kim-Kee
   Zainal, Nurhafiza
   Teoh, Boon-Teong
   Sam, Sing-Sin
   Khoo, Jing-Jing
   Lee, Hai-Yen
   Lim, Yvonne Ai-Lian
   Abubakar, Sazaly
TI Serological evidence of DENV, JEV, and ZIKV among the indigenous people
   (Orang Asli) of Peninsular Malaysia
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article; Early Access
DE dengue; infectious diseases; Japanese encephalitis; Orang Asli;
   seroprevalence; Zika
ID JAPANESE ENCEPHALITIS-VIRUS; RISK-FACTORS; INFECTION; NEUTRALIZATION;
   ANTIBODIES; MOSQUITOS; TRAVEL; AREAS; AEDES
AB Dengue virus (DENV), Japanese encephalitis virus (JEV), and Zika virus (ZIKV) are mosquito-borne flavivirus of medical importance in tropical countries such as Malaysia. However, much remains unknown regarding their prevalence among the underserved indigenous people (Orang Asli) living in communities in the forest fringe areas of Peninsular Malaysia. Information on the prevalence of diseases is necessary to elevate the effectiveness of disease control and preventive measures. This study aimed to determine the seroprevalence of the three major flaviviruses among the Orang Asli and investigate the association between demographic factors and seropositivities. Sampling activities were conducted in the Orang Asli villages to obtain serum samples and demographic data from consenting volunteers. The presence of DENV, JEV, and ZIKV immunoglobulin G (IgG) antibodies in the sera were examined using commercial enzyme-linked immunosorbent assay kits. A focus reduction neutralization assay was performed to measure virus-specific neutralizing antibodies. A total of 872 serum samples were obtained from the Orang Asli volunteers. Serological assay results revealed that DENV IgG, JEV IgG, and ZIKV IgG seropositivities among the Orang Asli were at 4.9%, 48.4%, and 13.2%, respectively. Neutralizing antibodies (FRNT50 >= 1:40) against JEV and ZIKV were found in 86.7% and 100.0%, respectively, out of the samples tested. Positive serology to all three viruses corresponded significantly to the age of the volunteers with increasing seropositivity in older volunteers. Findings from the study suggest that Orang Asli are at significant risk of contracting JEV and ZIKV infections despite the lack of active transmission of the viruses in the country.
C1 [Khor, Chee-Sieng; Mohd-Rahim, Nurul-Farhana; Hassan, Habibi; Tan, Kim-Kee; Zainal, Nurhafiza; Teoh, Boon-Teong; Sam, Sing-Sin; Khoo, Jing-Jing; Lee, Hai-Yen; Abubakar, Sazaly] Univ Malaya, Trop Infect Dis Res & Educ Ctr, Level 2,High Impact Res Bldg, Kuala Lumpur 50603, Malaysia.
   [Mohd-Rahim, Nurul-Farhana; Hassan, Habibi; Zainal, Nurhafiza; Abubakar, Sazaly] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.
   [Lim, Yvonne Ai-Lian] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia.
RP Abubakar, S (corresponding author), Univ Malaya, Trop Infect Dis Res & Educ Ctr, Level 2,High Impact Res Bldg, Kuala Lumpur 50603, Malaysia.
EM sazaly@um.edu.my
RI LIM, YVONNE AL/B-5276-2010; Tan, Kim-Kee/P-7285-2014; Khoo, Jing
   Jing/G-6198-2013; Zainal, Nurhafiza/H-6147-2017
OI LIM, YVONNE AL/0000-0003-4050-6332; Tan, Kim-Kee/0000-0002-5816-9146;
   Khoo, Jing Jing/0000-0003-1285-6052; Zainal,
   Nurhafiza/0000-0003-1750-8487
FU Ministry of Education MalaysiaMinistry of Education, Malaysia
   [MO002-2019, LRGS MRUN/F1/01/2018]; Universiti MalayaUniversiti Malaya
   [UM.00000188/HGA.GV, RU008-2018]
FX Ministry of Education Malaysia, Grant/Award Numbers: HICoE program:
   MO002-2019, LRGS MRUN Phase 1: LRGS MRUN/F1/01/2018; Universiti Malaya,
   Grant/Award Numbers: UMCoE Top 100 Research Grant: UM.00000188/HGA.GV,
   University Research Grant 2018: RU008-2018
CR Amicizia D, 2018, J Prev Med Hyg, V59, pE99, DOI 10.15167/2421-4248/jpmh2018.59.1.962
   Andy J, 1967, ECOLOGY DENGUE OTHER
   Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]
   Cardosa J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000423
   Chang CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190637
   Department of Environment Ministry of Natural Resources and Environment Malaysia, 2012, GUID SIT ZON IND RES, P29
   Dhanoa A, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-017-0384-1
   Dony JJF, 2018, PLOS CURR OUTBREAKS
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Ho LL, 2017, HEALTH SECUR, V15, P185, DOI 10.1089/hs.2016.0106
   Howell Colleen J., 2010, Environment Development and Sustainability, V12, P1, DOI 10.1007/s10668-008-9176-x
   ILKAL MA, 1994, ACTA VIROL, V38, P157
   ILKAL MA, 1988, T ROY SOC TROP MED H, V82, P628, DOI 10.1016/0035-9203(88)90536-6
   Impoinvil DE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002334
   Kumar K, 2018, ACTA TROP, V185, P219, DOI 10.1016/j.actatropica.2018.05.017
   Kumar K, 2018, TROP ANIM HEALTH PRO, V50, P741, DOI 10.1007/s11250-017-1490-6
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marlina S, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0597-0
   Ministry of Health M, 2016, KEN AKHB KPK 18 DIS
   Ministry of Rural and Regional Development Malaysia, 2014, BIL KAMP DAN PEND OR
   Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159
   Muhammad Azami Nor Azila, 2011, BMC Res Notes, V4, P216, DOI 10.1186/1756-0500-4-216
   Nealon J, 2019, J INFECT DIS, V219, P375, DOI 10.1093/infdis/jiy513
   Nurin-Zulkifli IM, 2015, SE ASIAN J TROP MED, V46, P574
   OKUNO Y, 1979, BIKEN J, V22, P131
   Prasith N, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/WPSAR.2012.3.4.020, 10.5365/wpsar.2012.3.4.020]
   Rahim AA, 2010, AM J TROP MED HYG, V83, P1119, DOI 10.4269/ajtmh.2010.10-0226
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   RUDNICK ALBERT, 1965, J MED ENTOMOL, V2, P203, DOI 10.1093/jmedent/2.2.203
   SIMPSON DIH, 1970, ANN TROP MED PARASIT, V64, P137, DOI 10.1080/00034983.1970.11686675
   SMITH CEG, 1956, NATURE, V178, P581, DOI 10.1038/178581a0
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Tan KK, 2018, EPIDEMIOL INFECT, V146, P1635, DOI [10.1017/s0950268818001425, 10.1017/S0950268818001425]
   Tan W, INT C ON HLTH 24 VAM
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tay ST, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002341
   Teoh BT, 2010, EMERG INFECT DIS, V16, P1783, DOI 10.3201/eid1611.100721
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Thevakumar K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159830
   VOELKER R, 2019, JAMA-J AM MED ASSOC, V321, P2066, DOI DOI 10.1001/JAMA.2019.6886
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   VYTHILINGAM I, 1995, J AM MOSQUITO CONTR, V11, P94
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong SS, 2007, VIRAL IMMUNOL, V20, P359, DOI 10.1089/vim.2006.0100
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
NR 48
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
DI 10.1002/jmv.25649
EA DEC 2019
PG 7
WC Virology
SC Virology
GA JW5PQ
UT WOS:000503104200001
PM 31814135
DA 2020-07-08
ER

PT J
AU Pantano, S
AF Pantano, Sergio
TI Dissecting the role of glycosylation in Zika virus envelope with
   biochemical methods
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Editorial Material
C1 [Pantano, Sergio] Inst Pasteur Montevideo, Montevideo, Uruguay.
RP Pantano, S (corresponding author), Inst Pasteur Montevideo, Montevideo, Uruguay.
EM spantano@pasteur.edu.uy
CR Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
NR 1
TC 0
Z9 0
U1 1
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 17
PY 2019
VL 520
IS 4
BP 690
EP 690
DI 10.1016/j.bbrc.2019.10.005
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KB3PK
UT WOS:000506411600018
PM 31761080
OA Bronze
DA 2020-07-08
ER

PT J
AU Mei, CL
   Yang, WN
   Wei, X
   Wu, KJ
   Huang, DH
AF Mei, Chunlei
   Yang, Weina
   Wei, Xin
   Wu, Kejia
   Huang, Donghui
TI The Unique Microbiome and Innate Immunity During Pregnancy
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE pregnancy; microorganisms; innate immunity; maternal-fetus interface; NK
   cells; placenta; defense
ID TOLL-LIKE RECEPTORS; FEMALE GENITAL-TRACT; ANTIMICROBIAL PEPTIDES;
   PRETERM BIRTH; ZIKA VIRUS; VERTICAL TRANSMISSION; BACTERIAL VAGINOSIS;
   VAGINAL MICROBIOTA; CELLS; INFECTION
AB A successful pregnancy depends on not only the tolerance of the fetal immune system by the mother but also resistance against the threat of hazardous microorganisms. Infection with pathogenic microorganisms during pregnancy may lead to premature delivery, miscarriage, growth restriction, neonatal morbidity, and other adverse outcomes. Moreover, the host also has an intact immune system to avoid these adverse outcomes. It is important to note the presence of normal bacteria in the maternal reproductive tract and the principal role of the maternal-placental-fetal interaction in antimicrobial immunity. Previous studies mainly focused on maternal infection during pregnancy. However, this review summarizes the new views on the study of the maternal microbiome and expounds the innate immune defense mechanism of the maternal vagina and decidua as well as how cytotrophoblasts and syncytiotrophoblasts recognize and kill bacteria in the placenta. Fetal immune systems, thought to be weak, also exhibit an immune defense function that is indispensable for maintaining the safety of the fetus. The skin, lungs, and intestines of the fetus during pregnancy constitute the main immune barriers. These findings will provide a new understanding of the effects of normal microbial flora and how the host resists harmful microbes during pregnancy. We believe that it may also contribute to the reference on the clinical prevention and treatment of gestational infection to avoid adverse pregnancy outcomes.
C1 [Mei, Chunlei; Yang, Weina; Huang, Donghui] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Reprod Hlth, Wuhan, Hubei, Peoples R China.
   [Wei, Xin] Jinlin Univ, Affiliated Hosp 2, Changchun, Jilin, Peoples R China.
   [Wu, Kejia] Wuhan Univ, Zhongnan Hosp, Wuhan, Hubei, Peoples R China.
RP Huang, DH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Reprod Hlth, Wuhan, Hubei, Peoples R China.
EM jhsyyjs@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81771575]; National Key RD Plan [2018YFC1004300]
FX This work was supported by National Natural Science Foundation of China
   (No. 81771575) and the National Key R&D Plan (No. 2018YFC1004300).
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466
   Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Bearfield C, 2002, BJOG-INT J OBSTET GY, V109, P527, DOI 10.1111/j.1471-0528.2002.01349.x
   Bernstein DI, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0129-1
   Bernstein DI, 2017, J INFECT DIS, V215, P856, DOI 10.1093/infdis/jix004
   Bulla R, 2009, J REPROD IMMUNOL, V82, P119, DOI 10.1016/j.jri.2009.06.124
   Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949
   Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9
   Chen C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00901-0
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Cluver C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010485.pub2
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Dasari P, 2011, PEDIAT ALLERG IMM-UK, V22, P221, DOI 10.1111/j.1399-3038.2010.01091.x
   de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571
   de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5
   Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245
   Doerflinger SY, 2014, J INFECT DIS, V209, P1989, DOI 10.1093/infdis/jiu004
   Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039
   Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107
   Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x
   Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x
   Dou YL, 2019, J IMMUNOL, V203, P873, DOI 10.4049/jimmunol.1900171
   El Costa H, 2008, J IMMUNOL, V181, P3009, DOI 10.4049/jimmunol.181.5.3009
   Erez O, 2017, AM J OBSTET GYNECOL, V217, P228, DOI 10.1016/j.ajog.2017.04.009
   Faure E, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002668
   Fox C, 2015, FERTIL STERIL, V104, P1358, DOI 10.1016/j.fertnstert.2015.09.037
   Franasiak JM, 2016, J ASSIST REPROD GEN, V33, P129, DOI 10.1007/s10815-015-0614-z
   Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023
   Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686
   Genc MR, 2011, BJOG-INT J OBSTET GY, V118, P154, DOI 10.1111/j.1471-0528.2010.02772.x
   Girardi G, 2006, MOL IMMUNOL, V43, P68, DOI 10.1016/j.molimm.2005.06.017
   Gjerdingen D, 2000, J FAM PRACTICE, V49, P39
   Goldberg M, 2007, MOL IMMUNOL, V44, P1737, DOI 10.1016/j.molimm.2006.07.298
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Gomez-Lopez N, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12827
   Gounder AP, 2012, J BIOL CHEM, V287, P24554, DOI 10.1074/jbc.M112.354068
   Greenhalgh K, 2016, ENVIRON MICROBIOL, V18, P2103, DOI 10.1111/1462-2920.13318
   Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0
   Harris M, 2009, MICROBIOL-SGM, V155, P1058, DOI 10.1099/mic.0.026120-0
   Hein M, 2002, AM J OBSTET GYNECOL, V187, P137, DOI 10.1067/mob.2002.123034
   Holmlund U, 2002, IMMUNOLOGY, V107, P145, DOI 10.1046/j.1365-2567.2002.01491.x
   Huang SJ, 2008, J PATHOL, V214, P328, DOI 10.1002/path.2257
   Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001
   Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039
   Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203
   Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836
   Jabrane-Ferrat N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01397
   Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218
   Jia ZF, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13096
   Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3
   Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2
   Jordan KA, 2009, INFECT IMMUN, V77, P3894, DOI 10.1128/IAI.00024-09
   Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860
   Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910
   Kim YM, 2006, HISTOPATHOLOGY, V49, P506, DOI 10.1111/j.1365-2559.2006.02542.x
   King AE, 2007, PLACENTA, V28, P1099, DOI 10.1016/j.placenta.2007.06.002
   King AE, 2007, PLACENTA, V28, P161, DOI 10.1016/j.placenta.2006.01.006
   Krieger Y, 2020, J EUR ACAD DERMATOL, V34, P319, DOI 10.1111/jdv.15881
   Kumamoto Y, 2012, CURR OPIN IMMUNOL, V24, P411, DOI 10.1016/j.coi.2012.05.006
   Lamont RF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00566
   Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3
   Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101
   Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.04.003
   Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210
   Malek A, 2001, J ASSIST REPROD GEN, V18, P299, DOI 10.1023/A:1016674503298
   Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110
   Marodi L, 2006, CLIN IMMUNOL, V118, P137, DOI 10.1016/j.clim.2005.10.012
   Marquardt N, 2016, J IMMUNOL, V197, P3069, DOI 10.4049/jimmunol.1502204
   Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729
   Martinez KA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1874
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   McMillan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14174
   Miller WR, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026997
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Momburg F, 2002, CURR TOP MICROBIOL, V269, P57
   Moore DL, 2019, PAED CHILD HEALT-CAN, V24, P128, DOI 10.1093/pch/pxz039
   Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64
   Moreno I, 2019, REPROD MED BIOL, V18, P40, DOI 10.1002/rmb2.12249
   Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776
   Nasioudis D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09857-z
   Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886
   Oh JE, 2019, NATURE, V571, P122, DOI 10.1038/s41586-019-1285-1
   Parnell LA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11514-4
   Patil AS, 2017, J MIDWIFERY WOM HEAL, V62, P298, DOI 10.1111/jmwh.12621
   Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4
   Petrova MI, 2013, FEMS MICROBIOL REV, V37, P762, DOI 10.1111/1574-6976.12029
   Porobic-Jahic Humera, 2019, Med Arch, V73, P149, DOI 10.5455/medarh.2019.73.149-153
   Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0
   Riley JK, 2010, CLIN REV ALLERG IMMU, V39, P185, DOI 10.1007/s12016-009-8178-2
   Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4
   Schleiss MR, 2016, TRENDS MICROBIOL, V24, P170, DOI 10.1016/j.tim.2016.01.007
   Schmidt W, 1992, Adv Anat Embryol Cell Biol, V127, P1
   Sgibnev AV, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.22913
   Shaw L, 2011, BIOCHEM SOC T, V39, P1450, DOI 10.1042/BST0391450
   Sheldon IM, 2011, AM J REPROD IMMUNOL, V66, P63, DOI 10.1111/j.1600-0897.2011.01034.x
   Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005
   Shimoya K, 2000, HUM REPROD, V15, P2234, DOI 10.1093/humrep/15.10.2234
   Silverman M, 2017, P NATL ACAD SCI USA, V114, P9671, DOI 10.1073/pnas.1712280114
   Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425
   Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336
   Taddei CR, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12993
   Tangeras LH, 2014, J REPROD IMMUNOL, V106, P89, DOI 10.1016/j.jri.2014.04.004
   Thompson JM, 2008, ADV DRUG DELIVER REV, V60, P786, DOI 10.1016/j.addr.2007.11.003
   Tribe RM, 2015, AM J REPROD IMMUNOL, V74, P123, DOI 10.1111/aji.12379
   Triggianese P, 2016, AM J REPROD IMMUNOL, V76, P245, DOI 10.1111/aji.12509
   Usui R, 2002, J PERINAT MED, V30, P458, DOI 10.1515/JPM.2002.072
   Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280
   Venkatesh KK, 2014, AM J REPROD IMMUNOL, V71, P495, DOI 10.1111/aji.12247
   Verstraelen H, 2007, AM J OBSTET GYNECOL, V196, P528, DOI 10.1016/j.ajog.2006.12.026
   Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116
   Wald A, 2016, JAMA-J AM MED ASSOC, V316, P2495, DOI 10.1001/jama.2016.18189
   Wald A, 2014, NEW ENGL J MED, V370, P201, DOI 10.1056/NEJMoa1301150
   Wang Z, 2014, VET J, V200, P116, DOI 10.1016/j.tvjl.2013.12.021
   Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   Wilkinson TS, 2011, BIOCHEM SOC T, V39, P1409, DOI 10.1042/BST0391409
   Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x
   Yarbrough VL, 2015, HUM REPROD UPDATE, V21, P353, DOI 10.1093/humupd/dmu065
   Yeh CC, 2013, REPROD SCI, V20, P339, DOI 10.1177/1933719112450330
   Yip LY, 2018, HEPATOLOGY, V67, P282, DOI 10.1002/hep.29327
   Yockey LJ, 2018, IMMUNITY, V49, P397, DOI 10.1016/j.immuni.2018.07.017
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Young OM, 2015, AM J REPROD IMMUNOL, V73, P22, DOI 10.1111/aji.12336
   Zarember KA, 2002, J IMMUNOL, V169, P1136, DOI 10.4049/jimmunol.169.2.1136
   Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821
   Zeldovich VB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002804
   Zhang YH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00120
   Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110
NR 132
TC 3
Z9 3
U1 9
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD DEC 17
PY 2019
VL 10
AR 2886
DI 10.3389/fimmu.2019.02886
PG 12
WC Immunology
SC Immunology
GA JZ3RH
UT WOS:000505018500001
PM 31921149
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gusmao, TPD
   de Faria, ABS
   Leao, JC
   Carvalho, ADT
   Gueiros, LAM
   Leao, JC
AF Gusmao, Teresa Paula de Lima
   de Faria, Andreza Barkokebas Santos
   Leao Filho, Jair Carneiro
   Carvalho, Alessandra de Albuquerque Tavares
   Gueiros, Luiz Alcino Monteiro
   Leao, Jair Carneiro
TI Dental changes in children with congenital Zika syndrome
SO ORAL DISEASES
LA English
DT Article
DE epidemiology; oral manifestations; Zika virus
ID VIRUS-INFECTION; TRANSMISSION; CHALLENGES; SPECTRUM; BRAZIL; CARE
AB Objective To describe oral alterations in children with congenital Zika syndrome (CZS). Methods This was a case series, whose research instrument was a structured questionnaire, associated with the use of medical record data and extra and intraoral clinical examination. Results Thirty-two children were evaluated, the majority male (18/32%-56.3%), mean age 22 months (SD = 2.71). It was also observed that the majority of the patients (19/32%-59.4%) presented a low family income. All the children had a mean head circumference of 29.43 cm (SD = 1.42). Regarding the alterations, an ogival-shaped palate was observed in 14 children (43.7%), and delayed chronology of eruption was observed in 15 children (46.9%), of whom 7 children (21.9%) did not present eruption of the upper left lateral incisor (p = .0002) and upper right lateral incisor (p = .002) until the moment of analysis. Additionally, 03 children with yellowish dental pigmentation were identified in erupted teeth after the onset of phenobarbital use. Enamel hypoplasia was identified in 9 children (28.1%) and only one child with ankyloglossia. Conclusion CZS may present delayed chronology of eruption, ankyloglossia, ogival-shaped palate, and enamel hypoplasia, requiring dental follow-up aimed at prevention, promotion, and rehabilitation of the health of these children.
C1 [Gusmao, Teresa Paula de Lima; de Faria, Andreza Barkokebas Santos; Leao Filho, Jair Carneiro; Carvalho, Alessandra de Albuquerque Tavares; Gueiros, Luiz Alcino Monteiro; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/F-7171-2012
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318
CR Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goldstein J, 2008, J CHILD NEUROL, V23, P407, DOI 10.1177/0883073807309230
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   Heckathorn DE, 2016, DYSPHAGIA, V31, P1, DOI 10.1007/s00455-015-9667-5
   Jaskoll T, 2008, ARCH ORAL BIOL, V53, P405, DOI 10.1016/j.archoralbio.2007.11.014
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leao JC, 2017, ORAL DIS, V23, P12, DOI 10.1111/odi.12512
   Lysell L., 1962, ODONTOL REVY, V13, P217
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Matsuo K, 2008, PHYS MED REH CLIN N, V19, P691, DOI 10.1016/j.pmr.2008.06.001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Programa das Nacoes Unidas para o desenvolvimento (PNUD), 2017, AV IMP SOC VIR ZIK A
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Secretaria de Saude de Pernambuco, 2017, INF EP INF TECN 21 S
   Seow WK, 2014, AUST DENT J, V59, P143, DOI 10.1111/adj.12104
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Walter L. R. F., 1999, ODONTOLOGIA BEBE ODO
   World Health Organization, 2016, WHOZIKVMOC163
NR 33
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD MAR
PY 2020
VL 26
IS 2
BP 457
EP 464
DI 10.1111/odi.13238
EA DEC 2019
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA KM7HG
UT WOS:000502876000001
PM 31742839
DA 2020-07-08
ER

PT J
AU Beau, F
   Mallet, HP
   Lastere, S
   Broult, J
   Laperche, S
AF Beau, Frederic
   Mallet, Henri-Pierre
   Lastere, Stephane
   Broult, Julien
   Laperche, Syria
TI Transfusion risk associated with recent arbovirus outbreaks in French
   Polynesia
SO VOX SANGUINIS
LA English
DT Article
DE arbovirus; blood safety; French Polynesia; nucleic acid testing; risk
   assessment
ID WEST-NILE VIRUS; BLOOD-TRANSFUSION; ZIKA VIRUS; DENGUE VIRUS;
   CHIKUNGUNYA; TRANSMISSION; SEROPREVALENCE; DONORS
AB Background and objectives French Polynesia, where dengue virus (DENV) has been present for a long time, experienced two successive outbreaks of Zika (ZIKV) and chikungunya viruses (CHIKV) between 2013 and 2015. To avoid the transmission of these viruses by transfusion, nucleic acid testing (NAT) has been in place for DENV since 2013 and for ZIKV and CHIKV during epidemics. The objective was to compare the estimated risk of viraemic blood donation with NAT results and to discuss the impact on the prevention of transfusion-related infectious risk. Materials and methods The average risks of viraemic blood donation were estimated per year for DENV, and during the epidemic periods for ZIKV and CHIKV, using the Biggerstaff and Petersen model based on the incidence rate, the mean length of viraemia and the frequency of asymptomatic infection. The estimated risks were compared with the number of viraemic blood donations detected by NAT. Results According to the different assumptions, risks estimates ranged from 11 center dot 2 to 53 center dot 1/100 000 donations for DENV, 746 to 1924/100 000 for ZIKV and 1083 /100 000 for CHIKV. When compared to the number of donations collected during the study periods, these estimates match NAT results (5 blood donors reactive for DENV, 42 for ZIKV and 34 for CHIKV). Conclusion The risks of viraemic blood donation were related to the viral incidence in the general population and concordant with NAT results. These findings suggest that the screening may be optimized by a targeted NAT implementation based on incidence data.
C1 [Beau, Frederic; Mallet, Henri-Pierre; Broult, Julien] Taaone Hosp, French Polynesia Blood Bank, Tahiti, French Polynesi, France.
   [Lastere, Stephane] Taaone Hosp, Clin Lab, Tahiti, French Polynesi, France.
   [Laperche, Syria] Natl Inst Blood Transfus INTS, Dept Blood Borne Agents, Natl Reference Ctr Infect Risks Blood Transfus, Paris, France.
RP Beau, F (corresponding author), Hop Taaone, Ctr Transfus Sanguine Polynesie Francaise, POB 4530, F-98713 Tahiti, French Polynesi, France.
EM frederic.beau@cht.pf
CR Aubry M, 2018, EMERG INFECT DIS, V24, P558, DOI 10.3201/eid2403.171149
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Biggerstaff BJ, 2003, TRANSFUSION, V43, P1007, DOI 10.1046/j.1537-2995.2003.00480.x
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Daudens E, 2009, B EPIDEMIOLOGIQUE HE, V48-49-50, P499
   Food and Drug Administration, 2018, REV REC RED RISK ZIK
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Lanteri MC, 2012, TRANSFUSION, V52, P1634, DOI 10.1111/j.1537-2995.2012.03747.x
   Mallet HP, 2014, B EPIDEMIOL HEBD, V2016, P20
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Pillonel J, 2009, TRANSFUS CLIN BIOL, V16, P138, DOI 10.1016/j.tracli.2009.03.016
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
NR 27
TC 1
Z9 1
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0042-9007
EI 1423-0410
J9 VOX SANG
JI Vox Sang.
PD FEB
PY 2020
VL 115
IS 2
BP 124
EP 132
DI 10.1111/vox.12855
EA DEC 2019
PG 9
WC Hematology
SC Hematology
GA KK7UC
UT WOS:000502875400001
PM 31845340
DA 2020-07-08
ER

PT J
AU Lin, JY
   Kuo, RL
   Huang, HI
AF Lin, Jhao-Yin
   Kuo, Rei-Lin
   Huang, Hsing-I
TI Activation of type I interferon antiviral response in human neural stem
   cells
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Neural stem cells; RIG-I; MDA5; IFN; Zika virus
ID TOLL-LIKE RECEPTORS; WEST NILE VIRUS; RIG-I; NEGATIVE REGULATOR;
   PROGENITOR CELLS; MESSENGER-RNA; EXPRESSION; MDA5; INFECTION; NEURONS
AB Background: Neural stem cells (NSCs) residing in the central nervous system play an important role in neurogenesis. Several viruses can infect these neural progenitors and cause severe neurological diseases. The innate immune responses against the neurotropic viruses in these tissue-specific stem cells remain unclear.
   Methods: Human NSCs were transfected with viral RNA mimics or infected with neurotropic virus for detecting the expression of antiviral interferons (IFNs) and downstream IFN-stimulated antiviral genes.
   Results: NSCs are able to produce interferon-beta (IFN-beta) (type I) and lambda 1 (type III) after transfection with poly(I:C) and that downstream IFN-stimulated antiviral genes, such as ISG56 and MxA, and the viral RNA sensors RIG-I, MDA5, and TLR3, can be expressed in NSCs under poly(I:C) or IFN-beta stimulation. In addition, our results show that the pattern recognition receptors RIG-I and MDA5, as well as the endosomal pathogen recognition receptor TLR3, but not TLR7 and TLR8, are involved in the activation of IFN-beta transcription in NSCs. Furthermore, NSCs infected with the neurotropic viruses, Zika and Japanese encephalitis viruses, are able to induce RIG-I-mediated IFN-beta expression.
   Conclusion: Human NSCs have the ability to activate IFN signals against neurotropic viral pathogens.
C1 [Lin, Jhao-Yin; Kuo, Rei-Lin; Huang, Hsing-I] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Kwei Shan, Tao Yuan, Taiwan.
   [Lin, Jhao-Yin] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Kwei Shan, Tao Yuan, Taiwan.
   [Kuo, Rei-Lin; Huang, Hsing-I] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Kwei Shan, Tao Yuan, Taiwan.
   [Kuo, Rei-Lin; Huang, Hsing-I] Chang Gung Mem Hosp, Dept Pediat, Linkou, Taiwan.
RP Huang, HI (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Kwei Shan, Tao Yuan, Taiwan.; Huang, HI (corresponding author), Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Kwei Shan, Tao Yuan, Taiwan.; Huang, HI (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Linkou, Taiwan.
EM hihuang@mail.cgu.edu.tw
FU Research Center for Emerging Viral Infections from The Featured Areas
   Research Center Program within Ministry of Education (MOE) in Taiwan;
   Ministry of Science and Technology (MOST), Taiwan
   [MOST108-3017-F-182-001]; Ministry of Science and Technology,
   TaiwanMinistry of Science and Technology, Taiwan
   [MOST-107-2320-B-182-001, MOST-108-2320-B-182-033,
   MOST-106-2362-B-182-001]; Chang Gung University [BMRPB33]; Chang Gung
   Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPD1G0431]
FX This work was financially supported by the Research Center for Emerging
   Viral Infections from The Featured Areas Research Center Program within
   the framework of the Higher Education Sprout Project by the Ministry of
   Education (MOE) in Taiwan and the Ministry of Science and Technology
   (MOST), Taiwan (MOST108-3017-F-182-001). This work was also supported by
   the Ministry of Science and Technology, Taiwan (MOST-107-2320-B-182-001,
   MOST-108-2320-B-182-033, and MOST-106-2362-B-182-001), Chang Gung
   University (BMRPB33), and Chang Gung Memorial Hospital, Taiwan
   (CMRPD1G0431).
CR Alberti A, 2003, J HEPATOL, V38, pS104, DOI 10.1016/S0168-8278(03)00008-4
   Alvarado AG, 2016, TRENDS NEUROSCI, V39, P463, DOI 10.1016/j.tins.2016.04.005
   Baker DG, 2013, J GEN VIROL, V94, P336, DOI 10.1099/vir.0.043984-0
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792
   Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309
   Chucair-Elliott AJ, 2014, GLIA, V62, P1418, DOI 10.1002/glia.22689
   Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610
   Colavita F, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2450540
   Covacu R, 2009, J IMMUNOL, V182, P6889, DOI 10.4049/jimmunol.0802907
   Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x
   De Miranda J, 2009, FASEB J, V23, P1064, DOI 10.1096/fj.08-121434
   Vaccari JPD, 2012, GLIA, V60, P414, DOI 10.1002/glia.22275
   Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Festi D, 2004, WORLD J GASTROENTERO, V10, P12
   Feuer R, 2005, J NEUROSCI, V25, P2434, DOI 10.1523/JNEUROSCI.4517-04.2005
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Furr SR, 2008, J NEUROVIROL, V14, P503, DOI 10.1080/13550280802337217
   Gebhardt A, 2017, J INTERF CYTOK RES, V37, P184, DOI 10.1089/jir.2016.0092
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531
   Hung YF, 2018, J CELL BIOL, V217, P2727, DOI 10.1083/jcb.201712113
   Kallfass C, 2012, J VIROL, V86, P11223, DOI 10.1128/JVI.01093-12
   Kapil P, 2012, GLIA, V60, P1555, DOI 10.1002/glia.22375
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kaul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037767
   Kuo RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063431
   Lasfar A, 2016, DRUG DISCOV TODAY, V21, P167, DOI 10.1016/j.drudis.2015.10.021
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li JL, 2012, J NEUROSCI RES, V90, P399, DOI 10.1002/jnr.22758
   Liu HY, 2013, J NEUROSCI, V33, P11479, DOI 10.1523/JNEUROSCI.5566-12.2013
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022
   Mukherjee S, 2015, CELL BIOL INT, V39, P224, DOI 10.1002/cbin.10354
   Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761
   Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886
   Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107
   Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X
   Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133
   Petes C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01075
   Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704
   Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005
   Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Shao Q, 2015, J GEN VIROL, V96, P277, DOI 10.1099/vir.0.069914-0
   Sher AA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00596
   Shirjang S, 2017, CELL IMMUNOL, V315, P1, DOI 10.1016/j.cellimm.2016.12.005
   Tengroth L, 2014, PLOS ONE, V9, P3, DOI DOI 10.1371/J0URNAL.P0NE.0098239
   Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.504
   Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012
NR 62
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD DEC 16
PY 2019
VL 10
IS 1
AR 387
DI 10.1186/s13287-019-1521-5
PG 17
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
SC Cell Biology; Research & Experimental Medicine
GA KC6OL
UT WOS:000507294500009
PM 31843025
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Soares, F
   Abranches, AD
   Villela, L
   Lara, S
   Araujo, D
   Nehab, S
   Silva, L
   Amaral, Y
   Junior, SG
   Pone, S
   Lobkowicz, L
   Clemente, NS
   Brasil, P
   Nielsen-Saines, K
   Pone, M
   Brickley, E
   Moreira, ME
AF Soares, Fernanda
   Abranches, Andrea D.
   Villela, Leticia
   Lara, Sarah
   Araujo, Daniele
   Nehab, Sylvia
   Silva, Leila
   Amaral, Yasmin
   Junior, Saint Clair G.
   Pone, Sheila
   Lobkowicz, Ludmila
   Clemente, Nuria Sanchez
   Brasil, Patricia
   Nielsen-Saines, Karin
   Pone, Marcos
   Brickley, Elizabeth
   Moreira, Maria Elisabeth
TI Zika virus infection in pregnancy and infant growth, body composition in
   the first three months of life: a cohort study
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AIR-DISPLACEMENT PLETHYSMOGRAPH; BIRTH; OUTBREAK; CHILDREN; WEIGHT;
   BRAZIL; BORN
AB The implications of Zika Virus exposure in pregnancy for early infant growth remains poorly described. The main goal of this study is to compare the growth, body composition, and feeding modality of infants in the first three months of life by prenatal Zika Virus exposure status. We selected an analytical cohort of 115 infants born without microcephaly, comprising 56 infants with qRT-PCR confirmed exposure to ZIKV during gestation and 59 infants born to women with presumptively no evidence of ZIKV in pregnancy. Infants were evaluated at birth, I and 3 months of age in terms of anthropometrics, body composition All the results were adjusted by maternal age, maternal BMI and gestational age. We observe no differences between anthropometric measurements at birth. Mothers in exposed group showed higher BMI. At 1 month and 3 months of age there were differences in mid arm circumference, arm muscle circumference and fat free mass. Weight and length was less in the ZIKV exposed in pregnancy infants and statistically different at 3 month of age. The findings of this investigation provide new evidence that ZIKV exposure in pregnancy may be associated with differences in body body composition.
C1 [Soares, Fernanda; Abranches, Andrea D.; Villela, Leticia; Lara, Sarah; Araujo, Daniele; Nehab, Sylvia; Silva, Leila; Amaral, Yasmin; Junior, Saint Clair G.; Pone, Sheila; Brasil, Patricia; Pone, Marcos; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Infectol, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
   [Lobkowicz, Ludmila; Clemente, Nuria Sanchez; Brickley, Elizabeth] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Clemente, Nuria Sanchez] Univ Sao Paulo, Dept Epidemiol, Sao Paulo, SP, Brazil.
   [Nielsen-Saines, Karin] UCLA, Univ Calif Pediat Infect Dis, Los Angeles, CA USA.
RP Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Lobkowicz,
   Ludmila/AAM-4279-2020; Lobkowicz, Ludmila/AAR-5878-2020; Clemente, Nuria
   Sanchez/AAL-4309-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Lobkowicz,
   Ludmila/0000-0002-9915-0361; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242; Amaral,
   Yasmin/0000-0001-8159-0564
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [441098/2016-9, 305090/2016-0]; FaperjCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [E_18/2015TXB];
   Wellcome TrustWellcome Trust [205377/Z/16/Z]; United Kingdom's
   Department for International Development [205377/Z/16/Z]; European
   UnionEuropean Union (EU) [734584]
FX CNPq 441098/2016-9 and 305090/2016-0; Faperj E_18/2015TXB; Wellcome
   Trust & the United Kingdom's Department for International Development
   (205377/Z/16/Z); European Union's Horizon 2020 research and innovation
   programme under Zika-PLAN grant agreement no. 734584.
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Beaudrap P, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1135-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fields DA, 2011, OBESITY, V19, P1887, DOI 10.1038/oby.2011.11
   Frisancho A., 1991, CLIN NUTR, V10, P131, DOI DOI 10.1016/0261-5614(91)90103-J
   Fung EB, 2002, J AM DIET ASSOC, V102, P361, DOI 10.1016/S0002-8223(02)90084-2
   Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Hortencio Taís Daiene Russo, 2015, Rev. paul. pediatr., V33, P3, DOI 10.1016/j.rpped.2014.11.004
   Kalanda BF, 2005, EARLY HUM DEV, V81, P841, DOI 10.1016/j.earlhumdev.2005.06.006
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Moreira MEL, 2010, CIENC SAUDE COLETIVA, V15, P321, DOI 10.1590/S1413-81232010000200002
   Ma GS, 2004, AM J CLIN NUTR, V79, P653
   Makasa M, 2007, TROP MED INT HEALTH, V12, P594, DOI 10.1111/j.1365-3156.2007.01836.x
   Mameli C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090838
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Nicholson L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0386-8
   Organization W. H., 2017, WHO IHR EM COMM ZIK
   Perng W, 2017, AM J CLIN NUTR, V106, P559, DOI 10.3945/ajcn.116.149617
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249
   Tang W, 1997, ARCH DIS CHILD-FETAL, V77, pF123, DOI 10.1136/fn.77.2.F123
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
   Walther B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-16
   WHO, 2013, PHYS STAT UINT ANT
   Yao M, 2003, ACTA DIABETOL, V40, pS55, DOI 10.1007/s00592-003-0027-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 36
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 16
PY 2019
VL 9
AR 19198
DI 10.1038/s41598-019-55598-6
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JW6WG
UT WOS:000503189100005
PM 31844129
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Link, N
   Chung, H
   Jolly, A
   Withers, M
   Tepe, B
   Arenkiel, BR
   Shah, PS
   Krogan, NJ
   Aydin, H
   Geckinli, BB
   Tos, T
   Isikay, S
   Tuysuz, B
   Mochida, GH
   Thomas, AX
   Clark, RD
   Mirzaa, GM
   Lupski, JR
   Bellen, HJ
AF Link, Nichole
   Chung, Hyunglok
   Jolly, Angad
   Withers, Marjorie
   Tepe, Burak
   Arenkiel, Benjamin R.
   Shah, Priya S.
   Krogan, Nevan J.
   Aydin, Hatip
   Geckinli, Bilgen B.
   Tos, Tulay
   Isikay, Sedat
   Tuysuz, Beyhan
   Mochida, Ganesh H.
   Thomas, Ajay X.
   Clark, Robin D.
   Mirzaa, Ghayda M.
   Lupski, James R.
   Bellen, Hugo J.
TI Mutations in ANKLE2, a ZIKA Virus Target, Disrupt an Asymmetric Cell
   Division Pathway in Drosophila Neuroblasts to Cause Microcephaly
SO DEVELOPMENTAL CELL
LA English
DT Article
ID PROTEIN PHOSPHATASE 2A; REGULATES SELF-RENEWAL; TUMOR-SUPPRESSOR;
   SPINDLE ORIENTATION; CORTICAL POLARITY; MOSAIC ANALYSIS; PAR COMPLEX;
   LEM-DOMAIN; KINASE; GENE
AB The apical Par complex, which contains atypical protein kinase C (aPKC), Bazooka (Par-3), and Par-6, is required for establishing polarity during asymmetric division of neuroblasts in Drosophila, and its activity depends on L(2)gl. We show that loss of Ankle2, a protein associated with microcephaly in humans and known to interact with Zika protein NS4A, reduces brain volume in flies and impacts the function of the Par complex. Reducing Ankle2 levels disrupts endoplasmic reticulum (ER) and nuclear envelope morphology, releasing the kinase Ballchen-VRK1 into the cytosol. These defects are associated with reduced phosphorylation of aPKC, disruption of Par-complex localization, and spindle alignment defects. Importantly, removal of one copy of ballchen or l(2)gl suppresses Ankle2 mutant phenotypes and restores viability and brain size. Human mutational studies implicate the above-mentioned genes in microcephaly and motor neuron disease. We suggest that NS4A, ANKLE2, VRK1, and LLGL1 define a pathway impinging on asymmetric determinants of neural stem cell division.
C1 [Link, Nichole; Chung, Hyunglok; Bellen, Hugo J.] BCM, Howard Hughes Med Inst, Houston, TX 77030 USA.
   [Link, Nichole; Chung, Hyunglok; Jolly, Angad; Withers, Marjorie; Tepe, Burak; Arenkiel, Benjamin R.; Lupski, James R.; Bellen, Hugo J.] BCM, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Link, Nichole; Chung, Hyunglok; Tepe, Burak; Arenkiel, Benjamin R.; Bellen, Hugo J.] Texas Childrens Hosp, Neurol Res Inst, Houston, TX 77030 USA.
   [Jolly, Angad; Bellen, Hugo J.] BCM, MD PhD Med Scientist Training Program, Houston, TX 77030 USA.
   [Jolly, Angad; Bellen, Hugo J.] BCM, MHG Grad program, Houston, TX 77030 USA.
   [Tepe, Burak; Arenkiel, Benjamin R.; Bellen, Hugo J.] BCM, Program Dev Biol, Houston, TX 77030 USA.
   [Shah, Priya S.] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.
   [Shah, Priya S.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.
   [Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.
   [Krogan, Nevan J.] Univ Calif San Francisco, QB3, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA.
   [Aydin, Hatip] Zeynep Kamil Matern & Childrens Training & Res Ho, Ctr Genet Diag, Istanbul, Turkey.
   [Geckinli, Bilgen B.] Marmara Univ, Sch Med, Dept Med Genet, Istanbul, Turkey.
   [Tos, Tulay] Dr Sami Ulus Res & Training Hosp Womens & Childre, Dept Med Genet, Ankara, Turkey.
   [Isikay, Sedat] Hasan Kalyoncu Univ, Sch Hlth Sci, Dept Physiotherapy & Rehabil, Gaziantep, Turkey.
   [Tuysuz, Beyhan] Istanbul Univ Cerrahpasa, Fac Med, Dept Pediat, Istanbul, Turkey.
   [Mochida, Ganesh H.] Boston Childrens Hosp, Dept Pediat, Div Genet & Genom, Boston, MA 02115 USA.
   [Mochida, Ganesh H.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA.
   [Mochida, Ganesh H.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   [Mochida, Ganesh H.] Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA.
   [Thomas, Ajay X.] BCM, Dept Pediat, Sect Neurol & Dev Neurosci, Houston, TX 77030 USA.
   [Thomas, Ajay X.] Texas Childrens Hosp, Sect Child Neurol, Houston, TX 77030 USA.
   [Clark, Robin D.] Loma Linda Univ, Med Ctr, Dept Pediat, Div Med Genet, Loma Linda, CA 92354 USA.
   [Mirzaa, Ghayda M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Mirzaa, Ghayda M.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98105 USA.
   [Lupski, James R.] BCM, Dept Pediat, Houston, TX 77030 USA.
   [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
RP Bellen, HJ (corresponding author), BCM, Howard Hughes Med Inst, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), BCM, Dept Mol & Human Genet, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Texas Childrens Hosp, Neurol Res Inst, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), BCM, MD PhD Med Scientist Training Program, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), BCM, MHG Grad program, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), BCM, Program Dev Biol, Houston, TX 77030 USA.
EM hbellen@bcm.edu
RI isikay, sedat/AAA-9993-2020; Tuysuz, Beyhan/AAN-4858-2020
OI isikay, sedat/0000-0003-0103-9612; , Beyhan/0000-0002-9620-5021
FU NIH/NICHDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [U54 HD083092];
   NIH/NINDSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [F32NS092270, K08NS092898, R35NS105078];
   Howard Hughes Medical Institute (HHMI) Medical Research Fellowship;
   Jordan's Guardian Angels; NHGRIUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Human Genome Research Institute (NHGRI) [UM1 HG006542]; NHLBIUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1
   HG006542]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U54NS093793,
   R24OD022005]; Huffington Foundation; HHMIHoward Hughes Medical Institute
FX We would like to thank many members of the Bellen lab for suggestions
   and Megan Campbell and Karen Schulze for critical reading. We thank
   Chris Doe, Jurgen Knoblich, Jim Skeath, Kenneth Prehoda, Alf Herzig,
   Hiroyuki Ohkura, and the Bloomington Drosophila Stock Center for
   providing stocks and reagents and the IDDRC Microscopy Core (NIH/NICHD
   U54 HD083092) for valuable input. This work was supported by NIH/NINDS
   F32NS092270 to N.L.; Howard Hughes Medical Institute (HHMI) Medical
   Research Fellowship to A.J.; the NIH/NINDS K08NS092898 and Jordan's
   Guardian Angels to G.M.M.; a jointly funded NHGRI and NHLBI grant to the
   Baylor-Hopkins Center for Mendelian Genomics (UM1 HG006542); NIH/NINDS
   R35NS105078 to J.R.L; and NIH U54NS093793, NIH R24OD022005, and the
   Huffington Foundation to H.J.B. N.L. and H.C. are supported by HHMI and
   H.J.B. is an Investigator of the Howard Hughes Medical Institute.
CR Andersen RO, 2012, DEV BIOL, V363, P258, DOI 10.1016/j.ydbio.2011.12.047
   Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043
   Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902
   Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056
   Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108
   Bamshad MJ, 2012, AM J MED GENET A, V158A, P1523, DOI 10.1002/ajmg.a.35470
   Barton LJ, 2015, CURR OPIN CELL BIOL, V34, P1, DOI 10.1016/j.ceb.2015.03.005
   Beattie R, 2017, NEURON, V94, P517, DOI 10.1016/j.neuron.2017.04.012
   Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486
   Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061
   BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137
   Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757
   Bonaccorsi S, 2007, DEVELOPMENT, V134, P2183, DOI 10.1242/dev.02848
   Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279
   Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009
   CAMPBELL G, 1994, DEVELOPMENT, V120, P2957
   Carvalho CA, 2015, CURR BIOL, V25, P53, DOI 10.1016/j.cub.2014.10.053
   Chabu C, 2008, DEVELOPMENT, V135, P2739, DOI 10.1242/dev.024059
   Chabu C, 2009, DEV BIOL, V330, P399, DOI 10.1016/j.ydbio.2009.04.014
   Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178
   Cullen CF, 2005, J CELL BIOL, V171, P593, DOI 10.1083/jcb.200508127
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820
   Dumas LJ, 2012, AM J HUM GENET, V91, P444, DOI 10.1016/j.ajhg.2012.07.016
   Feng SY, 2019, ANN CLIN TRANSL NEUR, V6, P401, DOI 10.1002/acn3.701
   Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343
   Gallaud E, 2017, RESULTS PROBL CELL D, V61, P183, DOI 10.1007/978-3-319-53150-2_8
   GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830
   Ghosh S, 2008, P NATL ACAD SCI USA, V105, P335, DOI 10.1073/pnas.0705713105
   Gonzaga-Jauregui C, 2013, JAMA NEUROL, V70, P1491, DOI 10.1001/jamaneurol.2013.4598
   Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644
   Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.0.CO;2-Q
   Harsh S, 2018, J IMMUNOL, V201, P3058, DOI 10.4049/jimmunol.1800597
   Herzig B, 2014, BIOL OPEN, V3, P510, DOI [10.1242/Bio.20147690, 10.1242/bio.20147690]
   Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515
   Ito K, 1997, DEVELOPMENT, V124, P761
   Jayaraman D, 2018, ANNU REV GENOM HUM G, V19, P177, DOI 10.1146/annurev-genom-083117-021441
   Kanai MI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22028-y
   Karaca E, 2018, GENET MED, V20, P1528, DOI 10.1038/gim.2018.33
   Katsani KR, 2008, MOL BIOL CELL, V19, P3652, DOI 10.1091/mbc.E07-11-1162
   Kim S, 2010, NEURON, V66, P69, DOI 10.1016/j.neuron.2010.03.019
   Kim S, 2009, J CELL SCI, V122, P3759, DOI 10.1242/jcs.052514
   Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737
   Krahn MP, 2009, DEV CELL, V16, P901, DOI 10.1016/j.devcel.2009.04.011
   Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406
   Lee PT, 2018, ELIFE, V7, DOI 10.7554/eLife.35574
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lim NR, 2017, STEM CELL REP, V9, P32, DOI 10.1016/j.stemcr.2017.05.015
   Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081
   LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787
   Lupski JR, 2015, ENVIRON MOL MUTAGEN, V56, P419, DOI 10.1002/em.21943
   Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461
   Manfruelli P, 1996, DEVELOPMENT, V122, P2283
   Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nagarkar-Jaiswal S., 2015, ELIFE, V4
   Nagarkar-Jaiswal S, 2015, ELIFE, V4, DOI 10.7554/eLife.05338
   Nair AR, 2016, CELL REP, V14, P1100, DOI 10.1016/j.celrep.2015.12.097
   Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423
   Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522
   Nguyen Thy P, 2015, J Clin Neuromuscul Dis, V17, P69, DOI 10.1097/CND.0000000000000096
   Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200
   Ogawa H, 2009, J CELL SCI, V122, P3242, DOI 10.1242/jcs.050955
   Olahova M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094
   Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550
   Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111
   Posey J.E., 2019, GENET MED, V11, P30
   Poulton JS, 2017, J CELL BIOL, V216, P1255, DOI 10.1083/jcb.201607022
   Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30
   Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006
   Riedel F, 2016, BIOL OPEN, V5, P987, DOI 10.1242/bio.018937
   RIEMER D, 1995, J CELL SCI, V108, P3189
   Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079
   Rujano MA, 2013, NAT CELL BIOL, V15, P1294, DOI 10.1038/ncb2858
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Sanz-Garcia M, 2011, J PROTEOMICS, V75, P548, DOI 10.1016/j.jprot.2011.08.019
   Sarov M, 2016, ELIFE, V5, DOI 10.7554/eLife.12068
   Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135
   Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019
   Seidl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062756
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shaheen R, 2019, GENET MED, V21, P545, DOI 10.1038/s41436-018-0140-3
   Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015
   Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412
   SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303
   Snyers L, 2018, EUR J CELL BIOL, V97, P63, DOI 10.1016/j.ejcb.2017.12.001
   Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250
   Stoll M, 2016, NEUROLOGY, V87, P65, DOI 10.1212/WNL.0000000000002813
   Summerville JB, 2016, J CELL SCI, V129, P1635, DOI 10.1242/jcs.184929
   Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426
   Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662
   Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]
   Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486
   Wang C, 2009, DEVELOPMENT, V136, P2287, DOI 10.1242/dev.035758
   Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506
   Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056
   Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049
   WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5
   Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829
   Yakulov T, 2014, BIOL OPEN, V3, P881, DOI 10.1242/bio.20148631
   Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002
   Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844
NR 111
TC 1
Z9 1
U1 3
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD DEC 16
PY 2019
VL 51
IS 6
BP 713
EP +
DI 10.1016/j.devcel.2019.10.009
PG 23
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA JW1VZ
UT WOS:000502848800007
PM 31735666
DA 2020-07-08
ER

PT J
AU Borchering, RK
   Huang, AT
   Mier-y-Teran-Romero, L
   Rojas, DP
   Rodriguez-Barraquer, I
   Katzelnick, LC
   Martinez, SD
   King, GD
   Cinkovich, SC
   Lessler, J
   Cummings, DAT
AF Borchering, Rebecca K.
   Huang, Angkana T.
   Mier-y-Teran-Romero, Luis
   Rojas, Diana P.
   Rodriguez-Barraquer, Isabel
   Katzelnick, Leah C.
   Martinez, Silvio D.
   King, Gregory D.
   Cinkovich, Stephanie C.
   Lessler, Justin
   Cummings, Derek A. T.
TI Impacts of Zika emergence in Latin America on endemic dengue
   transmission
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; AEDES-AEGYPTI; CROSS-REACTIVITY; VIRUS
   OUTBREAK; INFECTION; SPREAD; BRAZIL
AB In 2015 and 2016, Zika virus (ZIKV) swept through dengue virus (DENV) endemic areas of Latin America. These viruses are of the same family, share a vector and may interact competitively or synergistically through human immune responses. We examine dengue incidence from Brazil and Colombia before, during, and after the Zika epidemic. We find evidence that dengue incidence was atypically low in 2017 in both countries. We investigate whether subnational Zika incidence is associated with changes in dengue incidence and find mixed results. Using simulations with multiple assumptions of interactions between DENV and ZIKV, we find cross-protection suppresses incidence of dengue following Zika outbreaks and low periods of dengue incidence are followed by resurgence. Our simulations suggest correlations in DENV and ZIKV reproduction numbers could complicate associations between ZIKV incidence and post-ZIKV DENV incidence and that periods of low dengue incidence are followed by large increases in dengue incidence.
C1 [Borchering, Rebecca K.; Huang, Angkana T.; Katzelnick, Leah C.; Martinez, Silvio D.; King, Gregory D.; Cinkovich, Stephanie C.; Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA.
   [Borchering, Rebecca K.; Huang, Angkana T.; Katzelnick, Leah C.; Martinez, Silvio D.; King, Gregory D.; Cinkovich, Stephanie C.; Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.
   [Borchering, Rebecca K.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
   [Mier-y-Teran-Romero, Luis; Lessler, Justin] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Rojas, Diana P.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL 32610 USA.
   [Rodriguez-Barraquer, Isabel] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
RP Borchering, RK; Cummings, DAT (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.; Borchering, RK (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.; Borchering, RK (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
EM rebecca.borchering@uga.edu; datc@ufl.edu
OI Huang, Angkana/0000-0002-9857-3506
FU National Institute of Allergy and Infectious Diseases at the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI102939]
FX We thank S. E. Bellan, M. A. Johansson, and members of the U.F. and
   J.H.U. Infectious Disease Dynamics groups for helpful discussions. This
   research was supported by the National Institute of Allergy and
   Infectious Diseases at the National Institutes of Health (grant
   R01AI102939).
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Departamento Administrativo Nacional de Estadistica, EST POBL 1985 2005 P
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790
   Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Gabry J., 2016, RSTANARM BAYESIAN AP
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   *I BRAS GEOGR EST, EST POP
   Instituto Nacional de Salud Colombia, PORT WEB SIVIGILA 20
   Instituto Nacional de Salud Colombia, B EPIDEMIOLOGICO
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Ministerio da Saude Brasil, 2016, 47 MIN SAUD BRAS
   Ministerio da Saude Brasil, SIST INF AGR NOT
   Ministerio da Saude Brasil, 2015, B EPIDEMIOLOGICO
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pan American Health Organization. Health Information Platform for the Americas (PLISA), REP CAS DENG FEV AM
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   VDC Shields, 2017, BIOL CONTROL PEST VE
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 48
TC 1
Z9 1
U1 5
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD DEC 16
PY 2019
VL 10
AR 5730
DI 10.1038/s41467-019-13628-x
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JW0TM
UT WOS:000502772300001
PM 31844054
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Silva, MMO
   Tauro, LB
   Kikuti, M
AF Silva, M. M. O.
   Tauro, L. B.
   Kikuti, M.
TI Concomitant Transmission of Dengue, Chikungunya, and Zika Viruses in
   Brazil: Clinical and Epidemiological Findings From Surveillance for
   Acute Febrile Illness (vol 69, pg 1353, 2019)
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Correction
CR Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
NR 1
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 15
PY 2019
VL 69
IS 12
BP 2238
EP 2238
DI 10.1093/cid/ciz588
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JU5PX
UT WOS:000501729300044
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Pastuch-Gawolek, G
   Gillner, D
   Krol, E
   Walczak, K
   Wandzik, I
AF Pastuch-Gawolek, Gabriela
   Gillner, Danuta
   Krol, Ewelina
   Walczak, Krzysztof
   Wandzik, Ilona
TI Selected nucleos(t)ide-based prescribed drugs and their multi-target
   activity
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Nucleosides; Nucleotides; Prodrugs; Antiviral therapy; Chain
   termination; Antineoplastic agents
ID HEPATITIS-B-VIRUS; NUCLEOSIDE ANALOGS; ZIKA VIRUS; IN-VITRO; ANTIVIRAL
   ACTIVITY; GEMCITABINE; INHIBITORS; ACYCLOVIR; EFFICACY; ZOSTER
AB Nucleos(t)ide analogues play pivotal roles as antiviral, cytotoxic or immunosuppressive agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum activity towards multiple life-threatening RNA and DNA viruses. We also present a discussion about nucleoside antimetabolites-approved antineoplastic agents-that have recently been shown to have antiviral and/or antibacterial activity. The approved drugs and drug combinations, as well as recently identified candidates for investigation and/or experimentation, are discussed. Several examples of repurposed drugs that have already been approved for use are presented. This strategy can be crucial for the first-line treatment of acute infections or coinfections and for the management of drug-resistant strains.
C1 [Pastuch-Gawolek, Gabriela; Gillner, Danuta; Walczak, Krzysztof; Wandzik, Ilona] Silesian Tech Univ, Fac Chem, Dept Organ Chem Bioorgan Chem & Biotechnol, Krzywoustego 4, PL-44100 Gliwice, Poland.
   [Pastuch-Gawolek, Gabriela; Gillner, Danuta; Wandzik, Ilona] Silesian Tech Univ, Biotechnol Ctr, Krzywoustego 4, PL-44100 Gliwice, Poland.
   [Krol, Ewelina] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Recombinant Vaccines, Abrahama 58, PL-80307 Gdansk, Poland.
   [Krol, Ewelina] Med Univ Gdansk, Abrahama 58, PL-80307 Gdansk, Poland.
RP Wandzik, I (corresponding author), Silesian Tech Univ, Fac Chem, Dept Organ Chem Bioorgan Chem & Biotechnol, Krzywoustego 4, PL-44100 Gliwice, Poland.
EM Ilona.Wandzik@polsl.pl
RI Pastuch, Gabriela/R-9994-2018
OI Pastuch, Gabriela/0000-0001-8753-1143; Walczak,
   Krzysztof/0000-0001-8511-2009; Wandzik, Ilona/0000-0002-6592-4875;
   Gillner, Danuta/0000-0001-7187-2453
CR ABELE G, 1991, Antiviral Chemistry and Chemotherapy, V2, P163
   Agrawal K, 2018, PHARMACOL THERAPEUT, V188, P45, DOI 10.1016/j.pharmthera.2018.02.006
   Alexeeva I, 2001, NUCLEOS NUCLEOT NUCL, V20, P1147, DOI 10.1081/NCN-100002508
   Alexeeva I, 2015, NUCLEOS NUCLEOT NUCL, V34, P565, DOI 10.1080/15257770.2015.1034363
   Andrei G, 2005, ANTIMICROB AGENTS CH, V49, P1081, DOI 10.1128/AAC.49.3.1081-1086.2005
   Andrei G, 2012, J VIROL, V86, P2641, DOI 10.1128/JVI.06620-11
   [Anonymous], 1980, LANCET, V1, P1337
   Aoki F.Y., 2015, MANDELL DOUGLAS BENN
   Bauer L, 2017, CURR OPIN VIROL, V24, P1, DOI 10.1016/j.coviro.2017.03.009
   Beach LB, 2014, J GEN VIROL, V95, P2778, DOI 10.1099/vir.0.069864-0
   Beran RKF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030286
   Bosl K., 2019, BIORXIV, P1
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Burness CB, 2016, DRUGS, V76, P1393, DOI 10.1007/s40265-016-0633-9
   Cano-Soldado P, 2012, MED RES REV, V32, P428, DOI 10.1002/med.20221
   Cerqueira NMFSA, 2007, CHEM-EUR J, V13, P8507, DOI 10.1002/chem.200700260
   Chaudhuri S, 2018, ANTIVIR RES, V155, P76, DOI 10.1016/j.antiviral.2018.05.005
   Clouser CL, 2012, ANTIMICROB AGENTS CH, V56, P1942, DOI 10.1128/AAC.06161-11
   Clouser CL, 2010, J VIROL, V84, P9301, DOI 10.1128/JVI.01006-10
   Daly MB, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0254-0
   Dapp MJ, 2009, J VIROL, V83, P11950, DOI 10.1128/JVI.01406-09
   Das D., 2018, HERPESVIRUS POLYMERA
   Das P, 2019, J MED CHEM, V62, P4265, DOI 10.1021/acs.jmedchem.8b01610
   De Clercq E, 2004, BIOCHEM PHARMACOL, V68, P2301, DOI [10.1016/j.bcp.2004.07.039, 10.1016/j.bep.2004.07.039]
   De Clercq E., 2007, COMPR MED CHEM 2, V7, P253, DOI DOI 10.1016/B0-08-045044-X/00211-X
   De Clercq E, 2018, BIOCHEM PHARMACOL, V153, P2, DOI 10.1016/j.bcp.2017.11.023
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   De Clercq Erik, 2013, Antiviral Chemistry & Chemotherapy, V23, P93, DOI 10.3851/IMP2533
   De Clercq E, 2013, MED RES REV, V33, P1215, DOI 10.1002/med.21256
   de Freitas CS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007072
   Denisova OV, 2012, J BIOL CHEM, V287, P35324, DOI 10.1074/jbc.M112.392142
   Diamantopoulos PT, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-1
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   ELION GB, 1977, MED SCI, V74, P5716
   Ferreira AC, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01389-18
   Florescu DF, 2012, BIOL BLOOD MARROW TR, V18, P731, DOI 10.1016/j.bbmt.2011.09.007
   Gao LJ, 2016, BIOORG MED CHEM LETT, V26, P2142, DOI 10.1016/j.bmcl.2016.03.076
   Heinrich JC, 2011, J CANCER RES CLIN, V137, P1349, DOI 10.1007/s00432-011-1005-1
   HERTEL LW, 1990, CANCER RES, V50, P4417
   Ianevski A, 2019, DRUG DISCOV TODAY, V24, P1224, DOI 10.1016/j.drudis.2019.04.006
   Ianevski A, 2018, ANTIVIR RES, V154, P174, DOI 10.1016/j.antiviral.2018.04.016
   Iwatsubo K, 2012, AM J PHYSIOL-HEART C, V302, pH2622, DOI 10.1152/ajpheart.00190.2012
   JABS DA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1437
   Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010
   Jordheim LP, 2012, INT J ANTIMICROB AG, V39, P444, DOI 10.1016/j.ijantimicag.2012.01.019
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176
   Kang H, 2015, ANTIVIR RES, V124, P1, DOI 10.1016/j.antiviral.2015.10.011
   Kimberlin D.W., 2018, PRINCIPLES PRACTICE
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lahmer T, 2010, TRANSPL INT, V23, pe24, DOI 10.1111/j.1432-2277.2009.01045.x
   Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12
   LASKIN OL, 1984, ARCH INTERN MED, V144, P1241, DOI 10.1001/archinte.144.6.1241
   Lee K, 2017, ONCOTARGET, V8, P115315, DOI 10.18632/oncotarget.23258
   Leoni MC, 2018, INFECT DIS THER, V7, P407, DOI 10.1007/s40121-018-0210-5
   LIN JC, 1985, ANTIMICROB AGENTS CH, V27, P971, DOI 10.1128/AAC.27.6.971
   Littler E., 2007, COMPR MED CHEM 2, P295, DOI [10.1016/b0-08-045044-x/00212-1, DOI 10.1016/B0-08-045044-X/00212-1]
   Liu LZ, 2018, EXPERT REV GASTROENT, V12, P1153, DOI 10.1080/17474124.2018.1530986
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Luber AD, 1996, ANN PHARMACOTHER, V30, P978, DOI 10.1177/106002809603000913
   Luczkowiak J., 2019, NATURE
   Matsuoka Kazuaki, 2018, Oncotarget, V9, P13438, DOI 10.18632/oncotarget.24412
   McGuigan C, 2007, J ANTIMICROB CHEMOTH, V60, P1316, DOI 10.1093/jac/dkm376
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Nakano K, 2009, J VIROL METHODS, V161, P223, DOI 10.1016/j.jviromet.2009.06.016
   Namba T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.172
   NIKKELS AF, 1994, DRUGS, V48, P528, DOI 10.2165/00003495-199448040-00004
   OBRIEN JJ, 1989, DRUGS, V37, P233, DOI 10.2165/00003495-198937030-00002
   Pagano JS, 2018, CANCERS, V10, DOI 10.3390/cancers10060197
   Painter W, 2012, ANTIMICROB AGENTS CH, V56, P2726, DOI 10.1128/AAC.05983-11
   Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p
   Pauly MD, 2015, J VIROL, V89, P3584, DOI 10.1128/JVI.03483-14
   Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10
   Price NB, 2011, CURR OPIN VIROL, V1, P548, DOI 10.1016/j.coviro.2011.10.015
   PRUSOFF WH, 1959, BIOCHIM BIOPHYS ACTA, V32, P295, DOI 10.1016/0006-3002(59)90597-9
   Quenelle DC, 2010, J INFECT DIS, V202, P1492, DOI 10.1086/656717
   Ramakrishnan S, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0024-5
   Rawson JM, 2013, BIOORGAN MED CHEM, V21, P7222, DOI 10.1016/j.bmc.2013.08.023
   Rawson JMO, 2016, BIOORGAN MED CHEM, V24, P2410, DOI 10.1016/j.bmc.2016.03.052
   Rawson JMO, 2016, ANTIMICROB AGENTS CH, V60, P2318, DOI 10.1128/AAC.03084-15
   Rehermann B, 2015, HEPATOLOGY, V61, P712, DOI 10.1002/hep.27323
   Sagnelli E, 2017, EXPERT OPIN PHARMACO, V18, P1691, DOI 10.1080/14656566.2017.1398233
   Sandrini MPB, 2007, J ANTIMICROB CHEMOTH, V60, P510, DOI 10.1093/jac/dkm240
   Schaeffer H.J., 1978, NATURE
   Seifert R, 2014, BIOCHEM PHARMACOL, V87, P543, DOI 10.1016/j.bcp.2013.12.025
   Seley-Radtke KL, 2018, ANTIVIR RES, V154, P66, DOI 10.1016/j.antiviral.2018.04.004
   Shaimerdenova M, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0128-7
   Shin HJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040211
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Song JH, 2017, ANTIVIR RES, V145, P6, DOI 10.1016/j.antiviral.2017.07.003
   Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607
   Sugawara M, 2000, J PHARM SCI-US, V89, P781, DOI 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7
   Sun R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-184
   Thackray AM, 1998, ANTIMICROB AGENTS CH, V42, P1555, DOI 10.1128/AAC.42.7.1555
   Theobald R.J., 2016, REF MODUL BIOMED SCI, P1
   Thomson JM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00952
   Topalis D, 2016, NUCLEIC ACIDS RES, V44, P9530, DOI 10.1093/nar/gkw875
   TYRING S, 1995, ANN INTERN MED, V123, P89, DOI 10.7326/0003-4819-123-2-199507150-00002
   Van Linthout S, 2018, ESC HEART FAIL, V5, P818, DOI 10.1002/ehf2.12341
   Vatner SF, 2013, AM J PHYSIOL-HEART C, V305, pH1, DOI 10.1152/ajpheart.00080.2013
   WELLER S, 1993, CLIN PHARMACOL THER, V54, P595, DOI 10.1038/clpt.1993.196
   Westover JB, 2018, ANTIVIR RES, V156, P38, DOI 10.1016/j.antiviral.2018.05.013
   Wolff F, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0168-z
   World Health Organization, 2017, GLOB HEP REP 2017
   Xu H., 2017, SCI REP, V7, P1
   Yaldiz M, 2018, AM J THER, V25, pE626, DOI 10.1097/MJT.0000000000000436
   Yao J, 2013, J CONTROL RELEASE, V170, P414, DOI 10.1016/j.jconrel.2013.06.009
   Yates MK, 2019, ANTIVIR RES, V162, P5, DOI 10.1016/j.antiviral.2018.11.016
   Zhang ZR, 2017, ACS INFECT DIS, V3, P45, DOI 10.1021/acsinfecdis.6b00116
NR 111
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD DEC 15
PY 2019
VL 865
AR UNSP 172747
DI 10.1016/j.ejphar.2019.172747
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JS2ZF
UT WOS:000500178300044
PM 31634460
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Caine, EA
   Scheaffer, SM
   Broughton, DE
   Salazar, V
   Govero, J
   Poddar, S
   Osula, A
   Halabi, J
   Skaznik-Wikiel, ME
   Diamond, MS
   Moley, KH
AF Caine, Elizabeth A.
   Scheaffer, Suzanne M.
   Broughton, Darcy E.
   Salazar, Vanessa
   Govero, Jennifer
   Poddar, Subhajit
   Osula, Augustine
   Halabi, Jacques
   Skaznik-Wikiel, Malgorzata E.
   Diamond, Michael S.
   Moley, Kelle H.
TI Zika Virus Causes Acute Infection and Inflammation in the Ovary of Mice
   Without Apparent Defects in Fertility
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE fertility; inflammation; oophoritis; T cells; Zika virus
ID BLOOD-FOLLICLE BARRIER; SEXUAL TRANSMISSION; AUTOIMMUNE-DISEASE; INNATE
   IMMUNITY; MOUSE MODEL; MUMPS; OOPHORITIS; DAMAGE
AB Background. Zika virus (ZIKV) has become a global concern because infection of pregnant mothers was linked to congenital birth defects. Zika virus is unique from other flaviviruses, because it is transmitted vertically and sexually in addition to by mosquito vectors. Prior studies in mice, nonhuman primates, and humans have shown that ZIKV targets the testis in males, resulting in persistent infection and oligospermia. However, its effects on the corresponding female gonads have not been evaluated.
   Methods. In this study, we assessed the effects of ZIKV on the ovary in nonpregnant mice.
   Results. During the acute phase, ZIKV productively infected the ovary causing accumulation of CD4(+) and virus-specific CD8(+) T cells. T cells protected against ZIKV infection in the ovary, as higher viral burden was measured in CD8(-/-) and TCR beta delta(-/-) mice. Increased cell death and tissue inflammation in the ovary was observed during the acute phase of infection, but this normalized over time.
   Conclusions. In contrast to that observed with males, minimal persistence and no long-term consequences of ZIKV infection on ovarian follicular reserve or fertility were demonstrated in this model. Thus, although ZIKV replicates in cells of the ovary and causes acute oophoritis, there is rapid resolution and no long-term effects on fertility, at least in mice.
C1 [Scheaffer, Suzanne M.; Broughton, Darcy E.; Osula, Augustine; Halabi, Jacques; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Caine, Elizabeth A.; Salazar, Vanessa; Govero, Jennifer; Poddar, Subhajit; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Caine, Elizabeth A.; Salazar, Vanessa; Govero, Jennifer; Poddar, Subhajit; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Caine, Elizabeth A.; Salazar, Vanessa; Govero, Jennifer; Poddar, Subhajit; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.
   [Caine, Elizabeth A.; Salazar, Vanessa; Govero, Jennifer; Poddar, Subhajit; Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA.
   [Skaznik-Wikiel, Malgorzata E.] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA.
RP Moley, KH (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA.
EM moleyk@wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Skaznik-Wikiel,
   Malgorzata/0000-0002-5248-6909; Poddar, Subhajit/0000-0002-9764-3242;
   Salazar, Vanessa/0000-0002-1947-6039
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI073755,
   R01 AI127828, R01 HD091218, R01 HD083895]; NIH Shared Instrumentation
   GrantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [S10 RR0227552]
FX This work was funded by grants from the National Institutes of Health
   (NIH) (R01 AI073755, R01 AI127828, and R01 HD091218 [to M. S. D.] and
   R01 HD083895 [to K. H. M.]) and an NIH Shared Instrumentation Grant (S10
   RR0227552) to the Hope Center for Neurological Disorders at Washington
   University.
CR Araujo E, 2019, J BRAS REPROD ASSIST, V23, P172, DOI 10.5935/1518-0557.20180081
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   BRANNSTROM M, 1993, BIOL REPROD, V48, P277, DOI 10.1095/biolreprod48.2.277
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Han LS, 2018, NAT GENET, V50, P432, DOI 10.1038/s41588-018-0055-6
   Hess KA, 1998, BIOL REPROD, V58, P705, DOI 10.1095/biolreprod58.3.705
   Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107
   Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   KIRSCH TM, 1981, BIOL REPROD, V25, P629, DOI 10.1095/biolreprod25.3.629
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MORRISON JC, 1975, FERTIL STERIL, V26, P655
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PRINZ W, 1969, GYNAECOLOGIA, V167, P23, DOI 10.1159/000302156
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   RHIM SH, 1992, J CLIN INVEST, V89, P28, DOI 10.1172/JCI115572
   Samy ET, 2008, J IMMUNOL, V180, P4366, DOI 10.4049/jimmunol.180.7.4366
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Sheldon IM, 2017, J REPROD IMMUNOL, V119, P67, DOI 10.1016/j.jri.2016.07.002
   Sheldon IM, 2011, AM J REPROD IMMUNOL, V66, P63, DOI 10.1111/j.1600-0897.2011.01034.x
   Siu MKY, 2013, ADV EXP MED BIOL, V763, P186
   SUBIETAS A, 1977, HUM PATHOL, V8, P285, DOI 10.1016/S0046-8177(77)80025-7
   Suzuki T, 1998, HUM REPROD, V13, P2186, DOI 10.1093/humrep/13.8.2186
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wang Q, 2016, MOL CELL ENDOCRINOL, V436, P183, DOI 10.1016/j.mce.2016.07.033
   WILLIAMS DJ, 1990, HISTOPATHOLOGY, V16, P405, DOI 10.1111/j.1365-2559.1990.tb01150.x
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   Zhou H, 2007, REPRODUCTION, V134, P307, DOI 10.1530/REP-07-0062
NR 50
TC 2
Z9 2
U1 5
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2019
VL 220
IS 12
BP 1904
EP 1914
DI 10.1093/infdis/jiz239
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JN2ZL
UT WOS:000496768900006
PM 31063544
DA 2020-07-08
ER

PT J
AU Flamand, C
   Bailly, S
   Fritzell, C
   Berthelot, L
   Vanhomwegen, J
   Salje, H
   Paireau, J
   Matheus, S
   Enfissi, A
   Fernandes-Pellerin, S
   Djossou, F
   Linares, S
   Carod, JF
   Kazanji, M
   Manuguerra, JC
   Cauchemez, S
   Rousset, D
AF Flamand, Claude
   Bailly, Sarah
   Fritzell, Camille
   Berthelot, Lena
   Vanhomwegen, Jessica
   Salje, Henrik
   Paireau, Juliette
   Matheus, Severine
   Enfissi, Antoine
   Fernandes-Pellerin, Sandrine
   Djossou, Felix
   Linares, Sebastien
   Carod, Jean-Francois
   Kazanji, Mirdad
   Manuguerra, Jean-Claude
   Cauchemez, Simon
   Rousset, Dominique
TI Impact of Zika Virus Emergence in French Guiana: A Large General
   Population Seroprevalence Survey
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; seroprevalence study; general population survey; French
   Guiana
ID GUILLAIN-BARRE-SYNDROME; BLOOD-DONORS; TRANSMISSION; POLYNESIA; DENGUE;
   CHIKUNGUNYA; ANTIBODIES; INFECTION; OUTBREAK; STATES
AB Background. Since the identification of Zika virus (ZIKV) in Brazil in May 2015, the virus has spread throughout the Americas. However, ZIKV burden in the general population in affected countries remains unknown.
   Methods. We conducted a general population survey in the different communities of French Guiana through individual interviews and serologic survey during June-October 2017. All serum samples were tested for anti-ZIKV immunoglobulin G antibodies using a recombinant antigen-based SGERPAxMap microsphere immunoassay, and some of them were further evaluated through anti-ZIKV microneutralization tests.
   Results. The overall seroprevalence was estimated at 23.3% (95% confidence interval [CI], 20.9%-25.9%) among 2697 participants, varying from 0% to 45.6% according to municipalities. ZIKV circulated in a large majority of French Guiana but not in the most isolated forest areas. The proportion of reported symptomatic Zika infection was estimated at 25.5% (95% CI, 20.3%-31.4%) in individuals who tested positive for ZIKV.
   Conclusions. This study described a large-scale representative ZIKV seroprevalence study in South America from the recent 2015-2016 Zika epidemic. Our findings reveal that the majority of the population remains susceptible to ZIKV, which could potentially allow future reintroductions of the virus.
C1 [Flamand, Claude; Bailly, Sarah; Fritzell, Camille; Kazanji, Mirdad] Inst Pasteur, Epidemiol Unit, 23 Ave Louis Pasteur,BP 6010, Cayenne 97306, French Guiana.
   [Berthelot, Lena; Matheus, Severine; Enfissi, Antoine; Rousset, Dominique] Inst Pasteur, Arbovirus Natl Reference Ctr, Cayenne, French Guiana.
   [Vanhomwegen, Jessica; Manuguerra, Jean-Claude] Inst Pasteur, Environm & Infect Risks Unit, Paris, France.
   [Salje, Henrik; Paireau, Juliette; Cauchemez, Simon] Inst Pasteur, CNRS, Unite Mixte Rech 2000, Math Modelling Infect Dis Unit, Paris, France.
   [Fernandes-Pellerin, Sandrine] Inst Pasteur, Clin Coordinat Translat Res Ctr, Paris, France.
   [Djossou, Felix] Ctr Hosp Andree Rosemon, Infect & Trop Dis Unit, Cayenne, French Guiana.
   [Linares, Sebastien] Direct Environm Amenagement & Logement Guyane, Geog Informat & Knowledge Disseminat Unit, Cayenne, French Guiana.
   [Carod, Jean-Francois] Ctr Hosp Ouest Guyanais, Med Lab, St Laurent Du Maroni, French Guiana.
RP Flamand, C (corresponding author), Inst Pasteur, Epidemiol Unit, 23 Ave Louis Pasteur,BP 6010, Cayenne 97306, French Guiana.
EM cflamand@pasteur-cayenne.fr
RI Djossou, Felix/AAM-8640-2020
OI Flamand, Claude/0000-0002-8064-445X
FU European Regional Development Fund under EPI-ARBO grantEuropean Union
   (EU) [GY0008695]; Regional Health Agency of French Guiana; National
   Center of Spatial Studies; Centre National d'Etudes SpatialesTerre
   solide, Ocean, Surfaces Continentales, Atmosphere fund
   [CNES-TOSCA-4800000720]; AXA Research Fund; Investissement d'Avenir
   programFrench National Research Agency (ANR); Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases program
   [ANR-10-LABX-62-IBEID]; Models of Infectious Disease Agent Study of the
   National Institute of General Medical Sciences; INCEPTION project
   [PIA/ANR-16-CONV-0005]; European Union's Horizon 2020 research and
   innovation program under ZIKAlliance grant [734548]
FX This study was supported by the European Regional Development Fund under
   EPI-ARBO grant agreement GY0008695; the Regional Health Agency of French
   Guiana; and the National Center of Spatial Studies. C. Fl. acknowledges
   financial support from the Centre National d'Etudes SpatialesTerre
   solide, Ocean, Surfaces Continentales, Atmosphere fund (grant number
   CNES-TOSCA-4800000720) and funding from Calmette and Yersin allocated by
   the Pasteur Institut Department of International Affairs. S. C.
   acknowledges financial support from the AXA Research Fund, the
   Investissement d'Avenir program, the Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases program (grant
   number ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent
   Study of the National Institute of General Medical Sciences, the
   INCEPTION project (PIA/ANR-16-CONV-0005), and the European Union's
   Horizon 2020 research and innovation program under ZIKAlliance grant
   agreement number 734548.
CR [Anonymous], 2013, SPAD DAT MIN V 8 0 S
   Aubry M, 2018, EMERG INFECT DIS, V24, P558, DOI 10.3201/eid2403.171149
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Beck C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/678084
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Epelboin Y, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170398
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Flamand C, 2017, AM J TROP MED HYG, V97, P344, DOI 10.4269/ajtmh.16-1028
   Flamand C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172267
   Flamand C, 2011, STUD HEALTH TECHNOL, V169, P629, DOI 10.3233/978-1-60750-806-9-629
   Fouque F, 1996, B SOC PATHOL EXOT, V89, P115
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kama M, 2019, EMERG INFECT DIS, V25, P1535, DOI 10.3201/eid2508.180524
   Kucharski AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34848
   L'Azou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003235
   Langerak T, 2019, J INFECT DIS, V220, P28, DOI 10.1093/infdis/jiz063
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   QGIS Development Team, 2009, QGIS GEOGR INF SYST
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Salje H, 2019, ELIFE, V8, DOI 10.7554/eLife.42869
   Sante Publique France, 2016, SIT EP VIR ZIK ANT G
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   StataCorp, 2017, STAT STAT SOFTW REL
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   World Health Organization, 2016, 1 M INT HLTH REG 200
NR 49
TC 1
Z9 1
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2019
VL 220
IS 12
BP 1915
EP 1925
DI 10.1093/infdis/jiz396
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JN2ZL
UT WOS:000496768900007
PM 31418012
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shan, C
   Xie, XP
   Luo, HL
   Muruato, AE
   Liu, Y
   Wakamiya, M
   La, JH
   Chung, JM
   Weaver, SC
   Wang, T
   Shi, PY
AF Shan, Chao
   Xie, Xuping
   Luo, Huanle
   Muruato, Antonio E.
   Liu, Yang
   Wakamiya, Maki
   La, Jun-Ho
   Chung, Jin Mo
   Weaver, Scott C.
   Wang, Tian
   Shi, Pei-Yong
TI Maternal vaccination and protective immunity against Zika virus vertical
   transmission
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; PREGNANT-WOMEN; INFECTION;
   IMMUNOGENICITY; IMMUNIZATION; PHASE-1; SAFETY
AB An important goal of the Zika virus (ZIKV) vaccine is to prevent a congenital syndrome in fetuses of pregnant women, but studies directly evaluating maternal vaccination for ZIKV are lacking. Here we report maternal vaccination using a live-attenuated ZIKV vaccine (3'UTR-Delta 10-LAV) in a pregnant mouse model. Maternal immunization with 3'UTR-Delta 10-LAV does not cause any adverse effects on pregnancy, fetal development, or offspring behavior. One maternal immunization fully protects dams against ZIKV infection and in utero transmission. Although neutralizing antibody alone is sufficient to prevent in utero transmission, a higher neutralizing titer is required to protect pregnant mice against in utero transmission than that required to protect non-pregnant mice against viral infection. The immunized dams transfer maternal antibodies to pups, which protect neonates against ZIKV infection. Notably, pregnancy weakens maternal T cell response to 3'UTR-Delta 10-LAV vaccination. Our results suggest that, besides vaccinating non-pregnant individuals, 3'UTR-Delta 10-LAV may also be considered for maternal vaccination.
C1 [Shan, Chao; Xie, Xuping; Liu, Yang; Wakamiya, Maki; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shan, Chao] Chinese Acad Sci, Mega Sci Ctr Biosafety Res, Wuhan Natl Biosafety Lab, Wuhan, Hubei, Peoples R China.
   [Luo, Huanle; Muruato, Antonio E.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [La, Jun-Ho; Chung, Jin Mo] Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Wang, Tian; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Galveston, TX 77555 USA.
   [Wang, Tian; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
OI Shan, Chao/0000-0002-3953-3782
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI142759, AI127744, R01 AI099123,
   R01 AI27744]; Kleberg Foundation; John S. Dunn Foundation; Amon G.
   Carter Foundation; Summerfield Robert Foundation; CDCUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [U01CK0000512]; World Reference Center for Emerging
   Viruses and Arboviruses, NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI120942]; Sealy
   Institute for Vaccine Sciences at UTMB;  [UL1TR001439]
FX The authors thank all members of the Shi lab and colleagues at
   University of Texas Medical Branch (UTMB) for helpful discussions during
   the course of this study. The authors thank Dr. Robert Tesh at the World
   Reference Center of Emerging Virus and Arboviruses (WRCEVA) from UTMB
   for providing ZIKV PRVABC59 strain and ZIKVspecific hyper-immune ascitic
   fluid. P.-Y.S. lab was supported by NIH grants U19AI142759, AI127744,
   Clinical and Translational Science Award UL1TR001439, the Kleberg
   Foundation Award, John S. Dunn Foundation, Amon G. Carter Foundation,
   Summerfield Robert Foundation, and CDC grant U01CK0000512 for the
   Western Gulf Center of Excellence for Vector-Borne Diseases. This
   research was also supported by the World Reference Center for Emerging
   Viruses and Arboviruses, NIH grant AI120942 to S.C.W. T.W. was supported
   by NIH grants R01 AI099123 and R01 AI27744, and a grant from Sealy
   Institute for Vaccine Sciences at UTMB.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P69
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Camargos VN, 2019, EBIOMEDICINE, V44, P516, DOI 10.1016/j.ebiom.2019.05.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Faucette AN, 2015, HUM VACC IMMUNOTHER, V11, P2549, DOI 10.1080/21645515.2015.1070984
   Fouda Genevieve G, 2018, Immunohorizons, V2, P14, DOI 10.4049/immunohorizons.1700057
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Halstead SB, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a030700
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pazos M, 2012, IMMUNOL RES, V54, P254, DOI 10.1007/s12026-012-8303-9
   Qi ZZ, 2012, CLIN VACCINE IMMUNOL, V19, P1746, DOI 10.1128/CVI.00455-12
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 49
TC 3
Z9 3
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD DEC 12
PY 2019
VL 10
AR 5677
DI 10.1038/s41467-019-13589-1
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JV3GP
UT WOS:000502255000001
PM 31831806
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hobson-Peters, J
   Harrison, JJ
   Watterson, D
   Hazlewood, JE
   Vet, LJ
   Newton, ND
   Warrilow, D
   Colmant, AMG
   Taylor, C
   Huang, BX
   Piyasena, TBH
   Chow, WK
   Setoh, YX
   Tang, B
   Nakayama, E
   Yan, KX
   Amarilla, AA
   Wheatley, S
   Moore, PR
   Finger, M
   Kurucz, N
   Modhiran, N
   Young, PR
   Khromykh, AA
   Bielefeldt-Ohmann, H
   Suhrbier, A
   Hall, RA
AF Hobson-Peters, Jody
   Harrison, Jessica J.
   Watterson, Daniel
   Hazlewood, Jessamine E.
   Vet, Laura J.
   Newton, Natalee D.
   Warrilow, David
   Colmant, Agathe M. G.
   Taylor, Carmel
   Huang, Bixing
   Piyasena, Thisun B. H.
   Chow, Weng Kong
   Setoh, Yin Xiang
   Tang, Bing
   Nakayama, Eri
   Yan, Kexin
   Amarilla, Alberto A.
   Wheatley, Sarah
   Moore, Peter R.
   Finger, Mitchell
   Kurucz, Nina
   Modhiran, Naphak
   Young, Paul R.
   Khromykh, Alexander A.
   Bielefeldt-Ohmann, Helle
   Suhrbier, Andreas
   Hall, Roy A.
TI A recombinant platform for flavivirus vaccines and diagnostics using
   chimeras of a new insect-specific virus
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID WEST-NILE-VIRUS; MONOCLONAL-ANTIBODIES; JAPANESE ENCEPHALITIS; ZIKA
   VIRUS; NEUTRALIZING ANTIBODIES; CULEX FLAVIVIRUS; STRUCTURAL BASIS; SKIN
   REACTIONS; MOSQUITOS; ENVELOPE
AB Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being sought to address safety and manufacturing issues associated with current live attenuated vaccines. Here, we describe a new insect-specific flavivirus, Binjari virus, which was found to be remarkably tolerant for exchange of its structural protein genes (prME) with those of the aforementioned pathogenic vertebrate-infecting flaviviruses (VIFs). Chimeric BinJ/VIF-prME viruses remained replication defective in vertebrate cells but replicated with high efficiency in mosquito cells. Cryo-electron microscopy and monoclonal antibody binding studies illustrated that the chimeric BinJ/VIF-prME virus particles were structurally and immunologically similar to their parental VIFs. Pilot manufacturing in C6/36 cells suggests that high yields can be reached up to 10(9.5) cell culture infectious dose/ml or approximate to 7 mg/liter. BinJ/VIF-prME viruses showed utility in diagnostic (microsphere immunoassays and ELISAs using panels of human and equine sera) and vaccine applications (illustrating protection against Zika virus challenge in murine IFNAR(-/-) mouse models). BinJ/VIF-prME viruses thus represent a versatile, noninfectious (for vertebrate cells), high-yield technology for generating chimeric flavivirus particles with low biocontainment requirements.
C1 [Hobson-Peters, Jody; Harrison, Jessica J.; Watterson, Daniel; Vet, Laura J.; Newton, Natalee D.; Colmant, Agathe M. G.; Piyasena, Thisun B. H.; Setoh, Yin Xiang; Amarilla, Alberto A.; Modhiran, Naphak; Young, Paul R.; Khromykh, Alexander A.; Bielefeldt-Ohmann, Helle; Suhrbier, Andreas; Hall, Roy A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.
   [Hazlewood, Jessamine E.; Tang, Bing; Yan, Kexin; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol Grp, Brisbane, Qld 4029, Australia.
   [Warrilow, David; Taylor, Carmel; Huang, Bixing; Wheatley, Sarah; Moore, Peter R.; Finger, Mitchell] Queensland Govt, Dept Hlth, Publ Hlth Virol Lab, POB 594, Archerfield, Qld, Australia.
   [Chow, Weng Kong] Australian Def Force Malaria & Infect Dis Inst, Gallipoli Barracks, Qld, Australia.
   [Nakayama, Eri] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.
   [Kurucz, Nina] Northern Terr Dept Hlth, Ctr Dis Control, Hlth Protect Div, Darwin, NT, Australia.
   [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Gatton Campus, Gatton, Qld 4343, Australia.
RP Hobson-Peters, J; Hall, RA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.
EM j.peters2@uq.edu.au; roy.hall@uq.edu.au
OI Hazlewood, Jessamine/0000-0001-6104-4531; Vet,
   Laura/0000-0001-7587-2936; Yan, Kexin/0000-0003-2203-217X; Harrison,
   Jessica/0000-0002-3577-9910; Hobson-Peters, Jody/0000-0003-0139-9829;
   Newton, Natalee/0000-0002-5617-8639; Colmant,
   Agathe/0000-0002-2004-4073; /0000-0002-1657-8558; Warrilow,
   David/0000-0002-3221-7605
FU Australian Government National Health and Medical Research Council
   (NHMRC)National Health and Medical Research Council of Australia
   [APP1138611, APP1144950, APP1164216]; Australian Research
   CouncilAustralian Research Council [DP120103994]; University of
   QueenslandUniversity of Queensland [612023]; Australian Infectious
   Disease Research Center; Australian Postgraduate AwardsAustralian
   Government; Daiichi Sankyo Foundation of Life Science, Japan
FX This project was funded by the Australian Government National Health and
   Medical Research Council (NHMRC) project numbers APP1138611, APP1144950,
   and APP1164216; the Australian Research Council (DP120103994); the
   University of Queensland strategic funding grant (612023); and an
   intramural seed grant from the Australian Infectious Disease Research
   Center. A.A.K. and A.S. are NHMRC Research Fellows. J.J.H., J.E.H.,
   N.D.N., L.J.V., A.M.G.C., and T.B.H.P. were supported by Australian
   Postgraduate Awards. E.N. was supported in part by the Daiichi Sankyo
   Foundation of Life Science, Japan. The opinions expressed herein are
   those of the authors and do not necessarily reflect those of the
   Australian Defence Force and/or Defence Force Policy.
CR ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Adungo F, 2016, CLIN VACCINE IMMUNOL, V23, P689, DOI 10.1128/CVI.00209-16
   Aliota MT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-293
   Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Basile AJ, 2015, J VIROL METHODS, V225, P41, DOI 10.1016/j.jviromet.2015.08.025
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Blitvich BJ, 2009, J MED ENTOMOL, V46, P934, DOI 10.1603/033.046.0428
   Boigard H, 2018, VACCINE, V36, P7728, DOI 10.1016/j.vaccine.2018.10.072
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384
   CDC, 2016, ZIK MAC ELISA INSTR
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000
   Charles J, 2017, ARCH VIROL, V162, P3913, DOI 10.1007/s00705-017-3552-5
   Chen LH, 2019, CLIN INFECT DIS, V68, P1761, DOI 10.1093/cid/ciy777
   Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Colmant AMG, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00262-17, 10.1128/msphere.00262-17]
   Colmant AMG, 2016, J GEN VIROL, V97, P1087, DOI 10.1099/jgv.0.000430
   Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0
   Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Diaz C, 2018, AM J TROP MED HYG, V98, P1435, DOI 10.4269/ajtmh.17-0627
   Erasmus JH, 2018, J VIROL, V92, DOI 10.1128/JVI.01274-17
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119
   Evangelista J, 2013, J GEN VIROL, V94, P1266, DOI 10.1099/vir.0.050575-0
   FALCONAR AKI, 1991, J GEN VIROL, V72, P961, DOI 10.1099/0022-1317-72-4-961
   Fan YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25596-1
   Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/s1679-49742018000200014
   Frances SP, 2004, J MED ENTOMOL, V41, P115, DOI 10.1603/0022-2585-41.1.115
   Frost MJ, 2012, EMERG INFECT DIS, V18, P792, DOI 10.3201/eid1805.111720
   Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Goh LYH, 2013, CLIN IMMUNOL, V149, P487, DOI 10.1016/j.clim.2013.10.004
   Guzman H, 2018, AM J TROP MED HYG, V98, P410, DOI 10.4269/ajtmh.17-0350
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   HALL RA, 1990, J GEN VIROL, V71, P2923, DOI 10.1099/0022-1317-71-12-2923
   HALL RA, 1991, IMMUNOL CELL BIOL, V69, P47, DOI 10.1038/icb.1991.7
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harrison JJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050141
   Hegde NR, 2017, HUM VACC IMMUNOTHER, V13, P1320, DOI 10.1080/21645515.2017.1285472
   HIGGS S, 1991, ARCH VIROL, V119, P119, DOI 10.1007/BF01314328
   Hobson-Peters J, 2008, J GEN VIROL, V89, P3063, DOI 10.1099/vir.0.2008/003731-0
   Hobson-Peters J, 2016, VIROLOGY, V489, P269, DOI 10.1016/j.virol.2015.11.003
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hobson-Peters J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/379738
   Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025
   Huhtamo E, 2014, VIROLOGY, V464, P320, DOI 10.1016/j.virol.2014.07.015
   Huhtamo E, 2012, VIROLOGY, V433, P471, DOI 10.1016/j.virol.2012.08.038
   Jaberolansar N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10415-w
   Johnson AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P566, DOI 10.1128/CDLI.12.5.566-574.2005
   Johnson BW, 2016, AM J TROP MED HYG, V94, P820, DOI 10.4269/ajtmh.15-0631
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   Kato F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16475-2
   Kawai Y, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007387
   Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722
   Kolodziejek J, 2013, J GEN VIROL, V94, P2449, DOI 10.1099/vir.0.056200-0
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kudlacek ST, 2018, J BIOL CHEM, V293, P8922, DOI 10.1074/jbc.RA118.002658
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lee JS, 2018, VACCINE, V36, P2346, DOI 10.1016/j.vaccine.2018.03.002
   Li J, 2018, STRUCTURE, V26, P51, DOI 10.1016/j.str.2017.11.017
   Li XQ, 2013, J GEN VIROL, V94, P2191, DOI 10.1099/vir.0.055178-0
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Luo R, 2019, CLIN MICROBIOL INFEC, V25, P659, DOI 10.1016/j.cmi.2019.01.002
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Manini I, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030018
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   MATSUMUR.T, 1971, VIROLOGY, V46, P344, DOI 10.1016/0042-6822(71)90036-5
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696
   McNeil MM, 2018, J ALLERGY CLIN IMMUN, V141, P463, DOI 10.1016/j.jaci.2017.12.971
   MELLANBY K, 1946, NATURE, V158, P554, DOI 10.1038/158554c0
   Melville L., 2012, AUSTR GOVT RIRADC
   Metz SW, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0970-2
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303
   Muraki Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0282-8
   Nikolay A, 2018, APPL MICROBIOL BIOT, V102, P8725, DOI 10.1007/s00253-018-9275-z
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Parreira R, 2012, VIRUS RES, V167, P152, DOI 10.1016/j.virusres.2012.04.010
   Pauvolid-Correa A, 2015, ARCH VIROL, V160, P21, DOI 10.1007/s00705-014-2219-8
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Peng ZK, 1996, ANN ALLERG ASTHMA IM, V77, P238, DOI 10.1016/S1081-1206(10)63262-0
   Pijlman GP, 2006, EXPERT OPIN BIOL TH, V6, P135, DOI 10.1517/14712598.6.2.135
   Piyasena TBH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03120-1
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Prow NA, 2018, J GEN VIROL, V99, P596, DOI 10.1099/jgv.0.001038
   Pyke A. T., 2016, PLOS CURR, V8
   Quintel B. K., 2018, VACCINE
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006191
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   ROEHRIG JT, 1983, VIROLOGY, V128, P118, DOI 10.1016/0042-6822(83)90323-9
   Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sanchez MD, 2005, VIROLOGY, V336, P70, DOI 10.1016/j.virol.2005.02.020
   Schmidt AC, 2017, AM J TROP MED HYG, V96, P1325, DOI 10.4269/ajtmh.16-0634
   SCOTT RM, 1984, J ALLERGY CLIN IMMUN, V74, P808, DOI 10.1016/0091-6749(84)90183-0
   Setoh YX, 2012, J GEN VIROL, V93, P1965, DOI 10.1099/vir.0.044453-0
   Setoh YX, 2011, J VIROL METHODS, V175, P20, DOI 10.1016/j.jviromet.2011.04.010
   Setoh YX, 2019, NAT MICROBIOL, V4, P876, DOI 10.1038/s41564-019-0399-4
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shi PY, 2003, EXPERT REV MOL DIAGN, V3, P733, DOI 10.1586/14737159.3.6.733
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Suphatrakul A, 2015, VACCINE, V33, P5613, DOI 10.1016/j.vaccine.2015.08.090
   Tatsuno K, 2016, J DERMATOL SCI, V82, P145, DOI 10.1016/j.jdermsci.2016.04.010
   Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2
   Taucher C, 2010, J VIROL, V84, P599, DOI 10.1128/JVI.01063-09
   Taylor CT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050253
   Taylor TJ, 2016, VIROLOGY, V496, P186, DOI 10.1016/j.virol.2016.06.006
   TRIRAWATANAPONG T, 1992, GENE, V116, P139, DOI 10.1016/0378-1119(92)90509-N
   Tung YT, 2016, BIOSENS BIOELECTRON, V77, P90, DOI 10.1016/j.bios.2015.09.007
   Urakami A, 2017, J VIROL, V91, DOI [10.1128/JVI.01181-17, 10.1128/jvi.01181-17]
   WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601
   Wang SL, 1999, J VIROL, V73, P2547, DOI 10.1128/JVI.73.3.2547-2551.1999
   Wang Z.S., 2009, CHIN J PUBLIC HLTH, V25, P769
   Warrilow D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091103
   Weger-Lucarelli J, 2018, VIROLOGY, V521, P175, DOI 10.1016/j.virol.2018.06.007
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
   Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Woods CW, 2019, VACCINE, V37, P4222, DOI 10.1016/j.vaccine.2018.12.026
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
NR 145
TC 1
Z9 1
U1 6
U2 7
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD DEC 11
PY 2019
VL 11
IS 522
AR eaax7888
DI 10.1126/scitranslmed.aax7888
PG 15
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA JV4OE
UT WOS:000502343800006
PM 31826984
DA 2020-07-08
ER

PT J
AU Alvarado-Castro, V
   Paredes-Solis, S
   Nava-Aguilera, E
   Morales-Perez, A
   Flores-Moreno, M
   Legorreta-Soberanis, J
   Jaimes-Nestor, E
   Cockcroft, A
   Andersson, N
AF Alvarado-Castro, Victor
   Paredes-Solis, Sergio
   Nava-Aguilera, Elizabeth
   Morales-Perez, Arcadio
   Flores-Moreno, Miguel
   Legorreta-Soberanis, Jose
   Jaimes-Nestor, Esmeralda
   Cockcroft, Anne
   Andersson, Neil
TI Social capital is associated with lower mosquito vector indices:
   secondary analysis from a cluster randomised controlled trial of
   community mobilisation for dengue prevention in Mexico
SO POPULATION HEALTH METRICS
LA English
DT Article
DE Social capital; Community mobilisation; Dengue; Factor analysis; Vector
   indices
ID PUBLIC-HEALTH; AEDES-AEGYPTI; PARTICIPATION; INVOLVEMENT; MULTILEVEL;
   RISK
AB Background: Control of the Aedes aegypti mosquito is central to reducing the risk of dengue, zika, chikungunya, and yellow fever. Randomised controlled trials, including the Camino Verde trial in Mexico and Nicaragua, demonstrate the convincing impact of community mobilisation interventions on vector indices. These interventions might work through building social capital but little is known about the relationship between social capital and vector indices.
   Methods: A secondary analysis used data collected from 45 intervention clusters and 45 control clusters in the impact survey of the Mexican arm of the Camino Verde cluster randomised controlled trial. Factor analysis combined responses to questions about aspects of social capital to create a social capital index with four constructs, their weighted averages then combined into a single scale. We categorised households as having high or low social capital based on their score on this scale. We examined associations between social capital and larval and pupal vector indices, taking account of the effects of other variables in a multivariate analysis. We report associations as odds ratios and 95% confidence intervals.
   Results: The four social capital constructs were involvement, participation, investment, and communication. Among the 10, 112 households, those in rural communities were much more likely to have a high social capital score (OR 4.51, 95% CIca 3.26-6.26). Households in intervention sites had higher social capital, although the association was not significant at the 5% level. Households with high social capital were more likely to be negative for larvae or pupae (OR 1.38, 95% CIca 1.12-1.69) and for pupae specifically (OR 1.37, 95% CIca 1.08-1.74). There was interaction between intervention status and social capital; in multivariate analysis, a combined variable of intervention/high social capital remained associated with larvae or pupae (ORa l.56, 95% CIca 1.19-2.04) and with pupae specifically (ORa 1.65, 95% CIca 1.20-2.28).
   Conclusion: This is the first report of an association of high social capital with low vector indices. Our findings support the idea that the Camino Verde community mobilisation intervention worked partly through an interaction with social capital. Understanding such interactions may help to maximise the impact of future community mobilisation interventions.
C1 [Alvarado-Castro, Victor; Paredes-Solis, Sergio; Nava-Aguilera, Elizabeth; Morales-Perez, Arcadio; Flores-Moreno, Miguel; Legorreta-Soberanis, Jose; Jaimes-Nestor, Esmeralda; Andersson, Neil] Univ Autonoma Guerrero, CIET, Calle Pino S-N Colonia El Roble, Acapulco 39640, Guerrero, Mexico.
   [Cockcroft, Anne; Andersson, Neil] McGill Univ, Dept Family Med, Montreal, PQ, Canada.
RP Paredes-Solis, S (corresponding author), Univ Autonoma Guerrero, CIET, Calle Pino S-N Colonia El Roble, Acapulco 39640, Guerrero, Mexico.
EM srgprds@gmail.com
OI Paredes Solis, Sergio/0000-0002-3015-3038
FU UBS Optimus Foundation [2008-02-108541]; Fomix-CONACYTConsejo Nacional
   de Ciencia y Tecnologia (CONACyT) [GUE-2014-01-249567]
FX Funding for the Camino Verde trial was provided by the UBS Optimus
   Foundation. Fomix-CONACYT-GUERRERO also supported the research (Grant
   Number 2008-02-108541). Funding for publication of this article was
   provided by Fomix-CONACYT (Grant Number GUE-2014-01-249567). The funding
   bodies played no role in data collection, analysis, or preparation of
   this article.
CR Abeyewickreme W, 2012, PATHOG GLOB HEALTH, V106, P479, DOI 10.1179/2047773212Y.0000000060
   Acquaah M, 2015, NETWORK BUSINESS SUS
   Agampodi TC, 2015, SOC SCI MED, V128, P95, DOI 10.1016/j.socscimed.2015.01.005
   Alvarado-Castro V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4290-z
   Andersson Neil, 2006, Int J Health Geogr, V5, P1, DOI 10.1186/1476-072X-5-1
   Andersson N, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4288-6
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Andersson N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-S2-S15
   [Anonymous], 2015, R LANG ENV STAT COMP
   Arunachalam N, 2012, PATHOG GLOB HEALTH, V106, P488, DOI 10.1179/2047773212Y.0000000056
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4
   Bourdieu P, 1986, HDB THEORY RES SOCIO, DOI [10.1002/9780470755679.CH15, DOI 10.1002/9780470755679.CH15]
   Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187
   Alvarez EC, 2017, SOCIOL HEALTH ILL, V39, P5, DOI 10.1111/1467-9566.12506
   Castro M, 2012, T ROY SOC TROP MED H, V106, P315, DOI 10.1016/j.trstmh.2012.01.013
   Coleman James, 1990, FDN SOCIAL THEORY
   Cramm JM, 2013, GERONTOLOGIST, V53, P142, DOI 10.1093/geront/gns052
   Drukker M, 2005, SOC SCI MED, V61, P185, DOI 10.1016/j.socscimed.2004.11.041
   Ehsan AM, 2015, J EPIDEMIOL COMMUN H, V69, P1021, DOI 10.1136/jech-2015-205868
   Focks D.A., 2004, REV ENTOMOLOGICAL SA
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Frank L, 2006, SMART GROWTH BC
   Hofferth SL, 1998, RURAL SOCIOL, V63, P574, DOI 10.1111/j.1549-0831.1998.tb00693.x
   HONAKER J, AMELIA 2 PROGRAM MIS
   Jonker Emile F F, 2013, Ther Adv Vaccines, V1, P144, DOI 10.1177/2051013613498954
   Kabacoff RI, 2011, R ACTION DATA ANAL G, P331
   Kahssay H. M., 1999, COMMUNITY INVOLVEMEN
   Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187
   Kawachi I, 2013, GLOBAL PERSPECTIVES
   Kennedy BP, 1998, WORLD DEV, V26, P2029, DOI 10.1016/S0305-750X(98)00094-1
   Ledogar RJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4298-4
   Lomas J, 1998, SOC SCI MED, V47, P1181, DOI 10.1016/S0277-9536(98)00190-7
   Loutfi D, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0911-8
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Mohnen SM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-116
   Morales-Perez A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4300-1
   Morgan LM, 2001, HEALTH POLICY PLANN, V16, P221, DOI 10.1093/heapol/16.3.221
   Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128
   Nelson Nici, 1995, POWER PARTICIPATORY
   Nieminen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-613
   Pan American Health Organization World Health Organization, SCI STUD INT VECT CO
   Putnam RD, 2000, BOWLING ALONE COLLAP
   Rubin DB, 1987, MULTIPLE IMPUTATION
   Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918
   Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017
   Smiljanic J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171565
   Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5
   Subaris H, 2016, INT J PUBLIC HLTH SC, V5, P111
   Vanlerberghe V, 2010, MEDICC REV, V12, P41
   Villalonga-Olives E, 2018, SOC SCI MED, V212, P203, DOI 10.1016/j.socscimed.2018.07.022
   Wakefield SEL, 2001, HEALTH PLACE, V7, P163, DOI 10.1016/S1353-8292(01)00006-5
   World Health Organisation, 2016, IMM VACC BIOL DENG V
   World Health Organization, 2009, DENG SEV DENG
   Yen IH, 1999, AM J EPIDEMIOL, V149, P898
   ZELEN M, 1971, BIOMETRIKA, V58, P129, DOI 10.1093/biomet/58.1.129
   Ziersch AM, 2009, AUST NZ J PUBL HEAL, V33, P7, DOI 10.1111/j.1753-6405.2009.00332.x
NR 57
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-7954
J9 POPUL HEALTH METR
JI Popul. Health Metr.
PD DEC 10
PY 2019
VL 17
IS 1
AR 18
DI 10.1186/s12963-019-0199-3
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KQ1WJ
UT WOS:000516720700001
PM 31823786
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Durham, ND
   Agrawal, A
   Waltari, E
   Croote, D
   Zanini, F
   Fouch, M
   Davidson, E
   Smith, O
   Carabajal, E
   Pak, JE
   Doranz, BJ
   Robinson, M
   Sanz, AM
   Albornoz, LL
   Rosso, F
   Einav, S
   Quake, SR
   McCutcheon, KM
   Goo, L
AF Durham, Natasha D.
   Agrawal, Aditi
   Waltari, Eric
   Croote, Derek
   Zanini, Fabio
   Fouch, Mallorie
   Davidson, Edgar
   Smith, Olivia
   Carabajal, Esteban
   Pak, John E.
   Doranz, Benjamin J.
   Robinson, Makeda
   Sanz, Ana M.
   Albornoz, Ludwig L.
   Rosso, Fernando
   Einav, Shirit
   Quake, Stephen R.
   McCutcheon, Krista M.
   Goo, Leslie
TI Broadly neutralizing human antibodies against dengue virus identified by
   single B cell transcriptomics
SO ELIFE
LA English
DT Article
ID WEST-NILE-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; ZIKA VIRUS; STRUCTURAL
   BASIS; MEDIATED NEUTRALIZATION; DEPENDENT ENHANCEMENT;
   HEMORRHAGIC-FEVER; 4 SEROTYPES; INFECTION; POTENT
AB Eliciting broadly neutralizing antibodies (bNAbs) against the four dengue virus serotypes (DENV1-4) that are spreading into new territories is an important goal of vaccine design. To define bNAb targets, we characterized 28 antibodies belonging to expanded and hypermutated clonal families identified by transcriptomic analysis of single plasmablasts from DENV-infected individuals. Among these, we identified J9 and J8, two somatically related bNAbs that potently neutralized DENV1-4. Mutagenesis studies showed that the major recognition determinants of these bNAbs are in E protein domain I, distinct from the only known class of human bNAbs against DENV with a well-defined epitope. B cell repertoire analysis from acute-phase peripheral blood suggested that J9 and J8 followed divergent somatic hypermutation pathways, and that a limited number of mutations was sufficient for neutralizing activity. Our study suggests multiple B cell evolutionary pathways leading to DENV bNAbs targeting a new epitope that can be exploited for vaccine design.
C1 [Durham, Natasha D.; Agrawal, Aditi; Waltari, Eric; Smith, Olivia; Carabajal, Esteban; Pak, John E.; Quake, Stephen R.; McCutcheon, Krista M.; Goo, Leslie] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.
   [Croote, Derek; Zanini, Fabio; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
   [Fouch, Mallorie; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA.
   [Robinson, Makeda; Einav, Shirit] Stanford Univ, Dept Med, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Robinson, Makeda; Einav, Shirit] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.
   [Sanz, Ana M.; Rosso, Fernando] Fdn Valle Lili, Clin Res Ctr, Cali, Colombia.
   [Albornoz, Ludwig L.] Fdn Valle Lili, Pathol & Lab Dept, Cali, Colombia.
   [Rosso, Fernando] Fdn Valle Lili, Div Infect Dis, Dept Internal Med, Cali, Colombia.
   [Goo, Leslie] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Durham, Natasha D.] Univ Massachusetts, Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA.
   [Zanini, Fabio] Univ New South Wales, Lowy Canc Res Ctr, Kensington, NSW, Australia.
RP Goo, L (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Goo, L (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
EM lgoo@fredhutch.org
OI Robinson, Makeda/0000-0002-5919-4159; Waltari, Eric/0000-0001-6930-9645;
   Croote, Derek/0000-0003-4907-1865
FU Chan Zuckerberg Biohub; Fred Hutchinson Cancer Research Center; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HHSN272201400058C];
   National Science FoundationNational Science Foundation (NSF); Dr. Ralph
   and Marian Falk Medical Research Trust; Stanford Bio-X; Stanford
   UniversityStanford University
FX Chan Zuckerberg Biohub Natasha D Durham Aditi Agrawal Eric Waltari Fabio
   Zanini Olivia Smith Esteban Carabajal John E Pak Stephen R Quake Krista
   M McCutcheon Leslie Goo; Fred Hutchinson Cancer Research Center Leslie
   Goo; National Institutes of Health HHSN272201400058C Benjamin J Doranz;
   National Science Foundation Graduate Research Fellowship Derek Croote;
   Stanford University Kou-I Yeh Stanford Graduate Fellowship Derek Croote;
   Dr. Ralph and Marian Falk Medical Research Trust Catalyst Award Shirit
   Einav; Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program
   Shirit Einav; Stanford University Stanford Advanced Residency Training
   at Stanford Fellowship Program Makeda Robinson; The funders had no role
   in study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Alvarez M, 2006, AM J TROP MED HYG, V75, P1113, DOI 10.4269/ajtmh.2006.75.1113
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Appanna R, 2016, EBIOMEDICINE, V12, P178, DOI 10.1016/j.ebiom.2016.09.003
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bell SM, 2019, ELIFE, V8, DOI 10.7554/eLife.42496
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1590-z
   Biswal S, 2019, NEW ENGL J MED, V381, P2009, DOI 10.1056/NEJMoa1903869
   Boonyaratanakornkit J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01694
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chen F, 2019, CURR OPIN VIROL, V34, P149, DOI 10.1016/j.coviro.2019.02.004
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611
   Corti D, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0018-2014
   Cox KS, 2016, MABS-AUSTIN, V8, P129, DOI 10.1080/19420862.2015.1109757
   Crank MC, 2019, SCIENCE, V365, P505, DOI 10.1126/science.aav9033
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605
   Doria-Rose NA, 2012, J VIROL, V86, P3393, DOI 10.1128/JVI.06745-11
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Goo L, 2019, NAT MICROBIOL, V4, P71, DOI 10.1038/s41564-018-0283-7
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Goo L, 2012, J VIROL, V86, P10857, DOI 10.1128/JVI.01414-12
   Graham BS, 2019, ANNU REV MED, V70, P91, DOI 10.1146/annurev-med-121217-094234
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hoehn KB, 2016, MOL BIOL EVOL, V33, P1147, DOI 10.1093/molbev/msw015
   Hu D, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007836
   Juraska M, 2018, P NATL ACAD SCI USA, V115, pE8378, DOI 10.1073/pnas.1714250115
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Khursheed M, 2013, J PAK MED ASSOC, V63, P670
   Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029
   LI LK, 2019, PLOS PATHOG, V15, DOI DOI 10.1371/JOURNAL.PPAT.1007716
   Lim XN, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007996
   Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016
   Mattia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027252
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Ng KH, 2019, CELL HOST MICROBE, V26, P601, DOI 10.1016/j.chom.2019.10.005
   NIAID, 2019, IND MON BOARD REC EA
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Paes C, 2009, J AM CHEM SOC, V131, P6952, DOI 10.1021/ja900186n
   Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Raut R, 2019, P NATL ACAD SCI USA, V116, P227, DOI 10.1073/pnas.1812055115
   Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rothman AL, 2015, VACCINE, V33, P7083, DOI 10.1016/j.vaccine.2015.09.104
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227
   Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Sharma M, 2020, J INFECT DIS, V221, P867, DOI 10.1093/infdis/jiz081
   Shen WF, 2018, ELIFE, V7, DOI 10.7554/eLife.38970
   Shi X, 2016, MABS-AUSTIN, V8, P574, DOI 10.1080/19420862.2016.1148850
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DP, 2013, MBIO, V4, DOI 10.1128/mBio.00133-12
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110
   Thein TL, 2011, AM J TROP MED HYG, V85, P942, DOI 10.4269/ajtmh.2011.11-0149
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   Tsioris K, 2015, INTEGR BIOL-UK, V7, P1587, DOI [10.1039/c5ib00169b, 10.1039/C5IB00169B]
   Tzarum N, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1882
   Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09
   Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746
   Waltari E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01452
   Weidenbacher PA, 2019, P NATL ACAD SCI USA, V116, P9947, DOI 10.1073/pnas.1822062116
   Woda M, 2015, J IMMUNOL METHODS, V416, P167, DOI 10.1016/j.jim.2014.12.001
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532
   Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659
   Xu MH, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-016-0003-3
   Xu MH, 2016, J VIROL, V90, P11122, DOI 10.1128/JVI.01096-16
   Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zanini F, 2018, P NATL ACAD SCI USA, V115, pE12363, DOI 10.1073/pnas.1813819115
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhou JQ, 2019, J IMMUNOL, V203, P1687, DOI 10.4049/jimmunol.1900666
NR 115
TC 1
Z9 1
U1 3
U2 3
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD DEC 10
PY 2019
VL 8
AR e52384
DI 10.7554/eLife.52384
PG 29
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA JY5DT
UT WOS:000504436300001
PM 31820734
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Freedman, AA
   Goldstein, JA
   Miller, GE
   Borders, A
   Keenan-Devlin, L
   Ernst, LM
AF Freedman, Alexa A.
   Goldstein, Jeffery A.
   Miller, Gregory E.
   Borders, Ann
   Keenan-Devlin, Lauren
   Ernst, Linda M.
TI Seasonal Variation of Chronic Villitis of Unknown Etiology
SO PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
LA English
DT Article; Early Access
DE chronic placental inflammation; villitis of unknown etiology; seasonal
   trend; placenta
ID CHRONIC PLACENTAL INFLAMMATION; PRETERM BIRTH; VITAMIN-D; AIR-POLLUTION;
   ZIKA VIRUS; PREGNANCY; LESIONS; STRESS; FETAL; DEPRESSION
AB Introduction Chronic villitis of unknown etiology (VUE) is a chronic inflammatory lesion of the placenta. VUE is hypothesized to result from an alloimmune response or as response to an unidentified infection. Lack of a seasonal trend is thought to support VUE as an alloimmune response, though data on seasonal VUE trends are limited. Methods Data were obtained from a hospital in Chicago, Illinois, from 2011-2016. Placentas sent to pathology were reviewed using a standardized protocol, and VUE cases were identified based on an automated text search of pathology records. We used monthly VUE prevalence estimates to investigate the annual trend, and we used Poisson regression to evaluate seasonal variation in the number of VUE cases. Results There were 79 825 deliveries within the study period. Pathologists evaluated 12 074 placentas and identified 2873 cases of VUE. Regression results indicate that the risk of VUE is 16% to 17% higher in the fall and winter as compared to the summer (fall relative risk [RR]: 1.17, 95% confidence interval [CI]: 1.06-1.29; winter RR: 1.16, 95% CI: 1.05-1.29). Discussion Our results suggest that there may be seasonal variation in VUE prevalence, particularly for low-grade VUE. Future studies should evaluate seasonal variation in a representative sample rather than relying on pathology reports to estimate prevalence.
C1 [Freedman, Alexa A.; Miller, Gregory E.] Northwestern Univ, Inst Policy Res, Evanston, IL USA.
   [Freedman, Alexa A.] NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Evanston, IL USA.
   [Goldstein, Jeffery A.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Miller, Gregory E.] Northwestern Univ, Dept Psychol, Evanston, IL USA.
   [Borders, Ann; Keenan-Devlin, Lauren] Univ Chicago, NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Pritzker Sch Med, Evanston, IL 60637 USA.
   [Ernst, Linda M.] Univ Chicago, NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Pritzker Sch Med, 2650 Ridge Ave, Evanston, IL 60637 USA.
RP Ernst, LM (corresponding author), Univ Chicago, NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Pritzker Sch Med, 2650 Ridge Ave, Evanston, IL 60637 USA.
EM lernst@northshore.org
FU Institute for Policy Research at Northwestern University; Department of
   Obstetrics and Gynecology at NorthShore University HealthSystem
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article:
   Postdoctoral fellowship support (AAF) provided by the Institute for
   Policy Research at Northwestern University and the Department of
   Obstetrics and Gynecology at NorthShore University HealthSystem.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   American Lung Association, 2018, STAT AIR 2018
   Becroft DM, 2005, AM J OBSTET GYNECOL, V192, P264, DOI 10.1016/j.ajog.2004.06.062
   Bodnar LM, 2008, PAEDIATR PERINAT EP, V22, P538, DOI 10.1111/j.1365-3016.2008.00971.x
   Cai J, 2017, SCI TOTAL ENVIRON, V607, P1103, DOI 10.1016/j.scitotenv.2017.07.029
   Chazan B, 2011, CLIN MICROBIOL INFEC, V17, P851, DOI 10.1111/j.1469-0691.2010.03327.x
   Christensen AL, 2011, COMPUT METH PROG BIO, V104, P333, DOI 10.1016/j.cmpb.2011.07.016
   Currie J, 2013, P NATL ACAD SCI USA, V110, P13228, DOI 10.1073/pnas.1307582110
   Derricott H, 2013, PLACENTA, V34, P856, DOI 10.1016/j.placenta.2013.07.003
   Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000
   Dovnik A, 2014, EUR J OBSTET GYN R B, V181, P6, DOI 10.1016/j.ejogrb.2014.07.019
   Dubruc E, 2016, PLACENTA, V48, P104, DOI 10.1016/j.placenta.2016.10.009
   Ernst LM, 2013, AM J PERINAT, V30, P557, DOI 10.1055/s-0032-1329187
   Ernst LM, 2005, PEDIATR DEVEL PATHOL, V8, P647, DOI 10.1007/s10024-005-0412-1
   Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017
   Katzman PJ, 2019, PEDIATR DEVEL PATHOL, V22, P334, DOI 10.1177/1093526619825708
   Keenan-Devlin LS, 2017, AM J PERINAT, V34, P1003, DOI 10.1055/s-0037-1601353
   Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Kingsley SL, 2017, ENVIRON INT, V108, P204, DOI 10.1016/j.envint.2017.08.022
   KNOX WF, 1984, PLACENTA, V5, P395, DOI 10.1016/S0143-4004(84)80019-3
   Lee SJ, 2006, BJOG-INT J OBSTET GY, V113, P1280, DOI 10.1111/j.1471-0528.2006.01055.x
   Liu NQ, 2011, J IMMUNOL, V186, P5968, DOI 10.4049/jimmunol.1003332
   Maghbooli Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199772
   Marinescu IP, 2014, ROM J MORPHOL EMBRYO, V55, P1155
   Meijer WJ, 2014, INFECT DIS OBSTET GY, V2014, P1, DOI 10. 1155/2014/768380
   Paynter S, 2015, J INFECTION, V70, P1, DOI 10.1016/j.jinf.2014.09.006
   Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025
   REDLINE RW, 1993, AM J PATHOL, V143, P473
   REDLINE RW, 1985, HUM PATHOL, V16, P727, DOI 10.1016/S0046-8177(85)80159-3
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   RUSSELL P, 1980, PLACENTA, V1, P227, DOI 10.1016/S0143-4004(80)80005-1
   Sloka S, 2009, J OBSTET GYNAECOL CA, V31, P313, DOI 10.1016/S1701-2163(16)34148-2
   Weinberg CR, 2015, INT J EPIDEMIOL, V44, P1068, DOI 10.1093/ije/dyv100
   Wylie BJ, 2017, ENVIRON HEALTH PERSP, V125, P134, DOI 10.1289/EHP256
NR 35
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1093-5266
EI 1615-5742
J9 PEDIATR DEVEL PATHOL
JI Pediatr. Dev. Pathol.
AR 1093526619892353
DI 10.1177/1093526619892353
EA DEC 2019
PG 7
WC Pathology; Pediatrics
SC Pathology; Pediatrics
GA JV8XZ
UT WOS:000502645300001
PM 31821774
DA 2020-07-08
ER

PT J
AU Lima, MDQ
   Chouin-Carneiro, T
   Azeredo, E
   Barbosa, LS
   Souza, TMA
   da Silva, JBC
   Nunes, PCG
   Dal Fabbro, M
   Facco, IHR
   Venancio-Da-Cunha, R
   dos Santos, FB
AF Queiroz Lima, Monique da Rocha
   Chouin-Carneiro, Thais
   Azeredo, Elzinandes
   Barbosa, Luciana Santos
   Alves Souza, Thiara Manuele
   Correa da Silva, Jessica Badolato
   Guerra Nunes, Priscila Conrado
   Dal Fabbro, Marcia
   Romanholi Facco, Izilyanne H.
   Venancio-da-Cunha, Rivaldo
   dos Santos, Flavia Barreto
TI The inability of a dengue NS1 ELISA to detect Zika infections
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; CROSS-REACTIVITY; SPECIFICITY; ENHANCEMENT;
   BIOSENSOR; ASSAYS
AB The presence of dengue virus (DENV), Zika virus (ZIKV) and Chikungunya virus (CHIKV) in Brazil, may result in a difficult diagnosis due to the signs and symptoms shared by those. Moreover, as DENV and ZIKV belong to the same family, serological assays may show a high rate of cross-reactivity. Here, we evaluated a Dengue NS1 capture assay for early and differential diagnosis of dengue during the Zika epidemic occurred in Brazil in 2016. Samples (n = 227) from 218 patients included sera, plasma and urine from previously confirmed acute cases of Zika, dengue and Zika/dengue co-infections. Nine of those patients presented two specimens. The Dengue NS1 test was very specific for dengue diagnosis (99.32%), even in the co-circulation with ZIKV, and exhibited a high accuracy in not detecting acute Zika infections (92.43%). Our findings showed that the dengue NS1 capture test analyzed here was not able to recognize the ZIKV NS1 and its potential for cross-reaction.
C1 [Queiroz Lima, Monique da Rocha; Chouin-Carneiro, Thais; Azeredo, Elzinandes; Barbosa, Luciana Santos; Alves Souza, Thiara Manuele; Correa da Silva, Jessica Badolato; Guerra Nunes, Priscila Conrado; dos Santos, Flavia Barreto] Oswaldo Cruz Inst, Viral Immunol Lab, BR-21045360 Rio De Janeiro, Brazil.
   [Dal Fabbro, Marcia; Romanholi Facco, Izilyanne H.; Venancio-da-Cunha, Rivaldo] Univ Fed Mato Grosso do Sul, Med Clin Dept, BR-79070900 Campo Grande, MS, Brazil.
RP Lima, MDQ; dos Santos, FB (corresponding author), Oswaldo Cruz Inst, Viral Immunol Lab, BR-21045360 Rio De Janeiro, Brazil.
EM moniqueq@ioc.fiocruz.br; flaviab@ioc.fiocruz.br
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/201.489/2014, E-26/202.003/2016,
   E-26/202.659/2019]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [302462/2018-0, 312707/2018-5]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq); FIOCRUZ;
   Financiadora de Estudos e Projetos FINEPCiencia Tecnologia e Inovacao
   (FINEP) [04.16.0058.00]
FX We are grateful to all staff at the Viral Immunology Laboratory for
   technical support. We gratefully thank the voluntarily participation in
   this study of healthy individuals and patients from Walfrido Arruda
   Emergency Care Unit, Coronel Antonino (Mato Grosso do Sul, Brazil). This
   study was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro FAPERJ to ELA grant number E-26/201.489/2014 and to FBS grant
   number E-26/202.003/2016 and E-26/202.659/2019, to Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) grant number
   302462/2018-0 to FBS, and 312707/2018-5 to ELA, to Financiadora de
   Estudos e Projetos FINEP number 04.16.0058.00 to F.B.S., to FIOCRUZ, to
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and
   CNPq for the students fellowships. M.R.Q.L. is a CAPES fellowship
   recipient. The funders had no role in the study design, data collection,
   analysis and decision to publish or preparation of the manuscript.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   da Costa VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094655
   Darwish NT, 2018, J PHARMACEUT BIOMED, V149, P591, DOI 10.1016/j.jpba.2017.11.064
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Gelanew T, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0925-7
   Gomez EJ, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000862
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Omarjee R, 2013, EUROSURVEILLANCE, P19, DOI DOI 10.2807/1560-
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Lima MDQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001147
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tyson J, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01464-18
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xu X, 2016, PLOS CURR, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
NR 42
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 9
PY 2019
VL 9
AR 18596
DI 10.1038/s41598-019-55160-4
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JU5YU
UT WOS:000501753000007
PM 31819129
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carpio, LE
   Villalain, J
AF Carpio, Laureano E.
   Villalain, Jose
TI Identification of the phospholipid binding regions of the envelope E
   protein of flaviviruses by molecular dynamics
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Molecular dynamics; late endosomal membrane; flavivirus; envelope E
   protein; antiviral
ID DENGUE VIRUS; MEMBRANE-FUSION; LOW-PH; ZIKA; LIPIDS; GLYCOPROTEIN;
   PEPTIDE; BIOLOGY
AB The Flavivirus genus comprise several important human pathogens, including dengue, West Nile, Yellow fever, Japanese encephalitis, Zika, and tick-borne encephalitis viruses. These enveloped viruses affect more than 2 billion people in the world, mainly in less developed countries. Although some vaccines exist for some flaviviruses, these vaccines are not universally available due to many factors and since their infections are a world-wide public health issue, the development of antiviral molecules is fundamental. Flavivirus membranes, through the help of the envelope E glycoprotein, fuse with endosomal compartments in a pH-dependent way to release their genome into the cytoplasm and require specific lipids, such as bis(monoacylglycero)phosphate (BMP), for efficient fusion. The fundamental role the envelope E protein has on viral entry and membrane fusion suggest that it is an essential antiviral target. In this work, we have used atomistic molecular dynamics simulations to study the binding of the head-group of BMP to the tip of the envelope E proteins of ZIKV, DENV, TBEV and JEV viruses whose three-dimensional structures are known. Our results indicate that, apart from the fusion loop, there are different amino acid residues in different regions of the envelope E proteins of flaviviruses capable of binding the head-group of BMP. These regions should work together to accomplish the binding and fusion of the envelope and endosomal membranes and represent a new target to develop and design potent and effective antiviral agents capable of blocking flavivirus-endosome membrane fusion.
   [GRAPHICS]
   .
C1 Univ Miguel Hernandez, Mol & Cellular Biol Inst IBMC, Elche Alicante, Spain.
   Univ Miguel Hernandez, Inst Res Dev & Innovat Healthcare Biotechnol IDiB, Elche Alicante, Spain.
RP Villalain, J (corresponding author), Univ Miguel Hernandez, Inst Res Dev & Innovat Healthcare Biotechnol IDiB, E-03202 Alicante, Spain.
EM jvillalain@umh.es
OI Villalain, Jose/0000-0002-5148-141X; Carpio, Laureano
   E./0000-0001-6637-3537
CR Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Bitto D, 2016, J BIOL CHEM, V291, P6412, DOI 10.1074/jbc.M115.691113
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389
   Esposito DLA, 2015, J GEN VIROL, V96, P1702, DOI 10.1099/vir.0.000113
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   Frederick TE, 2009, BIOPHYS J, V96, P1847, DOI 10.1016/j.bpj.2008.12.3892
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Guardado-Calvo P, 2017, SCIENCE, V358, P663, DOI 10.1126/science.aal2712
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027
   Hullin-Matsuda F, 2014, SEMIN CELL DEV BIOL, V31, P48, DOI 10.1016/j.semcdb.2014.04.010
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Igonet S, 2012, CELL, V151, P1634, DOI 10.1016/j.cell.2012.11.041
   Kaiser R, 2012, WIEN MED WOCHENSCHR, V162, P239, DOI 10.1007/s10354-012-0105-0
   Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200
   Kobayashi T, 2001, BIOL CHEM, V382, P483, DOI 10.1515/BC.2001.059
   Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021
   Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468
   Marzinek JK, 2018, J CHEM THEORY COMPUT, V14, P3920, DOI 10.1021/acs.jctc.8b00438
   Marzinek JK, 2016, STRUCTURE, V24, P1410, DOI 10.1016/j.str.2016.05.014
   Matos PM, 2013, J BIOL CHEM, V288, P12416, DOI 10.1074/jbc.M113.462028
   Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425
   Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nour AM, 2014, TRENDS CELL BIOL, V24, P449, DOI 10.1016/j.tcb.2014.03.006
   Ozu M, 2013, EUR BIOPHYS J BIOPHY, V42, P223, DOI 10.1007/s00249-012-0880-y
   Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Rinkenberger N, 2019, VIROLOGY, V533, P59, DOI 10.1016/j.virol.2019.04.008
   Rogers DM, 2015, BBA-BIOMEMBRANES, V1848, P1041, DOI 10.1016/j.bbamem.2014.12.018
   Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315
   Schioler KL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004263.pub2
   Seligman SJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-27
   Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   van den Brink-van der Laan E, 2001, BIOCHEMISTRY-US, V40, P9677, DOI 10.1021/bi002903a
   Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702
   Ye CT, 2019, BIOCHEM BIOPH RES CO, V515, P366, DOI 10.1016/j.bbrc.2019.05.148
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zheng AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4877
NR 56
TC 0
Z9 0
U1 4
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2019.1697368
EA DEC 2019
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA JU1JX
UT WOS:000501434800001
PM 31779533
DA 2020-07-08
ER

PT J
AU Borucki, MK
   Collette, NM
   Coffey, LL
   Van Rompay, KKA
   Hwang, MH
   Thissen, JB
   Allen, JE
   Zemla, AT
AF Borucki, Monica K.
   Collette, Nicole M.
   Coffey, Lark L.
   Van Rompay, Koen K. A.
   Hwang, Mona H.
   Thissen, James B.
   Allen, Jonathan E.
   Zemla, Adam T.
TI Multiscale analysis for patterns of Zika virus genotype emergence,
   spread, and consequence
SO PLOS ONE
LA English
DT Article
ID TRANSMISSION; PROTEIN; INFECTIVITY; POPULATIONS; ADAPTATION; PHYLOGENY;
   MUTATIONS; MOSQUITOS; EPIDEMIC; PASSAGE
AB The question of how Zika virus (ZIKV) changed from a seemingly mild virus to a human pathogen capable of microcephaly and sexual transmission remains unanswered. The unexpected emergence of ZIKV's pathogenicity and capacity for sexual transmission may be due to genetic changes, and future changes in phenotype may continue to occur as the virus expands its geographic range. Alternatively, the sheer size of the 2015-16 epidemic may have brought attention to a pre-existing virulent ZIKV phenotype in a highly susceptible population. Thus, it is important to identify patterns of genetic change that may yield a better understanding of ZIKV emergence and evolution. However, because ZIKV has an RNA genome and a polymerase incapable of proofreading, it undergoes rapid mutation which makes it difficult to identify combinations of mutations associated with viral emergence. As next generation sequencing technology has allowed whole genome consensus and variant sequence data to be generated for numerous virus samples, the task of analyzing these genomes for patterns of mutation has become more complex. However, understanding which combinations of mutations spread widely and become established in new geographic regions versus those that disappear relatively quickly is essential for defining the trajectory of an ongoing epidemic. In this study, multiscale analysis of the wealth of genomic data generated over the course of the epidemic combined with in vivo laboratory data allowed trends in mutations and outbreak trajectory to be assessed. Mutations were detected throughout the genome via deep sequencing, and many variants appeared in multiple samples and in some cases become consensus. Similarly, amino acids that were previously consensus in pre-outbreak samples were detected as low frequency variants in epidemic strains. Protein structural models indicate that most of the mutations associated with the epidemic transmission occur on the exposed surface of viral proteins. At the macroscale level, consensus data was organized into large and interactive databases to allow the spread of individual mutations and combinations of mutations to be visualized and assessed for temporal and geographical patterns. Thus, the use of multiscale modeling for identifying mutations or combinations of mutations that impact epidemic transmission and phenotypic impact can aid the formation of hypotheses which can then be tested using reverse genetics.
C1 [Borucki, Monica K.; Collette, Nicole M.; Hwang, Mona H.; Thissen, James B.] Lawrence Livermore Natl Lab, Phys Life Sci Directorate, Livermore, CA 94550 USA.
   [Coffey, Lark L.; Van Rompay, Koen K. A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.
   [Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Allen, Jonathan E.; Zemla, Adam T.] Lawrence Livermore Natl Lab, Computat Directorate, Livermore, CA 94550 USA.
RP Borucki, MK (corresponding author), Lawrence Livermore Natl Lab, Phys Life Sci Directorate, Livermore, CA 94550 USA.
EM borucki2@llnl.gov
OI Collette, Nicole/0000-0002-9068-8712; Thissen,
   James/0000-0002-4693-5886; Allen, Jonathan/0000-0002-4359-8263
FU U.S. Department of Energy, Lawrence Livermore National LaboratoryUnited
   States Department of Energy (DOE) [DE-AC52-07NA27344]; LLNL LDRD-ER
   [17-ER-019]; CNPRC pilot research grant; Pathology, Microbiology and
   Immunology Department (University of California, Davis); NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [1R21AI129479-01]; Office of Research Infrastructure
   Programs/OD [P51OD011107]; U.S. Food and Drug Administration
   [HHSF223201610542P]
FX This work was performed under the auspices of the U.S. Department of
   Energy by Lawrence Livermore National Laboratory under Contract
   DE-AC52-07NA27344. Funding was provided through LLNL LDRD-ER 17-ER-019
   to MKB. The macaque work performed was supported by a CNPRC pilot
   research grant to LC and KVR, start-up funds from the Pathology,
   Microbiology and Immunology Department (University of California, Davis)
   to LC, NIAID 1R21AI129479-01 to KVR, and the Office of Research
   Infrastructure Programs/OD (P51OD011107) to the California National
   Primate Research Center. This work was also supported by U.S. Food and
   Drug Administration HHSF223201610542P to LC. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Borucki MK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002555
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chen-Harris H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-96
   Ciota AT, 2007, J GEN VIROL, V88, P865, DOI 10.1099/vir.0.82606-0
   Ciota AT, 2007, VIROLOGY, V357, P165, DOI 10.1016/j.virol.2006.08.005
   Ciota AT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-58
   Ciota AT, 2012, INFECT GENET EVOL, V12, P557, DOI 10.1016/j.meegid.2012.01.022
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151
   Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11
   Dowall SD, 2016, BIORXIV
   Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gardner Shea N., 2014, Advances in Bioinformatics, V2014, P101894, DOI 10.1155/2014/101894
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004
   Kumar A, 2016, EMBO REPORTS
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear Helen M, 2016, CELL HOST MICROBE
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li C, 2016, CELL STEM CELL
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner Jonathan J, 2016, CELL
   Mlakar J, 2016, NEW ENGLAND J MED
   Moreira J, 2016, CLIN MICROBIOLOGY IN
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pesko KN, 2012, INFECT GENET EVOL, V12, P181, DOI 10.1016/j.meegid.2011.11.014
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008
   Tang H, 2016, CELL STEM CELL
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Team RC, 2013, R LANG ENV STAT COMP
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307
   Wang L, 2016, CELL HOST MICROBE
   World Health Organization, WHO CHILD GROWTH STA
   Wu Y, 2017, CELL DISCOV, V3
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zemla AT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-226
   Zemla D, 2014, BIOINFORM BIOL INSIG, V8, P1, DOI 10.4137/BBI.S13076
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 64
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 6
PY 2019
VL 14
IS 12
AR e0225699
DI 10.1371/journal.pone.0225699
PG 38
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP0MQ
UT WOS:000534016700007
PM 31809512
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wen, FY
   Armstrong, N
   Hou, WH
   Cruz-Cosme, R
   Obwolo, LA
   Ishizuka, K
   Ullah, H
   Luo, MH
   Sawa, A
   Tang, QY
AF Wen, Fayuan
   Armstrong, Najealicka
   Hou, Wangheng
   Cruz-Cosme, Ruth
   Obwolo, Lilian Akello
   Ishizuka, Koko
   Ullah, Hemayet
   Luo, Min-Hua
   Sawa, Akira
   Tang, Qiyi
TI Zika virus increases mind bomb 1 levels, causing degradation of
   pericentriolar material 1 (PCM1) and dispersion of PCM1-containing
   granules from the centrosome
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE centrosome; flavivirus; deubiquitylation (deubiquitination); E3
   ubiquitin-protein ligase RNF8 (RNF8); infection; centrosomal protein 131
   (CEP131); mind bomb 1 (Mib1); pericentral material 1 (PCM1); Zika virus
   (ZIKV); pericentrin (PCNT); ubiquitination; proteasomal degradation;
   single-stranded RNA virus; microtubule-organizing center (MTOC)
ID MICROTUBULE ORGANIZATION; CENTRIOLAR SATELLITES; PROTEIN; INFECTION;
   CELLS; AUTOANTIGEN; HISTORY; BIOLOGY; MODELS; GROWTH
AB The centrosome is a cytoplasmic nonenveloped organelle functioning as one of the microtubule-organizing centers and composing a centriole center surrounded by pericentriolar material (PCM) granules. PCM consists of many centrosomal proteins, including PCM1 and centrosomal protein 131 (CEP131), and helps maintain centrosome stability. Zika virus (ZIKV) is a flavivirus of the family Flaviviridae whose RNA and viral particles are replicated in the cytoplasm. However, how ZIKV interacts with host cell components during its productive infection stage is incompletely understood. Here, using several primate cell lines, we report that ZIKV infection disrupts and disperses the PCM granules. We demonstrate that PCM1- and CEP131-containing granules are dispersed in ZIKV-infected cells, whereas the centrioles remain intact. We found that ZIKV does not significantly alter cellular skeletal proteins, and, hence, these proteins may not be involved in the interaction between ZIKV and centrosomal proteins. Moreover, ZIKV infection decreased PCM1 and CEP131 protein, but not mRNA, levels. We further found that the protease inhibitor MG132 prevents the decrease in PCM1 and CEP131 levels and centriolar satellite dispersion. Therefore, we hypothesized that ZIKV infection induces proteasomal PCM1 and CEP131 degradation and thereby disrupts the PCM granules. Supporting this hypothesis, we show that ZIKV infection increases levels of mind bomb 1 (MIB1), previously demonstrated to be an E3 ubiquitin ligase for PCM1 and CEP131 and that ZIKV fails to degrade or disperse PCM in MIB1-ko cells. Our results imply that ZIKV infection activates MIB1-mediated ubiquitination that degrades PCM1 and CEP131, leading to PCM granule dispersion.
C1 [Wen, Fayuan; Armstrong, Najealicka; Hou, Wangheng; Cruz-Cosme, Ruth; Obwolo, Lilian Akello; Tang, Qiyi] Howard Univ, Dept Microbiol, Coll Med, Seeley Mudd Bldg,Rm 315,520 W St NW, Washington, DC 20059 USA.
   [Ishizuka, Koko; Sawa, Akira] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21218 USA.
   [Ullah, Hemayet] Howard Univ, Dept Biol, Washington, DC 20059 USA.
   [Luo, Min-Hua] Chinese Acad Sci, Wuhan Inst Virol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China.
RP Tang, QY (corresponding author), Howard Univ, Dept Microbiol, Coll Med, Seeley Mudd Bldg,Rm 315,520 W St NW, Washington, DC 20059 USA.
EM qiyi.tang@howard.edu
OI luo, min hua/0000-0001-9352-0643
FU NIAID, National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [SC1AI112785]; NIMHD,
   National Institutes of Health [2U54MD007597]
FX This study was supported by NIAID, National Institutes of Health, Grant
   SC1AI112785 (to Q. T.) and NIMHD, National Institutes of Health, Grant
   2U54MD007597. The authors declare that they have no conflicts of
   interest with the contents of this article. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557
   Barenz F, 2011, EUR J CELL BIOL, V90, P983, DOI 10.1016/j.ejcb.2011.07.007
   BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783
   Barghout SH, 2019, LEUKEMIA, V33, P37, DOI 10.1038/s41375-018-0167-0
   BIEDLER JL, 1973, CANCER RES, V33, P2643
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Corvi R, 2000, ONCOGENE, V19, P4236, DOI 10.1038/sj.onc.1203772
   Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DETHE G, 1964, J CELL BIOL, V23, P265, DOI 10.1083/jcb.23.2.265
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gudi R, 2011, J CELL BIOL, V193, P711, DOI 10.1083/jcb.201006135
   Hickman HD, 2016, TRENDS MOL MED, V22, P639, DOI 10.1016/j.molmed.2016.06.004
   Hori A, 2017, CELL MOL LIFE SCI, V74, P213, DOI 10.1007/s00018-016-2315-x
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519
   KOPS AD, 1988, CELL, V55, P857, DOI 10.1016/0092-8674(88)90141-9
   Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Liu QQ, 2001, J CELL SCI, V114, P797
   Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046
   Mennella V, 2014, TRENDS CELL BIOL, V24, P188, DOI 10.1016/j.tcb.2013.10.001
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   MUNCH K, 1992, J GEN VIROL, V73, P499, DOI 10.1099/0022-1317-73-3-499
   Naghavi MH, 2017, J VIROL, V91, DOI 10.1128/JVI.00538-17
   OHATA H, 1994, GENOMICS, V24, P404, DOI 10.1006/geno.1994.1640
   Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2
   Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950
   Romei Cristina, 2012, Front Endocrinol (Lausanne), V3, P54, DOI 10.3389/fendo.2012.00054
   Staples CJ, 2012, J CELL SCI, V125, P4770, DOI 10.1242/jcs.104059
   Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Villumsen BH, 2013, EMBO J, V32, P3029, DOI 10.1038/emboj.2013.223
   Wang L, 2016, ELIFE, V5, DOI 10.7554/eLife.12950
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
NR 57
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 6
PY 2019
VL 294
IS 49
BP 18742
EP 18755
DI 10.1074/jbc.RA119.010973
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KD1GB
UT WOS:000507618800020
PM 31666336
DA 2020-07-08
ER

PT J
AU Wang, LL
   Liang, RY
   Gao, YN
   Li, YB
   Deng, XQ
   Xiang, R
   Zhang, YN
   Ying, TL
   Jiang, SB
   Yu, F
AF Wang, Lili
   Liang, Ruiying
   Gao, Yaning
   Li, Yanbai
   Deng, Xiaoqian
   Xiang, Rong
   Zhang, Yina
   Ying, Tianlei
   Jiang, Shibo
   Yu, Fei
TI Development of Small-Molecule Inhibitors Against Zika Virus Infection
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika virus; life cycle; small-molecule inhibitor; treatment; mechanism
ID FDA-APPROVED DRUG; NS2B-NS3 PROTEASE; DENGUE-VIRUS; IN-VITRO;
   BROAD-SPECTRUM; GREEN TEA; EPIGALLOCATECHIN GALLATE; PROMISCUOUS
   INHIBITORS; CRYSTAL-STRUCTURE; RNA-POLYMERASE
AB In recent years, the outbreak of infectious disease caused by Zika virus (ZIKV) has posed a major threat to global public health, calling for the development of therapeutics to treat ZIKV disease. Here, we have described the different stages of the ZIKV life cycle and summarized the latest progress in the development of small-molecule inhibitors against ZIKV infection. We have also discussed some general strategies for the discovery of small-molecule ZIKV inhibitors.
C1 [Wang, Lili] Hebei Agr Univ, Res Ctr Chinese Jujube, Baoding, Peoples R China.
   [Liang, Ruiying; Li, Yanbai; Deng, Xiaoqian; Xiang, Rong; Zhang, Yina; Yu, Fei] Hebei Agr Univ, Coll Life & Sci, Baoding, Peoples R China.
   [Gao, Yaning] Peking Univ, Sch Pharmaceut Scienoes, Dept Nat Med, Beijing, Peoples R China.
   [Ying, Tianlei; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, MOE NHC CAMS Key Lab Med Mol Virol, Shanghai, Peoples R China.
RP Yu, F (corresponding author), Hebei Agr Univ, Coll Life & Sci, Baoding, Peoples R China.; Ying, TL; Jiang, SB (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, MOE NHC CAMS Key Lab Med Mol Virol, Shanghai, Peoples R China.
EM tlying@fudan.edu.cn; shibojiang@fudan.edu.cn; shmyf@hebau.edu.cn
RI Yu, Fei/K-4953-2019
OI Yu, Fei/0000-0001-6332-4326; Ying, Tianlei/0000-0002-9597-2843
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81974302, 81601761]; Hebei Province's Program for
   Talents Returning from Studying Overseas [CN201707]; Hebei Agricultural
   University [ZD2016026, YJ201843]; Program for Youth Talent of Higher
   Learning Institutions of Hebei Province [BJ2018045]
FX This work was supported by grants from the National Natural Science
   Foundation of China (81974302 and 81601761), Hebei Province's Program
   for Talents Returning from Studying Overseas (CN201707), a starting
   grant from Hebei Agricultural University (ZD2016026 and YJ201843), and
   the Program for Youth Talent of Higher Learning Institutions of Hebei
   Province (BJ2018045).
CR Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Andersen AN, 2017, FERTIL STERIL, V107, P387, DOI 10.1016/j.fertnstert.2016.10.033
   Arbuckle JH, 2017, MBIO, V8, DOI [10.1128/mBio.01141-17, 10.1128/mbio.01141-17]
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Cho NJ, 2009, ACS CHEM BIOL, V4, P1061, DOI 10.1021/cb900149b
   Coronado MA, 2018, ANTIVIR RES, V160, P118, DOI 10.1016/j.antiviral.2018.10.019
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Barros JBD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00821
   Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duan D, 2015, ACS CHEM BIOL, V10, P978, DOI 10.1021/cb5009487
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638
   Fu BS, 2017, J EXP MED, V214, P919, DOI 10.1084/jem.20161270
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han YS, 2018, EXPERT OPIN INV DRUG, V27, P951, DOI 10.1080/13543784.2018.1548609
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Jin J, 2018, ARCH PHARM RES, V41, P664, DOI 10.1007/s12272-018-1022-6
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kim JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16714
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   KIRBY WMM, 1956, ARCH INTERN MED, V98, P1, DOI 10.1001/archinte.1956.00250250007001
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li FF, 2019, J BIOL CHEM, V294, P182, DOI 10.1074/jbc.RA118.005015
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Liu TG, 2008, CHEM BIOL, V15, P449, DOI 10.1016/j.chembiol.2008.04.006
   Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784
   McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Moghaddam E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05452
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Oo A, 2019, ARCH VIROL, V164, P585, DOI 10.1007/s00705-018-4083-4
   Oo A, 2018, ANTIVIR RES, V150, P101, DOI 10.1016/j.antiviral.2017.12.012
   Pal P., 2017, SILICO SCREENING SMA
   Passioura T, 2014, ANNU REV BIOCHEM, V83, P727, DOI 10.1146/annurev-biochem-060713-035456
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pryke KM, 2017, MBIO, V8, DOI [10.1128/mBio.00452-17, 10.1128/mbio.00452-17]
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rocker AE, 2018, ANTIVIR RES, V152, P26, DOI 10.1016/j.antiviral.2018.02.003
   Rohini K, 2019, APPL BIOCHEM BIOTECH, V187, P194, DOI 10.1007/s12010-018-2814-3
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Shannon AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep37539
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Singh A, 2017, COMPUT BIOL CHEM, V71, P144, DOI 10.1016/j.compbiolchem.2017.10.007
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Song JX, 1998, BIOCHEM CELL BIOL, V76, P177
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Suroengrit A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14121-5
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Tritsch D, 2015, BIOORG CHEM, V59, P140, DOI 10.1016/j.bioorg.2015.02.008
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Vasireddi M, 2019, ANTIVIR RES, V161, P46, DOI 10.1016/j.antiviral.2018.09.004
   Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/jvi.01055-17, 10.1128/JVI.01055-17]
   Wang XH, 2017, FRONT MED-PRC, V11, P449, DOI 10.1007/s11684-017-0589-5
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang HT, 2017, BRIEF BIOINFORM, V18, P488, DOI 10.1093/bib/bbw030
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214
   Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao Yanjie, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P461
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 126
TC 3
Z9 3
U1 8
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 6
PY 2019
VL 10
AR 2725
DI 10.3389/fmicb.2019.02725
PG 21
WC Microbiology
SC Microbiology
GA JX5ME
UT WOS:000503778100001
PM 31866959
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lyons, B
   Merola, V
   Reifler, J
AF Lyons, Benjamin
   Merola, Vittorio
   Reifler, Jason
TI Not Just Asking Questions: Effects of Implicit and Explicit Conspiracy
   Information About Vaccines and Genetic Modification
SO HEALTH COMMUNICATION
LA English
DT Article
ID MISINFORMATION; BELIEFS; NEWS; UNIQUENESS; OPINION; SPREAD; FALSE
AB While conspiracy ideation has attracted overdue attention from social scientists in recent years, little work focuses on how different pro-conspiracy messages affect the take-up of conspiracy beliefs. In this study, we compare the effect of explicit and implicit conspiracy cues on the adoption of conspiracy beliefs. We also examine whether corrective information can undo conspiracy cues, and whether there are differences in the effectiveness of corrective information based on whether a respondent received an explicit or implicit conspiracy cue. We examine these questions using a real-world but low-salience conspiracy theory concerning Zika, GM mosquitoes, and vaccines. Using a preregistered experiment (N?=?1018: ), we find that both explicit and implicit conspiracy cues increase conspiracy beliefs, but in both cases corrections are generally effective. We also find reception of an explicit conspiracy cue and its correction is conditional on feelings toward the media and pharmaceutical companies. Finally, we find that examining open-ended conspiracy belief items reveals similar patterns, but with a few key differences. These findings have implications for how news media cover controversial public health issues going forward.
C1 [Lyons, Benjamin; Merola, Vittorio; Reifler, Jason] Univ Exeter, Dept Polit, Amory Bldg, Exeter EX4 4RJ, Devon, England.
   [Merola, Vittorio] SUNY Stony Brook, Dept Polit Sci, Stony Brook, NY 11794 USA.
RP Lyons, B (corresponding author), Univ Exeter, Dept Polit, Amory Bldg, Exeter EX4 4RJ, Devon, England.
EM benjamin.a.lyons@gmail.com
RI Lyons, Ben/J-5323-2019
OI Lyons, Ben/0000-0001-7096-900X; Reifler, Jason/0000-0002-1116-7346
FU H2020 European Research Council [682758]
FX This work was supported by H2020 European Research Council [Grant number
   682758].
CR APPC, 2016, ANN SCI KNOWL SURV
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Bogart LM, 2010, JAIDS-J ACQ IMM DEF, V53, P648, DOI 10.1097/QAI.0b013e3181c57dbc
   Brossard D, 2007, INT J PUBLIC OPIN R, V19, P24, DOI 10.1093/ijpor/edl003
   Byford J., 2014, RHETORIC IDEOLOGY SO, P83
   Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113
   Enders Adam M., 2018, BRIT J POLIT SCI, DOI [10.1017/S0007123417000837, DOI 10.1017/S0007123417000837]
   Flynn DJ, 2017, POLIT PSYCHOL, V38, P127, DOI 10.1111/pops.12394
   Garrett RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184733
   Imhoff R, 2017, EUR J SOC PSYCHOL, V47, P724, DOI 10.1002/ejsp.2265
   Jolley D, 2017, J APPL SOC PSYCHOL, V47, P459, DOI 10.1111/jasp.12453
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   Keeley BL, 1999, J PHILOS, V96, P109, DOI 10.2307/2564659
   Kennedy R. F., 2005, ROLLING STONE
   Khanna K, 2018, POLIT BEHAV, V40, P79, DOI 10.1007/s11109-017-9395-7
   Lantian A, 2017, SOC PSYCHOL-GERMANY, V48, P160, DOI 10.1027/1864-9335/a000306
   Lantian A, 2016, INT REV SOC PSYCHOL, V29, P1, DOI 10.5334/irsp.8
   Lind F, 2017, COMMUN METHODS MEAS, V11, P191, DOI 10.1080/19312458.2017.1317338
   Lull R. B., 2018, WORKING PAPER
   Lynn M, 1997, J APPL SOC PSYCHOL, V27, P1861, DOI 10.1111/j.1559-1816.1997.tb01629.x
   Lyons BA, 2018, INT J PUBLIC OPIN R, V30, P583, DOI 10.1093/ijpor/edx013
   McCright AM, 2017, J APPL RES MEM COGN, V6, P389
   Miller JM, 2016, AM J POLIT SCI, V60, P824, DOI 10.1111/ajps.12234
   Mummolo J., 2018, WORKING PAPER
   Novak M., 2017, GIZMODO          JUL
   Nyhan B., WORKING PAPER
   Nyhan B, 2016, J EXPT POLITICAL SCI, V3, P109, DOI DOI 10.1017/XPS.2015.21
   Nyhan B, 2013, MED CARE, V51, P127, DOI 10.1097/MLR.0b013e318279486b
   Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2
   O'Keefe D. J., 1997, ARGUMENTATION ADVOCA, V34, P1, DOI DOI 10.1080/00028533.1997
   Oliver JE, 2014, AM J POLIT SCI, V58, P952, DOI 10.1111/ajps.12084
   Oliver JE, 2014, JAMA INTERN MED, V174, P817, DOI 10.1001/jamainternmed.2014.190
   Oswald S., 2016, OSSA C ARCH, V168, P1
   Patel N., 2017, THESIS
   Pennycook G., 2017, WHO FALLS FAKE NEWS, P1, DOI [DOI 10.2139/SSRN.3023545, 10.2139/ssrn.3023545]
   Pingree RJ, 2011, J COMMUN, V61, P22, DOI 10.1111/j.1460-2466.2010.01525.x
   Prooijen J.-W., 2017, EUROPEAN J SOCIAL PS, V48, P320, DOI 10.1002/ejsp.2331
   Raab MH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00453
   Rich PR, 2016, J EXP PSYCHOL LEARN, V42, P62, DOI 10.1037/xlm0000155
   Saunders KL, 2017, RES POLITICS, V4, DOI 10.1177/2053168017717602
   SCHUMAN H, 1980, AM J SOCIOL, V85, P1214, DOI 10.1086/227131
   Seay L., 2017, SLATE MAGAZINE
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Southwell B, 2017, OXFORD HDB SCI SCI C, P223
   Southwell B. G., 2018, MISINFORMATION MASS
   Starbird K., 2017, P INT AAAI C WEB SOC, P230
   Starbird K, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P360, DOI 10.1145/2858036.2858551
   Thomson KS, 2016, JUDGM DECIS MAK, V11, P99
   Uscinski JE, 2016, POLIT RES QUART, V69, P57, DOI 10.1177/1065912915621621
   Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559
   Vraga EK, 2017, SCI COMMUN, V39, P621, DOI 10.1177/1075547017731776
   Wood MJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00409
   Wood MJ, 2012, SOC PSYCHOL PERS SCI, V3, P767, DOI 10.1177/1948550611434786
   Wood T, 2019, POLIT BEHAV, V41, P135, DOI 10.1007/s11109-018-9443-y
NR 54
TC 0
Z9 0
U1 3
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1041-0236
EI 1532-7027
J9 HEALTH COMMUN
JI Health Commun.
PD DEC 6
PY 2019
VL 34
IS 14
BP 1741
EP 1750
DI 10.1080/10410236.2018.1530526
PG 10
WC Communication; Health Policy & Services
SC Communication; Health Care Sciences & Services
GA JI2QD
UT WOS:000493308200006
PM 30307753
OA Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Jerit, J
   Zhao, YZ
   Tan, M
   Wheeler, M
AF Jerit, Jennifer
   Zhao, Yangzi
   Tan, Megan
   Wheeler, Munifa
TI Differences between National and Local Media in News Coverage of the
   Zika Virus
SO HEALTH COMMUNICATION
LA English
DT Article
ID EFFICACY INFORMATION; NEWSPAPER COVERAGE; COMMUNICATION; PROXIMITY;
   EBOLA; RISK
AB Do national and local papers report on health threats in the same way? This question is investigated in an important and increasingly common context: the outbreak of an infectious disease. Although there is a large literature on how to measure the quality of health reporting, scant attention has been devoted to the role of audience considerations. We address this gap by comparing coverage of the 2016 Zika outbreak in the New York Times, a prestigious national newspaper, and the Tampa Bay Times, a well-regarded Florida newspaper. Based on an original content analysis, we find that audience considerations led to higher quality coverage in the local paper, particularly as it relates to avoiding infection. However, certain features of reporting, such as sensationalist language and imprecise risk information, were indistinguishable across the two outlets, which illustrates the challenges faced by reporters at both kinds of papers when it comes to accurately portraying risk.
C1 [Jerit, Jennifer; Zhao, Yangzi] SUNY Stony Brook, Dept Polit Sci, Stony Brook, NY 11794 USA.
   [Tan, Megan; Wheeler, Munifa] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.
   [Wheeler, Munifa] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.
RP Jerit, J (corresponding author), SUNY Stony Brook, Dept Polit Sci, Stony Brook, NY 11794 USA.
EM jennifer.jerit@stonybrook.edu
CR Barry JM, 2009, NATURE, V459, P324, DOI 10.1038/459324a
   Branton RP, 2009, POLIT RES QUART, V62, P289, DOI 10.1177/1065912908319252
   Carpenter S, 2007, J MASS COMMUN Q, V84, P761, DOI 10.1177/107769900708400407
   Centers for Disease Control and Prevention, 2018, ZIK VIR
   CHANG TK, 1992, JOURNALISM QUART, V69, P554, DOI 10.1177/107769909206900303
   Dudo AD, 2007, SCI COMMUN, V28, P429, DOI 10.1177/1075547007302211
   Evensen DT, 2012, SCI COMMUN, V34, P392, DOI 10.1177/1075547011421020
   Ferris S., 2016, HILL
   Fung TKF, 2011, J HEALTH COMMUN, V16, P889, DOI 10.1080/10810730.2011.561913
   Hamilton J., 2004, ALL NEWS THATS FIT S
   Henry J. Kaiser Family Foundation, 2016, DEC 2016 KAIS HLTH T
   Holody KJ, 2013, JOURNALISM STUD, V14, P568, DOI 10.1080/1461670X.2012.726499
   Ihekweazu C, 2017, HEALTH COMMUN, V32, P741, DOI 10.1080/10410236.2016.1172287
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Luke DA, 2011, COMMUN METHODS MEAS, V5, P76, DOI 10.1080/19312458.2010.547823
   Maron D. F., 2016, SCI AM
   Munzenrieder K., 2016, MIAMI NEW TIMES
   Ratzan SC, 2014, J HEALTH COMMUN, V19, P1213, DOI 10.1080/10810730.2014.977680
   RIFFE D, 1993, JOURNALISM QUART, V70, P133, DOI 10.1177/107769909307000115
   Roche JP, 2003, SCI COMMUN, V24, P353, DOI 10.1177/1075547002250300
   Shoemaker P. J., 2009, GATEKEEPING THEORY
   Shoemaker PJ, 2007, MEDIA STUDIES KEY IS, P231
   Slovic P, 1992, SOCIAL THEORIES RISK, P117
   Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950
NR 24
TC 2
Z9 2
U1 13
U2 23
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1041-0236
EI 1532-7027
J9 HEALTH COMMUN
JI Health Commun.
PD DEC 6
PY 2019
VL 34
IS 14
BP 1816
EP 1823
DI 10.1080/10410236.2018.1536949
PG 8
WC Communication; Health Policy & Services
SC Communication; Health Care Sciences & Services
GA JI2QD
UT WOS:000493308200013
PM 30358428
DA 2020-07-08
ER

PT J
AU Barbosa, RH
   dos Santos, MLB
   Silva, TP
   Rosa-Fernandes, L
   Pinto, AMV
   Spinola, PS
   Bonvicino, CR
   Fernandes, PV
   Lucena, E
   Palmisano, G
   Melo, RCN
   Cardoso, CAA
   Lemos, B
AF Barbosa, Raquel Hora
   dos Santos, Maria Luiza B.
   Silva, Thiago P.
   Rosa-Fernandes, Liva
   Pinto, Ana M., V
   Spinola, Pricila S.
   Bonvicino, Cibele R.
   Fernandes, Priscila, V
   Lucena, Evandro
   Palmisano, Giuseppe
   Melo, Rossana C. N.
   Araujo Cardoso, Claudete Aparecida
   Lemos, Bernardo
TI Impression Cytology Is a Non-invasive and Effective Method for Ocular
   Cell Retrieval of Zika Infected Babies: Perspectives in OMIC Studies
SO FRONTIERS IN MOLECULAR NEUROSCIENCE
LA English
DT Article
DE Congenital Zika Syndrome; neurodevelopmental disorders; ocular cells;
   molecular research; OMIC studies
ID OPHTHALMIC MANIFESTATIONS; VIRUS; INFANT; TRANSMISSION; SURFACE; ORIGIN;
   BRAZIL
AB Importance Non-invasive techniques for retrieving ocular surface cells from babies infected by zika virus (ZIKV) during the gestational period remain to be determined. Objectives The aim of this study was to describe an optimized impression cytology method for the isolation of viable cells from Zika infected babies with and without Congenital Zika Syndrome (CZS) in satisfactory amount and quality to enable easy adoption in the field and application in the context of genomic and molecular approaches. Design, Settings, and Participants Ocular surface samples were obtained with a hydrophilic nitrocellulose membrane (through optimized impression cytology method) from twelve babies referred to the Pediatric Service of the Antonio Pedro Hospital, Universidade Federal Fluminense (UFF), Niteroi, Rio de Janeiro, Brazil. After an authorized written informed consent from the parents, samples were collected from both eyes of 12 babies (4 babies with maternal ZIKV exposure during gestation and presence of clinical signs which included ocular abnormalities and microcephaly; 4 babies with maternal ZIKV exposure during gestation but no clinical signs; and 4 unaffected control babies with negative PCR for Zika virus and without clinical signs). Cells were used for microscopy analyses and evaluated for their suitability for downstream molecular applications in transcriptomic and proteomic experiments. Results Our optimized impression cytology protocol enabled the capture of a considerable number of viable cells. The microscopic features of the conjunctival epithelial cells were described by both direct analysis of the membrane-attached cells and analysis of cytospinned captured cells using several staining procedures. Epithelial basal, polyhedral and goblet cells were clearly identified in all groups. All cases of ZIKV infected babies showed potential morphological alterations (cell keratinization, pyknosis, karyolysis, anucleation, and vacuolization). Molecular approaches were also performed in parallel. Genomic DNA and RNA were successfully isolated from all samples to enable the establishment of transcriptomic and proteomic studies. Conclusions and Relevance Our method proved to be a suitable, fast, and non-invasive tool to obtain ocular cell preparations from babies with and without Zika infection. The method yielded sufficient cells for detailed morphological and molecular analyses of samples. We discuss perspectives for the application of impression cytology in the context of ZIKV studies in basic and clinical research.
C1 [Barbosa, Raquel Hora; Lemos, Bernardo] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA.
   [Barbosa, Raquel Hora; dos Santos, Maria Luiza B.; Araujo Cardoso, Claudete Aparecida] Univ Fed Fluminense, Sch Med, Dept Maternal & Child, Niteroi, RJ, Brazil.
   [Barbosa, Raquel Hora; Bonvicino, Cibele R.] Inst Nacl Canc, Genet Program, Rio De Janeiro, Brazil.
   [Silva, Thiago P.; Melo, Rossana C. N.] Univ Fed Juiz de Fora, Dept Biol, Lab Cellular Biol, Juiz De Fora, Brazil.
   [Rosa-Fernandes, Liva; Palmisano, Giuseppe] Univ Sao Paulo, ICB, Dept Parasitol, Glycoprote Lab, Sao Paulo, SP, Brazil.
   [Pinto, Ana M., V] Univ Fed Fluminense, Biomed Inst, Niteroi, RJ, Brazil.
   [Spinola, Pricila S.] Univ Fed Rio de Janeiro, Genet Dept, Rio De Janeiro, Brazil.
   [Fernandes, Priscila, V] Inst Nacl Canc, Div Pathol DIPAT, Rio De Janeiro, Brazil.
   [Lucena, Evandro] Inst Nacl Canc, Div Clin Res, Rio De Janeiro, Brazil.
RP Barbosa, RH; Lemos, B (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA.; Barbosa, RH (corresponding author), Univ Fed Fluminense, Sch Med, Dept Maternal & Child, Niteroi, RJ, Brazil.; Barbosa, RH (corresponding author), Inst Nacl Canc, Genet Program, Rio De Janeiro, Brazil.
EM barbosa.raquelh@gmail.com; blemos@hsph.harvard.edu
RI Melo, Rossana C. N./B-8248-2013; Rosa-Fernandes, Livia/AAH-3734-2019;
   Silva, Thiago/B-3293-2018; Palmisano, Giuseppe/N-3602-2013; Lemos,
   Bernardo/AAL-2429-2020
OI Melo, Rossana C. N./0000-0003-1736-0806; Rosa-Fernandes,
   Livia/0000-0003-1612-1950; Silva, Thiago/0000-0001-7122-3015; Palmisano,
   Giuseppe/0000-0003-1336-6151; Lemos, Bernardo/0000-0001-6996-9483
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ, Brazil)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [201.779/2017 -
   PDS/2017]; Brazilian FAPERJ senior postdoctoral fellowship; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG, Brazil)Minas Gerais State Research Foundation (FAPEMIG)
   [CBB-APQ-03647-16]
FX This study was supported by grant from the Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil, Proc.
   no 201.779/2017 - PDS/2017). RB was a recipient of a Brazilian FAPERJ
   senior postdoctoral fellowship. RM was supported by grants from the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG, Brazil, CBB-APQ-03647-16).
CR Agilent, 2018, GEN AG
   Bandyopadhyay D, 2018, EUR J INTERN MED, V47, pE18, DOI 10.1016/j.ejim.2017.06.016
   BARISHAK YR, 2001, EMBRYOLOGY EYE ITS A
   Boja ES, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-45
   Brazilian Ministry of Health, 2018, BRAZ MIN HLTH
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dahan O, 2011, TRENDS GENET, V27, P316, DOI 10.1016/j.tig.2011.05.008
   Dart J, 1997, BRIT J OPHTHALMOL, V81, P930, DOI 10.1136/bjo.81.11.930
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dhouailly D, 2014, DEV DYNAM, V243, P1226, DOI [10.1002/DVDY.24179, 10.1002/dvdy.24179]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2017, NEW ENGL J MED, V37, P51, DOI DOI 10.1097/01.AOA.0000512046.09676.84
   EGBERT PR, 1977, AM J OPHTHALMOL, V84, P798, DOI 10.1016/0002-9394(77)90499-8
   Expert Single Cell Sequencing Services-SingulOmics, 2018, EXPERT SINGLE CELL S
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Forrester JV, 2016, EYE, V1-102, pe2
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Gipson IK, 2016, PROG RETIN EYE RES, V54, P49, DOI 10.1016/j.preteyeres.2016.04.005
   Gokuladhas K, 2017, GENES DIS, V4, P88, DOI 10.1016/j.gendis.2017.01.002
   Hughes AP, 1997, EUR J PEDIATR, V156, P471, DOI 10.1007/s004310050642
   KJOLHEDE CL, 1989, AM J CLIN NUTR, V49, P490
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lebov JF, 2018, PEDIATR NEUROL, V85, P16, DOI 10.1016/j.pediatrneurol.2018.03.001
   Lleras-Forero L, 2012, CURR OPIN GENET DEV, V22, P315, DOI 10.1016/j.gde.2012.05.003
   London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227
   Lwigale PY, 2015, PROG MOL BIOL TRANSL, V134, P43, DOI 10.1016/bs.pmbts.2015.04.003
   MASKIN SL, 1986, OPHTHALMOLOGY, V93, P1518
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mizoguchi S, 2015, MOL VIS, V21, P793
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monnerat LS, 2010, BRAIN DEV-JPN, V32, P843, DOI 10.1016/j.braindev.2009.11.007
   Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   NATADISASTRA G, 1988, AM J CLIN NUTR, V48, P695
   NELSON JD, 1984, ARCH OPHTHALMOL-CHIC, V102, P1049
   NOLAN GR, 1994, DIAGN CYTOPATHOL, V11, P246, DOI 10.1002/dc.2840110310
   Novogene, 2018, GEN SEQ CO
   PARIDAENS ADA, 1992, BRIT J OPHTHALMOL, V76, P198, DOI 10.1136/bjo.76.4.198
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rocha N. S., 1999, REV ED CONTIN, V4, P3
   Singh PK, 2019, OCUL SURF, V17, P551, DOI 10.1016/j.jtos.2019.03.006
   Singh S., 2017, INT J OPHTHALMIC PAT, V6, P1, DOI [10.4172/2324-8599.1000195, DOI 10.4172/2324-8599.1000195]
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Swamynathan SK, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/103947
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TRIPATHI BJ, 1990, INVEST OPHTH VIS SCI, V31, P393
   TSENG SCG, 1985, OPHTHALMOLOGY, V92, P728
   Tzelikis Patrick Frensel de Moraes, 2004, Arq. Bras. Oftalmol., V67, P147, DOI 10.1590/S0004-27492004000100026
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 65
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5099
J9 FRONT MOL NEUROSCI
JI Front. Molec. Neurosci.
PD DEC 5
PY 2019
VL 12
AR 279
DI 10.3389/fnmol.2019.00279
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA JX0ZM
UT WOS:000503472600001
PM 31866819
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xie, XP
   Shi, PY
AF Xie, Xuping
   Shi, Pei-Yong
TI Repurposing an HIV Drug for Zika Virus Therapy
SO MOLECULAR THERAPY
LA English
DT Editorial Material
ID INHIBITORS
C1 [Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Azijn H, 2010, ANTIMICROB AGENTS CH, V54, P718, DOI 10.1128/AAC.00986-09
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Sariyer IK, 2019, MOL THER, V27, P2067, DOI 10.1016/j.ymthe.2019.10.006
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zou J, 2019, CURR OPIN VIROL, V35, P19, DOI 10.1016/j.coviro.2019.01.005
NR 15
TC 0
Z9 0
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD DEC 4
PY 2019
VL 27
IS 12
BP 2064
EP 2066
DI 10.1016/j.ymthe.2019.10.004
PG 3
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA JT3VR
UT WOS:000500921400005
PM 31624014
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Sariyer, IK
   Gordon, J
   Burdo, TH
   Wollebo, HS
   Gianti, E
   Donadoni, M
   Bellizzi, A
   Cicalese, S
   Loomis, R
   Robinson, JA
   Carnevale, V
   Steiner, J
   Ozdener, MH
   Miller, AD
   Amini, S
   Klein, ML
   Khalili, K
AF Sariyer, Ilker Kudret
   Gordon, Jennifer
   Burdo, Tricia H.
   Wollebo, Hassen S.
   Gianti, Eleonora
   Donadoni, Martina
   Bellizzi, Anna
   Cicalese, Stephanie
   Loomis, Regina
   Robinson, Jake A.
   Carnevale, Vincenzo
   Steiner, Joseph
   Ozdener, Mehmet H.
   Miller, Andrew D.
   Amini, Shohreh
   Klein, Michael L.
   Khalili, Kamel
TI Suppression of Zika Virus Infection in the Brain by the Antiretroviral
   Drug Rilpivirine
SO MOLECULAR THERAPY
LA English
DT Article
ID HIV-1 REVERSE-TRANSCRIPTASE; CRYSTAL-STRUCTURES; PROTEIN; NS5;
   METHYLTRANSFERASE; TRANSMISSION; FLEXIBILITY; GENERATION; REVEALS
AB Zika virus (ZIKV) infection is associated with microcephaly in neonates and Guillain-Barre syndrome in adults. ZIKV produces a class of nonstructural (NS) regulatory proteins that play a critical role in viral transcription and replication, including NS5, which possesses RNA-dependent RNA polymerase (RdRp) activity. Here we demonstrate that rilpivirine (RPV), a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infection, inhibits the enzymatic activity of NS5 and suppresses ZIKV infection and replication in primary human astrocytes. Similarly, other members of the NNRTI family, including etravirine and efavirenz, showed inhibitory effects on viral infection of brain cells. Site-directed mutagenesis identified 14 amino acid residues within the NS5 RdRp domain (AA265-903), which are important for the RPV interaction and the inhibition of NS5 polymerase activity. Administration of RPV to ZIKV-infected interferon-alpha/beta receptor (IFN-A/R) knockout mice improved the clinical outcome and prevented ZIKV-induced mortality. Histopathological examination of the brains from infected animals revealed that RPV reduced ZIKV RNA levels in the hippocampus, frontal cortex, thalamus, and cerebellum. Repurposing of NNRTIs, such as RPV, for the inhibition of ZIKV replication offers a possible therapeutic strategy for the prevention and treatment of ZIKV-associated disease.
C1 [Sariyer, Ilker Kudret; Gordon, Jennifer; Burdo, Tricia H.; Wollebo, Hassen S.; Donadoni, Martina; Bellizzi, Anna; Cicalese, Stephanie; Loomis, Regina; Robinson, Jake A.; Amini, Shohreh; Khalili, Kamel] Temple Univ, Lewis Katz Sch Med, Ctr Neurovirol, Dept Neurosci, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA.
   [Gianti, Eleonora; Carnevale, Vincenzo; Klein, Michael L.] Temple Univ, Coll Sci & Technol, Inst Computat Mol Sci, Dept Chem, 1901 N 12th St, Philadelphia, PA 19122 USA.
   [Steiner, Joseph] NINDS, Translat Neurosci Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Ozdener, Mehmet H.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.
   [Miller, Andrew D.] Cornell Univ, Coll Vet Med, T5-006A Vet Res Tower, Ithaca, NY 14853 USA.
RP Khalili, K (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Neurovirol, Dept Neurosci, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA.
EM kamel.khalili@temple.edu
RI Sariyer, Ilker/AAE-7677-2020
FU National Science FoundationNational Science Foundation (NSF) [1625061];
   US Army Research LaboratoryUnited States Department of DefenseUS Army
   Research Laboratory (ARL) [W911NF-16-2-0189]; Comprehensive NeuroAIDS
   Center (CNAC) [P30MH092177]
FX The authors wish to thank past and present members of the Department of
   Neuroscience and Center for Neurovirology, for their support, and
   sharing of reagents. We greatly appreciate the generosity of Dr. Howard
   Gendelman for his advice and sharing the results from his laboratory on
   the detection of RPV in the brains of experimental animals. We express
   our gratitude to Jessica Otte for her technical assistance and
   dedications. We would like to also thank Dr. Huaqing Zhao for
   biostatistical consultation. The computational work was carried out on
   Temple University's High Performance Computing facility, supported in
   part by the National Science Foundation through major research
   instrumentation grant number 1625061 and by the US Army Research
   Laboratory under contract number W911NF-16-2-0189. This work was
   supported in part by grants awarded to K.K., and we used services
   offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC)
   P30MH092177 awarded to K.K. All data in this manuscript are available
   from the authors upon reasonable request.
CR [Anonymous], 2018, 2018 2 LIGPREP
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bukrejewska M, 2017, ACTA CRYSTALLOGR D, V73, P767, DOI 10.1107/S2059798317010737
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chatrin C, 2018, ONCOTARGET, V9, P3160, DOI 10.18632/oncotarget.23223
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027
   Ferrero DS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007656
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Gianti E, 2016, J COMPUT AID MOL DES, V30, P285, DOI 10.1007/s10822-016-9899-y
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Lansdon EB, 2010, J MED CHEM, V53, P4295, DOI 10.1021/jm1002233
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321
   Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z
   Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x
   Thammaporn R, 2016, BIOL PHARM BULL, V39, P450, DOI 10.1248/bpb.b15-00880
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Watts KS, 2010, J CHEM INF MODEL, V50, P534, DOI 10.1021/ci100015j
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zukor K, 2018, J NEUROVIROL, V24, P273, DOI 10.1007/s13365-017-0595-z
NR 52
TC 1
Z9 1
U1 2
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD DEC 4
PY 2019
VL 27
IS 12
BP 2067
EP 2079
DI 10.1016/j.ymthe.2019.10.006
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA JT3VR
UT WOS:000500921400006
PM 31653397
DA 2020-07-08
ER

PT J
AU Ravasi, D
   Monton, DP
   Guidi, V
   Flacio, E
AF Ravasi, D.
   Parrondo Monton, D.
   Guidi, V.
   Flacio, E.
TI Evaluation of the public health risk for autochthonous transmission of
   mosquito-borne viruses in southern Switzerland
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; basic reproduction number R-0; human landing
   collection; mosquito-borne viruses
ID ALBOPICTUS DIPTERA-CULICIDAE; AEDES-ALBOPICTUS; EPIDEMIC; ROME
AB Epidemics of mosquito-borne diseases such as chikungunya and dengue fever are becoming more frequent around the world. In Switzerland, autochthonous cases have not been reported so far, although the presence of the vector Aedes albopictus in urban areas of southern Switzerland increases the risk of indigenous transmissions subsequent to imported cases. In 2018, the potential risk of an outbreak of arboviral diseases was assessed in five municipalities of southern Switzerland. The population abundance of Ae. albopictus was evaluated during the mosquito active season by the mean number of Ae. albopictus bites per day per person (estimated using the human landing collection method) and the risk of outbreak in the case of the introduction of chikungunya, dengue or Zika viruses was estimated. In the five localities investigated, no epidemic risk appeared to be present for any of the arboviruses taken into consideration in the initial months (i.e. mid-May to end of July) of Ae. albopictus activity. In the case of the introduction of chikungunya (mutated or not), dengue (serotype 1) or Zika (African lineage) viruses during mid-end August, an epidemic could have occurred in all the municipalities investigated. In mid-end September, the introduction of same arboviruses could have led to an epidemic in three of the five municipalities investigated.
C1 [Ravasi, D.; Parrondo Monton, D.; Guidi, V.; Flacio, E.] Univ Appl Sci & Arts Southern Switzerland, Dept Environm Construct & Design, Appl Microbiol Lab, Via Mirasole 22a, CH-6501 Bellinzona, Switzerland.
RP Ravasi, D (corresponding author), Univ Appl Sci & Arts Southern Switzerland, Dept Environm Construct & Design, Appl Microbiol Lab, Via Mirasole 22a, CH-6501 Bellinzona, Switzerland.
EM damiana.ravasi@supsi.ch
OI Ravasi, Damiana/0000-0003-2480-484X; Flacio,
   Eleonora/0000-0001-8267-6503
FU Swiss Expert Committee for Biosafety (Federal Office for the
   Environment); Ufficio del Medico Cantonale (Department of Public Health
   and Social Welfare of the Canton of Ticino); Swiss Federal Office of
   Public Health
FX We gratefully acknowledge Attila Giezendanner and Francesco Pace, from
   the Laboratory of Applied Microbiology, for their contribution to the
   human landing captures, as well as all of the Laboratory of Applied
   Microbiology staff who were involved in ovitrap evaluations. We thank
   the municipal workers from the municipalities involved in the study for
   the surveillance of ovitraps in the field. We are grateful to the Swiss
   Expert Committee for Biosafety (Federal Office for the Environment),
   Ufficio del Medico Cantonale (Department of Public Health and Social
   Welfare of the Canton of Ticino) and Swiss Federal Office of Public
   Health for providing financial support for the study. Meteorological
   data from the weather station were supplied by MeteoSwiss, Federal
   Office of Meteorology and Climatology. The authors declare that they
   have no conflicts of interest.
CR Barbazan P, 2010, MED VET ENTOMOL, V24, P66, DOI 10.1111/j.1365-2915.2009.00848.x
   Barzon L, 2018, J CLIN VIROL, V107, P38, DOI 10.1016/j.jcv.2018.08.007
   Bellini R., 2016, VECTOR BIOL J, V1, P10
   Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620
   Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259
   Carrieri M., 2012, ECOSCIENZA, V3, P80
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   European Centre for Disease Prevention and Control, 2018, LOC TRANSM DENG FEV
   Fine P.E.M., 1981, P77
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6
   Fortuna C, 2018, EUROSURVEILLANCE, V23, P6, DOI 10.2807/1560-7917.ES.2018.23.22.1800246
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Guzzetta G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004762
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lillepold K, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz017
   Lindh E, 2018, OPEN FORUM INFECT DI, V6, pofy321, DOI DOI 10.1128/GENOMEA.01306-17
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Manica M, 2017, PEERJ, V5, DOI 10.7717/peerj.2998
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Marklewitz M, 2019, ACTA TROP, V190, P52, DOI 10.1016/j.actatropica.2018.10.006
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446
   Peters C., 1990, VIROLOGY, P713
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   REISEN W K, 1989, Bulletin of the Society for Vector Ecology, V14, P67
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 31
TC 1
Z9 1
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD JUN
PY 2020
VL 34
IS 2
BP 244
EP 250
DI 10.1111/mve.12421
EA DEC 2019
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA LI8UK
UT WOS:000500528400001
PM 31802522
DA 2020-07-08
ER

PT J
AU D'Agostino, ES
   Chagas, JRLP
   Cangussu, MCT
   Vianna, MIP
AF D'Agostino, Erica Santana
   Chagas, Janeusa Rita Leite Primo
   Cangussu, Maria Cristina Teixeira
   Vianna, Maria Isabel Pereira
TI Chronology and sequence of deciduous teeth eruption in children with
   microcephaly associated to the Zika virus
SO SPECIAL CARE IN DENTISTRY
LA English
DT Article
DE pediatric dentistry; public health dentistry; rare disorders
ID TOOTH
AB Introduction Deciduous teeth eruption is connected to children's growth and development. In Brazil, with the increase in the occurrence of children born with microcephaly associated to exposure to Zika virus, studies about orofacial alterations were necessary. Objective Describe the chronology and sequence of deciduous teeth in children with microcephaly due to the fetal exposure to Zika virus. Methodology A cross-sectional study involving 74 children of a neuropediatric reference unit in Salvador, Bahia, in 2017 was conducted. Through use of secondary data, interviews with mothers and children's exam, the population was characterized, the chronology and sequence of deciduous teeth eruption was registered, and the analysis of the variables was proceeded. Results The first eruption happened between 4 and 17 months of age and 52.70% had a delay in the eruption of incisors. The average eruption time for the maxilla varies from 17.92 (16.56-19.28; 95% CI) to 20.43 (19.35-21.51; 95% CI) months, and the jaw from 11.57 (6.85-18.99; 95% CI) to 20.20 (19.09-21.31; 95% CI) months. In 77.94% of population, the eruption of the first teeth was in the lower arch and in 33.82%, molars and/or canines erupted before the incisors. Conclusions There were alteration in the chronology and sequence of deciduous teeth eruption.
C1 [D'Agostino, Erica Santana; Cangussu, Maria Cristina Teixeira; Vianna, Maria Isabel Pereira] Univ Fed Bahia, Sch Dent, 6th Floor,62 Canela, BR-41110150 Salvador, BA, Brazil.
   [Chagas, Janeusa Rita Leite Primo] Santo Antonio Hosp, Neuropediat Ambulatory, Salvador, BA, Brazil.
RP Vianna, MIP (corresponding author), Univ Fed Bahia, Sch Dent, 6th Floor,62 Canela, BR-41110150 Salvador, BA, Brazil.
EM isabel@ufba.br
OI Cangussu, Maria Cristina/0000-0001-9295-9486
CR Al-Batayneh OB, 2015, ARCH ORAL BIOL, V60, P126, DOI 10.1016/j.archoralbio.2014.08.014
   Alnemer KA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018621
   [Anonymous], 2009, INERTGROWTH THE INT
   [Anonymous], 2016, REC MAN REP ZIK VIR
   Cabral MBBD, 2017, REV SAUDE PUBL, V51, DOI [10.11606/s1518-8787.2017051006558, 10.11606/S1518-8787.2017051006558]
   Bonecker MJS, 2002, J BRAS ODONTOPEDIATR, V5, P425
   BRANDAO CF, 2004, JBP REV IBERO AM ODO, V7, P528
   Torres LB, 2015, EUR J PAEDIATR DENT, V16, P301
   Caregnato M, 2009, REV SUL BRAS ODONTOL, V6, P237
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Aguiar YPC, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.16
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Freitas RS, 2010, REV BRAS CIR CRANIOM, V13, P44
   Grau-Carbo J, 2007, MED ORAL PATOL ORAL, V12, P445
   GunaShekhar M., 2010, J CLIN EXP DENT, V3, P113
   Khanna R, 2017, J DENT RES REV, V4, P50
   Lam CU, 2016, CLIN ORAL INVEST, V20, P1871, DOI 10.1007/s00784-015-1670-6
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MORO Juliana da Silva, 2019, RGO, Rev. Gaúch. Odontol., V67, pe2019001, DOI 10.1590/1981-86372019000013597
   F. Neto Pedro Garcia, 2014, Rev. paul. pediatr., V32, P17, DOI 10.1590/S0103-05822014000100004
   Oziegbe EO, 2009, MATERN CHILD NUTR, V5, P86, DOI 10.1111/j.1740-8709.2008.00156.x
   PATRIANOVA ME, 2010, RSBO, V7, P406
   Pavicin IS, 2016, ANN ANAT, V203, P19, DOI 10.1016/j.aanat.2015.05.004
   Regen A, 2010, PEDIATR DENT, V32, P445
   Rodriguez-Caballero A, 2012, ORAL DIS, V18, P191, DOI 10.1111/j.1601-0825.2011.01864.x
   Sisodia Rinky, 2014, J Indian Soc Pedod Prev Dent, V32, P160, DOI 10.4103/0970-4388.130983
   Suri L, 2004, AM J ORTHOD DENTOFAC, V126, P432, DOI 10.1016/j.ajodo.2003.10.031
   Verma Neha, 2017, Int J Clin Pediatr Dent, V10, P278, DOI 10.5005/jp-journals-10005-1450
   Zaidi Iram, 2015, Int J Clin Pediatr Dent, V8, P215, DOI 10.5005/jp-journals-10005-1316
NR 29
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0275-1879
EI 1754-4505
J9 SPEC CARE DENT
JI Spec. Care Dent.
PD JAN
PY 2020
VL 40
IS 1
BP 3
EP 9
DI 10.1111/scd.12435
EA DEC 2019
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA KA7QB
UT WOS:000500088900001
PM 31794083
OA Bronze
DA 2020-07-08
ER

PT J
AU Leonhard, SE
   Conde, RM
   Gondim, FDA
   Jacobs, BC
AF Leonhard, Sonja E.
   Conde, Rodrigo M.
   Aquino Gondim, Francisco de Assis
   Jacobs, Bart C.
TI Diagnosis and treatment of Guillain-Barre syndrome during the Zika virus
   epidemic in Brazil: A national survey study
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Article; Early Access
DE clinical practice; Guillain-Barre syndrome; management; survey; Zika
   virus
AB The Zika virus (ZIKV) epidemic in Brazil in 2015-2016 was followed by an increase in the incidence of patients with Guillain-Barre syndrome (GBS). With this national survey study, we aimed to gain a better understanding of how neurologists in Brazil are currently diagnosing and treating patients with GBS, and how this increase in incidence has impacted the management of the disease. The questionnaire consisted of 52 questions covering: personal profile of the neurologist, practice of managing GBS during and outside of the ZIKV epidemic, and limitations in managing GBS. All 3264 neurologists that were member of the Brazilian Academy of Neurology at the time of the study were invited to participate. The questionnaire was fully answered by 171 (5%) neurologists. Sixty-one percent of neurologists noticed an increase in patients with GBS during the ZIKV epidemic, and 30% experienced an increase in problems in managing GBS during this time. The most important limitations in the diagnosis and management of GBS included the availability of nerve conduction studies (NCS), beds in the Intensive Care Unit (ICU) and referral to rehabilitation centers. Most neurologists did not use a protocol for treating patients with GBS and the treatment practice varied. Increasing availability of NCS and beds in the ICU and rehabilitation centers, and the implementation of (inter)national guidelines, are critical in supporting Brazilian neurologist in their management of GBS, and are especially important in preparing for future outbreaks.
C1 [Leonhard, Sonja E.; Jacobs, Bart C.] Erasmus Univ, Dept Neurol, Med Ctr, Wytemaweg 80, NL-2015 CN Rotterdam, Netherlands.
   [Conde, Rodrigo M.] Univ Sao Paulo FMRP USP, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil.
   [Aquino Gondim, Francisco de Assis] Univ Fed Ceara, Dept Internal Med, Neurol Div, Fortaleza, Ceara, Brazil.
   [Jacobs, Bart C.] Erasmus Univ, Dept Immunol, Med Ctr4, Rotterdam, Netherlands.
RP Leonhard, SE (corresponding author), Erasmus Univ, Dept Neurol, Med Ctr, Wytemaweg 80, NL-2015 CN Rotterdam, Netherlands.
EM s.leonhard@erasmusmc.nl
FU Erasmus University Medical Center; European UnionEuropean Union (EU)
   [734584]
FX Erasmus University Medical Center; European Union, Grant/Award Number:
   734584
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   [Anonymous], 1978, Ann Neurol, V3, P565
   [Anonymous], 2015, PROTOCOLOS CLIN DIRE
   [Anonymous], 2017, STROKE, V48, pe78
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Chevret S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub3
   Diaz-Soto S, 2019, eNeurologicalSci, V14, P89, DOI 10.1016/j.ensci.2019.02.001
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub5
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Leonhard SE, 2019, NAT REV NEUROL
   Pan American Health Organization, 2015, ZIK SUSP CONF CAS RE
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Verboon C, 2019, NEUROLOGY, V93, pE59, DOI 10.1212/WNL.0000000000007719
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2016, ZIK SIT REP FEBR 5 2
NR 20
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
DI 10.1111/jns.12358
EA DEC 2019
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JS1MO
UT WOS:000500077000001
PM 31746070
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leal, W
   Scheday, S
   Boenecke, J
   Gogoi, A
   Maharaj, A
   Korovou, S
AF Leal Filho, Walter
   Scheday, Svenja
   Boenecke, Juliane
   Gogoi, Abhijit
   Maharaj, Anish
   Korovou, Samuela
TI Climate Change, Health and Mosquito-Borne Diseases: Trends and
   Implications to the Pacific Region
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE climate change; global warming; human health; zika; pacific; extreme
   events
ID ZIKA VIRUS; EMERGING ARBOVIRUSES; CHIKUNGUNYA; SPREAD; DENGUE
AB Climate change is known to affect Pacific Island nations in a variety of ways. One of them is by increasing the vulnerability of human health induced by various climate change impacts, which pose an additional burden to the already distressed health systems in the region. This paper explores the associations between climate change and human health on the one hand, and outlines some of the health care challenges posed by a changing climate on the other. In particular, it describes the links between climate variations and the emergence of climate-sensitive infectious diseases, such as the mosquito-borne diseases dengue, chikungunya, and Zika. The paper also presents a summary of the key findings of the research initiatives Climate Change and Prevalence Study of ZIKA Virus Diseases in Fiji and the findings from the World Mosquito Program as two examples of public health action in the Pacific region.
C1 [Leal Filho, Walter; Scheday, Svenja; Boenecke, Juliane] Hamburg Univ Appl Sci, Res & Transfer Ctr Sustainable Dev & Climate Chan, Fac Life Sci, D-21033 Hamburg, Germany.
   [Leal Filho, Walter] Manchester Metropolitan Univ, Dept Nat Sci, Chester St, Manchester, Lancs, England.
   [Gogoi, Abhijit; Korovou, Samuela] Univ Fiji, Umanand Prasad Sch Med & Hlth Sci, Saweni 0700, Lautoka, Fiji.
   [Maharaj, Anish] Univ Fiji, Sch Sci & Technol, Saweni 0700, Lautoka, Fiji.
RP Leal, W (corresponding author), Hamburg Univ Appl Sci, Res & Transfer Ctr Sustainable Dev & Climate Chan, Fac Life Sci, D-21033 Hamburg, Germany.; Leal, W (corresponding author), Manchester Metropolitan Univ, Dept Nat Sci, Chester St, Manchester, Lancs, England.
EM walter.leal2@haw-hamburg.de; svenja.Scheday@haw-hamburg.de;
   Juliane.Boenecke@haw-hamburg.de; abhijitg@unifiji.ac.fj;
   anishm@unifiji.ac.fj; samuelak@unifiji.ac.fj
OI Leal Filho, Walter/0000-0002-1241-5225; Boenecke,
   Juliane/0000-0002-6327-8152
FU Fiji Ministry of Health and Medical Service; German Federal Ministry of
   Education and Research (BMBF)Federal Ministry of Education & Research
   (BMBF)
FX We thank the Fiji Ministry of Health and Medical Service for approval
   and support of the research project Climate Change and Prevalence Study
   of ZIKA Virus Diseases in Fiji, and the Fiji Meteorological Department
   for assistance and providing comprehensive meteorological reports. We
   furthermore thank Muni Nadan, Ricardo Corpuz, Sheemal Sharma, Diva
   Singh, Bijend P Ram from the Umanand Prasad School of Medicine and
   Health Sciences (UPSM&HS), University of Fiji, and the UPSM&HS student
   support for providing logistical and technical assistance during the
   field investigation. Furthermore, the support from the German Federal
   Ministry of Education and Research (BMBF) to the project Climate Change
   and Prevalence Study of ZIKA Virus Diseases in Fiji (Zika under a
   climate change and epidemiological perspective) is gratefully
   acknowledged.
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Anderson T, 2019, B WORLD HEALTH ORGAN, V97, P6, DOI 10.2471/BLT.19.020119
   Asad H, 2018, REV ENVIRON HEALTH, V33, P31, DOI 10.1515/reveh-2017-0042
   Aubry M., 2019, New Microbes and New Infections, V29, DOI 10.1016/j.nmni.2019.01.009
   California Institute of Technology, RAMP ANT IC LOSS SPE
   Calvez E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006637
   Campbell J, 2014, CLIMATE CHANGE MIGRA
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chang AY, 2014, HEALTH HUM RIGHTS, V16, P93
   Chouin-Carneiro T, 2020, MED VET ENTOMOL, V34, P116, DOI 10.1111/mve.12384
   Chowdhury Md. Rashed, 2010, Journal of Coastal Conservation, V14, P53, DOI 10.1007/s11852-010-0086-3
   Contopoulos-Ioannidis D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006510
   Craig AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198487
   Crimmins A., 2016, IMPACTS CLIMATE CHAN
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, DENG WORLDW OV
   Garriga C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14325
   Gomes AF, 2012, CAD SAUDE PUBLICA, V28, P2189, DOI 10.1590/S0102-311X2012001100018
   Gubler DJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5710
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Kama M, 2019, EMERG INFECT DIS, V25, P1535, DOI 10.3201/eid2508.180524
   Kucharski AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34848
   Leal W, 2018, J CLEAN PROD, V177, P589, DOI 10.1016/j.jclepro.2017.12.144
   Leal W, 2015, INT J CLIM CHANG STR, V7, P122, DOI 10.1108/IJCCSM-02-2015-0019
   Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512
   Lindegren M, 2018, GLOBAL CHANGE BIOL, V24, P796, DOI 10.1111/gcb.13993
   Marris E, 2017, NATURE, V548, P17, DOI 10.1038/548017a
   Matysiak A, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8947067
   Mavian C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010011
   Maynard J., 2019, PIFSC SPECIAL PUBLIC
   McIver L., 2015, ENV HLTH PERSPECT, V124, P1707, DOI DOI 10.1289/ehp.1509756
   Mimura N., 2007, CLIMATE CHANGE 2007
   Mirsaeidi M, 2016, ANN AM THORAC SOC, V13, P1223, DOI 10.1513/AnnalsATS.201511-729PS
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Ryan Peter A, 2019, Gates Open Res, V3, P1547, DOI 10.12688/gatesopenres.13061.2
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Shi Z., 2018, OALIB, V5, P1, DOI [10.4236/oalib.1104934, DOI 10.4236/OALIB.1104934]
   The Intergovernmental Panel on Climate Change, GLOB WARM 1 5 C
   WHO, CLIM CHANG HLTH KEY
   WHO, CHIK KEY FACTS
   WHO, 2015, HUM HLTH CLIM CHANG
   Wu XX, 2016, ENVIRON INT, V86, P14, DOI 10.1016/j.envint.2015.09.007
   Yang Y Tony, 2016, Prev Med Rep, V4, P444, DOI 10.1016/j.pmedr.2016.07.011
NR 47
TC 0
Z9 0
U1 10
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD DEC 2
PY 2019
VL 16
IS 24
AR 5114
DI 10.3390/ijerph16245114
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KC6VK
UT WOS:000507312700230
PM 31847373
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Santana, C
   Firmo, A
   Oliveira, R
   Buarque, P
   Alves, G
   Lima, R
AF Santana, C.
   Firmo, A.
   Oliveira, R.
   Buarque, P.
   Alves, G.
   Lima, R.
TI A Solution for Counting Aedes aegypti and Aedes albopictus Eggs in
   Paddles from Ovitraps Using Deep Learning
SO IEEE LATIN AMERICA TRANSACTIONS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; ovitraps; deep learning; egg counting
ID ZIKA VIRUS; COST
AB In 2018, the Epidemiological Record 36 of the World Health Organization (WHO) indicates that around 390 million people get infected from Arboviroses or mosquito-borne diseases. Among the transmission vectors of these diseases, the Aedes aegypti and Aedes albopictus are responsible for a considerable parcel of the infections since they can transmit a broad range of infections (e.g., dengue, yellow fever, and chikungunya). To reduce the number of infections and deaths caused by these mosquitoes, monitor and control the population of these insects is a key factor. In this sense, ovitraps can be employed to monitor the population of Aedes mosquitoes. Ovitrap is a dark container filled with water where a porous wooden paddle is inserted to serve as an oviposition substrate. These devices are installed in monitored areas and, periodically technicians collect them to count the number of eggs deposited in the paddles manually. Because the manual egg counting task can be time-consuming and susceptible to human errors, in this work we present a solution that uses deep learning algorithms to automate the counting process. Moreover, to further reduce the human effort in the counting process, hardware that automatically acquires the images of the wooden paddles is also presented. Experiments comparing the proposed solution, the manual counting method, and two other solutions, namely ICount and EggCounter, are performed. The results achieved indicate that the proposed method achieved a superior result than the two other methods. Moreover, the application of the Wilcoxon test with a confidence interval of 95% indicates that the solution presented can be as accurate as of the manual counting method which is currently adopted.
C1 [Santana, C.] Univ Exeter, Exeter, Devon, England.
   [Firmo, A.] Northeast Biotechnol Network RENORBIO, Recife, PE, Brazil.
   [Oliveira, R.; Buarque, P.; Alves, G.; Lima, R.] Univ Pernambuco, Polytech Sch, POLI UPE, Recife, PE, Brazil.
RP Santana, C (corresponding author), Univ Exeter, Exeter, Devon, England.
EM clodomir@ieee.org; andre.caetano@pickcells.bio; rodrigo@pickcells.bio;
   buarque.pedro@pickcells.bio; gabriel.alves@pickcells.bio;
   ricardo.lima@poli.br
RI Santana, Clodomir/B-3380-2019
OI Santana, Clodomir/0000-0001-7869-7184
CR Akhtar M., 2019, BIORXIV
   Banzi M., 2014, GETTING STARTED ARDU
   Barbedo JGA, 2012, IEEE LAT AM T, V10, P2112, DOI 10.1109/TLA.2012.6362356
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   CATHARINA L, 2017, J NURSING UFPE REV E, V11, DOI DOI 10.1177/1177932217712471
   Chakraborty T, 2019, PHYSICA A, V527, DOI 10.1016/j.physa.2019.121266
   D'Haro LF, 2014, IEEE LAT AM T, V12, P755, DOI 10.1109/TLA.2014.6868880
   da Silva MGNM, 2011, IEEE ENG MED BIO, P6810, DOI 10.1109/IEMBS.2011.6091679
   Dai J, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P1796, DOI 10.1109/ICIT.2016.7475036
   de Oliveira R. F., 2017, BRAZ C COMP INT NIT, V23, P1
   Eisenman B., 2015, LEARNING REACT NATIV
   FIX E, 1955, ANN MATH STAT, V26, P301, DOI 10.1214/aoms/1177728547
   Forcier J., 2008, PYTHON WEB DEV DJANG
   Gaburro J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1870-1
   Godoi I. P., 2019, HTAI COLOGNE
   Huang J., 2017, TENSORFLOW OBJECT DE
   Hussien W. A., 2016, COMP SCI INF TECHN C, P1
   Jawahir WN, 2018, 2018 INTERNATIONAL CONFERENCE ON SENSORS, SIGNAL AND IMAGE PROCESSING (SSIP 2018), P56, DOI 10.1145/3290589.3290594
   Jimenez FJ, 2014, IEEE LAT AM T, V12, P971, DOI 10.1109/TLA.2014.6893988
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Li Z, 2018, 32 AAAI C ART INT
   Liang Q., 2019, P 2019 4 INT C AUT C, P9
   Liang YX, 2018, BIOCYBERN BIOMED ENG, V38, P661, DOI 10.1016/j.bbe.2018.05.004
   Pham LD, 2017, CLINICOECONOMIC OUTC, V9, P1, DOI 10.2147/CEOR.S124023
   Mains JW, 2008, J AM MOSQUITO CONTR, V24, P496, DOI 10.2987/5740.1
   Mello C. A., 2009, RECENT ADV BIOMEDICA, P211
   Mello CAB, 2008, IEEE ENG MED BIO, P3103, DOI 10.1109/IEMBS.2008.4649860
   Messina J. P., 2019, NATURE MICROBIOLOGY, P1
   Mohanty SP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01419
   Moreira MWL, 2019, PATTERN RECOGN LETT, V125, P289, DOI 10.1016/j.patrec.2019.04.020
   Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58
   Perez MS, 2015, IEEE LAT AM T, V13, P455, DOI 10.1109/TLA.2015.7055564
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Polat K, 2008, DIGIT SIGNAL PROCESS, V18, P25, DOI 10.1016/j.dsp.2007.05.006
   Pombo A. P. M. M., THESIS
   Si J., 2019, NEUROCOMPUTING
   Teich V., 2017, JBES BRAZILIAN J HLT, V9
   Vimos V, 2018, IEEE LAT AM T, V16, P2496, DOI 10.1109/TLA.2018.8789574
   World Health Organization, 2018, WKLY EPIDEMIOL REC, V93, P457
NR 39
TC 0
Z9 0
U1 1
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1548-0992
J9 IEEE LAT AM T
JI IEEE Latin Am. Trans.
PD DEC
PY 2019
VL 17
IS 12
SI SI
BP 1987
EP 1994
DI 10.1109/TLA.2019.9011543
PG 8
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA KU8PB
UT WOS:000519973100008
DA 2020-07-08
ER

PT J
AU Cooper, HJ
   Iwamoto, M
   Lash, M
   Conners, EE
   Paladini, M
   Slavinski, S
   Fine, AD
   Kennedy, J
   Heinke, D
   Ciaranello, A
   Seage, GR
   Lee, EH
AF Cooper, Hannah J.
   Iwamoto, Martha
   Lash, Maura
   Conners, Erin E.
   Paladini, Marc
   Slavinski, Sally
   Fine, Anne D.
   Kennedy, Joseph
   Heinke, Dominique
   Ciaranello, Andrea
   Seage, George R., III
   Lee, Ellen H.
TI Maternal Zika Virus Infection Association With Small-for-Gestational-Age
   Neonates and Preterm Birth
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID NEW-YORK-CITY; WEIGHT; INTERGROWTH-21ST; RACE/ETHNICITY; OUTCOMES;
   INFANTS; FETAL; RISK
AB OBJECTIVE: To evaluate whether antenatal Zika virus infection is associated with risk of having a small-for-gestational-age (SGA) neonate, risk of preterm birth, and lower mean birth weight of term neonates.
   METHODS: For this retrospective observational study, we linked birth record data for women who delivered liveborn singleton neonates in New York City in 2016 to data for pregnant women with Zika virus infection reported to the New York City Health Department. We restricted the analysis to nonsmoking, nonwhite women and adjusted for maternal characteristics. Among women with antenatal Zika virus infection, we used modified Poisson regression to assess risks of having an SGA neonate and of delivering preterm, and linear regression to assess the association of infection with mean birth weight of term neonates.
   RESULTS: Of 116,034 deliveries of singleton neonates in New York City in 2016, 251 (0.2%) were to women with antenatal Zika virus infection. A higher percentage of women with Zika virus infection delivered an SGA neonate compared with those without (11.2% vs 5.8%; adjusted relative risk [RR] 1.8; 95% CI 1.3-2.6). There was no difference in preterm birth prevalence for women with and without Zika virus infection (adjusted RR 1.0; 95% CI 0.69-1.6). Mean birth weight of term neonates born to women with Zika virus infection was 47 g less (95% CI -105 to 11 g); this difference was not statistically significant in crude or adjusted analyses.
   CONCLUSION: For a cohort of New York City women, antenatal Zika virus infection was associated with an increased risk of having an SGA neonate, but not preterm birth or lower mean birth weight of term neonates. This supports a putative association between Zika virus infection during pregnancy and SGA.
C1 New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, Queens, NY USA.
   New York City Dept Hlth & Mental Hyg, Bur Vital Stat, New York, NY USA.
   Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Div Infect Dis, Boston, MA 02114 USA.
RP Lee, EH (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, New York, NY 11101 USA.
EM ELee4@health.nyc.gov
RI Heinke, Dominique/J-4593-2019
OI Heinke, Dominique/0000-0001-9217-3723
FU Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases
   Cooperative Agreement - Centers for Disease Control and Prevention (CDC)
   [NU50CK000407]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [T32HD060454]; Health Resources and Services Administration of the U.S.
   Department of Health and Human Services [T03MC07648]
FX This publication was supported (in part) by the Epidemiology and
   Laboratory Capacity (ELC) for Infectious Diseases Cooperative Agreement
   (Grant Number: NU50CK000407) funded by the Centers for Disease Control
   and Prevention (CDC). Its contents are solely the responsibility of the
   authors and do not necessarily represent the official views of CDC or
   the Department of Health and Human Services. Dominique Heinke was
   supported in part by Training Grant T32HD060454 from the National
   Institutes of Health and Training Grant T03MC07648 from the Health
   Resources and Services Administration of the U.S. Department of Health
   and Human Services.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   Borrell LN, 2016, AM J PUBLIC HEALTH, V106, P1491, DOI 10.2105/AJPH.2016.303242
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Centers for Disease Control and Prevention, CONG ZIK SYNDR OTH B
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Collins JW, 2013, MATERN CHILD HLTH J, V17, P1776, DOI 10.1007/s10995-012-1197-2
   Conners EE, 2018, OBSTET GYNECOL, V132, P487, DOI [10.1097/AOG.0000000000002737, 10.1097/aog.0000000000002737]
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   DiGiuseppe David L, 2002, Matern Child Health J, V6, P169, DOI 10.1023/A:1019726112597
   Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   Howard DL, 2006, PEDIATRICS, V118, pE1399, DOI 10.1542/peds.2006-0665
   Howland RE, 2015, MATERN CHILD HLTH J, V19, P1916, DOI 10.1007/s10995-015-1722-1
   James-Todd T, 2014, PAEDIATR PERINAT EP, V28, P157, DOI 10.1111/ppe.12100
   Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715
   Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9
   Kozuki N, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1438
   Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   New York City Department of Health and Mental Hygiene, 2016 DOHMH ADV 3 TES
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6
   Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Stein C.R., 2009, AM J OBSTET GYNECOL, V584, P1
   Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   World Health Organization, 2017, ZIK SIT REP JAN 5
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 37
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD DEC
PY 2019
VL 134
IS 6
BP 1197
EP 1204
DI 10.1097/AOG.0000000000003577
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KK7EA
UT WOS:000512899800012
PM 31764729
OA Other Gold
DA 2020-07-08
ER

PT J
AU Marinho, PES
   Alvarenga, PPM
   Lima, MT
   Andrade, AD
   Candiani, TMS
   Crispim, APC
   Gasparini, MCS
   Castro, FS
   de Sousa, AZA
   Viegas, ECC
   de Oliveira, DB
   Christo, PP
   Kroon, EG
AF Marinho, Paula Eillanny Silva
   Alvarenga, Pedro Paulo Martins
   Lima, Mauricio Teixeira
   de Souza Andrade, Adriana
   Candiani, Talitah Michel Sanchez
   Crispim, Ana Paula Correa
   Gasparini, Mirela Cristina Soares
   Castro, Fabrizia Santos
   de Sousa, Aline Zocrato Alves
   Viegas, Eisler Cristiane Carvalho
   de Oliveira, Danilo Bretas
   Christo, Paulo Pereira
   Kroon, Erna Geessien
TI Central and peripheral nervous system involvement in Zika virus
   infection in a child
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Central nervous system; Children; Peripheral nervous system
AB A 7-year-old boy that presented an encephalomyeloradiculitis and no classic symptoms of arboviruses. Zika virus (ZIKV) was confirmed by molecular analyses of cerebrospinal fluid and 1 year later by plaque reduction neutralization test. This case demonstrates that ZIKV can be associated with diffuse nervous system infection in children.
C1 [Marinho, Paula Eillanny Silva; Lima, Mauricio Teixeira; de Souza Andrade, Adriana; Crispim, Ana Paula Correa; Gasparini, Mirela Cristina Soares; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Inst Ciencias Biol, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
   [Alvarenga, Pedro Paulo Martins; Candiani, Talitah Michel Sanchez; Castro, Fabrizia Santos; de Sousa, Aline Zocrato Alves; Viegas, Eisler Cristiane Carvalho] Hosp Infantil Joao Paulo II, FHEMIG, Belo Horizonte, MG, Brazil.
   [Alvarenga, Pedro Paulo Martins] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo Bretas] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med Diamantina, Teofilo Otoni, MG, Brazil.
   [Christo, Paulo Pereira] Inst Ensino & Pesquisa Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virus, Inst Ciencias Biol, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Christo, Paulo Pereira/AAK-9780-2020
OI Christo, Paulo Pereira/0000-0003-1224-5243; Teixeira Lima,
   Mauricio/0000-0002-0830-3909
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior(CAPES)CAPES; Departamento de Ciencia e Tecnologia (DECIT) do
   Ministerio da Saude; Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
FX The authors received financial support from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior(CAPES), Departamento de
   Ciencia e Tecnologia (DECIT) do Ministerio da Saude and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). EGK is a fellow
   from CNPq.
CR Amoore Louise, 2017, SECURING ALGORITHMS, V48, P1
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Tyler KL, 2017, JAMA NEUROL, V74, P1169, DOI 10.1001/jamaneurol.2017.1471
NR 9
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD DEC
PY 2019
VL 25
IS 6
BP 893
EP 896
DI 10.1007/s13365-019-00770-x
PG 4
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA KI9UO
UT WOS:000511704500017
PM 31222674
DA 2020-07-08
ER

PT J
AU Abassi, M
   Sacktor, N
AF Abassi, Mahsa
   Sacktor, Ned
TI Central and peripheral nervous system involvement in Zika virus
   infection in a child
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Letter
ID CEREBROSPINAL-FLUID; S100B
C1 [Abassi, Mahsa] Univ Minnesota, Minneapolis, MN 55455 USA.
   [Abassi, Mahsa] Infect Dis Inst, Kampala, Uganda.
   [Sacktor, Ned] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
RP Abassi, M (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.; Abassi, M (corresponding author), Infect Dis Inst, Kampala, Uganda.
EM abass004@umn.edu
CR Abassi M, 2017, J NEUROVIROL, V23, P369, DOI 10.1007/s13365-016-0505-9
   Kallianpur Kalpana J, 2016, Open Med J, V3, P138
   Kallianpur KJ, 2016, MITOCHONDRION, V28, P8, DOI 10.1016/j.mito.2016.02.006
   Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005
   Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757
   NOPPE M, 1986, CLIN CHIM ACTA, V155, P143, DOI 10.1016/0009-8981(86)90275-5
   Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1
NR 7
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD DEC
PY 2019
VL 25
IS 6
BP 897
EP 898
DI 10.1007/s13365-019-00774-7
PG 2
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA KI9UO
UT WOS:000511704500018
PM 31278534
DA 2020-07-08
ER

PT J
AU Sen-Utsukarci, B
   Tabanca, N
   Estep, AS
   Akbal-Dagistan, O
   Kessler, SM
   Ozturk, Z
   Becnel, J
   Kiemer, AK
   Mat, A
AF Sen-Utsukarci, Burcu
   Tabanca, Nurhayat
   Estep, Alden S.
   Akbal-Dagistan, Ozlem
   Kessler, Sonja M.
   Ozturk, Zehra
   Becnel, James
   Kiemer, Alexandra K.
   Mat, Afife
TI The cytotoxicity and insecticidal activity of extracts from Delphinium
   formosum Boiss. & Huet
SO ISTANBUL JOURNAL OF PHARMACY
LA English
DT Article
DE Delphinium formosum; cytotoxic activity; HepG2; HUVEC; natural
   insecticidal; Aedes aegypti
ID BITING-DETERRENT COMPOUNDS; AEDES-AEGYPTI; ESSENTIAL OILS;
   NORDITERPENOID ALKALOIDS; LARVICIDAL ACTIVITY; FEVER MOSQUITO;
   IDENTIFICATION; CONSTITUENTS; REPELLENTS; BINDING
AB Delphinium species are well-known toxic plants with diterpenoid alkaloid contents. There has been no previous investigation on the cytotoxicity of Delphinium formosum. The extracts of the different parts of D. formosum, an endemic species in Turkey, were investigated for their cytotoxic activity against the human liver carcinoma cell line (HepG2) and primary human umbilical vein endothelial cells (HUVEC). The cytotoxic effects of twelve extracts and subtractions were determined against HepG2 cells using the MTT assay. The only active extract was applied to the HUVEC as a model for healthy cells. Only one of the alkaloid-containing extracts from the aerial parts was toxic (IC50=244,9 mu g/mL against HepG2 and 144,4 mu g/mL against HUVEC), while the root extracts were inactive. The results were improbable although it is predicted secondary metabolites, such as diterpene alkaloids (methyllycaconitine, browniine, lycoctonine, avardharidine, antranoyllycoctonine, delsemine A/B and lycoctonine). Based on previous studies in the literature, the cytotoxic plants were also expected to exhibit insecticidal activity. Therefore, the cytotoxic extract of D. formosum was examined for its adulticidal and larvicidal activity against the yellow fever, dengue fever and the Zika virus vector Aedes aegypti L.
C1 [Sen-Utsukarci, Burcu; Mat, Afife] Istanbul Univ, Fac Pharm, Dept Pharmacognosy, Istanbul, Turkey.
   [Tabanca, Nurhayat] USDA ARS, Subtrop Hort Res Stn, 13601 Old Cutler Rd, Miami, FL 33158 USA.
   [Estep, Alden S.] Navy Entomol Ctr Excellence, CMAVE Detachment, Gainesville, FL USA.
   [Estep, Alden S.; Becnel, James] USDA ARS, Ctr Med Agr & Vet Entomol, Washington, DC 20250 USA.
   [Akbal-Dagistan, Ozlem] Istanbul Univ, Fac Pharm, Dept Pharmaceut Technol, Istanbul, Turkey.
   [Kessler, Sonja M.; Kiemer, Alexandra K.] Saarland Univ, Dept Pharm, Pharmaceut Biol, Saarbrucken, Germany.
   [Ozturk, Zehra] Republ Turkey Minist Agr & Forestry, Ortahisar Dist Directorate Agr & Forestry, Trabzon, Turkey.
RP Sen-Utsukarci, B (corresponding author), Istanbul Univ, Fac Pharm, Dept Pharmacognosy, Istanbul, Turkey.
EM burcusn@gmail.com
RI Sen, Burcu/AAD-7817-2020; DAGISTAN, OZLEM AKBAL/Q-1443-2019
OI DAGISTAN, OZLEM AKBAL/0000-0002-6524-3535
FU Research Fund of Istanbul UniversityIstanbul University [33641];
   Deployed War-Fighter Protection Research Program
FX This work was partly supported by the Research Fund of Istanbul
   University (Project number: 33641) and partly funded by the Deployed
   War-Fighter Protection Research Program.
CR Bandara KANP, 2000, PHYTOCHEMISTRY, V54, P29, DOI 10.1016/S0031-9422(00)00025-X
   Baytop T., 1999, TURKIYEDE BITKILERLE
   Cantrell CL, 2016, J AGR FOOD CHEM, V64, P8352, DOI 10.1021/acs.jafc.6b01668
   Carroll JF, 2017, NAT PROD RES, V31, P2192, DOI 10.1080/14786419.2017.1280485
   Chanakul W, 2011, FITOTERAPIA, V82, P964, DOI 10.1016/j.fitote.2011.05.012
   Chantawee A, 2018, ASIAN PAC J TROP BIO, V8, P217, DOI 10.4103/2221-1691.231284
   Csupor D, 2007, Z NATURFORSCH B, V62, P135
   de Ines C, 2006, Z NATURFORSCH C, V61, P11
   Dias CN, 2017, MED PLANTS ENV CHALL
   Diesel B, 2012, INNATE IMMUN-LONDON, V18, P112, DOI 10.1177/1753425910394888
   Durust N, 1999, ANAL LETT, V32, P2841, DOI 10.1080/00032719908543010
   Garcez WS, 2009, BIORESOURCE TECHNOL, V100, P6647, DOI 10.1016/j.biortech.2009.06.092
   Gonzalez-Coloma A, 2004, CHEM BIODIVERS, V1, P1327, DOI 10.1002/cbdv.200490095
   Hiller K, 2006, LEXIKON ARZNEIPFLANZ
   Kamaraj C, 2010, PARASITOL RES, V107, P1337, DOI 10.1007/s00436-010-2006-8
   Kessler SM, 2013, AM J PHYSIOL-GASTR L, V304, pG328, DOI 10.1152/ajpgi.00005.2012
   Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3
   KUKEL CF, 1994, CAN J PHYSIOL PHARM, V72, P104, DOI 10.1139/y94-016
   Kumar S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00104
   Liu F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15240-9
   Liu ZL, 2012, PARASITOL RES, V111, P991, DOI 10.1007/s00436-012-2923-9
   Lu JJ, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/485042
   Maheswaran R, 2012, PARASITOL RES, V110, P1801, DOI 10.1007/s00436-011-2702-z
   Masi M, 2017, OPEN CHEM, V15, P156, DOI 10.1515/chem-2017-0019
   Masi M, 2017, FITOTERAPIA, V116, P34, DOI 10.1016/j.fitote.2016.11.007
   Masi M, 2016, MOLECULES, V21, DOI 10.3390/molecules21111432
   Mericli F, 1996, PHYTOCHEMISTRY, V42, P1249, DOI 10.1016/0031-9422(95)00921-3
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nugroho Agung Endro, 2015, Asian Pac J Cancer Prev, V16, P7337
   Pitarokili D, 2011, PARASITOL RES, V109, P425, DOI 10.1007/s00436-011-2271-1
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009
   Reina Matias, 2007, Phytochemistry Reviews, V6, P81, DOI 10.1007/s11101-006-9013-5
   Sen-Utsukarci B, 2018, CHEM NAT COMPD+, V54, P405, DOI 10.1007/s10600-018-2363-6
   Stappen I, 2018, OPEN CHEM, V16, P306, DOI 10.1515/chem-2018-0028
   Tabanca N, 2018, OPEN CHEM, V16, P324, DOI 10.1515/chem-2018-0030
   Tabanca N, 2016, CURR ORG CHEM, V20, P2690, DOI 10.2174/1385272820666160421151503
   Tabanca N, 2016, REC NAT PROD, V10, P311
   Tabanca N, 2013, J AGR FOOD CHEM, V61, P12283, DOI 10.1021/jf4052682
   Tabanca N, 2013, J AGR FOOD CHEM, V61, P8573, DOI 10.1021/jf402182h
   Tanker M, 1975, J FAC PHARM ANKARA U, V5, P113
   Ulubelen A, 2001, PHYTOTHER RES, V15, P170, DOI 10.1002/ptr.688
NR 42
TC 0
Z9 0
U1 4
U2 4
PU ISTANBUL UNIV, FAC PHARMACY
PI ISTANBUL
PA DEPT PHARMACEUTICAL TECHNOLOGY, ISTANBUL, 34116, TURKEY
SN 0367-7524
EI 2548-0731
J9 ISTANB J PHARM
JI Istanb. J. Pharm.
PD DEC
PY 2019
VL 49
IS 3
BP 148
EP 153
DI 10.26650/IstanbulJPharm.2019.19034
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KI1TD
UT WOS:000511129700006
DA 2020-07-08
ER

PT J
AU da Silva, MHM
   Moises, RNC
   Alves, BEB
   Pereira, HWB
   de Paiva, AAP
   Morais, IC
   Nascimento, YM
   Monteiro, JD
   de Souto, JT
   Nascimento, MSL
   de Araujo, JMG
   da Guedes, PMM
   Fernandes, JV
AF Matias da Silva, Marcelo Henrique
   Cunha Moises, Raiza Nara
   Bizerra Alves, Brenda Elen
   Bezerra Pereira, Hannaly Wana
   Pereira de Paiva, Anne Aline
   Morais, Ingryd Camara
   Nascimento, Yasmim Mesquita
   Monteiro, Joelma Dantas
   de Souto, Janeusa Trindade
   Lima Nascimento, Manuela Sales
   Galvao de Araujo, Joselio Maria
   Matta da Guedes, Paulo Marcos
   Fernandes, Jose Verissimo
TI Innate immune response in patients with acute Zika virus infection
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE Zika virus; Patient; Innate immune receptors; Toll-like receptors
   (TLRs); RIG-like receptors (RLRs); Cytokines
ID DENGUE VIRUS; BARRE-SYNDROME; TRANSMISSION; ENHANCEMENT; RECEPTORS;
   OUTBREAK; GUILLAIN; AMERICA
AB Innate immunity receptors (Toll-like receptors/TLRs and RIG-like receptors/RLRs) are important for the initial recognition of Zika virus (ZIKV), modulation of protective immune response, and IFN-alpha and IFN-beta production. Immunological mechanisms involved in protection or pathology during ZIKV infection have not yet been determined. In this study, we evaluated the mRNA expression of innate immune receptors (TLR3, TLR7, TLR8, TLR9, melanoma differentiation-associated protein 5/MDA-5, and retinoic acid inducible gene/RIG-1), its adapter molecules (Myeloid Differentiation Primary Response Gene 88/Myd88, Toll/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-beta/TRIF), and cytokines (IL-6, IL-12, TNF-alpha, IFN-alpha, IFN-beta, and IFN-gamma) in the acute phase of patients infected by ZIKV using real-time PCR in peripheral blood. Patients with acute ZIKV infection had high expression of TLR3, IFN-alpha, IFN-beta, and IFN-gamma when compared to healthy controls. In addition, there was a positive correlation between TLR3 expression compared to IFN-alpha and IFN-beta. Moreover, viral load is positively correlated with TLR8, RIG-1, MDA-5, IFN-alpha, and IFN-beta. On the other hand, patients infected by ZIKV showed reduced expression of RIG-1, TLR8, Myd88, and TNF-alpha molecules, which are also involved in antiviral immunity. Similar expressions of TLR7, TLR9, MDA-5, TRIF, IL-6, and IL-12 were observed between the group of patients infected with ZIKV and control subjects. Our results indicate that acute infection (up to 5 days after the onset of symptoms) by ZIKV in patients induces the high mRNA expression of TLR3 correlated to high expression of IFN-gamma, IFN-alpha, and IFN-beta, even though the high viral load is correlated to high expression of TLR8, RIG-1, MDA-5, IFN-alpha, and IFN-beta in ZIKV patients.
C1 [Matias da Silva, Marcelo Henrique; Bizerra Alves, Brenda Elen; Bezerra Pereira, Hannaly Wana; de Souto, Janeusa Trindade; Galvao de Araujo, Joselio Maria; Matta da Guedes, Paulo Marcos; Fernandes, Jose Verissimo] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Grad Program Parasitary Biol, Natal, RN, Brazil.
   [Cunha Moises, Raiza Nara; Bizerra Alves, Brenda Elen; Bezerra Pereira, Hannaly Wana; Pereira de Paiva, Anne Aline; Nascimento, Yasmim Mesquita; Monteiro, Joelma Dantas; de Souto, Janeusa Trindade; Galvao de Araujo, Joselio Maria; Matta da Guedes, Paulo Marcos; Fernandes, Jose Verissimo] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Natal, RN, Brazil.
   [Bizerra Alves, Brenda Elen; Bezerra Pereira, Hannaly Wana; Pereira de Paiva, Anne Aline; Morais, Ingryd Camara; Nascimento, Yasmim Mesquita; Monteiro, Joelma Dantas; Galvao de Araujo, Joselio Maria] Univ Fed Rio Grande do Norte, Virol Lab, Inst Trop Med, Natal, RN, Brazil.
   [Lima Nascimento, Manuela Sales] Santos Dumont Inst, Edmond & Lily Safra Int Inst Neurosci ELS IIN, Macaiba, RN, Brazil.
RP da Guedes, PMM; Fernandes, JV (corresponding author), Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Grad Program Parasitary Biol, Natal, RN, Brazil.; da Guedes, PMM; Fernandes, JV (corresponding author), Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Natal, RN, Brazil.
EM pauloguedes@cb.ufrn.br; veris@cb.ufrn.br
OI Fernandes, Jose Verissimo/0000-0002-5169-6496; Matta Guedes, Paulo
   Marcos/0000-0002-4564-6791
FU National Council for Scientific and Technological Development
   (MEC/MCTI/CAPES/CNPq/FAPS-PVE Grant) [400328/2014-3]; National Council
   for Scientific and Technological Development (MCTI/CNPq/Universal Grant)
   [404904/2016-5]; University Faculty Advanced Studies Coordination Unit
   (CAPES); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by the National Council for Scientific and
   Technological Development (MEC/MCTI/CAPES/CNPq/FAPS-PVE Grant no.
   400328/2014-3 and MCTI/CNPq/Universal Grant no. 404904/2016-5).
   Post-graduation research fellows are supported by University Faculty
   Advanced Studies Coordination Unit (CAPES). The author PMMG acknowledges
   the CNPq for the research productivity fellowship.
CR Abdalla LF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0938-2
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Garcez P, 2005, AM J HUM GENET, V76, P717, DOI [10.1086/429930, DOI 10.1086/429930]
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Kam Y-W, 2017, J INFECT DIS, DOI [10.1093/neuonc/nox188/4265638, DOI 10.1093/NEUONC/NOX188/4265638]
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson T, 2013, CELL HOST MICROBE, V17, P148, DOI [10.1007/s10461-012-0143-z.Provider-patient, DOI 10.1007/S10461-012-0143-Z.PROVIDER-PATIENT]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 46
TC 1
Z9 1
U1 1
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD DEC
PY 2019
VL 208
IS 6
BP 703
EP 714
DI 10.1007/s00430-019-00588-8
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KH8MA
UT WOS:000510903600001
PM 30879197
DA 2020-07-08
ER

PT J
AU Healy, KB
   Dugas, E
   Fonseca, DM
AF Healy, Kristen B.
   Dugas, Emily
   Fonseca, Dina M.
TI DEVELOPMENT OF A DEGREE-DAY MODEL TO PREDICT EGG HATCH OF AEDES
   ALBOPICTUS
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Asian tiger mosquito; development rates; temperature; thermal minimum;
   wing length
ID LARVAL COMPETITION; TRISERIATUS DIPTERA; TEMPERATURE; CULICIDAE;
   AEGYPTI; MOSQUITO; POPULATIONS; RANGE; SURVIVAL; INVASION
AB Aedes albopictus, the Asian tiger mosquito, is an important nuisance mosquito species and known vector of arboviruses such as dengue, chikungunya, and Zika. Despite their cosmopolitan distribution around the world, there is a paucity of accurate predictive models based on rates of development at different temperatures (degree-day models). These types of models can benefit mosquito control districts by predicting when to target early-season larval development, when populations are likely at their lowest levels. In this study, we determined the effect of temperature and nutrient levels on the development rates and male and female adult size of 2 Ae. albopictus populations: one field-collected, the other a 20-year-old lab colony. We found relatively small differences in the effects of temperature and nutrient levels between populations. Data from these studies were used to create a predictive degree-day model, which when tested in New Jersey correlated with field observations of early-season field populations of Ae. albopictus. While other important factors, such as day length and fluctuating temperatures, should be evaluated, data from this study will contribute to the development of operational strategies to effectively time early-season larviciding against this species.
C1 [Healy, Kristen B.] Louisiana State Univ, Dept Entomol, Life Sci Annex, Agr Ctr, Baton Rouge, LA 70803 USA.
   [Dugas, Emily] Adapco, Innovat Mosquito Solut, Stanford, FL 32771 USA.
   [Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, Dept Entomol, 180 Jones Ave, New Brunswick, NJ 08901 USA.
RP Healy, KB (corresponding author), Louisiana State Univ, Dept Entomol, Life Sci Annex, Agr Ctr, Baton Rouge, LA 70803 USA.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Armistead JS, 2008, J MED ENTOMOL, V45, P629, DOI 10.1603/0022-2585(2008)45[629:ILCBAA]2.0.CO;2
   Armstrong PM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005623
   Bartlett-Healy K, 2011, J MED ENTOMOL, V48, P712, DOI 10.1603/ME10168
   Bradshaw WE, 2000, ECOLOGY, V81, P1262
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Damos Petros, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/123405
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Kamimura Kiyoshi, 2002, Medical Entomology and Zoology, V53, P53
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   LANSDOWNE C, 1975, J MED ENTOMOL, V11, P723, DOI 10.1093/jmedent/11.6.723
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Little E., 2017, PLOS NEGLECT TROP D, V11, P1
   Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204
   Lounibos LP, 2011, J AM MOSQUITO CONTR, V27, P433, DOI 10.2987/11-6164.1
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2
   NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314
   NOVAK MG, 1993, ENVIRON ENTOMOL, V22, P311, DOI 10.1093/ee/22.2.311
   Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240
   Reiskind MH, 2012, J INSECT PHYSIOL, V58, P911, DOI 10.1016/j.jinsphys.2012.04.006
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Sinclair BJ, 2015, J THERM BIOL, V53, P180, DOI 10.1016/j.jtherbio.2015.11.003
   Southwood R., 1978, ECOLOGICAL METHODS P
   Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40
   Unlu I, 2014, T ROY SOC TROP MED H, V108, P699, DOI 10.1093/trstmh/tru139
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140
   Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709
   Vitek CJ, 2009, J MED ENTOMOL, V46, P766, DOI 10.1603/033.046.0406
   WIGGLESWORTH VB, 1950, PRINCIPLES INSECT PH
   Yee DA, 2012, J MED ENTOMOL, V49, P825, DOI 10.1603/ME11132
NR 39
TC 0
Z9 0
U1 1
U2 1
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD DEC
PY 2019
VL 35
IS 4
BP 249
EP 257
PG 9
WC Entomology
SC Entomology
GA KE0HH
UT WOS:000508242100001
PM 31922937
OA Bronze
DA 2020-07-08
ER

PT J
AU Kisuya, B
   Masika, MM
   Bahizire, E
   Oyugi, JO
AF Kisuya, Bramuel
   Masika, Moses M.
   Bahizire, Esto
   Oyugi, Julius O.
TI Seroprevalence of Zika virus in selected regions in Kenya
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Kenya; seroprevalence; Zika virus
ID HISTORY
AB Background: The Zika virus pandemic in South America in 2015-2016 and the association of Zika virus infection with neurological complications such as microcephaly in newborns distressed the global community. There is limited data on the prevalence of Zika virus in Kenya despite evidence of its circulation in East Africa. This study aimed at assessing the seroprevalence of Zika virus in selected areas in Kenya.
   Methods: Healthy adult human sera originally collected from Nairobi, Eldoret and Kisumu from 2009 to 2014 and archived at the University of Nairobi laboratories were examined for Zika virus antibodies. An IgG-based ELISA was used to screen 577 sera. Any serum tested positive by ELISA was confirmed for Zika virus infection by plaque reduction neutralization test (PRNT).
   Results: The seroprevalence of Zika virus in the study population was about 0.2%(1/577) as confirmed by PRNT. Additionally, three sera that were false positive by ELISA for Zika virus were confirmed as positive for dengue virus by PRNT.
   Conclusion: There was evidence of low previous exposure to Zika virus in the study population. Of the three regions in Kenya where sera for this study were obtained, only Kisumu County had one case of previous exposure to Zika virus.
C1 [Kisuya, Bramuel; Masika, Moses M.; Bahizire, Esto; Oyugi, Julius O.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya.
   [Bahizire, Esto] ICART, Bukavu, DEM REP CONGO.
   [Bahizire, Esto] Ctr Res Nat Sci Lwiro, Bukavu, DEM REP CONGO.
   [Oyugi, Julius O.] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya.
RP Kisuya, B (corresponding author), Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya.
EM kisuyabramuel@gmail.com
FU National Research Fund (NRF) of Kenya [NRF/1/Msc/158]
FX This work was partially supported by a grant (Ref: NRF/1/Msc/158) from
   the National Research Fund (NRF) of Kenya through competitive research
   grants for postgraduate students category. Additionally, Gitiche Chege
   of the Hospital Consumables Kenya Limited donated an ELISA kit to this
   work.
CR Aggarwal R, 2016, INT J COMMUNITY MED, V3, P1352
   Agha SB, 2017, PLOS NEGLECT TROP D, V11, P1
   Chepkorir E, 2018, ACTA TROP, V186, P50, DOI 10.1016/j.actatropica.2018.07.008
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Israel GD, 2013, SCIRP, P1
   Kayiwa JT, 2018, J GEN VIROL, V99, P1248, DOI 10.1099/jgv.0.001113
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lutomiah J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004981
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645
   Putnak JR, 2008, AM J TROP MED HYG, V79, P115, DOI 10.4269/ajtmh.2008.79.115
   Roth A, 2012, EUROSURVEILLANCE, V20, P148
   Shapshak P, 2016, GLOBAL VIROLOGY 1, P477, DOI [10.1007/978-1-4939-2410-3, DOI 10.1007/978-1-4939-2410-3]
   Soghaier Mohammed A, 2018, BMC Res Notes, V11, P906, DOI 10.1186/s13104-018-4027-9
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203
   Tsegaye MM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5726-9
   van Vuren PJ, 2018, MICROBIOL RESOUR ANN, V7, DOI [10.1128/MRA.01278-18, 10.1128/mra.01278-18]
   Velasquez-Serra GC, 2016, AM J EPIDEMIOLOGY IN, V4, P78
   Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208
   Weaver SC, 2010, PRESENT FUTURE ARBOV, V85
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 25
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD DEC
PY 2019
VL 113
IS 12
BP 735
EP 739
DI 10.1093/trstmh/trz077
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KF9IQ
UT WOS:000509553900001
PM 31639184
DA 2020-07-08
ER

PT J
AU Vianna, RAD
   Lovero, KL
   de Oliveira, SA
   Fernandes, AR
   dos Santos, TCS
   Lima, LCSD
   Carvalho, FR
   Quintans, MDS
   Bueno, AC
   Torbey, AFM
   de Souza, ALAAG
   de Farias, ADP
   Camacho, LAB
   Riley, LW
   Cardoso, CAA
AF de Oliveira Vianna, Renata Artimos
   Lovero, Kathryn Lynn
   de Oliveira, Solange Artimos
   Fernandes, Alexandre Ribeiro
   Sarmet dos Santos, Teresa Cristina
   Santos de Souza Lima, Luiz Claudio
   Carvalho, Fabiana Rabe
   Salgado Quintans, Maria Dolores
   Bueno, Arnaldo Costa
   Malheiros Torbey, Ana Flavia
   Azevedo Grippa de Souza, Aurea Lucia Alves
   Pache de Farias, Armanda de Oliveira
   Bastos Camacho, Luiz Antonio
   Riley, Lee Woodland
   Araujo Cardoso, Claudete Aparecida
TI Children Born to Mothers with Rash During Zika Virus Epidemic in Brazil:
   First 18 Months of Life
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
DE Zika virus; Congenital Zika syndrome; microcephaly; RT-PCR
ID EPILEPSY; INFANTS
AB Objective: To better understand the clinical spectrum and course of congenital Zika syndrome (CZS) during the first 18 months of life of children whose mothers had rash during pregnancy.
   Methods: This longitudinal observational study evaluated the clinical progress from birth until 18 months of life of children of mothers who developed rash during or up to 3 months before gestation. Maternal rash occurred from November 2015 to May 2017. The study subjects were divided into three groups: children whose mothers tested positive by RT-qPCR for Zika virus (ZIKV) (Group 1), children whose mothers tested negative by RT-qPCR for ZIKV (Group 2), and children whose mothers did not undergo any testing for ZIKV (Group 3) but tested negative for other congenital infections.
   Results: Between April 2016 and July 2018, we studied 108 children: 43 in Group 1, 26 in Group 2 and 39 in Group 3. The majority of children were admitted into the study within 6 months of life. CZS was diagnosed in 26 children, equally distributed in Groups 1 and 3. Of 18 children with microcephaly, 6 were in Group 1 (1 postnatal) and 12 were in Group 3 (5 postnatal). Maternal rash frequency was 10 times higher during the first trimester than in the other trimesters (OR: 10.35; CI 95%: 3.52-30.41). CZS was diagnosed during the follow-up period in 14 (54%) cases. Developmental delays and motor abnormalities occurred in all children and persisted up to 18 months. Epilepsy occurred in 18 (69%) of the cases.
   Conclusions: Infants born of mothers exposed to ZIKV during pregnancy showed progression of developmental, motor and neurologic abnormalities even if they were born asymptomatic. Continued postnatal monitoring of such newborns is necessary to preclude disability-associated complications.
C1 [de Oliveira Vianna, Renata Artimos; de Oliveira, Solange Artimos; Fernandes, Alexandre Ribeiro; Sarmet dos Santos, Teresa Cristina; Santos de Souza Lima, Luiz Claudio; Carvalho, Fabiana Rabe; Salgado Quintans, Maria Dolores; Bueno, Arnaldo Costa; Malheiros Torbey, Ana Flavia; Azevedo Grippa de Souza, Aurea Lucia Alves; Pache de Farias, Armanda de Oliveira; Araujo Cardoso, Claudete Aparecida] Univ Fed Fluminense, Fac Med, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
   [Lovero, Kathryn Lynn] Columbia Univ, Dept Psychiat, New York, NY 10032 USA.
   [Bastos Camacho, Luiz Antonio] Fundacao Oswaldo Cruz, Dept Epidemiol & Metodos Quantitativos Saude, BR-21 04121 Rio De Janeiro, RJ, Brazil.
   [Riley, Lee Woodland] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Cardoso, CAA (corresponding author), Univ Fed Fluminense, Fac Med, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
EM claudetecardoso@id.uff.br
OI Fernandes, Alexandre/0000-0001-6253-265X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [001]; Global Health Equity Scholars Program (Fogarty International
   Center, National Institutes of Health) [R25 TW009338]; Fulbright
   Commission
FX This work was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) Finance Code 001, and Fulbright
   Commission and Global Health Equity Scholars Program (Fogarty
   International Center, National Institutes of Health), grant number R25
   TW009338.
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil. Ministerio da Saude, OR INT VIG AT SAUD A
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, B EPIDEMIOLOGICO, V54
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Franca T.L.B., 2018, INT J ENV RES PUBLIC, V15
   FRANKENBURG WK, 1992, DENVER 2 TRAINING MA
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   IBGE. Instituto Brasileiro de Geografia e Estatistica, 2010, AGL SUBN INF TERR
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Ministerio da Saude, 2017, SECR VIG SAUD
   Mitchell PK, 2019, AM J EPIDEMIOL, V188, P206, DOI 10.1093/aje/kwy189
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   Van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1
   Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, 2006, ACTA PAEDIATR, V450, pS76
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 27
TC 3
Z9 3
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD DEC
PY 2019
VL 65
IS 6
BP 592
EP 602
DI 10.1093/tropej/fmz019
PG 11
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA KF6TH
UT WOS:000509372500010
PM 31006031
DA 2020-07-08
ER

PT J
AU Kayesh, MEH
   Hashem, MA
   Kitab, B
   Tsukiyama-Kohara, K
AF Kayesh, Mohammad Enamul Hoque
   Hashem, Md Abul
   Kitab, Bouchra
   Tsukiyama-Kohara, Kyoko
TI Pathogenesis and Immune Response Caused by Vector-Borne and Other Viral
   Infections in a Tupaia Model
SO MICROORGANISMS
LA English
DT Review
DE immune response; Tupaia; viral infections
ID EPSTEIN-BARR-VIRUS; ZIKA VIRUS; OXIDATIVE STRESS; ANIMAL-MODEL; TREE
   SHREW; DENGUE VIRUS; HUMAN LIVER; BELANGERI; EXPRESSION; REPLICATION
AB The Tupaia or tree shrew (Tupaia belangeri), a small mammal of the Tupaiidae family, is an increasingly used and promising infection model for virological and immunological research. Recently, sequencing of the Tupaia whole genome revealed that it is more homologous to the genome of humans than of rodents. Viral infections are a global threat to human health, and a complex series of events are involved in the interactions between a virus and the host immune system, which play important roles in the activation of an immune response and the outcome of an infection. Majority of immune response data in viral infections are obtained from studies using animal models that enhance the understanding of host-virus interactions; a proper understanding of these interactions is very important for the development of effective antivirals and prophylactics. Therefore, animal models that are permissive to infection and that recapitulate human disease pathogenesis and immune responses to viral infections are essential. Several studies have shown the permissiveness of Tupaia to a number of important human viral infections in vitro and in vivo without prior adaptation of the viruses; the immune responses and clinical manifestations were comparable to those observed in human infections. Thus, the Tupaia is being utilized and developed as a promising immunocompetent small animal model for viral infection studies. In this review, we focused on the immune responses, mostly innate, during viral infection and pathogenesis in the Tupaia model; we evaluated the interaction between the virus and the components of host resistance, the usefulness of this model for immunopathogenesis studies, and the vaccines and antivirals available.
C1 [Kayesh, Mohammad Enamul Hoque; Hashem, Md Abul; Kitab, Bouchra; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, 1-21-24 Korimoto, Kagoshima, KagoshimaKagosh 8900065, Japan.
   [Kayesh, Mohammad Enamul Hoque] Patuakhali Sci & Technol Univ, Fac Anim Sci & Vet Med, Dept Microbiol & Publ Hlth, Barishal 8210, Bangladesh.
RP Tsukiyama-Kohara, K (corresponding author), Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, 1-21-24 Korimoto, Kagoshima, KagoshimaKagosh 8900065, Japan.
EM mehkayesh@yahoo.com; mdhashem29@yahoo.com; bouchra.kitab17@gmail.com;
   kkohara@vet.kagoshima-u.ac.jp
OI Kayesh, Mohammad Enamul Hoque/0000-0003-4806-9843
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED); Tokyo Metropolitan
   GovernmentTokyo Metropolitan Government; Ministry of Health and Welfare
   of JapanMinistry of Health, Labour and Welfare, Japan; Ministry of
   Education, Culture, Sports, Science and Technology of JapanMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)
FX This work was supported by grants from the Japan Agency for Medical
   Research and Development (AMED), the Tokyo Metropolitan Government; the
   Ministry of Health and Welfare of Japan; and the Ministry of Education,
   Culture, Sports, Science and Technology of Japan.
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09
   Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chen J, 2019, FEMS MICROBIOL REV, V43, P674, DOI 10.1093/femsre/fuz023
   Chijioke O, 2013, CELL REP, V5, P1489, DOI 10.1016/j.celrep.2013.11.041
   Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305
   CLEARY ML, 1985, SCIENCE, V228, P722, DOI 10.1126/science.2986287
   Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783
   DeMaria N, 1996, FREE RADICAL BIO MED, V21, P291, DOI 10.1016/0891-5849(96)00044-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019
   Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168
   Ezzikouri S, 2015, EBIOMEDICINE, V2, P604, DOI 10.1016/j.ebiom.2015.04.007
   Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416
   Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087
   Hai-Ying C, 2016, EXP ANIM TOKYO, V65, P285, DOI 10.1538/expanim.15-0123
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141
   Hannigan A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-11
   Hartlage AS, 2015, CANCER IMMUNOL RES, V3, P787, DOI 10.1158/2326-6066.CIR-14-0242
   Huang YW, 2014, ANTIVIR THER, V19, P637, DOI 10.3851/IMP2762
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Kayesh MEH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10329-7
   Kayesh MEH, 2017, VIRUS RES, V237, P47, DOI 10.1016/j.virusres.2017.05.013
   Kayesh MEH, 2017, INFECT GENET EVOL, V51, P203, DOI 10.1016/j.meegid.2017.04.003
   Khan G, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0260-1
   Kouwaki T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00335
   Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963
   Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x
   Lee KS, 2016, NATURE, V533, P90, DOI 10.1038/nature17941
   Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406
   Li Jian-Ping, 2014, Zoological Research, V35, P485, DOI 10.13918/j.issn.2095-8137.2014.6.485
   Li LH, 2016, J VIROL, V90, P790, DOI 10.1128/JVI.02258-15
   Li RF, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0167-1
   Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346
   Ma ZY, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010006
   Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0
   Mrozek-Gorska P, 2019, P NATL ACAD SCI USA, V116, P16046, DOI 10.1073/pnas.1901314116
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NAHER H, 1992, J INVEST DERMATOL, V98, P791, DOI 10.1111/1523-1747.ep12499958
   NIEDOBITEK G, 1994, AM J PATHOL, V145, P969
   Okano M, 2000, BEST PRACT RES CL HA, V13, P199, DOI 10.1053/beha.1999.0068
   Okuno K, 2010, J MED VIROL, V82, P977, DOI 10.1002/jmv.21597
   OOKA T, 1985, BIOMED PHARMACOTHER, V39, P59
   Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246
   Peng Y., 1991, BIOL CHINESE TREE SH
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Ruan P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-333
   Saito M, 2012, J MED VIROL, V84, P733, DOI 10.1002/jmv.23250
   Sanada T, 2019, BIOCHEM BIOPH RES CO, V520, P86, DOI 10.1016/j.bbrc.2019.09.072
   Sanada T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48867-x
   Sanada T, 2019, VIROLOGY, V529, P101, DOI 10.1016/j.virol.2019.01.015
   Sanada T, 2016, BIOCHEM BIOPH RES CO, V469, P229, DOI 10.1016/j.bbrc.2015.11.121
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Shi Yu-jie, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P469
   SHOPE T, 1973, P NATL ACAD SCI USA, V70, P2487, DOI 10.1073/pnas.70.9.2487
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03932-1
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Takano T, 2011, J HEPATOL, V55, P512, DOI 10.1016/j.jhep.2010.12.011
   Takashima K, 2008, J MED VIROL, V80, P455, DOI 10.1002/jmv.21102
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Tsukiyama-Kohara K, 2014, EXP ANIM TOKYO, V63, P367, DOI 10.1538/expanim.14-0007
   Tsukiyama-Kohara K, 2012, INT J MOL SCI, V13, P15271, DOI 10.3390/ijms131115271
   Valgimigli L, 2000, FREE RADICAL RES, V33, P167, DOI 10.1080/10715760000300721
   Valgimigli M, 2002, FREE RADICAL RES, V36, P939, DOI 10.1080/107156021000006653
   Walter E, 1996, HEPATOLOGY, V24, P1, DOI 10.1002/hep.510240101
   Wang Z, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0859-5
   Wilson JB, 1996, EMBO J, V15, P3117, DOI 10.1002/j.1460-2075.1996.tb00674.x
   Xu FH, 2012, JNCI-J NATL CANCER I, V104, P1396, DOI 10.1093/jnci/djs320
   Xu L, 2016, P NATL ACAD SCI USA, V113, P10950, DOI 10.1073/pnas.1604939113
   Xu XP, 2007, J GEN VIROL, V88, P2504, DOI 10.1099/vir.0.82878-0
   Yang C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0256-x
   Yang ZF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-111
   Yu WH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1418-1
   Zhang L, 2019, EMERG MICROBES INFEC, V8, P232, DOI 10.1080/22221751.2018.1559707
   Zhang NN, 2019, J VIROL, V93, DOI [10.1128/JVI.01982-18, 10.1128/jvi.01982-18]
NR 85
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD DEC
PY 2019
VL 7
IS 12
AR 686
DI 10.3390/microorganisms7120686
PG 11
WC Microbiology
SC Microbiology
GA KB7BQ
UT WOS:000506646400103
PM 31842286
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aragao, CF
   Pinheiro, VCS
   Neto, JPN
   da Silva, EVP
   Pereira, GJG
   do Nascimento, BLS
   Castro, KD
   Maia, AM
   Catete, CP
   Martins, LC
   Tadei, WP
   da Silva, SP
   Cruz, ACR
AF Aragao, Carine Fortes
   Soares Pinheiro, Valeria Cristina
   Nunes Neto, Joaquim Pinto
   Pinto da Silva, Eliana Vieira
   Galvao Pereira, Glennda Juscely
   Sena do Nascimento, Bruna Lais
   Castro, Karoline da Silva
   Maia, Ariadne Mendonca
   Catete, Clistenes Pamplona
   Martins, Livia Caricio
   Tadei, Wanderli Pedro
   da Silva, Sandro Patroca
   Ribeiro Cruz, Ana Cecilia
TI Natural Infection of Aedes aegypti by Chikungunya and Dengue type 2
   Virus in a Transition Area of North-Northeast Brazil
SO VIRUSES-BASEL
LA English
DT Article
DE Aedes; Chikungunya virus; Dengue virus; arbovirus
ID ALBOPICTUS DIPTERA-CULICIDAE; ZIKA VIRUS; AUTOCHTHONOUS TRANSMISSION;
   DENGUE VIRUSES; 1ST REPORT; VECTOR; STATE; CELL; PERFORMANCE; MECHANISMS
AB Dengue fever, chikungunya, and Zika are diseases caused by viruses transmitted by Aedes aegypti and Aedes albopictus. In Brazil, the number of human infections is high, but few studies are performed in mosquito vectors. This study aimed to investigate the presence of Zika, Dengue and Chikungunya viruses in Ae. aegypti and Ae. albopictus from the municipalities of Alto Alegre, Caxias, Codo, and Sao Mateus do Maranhao, located in the state of Maranhao, Northeast Brazil. The mosquitoes were collected with a mechanical aspirator, identified, triturated, and then submitted to RNA extraction and RT-qPCR. The positive samples were confirmed by virus isolation and genome sequencing. Three hundred and forty-eight Ae. aegypti (176 males and 172 females) and 12 Ae. albopictus (eight males and four females) were collected and tested. Ae. aegypti was the only vector positive in two municipalities-Codo, with detection of Chikungunya virus (CHIKV) belonging to the East-Central-South African genotype, and in Caxias, with detection of Dengue virus (DENV)-2 belonging to the Asian/American genotype. The detection of CHIKV and DENV-2 is evidence that those viruses are maintained in arthropod vectors, and shows the epidemiological risk in the area for chikungunya cases and a possible increase of severe dengue cases, associated with the occurrence of dengue hemorrhagic fever.
C1 [Aragao, Carine Fortes] Univ Fed Para, Programa Posgrad Biol Agentes Infecciosos & Paras, BR-66075110 Belem, PA, Brazil.
   [Soares Pinheiro, Valeria Cristina] Univ Estadual Maranhao, Ctr Estudos Super Caxias, Lab Entomol Med, BR-65604380 Caxias, MA, Brazil.
   [Nunes Neto, Joaquim Pinto; Pinto da Silva, Eliana Vieira; Galvao Pereira, Glennda Juscely; Sena do Nascimento, Bruna Lais; Martins, Livia Caricio; da Silva, Sandro Patroca; Ribeiro Cruz, Ana Cecilia] Minist Saude, Secretaria Vigilancia & Saude, Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, BR-67030000 Ananindeua, PA, Brazil.
   [Castro, Karoline da Silva; Maia, Ariadne Mendonca] Univ Estado Para, Programa Posgrad Biol Parasitaria Amazonia, BR-66087670 Belem, PA, Brazil.
   [Catete, Clistenes Pamplona] Minist Saude, Secretaria Vigilancia & Saude, Inst Evandro Chagas, BR-67030000 Ananindeua, PA, Brazil.
   [Tadei, Wanderli Pedro] Inst Nacl de Pesquisas da Amazonia, Lab Malaria & Dengue, BR-69060001 Manaus, AM, Brazil.
RP Cruz, ACR (corresponding author), Minist Saude, Secretaria Vigilancia & Saude, Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, BR-67030000 Ananindeua, PA, Brazil.
EM carinefaragao@gmail.com; vc_pinheiro@hotmail.com;
   joaquimneto@iec.gov.br; elianapinto@iec.gov.br; bioagl2013@gmail.com;
   brunanascimento@iec.gov.br; karolflu@hotmail.com;
   ariadnemaia16@gmail.com; clistenescatete@iec.gov.br;
   liviamartins@iec.gov.br; wptadei@gmail.com; spatroca@gmail.com;
   anacecilia@iec.gov.br
OI PINTO NUNES NETO, JOAQUIM/0000-0001-5981-0065; Fortes Aragao,
   Carine/0000-0003-2721-6496; Nascimento, Bruna/0000-0002-8529-4751
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [427416/2016-7]; Decit/SCTIE/MS/CNPq/SES-MA/PPSUS [03392/13];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (Capes)CAPES; Pro-Reitoria de Pesquisa e Pos-Graduacao/Universidade
   Federal do Para (PROPESP/UFPA); Instituto Evandro Chagas/Ministerio da
   Saude
FX This research was funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) grant number 427416/2016-7,
   Decit/SCTIE/MS/CNPq/SES-MA/PPSUS grant number 03392/13, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Capes), Pro-Reitoria de
   Pesquisa e Pos-Graduacao/Universidade Federal do Para (PROPESP/UFPA),
   and Instituto Evandro Chagas/Ministerio da Saude.
CR Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263
   Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2
   Andrade A.T.d.S., 2018, AVANCOS CIENCIAS BIO, P135
   Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Ayllon T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195014
   Azevedo R., 2013, MED TROPICAL INFECT, P481
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Barcelos-Figueiredo L., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104516, DOI 10.1371/JOURNAL.PONE.0104516]
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   BEATY BJ, 1995, ARBOVIRUSES, P189
   Bezerra J. M. T., 2013, Open Tropical Medicine Journal, V6, P5, DOI 10.2174/1874315301306010005
   Bezerra J.M.T., 2017, REV PESQ SAUDE, V8, P102
   Brasil. Ministerio da Saude. Secretaria de Vigilancia e Saude, SECR VIG SAUD MON CA
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2016, SECR VIG SAUD MON CA
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, SECR VIG SAUD MON CA
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4
   Casseb A.R., 2013, VET ZOOTEC, V20, P9
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Cruz ACR, 2010, REV PAN AMAZ SAUDE, V1, P25, DOI DOI 10.5123/S2176-62232010000300004
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Faria NRD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002095
   de Castro MG, 2004, MEM I OSWALDO CRUZ, V99, P809, DOI 10.1590/S0074-02762004000800005
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860019, 10.1590/s1678-9946201860019]
   de Sousa AA, 2017, REV BRAS ENTOMOL, V61, P51, DOI 10.1016/j.rbe.2016.10.003
   de Souza SS, 2010, REV SOC BRAS MED TRO, V43, P152, DOI 10.1590/S0037-86822010000200009
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Dias JD, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759071, 10.1590/s1678-9946201759071]
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   DONALISIO M. R., 2017, REV SAUDE PUBL, V51, P1
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Ferreira AC, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000414, 10.11606/s1518-8787.2018052000414]
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   FORATTINI O. P., 1965, ENTOMOLOGIA MED CULI, V2
   Forattini O.P., 1962, ENTOMOLOGIA MED PART, V1
   FORATTINI O. P., 1965, ENTOMOLOGIA MED CULI, V3
   FORATTINI O.P., 2002, CULICIDOLOGIA MED, V2
   Gallichotte EN, 2018, CELL REP, V25, P1214, DOI 10.1016/j.celrep.2018.10.006
   de Araujo JMG, 2009, MEM I OSWALDO CRUZ, V104, P526, DOI 10.1590/S0074-02762009000300021
   Gonçalves Neto Vicente Silva, 2004, Cad. Saúde Pública, V20, P1427, DOI 10.1590/S0102-311X2004000500039
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Honorio NA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006521
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Instituto Brasileiro de Geografia e Estatistica, SINT IND SOC POBR AU
   Issack MI, 2010, EMERG INFECT DIS, V16, P716, DOI 10.3201/eid1604.091582
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lane J, 1953, NEOTROPICAL CULICIDA, VI
   Lane J, 1953, NEOTROPICAL CULICIDA, V2
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Lessa-Aquino C, 2018, EPIDEMIOL INFECT, V146, P2056, DOI 10.1017/S0950268818002467
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Machado LC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007332
   Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030178
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Menting S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/514681
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7
   NASCI RS, 1981, MOSQ NEWS, V41, P808
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pyke AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep22356
   Ramasamy R, 2016, J VECTOR DIS, V53, P91
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Soares Vanessa Aparecida Ribeiro Canela, 2008, EntomoBrasilis, V1, P63
   Soares-da-Silva J, 2012, REV SOC BRAS MED TRO, V45, P174, DOI 10.1590/S0037-86822012000200007
   Souza Thiara Manuele Alves, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Tauro LB, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180597
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649
   Vissoci JRN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006392
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Wei KF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45505
   Wirth W.W., 1973, Amazoniana, V4, P405
   Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 99
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2019
VL 11
IS 12
AR 1126
DI 10.3390/v11121126
PG 18
WC Virology
SC Virology
GA KC0RH
UT WOS:000506894800022
PM 31817553
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pauvolid-Correa, A
   Dias, HG
   Maia, LMS
   Porfirio, G
   Morgado, TO
   Sabino-Santos, G
   Santa Rita, PH
   Barreto, WTG
   de Macedo, GC
   Torres, JM
   Nantes, WAG
   Santos, FM
   de Assis, WO
   Rucco, AC
   Yui, RMD
   Campos, JBV
   Silva, RRLE
   Ferreira, RD
   Neves, NAD
   Costa, MCD
   Martins, LR
   de Souza, EM
   Carvalho, MD
   Lima, MG
   Alves, FDG
   Riquelme, LHG
   Figueiro, LLB
   de Santana, MFG
   Santos, LGRO
   Medeiros, SS
   Seino, LL
   Miranda, EH
   Linhares, JHR
   Santos, VD
   da Silva, SA
   Lucio, KA
   Gomes, VS
   Oliveira, AD
   Silva, JD
   Marques, WD
   Marques, MS
   de Barros, JF
   Campos, L
   Couto-Lima, D
   Netto, CC
   Strussmann, C
   Panella, N
   Hannon, E
   de Macedo, BC
   de Almeida, JR
   Ribeiro, KR
   de Castro, MCB
   Campos, LP
   dos Santos, APR
   de Souza, IM
   Bianchini, MD
   Correa, SHR
   Luz, ROB
   Vieira, AD
   Pinto, LMD
   Azeredo, E
   Figueiredo, LTM
   Alencar, JAF
   de Lima, SMB
   Herrera, HM
   Shlessarenko, RD
   dos Santos, FB
   de Filippis, AMB
   Salyer, S
   Montgomery, J
   Komar, N
AF Pauvolid-Correa, Alex
   Dias, Helver Goncalves
   Siqueira Maia, Laura Marina
   Porfirio, Grasiela
   Morgado, Thais Oliveira
   Sabino-Santos, Gilberto
   Santa Rita, Paula Helena
   Gomes Barreto, Wanessa Teixeira
   de Macedo, Gabriel Carvalho
   Torres, Jaire Marinho
   Gimenes Nantes, Wesley Arruda
   Santos, Filipe Martins
   de Assis, William Oliveira
   Rucco, Andreza Castro
   dos Santos Yui, Rafael Mamoru
   Vilela Campos, Joao Bosco
   Leandro e Silva, Renato Rodrigues
   Ferreira, Raquel da Silva
   da Silva Neves, Nilvanei Aparecido
   de Souza Costa, Michell Charlles
   Martins, Leticia Ramos
   de Souza, Emerson Marques
   dos Santos Carvalho, Michellen
   Lima, Marina Goncalves
   Goncalves Alves, Fernanda de Cassia
   Guimaraes Riquelme-Junior, Luiz Humberto
   Batista Figueiro, Luan Luiz
   Gomes de Santana, Matheus Fernandes
   Rodrigues Oliveira Santos, Luiz Gustavo
   Medeiros, Samara Serra
   Seino, Larissa Lopes
   Miranda, Emily Hime
   Rezende Linhares, Jose Henrique
   Santos, Vanessa de Oliveira
   da Silva, Stephanie Almeida
   Lucio, Kelly Araujo
   Gomes, Viviane Silva
   Oliveira, Alexandre de Araujo
   Silva, Julia dos Santos
   Marques, William de Almeida
   Marques, Marcio Schafer
   Franca de Barros, Jose Junior
   Campos, Leticia
   Couto-Lima, Dinair
   Netto, Claudia Coutinho
   Strussmann, Christine
   Panella, Nicholas
   Hannon, Emily
   de Macedo, Barbara Cristina
   de Almeida, Julia Ramos
   Ribeiro, Karen Ramos
   Barros de Castro, Maria Carolina
   Campos, Larissa Pratta
   Rosa dos Santos, Ana Paula
   de Souza, Isabelle Marino
   Bianchini, Mateus de Assis
   Ramiro Correa, Sandra Helena
   Baptista Luz, Renato Ordones
   Vieira, Ananda dos Santos
   de Oliveira Pinto, Luzia Maria
   Azeredo, Elzinandes
   Moraes Figueiredo, Luiz Tadeu
   Fonseca Alencar, Jeronimo Augusto
   Barbosa de Lima, Sheila Maria
   Herrera, Heitor Miraglia
   Shlessarenko, Renata Dezengrini
   dos Santos, Flavia Barreto
   Bispo de Filippis, Ana Maria
   Salyer, Stephanie
   Montgomery, Joel
   Komar, Nicholas
TI Zika Virus Surveillance at the Human-Animal Interface in West-Central
   Brazil, 2017-2018
SO VIRUSES-BASEL
LA English
DT Article
DE Zika; enzootic cycle; Brazil; zoonotic; plaque reduction neutralization
   test (PRNT)
ID IDENTIFICATION; TRANSMISSION; ARBOVIRUSES; GUIDELINES; INFECTION;
   EMERGENCE; MOSQUITOS; VECTORS
AB Zika virus (ZIKV) was first discovered in 1947 in Uganda but was not considered a public health threat until 2007 when it found to be the source of epidemic activity in Asia. Epidemic activity spread to Brazil in 2014 and continued to spread throughout the tropical and subtropical regions of the Americas. Despite ZIKV being zoonotic in origin, information about transmission, or even exposure of non-human vertebrates and mosquitoes to ZIKV in the Americas, is lacking. Accordingly, from February 2017 to March 2018, we sought evidence of sylvatic ZIKV transmission by sampling whole blood from approximately 2000 domestic and wild vertebrates of over 100 species in West-Central Brazil within the active human ZIKV transmission area. In addition, we collected over 24,300 mosquitoes of at least 17 genera and 62 species. We screened whole blood samples and mosquito pools for ZIKV RNA using pan-flavivirus primers in a real-time reverse-transcription polymerase chain reaction (RT-PCR) in a SYBR Green platform. Positives were confirmed using ZIKV-specific envelope gene real-time RT-PCR and nucleotide sequencing. Of the 2068 vertebrates tested, none were ZIKV positive. Of the 23,315 non-engorged mosquitoes consolidated into 1503 pools tested, 22 (1.5%) with full data available showed some degree of homology to insect-specific flaviviruses. To identify previous exposure to ZIKV, 1498 plasma samples representing 62 species of domestic and sylvatic vertebrates were tested for ZIKV-neutralizing antibodies by plaque reduction neutralization test (PRNT90). From these, 23 (1.5%) of seven species were seropositive for ZIKV and negative for dengue virus serotype 2, yellow fever virus, and West Nile virus, suggesting potential monotypic reaction for ZIKV. Results presented here suggest no active transmission of ZIKV in non-human vertebrate populations or in alternative vector candidates, but suggest that vertebrates around human populations have indeed been exposed to ZIKV in West-Central Brazil.
C1 [Pauvolid-Correa, Alex; Bispo de Filippis, Ana Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [Dias, Helver Goncalves; de Oliveira Pinto, Luzia Maria; Azeredo, Elzinandes; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, BR-21040900 Rio De Janeiro, Brazil.
   [Siqueira Maia, Laura Marina; Ferreira, Raquel da Silva; da Silva Neves, Nilvanei Aparecido; de Souza Costa, Michell Charlles; Martins, Leticia Ramos; de Souza, Emerson Marques; dos Santos Carvalho, Michellen; Shlessarenko, Renata Dezengrini] Univ Fed Mato Grosso, Fac Med, Lab Virol, BR-78060900 Cuiaba, Brazil.
   [Porfirio, Grasiela; de Macedo, Gabriel Carvalho; Torres, Jaire Marinho; Gimenes Nantes, Wesley Arruda; Santos, Filipe Martins; de Assis, William Oliveira; Rucco, Andreza Castro; dos Santos Yui, Rafael Mamoru; Vilela Campos, Joao Bosco; Leandro e Silva, Renato Rodrigues; Herrera, Heitor Miraglia] Univ Catolica Dom Bosco, Lab Biol Parasitaria, Programa Posgrad Ciencias Ambientais & Sustentabi, BR-79117010 Campo Grande, MS, Brazil.
   [Morgado, Thais Oliveira; Bianchini, Mateus de Assis; Ramiro Correa, Sandra Helena; Baptista Luz, Renato Ordones; Vieira, Ananda dos Santos] Univ Fed Mato Grosso, Hosp Vet, BR-78060900 Cuiaba, Brazil.
   [Sabino-Santos, Gilberto; Marques, Marcio Schafer; Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med, Ctr Pesquisa Virol, BR-14025099 Ribeirao Preto, Brazil.
   [Santa Rita, Paula Helena; Lima, Marina Goncalves; Goncalves Alves, Fernanda de Cassia; Guimaraes Riquelme-Junior, Luiz Humberto; Batista Figueiro, Luan Luiz; Gomes de Santana, Matheus Fernandes] Univ Catolica Dom Bosco, Bioterio, BR-79117010 Campo Grande, MS, Brazil.
   [Gomes Barreto, Wanessa Teixeira; Rodrigues Oliveira Santos, Luiz Gustavo; Medeiros, Samara Serra; Seino, Larissa Lopes] Univ Fed Mato Grosso do Sul UFMS, Lab Ecol Populacoes & Movimento, Programa Ecol & Conservacao, BR-79070900 Campo Grande, MS, Brazil.
   [Miranda, Emily Hime; Rezende Linhares, Jose Henrique; Santos, Vanessa de Oliveira; da Silva, Stephanie Almeida; Lucio, Kelly Araujo; Gomes, Viviane Silva; Barbosa de Lima, Sheila Maria] Fiocruz MS, Biomanguinhos, Lab Tecnol Virol, BR-21040900 Rio De Janeiro, Brazil.
   [Oliveira, Alexandre de Araujo; Silva, Julia dos Santos; Marques, William de Almeida; Fonseca Alencar, Jeronimo Augusto] Fiocruz MS, Inst Oswaldo Cruz, Lab Diptera, BR-21040900 Rio De Janeiro, Brazil.
   [Franca de Barros, Jose Junior; Campos, Leticia] Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Mol, BR-21040900 Rio De Janeiro, Brazil.
   [Couto-Lima, Dinair] Fiocruz MS, Lab Transmissores Hematozoarios, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, Brazil.
   [Netto, Claudia Coutinho] CRAS, BR-79037109 Campo Grande, MS, Brazil.
   [Strussmann, Christine; de Almeida, Julia Ramos; Ribeiro, Karen Ramos; Barros de Castro, Maria Carolina; Campos, Larissa Pratta; Rosa dos Santos, Ana Paula; de Souza, Isabelle Marino] Univ Fed Mato Grosso, Fac Med Vet, BR-78060900 Cuiaba, Brazil.
   [Panella, Nicholas; Hannon, Emily; Komar, Nicholas] US Ctr Dis Control & Prevent CDC, Arboviral Dis Branch, Lab Arbovirus Ecol, Ft Collins, CO 80521 USA.
   [de Macedo, Barbara Cristina] Univ Cuiaba UNIC, Fac Med Vet, BR-78065900 Cuiaba, Brazil.
   [Salyer, Stephanie; Montgomery, Joel] CDC, Global Epidemiol Lab, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Salyer, Stephanie; Montgomery, Joel] CDC, Surveillance Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
RP Pauvolid-Correa, A (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.; Komar, N (corresponding author), US Ctr Dis Control & Prevent CDC, Arboviral Dis Branch, Lab Arbovirus Ecol, Ft Collins, CO 80521 USA.
EM pauvolid@gmail.com; helvergd@gmail.com; lauramsmaia@gmail.com;
   grasi_porfirio@hotmail.com; thaismorgado@gmail.com; sabinogsj@usp.br;
   paulabiovet@ucdb.br; wanessatgbarreto@gmail.com;
   carvalhodemacedo@gmail.com; jairemarinho@hotmail.com;
   wesley_anantes@hotmail.com; filipemsantos@outlook.com;
   william.oliveira.assis@gmail.com; drezacastro.rucco@hotmail.com;
   rafayui99@gmail.com; bjoaocampos@gmail.com; renatorleandro@gmail.com;
   rah.kell_@hotmail.com; nilvanei@hotmail.com;
   michellcharlles2021@gmail.com; le_ramos@hotmail.com;
   emersonesem@gmail.com; michellengalex@gmail.com;
   marina-lima94@outlook.com; fdecassia.alves@gmail.com;
   bioriquelme@gmail.com; llb.figueiro@gmail.com;
   matheussantana_21@hotmail.com; gu_tapirus@hotmail.com;
   samarabio2013@gmail.com; larissalopesseino@hotmail.com;
   emily@bio.fiocruz.br; jose.henrique@bio.fiocruz.br;
   vanessa.oliveira@bio.fiocruz.br; stephanie.silva@bio.fiocruz.br;
   kelly.araujo@bio.fiocruz.br; viviane.gomes@bio.fiocruz.br;
   alexandre.bio.br@gmail.com; juliass@ioc.fiocruz.br;
   wmarques.bio@gmail.com; marcioschafer@msn.com; barros@ioc.fiocruz.br;
   leticia_bonfim1998@hotmail.com; dcouto@ioc.fiocruz.br;
   ccoutinhonetto@gmail.com; christrussmann@gmail.com; nap4@cdc.gov;
   hannon.emily.r@gmail.com; barbara_cm02macedo@hotmail.com;
   juh.ramos97@gmail.com; ramosrkaren@gmail.com; m.carolinac@outlook.com;
   larissapratta@gmail.com; anapaula.santosrosa@hotmail.com;
   isamarinodesouza@gmail.com; assisbianchini@gmail.com;
   correasandrahelena@gmail.com; renato.ordones@outlook.com;
   ananda.asv@gmail.com; lmopnogueira@gmail.com; naideazeredo@gmail.com;
   ltmfigue@fmrp.usp.br; jafalencar@gmail.com; smaria@bio.fiocruz.br;
   herrera@ucdb.br; renatadezengrini@yahoo.com.br; flaviab@ioc.fiocruz.br;
   abispo@ioc.fiocruz.br; wig9@cdc.gov; ztq9@cdc.gov; nck6@cdc.gov
RI Nantes, Wesley/AAQ-7412-2020; Oliveira-Santos, Luiz Gustavo Rodrigu G
   R/F-9562-2012; Torres, Jaire M/W-3898-2017; Sabino-Santos Jr,
   Gilberto/B-4305-2011; Herrera, Heitor/K-3759-2012; Pauvolid-Correa,
   Alex/D-3643-2017; Strussmann, Christine/D-5971-2013; Porfirio,
   Grasiela/F-3353-2019; Martins Santos, Filipe/P-2156-2014
OI Nantes, Wesley/0000-0002-3454-4714; Oliveira-Santos, Luiz Gustavo
   Rodrigu G R/0000-0001-9632-5173; Torres, Jaire M/0000-0001-6228-6161; de
   Araujo Oliveira, Alexandre/0000-0003-1289-8172; Sabino-Santos Jr,
   Gilberto/0000-0002-5462-5386; Herrera, Heitor/0000-0003-2404-8765;
   Pauvolid-Correa, Alex/0000-0002-6924-157X; Dias,
   Helver/0000-0001-5181-7078; Slhessarenko, Renata/0000-0002-3246-899X;
   Barbosa de Lima, Sheila Maria/0000-0001-9234-1678; Strussmann,
   Christine/0000-0001-9880-9489; Porfirio, Grasiela/0000-0003-0837-7489;
   Santos, Flavia/0000-0002-1309-5366; da S. Ferreira,
   Raquel/0000-0002-0969-1392; Martins Santos, Filipe/0000-0003-2032-8129
FU Office of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International Development (USAID)United States Agency for International
   Development (USAID); USAIDUnited States Agency for International
   Development (USAID); Health Surveillance and Reference Laboratories
   (CVSLR) of Fiocruz
FX This research was funded by the Office of Infectious Disease, Bureau for
   Global Health, U.S. Agency for International Development (USAID), and
   the APC was funded by USAID and the Health Surveillance and Reference
   Laboratories (CVSLR) of Fiocruz.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Beaty B, 1995, DIAGNOSTIC PROCEDURE, P189
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto SR, 2019, ECOHEALTH, V16, P61, DOI 10.1007/s10393-019-01394-7
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Forattini OP, 2002, CULICIDOLOGIA MED, P860
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Iwashita H, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0095-8
   Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09
   Karabatsos N., 1985, INT CATALOGUE ARBOVI, P1147
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lane J., 1953, NEOTROPICAL CULICIDA, V2, P1660
   LVOV DK, 2014, VOP VIRUSOL, V59, P18
   Machado NG, 2017, NATIVA, V5, P320, DOI 10.5935/2318-7670.v05n05a04
   Ferreira CMM, 2010, BIOTA NEOTROP, V10, P155, DOI 10.1590/S1676-06032010000300017
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742
   Ministry of Health (Ministerio da Saude), 2018, B EPIDEMIOLOGICO, V2
   Ministry of Health (Ministerio da Saude), 2019, B EPIDEMIOLOGICO, V4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Figueiredo LTM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00259
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pauvolid-Correa A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006014
   Pauvolid-Correa A, 2015, ARCH VIROL, V160, P21, DOI 10.1007/s00705-014-2219-8
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 41
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2019
VL 11
IS 12
AR 1164
DI 10.3390/v11121164
PG 18
WC Virology
SC Virology
GA KC0RH
UT WOS:000506894800036
PM 31888285
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pronost, S
   Fortier, C
   Marcillaud-Pitel, C
   Tapprest, J
   Foursin, M
   Saunier, B
   Pitel, PH
   Paillot, R
   Hue, ES
AF Pronost, Stephane
   Fortier, Christine
   Marcillaud-Pitel, Christel
   Tapprest, Jackie
   Foursin, Marc
   Saunier, Bertrand
   Pitel, Pierre-Hugues
   Paillot, Romain
   Hue, Erika S.
TI Further Evidence for in Utero Transmission of Equine Hepacivirus to
   Foals
SO VIRUSES-BASEL
LA English
DT Article
DE non-primate hepacivirus; equine hepacivirus; in utero transmission;
   horse; fetuses
ID HEPATITIS-C VIRUS; CROSS-SPECIES TRANSMISSION; NONPRIMATE HEPACIVIRUS;
   VERTICAL TRANSMISSION; HORSES; IDENTIFICATION; PREVALENCE; INFECTION;
   VIROME; RISK
AB (1) Background: Equine hepacivirus (EqHV), also referred to as non-primate hepacivirus (NPHV), infects horses-and dogs in some instances-and is closely related to hepatitis C virus (HCV) that has infected up to 3% of the world's human population, causing an epidemic of liver cirrhosis and cancer. EqHV also chronically infects the liver of horses, but does not appear to cause serious liver damages. Previous studies have been looking to identify route(s) of EqHV transmission to and between horses. (2) Methods: In this retrospective study, we sought to evaluate the prevalence of vertical transmission taking place in utero with measuring by quantitative RT-PCR the amounts of EqHV genome in samples from 394 dead foals or fetuses, paired with the allantochorion whenever available. (3) Results: Detection of EqHV in three foals most likely resulted from a vertical transmission from the mares to the fetuses, consistent with the in utero transmission hypothesis. In support of this observation, the presence of EqHV genome was found for the first time in two of the allantochorions. (4) Conclusions: As seemingly benign viruses could turn deadly (e.g., Zika flavivirus) and EqHV happens to have infected a significant proportion of the world's horse herds, EqHV infectious cycle should be further clarified.
C1 [Pronost, Stephane; Fortier, Christine; Pitel, Pierre-Hugues; Paillot, Romain; Hue, Erika S.] LABEO Frank Duncombe, F-14280 St Contest, France.
   [Pronost, Stephane; Fortier, Christine; Paillot, Romain; Hue, Erika S.] Normandie Univ, UNICAEN, BIOTARGEN EA7450, F-14000 Caen, France.
   [Marcillaud-Pitel, Christel] RESPE, F-14280 St Contest, France.
   [Tapprest, Jackie] French Agcy Food Environm & Occupat Hlth & Safety, Lab Anim Hlth Normandy, F-14430 Goustranville, France.
   [Foursin, Marc] Clin Equine Boisrie, F-61500 Chailloue, France.
   [Saunier, Bertrand] Inst Pasteur, Struct Virol Unit, CNRS UMR 3569, F-75015 Paris, France.
RP Pronost, S (corresponding author), LABEO Frank Duncombe, F-14280 St Contest, France.; Pronost, S (corresponding author), Normandie Univ, UNICAEN, BIOTARGEN EA7450, F-14000 Caen, France.
EM stephane.pronost@laboratoire-labeo.fr;
   christine.fortier@laboratoire-labeo.fr; c.marcillaud-pitel@respe.net;
   jackie.tapprest@anses.fr; marc.foursin@orange.fr;
   bertrand.saunier@pasteur.fr; Pierre-Hugues.PITEL@laboratoire-labeo.fr;
   Romain.PAILLOT@laboratoire-labeo.fr; erika.hue@laboratoire-labeo.fr
OI PAILLOT, Romain/0000-0003-3081-2037; Pronost,
   Stephane/0000-0002-2584-0933; HUE, Erika/0000-0001-6930-3606
FU RESPE; LABEO; CENTAURE European project - Normandy County Council;
   European UnionEuropean Union (EU)
FX This research was funded by the RESPE, LABEO and CENTAURE European
   project co-funded by Normandy County Council, European Union in the
   framework of the ERDF-ESF operational program 2014-2020.
CR ALTAN E, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/v11100942
   Badenhorst M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111014
   Badenhorst M, 2018, VET MICROBIOL, V223, P51, DOI 10.1016/j.vetmic.2018.07.015
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Benova L, 2014, CLIN INFECT DIS, V59, P765, DOI 10.1093/cid/ciu447
   Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Divers T.J., 2017, EQUINE INTERNAL MED, P843
   Figueiredo AS, 2015, VET J, V206, P414, DOI 10.1016/j.tvjl.2015.10.015
   Gather T, 2016, J GEN VIROL, V97, P2540, DOI 10.1099/jgv.0.000561
   Gemaque BS, 2014, EMERG INFECT DIS, V20, P2180, DOI 10.3201/eid2012.140603
   Gould LH, 2004, J CLIN INVEST, V113, P1102, DOI 10.1172/JCI21623
   Indolfi G, 2019, LANCET GASTROENTEROL, V4, P477, DOI 10.1016/S2468-1253(19)30046-9
   Khaiboullina SF, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01465
   Laugier C, 2011, J EQUINE VET SCI, V31, P116, DOI 10.1016/j.jevs.2010.12.012
   LeBlanc M. M., 1990, Equine clinical neonatology., P275
   Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410
   Li LL, 2015, J GEN VIROL, V96, P2721, DOI 10.1099/vir.0.000199
   Lu G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189208
   Lyons S, 2012, EMERG INFECT DIS, V18, P1976, DOI 10.3201/eid1812.120498
   Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268
   Matsuu A, 2015, VET MICROBIOL, V179, P219, DOI 10.1016/j.vetmic.2015.05.028
   Paim WP, 2019, BIOLOGICALS, V61, P1, DOI 10.1016/j.biologicals.2019.08.005
   Pfaender S, 2017, P NATL ACAD SCI USA, V114, pE2430, DOI 10.1073/pnas.1619380114
   Pfaender S, 2015, J GEN VIROL, V96, P2636, DOI 10.1099/vir.0.000208
   Pfaender S, 2015, HEPATOLOGY, V61, P447, DOI 10.1002/hep.27440
   Postel A, 2016, VET MICROBIOL, V182, P8, DOI 10.1016/j.vetmic.2015.10.032
   Pronost S, 2017, TRANSBOUND EMERG DIS, V64, P1884, DOI 10.1111/tbed.12587
   Pronost S., 2018, PRATIQUE VET EQUINE, V197, P24
   Pronost S, 2016, J EQUINE VET SCI, V39, pS22, DOI DOI 10.1016/j.jevs.2016.02.047
   Pybus OG, 2016, CURR OPIN VIROL, V16, P1, DOI 10.1016/j.coviro.2015.10.002
   Ramsay JD, 2015, HEPATOLOGY, V61, P1533, DOI 10.1002/hep.27689
   Rooney J.R., 1970, AUTOPSY HORSE TECHNI
   Scheel TKH, 2015, ANTIVIR RES, V115, P83, DOI 10.1016/j.antiviral.2014.12.014
   Scheel TKH, 2015, P NATL ACAD SCI USA, V112, P2192, DOI 10.1073/pnas.1500265112
   Steininger C, 2003, J INFECT DIS, V187, P345, DOI 10.1086/367704
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tanaka T, 2014, J VIROL, V88, P13352, DOI 10.1128/JVI.02280-14
   Tovo PA, 2016, WORLD J GASTROENTERO, V22, P1382, DOI 10.3748/wjg.v22.i4.1382
NR 41
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2019
VL 11
IS 12
AR 1124
DI 10.3390/v11121124
PG 12
WC Virology
SC Virology
GA KC0RH
UT WOS:000506894800030
PM 31817371
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rieder, CA
   Rieder, J
   Sannajust, S
   Goode, D
   Geguchadze, R
   Relich, RE
   Molliver, DC
   King, TE
   Vaughn, J
   May, M
AF Rieder, Courtney A.
   Rieder, Jonathan
   Sannajust, Sebastian
   Goode, Diana
   Geguchadze, Ramaz
   Relich, Ryan E.
   Molliver, Derek C.
   King, Tamara E.
   Vaughn, James
   May, Meghan
TI A Novel Mechanism for Zika Virus Host-Cell Binding
SO VIRUSES-BASEL
LA English
DT Article
DE Zika Virus; Neurotropism; Flavivirus; Microcephaly; ASN154;
   N-acetylglucosamine; Encephalitis; binding motif
ID ENDOTHELIAL-CELLS; DENGUE VIRUS; INFECTION; PROTEIN; AXL; DAMAGE; LEADS
AB Zika virus (ZIKV) recently emerged in the Western Hemisphere with previously unrecognized or unreported clinical presentations. Here, we identify two putative binding mechanisms of ancestral and emergent ZIKV strains featuring the envelope (E) protein residue asparagine 154 (ASN154) and viral phosphatidylserine (PS). Synthetic peptides representing the region containing ASN154 from strains PRVABC59 (Puerto Rico 2015) and MR_766 (Uganda 1947) were exposed to neuronal cells and fibroblasts to model ZIKV E protein/cell interactions and bound MDCK or Vero cells and primary neurons significantly. Peptides significantly inhibited Vero cell infectivity by ZIKV strains MR_766 and PRVABC59, indicating that this region represents a putative binding mechanism of ancestral African ZIKV strains and emergent Western Hemisphere strains. Pretreatment of ZIKV strains MR_766 and PRVABC59 with the PS-binding protein annexin V significantly inhibited replication of PRVABC59 but not MR_766, suggesting that Western hemisphere strains may additionally be capable of utilizing PS-mediated entry to infect host cells. These data indicate that the region surrounding E protein ASN154 is capable of binding fibroblasts and primary neuronal cells and that PS-mediated entry may be a secondary mechanism for infectivity utilized by Western Hemisphere strains.
C1 [Rieder, Courtney A.; Rieder, Jonathan; Sannajust, Sebastian; Goode, Diana; Geguchadze, Ramaz; Molliver, Derek C.; King, Tamara E.; Vaughn, James; May, Meghan] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.
   [Sannajust, Sebastian; Goode, Diana; Geguchadze, Ramaz; Molliver, Derek C.; King, Tamara E.; May, Meghan] Univ New England, Ctr Excellence Neurosci, Biddeford, ME 04005 USA.
   [Relich, Ryan E.] Indiana Univ, Dept Pathol & Lab Med, Sch Med, Indianapolis, IN 46202 USA.
RP May, M (corresponding author), Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.; May, M (corresponding author), Univ New England, Ctr Excellence Neurosci, Biddeford, ME 04005 USA.
EM calexispearson@gmail.com; jrieder@une.edu; ssannajust@une.edu;
   dgoode@une.edu; rgeguchadze@une.edu; rrelich@iupui.edu;
   dmolliver@une.edu; tking6@une.edu; jvaughn@une.edu; mmay3@une.edu
FU University of New England Center of Excellence for Neuroscience; Office
   of the Vice President for Research and Scholarship
FX This work was supported by intramural awards from the University of New
   England Center of Excellence for Neuroscience (C.E.N.) and the Office of
   the Vice President for Research and Scholarship.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Broucker T, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0590-9
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dub T, 2017, REV NEUROL-FRANCE, V173, P361, DOI 10.1016/j.neurol.2017.03.033
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Faustino AE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163870
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461
   May M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161355
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mehrjardi Mohammad Zare, 2017, Virology (Auckl), V8, p1178122X17708993, DOI [10.1177/1178122x17708993, 10.1177/1178122X17708993]
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONATH TP, 1980, AM J TROP MED HYG, V29, P948, DOI 10.4269/ajtmh.1980.29.948
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Roth W, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000349
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
   Uversky VN, 2019, PROG MOL BIOL TRANSL, V166, P1, DOI 10.1016/bs.pmbts.2019.05.003
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wang JF, 2017, J VIROL, V91, DOI 10.1128/JVI.01931-16
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 66
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2019
VL 11
IS 12
AR 1101
DI 10.3390/v11121101
PG 13
WC Virology
SC Virology
GA KC0RH
UT WOS:000506894800076
PM 31795144
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, MJA
   Chan, KWK
   Ng, IHW
   Zu Kong, SY
   Gwee, CP
   Watanabe, S
   Vasudevan, SG
AF Tan, Min Jie Alvin
   Chan, Kitti Wing Ki
   Ng, Ivan H. W.
   Zu Kong, Sean Yao
   Gwee, Chin Piaw
   Watanabe, Satoru
   Vasudevan, Subhash G.
TI The Potential Role of the ZIKV NS5 Nuclear Spherical-Shell Structures in
   Cell Type-Specific Host Immune Modulation during ZIKV Infection
SO CELLS
LA English
DT Review
DE flavivirus; Zika virus; NS5 protein; nuclear localization; inflammation;
   innate immunity
ID VIRUS NONSTRUCTURAL PROTEIN; WEST-NILE-VIRUS; ENHANCES RECOGNITION; RNA
   REPLICATION; CYTOKINE STORM; VIRAL HELICASE; LOCALIZATION; INHIBITION;
   IMPORTIN; POLYMERASE
AB The Zika virus (ZIKV) non-structural protein 5 (NS5) plays multiple viral and cellular roles during infection, with its primary role in virus RNA replication taking place in the cytoplasm. However, immunofluorescence assay studies have detected the presence of ZIKV NS5 in unique spherical shell-like structures in the nuclei of infected cells, suggesting potentially important cellular roles of ZIKV NS5 in the nucleus. Hence ZIKV NS5 ' s subcellular distribution and localization must be tightly regulated during ZIKV infection. Both ZIKV NS5 expression or ZIKV infection antagonizes type I interferon signaling, and induces a pro-inflammatory transcriptional response in a cell type-specific manner, but the mechanisms involved and the role of nuclear ZIKV NS5 in these cellular functions has not been elucidated. Intriguingly, these cells originate from the brain and placenta, which are also organs that exhibit a pro-inflammatory signature and are known sites of pathogenesis during ZIKV infection in animal models and humans. Here, we discuss the regulation of the subcellular localization of the ZIKV NS5 protein, and its putative role in the induction of an inflammatory response and the occurrence of pathology in specific organs during ZIKV infection.
C1 [Tan, Min Jie Alvin; Chan, Kitti Wing Ki; Ng, Ivan H. W.; Zu Kong, Sean Yao; Gwee, Chin Piaw; Watanabe, Satoru; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore.
   [Vasudevan, Subhash G.] Natl Univ Singapore, Dept Microbiol & Immunol, 5 Sci Dr 2, Singapore 117545, Singapore.
   [Vasudevan, Subhash G.] Griffith Univ, Inst Glyc, Gold Coast Campus, Gold Coast, Qld 4022, Australia.
RP Vasudevan, SG (corresponding author), Duke NUS Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore.; Vasudevan, SG (corresponding author), Natl Univ Singapore, Dept Microbiol & Immunol, 5 Sci Dr 2, Singapore 117545, Singapore.; Vasudevan, SG (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Gold Coast, Qld 4022, Australia.
EM alvin.tan@duke-nus.edu.tabsg; kitti.chan@duke-nus.edu.sg;
   hwing10@gmail.com; sean_kong@duke-nus.edu.sg;
   chinpiaw.gwee@duke-nus.edu.sg; satoru.watanabe@duke-nus.edu.sg;
   subhash.vasudevan@duke-nus.edu.sg
FU National Medical Research CouncilMedical Research Council UK (MRC)
   [NMRC/OFYIRG/0006/2016, NMRC/OFYIRG/0003/2016, NMRC/CBRG/0103/2016];
   National Research Foundation [NRF2016NRF-CRP001-063]; Ministry of
   HealthMinistry of Health - Turkey [MOH-000086
   (MOH-OFIRG18may-0006/2019)]
FX Our research is funded by National Medical Research Council grants
   NMRC/OFYIRG/0006/2016 to M.J.A.T., NMRC/OFYIRG/0003/2016 to S.W. and
   NMRC/CBRG/0103/2016 to S.G.V., a National Research Foundation grant
   NRF2016NRF-CRP001-063 as co-PI to S.G.V., and a Ministry of Health grant
   MOH-000086 (MOH-OFIRG18may-0006/2019) to S.G.V.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alvisi G, 2005, TRAFFIC, V6, P1002, DOI 10.1111/j.1600-0854.2005.00331.x
   Alvisi G, 2011, VIROLOGY, V417, P259, DOI 10.1016/j.virol.2011.06.015
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bauer NC, 2015, TRAFFIC, V16, P1039, DOI 10.1111/tra.12310
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bridges RJ, 2018, HANDB EXP PHARMACOL, V245, P385, DOI 10.1007/164_2018_103
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125
   Caine EA, 2019, J INFECT DIS, V220, P1904, DOI 10.1093/infdis/jiz239
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Crosse KM, 2018, J INNATE IMMUN, V10, P85, DOI 10.1159/000484258
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   EDWARD Z, 1993, MICROBIOL IMMUNOL, V37, P239, DOI 10.1111/j.1348-0421.1993.tb03206.x
   Eifler K, 2015, FEBS J, V282, P3669, DOI 10.1111/febs.13378
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Forrester JV, 2018, NAT REV NEUROSCI, V19, P655, DOI 10.1038/s41583-018-0070-8
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guardia CM, 2018, CURR OPIN NEUROBIOL, V51, P103, DOI 10.1016/j.conb.2018.02.021
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jans DA, 2018, ADV EXP MED BIOL, V1062, P199, DOI 10.1007/978-981-10-8727-1_15
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lima MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01928
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lopez-Denman AJ, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12848
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Maarifi G, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0198-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32
   Ng IHW, 2019, ACS INFECT DIS, V5, P932, DOI 10.1021/acsinfecdis.8b00373
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Ringel Marc, 2020, J Infect Dis, V221, pS389, DOI 10.1093/infdis/jiz440
   Schwartz D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001099
   Simonin Y, 2019, EBIOMEDICINE, V39, P315, DOI 10.1016/j.ebiom.2018.12.010
   Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1
   Su CI, 2016, J VIROL, V90, P4308, DOI 10.1128/JVI.00223-16
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Teijaro JR, 2014, P NATL ACAD SCI USA, V111, P3799, DOI 10.1073/pnas.1400593111
   Thurmond S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120712
   Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004
   Uchida L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07395
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xiao CY, 1998, FEBS LETT, V440, P297, DOI 10.1016/S0014-5793(98)01478-1
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zhao YQ, 2014, VIRUS RES, V179, P225, DOI 10.1016/j.virusres.2013.11.010
   Zhu Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020392
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 99
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD DEC
PY 2019
VL 8
IS 12
AR 1519
DI 10.3390/cells8121519
PG 15
WC Cell Biology
SC Cell Biology
GA KB7AN
UT WOS:000506643500047
PM 31779251
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Austin, AL
   Galasso, B
   Nickens, C
   Knollmann-Ritschel, B
   Sharma, A
AF Austin, Amy L.
   Galasso, Bianca
   Nickens, Caitlin
   Knollmann-Ritschel, Barbara
   Sharma, Anuj
TI Inactivation of Zika Virus by Photoactive Iodonaphthyl Azide Preserves
   Immunogenic Potential of the Virus
SO PATHOGENS
LA English
DT Article
DE Zika virus; vaccine; inactivation; iodonaphthyl azide; immunization
ID OUTBREAK
AB Zika virus's (ZIKV) emergence as a pathogen of significant public health importance has accelerated efforts to develop a ZIKV vaccine. To date, the need for an effective ZIKV vaccine is unmet. In this study, we report inactivation of ZIKV using a hydrophobic photoactive compound: 1, 5 iodonaphthyl azide (INA). 50 and 100 mu M of INA completely inactivated ZIKV (INA-ZIKV). Western blot and ELISA analysis show some loss of the binding capacity of INA-iZIKV to anti-ZIKV monoclonal antibodies; however, immunization of mice with INA-iZIKV demonstrated seroconversion and ZIKV-neutralizing antibody response. RNA isolated from INA-iZIKV did not induce productive infection in Vero cells, suggesting inactivation of ZIKV RNA. These results suggest that in the absence of an approved ZIKV vaccine, INA-iZIKV can be pursued as a viable ZIKV vaccine candidate.
C1 [Austin, Amy L.; Galasso, Bianca; Nickens, Caitlin; Knollmann-Ritschel, Barbara; Sharma, Anuj] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20853 USA.
RP Sharma, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20853 USA.
EM amy.l.austin20.mil@mail.mil; bianca.galasso.ctr@usuhs.edu;
   caitlin.m.nickens.mil@mail.mil; barbara.knollmann-ritschel@usuhs.edu;
   anuj.sharma.ctr@usuhs.edu
OI Sharma, Anuj/0000-0001-6906-190X
FU Uniformed Services University of the Health Sciences; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
FX The study was funded in part by grants from Uniformed Services
   University of the Health Sciences and National Institutes of Health.
   Opinions expressed herewith are those of the author(s) and are not
   necessarily representative of those of the USUHS, DoD, or the United
   States Army, Navy, or Air Force.
CR Anderson T, 2019, B WORLD HEALTH ORGAN, V97, P6, DOI 10.2471/BLT.19.020119
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   BERCOVICI T, 1978, BIOCHEMISTRY-US, V17, P1484, DOI 10.1021/bi00601a020
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Gupta P, 2016, VACCINE, V34, P2762, DOI 10.1016/j.vaccine.2016.04.049
   Gupta Paridhi, 2015, BMC Res Notes, V8, P44, DOI 10.1186/s13104-015-1006-2
   Honnold SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104708
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li J, 2003, P NATL ACAD SCI USA, V100, P886, DOI 10.1073/pnas.0237311100
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Medina LO, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02464
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Nurnberger C, 2019, J VIROL, V93, DOI 10.1128/JVI.01485-18
   Raviprakash K, 2013, HUM VACC IMMUNOTHER, V9, P2336, DOI 10.4161/hv.25602
   RAVIV Y, 1984, BIOCHEMISTRY-US, V23, P503, DOI 10.1021/bi00298a016
   Raviv Y, 2005, J VIROL, V79, P12394, DOI 10.1128/JVI.79.19.12394-12400.2005
   RAVIV Y, 1989, BIOCHEMISTRY-US, V28, P1313, DOI 10.1021/bi00429a055
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Sharma Anuj, 2018, F1000Res, V7, P9, DOI 10.12688/f1000research.13242.1
   Sharma A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-301
   Sharma A, 2011, VACCINE, V29, P953, DOI 10.1016/j.vaccine.2010.11.033
   Siedner MJ, 2018, LANCET PUBLIC HEALTH, V3, pE109, DOI 10.1016/S2468-2667(18)30029-X
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 27
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD DEC
PY 2019
VL 8
IS 4
AR 188
DI 10.3390/pathogens8040188
PG 10
WC Microbiology
SC Microbiology
GA KB7DX
UT WOS:000506652300031
PM 31614887
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Elshahawi, H
   Hassan, SS
   Balasubramaniam, V
AF Elshahawi, Hesham
   Syed Hassan, Sharifah
   Balasubramaniam, Vinod
TI Importance of Zika Virus NS5 Protein for Viral Replication
SO PATHOGENS
LA English
DT Review
DE Zika; NS5; Flavivirus; Arbovirus; TBK1; STAT2; IFN1; IFN3; RdRp; MTase
ID I INTERFERON-PRODUCTION; RNA-SYNTHESIS; NUCLEOSIDE INHIBITORS; ADAPTER
   PROTEIN; III INTERFERON; INFECTION; METHYLTRANSFERASE; EPIDEMIOLOGY;
   POLYMERASE; OUTBREAK
AB Zika virus is the latest addition to an ever-growing list of arboviruses that are causing outbreaks with serious consequences. A few mild cases were recorded between 1960 and 1980 until the first major outbreak in 2007 on Yap Island. This was followed by more severe outbreaks in French Polynesia (2013) and Brazil (2015), which significantly increased both Guillain-Barre syndrome and microcephaly cases. No current vaccines or treatments are available, however, recent studies have taken interest in the NS5 protein which encodes both the viral methyltransferase and RNA-dependent RNA polymerase. This makes it important for viral replication alongside other important functions such as inhibiting the innate immune system thus ensuring virus survival and replication. Structural studies can help design inhibitors, while biochemical studies can help understand the various mechanisms utilized by NS5 thus counteracting them might inhibit or abolish the viral infection. Drug repurposing targeting the NS5 protein has also proven to be an effective tool since hundreds of thousands of compounds can be screened therefore saving time and resources, moreover information on these compounds might already be available especially if they are used to treat other ailments.
C1 [Elshahawi, Hesham; Syed Hassan, Sharifah; Balasubramaniam, Vinod] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Jalan Lagoon Selatan, Subang Jaya 47500, Selangor, Malaysia.
   [Syed Hassan, Sharifah] Monash Univ Malaysia, Trop Med & Biol Multidisciplinary Platform, Jalan Lagoon Selatan, Subang Jaya 47500, Selangor, Malaysia.
RP Balasubramaniam, V (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Jalan Lagoon Selatan, Subang Jaya 47500, Selangor, Malaysia.
EM elshahawi.hesham@gmail.com; Sharifah.SyedHassan@monash.edu;
   vinod.balasubramaniam@monash.edu
RI ; RMT Balasubramaniam, Vinod/B-6957-2017
OI Hassan, sharifah/0000-0001-6347-4455; RMT Balasubramaniam,
   Vinod/0000-0001-9583-307X; Elshahawi, Hesham/0000-0002-8663-4287
FU Tropical Medicine & Biology Multidisciplinary Platform, Monash
   University Malaysia; Fundamental Research Grant Scheme (FRGS) from
   Ministry of Higher Education Malaysia [FRGS/1/2018/SKK11/MUSM/02/1]
FX This research was funded by seed grant from Tropical Medicine & Biology
   Multidisciplinary Platform, Monash University Malaysia and Fundamental
   Research Grant Scheme (FRGS) from Ministry of Higher Education Malaysia
   (FRGS/1/2018/SKK11/MUSM/02/1).
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   [Anonymous], HEP B C TREATM
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   CDC, FLAV
   CDC, STAT MAPS ZIK VIR
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Danthi P, 2016, ANNU REV VIROL, V3, P533, DOI 10.1146/annurev-virology-110615-042435
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Karkhah A, 2018, EUR J CLIN MICROBIOL, V37, P2035, DOI 10.1007/s10096-018-3354-z
   Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243
   KING DH, 1988, J AM ACAD DERMATOL, V18, P176, DOI 10.1016/S0190-9622(88)70022-5
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kovanich D, 2019, J PROTEOME RES, V18, P3203, DOI 10.1021/acs.jproteome.9b00318
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001
   Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lim SY, 2017, OPEN FORUM INFECT DI, DOI [DOI 10.1093/ofid/ofx162.129, 10.1093/ofid/ofx162.129]
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Lin Y, 2019, INT J ANTIMICROB AG, V54, P502, DOI 10.1016/j.ijantimicag.2019.07.010
   MacDonald PDM, 2018, PEDIATRICS, V141, pS137, DOI 10.1542/peds.2017-2038B
   Matthys V, 2012, ADV VIROL, V2012, DOI 10.1155/2012/524024
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Michalska A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01135
   Miorin L, 2019, J VIROL, V93, DOI 10.1128/JVI.00151-19
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Figueiredo LTM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00259
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Plazolles N, 2011, J LEUKOCYTE BIOL, V89, P329, DOI 10.1189/jlb.0710386
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Rusanov T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35511-3
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Sebera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29459-7
   Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Tham HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01040
   Tham HW, 2015, J INFECT DEV COUNTR, V9, P1338, DOI 10.3855/jidc.6422
   Tham HW, 2014, VIRUSES-BASEL, V6, P5028, DOI 10.3390/v6125028
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Westover JB, 2018, ANTIVIR RES, V156, P38, DOI 10.1016/j.antiviral.2018.05.013
   WHO, ZIK VIR
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization (WHO), ZIK SIT REP
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014
   Xu S, 2019, NUCLEIC ACIDS RES, V47, P8693, DOI 10.1093/nar/gkz650
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 79
TC 3
Z9 3
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD DEC
PY 2019
VL 8
IS 4
AR 169
DI 10.3390/pathogens8040169
PG 12
WC Microbiology
SC Microbiology
GA KB7DX
UT WOS:000506652300012
PM 31574966
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lopez-Camacho, C
   Kim, YC
   Abbink, P
   Larocca, RA
   Huiskonen, JT
   Barouch, DH
   Reyes-Sandoval, A
AF Lopez-Camacho, Cesar
   Kim, Young Chan
   Abbink, Peter
   Larocca, Rafael A.
   Huiskonen, Juha T.
   Barouch, Dan H.
   Reyes-Sandoval, Arturo
TI Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using
   Modified Vaccinia Ankara Virus as Carriers
SO PATHOGENS
LA English
DT Article
DE Zika virus; MVA; envelope proteins; vaccines; immunogenicity; efficacy;
   mice
ID CLINICAL-TRIAL; MVA
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has spread to more than 70 countries worldwide since 2015. Despite active research, there are currently no licensed vaccines or therapeutics. We have previously reported the development of various adenoviral vectored vaccine candidates (ChAdOx1 ZIKV) with the ability to stimulate effective immunity in mice and provide protection upon a ZIKV challenge model, using a non-adjuvanted single vaccination approach. In this study, we constructed various modified vaccinia Ankara (MVA) viruses to express the ZIKV Envelope (E) with modifications on the precursor membrane (prM) or on the C-terminus envelope transmembrane domain (TM), similar to our ChAdOx1 vaccine candidates. MVA-ZIKV vaccine candidates were evaluated as a non-adjuvanted single vaccination regimen against a ZIKV Brazilian isolate, using viraemia as the correlate of protection. Here, we report the induction of a modest level of anti-ZIKV E antibodies by all MVA vectored vaccines and sub-optimal efficacy in a ZIKV challenge model. Our results indicate the requirement of additional strategies when using MVA-ZIKV vaccines to afford sterile protection upon a non-adjuvanted and single vaccination regime.
C1 [Lopez-Camacho, Cesar; Kim, Young Chan; Reyes-Sandoval, Arturo] Univ Oxford, Jenner Inst, Nuffield Dept Med, Henry Wellcome Bldg Mol Physiol, Roosevelt Dr, Oxford OX3 7BN, England.
   [Kim, Young Chan; Huiskonen, Juha T.] Univ Oxford, Div Struct Biol, Wellcome Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.
   [Abbink, Peter; Larocca, Rafael A.; Barouch, Dan H.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
RP Reyes-Sandoval, A (corresponding author), Univ Oxford, Jenner Inst, Nuffield Dept Med, Henry Wellcome Bldg Mol Physiol, Roosevelt Dr, Oxford OX3 7BN, England.
EM cesar.lopez-camacho@ndm.ox.ac.uk; young.kim@some.ox.ac.uk;
   pabbink@bidmc.harvard.edu; larocca.rafael@gmail.com;
   juha@strubi.ox.ac.uk; dbarouch@bidmc.harvard.edu;
   arturo.reyes@ndm.ox.ac.uk
OI Kim, Young Chan/0000-0003-2847-9407; Huiskonen, Juha/0000-0002-0348-7323
FU UK Department of Health through Innovate UK "New vaccines for global
   epidemics: development and manufacture" [972216]; ODA budget (Global
   Health (ODA)) [16/107/05]
FX A.R.-S. is a Jenner Investigator and Oxford Martin Fellow. This work was
   supported by the UK Department of Health through Innovate UK "New
   vaccines for global epidemics: development and manufacture" grant No.
   972216 (A.R.-S.), and also funded from an ODA budget (Global Health
   (ODA), 16/107/05 (Design, development and GMP manufacture of a Zika
   vaccine).
CR Alharbi NK, 2017, VACCINE, V35, P3780, DOI 10.1016/j.vaccine.2017.05.032
   Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gallego-Gomez JC, 2003, J VIROL, V77, P10606, DOI 10.1128/JVI.77.19.10606-10622.2003
   Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098
   Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006
   Kim YC, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1104-6
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Lopez-Gil E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002309
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Perez P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35724-6
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09
   WHO, WHO TARG PROD PROF T
   World Health Organization (WHO), ZIK SIT REP
NR 26
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD DEC
PY 2019
VL 8
IS 4
AR 216
DI 10.3390/pathogens8040216
PG 11
WC Microbiology
SC Microbiology
GA KB7DX
UT WOS:000506652300059
PM 31684117
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Basak, SC
   Majumdar, S
   Nandy, A
   Roy, P
   Dutta, T
   Vracko, M
   Bhattacharjee, AK
AF Basak, Subhash C.
   Majumdar, Subhabrata
   Nandy, Ashesh
   Roy, Proyasha
   Dutta, Tathagata
   Vracko, Marjan
   Bhattacharjee, Apurba K.
TI Computer-Assisted and Data Driven Approaches for Surveillance, Drug
   Discovery, and Vaccine Design for the Zika Virus
SO PHARMACEUTICALS
LA English
DT Review
DE viral epidemics; Zika virus (ZIKV); SIR models; 2D graphical method;
   peptide vaccine design; mahalanobis distance; principal component
   analysis (PCA); neighborhood matrix; computer-assisted anti-Zika drug
   discovery
ID SMALL-MOLECULE INHIBITORS; DENGUE VIRUS; MATHEMATICAL DESCRIPTORS;
   NUCLEOSIDE INHIBITORS; SEQUENCE-ANALYSIS; PEPTIDE VACCINES; FIELD
   ANALYSIS; NS3 HELICASE; NS4B PROTEIN; IN-VITRO
AB Human life has been at the edge of catastrophe for millennia due diseases which emerge and reemerge at random. The recent outbreak of the Zika virus (ZIKV) is one such menace that shook the global public health community abruptly. Modern technologies, including computational tools as well as experimental approaches, need to be harnessed fast and effectively in a coordinated manner in order to properly address such challenges. In this paper, based on our earlier research, we have proposed a four-pronged approach to tackle the emerging pathogens like ZIKV: (a) Epidemiological modelling of spread mechanisms of ZIKV; (b) assessment of the public health risk of newly emerging strains of the pathogens by comparing them with existing strains/pathogens using fast computational sequence comparison methods; (c) implementation of vaccine design methods in order to produce a set of probable peptide vaccine candidates for quick synthesis/production and testing in the laboratory; and (d) designing of novel therapeutic molecules and their laboratory testing as well as validation of new drugs or repurposing of drugs for use against ZIKV. For each of these stages, we provide an extensive review of the technical challenges and current state-of-the-art. Further, we outline the future areas of research and discuss how they can work together to proactively combat ZIKV or future emerging pathogens.
C1 [Basak, Subhash C.] Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55812 USA.
   [Majumdar, Subhabrata] Univ Florida, Informat Inst, Gainesville, FL 32601 USA.
   [Nandy, Ashesh; Roy, Proyasha; Dutta, Tathagata] Ctr Interdisciplinary Res & Educ, Kolkata 700068, India.
   [Vracko, Marjan] Natl Inst Chem, Hajdrihova 19, Ljubljana 1000, Slovenia.
   [Bhattacharjee, Apurba K.] Georgetown Univ, Dept Microbiol & Immunol, Sch Med, Biomed Grad Res Org, Washington, DC 20057 USA.
RP Basak, SC (corresponding author), Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55812 USA.
EM sbasak@d.umn.edu; subho@research.att.com; anandy43@yahoo.com;
   proyasha.roy@gmail.com; tathagata.dk@gmail.com; marjan.vracko@ki.si;
   ab3094@georgetown.edu
RI Majumdar, Subhabrata/AAS-4590-2020
OI Majumdar, Subhabrata/0000-0003-3529-7820; Nandy,
   Ashesh/0000-0002-1649-7731
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Adolf-Bryfogle J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006112
   Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1
   Badawi MM, 2016, AM J BIOMED RES, V4, P46
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Basak S.C., 2019, ZIKA VIRUS SURVEILLA
   BASAK SC, 1988, DISCRETE APPL MATH, V19, P17, DOI 10.1016/0166-218X(88)90004-2
   Basak SC, 2013, CURR COMPUT-AID DRUG, V9, P449, DOI 10.2174/15734099113096660041
   Basak SC, 2011, J MATH CHEM, V49, P185, DOI 10.1007/s10910-010-9734-y
   Basak SC, 2010, ACTA CHIM SLOV, V57, P541
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bhattacharjee A. K., 2018, COMPUTATIONAL DESIGN, P139
   Bhattacharjee A.K., 2019, ZIKA VIRUS SURVEILLA, P39
   Bhattacharjee AK, 2004, J MED CHEM, V47, P5418, DOI 10.1021/jm040108f
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bruzzoni-Giovanelli H, 2018, DRUG DISCOV TODAY, V23, P272, DOI 10.1016/j.drudis.2017.10.016
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   CATE TR, 1977, J INFECT DIS, V136, pS450, DOI 10.1093/infdis/136.Supplement_3.S450
   CDC, ZIK VIR TRANSM METH
   Celis E, 2002, J CLIN INVEST, V110, P1765, DOI 10.1172/JCI200217405
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Choudhury AR, 2013, SCI WORLD J, DOI 10.1155/2013/607830
   Chowdhury R, 2018, ANTIBODIES, V7, DOI 10.3390/antib7030023
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Connelly CM, 2016, CELL CHEM BIOL, V23, P1077, DOI 10.1016/j.chembiol.2016.05.021
   Oliveira AFCD, 2017, MOLECULES, V22, DOI 10.3390/molecules22030505
   CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Devillers J, 2018, SAR QSAR ENVIRON RES, V29, P103, DOI 10.1080/1062936X.2017.1411642
   Dey S., 2017, ECON MICROBIOL, V8, P29
   Dey S, 2017, COMPUT BIOL CHEM, V68, P143, DOI 10.1016/j.compbiolchem.2017.03.002
   Dey S, 2016, CANCER INFORM, V15, P1, DOI 10.4137/CIN.S39071
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Drgan V, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0218-y
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Franco LD, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0395-z
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Ghosh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040749
   Giulietti M, 2018, VIRUS RES, V255, P133, DOI 10.1016/j.virusres.2018.07.010
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Han BA, 2019, EPIDEMICS-NETH, V27, P59, DOI 10.1016/j.epidem.2019.01.005
   Han YS, 2018, EXPERT OPIN INV DRUG, V27, P951, DOI 10.1080/13543784.2018.1548609
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Heesterbeek JAP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0307
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hermann T, 2016, WIRES RNA, V7, P726, DOI 10.1002/wrna.1373
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   JOHNSON M, 1988, MATH COMPUT MODEL, V11, P630, DOI 10.1016/0895-7177(88)90569-9
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kanno Tomoko, 2002, Physiological Chemistry and Physics and Medical NMR, V34, P1
   Kazmirchuk T, 2017, COMPUT BIOL CHEM, V71, P180, DOI 10.1016/j.compbiolchem.2017.10.011
   KIER LB, 1967, MOL PHARMACOL, V3, P487
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kularatne SAM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4661
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Liang D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176710
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Liu F, 2006, J CLIN INVEST, V116, P465, DOI 10.1172/JCI25608
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Luca Simona, 2013, Maedica (Buchar), V8, P53
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   MAASSAB HF, 1985, VACCINE, V3, P355, DOI 10.1016/0264-410X(85)90124-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahalanobis P. C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302
   Majumdar S., 2019, ZIKA VIRUS SURVEILLA, P129
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0
   Mayo Clinic, ZIK VIR SYMPT CAUS
   McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meng XY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01663
   Micewicz ED, 2018, BIOORG MED CHEM LETT, V28, P452, DOI 10.1016/j.bmcl.2017.12.019
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohr EL, 2015, ANTIVIR RES, V120, P40, DOI 10.1016/j.antiviral.2015.05.003
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Nandy A, 2017, EXPLOR RES HYPOTHESI, V2, P43
   Nandy A, 2006, ARKIVOC, P211, DOI 10.3998/ark.5550190.0007.907
   Nandy A, 2016, CURR COMPUT-AID DRUG, V12, P87, DOI 10.2174/1573409912666160401115812
   Nandy Ashesh, 2009, In Silico Biology, V9, P77, DOI 10.3233/ISB-2009-0389
   Ncube NB, 2018, APPL BIOCHEM BIOTECH, V185, P799, DOI 10.1007/s12010-017-2690-2
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030
   Oguntade S, 2017, FUTURE VIROL, V12, P261, DOI 10.2217/fvl-2017-0014
   Okafor I.I., 2016, DIVERSITY EQUALITY H, V13, P394, DOI 10.21767/2049-5471.100083
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Padmanabhan P., 2017, LETT BIOMATHEMATICS, V4, P148, DOI DOI 10.1080/23737867.2017.1319746
   Pan T, 2018, J VIROL, V92, DOI [10.1128/JVI.01018-18, 10.1128/jvi.01018-18]
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Podlogar B L, 2001, Curr Opin Drug Discov Devel, V4, P102
   Pringle H., EUROPEANS BROUGHT SI
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Randic M, 2009, INT J QUANTUM CHEM, V109, P2982, DOI 10.1002/qua.22175
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01417
   Raychaudhury C, 1999, J CHEM INF COMP SCI, V39, P243, DOI 10.1021/ci980077v
   Ren J, 2018, ANNU REV BIOMED DA S, V1, P93, DOI 10.1146/annurev-biodatasci-080917-013431
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rooney BV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00016
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Sarukhanyan E, 2018, ACS OMEGA, V3, P5281, DOI 10.1021/acsomega.8b00223
   Seley-Radtke KL, 2018, ANTIVIR RES, V154, P66, DOI 10.1016/j.antiviral.2018.04.004
   Sen D, 2016, CURR COMPUT-AID DRUG, V12, P216, DOI 10.2174/1573409912666160525111918
   Shawan M. M. A. K., 2014, INDIAN J PHARM BIOL, V2, P44
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Sinclair RM, 2017, J VIROL, V91, DOI 10.1128/JVI.02275-16
   Singh A, 2017, COMPUT BIOL CHEM, V71, P144, DOI 10.1016/j.compbiolchem.2017.10.007
   Sinigaglia A, 2018, EXPERT OPIN DRUG DIS, V13, P825, DOI 10.1080/17460441.2018.1515909
   Sperandio S, 2015, P NATL ACAD SCI USA, V112, pE3392, DOI 10.1073/pnas.1500857112
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stevens AJ, 2009, J MED CHEM, V52, P7911, DOI 10.1021/jm900652e
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
   Suparit P, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0083-z
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   van Hemert F, 2018, COMPUT MATH METHOD M, DOI 10.1155/2018/6490647
   Verity Murphy V., PANDEMICS RAVAGED EU
   Vracko M., 2019, CURR COMPUT AIDED DR
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wang ZZ, 2010, INT J MOL SCI, V11, P3434, DOI 10.3390/ijms11093434
   Warfield KL, 2017, ANTIVIR RES, V138, P22, DOI 10.1016/j.antiviral.2016.11.019
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2017, WHO SITUATION REPORT
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wiratsudakul A, 2018, PEERJ, V6, DOI 10.7717/peerj.4526
   Wiwanitkit V, 2009, INT J GEN MED, V2, P195
   Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007
   World Health Organization (WHO), REP ZIK VIR
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Xie YC, 2016, CURR DRUG TARGETS, V17, P1560, DOI 10.2174/1389450117666151209123751
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang HT, 2017, BRIEF BIOINFORM, V18, P488, DOI 10.1093/bib/bbw030
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu SY, 2019, MOLECULES, V24, DOI 10.3390/molecules24081465
   Zielezinski A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1319-7
NR 168
TC 0
Z9 0
U1 8
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD DEC
PY 2019
VL 12
IS 4
AR 157
DI 10.3390/ph12040157
PG 36
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KA4AQ
UT WOS:000505739800003
PM 31623241
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Vries, LS
AF de Vries, Linda S.
TI Viral Infections and the Neonatal Brain
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; POLYMERASE-CHAIN-REACTION;
   PARVOVIRUS B19 INFECTION; WHITE-MATTER INJURY; HUMAN PARECHOVIRUS; ZIKA
   VIRUS; CEREBROSPINAL-FLUID; ENTEROVIRUS; INFANTS; DIAGNOSIS
AB This review includes the congenital infections best known by the acronym TORCH (Toxoplasma gondii, rubella virus, cytomegalovirus, and herpes virus), as well as Zika virus infection and perinatally acquired infections (enterovirus, parechovirus, rotavirus, parvovirus). Congenital infections are due to pathogens that can cross the placenta and are more likely to injure the brain when the infection occurs early in pregnancy. There are many similarities, with regards to brain lesions, for congenital Zika syndrome and congenital cytomegalovirus infection. Perinatally acquired viral infections tend to injure the white matter, with cystic evolution being more likely in the (late) preterm infant compared to the full-term infant. Congenital and perinatally acquired viral infections can be associated with adverse neurological outcomes. Prevention is important, especially as therapeutic options are limited. In this review both congenital as well as perinatally acquired viral infections will be discussed with a focus on neuro-imaging findings. (C) 2019 Elsevier Inc. All rights reserved.
C1 [de Vries, Linda S.] Univ Utrecht, Univ Med Ctr, Dept Neonatol, Utrecht, Netherlands.
RP de Vries, LS (corresponding author), Dept Neonatol, KE 04-123-1,Lundlaan 6, NL-3584 EA Utrecht, Netherlands.
EM l.s.devries@umcutrecht.nl
CR Abed Y, 2006, EMERG INFECT DIS, V12, P969, DOI 10.3201/eid1206.051675
   Abzug MJ, 2016, J PEDIAT INF DIS SOC, V5, P53, DOI 10.1093/jpids/piv015
   Al Shukri I, 2015, CLIN MICROBIOL INFEC, V21, P193, DOI 10.1016/j.cmi.2014.09.009
   Alarcon A, 2016, NEONATOLOGY, V110, P277, DOI 10.1159/000446690
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Amarnath C, 2016, EUR J RADIOL, V85, P428, DOI 10.1016/j.ejrad.2015.11.038
   Amir J, 2016, ARCH DIS CHILD-FETAL, V101, pF428, DOI 10.1136/archdischild-2015-308357
   Amir J, 2011, ARCH DIS CHILD, V96, P846, DOI 10.1136/adc.2010.208405
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Bajaj M, 2014, J PEDIATR-US, V165, P404, DOI 10.1016/j.jpeds.2014.04.046
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   Besnard M, 2014, EURO SURVEILL, V19
   Boivin G, 2005, EMERG INFECT DIS, V11, P103, DOI 10.3201/eid1101.040606
   Boppana SB, 2005, J PEDIATR-US, V146, P817, DOI 10.1016/j.jpeds.2005.01.059
   Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561
   Brecht KF, 2015, J PEDIATR-US, V166, P834, DOI 10.1016/j.jpeds.2014.11.002
   Britt W, 2015, MED MICROBIOL IMMUN, V204, P263, DOI 10.1007/s00430-015-0399-9
   Britton PN, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2848
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Cabrerizo M, 2015, EUR J PEDIATR, V174, P1511, DOI 10.1007/s00431-015-2566-9
   Cannie MM, 2016, EUR RADIOL, V26, P3760, DOI 10.1007/s00330-015-4187-0
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, COMMUNICATION
   Chakrabarti P, 2018, EUR J PEDIATR, V177, P1523, DOI 10.1007/s00431-018-3209-8
   Cordier AG, 2012, J CLIN VIROL, V55, P158, DOI 10.1016/j.jcv.2012.06.022
   Courtier J, 2012, ULTRASOUND OBST GYN, V40, P604, DOI 10.1002/uog.11121
   Craze JL, 1996, DEV MED CHILD NEUROL, V38, P84
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Jong EP, 2017, EUR J PEDIATR, V176, P1595, DOI 10.1007/s00431-017-2981-1
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   FORDJONES EL, 1995, PEDIATR INFECT DIS J, V14, P638, DOI 10.1097/00006454-199507000-00028
   Ge Y, 2013, J VIROL, V87, P11160, DOI 10.1128/JVI.03099-12
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Glenn OA, 2007, J MATERN-FETAL NEO M, V20, P769, DOI 10.1080/14767050701580960
   Guerra B, 2000, AM J OBSTET GYNECOL, V183, P476, DOI 10.1067/mob.2000.106347
   Gunkel J, 2014, J CLIN VIROL, V61, P61, DOI 10.1016/j.jcv.2014.06.002
   Gunkel J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0635
   Gunkel J, 2017, FETAL DIAGN THER, V42, P144, DOI 10.1159/000456615
   Hadar E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2161-3
   Harris John Brock, 2017, J Pediatr Pharmacol Ther, V22, P88, DOI 10.5863/1551-6776-22.2.88
   Harvala H, 2011, J MED VIROL, V83, P889, DOI 10.1002/jmv.22023
   HERRMANN B, 1993, MONATSSCHR KINDERH, V141, P120
   Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Isumi H, 1999, PEDIATR NEUROL, V21, P661, DOI 10.1016/S0887-8994(99)00055-7
   Juca E, 2018, CHILD NERV SYST, V34, P101, DOI 10.1007/s00381-017-3636-2
   Kadambari S, 2014, CLIN MICROBIOL INFEC, V20, P1289, DOI 10.1111/1469-0691.12753
   Kadambari S, 2014, J INFECTION, V69, P326, DOI 10.1016/j.jinf.2014.05.012
   Kakiuchi S, 2013, J CLIN MICROBIOL, V51, P356, DOI 10.1128/JCM.02247-12
   Katz VL, 1996, AM J PERINAT, V13, P43, DOI 10.1055/s-2007-994201
   Kidokoro H, 2017, J PERINATOL, V37, P1210, DOI 10.1038/jp.2017.114
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2011, NEW ENGL J MED, V365, P1284, DOI 10.1056/NEJMoa1003509
   Kurz H, 2015, EUR J PEDIATR, V174, P1639, DOI 10.1007/s00431-015-2583-8
   Lanzieri TM, 2013, PEDIATRICS, V131, pE1937, DOI 10.1542/peds.2013-0076
   Lazzarotto T, 2004, HUM IMMUNOL, V65, P410, DOI 10.1016/j.humimm.2004.02.006
   Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015
   Lee KY, 2018, SEIZURE-EUR J EPILEP, V56, P14, DOI 10.1016/j.seizure.2018.01.023
   Lee KY, 2018, BRAIN DEV-JPN, V40, P211, DOI 10.1016/j.braindev.2017.10.006
   Lee KY, 2014, EUR J PAEDIATR NEURO, V18, P624, DOI 10.1016/j.ejpn.2014.04.005
   Leruez-Ville M, 2017, CLIN INFECT DIS, V65, P398, DOI 10.1093/cid/cix337
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martin NG, 2016, LANCET INFECT DIS, V16, P1279, DOI 10.1016/S1473-3099(16)30201-8
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Muller WJ, 2017, PEDIATR RES, V81, P162, DOI 10.1038/pr.2016.191
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Okanishi T, 2015, BRAIN DEV-JPN, V37, P423, DOI 10.1016/j.braindev.2014.07.006
   Oosterom N, 2015, NEONATOLOGY, V107, P289, DOI 10.1159/000375439
   Payne DC, 2014, CLIN INFECT DIS, V58, P173, DOI 10.1093/cid/cit671
   Pelligra G, 2007, PEDIATRICS, V120, pE442, DOI 10.1542/peds.2006-3757
   Pistorius LR, 2008, FETAL DIAGN THER, V24, P491, DOI 10.1159/000180119
   Prince HE, 2014, CLIN VACCINE IMMUNOL, V21, P1377, DOI 10.1128/CVI.00487-14
   Qiu JM, 2017, CLIN MICROBIOL REV, V30, P43, DOI 10.1128/CMR.00040-16
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rawlinson WD, 2017, LANCET INFECT DIS, V17, pE177, DOI 10.1016/S1473-3099(17)30143-3
   Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Ross SA, 2006, J PEDIATR-US, V148, P332, DOI 10.1016/j.jpeds.2005.09.003
   Schlfiss MR, 2007, J PEDIATR-US, V151, P564, DOI 10.1016/j.jpeds.2007.07.015
   Schulert GS, 2011, AJP REP, V1, P105, DOI 10.1055/s-0031-1285984
   Sheridan SL, 2016, J PEDIAT INF DIS SOC, V5, P206, DOI 10.1093/jpids/piu097
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Verboon-Maciolek MA, 2006, NEUROLOGY, V66, P1267, DOI 10.1212/01.wnl.0000208429.69676.23
   Verboon-Maciolek MA, 2002, J MED VIROL, V66, P241, DOI 10.1002/jmv.2136
   Verboon-Maciolek MA, 2008, PEDIATR INFECT DIS J, V27, P241, DOI 10.1097/INF.0b013e31815c1b07
   Verboon-Maciolek MA, 2012, J PEDIATR-US, V160, P165, DOI 10.1016/j.jpeds.2011.08.053
   Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664
   Volpe JJ, 2008, ANN NEUROL, V64, P232, DOI 10.1002/ana.21466
   Walker SP, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-96
   Yeom JS, 2015, NEUROLOGY, V84, P21, DOI 10.1212/WNL.0000000000001107
   Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840
NR 98
TC 0
Z9 0
U1 1
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
EI 1558-0776
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD DEC
PY 2019
VL 32
AR UNSP 100769
DI 10.1016/j.spen.2019.08.005
PG 10
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA KB3UP
UT WOS:000506425100011
PM 31813517
OA Other Gold
DA 2020-07-08
ER

PT J
AU Li, F
   Zhou, JZ
   Zhou, L
   Fu, SH
   Tian, ZZ
   Wang, Q
   Shao, N
   Li, D
   He, Y
   Lei, WW
   Tang, GP
   Liang, GD
   Wang, DM
   Zhang, YP
   Wang, HY
AF Li Fan
   Zhou Jing Zhu
   Zhou Lei
   Fu Shi Hong
   Tian Zhen Zao
   Wang Qi
   Shao Nan
   Li Dan
   He Ying
   Lei Wen Wen
   Tang Guang Peng
   Liang Guo Dong
   Wang Ding Ming
   Zhang Yan Ping
   Wang Huan Yu
TI Serological Survey of Zika Virus in Humans and Animals in Dejiang
   Prefecture, Guizhou Province, China
SO BIOMEDICAL AND ENVIRONMENTAL SCIENCES
LA English
DT Article
DE Zika Virus; Serological survey; Humans; Animals; China; Plague reduction
   neutralization test
ID WEST NILE VIRUS; AEDES-AEGYPTI; INFECTION; MOSQUITOS; IDENTIFICATION;
   COMPETENCE; EMERGENCE; XINJIANG; VECTORS
AB Objective The current outbreak of Zika virus (ZIKV) poses a severe threat to human health. Two ZIKV strains were isolated from mosquitoes collected from the Dejiang prefecture in China in 2016, which was the first isolation of ZIKV in nature in China.
   Methods In this study, serum samples were collected from 366 healthy individuals and 104 animals from Dejiang prefecture in 2017, and the plaque reduction neutralization test (PRNT) was used to evaluate the seroprevalence of ZIKV.
   Results None of the 366 residents from whom the samples were collected were seropositive for ZIKV. None of the 11 pigs from whom the samples were collected were seropositive for ZIKV, while 1 of 63 (1.59%) chickens and 2 of 30 (6.67%) sheep were seropositive for ZIKV.
   Conclusions The extremely low seropositivity rate of ZIKV antibodies in animals in the Dejiang prefecture, Guizhou province in this study indicates that ZIKV can infect animals; however, there is a low risk of ZIKV circulating in the local population.
C1 [Li Fan; Fu Shi Hong; Shao Nan; He Ying; Lei Wen Wen; Liang Guo Dong; Wang Huan Yu] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 102206, Peoples R China.
   [Li Fan; Fu Shi Hong; Shao Nan; He Ying; Lei Wen Wen; Liang Guo Dong; Wang Huan Yu] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
   [Zhou Jing Zhu; Tian Zhen Zao; Tang Guang Peng; Wang Ding Ming] Guizhou Ctr Dis Control & Prevent, Guiyang 550004, Guizhou, Peoples R China.
   [Zhou Lei; Wang Qi; Li Dan; Zhang Yan Ping] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing 102206, Peoples R China.
RP Wang, HY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 102206, Peoples R China.; Wang, HY (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.; Wang, DM (corresponding author), Guizhou Ctr Dis Control & Prevent, Guiyang 550004, Guizhou, Peoples R China.; Zhang, YP (corresponding author), Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing 102206, Peoples R China.
EM 2404766656@qq.com; zhangyp@chinacdc.cn; wanghy@ivdc.chinacdc.cn
FU National Science and Technology Major Project [2018ZX10713-002,
   2017ZX10104001, 2018ZX10711001]; National key research and development
   project [2017YFC1200505, 2016YFC1200905]; Development Grant of State Key
   Laboratory of Infectious Disease Prevention and Control [2015SKLID505,
   2014SKLID103]
FX This work was supported by the National Science and Technology Major
   Project [2018ZX10713-002, 2017ZX10104001, 2018ZX10711001]; National key
   research and development project [2017YFC1200505, 2016YFC1200905]; the
   Development Grant of State Key Laboratory of Infectious Disease
   Prevention and Control [2015SKLID505, 2014SKLID103].
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fu SH, 2017, SCI CHINA LIFE SCI, V60, P1364, DOI 10.1007/s11427-017-9196-8
   Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Li XL, 2013, VECTOR-BORNE ZOONOT, V13, P131, DOI 10.1089/vbz.2012.0995
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lu Z, 2014, EMERG INFECT DIS, V20, P1421, DOI 10.3201/eid2008.131433
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mehrjardi MZ, 2017, VIROLOGY AUCKL, V8
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0
   Ward MJ, 2018, AM J TROP MED HYG, V99, P780, DOI 10.4269/ajtmh.18-0237
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09
NR 33
TC 0
Z9 0
U1 0
U2 0
PU CHINESE CENTER DISEASE CONTROL & PREVENTION
PI BEIJING
PA 155 CHANGBAI RD, CHANGPING DISTRICT, BEIJING, 102206, PEOPLES R CHINA
SN 0895-3988
J9 BIOMED ENVIRON SCI
JI Biomed. Environ. Sci.
PD DEC
PY 2019
VL 32
IS 12
BP 875
EP 880
DI 10.3967/bes2019.108
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KA4MO
UT WOS:000505771200001
PM 31918792
DA 2020-07-08
ER

PT J
AU Fischer, LS
   Mansergh, G
   Lynch, J
   Santibanez, S
AF Fischer, Leah S.
   Mansergh, Gordon
   Lynch, Jonathan
   Santibanez, Scott
TI Addressing Disease-Related Stigma During Infectious Disease Outbreaks
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE infectious disease; public health response; stigma
ID SEXUAL RISK BEHAVIOR; HIV-RELATED STIGMA; INTERNALIZED HOMOPHOBIA;
   HIV/AIDS STIGMA; MEN; COMMUNITY; EXPERIENCE; LESSONS; INTERVENTION;
   PERCEPTIONS
AB Outbreaks of emerging infectious disease are a constant threat. In the last 10 years, there have been outbreaks of 2009 influenza A (H1N1), Ebola virus disease, and Zika virus. Stigma associated with infectious disease can be a barrier to adopting healthy behaviors, leading to more severe health problems, ongoing disease transmission, and difficulty controlling infectious disease outbreaks. Much has been learned about infectious disease and stigma in the context of nearly 4 decades of the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome pandemic. In this paper, we define stigma, discuss its relevance to infectious disease outbreaks, including how individuals and communities can be affected. Adapting lessons learned from the rich literature on HIV-related stigma, we propose a strategy for reducing stigma during infectious disease outbreaks such as Ebola virus disease and Zika virus. The implementation of brief, practical strategies such as the ones proposed here might help reduce stigma and facilitate more effective control of emerging infectious diseases.
C1 [Fischer, Leah S.; Santibanez, Scott] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, 1600 Clifton Rd,MS-C18, Atlanta, GA 30333 USA.
   [Mansergh, Gordon] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA.
   [Lynch, Jonathan] Ctr Dis Control & Prevent, Div Emergency Operat, Atlanta, GA USA.
RP Fischer, LS (corresponding author), Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, 1600 Clifton Rd,MS-C18, Atlanta, GA 30333 USA.
EM LSFischer@cdc.gov
FU Intramural CDC HHS [CC999999]
CR American Experience, AM EXPERIENCE
   Batey DS, 2016, AIDS PATIENT CARE ST, V30, P519, DOI 10.1089/apc.2016.0223
   Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844
   Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x
   Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181
   Chikovore J, 2017, INT J TUBERC LUNG D, V21, pS26, DOI 10.5588/ijtld.16.0925
   Comfort J, 2013, HEALTH PROMOT J AUST, V24, P20, DOI 10.1071/HE12906
   Courtenay-Quirk C, 2006, AIDS EDUC PREV, V18, P56, DOI 10.1521/aeap.2006.18.1.56
   Crawford ND, 2014, HEALTH EDUC BEHAV, V41, P397, DOI 10.1177/1090198114529131
   Darrow WW, 2009, AIDS BEHAV, V13, P1178, DOI 10.1007/s10461-009-9601-7
   Deacon H, 2006, J COMMUNITY APPL SOC, V16, P418, DOI 10.1002/casp.900
   Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3
   Faccini M, 2015, EPIDEMIOL INFECT, V143, P2841, DOI 10.1017/S095026881400394X
   Geibel S, 2017, J ADOLESCENT HEALTH, V60, pS35, DOI 10.1016/j.jadohealth.2016.09.026
   GRECO RS, 1983, LANCET, V2, P515
   Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069
   Herrick AL, 2013, AIDS BEHAV, V17, P1423, DOI 10.1007/s10461-012-0392-x
   Hunt D, 2014, DALLAS MORNING NEWS
   Johns Hopkins Center for Health Security, 2017, HLTH SECT RES CHECKL
   Kraut AM, 1998, B HIST MED, V72, P785, DOI 10.1353/bhm.1998.0196
   Lin ECL, 2010, AM J INFECT CONTROL, V38, P302, DOI 10.1016/j.ajic.2009.09.008
   Lorway R, 2014, CRIT PUBLIC HEALTH, V24, P73, DOI 10.1080/09581596.2013.791386
   Lowther K, 2014, INT J NURS STUD, V51, P1171, DOI 10.1016/j.ijnurstu.2014.01.015
   Malave S, 2014, AIDS CARE, V26, P396, DOI 10.1080/09540121.2013.819409
   Maleche A, 2017, INT J TUBERC LUNG D, V21, pS4, DOI 10.5588/ijtld.17.0581
   Mansergh G, 2015, SEX TRANSM INFECT, V91, P324, DOI 10.1136/sextrans-2014-051827
   Markham C, 2000, AIDS EDUC PREV, V12, P442
   Mburu G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1061
   Oaten M, 2011, PHILOS T R SOC B, V366, P3433, DOI 10.1098/rstb.2011.0095
   Perry Phil, 2010, Virtual Mentor, V12, P225, DOI 10.1001/virtualmentor.2010.12.3.mhst1-1003
   Preston DB, 2004, AIDS EDUC PREV, V16, P291, DOI 10.1521/aeap.16.4.291.40401
   Prinsloo CD, 2016, AJAR-AFR J AIDS RES, V15, P261, DOI 10.2989/16085906.2016.1200640
   Rood EJJ, 2017, INT J TUBERC LUNG D, V21, pS60, DOI 10.5588/ijtld.16.0909
   Rowe C, 2015, DRUG ALCOHOL DEPEN, V147, P160, DOI 10.1016/j.drugalcdep.2014.11.023
   Rueda S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011453
   Sanders S., 2014, ALL THINGS CONS 1007
   Santibanez S, 2016, HEALTH SECUR, V14, P345, DOI 10.1089/hs.2016.0038
   Skinner D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2054-5
   Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977
   Sommerland N, 2017, INT J TUBERC LUNG D, V21, pS75, DOI 10.5588/ijtld.17.0030
   Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734
   Sweeney SM, 2016, AIDS BEHAV, V20, P29, DOI 10.1007/s10461-015-1164-1
NR 42
TC 0
Z9 0
U1 12
U2 12
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD DEC
PY 2019
VL 13
IS 5-6
BP 989
EP 994
AR PII S193578931800157X
DI 10.1017/dmp.2018.157
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JZ4OS
UT WOS:000505082200024
PM 31156079
DA 2020-07-08
ER

PT J
AU Gim, E
   Shim, DW
   Hwang, I
   Shin, OS
   Yu, JW
AF Gim, Eunji
   Shim, Do-Wan
   Hwang, Inhwa
   Shin, Ok Sarah
   Yu, Je-Wook
TI Zika Virus Impairs Host NLRP3-mediated Inflammasome Activation in an
   NS3-dependent Manner
SO IMMUNE NETWORK
LA English
DT Article
DE Zika virus; Caspase 1; Inflammasome; NLRP3; Macrophages; Glial cells
ID CELL-DEATH; INFECTION; CASPASES; IMMUNITY
AB Zika virus (ZIKV) is a mosquito-borne flavivirus associated with severe neurological disorders including Guillain-Barre syndrome and microcephaly. The host innate immune responses against ZIKV infection are essential for protection; however, ZIKV has evolved strategies to evade and antagonize antiviral responses via its nonstructural (NS) proteins. Here, we demonstrated that ZIKV infection unexpectedly inhibits NLRP3-dependent inflammasome activation in bone marrow-derived macrophages and mixed glial cells from mouse brain. ZIKV infection led to increased transcript levels of proinflammatory cytokines such as IL-1 beta and IL-6 via activating NF-kappa B signaling. However, ZIKV infection failed to trigger the secretion of active caspase-1 and IL-1 beta from macrophages and glial cells even in the presence of LPS priming or ATP costimulation. Intriguingly, ZIKV infection significantly attenuated NLRP3-dependent, but not absent in melanoma 2-dependent caspase-1 activation and IL-1 beta secretion from both cells. ZIKV infection further blocked apoptosis-associated speck-like protein containing a caspase recruitment domain oligomerization in LPS/ATP-stimulated macrophages. Interestingly, expression of ZIKV NS3 protein reduced NLRP3-mediated caspase-1 activation and IL-1 beta secretion in macrophages, whereas NS1 and NS5 proteins showed no effects. Furthermore, NLRP3 was found to be degraded by the overexpression of ZIKV NS3 in 293T cells. Collectively, these results indicate that ZIKV evades host NLRP3 inflammasome-mediated innate immune responses in macrophages and glial cells; this may facilitate ZIKV's ability to enhance the replication and dissemination in these cells.
C1 [Gim, Eunji; Shim, Do-Wan; Hwang, Inhwa; Yu, Je-Wook] Yonsei Univ, Dept Microbiol & Immunol, Coll Med, Inst Immunol & Immunol Dis,Brain Korea 21 Plus Pr, Seoul 03722, South Korea.
   [Shin, Ok Sarah] Korea Univ, Coll Med, Dept Biomed Sci, Guro Hosp, Seoul 08308, South Korea.
RP Yu, JW (corresponding author), Yonsei Univ, Dept Microbiol & Immunol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jewookyu@yuhs.ac
OI Hwang, Inhwa/0000-0001-5235-3519; Shin, Ok Sarah/0000-0002-3977-2492;
   Yu, Je-Wook/0000-0001-5943-4071
FU National Research Foundation of Korea - Korean GovernmentNational
   Research Foundation of KoreaKorean Government [2015M3A9B6073856,
   2017R1A2B2007467]
FX This work was supported by the National Research Foundation of Korea
   Grant funded by the Korean Government (2015M3A9B6073856,
   2017R1A2B2007467).
CR Avelino-Silva VI, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30843-1
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Connolly PF, 2017, CELL DEATH DIFFER, V24, P1401, DOI 10.1038/cdd.2017.59
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Dowall SD, 2020, CYTOKINE, V125, DOI 10.1016/j.cyto.2019.154864
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859
   Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Kim Eun-Hee, 2013, Immune Netw, V13, P141, DOI 10.4110/in.2013.13.4.141
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lang JS, 2018, STEM CELL REP, V11, P348, DOI 10.1016/j.stemcr.2018.06.006
   Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452
   Li K, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e4
   Maruzuru Y, 2018, CELL HOST MICROBE, V23, P254, DOI 10.1016/j.chom.2017.12.014
   Nikitina E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092821
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Riedl W, 2019, CELL HOST MICROBE, V26, P493, DOI 10.1016/j.chom.2019.09.012
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514
   Shim DW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01054
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu S, 2019, NUCLEIC ACIDS RES, V47, P8693, DOI 10.1093/nar/gkz650
   Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029
   Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734
   Zheng Y, 2018, EMBO J, V37, P37
NR 40
TC 1
Z9 1
U1 4
U2 4
PU KOREA ASSOC IMMUNOLOGISTS
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER, RM 701, 7 GIL 22, TEHERAN-RO, (635-4
   YEOKSAM-DONG) GANGMAN-GU, SEOUL, 06130, SOUTH KOREA
SN 1598-2629
EI 2092-6685
J9 IMMUNE NETW
PD DEC
PY 2019
VL 19
IS 6
AR e40
DI 10.4110/in.2019.19.e40
PG 13
WC Immunology
SC Immunology
GA KA3QV
UT WOS:000505714300004
PM 31921470
OA Green Published
DA 2020-07-08
ER

PT J
AU Vasconcelos, GC
   Pereira, CMM
   de Paula, CHT
   Barbosa, PDS
   de Souza, DM
   Coelho, LM
AF Vasconcelos, Galton Carvalho
   Macedo Pereira, Carolina Milagres
   Toledo de Paula, Cristina Helena
   Haueisen Barbosa, Pamela de Souza
   de Souza, Davi Machado
   Coelho, Leticia Maria
TI Corneal ectasia and high ametropia in an infant with microcephaly
   associated with presumed Zika virus congenital infection: new ocular
   findings
SO JOURNAL OF AAPOS
LA English
DT Article
AB We report the first case of a corneal ocular ectasia in an infant with Zika virus congenital infection (CZS). We suspect that the ocular embryology and neurotropism of the Zika virus could account for the corneal involvement.
C1 [Vasconcelos, Galton Carvalho; Macedo Pereira, Carolina Milagres; Toledo de Paula, Cristina Helena; Haueisen Barbosa, Pamela de Souza; de Souza, Davi Machado; Coelho, Leticia Maria] Univ Fed Minas Gerais, Dept Ophthalmol, Rua Alfredo Balena 190,Sl 199, BR-30130100 Belo Horizonte, MG, Brazil.
RP Vasconcelos, GC (corresponding author), Univ Fed Minas Gerais, Dept Ophthalmol, Rua Alfredo Balena 190,Sl 199, BR-30130100 Belo Horizonte, MG, Brazil.
EM galton@lua.com.br
CR Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Ventura LO, 2017, J AAPOS, V21, P480, DOI 10.1016/j.jaapos.2017.07.206
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 6
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD DEC
PY 2019
VL 23
IS 6
BP 354
EP 356
DI 10.1016/j.jaapos.2019.08.281
PG 3
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA JZ4YJ
UT WOS:000505109000022
PM 31707055
DA 2020-07-08
ER

PT J
AU Wang, XY
   Tai, WB
   Zhang, XL
   Zhou, YS
   Du, LY
   Shen, CL
AF Wang, Xinyi
   Tai, Wanbo
   Zhang, Xiaolu
   Zhou, Yusen
   Du, Lanying
   Shen, Chuanlai
TI Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus
   Envelope Domain III Subunit Vaccine
SO VACCINES
LA English
DT Article
DE flavivirus; Zika virus; envelope domain III; immune response; protective
   efficacy; adjuvants; subunit vaccine
ID FC-FUSION PROTEINS; MONOPHOSPHORYL-LIPID-A; IMMUNE-RESPONSE; MOUSE
   MODEL; DESIGN; ADVANCEMENTS; INFECTION; US
AB Zika virus (ZIKV), a mosquito-borne flavivirus, has attracted global attention due to its close association with congenital Zika syndrome and neurological diseases, and transmission through additional routes, such as sexual contact. Currently there are no vaccines approved for ZIKV, and thus, there is an urgent need to develop an effective and safe ZIKV vaccine. Domain III (DIII) of the ZIKV envelope (E) protein is an important vaccine target, and a vaccine developed using a mutant DIII of E (EDIII) protein protects adult and pregnant mice, and unborn offspring, against ZIKV infection. Here, we have used immunocompetent BALB/c mice treated with anti-interferon-alpha/beta receptor 1 (Ifnar1) antibodies to investigate whether three adjuvants (aluminum (Alum), monophosphoryl lipid A (MPL), and MF59), either alone or in combination, could improve the efficacy of this EDIII subunit vaccine. Our data show that, although vaccine formulated with a single adjuvant induced a specific antibody and cellular immune response, and reduced viral load in mice challenged with ZIKV, the combination of Alum and MPL adjuvants led to a more robust and balanced immune response, stronger neutralizing activity against three recent ZIKV human strains, and greater protection against a high-dose ZIKV challenge. Particularly, the combination of Alum with MPL significantly reduced viral titers and viral RNA copy numbers in sera and tissues, including the male reproductive organs. Overall, this study has identified the combination of Alum and MPL as the most effective adjuvant for ZIKV EDIII subunit vaccines, and it has important implications for subunit vaccines against other enveloped viruses, including non-ZIKV flaviviruses.
C1 [Wang, Xinyi; Shen, Chuanlai] Southeast Univ, Med Sch, Dept Microbiol & Immunol, Nanjing 210009, Jiangsu, Peoples R China.
   [Wang, Xinyi; Tai, Wanbo; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
   [Zhang, Xiaolu; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhou, Yusen] Zhengzhou Univ, Inst Med & Pharmaceut Sci, Zhengzhou 450001, Henan, Peoples R China.
RP Shen, CL (corresponding author), Southeast Univ, Med Sch, Dept Microbiol & Immunol, Nanjing 210009, Jiangsu, Peoples R China.; Du, LY (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
EM XWang@nybc.org; wtai@nybc.org; xlzhang0123@163.com; yszhou@bmi.ac.cn;
   ldu@nybc.org; chuanlaishen@seu.edu.cn
RI ; Tai, Wanbo/G-3838-2018
OI shen, chuanlai/0000-0002-3748-3742; Tai, Wanbo/0000-0002-9864-8993
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R21AI137790];
   New York Blood Center [NYB616]
FX This research was funded by the National Institutes of Health (NIH)
   grant (R21AI137790) and intramural funds of the New York Blood Center
   (NYB616). ZIKV strains (R103451, PAN2016, and PAVABC59) were obtained
   from BEI Resources.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Beattie J, 2018, INFECT DIS CLIN PRAC, V26, pE80, DOI 10.1097/IPC.0000000000000654
   Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002
   Bullard BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35755-z
   Cabral-Miranda G, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030072
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6
   Chen TH, 2019, VACCINE, V37, P6933, DOI 10.1016/j.vaccine.2019.02.040
   Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Crank MC, 2019, SCIENCE, V365, P505, DOI 10.1126/science.aav9033
   Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Del Giudice G, 2018, SEMIN IMMUNOL, V39, P14, DOI 10.1016/j.smim.2018.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Du LY, 2017, EXPERT REV VACCINES, V16, P951, DOI 10.1080/14760584.2017.1363648
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14
   Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555
   Elong Ngono A, 2019, PLOS PATHOG, V15, DOI DOI 10.1371/J0URNAL.PPAT.1007474
   Freire IM, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00176217, 10.1590/0102-311x00176217]
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   HogenEsch H, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0089-x
   Jafari R, 2017, CURR MED CHEM, V24, P1228, DOI 10.2174/0929867324666170113112759
   Jagger BW, 2019, J INFECT DIS, V220, P1577, DOI 10.1093/infdis/jiz338
   Konduru K, 2011, VACCINE, V29, P2968, DOI 10.1016/j.vaccine.2011.01.113
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51
   Levin D, 2015, TRENDS BIOTECHNOL, V33, P27, DOI 10.1016/j.tibtech.2014.11.001
   Li XD, 2018, VIRUS RES, V254, P10, DOI 10.1016/j.virusres.2017.09.005
   Loureiro S, 2011, J VIROL, V85, P3010, DOI 10.1128/JVI.01241-10
   Lu L, 2011, J VIROL, V85, P10542, DOI 10.1128/JVI.05441-11
   Ma CQ, 2014, VACCINE, V32, P6170, DOI 10.1016/j.vaccine.2014.08.086
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mitchell TC, 2017, CURR OPIN IMMUNOL, V47, P17, DOI 10.1016/j.coi.2017.06.009
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Myler HA, 2012, BIOANALYSIS, V4, P1215, DOI [10.4155/BIO.12.79, 10.4155/bio.12.79]
   National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ogasawara K, 2019, CLIN PHARM DRUG DEV, V8, P914, DOI 10.1002/cpdd.658
   Pardy RD, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080820
   Petridou C, 2019, EMERG INFECT DIS, V25, P1598, DOI 10.3201/eid2508.181543
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Sastry M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186854
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soleimanpour S, 2017, CRIT REV BIOTECHNOL, V37, P371, DOI 10.3109/07388551.2016.1163323
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tai WB, 2019, J VIROL, V93, DOI 10.1128/JVI.02187-18
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Tregoning JS, 2018, HUM VACC IMMUNOTHER, V14, P550, DOI 10.1080/21645515.2017.1415684
   Wen JS, 2017, J INTERF CYTOK RES, V37, P475, DOI 10.1089/jir.2017.0106
   Xia S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020487
   Yang CP, 2019, J BIOL CHEM, V294, P10638, DOI 10.1074/jbc.RA119.007443
   Valdespino-Vazquez MY, 2019, CLIN INFECT DIS, V68, P903, DOI 10.1093/cid/ciy616
   Zhang NR, 2016, CELL MOL IMMUNOL, V13, P180, DOI 10.1038/cmi.2015.03
   Zhang NR, 2014, EXPERT REV VACCINES, V13, P761, DOI 10.1586/14760584.2014.912134
   Zhang W, 2019, ANTIVIR RES, V170, DOI 10.1016/j.antiviral.2019.104578
   Zhao BC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00932
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 71
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD DEC
PY 2019
VL 7
IS 4
AR 161
DI 10.3390/vaccines7040161
PG 16
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KA3PC
UT WOS:000505709700016
PM 31717890
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wong, SH
   Jassey, A
   Wang, JY
   Wang, WC
   Liu, CH
   Lin, LT
AF Wong, Shu Hui
   Jassey, Alagie
   Wang, Jonathan Y.
   Wang, Wei-Cheng
   Liu, Ching-Hsuan
   Lin, Liang-Tzung
TI Virus-Like Particle Systems for Vaccine Development against Viruses in
   the Flaviviridae Family
SO VACCINES
LA English
DT Review
DE virus-like particles; Flaviviridae; immunogenicity; vaccines
ID WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; CELLULAR IMMUNE-RESPONSES;
   ENVELOPE DOMAIN III; YELLOW-FEVER-VIRUS; ZIKA VIRUS; DENGUE VIRUS;
   NEUTRALIZING ANTIBODIES; PICHIA-PASTORIS; INFECTION
AB Viruses in the Flaviviridae family are important human and animal pathogens that impose serious threats to global public health. This family of viruses includes emerging and re-emerging viruses, most of which are transmitted by infected mosquito or tick bites. Currently, there is no protective vaccine or effective antiviral treatment against the majority of these viruses, and due to their growing spread, several strategies have been employed to manufacture prophylactic vaccines against these infectious agents including virus-like particle (VLP) subunit vaccines. VLPs are genomeless viral particles that resemble authentic viruses and contain critical repetitive conformational structures on their surface that can trigger the induction of both humoral and cellular responses, making them safe and ideal vaccine candidates against these viruses. In this review, we focus on the potential of the VLP platform in the current vaccine development against the medically important viruses in the Flaviviridae family.
C1 [Wong, Shu Hui; Wang, Jonathan Y.] Taipei Med Univ, Coll Med, Int Master Program Med, Taipei 11031, Taiwan.
   [Wong, Shu Hui] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.
   [Jassey, Alagie] Taipei Med Univ, Coll Med, Int PhD Program Med, Taipei 11031, Taiwan.
   [Wang, Wei-Cheng; Liu, Ching-Hsuan; Lin, Liang-Tzung] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 11031, Taiwan.
   [Liu, Ching-Hsuan] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada.
   [Lin, Liang-Tzung] Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med, Taipei 11031, Taiwan.
RP Lin, LT (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 11031, Taiwan.; Lin, LT (corresponding author), Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med, Taipei 11031, Taiwan.
EM m142107001@tmu.edu.tw; d142105007@tmu.edu.tw; m142107002@tmu.edu.tw;
   m120107011@tmu.edu.tw; d119107007@tmu.edu.tw; ltlin@tmu.edu.tw
OI Lin, Liang-Tzung/0000-0001-7374-7234
FU Ministry of Science and Technology of TaiwanMinistry of Science and
   Technology, Taiwan [MOST107-2320-B-038-034-MY3]
FX This study was supported in part by funding from the Ministry of Science
   and Technology of Taiwan (MOST107-2320-B-038-034-MY3).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   [Anonymous], 2017, GLOB HEP REP 2017, P3
   Arora U, 2013, VACCINE, V31, P873, DOI 10.1016/j.vaccine.2012.12.016
   Arora U, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-30
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Baumert TF, 1999, GASTROENTEROLOGY, V117, P1397, DOI 10.1016/S0016-5085(99)70290-8
   Baumert TF, 1998, J VIROL, V72, P3827, DOI 10.1128/JVI.72.5.3827-3836.1998
   Beaumont E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151626
   Beaumont E, 2013, HEPATOLOGY, V57, P1303, DOI 10.1002/hep.26132
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384
   Cao L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004686
   Castano-Osorio J.C., 2018, DENGUE FEVER RESILIE
   Chevaliez S., 2006, HEPATITIS C VIRUSES, V1, P5
   CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294
   Christiansen D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45461-z
   Christiansen D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24762-9
   Chua BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047492
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Dai SY, 2018, VIROL SIN, V33, P213, DOI 10.1007/s12250-018-0030-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Desjardins D, 2009, J GENE MED, V11, P313, DOI 10.1002/jgm.1307
   Du RK, 2015, J GEN VIROL, V96, P1006, DOI 10.1099/vir.0.000052
   Earnest-Silveira L, 2016, J GEN VIROL, V97, P1865, DOI 10.1099/jgv.0.000493
   El Garch H, 2008, VET IMMUNOL IMMUNOP, V123, P230, DOI 10.1016/j.vetimm.2008.02.002
   Elmowalid GA, 2007, P NATL ACAD SCI USA, V104, P8427, DOI 10.1073/pnas.0702162104
   Erra EO, 2013, CLIN INFECT DIS, V56, P267, DOI 10.1093/cid/cis883
   Fan YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25596-1
   Fatmi SS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00342
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Garrone P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002330
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003
   Hua RH, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-62
   Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Javelle E, 2019, CLIN MICROBIOL INFEC, V25, P10, DOI 10.1016/j.cmi.2018.08.015
   Julander JG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01756
   Kaaijk P, 2018, HUM VACC IMMUNOTHER, V14, P337, DOI 10.1080/21645515.2017.1389363
   Khetarpal N, 2017, AM J TROP MED HYG, V96, P126, DOI 10.4269/ajtmh.16-0503
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kojima A, 2003, J VIROL, V77, P8745, DOI 10.1128/JVI.77.16.8745-8755.2003
   Konishi E, 1997, VACCINE, V15, P281, DOI 10.1016/S0264-410X(96)00180-6
   KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U
   Konishi E, 2001, J VIROL, V75, P2204, DOI 10.1128/JVI.75.5.2204-2212.2001
   Koraka P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/864029
   Krol E, 2019, TRENDS BIOTECHNOL, V37, P1202, DOI 10.1016/j.tibtech.2019.03.013
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lauer GM, 2004, GASTROENTEROLOGY, V127, P924, DOI 10.1053/j.gastro.2004.06.015
   Lechmann M, 2001, HEPATOLOGY, V34, P417, DOI 10.1053/jhep.2001.26523
   Li W, 2006, J IMMUNOL, V176, P6065, DOI 10.4049/jimmunol.176.10.6065
   Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811
   Lindenbach BD, 2013, FIELDS VIROLOGY, P712
   Liu WQ, 2010, VIRUS GENES, V40, P53, DOI 10.1007/s11262-009-0418-2
   Liu Yan, 2014, BMC Microbiol, V14, P233, DOI 10.1186/s12866-014-0233-3
   Liu Yan-li, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P335
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Mani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064595
   Mason PW, 2006, VIROLOGY, V351, P432, DOI 10.1016/j.virol.2006.04.003
   Matsuda S, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00286
   McAuley AJ, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0009-5
   McGuinness I, 2017, NEUROHOSPITALIST, V7, P157, DOI 10.1177/1941874417708129
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mohsen MO, 2017, SEMIN IMMUNOL, V34, P123, DOI 10.1016/j.smim.2017.08.014
   Monath TP, 2001, ANN NY ACAD SCI, V951, P1
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neddermeyer AH, 2018, CURR THER RES CLIN E, V88, P8, DOI 10.1016/j.curtheres.2017.10.003
   Neilson AA, 2010, AUST FAM PHYSICIAN, V39, P570
   Ng T, 2003, Dev Biol (Basel), V114, P221
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055
   Patient R, 2009, NEW BIOTECHNOL, V25, P226, DOI 10.1016/j.nbt.2009.01.001
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pesko KN, 2010, J GEN VIROL, V91, P2698, DOI 10.1099/vir.0.024232-0
   Poddar A, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0280-y
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   PRICE WH, 1963, AM J TROP MED HYG, V12, P787, DOI 10.4269/ajtmh.1963.12.787
   Pushko P, 2016, EXPERT REV VACCINES, V15, P1223, DOI 10.1080/14760584.2016.1175943
   Qiao M, 2004, J INFECT DIS, V190, P2104, DOI 10.1086/425933
   Rajpoot RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26904-5
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006191
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shukla R, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02644
   Shustov AV, 2007, J VIROL, V81, P11737, DOI 10.1128/JVI.01112-07
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146
   Suphatrakul A, 2015, VACCINE, V33, P5613, DOI 10.1016/j.vaccine.2015.08.090
   Tan Boon-Huan, 2007, Methods Mol Biol, V379, P163
   Tang YX, 2012, CHINESE MED J-PEKING, V125, P1986, DOI 10.3760/cma.j.issn.0366-6999.2012.11.027
   Taylor TJ, 2016, VIROLOGY, V496, P186, DOI 10.1016/j.virol.2016.06.006
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tripathi L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01005
   Urakami A, 2017, J VIROL, V91, DOI [10.1128/JVI.01181-17, 10.1128/jvi.01181-17]
   VanBlargan LA, 2018, CELL REP, V25, P3382, DOI 10.1016/j.celrep.2018.11.082
   Verma R, 2014, HUM VACC IMMUNOTHER, V10, P126, DOI 10.4161/hv.26549
   WHO, ZIK EP UPD
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay057
   Yamaji H, 2013, BIOENGINEERED, V4, P438, DOI 10.4161/bioe.24514
   Yamaji H, 2012, J BIOSCI BIOENG, V114, P657, DOI 10.1016/j.jbiosc.2012.06.012
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yoshii K, 2003, J VIROL METHODS, V108, P171, DOI 10.1016/S0166-0934(02)00283-5
   Yun Seok-Min, 2014, Osong Public Health Res Perspect, V5, P274, DOI 10.1016/j.phrp.2014.08.005
   Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1
   Zhang FQ, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-17
   Zhang S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-333
NR 116
TC 1
Z9 1
U1 4
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD DEC
PY 2019
VL 7
IS 4
AR 123
DI 10.3390/vaccines7040123
PG 20
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KA3PC
UT WOS:000505709700065
PM 31547131
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Grubor-Bauk, B
   Wijesundara, DK
   Masavuli, M
   Abbink, P
   Peterson, RL
   Prow, NA
   Larocca, RA
   Mekonnen, ZA
   Shrestha, A
   Eyre, NS
   Beard, MR
   Gummow, J
   Carr, J
   Robertson, SA
   Hayball, JD
   Barouch, DH
   Gowans, EJ
AF Grubor-Bauk, B.
   Wijesundara, D. K.
   Masavuli, M.
   Abbink, P.
   Peterson, R. L.
   Prow, N. A.
   Larocca, R. A.
   Mekonnen, Z. A.
   Shrestha, A.
   Eyre, N. S.
   Beard, M. R.
   Gummow, J.
   Carr, J.
   Robertson, S. A.
   Hayball, J. D.
   Barouch, D. H.
   Gowans, E. J.
TI NS1 DNA vaccination protects against Zika infection through T
   cell-mediated immunity in immunocompetent mice
SO SCIENCE ADVANCES
LA English
DT Article
ID DENGUE VIRUS-INFECTION; CROSS-REACTIVITY; RESPONSES; IMMUNOGENICITY;
   SPECIFICITY; ANTIBODIES; EFFECTOR; PERFORIN; PHASE-1; SAFETY
AB The causal association of Zika virus (ZIKV) with microcephaly, congenital malformations in infants, and Guillain-Barre syndrome in adults highlights the need for effective vaccines. Thus far, efforts to develop ZIKV vaccines have focused on the viral envelope. ZIKV NS1 as a vaccine immunogen has not been fully explored, although it can circumvent the risk of antibody-dependent enhancement of ZIKV infection, associated with envelope antibodies. Here, we describe a novel DNA vaccine encoding a secreted ZIKV NS1, that confers rapid protection from systemic ZIKV infection in immunocompetent mice. We identify novel NS1 T cell epitopes in vivo and show that functional NS1-specific T cell responses are critical for protection against ZIKV infection. We demonstrate that vaccine-induced anti-NS1 antibodies fail to confer protection in the absence of a functional T cell response. This highlights the importance of using NS1 as a target for T cell-based ZIKV vaccines.
C1 [Grubor-Bauk, B.; Wijesundara, D. K.; Masavuli, M.; Mekonnen, Z. A.; Shrestha, A.; Gowans, E. J.] Univ Adelaide, Discipline Surg, Adelaide, SA 5005, Australia.
   [Grubor-Bauk, B.; Wijesundara, D. K.; Masavuli, M.; Mekonnen, Z. A.; Shrestha, A.; Gowans, E. J.] Basil Hetzel Inst Translat Hlth Res, Adelaide, SA 5005, Australia.
   [Abbink, P.; Peterson, R. L.; Larocca, R. A.; Barouch, D. H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Prow, N. A.; Hayball, J. D.] Univ South Australia, Canc Res Inst, Sch Pharm & Med Sci, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
   [Prow, N. A.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia.
   [Prow, N. A.] Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.
   [Eyre, N. S.; Beard, M. R.] Univ Adelaide, Sch Biol Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia.
   [Gummow, J.] Univ Adelaide, Robinson Res Inst, Adelaide Hlth & Med Sci, Gene Silencing & Express Core Facil, Adelaide, SA 5005, Australia.
   [Carr, J.] Flinders Univ S Australia, Coll Med & Publ Hlth, Microbiol & Infect Dis, Adelaide, SA 5042, Australia.
   [Robertson, S. A.; Hayball, J. D.] Univ Adelaide, Robinson Res Inst, Sch Med, Adelaide, SA 5005, Australia.
   [Barouch, D. H.] MIT, Ragon Inst MGH, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Barouch, D. H.] Harvard, Cambridge, MA 02139 USA.
RP Grubor-Bauk, B (corresponding author), Univ Adelaide, Discipline Surg, Adelaide, SA 5005, Australia.; Grubor-Bauk, B (corresponding author), Basil Hetzel Inst Translat Hlth Res, Adelaide, SA 5005, Australia.
EM branka.grubor@adelaide.edu.au
RI Shrestha, Ashish/F-4588-2014; Hayball, John/F-4137-2013; Assumpcao
   Larocca, Rafael/H-1655-2015
OI Shrestha, Ashish/0000-0001-5049-8351; Grubor-Bauk,
   Branka/0000-0002-4642-105X; Mekonnen, Zelalem Addis/0000-0002-3705-4526;
   Hayball, John/0000-0002-3089-4506; Assumpcao Larocca,
   Rafael/0000-0002-9995-1804; Abbink, Peter/0000-0003-1978-088X; Prow,
   Natalie/0000-0001-7312-8767; Carr, Jillian/0000-0002-1080-1472
FU National Foundation for Medical Research and Innovation (NFMRI),
   Australia [274]; Hospital Research Foundation, Australia; Hospital
   Research Foundation (THRF; Australia); University of Adelaide
   Postgraduate Award (Australia); International Postgraduate Research
   Scholarship (IPRS; Australia); Australian Postgraduate Award (APA;
   Australia)
FX This work was supported by a grant from the National Foundation for
   Medical Research and Innovation (NFMRI), Australia (no. 274) and in part
   by a grant from The Hospital Research Foundation, Australia. D.K.W. and
   A.C.S. were supported by the Early Career Fellowships from The Hospital
   Research Foundation (THRF; Australia). M.M. was the recipient of the
   University of Adelaide Postgraduate Award (Australia), and Z.A.M. was
   the recipient of the International Postgraduate Research Scholarship
   (IPRS) and Australian Postgraduate Award (APA; Australia).
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bartsch SM, 2019, J INFECT DIS, V220, P920, DOI 10.1093/infdis/jiy688
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen HW, 2014, J GEN VIROL, V95, P1983, DOI 10.1099/vir.0.067280-0
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Gargett T, 2014, IMMUNOL CELL BIOL, V92, P359, DOI 10.1038/icb.2013.93
   Garrod T, 2014, HUM VACC IMMUNOTHER, V10, P2679, DOI 10.4161/hv.29527
   Garrod TJ, 2014, EUR J IMMUNOL, V44, P1992, DOI 10.1002/eji.201343983
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grubor-Bauk B, 2016, GENE THER, V23, P26, DOI 10.1038/gt.2015.86
   Gummow J, 2015, J VIROL, V89, P7991, DOI 10.1128/JVI.00803-15
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Li YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18848
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu XY, 2018, 2018 4TH INTERNATIONAL CONFERENCE ON INDUSTRIAL AND BUSINESS ENGINEERING (ICIBE 2018), P29, DOI 10.1145/3288155.3288174
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Masavuli MG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01145
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Quah BJC, 2013, J IMMUNOL METHODS, V387, P181, DOI 10.1016/j.jim.2012.10.013
   Quah BJC, 2012, CYTOM PART A, V81A, P679, DOI 10.1002/cyto.a.22084
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Saron WAA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4297
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Singh R, 2010, J INFECT DIS, V202, P223, DOI 10.1086/653486
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Spencer AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033555
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tau GZ, 2001, J IMMUNOL, V167, P5574, DOI 10.4049/jimmunol.167.10.5574
   Tomusange K, 2016, SCI REP-UK, V6, DOI 10.1038/srep36658
   Tomusange K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29131
   Trobaugh DW, 2010, EUR J IMMUNOL, V40, P1315, DOI 10.1002/eji.200839108
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wijesundara DK, 2018, J VIROL, V92, DOI 10.1128/JVI.02133-17
   Wijesundara DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105366
   Xu J, 2016, J IMMUNOL, V197, P326, DOI 10.4049/jimmunol.1500152
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 68
TC 0
Z9 0
U1 1
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD DEC
PY 2019
VL 5
IS 12
AR eaax2388
DI 10.1126/sciadv.aax2388
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JZ4JZ
UT WOS:000505069600029
PM 31844662
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tsui, I
   Neves, LM
   Adachi, K
   Gaw, SL
   Pereira, JP
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
   Zin, AA
AF Tsui, Irena
   Neves, Luiza M.
   Adachi, Kristina
   Gaw, Stephanie L.
   Pereira Jr, Jose Paulo
   Brasil, Patricia
   Nielsen-Saines, Karin
   Moreira, Maria Elisabeth Lopes
   Zin, Andrea A.
TI Overlapping Spectrum of Retinochoroidal Scarring in Congenital Zika
   Virus and Toxoplasmosis Infections
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID OCULAR TOXOPLASMOSIS; GENE POLYMORPHISM; MANIFESTATIONS; INFANTS
AB BACKGROUND AND OBJECTIVE: Antenatal Zika virus (ZIKV) or toxoplasmosis infections may present with isolated eye abnormalities with absence of other apparent birth defects. The purpose of this article is to discuss the overlapping spectrum of clinical presentation and retinochoroidal scarring in congenital ZIKV and toxoplasmosis infections.
   PATIENTS AND METHODS: Prenatal ultrasound abnormalities seen from antenatal ZIKV and toxoplasmosis infections overlap and may include intracranial calcifications, microcephaly, and intrauterine growth restriction. The clinical spectrum of both infections in less severely affected infants and children may include nonspecific neurological impairment such as developmental delay and seizures.
   RESULTS: Inherent limitations in serological testing pose additional barriers in establishing a diagnosis. Retinal pigment epithelium (RPE) mottling in ZIKV infection can occur in isolation or adjacent to retinochoroidal atrophy. In contrast, RPE mottling outside of the borders of retinochoroidal atrophy is not typically seen in toxoplasmosis. To date, postnatal reactivation of congenital eye lesions as seen in toxoplasmosis have not been reported with ZIKV infection.
   CONCLUSIONS: As children infected with congenital ZIKV grow older, subclinical eye abnormalities may be indistinguishable from toxoplasmosis. Brazil has had high prevalence of both diseases with long-term information available on toxoplasmosis only. Surveillance guidelines for asymptomatic eye abnormalities will likely evolve.
C1 [Tsui, Irena] Univ Calif Los Angeles, Dept Ophthalmol, Div Retina, 100 Stein Plaza, Los Angeles, CA 90095 USA.
   [Neves, Luiza M.; Pereira Jr, Jose Paulo; Moreira, Maria Elisabeth Lopes; Zin, Andrea A.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescent Ferna, Rio De Janeiro, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Serv, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Tsui, I (corresponding author), Univ Calif Los Angeles, Dept Ophthalmol, Div Retina, 100 Stein Plaza, Los Angeles, CA 90095 USA.
EM itsui@jsei.ucla.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Eye InstituteUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318-02, R01 AI121207]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129534-02]; Research to Prevent BlindnessResearch to Prevent
   Blindness (RPB)
FX Funded by the Brazilian National Council for Scientific and
   Technological Development [441098/2016-9], National Eye Institute
   [R21EY028318-02 and [R01 AI121207], and National Institute of Allergy
   and Infectious Diseases [R21AI129534-02]. Dr. Tsui was supported in part
   by an unrestricted Research to Prevent Blindness grant given to the
   Stein Eye Institute. Funding sources had no involvement in design, data
   collection/interpretation, or manuscript preparation.
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Andrade GMQ, 2010, J PEDIAT-BRAZIL, V86, P85, DOI [10.1590/S0021-75572010000100015, 10.2223/JPED.1948]
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030
   Cordeiro CA, 2008, BRIT J OPHTHALMOL, V92, P986, DOI 10.1136/bjo.2008.140590
   Cordeiro CA, 2008, INVEST OPHTH VIS SCI, V49, P1979, DOI 10.1167/iovs.07-1393
   Cordeiro CA, 2008, MOL VIS, V14, P1845
   de Albuquerque MC, 2009, MEM I OSWALDO CRUZ, V104, P451, DOI 10.1590/S0074-02762009000300009
   Fonseca ZC, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6020026
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536
   Garweg JG, 2011, OCUL IMMUNOL INFLAMM, V19, P255, DOI 10.3109/09273948.2011.595872
   Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277
   GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5
   Haddad Maria Aparecida Onuki, 2006, Clinics, V61, P239, DOI 10.1590/S1807-59322006000300009
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Jamieson SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002285
   Kimberlin DW, 2018, RED BOOK 2018 REPORT
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Melamed J, 2010, EYE, V24, P528, DOI 10.1038/eye.2009.140
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Montoya JG, 1999, OPHTHALMOLOGY, V106, P1554, DOI 10.1016/S0161-6420(99)90453-0
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304
   Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7
   Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   de Paula CHT, 2015, J AAPOS, V19, P252, DOI 10.1016/j.jaapos.2015.03.011
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 40
TC 1
Z9 1
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD DEC
PY 2019
VL 50
IS 12
BP 779
EP 784
DI 10.3928/23258160-20191119-05
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA JZ0XL
UT WOS:000504829700005
PM 31877223
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Park, S
   Boatwright, B
   Avery, EJ
AF Park, Sejin
   Boatwright, Brandon
   Avery, Elizabeth Johnson
TI Information channel preference in health crisis: Exploring the roles of
   perceived risk, preparedness, knowledge, and intent to follow directives
SO PUBLIC RELATIONS REVIEW
LA English
DT Article
DE Crisis communication; Media strategy; Health communication
ID SOCIAL MEDIA; SEEKING; SELECTION; MODEL; DIFFUSION; COMMUNITY; MESSAGES
AB The 2016 Zika virus epidemic presented a serious threat to public health and left publics confused and anxious about their risks. A survey (n = 370) was distributed in late Summer 2016 in the U.S., when public anxiety regarding Zika was peaking. Results indicate interesting differences in channel preferences based on audiences' preparedness, risk, and intention to follow crisis directives. Television news was the most important channels for Zika information, indicating the continued importance of traditional media in crisis communication.
C1 [Park, Sejin] Republ Korea Army, Gyeryong Si, South Korea.
   [Boatwright, Brandon; Avery, Elizabeth Johnson] Univ Tennessee, Knoxville, TN 37996 USA.
RP Park, S (corresponding author), 70 Yang Jung Jook Chon Ro, Young Dong 29152, Choong Book, South Korea.
EM sj4297@gmail.com
CR Ajzen I, 1985, ACTION CONTROL COGNI, DOI DOI 10.1007/978-3-642-69746-3_2
   Alexander DE, 2014, SCI ENG ETHICS, V20, P717, DOI 10.1007/s11948-013-9502-z
   Austin L, 2012, J APPL COMMUN RES, V40, P188, DOI 10.1080/00909882.2012.654498
   Avery E, 2010, J PUBLIC RELAT RES, V22, P378, DOI 10.1080/10627261003801404
   Avery E, 2010, J PUBLIC RELAT RES, V22, P336, DOI 10.1080/10627261003614427
   Avery EJ, 2017, PUBLIC RELAT REV, V43, P468, DOI 10.1016/j.pubrev.2017.02.018
   Avery EJ, 2014, HEALTH COMMUN, V29, P826, DOI 10.1080/10410236.2013.804486
   Avery EJ, 2009, J PUBLIC RELAT RES, V21, P187, DOI 10.1080/10627260802557449
   Belluck P., 2017, ONE 10 PREGNANT WOME
   Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057
   Bialik K, 2017, KEY TRENDS SOCIAL DI
   Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567
   Casler K, 2013, COMPUT HUM BEHAV, V29, P2156, DOI 10.1016/j.chb.2013.05.009
   Cho H, 2006, HEALTH COMMUN, V20, P91, DOI 10.1207/s15327027hc2001_9
   Colley K. L., 2009, PUBLIC RELATIONS STR, V19, P110
   Committee on Public Health, 2012, PUBL HLTH INV HLTH F
   DeLorme DE, 2011, J HEALTH COMMUN, V16, P766, DOI 10.1080/10810730.2011.561914
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Eastin M. S., 2001, J COMPUT-MEDIAT COMM, V6, DOI [10.1111/j.1083-6101.2001.tb00126.x, DOI 10.1111/J.1083-6101.2001.TB00126.X]
   Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3
   Faustino J. D, 2012, SOCIAL MEDIA DISASTE
   Fishbein M, 1975, BELIEF ATTITUDE INTE
   Fox S., 2013, HLTH ONLINE 2013
   Freberg K, 2013, PUBLIC RELAT REV, V39, P178, DOI 10.1016/j.pubrev.2013.02.007
   Freberg K, 2013, HEALTH COMMUN, V28, P359, DOI 10.1080/10410236.2012.688657
   Freberg K, 2012, PUBLIC RELAT REV, V38, P416, DOI 10.1016/j.pubrev.2012.01.008
   Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940
   Houston JB, 2015, DISASTERS, V39, P1, DOI 10.1111/disa.12092
   Hu BJ, 2014, CHIN J COMMUN, V7, P299, DOI 10.1080/17544750.2014.926951
   Jang K, 2019, HEALTH COMMUN, V34, P991, DOI 10.1080/10410236.2018.1449552
   Jennings F. J, 2019, J RISK RES, DOI [10.1080/13669877.2017.1449552, DOI 10.1080/13669877.2017.1449552]
   Kallas P., 2018, TOP 10 SOCIAL NETWOR
   Kees J, 2017, J ADVERTISING, V46, P141, DOI 10.1080/00913367.2016.1269304
   Kim J, 2017, HOWARD J COMMUN, V28, P234, DOI 10.1080/10646175.2016.1270862
   Li YB, 2018, TECHNOL FORECAST SOC, V126, P28, DOI 10.1016/j.techfore.2016.07.021
   Liu BF, 2011, PUBLIC RELAT REV, V37, P345, DOI 10.1016/j.pubrev.2011.08.004
   Morrow J. A, 2014, ANN M AM EV ASS
   Newkirk V. R., 2017, TRUMPS BUDGET WOULD
   OWEN N, 2002, HLTH BEHAV HLTH ED T, P510
   Park S, 2018, J CONTING CRISIS MAN, V26, P69, DOI 10.1111/1468-5973.12137
   Pokrywczynski J, 2019, J MASS COMMUN Q, V96, P239, DOI 10.1177/1077699018801315
   Reifegerste D, 2017, INT J MED INFORM, V103, P7, DOI 10.1016/j.ijmedinf.2017.04.006
   Reuter C, 2018, INT J HUM-COMPUT INT, V34, P280, DOI 10.1080/10447318.2018.1427832
   Reuter C, 2018, J CONTING CRISIS MAN, V26, P41, DOI 10.1111/1468-5973.12196
   Reuters, 2016, REUTERS
   Rimal RN, 2009, HEALTH COMMUN, V24, P210, DOI 10.1080/10410230902804109
   Rose KM, 2017, CAN J FOREST RES, V47, P1527, DOI 10.1139/cjfr-2017-0099
   Shannon CE, 1948, MATH THEORY COMMUNIC, P117
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Stieglitz S, 2013, J MANAGE INFORM SYST, V29, P217, DOI 10.2753/MIS0742-1222290408
   Thompson B., 2017, QUALITATIVE RES REPO, V18, P8
   Venkatraman A, 2016, TRAVEL MED INFECT DI, V14, P421, DOI 10.1016/j.tmaid.2016.05.018
   Vos SC, 2016, J HEALTH COMMUN, V21, P301, DOI 10.1080/10810730.2015.1064495
   Wang WR, 2015, SOC INFLUENCE, V10, P137, DOI 10.1080/15534510.2015.1011227
   Wedderhoff O, 2018, FRONTIERS COMMUNICAT, V3, P57
   Zhang X, 2019, HEALTH COMMUN, DOI [10.1080/10410236.2018.149202, DOI 10.1080/10410236.2018.149202]
   Zhao XQ, 2014, HEALTH COMMUN, V29, P574, DOI 10.1080/10410236.2013.784937
NR 57
TC 1
Z9 1
U1 22
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0363-8111
EI 1873-4537
J9 PUBLIC RELAT REV
JI Public Relat. Rev.
PD DEC
PY 2019
VL 45
IS 5
SI SI
AR UNSP 101794
DI 10.1016/j.pubrev.2019.05.015
PG 8
WC Business; Communication
SC Business & Economics; Communication
GA JX7LX
UT WOS:000503913300019
DA 2020-07-08
ER

PT J
AU de Oliveira, BSB
   Melo, FMD
   de Oliveira, RKL
   Neta, JFD
   Monteiro, FPM
   Joventino, ES
AF Bessa de Oliveira, Brena Shellem
   de Sousa Melo, Francisca Mayra
   Lopes de Oliveira, Rhaiany Kelly
   de Figueiredo Neta, Joana Furtado
   Magalhaes Monteiro, Flavia Paula
   Joventino, Emanuella Silva
TI Early stimulation in the development of children with microcephaly:
   maternal perception
SO REVISTA BRASILEIRA DE ENFERMAGEM
LA English
DT Article
DE Microcephaly; Child Development; Child Health; Zika Virus; Pediatric
   Nursing
ID ZIKA VIRUS; LIVE BIRTHS; BRAZIL
AB Objective: To know the maternal perception about early stimulation and its repercussion in the development of the child with microcephaly associated with zika virus. Method: A qualitative study was carried out from June to August 2017 with five mothers of children diagnosed with microcephaly associated with zika virus. The data were collected through individual interviews with semi-structured script and evaluated by the content analysis, in its thematic modality. Results: Mothers recognized the benefits and the advances in the development of the child after the beginning of the early stimulation. It is noteworthy that the difficulty of transportation was the main reason for the lack of attendance at consultations, and that the short time of stimulation was the main weakness of the service. Final considerations: The recognition of maternal perception and the difficulties and weaknesses of the service can contribute to the elaboration of public policies and the planning of holistic care for children with microcephaly and their families.
C1 [Bessa de Oliveira, Brena Shellem; de Sousa Melo, Francisca Mayra; Lopes de Oliveira, Rhaiany Kelly; Magalhaes Monteiro, Flavia Paula; Joventino, Emanuella Silva] Univ Integracao Int Lusofonia Afro Brasileira, Redencao, Ceara, Brazil.
   [de Figueiredo Neta, Joana Furtado] Policlin Doutor Clovis Amora Vasconcelos, Aracoiaba, Ceara, Brazil.
RP de Oliveira, BSB (corresponding author), Univ Integracao Int Lusofonia Afro Brasileira, Redencao, Ceara, Brazil.
EM brennashellem@gmail.com
OI Melo, Francisca/0000-0002-9622-7669
CR Abreu T. T., 2016, Revista de Ciencias Medicas e Biologicas, V15, P426, DOI 10.9771/cmbio.v15i3.18347
   Ansari NJR, 2016, J CLIN DIAGN RES, V10, pSC16, DOI 10.7860/JCDR/2016/22538.9039
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Botelho Ana Carla Gomes, 2016, Rev. Bras. Saude Mater. Infant., V16, P39, DOI 10.1590/1806-9304201600s100004
   Cabral CM, 2017, EPIDEMIOL SERV SAUDE, V26, P245, DOI [10.5123/S1679-49742017000200002, 10.5123/s1679-49742017000200002]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Escobar EMA, 2013, REV CIENC EXT, V9, P106
   Feitosa IML, 2016, BOL CIENT PEDIATR, V5, P75
   Franco V, 2016, EDUC REV-CURITIBA, P35, DOI 10.1590/0104-4060.44689
   Lucia CMD, 2017, RASBRAN, V8, P3
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Meireles NFP, 2017, ARCH HEALTH INVEST, V6, P495, DOI [10.21270/archi.v6i10.2256, DOI 10.21270/ARCHI.V6I10.2256]
   MINAYO M. C. S., 2015, PESQUISA SOCIAL TEOR
   Ministerio da Saude (BR), 2016, PROTOCOLO DE ATENCAO
   Ministerio da Saude (BR), 2016, PROTOCOLO DE VIGILAN
   Ministerio da Saude (BR), 2016, DIRETRIZES DE ESTIMU
   Ministerio da Saude (BR), 2016, A ESTIMULACAO PRECOC
   Ministerio da Saude (BR), 2015, PROTOCOLO DE ATENCAO
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Pedroso CNLS, 2014, REV CIENC SAUDE, V7, P61, DOI DOI 10.15448/1983-652X.2014.2.16464
   Pereira EL, 2017, CIENC SAUDE COLETIVA, V22, P3557, DOI 10.1590/1413-812320172211.22182017
   Pichini Fernanda dos Santos, 2016, Rev. CEFAC, V18, P55, DOI 10.1590/1982-021620161810915
   Sa FE, 2017, REV BRAS EDUC MED, V30, P1, DOI DOI 10.5020/18061230.2017.6629
   Santos RD, 2005, REV BRAS ENFERM, V58, P592, DOI 10.1590/S0034-71672005000500017
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silva PLN, 2015, ONLINE BRAZ J NURS, V14, P190, DOI [10.17665/1676-4285.20155199, DOI 10.17665/1676-4285.20155199]
   United Nations International Children's Emergency Fund (Unicef ), 2015, EARLY CHILDHOOD DEVE
   Veiga AS, 2017, REV CIENT INTERDISCI, V2, P116
NR 34
TC 0
Z9 0
U1 2
U2 2
PU ASSOC BRASILEIRA ENFERMAGEM
PI BRASILIA DF
PA SGA NORTE QUADRA 603 CONJ B AV L2 NORTE, BRASILIA DF, 70830-030, BRAZIL
SN 0034-7167
EI 1984-0446
J9 REV BRAS ENFERM
JI Rev. Bras. Enferm.
PD DEC
PY 2019
VL 72
SU 3
BP 139
EP 146
DI 10.1590/0034-7167-2018-0272
PG 8
WC Nursing
SC Nursing
GA JW1PZ
UT WOS:000502832700020
PM 31851246
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Huang, RL
   Zhu, H
   Shinn, P
   Ngan, D
   Ye, L
   Thakur, A
   Grewal, G
   Zhao, TG
   Southall, N
   Hall, MD
   Simeonov, A
   Austin, CP
AF Huang, Ruili
   Zhu, Hu
   Shinn, Paul
   Ngan, Deborah
   Ye, Lin
   Thakur, Ashish
   Grewal, Gurmit
   Zhao, Tongan
   Southall, Noel
   Hall, Mathew D.
   Simeonov, Anton
   Austin, Christopher P.
TI The NCATS Pharmaceutical Collection: a 10-year update
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID NIEMANN-PICK-DISEASE; EBOLA-VIRUS DISEASE; ZIKA VIRUS; STEM-CELLS;
   IDENTIFY COMPOUNDS; DRUGS; IDENTIFICATION;
   2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; COMBINATION; INHIBITORS
AB The National Center for Advancing Translational Sciences (NCATS) Pharmaceutical Collection (NPC), a comprehensive collection of clinically approved drugs, was made a public resource in 2011. Over the past decade, the NPC has been systematically profiled for activity across an array of pathways and disease models, generating an unparalleled amount of data. These data have not only enabled the identification of new repurposing candidates with several in clinical trials, but also uncovered new biological insights into drug targets and disease mechanisms. This retrospective provides an update on the NPC in terms of both successes and lessons learned. We also report our efforts in bringing the NPC up-to-date with drugs approved in recent years.
C1 [Huang, Ruili; Zhu, Hu; Shinn, Paul; Ngan, Deborah; Ye, Lin; Thakur, Ashish; Grewal, Gurmit; Zhao, Tongan; Southall, Noel; Hall, Mathew D.; Simeonov, Anton; Austin, Christopher P.] NIH, Div Preclin Innovat, NCATS, Rockville, MD 20850 USA.
RP Huang, RL (corresponding author), NIH, Div Preclin Innovat, NCATS, Rockville, MD 20850 USA.
EM huangru@mail.nih.gov
RI Southall, Noel/H-8991-2012
OI Southall, Noel/0000-0003-4500-880X; Thakur, Ashish/0000-0002-8456-1088
FU Intramural Program of the National Center for Advancing Translational
   Sciences, NIH
FX This work was supported by the Intramural Program of the National Center
   for Advancing Translational Sciences, NIH. R.H. coordinated the project,
   sourced and compiled drug lists to construct the updated NPC, helped
   with the NPC procurement, and wrote the manuscript; H.Z. and D.N. helped
   find drug sources, procured compounds for the NPC, and helped write the
   manuscript; P.S. helped procure compounds for the NPC and selected
   compounds for the NPC screening collection; L.Y. helped curate the drug
   list; A.T. and G.G. coordinated the custom synthesis of the new NPC
   compounds; T.Z. helped with the curation of the drug list; N.S. helped
   with the compilation and curation of the drug list; M.H. helped find
   drug sources; and C.P.A., A.S., and M.H. conceived and directed the
   project and helped write the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Baxter LL, 2012, NUTRIENTS, V4, P467, DOI 10.3390/nu4060467
   Bernstock JD, 2016, J CEREBR BLOOD F MET, V36, P426, DOI 10.1177/0271678X15609939
   Bixler Sandra L, 2017, Curr Treat Options Infect Dis, V9, P299, DOI 10.1007/s40506-017-0130-z
   Callaway E, 2014, NATURE, V508, P295, DOI 10.1038/508295a
   Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4
   Chen Catherine Z, 2012, Curr Chem Genomics, V6, P93, DOI 10.2174/1875397301206010093
   Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054
   Chen YM, 2012, CANCER-AM CANCER SOC, V118, P5811, DOI 10.1002/cncr.27623
   Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720
   Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306
   Cremers S, 2017, BRIT J CLIN PHARMACO, V83, P1607, DOI 10.1111/bcp.13331
   Dai S, 2017, AUTOPHAGY, V13, P1435, DOI 10.1080/15548627.2017.1329081
   Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576
   Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12
   FDA, 2014, NEW CHEM ENT EXCL DE
   Feasey N, 2010, BRIT MED BULL, V93, P179, DOI 10.1093/bmb/ldp046
   Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8
   FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0
   Gandin V, 2010, BIOCHEM PHARMACOL, V79, P90, DOI 10.1016/j.bcp.2009.07.023
   Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030
   Giubellino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090458
   Hamilton DH, 2016, CLIN CANCER RES, V22, P6204, DOI 10.1158/1078-0432.CCR-15-3059
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hu ZY, 2014, ANTIMICROB AGENTS CH, V58, P995, DOI 10.1128/AAC.02094-13
   Huang RL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22046-w
   Huang RL, 2016, METHODS MOL BIOL, V1473, P111, DOI 10.1007/978-1-4939-6346-1_12
   Huang RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10425
   Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862
   Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103
   Jacobson J M, 2000, Expert Opin Pharmacother, V1, P849, DOI 10.1517/14656566.1.4.849
   Jang SW, 2012, ACS CHEM BIOL, V7, P1205, DOI 10.1021/cb300048d
   Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166
   Karten B, 2003, J BIOL CHEM, V278, P4168, DOI 10.1074/jbc.M205406200
   Kean WF, 1997, BRIT J RHEUMATOL, V36, P560
   Keswani RK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23528
   Ketley A, 2014, HUM MOL GENET, V23, P1551, DOI 10.1093/hmg/ddt542
   Koh C, 2019, ANTIVIR RES, V163, P149, DOI 10.1016/j.antiviral.2019.01.017
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Kumari D, 2015, STEM CELL TRANSL MED, V4, P800, DOI 10.5966/sctm.2014-0278
   Lee JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130796
   Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651
   Long Y, 2016, STEM CELL TRANSL MED, V5, P1644, DOI 10.5966/sctm.2015-0373
   Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26
   McKew J, U.S. Patent, Patent No. [US20150216895A1, 20150216895]
   Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a
   Ory DS, 2017, LANCET, V390, P1758, DOI 10.1016/S0140-6736(17)31465-4
   Ottinger EA, 2014, CURR TOP MED CHEM, V14, P330, DOI 10.2174/1568026613666131127160118
   Patterson M.C, 2014, ONLINE METABOLIC MOL
   Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Rolt A, 2018, J INFECT DIS, V217, P1761, DOI 10.1093/infdis/jiy039
   Rosenbaum AI, 2009, BBA-MOL CELL BIOL L, V1791, P1155, DOI 10.1016/j.bbalip.2009.08.005
   Saba NS, 2013, BLOOD, V122
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681
   Schneider C, 2005, MOL NUTR FOOD RES, V49, P7, DOI 10.1002/mnfr.200400049
   Sharma S, 2019, CANCER-AM CANCER SOC, V125, P1432, DOI 10.1002/cncr.31931
   Shen MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057667
   Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342
   Sun W, 2017, ANTIVIR RES, V137, P165, DOI 10.1016/j.antiviral.2016.11.017
   Sun W, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.123
   Sun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070506
   Tam CS, 2010, NAT REV CLIN ONCOL, V7, P521, DOI 10.1038/nrclinonc.2010.101
   Tang YJ, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34607
   Thorne N, 2016, STEM CELL TRANSL MED, V5, P613, DOI 10.5966/sctm.2015-0170
   Trucco MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079950
   Tschapalda K, 2016, EBIOMEDICINE, V8, P49, DOI 10.1016/j.ebiom.2016.04.014
   Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x
   Vazquez-Ortiz G, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3682
   Wang LQ, 2016, COMB CHEM HIGH T SCR, V19, P855, DOI 10.2174/1386207319666161010163249
   White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8
   Xia MH, 2013, CANCER BIOL THER, V14, P638, DOI 10.4161/cbt.24596
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.357707
   Yu DZ, 2014, J BIOMOL SCREEN, V19, P1164, DOI 10.1177/1087057114537378
   Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216
NR 84
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
EI 1878-5832
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD DEC
PY 2019
VL 24
IS 12
BP 2341
EP 2349
DI 10.1016/j.drudis.2019.09.019
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JW8SP
UT WOS:000503317100014
PM 31585169
DA 2020-07-08
ER

PT J
AU Shoukat, A
   Vilches, T
   Moghadas, SM
AF Shoukat, Affan
   Vilches, Thomas
   Moghadas, Seyed M.
TI Cost-effectiveness of Prophylactic Zika Virus Vaccine in the Americas
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID FRENCH-POLYNESIA; BIRTH-DEFECTS; INFANTS; THRESHOLDS; DISEASE; UPDATE
AB Zika virus remains a major public health concern because of its association with microcephaly and other neurologic disorders in newborns. A prophylactic vaccine has the potential to reduce disease incidence and eliminate birth defects resulting from prenatal Zika virus infection in future outbreaks. We evaluated the cost-effectiveness of a Zika vaccine candidate, assuming a protection efficacy of 60%-90%, for 18 countries in the Americas affected by the 2015-2017 Zika virus outbreaks. Encapsulating the demographics of these countries in an agent-based model, our results show that vaccinating women of reproductive age would be very cost-effective for sufficiently low (<$16) vaccination costs per recipient, depending on the country-specific Zika attack rate. In all countries studied, the median reduction of microcephaly was >75% with vaccination. These findings indicate that targeted vaccination of women of reproductive age is a noteworthy preventive measure for mitigating the effects of Zika virus infection in future outbreaks.
C1 [Shoukat, Affan; Moghadas, Seyed M.] York Univ, Toronto, ON, Canada.
   [Vilches, Thomas] Sao Paulo State Univ, Botucatu, SP, Brazil.
   [Shoukat, Affan] Yale Univ, New Haven, CT USA.
RP Moghadas, SM (corresponding author), York Univ, Agent Based Modelling Lab, 4700 Keele St, Toronto, ON M3J 1P3, Canada.
EM moghadas@yorku.ca
OI Nogueira Vilches, Thomas/0000-0002-4980-7564
FU Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrazilCAPES [88881.132327/2016-01]; Canadian Foundation for Innovation
   (CFI)Canada Foundation for Innovation
FX This study was supported in part by the Natural Sciences and Engineering
   Research Council of Canada (NSERC), and Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES), Brazil, grant no.
   88881.132327/2016-01. The authors acknowledge the financial support of
   the Canadian Foundation for Innovation (CFI) for the establishment of
   the Areto Computational Cluster at York University that was used to
   perform simulations in this study.
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Bartsch SM, 2019, J INFECT DIS, V220, P920, DOI 10.1093/infdis/jiy688
   Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durham DP, 2018, ANN INTERN MED, V168, P621, DOI 10.7326/M17-0641
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Shoukat A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1091-x
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   WHO, 2017, ZIK SIT REP
   World Health Organization, 2017, ZIK VIR ZIKV VACC TA
   World Health Organization (WHO), 5 M EM COMM INT HLTH
   Zeng W, 2018, VACCINE, V36, P413, DOI 10.1016/j.vaccine.2017.11.064
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 33
TC 1
Z9 1
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2019
VL 25
IS 12
BP 2191
EP 2196
DI 10.3201/eid2512.181324
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA JX9ES
UT WOS:000504030700004
PM 31742512
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Griffin, I
   Martin, SW
   Fischer, M
   Chambers, TV
   Kosoy, OL
   Goldberg, C
   Falise, A
   Villamil, V
   Ponomareva, O
   Gillis, LD
   Blackmore, C
   Jean, R
AF Griffin, Isabel
   Martin, Stacey W.
   Fischer, Marc
   Chambers, Trudy V.
   Kosoy, Olga L.
   Goldberg, Cynthia
   Falise, Alyssa
   Villamil, Vanessa
   Ponomareva, Olga
   Gillis, Leah D.
   Blackmore, Carina
   Jean, Reynald
TI Zika Virus IgM 25 Months after Symptom Onset, Miami-Dade County,
   Florida, USA
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ANTIBODY; PERSISTENCE
AB We assessed IgM detection in Zika patients from the 2016 outbreak in Miami-Dade County, Florida, USA. Of those with positive or equivocal IgM after 12-19 months, 87% (26/30) had IgM 6 months later. In a survival analysis, approximate to 76% had IgM at 25 months. Zika virus IgM persists for years, complicating serologic diagnosis.
C1 [Griffin, Isabel; Goldberg, Cynthia; Falise, Alyssa; Villamil, Vanessa; Ponomareva, Olga; Jean, Reynald] Florida Dept Hlth Miami Dade Cty, Miami, FL USA.
   [Martin, Stacey W.; Fischer, Marc; Chambers, Trudy V.; Kosoy, Olga L.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Gillis, Leah D.] Bur Publ Hlth Labs, Miami, FL USA.
   [Blackmore, Carina] Florida Dept Hlth, Tallahassee, FL USA.
RP Griffin, I (corresponding author), Florida Dept Hlth Miami Dade Cty, Dept Epidemiol Dis Control & Immunizat Serv, 8175 NW 12th St,Ste 314, Miami, FL 33126 USA.
EM griffin.isabel@gmail.com
CR Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Gibney KB, 2012, AM J TROP MED HYG, V87, P1112, DOI 10.4269/ajtmh.2012.12-0182
   Griffin I, 2019, EMERG INFECT DIS, V25, P299, DOI 10.3201/eid2502.181286
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
NR 10
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2019
VL 25
IS 12
BP 2264
EP 2265
DI 10.3201/eid2512.191022
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA JX9ES
UT WOS:000504030700014
PM 31742511
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Godoy, AS
   Fernandes, RS
   Aguiar, ACC
   Bueno, RV
   Mesquita, NCDR
   Guido, RVC
   Oliva, G
AF de Godoy, Andre Schutzer
   Fernandes, Rafaela Sachetto
   Campos Aguiar, Anna Caroline
   Bueno, Renata Vieira
   de Moraes Roso Mesquita, Nathalya Cristina
   Carvalho Guido, Rafael Victorio
   Oliva, Glaucius
TI Structural and mechanistic insight from antiviral and antiparasitic
   enzyme drug targets for tropical infectious diseases
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Article
ID VIRUS NS3 PROTEASE; DENGUE VIRUS; CHIKUNGUNYA VIRUS; MEDICINAL
   CHEMISTRY; PEPTIDE INHIBITORS; ZIKA VIRUS; REPLICATION; HELICASE;
   POLYMERASE; SOFOSBUVIR
AB With almost half of the world population living at risk, tropical infectious diseases cause millions of deaths every year in developing countries. Considering the lack of economic prospects for investment in this field, approaches aiming the rational design of compounds, such as structure-based drug discovery (SBDD), fragment screening, target-based drug discovery, and drug repurposing are of special interest. Herein, we focused in the advances on the field of SBDD targeting arboviruses such as dengue, yellow fever, zika and chikungunya enzymes of the RNA replication complex (RC) and enzymes involved in a variety of pathways essential to ensure parasitic survival in the host, for malaria, Chagas e leishmaniasis diseases. We also highlighted successful examples such as promising new inhibitors and molecules already in preclinical/clinical phase tests, major gaps in the field and perspectives for the future of drug design for tropical diseases.
C1 [de Godoy, Andre Schutzer; Fernandes, Rafaela Sachetto; Campos Aguiar, Anna Caroline; Bueno, Renata Vieira; de Moraes Roso Mesquita, Nathalya Cristina; Carvalho Guido, Rafael Victorio; Oliva, Glaucius] Univ Sao Paulo, Inst Phys Sao Carlos, Ave Joao Dagnone 1100, BR-13563120 Sao Carlos, SP, Brazil.
RP Oliva, G (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Ave Joao Dagnone 1100, BR-13563120 Sao Carlos, SP, Brazil.
EM oliva@ifsc.usp.br
RI Godoy, Andre/AAF-2432-2020; Fernandes, Rafaela Sachetto/S-6721-2017;
   Guido, Rafael/A-7450-2009
OI Godoy, Andre/0000-0002-0613-9164; Fernandes, Rafaela
   Sachetto/0000-0002-4332-0448; Guido, Rafael/0000-0002-7187-0818
FU Sao Paulo Research Foundation - FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/07600-3, 2015/18192-9, 2016/19712-9,
   2018/05130-3]; National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [405330/2016-2, 307132/2016-1, 151058/2018-0]; Institute
   Serrapilheira [Serra-1708-16250]
FX The authors would like to thank the funding from the Sao Paulo Research
   Foundation - FAPESP (CEPID grant # 2013/07600-3 and post-doctoral grants
   2015/18192-9, 2016/19712-9, 2018/05130-3), The National Council for
   Scientific and Technological Development (grants 405330/2016-2,
   307132/2016-1, 151058/2018-0) and the Institute Serrapilheira (#grant
   Serra-1708-16250).
CR Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Bakar FA, 2018, VIRUSES, V10, P1
   Baragana B, 2015, NATURE, V522, P315, DOI 10.1038/nature14451
   Bassetto M, 2013, ANTIVIR RES, V98, P12, DOI 10.1016/j.antiviral.2013.01.002
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brown R. S, 2018, VIRUSES, V10, pE89
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Cowell Annie, 2018, Microbiol Insights, V11, p1178636118808529, DOI 10.1177/1178636118808529
   da Silva-Junior EF, 2017, BIOORGAN MED CHEM, V25, P4219, DOI 10.1016/j.bmc.2017.06.049
   de Lamballerie Xavier, 2009, Infectious Disorders - Drug Targets, V9, P101
   De Rycker M, 2018, NATURE, V559, P498, DOI 10.1038/s41586-018-0327-4
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   DELANG L, 2016, SCI REP, V6, P1
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Ferreira AC, 2018, ANTIMICROB AGENTS CH, V63
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953
   Holdgate GA, 2018, NAT REV DRUG DISCOV, V17, P115, DOI 10.1038/nrd.2017.219
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Knox JE, 2006, J MED CHEM, V49, P6585, DOI 10.1021/jm0607606
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Levitsky J, 2016, NEW ENGL J MED, V375, P2106, DOI 10.1056/NEJMc1611829
   Lim SP, 2019, ANTIVIR RES, V163, P156, DOI 10.1016/j.antiviral.2018.12.016
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Llanos-Cuentas A, 2018, LANCET INFECT DIS, V18, P874, DOI 10.1016/S1473-3099(18)30309-8
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Morillo CA, 2017, J AM COLL CARDIOL, V69, P939, DOI 10.1016/j.jacc.2016.12.023
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Paquet T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9735
   Phillips MA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6645
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Singh SK, 2011, REV MED VIROL, V21, P78, DOI 10.1002/rmv.681
   Silva SCSPE, 2016, EXP PARASITOL, V163, P68, DOI 10.1016/j.exppara.2016.01.007
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Tardugno R, 2018, BIOORGAN MED CHEM, V26, P869, DOI 10.1016/j.bmc.2018.01.002
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   World Health Organization, 2019, WORLD MAL REP 2018
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Wyllie S, 2018, NATURE, V560, P192, DOI 10.1038/s41586-018-0356-z
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
NR 49
TC 2
Z9 2
U1 2
U2 3
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
EI 1879-033X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD DEC
PY 2019
VL 59
BP 65
EP 72
DI 10.1016/j.sbi.2019.02.014
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA JW2JV
UT WOS:000502884900010
PM 30954758
DA 2020-07-08
ER

PT J
AU Parker, C
   Ramirez, D
   Connelly, CR
AF Parker, Casey
   Ramirez, Daviela
   Connelly, C. Roxanne
TI State-wide survey of Aedes aegypti and Aedes albopictus (Diptera:
   Culicidae) in Florida
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Florida; container mosquito;
   distribution
ID UNITED-STATES; STEGOMYIA AEGYPTI; SOUTH FLORIDA; DENGUE; COEXISTENCE;
   MOSQUITOS; SATYRIZATION; COMPETITION; RESISTANCE; OUTBREAK
AB Aedes aegypti and Aedes albopictus are invasive mosquito species with geographic ranges that have oscillated within Florida since their presence was first documented. Local transmission of dengue, chikungunya, and Zika viruses serves as evidence of the public health importance of these two species. It is important to have detailed knowledge of their distribution to aid in mosquito control efforts and understand the risk of arbovirus transmission to humans. Through a partnership involving the University of Florida Institute of Food and Agricultural Sciences Cooperative Extension Service and the Florida Medical Entomology Laboratory; the Florida Department of Health; and mosquito control agencies throughout Florida, a container mosquito surveillance program involving all life stages was launched in the summer of 2016 to detect the presence of Ae. aegypti and Ae. albopictus. Results from this survey were mapped to provide a picture of the current known distribution of Ae. aegypti and Ae. albopictus in Florida. Aedes aegypti and/or Ae. albopictus were detected in the 56 counties that were part of the survey. Only Aedes albopictus was detected in 26 counties, primarily in the panhandle region of Florida. The results of this work underscore the importance of maintaining container mosquito surveillance in a state where chikungunya, dengue, and Zika viruses are present and where there is continued risk for exotic arbovirus introductions.
C1 [Parker, Casey; Ramirez, Daviela; Connelly, C. Roxanne] Univ Florida, Inst Food & Agr Sci, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
   [Connelly, C. Roxanne] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
RP Parker, C (corresponding author), Univ Florida, Inst Food & Agr Sci, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
EM caseyparker@ufl.edu
OI Parker, Casey/0000-0002-4173-0881
FU Florida Department of Health [C0064]; CODNW; University of Florida Open
   Access Publishing Fund
FX This work was funded in part by the Florida Department of Health,
   Contract C0064 and CODNW. For assistance with immature mosquito field
   collections, sorting and identifications, we thank Aimee Cooper, Bradley
   Eastmond, Sheila O'Connell, and Anna Carels; for field trip
   organization, rearing room organization, and mosquito identification, we
   thank Carol Thomas; for assistance with data mining, we thank Andrew
   Paige; for sharing egg collection sites and data, we thank Al Estep,
   USDA; for internal review of the manuscript, we thank Dr. George
   O'Meara, Dr. Jorge Rey, and Dr. Nathan Burkett-Cadena. We are thankful
   to the dozens of Florida mosquito control workers, agencies, and
   individuals who were involved in this survey and recognize that this
   work was possible due to their participation. Publication of this
   article was funded in part by the University of Florida Open Access
   Publishing Fund.
CR Arevalo M.T., 2015, J HUMAN VIROL, V2, P1
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Bargielowski IE, 2016, INSECT SCI, V23, P162, DOI 10.1111/1744-7917.12291
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bradley G. H., 1953, P NEW JERSEY MOSQ EX, V104
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Burkett-Cadena N. D, 2013, MOSQUITOES SE US
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CARPENTER SJ, 1955, MOSQUITOES N AM N ME
   CDC, 2017, EST RANG AED AEG AED
   Craig G.B. Jr, 1983, Progress in Clinical and Biological Research, V123, P329
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Darsie Jr. R.F., 2003, KEYS ADULT FEMALES 4
   Darsie R.F. Jr, 1981, Mosquito Systematics Supplement, V1, P1
   Dickens BL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000801
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Gratz N., 1994, TROP MED, V35, P243
   GRIMSTAD PR, 1977, AM J TROP MED HYG, V26, P990, DOI 10.4269/ajtmh.1977.26.990
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   HAYES GEORGE R., 1958, MOSQUITO NEWS, V18, P253
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Hopperstad KA, 2016, J MED ENTOMOL, V53, P836, DOI 10.1093/jme/tjw050
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Kendrick K., 2014, NOTES FIELD TRANSMIS
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142
   Lounibos LP, 2016, J MED ENTOMOL, V53, P1385, DOI 10.1093/jme/tjw122
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   MOORE CG, 1990, J AM MOSQUITO CONTR, V6, P173
   MORLAN HB, 1965, AM J TROP MED HYG, V14, P892, DOI 10.4269/ajtmh.1965.14.892
   Murray HL, 2018, J MED ENTOMOL, V55, P1607, DOI 10.1093/jme/tjy102
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   OMEARA GF, 1997, ASIAN TIGER MOSQUITO
   PEACOCK BE, 1988, J AM MOSQUITO CONTR, V4, P362
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Riles MT, 2017, J AM MOSQUITO CONTR, V33, P340, DOI 10.2987/17-6696.1
   SMITH JP, 1990, J AM MOSQUITO CONTR, V6, P318
   TINKER MILTON E., 1959, MOSQUITO NEWS, V19, P73
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
NR 40
TC 1
Z9 1
U1 2
U2 2
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
SN 1081-1710
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD DEC
PY 2019
VL 44
IS 2
BP 210
EP 215
DI 10.1111/jvec.12351
PG 6
WC Entomology
SC Entomology
GA JV1OP
UT WOS:000502138300001
PM 31729793
OA Bronze
DA 2020-07-08
ER

PT J
AU Andrade, PD
   Urbinatti, PR
   Coelho, RD
   Almeida, RMMD
   Ribeiro, SS
   de Lima-Camara, TN
AF Andrade, Pamela dos Santos
   Urbinatti, Paulo Roberto
   Coelho, Ronan da Rocha
   Marques de Sa Almeida, Rosa Maria
   Ribeiro, Sabrina Santana
   de Lima-Camara, Tamara Nunes
TI Parity and gonotrophic discordance of females of Aedes aegypti and Aedes
   albopictus (Diptera: Culicidae) in the city of SAo Paulo, SP, Brazil
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Mosquito vectors; arbovirus; transmission; parity; ovaries; gonotrophic
   discordance
ID HOST-SEEKING BEHAVIOR; DENGUE VIRUS TYPE-3; CHIKUNGUNYA VIRUS; VECTORIAL
   CAPACITY; YELLOW-FEVER; ZIKA VIRUS; BODY-SIZE; POPULATION; MOSQUITOS;
   COMPETENCE
AB The objective of this study was to assess the parity, presence of blood in the stomach, and the gonotrophic discordance of females of Aedes aegypti and Aedes albopictus captured in two areas of the city of SAo Paulo. The captures were undertaken monthly, by aspiration, in the period from January, 2015 to August, 2017. All the females of the two species had their midguts and ovaries dissected to determine the presence of blood and the parity/stage of maturation. With regard to parity, 27% and 34% of the females of Ae. aegypti and Ae. albopictus, respectively, were parous or were in advanced stages of the development of their ovaries (33% and 27%, respectively). The larger part of the females of Ae. aegypti and Ae. albopictus contained blood in their stomachs (77% and 60%, respectively), beyond which 36% and 27% of the females of Ae. aegypti and Ae. albopictus, respectively, were in gonotrophic discordance. Our results indicate favorable conditions in the study areas because of the presence of parous females. Moreover, this frequent and multiple contact of Ae. aegypti and Ae. albopictus females with vertebrate hosts, such as humans, increases the possibility of transmitting the viruses they may be carrying.
C1 [Andrade, Pamela dos Santos; Urbinatti, Paulo Roberto; Coelho, Ronan da Rocha; Marques de Sa Almeida, Rosa Maria; Ribeiro, Sabrina Santana; de Lima-Camara, Tamara Nunes] Univ Sao Paulo, Sch Publ Hlth, Lab Entomol Publ Hlth, Sao Paulo, SP, Brazil.
   [Urbinatti, Paulo Roberto; Marques de Sa Almeida, Rosa Maria; de Lima-Camara, Tamara Nunes] Univ Sao Paulo, Sch Publ Hlth, Epidemiol Dept, Sao Paulo, SP, Brazil.
   [de Lima-Camara, Tamara Nunes] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
RP de Lima-Camara, TN (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Lab Entomol Publ Hlth, Sao Paulo, SP, Brazil.; de Lima-Camara, TN (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Epidemiol Dept, Sao Paulo, SP, Brazil.; de Lima-Camara, TN (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM limacamara@usp.br
CR Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2
   Barata EAMD, 2001, REV SAUDE PUBL, V35, P237, DOI 10.1590/S0034-89102001000300004
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   CEPEUSP, 2016, PARQ ESP TOD ESP PRI
   CHAMBERS GM, 1990, J AM MOSQUITO CONTR, V6, P394
   Charlwood J.D., 1980, REVISAO COM ESPECIAL, V10, P311
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CHRISTOPHERS SR, 1960, AEDES AEGYPTI YELLOW
   Clements A.N., 1992, BIOL MOSQUITOES DEV
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   de Castro MG, 2004, MEM I OSWALDO CRUZ, V99, P809, DOI 10.1590/S0074-02762004000800005
   Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013
   DETINOVA TS, 1962, WHO MONOGRAPH SERIES, V47
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Fernandez Z, 2003, REV SAUDE PUBL, V37, P285, DOI 10.1590/S0034-89102003000300004
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gottfried KL, 2002, J AM MOSQUITO CONTR, V18, P164
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hien D.S., 1976, ACTA PARASITOL POL, V24, P34
   Hoeck PAE, 2003, J VECTOR ECOL, V28, P65
   Honorio N.A., 2017, CAD SAUDE PUBLICA, V31, P906
   KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P583, DOI 10.1016/0022-1910(79)90073-8
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006245, 10.1590/s1518-8787.2016050006245]
   Lima-Camara TN, 2007, J VECTOR ECOL, V32, P34, DOI DOI 10.3376/1081-1710(2007)32[34:PA0D0A]2.0.C0;2
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   MACDONALD W W, 1956, Ann Trop Med Parasitol, V50, P399
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Mer G. G., 1936, Bulletin of Entomological Research London, V27, P351, DOI 10.1017/S0007485300058193
   MILLER BR, 1988, T ROY SOC TROP MED H, V82, P476, DOI 10.1016/0035-9203(88)90168-X
   Bermudi PMM, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051000087, 10.11606/s1518-8787.2017051000087]
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Stenn T, 2019, J MED ENTOMOL, V56, P10, DOI 10.1093/jme/tjy148
   Tauil PL, 2010, REV SAUDE PUBL, V44, P555, DOI 10.1590/S0034-89102010005000014
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   de Deus JT, 2006, REV SAUDE PUBL, V40, P505, DOI 10.1590/S0034-89102006000300020
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Valerio L, 2012, AM J TROP MED HYG, V86, P665, DOI 10.4269/ajtmh.2012.11-0513
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   WILLIS FS, 1994, J MED ENTOMOL, V31, P594, DOI 10.1093/jmedent/31.4.594
   XUE RD, 1995, J MED ENTOMOL, V32, P471, DOI 10.1093/jmedent/32.4.471
NR 54
TC 1
Z9 1
U1 0
U2 0
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
SN 1081-1710
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD DEC
PY 2019
VL 44
IS 2
BP 233
EP 240
DI 10.1111/jvec.12354
PG 8
WC Entomology
SC Entomology
GA JV1OP
UT WOS:000502138300004
PM 31729798
OA Bronze
DA 2020-07-08
ER

PT J
AU Gamboa, LF
   Lesmes, PR
AF Fernando Gamboa, Luis
   Rodriguez Lesmes, Paul
TI The fertility-inhibiting effect of mosquitoes: Socio-economic
   differences in response to the Zika crisis in Colombia
SO ECONOMICS & HUMAN BIOLOGY
LA English
DT Article
DE Zika; Fertility; Synthetic control; Colombia
ID PROPENSITY SCORE; HIV; BEHAVIOR
AB We estimated the impact of the Zika virus outbreak on birth rates and demand for health care services in Colombia. Our analysis exploits the variation in the level of natural protection against mosquito-transmitted diseases across the country. This characteristic induced exogenous variation in Zika incidence, which allows us to construct a control group of municipalities with similar historical fertility trends but with differential exposure to the Zika crisis. We implemented a difference-in-differences model after matching, as well as synthetic control. We found a decrease in birth rates of approx.10% in the last two quarters of 2019. The impact of the virus was similar irrespective of the women's education level, and we found no discernible impact on teenage pregnancy. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Rodriguez Lesmes, Paul] Univ Rosario, Cl 12c 4-59, Bogota 11001, Colombia.
   [Fernando Gamboa, Luis] Univ Jorge Tadeo Lozano, Cra 4 22-61, Bogota, Colombia.
RP Lesmes, PR (corresponding author), Univ Rosario, Cl 12c 4-59, Bogota 11001, Colombia.
EM luisfw.gamboan@utadeo.edu.co; paul.rodriguez@urosario.edu.co
RI ; Rodriguez-Lesmes, Paul/S-1357-2017
OI Gamboa Nino, Luis Fernando/0000-0002-7273-7381; Rodriguez-Lesmes,
   Paul/0000-0003-1058-3062
CR Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188
   Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307
   Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746
   Adda J, 2007, J RISK UNCERTAINTY, V35, P285, DOI 10.1007/s11166-007-9026-5
   Adda J, 2016, Q J ECON, V131, P891, DOI 10.1093/qje/qjw005
   Barron K, 2019, J DEV STUD, V55, P620, DOI 10.1080/00220388.2018.1425392
   Blundell R, 2009, J HUM RESOUR, V44, P565, DOI 10.1353/jhr.2009.0009
   Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x
   Callaway B, 2018, ARXIV180309015
   Cavallo E, 2013, REV ECON STAT, V95, P1549, DOI 10.1162/REST_a_00413
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Collinson S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-376
   Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9
   Galiani S, 2017, STATA J, V17, P834, DOI 10.1177/1536867X1701700404
   Gregson S, 1998, SOC SCI MED, V46, P321, DOI 10.1016/S0277-9536(97)00165-2
   Jaeger D.A., 2018, J BUSINESS EC STAT, P1, DOI DOI 10.1080/07350015.2018.1497510
   Johnson KB, 2009, AIDS, V23, pS7, DOI 10.1097/01.aids.0000363773.83753.27
   Junior I.L, 2019, ANATOMY PUBLIC UNPUB
   Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Leuven E., 2003, PSMATCH2 STATA MODUL
   Ministerio de Salud y Proteccitm Social and Profamilia, 2017, COL ENC NAC DEM SAL
   de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X
   Moore AM, 2014, SOC SCI MED, V119, P88, DOI 10.1016/j.socscimed.2014.08.015
   Murray DR, 2013, PERS INDIV DIFFER, V54, P103, DOI 10.1016/j.paid.2012.08.021
   National Research Council, 1998, DEATH BIRTH MORTALIT, DOI [10.17226/5842, DOI 10.17226/5842]
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Ploem C, 1997, J Psychol Human Sex, V9, P1, DOI 10.1300/J056v09n01_01
   Quintana-Domeque C, 2018, ECON HUM BIOL, V30, P14, DOI 10.1016/j.ehb.2018.04.003
   Reitman D, 1996, AIDS EDUC PREV, V8, P499
   ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Viscusi WK, 1997, ECON J, V107, P1657, DOI 10.1111/1468-0297.00248
   World Health Organization, 2018, ZIK VIR FACT SHEET
   Yan QL, 2016, J THEOR BIOL, V390, P1, DOI 10.1016/j.jtbi.2015.11.002
NR 36
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-677X
EI 1873-6130
J9 ECON HUM BIOL
JI Econ. Hum. Biol.
PD DEC
PY 2019
VL 35
BP 63
EP 72
DI 10.1016/j.ehb.2019.05.001
PG 10
WC Economics; Public, Environmental & Occupational Health
SC Business & Economics; Public, Environmental & Occupational Health
GA JU4ND
UT WOS:000501653400006
PM 31154121
DA 2020-07-08
ER

PT J
AU Hossain, MG
   Nazir, KHMNH
   Saha, S
   Rahman, MT
AF Hossain, Md. Golzar
   Nazir, K. H. M. Nazmul Hussain
   Saha, Sukumar
   Rahman, Md. Tanvir
TI Zika virus: A possible emerging threat for Bangladesh!
SO JOURNAL OF ADVANCED VETERINARY AND ANIMAL RESEARCH
LA English
DT Review
DE Zika virus; Bangladesh; Aedes mosquitoes; Zika diagnosis and Zika
   prevention
ID UNITED-STATES; INFECTION; TRANSMISSION; OUTBREAK; DENGUE; CHALLENGES;
   ANTIBODIES; BIOLOGY; ORIGIN; SPREAD
AB Zika virus, a member of Flaviviridae is the etiology of Zika or Zika fever or Zika virus (ZIKV) disease characterized by mild symptoms similar to very mild form of Dengue or Chikungunya. The virus transmits through Aedes mosquitoes, particularly by Aedes aegypti. The most dangerous effect of ZIKV infection is the ability of the virus to cause microcephaly and congenital malformation to the newborn baby if the mother is infected. The neurological disorders including Guillain-Barre syndrome might be associated with adults and children due to ZIKV infections. Zika has emerged as a serious global public health problem as it has been found in 87 countries, particularly in Africa, America, and Asia and has no vaccine and treatment so far. Bangladesh is at a high risk of ZIKV infection and we consider ZIKV as a possible emerging threat for Bangladesh. This short review summarizes the insights of ZIKV infection, present status of the disease in Bangladesh and its neighboring countries, and recommendations for necessary preparations and strategies to be taken for effective controlling of the ZIKV infection in Bangladesh before getting any havoc.
C1 [Hossain, Md. Golzar; Nazir, K. H. M. Nazmul Hussain; Saha, Sukumar; Rahman, Md. Tanvir] Bangladesh Agr Univ, Dept Microbiol & Hyg, Fac Vet Sci, Mymensingh 2202, Bangladesh.
   [Hossain, Md. Golzar] Osaka Univ, Grad Sch Med, Div Virol, Dept Microbiol & Immunol, Suita, Osaka, Japan.
RP Hossain, MG (corresponding author), Bangladesh Agr Univ, Dept Microbiol & Hyg, Fac Vet Sci, Mymensingh 2202, Bangladesh.; Hossain, MG (corresponding author), Osaka Univ, Grad Sch Med, Div Virol, Dept Microbiol & Immunol, Suita, Osaka, Japan.
EM mghossain@bau.edu.bd
RI Hossain, Golzar/N-7468-2019
OI Hossain, Golzar/0000-0002-1487-5444; Nazir, K H M Nazmul
   Hussain/0000-0002-3893-754X
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Adams MJ, 2015, ARCH VIROL, V160, P1375, DOI 10.1007/s00705-015-2376-4
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Ali MY, 2016, FARIDPUR MED COLL J, V11, DOI 10.3329/fmcj.v11i1.30867
   Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, LANCET INFECT DIS, V16, P866, DOI 10.1016/S1473-3099(16)30117-7
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   Dhar-Chowdhury P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005475
   Dhimal M, 2016, J NEPAL HLTH RES COU, DOI [10.33314/jnhrc.v0i0.686, DOI 10.33314/JNHRC.V0I0.686]
   Diaz JH, 2016, WILD ENVIRON MED, V27, P450, DOI 10.1016/j.wem.2016.07.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Chu DT, 2017, EUR J CLIN MICROBIOL, V36, P2041, DOI 10.1007/s10096-017-3030-8
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Gonzalez JP, 2018, METHODS MOL BIOL, V1604, P3, DOI 10.1007/978-1-4939-6981-4_1
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hery L, 2019, EMERG MICROBES INFEC, V8, P699, DOI 10.1080/22221751.2019.1615849
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hraber P, 2018, VACCINE, V36, P6911, DOI 10.1016/j.vaccine.2018.10.022
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.3290
   Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012
   Jiang D, 2018, ACTA TROP, V185, P391, DOI 10.1016/j.actatropica.2018.06.021
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Khurshid Z, 2019, J INFECT PUBLIC HEAL, V12, P601, DOI 10.1016/j.jiph.2019.05.004
   Khusro A, 2018, MICROB PATHOGENESIS, V116, P289, DOI 10.1016/j.micpath.2018.02.001
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Mlacker S, 2016, INT J DERMATOL, V55, P1369, DOI 10.1111/ijd.13399
   Muraduzzaman AKM, 2017, ASIAN PAC J TROP MED, V10, P925, DOI 10.1016/j.apjtm.2017.08.015
   Musso D, 2018, CLIN MICROBIOL INFEC, V24, P566, DOI 10.1016/j.cmi.2018.03.007
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Peregrine J, 2020, J VIROL, V94, DOI 10.1128/JVI.01434-19
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rahman MT, 2017, J ADV VET ANIM RES, V4, P125, DOI 10.5455/javar.2017.d211
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sharmin S, 2015, T ROY SOC TROP MED H, V109, P619, DOI 10.1093/trstmh/trv067
   Shehu Nathan Yakubu, 2018, Niger Postgrad Med J, V25, P67, DOI 10.4103/npmj.npmj_36_18
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Siqueira WL, 2016, ORAL HLTH, P1
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Streatfield PK, 2008, J HEALTH POPUL NUTR, V26, P261
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tuite AR, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz063
   Tun MMN, 2018, AM J TROP MED HYG, V98, P868, DOI 10.4269/ajtmh.17-0708
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   WHO, 2019, ZIK EP UPD 2019
   Woon YL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3786-9
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 75
TC 0
Z9 0
U1 2
U2 2
PU NETWORK VETERINARIANS BANGLADESH
PI MYMENSINGH
PA FAC VETERINARY SCIENCE, BANGLADESH AGRICULTURAL UNIV, MYMENSINGH, 2202,
   BANGLADESH
EI 2311-7710
J9 J ADV VET ANIM RES
JI J. Adv. Vet. Anim. Res.
PD DEC
PY 2019
VL 6
IS 4
BP 575
EP 582
DI 10.5455/javar.2019.f385
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA JT5HU
UT WOS:000501021600022
PM 31819889
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ismail, AA
   Mahboob, T
   Raju, CS
   Sekaran, SD
AF Ismail, A. A.
   Mahboob, T.
   Raju, Samudi C.
   Sekaran, S. D.
TI Zika virus modulates blood-brain barrier of brain microvascular
   endothelial cells
SO TROPICAL BIOMEDICINE
LA English
DT Article
ID DENGUE VIRAL LOAD; INFECTION; EXPRESSION; GROWTH
AB Zika virus (ZIKV) is a mosquito-borne Flaviviruses. ZIKV is known to cause birth defect in pregnant women, especially microcephaly in the fetus. Hence, more study is required to understand the infection of Zika virus towards human brain microvascular endothelial cells (MECs). In this study, brain MECs were infected with ZIKV at MOI of 1 and 5 in vitro. The changes in barrier function and membrane permeability of ZIKV-infected brain MECs were determined using electric cell-substrate impedance sensing (ECIS) system followed by gene expression of ZIKV-infected brain MECs at 24 hours post infection using one-color gene expression microarray. The ECIS results demonstrated that ZIKV infection enhances vascular leakage by increasing cell membrane permeability via alteration of brain MECs barrier function. This was further supported by high expression of proinflammatory cytokine genes (lnc-IL6-2, TNFAIP1 and TNFAIP6), adhesion molecules (CERCAM and ESAM) and growth factor (FIGF). Overall, findings of this study revealed that ZIKV infection could alter the barrier function of brain MECs by altering adhesion molecules and inflammatory response.
C1 [Ismail, A. A.; Mahboob, T.; Raju, Samudi C.] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.
   [Sekaran, S. D.] MAHSA Univ, Fac Med & Biomed Sci, Jenjarom, Selangor, Malaysia.
RP Raju, CS (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.; Sekaran, SD (corresponding author), MAHSA Univ, Fac Med & Biomed Sci, Jenjarom, Selangor, Malaysia.
EM chandramathi@um.edu.my; shamaladevi@mahsa.edu.my
RI Sekaran, Shamala Devi/B-8482-2008
OI Sekaran, Shamala Devi/0000-0002-0478-0425
FU University of MalayaUniversiti Malaya; Malaysia Ministry of Higher
   EducationMinistry of Education, Malaysia; Fundamental Research Grant
   Scheme (FRGS) by Ministry of Higher Education, Malaysia [FP005-2017A];
   University of Malaya Research Grant [UMRG-RP021C-13HTM]
FX We thank University of Malaya and Malaysia Ministry of Higher Education
   for providing the support to conduct this study. This project was
   financially supported by Fundamental Research Grant Scheme (FRGS):
   FP005-2017A by Ministry of Higher Education, Malaysia and also
   University of Malaya Research Grant (UMRG-RP021C-13HTM).
CR Al-Obaidi MMJ, 2017, VIRUS RES, V233, P17, DOI 10.1016/j.virusres.2017.02.012
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azouz F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020162
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017
   Iani FCD, 2016, AM J TROP MED HYG, V95, P193, DOI 10.4269/ajtmh.15-0537
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ferreira RN, 2018, VIRAL IMMUNOL, V31, P583, DOI 10.1089/vim.2017.0186
   Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Nag S., 2003, BLOOD BRAIN BARRIER, V89
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Nomaguchi Masako, 2012, Front Microbiol, V3, P281, DOI 10.3389/fmicb.2012.00281
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pal T, 2014, J CLIN VIROL, V61, P365, DOI 10.1016/j.jcv.2014.09.003
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rubin E.J., 2016, ZIKA VIRUS MICROCEPH
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Soe HJ, 2017, J GEN VIROL, V98, P2993, DOI 10.1099/jgv.0.000981
   Szulcek R, 2014, JOVE-J VIS EXP, V85, P1
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   Xu X., 2016, PLOS CURRENTS, V8
   Zandi K, 2012, MOLECULES, V17, P2437, DOI 10.3390/molecules17032437
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 35
TC 0
Z9 0
U1 0
U2 0
PU MALAYSIAN SOC PARASITOLOGY TROPICAL MEDICINE
PI KUALA LUMPUR
PA C/O INST MEDICAL REEARCH, JALAN PAHANG, KUALA LUMPUR, 50588, MALAYSIA
SN 0127-5720
J9 TROP BIOMED
JI Trop. Biomed.
PD DEC
PY 2019
VL 36
IS 4
BP 888
EP 897
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JT4II
UT WOS:000500954500010
DA 2020-07-08
ER

PT J
AU Nagy, O
   Nagy, A
   Toth, S
   Palyi, B
   Koroknai, AV
   Takacs, M
AF Nagy, Orsolya
   Nagy, Anna
   Toth, Szilvia
   Palyi, Bernadett
   Koroknai, Anita Vargane
   Takacs, Maria
TI IMPORTED ZIKA VIRUS INFECTIONS IN HUNGARY BETWEEN 2016 AND 2018
SO ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
LA English
DT Article
DE Zika cases; phylogenetic tree; serological cross-reactivity
ID WEST-NILE-VIRUS; DENGUE VIRUS; CROSS-REACTIVITY; STRUCTURAL BASIS;
   YELLOW-FEVER; WHOLE-BLOOD; RESPONSES; BRAZIL; URINE; RNA
AB Zika virus is a mosquito-borne flavivirus with significant public health concern due to its association with neurological symptoms and intrauterine malformations. Although it is endemic in tropical and subtropical areas, sexual transmission raises the possibility of autochthonous spreading elsewhere. We describe the first laboratory diagnosed imported Zika-infections of Hungary, to highlight the challenges of microbiological identification of the pathogen, caused by serological cross-reactivity and short viremia. Serological examination was carried out using indirect immunofluorescent assay and enzyme-linked immunosorbent assay. Plaque-reduction neutralization test was used for verification purposes. A wide range of clinical specimens: serum, whole-blood, urine, saliva, and semen were analyzed by molecular methods, and sequencing was applied in case of PCR positive results to identify the virus strain. Zika-infected patients with previous vaccination against flaviviruses or possible flavivirus infection in the past showed high serological cross-reactivity, and even cross-neutralizing antibodies were observed. Zika virus RNA could be detected in urine specimen in case of two patients, and in EDTA-anticoagulated whole-blood sample of one patient. The detected strains belong to the Asian lineage of the virus. We presume that serological investigation of imported Zika virus could be altered by infections, vaccination of endemic flaviviruses in Hungary and vice versa.
C1 [Nagy, Orsolya; Nagy, Anna; Palyi, Bernadett; Koroknai, Anita Vargane; Takacs, Maria] Natl Publ Hlth Ctr, Dept Virol, Budapest, Hungary.
   [Nagy, Orsolya; Takacs, Maria] Semmelweis Univ, Inst Med Microbiol, Budapest, Hungary.
   [Toth, Szilvia] Cent Hosp Southern Pest, Natl Inst Hematol & Infect Dis, Budapest, Hungary.
RP Takacs, M (corresponding author), Natl Publ Hlth Ctr, Dept Virol, Budapest, Hungary.; Takacs, M (corresponding author), Semmelweis Univ, Inst Med Microbiol, Budapest, Hungary.
EM takmar@gmail.com
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   Avsic Zupanc Tatjana, 2016, Zdr Varst, V55, P228
   Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07
   Balogh Z, 2012, INTERVIROLOGY, V55, P194, DOI 10.1159/000324023
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Beaute J, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.45.1800201
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   CDC, 2017, UPD GUID US LAB TEST
   Chanama S, 2004, J CLIN VIROL, V31, P185, DOI 10.1016/j.jcv.2004.03.005
   Ciocchetta S, 2018, PATHOG GLOB HEALTH, V112, P107, DOI 10.1080/20477724.2018.1464780
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dorigatti I, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.28.30572
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Erber W, 2018, TICKS TICK-BORNE DIS, V9, P768, DOI 10.1016/j.ttbdis.2018.02.007
   European Centre for Disease Prevention and Control, 2019, AED AEG CURR KNOWN D
   European Centre for Disease Prevention and Control, 2019, AED KOR CURR KNOWN D
   European Centre for Disease Prevention and Control, 2019, AED JAP CURR KNOWN D
   European Centre for Disease Prevention and Control (ECDC), 2016, INT GUID HEALTHC PRO
   European Centre for Disease Prevention and Control European Food Safety Authority, 2019, AED ALB CURR KNOWN D
   Fields B. N, 2007, FIELDS VIROLOGY, P1153
   Haaheim L R, 2003, Dev Biol (Basel), V115, P49
   Haussig JM, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.32.1800428
   Ingelbeen B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0007029
   Jansen S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0195-x
   Kaiser R, 2008, INFECT DIS CLIN N AM, V22, P561, DOI 10.1016/j.idc.2008.03.013
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Khan AW, 2017, ACTA MICROBIOL IMM H, V64, P353, DOI 10.1556/030.64.2017.034
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Nagy A, 2019, EUROSURVEILLANCE, V24, P24, DOI 10.2807/1560-7917.ES.2019.24.28.1900038
   Nagy A, 2016, ARCH VIROL, V161, P1797, DOI 10.1007/s00705-016-2844-5
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Selemane I, 2019, TRAVEL MED INFECT DI, V28, P46, DOI 10.1016/j.tmaid.2018.12.008
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tamas B, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.72
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   WHO, 2007, GUID PLAQ RED NEUTR
   World Health Organization, 2016, ZIK VIR TECHN REP IN
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 58
TC 0
Z9 0
U1 0
U2 0
PU AKADEMIAI KIADO ZRT
PI BUDAPEST
PA BUDAFOKI UT 187-189-A-3, H-1117 BUDAPEST, HUNGARY
SN 1217-8950
EI 1588-2640
J9 ACTA MICROBIOL IMM H
JI Acta Microbiol. Immunol. Hung.
PD DEC
PY 2019
VL 66
IS 4
BP 423
EP 442
DI 10.1556/030.66.2019.025
PG 20
WC Immunology; Microbiology
SC Immunology; Microbiology
GA JS8RW
UT WOS:000500570100002
PM 31658836
OA Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Wilburn, J
   O'Connor, C
   Walsh, AL
   Morgan, D
AF Wilburn, Jennifer
   O'Connor, Catherine
   Walsh, Amanda L.
   Morgan, Dilys
TI Identifying potential emerging threats through epidemic intelligence
   activities-looking for the needle in the haystack?
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Epidemic intelligence; Disease surveillance; Early detection;
   Surveillance systems; Epidemiology
ID ZIKA VIRUS; OUTBREAK; SURVEILLANCE; HEALTH; NETWORK
AB Background: Epidemic intelligence (EI) for emerging infections is the process of identifying key information on emerging infectious diseases and specific incidents. Automated web-based infectious disease surveillance technologies are available; however, human input is still needed to review, validate, and interpret these sources. In this study, entries captured by Public Health England's (PHE) manual event-based EI system were examined to inform future intelligence gathering activities.
   Methods: A descriptive analysis of unique events captured in a database between 2013 and 2017 was conducted. The top five diseases in terms of the number of entries were described in depth to determine the effectiveness of PHE's EI surveillance system compared to other sources.
   Results: Between 2013 and 2017, a total of 22 847 unique entries were added to the database. The top three initial and definitive information sources varied considerably by disease. Ebola entries dominated the database, making up 23.7% of the total, followed by Zika (11.8%), Middle East respiratory syndrome (6.7%), cholera (5.5%), and yellow fever and undiagnosed morbidity (both 3.3%). Initial reports of major outbreaks due to the top five disease agents were picked up through the manual system prior to being publicly reported by official sources.
   Conclusions: PHE's manual EI process quickly and accurately detected global public health threats at the earliest stages and allowed for monitoring of events as they evolved. Crown Copyright (C) 2019 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Wilburn, Jennifer; O'Connor, Catherine; Walsh, Amanda L.; Morgan, Dilys] Publ Hlth England, 61 Colindale Ave, Colindale NW9 5EQ, England.
RP Wilburn, J (corresponding author), Publ Hlth England, 61 Colindale Ave, Colindale NW9 5EQ, England.
EM Jennifer.Wilburn@nhs.net
FU Public Health England
FX This study was supported by Public Health England.
CR Anema A, 2014, LANCET INFECT DIS, V14, P1035, DOI 10.1016/S1473-3099(14)70953-3
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Barboza P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090536
   Brownstein J.S., 2007, EUROSURVEILLANCE, V12
   Camacho A, 2018, LANCET GLOB HEALTH, V6, pE680, DOI 10.1016/S2214-109X(18)30230-4
   Delatorre E, 2018, EMERG INFECT DIS, V24, P2119, DOI 10.3201/eid2411.180586
   Fisichella M, 2011, LECT NOTES COMPUT SC, V7024, P87, DOI 10.1007/978-3-642-24583-1_10
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9
   Ki M, 2015, EPIDEMIOL HLTH, V2015, P37, DOI DOI 10.4178/EPIH/E2015033
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lau EHY, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-88
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003
   Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Mukhopadhyay AK, 2016, EMERG INFECT DIS, V22, P1693, DOI 10.3201/eid2209.160811
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Mykhalovskiy E, 2006, CAN J PUBLIC HEALTH, V97, P42, DOI 10.1007/BF03405213
   Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636
   Paquet C, 2006, Euro Surveill, V11, P212
   Raj VS, 2014, CURR OPIN VIROL, V5, P58, DOI 10.1016/j.coviro.2014.01.010
   Riccardo F, 2014, BIOSECUR BIOTERROR, V12, P325, DOI 10.1089/bsp.2014.0031
   United Nations, 2019, METH STAND COUNTR AR
   WHO, 2005, STAT 1 M INT HLTH RE
   Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]
   World Health Organization, 2005, STRENGTH HLTH SEC IM
   World health Organization, 2019, YELLOW FEVER
   World Health Organization (WHO), 2017, EB VIR DIS DEM REP C
   Yan SJ, 2017, INT J INFECT DIS, V63, P77, DOI 10.1016/j.ijid.2017.07.020
NR 31
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2019
VL 89
BP 146
EP 153
DI 10.1016/j.ijid.2019.10.011
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA JS7FF
UT WOS:000500468100027
PM 31629079
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shen, ZL
   Li, XF
   Lu, YL
   Li, J
   Xiao, H
   Yuan, W
   Zhang, ZY
   Zhou, Y
   Feng, Y
   Qin, WH
   Xia, XS
AF Shen, Zhili
   Li, Xiaofei
   Lu, Yunlan
   Li, Jie
   Xiao, Hui
   Yuan, Wei
   Zhang, Ziyang
   Zhou, Yan
   Feng, Yue
   Qin, Weihong
   Xia, Xueshan
TI Nonindigenous case of Asian Zika virus lineage in Yunnan, China, 2019
SO JOURNAL OF INFECTION
LA English
DT Letter
C1 [Shen, Zhili; Xiao, Hui; Feng, Yue; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.
   [Li, Xiaofei] Third Peoples Hosp Kunming City, Dept Clin Lab, Kunming, Yunnan, Peoples R China.
   [Lu, Yunlan; Li, Jie; Qin, Weihong] Yunnan Int Travel Healthcare Ctr, Kunming, Yunnan, Peoples R China.
   [Yuan, Wei; Zhang, Ziyang; Zhou, Yan] Kunming Changshui Airport Customs, Kunming, Yunnan, Peoples R China.
RP Feng, Y; Xia, XS (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.; Qin, WH (corresponding author), Yunnan Int Travel Healthcare Ctr, Kunming, Yunnan, Peoples R China.
EM fyky2005@163.com; qinwh19@sina.com; oliverxia2000@aliyun.com
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [U1702282]; Reserve Talents Project for
   Young and Middle-Aged Academic and Technical Leaders of Yunnan Province
   [2019HB012]; Youth Talent Program of Yunnan "Ten-thousand Talents
   Program" [YNWR-QNBJ-2018-054]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) (U1702282), the Reserve Talents Project for Young and
   Middle-Aged Academic and Technical Leaders of Yunnan Province
   (2019HB012), and Youth Talent Program of Yunnan "Ten-thousand Talents
   Program" (YNWR-QNBJ-2018-054).
CR Romero HA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01617
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Borges ED, 2019, J ASSIST REPROD GEN, V36, P1339, DOI 10.1007/s10815-019-01493-y
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Wang BH, 2018, J INFECTION, V76, P106, DOI 10.1016/j.jinf.2017.09.002
   Xia H, 2018, NATURE COMMUNICATION, V9, P1, DOI DOI 10.1038/S41467-017-02816-2
   Xia H, 2018, VIROL SIN, V33, P5, DOI 10.1007/s12250-018-0002-9
NR 9
TC 0
Z9 0
U1 1
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD DEC
PY 2019
VL 79
IS 6
BP 615
EP 617
DI 10.1016/j.jinf.2019.10.023
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA JT4AQ
UT WOS:000500934300016
PM 31678288
DA 2020-07-08
ER

PT J
AU Poland, GA
   Ovsyannikova, IG
   Kennedy, RB
AF Poland, Gregory A.
   Ovsyannikova, Inna G.
   Kennedy, Richard B.
TI Zika Vaccine Development: Current Status
SO MAYO CLINIC PROCEEDINGS
LA English
DT Review
ID VIRUS-INFECTION; ANIMAL-MODELS; DNA VACCINE; DENGUE; RESPONSES;
   IMMUNOGENICITY; TRANSMISSION; AMERICA; AFRICAN; DISEASE
AB Zika virus outbreaks have been explosive and unpredictable and have led to significant adverse health effectsdas well as considerable public anxiety. Significant scientific work has resulted in multiple candidate vaccines that are now undergoing further clinical development, with several vaccines now in phase 2 clinical trials. In this review, we survey current vaccine efforts, preclinical and clinical results, and ethical and other concerns that directly bear on vaccine development. It is clear that the world needs safe and effective vaccines to protect against Zika virus infection. Whether such vaccines can be developed through to licensure and public availability absent significant financial investment by countries, and other barriers discussed within this article, remains uncertain. (C) 2019 Mayo Foundation for Medical Education and Research
C1 [Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, 200 First St SW, Rochester, MN 55905 USA.
   Mayo Clin, Div Gen Internal Med, Rochester, MN USA.
RP Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, 200 First St SW, Rochester, MN 55905 USA.
EM poland.gregory@mayo.edu
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blaney JE, 2006, VIRAL IMMUNOL, V19, P10, DOI 10.1089/vim.2006.19.10
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bowen JR, 2018, VIRUS RES, V254, P21, DOI 10.1016/j.virusres.2017.08.018
   Bradley MP, 2017, COMPARATIVE MED, V67, P242
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Centers for Disease Control and Prevention, ZIK VIR STAT MAPS
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Ethics Working Group on ZIKV Research & Pregnancy, PREGN WOM ZIK VIR VA
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Grifoni A, 2017, J VIROL, V91
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gruber MF, 2017, J INFECT DIS, V216, pS964, DOI 10.1093/infdis/jix433
   Hamer DH, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz012
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Julander JG, 2016, CURR OPIN VIROL, V18, P64, DOI 10.1016/j.coviro.2016.03.010
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Oehler E, 2014, EURO SURVEILL, V19
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Roth C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020385
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Shah SK, ETHICAL CONSIDERATIO
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Watts AG, 2018, J TRAV MED, V25
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   WHO, ZIK VIR
   WHO, ZIKA SIT REP
   Wilder-Smith A, 2018, J TRAV MED, V25
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   World Health Organization, ZIK VIR VACC PROD DE
   World Health Organization, GUILL BARR SYNDR
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 80
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD DEC
PY 2019
VL 94
IS 12
BP 2572
EP 2586
DI 10.1016/j.mayocp.2019.05.016
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA JT1XY
UT WOS:000500791900028
PM 31806107
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Hintzen, L
   Karow, U
   Khan, A
   Kr?nke, M
   Langmann, T
   Uterm?hlen, O
AF Hintzen, Laura
   Karow, Ulrike
   Khan, Amir
   Kronke, Martin
   Langmann, Thomas
   Utermohlen, Olaf
TI How do microglia cells respond to Zika virus infection?
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 45th Annual Meeting of the Scandinavian-Society-for-Immunology
CY APR 03-06, 2019
CL Geilo, NORWAY
SP Scandinavian Soc Immunol
C1 [Hintzen, Laura; Karow, Ulrike; Kronke, Martin; Utermohlen, Olaf] Univ Cologne, Fac Med, Inst Med Microbiol Immunol & Hyg, Cologne, Germany.
   [Khan, Amir; Langmann, Thomas] Univ Cologne, Fac Med, Dept Expt Immunol Eye, Cologne, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-9475
EI 1365-3083
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD DEC
PY 2019
VL 90
IS 6
MA 60
PG 1
WC Immunology
SC Immunology
GA JR2VR
UT WOS:000499489600069
DA 2020-07-08
ER

PT J
AU Stone, L
AF Stone, Louise
TI ZIKA virus causes prostatitis
SO NATURE REVIEWS UROLOGY
LA English
DT Editorial Material
CR Halabi J, 2020, J INFECT DIS, V221, P1506, DOI 10.1093/infdis/jiz533
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
NR 2
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4812
EI 1759-4820
J9 NAT REV UROL
JI Nat. Rev. Urol.
PD DEC
PY 2019
VL 16
IS 12
BP 694
EP 694
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA JS4LQ
UT WOS:000500278700003
PM 31712766
OA Bronze
DA 2020-07-08
ER

PT J
AU Yockey, LJ
   Jurado, KA
   Condiff, EK
   Iwasaki, A
AF Yockey, L. J.
   Jurado, K. A.
   Condiff, E. K.
   Iwasaki, A.
TI Hematopoietic type I interferon signaling controls Zika virus viremia
   after intravaginal exposure
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
C1 [Yockey, L. J.; Jurado, K. A.; Condiff, E. K.; Iwasaki, A.] Yale Univ, New Haven, CT USA.
   [Iwasaki, A.] Howard Hughes Med Inst, Chevy Chase, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2019
VL 221
IS 6
MA 24
BP 675
EP 675
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JR4XY
UT WOS:000499631100068
DA 2020-07-08
ER

PT J
AU Jaffe, EF
   Goldfarb, IT
   Lyerly, AD
AF Jaffe, E. F.
   Goldfarb, I. T.
   Lyerly, A. D.
TI Pregnant women's perceptions of types and levels of evidence when
   considering participation in hypothetical Zika virus vaccine trials
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
C1 [Jaffe, E. F.; Lyerly, A. D.] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA.
   [Goldfarb, I. T.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2019
VL 221
IS 6
MA 43
BP 692
EP 692
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JR4XY
UT WOS:000499631100110
DA 2020-07-08
ER

PT J
AU Ooi, YS
   Majzoub, K
   Flynn, RA
   Mata, MA
   Diep, J
   Li, JK
   van Buuren, N
   Rumachik, N
   Johnson, AG
   Puschnik, AS
   Marceau, CD
   Mlera, L
   Grabowski, JM
   Kirkegaard, K
   Bloom, ME
   Sarnow, P
   Bertozzi, CR
   Carette, JE
AF Ooi, Yaw Shin
   Majzoub, Karim
   Flynn, Ryan A.
   Mata, Miguel A.
   Diep, Jonathan
   Li, Jason Kenichi
   van Buuren, Nicholas
   Rumachik, Neil
   Johnson, Alex G.
   Puschnik, Andreas S.
   Marceau, Caleb D.
   Mlera, Luwanika
   Grabowski, Jeffrey M.
   Kirkegaard, Karla
   Bloom, Marshall E.
   Sarnow, Peter
   Bertozzi, Carolyn R.
   Carette, Jan E.
TI An RNA-centric dissection of host complexes controlling flavivirus
   infection
SO NATURE MICROBIOLOGY
LA English
DT Article
ID MESSENGER-RNAS; 3'-UNTRANSLATED REGION; ENDOPLASMIC-RETICULUM; PROTEIN;
   BINDING; DENGUE; VIRUS; IDENTIFICATION; TRANSLATION; SCP160P
AB Flaviviruses, including dengue virus (DENV) and Zika virus (ZIKV), cause severe human disease. Co-opting cellular factors for viral translation and viral genome replication at the endoplasmic reticulum is a shared replication strategy, despite different clinical outcomes. Although the protein products of these viruses have been studied in depth, how the RNA genomes operate inside human cells is poorly understood. Using comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS), we took an RNA-centric viewpoint of flaviviral infection and identified several hundred proteins associated with both DENV and ZIKV genomic RNA in human cells. Genome-scale knockout screens assigned putative functional relevance to the RNA-protein interactions observed by ChIRP-MS. The endoplasmic-reticulum-localized RNA-binding proteins vigilin and ribosome-binding protein 1 directly bound viral RNA and each acted at distinct stages in the life cycle of flaviviruses. Thus, this versatile strategy can elucidate features of human biology that control the pathogenesis of clinically relevant viruses.
C1 [Ooi, Yaw Shin; Majzoub, Karim; Mata, Miguel A.; Diep, Jonathan; Puschnik, Andreas S.; Marceau, Caleb D.; Sarnow, Peter; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Majzoub, Karim] Univ Strasbourg, Inst Viral & Liver Dis, INSERM U1110, Strasbourg, France.
   [Flynn, Ryan A.; Rumachik, Neil; Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
   [Li, Jason Kenichi; van Buuren, Nicholas; Kirkegaard, Karla] Stanford Univ, Dept Genet, Stanford, CA 94305 USA.
   [Johnson, Alex G.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.
   [Mlera, Luwanika; Grabowski, Jeffrey M.; Bloom, Marshall E.] NIAID, Biol Vector Borne Viruses Sect, Rocky Mt Labs, NIH, Hamilton, MT USA.
   [Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.
RP Carette, JE (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Flynn, RA (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
EM raflynn@stanford.edu; carette@stanford.edu
OI Ooi, Yaw Shin/0000-0001-9014-1365; Johnson,
   Alexander/0000-0002-4040-9797; Majzoub, Karim/0000-0001-7345-6840;
   Flynn, Ryan/0000-0001-5013-0442
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [DP2 AI104557, R01 AI141970, U19
   AI109662, R37 AI047365, R01 AI069000, R01 AI051622]; Burroughs Wellcome
   Investigators in the Pathogenesis of Infectious DiseaseBurroughs
   Wellcome Fund; David and Lucile Packard FoundationThe David & Lucile
   Packard Foundation; Stanford Dean's Fellowship; Child Health Research
   Institute Stanford; Damon Runyon Cancer Research Foundation;
   NSF-GRFNational Science Foundation (NSF); Howard Hughes Medical
   InstituteHoward Hughes Medical Institute; Intramural Research Program of
   the NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID)
FX We would like to thank A. Rubin, O. Botvinnik, M. R. Corces and A. Za
   for their helpful discussions on statistical and computational analyses;
   J. Ule, J. Zmrzlikar and N. Haberman for help with the iCount
   peak-calling software; L. Zhang and the Elias lab for assistance running
   samples for mass spectrometry analysis; J. Coller, X. Ji, D. Wagh and
   the Stanford Functional Genomics Facility for assistance with running
   samples for deep sequencing. We also thank the Stanford shared FACS
   facility and its former director M. Bigos for technical assistance. We
   acknowledge the NIH Biodefense and Emerging Infections Research
   Repository (BEI Resources) and the NIAID, NIH for providing the multiple
   DENV and ZIKV strains mentioned in Methods. We thank S. Braun and the
   members of the Carette, Kirkegaard and Sarnow labs for their helpful
   discussions and critical reading of the manuscript. The work was funded
   in part by the NIH (grant nos DP2 AI104557, R01 AI141970 and U19
   AI109662 to J.E.C.; R37 AI047365 and R01 AI069000 to P.S. and R01
   AI051622 to C.R.B.), the Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease (J.E.C.), the David and Lucile
   Packard Foundation (J.E.C.), the Stanford Dean's Fellowship (Y.S.O.),
   the Child Health Research Institute Stanford (K.M.), the Damon Runyon
   Cancer Research Foundation (R.A.F.), the NSF-GRF (A.G.J. and C.D.M.) and
   the Howard Hughes Medical Institute (C.R.B.). C.D.M., J.G., L.M. and
   M.E.B. were supported by the Intramural Research Program of the NIAID.
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Balinsky CA, 2017, J VIROL, V91, DOI [10.1128/JVI.01606-16, 10.1128/jvi.01606-16]
   Batlle M, 2011, BBA-GENE REGUL MECH, V1809, P46, DOI 10.1016/j.bbagrm.2010.10.005
   BELANGER L, 1994, J BIOL CHEM, V269, P5481
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857
   Chen CK, 2016, SCIENCE, V354, P468, DOI 10.1126/science.aae0047
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Cheng MHK, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1448
   Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025
   Cui XYA, 2014, WIRES RNA, V5, P481, DOI 10.1002/wrna.1225
   Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336
   Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497
   Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013
   Eliseev B, 2018, NUCLEIC ACIDS RES, V46, P2678, DOI 10.1093/nar/gky054
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130
   Hirschmann WD, 2014, NUCLEIC ACIDS RES, V42, P4043, DOI 10.1093/nar/gkt1392
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008
   Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162
   Kruse C, 2003, CELL MOL LIFE SCI, V60, P2219, DOI 10.1007/s00018-003-3235-0
   Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09
   Lei YF, 2011, J GEN VIROL, V92, P796, DOI 10.1099/vir.0.028597-0
   Li JQ, 2013, MBIO, V4, DOI 10.1128/mBio.00385-13
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Losfeld ME, 2012, FASEB J, V26, P4210, DOI 10.1096/fj.12-211656
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468
   Mlera L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005346
   Mobin MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12848
   Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Reid DW, 2015, NAT REV MOL CELL BIO, V16, P221, DOI 10.1038/nrm3958
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shelness GS, 1999, J NUTR, V129, p456S, DOI 10.1093/jn/129.2.456S
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Teo G, 2016, PROTEOMICS, V16, P2238, DOI 10.1002/pmic.201500499
   Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197
   Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655
   Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 54
TC 3
Z9 3
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD DEC
PY 2019
VL 4
IS 12
BP 2369
EP 2382
DI 10.1038/s41564-019-0518-2
PG 14
WC Microbiology
SC Microbiology
GA JQ6RV
UT WOS:000499071100038
PM 31384002
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Neufeldt, CJ
   Cortese, M
   Scaturro, P
   Cerikan, B
   Wideman, JG
   Tabata, K
   Moraes, T
   Oleksiuk, O
   Pichlmair, A
   Bartenschlager, R
AF Neufeldt, Christopher J.
   Cortese, Mirko
   Scaturro, Pietro
   Cerikan, Berati
   Wideman, Jeremy G.
   Tabata, Keisuke
   Moraes, Thais
   Oleksiuk, Olga
   Pichlmair, Andreas
   Bartenschlager, Ralf
TI ER-shaping atlastin proteins act as central hubs to promote flavivirus
   replication and virion assembly
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ADP-RIBOSYLATION FACTORS; DENGUE VIRUS-REPLICATION;
   ENDOPLASMIC-RETICULUM; COMPUTATIONAL PLATFORM; RETROGRADE TRANSPORT;
   SENSORY-NEUROPATHY; MEMBRANE; GTPASES; NETWORK; FUSION
AB Flaviviruses, including dengue virus and Zika virus, extensively remodel the cellular endomembrane network to generate replication organelles that promote viral genome replication and virus production. However, it remains unclear how these membranes and associated cellular proteins act during the virus cycle. Here, we show that atlastins (ATLs), a subset of ER resident proteins involved in neurodegenerative diseases, have dichotomous effects on flaviviruses-with ATL2 depletion leading to replication organelle defects, and ATL3 depletion to changes in virus production pathways. We characterized non-conserved functional domains in ATL paralogues and show that the ATL interactome is profoundly reprogrammed following dengue virus infection. Screen analysis confirmed non-redundant ATL functions and identified a specific role for ATL3, and its interactor ARF4, in vesicle trafficking and virion maturation. Our data identify ATLs as central hubs targeted by flaviviruses to establish their replication organelle and to achieve efficient virion maturation and secretion.
C1 [Neufeldt, Christopher J.; Cortese, Mirko; Cerikan, Berati; Tabata, Keisuke; Moraes, Thais; Oleksiuk, Olga; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.
   [Scaturro, Pietro; Pichlmair, Andreas] Tech Univ Munich, Sch Med, Inst Virol, Munich, Germany.
   [Wideman, Jeremy G.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.
   [Wideman, Jeremy G.] Arizona State Univ, Biodesign Ctr Mech Evolut, Sch Life Sci, Tempe, AZ USA.
   [Pichlmair, Andreas] German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany.
   [Bartenschlager, Ralf] German Ctr Infect Res DZIF, Heidelberg Partner Sitec, Heidelberg, Germany.
   [Bartenschlager, Ralf] German Canc Res Ctr, Div Virus Associated Carcinogenesis, Heidelberg, Germany.
RP Neufeldt, CJ; Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.; Bartenschlager, R (corresponding author), German Ctr Infect Res DZIF, Heidelberg Partner Sitec, Heidelberg, Germany.; Bartenschlager, R (corresponding author), German Canc Res Ctr, Div Virus Associated Carcinogenesis, Heidelberg, Germany.
EM christopher.neufeldt@med.uni-heidelberg.de;
   ralf.bartenschlager@med.uni-heidelberg.de
RI ; Bartenschlager, Ralf/L-2582-2015
OI Wideman, Jeremy/0000-0002-4426-9533; Bartenschlager,
   Ralf/0000-0001-5601-9307; Oleksiuk, Olga/0000-0002-6100-107X; Cortese,
   Mirko/0000-0003-1786-4211; Neufeldt, Christopher/0000-0002-4551-1811
FU Department of Proteomics and Signal Transduction of the Max-Planck
   Institute of Biochemistry; Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [SFB1129, TP11, BA1505/8-1, TRR179];
   ERCEuropean Research Council (ERC) [StG iVIP 331339, CoG ProDAP 817798];
   European Molecular Biology Organization (EMBO)European Molecular Biology
   Organization (EMBO) [ALTF 466-2016]
FX We thank A. Ruggieri, L. Chatel-Chaix and M. Joyce for constructive
   scientific discussions and valuable comments. We also thank U.
   Haselmann, M. Bartenschlager, I. Paron, A. Piras and S. Kallis for
   excellent technical support. We acknowledge the Electron Microscopy Core
   Facility at Heidelberg University and the Infectious Diseases Imaging
   Platform (IDIP) at the Center for Integrative Infectious Disease
   Research, Heidelberg, Germany, for expert assistance and access to their
   equipment as well as the Department of Proteomics and Signal
   Transduction of the Max-Planck Institute of Biochemistry for continuous
   and generous support. We thank the European Virus Archive (EVAg, France)
   for provision of ZV strains, J. Schmidt-Chanasit for providing WNV
   strains, F. Weber for providing the RVFV isolate, D. Trono for providing
   the lentiviral transduction system and M. Stanifer for providing the
   VSVg constructs. This work was supported by grants from the Deutsche
   Forschungsgemeinschaft (SFB1129, TP11 and BA1505/8-1, both to R.B., and
   TRR179 and TP11 to A.P.) and the ERC (StG iVIP 331339, CoG ProDAP
   817798) to A.P. C.J.N. was supported in part by a European Molecular
   Biology Organization (EMBO) LongTerm Fellowship (ALTF 466-2016).
CR Behrendt L, 2019, CELL MOL LIFE SCI, V76, P1433, DOI 10.1007/s00018-019-03010-x
   Chia PZC, 2011, J CELL SCI, V124, P2401, DOI 10.1242/jcs.083782
   Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373
   Cortese M, 2019, CELL REP, V27, P2579, DOI 10.1016/j.celrep.2019.04.105
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Di Mattia T, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.06.016
   Doerflinger SY, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006705
   Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Faust JE, 2015, J BIOL CHEM, V290, P4772, DOI 10.1074/jbc.M114.601823
   Fischer D, 2014, BRAIN, V137, DOI 10.1093/brain/awu091
   Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17
   Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005
   Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009
   GRIFFITHS G, 1983, METHOD ENZYMOL, V96, P466
   Holze C, 2018, NAT IMMUNOL, V19, P130, DOI 10.1038/s41590-017-0013-y
   Hu JJ, 2016, SEMIN CELL DEV BIOL, V60, P105, DOI 10.1016/j.semcdb.2016.06.001
   Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025
   Hu XY, 2015, PROTEIN CELL, V6, P307, DOI 10.1007/s13238-015-0139-3
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Klemm RW, 2013, CELL REP, V3, P1465, DOI 10.1016/j.celrep.2013.04.015
   Kornak U, 2014, BRAIN, V137, P683, DOI 10.1093/brain/awt357
   Krols M, 2018, CELL REP, V23, P2026, DOI 10.1016/j.celrep.2018.04.071
   Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579
   Kuri T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-50
   Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067
   Lee JY, 2019, CELL REP, V27, P3602, DOI 10.1016/j.celrep.2019.05.063
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113
   Liang JR, 2018, J CELL BIOL, V217, P3354, DOI 10.1083/jcb.201804185
   Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345
   Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267
   Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117
   Munster M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070368
   Nakai W, 2013, MOL BIOL CELL, V24, P2570, DOI 10.1091/mbc.E13-04-0197
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280
   Pawar S, 2017, ELIFE, V6, DOI 10.7554/eLife.28202
   Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012
   Powers RE, 2017, NATURE, V543, P257, DOI 10.1038/nature21387
   Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8
   Sandoval CO, 2012, BIOCHEM SOC T, V40, P1426, DOI 10.1042/BST20120158
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]
   Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859
   Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042
   Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
   Wu FY, 2015, PROTEIN CELL, V6, P139, DOI 10.1007/s13238-014-0118-0
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Zhang H, 2016, TRENDS CELL BIOL, V26, P934, DOI 10.1016/j.tcb.2016.06.002
   Zhao GH, 2016, EXP CELL RES, V349, P32, DOI 10.1016/j.yexcr.2016.09.015
   Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758
NR 65
TC 1
Z9 1
U1 5
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD DEC
PY 2019
VL 4
IS 12
BP 2416
EP +
DI 10.1038/s41564-019-0586-3
PG 24
WC Microbiology
SC Microbiology
GA JQ6RV
UT WOS:000499071100042
PM 31636417
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wang, B
   Wang, F
   Huang, H
   Zhao, ZD
AF Wang, Bei
   Wang, Fei
   Huang, He
   Zhao, Zhendong
TI A Novel DT40 Antibody Library for the Generation of Monoclonal
   Antibodies
SO VIROLOGICA SINICA
LA English
DT Article
DE Antibody library; DT40 cell line; Activation-induced cytidine deaminase
   (AID); Zika virus (ZIKV)
ID V GENE CONVERSION; RAPID GENERATION; AID; HYPERMUTATION; EXPRESSION;
   PHAGE; CELLS
AB Early etiological diagnosis is very important for the control of sudden viral infections, and requires antibodies with both high sensitivity and high specificity. Traditional antibody preparation methods have limitations, such as a long and arduous cycle, complicated operation, and high expenses. A chicken lymphoma cell line, DT40, is known to produce IgM-type antibodies and undergo gene conversion and somatic mutation in the variable region of the immunoglobulin gene during culture. Here, the DT40 cell line was developed to produce antibody libraries and prepare antibody rapidly in vitro. Since hypermutation in DT40 cells was regulated by the activation-induced cytidine deaminase (AID) gene, AID expression needs to be controlled to either fix the Ig sequence by stopping mutation or improve affinity by resuming mutation after the antibodies have been selected. In this study, we generated a novel AID-inducible DT40 cell line (DT40-H7), in which the endogenous AID gene was knocked out using the CRISPR/Cas9 genome editing system, and an inducible AID gene, based on the Tet-Off expression system, was stably transfected. AID expression was controlled in DT40-H7 cells in a simple and efficient manner; gene conversion and point mutations were observed only when AID was expressed. Using the antibody library generated from this cell line, we successfully obtained monoclonal antibodies against the NS1 protein of Zika virus. The DT40-H7 cell line represents a useful tool for the selection and evolution of antibodies and may also be a powerful tool for the rapid selection and generation of diagnostic antibodies for emerging infectious diseases.
C1 [Wang, Bei; Wang, Fei; Huang, He; Zhao, Zhendong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.
   [Zhao, Zhendong] Chinese Acad Med Sci & Peking Union Med Coll, Clin Immunol Ctr, Beijing 100730, Peoples R China.
   [Zhao, Zhendong] Chinese Acad Med Sci & Peking Union Med Coll, CAMS Oxford Univ Int Ctr Translat Immunol, Beijing 100730, Peoples R China.
RP Huang, H; Zhao, ZD (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.; Zhao, ZD (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Clin Immunol Ctr, Beijing 100730, Peoples R China.; Zhao, ZD (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, CAMS Oxford Univ Int Ctr Translat Immunol, Beijing 100730, Peoples R China.
EM huanghe@ipbcams.ac.cn; timjszzd@163.com
FU Project of the National Defense Science and Technology Innovation
   Special Zone [17-163-12-ZT-005-013-01]; CAMS Innovation Fund for Medical
   Sciences [CIFMS 2016-12 M-1-013, CIFMS 2016-12 M-1-014, 2016-12
   M-3-020]; National Key Research and Development Program
   [2016YFD0500300]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [2018PT31032]
FX This work was sponsored by the Project of the National Defense Science
   and Technology Innovation Special Zone (to HH, 17-163-12-ZT-005-013-01),
   the CAMS Innovation Fund for Medical Sciences (to HH, CIFMS 2016-12
   M-1-013 and to ZZ, CIFMS 2016-12 M-1-014 and 2016-12 M-3-020), the
   National Key Research and Development Program (to ZZ, 2016YFD0500300),
   and the Fundamental Research Funds for the Central Universities (to HH,
   2018PT31032).
CR Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752
   GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133
   Kajita M, 2010, J BIOSCI BIOENG, V110, P351, DOI 10.1016/j.jbiosc.2010.03.006
   Kanayama N, 2005, BIOCHEM BIOPH RES CO, V327, P70, DOI 10.1016/j.bbrc.2004.11.143
   Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Magari M, 2010, BIOCHEM BIOPH RES CO, V396, P353, DOI 10.1016/j.bbrc.2010.04.096
   Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714
   Romanello M, 2016, EMBO J, V35, P1452, DOI 10.15252/embj.201693958
   Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100
   Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092
   Seo H, 2006, NAT PROTOC, V1, P1502, DOI 10.1038/nprot.2006.248
   SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556
NR 19
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD DEC
PY 2019
VL 34
IS 6
BP 641
EP 647
DI 10.1007/s12250-019-00142-z
PG 7
WC Virology
SC Virology
GA JS1QW
UT WOS:000500088400005
PM 31240617
OA Green Published
DA 2020-07-08
ER

PT J
AU Basic, M
   Elgner, F
   Bender, D
   Sabino, C
   Herrlein, ML
   Roth, H
   Glitscher, M
   Fath, A
   Kerl, T
   Schmalz, HG
   Hildt, E
AF Basic, Michael
   Elgner, Fabian
   Bender, Daniela
   Sabino, Catarina
   Herrlein, Marie-Luise
   Roth, Hanna
   Glitscher, Mirco
   Fath, Alicia
   Kerl, Thomas
   Schmalz, Hans-Guenther
   Hildt, Eberhard
TI A synthetic derivative of houttuynoid B prevents cell entry of Zika
   virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Houttuynoid; Zika virus; Flavivirus; Antiviral activity; Natural
   compounds; Flavonoids
ID CORDATA; FLAVONOIDS; HSV-1
AB Zika virus (ZIKV) is a re-emerging virus belonging to the family of Flaviviridae, which contains several human pathogens. A great deal of attention came through the association of ZIKV infection with an increasing number of microcephaly cases in newborns during the 2016 outbreak in Brazil. Currently, no anti-viral drug or vaccine is available.
   Houttuynoids are a group of structurally related flavonoid glycosides that can be isolated from Houttuynia cordata belonging to the family of Sauraceae. Moreover, H. cordata was described to have an antiviral effect on herpes simplex virus type 1 (HSV-1), human immunodeficiency virus type 1 (HIV-1) and influenza A virus (Hayashi et al., 1995). In light of this, this study aimed to investigate a potential antiviral effect of the synthetic houttuynoids TK1023 and TK1024 (i.e. houttuynoid B) on two ZIKV isolates (Uganda and French Polynesia).
   A significant decrease in the amount of intra- and extracellular viral genomes as well as infectious viral particles was observed after treatment with the tetra-O-acetylated houttuynoid TK1023 independent from the analyzed virus isolate. In contrast, TK1024 (houttuynoid B) had no effect on ZIKV. Treatment with TK1023 significantly decreases the number of infected cells 24 h and 48 h after infection, as compared to the control. Analysis of the mode of action revealed that TK1023 neither affects the viral genome replication nor the production of viral proteins nor morphogenesis or release. Binding and entry assays showed that TK1023 interferes with the entry of the virus in the cell. Thereby, the spread of ZIKV infection is impaired as the infection of the individual cell is inhibited.
   These data indicate that for both analyzed virus isolates the spread of ZIKV infection can be impaired by the synthetic houttuynoid TK1023 due to an inhibition of the viral entry.
C1 [Basic, Michael; Elgner, Fabian; Bender, Daniela; Sabino, Catarina; Herrlein, Marie-Luise; Roth, Hanna; Glitscher, Mirco; Fath, Alicia; Hildt, Eberhard] Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
   [Kerl, Thomas; Schmalz, Hans-Guenther] Univ Cologne, Dept Chem, D-50939 Cologne, Germany.
   [Hildt, Eberhard] German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
RP Hildt, E (corresponding author), Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
EM Michael.basic@kgu.de; Fabian.Elgner@pei.de; Daniela.Bender@pei.de;
   Catarina.Sabino@pei.de; Marie-Luise.Herrlein@pei.de; Hanna.Roth@pei.de;
   Mirco.Glitscher@pei.de; Alicia.Fath@pei.de; Kerl@uni-koeln.de;
   Schmalz@uni-koeln.de; Eberhard.Hildt@pei.de
RI Hildt, Eberhard/A-1040-2015
OI Bender, Daniela/0000-0002-8991-126X
FU Federal Ministry of Health (BMG); LOEWE Center DRUID (Novel Drug Targets
   against Poverty-Related and Neglected Tropical Infectious Diseases);
   European Virus Archive goes Global (EVAg) project from the European
   Union's Horizon 2020 research and innovation program [653316]
FX This research was funded by a grant from the Federal Ministry of Health
   (BMG) to E.H. and by a grant from the LOEWE Center DRUID (Novel Drug
   Targets against Poverty-Related and Neglected Tropical Infectious
   Diseases) to D.B. and E.H. This publication was supported by the
   European Virus Archive goes Global (EVAg) project that has received
   funding from the European Union's Horizon 2020 research and innovation
   program under grant agreement No 653316. Based on this funding, EVAg
   provided the ZIKV Uganda 976 strain.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen SD, 2012, ORG LETT, V14, P1772, DOI 10.1021/ol300017m
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elgner F, 2018, VIRUSES, V10, P4
   Elgner F, 2016, J VIROL, V90, P11181, DOI 10.1128/JVI.01053-16
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Glitscher M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060301
   HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063
   Himmelsbach K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0198-7
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   Jian J, 2018, J NAT PROD, V81, P371, DOI 10.1021/acs.jnatprod.7b00791
   Kerl T, 2016, CHEM-EUR J, V22, P2935, DOI 10.1002/chem.201505118
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li GZ, 2005, BIOL PHARM BULL, V28, P1864, DOI 10.1248/bpb.28.1864
   Li T, 2017, ANTIVIR RES, V144, P273, DOI 10.1016/j.antiviral.2017.06.010
   Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Munz C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00269
   Sabino C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060524
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2019
VL 172
AR 104644
DI 10.1016/j.antiviral.2019.104644
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9MF
UT WOS:000499939700018
PM 31697958
DA 2020-07-08
ER

PT J
AU Gouel-Cheron, A
   Lumbard, K
   Hunsberger, S
   Arteaga-Cabello, FJ
   Beigel, J
   Belaunzaran-Zamudio, PF
   Caballero-Sosa, S
   Escobedo-Lopez, K
   Ibarra-Gonzalez, V
   Najera-Cancino, JG
   Rincon-Leon, HA
   Ruiz-Hernandez, E
   Sepulveda-Delgado, J
   Trujillo-Murillo, K
   Ruiz-Palacios, G
AF Gouel-Cheron, Aurelie
   Lumbard, Keith
   Hunsberger, Sally
   Arteaga-Cabello, Fernando J.
   Beigel, John
   Belaunzaran-Zamudio, Pablo F.
   Caballero-Sosa, Sandra
   Escobedo-Lopez, Kenia
   Ibarra-Gonzalez, Violeta
   Gabriel Najera-Cancino, Jose
   Armando Rincon-Leon, Hector
   Ruiz-Hernandez, Emilia
   Sepulveda-Delgado, Jesus
   Trujillo-Murillo, Karina
   Ruiz-Palacios, Guillermo
TI Serial real-time RT-PCR and serology measurements substantially improve
   Zika and Dengue virus infection classification in a co-circulation area
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Dengue virus; Reverse transcriptase polymerase chain
   reaction; Antibodies; Kinetics; Viremia
ID EXTERNAL QUALITY ASSESSMENT; CHIKUNGUNYA-VIRUS; CROSS-REACTIVITY;
   COINFECTION; ANTIBODIES; TRANSMISSION; ENHANCEMENT
AB Background: Real-time RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) is considered the gold standard for Zika virus (ZIKV) infection diagnosis, despite its low sensitivity. Diagnosis using recommended serologic cutoffs in co-circulating Flaviviruses areas maybe inadequate due to in-vitro cross-reactivities of Flaviviruses-specific antibodies. We evaluated Zika diagnosis in symptomatic patients using serial RT-PCR and develop a classification model using serial Dengue virus (DENV) and ZIKV serologies.
   Methods: A prospective longitudinal multicentric study in Southern Mexico (NCT02831699) enrolled symptomatic and non-symptomatic participants. In the classification model, true positives were symptomatic (using a modified World Health Organization/Pan American Health Organization definition) with RT-PCR positive for ZIKV or DENV. True negatives were non-symptomatic with negative RT-PCR. Serial serology measurements were used to predict disease status.
   Results: Analyzing ZIKV and DENV RT-PCR at 3 timepoints between days 3 and 13 of symptom onset detected 25% more cases than a single RT-PCR analysis between day 0 and 6. When considering sensitivity and specificity together, the serial serology model predicted all categories of disease and negatives better than manufactures cutoffs. Their cutoffs optimized sensitivity or specificity but not both.
   Conclusions: We demonstrated the importance of serial RT-PCR and antibody measurements to diagnose arbovirus infection in symptomatic patients living in regions with co-circulating flaviviruses.
C1 [Gouel-Cheron, Aurelie; Lumbard, Keith; Hunsberger, Sally] NIAID, Biostat Res Branch, NIH, Rockville, MD USA.
   [Arteaga-Cabello, Fernando J.; Belaunzaran-Zamudio, Pablo F.; Escobedo-Lopez, Kenia; Ibarra-Gonzalez, Violeta; Ruiz-Palacios, Guillermo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City, DF, Mexico.
   [Beigel, John] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Caballero-Sosa, Sandra] Clin Hosp Dr Roberto Nettel Flores, Inst Seguridad & Serv Sociales Trabajadores Estad, Tapachula, Chiapas, Mexico.
   [Gabriel Najera-Cancino, Jose; Sepulveda-Delgado, Jesus; Trujillo-Murillo, Karina] Hosp Reg Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
   [Armando Rincon-Leon, Hector] Inst Mexicano Seguro Social, Unidad Med Familiar 11, Tapachula, Chiapas, Mexico.
   [Ruiz-Hernandez, Emilia] Hosp Gen Tapachula, Tapachula, Chiapas, Mexico.
   [Gouel-Cheron, Aurelie] Univ Paris, Grp Hosp Bichat Claude Bernard, AP HP, Dept Anesthesie & Reanimat Chirurg, Paris, France.
   [Gouel-Cheron, Aurelie] Pasteur Inst, INSERM, UMR 1222, Unit Antibodies Therapy & Pathol, Paris, France.
   [Gouel-Cheron, Aurelie] GHUPNVS, APHP, CHU Bichat Claude Bernard, Dept Anesthesie Reanimat, Paris, France.
RP Gouel-Cheron, A (corresponding author), CHU Bichat Claude Bernard, Dept Anesthesie Reanimat, 46 Rue Henri Huchard, F-75018 Paris, France.
EM aurelie.gouel@aphp.fr; keith.lumbard@nih.gov; sally.hunsberger@nih.gov;
   ferartc@gmail.com; jbeigel@niaid.nih.gov; p.belaunz@infecto.mx;
   sandracaballero@redmexei.mx; kemesk@yahoo.com; violetaig@gotmail.com;
   gabriel.najera.78@gmail.com; hector.rinconl@imss.gob.mx;
   dramilieruiz@gmail.com; jesussd52@gmail.com; kary_trujillo@hotmail.com;
   gmrps@unam.mx
RI Belaunzaran-Zamudio, Pablo Francisco/T-4085-2019; Leon, Hector Armando
   Rincon/AAO-2935-2020
OI Leon, Hector Armando Rincon/0000-0003-0715-200X; Gouel,
   Aurelie/0000-0003-2648-1693; Belaunzaran, Pablo/0000-0003-4775-4734
FU Mexico Emerging Infectious Diseases Clinical Research Network (La Red);
   CONACYT (Fondo Sectorial SSA/IMSS/ISSSTE) [71260, 127088]; federal funds
   from the National Cancer Institute, NIH [HHSN261200800001E]
FX Funded through the Mexico Emerging Infectious Diseases Clinical Research
   Network (La Red). La Red is collaboration between the Mexico Ministry of
   Health and the U.S. National Institute of Allergy and Infectious
   Diseases. This study has been funded in part by CONACYT (Fondo Sectorial
   SSA/IMSS/ISSSTE, Projects No. 71260 and No. 127088). This project was
   funded in whole or in part with federal funds from the National Cancer
   Institute, NIH, under Contract No. HHSN261200800001E. The content of
   this publication does not necessarily reflect the views or policies of
   the Department of Health and Human Services, nor does mention of trade
   names, commercial products, or organizations imply endorsement by the
   U.S. Government.
CR Arellanos-Soto D, 2015, TRANSFUSION MED, V25, P122, DOI 10.1111/tme.12198
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carletti F, 2007, AM J TROP MED HYG, V77, P521, DOI 10.4269/ajtmh.2007.77.521
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   CDC, 2017, GUID US LAB TEST ZIK
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   De Ory F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070379
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Euro Immun. Medizinische Labordiagnostika G, ZIK VIR INF
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Mendoza EJ, 2019, DIAGN MICR INFEC DIS, V94, P140, DOI 10.1016/j.diagmicrobio.2019.01.004
   Michelson Y, 2019, J INFECT DIS, V219, P1035, DOI 10.1093/infdis/jiy606
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Number P.A.H.O., 2016, REP CAS DENG SEV DEN
   PAHO, 2016, ZIK
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   R Core Team, 2017, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez DR, 2009, TRANSFUSION MED, V19, P125, DOI 10.1111/j.1365-3148.2009.00922.x
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Therneau T. M., 2018, R PACKAGE VERSION, V4, P1
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 48
TC 2
Z9 2
U1 2
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2019
VL 172
AR 104638
DI 10.1016/j.antiviral.2019.104638
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9MF
UT WOS:000499939700012
PM 31672665
DA 2020-07-08
ER

PT J
AU Li, Z
   Yao, FJ
   Xue, G
   Xu, YF
   Niu, JL
   Cui, MM
   Wang, HB
   Wu, SX
   Lu, AL
   Zhong, J
   Meng, GX
AF Li, Zheng
   Yao, Fujia
   Xue, Guang
   Xu, Yongfen
   Niu, Junling
   Cui, Mengmeng
   Wang, Hongbin
   Wu, Shuxian
   Lu, Ailing
   Zhong, Jin
   Meng, Guangxun
TI Antiviral effects of simeprevir on multiple viruses
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Simeprevir; ZIKV; EV-A71; HSV-1; IFN-beta; ISG15
ID INHIBITS ENTEROVIRUS-71 INFECTION; HEPATITIS-C; IMMUNE EVASION; ZIKA
   VIRUS; PROTEIN; GENOTYPE; SOFOSBUVIR; COLITIS; DISEASE
AB Simeprevir was developed as a small molecular drug targeting the NS3/4A protease of hepatitis C virus (HCV). Unexpectedly, our current work discovered that Simeprevir effectively promoted the transcription of IFN-beta and ISG15, inhibited the infection of host cells by multiple viruses including Zika virus (ZIKV), Enterovirus A71 (EV-A71), as well as herpes simplex virus type 1 (HSV-1). However, the inhibitory effects of Simeprevir on ZIKV, EV-A71 and HSV-1 were independent from IFN-beta and ISG15. This study thus demonstrates that the application of Simeprevir can be extended to other viruses besides HCV.
C1 [Li, Zheng; Yao, Fujia; Xue, Guang; Xu, Yongfen; Niu, Junling; Cui, Mengmeng; Wang, Hongbin; Wu, Shuxian; Lu, Ailing; Zhong, Jin; Meng, Guangxun] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
   [Li, Zheng; Yao, Fujia; Xue, Guang; Xu, Yongfen; Niu, Junling; Cui, Mengmeng; Wang, Hongbin; Wu, Shuxian; Lu, Ailing; Zhong, Jin; Meng, Guangxun] Univ Chinese Acad Sci, Beijing 100039, Peoples R China.
   [Lu, Ailing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Fac Med Lab Sci, Shanghai 200025, Peoples R China.
RP Meng, GX (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, 320 Yueyang Rd,Life Sci Res Bldg B-205, Shanghai 200031, Peoples R China.
EM gxmeng@ips.ac.cn
FU National Key Basic Research Programs of ChinaNational Basic Research
   Program of China [2015CB554302, 2016YFE0133500, 2018YFA0507300]; Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [81830049, 81761128012, 31570895, 31600146]; Shanghai Sailing Program
   [16YF1412400]; Shanghai Natural Science FoundationNatural Science
   Foundation of Shanghai [16ZR1439900]; TOTAL foundation; Strategic
   Priority Research Program of the Chinese Academy of SciencesChinese
   Academy of Sciences [XDB29030303]; International Partnership Program of
   the Chinese Academy of Sciences [153831KYSB20190008]
FX This work was supported by grants from National Key Basic Research
   Programs of China (2015CB554302, 2016YFE0133500, 2018YFA0507300),
   Natural Science Foundation of China (81830049, 81761128012, 31570895,
   31600146), Strategic Priority Research Program Grant (XDB29030303) and
   International Partnership Program (153831KYSB20190008) of the Chinese
   Academy of Sciences, Shanghai Sailing Program (16YF1412400), Shanghai
   Natural Science Foundation (16ZR1439900) and the TOTAL foundation for
   HFMD.
CR Babatin MA, 2018, J CLIN GASTROENTEROL, V52, P452, DOI 10.1097/MCG.0000000000000896
   Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097
   Flanagan S, 2014, EXPERT REV CLIN PHAR, V7, P691, DOI 10.1586/17512433.2014.956091
   Gane EJ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2444-3
   Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245
   Izzo I, 2016, INFECTION, V44, P811, DOI 10.1007/s15010-016-0915-x
   Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09
   Leib DA, 2002, CURR TOP MICROBIOL, V269, P171
   Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663
   Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102
   Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102
   Li Z, 2017, CYTOKINE, V96, P132, DOI 10.1016/j.cyto.2017.04.002
   Lin TY, 2002, J INFECT DIS, V186, P1161, DOI 10.1086/343809
   Majumdar A, 2016, ALIMENT PHARM THER, V43, P1276, DOI 10.1111/apt.13633
   MITTNACHT S, 1988, VIROLOGY, V164, P201, DOI 10.1016/0042-6822(88)90637-X
   Muench L.J.R.A.H, 1938, AM J HYG, V27
   Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7
   Pathinayake PS, 2015, VIRUSES-BASEL, V7, P6613, DOI 10.3390/v7122961
   Piret J, 2018, J GEN VIROL, V99, P209, DOI 10.1099/jgv.0.000992
   Sarkar S, 2015, ACG CASE REP J, V3, P42, DOI 10.14309/crj.2015.96
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Tsantrizos YS, 2009, CURR OPIN INVEST DR, V10, P871
   Wang HB, 2015, CELL REP, V12, P42, DOI 10.1016/j.celrep.2015.05.047
   Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002
   Weng TY, 2005, ANTIVIR RES, V67, P31, DOI 10.1016/j.antiviral.2005.03.005
   Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110
   Zhang XQ, 2016, ACTA PHARM SIN B, V6, P26, DOI 10.1016/j.apsb.2015.09.008
   Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062007
NR 28
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2019
VL 172
AR 104607
DI 10.1016/j.antiviral.2019.104607
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9MF
UT WOS:000499939700020
PM 31563599
DA 2020-07-08
ER

PT J
AU Loe, MWC
   Lee, RCH
   Chu, JJH
AF Loe, Marcus Wing Choy
   Lee, Regina Ching Hua
   Chu, Justin Jang Hann
TI Antiviral activity of the FDA-approved drug candesartan cilexetil
   against Zika virus infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika; Antiviral; FDA-approved compounds; High-throughput screening
ID IN-VITRO; REPLICATION; INHIBITORS
AB Zika virus (ZIKV) is a mosquito-borne virus that has risen to prominence as a significant threat to public health in the recent decade. Since its re-emergence in 2007, ZIKV has spread at an alarming rate and has since become endemic to multiple regions around the world. Infections are primarily asymptomatic, however the virus has become associated with the development of severe neurological complications such as Guillain-Barre syndrome (GBS) and congenital microcephaly. At present, there are currently no approved antivirals for ZIKV infections. In this study, we utilised a phenotype-based screening platform to perform a high-throughput screen on a 1172-compound US FDA-approved drug library to identify potential novel inhibitors against ZIKV. Candesartan cilexetil, an angiotensin II receptor inhibitor, displayed potent inhibition effects against ZIKV and subsequent downstream time-course studies revealed that it targets a post-entry stage(s) of the ZIKV replication cycle. Moreover, candesartan cilexetil also inhibited viral RNA production and viral protein synthesis. Candesartan cilexetil also exhibited antiviral effects against Dengue virus serotype-2 (DENV2), Kunjin virus (KUNV) and Chikungunya virus (CHIKV), indicating that its antiviral properties may not be restricted to ZIKV. Our study has demonstrated for the first time the potential application of candesartan cilexetil as an antiviral.
C1 [Loe, Marcus Wing Choy; Lee, Regina Ching Hua; Chu, Justin Jang Hann] Natl Univ Singapore, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies, Dept Microbiol & Immunol,Yong Loo Lin Sch Med, MD4 Level 5,5 Sci Dr 2, Singapore 117597, Singapore.
   [Chu, Justin Jang Hann] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr,Proteos 06-05, Singapore 138673, Singapore.
RP Chu, JJH (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies, Dept Microbiol & Immunol,Yong Loo Lin Sch Med, MD4 Level 5,5 Sci Dr 2, Singapore 117597, Singapore.
EM miccjh@nus.edu.sg
FU MOE Tier 2 grantMinistry of Education, Singapore [MOE 2017-T2-1-078, MOE
   2017-T2-2-014]; Singapore National Research FoundationSingapore National
   Research Foundation [NRF2016NRF-NSFC002-012]
FX This study was funded by the following grants: MOE Tier 2 grant (MOE
   2017-T2-1-078 and MOE 2017-T2-2-014) and Singapore National Research
   Foundation NRF2016NRF-NSFC002-012.
CR Alwan S, 2005, BIRTH DEFECTS RES A, V73, P123, DOI 10.1002/bdra.20102
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10
   Gilfoy F, 2009, VIROLOGY, V385, P74, DOI 10.1016/j.virol.2008.11.034
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lanz B, 2003, KIDNEY INT, V64, P970, DOI 10.1046/j.1523-1755.2003.00192.x
   Lee JL, 2019, ANTIVIR RES, V167, P13, DOI 10.1016/j.antiviral.2019.04.003
   Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   McClellan KJ, 1998, DRUGS, V56, P847, DOI 10.2165/00003495-199856050-00013
   Melnick J.L, 1996, FIELDS VIROLOGY
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nahman N.S., 1996, ANGIOTENSIN 2 INDUCT
   Ong CW, 2016, INTERN MED J, V46, P525, DOI 10.1111/imj.13059
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1
   Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10
   Richard A.S., 2017, P NATL ACAD SCI
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sreekumar E, 2010, VIRUS GENES, V40, P14, DOI 10.1007/s11262-009-0411-9
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin Low JS, 2009, J ANTIVIR ANTIRETROV, V1, P62, DOI DOI 10.4172/JAA.1000009
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
NR 41
TC 1
Z9 1
U1 8
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2019
VL 172
AR 104637
DI 10.1016/j.antiviral.2019.104637
PG 13
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9MF
UT WOS:000499939700011
PM 31669333
DA 2020-07-08
ER

PT J
AU Koujah, L
   Shukla, D
   Naqvi, AR
AF Koujah, Lulia
   Shukla, Deepak
   Naqvi, Afsar R.
TI CRISPR-Cas based targeting of host and viral genes as an antiviral
   strategy
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE CRISPR-Cas; Viruses; Antiviral immunity; Gene editing; Restriction
   factors
ID HEPATITIS-B-VIRUS; INFLUENZA-A VIRUS; CD4(+) T-CELLS; HIV-1 INFECTION;
   ZIKA VIRUS; DRUG-RESISTANCE; GENOME; CCR5; DNA; RNA
AB Viral infections in human are leading cause of mortality and morbidity across the globe. Several viruses (including HIV and Herpesvirus), have evolved ingenious strategies to evade host-immune system and persist lifelong. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) is an ancient antiviral system recently discovered in bacteria that has shown tremendous potential as a precise, invariant genome editing tool. Using CRISPR-Cas based system to activate host defenses or genetic modification of viral genome can provide novel, exciting and successful antiviral mechanisms and treatment modalities. In this review, we will provide progress on the CRISPR-Cas based antiviral approaches that facilitate clearance of virus-infected cells and/or prohibit virus infection or replication. We will discuss on the possibilities of CRIPSR-Cas as prophylaxis and therapy in viral infections and review the challenges of this potent gene editing technology.
C1 [Koujah, Lulia; Shukla, Deepak] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.
   [Koujah, Lulia; Shukla, Deepak] Univ Illinois, Med Ctr, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA.
   [Naqvi, Afsar R.] Univ Illinois, Mucosal Immunol Lab, Coll Dent, Chicago, IL 60612 USA.
RP Naqvi, AR (corresponding author), Univ Illinois, Coll Dent, Dept Periodont, 561B Dent MC 859,801 South Paulina, Chicago, IL 60612 USA.; Shukla, D (corresponding author), Univ Illinois, Dept Ophthalmol, LIERI Room 233 MC 648,1855 W Taylor St, Chicago, IL 60612 USA.
EM dshukla@uic.edu; afsarraz@uic.edu
FU  [NIH/NIDCRR21 DE026259-01A1];  [R01 DE027980];  [2R01 EY024710-04]
FX Part of this work was funded by the NIH/NIDCRR21 DE026259-01A1 and R01
   DE027980 to ARN and 2R01 EY024710-04 to DS.
CR Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591
   Allweiss L, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060156
   [Anonymous], 2016, NATURE, V540, P487
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659
   Biswas PS, 2005, MICROBES INFECT, V7, P799, DOI 10.1016/j.micinf.2005.03.003
   Bogerd HP, 2015, P NATL ACAD SCI USA, V112, pE7249, DOI 10.1073/pnas.1516305112
   Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689
   Chen SL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010040
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Chou YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36921
   Cohen JI, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2014.27
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   de Chassey B, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0115-1
   Deeks SG, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.35
   Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262
   Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo E, 1997, Prog Drug Res, V48, P99
   Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2
   Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0
   ELION GB, 1993, J MED VIROL, P2
   ELION GB, 1982, AM J MED, V73, P7, DOI 10.1016/0002-9343(82)90055-9
   Endy D, 2000, ANTIMICROB AGENTS CH, V44, P1097, DOI 10.1128/AAC.44.4.1097-1099.2000
   ENGLUND JA, 1990, ANN INTERN MED, V112, P416, DOI 10.7326/0003-4819-76-3-112-6-416
   Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405
   Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319
   FIELD AK, 1994, CLIN MICROBIOL REV, V7, P1
   Foster TL, 2016, CELL HOST MICROBE, V20, P429, DOI 10.1016/j.chom.2016.08.006
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Gergen J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192602
   Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006
   Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623
   Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766
   Grutter MG, 2012, CURR OPIN VIROL, V2, P142, DOI 10.1016/j.coviro.2012.02.003
   Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]
   Han J, 2018, CELL REP, V23, P596, DOI 10.1016/j.celrep.2018.03.045
   Heaton BE, 2017, CELL REP, V20, P1503, DOI 10.1016/j.celrep.2017.07.060
   Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663
   Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577
   Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hutter G, 2015, VIRUSES-BASEL, V7, P4186, DOI 10.3390/v7082816
   Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905
   Hussain M, 2017, INFECT DRUG RESIST, V10, P121, DOI 10.2147/IDR.S105473
   Irwin KK, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew014
   Jaggi U, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02895
   Jaishankar D, 2016, MICROB CELL, V3, P438, DOI 10.15698/mic2016.09.528
   Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822
   Jin DY, 2018, VIRUS RES, V244, P285, DOI 10.1016/j.virusres.2017.12.010
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41
   Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555
   Kane M, 2010, J VIROL, V84, P4116, DOI 10.1128/JVI.01905-09
   Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734
   Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203
   Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001
   Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699
   Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201
   Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117
   Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968
   Lei LQ, 2018, NAT STRUCT MOL BIOL, V25, P45, DOI 10.1038/s41594-017-0004-6
   Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022
   Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139
   Li H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00091
   Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65
   Li X, 2017, J VIRAL HEPATITIS, V24, P59, DOI 10.1111/jvh.12612
   Lieberman PM, 2016, CELL HOST MICROBE, V19, P619, DOI 10.1016/j.chom.2016.04.008
   Lin CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34531
   Lin GG, 2015, INT J MOL SCI, V16, P26077, DOI 10.3390/ijms161125950
   Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38
   Liu C, 2017, J CONTROL RELEASE, V266, P17, DOI 10.1016/j.jconrel.2017.09.012
   Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159
   Liu ZP, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0174-2
   Lobo AM, 2019, OCUL SURF, V17, P40, DOI 10.1016/j.jtos.2018.10.002
   Lok ASF, 2016, HEPATOLOGY, V63, P284, DOI 10.1002/hep.28280
   Lopalco L, 2010, VIRUSES-BASEL, V2, P574, DOI 10.3390/v2020574
   Ma YJ, 2017, CELL HOST MICROBE, V21, P580, DOI 10.1016/j.chom.2017.04.005
   Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1
   MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289
   Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569
   Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577
   Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386
   Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0
   Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3
   Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354
   Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553
   Ophinni Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26190-1
   Palmisano L, 2011, ANN I SUPER SANITA, V47, P44, DOI 10.4415/ANN_11_01_10
   Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410
   Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039
   Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10
   Rajao DS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00123
   Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   RICHMAN DD, 1996, ANTIVIRAL DRUG RESIS
   Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116
   Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5
   Rupp LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00462-8
   SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151
   Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842
   Santa-Marta M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00343
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Seeger C, 2016, MOL THER, V24, P1258, DOI 10.1038/mt.2016.94
   Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68
   Sehrawat S, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00177
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168
   Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41
   Soppe JA, 2017, TRENDS MICROBIOL, V25, P833, DOI 10.1016/j.tim.2017.04.005
   Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011
   Strasfeld L, 2010, INFECT DIS CLIN N AM, V24, P413, DOI 10.1016/j.idc.2010.01.001
   Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x
   Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879
   Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009
   Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662
   Testoni B, 2017, SEMIN LIVER DIS, V37, P231, DOI 10.1055/s-0037-1606212
   Tsatsos M, 2016, CLIN EXP OPHTHALMOL, V44, P824, DOI 10.1111/ceo.12785
   van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701
   Vanarsdall AL, 2012, CURR OPIN VIROL, V2, P37, DOI 10.1016/j.coviro.2012.01.001
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036
   Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877
   Wang B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01193
   Wang G, 2016, CELL REP, V17, P2819, DOI 10.1016/j.celrep.2016.11.057
   Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607
   Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111
   Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554
   Whitley R.J., 1996, MED MICROBIOLOGY GAL
   Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866
   Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035
   Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255
   Xu L, 2017, MOL THER, V25, P1782, DOI 10.1016/j.ymthe.2017.04.027
   Xu X, 2016, 2016 IEEE 18TH INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES (HEALTHCOM), P194
   Yang J, 2013, VIRUSES-BASEL, V5, P352, DOI 10.3390/v5010352
   Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111
   Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012
   Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055
   Yuan M, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.35
   Yuan M, 2015, J VIROL, V89, P5176, DOI 10.1128/JVI.00339-15
   Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16277
   Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2
   Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014
   Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z
   Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998
NR 148
TC 2
Z9 2
U1 18
U2 31
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD DEC
PY 2019
VL 96
SI SI
BP 53
EP 64
DI 10.1016/j.semcdb.2019.04.004
PG 12
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA JR9RR
UT WOS:000499954000007
PM 30953741
DA 2020-07-08
ER

PT J
AU Mrzljak, A
   Tabain, I
   Premac, H
   Bogdanic, M
   Barbic, L
   Savic, V
   Stevanovic, V
   Jelic, A
   Mikulic, D
   Vilibic-Cavlek, T
AF Mrzljak, Anna
   Tabain, Irena
   Premac, Hrvoje
   Bogdanic, Maja
   Barbic, Ljubo
   Savic, Vladimir
   Stevanovic, Vladimir
   Jelic, Ana
   Mikulic, Danko
   Vilibic-Cavlek, Tatjana
TI The Role of Emerging and Neglected Viruses in the Etiology of Hepatitis
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Hepatotropic viruses; Hepatitis E virus; Arboviruses; Adenoviruses;
   Parvovirus B19; Anelloviruses; Human bocavirus; Pegiviruses;
   Arenaviruses
ID ACUTE LIVER-FAILURE; TORQUE TENO VIRUS; WEST-NILE-VIRUS; SEN-VIRUS;
   ADENOVIRUS HEPATITIS; LYMPHOCYTIC CHORIOMENINGITIS; FULMINANT-HEPATITIS;
   HUMAN PARVOVIRUS; HUMAN PEGIVIRUS; HUMAN BOCAVIRUS
AB Purpose of Review In this review, we present the overview of emerging and neglected viruses associated with liver involvement. Recent Findings Hepatitis E virus (HEV) emerged in the last two decades, causing hepatitis in many parts of the world. Moreover, liver involvement was also described in some emerging arboviral infections. Many reports showed dengue-associated liver injury; however, chikungunya, West Nile, tick-borne encephalitis, and Zika virus are rarely associated with clinically manifest liver disease. In addition, some neglected highly prevalent viruses such as adenoviruses and parvovirus B19 are capable of causing hepatitis in specific population groups. Anelloviruses (torque teno virus/torque teno mini virus/torque teno midi virus, SEN virus), human bocavirus, pegiviruses, and lymphocytic choriomeningitis virus have shown a little potential for causing hepatitis, but their role in the etiology of liver disease remains to be determined. In addition to the well-known hepatotropic viruses, many emerging and neglected viruses have been associated with liver diseases. The number of emerging zoonotic viruses has been increasingly recognized. While zoonotic potential of HEV is well documented, the recent identification of new hepatitis-related animal viruses such as HEV strains from rabbits and camels, non-primate hepaciviruses in domestic dogs and horses, as well as equine and porcine pegivirus highlights the possible zoonotic transmission in the context of "One Health." However, zoonotic potential and hepatotropism of animal hepatitis viruses remain to be determined.
C1 [Mrzljak, Anna; Jelic, Ana] Merkur Univ Hosp, Dept Med, Salata 3b, Zagreb 10000, Croatia.
   [Mrzljak, Anna; Vilibic-Cavlek, Tatjana] Univ Zagreb, Sch Med, Zagreb, Croatia.
   [Tabain, Irena; Bogdanic, Maja; Vilibic-Cavlek, Tatjana] Croatian Inst Publ Hlth, Dept Virol, Zagreb, Croatia.
   [Premac, Hrvoje] Varazdin Gen Hosp, Dept Med, Varazhdin, Croatia.
   [Barbic, Ljubo; Stevanovic, Vladimir] Univ Zagreb, Fac Vet Med, Dept Microbiol & Infect Dis Clin, Zagreb, Croatia.
   [Savic, Vladimir] Croatian Vet Inst, Lab Virol & Serol, Poultry Ctr, Zagreb, Croatia.
   [Mikulic, Danko] Merkur Univ Hosp, Dept Surg, Zagreb, Croatia.
RP Mrzljak, A (corresponding author), Merkur Univ Hosp, Dept Med, Salata 3b, Zagreb 10000, Croatia.; Mrzljak, A (corresponding author), Univ Zagreb, Sch Med, Zagreb, Croatia.
EM anna.mrzljak@mef.hr
RI Vilibic-Cavlek, Tatjana/AAI-2010-2019; Mrzljak, Anna/J-7465-2017
OI Mrzljak, Anna/0000-0001-6270-2305; Vilibic-Cavlek,
   Tatjana/0000-0002-1877-5547; Bogdanic, Maja/0000-0002-8236-3205; Savic,
   Vladimir/0000-0003-0398-5346; Stevanovic, Vladimir/0000-0002-9572-8760
FU Croatian Science Foundation [HRZZ IP 2016-06-7456]
FX This study was supported in part by the Croatian Science Foundation,
   project no. HRZZ IP 2016-06-7456: Prevalence and Molecular Epidemiology
   of Emerging and Re-emerging Neuroinvasive Arboviral Infections in
   Croatia; CRONEUROARBO (to TVC).
CR Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016
   Ahmed F, 2015, SM J HEPAT RES TREAT, V1, P1002
   Akiba J, 2005, TRANSFUSION, V45, P1084, DOI 10.1111/j.1537-2995.2004.00209.x
   Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102
   Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196
   Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391
   Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Beier JI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122839
   Beland K, 2014, J INFECT DIS, V209, P247, DOI 10.1093/infdis/jit423
   Berg MG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005325
   Bihari Chhagan, 2013, Hepat Res Treat, V2013, P472027, DOI 10.1155/2013/472027
   Blasco-Perrin H, 2015, ALIMENT PHARM THER, V42, P574, DOI 10.1111/apt.13309
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Bonifay T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207406
   Bowman S, 2012, AM J MED SCI, V344, P335, DOI 10.1097/MAJ.0b013e318257c1db
   Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12
   Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110
   Chivero ET, 2015, J GEN VIROL, V96, P1521, DOI 10.1099/vir.0.000086
   Chongsrisawat V, 2009, SE ASIAN J TROP MED, V40, P47
   Chua H H, 2010, Med J Malaysia, V65, P83
   Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448
   Corman VM, 2015, J VIROL, V89, P5876, DOI 10.1128/JVI.00393-15
   Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a
   Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778
   Darrigo LG, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0612-2
   de la Serna-Higuera C, 1999, J CLIN GASTROENTEROL, V29, P276, DOI 10.1097/00004836-199910000-00010
   De Schryver A, 2015, OCCUP MED-OXFORD, V65, P667, DOI 10.1093/occmed/kqv154
   de Souza LJ, 2007, BRAZ J INFECT DIS, V11, P407, DOI 10.1590/S1413-86702007000400007
   Souza Luiz José de, 2002, Braz J Infect Dis, V6, P322, DOI 10.1590/S1413-86702002000600010
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Drexler JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003438
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Fabre A, 2001, GUT, V49, P864, DOI 10.1136/gut.49.6.864
   Galante A, 2019, HEPATOLOGY, V70, P1863, DOI 10.1002/hep.30803
   Gandhi K, 2013, MED J DY PATIL U, V6, P370
   Garnier P, 2006, J CLIN VIROL, V36, pS60, DOI 10.1016/S1386-6532(06)80184-8
   GEORGES AJ, 1987, ANN INST PASTEUR VIR, V138, P237, DOI 10.1016/S0769-2617(87)80007-2
   Gyure KA, 2009, J NEUROPATH EXP NEUR, V68, P1053, DOI 10.1097/NEN.0b013e3181b88114
   Haberle S, 2019, THESIS
   Han T, 2006, KOREAN J BLOOD TRANS, V17, P126
   Haytoglu Z, 2017, BALK MED J, V34, P281, DOI 10.4274/balkanmedj.2015.1492
   Hosnut FO, 2008, TURK J GASTROENTEROL, V19, P281
   Hussain T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-320
   Islek A, 2019, TRANSPL P, V51, P1169, DOI 10.1016/j.transproceed.2019.01.084
   Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057
   Jagadishkumar K, 2012, IRAN J PEDIATR, V22, P231
   Jemersic L, 2017, VET ARHIV, V87, P651, DOI 10.24099/vet.arhiv.170208
   Kainulainen L, 2008, J CLIN MICROBIOL, V46, P4104, DOI 10.1128/JCM.01288-08
   Kamal SM, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.001
   Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992
   Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7
   Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050
   Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831
   Kapoor A, 2015, MBIO, V6, DOI 10.1128/mBio.01466-15
   Kapoor A, 2013, J VIROL, V87, P7185, DOI 10.1128/JVI.00324-13
   Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108
   Kennedy J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44642-0
   Khameneh ZR, 2014, INDIAN J PATHOL MICR, V57, P442, DOI 10.4103/0377-4929.138748
   Kobayashi N, 2003, NEPHROL DIAL TRANSPL, V18, P348, DOI 10.1093/ndt/18.2.348
   Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018
   Ling LM, 2007, J CLIN VIROL, V38, P265, DOI 10.1016/j.jcv.2006.12.011
   LOTRICFURLAN S, 1995, ZBL BAKT-INT J MED M, V282, P275
   Lukashevich IS, 2004, ARCH VIROL, V149, P2319, DOI 10.1007/s00705-004-0385-9
   Lyons S, 2014, J GEN VIROL, V95, P1701, DOI 10.1099/vir.0.065094-0
   MacNeil A, 2012, EMERG INFECT DIS, V18, P1256, DOI 10.3201/eid1808.120212
   Mancuso R, 2013, J MED VIROL, V85, P2176, DOI 10.1002/jmv.23707
   Matoq A, 2016, CASE REP PEDIAT, DOI 10.1155/2016/8648190
   McKillop SJ, 2015, PEDIATR INT, V57, P974, DOI 10.1111/ped.12674
   Mellinger JL, 2014, DIGEST DIS SCI, V59, P1630, DOI 10.1007/s10620-014-3029-2
   Mi Zhiqiang, 2014, Virologica Sinica, V29, P112, DOI 10.1007/s12250-014-3424-z
   Misic-Majerus Ljiljana, 2005, Acta Med Croatica, V59, P347
   Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x
   Momosaki S, 2005, J VIRAL HEPATITIS, V12, P435, DOI 10.1111/j.1365-2893.2005.00618.x
   Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765
   Ohto H, 2002, TRANSFUSION, V42, P892, DOI 10.1046/j.1537-2995.2002.00150.x
   Paddock CD, 2006, CLIN INFECT DIS, V42, P1527, DOI 10.1086/503841
   Pavio N, 2015, CURR OPIN VIROL, V10, P34, DOI 10.1016/j.coviro.2014.12.006
   Peled N, 2004, CLIN PEDIATR, V43, P223, DOI 10.1177/000992280404300303
   Peng J, 2015, VIROL SIN, V30, P218, DOI 10.1007/s12250-014-3531-x
   Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7
   Perez D, 2007, TRANSPL INFECT DIS, V9, P318, DOI 10.1111/j.1399-3062.2007.00205.x
   Poovorawan Y, 2006, ANN TROP PAEDIATR, V26, P17, DOI 10.1179/146532806X90565
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Primi D, IDENTIFICATION SEN V
   Qiu JM, 2017, CLIN MICROBIOL REV, V30, P43, DOI 10.1128/CMR.00040-16
   Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110
   Rasche A, 2019, J HEPATOL, V70, P501, DOI 10.1016/j.jhep.2018.11.010
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Ronan BA, 2014, INFECTION, V42, P105, DOI 10.1007/s15010-013-0527-7
   Rosa AS, 2017, VIRUS RES, V242, P166, DOI 10.1016/j.virusres.2017.09.022
   Ruiz P, 2019, LIVER TRANSPLANT, V25, P302, DOI 10.1002/lt.25374
   Sagir A, 2004, REV MED VIROL, V14, P141, DOI 10.1002/rmv.421
   Saha AK, 2013, INDIAN J GASTROENTER, V32, P400, DOI 10.1007/s12664-013-0382-6
   Schaberg KB, 2017, AM J SURG PATHOL, V41, P810, DOI 10.1097/PAS.0000000000000834
   Schafer IJ, 2014, AM J TRANSPLANT, V14, P1459, DOI 10.1111/ajt.12802
   Schlosser B, 2012, J HEPATOL, V56, P500, DOI 10.1016/j.jhep.2011.06.021
   Schlottau K, 2019, ARCH VIROL, V164, P391, DOI 10.1007/s00705-018-4077-2
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Sherman KE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214016
   Shibata M, 2001, J INFECT DIS, V184, P400, DOI 10.1086/322050
   Shui JW, 2019, J GEN VIROL, V100, P968, DOI 10.1099/jgv.0.001266
   SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564
   Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0
   Steiner I, 2008, PEDIATR BLOOD CANCER, V50, P647, DOI 10.1002/pbc.21120
   Teshale EH, 2010, EMERG INFECT DIS, V16, P126, DOI 10.3201/eid1601.090764
   Tong Rui, 2013, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V27, P135
   Umemura T, 2001, J INFECT DIS, V184, P1246, DOI 10.1086/324210
   Umemura T, 2001, HEPATOLOGY, V33, P1303, DOI 10.1053/jhep.2001.24268
   Umemura T, 2002, HEPATOLOGY, V35, P953, DOI 10.1053/jhep.2002.32536
   Umemura T, 2002, FEBS LETT, V510, P171, DOI 10.1016/S0014-5793(01)03258-6
   Vine L. J., 2015, MEDICINE, V43, P594, DOI [10.1016/j.mpmed.2015.07.006, DOI 10.1016/J.MPMED.2015.07.006]
   von Felden J, 2019, J HEPATOL, V71, P465, DOI 10.1016/j.jhep.2019.04.022
   Wang C, 2009, J MED VIROL, V81, P2079, DOI 10.1002/jmv.21638
   Wang HY, 2018, CLIN INFECT DIS, V66, P29, DOI 10.1093/cid/cix748
   WHO, DENGUE
   Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107
   Wiwanitkit V, 2016, HEPATOMA RES, V2, P203, DOI [10.20517/2394-5079.2016.17, DOI 10.20517/2394-5079.2016.17]
   Woo PCY, 2014, EMERG INFECT DIS, V20, P1044, DOI 10.3201/eid2006.140140
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Yoshida H, 2002, J CLIN MICROBIOL, V40, P3140, DOI 10.1128/JCM.40.9.3140-3145.2002
   Yun NE, 2012, VIRUSES-BASEL, V4, P2031, DOI 10.3390/v4102031
NR 124
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD DEC
PY 2019
VL 21
IS 12
AR 51
DI 10.1007/s11908-019-0709-2
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA JR2KS
UT WOS:000499461100002
PM 31754812
DA 2020-07-08
ER

PT J
AU Perkin, TA
   Rodriguez-Barraquer, I
   Manore, C
   Siraj, AS
   Espana, G
   Barker, CM
   Johansson, MA
   Reiner, RC
AF Perkin, T. Alex
   Rodriguez-Barraquer, Isabel
   Manore, Carrie
   Siraj, Amir S.
   Espana, Guido
   Barker, Christopher M.
   Johansson, Michael A.
   Reiner, Robert C., Jr.
TI Heterogeneous local dynamics revealed by classification analysis of
   spatially disaggregated time series data
SO EPIDEMICS
LA English
DT Article
DE Emerging disease; Spatial dynamics; Spatial heterogeneity; Time series
   data; Vector-borne disease
ID INTERMEDIATE-SCALE; TRAVELING-WAVES; TRANSMISSION; CHIKUNGUNYA;
   DETERMINISM; COLOMBIA
AB Time series data provide a crucial window into infectious disease dynamics, yet their utility is often limited by the spatially aggregated form in which they are presented. When working with time series data, violating the implicit assumption of homogeneous dynamics below the scale of spatial aggregation could bias inferences about underlying processes. We tested this assumption in the context of the 2015-2016 Zika epidemic in Colombia, where time series of weekly case reports were available at national, departmental, and municipal scales. First, we performed a descriptive analysis, which showed that the timing of departmental-level epidemic peaks varied by three months and that departmental-level estimates of the time-varying reproduction number, R(t), showed patterns that were distinct from a national-level estimate. Second, we applied a classification algorithm to six features of proportional cumulative incidence curves, which showed that variability in epidemic duration, the length of the epidemic tail, and consistency with a cumulative normal density curve made the greatest contributions to distinguishing groups. Third, we applied this classification algorithm to data simulated with a stochastic transmission model, which showed that group assignments were consistent with simulated differences in the basic reproduction number, R-0. This result, along with associations between spatial drivers of transmission and group assignments based on observed data, suggests that the classification algorithm is capable of detecting differences in temporal patterns that are associated with differences in underlying drivers of incidence patterns. Overall, this diversity of temporal patterns at local scales underscores the value of spatially disaggregated time series data.
C1 [Perkin, T. Alex; Siraj, Amir S.; Espana, Guido] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Perkin, T. Alex; Siraj, Amir S.; Espana, Guido] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Rodriguez-Barraquer, Isabel] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Manore, Carrie] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM USA.
   [Barker, Christopher M.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA USA.
   [Johansson, Michael A.] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA USA.
   [Reiner, Robert C., Jr.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
RP Perkin, TA (corresponding author), 100 Galvin Hall, Notre Dame, IN 46556 USA.; Reiner, RC (corresponding author), 325 9th Ave,Box 359931, Seattle, WA 98104 USA.
EM taperkins@nd.edu; Isabel.Rodriguez@ucsf.edu; cmanore@lanl.gov;
   asiraj@nd.edu; guido.espana@nd.edu; cmbarker@ucdavis.edu;
   mjohansson@cdc.gov; bcreiner@uw.edu
OI Johansson, Michael/0000-0002-5090-7722; Camargo Espana,
   guido/0000-0002-9915-8056
FU RAPID grant from the National Science Foundation [DEB 1641130]; Defense
   Advanced Research Projects AgencyUnited States Department of
   DefenseDefense Advanced Research Projects Agency (DARPA) [D16AP00114]
FX This research was supported by a RAPID grant from the National Science
   Foundation (DEB 1641130) and by a Young Faculty Award from the Defense
   Advanced Research Projects Agency (D16AP00114).
CR ACHEE NL, 2015, PLOS CURR, V9, DOI DOI 10.1371/CURRENTS.OUTBREAKS
   Asher J., 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226
   Chretien JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002109
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Dalziel BD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0763
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032
   Escobar LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1403-y
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a
   Hastings A, 2010, ECOLOGY, V91, P3471, DOI 10.1890/10-0776.1
   Huber J.H., 2017, BIORXIV, DOI [10.1101/230383, DOI 10.1101/230383]
   Imai N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004833
   Instituto Nacional de Salud, 2017, B EPIDEMIOLOGICO
   Keeling MJ, 1997, PHILOS T ROY SOC B, V352, P1589, DOI 10.1098/rstb.1997.0143
   King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347
   Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447
   Maechler M., 2017, CLUSTER CLUSTER ANAL
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Metcalf CJE, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0901
   Mills HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003561
   Moore SM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1127-2
   Pascual M, 1999, ECOLOGY, V80, P2225, DOI 10.1890/0012-9658(1999)080[2225:FITPDS]2.0.CO;2
   Perkins T.A., 2016, MICROBIOLOGY NATURE
   Perkins TA, 2017, P NATL ACAD SCI USA, V114, P5558, DOI 10.1073/pnas.1705969114
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P111, DOI 10.1098/rspb.1995.0017
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Reynolds A, 2006, J MATH MODEL ALGORIT, V5, P475, DOI DOI 10.1007/S10852-005-9022-1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Siraj AS, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.73
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740
NR 42
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD DEC
PY 2019
VL 29
AR UNSP 100357
DI 10.1016/j.epidem.2019.100357
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA JR5XM
UT WOS:000499697600005
PM 31607654
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Harapan, H
   Mudatsir, M
   Indah, R
   Utomo, PS
   Anwar, S
   Wahyuniati, N
   Maulana, R
   Ichsan, I
   Aletta, A
   Ikram, I
   Ramadana, MR
   Rajamoorthy, Y
   Setiawan, AM
   Wagner, AL
   Andalas, M
AF Harapan, Harapan
   Mudatsir, Mudatsir
   Indah, Rosaria
   Utomo, Prattama S.
   Anwar, Samsul
   Wahyuniati, Nur
   Maulana, Reza
   Ichsan, Ichsan
   Aletta, Alma
   Ikram, Ikram
   Ramadana, Muhammad R.
   Rajamoorthy, Yogambigai
   Setiawan, Abdul M.
   Wagner, Abram L.
   Andalas, Mohd
TI Knowledge towards Zika among medical students, interns and general
   practitioners in Indonesia: A cross-sectional study in Aceh
SO CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH
LA English
DT Article
DE Zika; Zika infection; Knowledge; Healthcare worker; Medical student
ID HEALTH-CARE STUDENTS; WORKERS KNOWLEDGE; VIRUS-INFECTION; ATTITUDES;
   PATIENT; CITIES; IMPACT; FEVER
AB Background: The aim of this study was to assess the level of knowledge towards Zika among medical students, medical interns and general practitioners (GPs) in Indonesia.
   Methods: A cross-sectional study was conducted in Aceh province of Indonesia in 2016. A set of validated questionnaire, consisting 24 questions, was used to assess the knowledge. Logistic regression was used to estimate the differences in knowledge between groups.
   Results: A total of 1031 participants were included in the final analysis in which most of them were medical student (39.7%), followed by GPs (37.7%) and medical intern (22.6%). Approximately 17%, 19%, and 64% of the medical students, interns and GPs had good knowledge, respectively. The knowledge level of medical student and medical interns was roughly equivalent. Medical students and medical interns had significantly lower odds of having a good knowledge compared to GPs, OR: 0.12 (95%CI: 0.08-0.16) and OR: 0.13 (95%CI: 0.09-0.20), respectively.
   Conclusion: General practitioners have greater knowledge of Zika than medical students or interns, possibly as a result of clinical experiences or exposure to learning. Inclusion of Zika learning materials in the national medical curriculum could improve knowledge of Zika and the ability of the health care workforce to respond to future outbreaks.
C1 [Harapan, Harapan; Mudatsir, Mudatsir; Wahyuniati, Nur; Maulana, Reza; Ichsan, Ichsan; Ikram, Ikram; Ramadana, Muhammad R.; Andalas, Mohd] Syiah Kuala Univ, Sch Med, Med Res Unit, Jl T Tanoeh Abe, Darussalam 23111, Banda Aceh, Indonesia.
   [Harapan, Harapan; Mudatsir, Mudatsir; Ichsan, Ichsan] Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia.
   [Harapan, Harapan; Mudatsir, Mudatsir] Syiah Kuala Univ, Trop Dis Ctr, Sch Med, Banda Aceh, Indonesia.
   [Indah, Rosaria] Syiah Kuala Univ, Sch Med, Med Educ Unit, Banda Aceh, Indonesia.
   [Indah, Rosaria] Univ Sydney, Fac Arts & Social Sci, Sydney Sch Educ & Social Work, Sydney, NSW, Australia.
   [Utomo, Prattama S.] Gadjah Mada Univ, Fac Med, Dept Med Educ, Yogyakarta, Indonesia.
   [Anwar, Samsul] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Stat, Banda Aceh, Indonesia.
   [Aletta, Alma] Syiah Kuala Univ, Sch Med, Dept Family Med, Banda Aceh, Indonesia.
   [Rajamoorthy, Yogambigai] Univ Tunku Abdul Rahman, Kajang, Selangor, Malaysia.
   [Setiawan, Abdul M.] State Islamic Univ Maulana Malik Ibrah, Fac Med & Hlth Sci, Dept Microbiol, Malang, Indonesia.
   [Wagner, Abram L.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Andalas, Mohd] Syiah Kuala Univ, Sch Med, Dept Obstet & Gynecol, Banda Aceh, Indonesia.
RP Harapan, H; Mudatsir, M (corresponding author), Syiah Kuala Univ, Sch Med, Med Res Unit, Jl T Tanoeh Abe, Darussalam 23111, Banda Aceh, Indonesia.
EM harapan@unsyiah.ac.id; mudatsir@unsyiah.ac.id
RI Mudatsir, Mudatsir/Q-4999-2017; Harapan, Harapan/I-8741-2016
OI Mudatsir, Mudatsir/0000-0002-5643-9384; Harapan,
   Harapan/0000-0001-7630-8413; Ichsan, Ichsan/0000-0002-8903-9977;
   Setiawan, abdul Malik/0000-0002-6913-2007
CR Cervero RM, 2015, J CONTIN EDUC HEALTH, V35, P131, DOI 10.1002/chp.21290
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gokce A, 2016, EUR J PUBLIC HEALTH, V26, P452
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Harapan H., 2018, VACCINE UNPUB
   Harapan H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110648
   Harapan H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3006-z
   Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ibrahim NK, 2018, J INFECT PUBLIC HEAL, V11, P18, DOI 10.1016/j.jiph.2017.02.015
   Indonesian Medical Council, 2006, STAND KOMP DOKT IND
   Iqbal MZ, 2016, VALUE HEALTH, V19, pA484, DOI 10.1016/j.jval.2016.09.798
   Janiga J, 2015, OBSTET GYNECOL, V125, p38S, DOI 10.1097/01.AOG.0000463044.17528.0f
   Kaufman DM, 2003, BMJ-BRIT MED J, V326, P213, DOI 10.1136/bmj.326.7382.213
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Ministry of Health Republic of Indonesia, 2016, PERT SEP PEN VIR ZIK
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Yardley S, 2012, MED TEACH, V34, P161, DOI 10.3109/0142159X.2012.643264
   Yudhaputri FA, 2017, VIROLOGY, V510, P248, DOI 10.1016/j.virol.2017.07.026
NR 31
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTD
PI NEW DELHI
PA 17-A/1 MAIN RING ROAD, LAJPAT NAGAR IV, NEW DELHI, 110024, INDIA
SN 2452-0918
EI 2213-3984
J9 CLIN EPIDEMIOL GLOB
JI Clin. Epidemiol. Glob. Health
PD DEC
PY 2019
VL 7
IS 4
BP 542
EP 545
DI 10.1016/j.cegh.2018.12.006
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JQ3YM
UT WOS:000498884500005
OA Bronze
DA 2020-07-08
ER

PT J
AU Colombo, TE
   Versiani, AF
   Dutra, KR
   Rubiato, JGD
   Galvao, TM
   Reis, AFN
   Nogueira, ML
AF Colombo, Tatiana Elias
   Versiani, Alice Freitas
   Dutra, Karina Rocha
   Dias Rubiato, Julia Guimaraes
   Galvao, Tayna Manfrin
   Negri Reis, Andreia Francesli
   Nogueira, Mauricio Lacerda
TI Performance of CDC Trioplex qPCR during a dengue outbreak in Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Detection; Dengue virus; Sensitivity; Specificity
ID REVERSE TRANSCRIPTION-PCR; ZIKA VIRUS; CHIKUNGUNYA; INFECTION; ASSAYS
AB Background: In recent years real-time reverse transcription polymerase chain reaction (real-time RT-PCR) has become a leading technique for nucleic acid detection and quantification of flaviviruses, including Dengue virus (DENV). Trioplex real-time RT-PCR has the advantages of providing the concurrent detection of Zika virus (ZIKV), DENV, and Chikungunya virus (CHIKV) RNA in human serum.
   Objective: This study sought to compare the sensitivity and specificity of the Trioplex real-time RT-PCR assay to those provided by CDC DENV TaqMan (R) RT-qPCR assay and conventional PCR when used for DENV detection in the context of a dengue epidemic.
   Study design: We analyzed 1656 serum samples from symptomatic patients with acute febrile disease for 5 days less between December 2018 and May 2019. The samples were tested using the various PCR-based assays.
   Results: Of the 1656 serum samples analyzed, 713 (43%) were laboratory-confirmed as arboviruses: 99.86% (712/713) were confirmed as DENV and 0.14% (1/713) were confirmed as ZIKV. Next, 590 samples were selected, and of these, 331 samples (56.1%) were determined to be positive (Ct < 38) and 259 samples (43.9%) were determined to be negative (Ct > 38) using the Trioplex real-time RT-PCR assay. The multiplex method found that the test exhibits 95% sensitivity and 100% specificity.
   Conclusion: This evaluation demonstrates the capacity of the Trioplex real-time RT-PCR assay to detect DENV at a high sensitivity and specificity in a geographic area with a current dengue outbreak and a lower co-circulation of other arboviruses - such as ZIKV and CHIKV, and the results prove it's applicability as clinical screening test that can serve as a confirmatory test.
C1 [Colombo, Tatiana Elias; Versiani, Alice Freitas; Dutra, Karina Rocha; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Colombo, Tatiana Elias; Dias Rubiato, Julia Guimaraes; Galvao, Tayna Manfrin] Univ Paulista UNIP, Sao Jose Do Rio Preto, SP, Brazil.
   [Negri Reis, Andreia Francesli] Prefeitura Sao Jose do Rio Preto, Dept Vigilancia Saude, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), FAMERP, Dept Doencas Dermatol Infecciosas & Parasitaria, Sao Jose Do Rio Preto, SP, Brazil.
EM mauricio.nogueira@edu.famerp.br
RI Nogueira, Mauricio L/B-7599-2012; Versiani, Alice/M-9782-2018
OI Nogueira, Mauricio L/0000-0003-1102-2419; Versiani,
   Alice/0000-0003-1378-5380
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2018/17647-0]
FX This work was supported by the Sao Paulo Research Foundation (FAPESP)
   under grant number #2013/21719-3 awarded to MLN. AFV is currently a
   FAPESP fellow (grant #2018/17647-0).
CR Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004
   Donalisio M.R., 2017, REV SAUDE PUBL, V51
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Estofolete CF, 2019, J INFECT PUBLIC HEAL, V12, P178, DOI 10.1016/j.jiph.2018.09.007
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Pinheiro TM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006525
   Vega FLR, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0347-2018
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Subedi D, 2014, OPEN J CLIN DIAGN, V4, P63
   U.S. Food and Drug Administration, 2016, EM US AUTH TRIOPL RE
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   WHO, 2011, COMPR GUID PREV CONT
   World Health Organization, 2010, IMP DENG
   World Health Organization, 2019, DENG SEV DENG
NR 32
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD DEC
PY 2019
VL 121
AR 104208
DI 10.1016/j.jcv.2019.104208
PG 4
WC Virology
SC Virology
GA JQ2QX
UT WOS:000498796600009
PM 31707203
DA 2020-07-08
ER

PT J
AU Elfiky, AA
   Ismail, A
AF Elfiky, Abdo A.
   Ismail, Alaa
TI Molecular dynamics and docking reveal the potency of novel GTP
   derivatives against RNA dependent RNA polymerase of genotype 4a HCV
SO LIFE SCIENCES
LA English
DT Article
DE Molecular modeling; Molecular dynamics simulation; HCV genotype 4a;
   Polymerase; Nucleotide inhibitors; Protein-ligand docking
ID SERINE-PROTEASE; HEPATITIS; POTENTIALS; SOFOSBUVIR; THERAPY
AB Aim: To work on Hepatitis C Virus (HCV), one of the major causes of liver cirrhosis and hepatocellular carcinoma, polymerase of genotype 4a that have no solved structures deposited in the protein data bank (PDB) yet. Understanding the dynamics and testing some novel inhibitors are also covered.
   Materials and methods: Molecular Dynamics Simulation (MDS) is performed for a period of 1 mu s on comparatively modeled then validated NS5b of subtype 4a. Following MDS analysis, molecular docking is performed to test the inhibitory performance of eight novels suggested guanosine derivatives using 181 different conformations of the protein model gathered during the MDS run after the equilibration period.
   Key findings: The results yield that the eight modified, at position 2', GTP derivatives (fluorine, Hydroxyl, and sulphonyl oxydanyl) have binding energies comparable to the parent molecule, GTP. Besides, the eight suggested compounds have lower binding energies (and hence better in binding) compared to sofosbuvir (a drug approved by FDA in 2013 against HCV) and ribavirin (a wide range acting antiviral drug used before against HCV).
   Significance: Combined molecular dynamics and molecular docking are able to test the hypothesis of HCV polymerase dynamics doesn't affect the nucleotides (or nucleotide inhibitors) binding to its active site. Despite the reported highly dynamic subtype 4a of HCV; all the nucleotide inhibitors under the study are able to, tightly, bind to NS5b of genotype 4a. This behavior is reported before for the Zika virus polymerase, as well.
C1 [Elfiky, Abdo A.; Ismail, Alaa] Cairo Univ, Fac Sci, Biophys Dept, Giza, Egypt.
RP Elfiky, AA (corresponding author), Cairo Univ, Fac Sci, Biophys Dept, Giza, Egypt.
EM abdo@sci.cu.edu.eg
RI Mohamed, Abdo/H-3595-2019
OI Mohamed, Abdo/0000-0003-4600-6240
FU Cyprus Institute of Science [pro15b114s1]; Abdus Salam International
   Center for Theoretical Physics (ICTP), Trieste, Italy
FX Dr. Ali Hassanali is appreciated for his guidance and his revision.
   Prof. Dr. Wael Elshemey is appreciated for performing the docking
   calculations on his computational facility. MDS was carried out on the
   Cy-Tera supercomputer facility of Cyprus Institute of Science under the
   production run of the project "pro15b114s1". This work is done during
   the Junior associate award granted to Abdo Elfiky 2016-2021 of the Abdus
   Salam International Center for Theoretical Physics (ICTP), Trieste,
   Italy.
CR [Anonymous], 2016, S REL 1 MAESTR
   Asselah T, 2014, J HEPATOL, V61, P435, DOI 10.1016/j.jhep.2014.04.042
   Bahgat MM, 2009, ARCH VIROL, V154, P1649, DOI 10.1007/s00705-009-0500-z
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   De Francesco R, 2003, ANTIVIR RES, V58, P1, DOI 10.1016/S0166-3542(03)00028-7
   De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016
   DeLano WL, 2002, PYMOL, P700
   Elfiky A.A., 2016, J MED VIROL
   Elfiky A.A., 2016, SOFTWARE TECHNIQUES, P197
   Elfiky AA, 2016, MED CHEM RES, V25, P1005, DOI 10.1007/s00044-016-1533-y
   Elfiky AA, 2015, J COMPUT THEOR NANOS, V12, P376, DOI 10.1166/jctn.2015.3739
   Elfiky AA, 2013, PROTEIN J, V32, P75, DOI 10.1007/s10930-013-9462-9
   Elshemey WM, 2010, PROTEIN J, V29, P545, DOI 10.1007/s10930-010-9291-z
   Genovese D, 2005, J CLIN MICROBIOL, V43, P1902, DOI 10.1128/JCM.43.4.1902-1909.2005
   Gonzalez-Grande R, 2016, WORLD J GASTROENTERO, V22, P1421, DOI 10.3748/wjg.v22.i4.1421
   Graham DJ, 2006, ANTIVIR RES, V69, P24, DOI 10.1016/j.antiviral.2005.08.005
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lemon SM, 2010, ANTIVIR RES, V86, P79, DOI 10.1016/j.antiviral.2010.02.003
   LII JH, 1989, J AM CHEM SOC, V111, P8576, DOI 10.1021/ja00205a003
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628
   Saleh NA, 2015, J COMPUT THEOR NANOS, V12, P371, DOI 10.1166/jctn.2015.3738
   Saleh NA, 2014, J COMPUT THEOR NANOS, V11, P544, DOI 10.1166/jctn.2014.3392
   Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315
   Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5
   STEWART JJP, 1991, J COMPUT CHEM, V12, P320, DOI 10.1002/jcc.540120306
   Summers KL, 2012, BIOCHEM BIOPH RES CO, V425, P485, DOI 10.1016/j.bbrc.2012.07.141
   Yan SQ, 2007, BIOORG MED CHEM LETT, V17, P63, DOI 10.1016/j.bmcl.2006.09.095
   Yan SQ, 2006, BIOORG MED CHEM LETT, V16, P5888, DOI 10.1016/j.bmcl.2006.08.056
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Yang PL, 2011, CURR OPIN VIROL, V1, P607, DOI 10.1016/j.coviro.2011.10.019
   Zhang C, 2004, BIOPHYS J, V86, P3349, DOI 10.1529/biophysj.103.035998
NR 34
TC 5
Z9 5
U1 2
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD DEC 1
PY 2019
VL 238
AR 116958
DI 10.1016/j.lfs.2019.116958
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA JQ3MG
UT WOS:000498852700013
PM 31628915
DA 2020-07-08
ER

PT J
AU Li, CF
   Zu, SL
   Deng, YQ
   Li, DP
   Parvatiyar, K
   Quanquin, N
   Shang, JZ
   Sun, NN
   Su, JQ
   Liu, ZY
   Wang, M
   Aliyari, SR
   Li, XF
   Wu, AP
   Ma, F
   Shi, Y
   Nielsen-Saines, K
   Jung, JU
   Qin, FXF
   Qin, CF
   Cheng, GH
AF Li, Chunfeng
   Zu, Shulong
   Deng, Yong-Qiang
   Li, Dapei
   Parvatiyar, Kislay
   Quanquin, Natalie
   Shang, Jingzhe
   Sun, Nina
   Su, Jiaqi
   Liu, Zhenyang
   Wang, Min
   Aliyari, Saba R.
   Li, Xiao-Feng
   Wu, Aiping
   Ma, Feng
   Shi, Yi
   Nielsen-Saines, Karin
   Jung, Jae U.
   Qin, Frank Xiao-Feng
   Qin, Cheng-Feng
   Cheng, Genhong
TI Azithromycin Protects against Zika Virus Infection by Upregulating
   Virus-Induced Type I and III Interferon Responses
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE FDA-approved drug; azithromycin; Zika virus; type I and III interferon
   responses; antibiotics; antiviral agents; innate immunity; interferons
ID RNA VIRUSES; RIG-I; SPECTRUM; DRUG; MDA5; IDENTIFICATION; TRANSMISSION;
   INHIBITORS; SCREEN; CELLS
AB Azithromycin (AZM) is a widely used antibiotic, with additional antiviral and anti-inflammatory properties that remain poorly understood. Although Zika virus (ZIKV) poses a significant threat to global health, there are currently no vaccines or effective therapeutics against it. Here, we report that AZM effectively suppresses ZIKV infection in vitro by targeting a late stage in the viral life cycle. In addition, AZM upregulates the expression of host type I and III interferons and several of their downstream interferon-stimulated genes in response to ZIKV infection. In particular, we found that AZM upregulated the expression of MDA5 and RIG-I (pathogen recognition receptors induced by ZIKV infection) and increased the levels of phosphorylated TBK1 and IRF3. Interestingly, AZM treatment upregulated the phosphorylation of TBK1 without inducing the phosphorylation of IRF3 by itself. These findings highlight the potential use of AZM as a broad antiviral agent to combat viral infection and to prevent devastating ZIKV-associated clinical outcomes, such as congenital microcephaly.
C1 [Li, Chunfeng; Li, Dapei; Shang, Jingzhe; Wu, Aiping; Ma, Feng; Qin, Frank Xiao-Feng] Chinese Acad Med Sci & Peking Union Med Coll, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China.
   [Li, Chunfeng; Li, Dapei; Shang, Jingzhe; Wu, Aiping; Ma, Feng; Qin, Frank Xiao-Feng] Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China.
   [Li, Chunfeng; Deng, Yong-Qiang; Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.
   [Li, Chunfeng] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.
   [Zu, Shulong; Sun, Nina] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing, Peoples R China.
   [Zu, Shulong; Sun, Nina; Su, Jiaqi; Liu, Zhenyang; Wang, Min; Shi, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Parvatiyar, Kislay; Quanquin, Natalie; Aliyari, Saba R.; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Su, Jiaqi; Liu, Zhenyang; Wang, Min; Shi, Yi] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
   [Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90007 USA.
   [Parvatiyar, Kislay] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.
RP Li, CF (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China.; Li, CF (corresponding author), Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China.; Li, CF; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.; Li, CF (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
EM chunfeng@stanford.edu; qincf@bmi.ac.cn; gcheng@mednet.ucla.edu
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [91542201, 81590765, 31670883, 31500145,
   31870912, 81701567, 81773058, 31800726]; Fundamental Research Funds for
   the Central UniversitiesFundamental Research Funds for the Central
   Universities; PUMC Youth Fund [3332016125]; CAMS Initiative for
   Innovative Medicine [2016-I2M-1-005]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01AI069120-06, R01AI140718]; National Key Research and Development
   Project of China [2016YFD0500304]; National Science and Technology Major
   Project of China [2018ZX09711003]; NSFCNational Natural Science
   Foundation of China [81522025, 81661130162]; Innovative Research Group
   [81621005]; UK Academy of Medical Sciences; Jiangsu Provincial Natural
   Science FoundationNatural Science Foundation of Jiangsu Province
   [BK20171232]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) (91542201, 81590765, 31670883, 31500145, 31870912,
   81701567, 81773058, and 31800726). The Fundamental Research Funds for
   the Central Universities and PUMC Youth Fund (grant 3332016125) (C. Li),
   the CAMS Initiative for Innovative Medicine (grant 2016-I2M-1-005), the
   NIH (grants R01AI069120-06 and R01AI140718) (G. Cheng), the National Key
   Research and Development Project of China (grant 2016YFD0500304), the
   National Science and Technology Major Project of China (grant
   2018ZX09711003), the NSFC Excellent Young Scientist Fund (grant
   81522025), the Innovative Research Group (grant 81621005), the Newton
   Advanced Fellowship from the UK Academy of Medical Sciences, the NSFC
   (grant 81661130162) (C.-F. Qin), and Jiangsu Provincial Natural Science
   Foundation (BK20171232) (F. X.-F. Qin).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Badal S, 2015, J BIOL CHEM, V290, P22287, DOI 10.1074/jbc.M115.671222
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Daniels BP, 2019, IMMUNITY, V50, P64, DOI 10.1016/j.immuni.2018.11.017
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968
   DJOKIC S, 1987, J ANTIBIOT, V40, P1006, DOI 10.7164/antibiotics.40.1006
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Iannetta M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01152-17
   Jaruratanasirikul S, 1996, ANTIMICROB AGENTS CH, V40, P825, DOI 10.1128/AAC.40.3.825
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kemp MW, 2014, ANTIMICROB AGENTS CH, V58, P6581, DOI 10.1128/AAC.03721-14
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, J VIROL, V91, DOI 10.1128/JVI.02282-16
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li LL, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aas9332
   Li Y, 2011, ARCH VIROL, V156, P2267, DOI 10.1007/s00705-011-1094-9
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin KJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.023
   Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Menzel M, 2017, ONCOTARGET, V8, P31601, DOI 10.18632/oncotarget.16364
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323
   Palma-Ocampo HK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0383-4
   Panayiotou C, 2018, J VIROL, V92, DOI 10.1128/JVI.00501-18
   Prescott J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011159
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   RETSEMA J, 1987, ANTIMICROB AGENTS CH, V31, P1939, DOI 10.1128/AAC.31.12.1939
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01192-17
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Sarkar Moumita, 2006, BMC Pregnancy Childbirth, V6, P18, DOI 10.1186/1471-2393-6-18
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schogler A, 2015, EUR RESPIR J, V45, P428, DOI 10.1183/09031936.00102014
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Sutton AL, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.015
   Wang YQ, 2017, GENOM PROTEOM BIOINF, V15, P14, DOI 10.1016/j.gpb.2017.01.001
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
NR 68
TC 5
Z9 5
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD DEC
PY 2019
VL 63
IS 12
AR e00394-19
DI 10.1128/AAC.00394-19
PG 14
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA JP0YE
UT WOS:000497999100038
PM 31527024
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Liu, L
   Chen, ZY
   Zhang, X
   Li, S
   Hui, Y
   Feng, HX
   Du, YH
   Jin, GH
   Zhou, XH
   Zhang, XQ
AF Liu, Ling
   Chen, Zhenyu
   Zhang, Xin
   Li, Shun
   Hui, Yi
   Feng, Hexi
   Du, Yanhua
   Jin, Guohua
   Zhou, Xiaohui
   Zhang, Xiaoqing
TI Protection of ZIKV infection-induced neuropathy by abrogation of acute
   antiviral response in human neural progenitors
SO CELL DEATH AND DIFFERENTIATION
LA English
DT Article
ID EMBRYONIC STEM-CELLS; INTERFERON-STIMULATED GENES; VIRUS;
   DIFFERENTIATION; IMMUNE; BRAIN; BETA; IDENTIFICATION; PRECURSORS;
   ORGANOIDS
AB It remains largely unknown how Zika virus (ZIKV) infection causes severe microcephaly in human newborns. We examined an Asian lineage ZIKV, SZ01, which similarly infected and demonstrated comparable growth arrest and apoptotic pathological changes in human neuroprogenitors (NPCs) from forebrain dorsal, forebrain ventral as well as hindbrain and spinal cord brain organoids derived from human pluripotent stem cells. Transcriptome profiling showed common overactivated antiviral response in all regional NPCs upon ZIKV infection. ZIKV infection directly activated a subset of IFN-stimulated genes (ISGs) in human NPCs, which depended on the presence of IRF3 and NF-kappa B rather than IFN production and secretion, highlighting a key role of IFN-independent acute antiviral pathway underlying ZIKV infection-caused neuropathy. Our findings therefore reveal that overactivated antiviral response is detrimental rather than protective in human NPCs, and the IFN-independent acute antiviral pathway may serve as a potential target to ameliorate ZIKV infection-triggered neuropathy.
C1 [Liu, Ling; Chen, Zhenyu; Hui, Yi; Feng, Hexi; Du, Yanhua; Zhang, Xiaoqing] Tongji Univ, Sch Med, Brain & Spinal Cord Innovat Res Ctr, Tongji Hosp, Shanghai 200065, Peoples R China.
   [Liu, Ling; Chen, Zhenyu; Hui, Yi; Feng, Hexi; Du, Yanhua; Zhang, Xiaoqing] Minist Educ, Key Lab Reconstruct & Regenerat Spine & Spinal Co, Shanghai 200065, Peoples R China.
   [Liu, Ling; Zhang, Xiaoqing] Tongji Univ, Sch Med, Key Lab Neuroregenerat Shanghai Univ, Shanghai 200092, Peoples R China.
   [Zhang, Xin; Jin, Guohua] Nantong Univ, Dept Anat & Neurobiol, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
   [Li, Shun; Zhou, Xiaohui] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China.
   [Zhang, Xiaoqing] Tongji Univ, Tsingtao Adv Res Inst, Shanghai 200092, Peoples R China.
   [Zhang, Xiaoqing] Shanghai Inst Stem Cell Res & Clin Translat, Shanghai 200120, Peoples R China.
   [Zhang, Xiaoqing] Tongji Univ, Translat Med Ctr Stem Cell Therapy, Shanghai East Hosp, Sch Med, Shanghai 200120, Peoples R China.
RP Zhang, XQ (corresponding author), Tongji Univ, Sch Med, Brain & Spinal Cord Innovat Res Ctr, Tongji Hosp, Shanghai 200065, Peoples R China.; Zhang, XQ (corresponding author), Minist Educ, Key Lab Reconstruct & Regenerat Spine & Spinal Co, Shanghai 200065, Peoples R China.; Zhang, XQ (corresponding author), Tongji Univ, Sch Med, Key Lab Neuroregenerat Shanghai Univ, Shanghai 200092, Peoples R China.; Jin, GH (corresponding author), Nantong Univ, Dept Anat & Neurobiol, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.; Zhou, XH (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China.; Zhang, XQ (corresponding author), Tongji Univ, Tsingtao Adv Res Inst, Shanghai 200092, Peoples R China.; Zhang, XQ (corresponding author), Shanghai Inst Stem Cell Res & Clin Translat, Shanghai 200120, Peoples R China.; Zhang, XQ (corresponding author), Tongji Univ, Translat Med Ctr Stem Cell Therapy, Shanghai East Hosp, Sch Med, Shanghai 200120, Peoples R China.
EM jguohua@ntu.edu.cn; zhouxiaohui@shphc.org.cn; xqzhang@tongji.edu.cn
RI Zhang, Xiaoqing/O-3424-2017
OI Zhang, Xiaoqing/0000-0002-7405-1893
FU National Key Research and Development Program of China [2018YFA0108000];
   National Natural Science foundation of ChinaNational Natural Science
   Foundation of China [31771132, 31872760, 31301157, 31400934, 81471397,
   31601908]; National Science and Technology Major Project
   [2016YFD0500208, 2017ZX10304402001012, 2017ZX10304402001006]; Shanghai
   Municipal Education CommissionShanghai Municipal Education Commission
   (SHMEC) [C120114]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities;
   Major Program of Development Fund for Shanghai Zhangjiang National
   Innovation Demonstration Zone (Stem Cell Strategic Biobank)
   [ZJ2018-ZD-004]; Major Program of Development Fund for Shanghai
   Zhangjiang National Innovation Demonstration Zone (Clinical Translation
   Platform of Stem Cell Technology) [ZJ2018-ZD-004]
FX The present study was supported by the National Key Research and
   Development Program of China (grant no. 2018YFA0108000), the National
   Natural Science foundation of China (31771132, 31872760, 31301157,
   31400934, 81471397 and 31601908), the National Science and Technology
   Major Project (2016YFD0500208, 2017ZX10304402001012,
   2017ZX10304402001006); the Shanghai Municipal Education Commission
   (C120114), the Fundamental Research Funds for the Central Universities,
   and the Major Program of Development Fund for Shanghai Zhangjiang
   National Innovation Demonstration Zone (Stem Cell Strategic Biobank and
   Clinical Translation Platform of Stem Cell Technology, ZJ2018-ZD-004).
CR Aschner M, 1998, NEUROTOXICOLOGY, V19, P269
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001
   Chen ZY, 2018, STEM CELL REP, V11, P1257, DOI 10.1016/j.stemcr.2018.09.014
   Chi LK, 2017, CEREB CORTEX, V27, P2941, DOI 10.1093/cercor/bhw152
   Chi LK, 2016, STEM CELL REP, V7, P941, DOI 10.1016/j.stemcr.2016.09.003
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   Du YH, 2017, CELL DEATH DIFFER, V24, P1121, DOI 10.1038/cdd.2017.62
   Freaney JE, 2013, CELL REP, V4, P959, DOI 10.1016/j.celrep.2013.07.043
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hsu YA, 2011, DNA CELL BIOL, V30, P671, DOI 10.1089/dna.2010.1149
   Husband AJ, 2001, ADV NUTR RES, V10, P3
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063
   Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620
   Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21602
   Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633
   Liu ZL, 2016, STEM CELL REP, V7, P496, DOI 10.1016/j.stemcr.2016.07.021
   Lupo G, 2014, CELL MOL LIFE SCI, V71, P2917, DOI 10.1007/s00018-014-1596-1
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707
   Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7
   Pattyn A, 1997, DEVELOPMENT, V124, P4065
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Swaim CD, 2017, MOL CELL, V68, P581, DOI 10.1016/j.molcel.2017.10.003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19
   Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017
NR 56
TC 1
Z9 1
U1 4
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1350-9047
EI 1476-5403
J9 CELL DEATH DIFFER
JI Cell Death Differ.
PD DEC
PY 2019
VL 26
IS 12
BP 2607
EP 2621
DI 10.1038/s41418-019-0324-7
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA JN5BS
UT WOS:000496914400010
PM 30952992
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Duarte, GB
   Melo, AD
   da Silva, DFC
AF Duarte, Gisleia Benini
   Melo, Andre de Souza
   Costa da Silva, Diego Firmino
TI Do government audits reduce dengue? Estimating the impact of federal
   monitoring lotteries program on dengue incidence
SO INTERNATIONAL JOURNAL OF HEALTH ECONOMICS AND MANAGEMENT
LA English
DT Article
DE Policy evaluation; Randomized; Audit; Dengue
ID ZIKA VIRUS
AB The paper examines the relationship between the supervision carried out in the municipalities by the main Brazilan supervisory institution (Controladoria Geral da Uniao-CGU, in portuguese) and the incidence of dengue cases in them. Since the audited municipalities were randomized, this allows the identification of a control group that adequately represents the counterfactual of the treated group. The sample was composed of all municipalities that could be selected for that CGU inspection cycle, that is, 1520 municipalities, of which 70 were drawn and therefore belong to the study treatment group. We identified a negative effect of the policy on the incidence of the disease. However, when we consider a model with lags, we note that this initial impact from the drawing did not persist throughout the year of the inspection. Our analysis suggests that when federal resources are monitored, municipalities reduce irregularities, which may contribute to a decrease in the number of dengue cases.
C1 [Duarte, Gisleia Benini; Melo, Andre de Souza; Costa da Silva, Diego Firmino] Univ Fed Rural Pernambuco, Dept Econ, Recife, PE, Brazil.
RP da Silva, DFC (corresponding author), Univ Fed Rural Pernambuco, Dept Econ, Recife, PE, Brazil.
EM gisleiaduarte@gmail.com; andredesouzam@gmail.com; diegofirmino@gmail.com
RI ; Firmino Costa da Silva, Diego/E-2069-2016
OI Melo, Andre/0000-0002-8398-4070; Firmino Costa da Silva,
   Diego/0000-0001-8819-7546
CR Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1
   [Anonymous], 2017, B EPIDEMIOLOGICO, V48
   [Anonymous], 2015, B EPIDEMIOLOGICO, V46
   Avis E., 2017, W23508 NAT BUR EC RE
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   CGU, 2016, REL GER 3 CICL PROG
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Ferraz C, 2008, Q J ECON, V123, P703, DOI 10.1162/qjec.2008.123.2.703
   Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83
   GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8
   Imbens GW, 2004, REV ECON STAT, V86, P4, DOI 10.1162/003465304323023651
   Lichand G., 2016, WORKING PAPER
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Olken BA, 2007, J POLIT ECON, V115, P200, DOI 10.1086/517935
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   WHO, 2009, FACT SHEET
   World Health Organization, 2017, ZIK PUBL HLTH EM INT
   Zamboni F.Y.B, 2012, THESIS
NR 22
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2199-9023
EI 2199-9031
J9 INT J HEALTH ECON MA
JI Int. J. Health Econom. Manag.
PD DEC
PY 2019
VL 19
IS 3-4
BP 359
EP 369
DI 10.1007/s10754-018-9259-7
PG 11
WC Business, Finance; Economics; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA JN1WZ
UT WOS:000496694400006
PM 30560427
DA 2020-07-08
ER

PT J
AU Monel, B
   Rajah, MM
   Hafirassou, ML
   Ahmed, SS
   Burlaud-Gaillard, J
   Zhu, PP
   Nevers, Q
   Buchrieser, J
   Porrot, F
   Meunier, C
   Amraoui, S
   Chazal, M
   Salles, A
   Jouvenet, N
   Roingeard, P
   Blackstone, C
   Amara, A
   Schwartz, O
AF Monel, Blandine
   Rajah, Maaran Michael
   Hafirassou, Mohamed Lamine
   Ahmed, Samy Sid
   Burlaud-Gaillard, Julien
   Zhu, Peng-Peng
   Nevers, Quentin
   Buchrieser, Julian
   Porrot, Francoise
   Meunier, Cecile
   Amraoui, Sonia
   Chazal, Maxime
   Salles, Audrey
   Jouvenet, Nolwenn
   Roingeard, Philippe
   Blackstone, Craig
   Amara, Ali
   Schwartz, Olivier
TI Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus
   Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE atlastin; Zika; endoplasmic reticulum
ID HEREDITARY SPASTIC PARAPLEGIA; COMMON PATHWAY; RNA-SYNTHESIS; DENGUE;
   GTPASES; BRAIN; FLAVIVIRUSES; MECHANISMS; MUTATIONS; INFECTION
AB The endoplasmic reticulum (ER) is the site for Zika virus (ZIKV) replication and is central to the cytopathic effects observed in infected cells. ZIKV induces the formation of ER-derived large cytoplasmic vacuoles followed by "implosive" cell death. Little is known about the nature of the ER factors that regulate flavivirus replication. Atlastins (ATL1, -2, and -3) are dynamin-related GTPases that control the structure and the dynamics of the ER membrane. We show here that ZIKV replication is significantly decreased in the absence of ATL proteins. The appearance of infected cells is delayed, the levels of intracellular viral proteins and released virus are reduced, and the cytopathic effects are strongly impaired. We further show that ATL3 is recruited to viral replication sites and interacts with the nonstructural viral proteins NS2A and NS2B3. Thus, proteins that shape and maintain the ER tubular network ensure efficient ZIKV replication.
   IMPORTANCE Zika virus (ZIKV) is an emerging virus associated with Guillain-Barre syndrome, and fetal microcephaly as well as other neurological complications. There is no vaccine or specific antiviral treatment against ZIKV. We found that endoplasmic reticulum (ER)-shaping atlastin proteins (ATL1, -2, and -3), which induce ER membrane fusion, facilitate ZIKV replication. We show that ATL3 is recruited to the viral replication site and colocalize with the viral proteins NS2A and NS2B3. The results provide insights into host factors used by ZIKV to enhance its replication.
C1 [Monel, Blandine; Rajah, Maaran Michael; Ahmed, Samy Sid; Nevers, Quentin; Buchrieser, Julian; Porrot, Francoise; Meunier, Cecile; Amraoui, Sonia; Schwartz, Olivier] CNRS, UMR3569, Inst Pasteur, Virus & Immun Unit, Paris, France.
   [Rajah, Maaran Michael] Univ Paris Diderot, Ecole Doctorale Bio Sorbonne Paris Cite BioSPC, Paris, France.
   [Hafirassou, Mohamed Lamine; Amara, Ali] Ctr Rech St Louis, CNRS 7212, INSERM, U944,Equipe Biol Cellulaire Infect Virales, Paris, France.
   [Burlaud-Gaillard, Julien; Roingeard, Philippe] Univ Tours, INSERM, U1259 Plateforme IBiSA Microscopie Elect, Tours, France.
   [Burlaud-Gaillard, Julien; Roingeard, Philippe] CHU Tours, Tours, France.
   [Zhu, Peng-Peng; Blackstone, Craig] NIH, Cell Biol Sect, Neurogenet Branch, Bldg 10, Bethesda, MD 20892 USA.
   [Chazal, Maxime; Jouvenet, Nolwenn] Inst Pasteur, Viral Genom & Vaccinat Unit, Paris, France.
   [Salles, Audrey] C2RT, Inst Pasteur, UtechS Photon BioImaging PBI Imagopole, Paris, France.
RP Monel, B; Schwartz, O (corresponding author), CNRS, UMR3569, Inst Pasteur, Virus & Immun Unit, Paris, France.
EM blandine.monel@pasteur.fr; olivier.schwartz@pasteur.fr
OI AMARA, Ali/0000-0002-0283-1815; Salles, Audrey/0000-0002-1890-6957;
   Buchrieser, Julian/0000-0003-4790-7577
FU Institut Pasteur; ANRSANRSFrench National Research Agency (ANR);
   Sidaction; Vaccine Research Institute [ANR-10-LABX-77]; Labex IBEID
   [ANR-10-LABX-62-IBEID]; TIMTAMDEN [ANR-14-CE14-0029]; CHIKV-Viro-Immuno
   [ANR-14-CE14-0015-01]; Gilead HIV cure program; ANRFrench National
   Research Agency (ANR) [ANR-15-CE15-00029 ZIKAHOST]; Intramural Research
   Program of the NINDS, NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS); French National Research
   AgencyFrench National Research Agency (ANR) [ANR-10-INSB-04];
   Pasteur-Paris University International PhD program
FX Work in the O.S. lab is funded by Institut Pasteur, ANRS, Sidaction, the
   Vaccine Research Institute (ANR-10-LABX-77), Labex IBEID
   (ANR-10-LABX-62-IBEID), TIMTAMDEN ANR-14-CE14-0029, CHIKV-Viro-Immuno
   ANR-14-CE14-0015-01, and the Gilead HIV cure program. Work in the A.A.
   lab is funded by ANR (ANR-15-CE15-00029 ZIKAHOST). This study was
   supported in part by the Intramural Research Program of the NINDS, NIH.
   UTechS PBI is part of the France-BioImaging infrastructure network (FBI)
   supported by the French National Research Agency (ANR-10-INSB-04;
   Investments for the Future) and acknowledges support from ANR/FBI and
   the Region Ile-de-France (program "Domaine d'Interet Majeur-Malinf") for
   the use of the Zeiss LSM 780 Elyra PS1 microscope. M.M.R. is supported
   by the Pasteur-Paris University International PhD program.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Aktepe TE, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12884
   Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946
   Blanchard E, 2015, CELL MICROBIOL, V17, P45, DOI 10.1111/cmi.12372
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Daniels BP, 2019, IMMUNITY, V50, P64, DOI 10.1016/j.immuni.2018.11.017
   Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107
   Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006167
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025
   Hubner CA, 2014, BRAIN, V137, P3109, DOI 10.1093/brain/awu287
   da Cruz LCH, 2018, AM J NEURORADIOL, V39, P1967, DOI 10.3174/ajnr.A5649
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Niu LL, 2019, P NATL ACAD SCI USA, V116, P14029, DOI 10.1073/pnas.1908409116
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280
   Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Petrova E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010068
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Ravindran MS, 2016, NAT REV MICROBIOL, V14, P407, DOI 10.1038/nrmicro.2016.60
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Saeedi BJ, 2013, WIRES RNA, V4, P723, DOI 10.1002/wrna.1191
   Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WF, 2007, J BIOL CHEM, V282, P5888, DOI 10.1074/jbc.M611145200
   Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047
   Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Westrate LM, 2015, ANNU REV BIOCHEM, V84, P791, DOI 10.1146/annurev-biochem-072711-163501
   Willkomm L, 2016, J HUM GENET, V61, P571, DOI 10.1038/jhg.2016.6
   Wu MJ, 2014, CELL MICROBIOL, V16, P1603, DOI 10.1111/cmi.12318
   Zhao GH, 2016, EXP CELL RES, V349, P32, DOI 10.1016/j.yexcr.2016.09.015
   Zhao JL, 2013, MOL CELL NEUROSCI, V52, P87, DOI 10.1016/j.mcn.2012.10.005
   Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200
NR 81
TC 1
Z9 1
U1 6
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2019
VL 93
IS 23
AR e01047-19
DI 10.1128/JVI.01047-19
PG 20
WC Virology
SC Virology
GA JN5CM
UT WOS:000496916400013
PM 31534046
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Sourisseau, M
   Lawrence, DJP
   Schwarz, MC
   Storrs, CH
   Veit, EC
   Bloom, JD
   Evans, MJ
AF Sourisseau, Marion
   Lawrence, Daniel J. P.
   Schwarz, Megan C.
   Storrs, Carina H.
   Veit, Ethan C.
   Bloom, Jesse D.
   Evans, Matthew J.
TI Deep Mutational Scanning Comprehensively Maps How Zika Envelope Protein
   Mutations Affect Viral Growth and Antibody Escape
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; glycoproteins; mutagenesis; neutralizing antibodies; virus
   entry
ID HEPATITIS-C VIRUS; IDENTIFICATION; NEUTRALIZATION; GLYCOPROTEIN;
   INFECTIVITY; OUTBREAK
AB Functional constraints on viral proteins are often assessed by examining sequence conservation among natural strains, but this approach is relatively ineffective for Zika virus because all known sequences are highly similar. Here, we take an alternative approach to map functional constraints on Zika virus's envelope (E) protein by using deep mutational scanning to measure how all amino acid mutations to the E protein affect viral growth in cell culture. The resulting sequence-function map is consistent with existing knowledge about E protein structure and function but also provides insight into mutation-level constraints in many regions of the protein that have not been well characterized in prior functional work. In addition, we extend our approach to completely map how mutations affect viral neutralization by two monoclonal antibodies, thereby precisely defining their functional epitopes. Overall, our study provides a valuable resource for understanding the effects of mutations to this important viral protein and also offers a roadmap for future work to map functional and antigenic selection to Zika virus at high resolution.
   IMPORTANCE Zika virus has recently been shown to be associated with severe birth defects. The virus's E protein mediates its ability to infect cells and is also the primary target of the antibodies that are elicited by natural infection and vaccines that are being developed against the virus. Therefore, determining the effects of mutations to this protein is important for understanding its function, its susceptibility to vaccine-mediated immunity, and its potential for future evolution. We completely mapped how amino acid mutations to the E protein affected the virus's ability to grow in cells in the laboratory and escape from several antibodies. The resulting maps relate changes in the E protein's sequence to changes in viral function and therefore provide a valuable complement to existing maps of the physical structure of the protein.
C1 [Sourisseau, Marion; Schwarz, Megan C.; Storrs, Carina H.; Veit, Ethan C.; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Lawrence, Daniel J. P.; Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Basic Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Lawrence, Daniel J. P.; Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA.
   [Lawrence, Daniel J. P.; Bloom, Jesse D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Bloom, Jesse D.] Howard Hughes Med Inst, Seattle, WA 98195 USA.
RP Bloom, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Basic Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.; Bloom, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA.; Bloom, JD (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Bloom, JD (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.
EM jbloom@fredhutch.org; matthew.evans@mssm.edu
RI Bloom, Jesse/C-6837-2013
OI Bloom, Jesse/0000-0003-1267-3408; Veit, Ethan/0000-0002-3956-5928;
   Lawrence, Daniel/0000-0002-2181-9352
FU Burroughs Wellcome FundBurroughs Wellcome Fund;  [R21 AI133649];  [R21
   AI140196];  [R01 AI141707]
FX This work was supported by grants number R21 AI133649 (to M.J.E. and
   J.D.B.), R21 AI140196 (to M.J.E.), and R01 AI141707 (to J.D.B.). J.D.B.
   is an Investigator of the Howard Hughes Medical Institute. M.J.E. and
   J.D.B. hold Investigator in Pathogenesis of Infectious Disease Awards
   from the Burroughs Wellcome Fund.
CR Bloom JD, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0590-4
   Bloom JD, 2014, MOL BIOL EVOL, V31, P1956, DOI 10.1093/molbev/msu173
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chambers MT, 2018, J VIROL, V92, DOI [10.1128/JVI.00505-18, 10.1128/jvi.00505-18]
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dingens AS, 2019, IMMUNITY, V50, P520, DOI 10.1016/j.immuni.2018.12.017
   Dingens AS, 2017, CELL HOST MICROBE, V21, P777, DOI 10.1016/j.chom.2017.05.003
   Doud MB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006271
   Doud MB, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060155
   Doud MB, 2015, MOL BIOL EVOL, V32, P2944, DOI 10.1093/molbev/msv167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Haddox HK, 2018, ELIFE, V7, DOI 10.7554/eLife.34420
   Haddox HK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006114
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698
   Lee JM, 2019, BIORXIV, DOI [10.1101/670497, DOI 10.1101/670497]
   Lee JM, 2018, P NATL ACAD SCI USA, V115, pEB276, DOI 10.1073/pnas.1806133115
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Michta ML, 2010, J VIROL, V84, P11696, DOI 10.1128/JVI.01555-10
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nelson S, 2009, J VIROL, V83, P12631, DOI 10.1128/JVI.01072-09
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Ramsey DC, 2011, GENETICS, V188, P479, DOI 10.1534/genetics.111.128025
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2019, NAT MICROBIOL, V4, P876, DOI 10.1038/s41564-019-0399-4
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soh YQS, 2019, ELIFE, V8, DOI 10.7554/eLife.45079
   Sourisseau M, 2019, BIORXIV, DOI [10.1101/725556, DOI 10.1101/725556]
   Sourisseau M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003244
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885
   Thyagarajan B, 2014, ELIFE, V3, DOI 10.7554/eLife.03300
   Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635
   Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wu NC, 2014, J VIROL, V88, P10157, DOI 10.1128/JVI.01494-14
   Wu Nicholas C, 2014, Sci Rep, V4, P4942, DOI 10.1038/srep04942
NR 50
TC 1
Z9 1
U1 4
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2019
VL 93
IS 23
AR e01291-19
DI 10.1128/JVI.01291-19
PG 17
WC Virology
SC Virology
GA JN5CM
UT WOS:000496916400024
PM 31511387
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zimmerman, MG
   Bowen, JR
   McDonald, CE
   Young, E
   Baric, RS
   Pulendran, B
   Suthar, MS
AF Zimmerman, Matthew G.
   Bowen, James R.
   McDonald, Circe E.
   Young, Ellen
   Baric, Ralph S.
   Pulendran, Bali
   Suthar, Mehul S.
TI STAT5: a Target of Antagonism by Neurotropic Flaviviruses
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE interferon; RIG-I-like receptors; West Nile virus; dendritic cells;
   mRNA-seq
ID WEST-NILE-VIRUS; HUMAN DENDRITIC CELLS; RIG-I; TYROSINE KINASE;
   TNF-ALPHA; ACTIVATION; INTERFERON; RECEPTOR; IFN; INFECTION
AB Flaviviruses are a diverse group of arthropod-borne viruses responsible for numerous significant public health threats; therefore, understanding the interactions between these viruses and the human immune response remains vital. West Nile virus (WNV) and Zika virus (ZIKV) infect human dendritic cells (DCs) and can block antiviral immune responses in DCs. Previously, we used mRNA sequencing and weighted gene coexpression network analysis (WGCNA) to define molecular signatures of antiviral DC responses following activation of innate immune signaling (RIG-I, MDA5, or type I interferon [IFN) signaling) or infection with WNV. Using this approach, we found that several genes involved in T cell cosignaling and antigen processing were not enriched in DCs during WNV infection. Using cis-regulatory sequence analysis, STATS was identified as a regulator of DC activation and immune responses downstream of innate immune signaling that was not activated during either WNV or ZIKV infection. Mechanistically, WNV and ZIKV actively blocked STATS phosphorylation downstream of RIG-I, IFN-beta, and interleukin-4 (1-4), but not granulocyte-macrophage colony-stimulating factor (GM-CSF), signaling. Unexpectedly, dengue virus serotypes 1 to 4 (DENV1 to DENV4) and the yellow fever 17D vaccine strain (YFV-17D) did not antagonize STATS phosphorylation. In contrast to WNV, ZIKV inhibited JAK1 and TYK2 phosphorylation following type I IFN treatment, suggesting divergent mechanisms used by these viruses to inhibit STAT5 activation. Combined, these findings identify STAT5 as a target of antagonism by specific pathogenic flaviviruses to subvert the immune response in infected DCs.
   IMPORTANCE Flaviviruses are a diverse group of insect-borne viruses responsible for numerous significant public health threats. Previously, we used a computational biology approach to define molecular signatures of antiviral DC responses following activation of innate immune signaling or infection with West Nile virus (WNV). In this work, we identify STATS as a regulator of DC activation and antiviral immune responses downstream of innate immune signaling that was not activated during either WNV or Zika virus (ZIKV) infection. WNV and ZIKV actively blocked STAT5 phosphorylation downstream of RIG-I, IFN-beta, and IL-4, but not GM-CSF, signaling. However, other related flaviviruses, dengue virus serotypes 1 to 4 and the yellow fever 17D vaccine strain, did not antagonize STATS phosphorylation. Mechanistically, WNV and ZIKV showed differential inhibition of Jak kinases upstream of STAT5, suggesting divergent countermeasures to inhibit STAT5 activation. Combined, these findings identify STAT5 as a target of antagonism by specific pathogenic flaviviruses to subvert antiviral immune responses in human DCs.
C1 [Zimmerman, Matthew G.; Bowen, James R.; McDonald, Circe E.; Suthar, Mehul S.] Emory Univ, Sch Med, Div Infect Dis, Dept Pediat, Atlanta, GA 30322 USA.
   [Zimmerman, Matthew G.; Bowen, James R.; McDonald, Circe E.; Pulendran, Bali; Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Young, Ellen; Baric, Ralph S.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA.
   [Baric, Ralph S.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA USA.
RP Suthar, MS (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Dept Pediat, Atlanta, GA 30322 USA.; Suthar, MS (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM msuthar@emory.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19AI083019,
   R56AI110516, R21AI113485, 2U19AI090023, 5R37DK057665, 5R37AI048638,
   2U19AI057266, ORIP/OD P51OD011132]; Emory University Department of
   Pediatrics Junior Faculty Focused Award; Children's Healthcare of
   Atlanta; Emory Vaccine Center; Georgia Research Alliance
FX This work was funded in part by National Institutes of Health grants
   U19AI083019 (M.S.S.), R56AI110516 (M.S.S.), R21AI113485 (M.S.S.),
   2U19AI090023 (B.P.), 5R37DK057665 (B.P.), 5R37AI048638 (B.P.),
   2U19AI057266 (B.P.), and ORIP/OD P51OD011132 (M.S.S. and B.P.), the
   Emory University Department of Pediatrics Junior Faculty Focused Award
   (M.S.S.), Children's Healthcare of Atlanta, the Emory Vaccine Center,
   and the Georgia Research Alliance (M.S.S.).
CR Al-Shami A, 1998, J BIOL CHEM, V273, P1058, DOI 10.1074/jbc.273.2.1058
   Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Burakoff A, 2018, MMWR-MORBID MORTAL W, V67, P13, DOI 10.15585/mmwr.mm6701a3
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chin H, 1998, BLOOD, V91, P3734
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Durrant DM, 2013, J EXP MED, V210, P503, DOI 10.1084/jem.20121897
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013
   Evans JD, 2011, VIRAL IMMUNOL, V24, P253, DOI 10.1089/vim.2010.0126
   Fish EN, 1999, J BIOL CHEM, V274, P571, DOI 10.1074/jbc.274.2.571
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012
   GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hammaren HM, 2019, CYTOKINE, V118, P48, DOI 10.1016/j.cyto.2018.03.041
   Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908
   Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499
   Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731
   Johnsen IB, 2009, J BIOL CHEM, V284, P19122, DOI 10.1074/jbc.M808233200
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kovats S, 2016, CLIN EXP IMMUNOL, V186, P214, DOI 10.1111/cei.12850
   Lim DSL, 2014, J IMMUNOL, V193, P5065, DOI 10.4049/jimmunol.1302240
   Lim YJ, 2015, CYTOKINE, V72, P63, DOI 10.1016/j.cyto.2014.12.008
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574
   Meinke A, 1996, MOL CELL BIOL, V16, P6937
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Okutani Y, 2001, ONCOGENE, V20, P6643, DOI 10.1038/sj.onc.1204807
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Pulendran B, 2015, ANNU REV IMMUNOL, V33, P563, DOI 10.1146/annurev-immunol-020711-075049
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Sharma N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27685
   Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suthar MS, 2012, J VIROL, V86, P7704, DOI 10.1128/JVI.00401-12
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609
   Toniolo PA, 2015, J IMMUNOL, V194, P3180, DOI 10.4049/jimmunol.1401635
   Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681
   Widman DG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17355-5
   Xiao WB, 2010, BLOOD, V116, P6003, DOI 10.1182/blood-2010-05-283937
   Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599
   Zimmerman MG, 2019, BIORXIV, DOI [10.1101/606608, DOI 10.1101/606608]
   Zimmermann C, 2018, J VIROL, V92, DOI 10.1128/JVI.01180-18
NR 58
TC 0
Z9 0
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2019
VL 93
IS 23
AR e00665-19
DI 10.1128/JVI.00665-19
PG 15
WC Virology
SC Virology
GA JN5CM
UT WOS:000496916400002
PM 31534033
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Perez-Olais, JH
   Ruiz-Jimenez, F
   Calderon-Garcia, EJ
   De Jesus-Gonzalez, LA
   Hernandez-Rivas, R
   del Angel, RM
AF Humberto Perez-Olais, J.
   Ruiz-Jimenez, Fernando
   Calderon-Garcia, Esther J.
   Adrian De Jesus-Gonzalez, L.
   Hernandez-Rivas, Rosaura
   del Angel, Rosa M.
TI The activity of Aurora kinase B is required for dengue virus release
SO VIRUS RESEARCH
LA English
DT Article
DE Kinases; Dengue virus; Aurora kinase B; Viral release
ID VIMENTIN PHOSPHORYLATION; AEDES-AEGYPTI; PROTEIN; REPLICATION;
   INHIBITORS; SUBSTRATE; SITES; NS5
AB Flaviviruses, such as Dengue (DENV), Zika, Yellow Fever, Japanese Encephalitis and West Nile are important pathogens with high morbidity and mortality. The last estimation indicates that similar to 390 millions of people are infected by DENV per year. The DENV replicative cycle occurs mainly in the cytoplasm of the infected cells and different cytoplasmic, nuclear and mitochondrial proteins participate in viral replication. In this paper we analyzed the participation of Aurora kinase B (AurKB) in the DENV replicative cycle using the specific AurKB inhibitor ZM 447439. The kinase inhibition does not alter the viral protein production/secretion or genome replication but impaired the viral yield without altering the percentage of infected cells. Moreover, confocal microscopy analysis of DENV-infected ZM 447439-treated cells show a delocalization of viral components from the replicative complexes. In summary, these observations indicate that AurKB participates in DENV viral morphogenesis or release.
C1 [Humberto Perez-Olais, J.; Calderon-Garcia, Esther J.; Adrian De Jesus-Gonzalez, L.; del Angel, Rosa M.] IPN, Infect & Mol Pathogenesis Dept, Ctr Res & Adv Studies, Mexico City, DF, Mexico.
   [Ruiz-Jimenez, Fernando] Univ Nottingham, Sch Life Sci, Mol Virol, Nottingham, England.
   [Hernandez-Rivas, Rosaura] IPN, Mol Biomed Dept, Ctr Res & Adv Studies, Mexico City, DF, Mexico.
RP del Angel, RM (corresponding author), IPN, Infect & Mol Pathogenesis Dept, Ctr Res & Adv Studies, Mexico City, DF, Mexico.
EM jholais@gmail.com; ferrj2510@gmail.com; ejcalderon@outlook.com;
   luis.dejesus@cinvestav.mx; rohernan@cinvestav.mx; rmangel@cinvestav.mx
RI Perez-Olais, Jose Humberto/AAH-6869-2020
OI De Jesus Gonzalez, Luis Adrian/0000-0003-1415-6260; Perez-Olais, Jose
   Humberto/0000-0003-0109-5606
FU National Council of Science and Technology of Mexico (CONACyT)Consejo
   Nacional de Ciencia y Tecnologia (CONACyT) [417968]; CONACyTConsejo
   Nacional de Ciencia y Tecnologia (CONACyT)
FX This work was funded by the National Council of Science and Technology
   of Mexico (CONACyT) Grant 417968. Jose Humberto Perez Olais had a
   scholarship from CONACyT. We thank to Dr. Ana Lorena Gutierrez Escolano
   for critical review of manuscript, Diego SotoCabrera and Jaime Zarco for
   technical assistance, Fernando MedinaRamirez for the maintenance of cell
   lines and mice.
CR Anwar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023246
   Ardito F, 2017, INT J MOL MED, V40, P271, DOI 10.3892/ijmm.2017.3036
   Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharya D, 2009, VIRUS RES, V141, P101, DOI 10.1016/j.virusres.2009.01.002
   Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180
   Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208
   Georgieva I, 2010, NEUROENDOCRINOLOGY, V91, P121, DOI 10.1159/000258705
   Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200
   Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029
   Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867
   Hu Y., 2017, INT J MOL SCI, V18
   Jha HC, 2015, ONCOTARGET, V6, P5788, DOI 10.18632/oncotarget.3310
   Jha HC, 2013, J VIROL, V87, P12121, DOI 10.1128/JVI.02379-13
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f
   Keating JA, 2013, VECTOR-BORNE ZOONOT, V13, P590, DOI 10.1089/vbz.2012.1110
   Kovackova S, 2015, J MED CHEM, V58, P3393, DOI 10.1021/jm501759m
   Limjindaporn T, 2017, BIOCHEM BIOPH RES CO, V483, P58, DOI 10.1016/j.bbrc.2017.01.006
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Madejon A, 2015, J HEPATOL, V63, P312, DOI 10.1016/j.jhep.2015.02.036
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   MURRAY JM, 1993, J GEN VIROL, V74, P175, DOI 10.1099/0022-1317-74-2-175
   Noppakunmongkolchai W, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0494-6
   Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005
   Sanofi, 2017, SAN UPD INF DENG VAC
   Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018
   Suwonkerd W, 2006, J VECTOR ECOL, V31, P311, DOI 10.3376/1081-1710(2006)31[311:TEOHTO]2.0.CO;2
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13
   Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200
   Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 36
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD DEC
PY 2019
VL 274
AR 197777
DI 10.1016/j.virusres.2019.197777
PG 10
WC Virology
SC Virology
GA JM2FZ
UT WOS:000496038100012
PM 31626875
DA 2020-07-08
ER

PT J
AU Barzilai, LP
   Schrago, CG
AF Barzilai, Lucia P.
   Schrago, Carlos G.
TI The range of sampling times affects Zika virus evolutionary rates and
   divergence times
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID DYNAMICS; TRANSMISSION
AB The rate of evolution of viral genomes is a fundamental parameter for understanding the origin and spread of epidemics. For instance, molecular dating is one of the many practical outcomes of evolutionary rate estimation. In this sense, the rate of evolution of ZIKV merits attention, because it has been shown to be higher than the average rate reported for other flaviviruses. It has been hypothesized that the higher rate of ZIKV evolution is due to a bias related to the analysis of sequences collected within a short time range, which would increase the chance of sampling slightly deleterious nucleotide polymorphisms. To investigate this hypothesis, we assembled datasets with different ranges of sampling times and also decomposed the ZIKV evolutionary rate into synonymous and non-synonymous rates. Our results demonstrated that the rate of ZIKV evolution is time dependent and that the observed increase in short-term rates is largely accounted for by a higher non-synonymous rate, suggesting the presence of slightly deleterious variants not yet eliminated by purifying selection. On the other hand, we show that synonymous rates were less impacted by the range of sampling times, generating timescales with reduced uncertainty. We conclude that, for inferring the ZIKV timescale and reconstructing the history of epidemics, synonymous changes are the most appropriate substitution type to be examined. We were able to obtain ZIKV divergence times that were time independent and exhibited greater precision than previous estimates. This observation should also hold for other serially sampled fast-evolving pathogens with evidence of time dependence of evolutionary rates.
C1 [Barzilai, Lucia P.; Schrago, Carlos G.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, CCS, Rua Prof Rodolpho Paulo Rocco,Cidade Univ,A2-092, BR-21941617 Rio De Janeiro, Brazil.
RP Schrago, CG (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, CCS, Rua Prof Rodolpho Paulo Rocco,Cidade Univ,A2-092, BR-21941617 Rio De Janeiro, Brazil.
EM carlos.schrago@gmail.com
RI Schrago, Carlos/E-4612-2012
OI Schrago, Carlos/0000-0001-6257-8906
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [440954/2016-9, 310974/2015-1, 200332/2018-0, 421392/2016-9]
CR Baele G, 2017, SYST BIOL, V66, pE47, DOI 10.1093/sysbio/syw054
   Bolstad WM, 2007, INTRO BAYESIAN STAT, P239
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, ZIKA VIRUS AM EARLY, V5036, P1
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145
   Kimura M., 1983, NEUTRAL THEORY MOL E
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Meyer AG, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev006
   Miller MA, 2010, 2010 GAT COMP ENV WO
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Moller S, 2018, P NATL ACAD SCI USA, V115, P4200, DOI 10.1073/pnas.1713314115
   MUSE SV, 1994, MOL BIOL EVOL, V11, P715
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Pond SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011230
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074
   SIEVERS F, 2014, CURR PROTOC BIOINFOR, V48, P3, DOI DOI 10.1002/0471250953.BI0313S48
   Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005
   To TH, 2016, SYST BIOL, V65, P82, DOI 10.1093/sysbio/syv068
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 32
TC 0
Z9 0
U1 4
U2 9
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD DEC
PY 2019
VL 164
IS 12
BP 3027
EP 3034
DI 10.1007/s00705-019-04430-7
PG 8
WC Virology
SC Virology
GA JI6XN
UT WOS:000493610100010
PM 31598845
DA 2020-07-08
ER

PT J
AU Santos, CNO
   Ribeiro, DR
   Alves, JC
   Cazzaniga, RA
   Magalhaes, LS
   de Souza, MSF
   Fonseca, ABL
   Bispo, AJB
   Porto, RLS
   dos Santos, CA
   da Silva, AM
   Teixeira, MM
   de Almeida, RP
   de Jesus, AR
AF Santos, Camilla N. O.
   Ribeiro, Danielle R.
   Alves, Juliana Cardoso
   Cazzaniga, Rodrigo A.
   Magalhaes, Lucas S.
   de Souza, Mercia S. F.
   Fonseca, Adriana B. L.
   Bispo, Ana J. B.
   Porto, Roseane L. S.
   dos Santos, Cliomar Alves
   da Silva, Angela M.
   Teixeira, Mauro M.
   de Almeida, Roque P.
   de Jesus, Amelia R.
TI Association Between Zika Virus Microcephaly in Newborns With the
   rs3775291 Variant in Toll-Like Receptor 3 and rs1799964 Variant at Tumor
   Necrosis Factor-alpha Gene
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE congenital Zika syndrome; microcephaly; polymorphism; TLR3; TNF alpha
ID POLYMORPHISM; TLR3
AB Congenital Zika syndrome (CZS) is a cluster of malformation, and the mechanisms that lead it are still unclear. Using hypothesis-driven candidate genes and their function in viral infections, single-nucleotide polymorphisms (SNPs) were genotyped by quantitative polymerase chain reaction in a sample population from Sergipe State, Brazil. This study shows that rs3775291 SNP at Toll-like receptor 3, which triggers type I interferon antiviral responses in mothers infected by Zika virus during pregnancy, is associated with CZS occurrence (odds ratio [OR], 2.19; 95% confidence interval [CI], 1.158-4.148). Moreover, rs1799964 SNP at tumor necrosis factor-alpha gene in CZS babies is associated with severe microcephaly (OR, 2.63; 95% CI, 1.13-6.21).
C1 [Santos, Camilla N. O.; Alves, Juliana Cardoso; Magalhaes, Lucas S.; de Almeida, Roque P.; de Jesus, Amelia R.] Univ Fed Sergipe, Univ Hosp, Med Biol Lab, Aracaju, Brazil.
   [Santos, Camilla N. O.; Alves, Juliana Cardoso; Magalhaes, Lucas S.; de Almeida, Roque P.; de Jesus, Amelia R.] Univ Fed Sergipe, Univ Hosp, Grad Program Hlth Sci, Aracaju, Brazil.
   [Ribeiro, Danielle R.; Cazzaniga, Rodrigo A.] Univ Fed Sergipe, Univ Hosp, Mol Biol Lab, Aracaju, Brazil.
   [Fonseca, Adriana B. L.; Bispo, Ana J. B.; Porto, Roseane L. S.] Univ Fed Sergipe, Univ Hosp, Microcephaly Clin, Pediat Div, Aracaju, Brazil.
   [da Silva, Angela M.] Univ Fed Sergipe, Univ Hosp, Infect Dis Div, Aracaju, Brazil.
   [de Almeida, Roque P.; de Jesus, Amelia R.] Univ Fed Sergipe, Univ Hosp, Dept Med, Aracaju, Brazil.
   [de Souza, Mercia S. F.] Secretaria Estado Saude Sergipe, Aracaju, Brazil.
   [dos Santos, Cliomar Alves] Cent Publ Hlth Lab Sergipe, Aracaju, Brazil.
   [Teixeira, Mauro M.] Univ Fed Minas Gerais, Immunopharmacol, Belo Horizonte, MG, Brazil.
RP de Jesus, AR (corresponding author), Univ Fed Sergipe, Hosp Univ, Lab Imunol & Biol Mol, Predio Patol,Rua Claudio Batista S-N, BR-19060108 Aracaju, Sergipe, Brazil.
EM ameliaribeirodejesuse@gmail.com
FU Financiadora de Estudos e Projetos -BrazilCiencia Tecnologia e Inovacao
   (FINEP) [0116005600]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - BrasilCAPES; Conselho Nacional de Pesquisa e Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq); Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq)
FX This work was funded by the Financiadora de Estudos e Projetos -Brazil
   (Grant Number 0116005600), Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (fellowship to C. N. O. S., J. C. A., and R. A.
   C.), Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e
   Tecnologico (fellowship to D. R. R.), and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (to A. R. d. J., R. P. d. A.,
   and M. M. T.).
CR Alagarasu K, 2015, IMMUNOBIOLOGY, V220, P164, DOI 10.1016/j.imbio.2014.09.020
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x
   Kasztelewicz B, 2017, EUR J CLIN MICROBIOL, V36, P1811, DOI 10.1007/s10096-017-2996-6
   Kindberg E, 2011, J INFECT DIS, V203, P523, DOI 10.1093/infdis/jiq082
   Phillips JA, 2016, WORKPLACE HEALTH SAF, V64, P396, DOI 10.1177/2165079916657109
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Sironi M, 2012, J IMMUNOL, V188, P818, DOI 10.4049/jimmunol.1102179
   Studzinska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169420
   SWINGLER S, 1994, BIOCHEM BIOPH RES CO, V203, P623, DOI 10.1006/bbrc.1994.2228
   Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258
NR 14
TC 2
Z9 2
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC
PY 2019
VL 220
IS 11
BP 1797
EP 1801
DI 10.1093/infdis/jiz392
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JI4XB
UT WOS:000493469600012
PM 31352487
DA 2020-07-08
ER

PT J
AU Abdulrahman, AY
   Khazali, AS
   Teoh, TC
   Rothan, HA
   Yusof, R
AF Abdulrahman, Ammar Yasir
   Khazali, Ahmad S.
   Teoh, Teow Chong
   Rothan, Hussin A.
   Yusof, Rohana
TI Novel Peptides Inhibit Zika NS2B-NS3 Serine Protease and Virus
   Replication in Human Hepatic Cell Line
SO INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
LA English
DT Article
DE Zika virus; NS2B-NS3pro; Synthetic peptide; Fusion peptide; MAP30
   peptide
ID IDENTIFICATION; INFECTION
AB Zika virus (ZIKV) is a Flavivirus associated with several neurological complications. Currently, there are no vaccines or cures available and an efficient antiviral treatment is urgently needed to combat ZIKV infection. Herein, we targeted ZIKV NS2B-NS3 serine protease with short peptides to inhibit ZIKV replication in human hepatic cell line (WRL-68). The short peptide inhibitors were designed using Hyperchem 8.0.10 software. Docking energy and binding configuration were calculated using HADDOCK webserver. ZIKV NS2B-NS3 protease was produced as a recombinant single peptide in Escherichia coli and the protease activity was examined by measuring the cleavage of a fluorescent substrate in the presence of the peptides or aprotinin as a standard protease inhibitor. Computational analysis revealed that the short peptides, AYA2 and AYA9, exhibited lower docking energy to ZIKV protease than aprotinin. Both peptides also possessed lower half maximal inhibitory concentration (IC50), 30.9 and 22.1 mu M respectively, against ZIKV protease activity when compared to aprotinin (35.4 mu M). Interestingly, AYA2 and AYA9 exhibited minimal cytotoxic effects in WRL-68 cells and showed considerable inhibition against ZIKV replication in vitro at half maximal effective concentration (EC50) of 40.73 +/- 2.3 mu M and 34.65 +/- 1.8 mu M respectively. Fusion of these two peptides to MAP30 peptide substantially reduced the IC50 of ZIKV protease inhibition to 1.1 mu M and inhibited ZIKV replication at EC50 of 0.5157 +/- 0.03 mu M. In sum, we reported novel peptides that effectively inhibited ZIKV replication in vitro. This study represents a cost-effective strategy of developing peptide inhibitors by shortening the peptides and producing them in recombinant form.
C1 [Abdulrahman, Ammar Yasir; Khazali, Ahmad S.; Yusof, Rohana] Univ Malaya, Dept Mol Med, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Teoh, Teow Chong] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
   [Rothan, Hussin A.] Georgia State Univ, Dept Biol, Coll Arts & Sci, Atlanta, GA 30303 USA.
RP Yusof, R (corresponding author), Univ Malaya, Dept Mol Med, Fac Med, Kuala Lumpur 50603, Malaysia.
EM rohana@um.edu.my
RI KHAZALI, AHMAD SUHAIL/AAA-7175-2020; Abdulrahman, Ammar
   Yasir/AAF-9133-2019; TEOH, TEOW CHONG/B-9950-2010
OI KHAZALI, AHMAD SUHAIL/0000-0001-8830-441X; 
FU Ministry of Higher Education of Malaysia through FRGS [FP007-2017A];
   University of MalayaUniversiti Malaya [PG012-2014B]
FX This study was supported by the Ministry of Higher Education of Malaysia
   through FRGS Grant No. FP007-2017A and by the University of Malaya
   Postgraduate Research Grant (PPP) -Research (PG012-2014B).
CR Abdulrahman AY, 2017, INT J PEPT RES THER, V23, P163, DOI 10.1007/s10989-016-9544-6
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Bruno BJ, 2013, THER DELIV, V4, P1443, DOI [10.4155/TDE.13.104, 10.4155/tde.13.104]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fei LK, 2011, J DRUG TARGET, V19, P675, DOI 10.3109/1061186X.2010.531729
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104
   Kugler J, 2012, J BIOL CHEM, V287, P39224, DOI 10.1074/jbc.M112.393843
   Kugler J, 2011, THESIS
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   LEEHUANG S, 1990, FEBS LETT, V272, P12, DOI 10.1016/0014-5793(90)80438-O
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Rothan HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094561
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
NR 22
TC 3
Z9 3
U1 2
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1573-3149
EI 1573-3904
J9 INT J PEPT RES THER
JI Int. J. Pept. Res. Ther.
PD DEC
PY 2019
VL 25
IS 4
BP 1659
EP 1668
DI 10.1007/s10989-019-09808-4
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JG9WT
UT WOS:000492427400038
DA 2020-07-08
ER

PT J
AU Wang, YC
   Ren, K
   Liao, XZ
   Luo, GW
   Kumthip, K
   Leetrakool, N
   Li, SL
   Chen, LM
   Yang, CH
   Chen, YJ
AF Wang, Yancui
   Ren, Kai
   Liao, Xinzhong
   Luo, Guanwen
   Kumthip, Kattareeya
   Leetrakool, Nipapan
   Li, Shilin
   Chen, Limin
   Yang, Chunhui
   Chen, Yongjun
TI Inactivation of Zika virus in plasma and derivatives by four different
   methods
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE low pH; methylene blue; pasteurization; solvent; detergent; ZIKV
ID WEST-NILE-VIRUS; PATHOGEN INACTIVATION; TRANSMISSION; ULTRAVIOLET;
   REDUCTION; OUTBREAK; SAFETY; ISLAND
AB Zika virus (ZIKV) is an emerging arbovirus with increasing prevalence in recent years. To reduce the risk of ZIKV transmission by transfusion, some mitigation strategies were recommended based on pathogen reduction technologies for blood products. In this study, we aimed to study the efficacy of several common pathogen reduction methods in the inactivation of ZIKV. The fresh frozen plasma and derivatives were spiked with a high titer of ZIKV or Sindbis virus (SINV). Viral titers and ZIKV RNA were measured before and after the inactivation treatment by methylene blue (MB), solvent/detergent (S/D), pasteurization, and low pH. The mean ZIKV infectivity titers in plasma and derivatives were 7.08 +/- 0.14, 5.17 +/- 0.14, 7.08 +/- 0.14, and 5.80 +/- 0.14 log(10)TCID(50)/mL, respectively before MB, S/D, pasteurization, and low pH inactivation. We found no detectable ZIKV RNA after five successive passages of inoculation on host cells, indicating there is no infectivity after inactivation. Similar inactivation results were observed for SINV. In conclusion, we achieved robust ZIKV inactivation through the four inactivation procedures in several blood products. These findings suggest that the pathogen reduction technologies commonly applied in plasma and derivatives have the capacity to mitigate the risk of ZIKV transmission by transfusion.
C1 [Wang, Yancui; Ren, Kai; Liao, Xinzhong; Li, Shilin; Chen, Limin; Yang, Chunhui; Chen, Yongjun] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu 610052, Sichuan, Peoples R China.
   [Wang, Yancui; Ren, Kai; Liao, Xinzhong; Li, Shilin; Chen, Limin; Yang, Chunhui; Chen, Yongjun] Peking Union Med Coll, Chengdu 610052, Sichuan, Peoples R China.
   [Luo, Guanwen] Guangdong Shuanglin Biopharm Co Ltd, Zhanjiang, Peoples R China.
   [Kumthip, Kattareeya] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand.
   [Leetrakool, Nipapan] Chiang Mai Univ, Fac Med, Blood Bank Sect, Chiang Mai, Thailand.
   [Chen, Limin] Univ Toronto, Toronto Gen Res Inst, Toronto, ON, Canada.
RP Yang, CH; Chen, YJ (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu 610052, Sichuan, Peoples R China.; Yang, CH; Chen, YJ (corresponding author), Peking Union Med Coll, Chengdu 610052, Sichuan, Peoples R China.
EM yangchunhui@ibt.pumc.edu.cn; chenyongjun@ibt.pumc.edu.cn
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bryant BJ, 2007, ARCH PATHOL LAB MED, V131, P719
   Burnouf T, 2007, TRANSFUS MED REV, V21, P101, DOI 10.1016/j.tmrv.2006.11.001
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eickmann M, 2018, TRANSFUSION, V58, P2202, DOI 10.1111/trf.14652
   Epstein JS, 2003, TRANSFUSION, V43, P1347, DOI 10.1046/j.1537-2995.2003.00584.x
   Gravemann U, 2018, VOX SANG, V113, P368, DOI 10.1111/vox.12643
   Groner A, 2018, TRANSFUSION, V58, P41, DOI 10.1111/trf.14390
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   HOROWITZ B, 1992, BLOOD, V79, P826
   Hsieh YT, 2016, TRANSFUSION, V56, P1384, DOI 10.1111/trf.13619
   Kempf C, 2007, BIOLOGICALS, V35, P35, DOI 10.1016/j.biologicals.2006.01.002
   KIMURA T, 1986, J GEN VIROL, V67, P2423, DOI 10.1099/0022-1317-67-11-2423
   Klein HG, 2009, TRANSFUSION, V49, P1262, DOI 10.1111/j.1537-2995.2009.02210.x
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Kreil TR, 2003, TRANSFUSION, V43, P1023, DOI 10.1046/j.1537-2995.2003.00496.x
   LAMBRECHT B, 1991, VOX SANG, V60, P207, DOI 10.1111/j.1423-0410.1991.tb00907.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leydold SM, 2012, TRANSFUSION, V52, P2122, DOI 10.1111/j.1537-2995.2012.03565.x
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Oh DJ, 2010, KOREAN J LAB MED, V30, P45, DOI 10.3343/kjlm.2010.30.1.45
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Remington KM, 2004, VOX SANG, V87, P10, DOI 10.1111/j.1423-0410.2004.00530.x
   Ruibal Brunet I J, 1999, Sangre (Barc), V44, P352
   Sofer G, 2003, BIOPHARM INT, V16, P42
   Solheim BG, 2008, TRANSFUS APHER SCI, V39, P75, DOI 10.1016/j.transci.2008.05.003
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Webert KE, 2008, TRANSFUS MED REV, V22, P1, DOI 10.1016/j.tmrv.2007.09.001
   Zhou HD, 2016, VIROL SIN, V31, P357, DOI 10.1007/s12250-016-3821-6
NR 43
TC 1
Z9 1
U1 1
U2 66
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2019
VL 91
IS 12
BP 2059
EP 2065
DI 10.1002/jmv.25538
PG 7
WC Virology
SC Virology
GA JE1RN
UT WOS:000490473300003
PM 31389019
DA 2020-07-08
ER

PT J
AU Almeida, MO
   Bezerra, TT
   Lima, NMA
   Sousa, AF
   Trevisan, MTS
   Ribeiro, VGP
   Lomonaco, D
   Mazzetto, SE
AF Almeida, Mayara O.
   Bezerra, Thayllan T.
   Lima, Nayane M. A.
   Sousa, Anderson F.
   Trevisan, Maria T. S.
   Ribeiro, Viviane G. P.
   Lomonaco, Diego
   Mazzetto, Selma E.
TI Cardol-Derived Organophosphorothioates as Inhibitors of
   Acetylcholinesterase for Dengue Vector Control
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE cardol; AChE inhibition; Aedes aegypti
ID LARVICIDAL ACTIVITY; AEDES-AEGYPTI; MOSQUITO
AB Aedes aegypti is the main vector of three neglected tropical diseases: dengue, zika and chikungunya. Dengue is under surveillance by health organizations worldwide due to the risk of epidemics. Since there is no specific treatment for dengue, most studies have focused on preventing the reproduction and/or development of the mosquitoes. We studied the larvicidal activity of five phosphates and phosphorothioates derived from cardol. one of the four main components of cashew nut shell liquid (Anacardium occidentale L.). at different concentrations. The organophosphorothioate derivatives were tested for their in vitro inhibitory potential against acetylcholinesterase (AChE). One compound, Cdl.i-dPS (median lethal concentration (LC50)= 0.8 ppm), was four times more efficient compared to an important commercial larvicide, Temephos (LC50 = 3.2 ppm), and showed greater AChE inhibition than its monosubstituted analogue and Temephos.
C1 [Almeida, Mayara O.; Bezerra, Thayllan T.; Lima, Nayane M. A.; Lomonaco, Diego; Mazzetto, Selma E.] Univ Fed Ceara, Lab Prod & Tecnol Proc LPT, Campus Pici, BR-60455900 Fortaleza, Ceara, Brazil.
   [Sousa, Anderson F.; Trevisan, Maria T. S.] Univ Fed Ceara, LPNBio, Campus Pici, BR-60455900 Fortaleza, Ceara, Brazil.
   [Ribeiro, Viviane G. P.] Univ Integracao Int Lusofonia Afro Brasileira, ICEN, BR-62790000 Redencao, CE, Brazil.
RP Mazzetto, SE (corresponding author), Univ Fed Ceara, Lab Prod & Tecnol Proc LPT, Campus Pici, BR-60455900 Fortaleza, Ceara, Brazil.
EM selma@ufc.br
RI ; LOMONACO, DIEGO/F-3430-2013
OI Mazzetto, Selma Elaine/0000-0002-6879-3209; LOMONACO,
   DIEGO/0000-0001-5763-4336
FU CAPES (Brazilian agency)CAPES; CNPq (Brazilian agency)National Council
   for Scientific and Technological Development (CNPq); FUNCAP (State
   agency)
FX We thank the support from CAPES, CNPq (Brazilian agencies) and FUNCAP
   (State agency) for the financial support; Amendoas do Brasil, for
   providing CNSL; CENAUREMN (Centro Nordestino de Aplicacao e Uso da RMN,
   Fortaleza-CE) for the NMR analyses and; NUVET (Nucleo de Controle de
   Vetores e Endemias).
CR [Anonymous], 2009, BIOSTAT FULL VERS
   Bharate SB, 2010, J AGR FOOD CHEM, V58, P8460, DOI 10.1021/jf100976v
   Chansang A, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3001-7
   Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006
   Oliveira MSC, 2011, ACTA TROP, V117, P165, DOI 10.1016/j.actatropica.2010.08.003
   Daniel JFS, 2017, J BRAZIL CHEM SOC, V28, P1003, DOI 10.21577/0103-5053.20160253
   de Oliveira OV, 2018, CHEM PHYS LETT, V706, P82, DOI 10.1016/j.cplett.2018.05.072
   Devi U, 2017, ASIAN PAC J TROP MED, V10, P850, DOI 10.1016/j.apjtm.2017.08.003
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Feitosa EMA, 2009, J BRAZIL CHEM SOC, V20, P375, DOI 10.1590/S0103-50532009000200024
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Horn G, 2018, TOXICOL LETT, V299, P218, DOI 10.1016/j.toxlet.2018.10.004
   Hu WQ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3210-0
   Kanis LA, 2018, IND CROP PROD, V122, P148, DOI 10.1016/j.indcrop.2018.05.055
   Kannathasan K, 2011, ACTA TROP, V120, P115, DOI 10.1016/j.actatropica.2011.07.001
   Krzyzaniak LM, 2017, EVID-BASED COMPL ALT, DOI 10.1155/2017/9602368
   Laurens A, 1997, PHYTOTHER RES, V11, P145, DOI 10.1002/(SICI)1099-1573(199703)11:2<145::AID-PTR40>3.0.CO;2-#
   Lomonaco D, 2009, GREEN CHEM, V11, P31, DOI 10.1039/b811504d
   Lomonaco D, 2013, J THERM ANAL CALORIM, V111, P619, DOI 10.1007/s10973-012-2383-6
   Lomonaco D, 2012, FUEL, V97, P552, DOI 10.1016/j.fuel.2012.01.059
   Lomonaco D, 2011, J THERM ANAL CALORIM, V104, P1177, DOI 10.1007/s10973-011-1404-1
   Lopez O, 2011, GREEN TRENDS INSECT
   Mazzetto SE, 2009, QUIM NOVA, V32, P732, DOI 10.1590/S0100-40422009000300017
   Moreira ASN, 2016, REV BRAS FARMACOGN, V26, P530, DOI 10.1016/j.bjp.2016.03.006
   Mota JPF, 2016, SEP SCI TECHNOL, V51, P2473, DOI 10.1080/01496395.2016.1213284
   Paiva DR, 2017, AN ACAD BRAS CIENC, V89, P373, DOI 10.1590/0001-3765201720160615
   Rhee IK, 2001, J CHROMATOGR A, V915, P217, DOI 10.1016/S0021-9673(01)00624-0
   Rocha DK, 2015, NAT PROD COMMUN, V10, P677
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Verheyen J, 2019, ENVIRON POLLUT, V248, P209, DOI 10.1016/j.envpol.2019.02.022
   Yu S. J., 2008, TOXYCOLOGY BIOCH INS
NR 31
TC 0
Z9 0
U1 4
U2 16
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD DEC
PY 2019
VL 30
IS 12
SI SI
BP 2634
EP 2641
DI 10.21577/0103-5053.20190181
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA JB9DU
UT WOS:000488882300011
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ahmed, I
   Nasir, S
   Yousaf, I
   Ahmad, B
   Zafar, S
   Javaid, A
AF Ahmed, Imran
   Nasir, Shabab
   Yousaf, Iqra
   Ahmad, Bilal
   Zafar, Sumbal
   Javaid, Aqib
TI PLANT EXTRACTS ALONG WITH SELECTIVE CHEMICALS AND Bacillus thuringiensis
   israelensis: A NOVEL APPROACH TO TACKLE THE PROBLEM OF INSECTICIDAL
   RESISTANCE IN MOSQUITOES
SO PAKISTAN JOURNAL OF AGRICULTURAL SCIENCES
LA English
DT Article
DE Mosquito-borne diseases; dengue fever; Aedes aegypti; mortality; plant
   extracts; resistance management
ID DIPTERA-CULICIDAE; SUBSP ISRAELENSIS; ESSENTIAL OILS; AEDES-AEGYPTI;
   LEAF; EFFICACY; VECTOR; DELTAMETHRIN; TOXICITY
AB Mosquitoes act as vectors for many life-threatening diseases such as malaria, dengue fever, West Nile virus, zika virus etc. Continuous use of pesticides caused insecticidal resistance in mosquitoes along with many other detrimental effects on the environment. Therefore, this study was designed to manage the mosquito population under laboratory conditions with synthetic insecticides, plant extracts, and Bacillus thuringiensis israelensis (Bti). Mosquito larvae (Aedes aegypti) were collected, identified and reared in cages for bioassay. Along with synthetic chemicals and Bti, fifteen plants were selected for this study and their extracts were obtained through ether as a solvent. Two concentrations (0.001 and 10%) of each treatment were applied against 2nd and 3rd instar larvae for screening trails. Data were collected to check knockdown effect after 4 and 64 h and analysed through two-level factorial design. Datura (Datura wrightii) leaf, kortumma (Citrullus colocynthis), chirata (Swertia chirayaita), Bti, deltamethrin and mortein liquid was screened out as significant factors. After screening experiments, significant factors were tested in combination with five concentrations (0.001, 0.01, 0.1, 1.0 and 10%) of each treatment to test their efficacy after 2, 4, 8, 16, 32, 64 and 128 h. In the mixing trials, the highest mortality was observed with those solution having kortumma, insecticides and Bti whereas the least value of LC50 (45.2%) with 100% mortality was found in combination of Kortumma, Datura leaf, Bti, deltamethrin and mortein liquid. Plant extracts along with chemicals and Bti can be considered as an alternative strategy for the control of mosquitoes.
C1 [Ahmed, Imran; Nasir, Shabab; Yousaf, Iqra; Ahmad, Bilal; Zafar, Sumbal; Javaid, Aqib] Govt Coll Univ, Dept Zool, Faisalabad 38040, Punjab, Pakistan.
RP Nasir, S (corresponding author), Govt Coll Univ, Dept Zool, Faisalabad 38040, Punjab, Pakistan.
EM flourenceshabab@yahoo.com
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Ahmad I, 2002, FARMING OUTLOOK  OCT, P14
   Ahmad KR, 2018, PAK VET J, V38, P46, DOI 10.29261/pakvetj/2018.009
   Ahmad T, 2017, PAK VET J, V37, P465
   BHAN S, 2015, INT J MOSQ RES A, V2, P34
   Borum AE, 2018, PAK VET J, V38, P321, DOI 10.29261/pakvetj/2018.031
   Chang KS, 2014, J MED ENTOMOL, V51, P804, DOI 10.1603/ME13128
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Cheng SS, 2009, PEST MANAG SCI, V65, P339, DOI 10.1002/ps.1693
   Elango G, 2011, PARASITOL RES, V109, P715, DOI 10.1007/s00436-011-2306-7
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Gurudeeban S., 2010, Asian Journal of Plant Sciences, V9, P394
   Kumar BR, 2015, J PHARMACOGN PHYTOCH, V4, P7
   Kumar PM, 2012, PARASITOL RES, V110, P2541, DOI 10.1007/s00436-011-2797-2
   Naseem MN, 2018, PAK VET J, V38, P209, DOI 10.29261/pakvetj/2018.028
   Nasir S, 2017, BANGL J BOT, V46, P27
   Nasir S, 2017, INDIAN J ANIM RES, V51, P155, DOI 10.18805/ijar.9592
   Prabhu K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P124, DOI 10.1016/S2221-1691(11)60009-9
   Qasim M, 2014, PAK J ZOOL, V46, P523
   Raghavendra BS, 2013, ENVIRON SCI POLLUT R, V20, P3830, DOI 10.1007/s11356-012-1308-z
   RATHY MC, 2015, INT J MOSQ RES B, V2, P80
   Raveen R., 2014, INT J MOSQUITO RES, V1, P38
   Shakoor Muhammad T, 2012, WHO South East Asia J Public Health, V1, P229, DOI 10.4103/2224-3151.207018
   Sinha C, 2004, INT J DEV NEUROSCI, V22, P31, DOI 10.1016/j.ijdevneu.2003.10.005
   Tetreau G, 2013, LETT APPL MICROBIOL, V57, P151, DOI 10.1111/lam.12089
   WHO, 2011, DENGUE DENGUE HEMORR
NR 26
TC 0
Z9 0
U1 0
U2 99
PU UNIV AGRICULTURE, FAC VETERINARY SCIENCE
PI FAISALABAD
PA UNIV AGRICULTURE, FAC VETERINARY SCIENCE, FAISALABAD, 00000, PAKISTAN
SN 0552-9034
EI 2076-0906
J9 PAK J AGR SCI
JI Pak. J. Agric. Sci.
PD DEC
PY 2019
VL 56
IS 4
BP 905
EP 911
DI 10.21162/PAKJAS/19.8481
PG 7
WC Agriculture, Multidisciplinary
SC Agriculture
GA IZ2UX
UT WOS:000486942300016
DA 2020-07-08
ER

PT J
AU Li, J
   Yangb, K
   Wu, Z
   Li, XD
   Duan, QY
AF Li, Jie
   Yangb, Ke
   Wu, Zheng
   Li, Xuede
   Duan, Qingyun
TI Nitrogen-doped porous carbon-based fluorescence sensor for the detection
   of ZIKV RNA sequences: fluorescence image analysis
SO TALANTA
LA English
DT Article
DE Nitrogen-doped porous carbon; ZIKV RNA sequences; Fluorescence quenching
   and recovery; CCD-Based imaging platform
ID METAL-ORGANIC FRAMEWORKS; SENSING PLATFORM; DS-DNA; VIRUS; SINGLE;
   RECOGNITION; MOF
AB Many studies have demonstrated that metal-organic frameworks (MOFs) are universal fluorescence quenchers for DNA/RNA detection. Nevertheless, the structural stability of many MOFs is relatively weak, which limits their practical applications. Thus, it remains a great interest to develop constitutionally stable nano biosensor suitable for application in the complex environment. Herein, a new angle of nitrogen-doped porous carbon (NPC) obtained from MOFs-based precursors by virtue of a simple method was applied as a nano biosensor for the fluorescence detection of Zika virus (ZIKV) RNA sequences. The fluorescence signal capturing was carried out by using a charge-coupled device (CCD)-based imaging system. The NPC could adsorb TAMRA-tagged ZIKV RNA probe (P-DNA) to form P-DNA@NPC complex accompanied by substantial fluorescence quenching. Upon adding the complementary target RNA (T-RNA), the P-DNA could release from NPC by forming a doublestranded hybrid and induce the fluorescence recovery. The P-DNA@NPC complex was valid and reliable for ZIKV RNA sequences assay with a limit of detection (LoD) at 0.23 nM, which is superior to many of the previously reported fluorescent DNA sensors. Moreover, it could distinguish mismatched RNA and was effective in detecting ZIKV RNA sequences spiked in the human saliva sample. We envision that this study would offer an interesting new angle on the potential integrating application of carbon nanomaterials and CCD-based fluorescence imaging platform in the field of nucleic acid assay.
C1 [Li, Jie; Wu, Zheng; Li, Xuede; Duan, Qingyun] Anhui Agr Univ, Sch Resources & Environm, Hefei, Anhui, Peoples R China.
   [Yangb, Ke] Chinese Acad Sci, Inst Appl Technol, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China.
RP Yangb, K (corresponding author), Chinese Acad Sci, Inst Appl Technol, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China.
EM keyang@rntek.cas.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31800713, 21806001]; Dean's Fund of Hefei Institute
   of Physical Science, China [YZJJ2018QN22]
FX This work was financially supported by the National Natural Science
   Foundation of China (31800713 and 21806001); Dean's Fund of Hefei
   Institute of Physical Science, China (YZJJ2018QN22). Jie Li and Ke Yang
   thank Dr. lin from University of Manitoba for his kind suggestion.
CR Bai ZQ, 2015, J MATER CHEM A, V3, P525, DOI 10.1039/c4ta04878d
   Cao XH, 2017, CHEM SOC REV, V46, P2660, DOI 10.1039/c6cs00426a
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang S, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.75
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   Duan QY, 2019, J COLLOID INTERF SCI, V533, P700, DOI 10.1016/j.jcis.2018.09.007
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Khan IA, 2016, ACS APPL MATER INTER, V8, P17268, DOI 10.1021/acsami.6b04548
   Lei W., 2011, NUCLEIC ACIDS RES, V39, P1
   Li HL, 2011, J MATER CHEM, V21, P824, DOI 10.1039/c0jm02695f
   Li HL, 2011, CHEM COMMUN, V47, P961, DOI 10.1039/c0cc04326e
   Li H, 2015, CHEM COMMUN, V51, P11321, DOI 10.1039/c5cc03756e
   Li J, 2018, CHEM SOC REV, V47, P2322, DOI 10.1039/c7cs00543a
   Lin YC, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601296
   Liu BW, 2014, CHEM COMMUN, V50, P8568, DOI 10.1039/c4cc03264k
   Liu S, 2011, NANOSCALE, V3, P967, DOI 10.1039/c0nr00873g
   Liu S, 2011, J MATER CHEM, V21, P339, DOI 10.1039/c0jm03337e
   Liu ZB, 2014, ANAL BIOANAL CHEM, V406, P6885, DOI 10.1007/s00216-014-7888-3
   Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479
   Lu WB, 2011, SYNTHETIC MET, V161, P1766, DOI 10.1016/j.synthmet.2011.06.021
   Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pan Y, 2018, ANAL BIOCHEM, V546, P5, DOI 10.1016/j.ab.2018.01.017
   Pedro GC, 2019, ANAL CHIM ACTA, V1047, P214, DOI 10.1016/j.aca.2018.10.010
   Qiu GH, 2018, TALANTA, V180, P396, DOI 10.1016/j.talanta.2017.12.045
   Safavieh M, 2016, ACS BIOMATER SCI ENG, V2, P278, DOI 10.1021/acsbiomaterials.5b00449
   Song C, 2015, BIOSENS BIOELECTRON, V68, P239, DOI 10.1016/j.bios.2015.01.006
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Sun B, 2017, J INORG BIOCHEM, V176, P17, DOI 10.1016/j.jinorgbio.2017.07.024
   Sun XP, 2014, ANALYST, V139, P2318, DOI 10.1039/c3an02364h
   Tan HL, 2016, ANAL CHIM ACTA, V940, P136, DOI 10.1016/j.aca.2016.08.024
   Wang HS, 2017, ANAL CHEM, V89, P11366, DOI 10.1021/acs.analchem.7b02256
   Wang HS, 2017, COORDIN CHEM REV, V349, P139, DOI 10.1016/j.ccr.2017.08.015
   Wang YH, 2016, BIOSENS BIOELECTRON, V80, P140, DOI 10.1016/j.bios.2016.01.052
   Wen YQ, 2010, CHEM COMMUN, V46, P2596, DOI 10.1039/b924832c
   Wu YF, 2015, NANOSCALE, V7, P1753, DOI 10.1039/c4nr05447d
   Xie BP, 2019, INORG CHEM FRONT, V6, P148, DOI 10.1039/c8qi01031e
   Xie BP, 2018, SENSOR ACTUAT B-CHEM, V254, P1133, DOI 10.1016/j.snb.2017.06.085
   Yang SP, 2017, INORG CHEM, V56, P14880, DOI 10.1021/acs.inorgchem.7b02107
   Yang SP, 2015, ANAL CHEM, V87, P12206, DOI 10.1021/acs.analchem.5b03084
   Yang W, 2018, ADV METEOROL, V2018, DOI 10.1155/2018/2809649
   Ye YD, 2016, BIOSENS BIOELECTRON, V85, P837, DOI 10.1016/j.bios.2016.06.001
   Yu Z. B., 2017, NAT COMMUN, V8, P14762
   Zhang JW, 2014, CHEM COMMUN, V50, P1092, DOI 10.1039/c3cc48398c
   Zhang LB, 2010, CHEM COMMUN, V46, P1476, DOI 10.1039/b921191h
   Zhang Q, 2018, ANALYST, V143, P4221, DOI 10.1039/c8an00816g
   Zhao HQ, 2016, ANAL CHIM ACTA, V922, P55, DOI 10.1016/j.aca.2016.03.054
   Zhao HQ, 2016, DALTON T, V45, P5092, DOI 10.1039/c5dt04410c
   Zhu CF, 2013, J AM CHEM SOC, V135, P5998, DOI 10.1021/ja4019572
   Zhu SY, 2011, CHEM COMMUN, V47, P6099, DOI 10.1039/c1cc10952a
   Zhu X, 2013, CHEM COMMUN, V49, P1276, DOI 10.1039/c2cc36661d
NR 58
TC 2
Z9 2
U1 25
U2 168
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD DEC 1
PY 2019
VL 205
AR UNSP 120091
DI 10.1016/j.talanta.2019.06.091
PG 9
WC Chemistry, Analytical
SC Chemistry
GA IX7IH
UT WOS:000485856500025
PM 31450455
DA 2020-07-08
ER

PT J
AU Odinolfi, MT
   Romanato, A
   Bergamaschi, G
   Strada, A
   Sola, L
   Girella, A
   Milanese, C
   Chiari, M
   Gori, A
   Cretich, M
AF Odinolfi, Maria Teresa
   Romanato, Alessandro
   Bergamaschi, Greta
   Strada, Alessandro
   Sola, Laura
   Girella, Alessandro
   Milanese, Chiara
   Chiari, Marcella
   Gori, Alessandro
   Cretich, Marina
TI Clickable cellulosic surfaces for peptide-based bioassays
SO TALANTA
LA English
DT Article
DE Click chemistry; Peptides; Microarrays; Immunodiagnostics; Cellulose;
   Paper based assays
ID LATERAL FLOW; PAPER; IMMUNOASSAY; PATTERNS; ASSAYS
AB The use of peptides in paper-based analytics is a highly appealing field, yet it suffers from severe limitations. This is mostly due to the loss of effective target recognition properties of this relatively small probes upon nonspecific adsorption onto cellulose substrates. Here we address this issue by introducing a simple polymer-based strategy to obtain clickable cellulose surfaces, that we exploited for the chemoselective bioconjugation of peptide bioprobes. Our method largely outperformed standard adsorption-based immobilization strategy in a challenging, real case immunoassay, namely the diagnostic discrimination of Zika + individuals from healthy controls. Of note, the clickable polymeric coating not only allows efficient peptides bioconjugation, but it provides favorable anti-fouling properties to the cellulosic support. We envisage our strategy to broaden the repertoire of cellulosic materials manipulation and promote a renewed interest in peptide-based paper bioassays.
C1 [Odinolfi, Maria Teresa; Romanato, Alessandro; Bergamaschi, Greta; Strada, Alessandro; Sola, Laura; Chiari, Marcella; Gori, Alessandro; Cretich, Marina] CNR, ICRM, Via Mario Bianco 9, I-20131 Milan, Italy.
   [Girella, Alessandro; Milanese, Chiara] Pavia Hydrogen Lab, Chem Dept, Phys Chem Sect, Via Taramelli 12, Pavia, Italy.
RP Gori, A; Cretich, M (corresponding author), CNR, ICRM, Via Mario Bianco 9, I-20131 Milan, Italy.
EM alessandro.gori@cnr.it; marina.cretich@cnr.it
RI BERGAMASCHI, Greta/AAK-1164-2020
OI BERGAMASCHI, Greta/0000-0002-4501-4057
FU Regione Lombardia, project READY (Regional Network for developing
   diagnostic methods in rapid response to emerging epidemics and
   bio-emergencies) [229472, 2015JTL4HL]
FX Work partially funded by Regione Lombardia, project READY (Regional
   Network for developing diagnostic methods in rapid response to emerging
   epidemics and bio-emergencies) ID 229472. PRIN 2015JTL4HL is also
   acknowledged for financial support to A. S.
CR Chen P, 2019, TALANTA, V191, P81, DOI 10.1016/j.talanta.2018.08.043
   Cretich M, 2015, TALANTA, V132, P315, DOI 10.1016/j.talanta.2014.09.027
   de Puig H, 2017, TRENDS BIOTECHNOL, V35, P1169, DOI 10.1016/j.tibtech.2017.09.001
   Deraney RN, 2016, ANAL CHEM, V88, P6161, DOI 10.1021/acs.analchem.6b00854
   Draz MS, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201707161
   Feng WQ, 2015, ANGEW CHEM INT EDIT, V54, P8732, DOI 10.1002/anie.201502954
   Gori A, 2017, ANAL CHIM ACTA, V983, P189, DOI 10.1016/j.aca.2017.06.027
   Gori A, 2016, BIOCONJUGATE CHEM, V27, P2669, DOI 10.1021/acs.bioconjchem.6b00426
   Grosse S, 2016, ANGEW CHEM INT EDIT, V55, P11266, DOI 10.1002/anie.201601603
   Guo JQ, 2018, CELLULOSE, V25, P367, DOI 10.1007/s10570-017-1593-2
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kong FZ, 2012, ANAL BIOANAL CHEM, V403, P7, DOI 10.1007/s00216-012-5821-1
   Lopez-Marzo AM, 2016, LAB CHIP, V16, P3150, DOI 10.1039/c6lc00737f
   Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989
   Oyola-Reynoso S, 2015, TALANTA, V145, P73, DOI 10.1016/j.talanta.2015.09.042
   Parolo C, 2013, CHEM SOC REV, V42, P450, DOI 10.1039/c2cs35255a
   Pirri G, 2004, ANAL CHEM, V76, P1352, DOI 10.1021/ac0352629
   Quesada-Gonzalez D, 2015, BIOSENS BIOELECTRON, V73, P47, DOI 10.1016/j.bios.2015.05.050
   Riccardi C., 2018, ANGEW CHEM, V130, P10315, DOI [10.1002/ANGE.201805074, DOI 10.1002/ANGE.201805074]
   Singh AT, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18092838
   Sola L, 2018, ACS INFECT DIS, V4, P998, DOI 10.1021/acsinfecdis.8b00014
   Sola L, 2016, LANGMUIR, V32, P10284, DOI 10.1021/acs.langmuir.6b02816
   Wu YP, 2019, TALANTA, V200, P177, DOI 10.1016/j.talanta.2019.03.033
NR 23
TC 1
Z9 1
U1 8
U2 34
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD DEC 1
PY 2019
VL 205
AR UNSP 120152
DI 10.1016/j.talanta.2019.120152
PG 6
WC Chemistry, Analytical
SC Chemistry
GA IX7IH
UT WOS:000485856500100
PM 31450458
DA 2020-07-08
ER

PT J
AU Hasan, B
   Singh, M
   Richards, D
   Blicblau, A
AF Hasan, Bushra
   Singh, Manmohan
   Richards, David
   Blicblau, Aaron
TI Mathematical modelling of Zika virus as a mosquito-borne and sexually
   transmitted disease with diffusion effects
SO MATHEMATICS AND COMPUTERS IN SIMULATION
LA English
DT Article
DE Zika virus; Equilibrium; Disease-free equilibrium; Endemic equilibrium;
   Stability; Diffusion
ID PREY-TAXIS
AB Zika virus disease is an infection transmitted primarily by Aedes mosquitoes, and can be a serious epidemic if not contained and controlled in its early stages. The purpose of this study is to investigate the transmission dynamics of Zika virus epidemic. A mathematical model of Zika virus with the inclusion of diffusion in the system is formulated, using a system of ordinary differential equations. Mathematical models assume transmission of the virus by mosquitoes, with and without transmission through sexual contact by humans. The basic properties of the model in the absence and presence of diffusion are determined including, points of the disease-free equilibrium (DFE) and the endemic equilibrium (EE). Stability of the disease-free equilibrium using the reproduction number, R-0 is established. The stability of the endemic equilibrium is established using the Routh-Hurwitz stability conditions. Bifurcation values for transmission rates and human recovery rate are also calculated. Numerical simulations based on different population distributions help to understand how the diffusion of human and mosquitoes affects the transmission of the disease. (C) 2019 International Association for Mathematics and Computers in Simulation (IMACS). Published by Elsevier B.V. All rights reserved.
C1 [Hasan, Bushra; Singh, Manmohan; Richards, David; Blicblau, Aaron] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
RP Hasan, B (corresponding author), Swinburne Univ Technol, Fac Sci Engn & Technol, Math Dept, Hawthorn, Vic 3122, Australia.
EM bhasan@swin.edu.au
RI blicblau, aaron s/A-4861-2008
FU Republic of Iraq, Ministry of Higher Education and Scientific Research
FX One of the authors, Bushra Hasan is thankful to Swinburne University of
   Technology, Hawthorn, Australia for providing the necessary facilities
   to carry on this work. and also to the Republic of Iraq, Ministry of
   Higher Education and Scientific Research for the postgraduate research
   award.
CR Alexandra M., 2016, MMWR MORB MORTAL WKL, V65
   Ali L., 2012, THESIS
   ANDERSON R M, 1991
   [Anonymous], 2017, DENGUE SEVERE DENGUE
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Blayneh K, 2009, DISCRETE CONT DYN-B, V11, P587, DOI 10.3934/dcdsb.2009.11.587
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Chakraborty A, 2007, MATH COMPUT MODEL, V46, P482, DOI 10.1016/j.mcm.2006.10.010
   Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427
   Ding CX, 2016, CHIN CONTR CONF, P2642, DOI 10.1109/ChiCC.2016.7553763
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Easton A., 1997, CAN APPL MATH Q, V5, P359
   Elsaka H., 2016, BIORXIV
   Gao D., 2016, SCI REP, V6
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Isea R., 2016, ARXIV160608233
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambert JD, 1991, NUMERICAL METHODS OR
   Lashari AA, 2012, J APPL MATH, DOI 10.1155/2012/946504
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Manore C, 2016, SIAM NEWS
   Margiotta V., 2010, SCIENCE
   MEINSMA G, 1995, SYST CONTROL LETT, V25, P237, DOI 10.1016/0167-6911(94)00089-E
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Sapoukhina N, 2003, AM NAT, V162, P61, DOI 10.1086/375297
   Singh Manmohan, 2000, Natural Resource Modeling, V13, P535
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Yanenko N. N., 1971, METHOD FRACTIONAL ST
NR 33
TC 0
Z9 0
U1 5
U2 53
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-4754
EI 1872-7166
J9 MATH COMPUT SIMULAT
JI Math. Comput. Simul.
PD DEC
PY 2019
VL 166
BP 56
EP 75
DI 10.1016/j.matcom.2019.04.007
PG 20
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA IU1JT
UT WOS:000483333300004
DA 2020-07-08
ER

PT J
AU Khan, MA
   Shah, SW
   Ullah, S
   Gomez-Aguilar, JF
AF Khan, M. A.
   Shah, Syed Wasim
   Ullah, Saif
   Gomez-Aguilar, J. F.
TI A dynamical model of asymptomatic carrier zika virus with optimal
   control strategies
SO NONLINEAR ANALYSIS-REAL WORLD APPLICATIONS
LA English
DT Article
DE Zika asymptomatic carrier model; Stability results; Backward
   bifurcation; Optimal controls; Optimal control strategies; Numerical
   results
ID TRANSMISSION; INFECTION; MALARIA
AB A dynamical model of asymptomatic carrier zika virus model with optimal control strategies is presented. The basic model zika without control and basic mathematical results are obtained. The stability results for the zika model without controls are obtained when the basic reproduction number is less than unity at the disease free case. We show that the zika model without controls is locally and globally asymptotically stable when the basic reproduction number is less than 1. Further, we show the model stability at the endemic equilibrium and present that the model at the endemic equilibrium is locally and globally asymptotically stable when R-0 > 1. Further, for the case when 12. R-0 = 1, we analyze the model and presents its backward bifurcation, and it may have the phenomena of backward bifurcation if the conditions provided is satisfied. After that we chose the appropriate controls for the zika virus eliminations and formulated the zika control model. These controls are the preventions through bednets, the treatment of the infected individuals due to zika virus infection, and the insecticides spraying on mosquitoes. With these controls, the model and the optimal controls characterizations are obtained. Furthermore, we provided the existence of optimal control problem. The model with controls and the model without controls are solved numerically by using backward Runge-Kutta method and obtain the graphical results. The graphical results are obtained by setting appropriate set of controls and the associated results are shown. We show that each strategy has its own importance for the elimination of zika virus infection, but we suggest based on the numerical results that the uses of bednets as a prevention from the zika mosquitoes, the treatment of individuals infected through zika mosquitoes and the insecticides spraying on mosquitoes could be more useful for the elimination of zika virus infection from the community. With this new idea of asymptotic carrier class the results provided in the present paper would be more useful for public health department and other health agencies to reduce the burden of zika virus infection from the community. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Khan, M. A.; Shah, Syed Wasim] City Univ Sci & Informat Technol, Dept Math, Peshawar 25000, KP, Pakistan.
   [Ullah, Saif] Univ Peshawar, Dept Math, Peshawar, KP, Pakistan.
   [Gomez-Aguilar, J. F.] CONACyT Tecnol Nacl Mexico, CENIDET, Interior Internado Palmira S-N, Cuernavaca 62490, Morelos, Mexico.
RP Khan, MA (corresponding author), City Univ Sci & Informat Technol, Dept Math, Peshawar 25000, KP, Pakistan.
EM altafdir@gmail.com
RI Khan, Muhammad Altaf/K-2201-2013
OI Khan, Muhammad Altaf/0000-0002-4483-7879
FU CONACyT (Mexico): Catedras CONACyT para jovenes investigadores; SNI
   CONACyT (Mexico)Consejo Nacional de Ciencia y Tecnologia (CONACyT)
FX The authors are grateful to all of the anonymous reviewers for their
   valuable suggestions. Jose Francisco Gomez Aguilar acknowledges the
   support provided by CONACyT (Mexico): Catedras CONACyT para jovenes
   investigadores 2014 and SNI CONACyT (Mexico).
CR Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   Birkhoff G., 1982, ORDINARY DIFFERENTIA
   Birkhoff G., 1989, ORDINARY DIFFERENTIA
   Blayneh KW, 2010, B MATH BIOL, V72, P1006, DOI 10.1007/s11538-009-9480-0
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540
   Bonyah E, 2014, COMPUT MATH METHOD M, DOI 10.1155/2014/576039
   Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361
   Castillo-Chavez C., 2002, MATH APPROACHES EMER, V1
   Chang CH, 2014, IEEE INT SYMP CIRC S, P1540
   Ding CX, 2016, CHIN CONTR CONF, P2642, DOI 10.1109/ChiCC.2016.7553763
   Doungmo Goufo E. F., 2017, MATH PROBL ENG, V2017, P1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fleming WH, 2012, DETERMINISTIC STOCHA, V1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03179-w
   Khan Muhammad Altaf, 2016, INT J APPL COMPUT MA, V2, P435, DOI DOI 10.1007/S40819-015-0102-2
   Kumar S, 2016, NONLINEAR DYNAM, V85, P699, DOI 10.1007/s11071-016-2716-2
   Lee Eva K, 2016, AMIA Annu Symp Proc, V2016, P743
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   Linda JA, 2007, INTRO MATH BIOL
   Lukes DL, 1982, DIFFERENTIAL EQUATIO
   Majumder Maimuna S., 2016, B WHO, V10
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Okosun KO, 2014, MATH BIOSCI, V258, P19, DOI 10.1016/j.mbs.2014.09.008
   Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sunil Kumar, 2014, WALAILAK J SCI TECHN, V11, P1057
   Suparit P, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0083-z
   Terefe YA, 2018, THEOR BIOSCI, V137, P209, DOI 10.1007/s12064-018-0272-7
   Tesla Blanka, 2018, BIORXIV
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wan Hui, 2013, J APPL MATH, V2013
   WHO, WHO WHO ZIK VIR
   Zhang JH, 2014, SCI WORLD J, DOI 10.1155/2014/910421
   Zhou XY, 2008, J MATH ANAL APPL, V342, P1342, DOI 10.1016/j.jmaa.2008.01.008
NR 39
TC 9
Z9 8
U1 3
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1468-1218
J9 NONLINEAR ANAL-REAL
JI Nonlinear Anal.-Real World Appl.
PD DEC
PY 2019
VL 50
BP 144
EP 170
DI 10.1016/j.nonrwa.2019.04.006
PG 27
WC Mathematics, Applied
SC Mathematics
GA IM1XA
UT WOS:000477783900009
DA 2020-07-08
ER

PT J
AU Yamazaki, K
AF Yamazaki, Kazuo
TI Zika virus dynamics partial differential equations model with sexual
   transmission route
SO NONLINEAR ANALYSIS-REAL WORLD APPLICATIONS
LA English
DT Article
DE Basic reproduction number; Diffusion; Persistence; Stability; Zika virus
ID GLOBAL WELL-POSEDNESS; CHOLERA; STATES; PERSISTENCE
AB Inspired by the system of ordinary differential equations in Agusto et al. (2017) that models Zika virus dynamics by taking into account of both sexual and vector-borne transmissions, we furthermore add diffusive terms in order to capture the movement of human hosts and mosquitoes, considering the unique threat of the sexual transmission route of Zika virus. We conduct complete theoretical analysis. In particular, we show that every initial data that is continuous and non-negative admits a unique continuous and non-negative solution for all positive times. Moreover, we derive the basic reproduction number and when it is beneath one, we prove that the disease-free-equilibrium is globally attractive. Finally, when the basic reproduction number is above one, and any of the exposed males or the exposed females or the exposed mosquitoes is not identically zero, we prove the existence of a positive asymptotic lower bound for every component of the solution which in particular implies the uniform persistence of the disease, as well as the existence of at least one positive steady state. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yamazaki, Kazuo] Univ Rochester, Dept Math, Rochester, NY 14627 USA.
RP Yamazaki, K (corresponding author), Univ Rochester, Dept Math, Rochester, NY 14627 USA.
EM kyamazak@ur.rochester.edu
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Cai Y., 2019, TRANSMISSION DYNAMIC, V514, P792
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carlson C, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004968
   Centers for disease control and prevention, ZIK BAS VIR PROT IT
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Ding CX, 2016, CHIN CONTR CONF, P2642, DOI 10.1109/ChiCC.2016.7553763
   Du ZJ, 2016, J MATH BIOL, V72, P1429, DOI 10.1007/s00285-015-0914-z
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Evans L. C., 1998, PARTIAL DIFFERENTIAL
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lou YJ, 2011, J MATH BIOL, V62, P543, DOI 10.1007/s00285-010-0346-8
   Magal P, 2005, SIAM J MATH ANAL, V37, P251, DOI 10.1137/S0036141003439173
   MARTIN RH, 1990, T AM MATH SOC, V321, P1, DOI 10.2307/2001590
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Saad-Roy CM, 2018, J MATH BIOL, V77, P1917, DOI 10.1007/s00285-018-1230-1
   Smith H. L., 1995, MATH SURVEYS MONOGR, V41
   Smith HL, 2001, NONLINEAR ANAL-THEOR, V47, P6169, DOI 10.1016/S0362-546X(01)00678-2
   Thieme HR, 2009, SIAM J APPL MATH, V70, P188, DOI 10.1137/080732870
   THIEME HR, 1992, J MATH BIOL, V30, P755
   Vaidya NK, 2012, DISCRETE CONT DYN-B, V17, P2829, DOI 10.3934/dcdsb.2012.17.2829
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wang WD, 2012, SIAM J APPL DYN SYST, V11, P1652, DOI 10.1137/120872942
   Wang WD, 2011, SIAM J APPL MATH, V71, P147, DOI 10.1137/090775890
   Wang XY, 2015, J BIOL DYNAM, V9, P233, DOI 10.1080/17513758.2014.974696
   WHO, HIST ZIK VIR
   World Health Organization, ZIK VIR FACT SHEET
   Wu J., 1996, THEORY APPL PARTIAL
   Yamazaki K, 2018, INT J BIOMATH, V11, DOI 10.1142/S1793524518501085
   Yamazaki K, 2018, MATH MED BIOL, V35, P427, DOI 10.1093/imammb/dqx016
   Yamazaki K, 2017, MATH BIOSCI ENG, V14, P559, DOI 10.3934/mbe.2017033
   Yamazaki K, 2016, DISCRETE CONT DYN-B, V21, P1297, DOI 10.3934/dcdsb.2016.21.1297
NR 40
TC 0
Z9 0
U1 2
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1468-1218
J9 NONLINEAR ANAL-REAL
JI Nonlinear Anal.-Real World Appl.
PD DEC
PY 2019
VL 50
BP 290
EP 315
DI 10.1016/j.nonrwa.2019.05.003
PG 26
WC Mathematics, Applied
SC Mathematics
GA IM1XA
UT WOS:000477783900015
DA 2020-07-08
ER

PT J
AU Liu, T
   Yang, WQ
   Xie, YG
   Liu, PW
   Xie, LH
   Lin, F
   Li, CY
   Gu, JB
   Wu, K
   Yan, GY
   Chen, XG
AF Liu, Tong
   Yang, Wen-Qiang
   Xie, Yu-Gu
   Liu, Pei-Wen
   Xie, Li-Hua
   Lin, Feng
   Li, Chen-Ying
   Gu, Jin-Bao
   Wu, Kun
   Yan, Gui-Yun
   Chen, Xiao-Guang
TI Construction of an efficient genomic editing system with CRISPR/Cas9 in
   the vector mosquito Aedes albopictus
SO INSECT SCIENCE
LA English
DT Article
DE Aedes albopictus; CRISPR; Cas9; dopachrome conversion enzyme (yellow);
   gene editing; kynurenine hydroxylase (kh)
ID YELLOW-FEVER MOSQUITO; OFF-TARGET MUTATIONS; GENE DRIVE; CRISPR-CAS9;
   TRANSFORMATION; MUTAGENESIS; POPULATION; EVOLUTION; PIGGYBAC; SEQUENCE
AB Aedes (Stegomyia) albopictus, also known as the Asian tiger mosquito, is a mosquito which originated in Asia. In recent years, it has become increasingly rampant throughout the world. This mosquito can transmit several arboviruses, including dengue, Zika and chikungunya viruses, and is considered a public health threat. Despite the urgent need of genome engineering to analyze specific gene functions, progress in genetical manipulation of Ae. albopictus has been slow due to a lack of efficient methods and genetic markers. In the present study, we established targeted disruptions in two genes, kynurenine hydroxylase (kh) and dopachrome conversion enzyme (yellow), to analyze the feasibility of generating visible phenotypes with genome editing by the clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR-associated protein 9 (Cas9) system in Ae. albopictus. Following Cas9 single guide RNA ribonucleoprotein injection into the posterior end of pre-blastoderm embryos, 30%-50% of fertile survivors produced alleles that failed to complement existing kh and yellow mutations. Complete eye and body pigmentation defects were readily observed in G1 pupae and adults, indicating successful generation of highly heritable mutations. We conclude that the CRISPR/Cas9-mediated gene editing system can be used in Ae. albopictus and that it can be adopted as an efficient tool for genome-scale analysis and biological study.
C1 [Liu, Tong; Yang, Wen-Qiang; Xie, Yu-Gu; Liu, Pei-Wen; Xie, Li-Hua; Lin, Feng; Li, Chen-Ying; Gu, Jin-Bao; Wu, Kun; Yan, Gui-Yun; Chen, Xiao-Guang] Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou North Ave 1838, Guangzhou 510515, Guangdong, Peoples R China.
   [Yan, Gui-Yun] Univ Calif Irvine, Room 3038 Hewitt Hall, Irvine, CA 92697 USA.
RP Yan, GY; Chen, XG (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou North Ave 1838, Guangzhou 510515, Guangdong, Peoples R China.
EM guiyuny@uci.edu; xgchen@fimmu.com
OI Liu, Tong/0000-0001-9134-1860
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81420108024, 81528013]; National Institute of
   Allergy and Infectious Diseases Grants of USA [AI136850]; National Key
   R&D Program of China [2016YFC1200500]; Natural Science Foundation of
   Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2014A030312016, 2016A020251001]; Guangzhou Synergy Innovation
   Key Program for Health [201508020263, 201605030010]
FX This work was supported by grants from the National Natural Science
   Foundation of China (81420108024, 81528013), National Institute of
   Allergy and Infectious Diseases Grants of USA (AI136850), the National
   Key R&D Program of China (2016YFC1200500), the Natural Science
   Foundation of Guangdong Province (2014A030312016, 2016A020251001), the
   Guangzhou Synergy Innovation Key Program for Health (201508020263,
   201605030010).
CR Adelman ZN, 2008, INSECT BIOCHEM MOLEC, V38, P705, DOI 10.1016/j.ibmb.2008.04.002
   Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Aryan A, 2014, METHODS, V69, P38, DOI 10.1016/j.ymeth.2014.02.008
   Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082
   Basu S., 2016, TALENS METHODS PROTO
   Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112
   Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809
   Chen XE, 2018, INSECT BIOCHEM MOLEC, V94, P1, DOI 10.1016/j.ibmb.2018.01.002
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353
   Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666
   Drapeau MD, 2003, J NEUROBIOL, V55, P53, DOI 10.1002/neu.10196
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gregianini TS, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1943
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Han Q, 2003, INSECT MOL BIOL, V12, P483, DOI 10.1046/j.1365-2583.2003.00433.x
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Itokawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24652
   Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408
   Jasinskiene Nijole, 2007, J Vis Exp, P219, DOI 10.3791/219
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5
   Labbe GMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000788
   Li J., 2011, RECENT ADV ENTOMOLOG
   Li M, 2017, P NATL ACAD SCI USA, V114, pE10540, DOI 10.1073/pnas.1711538114
   Li YJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2581-y
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Riedel F, 2011, DEVELOPMENT, V138, P149, DOI 10.1242/dev.056309
   Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2
   Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849
   Xia D, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0466-8
   Zhang Y, 2016, P NATL ACAD SCI USA, V113, pE4828, DOI 10.1073/pnas.1609792113
   Zhao CZ, 2017, INT J BIOL SCI, V13, P1470, DOI 10.7150/ijbs.21312
   Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003
   Zuo EW, 2017, CELL RES, V27, P933, DOI 10.1038/cr.2017.81
NR 46
TC 1
Z9 2
U1 5
U2 170
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1672-9609
EI 1744-7917
J9 INSECT SCI
JI Insect Sci.
PD DEC
PY 2019
VL 26
IS 6
SI SI
BP 1045
EP 1054
DI 10.1111/1744-7917.12645
PG 10
WC Entomology
SC Entomology
GA IE7TQ
UT WOS:000472577600010
PM 30311353
OA Bronze
DA 2020-07-08
ER

PT J
AU Brady, OJ
   Hay, SI
AF Brady, Oliver J.
   Hay, Simon I.
TI The first local cases of Zika virus in Europe
SO LANCET
LA English
DT Letter
C1 [Brady, Oliver J.] London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
RP Brady, OJ (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.
EM oliver.brady@lshtm.ac.uk
CR Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brady OJ, ANN REV ENTOMOL, V65, P1
   Giron S, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.45.1900655
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
NR 5
TC 2
Z9 2
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD NOV 30
PY 2019
VL 394
IS 10213
BP 1991
EP 1992
DI 10.1016/S0140-6736(19)32790-4
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA JT4GR
UT WOS:000500950200023
PM 31753318
OA Bronze
DA 2020-07-08
ER

PT J
AU Zhou, SL
   Yang, C
   Zhao, FF
   Huang, YX
   Lin, YX
   Huang, CB
   Ma, XC
   Du, JJ
   Wang, Y
   Long, G
   He, JF
   Liu, C
   Zhang, P
AF Zhou, Shili
   Yang, Chao
   Zhao, Fanfan
   Huang, Yanxia
   Lin, Yuxia
   Huang, Changbai
   Ma, Xiaocao
   Du, Jingjie
   Wang, Yi
   Long, Gang
   He, Junfang
   Liu, Chao
   Zhang, Ping
TI Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication
   by inhibiting the activation of protein kinase PKR
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE viral replication; interferon; flavivirus; RNA editing; host-pathogen
   interaction; post-transcriptional regulation; adenosine deaminase; host
   factor; positive stranded RNA virus; protein kinase regulated by dsRNA;
   Zika virus; arbovirus
ID STRESS GRANULE FORMATION; ADENOSINE-DEAMINASE; MEASLES-VIRUS; EMERGENCE;
   PLAYS
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has emerged as a threat to global health. The family of adenosine deaminases acting on dsRNA (ADARs) are human host factors important for the genetic diversity and evolution of ZIKV. Here, we further investigated the role of ADAR1 in ZIKV replication by utilizing CRISPR/Cas9-based gene editing and RNAi-based gene knockdown techniques. Both ADAR1 knockout and knockdown significantly reduced ZIKV RNA synthesis, protein levels, and viral titers in several human cell lines. Trans-complementation with the full-length ADAR1 form p150 or the shorter form p110 lacking the Z? domain restored viral replication levels suppressed by the ADAR1 knockout. Moreover, we observed that the nuclear p110 form was redistributed to the cytoplasm in response to ZIKV infection. ADAR1 was not involved in viral entry but promoted viral protein translation by impairing ZIKV-induced activation of protein kinase regulated by dsRNA (PKR). Of note, the RNA-editing activity of ADAR1 was not required to promote ZIKV replication. We also found that the proviral role of ADAR1 was partially mediated through its ability to suppress IFN production and PKR activation. Our work identifies ADAR1 as a proviral factor involved in ZIKV replication, suggesting that ADAR1 could be a potential antiviral target.
C1 [Zhou, Shili; Huang, Yanxia; Lin, Yuxia; Huang, Changbai; Ma, Xiaocao; Du, Jingjie; Wang, Yi; He, Junfang; Liu, Chao; Zhang, Ping] Sun Yat Sen Univ, Dept Immunol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.
   [Zhou, Shili; Huang, Yanxia; Lin, Yuxia; Huang, Changbai; Ma, Xiaocao; Du, Jingjie; Wang, Yi; He, Junfang; Liu, Chao; Zhang, Ping] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510080, Guangdong, Peoples R China.
   [Yang, Chao] Sun Yat Sen Univ, Dept Neurosurg, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China.
   [Zhao, Fanfan; Long, Gang] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.
RP Zhang, P (corresponding author), Sun Yat Sen Univ, Dept Immunol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.; Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.
EM liuchao9@mail.sysu.edu.cn; zhangp36@mail.sysu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31970887]; Guangdong Science and Technology Program
   Grants [2017A050501012, 2018A050506029]; Natural Science Foundation of
   Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2017A030313504]
FX This work was supported by National Natural Science Foundation of China
   Grant 31970887, Guangdong Science and Technology Program Grants
   2017A050501012 and 2018A050506029, and Natural Science Foundation of
   Guangdong Province Grant 2017A030313504. The authors declare that they
   have no conflicts of interest with the contents of this article.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Casey JL, 2012, CURR TOP MICROBIOL, V353, P123, DOI 10.1007/82_2011_146
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038
   Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598
   Dauber B, 2009, VIRUSES-BASEL, V1, P523, DOI 10.3390/v1030523
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gannon HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07824-4
   Gao HX, 2019, VIROLOGY, V529, P91, DOI 10.1016/j.virol.2019.01.019
   Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11
   George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014
   George CX, 2011, J INTERF CYTOK RES, V31, P99, DOI 10.1089/jir.2010.0097
   George CX, 2009, J INTERF CYTOK RES, V29, P477, DOI 10.1089/jir.2009.0065
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Khrustalev VV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00044
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li Y, 2017, ELIFE, V6, DOI [10.7554/eLife.29914, 10.7554/eLife.25687]
   Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06
   Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005
   Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Piontkivska H, 2017, ECOL EVOL, V7, P4475, DOI 10.1002/ece3.3033
   Pujantell M, 2018, ANTIVIR RES, V156, P116, DOI 10.1016/j.antiviral.2018.05.012
   Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414
   Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Tomaselli S, 2015, CURR ISSUES MOL BIOL, V17, P37
   Tomaselli S, 2014, CELL TISSUE RES, V356, P527, DOI 10.1007/s00441-014-1863-3
   Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang QD, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010041
   Wang Y, 2019, J VIROL, V93, DOI 10.1128/JVI.01306-18
   Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108
   Weiden MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108476
   Whelan JN, 2019, J VIROL, V93, DOI 10.1128/JVI.00313-19
   Yang SY, 2014, J IMMUNOL, V193, P3436, DOI 10.4049/jimmunol.1401136
   Zhang PF, 2014, J CELL SCI, V127, P2471, DOI 10.1242/jcs.139626
   Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07
   Zhao FF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28890-0
NR 46
TC 0
Z9 0
U1 1
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 29
PY 2019
VL 294
IS 48
BP 18168
EP 18180
DI 10.1074/jbc.RA119.009113
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KA1GS
UT WOS:000505547900015
PM 31636123
DA 2020-07-08
ER

PT J
AU Choi, H
   Kudchodkar, SB
   Reuschel, EL
   Asija, K
   Borole, P
   Agarwal, S
   Van Gorder, L
   Reed, CC
   Gulendran, G
   Ramos, S
   Broderick, KE
   Kim, JJ
   Ugen, KE
   Kobinger, G
   Siegel, DL
   Weiner, DB
   Muthumani, K
AF Choi, Hyeree
   Kudchodkar, Sagar B.
   Reuschel, Emma L.
   Asija, Kanika
   Borole, Piyush
   Agarwal, Sangya
   Van Gorder, Lucas
   Reed, Charles C.
   Gulendran, Gayathri
   Ramos, Stephanie
   Broderick, Kate E.
   Kim, J. Joseph
   Ugen, Kenneth E.
   Kobinger, Gary
   Siegel, Don L.
   Weiner, David B.
   Muthumani, Kar
TI Synthetic nucleic acid antibody prophylaxis confers rapid and durable
   protective immunity against Zika virus challenge
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE Zika virus; antibodies; dMAb-DNA encoded monoclonal antibodies;
   vaccination; immunotherapy; DNA vaccine
ID FUNCTIONAL-CHARACTERIZATION; STRUCTURAL BASIS; DNA VACCINATION
AB Significant concerns have arisen over the past 3 y from the increased global spread of the mosquito-borne flavivirus, Zika. Accompanying this spread has been an increase in cases of the devastating birth defect microcephaly as well as of Guillain-Barre syndrome in adults in many affected countries. Currently there is no vaccine or therapy for this infection; however, we sought to develop a combination approach that provides more rapid and durable protection than traditional vaccination alone. A novel immune-based prophylaxis/therapy strategy entailing the facilitated delivery of a synthetic DNA consensus prME vaccine along with DNA-encoded anti-ZIKV envelope monoclonal antibodies (dMAb) were developed and evaluated for antiviral efficacy. This immediate and persistent protection strategy confers the ability to overcome shortcomings inherent with conventional active vaccination or passive immunotherapy. A collection of novel dMAbs were developed which were potent against ZIKV and could be expressed in serum within 24-48 h of in vivo administration. The DNA vaccine, from a previous development, was potent after adaptive immunity was developed, protecting against infection, brain and testes pathology in relevant mouse challenge models and in an NHP challenge. Delivery of potent dMAbs protected mice from the same murine viral challenge within days of delivery. Combined injection of dMAb and the DNA vaccine afforded rapid and long-lived protection in this challenge model, providing an important demonstration of the advantage of this synergistic approach to pandemic outbreaks.
C1 [Choi, Hyeree; Kudchodkar, Sagar B.; Reuschel, Emma L.; Asija, Kanika; Borole, Piyush; Agarwal, Sangya; Van Gorder, Lucas; Weiner, David B.; Muthumani, Kar] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Reed, Charles C.; Ramos, Stephanie; Broderick, Kate E.; Kim, J. Joseph] Inovio Pharmaceut, R&D, Plymouth Meeting, PA USA.
   [Gulendran, Gayathri; Siegel, Don L.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Ugen, Kenneth E.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA.
   [Kobinger, Gary] Univ Laval, Quebec City, PQ, Canada.
RP Muthumani, K (corresponding author), Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM kmuthumani@wistar.org
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065; Choi, Hyeree/0000-0003-4999-3640;
   Van Gorder, Lucas/0000-0002-7835-2677; Ramos,
   Stephanie/0000-0002-5326-4937; Borole, Piyush/0000-0003-3327-5847
FU Wistar Science Discovery fund
FX This work was supported by the Wistar Science Discovery fund awarded to
   K.M.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Elliott STC, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0020-x
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Esquivel RN, 2019, MOL THER, V27, P974, DOI 10.1016/j.ymthe.2019.03.005
   Flingai S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12616
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Muthumani K, 2016, J INFECT DIS, V214, P369, DOI 10.1093/infdis/jiw111
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Ostertag EM, 2016, TRANSFUSION, V56, P1763, DOI 10.1111/trf.13584
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Patel A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00576-7
   Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185
   Perales-Puchalt A, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126086
   Perales-Puchalt A, 2019, MOL THER, V27, P314, DOI 10.1016/j.ymthe.2018.11.014
   Rana J, 2018, J VIROL, V92, DOI 10.1128/JVI.01174-18
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Steinberger P, 2011, COLD SPRING HARB PRO, V2011
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wise MC, 2015, J VIROL, V89, P9154, DOI 10.1128/JVI.00652-15
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 44
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD APR 2
PY 2020
VL 16
IS 4
BP 907
EP 918
DI 10.1080/21645515.2019.1688038
EA NOV 2019
PG 12
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA LE0VG
UT WOS:000500709700001
PM 31799896
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, GY
   Adam, A
   Luo, HL
   Shan, C
   Cao, ZG
   Fontes-Garfias, CR
   Sarathy, VV
   Teleki, C
   Winkelmann, ER
   Liang, YJ
   Sun, JR
   Bourne, N
   Barrett, ADT
   Shi, PY
   Wang, T
AF Li, Guangyu
   Adam, Awadalkareem
   Luo, Huanle
   Shan, Chao
   Cao, Zengguo
   Fontes-Garfias, Camila R.
   Sarathy, Vanessa V.
   Teleki, Cody
   Winkelmann, Evandro R.
   Liang, Yuejin
   Sun, Jiaren
   Bourne, Nigel
   Barrett, Alan D. T.
   Shi, Pei-Yong
   Wang, Tian
TI An attenuated Zika virus NS4B protein mutant is a potent inducer of
   antiviral immune responses
SO NPJ VACCINES
LA English
DT Article
ID WEST-NILE-VIRUS; T-CELL RESPONSES; DENDRITIC CELLS; INHIBITION;
   INFECTION; VACCINE; PROTECTION; CD4(+); ACTIVATION; ANTIGEN
AB Live attenuated vaccines (LAVs) are one of the most important strategies to control flavivirus diseases. The flavivirus nonstructural (NS) 4B proteins are a critical component of both the virus replication complex and evasion of host innate immunity. Here we have used site-directed mutagenesis of residues in the highly conserved N-terminal and central hydrophobic regions of Zika virus (ZIKV) NS4B protein to identify candidate attenuating mutations. Three single-site mutants were generated, of which the NS4B-C100S mutant was more attenuated than the other two mutants (NS4B-C100A and NS4B-P36A) in two immunocompromised mouse models of fatal ZIKV disease. The ZIKV NS4B-C100S mutant triggered stronger type 1 interferons and interleukin-6 production, and higher ZIKV-specific CD4(+) and CD8(+) T-cell responses, but induced similar titers of neutralization antibodies compared with the parent wild-type ZIKV strain and a previously reported candidate ZIKV LAV with a 10-nucleotide deletion in 3'-UTR (ZIKV-3'UTR-Delta 10). Vaccination with ZIKV NS4B-C100S protected mice from subsequent WT ZIKV challenge. Furthermore, either passive immunization with ZIKV NS4B-C100S immune sera or active immunization with ZIKV NS4B-C100S followed by the depletion of T cells affords full protection from lethal WT ZIKV challenge. In summary, our results suggest that the ZIKV NS4B-C100S mutant may serve as a candidate ZIKV LAV due to its attenuated phenotype and high immunogenicity.
C1 [Li, Guangyu; Adam, Awadalkareem; Luo, Huanle; Teleki, Cody; Winkelmann, Evandro R.; Liang, Yuejin; Sun, Jiaren; Bourne, Nigel; Barrett, Alan D. T.; Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Shan, Chao; Cao, Zengguo; Fontes-Garfias, Camila R.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Sarathy, Vanessa V.; Barrett, Alan D. T.; Wang, Tian] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Sarathy, Vanessa V.; Bourne, Nigel; Barrett, Alan D. T.; Shi, Pei-Yong; Wang, Tian] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Bourne, Nigel] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Wang, T (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Wang, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Shi, PY; Wang, T (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu; ti1wang@utmb.edu
OI Sarathy, Vanessa/0000-0002-1262-2101; Shan, Chao/0000-0002-3953-3782
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI142759, 1R41AI136126, R01
   AI099123, R01AI127744]; Sealy Institute for Vaccine Sciences at UTMB;
   NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI078878]; John S. Dunn Foundation; Amon G.
   Carter Foundation; Kleberg Foundation; Gilson Longenbaugh Foundation;
   Summerfield Robert Foundation; CDCUnited States Department of Health &
   Human ServicesCenters for Disease Control & Prevention - USA
   [U01CK0000512]
FX We thank Dr. Bob Tesh for providing ZIKV antibodies and Dr. Michael Gale
   from University of Washington for Mavs<SUP>-/-</SUP> mice. This work was
   supported in part by NIH grant R01 AI099123 (T.W.), R01AI127744 (T.W.),
   and a grant from Sealy Institute for Vaccine Sciences at UTMB (T.W. and
   P.Y.S.). C. T. was a recipient of a summer internship from NIAID T35
   training grant (AI078878, PI: L Soong). P.Y.S. was supported by the John
   S. Dunn Foundation, the Amon G. Carter Foundation, the Kleberg
   Foundation, the Gilson Longenbaugh Foundation, the Summerfield Robert
   Foundation, CDC grant U01CK0000512, and NIH grants U19AI142759 and
   1R41AI136126.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112
   [Anonymous], 2017, LANCET INFECT DIS, V17, P1003, DOI 10.1016/S1473-3099(17)30534-0
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252
   Curtsinger JM, 1999, J IMMUNOL, V162, P3256
   Dieli F, 2004, EUR J IMMUNOL, V34, P3227, DOI 10.1002/eji.200425368
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07
   Giel-Moloney M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31375-9
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251
   Haynes L, 2004, J IMMUNOL, V172, P5194, DOI 10.4049/jimmunol.172.9.5194
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Isakov N, 1997, IMMUNOL RES, V16, P85, DOI 10.1007/BF02786325
   Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kum DB, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0092-2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003
   Luo HL, 2017, J VIROL, V91, DOI 10.1128/JVI.02097-16
   Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521
   MATHEWS JH, 1992, J VIROL, V66, P6555, DOI 10.1128/JVI.66.11.6555-6562.1992
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pape KA, 1997, J IMMUNOL, V159, P591
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Welte T, 2011, FEMS IMMUNOL MED MIC, V63, P183, DOI 10.1111/j.1574-695X.2011.00840.x
   Welte T, 2011, VACCINE, V29, P4853, DOI 10.1016/j.vaccine.2011.04.057
   Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007
   Wicker JA, 2012, VIROLOGY, V426, P22, DOI 10.1016/j.virol.2011.11.022
   Xie G, 2016, J VIROL, V90, P1333, DOI 10.1128/JVI.02488-15
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
NR 57
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD NOV 28
PY 2019
VL 4
AR 48
DI 10.1038/s41541-019-0143-3
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JW4BM
UT WOS:000502998500001
PM 31815005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Giersing, BK
   Vekemans, J
   Nava, S
   Koslow, DC
   Moorthy, V
   Abdulla, S
   Bavdekar, A
   Cichutek, K
   Cravioto, A
   Fritzell, B
   Graham, BS
   Karron, RA
   Lanata, CF
   Shao, YM
   Smith, PG
AF Giersing, Birgitte K.
   Vekemans, Johan
   Nava, Samantha
   Koslow, David C.
   Moorthy, Vasee
   Abdulla, Salim
   Bavdekar, Ashish
   Cichutek, Klaus
   Cravioto, Alejandro
   Fritzell, Bernard
   Graham, Barney S.
   Karron, Ruth A.
   Lanata, Claudio F.
   Shao, Yiming
   Smith, Peter G.
CA WHO Prod Dev Vaccines Advisory
TI Report from the World Health Organization's third Product Development
   for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June
   2016
SO VACCINE
LA English
DT Article
DE Vaccine; Product development; LMICs; Bacterial; Viral; PDVAC; SAGE
ID CLOSTRIDIUM-DIFFICILE INFECTION; RESEARCH-AND-DEVELOPMENT; ENTEROVIRUS
   71 VACCINE; IMMUNOGENICITY; SAFETY; CHILDREN; CANDIDATE; MORTALITY;
   EFFICACY; ROADMAP
AB The third meeting of WHO's Product Development for Vaccines Advisory Committee (PDVAC) was held in June 2016, with a remit to revisit the pathogen areas for which significant progress has occurred since recommendations from the 2015 meeting, as well as to consider new advances in the development of vaccines against other pathogens. Since the previous meeting, significant progress has been made with regulatory approvals of the first malaria and dengue vaccines, and the first phase III trials of a respiratory syncytial virus (RSV) vaccine candidate has started in the elderly and pregnant women. In addition, PDVAC has also supported vaccine development efforts against important emerging pathogens, including Middle Eastern Coronavirus (MERS CoV) and Zika virus. Trials of HIV and tuberculosis vaccine candidates are steadily progressing towards pivotal data points, and the leading norovirus vaccine candidate has entered a phase lib efficacy study. WHO's Immunization, Vaccine and Biologicals (IVB) department is actively working in several pathogen areas on the recommendation of PDVAC, as well as continuing horizon scanning for advances in the development of vaccines that may benefit low and middle income countries (LMICs), such as the recent licensure of the enterovirus 71 (EV71) vaccine in China. Following on from discussions with WHO's Strategic Advisory Group of Experts (SAGE) on Immunization, PDVAC will also look beyond licensure and consider data needs for vaccine recommendation and implementation to reduce the delay between vaccine approval and vaccine impact. (C) 2017 World Health Organization; licensee Elsevier Ltd.
C1 [Giersing, Birgitte K.; Vekemans, Johan; Moorthy, Vasee] WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
   [Nava, Samantha] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Koslow, David C.] PATH, Seattle, WA 98109 USA.
   [Abdulla, Salim] Ifakara Hlth Inst, Ifakara, Tanzania.
   [Bavdekar, Ashish] Kem Hosp & Res Ctr, Pune, Maharashtra, India.
   [Cichutek, Klaus] Paul Ehrlich Inst, Langen, Germany.
   [Cravioto, Alejandro] Global Evaluat Sci Inc, Seattle, WA USA.
   [Graham, Barney S.] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Lanata, Claudio F.] Inst Invest Nutr, Lima, Peru.
   [Shao, Yiming] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.
   [Smith, Peter G.] London Sch Hyg & Trop Med, London, England.
RP Moorthy, V (corresponding author), WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM moorthyv@who.int
OI Moorthy, Vasee/0000-0002-6535-2854
FU World Health OrganizationWorld Health Organization [001]
CR Anderson AS, 2012, HUM VACC IMMUNOTHER, V8, P1585, DOI 10.4161/hv.21872
   Bezay N, 2016, VACCINE, V34, P2585, DOI 10.1016/j.vaccine.2016.03.098
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   CATES W, 1985, FAM PLANN PERSPECT, V17, P175, DOI 10.2307/2135243
   de Bruyn G, 2016, VACCINE, V34, P2170, DOI 10.1016/j.vaccine.2016.03.028
   Evans TG, 2016, VACCINE, V34, P2911, DOI 10.1016/j.vaccine.2016.02.079
   Giersing BK, 2016, VACCINE, V34, P2865, DOI 10.1016/j.vaccine.2016.02.078
   Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111
   Henao-Restrepo AM, 2016, CURR OPIN VIROL, V17, P138, DOI 10.1016/j.coviro.2016.03.008
   Kayvon Modjarrad, WHO PRODUCT DEV VACC, V34, P2863
   Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111
   Lanzieri TM, 2014, INT J INFECT DIS, V22, P44, DOI 10.1016/j.ijid.2013.12.010
   Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319
   Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224
   Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999
   Miwako Kobayashia, 2016, M HELD 27 28 A UNPUB
   Modjarrad K, 2016, NAT MED, V22, P701, DOI 10.1038/nm.4131
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Nesin M., ADV MATERNAL IMMUNIZ, V33, P6371
   Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304
   O'Brien KL, 2016, LANCET, V387, P1887, DOI 10.1016/S0140-6736(16)30394-4
   Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Seale AC, 2016, EMERG INFECT DIS, V22, P224, DOI 10.3201/eid2202.151358
   Sheldon E, 2016, VACCINE, V34, P2082, DOI 10.1016/j.vaccine.2016.03.010
   Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013
   Vannice KS, 2019, VACCINE, V37, P7443, DOI 10.1016/j.vaccine.2016.10.034
   Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6
   Zeng M, 2015, LANCET, V386, P1457, DOI 10.1016/S0140-6736(15)60310-5
   Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923
NR 32
TC 7
Z9 7
U1 8
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7315
EP 7327
DI 10.1016/j.vaccine.2016.10.090
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100005
PM 28262332
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Vannice, KS
   Giersing, BK
   Kaslow, DC
   Griffiths, E
   Meyer, H
   Barrett, A
   Durbin, AP
   Wood, D
   Hombach, J
AF Vannice, K. S.
   Giersing, B. K.
   Kaslow, D. C.
   Griffiths, E.
   Meyer, H.
   Barrett, A.
   Durbin, A. P.
   Wood, D.
   Hombach, J.
TI Meeting Report: WHO consultation on considerations for regulatory
   expectations of Zika virus vaccines for use during an emergency
SO VACCINE
LA English
DT Article
DE Zika virus; Zika vaccines; Vaccine regulation
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; CROSS-REACTIVITY; PROTECTION;
   INFECTION; TRANSMISSION; CHALLENGE; EPIDEMIC; RISK
AB On 1 February 2016, in the context of the ongoing Zika virus epidemic, the WHO declared that the recently reported clusters of microcephaly and other neurological disorders constituted a Public Health Emergency of International Concern (PHEIC). In response, WHO in collaboration with UNICEF and a working group of independent subject matter experts developed a Zika virus vaccine Target Product Profile (TPP) for use in an emergency, or in a future outbreak scenario. The drafting process of the Zika virus vaccine TPP included the opportunity for public comment, as well as consultation with epidemiologists, flavivirus vaccine subject matter experts, vaccine developers and global regulators to consider the regulatory expectations and potential emergency use pathways for a vaccine with the characteristics described in the TPP. This report summarizes an expert consultation held 6-7 June 2016 on the regulatory considerations for a Zika vaccine for emergency use. (C) 2017 Elsevier Ltd.
C1 [Vannice, K. S.; Giersing, B. K.; Hombach, J.] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland.
   [Kaslow, D. C.] PATH, Seattle, WA 98109 USA.
   [Griffiths, E.] The Farthings, Kingston Upon Thames KT2 7PT, Surrey, England.
   [Meyer, H.] Paul Ehrlich Inst, D-63225 Langen, Germany.
   [Barrett, A.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Barrett, A.] Univ Texas Med Branch, World Hlth Org, Collaborating Ctr Vaccine Res Evaluat & Training, Galveston, TX 77555 USA.
   [Durbin, A. P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   [Wood, D.] WHO, Dept Essential Med & Hlth Prod, CH-1211 Geneva 27, Switzerland.
RP Hombach, J (corresponding author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland.
EM hombachj@who.int
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Brasil P, 2016, N ENGL J MED
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dodd CN, 2013, VACCINE, V31, P4448, DOI 10.1016/j.vaccine.2013.06.032
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   JACKSON N, 2014, AM J TROP MED HYG, V91, P172
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization, 2016, CAS DEF
   Pan American Health Organization, 2016, ZIK ETH CONS ETH GUI
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun W, 2013, J INFECT DIS, V207, P700, DOI 10.1093/infdis/jis744
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Vannice KS, 2015, VACCINE, V33, P7091, DOI 10.1016/j.vaccine.2015.09.053
   WHO Expert Committee on Biological Standardization, 2015, WHO TECHN REP SER
   World Health Organization, 2016, WHO VACC PIP TRACK
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2016, WHO EXP PRIOR VACC D
   World Health Organization, 2016, ZIK VIR VACC PROD DE
   World Health Organization, 2014, SAF IMM PREGN REV EV
   World Health Organization, 2016, WHO CONS CONS REG EX
   World Health Organization, 2015, EM US ASS LIST PROC
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 56
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 28
PY 2019
VL 37
IS 50
SI SI
BP 7443
EP 7450
DI 10.1016/j.vaccine.2016.10.034
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JU0XI
UT WOS:000501402100020
PM 27916410
DA 2020-07-08
ER

PT J
AU Mariconti, M
   Obadia, T
   Mousson, L
   Malacrida, A
   Gasperi, G
   Failloux, AB
   Yen, PS
AF Mariconti, Marina
   Obadia, Thomas
   Mousson, Laurence
   Malacrida, Anna
   Gasperi, Giuliano
   Failloux, Anna-Bella
   Yen, Pei-Shi
TI Estimating the risk of arbovirus transmission in Southern Europe using
   vector competence data
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AEDES-ALBOPICTUS; CHIKUNGUNYA VIRUS; DENGUE; INFECTION; MOSQUITO;
   AEGYPTI; SUSCEPTIBILITY; EPIDEMIC; OUTBREAK; SKUSE
AB Arboviral diseases such as chikungunya, dengue, and Zika viruses have been threatening the European countries since the introduction in 1979 of the major vector Aedes albopictus. In 2017, more than three hundred of CHIKV autochthonous cases were reported in Italy, highlighting the urgent need for a risk assessment of arboviral diseases in European countries. In this study, the vector competence for three major arboviruses were analyzed in eight Ae. albopictus populations from Europe. Here we show that Southern European Ae. albopictus were susceptible to CHIKV, DENV-1 and ZIKV with the highest vector competence for CHIKV. Based on vector competence data and vector distribution, a prediction risk map for CHIKV was generated stressing the fear of CHIKV and to a lesser extent, of other arboviruses for Europe, calling us for new public health strategies.
C1 [Mariconti, Marina; Mousson, Laurence; Failloux, Anna-Bella; Yen, Pei-Shi] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, F-75724 Paris, France.
   [Mariconti, Marina; Malacrida, Anna; Gasperi, Giuliano] Univ Pavia, Dept Biol & Biotechnol, I-27110 Pavia, Italy.
   [Obadia, Thomas] Inst Pasteur, Dept Parasites & Insect Vectors, Malaria Unit Parasites & Hosts, F-75724 Paris, France.
   [Obadia, Thomas] Inst Pasteur, Dept Computat Biol, Hub Bioinformat & Biostat, USR 3756,CNRS, Paris, France.
RP Failloux, AB; Yen, PS (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, F-75724 Paris, France.
EM anna-bella.failloux@pasteur.fr; pei-shi.yen@pasteur.fr
OI FAILLOUX, Anna-Bella/0000-0001-6890-0820; Yen,
   Pei-Shi/0000-0002-2113-7394
FU Institut Pasteur; French Government's Investissement d'Avenir program,
   Laboratoire d'Excellence "Integrative Biology of Emerging Infectious
   Diseases"French National Research Agency (ANR); European Union's Horizon
   2020 research and innovation program under ZIKAlliance [734548];
   European UnionEuropean Union (EU) [731060]
FX This study was supported by the Institut Pasteur, the French
   Government's Investissement d'Avenir program, Laboratoire d'Excellence
   "Integrative Biology of Emerging Infectious Diseases" (grant
   noANR-10-LABX-62-IBEID to A-BF), the European Union's Horizon 2020
   research and innovation program under ZIKAlliance grant agreement no.
   734548 and the European Union's Horizon 2020 research and innovation
   program under grant agreement No 731060 (Infravec2, Research
   Infrastructures for the control of vector-borne diseases;
   http://infravec2.eu/). We are grateful to Francesca Scolari, Antonios
   Michaelakis, Igor Pajovic, Mario Bjelis, Eleonora Faccio, Claudio
   Venturelli, Xiaoguang Chen and Ludvik M. Gomulski for providing mosquito
   samples.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Alto BW, 2014, J VECTOR ECOL, V39, P406, DOI 10.1111/jvec.12116
   Angelini P., 2008, Parassitologia (Rome), V50, P97
   Angelini R., 2007, EUROSURVEILLANCE, V12
   [Anonymous], 1928, LEAGUE NATIONS MONTH, V7, P334
   [Anonymous], 2019, RASTER GEOGRAPHIC DA
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   CARRAT F, 1992, AM J EPIDEMIOL, V135, P1293, DOI 10.1093/oxfordjournals.aje.a116236
   Cassadou S., 2014, EURO SURVEILLANCE B, V19
   Dalla Pozza G., 1992, Journal of the American Mosquito Control Association, V8, P318
   Delisle E., 2015, EUROSURVEILLANCE B E, V20
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Dickens BL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000801
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Enserink M, 2007, SCIENCE, V317, P1485, DOI 10.1126/science.317.5844.1485a
   European Centre for Disease Prevention and Control (ECDC), 2019, ZIK VIR DIS VAR DEP
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gonzalez MA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3359-1
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Graler B, 2016, R J, V8, P204
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012
   Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.21.30238
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Ross PA, 2019, EVOL APPL, V12, P572, DOI 10.1111/eva.12740
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Schmidt-Chanasit J., 2010, EUROSURVEILLANCE B E, V15
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Severini F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006435
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   You JHS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033123
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 60
TC 1
Z9 1
U1 2
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 28
PY 2019
VL 9
AR 17852
DI 10.1038/s41598-019-54395-5
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JR5NP
UT WOS:000499671900001
PM 31780744
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu, ZY
   Qin, CF
AF Liu, Zhong-Yu
   Qin, Cheng-Feng
TI Structure and function of cis-acting RNA elements of flavivirus
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE Evolution; flavivirus; genome cyclization; pseudoknot; RNA structure
ID BORNE ENCEPHALITIS-VIRUS; DENGUE-VIRUS; ZIKA VIRUS; SEXUAL TRANSMISSION;
   SECONDARY STRUCTURE; GENOME CYCLIZATION; SUBGENOMIC RNA; CODING REGION;
   VACCINE CANDIDATE; MOSQUITO-BORNE
AB The genus Flavivirus is a group of single-stranded, positive-sense RNA viruses that includes numerous human pathogens with global impact, such as dengue virus (DENV), yellow fever virus (YFV), West Nile virus (WNV), and Zika virus (ZIKV). The approximately 11-kilobase genome is flanked by highly structured untranslated regions (UTRs), which contain various cis-acting RNA elements with unique structures and functions. Moreover, local RNA elements circularize the genome non-covalently through long-range interactions. Interestingly, many flavivirus cis-acting RNA elements contain group-specific motifs or are specific for the given phylogenetic groups, suggesting their potential association with flavivirus evolution and diversification. In this review, we summarize recent advances about the structure and function of cis-acting RNA elements in flavivirus genomes and highlight the potential implications for flavivirus evolution. Finally, the scientific questions remained to be answered in the field are also discussed.
C1 [Liu, Zhong-Yu; Qin, Cheng-Feng] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.
   [Liu, Zhong-Yu] Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou, Guangdong, Peoples R China.
   [Liu, Zhong-Yu; Qin, Cheng-Feng] Guangzhou Med Univ, Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
RP Qin, CF (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81522025, 81621005, 81661148054, 31770190, 8187163
   81871632]; Newton Advanced Fellowship from the Academy of Medical
   Sciences, UK; National Science and Technology Major Project of China
   [2018ZX09711003]; National Key Research and Development Project of China
   [2016YFC1202402]
FX National Natural Science Foundation of China, Grant/Award Number:
   81522025, 81621005, 81661148054, 31770190, 8187163 81871632, 31770190,
   81661148054 and 81621005; Newton Advanced Fellowship from the Academy of
   Medical Sciences, UK; National Science and Technology Major Project of
   China, Grant/Award Number: 2018ZX09711003; National Key Research and
   Development Project of China, Grant/Award Number: 2016YFC1202402
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Bustos-Arriaga J, 2018, VACCINE, V36, P3460, DOI 10.1016/j.vaccine.2018.04.087
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chiu HP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007166
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   Diagne MM, 2017, ONE HEALTH-AMSTERDAM, V3, P23, DOI 10.1016/j.onehlt.2017.02.001
   Ding YL, 2015, NAT PROTOC, V10, P1050, DOI 10.1038/nprot.2015.064
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eiden M, 2018, INFECT GENET EVOL, V61, P151, DOI 10.1016/j.meegid.2018.03.020
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Friebe P, 2012, VIROLOGY, V422, P346, DOI 10.1016/j.virol.2011.10.025
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Friedrich S, 2018, J VIROL, V92, DOI 10.1128/JVI.01647-17
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Huhtamo E, 2009, J VIROL, V83, P9532, DOI 10.1128/JVI.00529-09
   Ishikawa T, 2015, EXPERT OPIN THER TAR, V19, P1379, DOI 10.1517/14728222.2015.1065817
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kofler RM, 2006, J VIROL, V80, P4099, DOI 10.1128/JVI.80.8.4099-4113.2006
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Luhken R, 2017, EMERG INFECT DIS, V23, P1991, DOI 10.3201/eid2312.171257
   MacFadden A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02604-y
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Melian EB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004447
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Norberg P, 2013, VIROLOGY, V440, P105, DOI 10.1016/j.virol.2013.02.017
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Olsthoorn RCL, 2001, RNA, V7, P1370
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194
   Rouha H, 2011, VIROLOGY, V417, P79, DOI 10.1016/j.virol.2011.05.008
   Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894
   Sanford TJ, 2019, NUCLEIC ACIDS RES, V47, P9789, DOI 10.1093/nar/gkz686
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/NMETH.3029, 10.1038/nmeth.3029]
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Song YT, 2019, MBIO, V10, DOI [10.1128/mBio.00459-19, 10.1128/mbio.00459-19]
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004
   Tsetsarkin KA, 2016, NUCLEIC ACIDS RES, V44, P3330, DOI 10.1093/nar/gkw061
   Tuplin A, 2011, NUCLEIC ACIDS RES, V39, P7034, DOI 10.1093/nar/gkr237
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2013, J VIROL, V87, P9365, DOI 10.1128/JVI.00567-13
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Wang JM, 2015, INFECT GENET EVOL, V36, P116, DOI 10.1016/j.meegid.2015.09.013
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   White GS, 2016, EMERG INFECT DIS, V22, P2185, DOI 10.3201/eid2212.160805
   Whitehead SS, 2003, J VIROL, V77, P1653, DOI 10.1128/JVI.77.2.1653-1657.2003
   Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Zakaria MK, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00398
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 101
TC 0
Z9 0
U1 3
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD JAN
PY 2020
VL 30
IS 1
AR e2092
DI 10.1002/rmv.2092
EA NOV 2019
PG 11
WC Virology
SC Virology
GA KC6MC
UT WOS:000499010600001
PM 31777997
OA Other Gold
DA 2020-07-08
ER

PT J
AU Silva, S
   Shimizu, JF
   de Oliveira, DM
   de Assis, LR
   Bittar, C
   Mottin, M
   Sousa, BKD
   Mesquita, NCDR
   Regasini, LO
   Rahal, P
   Oliva, G
   Perryman, AL
   Ekins, S
   Andrade, CH
   Goulart, LR
   Sabino-Silva, R
   Merits, A
   Harris, M
   Jardim, ACG
AF Silva, Suely
   Shimizu, Jacqueline Farinha
   de Oliveira, Debora Moraes
   de Assis, Leticia Ribeiro
   Bittar, Cintia
   Mottin, Melina
   de Paula Sousa, Bruna Katiele
   de Moraes Roso Mesquita, Nathalya Cristina
   Regasini, Luis Octavio
   Rahal, Paula
   Oliva, Glaucius
   Perryman, Alexander Luke
   Ekins, Sean
   Andrade, Carolina Horta
   Goulart, Luiz Ricardo
   Sabino-Silva, Robinson
   Merits, Andres
   Harris, Mark
   Gomes Jardim, Ana Carolina
TI A diarylamine derived from anthranilic acid inhibits ZIKV replication
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEPATITIS-C VIRUS; NATURAL-PRODUCTS; DENGUE VIRUS; NS2B-NS3 PROTEASE;
   CRYSTAL-STRUCTURE; HELICASE ACTIVITY; STRUCTURAL BASIS; DRUG DISCOVERY;
   NS3 HELICASE; IN-VITRO
AB Zika virus (ZIKV) is a mosquito-transmitted Flavivirus, originally identified in Uganda in 1947 and recently associated with a large outbreak in South America. Despite extensive efforts there are currently no approved antiviral compounds for treatment of ZIKV infection. Here we describe the antiviral activity of diarylamines derived from anthranilic acid (FAMs) against ZIKV. A synthetic FAM (E3) demonstrated anti-ZIKV potential by reducing viral replication up to 86%. We analyzed the possible mechanisms of action of FAM E3 by evaluating the intercalation of this compound into the viral dsRNA and its interaction with the RNA polymerase of bacteriophage SP6. However, FAM E3 did not act by these mechanisms. In silico results predicted that FAM E3 might bind to the ZIKV NS3 helicase suggesting that this protein could be one possible target of this compound. To test this, the thermal stability and the ATPase activity of the ZIKV NS3 helicase domain (NS3(Hel)) were investigated in vitro and we demonstrated that FAM E3 could indeed bind to and stabilize NS3(Hel).
C1 [Silva, Suely; Shimizu, Jacqueline Farinha; de Oliveira, Debora Moraes; Gomes Jardim, Ana Carolina] Univ Fed Uberlandia, ICBIM, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil.
   [Silva, Suely; Shimizu, Jacqueline Farinha; Bittar, Cintia; Rahal, Paula; Gomes Jardim, Ana Carolina] Sao Paulo State Univ, IBILCE, Sao Jose Do Rio Preto, SP, Brazil.
   [de Assis, Leticia Ribeiro; Regasini, Luis Octavio] Sao Paulo State Univ, IBILCE, Lab Antibiot & Chemotherapeut, Sao Jose Do Rio Preto, SP, Brazil.
   [Mottin, Melina; de Paula Sousa, Bruna Katiele; Andrade, Carolina Horta] Univ Fed Goias, Fac Farm, LabMol Lab Mol Modeling & Drug Design, BR-74605170 Goiania, Go, Brazil.
   [de Moraes Roso Mesquita, Nathalya Cristina; Oliva, Glaucius] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil.
   [Perryman, Alexander Luke] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA.
   [Perryman, Alexander Luke] Repare Therapeut, 7210 Rue Frederick Banting,Suite 100, Montreal, PQ H4S 2A1, Canada.
   [Ekins, Sean] Collaborat Pharmaceut Inc, 840 Main Campus Dr,Lab 3510, Raleigh, NC 27606 USA.
   [Goulart, Luiz Ricardo] Univ Fed Uberlandia, Lab Nanobiotechnol, Uberlandia, MG, Brazil.
   [Sabino-Silva, Robinson] Univ Fed Uberlandia, Integrat Physiol & Salivary Nanobiotechnol Grp, Uberlandia, MG, Brazil.
   [Merits, Andres] Univ Tartu, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia.
   [Harris, Mark] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.
   [Harris, Mark] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
RP Jardim, ACG (corresponding author), Univ Fed Uberlandia, ICBIM, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil.; Jardim, ACG (corresponding author), Sao Paulo State Univ, IBILCE, Sao Jose Do Rio Preto, SP, Brazil.
EM jardim@ufu.br
RI Sabino-Silva, Robinson/I-2264-2012; Bittar, Cintia/A-5042-2015; Mottin,
   Melina/D-8700-2016; Jardim, Ana Carolina Gomes/H-3615-2012
OI Sabino-Silva, Robinson/0000-0002-2104-5780; Bittar,
   Cintia/0000-0002-2048-4589; Mottin, Melina/0000-0003-0878-9029; Jardim,
   Ana Carolina Gomes/0000-0002-6348-7923; Ribeiro de Assis,
   Leticia/0000-0001-9869-8934; De Paula Sousa, Bruna
   Katiele/0000-0002-3204-5591
FU Royal Society -Newton Advanced Fellowship [NA 150195]; CNPQ (National
   Counsel of Technological and Scientific Development)National Council for
   Scientific and Technological Development (CNPq) [445021/2014-4];
   CNPq/FAPEG DCR [300508/2017-4, 201710267000063]; FAPEMIG (Minas Gerais
   Research Foundation)Minas Gerais State Research Foundation (FAPEMIG)
   [APQ-00587-14, SICONV 793988/2013]; CAPES (Coordination for the
   Improvement of Higher Education Personnel)CAPES [001]; Brazilian funding
   agency CNPqNational Council for Scientific and Technological Development
   (CNPq) [CNPq-465669/2014-0, 440610/2016-8]; Brazilian funding agency
   CAPESCAPES [CNPq-465669/2014-0, 440610/2016-8]; Brazilian funding agency
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CNPq-465669/2014-04, 40610/2016-8]; Wellcome TrustWellcome Trust
   [096670]; L'Oreal-UNESCO-ABC Para Mulheres na Ciencia; L'Oreal-UNESCO
   International Rising Talents Program; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX We would like to thank the Royal Society -Newton Advanced Fellowship
   (Grant reference NA 150195), CNPQ (National Counsel of Technological and
   Scientific Development -grant 445021/2014-4), CNPq/FAPEG DCR (Grant
   300508/2017-4 and 201710267000063), FAPEMIG (Minas Gerais Research
   Foundation -APQ-00587-14, SICONV 793988/2013) and CAPES (Coordination
   for the Improvement of Higher Education Personnel -Code 001), for
   financial support. The authors thank the Brazilian funding agencies
   CNPq, CAPES and FAPEMIG for providing financial support to the National
   Institute of Science and Technology in Theranostics and
   Nanobiotechnology -INCT-Teranano (CNPq-465669/2014-0;
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-DECIT; Preventing and Combating the Zika
   Virus ##440610/2016-8). Research in the MH laboratory was funded by a
   Wellcome Trust Investigator Award (grant reference 096670). CHA also
   thanks the "L'Oreal-UNESCO-ABC Para Mulheres na Ciencia" and "L'Ore '
   al-UNESCO International Rising Talents Program" for the awards and
   fellowships received. CHA has CNPq productivity fellowship. We also
   thank the computational contribution of the collaborators and volunteers
   of the OpenZika project (http://openzika.ufg.br), as well as the support
   from IBM's World Community Grid team.
CR Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Amines Robert W., 2000, ENCY CHEM TECHNOLOGY, P1
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   CRANCE JM, 1994, ANTIVIR RES, V23, P63, DOI 10.1016/0166-3542(94)90033-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva-Junior EF, 2017, BIOORGAN MED CHEM, V25, P4219, DOI 10.1016/j.bmc.2017.06.049
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Campos GRF, 2017, J GEN VIROL, V98, P1693, DOI 10.1099/jgv.0.000808
   Gniazdowski M, 2005, EXPERT OPIN THER TAR, V9, P471, DOI 10.1517/14728222.9.3.471
   Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hussein HA, 2015, NUCLEIC ACIDS RES, V43, pW436, DOI 10.1093/nar/gkv462
   Huynh K, 2015, CURRENT PROTOCOLS PR, V2015, DOI DOI 10.1002/0471140864.PS1926S79
   Jardim ACG, 2015, ANTIVIR RES, V115, P39, DOI 10.1016/j.antiviral.2014.12.018
   Kitazato K, 2007, DRUG DISCOV THER, V1, P14
   Krawczyk M, 2009, BIOL CHEM, V390, P351, DOI 10.1515/BC.2009.040
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Matsumoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068992
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   NanoTemper Technologies GmbH, 2007, US MAN MON NT 115, P1
   Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nittoli T, 2007, J MED CHEM, V50, P2108, DOI 10.1021/jm061428x
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Robinson WE, 1996, P NATL ACAD SCI USA, V93, P6326, DOI 10.1073/pnas.93.13.6326
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Schrodinger, 2015, PYMOL MOL GRAPHICS S
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Singh P, 2009, BIOORGAN MED CHEM, V17, P3973, DOI 10.1016/j.bmc.2009.04.026
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   Stankiewicz-Drogon A, 2008, BIOORGAN MED CHEM, V16, P8846, DOI 10.1016/j.bmc.2008.08.074
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vrontaki E, 2016, J ENZYM INHIB MED CH, V31, P38, DOI 10.3109/14756366.2014.1003925
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wan ZT, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0088-6
   WHO, 2016, HIST ZIK VIR
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanello PR, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0443-9
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 75
TC 1
Z9 1
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 27
PY 2019
VL 9
AR 17703
DI 10.1038/s41598-019-54169-z
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JQ8TJ
UT WOS:000499210500001
PM 31776405
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rusanen, J
   Toivonen, A
   Hepojoki, J
   Hepojoki, S
   Arikoski, P
   Heikkinen, M
   Vaarala, O
   Ilonen, J
   Hedman, K
AF Rusanen, Juuso
   Toivonen, Anne
   Hepojoki, Jussi
   Hepojoki, Satu
   Arikoski, Pekka
   Heikkinen, Markku
   Vaarala, Outi
   Ilonen, Jorma
   Hedman, Klaus
TI LFRET, a novel rapid assay for anti-tissue transglutaminase antibody
   detection
SO PLOS ONE
LA English
DT Article
ID ADULT CELIAC-DISEASE; DIAGNOSIS; GUIDELINES; MANAGEMENT; HLA-DQB1;
   SOCIETY
AB The diagnosis of celiac disease (CD) is currently based on serology and intestinal biopsy, with detection of anti-tissue transglutaminase (tTG) IgA antibodies recommended as the first-line test. Emphasizing the increasing importance of serological testing, new guidelines and evidence suggest basing the diagnosis solely on serology without confirmatory biopsy. Enzyme immunoassays (EIAs) are the established approach for anti-tTG antibody detection, with the existing point-of-care (POC) tests lacking sensitivity and/or specificity. Improved POC methods could help reduce the underdiagnosis and diagnostic delay of CD. We have previously developed rapid homogenous immunoassays based on time-resolved Forster resonance energy transfer (TR-FRET), and demonstrated their suitability in serodiagnostics with hanta- and Zika virus infections as models. In this study, we set out to establish a protein L-based TR-FRET assay (LFRET) for the detection of anti-tTG antibodies. We studied 74 patients with biopsy-confirmed CD and 70 healthy controls, with 1) the new tTG-LFRET assay, and for reference 2) a well-established EIA and 3) an existing commercial POC test. IgG depletion was employed to differentiate between anti-tTG IgA and IgG positivity. The sensitivity and specificity of the first-generation tTG-LFRET POC assay in detection of CD were 87.8% and 94.3%, respectively, in line with those of the reference POC test. The sensitivity and specificity of EIA were 95.9% and 91.9%, respectively. This study demonstrates the applicability of LFRET to serological diagnosis of autoimmune diseases in general and of CD in particular.
C1 [Rusanen, Juuso; Hepojoki, Jussi; Hepojoki, Satu; Hedman, Klaus] Univ Helsinki, Med, Dept Virol, Helsinki, Finland.
   [Toivonen, Anne; Hedman, Klaus] Univ Helsinki, Dept Virol & Immunol, Lab Serv HUSLAB, Helsinki, Finland.
   [Toivonen, Anne; Hedman, Klaus] Helsinki Univ Hosp, Helsinki, Finland.
   [Toivonen, Anne] Univ Eastern Finland, Inst Clin Med, Dept Clin Microbiol, Kuopio, Finland.
   [Hepojoki, Jussi] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland.
   [Arikoski, Pekka] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland.
   [Arikoski, Pekka] Univ Eastern Finland, Kuopio, Finland.
   [Heikkinen, Markku] Kuopio Univ Hosp, Dept Gastroenterol, Kuopio, Finland.
   [Vaarala, Outi] Univ Helsinki, Clinicum, Helsinki, Finland.
   [Ilonen, Jorma] Univ Turku, Inst Biomed, Immunogenet Lab, Turku, Finland.
   [Ilonen, Jorma] Turku Univ Hosp, Clin Microbiol, Turku, Finland.
RP Rusanen, J (corresponding author), Univ Helsinki, Med, Dept Virol, Helsinki, Finland.
EM juuso.rusanen@helsinki.fi
RI ; Hepojoki, Jussi/W-4667-2017
OI Ilonen, Jorma/0000-0002-9973-2062; Hedman, Klaus/0000-0003-1779-7960;
   Rusanen, Juuso/0000-0002-3954-5118; Hepojoki, Jussi/0000-0001-5699-214X
FU Special Research Funds for University Hospitals in Finland; Paivikki and
   Sakari Sohlberg Foundation; Sigrid Juselius FoundationSigrid Juselius
   Foundation; Medical Society of Finland; Magnus Ehrnrooth Foundation;
   Finnish Society of Sciences and Letters; Research Funds of University of
   Helsinki; Academy of FinlandAcademy of Finland [1308613]; Helsinki
   University Hospital
FX This work was funded by Special Research Funds for University Hospitals
   in Finland (to J.I., stm.fi), Paivikki and Sakari Sohlberg Foundation
   (to J.I., pss-saatio.fi), Sigrid Juselius Foundation (to J.I. and K.H.,
   sigridjuselius.fi), Medical Society of Finland (FLS) (to K.H., fls.fi),
   Magnus Ehrnrooth Foundation (to K.H., magnusehrnroothinsaatio.fi),
   Finnish Society of Sciences and Letters (to K.H., scientiarum.fi), and
   the Research Funds of University of Helsinki and Helsinki University
   Hospital (to K.H., hus.fi) and the Academy of Finland (to J.H., grant
   1308613, aka. fi). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Downey L, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4513
   Fuchs V, 2019, ALIMENT PHARM THER, V49, P277, DOI 10.1111/apt.15109
   Fuchs V, 2018, UNITED EUR GASTROENT, V6, P567, DOI 10.1177/2050640617751253
   Gray AM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-105
   Hemmila I, 2005, J FLUORESC, V15, P529, DOI 10.1007/s10895-005-2826-6
   Hepojoki S, 2015, J CLIN MICROBIOL, V53, P636, DOI 10.1128/JCM.02994-14
   Hepojoki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106432
   Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0
   Kareinen L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219474
   Kiviniemi M, 2005, CLIN BIOCHEM, V38, P1015, DOI 10.1016/j.clinbiochem.2005.08.001
   Lebwohl B, 2018, LANCET, V391, P70, DOI 10.1016/S0140-6736(17)31796-8
   Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276
   Lewis NR, 2009, ALIMENT PHARM THER, V31, P73, DOI 10.1111/j.1365-2036.2009.04110.x
   Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578
   Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x
   Norstrom F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-118
   Paarlahti P, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-75
   Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79
   Saraheimo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062739
   Singh P, 2019, J CLIN GASTROENTEROL, V53, P535, DOI 10.1097/MCG.0000000000001081
   Singh P, 2018, CLIN GASTROENTEROL H, V16, P823, DOI 10.1016/j.cgh.2017.06.037
   Trovato CM, 2015, AM J GASTROENTEROL, V110, P1485, DOI 10.1038/ajg.2015.285
   Vavricka SR, 2016, DIGEST LIVER DIS, V48, P1148, DOI 10.1016/j.dld.2016.06.016
NR 23
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 26
PY 2019
VL 14
IS 11
AR e0225851
DI 10.1371/journal.pone.0225851
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LO8RE
UT WOS:000533892300041
PM 31770411
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Apari, P
   Bajer, K
   Brooks, DR
   Molnar, O
AF Apari, Peter
   Bajer, Katalin
   Brooks, Daniel R.
   Molnar, Orsolya
TI Hiding in plain sight: an evolutionary approach to the South American
   Zika outbreak and its future consequences
SO ZOOLOGIA
LA English
DT Article
DE Emerging Infectious Disease; outbreaks; Stockholm Paradigm; Zika virus
ID VIRUS; PARASITES; DIVERSIFICATION; ASSOCIATIONS; COEVOLUTION; GENETICS
AB Emerging Infectious Diseases (EID) pose a world-wide health and socio-economic threat. Accelerating climate change and globalization are exposing unforeseen ways that pathogens cope with their surroundings. The 2015 Zika virus (ZIKV) outbreak was an example of expansion into previously inaccessible fitness spaces, causing a sudden epidemic. Recent studies indicating the subsequent decrease in symptomatic cases means the virus is in remission, currently poses little threat, and therefore can be ignored. We present an evolutionary scenario derived from the Stockholm Paradigm, of oscillating phases of expansion and isolation, accompanied by changes in transmission, persistence, virulence, and pathology. Chief among these is the likelihood that asymptomatic strains are constantly transmitted sexually. This suggests that the currently quiescent virus retains capacities to reemerge abruptly and spread rapidly in an arena of changing opportunity.
C1 [Apari, Peter] Ctr Ecol Res, Evolutionary Syst Res Grp, Tihany, Hungary.
   [Bajer, Katalin; Molnar, Orsolya] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Budapest, Hungary.
   [Brooks, Daniel R.] Univ Nebraska, Univ Nebraska State Museum, Harold W Manter Lab Parasitol, Lincoln, NE USA.
RP Molnar, O (corresponding author), Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Budapest, Hungary.
EM omolnar@caesar.elte.hu
RI Molnar, Orsolya/E-9684-2014
OI Molnar, Orsolya/0000-0002-2458-4659
FU Economic Development and Innovation Operational Programme [GINOP
   2.3.2-15-2016-00057]
FX We thank Eors Szathmary for his support and valuable contributions to
   the study. We also thank the Economic Development and Innovation
   Operational Programme (GINOP 2.3.2-15-2016-00057) for providing funding
   for the study. Funder website: https://www.palyazat.gov.hu/evaluation
CR Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x
   Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x
   Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001
   Ahmad F, 2018, CNS NEUROL DISORD-DR, V17, P78, DOI 10.2174/1871527317666180202115114
   ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Apari P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004111
   Araujo SBL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139225
   Audy JR, 1958, T ROY SOC TROP MED H, V52, P309, DOI [10.1016/0035-9203(58)90045-2, DOI 10.1016/0035-9203(58)90045-2]
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Braga MP, 2018, EVOLUTION, V72, P1773, DOI 10.1111/evo.13557
   Brooks Daniel R., 2019, Current Opinion in Systems Biology, V13, P75, DOI 10.1016/j.coisb.2018.11.001
   Brooks D.R., 2019, STOCKHOLM PARADIGM C
   Brooks DR, 2006, ECOLOGY, V87, pS76, DOI 10.1890/0012-9658(2006)87[76:EFAADO]2.0.CO;2
   Brooks DR, 2014, COMP PARASITOL, V81, P155, DOI 10.1654/4724b.1
   BROOKS DR, 2002, NATURE DIVERSITY EVO
   Budhwani M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00322
   Chakhtoura N, 2018, CURR OPIN OBSTET GYN, V30, P116, DOI 10.1097/GCO.0000000000000440
   Cohen J, 2018, SCIENCE, V361, P1055, DOI 10.1126/science.361.6407.1055
   Darwin C, 1872, ORIGIN SPECIES
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dodson BL, 2018, PEERJ, V6, DOI 10.7717/peerj.4324
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erwin T.L., 1981, P159
   Ewald PW, 2004, INFECT DIS CLIN N AM, V18, P1, DOI 10.1016/S0891-5520(03)00099-0
   Ferdousi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43651-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Halas D, 2005, J BIOGEOGR, V32, P249, DOI 10.1111/j.1365-2699.2004.01147.x
   Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x
   Hoberg EP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0553
   Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4
   Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203
   JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565
   Silva JVJ, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759021, 10.1590/s1678-9946201759021]
   Limonta D, 2019, J INFECT DIS, V220, P1377, DOI 10.1093/infdis/jiz073
   MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Provine WB, 2004, GENETICS, V167, P1041
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   THOMPSON JN, 1994, COEVOLUTIONARY PROCE
   Vianna P, 2018, NEUROIMMUNOMODULAT, V25, P320, DOI 10.1159/000495660
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
NR 54
TC 0
Z9 0
U1 4
U2 5
PU SOC BRASILEIRA ZOOLOGIA, UNIV FEDERAL PARANA
PI CURITIBA
PA CAIXA POSTAL 19020, CURITIBA, PARANA 81531-980, BRAZIL
SN 1984-4689
J9 ZOOLOGIA-CURITIBA
JI Zoologia
PD NOV 26
PY 2019
VL 36
AR e36272
DI 10.3897/zoologia.36.e36272
PG 7
WC Zoology
SC Zoology
GA JQ7DS
UT WOS:000499102100001
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Choudhry, H
   Alzahrani, FA
   Hassan, MA
   Alghamdi, A
   Abdulaal, WH
   Bakhrebah, MA
   Zamzami, MA
   Helmi, N
   Bokhari, FF
   Zeyadi, M
   Baothman, OA
   Kamal, MA
   Warsi, MK
   Ali, A
   Jarullah, B
   Jamal, MS
AF Choudhry, Hani
   Alzahrani, Faisal A.
   Hassan, Mohammed A.
   Alghamdi, Asma
   Abdulaal, Wesam H.
   Bakhrebah, Muhammed A.
   Zamzami, Mazin A.
   Helmi, Nawal
   Bokhari, Fawzi F.
   Zeyadi, Mustafa
   Baothman, Othman A.
   Kamal, Mohammad A.
   Warsi, Mohiuddin K.
   Ali, Ashraf
   Jarullah, Bushra
   Jamal, Mohammad S.
TI Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID GENETIC ALGORITHM; NS2B-NS3 PROTEASE; VALIDATION; BINDING; DESIGN
AB Zika flavivirus is suspected to cause Guillain-Barre syndrome in adults and microcephaly, along with other congenital abnormalities in infants. Presently, no vaccines or therapeutics are available. Here, we report novel compounds identified by high-throughput virtual screening of Maybridge chemical database and molecular docking studies. We selected viral enzyme NS2B/NS3 serine protease as the therapeutic target because of its important role in viral replication. We selected seven potential compounds as antiviral drug candidates because of their high GOLD fitness score, high AutoDock Vina score, or X-Score binding energy and analyzed the strength of molecular interactions between the active site amino acids and selected compounds. Our study also provides a foundation for similar studies for the search of novel therapeutics against Zika virus.
C1 [Choudhry, Hani; Alzahrani, Faisal A.; Hassan, Mohammed A.; Alghamdi, Asma; Abdulaal, Wesam H.; Zamzami, Mazin A.; Helmi, Nawal; Zeyadi, Mustafa; Baothman, Othman A.] King Abdulaziz Univ, Canc Metab & Epigenet Unit, King Fahd Med Res Ctr, Dept Biochem,Fac Sci,Canc & Mutagenesis Un, Jeddah 21589, Saudi Arabia.
   [Alzahrani, Faisal A.] King Abdulaziz Univ, Dept Biol Sci, Rabigh Coll Sci & Arts, Rabigh Campus, Jeddah, Saudi Arabia.
   [Bakhrebah, Muhammed A.] KACST, Life Sci & Environm Res Inst, Natl Ctr Genome Technol, Riyadh 12371, Saudi Arabia.
   [Helmi, Nawal] Univ Jeddah, Dept Appl Biochem, Fac Sci, Jeddah, Saudi Arabia.
   [Bokhari, Fawzi F.] Armed Forces Hosp, Ctr Hlth Studies, At Taif, Taif Region, Saudi Arabia.
   [Kamal, Mohammad A.; Warsi, Mohiuddin K.] Univ Jeddah, Dept Biochem, Fac Sci, Jeddah, Saudi Arabia.
   [Kamal, Mohammad A.; Warsi, Mohiuddin K.] Univ Jeddah, Ctr Sci & Med Res, Jeddah, Saudi Arabia.
   [Ali, Ashraf; Jamal, Mohammad S.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia.
   [Ali, Ashraf] Univ Foggia, Dept Sci Agr Food & Environm SAFE, Via Napoli 25, I-71122 Foggia, Italy.
   [Jarullah, Bushra] Kadi Sarva Vishwavidyalaya, Dept Biotechnol, Gandhinagar, Gujrat, India.
RP Choudhry, H (corresponding author), King Abdulaziz Univ, Canc Metab & Epigenet Unit, King Fahd Med Res Ctr, Dept Biochem,Fac Sci,Canc & Mutagenesis Un, Jeddah 21589, Saudi Arabia.; Kamal, MA (corresponding author), Univ Jeddah, Dept Biochem, Fac Sci, Jeddah, Saudi Arabia.; Kamal, MA (corresponding author), Univ Jeddah, Ctr Sci & Med Res, Jeddah, Saudi Arabia.
EM hchoudhry@kau.edu.sa; faahalzahrani@kau.edu.sa; maah3512@gmail.com;
   starquaint2007@hotmail.com; whabdulaal@kau.edu.sa;
   mbakhrbh@kacst.edu.sa; mzamzami@kau.edu.sa; nahelmy@kau.edu.sa;
   fawzi_bokhari@hotmail.com; mzyadi@kau.edu.sa; oabaothman@kau.edu.sa;
   makamal@uj.edu.sa; mwarsi@uj.edu.sa; ashrafbiochem@gmail.com;
   bjarullah@gmail.com; msjamal@kau.edu.sa
RI Kamal, Mohammad Amjad/J-2918-2014; Helmi, Nawal/E-7049-2016
OI Kamal, Mohammad Amjad/0000-0003-0088-0565; Helmi,
   Nawal/0000-0001-5460-1440
FU King Abdulaziz City for Science and Technology; Deanship of Scientific
   Research, King Abdulaziz University
FX This work was supported by King Abdulaziz City for Science and
   Technology and Deanship of Scientific Research, King Abdulaziz
   University.
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Danishuddin M, 2014, J BIOMOL STRUCT DYN, V32, P741, DOI 10.1080/07391102.2013.789988
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Lima WEA, 2016, LETT DRUG DES DISCOV, V13, P360, DOI 10.2174/1570180812666150918191550
   DeLano W. L., 2002, PYMOL DELANO SCI
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Goncalves AD, 2014, J BIOMOL STRUCT DYN, V32, P301, DOI 10.1080/07391102.2013.765361
   Higgs S, 2016, T ROY SOC TROP MED H, V110, P207, DOI 10.1093/trstmh/trw020
   Hill ME, 2018, ACS CHEM BIOL, V13, P2398, DOI 10.1021/acschembio.8b00508
   JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9
   Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li HD, 2019, NEURON, V101, P1089, DOI 10.1016/j.neuron.2019.01.010
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nagpal I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030305
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Rohini K, 2019, APPL BIOCHEM BIOTECH, V187, P194, DOI 10.1007/s12010-018-2814-3
   Sakkiah S, 2012, J BIOMOL STRUCT DYN, V30, P235, DOI 10.1080/07391102.2012.680026
   Torres JR, 2016, INT J INFECT DIS, V51, P123, DOI 10.1016/j.ijid.2016.09.001
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Wade R C, 1989, Prog Clin Biol Res, V289, P433
   Wadood A, 2013, OA DRUG DES DELIV, V1, P1, DOI DOI 10.13172/2054-4057-1-1-1119
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
NR 46
TC 0
Z9 0
U1 1
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD NOV 22
PY 2019
VL 2019
AR 3947245
DI 10.1155/2019/3947245
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA JT2BX
UT WOS:000500802300004
PM 31886207
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Williams, NA
   Villachan-Lyra, P
   Marvin, C
   Chaves, E
   Hollist, C
   Hatton-Bowers, H
   Barbosa, LNF
AF Williams, Natalie A.
   Villachan-Lyra, Pompeia
   Marvin, Christine
   Chaves, Emmanuelle
   Hollist, Cody
   Hatton-Bowers, Holly
   Barbosa, Leopoldo Nelson F.
TI Anxiety and depression among caregivers of young children with
   Congenital Zika Syndrome in Brazil
SO DISABILITY AND REHABILITATION
LA English
DT Article; Early Access
DE Children; Zika; parents; psychological adaptation; caregiving
ID QUALITY-OF-LIFE; VIRUS-INFECTION; MATERNAL DEPRESSION; MENTAL-HEALTH;
   PARENTS; MOTHERS; INVENTORY; INFANTS; DISABILITIES; VALIDATION
AB Purpose: To examine the psychological well-being of primary caregivers of infants and toddlers with Congenital Zika Syndrome (CZS), and the roles of family resources, parenting stress, and coping strategies in caregivers' adaptation. Materials and methods: Family caregivers (N = 50) of children with CZS who were receiving treatment at a rehabilitation hospital in Recife, Brazil participated a cross-sectional survey study. Caregivers completed measures of anxiety and depression, coping strategies, family resources, and parenting stress. Results: Mild to severe symptoms of depression were identified in 40% of caregivers and were a more prominent concern than symptoms of anxiety. Fewer family resources and high levels of parenting stress were significantly associated with both anxiety and depression. The association between parenting stress and depression was moderated by coping, such that parenting stress was associated with higher caregiver depression at low but not high levels of coping strategy use. Conclusions: Practitioners in Brazil should consider the role of family coping and resources as important resilience promoting factors in the development of new programs designed to promote psychological adaptation in caregivers to children with CZS. It is recommended that caregiver mental health support services be integrated into existing early intervention programs targeting children with CZS.
C1 [Williams, Natalie A.; Hollist, Cody; Hatton-Bowers, Holly] Univ Nebraska, Dept Child Youth & Family Studies, 231M Louise Pound Hall,POB 880366, Lincoln, NE 68588 USA.
   [Villachan-Lyra, Pompeia; Chaves, Emmanuelle] Univ Fed Rural Pernambuco, Dept Educ, Recife, PE, Brazil.
   [Marvin, Christine] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA.
   [Barbosa, Leopoldo Nelson F.] Fac Pernambucana Saude, Dept Psychol, Recife, PE, Brazil.
RP Williams, NA (corresponding author), Univ Nebraska, Dept Child Youth & Family Studies, 231M Louise Pound Hall,POB 880366, Lincoln, NE 68588 USA.
EM nwilliams17@unl.edu
RI ; Barbosa, Leopoldo/V-2869-2018
OI Williams, Natalie/0000-0002-3208-1672; Chaves,
   Emmanuelle/0000-0002-4097-4470; Barbosa, Leopoldo/0000-0002-0856-8915
FU University of Nebraska-Lincoln; Fundacao Maria Cecilia Souto Vidigal
   (FMCSV) through its collaborative Pilot Impact Program
FX Funding for this project was provided by the University of
   Nebraska-Lincoln and the Fundacao Maria Cecilia Souto Vidigal (FMCSV)
   through its collaborative Pilot Impact Program.
CR Abidin RR, 2012, PARENTING STRESS IND
   Aiello Camila Piccini, 2014, Rev. CEFAC, V16, P413, DOI 10.1590/1982-0216201417612
   Alvarez SL, 2015, INFANT YOUNG CHILD, V28, P72, DOI 10.1097/IYC.0000000000000024
   [Anonymous], 2018, MMWR-MORBID MORTAL W, V67, P858
   Antonak R F, 1991, Int J Rehabil Res, V14, P13, DOI 10.1097/00004356-199103000-00002
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Barroso NE, 2016, PSYCHOL ASSESSMENT, V28, P1331, DOI 10.1037/pas0000257
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Beck A.T., 1996, MANUAL BECK DEPRESSI
   BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Carpentier MY, 2006, CHILD HEALTH CARE, V35, P141, DOI 10.1207/s15326888chc3502_3
   Carvalho Cd, 2018, BIOSCI J, V34, P1422
   Chambers HG, 2015, PHYS MED REH CLIN N, V26, P1, DOI 10.1016/j.pmr.2014.09.004
   Collins PY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002393
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   de Souza LEC, 2018, J CHILD FAM STUD, V27, P1207, DOI 10.1007/s10826-017-0969-0
   Cunha J. A., 2001, MANUAL VERSAO PORTUG
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Don BP, 2014, ANXIETY STRESS COPIN, V27, P633, DOI 10.1080/10615806.2014.903473
   Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83
   Dunst C. J, 2016, HDB EARLY CHILDHOOD, P37, DOI DOI 10.1007/978-3-319-28492-7
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freire IM, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00176217, 10.1590/0102-311x00176217]
   Frishman N, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0612-1
   GELFAND DM, 1990, CLIN PSYCHOL REV, V10, P329, DOI 10.1016/0272-7358(90)90065-I
   Oliveira SJGD, 2017, ARCH WOMEN MENT HLTH, V20, P473, DOI 10.1007/s00737-017-0724-y
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Gomes-Oliveira MH, 2012, REV BRAS PSIQUIATR, V34, P389, DOI 10.1016/j.rbp.2012.03.005
   Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1
   Hatzmann J, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-72
   Hayes A. F., 2018, INTRO MEDIATION MODE
   Isa SNI, 2016, ASIAN J PSYCHIATR, V23, P71, DOI 10.1016/j.ajp.2016.07.007
   Kazak AE, 2006, J PEDIATR PSYCHOL, V31, P343, DOI 10.1093/jpepsy/jsj054
   Kotzky K, 2019, J DEV BEHAV PEDIATR, V40, P344, DOI 10.1097/DBP.0000000000000666
   Kuo DZ, 2011, ARCH PEDIAT ADOL MED, V165, P1020, DOI 10.1001/archpediatrics.2011.172
   Kuper H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030514
   Lindo EJ, 2016, FAM RELAT, V65, P207, DOI 10.1111/fare.12185
   McClung N, 2018, CONGENIT HEART DIS, V13, P554, DOI 10.1111/chd.12605
   McCubbin HI, 2000, MEAS CLIN PRACT SOUR, V1, P294
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moraes EV, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2157-9
   Mullins LL, 2015, FAM RELAT, V64, P176, DOI 10.1111/fare.12104
   Mung'ala-Odera V, 2004, NEUROEPIDEMIOLOGY, V23, P67, DOI 10.1159/000073977
   Muscara F, 2015, EUR PSYCHIAT, V30, P555, DOI 10.1016/j.eurpsy.2014.12.008
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Osorio FD, 2011, INT J PSYCHIAT CLIN, V15, P255, DOI 10.3109/13651501.2011.605955
   Pinquart M, 2019, J PEDIATR PSYCHOL, V44, P139, DOI 10.1093/jpepsy/jsy075
   Raina Parminder, 2004, BMC Pediatr, V4, P1, DOI 10.1186/1471-2431-4-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Secretaria de Vigilancia em Saude, 2019, 50 MIN SAUD, V8
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   Singer GHS, 2006, AM J MENT RETARD, V111, P155, DOI 10.1352/0895-8017(2006)111[155:MOCSOD]2.0.CO;2
   Tabachnick BG, 2013, USING MULTIVARIATE S
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Van Horn ML, 2001, J PSYCHOEDUC ASSESS, V19, P54, DOI 10.1177/073428290101900104
   Wang M, 2004, RES PRACT PERS SEV D, V29, P82, DOI 10.2511/rpsd.29.2.82
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   Youngblut JM, 2008, J HEAD TRAUMA REHAB, V23, P92, DOI 10.1097/01.HTR.0000314528.85758.30
NR 64
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-8288
EI 1464-5165
J9 DISABIL REHABIL
JI Disabil. Rehabil.
DI 10.1080/09638288.2019.1692252
EA NOV 2019
PG 10
WC Rehabilitation
SC Rehabilitation
GA JP2FF
UT WOS:000498085000001
PM 31760845
DA 2020-07-08
ER

PT J
AU Lull, RB
   Akin, H
   Hallman, WK
   Brossard, D
   Jamieson, KH
AF Lull, Robert B.
   Akin, Heather
   Hallman, William K.
   Brossard, Dominique
   Jamieson, Kathleen Hall
TI Modeling Risk Perceptions, Benefit Perceptions, and Approval of
   Releasing Genetically Engineered Mosquitoes as a Response to Zika Virus
SO ENVIRONMENTAL COMMUNICATION-A JOURNAL OF NATURE AND CULTURE
LA English
DT Article; Early Access
DE GMO; risk perception; genetic engineering; Zika; risk communication;
   structural equation modeling
ID AEDES-AEGYPTI; TRUST; KNOWLEDGE; ACCEPTANCE; ATTITUDES; SUPPORT;
   TRANSMISSION; PLANT; FOOD
AB Public opinion regarding genetic control of infectious disease vectors such as mosquitoes varies in part because the underlying risk and benefit perceptions about novel gene editing and genetic engineering (GE) techniques are multi-faceted. We designed a survey of the US population (N = 1137) to unpack some of those complexities. Of particular interest was modeling the constituent attitudes and perceptions that contribute to individuals' approval or disapproval of releasing GE mosquitoes to prevent the spread of Zika virus, including deference to scientific authority, Zika issue involvement, Zika concern, Zika knowledge, GE food approval, GE mosquito risk perceptions, and GE mosquito benefit perceptions. Deference to scientific authority and GE mosquito benefit perceptions had the largest influences on GE mosquito approval, while several other concepts had smaller influences. We discuss the societal relevance of these findings as well as their relevance to theory and stakeholder communication.
C1 [Lull, Robert B.] Calif State Univ Fresno, Dept Commun, Fresno, CA 93740 USA.
   [Lull, Robert B.; Akin, Heather; Hallman, William K.; Brossard, Dominique; Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA.
   [Akin, Heather] Univ Nebraska, Dept Agr Leadership Educ & Commun, Lincoln, NE USA.
   [Hallman, William K.] Rutgers State Univ, Dept Human Ecol, New Brunswick, NJ USA.
   [Brossard, Dominique] Univ Wisconsin, Dept Life Sci Commun, Madison, AL USA.
RP Lull, RB (corresponding author), Calif State Univ Fresno, Dept Commun, Fresno, CA 93740 USA.; Lull, RB (corresponding author), Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA.
EM lull@mail.fresnostate.edu
RI Hallman, William/G-3591-2017
OI Hallman, William/0000-0002-4524-9876; Brossard,
   Dominique/0000-0002-9188-8388
CR Adalja Amesh, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.1c39ec05a743d41ee39391ed0f2ed8d3
   Akin H, 2019, J RESPONSIBLE INNOV, V6, P50, DOI 10.1080/23299460.2018.1495026
   Alleyne O. E., 2017, MOSQUITO CONTROL CAP
   Allison PD, 2003, J ABNORM PSYCHOL, V112, P545, DOI 10.1037/0021-843X.112.4.545
   Amin L, 2015, SCI ENG ETHICS, V21, P655, DOI 10.1007/s11948-014-9557-5
   [Anonymous], 2016, GENETICALLY ENG CROP
   Atkins K., 2016, MIAMI HERALD
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]
   Barrera R, 2019, J MED ENTOMOL, V56, P1033, DOI 10.1093/jme/tjz009
   Bearth A, 2016, TRENDS FOOD SCI TECH, V49, P14, DOI 10.1016/j.tifs.2016.01.003
   Binder AR, 2016, RISK ANAL, V36, P831, DOI 10.1111/risa.12462
   Blancke S, 2015, TRENDS PLANT SCI, V20, P414, DOI 10.1016/j.tplants.2015.03.011
   Bostick T., 2017, SOC RISK AN POL FOR
   Bostrom A., 2018, PSYCHOL ASPECTS RISK, P251, DOI [10.1007/978-3-319-92478-6, DOI 10.1007/978-3-319-92478-6]
   Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Brossard D., 2003, MASS COMMUNICATION S, V6, P291, DOI DOI 10.1207/S15327825MCS0603_
   Brossard D, 2007, INT J PUBLIC OPIN R, V19, P24, DOI 10.1093/ijpor/edl003
   Brossard D, 2012, ROLE OF BIOTECHNOLOGY IN A SUSTAINABLE FOOD SUPPLY, P17
   Cacciatore MA, 2018, PUBLIC UNDERST SCI, V27, P11, DOI 10.1177/0963662516661090
   Carvalho DO, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P409
   Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875
   Chen NTN, 2015, RISK ANAL, V35, P1268, DOI 10.1111/risa.12348
   Connor M, 2010, SCI COMMUN, V32, P514, DOI 10.1177/1075547009358919
   de Andrade PP, 2016, B WORLD HEALTH ORGAN, V94, P766, DOI 10.2471/BLT.16.173377
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Fielding KS, 2019, INT J WATER RESOUR D, V35, P551, DOI 10.1080/07900627.2017.1419125
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gaskell G, 2004, RISK ANAL, V24, P185, DOI 10.1111/j.0272-4332.2004.00421.x
   Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324
   Hair J.F., 2010, MULTIVARIATE DATA AN
   Hallman W. K, 2002, PUBLIC PERCEPTIONS G
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Heck N, 2016, ENVIRON SCI POLICY, V66, P101, DOI 10.1016/j.envsci.2016.08.009
   Hmielowski JD, 2019, ENVIRON COMMUN, V13, P894, DOI 10.1080/17524032.2018.1500926
   Holbert RL, 2015, J MASS COMMUN Q, V92, P292, DOI 10.1177/1077699015583718
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004648
   Impossible Foods, 2018, IMP BURG
   Johnson BB, 2018, RISK ANAL, V38, P2561, DOI 10.1111/risa.13184
   Kahan DM, 2017, J RISK RES, V20, P1, DOI 10.1080/13669877.2016.1260631
   KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Kenski K, 2006, J BROADCAST ELECTRON, V50, P173, DOI 10.1207/s15506878jobem5002_1
   Kline RB, 2015, PRINCIPLES PRACTICE
   Knight A, 2007, RISK ANAL, V27, P1553, DOI 10.1111/j.1539-6924.2007.00988.x
   Kronberger N, 2012, PUBLIC UNDERST SCI, V21, P174, DOI 10.1177/0963662511400331
   Lamphere JA, 2017, ENVIRON COMMUN, V11, P75, DOI 10.1080/17524032.2016.1198823
   Landrum AR, 2018, JCOM-J SCI COMMUN, V17, DOI 10.22323/2.17020204
   Lavery JV, 2010, TRENDS PARASITOL, V26, P279, DOI 10.1016/j.pt.2010.02.009
   Lull R. B., 2017, OXFORD HDB SCI SCI C, P409
   Marques MD, 2015, PUBLIC UNDERST SCI, V24, P601, DOI 10.1177/0963662514542372
   Marshall JM, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P169
   McComas KA, 2006, J HEALTH COMMUN, V11, P75, DOI 10.1080/10810730500461091
   McComas KA, 2014, APPETITE, V78, P8, DOI 10.1016/j.appet.2014.02.006
   McKeever BW, 2016, MASS COMMUN SOC, V19, P476, DOI 10.1080/15205436.2016.1148172
   Moise I. K., 2018, LOCAL GLOBAL IMPACT, DOI [10.5772/intechopen.76774, DOI 10.5772/INTECHOPEN.76774]
   Moro ML, 2010, INT HEALTH, V2, P223, DOI 10.1016/j.inhe.2010.07.003
   Muthen BO, 2016, REGRESSION MEDIATION
   Muthen L., 2017, MPLUS USERS GUIDE
   National Academies of Sciences Engineering and Medicine, 2017, COMM SCI EFF RES AG
   PERSE EM, 1990, HUM COMMUN RES, V16, P556, DOI 10.1111/j.1468-2958.1990.tb00222.x
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2
   SACHS C, 1987, J CONSUM AFF, V21, P96, DOI 10.1111/j.1745-6606.1987.tb00190.x
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Savadori L, 2004, RISK ANAL, V24, P1289, DOI 10.1111/j.0272-4332.2004.00526.x
   Scheufele D. A., 2011, J SHORENSTEIN CTR PR, V34
   Scheufele DA, 2002, HARV INT J PRESS-POL, V7, P55, DOI 10.1177/1081180X0200700304
   Scheufele DA, 2013, P NATL ACAD SCI USA, V110, P14040, DOI 10.1073/pnas.1213275110
   Sell TK, 2018, RISK ANAL, V38, P2514, DOI 10.1111/risa.12961
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Siegrist M, 2000, RISK ANAL, V20, P195, DOI 10.1111/0272-4332.202020
   Siegrist M, 2000, RISK ANAL, V20, P713, DOI 10.1111/0272-4332.205064
   Song G, 2014, RISK ANAL, V34, P541, DOI 10.1111/risa.12114
   Tallapragada M., 2017, STRAT ENV COMM PREC
   Traill W. B., 2004, AgBioForum, V7, P176
   Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963
   Webb JLA, 2016, LANCET, V388, P556, DOI 10.1016/S0140-6736(16)31225-9
   Winneg KM, 2018, RISK ANAL, V38, P2546, DOI 10.1111/risa.13010
   Wirz CD, 2018, RISK ANAL, V38, P2599, DOI 10.1111/risa.13228
   Xi ZY, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P305
NR 81
TC 0
Z9 0
U1 11
U2 13
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1752-4032
EI 1752-4040
J9 ENVIRON COMMUN
JI Environ. Commun.
DI 10.1080/17524032.2019.1685558
EA NOV 2019
PG 21
WC Communication; Environmental Studies
SC Communication; Environmental Sciences & Ecology
GA JP0AQ
UT WOS:000497935000001
DA 2020-07-08
ER

PT J
AU Pogreba-Brown, K
   Austhof, E
   Okello, A
   Weiss, J
   Lira, R
   Ernst, K
AF Pogreba-Brown, K.
   Austhof, E.
   Okello, A.
   Weiss, J.
   Lira, R.
   Ernst, K.
TI Public perceptions of non-pharmaceutical interventions for influenza and
   mosquito-borne illnesses - a statewide survey in Arizona
SO PERSPECTIVES IN PUBLIC HEALTH
LA English
DT Article; Early Access
DE emergency preparedness and response; influenza; pandemic influenza;
   vector-borne disease
ID WEST-NILE-VIRUS; KNOWLEDGE
AB Aims: We conducted a statewide online survey to understand public knowledge, attitudes, and practices (KAP) related to non-pharmaceutical interventions (NPIs) for mosquito-borne diseases and influenza in Arizona. Method: The survey included knowledge of diseases, major health concerns, and sources of health information and KAP of NPIs for influenza and mosquito-borne diseases. Our team worked with Qualtrics (R), an online survey company, to recruit a representative sample of 1500 adults in Arizona. Results: Of the 1531 respondents who completed the survey, most indicated that chronic conditions were their primary health concern (48%), with the other half split between infectious diseases (25%) and health effects of environmental conditions (26%). The majority (88%) of respondents indicated that they use the Internet to get their health information. Approximately one in eight people reported not emptying standing water and reducing potential mosquito habitats, despite respondents citing them as being the most effective factors in reducing mosquitoes. Regarding specific diseases, about half of the respondents were concerned about West Nile virus and/or Zika virus. Most (85%) people knew the signs and symptoms of influenza and 63% of people reported being likely to get the influenza shot. Those who did not vaccinate (n = 285) reported concerns that the vaccine would make them sick (41%), was ineffective (37%), or others indicated, 'I don't want to' (37%). Conclusion: Overall, respondents were most concerned with chronic conditions and received their information from the Internet. Knowledge about mosquito-borne diseases was low. There were high levels of acceptance and self-reported uptake of the influenza vaccine.
C1 [Pogreba-Brown, K.; Austhof, E.; Ernst, K.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Epidemiol & Biostat, 1295 N Martin Ave,A220,POB 245211, Tucson, AZ 85724 USA.
   [Okello, A.] Govt Resource Ctr, Ohio Coll Med, Columbus, OH USA.
   [Weiss, J.; Lira, R.] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA.
RP Pogreba-Brown, K (corresponding author), Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Epidemiol & Biostat, 1295 N Martin Ave,A220,POB 245211, Tucson, AZ 85724 USA.
EM kpogreba@email.arizona.edu
OI Austhof, Erika/0000-0002-1217-8733
FU Arizona Department of Health Services [ADHS 16-105306]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the Arizona Department of Health Services (grant
   number: ADHS 16-105306).
CR Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208
   Bodner D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155011
   Bults M, 2015, DISASTER MED PUBLIC, V9, P207, DOI 10.1017/dmp.2014.160
   Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810
   Chowell G, 2012, COMPUT MATH METHOD M, DOI 10.1155/2012/914196
   Dickinson K, 2012, VECTOR-BORNE ZOONOT, V12, P886, DOI 10.1089/vbz.2011.0810
   Fox MH, 2006, AM J HEALTH BEHAV, V30, P483, DOI 10.5993/AJHB.30.5.5
   Haenchen SD, 2016, AM J TROP MED HYG, V95, P945, DOI 10.4269/ajtmh.15-0732
   Jones JM, 2016, MMWR-MORBID MORTAL W, V65, P495, DOI 10.15585/mmwr.mm6519a3
   Matthias J, 2014, VECTOR-BORNE ZOONOT, V14, P788, DOI 10.1089/vbz.2014.1664
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Roehrig JT, 2002, CURR TOP MICROBIOL, V267, P223
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Smith SMS, 2015, RESPIROLOGY, V20, P896, DOI 10.1111/resp.12541
   Teasdale E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-589
   US Centers for Disease Control and Prevention, INFL VACC COV SEAS I
   US Centers for Disease Control and Prevention, FIN CUM MAPS DAT W N
   US Centers for Disease Control and Prevention, 2019, CDC VACC PRIC LIST
NR 19
TC 0
Z9 0
U1 4
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1757-9139
EI 1757-9147
J9 PERSPECT PUBLIC HEAL
JI Perspect. Public Health
AR UNSP 1757913919886605
DI 10.1177/1757913919886605
EA NOV 2019
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JP2SJ
UT WOS:000498119200001
PM 31755813
OA Bronze
DA 2020-07-08
ER

PT J
AU Messias, CV
   Lemos, JP
   Cunha, DP
   Vasconcelos, Z
   Raphael, LMS
   Bonaldo, MC
   Cister-Alves, B
   Bou-Habib, DC
   Cotta-de-Almeida, V
   Savino, W
   Mendes-da-Cruz, DA
AF Messias, Carolina, V
   Lemos, Julia P.
   Cunha, Daniela P.
   Vasconcelos, Zilton
   Raphael, Lidiane M. S.
   Bonaldo, Myrna C.
   Cister-Alves, Bruno
   Bou-Habib, Dumith Chequer
   Cotta-de-Almeida, Vinicius
   Savino, Wilson
   Mendes-da-Cruz, Daniella A.
TI Zika virus infects human blood mononuclear cells
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Lymphocytes; Monocytes; Flow cytometry; RT-qPCR
ID MONOCYTES; TARGET
AB Background Zika virus (ZIKV) infection gained public health concern after the 2015 outbreak in Brazil, when microcephaly rates increased in babies born from infected mothers. It was demonstrated that ZIKV causes a congenital Zika virus syndrome, including various alterations in the development of the central nervous system. Although the infection of cells from the nervous system has been well documented, less is known in respect of ZIKV ability to infect immune cells. Herein, we investigated if peripheral blood mononuclear cells (PBMCs), freshly-isolated from healthy donors, could be infected by ZIKV. Methods PBMCs from healthy donors were isolated and cultured in medium with ZIKV strain Rio-U1 (MOI = 0.1). Infection was analyzed by RT-qPCR and flow cytometry. Results We detected the ZIKV RNA in PBMCs from all donors by RT-qPCR analysis. The detection of viral antigens by flow cytometry revealed that PBMC from more than 50% the donors were infected by ZIKV, with CD3(+)CD4(+) T cells, CD3(-)CD19(+) B cells and CD3(+)CD8(+) T cells being, respectively, the most frequently infected subpopulations, followed by CD14(+) monocytes. Additionally, we observed high variability in PBMC infection rates among different donors, either by numbers or type infected cells. Conclusions These findings raise the hypothesis that PBMCs can act as a reservoir of the virus, which may facilitate viral dissemination to different organs, including immune-privileged sites.
C1 [Messias, Carolina, V; Lemos, Julia P.; Cister-Alves, Bruno; Bou-Habib, Dumith Chequer; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Messias, Carolina, V; Lemos, Julia P.; Cister-Alves, Bruno; Bou-Habib, Dumith Chequer; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella A.] Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [Cunha, Daniela P.; Vasconcelos, Zilton] Fundacao Oswaldo Cruz, High Complex Lab, Fernandes Figueira Natl Inst Hlth Mother Infant &, Rio De Janeiro, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Mol Biol Flavivirus, Rio De Janeiro, Brazil.
RP Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Thymus Res, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Sci & Technol Neuroimmunomodulat, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
EM daniareas@yahoo.com.br
RI Mendes-da-Cruz, Daniella/AAN-6644-2020
OI Mendes-da-Cruz, Daniella/0000-0003-3697-1506
FU Oswaldo Cruz Foundation (Fiocruz); Carlos Chagas Filho Foundation for
   Funding Research in the State of Rio de Janeiro (Faperj)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Brazilian National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Brazilian National Coordination for Advancement of
   University Personnel (Capes); Mercosur Fund for Structural Convergence
   (FOCEM) [Mercosur 03/11]
FX This work was funded by the Oswaldo Cruz Foundation (Fiocruz), Carlos
   Chagas Filho Foundation for Funding Research in the State of Rio de
   Janeiro (Faperj), Brazilian National Council for Scientific and
   Technological Development (CNPq), Brazilian National Coordination for
   Advancement of University Personnel (Capes) and Mercosur Fund for
   Structural Convergence (FOCEM-Mercosur 03/11). Additionally, it was
   developed in the framework of the Brazilian National Institute of
   Science and Technology on Neuroimmunomodulation (INCT-NIM). The funding
   body had no role in the design of the study and collection, analysis,
   interpretation of data, nor writing the manuscript.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 18
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 21
PY 2019
VL 19
IS 1
AR 986
DI 10.1186/s12879-019-4622-y
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA JV9WR
UT WOS:000502710700005
PM 31752731
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wei, Y
   Wang, JT
   Song, ZY
   He, YL
   Zheng, ZH
   Fan, PY
   Yang, DZ
   Zhou, GF
   Zhong, DB
   Zheng, XL
AF Wei, Yong
   Wang, Jiatian
   Song, Zhangyao
   He, Yulan
   Zheng, Zihao
   Fan, Peiyang
   Yang, Dizi
   Zhou, Guofa
   Zhong, Daibin
   Zheng, Xueli
TI Patterns of spatial genetic structures in Aedes albopictus (Diptera:
   Culicidae) populations in China
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes albopictus; Microsatellite; Genetic diversity; Population
   structure; Gene flow; Dengue
ID MICROSATELLITE NULL ALLELES; DENGUE VIRUS; ANOPHELES-ARABIENSIS; WESTERN
   KENYA; 1ST RECORD; VECTOR; SOFTWARE; AEGYPTI; PROGRAM; LOCI
AB Background The Asian tiger mosquito, Aedes albopictus, is one of the 100 worst invasive species in the world and the vector for several arboviruses including dengue, Zika and chikungunya viruses. Understanding the population spatial genetic structure, migration, and gene flow of vector species is critical to effectively preventing and controlling vector-borne diseases. Little is known about the population structure and genetic differentiation of native Ae. albopictus in China. The aim of this study was to examine the patterns of the spatial genetic structures of native Ae. albopictus populations, and their relationship to dengue incidence, on a large geographical scale. Methods During 2016-2018, adult female Ae. albopictus mosquitoes were collected by human landing catch (HLC) or human-bait sweep-net collections in 34 localities across China. Thirteen microsatellite markers were used to examine the patterns of genetic diversity, population structure, and gene flow among native Ae. albopictus populations. The correlation between population genetic indices and dengue incidence was also examined. Results A total of 153 distinct alleles were identified at the 13 microsatellite loci in the tested populations. All loci were polymorphic, with the number of distinct alleles ranging from eight to sixteen. Genetic parameters such as PIC, heterozygosity, allelic richness and fixation index (F-ST) revealed highly polymorphic markers, high genetic diversity, and low population genetic differentiation. In addition, Bayesian analysis of population structure showed two distinct genetic groups in southern-western and eastern-central-northern China. The Mantel test indicated a positive correlation between genetic distance and geographical distance (R-2 = 0.245, P = 0.01). STRUCTURE analysis, PCoA and GLS interpolation analysis indicated that Ae. albopictus populations in China were regionally clustered. Gene flow and relatedness estimates were generally high between populations. We observed no correlation between population genetic indices of microsatellite loci in Ae. albopictus populations and dengue incidence. Conclusion Strong gene flow probably assisted by human activities inhibited population differentiation and promoted genetic diversity among populations of Ae. albopictus. This may represent a potential risk of rapid spread of mosquito-borne diseases. The spatial genetic structure, coupled with the association between genetic indices and dengue incidence, may have important implications for understanding the epidemiology, prevention, and control of vector-borne diseases.
C1 [Wei, Yong; Wang, Jiatian; Song, Zhangyao; He, Yulan; Zheng, Zihao; Fan, Peiyang; Yang, Dizi; Zheng, Xueli] Southern Med Univ, Dept Pathogen Biol, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Zhou, Guofa; Zhong, Daibin] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA.
RP Zheng, XL (corresponding author), Southern Med Univ, Dept Pathogen Biol, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
EM zhengxueli2001@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31630011]; Science and Technology Planning Project
   of Guangzhou [201804020084]
FX This work was supported by the National Natural Science Foundation of
   China (No. 31630011) and the Science and Technology Planning Project of
   Guangzhou (No. 201804020084).
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Mendonca BAA, 2014, ACTA TROP, V134, P80, DOI 10.1016/j.actatropica.2014.02.014
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x
   Calvez E, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2319-x
   Campos M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2014-y
   Carvajal TM, 2019, FINE SCALE POPULATIO, DOI [10.1101/561621, DOI 10.1101/561621]
   Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191
   Chapuis MP, 2005, MOL ECOL NOTES, V5, P554, DOI 10.1111/j.1471-8286.2005.00987.x
   CRUZ LCT, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545
   DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92
   Guo YH, 2016, ACTA TROP, V156, P17, DOI 10.1016/j.actatropica.2015.12.011
   Guo YY, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2814-8
   Gutierrez-Bugallo G, 2017, ACTA TROP, V174, P146, DOI 10.1016/j.actatropica.2017.07.012
   Gutierrez-Espeleta Gustavo A., 2000, Conservation Genetics, V1, P3, DOI 10.1023/A:1010125519304
   Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Houe V, 2019, EMERG MICROBES INFEC, V8, P542, DOI 10.1080/22221751.2019.1599302
   Hulce D., 2011, J BIOMOL TECH, V22, pS35, DOI DOI 10.1111/J.1556-4029.2010.01565.X
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   Jiggins FM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002780
   Jing Q, 2019, GLOB HLTH J, V3, P37
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kang S, 2015, J MED ENTOMOL, V52, P1270, DOI 10.1093/jme/tjv114
   Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003
   Lai YH, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0575-4
   LAILLE M, 1990, B SOC PATHOL EXOT, V83, P394
   Lehmann T, 1996, GENETICS, V144, P1155
   Lehmann T, 1997, MOL ECOL, V6, P243, DOI 10.1046/j.1365-294X.1997.00177.x
   Lehmann T, 1996, HEREDITY, V77, P192, DOI 10.1038/hdy.1996.124
   Li RY, 2019, P NATL ACAD SCI USA, V116, P3624, DOI 10.1073/pnas.1806094116
   Li YJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2581-y
   Liu Q., 2016, OPEN J SOCIAL SCI, V4, P172, DOI [10.4236/jss.2016.47027, DOI 10.4236/JSS.2016.47027]
   Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Lynch M, 1999, GENETICS, V152, P1753
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x
   Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119
   Murillo D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050803
   Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159
   Pacidonio EC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2236-z
   PAETKAU D, 1995, MOL ECOL, V4, P519, DOI 10.1111/j.1365-294X.1995.tb00248.x
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Pfeiler E, 2013, SCI WORLD J, DOI 10.1155/2013/724609
   Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502
   Poelchau MF, 2013, PHYSIOL ENTOMOL, V38, P173, DOI 10.1111/phen.12016
   Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200
   Pritchard JK, 2000, GENETICS, V155, P945
   QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349
   QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Sang SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003808
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Saraiva JF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193591
   SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101
   Shaibi T, 2008, MOL ECOL RESOUR, V8, P1034, DOI 10.1111/j.1755-0998.2008.02146.x
   Shapiro LLM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003489
   Si Z, 2010, ADV ENG SOFTW, V41, P962, DOI 10.1016/j.advengsoft.2010.05.007
   SLATKIN M, 1981, GENETICS, V99, P323
   SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Sumi A, 2017, EPIDEMIOL INFECT, V145, P78, DOI 10.1017/S095026881600203X
   Sun JT, 2018, INSECT MOL BIOL, V27, P698, DOI 10.1111/imb.12501
   Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478
   Takezaki N, 1996, GENETICS, V144, P389
   Temu EA, 2005, AM J TROP MED HYG, V73, P726, DOI 10.4269/ajtmh.2005.73.726
   Thongrungkiat S, 2012, SE ASIAN J TROP MED, V43, P1146
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x
   Wondji C, 2005, MOL ECOL, V14, P3683, DOI 10.1111/j.1365-294X.2005.02699.x
   Wu F, 2011, VECTOR-BORNE ZOONOT, V11, P1181, DOI 10.1089/vbz.2010.0032
   Zhang RL, 2018, MITOCHONDRIAL DNA A, V29, P594, DOI 10.1080/24701394.2017.1325481
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
   Zou L, 2018, B MATH BIOL, V80, P2633, DOI 10.1007/s11538-018-0480-9
NR 97
TC 1
Z9 1
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD NOV 21
PY 2019
VL 12
IS 1
AR 552
DI 10.1186/s13071-019-3801-4
PG 15
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JR2PJ
UT WOS:000499473200006
PM 31752961
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Waller, LA
AF Waller, Lance A.
TI The Atlas of Disease: Mapping Deadly Epidemics and Contagion from the
   Plague to the Zika Virus
SO CARTOGRAPHIC JOURNAL
LA English
DT Book Review
C1 [Waller, Lance A.] Emory Univ, Atlanta, GA 30322 USA.
RP Waller, LA (corresponding author), Emory Univ, Atlanta, GA 30322 USA.
OI Waller, Lance/0000-0001-5002-8886
CR HEMPEL S, 2018, ATLAS DISEASE MAPPIN
   Koch Tom, 2005, CARTOGRAPHIES DIS MA
   Waller LA, 2017, MAPPING ACAD, P169
   Wertheim HFL, 2012, ATLAS HUMAN INFECT D
NR 4
TC 0
Z9 0
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0008-7041
EI 1743-2774
J9 CARTOGR J
JI Cartogr. J.
PD JAN 2
PY 2020
VL 57
IS 1
BP 86
EP 86
DI 10.1080/00087041.2019.1688971
EA NOV 2019
PG 1
WC Geography
SC Geography
GA KX6BA
UT WOS:000497713300001
DA 2020-07-08
ER

PT J
AU Robert, MA
   Tinunin, DT
   Benitez, EM
   Luduena-Almeida, FF
   Romero, M
   Stewart-Ibarra, AM
   Estallo, EL
AF Robert, Michael A.
   Tinunin, Daniela T.
   Benitez, Elisabet M.
   Luduena-Almeida, Francisco F.
   Romero, Moory
   Stewart-Ibarra, Anna M.
   Estallo, Elizabet L.
TI Arbovirus emergence in the temperate city of Cordoba, Argentina,
   2009-2018
SO SCIENTIFIC DATA
LA English
DT Article; Data Paper
ID DENGUE; OUTBREAK
AB The distribution of arbovirus disease transmission is expanding from the tropics and subtropics into temperate regions worldwide. The temperate city of Cordoba, Argentina has been experiencing the emergence of dengue virus, transmitted by the mosquito Aedes aegypti, since 2009, when autochthonous transmission of the virus was first recorded in the city. The aim of this work is to characterize the emergence of dengue and related arboviruses (Zika and chikungunya) in Cordoba since 2009. Herein, we present a data set with all known information about transmission of dengue, Zika, and chikungunya viruses in Cordoba, Argentina from 2009-2018, including what information is known of dengue virus (DENV) serotypes in circulation and origins of imported cases. The data presented in this work will assist researchers in investigating drivers of arbovirus emergence and transmission in Cordoba, Argentina and contribute to a better understanding of the global problem of the expanding distribution of arbovirus disease transmission.
C1 [Robert, Michael A.] Univ Sci, Dept Math Phys & Stat, Philadelphia, PA 19104 USA.
   [Tinunin, Daniela T.; Benitez, Elisabet M.; Luduena-Almeida, Francisco F.; Estallo, Elizabet L.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Invest Entomol Cordoba, IIBYT,CONICET, Av Velez Sarsfield 1611,CP X5016GCA,Ciudad Univ, Cordoba Capital, Argentina.
   [Luduena-Almeida, Francisco F.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Catedra Matemat Cs Biol, Av Velez Sarsfield 1611,CP X5016GCA,Ciudad Univ, Cordoba Capital, Argentina.
   [Romero, Moory] SUNY Coll Environm Sci & Forestry, Dept Environm Studies, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] Interamer Inst Global Change Res IAI, Dept Montevideo, Montevideo, Uruguay.
RP Estallo, EL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Invest Entomol Cordoba, IIBYT,CONICET, Av Velez Sarsfield 1611,CP X5016GCA,Ciudad Univ, Cordoba Capital, Argentina.
EM eelizabet@gmail.com
FU United States Embassy in Argentina; CONICETConsejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET); Consejo
   Interuniversitario Nacional (National Interuniversity Council)
FX This work was supported in part by grants awarded to A.M. Stewart-Ibarra
   and M.A. Robert by the United States Embassy in Argentina administered
   through the Fulbright Commission. ELE is a member of the Consejo de
   Investigaciones Cientificas y Tecnologicas (CONICET) from Argentina, EMB
   is a PhD Student with scholarship support from CONICET and DTT is a
   biology undergraduate student with scholarship support from Consejo
   Interuniversitario Nacional (National Interuniversity Council)
   (CIN-https://www.cin.edu.ar/) by the direction of ELE and FFL.
CR Almiron Walter R., 1998, Revista de la Sociedad Entomologica Argentina, V57, P27
   Aviles G, 1999, EMERG INFECT DIS, V5, P575, DOI 10.3201/eid0504.990424
   Censo, 2010, RESULTADOS DEFINITIV
   Direccion general de estadistica y censos Gobierno de la Provincia de Cordoba, 2008, CENS PROV POBL 2008
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Grillet ME, 2019, LANCET INFECT DIS, V19, pE149, DOI 10.1016/S1473-3099(18)30757-6
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Ministerio de Salud, 2009, PLAN NAC PREV CONTR
   Ministerio de Salud y Desarrolo Social, 2018, MIN SAL DES SOC B EP
   Mordecai EA, 2019, ECOL LETT, V22, P1690, DOI 10.1111/ele.13335
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rotela C, 2017, GEOSPATIAL HEALTH, V12, P226, DOI 10.4081/gh.2017.564
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 19
TC 0
Z9 0
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2052-4463
J9 SCI DATA
JI Sci. Data
PD NOV 21
PY 2019
VL 6
AR 276
DI 10.1038/s41597-019-0295-z
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JO7VI
UT WOS:000497782800003
PM 31754110
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Su, KY
   Balasubramaniam, VRMT
AF Su, Kar Yan
   Balasubramaniam, Vinod R. M. T.
TI Zika Virus as Oncolytic Therapy for Brain Cancer: Myth or Reality?
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika; neurotropism; glioblastoma; MSI1; AXL; oncolytic
ID BINDING PROTEIN MUSASHI1; STEM-CELLS; GLIOBLASTOMA-MULTIFORME; MOLECULAR
   PATHOLOGY; INFECTION; AXL; TRANSMISSION; GROWTH; RECEPTORS; OUTBREAK
AB The ability of self-replicating oncolytic viruses (OVs) to preferentially infect and lyse cancer cells while stimulating anti-tumor immunity of the host strongly indicates its value as a new field of cancer therapeutics to be further explored. The emergence of Zika virus (ZIKV) as a global health threat due to its recent outbreak in Brazil has caught the attention of the scientific community and led to the discovery of its oncolytic potential for the treatment of glioblastoma multiforme (GBM), the most common and fatal brain tumor with poor prognosis. Herein, we evaluate the neurotropism of ZIKV relative to the receptor tyrosine kinase AXL and its ligand Gas6 in viral entry and the RNA-binding protein Musashi-1 (MSI1) in replication which are also overexpressed in GBM, suggesting its potential for specific targeting of the tumor. Additionally, this review discusses genetic modifications performed to enhance safety and efficacy of ZIKV as well as speculates future directions for the OV therapy.
C1 [Su, Kar Yan; Balasubramaniam, Vinod R. M. T.] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Malaysia.
   [Su, Kar Yan] Monash Univ Malaysia, Sch Sci, Bandar Sunway, Malaysia.
RP Balasubramaniam, VRMT (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Malaysia.
EM vinod.balasubramaniam@monash.edu
RI Su, Kar Yan/AAK-1653-2020
OI Su, Kar Yan/0000-0001-5527-2036
FU MOE Malaysia [FRGS/1/2018/SKK11/MUSM/02/1]
FX This research was funded by the MOE Malaysia
   FRGS/1/2018/SKK11/MUSM/02/1.
CR Botto-Menezes CHA, 2019, EMERG INFECT DIS, V25, P951, DOI 10.3201/eid2505.180904
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005
   Alimonti JB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0100-y
   Alonso MM, 2012, METHODS MOL BIOL, V797, P111, DOI 10.1007/978-1-61779-340-0_9
   Alvarado AG, 2017, CELL STEM CELL, V20, P450, DOI 10.1016/j.stem.2016.12.001
   Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cassady KA, 2017, MOL THER-ONCOLYTICS, V5, P1, DOI 10.1016/j.omto.2017.02.001
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cheema TA, 2013, P NATL ACAD SCI USA, V110, P12006, DOI 10.1073/pnas.1307935110
   Chen HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09504-7
   Chen HY, 2016, ONCOTARGET, V7, P42485, DOI 10.18632/oncotarget.9890
   Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chiocca EA, 2014, CANCER IMMUNOL RES, V2, P295, DOI 10.1158/2326-6066.CIR-14-0015
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Elshahawi H, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040169
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Hou Lewis C, 2006, Neurosurg Focus, V20, pE5
   Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862
   Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lan L, 2015, MOL ONCOL, V9, P1406, DOI 10.1016/j.molonc.2015.03.014
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin CA, 2016, GENE DEV, V30, P2158, DOI 10.1101/gad.286351.116
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Puzanov I, 2016, J CLIN ONCOL, V34, P2619, DOI 10.1200/JCO.2016.67.1529
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499
   Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289
   Shibata S, 2012, BRAIN RES, V1462, P162, DOI 10.1016/j.brainres.2012.01.068
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187
   Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
   Tham HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01040
   Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WALLNER KE, 1989, INT J RADIAT ONCOL, V16, P1405, DOI 10.1016/0360-3016(89)90941-3
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, 2017, ZIK THEN NOW TOM
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 85
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD NOV 20
PY 2019
VL 10
AR 2715
DI 10.3389/fmicb.2019.02715
PG 8
WC Microbiology
SC Microbiology
GA JT9FR
UT WOS:000501287600001
PM 31824472
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fares-Gusmao, R
   Rocha, BC
   Sippert, E
   Lanteri, MC
   Anez, G
   Rios, M
AF Fares-Gusmao, Rafaelle
   Rocha, Bruno Coelho
   Sippert, Emilia
   Lanteri, Marion C.
   Anez, German
   Rios, Maria
TI Differential Pattern of Soluble Immune Markers in Asymptomatic Dengue,
   West Nile and Zika Virus Infections
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MOBILITY GROUP BOX-1; HEMORRHAGIC-FEVER; DENDRITIC CELLS; 1 PROTEIN;
   CYTOKINE; EXPRESSION; CHEMOKINE; APOPTOSIS; OUTBREAK; CHILDREN
AB Infections with dengue virus (DENV), West Nile virus (WNV) and Zika virus (ZIKV) usually present similar mild symptoms at early stages, and most infections (similar to 80%) are asymptomatic. However, these infections may progress to severe disease with different clinical manifestations. In this study we attempted to identify unique characteristics for each infection at the presymptomatic/asymptomatic stage of infection and compared levels of soluble immune markers that have been shown to be altered during clinical course of these viral infections. Levels of soluble markers were determined by Luminex-based assays or by ELISA in plasma samples from asymptomatic blood donors who were reactive for RNA from DENV (n = 71), WNV (n = 52) or ZIKV (n = 44), and a control or non-infected (NI) group (n = 22). Results showed that even in the absence of symptoms, increased interleukin (IL) levels of IL-12, IL-17, IL-10, IL-5, CXCL9, E-Selectin and ST2/IL-1R4; and decreased levels of IL-13 and CD40 were found in all flavivirus group samples, compared to those from NI donors. DENV-infected donors demonstrated variation in expression of IL-1ra and IL-2; WNV-infected donors demonstrated variation in expression of IL-1ra, P-Selectin, IL-4 and IL-5; ZIKV-infected donors demonstrated variation in expression of IL-1ra, P-Selectin, IL-4, RANK-L, CD40L and C3a. The findings suggest that, even in the presymptomatic/asymptomatic phase of the infection, different immunomodulation profiles were associated with DENV, WNV and ZIKV infections.
C1 [Fares-Gusmao, Rafaelle; Rocha, Bruno Coelho; Sippert, Emilia; Anez, German; Rios, Maria] US FDA, OBRR, CBER, Silver Spring, MD 20993 USA.
   [Lanteri, Marion C.] Blood Syst Res Inst, San Francisco, CA USA.
   [Lanteri, Marion C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Anez, German] Sanofi Pasteur, Swiftwater, PA USA.
RP Rios, M (corresponding author), US FDA, OBRR, CBER, Silver Spring, MD 20993 USA.
EM maria.rios@fda.hhs.gov
RI Rocha, Bruno C/M-6397-2015; Sippert, Emilia Angela/B-3033-2013; Anez,
   German/B-3643-2008
OI Rocha, Bruno C/0000-0003-0118-3913; Sippert, Emilia
   Angela/0000-0002-6341-3879; Anez, German/0000-0001-5361-3001
CR Acharya D, 2017, J VIROL, V91, DOI [10.1128/JVI.01529-16, 10.1128/jvi.01529-16]
   Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565
   Arias J, 2014, VIROLOGY, V452, P42, DOI 10.1016/j.virol.2013.12.027
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC. Centers for Disease Control and Prevention, FIN CUM MAPS DAT 199
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300
   Frank E, 2016, WEKA WORKBENCH ONLIN
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Jadhav M, 2017, OMICS, V21, P665, DOI 10.1089/omi.2017.0135
   John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0
   Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune
   Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Matos D, 2016, TRANSFUSION, V56, P215, DOI 10.1111/trf.13288
   Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307
   Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Pacsa AS, 2000, FEMS IMMUNOL MED MIC, V28, P151, DOI 10.1111/j.1574-695X.2000.tb01470.x
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Qian F, 2014, VIRAL IMMUNOL, V27, P39, DOI 10.1089/vim.2013.0074
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Roe K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00627
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sathupan P, 2007, ANN TROP PAEDIATR, V27, P179, DOI 10.1179/146532807X220280
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6
   Sun PF, 2006, J IMMUNOL, V177, P6497, DOI 10.4049/jimmunol.177.9.6497
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tobler LH, 2008, J INFECT DIS, V198, P979, DOI 10.1086/591466
   Veldhoen M, 2017, NAT IMMUNOL, V18, P612, DOI 10.1038/ni.3742
   Wang HC, 2006, VIRAL IMMUNOL, V19, P3, DOI 10.1089/vim.2006.19.3
   World Health Organization, DENG SEV DENG FACT S
   Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008
NR 55
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 20
PY 2019
VL 9
AR 17172
DI 10.1038/s41598-019-53645-w
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JO6UG
UT WOS:000497712000017
PM 31748599
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gonzales, VGB
   Lichtenberger, P
   Fishman, J
   Siegel, Y
   Ghersin, E
   Hurwitz, BE
   Martinez, C
AF Gonzales, Victor G. Becerra
   Lichtenberger, Paola
   Fishman, Joel
   Siegel, Yoel
   Ghersin, Eduard
   Hurwitz, Barry E.
   Martinez, Claudia
TI Cardiovascular Complications Related to Zika Virus
SO CIRCULATION
LA English
DT Meeting Abstract
CT Scientific Sessions of the American-Heart-Association
CY NOV 16-18, 2019
CL Philadelphia, PA
SP Amer Heart Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD NOV 19
PY 2019
VL 140
SU 1
MA A17256
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA LJ2KE
UT WOS:000529998008077
DA 2020-07-08
ER

PT J
AU Lebov, JF
   Arias, JF
   Balmaseda, A
   Britt, W
   Cordero, JF
   Galvao, LA
   Garces, AL
   Hambidge, KM
   Harris, E
   Ko, A
   Krebs, N
   Marques, ETA
   Martinez, AM
   McClure, E
   Miranda, DB
   Moreira, MEL
   Mussi-Pinhata, MM
   Ochoa, TJ
   Osorio, JE
   Scalabrin, DMF
   Schultz-Cherry, S
   Seage, GR
   Stolka, K
   Ugarte-Gil, CA
   Vega, CMV
   Welton, M
   Ximenes, R
   Zorrilla, C
AF Lebov, Jill F.
   Arias, Juan F.
   Balmaseda, Angel
   Britt, William
   Cordero, Jose F.
   Galvao, Luiz Augusto
   Lucia Garces, Ana
   Hambidge, K. Michael
   Harris, Eva
   Ko, Albert
   Krebs, Nancy
   Marques, Ernesto T. A.
   Martinez, Alexander M.
   McClure, Elizabeth
   Miranda-Filho, Democrito B.
   Lopes Moreira, Maria Elisabeth
   Mussi-Pinhata, Marisa M.
   Ochoa, Theresa J.
   Osorio, Jorge E.
   Scalabrin, Deolinda M. F.
   Schultz-Cherry, Stacey
   Seage, George R., III
   Stolka, Kristen
   Augusto Ugarte-Gil, Cesar
   Vega, Carmen Milagros Velez
   Welton, Michael
   Ximenes, Ricardo
   Zorrilla, Carmen
TI International prospective observational cohort study of Zika in infants
   and pregnancy (ZIP study): study protocol (vol 19, 282, 2019)
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Correction
C1 [Lebov, Jill F.; McClure, Elizabeth; Stolka, Kristen] RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
   [Arias, Juan F.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.
   [Balmaseda, Angel] Complejo Nacl Salud, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Britt, William] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA.
   [Cordero, Jose F.; Welton, Michael] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Galvao, Luiz Augusto] Fiocruz MS, Ctr Global Hlth CRIS, Rio De Janeiro, Brazil.
   [Lucia Garces, Ana] Ctr Amer & Panama INCAP, Fdn Alimentac & Nutr, Guatemala City, Guatemala.
   [Hambidge, K. Michael; Krebs, Nancy] Univ Colorado, Sect Nutr, Pediat, Aurora, CO USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] Fiocruz MS, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Martinez, Alexander M.] Imbanaco Med Ctr, Res Inst, Cali, Colombia.
   [Miranda-Filho, Democrito B.] Univ Pernambuco, Microcephaly Epidem Res Grp, PPGCS, Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Mussi-Pinhata, Marisa M.] Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Seage, George R., III] Harvard Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Vega, Carmen Milagros Velez] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Ximenes, Ricardo] Univ Fed Pernambuco, Microcephaly Epidem Res Grp, Dept Med Trop, Recife, PE, Brazil.
   [Zorrilla, Carmen] Maternal Infant Studies Ctr CEMI, San Juan, PR USA.
RP Lebov, JF (corresponding author), RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
EM jlebov@rti.org
RI Marques, Ernesto T. A/L-4967-2013; Ugarte-Gil, Cesar/E-6074-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Ugarte-Gil,
   Cesar/0000-0002-2833-9087; McClure, Elizabeth/0000-0001-8659-5444;
   Galvao, Luiz Augusto/0000-0002-3918-0286
FU NIMH NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R25 MH083617]
CR Lebov JF, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2430-4
NR 1
TC 1
Z9 1
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD NOV 19
PY 2019
VL 19
IS 1
AR 423
DI 10.1186/s12884-019-2589-8
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE3OE
UT WOS:000508467800004
PM 31744466
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Denes, A
   Ibrahim, MA
   Oluoch, L
   Tekeli, M
   Tekeli, T
AF Denes, Attila
   Ibrahim, Mahmoud A.
   Oluoch, Lillian
   Tekeli, Miklos
   Tekeli, Tamas
TI Impact of weather seasonality and sexual transmission on the spread of
   Zika fever
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; REPRODUCTIVE NUMBER; VIRUS OUTBREAK; DISEASE;
   EPIDEMICS; MODELS
AB We establish a compartmental model to study the transmission of Zika virus disease including spread through sexual contacts and the role of asymptomatic carriers. To incorporate the impact of the seasonality of weather on the spread of Zika, we apply a nonautonomous model with time-dependent mosquito birth rate and biting rate, which allows us to explain the differing outcome of the epidemic in different countries of South America: using Latin Hypercube Sampling for fitting, we were able to reproduce the different outcomes of the disease in various countries. Sensitivity analysis shows that, although the most important factors in Zika transmission are the birth rate of mosquitoes and the transmission rate from mosquitoes to humans, spread through sexual contacts also highly contributes to the transmission of Zika virus: our study suggests that the practice of safe sex among those who have possibly contracted the disease, can significantly reduce the number of Zika cases.
C1 [Denes, Attila; Ibrahim, Mahmoud A.; Oluoch, Lillian; Tekeli, Miklos; Tekeli, Tamas] Univ Szeged, Bolyai Inst, Aradi Vertanuk Tere 1, H-6720 Szeged, Hungary.
   [Ibrahim, Mahmoud A.] Mansoura Univ, Fac Sci, Dept Math, Mansoura 35516, Egypt.
RP Denes, A (corresponding author), Univ Szeged, Bolyai Inst, Aradi Vertanuk Tere 1, H-6720 Szeged, Hungary.
EM denesa@math.u-szeged.hu
RI Ibrahim, Mahmoud/M-5163-2018
OI Ibrahim, Mahmoud/0000-0003-0258-2019
FU Janos Bolyai Research Scholarship of the Hungarian Academy of
   SciencesHungarian Academy of Sciences [128363]; National Research,
   Development and Innovation Fund of Hungary [PD_18, FK_17]; Egyptian
   government in the long-term mission system [124016]
FX A. Denes was supported by the Janos Bolyai Research Scholarship of the
   Hungarian Academy of Sciences, by the project no. 128363, implemented
   with the support provided from the National Research, Development and
   Innovation Fund of Hungary, financed under the PD_18 funding scheme. M.
   A. Ibrahim was supported by a fellowship from the Egyptian government in
   the long-term mission system. T. Tekeli was supported by the project no.
   124016, implemented with the support provided from the National
   Research, Development and Innovation Fund of Hungary, financed under the
   FK_17 funding scheme. The authors are grateful to the anonymous
   reviewers for their insightful and constructive comments and suggestions
   which helped to improve the paper.
CR Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2016, UNIVERSO        0714
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Centers for Disease Control and Prevention, 1 FEM TO MAL SEX TRA
   Centers for Disease Control and Prevention, CLIN GUID HEALTHC PR
   Chen J, 2018, J THEOR BIOL, V455, P342, DOI 10.1016/j.jtbi.2018.07.026
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cruz-Pacheco G, 2019, J BIOL SYST, V27, P83, DOI 10.1142/S0218339019500050
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Guzzetta G., 2016, EUROSURVEILLANCE, V21, P15
   Guzzetta G, 2015, J THEOR BIOL, V380, P238, DOI 10.1016/j.jtbi.2015.05.031
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Marini G., 2017, EUROSURVEILLANCE, V22, P37
   MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Ministerio de Salud Costa Rica, 2018, MIN SAL B
   Mitchell C, 2017, B MATH BIOL, V79, P1846, DOI 10.1007/s11538-017-0309-y
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Okuneye KO, 2017, J BIOL SYST, V25, P545, DOI 10.1142/S0218339017400046
   Padmanabhan P., 2017, LETT BIOMATHEMATICS, V4, P148, DOI DOI 10.1080/23737867.2017.1319746
   Pan American Health Organization, COUNTR TERR AUT TRAN
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Saad-Roy CM, 2018, J MATH BIOL, V77, P1917, DOI 10.1007/s00285-018-1230-1
   Saad-Roy CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2076-z
   Sasmal SK, 2018, B MATH BIOL, V80, P3038, DOI 10.1007/s11538-018-0510-7
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Suparit P, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0083-z
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Wang WD, 2008, J DYN DIFFER EQU, V20, P699, DOI 10.1007/s10884-008-9111-8
   World Health Organization, 2018, WHO LIST BLUEPR PRIO
NR 55
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 19
PY 2019
VL 9
AR 17055
DI 10.1038/s41598-019-53062-z
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JO6QJ
UT WOS:000497701800012
PM 31745123
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Wassenaar, TM
   Jun, SR
   Robeson, M
   Ussery, DW
AF Wassenaar, Trudy M.
   Jun, Se-Ran
   Robeson, Michael
   Ussery, David W.
TI Comparative genomics of hepatitis A virus, hepatitis C virus, and
   hepatitis E virus provides insights into the evolutionary history of
   Hepatovirus species
SO MICROBIOLOGYOPEN
LA English
DT Article
DE codon bias; comparative genomics; evolution; Hepactovirus A; hepatitis A
   virus
ID CODON USAGE; NUCLEOTIDE-SEQUENCE; MOLECULAR EVOLUTION; POPULATIONS;
   EPIDEMIOLOGY; NOMENCLATURE; SELECTION; GENOTYPES; SUBTYPES; RATES
AB The intraspecies genomic diversity of the single-strand RNA (+) virus species hepatitis A virus (Hepatovirus), hepatitis C virus (Hepacivirus), and hepatitis E virus (Orthohepevirus) was compared. These viral species all can cause liver inflammation (hepatitis), but share no gene similarity. The codon usage of human hepatitis A virus (HAV) is suboptimal for replication in its host, a characteristic it shares with taxonomically related rodent, simian, and bat hepatitis A virus species. We found this codon usage to be strikingly similar to that of Triatoma virus that infects blood-sucking kissing bugs. The codon usage of that virus is well adapted to its insect host. The codon usage of HAV is also similar to other invertebrate viruses of various taxonomic families. An evolutionary ancestor of HAV and related virus species is hypothesized to be an insect virus that underwent a host jump to infect mammals. The similarity between HAV and invertebrate viruses goes beyond codon usage, as they also share amino acid composition characteristics, while not sharing direct sequence homology. In contrast, hepatitis C virus and hepatitis E virus are highly similar in codon usage preference, nucleotide composition, and amino acid composition, and share these characteristics with Human pegivirus A, West Nile virus, and Zika virus. We present evidence that these observations are only partly explained by differences in nucleotide composition of the complete viral codon regions. We consider the combination of nucleotide composition, amino acid composition, and codon usage preference suitable to provide information on possible evolutionary similarities between distant virus species that cannot be investigated by phylogeny.
C1 [Wassenaar, Trudy M.] Mol Microbiol & Genom Consultants, Tannenstr 7, D-55576 Zotzenheim, Germany.
   [Jun, Se-Ran; Robeson, Michael; Ussery, David W.] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA.
RP Wassenaar, TM (corresponding author), Mol Microbiol & Genom Consultants, Tannenstr 7, D-55576 Zotzenheim, Germany.
EM trudy@mmgc.eu
RI Robeson, Michael Scott/J-5211-2019
OI Robeson, Michael Scott/0000-0001-7119-6301; Jun,
   Se-Ran/0000-0003-2681-3950; Ussery, David/0000-0003-3632-5512
FU NIH/NIGMSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [1P20GM121293]
FX NIH/NIGMS, Grant/Award Number: 1P20GM121293
CR Ansaldi F, 2014, WORLD J GASTROENTERO, V20, P9633, DOI 10.3748/wjg.v20.i29.9633
   BRADLEY DW, 1990, BRIT MED BULL, V46, P442, DOI 10.1093/oxfordjournals.bmb.a072409
   Brayne AB, 2017, J VIROL, V91, DOI 10.1128/JVI.02241-16
   Callanan J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070386
   Costa-Mattioli M, 2003, VIROLOGY, V311, P51, DOI 10.1016/S0042-6822(03)00109-0
   Czibener C, 2000, J GEN VIROL, V81, P1149, DOI 10.1099/0022-1317-81-4-1149
   Drexler JF, 2015, P NATL ACAD SCI USA, V112, P15190, DOI 10.1073/pnas.1516992112
   Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323
   Galtier N, 2018, MOL BIOL EVOL, V35, P1092, DOI 10.1093/molbev/msy015
   Hartlage AS, 2016, ANNU REV VIROL, V3, P53, DOI 10.1146/annurev-virology-100114-055104
   Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025
   Costafreda MI, 2014, J VIROL, V88, P5029, DOI 10.1128/JVI.00087-14
   Jackowiak P, 2014, INFECT GENET EVOL, V21, P67, DOI 10.1016/j.meegid.2013.10.021
   Kamar N, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.86
   Klovins J, 2002, J GEN VIROL, V83, P1523, DOI 10.1099/0022-1317-83-6-1523
   Kulkarni MA, 2009, INFECT GENET EVOL, V9, P1287, DOI 10.1016/j.meegid.2009.08.009
   Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482
   Marano G, 2017, ACTA VIROL, V61, P401, DOI 10.4149/av_2017_402
   McKnight KL, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a033480
   McWilliam A. N., 1987, RECENT ADV STUDY BAT, P281
   Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0
   Olsthoorn R., 2011, BACTERIOPHAGES SSRNA, DOI 10.1002/9780470015902.a0000778.pub3
   Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215
   Pinto RM, 2007, VIRUS RES, V127, P158, DOI 10.1016/j.virusres.2007.04.010
   Pinto RM, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031781
   Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077
   Primadharsini PP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050456
   SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948
   Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819
   Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   Takahashi K, 2004, HEPATOL RES, V29, P212, DOI 10.1016/j.hepres.2004.04.004
   Tokita H, 1996, J GEN VIROL, V77, P293, DOI 10.1099/0022-1317-77-2-293
   Vaughan G, 2014, INFECT GENET EVOL, V21, P227, DOI 10.1016/j.meegid.2013.10.023
   Preciado MV, 2014, WORLD J GASTROENTERO, V20, P15992, DOI 10.3748/wjg.v20.i43.15992
   Wang XX, 2015, NATURE, V517, P85, DOI 10.1038/nature13806
   Webb GW, 2019, THER ADV INFECT DIS, V6, DOI 10.1177/2049936119837162
   Whitman WB, 2018, INT J SYST EVOL MICR, V68, P967, DOI 10.1099/ijsem.0.002593
   Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064
   Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412
   Zhang X, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082397
   Zirkel F, 2011, MBIO, V2, DOI 10.1128/mBio.00077-11
NR 44
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-8827
J9 MICROBIOLOGYOPEN
JI MicrobiologyOpen
PD FEB
PY 2020
VL 9
IS 2
AR e973
DI 10.1002/mbo3.973
EA NOV 2019
PG 16
WC Microbiology
SC Microbiology
GA KK1VK
UT WOS:000497057100001
PM 31742930
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Elizondo-Quiroga, D
   Ramirez-Medina, M
   Gutierrez-Ortega, A
   Elizondo-Quiroga, A
   Munoz-Medina, JE
   Sanchez-Tejeda, G
   Gonzalez-Acosta, C
   Correa-Morales, F
AF Elizondo-Quiroga, Darwin
   Ramirez-Medina, Miriam
   Gutierrez-Ortega, Abel
   Elizondo-Quiroga, Armando
   Esteban Munoz-Medina, Jose
   Sanchez-Tejeda, Gustavo
   Gonzalez-Acosta, Cassandra
   Correa-Morales, Fabian
TI Vector competence of Aedes aegypti and Culex quinquefasciatus from the
   metropolitan area of Guadalajara, Jalisco, Mexico for Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID WEST NILE VIRUS; TRANSMISSION; MOSQUITOS; INFECTION; BRAZIL
AB Zika virus (ZIKV) is a mosquito-borne pathogen discovered in the late 40's in Uganda during a surveillance program for yellow fever. By 2014 the virus reached Eastern Island in the Americas, and two years later, the virus spread to almost all countries and territories of the Americas. The mosquito Aedes aegypti has been identified as the main vector of the disease, and several researchers have also studied the vector competence of Culex quinquefasciatus in virus transmission. The aim of the present study was to evaluate the vector competence of Ae. aegypti and Cx. quinquefasciatus in order to understand their roles in the transmission of ZIKV in Guadalajara, Jalisco, Mexico. In blood feeding laboratry experiments, we found that Ae. aegypti mosquitoes showed to be a competent vector able to transmit ZIKV in this area. On the other hand, we found that F0 Cx. quinquefasciatus mosquitoes are refractory to ZIKV infection, dissemination and transmission.
C1 [Elizondo-Quiroga, Darwin; Ramirez-Medina, Miriam; Gutierrez-Ortega, Abel] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Biotecnol Med & Farmaceut, Guadalajara, Jalisco, Mexico.
   [Elizondo-Quiroga, Armando] Secretaria Salud Jalisco, Guadalajara, Jalisco, Mexico.
   [Esteban Munoz-Medina, Jose] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Lab Cent Epidemiol, Mexico City, DF, Mexico.
   [Sanchez-Tejeda, Gustavo; Gonzalez-Acosta, Cassandra; Correa-Morales, Fabian] Secretaria Salud Mexico, Ctr Nacl Programas Prevent & Control Enfermedades, Direcc Programa Enfermedades Transmitidas Vector, Mexico City, DF, Mexico.
RP Elizondo-Quiroga, D (corresponding author), Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Biotecnol Med & Farmaceut, Guadalajara, Jalisco, Mexico.
EM delizondo@ciatej.mx
OI Correa Morales, Fabian/0000-0002-6193-1242; Gonzalez Acosta,
   Cassandra/0000-0003-2682-908X
CR Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Esposito A., 2016, MAINLAND CHILE CONFI
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Matheus S, 2017, EMERG INFECT DIS, V23, P1910, DOI 10.3201/eid2311.170337
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Smartt CT, 2009, AM J TROP MED HYG, V81, P258, DOI 10.4269/ajtmh.2009.81.258
   Smith DR, 2006, EMERG INFECT DIS, V12, P1190, DOI 10.3201/eid1708.050841
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Tsujimoto H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171345
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zimler RA, 2019, J MED ENTOMOL, V56, P341, DOI 10.1093/jme/tjy231
NR 41
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 18
PY 2019
VL 9
AR 16955
DI 10.1038/s41598-019-53117-1
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JN5EF
UT WOS:000496920900011
PM 31740702
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu, X
   Zhao, Y
   Zhang, O
AF Liu, Xiao
   Zhao, Yang
   Zhang, John Z. H.
TI Molecular mechanism of ligand bindings to Zika virus at SAM site
SO CHEMICAL PHYSICS LETTERS
LA English
DT Article
ID NS5 METHYLTRANSFERASE; INTERACTION ENTROPY; PROTEIN
AB We investigated residue-specific binding free energies using computational alanine scanning with interaction entropy method to identify hot-spots and unravel molecular basis in 3 ligand bindings to Zika SAM binding site. This approach allows one to obtain quantitatively residue-specific contributions to protein-ligand binding free energy. Our computational analysis identified four major residues, W87, 1147, H110, and K105 that contribute most to the ZIKV bindings to both SAH and SFG ligands. There are two additional residues, R160 and R163, that also contribute significantly to the binding. Finally, the computed total binding free energies are in good agreement with experimentally measured data.
C1 [Liu, Xiao; Zhang, John Z. H.] East China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Sch Chem & Mol Engn, Shanghai 200062, Peoples R China.
   [Liu, Xiao] Shanghai Univ Engn Sci, Sch Math Phys & Stat, Shanghai 201620, Peoples R China.
   [Zhao, Yang] Nanyang Technol Univ, Div Mat Sci, Singapore 639798, Singapore.
   [Zhang, John Z. H.] NYU Shanghai, NYU ECNU Ctr Computat Chem, Shanghai 200062, Peoples R China.
   [Zhang, John Z. H.] NYU, Dept Chem, New York, NY 10003 USA.
RP Zhao, Y (corresponding author), Nanyang Technol Univ, Div Mat Sci, Singapore 639798, Singapore.; Zhang, O (corresponding author), NYU Shanghai, NYU ECNU Ctr Computat Chem, Shanghai 200062, Peoples R China.
EM yzhao@ntu.edu.sg; John.zhang@nyu.edu
FU National Key R&D Program of China [2016YFA0501700]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [21433004, 91753103]; Singapore Ministry of Education Academic Research
   Fund Tier 1Ministry of Education, Singapore [2-17-T1-001-161,
   2018-T1-002-172]; Innovation Program of Shanghai Municipal Education
   CommissionInnovation Program of Shanghai Municipal Education Commission
   [201701070005E00020]; Shanghai University of Engineering Science
   research start-up fund [0244-E3-0507-19-05203]; NYU Global Seed Grant;
   NYU-ECNU Center for Computational Chemistry at NYU Shanghai
FX This work was supported by National Key R&D Program of China (Grant no.
   2016YFA0501700), National Natural Science Foundation of China (Grant
   nos. 21433004, 91753103), Singapore Ministry of Education Academic
   Research Fund Tier 1 (Grant Nos. 2-17-T1-001-161, 2018-T1-002-172),
   Innovation Program of Shanghai Municipal Education Commission
   (201701070005E00020), Shanghai University of Engineering Science
   research start-up fund (no. 0244-E3-0507-19-05203) and NYU Global Seed
   Grant. JZ acknowledges the support of NYU-ECNU Center for Computational
   Chemistry at NYU Shanghai. We also thank the ECNU Public Platform for
   Innovation 001 for providing supercomputer time.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Bauman JD, 2016, IUCRJ, V3, P51, DOI 10.1107/S2052252515021259
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Burgoyne NJ, 2006, BIOINFORMATICS, V22, P1335, DOI 10.1093/bioinformatics/btl079
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Liu X, 2018, J CHEM THEORY COMPUT, V14, P1772, DOI 10.1021/acs.jctc.7b01295
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Ribas J, 2002, J ORG CHEM, V67, P7057, DOI 10.1021/jo0201225
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Yan Y, 2017, J CHEM INF MODEL, V57, P1112, DOI 10.1021/acs.jcim.6b00734
   Yang YP, 2019, CHINESE J CHEM PHYS, V32, P134, DOI 10.1063/1674-0068/cjcp1901012
   [张右梓 Zhang Youzi], 2018, [中国科学. 化学, Scientia Sinica Chimica], V48, P204
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zhou Y., 2018, MOL PHYS, V116, P1
NR 31
TC 0
Z9 0
U1 3
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0009-2614
EI 1873-4448
J9 CHEM PHYS LETT
JI Chem. Phys. Lett.
PD NOV 16
PY 2019
VL 735
AR UNSP 136771
DI 10.1016/j.cplett.2019.136771
PG 6
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA JD0XC
UT WOS:000489698800015
DA 2020-07-08
ER

PT J
AU Garg, H
   Mehmetoglu-Gurbuz, T
   Ruddy, GM
   Joshi, A
AF Garg, Himanshu
   Mehmetoglu-Gurbuz, Tugba
   Ruddy, Gregory M.
   Joshi, Anjali
TI Capsid containing virus like particle vaccine against Zika virus made
   from a stable cell line
SO VACCINE
LA English
DT Article
DE Zika; Vaccine; CprME; prME; NS2B-3; Virus like particle
ID ROUND INFECTIOUS PARTICLES; DNA VACCINE; PROTECTION; IMMUNOGENICITY;
   DETERMINANTS; CLEAVAGE
AB Zika virus infection during pregnancy is associated with severe birth defects including microcephaly in the new born. The lack of specific treatment calls for the development of a safe and effective vaccine for use in pregnant women. We recently tested the efficacy of a Virus Like Particle (VLP) vaccine for Zika virus in mice and found that Capsid-preMembrane-Env (CprME) VLPs generated a better neutralizing antibody response than preMembrane-Env (prME) VLPs. The superiority of CprME VLPs suggested that inclusion of capsid in the vaccine may enhance the immune response. However, production of CprME VLPs requires co-expression of NS2B-3 protease, which creates a major hurdle for generation of stable cell lines. To overcome this limitation, we generated a bicistronic vector that expresses CprME and NS2B-3 using an IRES sequence. This bicistronic expression cassette, in a lentiviral vector, was used to create a stable cell line that constitutively secretes CprME VLPs. The expression of NS2B-3, presence of capsid in the secreted VLPs, efficiency of VLP release, and stability of the cell line was extensively tested. Antigen sparing studies in mice using prME and CprME VLPs, both derived from stable cell lines, confirmed the superiority of CprME VLPs in generation of neutralizing antibody response. Capsid specific antibodies were detected in CprME VLP immunized mice providing mechanistic insights into the superiority of these VLPs. Challenge of CprME VLP immunized mice with Zika PRVABC59 showed complete protection against day 3 viremia further validating the efficacy of the vaccine. Our study is the first to generate a stable cell line secreting Zika CprME VLPs via natural NS2B-3 cleavage, demonstrate incorporation of capsid in CprME VLPs and complete protection in challenge studies. This is a major advancement for the Zika vaccine platform that is safe for use in pregnant women and readily scalable for use in developing countries. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Garg, Himanshu; Mehmetoglu-Gurbuz, Tugba; Ruddy, Gregory M.; Joshi, Anjali] Texas Tech Univ, Hlth Sci Ctr, Ctr Emphasis Infect Dis, Dept Mol & Translat Med, El Paso, DC USA.
RP Garg, H; Joshi, A (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Mol & Translat Med, 5001 El Paso Dr, El Paso, DC 79905 USA.
EM Himanshu.garg@ttuhsc.edu; anjali.joshi@ttuhsc.edu
OI Mehmetoglu-Gurbuz, Tugba/0000-0003-1417-9446
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Basu R, 2018, VACCINE, V36, P1256, DOI 10.1016/j.vaccine.2018.01.056
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brien JD, 2013, CURR PROTOCOLS MICRO, V31, DOI [10.1002/9780471729259.mcl5d03s31, DOI 10.1002/9780471729259.MCL5D03S31]
   Bullard BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35755-z
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chang DC, 2008, NAT BIOTECHNOL, V26, P571, DOI 10.1038/nbt1400
   Dai SY, 2018, VIROL SIN, V33, P213, DOI 10.1007/s12250-018-0030-5
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Garg H, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-197
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Jeong H., 2017, MICROBIOL, V55, P220, DOI DOI 10.1007/S12275-017-7056-1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Roby JA, 2014, J GEN VIROL, V95, P2176, DOI 10.1099/vir.0.064121-0
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   YAMSHCHIKOV VF, 1995, J VIROL, V69, P1995, DOI 10.1128/JVI.69.4.1995-2003.1995
NR 37
TC 0
Z9 0
U1 4
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 15
PY 2019
VL 37
IS 48
BP 7123
EP 7131
DI 10.1016/j.vaccine.2019.09.093
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JQ1ZW
UT WOS:000498752300001
PM 31607605
DA 2020-07-08
ER

PT J
AU de Quental, OB
   Franca, EL
   Honorio-Franca, AC
   Morais, TC
   Daboin, BEG
   Bezerra, IMP
   Komninakis, SV
   de Abreu, LC
AF de Quental, Ocilma B.
   Franca, Eduardo L.
   Honorio-Franca, Adenilda C.
   Morais, Tassiane C.
   Daboin, Blanca E. G.
   Bezerra, Italla M. P.
   Komninakis, Shirley, V
   de Abreu, Luiz C.
TI Zika Virus Alters the Viscosity and Cytokines Profile in Human Colostrum
SO JOURNAL OF IMMUNOLOGY RESEARCH
LA English
DT Article
ID HUMAN-MILK; MODULATION; BLOOD; CELLS
AB The resurgence of cases of Zika virus (ZIKV) infection, accompanied by epidemic of microcephaly in Brazil, has aroused worldwide interest in understanding the biological mechanisms of the virus that allow patient management and the viral dissemination control. Colostrum and human milk are possible sources of virus spread. Therefore, the objective of this study was to analyze the repercussions of ZIKV infection on rheological parameters and inflammatory cytokines of colostrum. The prospective cohort study included 40 puerperal donors of colostrum, divided into 2 groups: control (without ZIKV infection, n=20) and a group infected with ZIKV during the gestational period (n=20). Analyses were performed for the detection of ZIKV by polymerase chain reaction (PCR). In addition to obtaining the rheological parameters and quantification of IL-10 and IL-6 cytokines by flow cytometry, ZIKV and other flaviviruses were not detected in colostrum. However, maternal infection reflected increased viscosity, decreased levels of IL-10, and elevated levels of IL-6. The higher viscosity may represent a mechanical barrier that hinders the spread of the virus. The lower levels of anti-inflammatory mediators and higher inflammatory cytokines may possibly alter the viscosity, and it seems the higher viscosity represents a possible mechanism of adaptation of breastfeeding against a response to ZIKV.
C1 [de Quental, Ocilma B.] FSM, Dept Nursing, BR-58900000 Cajazeiras, Brazil.
   [de Quental, Ocilma B.; Franca, Eduardo L.; Honorio-Franca, Adenilda C.; Morais, Tassiane C.; Daboin, Blanca E. G.; Bezerra, Italla M. P.; Komninakis, Shirley, V; de Abreu, Luiz C.] Ctr Univ Saude ABC FMABC, Lab Study Design & Sci Writing, Dept Morphol & Physiol, BR-09060870 Santo Andre, SP, Brazil.
   [Franca, Eduardo L.; Honorio-Franca, Adenilda C.] Univ Fed Mato Grosso UFMT, Dept Biol & Hlth Sci, BR-78600000 Barra Do Garcas, Brazil.
   [Morais, Tassiane C.; de Abreu, Luiz C.] Univ Sao Paulo, Sch Publ Hlth, Postgrad Program Publ Hlth, BR-01246904 Sao Paulo, SP, Brazil.
   [Bezerra, Italla M. P.; de Abreu, Luiz C.] Escola Super Ciencias Santa Casa Misericordia Vit, Postgrad Program Publ Policies & Local Dev, BR-29027502 Vitoria, ES, Brazil.
RP Franca, EL (corresponding author), Ctr Univ Saude ABC FMABC, Lab Study Design & Sci Writing, Dept Morphol & Physiol, BR-09060870 Santo Andre, SP, Brazil.; Franca, EL (corresponding author), Univ Fed Mato Grosso UFMT, Dept Biol & Hlth Sci, BR-78600000 Barra Do Garcas, Brazil.
EM dr.eduardo.franca@gmail.com
RI Honorio-Franca, Adenilda C/C-8012-2012; Guerrero, Blanca/AAR-3740-2020;
   BEZERRA, ITALLA MARIA/N-9130-2016
OI BEZERRA, ITALLA MARIA/0000-0002-8604-587X; Honorio-Franca,
   Adenilda/0000-0002-0452-9804; Guerrero Daboin, Blanca
   Elena/0000-0001-9052-1923
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/19922-0,
   2015/01051-3, 2019/24232-4]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq) [303983/2016-7, 403383/2016-1,
   305725/2018-1]
FX Funding for this research was provided by Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP no: 2015/19922-0; no: 2015/01051-3; no:
   2019/24232-4) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq no: 303983/2016-7; no: 403383/2016-1; and no:
   305725/2018-1).
CR Ahmed ST, 2000, J IMMUNOL, V165, P5227, DOI 10.4049/jimmunol.165.9.5227
   Al-Shehri SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135047
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Pereira QLC, 2018, PARASITOL RES, V117, P1783, DOI 10.1007/s00436-018-5860-4
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Colavita F, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2450540
   Cumming HE, 2019, J LEUKOCYTE BIOL, V105, P353, DOI 10.1002/JLB.MR0318-122RR
   de Almeida MBD, 2011, J APPL ORAL SCI, V19, P554, DOI 10.1590/S1678-77572011000600003
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Franca EL, 2014, BIOMED RES INT, DOI 10.1155/2014/840379
   Franca EL, 2011, APMIS, V119, P710, DOI 10.1111/j.1600-0463.2011.02789.x
   Franca EL, 2011, J MICROBIOL IMMUNOL, V44, P1, DOI 10.1016/j.jmii.2011.01.002
   Franca EL, 2010, BIOL RHYTHM RES, V41, P333, DOI 10.1080/09291010903407441
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   FUJIHASHI K, 1992, RES IMMUNOL, V143, P744, DOI 10.1016/0923-2494(92)80015-D
   Garofalo R, 2010, J PEDIATR-US, V156, pS36, DOI 10.1016/j.jpeds.2009.11.019
   GOLDMAN AS, 1982, J PEDIATR-US, V100, P563, DOI 10.1016/S0022-3476(82)80753-1
   Fagundes DLG, 2016, J MATERN-FETAL NEO M, V29, P998, DOI 10.3109/14767058.2015.1031739
   Fagundes DLG, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/590190
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hassiotou F, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.1
   Honorio-Franca AC, 2016, ONCOTARGETS THER, V9, P617, DOI 10.2147/OTT.S99839
   Honorio-Franca AC, 2013, J APPL BIOMED, V11, P153, DOI 10.2478/v10136-012-0039-2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41
   Marcuzzi A, 2013, J HUM LACT, V29, P26, DOI 10.1177/0890334412466958
   McGhee J R, 1991, Adv Exp Med Biol, V310, P113
   Morais TC, 2015, BIOL RHYTHM RES, V46, P811, DOI 10.1080/09291016.2015.1056434
   Morceli G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056915
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Oliveira DBL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110615
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Radillo O, 2013, CYTOKINE, V61, P26, DOI 10.1016/j.cyto.2012.09.001
   Rojas JM, 2017, J IMMUNOL RES, DOI 10.1155/2017/6104054
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Scherer EF, 2016, ACTA TROP, V158, P139, DOI 10.1016/j.actatropica.2016.03.001
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Sunaric S, 2017, TURK J MED SCI, V47, P246, DOI 10.3906/sag-1511-110
   Valentine GC, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.06.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 48
TC 0
Z9 0
U1 1
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-8861
EI 2314-7156
J9 J IMMUNOL RES
JI J Immunol. Res.
PD NOV 15
PY 2019
VL 2019
AR 9020519
DI 10.1155/2019/9020519
PG 9
WC Immunology
SC Immunology
GA JQ7ZY
UT WOS:000499160000001
PM 31828175
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU van der Linden, V
   Lins, OG
   Petribu, NCD
   de Melo, ACMG
   Moore, J
   Rasmussen, SA
   Moore, CA
AF van der Linden, Vanessa
   Lins, Otavio Gomes
   de Lima Petribu, Natacha Calheiros
   Marques Gouveia de Melo, Ana Claudia
   Moore, Jazmyn
   Rasmussen, Sonja A.
   Moore, Cynthia A.
TI Diaphragmatic paralysis: Evaluation in infants with congenital Zika
   syndrome
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE arthrogryposis; congenital infection; diaphragmatic paralysis; phrenic
   nerve; Zika virus
ID VIRUS-INFECTION; SPINAL-CORD; BRAZIL; EVENTRATION; FETAL; ASSOCIATION
AB Background Paralysis of the diaphragm in newborn infants can lead to recurrent infections and life-threatening respiratory insufficiency. The clinical diagnosis of unilateral diaphragmatic paralysis has been reported in infants with laboratory evidence of congenital Zika virus infection and/or the congenital Zika syndrome (CZS) phenotype but no evaluation of phrenic nerve function has been described. All reported infants have had accompanying arthrogryposis. High infant mortality is reported. Methods The causal mechanism of congenital diaphragmatic paralysis was evaluated in three infants with arthrogryposis as a manifestation of CZS (two of the three infants had laboratory evidence of ZIKV infection shortly after birth; the remaining infant had negative serology for ZIKV when first tested at 7 months of age). Electromyography and phrenic nerve compound muscle action potential (CMAP) were performed in all infants with diaphragmatic paralysis demonstrated on imaging studies. Results All infants had evidence of moderate chronic involvement of peripheral motor neurons. Phrenic nerve CMAP was reduced on the side of the diaphragmatic paralysis in two infants and reduced bilaterally in the remaining infant who had primarily anterior involvement of the diaphragm. All three infants had multiple medical complications and one infant died at 18 months of age. Conclusion Evaluation of three infants with CZS and diaphragmatic paralysis demonstrated phrenic nerve dysfunction. In these and other affected infants, arthrogryposis appears to be a constant co-occurring condition and health problems are significant; both conditions are likely due to involvement of the peripheral nervous system in some infants with CZS.
C1 [van der Linden, Vanessa] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [van der Linden, Vanessa; de Lima Petribu, Natacha Calheiros] Barao Lucena Hosp, Recife, PE, Brazil.
   [Lins, Otavio Gomes] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Marques Gouveia de Melo, Ana Claudia] Restauracao Hosp, Recife, PE, Brazil.
   [Moore, Jazmyn; Moore, Cynthia A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Rasmussen, Sonja A.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA.
   [Rasmussen, Sonja A.] Univ Florida, Coll Med, Gainesville, FL USA.
   [Rasmussen, Sonja A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA.
   [Moore, Jazmyn] London Sch Hyg & Trop Med, London, England.
RP Moore, CA (corresponding author), Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Hwy NE,Mail Stop S106-3, Atlanta, GA 30341 USA.
EM cam0@cdc.gov
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Alamo L, 2015, PEDIATR RADIOL, V45, P1887, DOI 10.1007/s00247-015-3418-5
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   BECROFT DMO, 1979, J PEDIATR-US, V94, P74, DOI 10.1016/S0022-3476(79)80358-3
   Bowerson M, 2010, PEDIATR NEUROL, V42, P234, DOI 10.1016/j.pediatrneurol.2009.11.005
   CHRISTENSEN P, 1959, Thorax, V14, P311, DOI 10.1136/thx.14.4.311
   COMMARE MC, 1994, PEDIATR PULM, V18, P187, DOI 10.1002/ppul.1950180311
   Monteiro LMC, 2019, J PEDIATR UROL, V15, DOI 10.1016/j.jpurol.2019.04.018
   de Araujo LA, 2013, J PEDIATR UROL, V9, P895, DOI 10.1016/j.jpurol.2012.12.011
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Greer JJ, 2012, COMPR PHYSIOL, V2, P1873, DOI 10.1002/cphy.c110006
   HALL JG, 1982, TERATOLOGY, V25, P173, DOI 10.1002/tera.1420250207
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Izumi K, 2010, J PERINATOL, V30, P691, DOI 10.1038/jp.2010.65
   KOKATNUR L, 2018, DISEASES, V6, pE16
   Konstantinidou A, 2007, J MED VIROL, V79, P754, DOI 10.1002/jmv.20887
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rajapakse NS, 2018, EMERG INFECT DIS, V24, P1422, DOI 10.3201/eid2408.180057
   Ramalho FS, 2017, CLIN INFECT DIS, V65, P687, DOI 10.1093/cid/cix374
   Ratnayake EC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-46
   Reddy KP, 2015, ANN AM THORAC SOC, V12, P618, DOI 10.1513/AnnalsATS.201501-070LE
   Rudrappa Mohan, 2018, Diseases, V6, DOI 10.3390/diseases6010007
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Souza Alex Sandro Rolland, 2016, Rev. Bras. Saude Mater. Infant., V16, P467, DOI 10.1590/1806-93042016000400007
   Tiryaki T, 2006, ASIAN J SURG, V29, P8, DOI 10.1016/S1015-9584(09)60285-2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   WAYNE ER, 1973, J PEDIATR-US, V83, P164, DOI 10.1016/S0022-3476(73)80339-7
NR 35
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD NOV 15
PY 2019
VL 111
IS 19
BP 1577
EP 1583
DI 10.1002/bdr2.1597
PG 7
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA JM8RZ
UT WOS:000496476700014
PM 31595718
DA 2020-07-08
ER

PT J
AU Silva, ML
   Stehmann, JR
   Serafim, MSM
   Vale, VV
   Gontijo, DC
   Brandao, GC
   Kroon, EG
   de Oliveira, AB
AF Silva, Marlene Lourenco
   Stehmann, Joao Renato
   Magalhaes Serafim, Mateus Sa
   Vale, Valdicley Vieira
   Gontijo, Douglas Costa
   Brandao, Geraldo Celio
   Kroon, Erna Geessien
   de Oliveira, Alaide Braga
TI Himatanthus bracteatus stem extracts present anti-flavivirus activity
   while an isolated sesquiterpene glucoside present only anti-Zika virus
   activity in vitro
SO NATURAL PRODUCT RESEARCH
LA English
DT Article; Early Access
DE Himatanthus bracteatus; Zika virus; yellow fever virus; dengue virus;
   plumieride; spectroscopic analyses
AB The hexane and ethanol extracts from Himatanthus bracteatus (Apocynaceae) stems were evaluated for antiviral activity against Zika virus, yellow fever virus and dengue virus 2 and for cytotoxicity in Vero cells by MTT assay. The ethanol extract showed good antiviral activity against the three viruses with selective indexes (SI) > 10 and its fractionation led to the isolation of the known plumieride that was active only against Zika virus (SI of 15.97).
C1 [Silva, Marlene Lourenco; Gontijo, Douglas Costa; de Oliveira, Alaide Braga] Univ Fed Minas Gerais, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil.
   [Stehmann, Joao Renato] Univ Fed Minas Gerais, Dept Bot, Belo Horizonte, MG, Brazil.
   [Magalhaes Serafim, Mateus Sa; Kroon, Erna Geessien] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Vale, Valdicley Vieira] Univ Fed Para, Programa Posgrad Ciencias Farmaceut, Belem, Para, Brazil.
   [Brandao, Geraldo Celio] Univ Fed Ouro Preto, Escola Farm, Ouro Preto, Brazil.
RP Gontijo, DC; de Oliveira, AB (corresponding author), Univ Fed Minas Gerais, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil.
EM gontijo.douglas@outlook.com; bragalaide@gmail.com
RI Serafim, Mateus Sa Magalhaes/AAL-9280-2020
OI Serafim, Mateus Sa Magalhaes/0000-0002-7505-8659; /0000-0002-7330-051X;
   VALE, VALDICLEY VIEIRA/0000-0001-6570-4875
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG) [APQ-01410-14];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [440911/2016]; CapesCAPES [2058/2016]; DECIT/MS; CNPqNational Council
   for Scientific and Technological Development (CNPq)
FX To FAPEMIG Process APQ-01410-14 for financial support to ABO. To CNPq
   Process 440911/2016, Capes Process 2058/2016 and DECIT/MS for financial
   support to EGK. To CNPq for scholarship to MLS and fellowship to ABO.
CR BrandAo GC, 2010, THESIS
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Gandhi GR, 2016, PHYTOMEDICINE, V23, P1830, DOI 10.1016/j.phymed.2016.11.005
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Linhares JCS, 2010, THESIS
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Pugas Rejane Martins, 2018, Hoehnea, V45, P405, DOI 10.1590/2236-8906-23/2017
   Segun PA, 2019, NAT PROD RES, DOI 10.1080/14786419.2019.1644505
   Vale VV, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0643-1
   Vanderlei M.F., 1991, J BRAZIL CHEM SOC, V2, P51
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Veloso MP, 1999, BIOCHEM SYST ECOL, V27, P669, DOI 10.1016/S0305-1978(98)00125-2
   de Almeida SCX, 2017, REV BRAS FARMACOGN, V27, P788, DOI 10.1016/j.bjp.2017.10.002
NR 14
TC 0
Z9 0
U1 2
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
DI 10.1080/14786419.2019.1690487
EA NOV 2019
PG 5
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA JO0HZ
UT WOS:000497269700001
PM 31746240
DA 2020-07-08
ER

PT J
AU Jagger, BW
   Dowd, KA
   Chen, RE
   Dead, P
   Foreman, B
   Burgomaster, KE
   Himansu, S
   Kong, WP
   Graham, BS
   Pierson, TC
   Diamond, MS
AF Jagger, Brett W.
   Dowd, Kimberly A.
   Chen, Rita E.
   Dead, Pritesh
   Foreman, Bryant
   Burgomaster, Katherine E.
   Himansu, Sunny
   Kong, Wing-Pui
   Graham, Barney S.
   Pierson, Theodore C.
   Diamond, Michael S.
TI Protective Efficacy of Nucleic Acid Vaccines Against Transmission of
   Zika Virus During Pregnancy in Mice
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; vaccine; pregnancy; congenital Zika syndrome; vaccine;
   neutralizing antibody
ID MESSENGER-RNA VACCINES; DNA VACCINE; MOUSE MODEL; INFECTION; RESPONSES;
   ANTIGEN
AB Zika virus (ZIKV) caused an epidemic of congenital malformations in 2015-2016. Although many vaccine candidates have been generated, few have demonstrated efficacy against congenital ZIKV infection. Here, we evaluated lipid-encapsulated messenger RNA (mRNA) vaccines and a DNA plasmid vaccine encoding the prM-E genes of ZIKV in mouse models of congenital infection. Although the DNA vaccine provided comparable efficacy against vertical transmission of ZIKV, the mRNA vaccines, including one that minimizes antibody-dependent enhancement of infection, elicited higher levels of antigen-specific long-lived plasma cells and memory B cells. Despite the induction of robust neutralizing antibody titers by all vaccines, breakthrough seeding of the placenta and fetal head was observed in a small subset of type I interferon signaling-deficient immunocompromised dams. In comparison, evaluation of one of the mRNA vaccines in a human STAT2-knockin transgenic immunocompetent mouse showed complete protection against congenital ZIKV transmission. These data will inform ongoing human ZIKV vaccine development efforts and enhance our understanding of the correlates of vaccine-induced protection.
C1 [Jagger, Brett W.; Chen, Rita E.; Dead, Pritesh; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.
   [Dowd, Kimberly A.; Foreman, Bryant; Burgomaster, Katherine E.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Lab Viral Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Kong, Wing-Pui; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Himansu, Sunny] Moderna, Cambridge, MA USA.
   [Jagger, Brett W.] Western Michigan Univ, Dept Med, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Desai, Pritesh/0000-0002-4697-9475
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI073755,
   R01 HD091218, T32 AI007172]; National Institute of Allergy and
   Infectious Diseases Intramural Research ProgramUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID); Moderna
FX This work was supported by the National Institutes of Health (NIH;
   grants R01 AI073755 and R01 HD091218 to M. S. D. and grant T32 AI007172
   to B. W. J.), the National Institute of Allergy and Infectious Diseases
   Intramural Research Program (grants to T. C. P. and B. S. G.), and
   Moderna.
CR Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005
   Ander SE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat6114
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074
   Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Stanelle-Bertram S, 2018, NAT MICROBIOL, V3, P1161, DOI 10.1038/s41564-018-0236-1
   Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712
   Weissman D, 2015, EXPERT REV VACCINES, V14, P265, DOI 10.1586/14760584.2015.973859
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
NR 49
TC 5
Z9 5
U1 6
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 15
PY 2019
VL 220
IS 10
BP 1577
EP 1588
DI 10.1093/infdis/jiz338
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JF2UT
UT WOS:000491241900006
PM 31260518
DA 2020-07-08
ER

PT J
AU Rakkiyappan, R
   Latha, VP
   Rihan, FA
AF Rakkiyappan, R.
   Latha, V. Preethi
   Rihan, Fathalla A.
TI A Fractional-Order Model for Zika Virus Infection with Multiple Delays
SO COMPLEXITY
LA English
DT Article
ID EPIDEMIC MODEL; VIRAL MODEL; DYNAMICS; TRANSMISSION; BIFURCATION;
   STABILITY; CHAOS
AB Time delays and fractional order play a vital role in biological systems with memory. In this paper, we propose an epidemic model for Zika virus infection using delay differential equations with fractional order. Multiple time delays are incorporated in the model to consider the latency of the infection in a vector and the latency of the infection in the infected host. We investigate the necessary and sufficient conditions for stability of the steady states and Hopf bifurcation with respect to three time delays tau 1, tau 2, and tau 3. The model undergoes a Hopf bifurcation at the threshold parameters tau 1*, tau 2*, and tau 3*. Some numerical simulations are given to show the effectiveness of obtained results. The numerical simulations confirm that combination of fractional order and time delays in the epidemic model effectively enriches the dynamics and strengthens the stability condition of the model.
C1 [Rakkiyappan, R.; Latha, V. Preethi] Bharathiar Univ, Dept Math, Coimbatore 641046, Tamil Nadu, India.
   [Rihan, Fathalla A.] UAE Univ, Coll Sci, Dept Math Sci, Al Ain 15551, U Arab Emirates.
RP Rihan, FA (corresponding author), UAE Univ, Coll Sci, Dept Math Sci, Al Ain 15551, U Arab Emirates.
EM frihan@uaeu.ac.ae
OI Rihan, Fathalla A./0000-0003-3855-5944
FU UAE University [31S265]; DST-SERB Project [SB/FTP/MS-045/2013]
FX This manuscript was funded from the project no. 31S265 (UAE University)
   and DST-SERB Project # SB/FTP/MS-045/2013 (Bharathiar University).
CR Ahmed E, 2012, J FRACT CALC APPL AN, V3, P1, DOI DOI 10.1142/9789814355216_0001
   Althaus CL, 2007, J IMMUNOL, V179, P2944, DOI 10.4049/jimmunol.179.5.2944
   ANDERSON R M, 1991
   Atangana A, 2018, CHAOS SOLITON FRACT, V114, P347, DOI 10.1016/j.chaos.2018.07.022
   Atangana A, 2018, PHYSICA A, V505, P688, DOI 10.1016/j.physa.2018.03.056
   Atangana A, 2018, EUR PHYS J PLUS, V133, DOI 10.1140/epjp/i2018-12021-3
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Brauer F., 2019, TEXTS APPL MATH, P409, DOI [10.1007/978-1-4939-9828-9_12, DOI 10.1007/978-1-4939-9828-9_12]
   Buric N, 2002, CHAOS SOLITON FRACT, V13, P645, DOI 10.1016/S0960-0779(00)00275-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen WC, 2008, CHAOS SOLITON FRACT, V36, P1305, DOI 10.1016/j.chaos.2006.07.051
   Chiyaka C, 2008, APPL MATH COMPUT, V195, P641, DOI 10.1016/j.amc.2007.05.016
   COLE KENNETH S., 1933, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOL, V1, P107
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gao SJ, 2008, NONLINEAR ANAL-REAL, V9, P599, DOI 10.1016/j.nonrwa.2006.12.004
   Hilfer R., 2000, APPL FRACTIONAL CALC
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Latha VP, 2018, J COMPUT APPL MATH, V339, P134, DOI 10.1016/j.cam.2017.11.032
   Latha VP, 2017, INT J BIOMATH, V10, DOI 10.1142/S179352451750111X
   Li MY, 2010, B MATH BIOL, V72, P1492, DOI 10.1007/s11538-010-9503-x
   MacDonald N., 1989, BIOL DELAY SYSTEMS
   Moghaddam BP, 2016, J COMPUT NONLIN DYN, V11, DOI 10.1115/1.4032574
   Moreno Victor M, 2017, Infect Dis Model, V2, P21, DOI 10.1016/j.idm.2016.12.002
   Muth E. J., 1977, TRANSFORM METHODS AP
   Pinto CMA, 2018, J COMPUT NONLIN DYN, V13, DOI 10.1115/1.4038643
   PODLUBNY I., 1999, FRACTIONAL DIFFERENT
   Rihan FA, 2019, APPL MATH COMPUT, V353, P147, DOI 10.1016/j.amc.2019.02.002
   Rihan FA, 2017, MATH MODEL NAT PHENO, V12, P33, DOI 10.1051/mmnp/201712503
   Rihan FA, 2015, NONLINEAR DYNAM, V80, P777, DOI 10.1007/s11071-015-1905-8
   Rihan F.A., 2014, ABSTR APPL ANAL, V2014, P9, DOI DOI 10.1155/2014/136263
   Rihan FA, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/816803
   Rihan FA, 2013, INT J COMPUT MATH, V90, P594, DOI 10.1080/00207160.2012.726354
   Sakdanupaph W, 2009, AIP CONF PROC, V1148, P816, DOI 10.1063/1.3225441
   Sheng H, 2012, FRACTIONAL PROCESSES AND FRACTIONAL-ORDER SIGNAL PROCESSING: TECHNIQUES AND APPLICATIONS, P1, DOI 10.1007/978-1-4471-2233-3
   Tateishi AA, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00052
   Usman S., 2017, J NIGERIAN ASS MATH, V40
   Wang KF, 2007, PHYSICA D, V226, P197, DOI 10.1016/j.physd.2006.12.001
   Wang XH, 2019, J FRANKLIN I, V356, P8278, DOI 10.1016/j.jfranklin.2019.07.028
   Wang XH, 2019, APPL MATH LETT, V94, P292, DOI 10.1016/j.aml.2019.03.011
   Wang XH, 2018, INT J BIFURCAT CHAOS, V28, DOI 10.1142/S0218127418501808
   Wang Z, 2019, APPL MATH COMPUT, V347, P360, DOI 10.1016/j.amc.2018.11.016
   Wei HM, 2008, J MATH ANAL APPL, V342, P895, DOI 10.1016/j.jmaa.2007.12.058
   Zaslavsky GM, 2002, PHYS REP, V371, P461, DOI 10.1016/S0370-1573(02)00331-9
   Zhang LL, 2015, DISCRETE DYN NAT SOC, DOI 10.1155/2015/563127
NR 45
TC 0
Z9 0
U1 3
U2 3
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1076-2787
EI 1099-0526
J9 COMPLEXITY
JI Complexity
PD NOV 14
PY 2019
VL 2019
AR 4178073
DI 10.1155/2019/4178073
PG 20
WC Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences
SC Mathematics; Science & Technology - Other Topics
GA JQ7WR
UT WOS:000499151400001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU So, RWL
   Chung, SW
   Lau, HHC
   Watts, JJ
   Gaudette, E
   Al-Azzawi, ZAM
   Bishay, J
   Lin, LTW
   Joung, J
   Wang, XZ
   Schmitt-Ulms, G
AF So, Raphaella W. L.
   Chung, Sai Wai
   Lau, Heather H. C.
   Watts, Jeremy J.
   Gaudette, Erin
   Al-Azzawi, Zaid A. M.
   Bishay, Jossana
   Lin, Lilian Tsai-Wei
   Joung, Julia
   Wang, Xinzhu
   Schmitt-Ulms, Gerold
TI Application of CRISPR genetic screens to investigate neurological
   diseases
SO MOLECULAR NEURODEGENERATION
LA English
DT Review
DE CRISPR-Cas9; Functional genetics; sgRNA; CRISIPR KO; CRISPRi; CRISPRa;
   Neurological diseases; Neurodegenerative diseases; Survival screens;
   Marker selection screens
ID SEQUENCE-SPECIFIC CONTROL; TRANSCRIPTIONAL ACTIVATION; MOUSE MODEL; ZIKA
   VIRUS; TARGET DNA; A-BETA; GENOME; NEURODEGENERATION; IDENTIFICATION;
   KNOCKOUT
AB The adoption of CRISPR-Cas9 technology for functional genetic screens has been a transformative advance. Due to its modular nature, this technology can be customized to address a myriad of questions. To date, pooled, genome-scale studies have uncovered genes responsible for survival, proliferation, drug resistance, viral susceptibility, and many other functions. The technology has even been applied to the functional interrogation of the non-coding genome. However, applications of this technology to neurological diseases remain scarce. This shortfall motivated the assembly of a review that will hopefully help researchers moving in this direction find their footing. The emphasis here will be on design considerations and concepts underlying this methodology. We will highlight groundbreaking studies in the CRISPR-Cas9 functional genetics field and discuss strengths and limitations of this technology for neurological disease applications. Finally, we will provide practical guidance on navigating the many choices that need to be made when implementing a CRISPR-Cas9 functional genetic screen for the study of neurological diseases.
C1 [So, Raphaella W. L.; Chung, Sai Wai; Lau, Heather H. C.; Gaudette, Erin; Al-Azzawi, Zaid A. M.; Bishay, Jossana; Lin, Lilian Tsai-Wei; Wang, Xinzhu; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Med Sci Bldg,6th Floor,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
   [So, Raphaella W. L.; Lau, Heather H. C.; Lin, Lilian Tsai-Wei; Wang, Xinzhu; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Ctr, 6th Floor60 Leonard Ave, Toronto, ON M5T 2S8, Canada.
   [Watts, Jeremy J.] Univ Toronto, Dept Pharmacol & Toxicol, Med Sci Bldg,6th Floor,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
   [Joung, Julia] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Joung, Julia] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.
   [Joung, Julia] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Joung, Julia] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
RP Schmitt-Ulms, G (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Med Sci Bldg,6th Floor,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.; Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Ctr, 6th Floor60 Leonard Ave, Toronto, ON M5T 2S8, Canada.
EM g.schmittulms@utoronto.ca
OI Watts, Jeremy/0000-0003-1751-5409; Wang, Xinzhu/0000-0002-1438-1153
FU Krembil Foundation
FX Work on this project was funded through a Krembil Foundation grant and
   generous philanthropic support from the Borden Rosiak and Arnold Irwin
   families.
CR Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300
   Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154
   Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371
   Bertomeu T, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00302-17
   Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361
   Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028
   Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599
   Carlin AF, 2019, CURR OPIN VIROL, V34, P29, DOI 10.1016/j.coviro.2018.11.010
   Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]
   Chen CH, 2018, BIOINFORMATICS, V34, P4095, DOI 10.1093/bioinformatics/bty450
   Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268
   Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038
   Chen X, 2014, EUR J NEUROL, V21, P1060, DOI 10.1111/ene.12398
   Chen YC, 2017, MOL CELL, V68, P247, DOI 10.1016/j.molcel.2017.09.014
   Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008
   Chow RD, 2017, NAT NEUROSCI, V20, P1329, DOI 10.1038/nn.4620
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cykowski MD, 2017, J NEUROPATH EXP NEUR, V76, P402, DOI 10.1093/jnen/nlx025
   DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]
   Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437
   Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Dukhovny A, 2019, J VIROL, V93, DOI 10.1128/JVI.00211-19
   Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536
   Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250
   Ford K, 2019, J MOL BIOL, V431, P48, DOI 10.1016/j.jmb.2018.06.034
   Fortin JP, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1621-7
   Gandhi S, 2017, DEV BIOL, V425, P8, DOI 10.1016/j.ydbio.2017.03.003
   Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029
   Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044
   Gilson V, 2015, J ALZHEIMERS DIS, V47, P453, DOI 10.3233/JAD-142529
   Graham DB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0823-x
   Haack TB, 2016, AM J HUM GENET, V99, P735, DOI 10.1016/j.ajhg.2016.06.026
   Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015
   Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999
   Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155
   Huber CM, 2018, J ALZHEIMERS DIS, V61, P265, DOI 10.3233/JAD-170490
   Hughes R. A., 2017, COLD SPRING HARB PER, V9, P1
   Jia GX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3938-5
   Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688
   Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451
   Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016
   Juillerat A, 2014, NUCLEIC ACIDS RES, V42, P5390, DOI 10.1093/nar/gku155
   Kampmann M, 2017, TRENDS MOL MED, V23, P483, DOI 10.1016/j.molmed.2017.04.003
   Kato-Inui T, 2018, NUCLEIC ACIDS RES, V46, P4677, DOI 10.1093/nar/gky264
   Kim J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020124
   Kim J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-15
   Kim MJ, 2007, EXP MOL MED, V39, P14, DOI 10.1038/emm.2007.3
   Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526
   Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592
   Klompe SE, 2019, NATURE, V571, P219, DOI 10.1038/s41586-019-1323-z
   Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089
   Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136
   Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450
   Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192
   Kramer NJ, 2018, NAT GENET, V50, P603, DOI 10.1038/s41588-018-0070-7
   Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009
   Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132
   Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Li Y, 2019, P NATL ACAD SCI USA, V116, P9527, DOI 10.1073/pnas.1900867116
   Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402
   Liu JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10963-x
   Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111
   Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016
   Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   Miles LA, 2016, FEBS J, V283, P3170, DOI 10.1111/febs.13770
   Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178
   Nagy T, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1759-9
   Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Perkel JM, 2019, NATURE, V566, P565, DOI 10.1038/d41586-019-00682-0
   Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014
   Potting C, 2018, P NATL ACAD SCI USA, V115, pE180, DOI 10.1073/pnas.1711023115
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022
   Ramdzan YM, 2012, NAT METHODS, V9, P467, DOI [10.1038/NMETH.1930, 10.1038/nmeth.1930]
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ranjan VD, 2018, J TISSUE ENG REGEN M, V12, P1944, DOI 10.1002/term.2728
   Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839
   Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529
   Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235
   Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016
   Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138
   Spahn PN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16193-9
   Strecker J, 2019, SCIENCE, V365, P48, DOI 10.1126/science.aax9181
   Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039
   Tang XD, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00551
   Tian R, 2019, NEURON
   Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004
   Vatsavayai SC, 2016, BRAIN, V139, P3202, DOI 10.1093/brain/aww250
   Vesikansa A, 2018, J CENT NERV SYST DIS, V10, DOI 10.1177/1179573518787469
   Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9
   Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248
   Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019
   Wang LX, 2017, PROTEIN CELL, V8, P365, DOI 10.1007/s13238-017-0397-3
   Wang TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04899-x
   Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007
   Whiten DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep31138
   Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115
   Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737
   Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029
NR 120
TC 0
Z9 0
U1 3
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1326
J9 MOL NEURODEGENER
JI Mol. Neurodegener.
PD NOV 14
PY 2019
VL 14
IS 1
AR 41
DI 10.1186/s13024-019-0343-3
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA JO5ZB
UT WOS:000497655400001
PM 31727120
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Carvalho, AL
   Ventura, P
   Taguchi, T
   Brandi, I
   Brites, C
   Lucena, R
AF de Carvalho, Alessandra Lemos
   Ventura, Paloma
   Taguchi, Tania
   Brandi, Ivar
   Brites, Carlos
   Lucena, Rita
TI Cerebral Palsy in Children With Congenital Zika Syndrome: A 2-Year
   Neurodevelopmental Follow-up
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Zika virus; congenital Zika; cerebral palsy; neurodevelopment
ID INFANT NEUROLOGICAL EXAMINATION; AGE
AB Objective: To describe the 2-year neurodevelopmental outcome in children with cerebral palsy associated with congenital Zika (CZ) and explore variables associated with a more severe presentation. Methods: Data on 69 children with cerebral palsy associated with CZ, followed in a neurorehabilitation hospital, who consecutively attended the neurodevelopmental assessment at 2 years of age, were collected. Bayley III Scales of Infant and Toddler Development, Hammersmith Infant Neurological Examination, and Gross Motor Function Classification System were used for the outcome evaluation. Descriptive and inferential statistical analysis were performed. Results: The median age at follow-up was of 24.0 (23-32) months. Only 3 (4.3%) children were not microcephalic. The majority presented with bilateral (94.2%), spastic (100.0%), Gross Motor Function Classification System grade IV or V (92.8%) cerebral palsy, epilepsy (73.1%), extremely low performances on cognitive (94.2%), language (95.7%), and motor (95.7%) Bayley-III Scales of Infant and Toddler Development Test scores. The median Hammersmith Infant Neurological Examination score was of 21.0 (range 9-75). There was a correlation between birth head circumference with the cognitive (r = 0.3, P < .01), language (r = 0.3, P < .01), and motor (r = 0.3, P < .01) Bayley-III Scales of Infant and Toddler Development Test scores, as well as with the Hammersmith Infant Neurological Examination score (r = 0.2, P < .03). An association was observed between an inferior median Hammersmith Infant Neurological Examination score with congenital microcephaly (P = .04), arthrogryposis (P = .02), and epilepsy in the first year (P < .01). Conclusion: Cerebral palsy related to CZ presents with a severe global impairment at a 2-year follow-up. Birth head circumference, arthrogryposis, and early epilepsy are associated with a worse outcome and may be considered as prognostic markers. These findings are important for the neurorehabilitation planning, parents' guiding, and future prognostic studies.
C1 [de Carvalho, Alessandra Lemos; Ventura, Paloma; Taguchi, Tania; Brandi, Ivar] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Brites, Carlos; Lucena, Rita] Univ Fed Bahia, Salvador, BA, Brazil.
RP de Carvalho, AL (corresponding author), SARAH Salvador Hosp, Ave Tancredo Neves,2782 Caminho Arvores, BR-41820900 Salvador, BA, Brazil.
EM 13110@sarah.br
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Botelho Ana Carla Gomes, 2016, Rev. Bras. Saude Mater. Infant., V16, P39, DOI 10.1590/1806-9304201600s100004
   BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Carvalho A, 2019, BRAIN DEV-JPN, V41, P587, DOI 10.1016/j.braindev.2019.03.005
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   de Carvalho AL, 2018, EMERG INFECT DIS, V24, P2128, DOI 10.3201/eid2411.180883
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Melo A, 2020, DEV MED CHILD NEUROL, V62, P221, DOI 10.1111/dmcn.14227
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   Pan American Health Organization Organization PAHOWH, 2016, NEUR SYNDR CONG AN Z
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Report S, 2017, ZIK VIR MICR GUILL B
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Romeo DM, 2016, DEV MED CHILD NEUROL, V58, P240, DOI 10.1111/dmcn.12876
   Romeo DMM, 2008, EUR J PAEDIATR NEURO, V12, P24, DOI 10.1016/j.ejpn.2007.05.006
   Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Soares-Marangoni D, 2018, DEV NEUROREHABIL, V16, P1
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 25
TC 1
Z9 1
U1 3
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR
PY 2020
VL 35
IS 3
BP 202
EP 207
AR UNSP 0883073819885724
DI 10.1177/0883073819885724
EA NOV 2019
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA KF9TL
UT WOS:000497623200001
PM 31718421
DA 2020-07-08
ER

PT J
AU Larocca, RA
   Mendes, EA
   Abbink, P
   Peterson, RL
   Martinot, AJ
   Iampietro, MJ
   Kang, ZH
   Aid, M
   Kirilova, M
   Jacob-Dolan, C
   Tostanoski, L
   Borducchi, EN
   De La Barrera, RA
   Barouch, DH
AF Larocca, Rafael A.
   Mendes, Erica A.
   Abbink, Peter
   Peterson, Rebecca L.
   Martinot, Amanda J.
   Iampietro, Mark Justin
   Kang, Zi H.
   Aid, Malika
   Kirilova, Marinela
   Jacob-Dolan, Catherine
   Tostanoski, Lisa
   Borducchi, Erica N.
   De La Barrera, Rafael A.
   Barouch, Dan H.
TI Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection
   against Zika Virus Challenge in Pregnant IFN-alpha beta R-/- Mice
SO CELL HOST & MICROBE
LA English
DT Article
ID TRANSMISSION; INFECTION
AB Maternal infection with Zika virus (ZIKV) can lead to microcephaly and other congenital abnormalities of the fetus. Although ZIKV vaccines that prevent or reduce viremia in non-pregnant mice have been described, a maternal vaccine that provides complete fetal protection would be desirable. Here, we show that adenovirus (Ad) vector-based ZIKV vaccines induce potent neutralizing antibodies that confer robust maternal and fetal protection against ZIKV challenge in pregnant, highly susceptible IFN-alpha beta R-/- mice. Moreover, passive transfer of maternal antibodies from vaccinated dams protected pups against post-natal ZIKV challenge. These data suggest that Ad-based ZIKV vaccines may be able to provide protection in pregnant females against fetal ZIKV transmission in utero as well as in infants against ZIKV infection after birth.
C1 [Larocca, Rafael A.; Mendes, Erica A.; Abbink, Peter; Peterson, Rebecca L.; Martinot, Amanda J.; Iampietro, Mark Justin; Kang, Zi H.; Aid, Malika; Kirilova, Marinela; Jacob-Dolan, Catherine; Tostanoski, Lisa; Borducchi, Erica N.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Mendes, Erica A.] Univ Sao Paulo, BR-05508000 Sao Paulo, SP, Brazil.
   [De La Barrera, Rafael A.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
OI Jacob-Dolan, Catherine/0000-0001-6641-0342
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI124377, AI128751];
   Ragon Institute of MGH, MIT, and Harvard
FX We thank Helen DeCosta, Denise Glass, Laurie Skowronski, Sandy
   Vertentes, Lindsay Bright, and Ernesto Ospina from Animal Research
   Facility for help with the experiments. We thank Brianna Alimonti,
   Kittipos Visitsunthorn, Shant Mahrokhian, David Jetton, Rod Bronson, and
   Priya Gandhi for technical support. We acknowledge support from the
   National Institutes of Health (AI124377 and AI128751) and the Ragon
   Institute of MGH, MIT, and Harvard.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lavenex P, 2007, DEV NEUROSCI-BASEL, V29, P179, DOI 10.1159/000096222
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Wang R, 2018, VACCINE, V36, P3522, DOI 10.1016/j.vaccine.2018.04.051
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 21
TC 2
Z9 2
U1 4
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD NOV 13
PY 2019
VL 26
IS 5
BP 591
EP +
DI 10.1016/j.chom.2019.10.001
PG 14
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA JM5OX
UT WOS:000496264400008
PM 31668877
DA 2020-07-08
ER

PT J
AU Kumar, D
   Aarthy, M
   Kumar, P
   Singh, SK
   Uversky, VN
   Giri, R
AF Kumar, Deepak
   Aarthy, Murali
   Kumar, Prateek
   Singh, Sanjeev Kumar
   Uversky, Vladimir N.
   Giri, Rajanish
TI Targeting the NTPase site of Zika virus NS3 helicase for inhibitor
   discovery
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE NS3 helicase; molecular docking; MD simulations; NTPase; Zika virus
ID MOLECULAR-DYNAMICS SIMULATION; ANTIVIRAL ACTIVITY; IN-VITRO; ACCURATE
   DOCKING; HEPATITIS-C; PROTEIN; TRANSMISSION; PREDICTION; INFECTION;
   GLIDE
AB The major threats linked to Zika virus (ZIKV) are microcephaly, Guillain-Barre syndrome, and the ability to transfer through sexual transmission. Despite these threats, Zika specific FDA approved drugs or vaccines are not available as of yet. Additionally, the involvement of pregnant women makes the drug screening process lengthy and complicated in terms of safety and minimum toxicity of the molecules. Since NS3 helicase of ZIKV performs the critical function of unwinding double-stranded RNA during replication, it is considered as a promising drug target to block ZIKV replication. In the present study, we have exploited the NTPase site of ZIKV NS3 helicase for screening potential inhibitor compounds by molecular docking, and molecular dynamics (MD) simulation approaches. NS3 helicase hydrolyzes the ATP to use its energy for unwinding RNA. We have chosen twenty natural compounds from ZINC library with known antiviral properties and a helicase focused library (HFL) of small molecules from Life Chemicals compounds. After going through docking, the top hit molecules from ZINC and HFL library were further analysed by MD simulations to find out stable binding poses. Finally, we have reported the molecules with potential of binding at NTPase pocket of ZIKV NS3 helicase, which could be further tested on virus through in vitro experiments to check their efficacy. Communicated by Ramaswamy H. Sarma
C1 [Kumar, Deepak; Kumar, Prateek; Giri, Rajanish] Sch Basic Sci, Indian Inst Technol Mandi, VPO Kamand, Mandi 175005, Himachal Prades, India.
   [Aarthy, Murali; Singh, Sanjeev Kumar] Alagappa Univ, Dept Bioinformat Comp Aided Drug Design & Mol Mod, Karaikkudi, Tamil Nadu, India.
   [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA.
   [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL USA.
   [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Moscow, Russia.
   [Giri, Rajanish] Indian Inst Technol Mandi, BioX Ctr, Mandi, Himachal Prades, India.
RP Giri, R (corresponding author), Sch Basic Sci, Indian Inst Technol Mandi, VPO Kamand, Mandi 175005, Himachal Prades, India.
EM rajanishgiri@iitmandi.ac.in
RI Singh, Kumar/AAP-1954-2020; Uversky, Vladimir N./F-4515-2011; Giri,
   Rajanish/Q-6530-2018
OI Singh, Kumar/0000-0003-4153-6437; Uversky, Vladimir
   N./0000-0002-4037-5857; Giri, Rajanish/0000-0002-2046-836X; Kumar,
   Deepak/0000-0001-8182-0016; Kumar, Prateek/0000-0001-7392-5045
FU DBT grant, India [BT/11/IYBA/2018/06]; ICMR fellowship India
FX This work was partially supported by DBT grant, India
   (BT/11/IYBA/2018/06) to RG. DK is grateful to ICMR fellowship India.
CR Abba Y, 2015, ADV VIROL, V2015, DOI 10.1155/2015/184241
   Ambadipudi S, 2016, EXPERT OPIN DRUG DIS, V11, P65, DOI 10.1517/17460441.2016.1107041
   Bowers K.J., 2006, P 2006 ACM IEEE C SU, DOI [10.1145/1188455.1188544, DOI 10.1109/SC.2006.54]
   Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197
   Choudhary P, 2020, J BIOMOL STRUCT DYN, V38, P1143, DOI 10.1080/07391102.2019.1597767
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Davidson RB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006103
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   deSouza ON, 1997, BIOPHYS J, V72, P2395, DOI 10.1016/S0006-3495(97)78884-2
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016
   Estevez AM, 2012, MINI-REV MED CHEM, V12, P1443
   Fan WC, 2016, VIRUS RES, V220, P112, DOI 10.1016/j.virusres.2016.04.021
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Ganapaty S., 2009, Journal of Natural Remedies, V9, P202
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356
   Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jassim SAA, 2010, EVID-BASED COMPL ALT, V7, P57, DOI 10.1093/ecam/nem160
   Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kumar D., 2019, 530600 BIORXIV, DOI [10.1101/530600, DOI 10.1101/530600]
   Kumar D, 2017, CANCER INFORM, V16, DOI 10.1177/1176935117699408
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lin Liang-Tzung, 2014, J Tradit Complement Med, V4, P24, DOI 10.4103/2225-4110.124335
   Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007
   Matallo MB, 2014, PLANTA DANINHA, V32, P601, DOI 10.1590/S0100-83582014000300016
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Pasetto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115323
   Polyak SJ, 2008, HEPATOLOGY, V48, P345, DOI 10.1002/hep.22235
   Pradiba D, 2018, J BIOMOL STRUCT DYN, V36, P3718, DOI 10.1080/07391102.2017.1397058
   Ramharack P, 2017, RSC ADV, V7, P22133, DOI 10.1039/c7ra01376k
   Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Suarez B, 2010, FOOD CHEM, V120, P339, DOI 10.1016/j.foodchem.2009.09.073
   Sun YG, 2013, PHARM BIOL, V51, P1137, DOI 10.3109/13880209.2013.781197
   Suryanarayanan V, 2015, J RECEPT SIG TRANSD, V35, P370, DOI 10.3109/10799893.2014.956756
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Traboulsi H, 2015, ANTIMICROB AGENTS CH, V59, P6317, DOI 10.1128/AAC.01098-15
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   WHOh, 2018, ZIK VIR INF IND
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu WH, 2015, CHEM BIODIVERS, V12, P54, DOI 10.1002/cbdv.201300269
   Yang XY, 2018, FASEB J, V32, P5250, DOI 10.1096/fj.201701140R
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zandi K, 2011, J MED PLANTS RES, V5, P5534
   Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030259
   Zhang XCG, 2009, ANTIVIR RES, V83, P21, DOI 10.1016/j.antiviral.2009.02.204
NR 64
TC 5
Z9 5
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2019.1689851
EA NOV 2019
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA JM7DF
UT WOS:000496369800001
PM 31690231
DA 2020-07-08
ER

PT J
AU Lim, SM
   Wever, R
   Pas, SD
   Bonofacio, G
   Koopmans, MPG
   Martina, BEE
AF Lim, Stephanie M.
   Wever, Robert
   Pas, Suzan D.
   Bonofacio, Gygliola
   Koopmans, Marion P. G.
   Martina, Byron E. E.
TI Zika Virus Outbreak on Curacao and Bonaire, a Report Based on Laboratory
   Diagnostics Data
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE Zika virus; outbreak; laboratory; qRT-PCR; epidemiology; Curacao;
   Bonaire
ID SEXUAL TRANSMISSION; BARRE-SYNDROME; VAGINAL SECRETIONS; INFECTION;
   DENGUE; GUILLAIN; BRAZIL; EPIDEMIC; PACIFIC; AMERICA
AB Background: Zika virus (ZIKV) emerged in May 2015 in Brazil, from which it spread to many other countries in Latin America. Cases of ZIKV infection were eventually also reported in Curacao (January 2016) and Bonaire (February 2016). Methods: In the period of 16 December 2015 until 26 April 2017, serum, EDTA-plasma or urine samples were taken at Medical Laboratory Services (MLS) from patients on Curacao and tested in qRT-PCR at the Erasmus Medical Centre (EMC) in the Netherlands. Between 17 October 2016 until 26 April 2017 all samples of suspected ZIKV-patients collected on Curacao, as well as on Bonaire, were tested at MLS. Paired urine and/or serum samples from patients were analyzed for ZIKV shedding kinetics, and compared in terms of sensitivity for ZIKV RNA detection. Furthermore, the age and gender of patients were used to determine ZIKV incidence rates, and their geozone location to determine the spatial distribution of ZIKV cases. Results: In total, 781 patients of 2820 tested individuals were found qRT-PCR-positive for ZIKV on Curacao. The first two ZIKV cases were diagnosed in December 2015. A total of 112 patients of 382 individuals tested qRT-PCR-positive for ZIKV on Bonaire. For both islands, the peak number of absolute cases occurred in November 2016, with 247 qRT-PCR confirmed cases on Curacao and 66 qRT-PCR-positive cases on Bonaire. Overall, a higher proportion of women than men was diagnosed with ZIKV on both islands, as well as mostly individuals in the age category of 25-54 years old. Furthermore, ZIKV cases were mostly clustered in the east of the island, in Willemstad. Conclusions: ZIKV cases confirmed by qRT-PCR indicate that the virus was circulating on Curacao between at least December 2015 and March 2017, and on Bonaire between at least October 2016 and February 2017, with peak cases occurring in November 2016. The lack of preparedness of Curacao for the ZIKV outbreak was compensated by shipping all samples to the EMC for diagnostic testing; however, both islands will need to put the right infrastructure in place to enable a rapid response to an outbreak of any new emergent virus in the future.
C1 [Lim, Stephanie M.; Martina, Byron E. E.] Artemis One Hlth Res Fdn, Delft, Netherlands.
   [Wever, Robert; Bonofacio, Gygliola] Med Lab Serv, Willemstad, Curacao.
   [Pas, Suzan D.; Koopmans, Marion P. G.; Martina, Byron E. E.] Erasmus MC, WHO Collaborating Ctr Arboviruses & Hemorrhag Fev, Dept Virosci, Rotterdam, Netherlands.
RP Lim, SM (corresponding author), Artemis One Hlth Res Fdn, Delft, Netherlands.
EM s.lim@artemisonehealth.com
FU COMPARE (European Union's Horizon 2020) [643476]; ZikaRisk (NWO ZonMW
   Project) [522003001]; ZIKAlliance (European Union's Horizon 2020)
   [734548]
FX The research leading to these results has received funding from COMPARE
   (European Union's Horizon 2020, Grant Agreement No. 643476), ZikaRisk
   (NWO ZonMW Project No. 522003001), and ZIKAlliance (European Union's
   Horizon 2020, Grant Agreement No. 734548). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carias AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005885
   Codrington J, 2018, PLOS CURR, P10, DOI [10.1371/currents.outbreaks.ff0f6190d5431c2a2e824255eaeaf33929896441, DOI 10.1371/CURRENTS.OUTBREAKS.FF0F6190D5431C2A2E824255EAEAF33929896441]
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galan-Huerta K, 2016, MED U, V18, P115, DOI DOI 10.1016/J.RMU.2016.05.003
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoek RAS, 2013, SCAND J INFECT DIS, V45, P65, DOI 10.3109/00365548.2012.708942
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lamb LE, 2016, INT UROL NEPHROL, V48, P1961, DOI 10.1007/s11255-016-1406-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2014, NUMB REP CAS CHIK FE
   Pan American Health Organization, 2016, TIM EM ZIK VIR AM
   Pan American Health Organization, PLISA HLTH INF PLATF
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Ter Bals M., 2014, DEMOGRAPHY CURACAO P
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Wong Chee Wai, 2019, Retin Cases Brief Rep, V13, P171, DOI 10.1097/ICB.0000000000000552
   World Health Organization, 2016, WHOZIKVLAB161
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 48
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD NOV 12
PY 2019
VL 7
AR 333
DI 10.3389/fpubh.2019.00333
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JQ8OE
UT WOS:000499197000001
PM 31781532
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Black, A
   Moncla, LH
   Laiton-Donato, K
   Potter, B
   Pardo, L
   Rico, A
   Tovar, C
   Rojas, DP
   Longini, IM
   Halloran, ME
   Pelaez-Carvajal, D
   Ramirez, JD
   Mercado-Reyes, M
   Bedford, T
AF Black, Allison
   Moncla, Louise H.
   Laiton-Donato, Katherine
   Potter, Barney
   Pardo, Lissethe
   Rico, Angelica
   Tovar, Catalina
   Rojas, Diana P.
   Longini, Ira M.
   Halloran, M. Elizabeth
   Pelaez-Carvajal, Dioselina
   Ramirez, Juan D.
   Mercado-Reyes, Marcela
   Bedford, Trevor
TI Genomic epidemiology supports multiple introductions and cryptic
   transmission of Zika virus in Colombia
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Colombia; Genomic epidemiology; Phylogeography; Virus evolution; Zika
   virus
ID INFECTION; ALIGNMENT
AB Background Colombia was the second most affected country during the American Zika virus (ZIKV) epidemic, with over 109,000 reported cases. Despite the scale of the outbreak, limited genomic sequence data were available from Colombia. We sought to sequence additional samples and use genomic epidemiology to describe ZIKV dynamics in Colombia. Methods We sequenced ZIKV genomes directly from clinical diagnostic specimens and infected Aedes aegypti samples selected to cover the temporal and geographic breadth of the Colombian outbreak. We performed phylogeographic analysis of these genomes, along with other publicly-available ZIKV genomes from the Americas, to estimate the frequency and timing of ZIKV introductions to Colombia. Results We attempted PCR amplification on 184 samples; 19 samples amplified sufficiently to perform sequencing. Of these, 8 samples yielded sequences with at least 50% coverage. Our phylogeographic reconstruction indicates two separate introductions of ZIKV to Colombia, one of which was previously unrecognized. We find that ZIKV was first introduced to Colombia in February 2015 (95%CI: Jan 2015 - Apr 2015), corresponding to 5 to 8 months of cryptic ZIKV transmission prior to confirmation in September 2015. Despite the presence of multiple introductions, we find that the majority of Colombian ZIKV diversity descends from a single introduction. We find evidence for movement of ZIKV from Colombia into bordering countries, including Peru, Ecuador, Panama, and Venezuela. Conclusions Similarly to genomic epidemiological studies of ZIKV dynamics in other countries, we find that ZIKV circulated cryptically in Colombia. More accurately dating when ZIKV was circulating refines our definition of the population at risk. Additionally, our finding that the majority of ZIKV transmission within Colombia was attributable to transmission between individuals, rather than repeated travel-related importations, indicates that improved detection and control might have succeeded in limiting the scale of the outbreak within Colombia.
C1 [Black, Allison; Halloran, M. Elizabeth; Bedford, Trevor] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Black, Allison; Moncla, Louise H.; Potter, Barney; Halloran, M. Elizabeth; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Laiton-Donato, Katherine; Pardo, Lissethe; Rico, Angelica; Pelaez-Carvajal, Dioselina; Mercado-Reyes, Marcela] Inst Nacl Salud, Lab Virol, Subdirecc Lab Nacl Referencia, Direcc Redes Salud Publ, Bogota, Colombia.
   [Tovar, Catalina] Univ Sinu, Fac Ciencias Salud, Grp Enfermedades Trop & Resistencia Bacteriana, Cordoba, Colombia.
   [Rojas, Diana P.; Longini, Ira M.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Ramirez, Juan D.] Univ Rosario, Fac Ciencias Nat & Matemat, Dept Biol, GIMUR, Bogota, Colombia.
RP Bedford, T (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Bedford, T (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
EM trevor@bedford.io
FU National Science Foundation Graduate Research Fellowship ProgramNational
   Science Foundation (NSF) [DGE-1256082]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [U54
   GM111274, R35 GM119774-01]; Grupo de Virologia, Direccion de Redes en
   Salud Publica, Instituto Nacional de Salud. Bogota D.C, Colombia;
   Gobernacion de Cordoba, sistema general de regalias (SGR) Colombia
   [754/2013]; Direccion de Investigacion e Innovacion from Universidad del
   Rosario
FX AB is supported by the National Science Foundation Graduate Research
   Fellowship Program under Grant No. DGE-1256082. LHM, DPR, MEH, and IML
   are supported by NIH U54 GM111274. LHM is an Open Philanthropy Project
   fellow of the Life Sciences Research Foundation. This work was partially
   supported by Grupo de Virologia, Direccion de Redes en Salud Publica,
   Instituto Nacional de Salud. Bogota D.C, Colombia. CT and JDR are funded
   by Gobernacion de Cordoba, sistema general de regalias (SGR) Colombia,
   Grant No. 754/2013 and by Direccion de Investigacion e Innovacion from
   Universidad del Rosario. TB is a Pew Biomedical Scholar and is supported
   by NIH R35 GM119774-01. The funding bodies had no role in the design of
   the study, data collection, data analysis, data interpretation, nor in
   the writing of the manuscript.
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Instituto Nacional de Salud, B EP SEM SEM EP 08 2
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJM0A1604037]
   PAHO, ZIK CUM CAS
   PAHO/WHO, 2015, EP AL ZIK VIR INF
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
NR 37
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 12
PY 2019
VL 19
IS 1
AR 963
DI 10.1186/s12879-019-4566-2
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA JO6DH
UT WOS:000497667000001
PM 31718580
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Ahlers, LRH
   Trammell, CE
   Carrell, GF
   Mackinnon, S
   Torrevillas, BK
   Chow, CY
   Luckhart, S
   Goodman, AG
AF Ahlers, Laura R. H.
   Trammell, Chasity E.
   Carrell, Grace F.
   Mackinnon, Sophie
   Torrevillas, Brandi K.
   Chow, Clement Y.
   Luckhart, Shirley
   Goodman, Alan G.
TI Insulin Potentiates JAK/STAT Signaling to Broadly Inhibit Flavivirus
   Replication in Insect Vectors
SO CELL REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; ANTIVIRAL IMMUNITY; RNA INTERFERENCE;
   PLASMODIUM-FALCIPARUM; NATURAL VARIATION; TYROSINE KINASE; INNATE
   IMMUNITY; UNITED-STATES; DENGUE VIRUS; ZIKA VIRUS
AB The World Health Organization estimates that more than half of the world's population is at risk for vector-borne diseases, including arboviruses. Because many arboviruses are mosquito borne, investigation of the insect immune response will help identify targets to reduce the spread of arboviruses. Here, we use a genetic screening approach to identify an insulin-like receptor as a component of the immune response to arboviral infection. We determine that vertebrate insulin reduces West Nile virus (WNV) replication in Drosophila melanogaster as well as WNV, Zika, and dengue virus titers in mosquito cells. Mechanistically, we show that insulin signaling activates the JAK/STAT, but not RNAi, pathway via ERK to control infection in Drosophila cells and Culex mosquitoes through an integrated immune response. Finally, we validate that insulin priming of adult female Culex mosquitoes through a blood meal reduces WNV infection, demonstrating an essential role for insulin signaling in insect antiviral responses to human pathogens.
C1 [Ahlers, Laura R. H.; Trammell, Chasity E.; Carrell, Grace F.; Mackinnon, Sophie; Goodman, Alan G.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.
   [Torrevillas, Brandi K.; Luckhart, Shirley] Univ Idaho, Coll Agr & Life Sci, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83844 USA.
   [Chow, Clement Y.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA.
   [Luckhart, Shirley] Univ Idaho, Dept Biol Sci, Coll Sci, Moscow, ID 83844 USA.
   [Goodman, Alan G.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
   [Ahlers, Laura R. H.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20814 USA.
RP Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.; Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
EM alan.goodman@wsu.edu
RI Smith, Haley/AAJ-3781-2020; Goodman, Alan/AAQ-1108-2020
OI Goodman, Alan/0000-0001-6394-332X
FU NIH/National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R00 AI106963, R21 AI128103]; NIH/National Institute of
   General Medical Sciences (NIGMS)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [T32 GM008336]; Poncin
   Fellowship; Stanley L. Adler Research Fund; Mary V. Schindler Equine
   Research Endowment; NIH/NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R56 AI118926]; NIH/NIGMSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [R35 GM124780]; Glenn Award from the Glenn Foundation for
   Medical Research
FX We thank S. Best, A. Nicola, R. Tesh, and S. O'Neill for cells and
   viruses used in these experiments, and we thank the staff, particularly
   J. Huffman, at the Laboratory Animal Research Facility at the University
   of Idaho for assistance with mosquito husbandry. We thank M. LeBlanc for
   expert advice on methods of statistical analysis, A. Brown and J. Ahlers
   for expertise in analyzing bioinformatics data, and S. Balachandran for
   critical reading of our manuscript. This research was supported by
   NIH/National Institute of Allergy and Infectious Diseases (NIAID) grants
   R00 AI106963 and R21 AI128103 to A.G.G., an NIH/National Institute of
   General Medical Sciences (NIGMS)-funded pre-doctoral fellowship (T32
   GM008336) and a Poncin Fellowship to L.R.H.A., the Stanley L. Adler
   Research Fund, and the Mary V. Schindler Equine Research Endowment. S.L.
   was supported by an NIH/NIAID R56 award (R56 AI118926). C.Y.C. was
   supported by an NIH/NIGMS R35 award (R35 GM124780) and a Glenn Award
   from the Glenn Foundation for Medical Research. C.Y.C. is the University
   of Utah Mario R. Capecchi Endowed Chair in Genetics.
CR Ahlers LRH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166088
   Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411
   Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Arik AJ, 2015, FASEB J, V29, P1404, DOI 10.1096/fj.14-261479
   Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745
   BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109
   Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105
   Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3
   Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x
   Choi NH, 2011, P NATL ACAD SCI USA, V108, P18702, DOI 10.1073/pnas.1109348108
   Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021
   Chow CY, 2016, HUM MOL GENET, V25, P651, DOI 10.1093/hmg/ddv502
   Chow CY, 2013, P NATL ACAD SCI USA, V110, P9013, DOI 10.1073/pnas.1307125110
   Ciota Alexander T., 2011, BMC Ecology, V11, P23, DOI 10.1186/1472-6785-11-23
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]
   Darby SM, 2001, J ANAL TOXICOL, V25, P8, DOI 10.1093/jat/25.1.8
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Drexler A, 2013, J EXP BIOL, V216, P208, DOI 10.1242/jeb.078873
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032
   FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219
   Gonzalez I, 2014, MOL CELL, V54, P485, DOI 10.1016/j.molcel.2014.03.004
   Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115
   Hadler JL, 2014, MMWR-MORBID MORTAL W, V63, P281
   Haqshenas G, 2019, CELL REP, V26, P529, DOI 10.1016/j.celrep.2018.12.068
   Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252
   Harsh S, 2018, J IMMUNOL, V201, P3058, DOI 10.4049/jimmunol.1800597
   Hiroyasu A, 2018, JOVE-J VIS EXP, DOI 10.3791/57077
   Howick VM, 2017, MOL ECOL, V26, P1533, DOI 10.1111/mec.14017
   HSU SH, 1970, J MED ENTOMOL, V7, P703, DOI 10.1093/jmedent/7.6.703
   Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549
   Inoue YH, 2018, ADV EXP MED BIOL, V1076, P235, DOI 10.1007/978-981-13-0529-0_13
   Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955
   Kauffman E, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2542
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Kumar M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-80
   Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044682
   Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   LAUTIEHARIVEL N, 1990, BIOL CELL, V69, P35, DOI 10.1016/0248-4900(90)90326-X
   Lavoy S, 2018, GENETICS, V209, P1345, DOI 10.1534/genetics.118.301119
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005
   Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200
   Loza-Coll MA, 2014, EMBO J, V33, P2983, DOI 10.15252/embj.201489050
   Luckhart S, 2007, DEV COMP IMMUNOL, V31, P647, DOI 10.1016/j.dci.2006.10.005
   Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811
   Marques JT, 2016, CURR OPIN MICROBIOL, V32, P71, DOI 10.1016/j.mib.2016.05.002
   Martin M, 2018, CELL REP, V23, P3537, DOI 10.1016/j.celrep.2018.05.029
   Marzi A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00117
   Mavrouli M, 2019, AM J TROP MED HYG, V100, P420, DOI 10.4269/ajtmh.18-0339
   Molleston JM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010002
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Mukherjee S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-127
   Mussabekova A, 2017, CELL MOL LIFE SCI, V74, P2039, DOI 10.1007/s00018-017-2453-9
   Musselman LP, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163881
   Musselman LP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00259-17
   Nag DK, 2017, J GEN VIROL, V98, P2731, DOI 10.1099/jgv.0.000945
   Nag DK, 2016, VIROLOGY, V498, P164, DOI 10.1016/j.virol.2016.08.022
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nassel DR, 2016, CELL MOL LIFE SCI, V73, P271, DOI 10.1007/s00018-015-2063-3
   Nuss AB, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006413
   ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067
   Pabalan N, 2017, ACTA TROP, V173, P17, DOI 10.1016/j.actatropica.2017.05.007
   Pakpour N, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1277-7
   Pakpour N, 2012, INFECT IMMUN, V80, P2141, DOI 10.1128/IAI.00024-12
   Paradkar PN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002823
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   PETRUZZELLI L, 1985, J BIOL CHEM, V260, P6072
   Petruzzelli L, 1985, GROWTH FACTORS TRANS, V3, P115
   Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703
   Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019
   Reid WR, 2015, INT J BIOL SCI, V11, P1306, DOI 10.7150/ijbs.12829
   Rios JJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-313
   Rios JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010537
   Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18
   Rossi AD, 2019, J INTERN MED, V285, P215, DOI 10.1111/joim.12829
   Scherbik SV, 2010, J VIROL, V84, P8721, DOI 10.1128/JVI.00144-10
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14
   Sleiman MSB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8829
   Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606
   Smith JL, 2014, J VIROL, V88, P5533, DOI 10.1128/JVI.00365-14
   Spellberg MJ, 2015, P NATL ACAD SCI USA, V112, P14587, DOI 10.1073/pnas.1517124112
   Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907
   Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Surachetpong W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000366
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Tham HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01040
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   U.S. Department of Health and Human Services, 2009, BIOSAFETY IN MICROBI
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Wang JB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006260
   Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210
   West C, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007020
   Xavier-Carvalho C, 2017, INFECT GENET EVOL, V56, P99, DOI 10.1016/j.meegid.2017.11.009
   Xia ZC, 2017, J IMMUNOL, V198, P3690, DOI 10.4049/jimmunol.1601588
   Xu J, 2013, P NATL ACAD SCI USA, V110, P15025, DOI 10.1073/pnas.1303193110
   YAMAGUCHI T, 1995, BIOCHEMISTRY-US, V34, P4962, DOI 10.1021/bi00015a007
   Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974
   Zhang HX, 2018, HEPATOLOGY, V68, P1710, DOI 10.1002/hep.30073
   Zhang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002429
   Zhou F., 2012, JAK STAT SIGNALING B
   Zhou SS, 2016, ENVIRON HEALTH PERSP, V124, P1062, DOI 10.1289/ehp.1510513
NR 125
TC 2
Z9 2
U1 4
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD NOV 12
PY 2019
VL 29
IS 7
BP 1946
EP +
DI 10.1016/j.celrep.2019.10.029
PG 20
WC Cell Biology
SC Cell Biology
GA JN2FW
UT WOS:000496717500018
PM 31722209
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Hao, YL
   Wang, WF
   Jacobs, BC
   Qiao, BJ
   Chen, MS
   Liu, DQ
   Feng, XG
   Wang, YZ
AF Hao, Yanlei
   Wang, Weifang
   Jacobs, Bart C.
   Qiao, Baojun
   Chen, Mengshi
   Liu, Daiqiang
   Feng, Xungang
   Wang, Yuzhong
TI Antecedent infections in Guillain-Barre syndrome: a single-center,
   prospective study
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article; Early Access
ID CAMPYLOBACTER-JEJUNI INFECTION; AUTOIMMUNE HEPATITIS; VIRUS; ANTIBODIES;
   CHINA
AB Objective To investigate the spectrum of antecedent infections in Chinese patients with Guillain-Barre syndrome (GBS) and analyze the infections-related clinical phenotypes locally. Methods A prospective case-control study of 150 patients diagnosed with GBS and age- and sex-matched neurological and healthy controls was performed to investigate recent infections of 14 pathogens serologically and collect the clinical data during a follow-up of 12 months. Results In total, 53% of patients with GBS had a positive serology for recent infection, including Campylobacter jejuni (27%), influenza A (17%) and B (16%), hepatitis A virus (5%), dengue virus (3%), cytomegalovirus (3%), Epstein-Barr virus (3%), Mycoplasma pneumoniae (2%), herpes simplex virus (2%), varicella-zoster virus (1%), and rubella virus (1%). Serology for infections of hepatitis E virus, Haemophilus influenzae, and Zika virus was negative. There was a higher frequency of C. jejuni, influenza A, influenza B, and hepatitis A virus infections in GBS patients than both the neurological and healthy controls. C. jejuni infection was more frequent in younger GBS patients and was associated with antibodies against GM1, GalNAc-GD1a, and GM1:galactocerebroside complex. Influenza B infection was associated with a pure motor form of GBS. Interpretation C. jejuni, influenza A, influenza B, and hepatitis A virus serve as the most common cause of antecedent infections in GBS locally. Influenza B-related GBS may represent a pure motor phenotype. Differences in the infectious spectrum worldwide may contribute to the geographical clinical heterogeneity of GBS.
C1 [Hao, Yanlei; Wang, Weifang; Qiao, Baojun; Liu, Daiqiang; Feng, Xungang; Wang, Yuzhong] Jining Med Univ, Affiliated Hosp, Dept Neurol, 89 Guhuai Rd, Jining 272029, Shandong, Peoples R China.
   [Jacobs, Bart C.] Erasmus MC, Dept Neurol & Immunol, Rotterdam, Netherlands.
   [Chen, Mengshi] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.
   [Wang, Yuzhong] Jining Med Univ, Affiliated Hosp, Cent Lab, 89 Guhuai Rd, Jining 272029, Shandong, Peoples R China.
RP Wang, YZ (corresponding author), Jining Med Univ, Affiliated Hosp, Dept Neurol, 89 Guhuai Rd, Jining 272029, Shandong, Peoples R China.; Wang, YZ (corresponding author), Jining Med Univ, Affiliated Hosp, Cent Lab, 89 Guhuai Rd, Jining 272029, Shandong, Peoples R China.
EM wangyuzhong_ni@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81771298, 81771360, 81301072]; Shandong Province
   Natural Science Fund Project [ZR2017LH034]; Shandong Medical and Healthy
   Science Technology Development Plan [2016WS0184, 2017SMNS002]
FX This work was supported by the National Natural Science Foundation of
   China (81771298, 81771360, and 81301072), Shandong Province Natural
   Science Fund Project (ZR2017LH034), Shandong Medical and Healthy Science
   Technology Development Plan (2016WS0184), and the Technology boosting
   new and old kinetic energy conversion projects of Jining City
   (2017SMNS002).
CR Al-Hamoudi WK, 2009, WORLD J GASTROENTERO, V15, P1004, DOI 10.3748/wjg.15.1004
   Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   CHIBA A, 1992, ANN NEUROL, V31, P677, DOI 10.1002/ana.410310619
   Doets AY, 2018, BRAIN, V141, P2866, DOI 10.1093/brain/awy232
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   HUPPERTZ HI, 1995, J HEPATOL, V23, P204, DOI 10.1016/0168-8278(95)80336-X
   Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Jayashree K, 2017, INDIAN J CRIT CARE M, V21, P802, DOI 10.4103/0972-5229.218137
   Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14
   Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C
   Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014
   Liu SP, 2018, J NEUROL NEUROSUR PS, V89, P618, DOI 10.1136/jnnp-2017-316930
   Mitsui Y, 2015, J NEUROL NEUROSUR PS, V86, P110, DOI 10.1136/jnnp-2013-306509
   Oomes PG, 1996, NEUROLOGY, V46, P96, DOI 10.1212/WNL.46.1.96
   Papic N, 2012, INFLUENZA OTHER RESP, V6, pe2, DOI 10.1111/j.1750-2659.2011.00287.x
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   Sauteur PMM, 2016, ANN NEUROL, V80, P566, DOI 10.1002/ana.24755
   Sekiguchi Y, 2012, J NEUROL NEUROSUR PS, V83, P23, DOI 10.1136/jnnp-2011-300309
   Shahrizaila N, 2014, NEUROLOGY, V83, P118, DOI 10.1212/WNL.0000000000000577
   Sivadon-Tardy V, 2009, CLIN INFECT DIS, V48, P48, DOI 10.1086/594124
   VENTO S, 1995, LANCET, V346, P608, DOI 10.1016/S0140-6736(95)91438-2
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Ye YQ, 2013, MUSCLE NERVE, V47, P68, DOI 10.1002/mus.23477
   Yuki N, 1999, J NEUROL SCI, V164, P134, DOI 10.1016/S0022-510X(99)00056-8
   YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771
NR 32
TC 1
Z9 1
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
DI 10.1002/acn3.50946
EA NOV 2019
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JL9JB
UT WOS:000495841100001
PM 31714025
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU No, JS
   Kim, WK
   Cho, S
   Lee, SH
   Kim, JA
   Lee, D
   Song, DH
   Gu, SH
   Jeong, ST
   Wiley, MR
   Palacios, G
   Song, JW
AF No, Jin Sun
   Kim, Won-Keun
   Cho, Seungchan
   Lee, Seung-Ho
   Kim, Jeong-Ah
   Lee, Daesang
   Song, Dong Hyun
   Gu, Se Hun
   Jeong, Seong Tae
   Wiley, Michael R.
   Palacios, Gustavo
   Song, Jin-Won
TI Comparison of targeted next-generation sequencing for whole- genome
   sequencing of Hantaan orthohantavirus in Apodemus agrarius lung tissues
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VIRUS; AMPLIFICATION; DIVERSITY; TRANSMISSION; EVOLUTION; INFECTION;
   ORIGINS; CLONING; ZIKA
AB Orthohantaviruses, negative-sense single-strand tripartite RNA viruses, are a global public health threat. In humans, orthohantavirus infection causes hemorrhagic fever with renal syndrome or hantavirus cardiopulmonary syndrome. Whole-genome sequencing of the virus helps in identification and characterization of emerging or re-emerging viruses. Next-generation sequencing (NGS) is a potent method to sequence the viral genome, using molecular enrichment methods, from clinical specimens containing low virus titers. Hence, a comparative study on the target enrichment NGS methods is required for whole-genome sequencing of orthohantavirus in clinical samples. In this study, we used the sequence-independent, single-primer amplification, target capture, and amplicon NGS for whole-genome sequencing of Hantaan orthohantavirus (HTNV) from rodent specimens. We analyzed the coverage of the HTNV genome based on the viral RNA copy number, which is quantified by real-time quantitative PCR. Target capture and amplicon NGS demonstrated a high coverage rate of HTNV in Apodemus agrarius lung tissues containing up to 10(3)-10(4) copies/mu L of HTNV RNA. Furthermore, the amplicon NGS showed a 10-fold (10(2) copies/mu L) higher sensitivity than the target capture NGS. This report provides useful insights into target enrichment NGS for whole-genome sequencing of orthohantaviruses without cultivating the viruses.
C1 [No, Jin Sun; Cho, Seungchan; Lee, Seung-Ho; Kim, Jeong-Ah; Song, Jin-Won] Korea Univ, Coll Med, Dept Microbiol, Seoul 02841, South Korea.
   [Kim, Won-Keun] Hallym Univ, Coll Med, Dept Microbiol, Chunchon 24252, South Korea.
   [Kim, Won-Keun] Hallym Univ, Coll Med, Ctr Med Sci Res, Chunchon 24252, South Korea.
   [Lee, Daesang; Song, Dong Hyun; Gu, Se Hun; Jeong, Seong Tae] Agcy Def Dev, R&D Inst 4, Daejeon 34186, South Korea.
   [Wiley, Michael R.; Palacios, Gustavo] US Army Med Res Inst Infect Dis Ft Detrick, Ctr Genome Sci, Frederick, MD 21702 USA.
RP Song, JW (corresponding author), Korea Univ, Coll Med, Dept Microbiol, Seoul 02841, South Korea.
EM jwsong@korea.ac.kr
RI Palacios, Gustavo/I-7773-2015
OI Palacios, Gustavo/0000-0001-5062-1938; Wiley,
   Michael/0000-0001-6688-007X
FU Agency for Defense Development [UD160022ID]; Research Program To Solve
   Social Issues of the National Research Foundation of Korea (NRF) -
   Ministry of Science and ICT [NRF2017M3A9E4061992]; Institute of
   Biomedical Science & Food Safety, Korea University [K1909531]
FX We thank Mr. Charles Hong from Defense Threat Reduction Agency (DTRA)
   for critical discussion and experimental support. We thank Dr. Gary
   Schroth and Dr. Stephen Gross (Illumina) for technical supports. We
   thank Dr. Man-Seong Park (Korea University College of medicine) for
   supporting NGS facility. This work was supported by the Agency for
   Defense Development (UD160022ID), the Research Program To Solve Social
   Issues of the National Research Foundation of Korea (NRF) funded by the
   Ministry of Science and ICT (NRF2017M3A9E4061992), and the Institute of
   Biomedical Science & Food Safety, Korea University (K1909531).
CR Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3
   Chalkias S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186945
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Cotten M, 2016, FUTURE VIROL, V11, P719, DOI 10.2217/fvl-2016-0099
   Cruz CD, 2016, J VIROL METHODS, V235, P158, DOI 10.1016/j.jviromet.2016.06.001
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gizzi M, 2013, EUR J CLIN MICROBIOL, V32, P1341, DOI 10.1007/s10096-013-1885-x
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385
   Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005
   Kim WK, 2018, EMERG INFECT DIS, V24, P249, DOI 10.3201/eid2402.171216
   Kim WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26017
   Laenen L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090788
   LAMBDEN PR, 1992, J VIROL, V66, P1817, DOI 10.1128/JVI.66.3.1817-1822.1992
   LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298
   Li K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-261
   Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419
   Martinez-Martinez M, 2011, FOOD ENVIRON VIROL, V3, P92, DOI 10.1007/s12560-011-9062-9
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   MATSUI SM, 1993, J VIROL, V67, P1712, DOI 10.1128/JVI.67.3.1712-1715.1993
   Metsky HC, 2019, NAT BIOTECHNOL, V37, P160, DOI 10.1038/s41587-018-0006-x
   Neverov A, 2010, P NATL ACAD SCI USA, V107, P20063, DOI 10.1073/pnas.1012537107
   No JS, 2016, MICROBIOL IMMUNOL, V60, P268, DOI 10.1111/1348-0421.12370
   Quan PL, 2008, ANTIVIR RES, V79, P1, DOI 10.1016/j.antiviral.2008.02.002
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0
   Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468
   REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9
   Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013
   Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Song DH, 2017, AM J TROP MED HYG, V96, P389, DOI 10.4269/ajtmh.16-0683
   Song JW, 2009, EMERG INFECT DIS, V15, P1833, DOI 10.3201/eid1511.090076
   Song JW, 2000, VIRUS GENES, V21, P227, DOI 10.1023/A:1008199800011
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066
   Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163
   Wang F, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2596782
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Yu Q, 2011, BIOINFORMATICS, V27, P266, DOI 10.1093/bioinformatics/btq624
NR 43
TC 1
Z9 1
U1 2
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 12
PY 2019
VL 9
AR 16631
DI 10.1038/s41598-019-53043-2
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JL9PK
UT WOS:000495857600085
PM 31719616
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, F
   Cheng, WZ
   Zhao, FY
   Tang, MQ
   Diao, Y
   Xu, RA
AF Wu, Fang
   Cheng, Wenzhao
   Zhao, Feiyuan
   Tang, Mingqing
   Diao, Yong
   Xu, Ruian
TI Association of N6-methyladenosine with viruses and related diseases
SO VIROLOGY JOURNAL
LA English
DT Review
DE N6-methyladenosine (m6A); Methyltransferases; Demethylases; m6A-binding
   proteins; Viral diseases
ID MESSENGER-RNA METHYLATION; SARCOMA-ASSOCIATED HERPESVIRUS; ZIKA VIRUS;
   GENE-EXPRESSION; DNA-SEQUENCES; NUCLEAR-RNA; M(6)A METHYLTRANSFERASE;
   HEPATITIS-B; N-6-METHYLADENOSINE; REVEALS
AB Background N6-methyladenosine (m6A) modification is the most prevalent internal modification of eukaryotic mRNA modulating gene expression. m6A modification is a dynamic reversible process regulated by three protein groups: methyltransferases (writers), demethylases (erasers), and m6A-binding proteins (readers). m6A modification is involved in all phases of RNA metabolism, including RNA folding, stability, splicing, nuclear exporting, translational modulation and degradation. Main body In recent years, numerous studies have reported that abnormal m6A modification causes aberrant expression of important viral genes. Herein, we review the role of m6A in viral lifecycle and its contribution to the pathogenesis of human diseases. Particularly, we focus on the viruses associated with human diseases such as HIV-1, IAV, HBV, HCV, EBV and many others. Conclusions A better understanding of m6A-virus relationship would provide new insights into the viral replication process and pathogenesis of human diseases caused by viruses. In addition, exploration of the role of m6A in disease-causing viruses will reveal novel approaches for the treatment of such diseases.
C1 [Wu, Fang; Cheng, Wenzhao; Zhao, Feiyuan; Tang, Mingqing; Xu, Ruian] Huaqiao Univ, Engn Res Ctr Mol Med, Minist Educ, Xiamen, Fujian, Peoples R China.
   [Wu, Fang; Zhao, Feiyuan; Tang, Mingqing; Diao, Yong; Xu, Ruian] Huaqiao Univ, Sch Med, Xiamen, Fujian, Peoples R China.
   [Cheng, Wenzhao] Fujian Med Univ, Affiliated Hosp 2, Stem Cell Lab, Quanzhou, Fujian, Peoples R China.
   [Tang, Mingqing; Xu, Ruian] Fujian Prov Key Lab Mol Med, Xiamen, Fujian, Peoples R China.
   Fujian Prov Key Lab Precis Med & Mol Detect Univ, Xiamen, Fujian, Peoples R China.
RP Cheng, WZ; Xu, RA (corresponding author), Huaqiao Univ, Engn Res Ctr Mol Med, Minist Educ, Xiamen, Fujian, Peoples R China.
EM wenzhao.cheng@hotmail.com; ruianxu@hqu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81271692]; Ocean Antithrombotic Fibrinolytic Enzyme
   Gene Bank of Taiwan Strait [2014FJPT08]; Science and Technology
   Innovation Public Technology Service Platform of Function of Drugs and
   Food [3502Z20141015]; Education Department of Fujian Province [JA14020];
   Huaqiao University [17013071028]
FX This study was supported by the National Natural Science Foundation of
   China (No. 81271692), the Ocean Antithrombotic Fibrinolytic Enzyme Gene
   Bank of Taiwan Strait (No. 2014FJPT08), the Science and Technology
   Innovation Public Technology Service Platform of Function of Drugs and
   Food (No. 3502Z20141015), Education Department of Fujian Province
   (JA14020) and Subsidized Project for Postgraduates' Innovative Fund in
   Scientific Research of Huaqiao University (No. 17013071028).
CR Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011
   Barry PA, 2007, PRIMATE BETAHERPESVI
   Bartosovic M, 2017, NUCLEIC ACIDS RES, V45, P11356, DOI 10.1093/nar/gkx778
   BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X
   Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030
   BOKAR JA, 1994, J BIOL CHEM, V269, P17697
   Bu W, 2019, IMMUNITY, V50, P1305, DOI 10.1016/j.immuni.2019.03.010
   CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879
   Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   Chang PC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090890
   CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879
   Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683
   Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004
   DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Doxtader KA, 2018, MOL CELL, V71, P1001, DOI 10.1016/j.molcel.2018.07.025
   Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Hao HJ, 2019, NUCLEIC ACIDS RES, V47, P362, DOI 10.1093/nar/gky1007
   HASHIMOTO S, 1976, J VIROL, V20, P425, DOI 10.1128/JVI.20.2.425-435.1976
   Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995
   Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99
   Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z
   Ianniello Z, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082345
   Imam H, 2018, P NATL ACAD SCI USA, V115, P8829, DOI 10.1073/pnas.1808319115
   Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019
   Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]
   Jung KW, 2019, CANCER RES TREAT, V51, P417, DOI 10.4143/crt.2019.138
   KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Kwok CT, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0410-6
   Lang FC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007796
   Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022
   Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10
   Li YL, 2014, RNA BIOL, V11, P1180, DOI 10.4161/rna.36281
   Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0
   Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Liu JQ, 2018, BIOCHEM BIOPH RES CO, V502, P456, DOI 10.1016/j.bbrc.2018.05.175
   Liu Z, 2018, MOL BIOL EVOL, V35, P963, DOI 10.1093/molbev/msy011
   Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999
   Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885
   Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022
   Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2
   Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342
   Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003
   Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3
   Raza SA, 2007, BRIT J CANCER, V96, P1127, DOI 10.1038/sj.bjc.6603649
   Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479
   Roundtree IA, 2017, ELIFE, V6, DOI 10.7554/eLife.31311
   Roundtree IA, 2016, TRENDS GENET, V32, P320, DOI 10.1016/j.tig.2016.03.006
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048
   Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Sun J, 2013, CURR OPIN VIROL, V3, P425, DOI 10.1016/j.coviro.2013.05.001
   Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   To EE, 2019, RESPIROLOGY, V24, P1011, DOI 10.1111/resp.13524
   Tsai K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006919
   Vilchez RA, 2003, AM J MED, V114, P675, DOI 10.1016/S0002-9343(03)00087-1
   Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416
   Wang HQ, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0674-4
   Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014
   Wang XL, 2017, ONCOTARGET, V8, P98918, DOI 10.18632/oncotarget.22041
   Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940
   Ye F, 2017, INFLAMM CELL SIGNAL, V4
   Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17
   Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zheng QL, 2017, NAT IMMUNOL, V18, P1361, DOI 10.1038/ni1217-1361a
   Zhou S, 2018, MOL CARCINOGEN, V57, P590, DOI 10.1002/mc.22782
NR 84
TC 1
Z9 1
U1 8
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD NOV 11
PY 2019
VL 16
IS 1
AR 133
DI 10.1186/s12985-019-1236-3
PG 10
WC Virology
SC Virology
GA JM8KY
UT WOS:000496458200002
PM 31711514
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kamelian, K
   Montoya, V
   Olmstead, A
   Dong, WN
   Harrigan, R
   Morshed, M
   Joy, JB
AF Kamelian, Kimia
   Montoya, Vincent
   Olmstead, Andrea
   Dong, Winnie
   Harrigan, Richard
   Morshed, Muhammad
   Joy, Jeffrey B.
TI Phylogenetic surveillance of travel-related Zika virus infections
   through whole-genome sequencing methods
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SEXUAL TRANSMISSION; ALIGNMENT; EMERGENCE
AB In 2018, the World Health Organization identified the Zika virus (ZIKV) as a pathogen that should be prioritized for public health research due to its epidemic potential. In this study, whole-genome sequencing (WGS) of travel-acquired ZIKV infections was used to examine the limitations of phylogenetic analysis. WGS and phylogenetic analysis were performed to investigate geographic clustering of samples from five Canadians with travel-acquired ZIKV infections and to assess the limitations of phylogenetic analysis of ZIKV sequences using a phylogenetic cluster approach. Genomic variability of ZIKV samples was assessed and for context, compared with hepatitis C virus (HCV) samples. Phylogenetic analysis confirmed the suspected region of ZIKV infection for one of five samples and one sample failed to cluster with sequences from its suspected country of infection. Travel-acquired ZIKV samples depicted low genomic variability relative to HCV samples. A floating patristic distance threshold classified all pre-2000 ZIKV sequences into separate clusters, while only Cambodian, Peruvian, Malaysian, and South Korean sequences were similarly classifiable. While phylogenetic analysis of ZIKV data can identify the broad geographical region of ZIKV infection, ZIKV's low genomic variability is likely to limit precise interpretations of phylogenetic analysis of the origins of travel-related cases.
C1 [Kamelian, Kimia; Harrigan, Richard] Univ British Columbia, Div AIDS, Dept Med, Vancouver, BC, Canada.
   [Kamelian, Kimia; Montoya, Vincent; Olmstead, Andrea; Dong, Winnie; Joy, Jeffrey B.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.
   [Morshed, Muhammad] BC Ctr Dis Control Publ Hlth Lab, Vancouver, BC, Canada.
   [Morshed, Muhammad] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Joy, Jeffrey B.] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC, Canada.
RP Joy, JB (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.; Joy, JB (corresponding author), Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC, Canada.
EM jjoy@cfenet.ubc.ca
CR Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   [Anonymous], 2017, LANCET, V389, P573, DOI 10.1016/S0140-6736(17)30325-2
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Colombo TE, 2018, BRAZ J MICROBIOL, V49, P144, DOI 10.1016/j.bjm.2017.04.011
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Echeverria N, 2015, WORLD J HEPATOL, V7, P831, DOI 10.4254/wjh.v7.i6.831
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   European Bioinformatics Institute, 2017, INT NUCL SEQ DAT COL
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Government of Canada, 2018, ZIK VIR HLTH PROF
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hedskog C, 2015, J CLIN MICROBIOL, V53, P2049, DOI 10.1128/JCM.02624-14
   Houlihan CF, 2018, J INFECT DIS, V218, P1485, DOI 10.1093/infdis/jiy335
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485
   Lam TTY, 2010, CRIT REV CL LAB SCI, V47, P5, DOI 10.3109/10408361003633318
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lapointe HR, 2015, ANTIMICROB AGENTS CH, V59, P6824, DOI 10.1128/AAC.01490-15
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lemaire D, 2012, BRAZ J MED BIOL RES, V45, P376, DOI 10.1590/S0100-879X2011007500142
   Li H, 2009, BIOINFORMATICS, V25, P2079
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Selisko B., 2018, VIRUSES, V10, pE59
   Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/NMETH.3029, 10.1038/nmeth.3029]
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228
   Theys K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006528
   Trosemeier JH, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00917-16
   United Nations Statistics Division, 1999, METH STAND COUNTR AR
   Wang H, 2015, VIROL REP, V5, P29, DOI [10.1016/j.virep.2015.03.001, DOI 10.1016/J.VIREP.2015.03.001]
   Wickam H., 2016, GGPLOT2 ELEGANT GRAP
   World Health Organization, 2018, R D BLUEPR LIST BLUE
NR 48
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 11
PY 2019
VL 9
AR 16433
DI 10.1038/s41598-019-52613-8
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JL5ZV
UT WOS:000495611100025
PM 31712570
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sanchez, LAG
   Martinez, DKS
   Diaz-Martinez, LA
   Mojica, CHB
AF Gutierrez Sanchez, Luz A.
   Sandoval Martinez, Diana K.
   Diaz-Martinez, Luis A.
   Becerra Mojica, Carlos H.
TI Zika virus infection: A correlation between prenatal ultrasonographic
   and postmortem neuropathologic changes
SO NEUROPATHOLOGY
LA English
DT Article
DE arthrogryposis; corpus callosum dysgenesis; lissencephaly; microcephaly;
   Zika virus infection
ID FETUSES; INFANTS; FETAL
AB This study presents a correlation between prenatal ultrasonographic images and neuropathologic findings of postmortem tissue samples from five confirmed cases of perinatal Zika virus (ZIKV) infection belonging to the cohort of the ZEN Initiative in Bucaramanga, Colombia. Deaths occurred between June 2016 and March 2017. Mothers consulted with ZIKV infection clinical manifestations or fetal central nervous system (CNS) abnormalities or both. A detailed ultrasound scan and neurosonographic protocol was performed by maternal fetal specialists. Perinatal autopsies were performed following the Colombian National Health Institute's ZIKV protocol. The autopsies were from two fetal deaths, and three early neonatal deaths. Gestational age was between 26(2/7) and 38(2/7) weeks. Two cases were classified as mild microcephaly. Few findings by ultrasound and pathology were found in case 1 because it was a late infection; the other cases presented findings corresponding to congenital Zika syndrome: craniofacial malformations, cerebellar hypoplasia, anomalies of the corpus callosum and ventriculomegaly, all confirmed in autopsy specimens. By ultrasonography, hyperechogenicities were seen in several brain structures, which correspond to cortical and periventricular calcifications, subependymal glial reactivity and perivascular rings. The ultrasound and pathological findings show a wide spectrum of CNS anomalies that confirm the neurotropic effect of the ZIKV, recognizing the neuroimaging findings of this disease (unilateral ventriculomegaly, alterations in the corpus callosum and cerebellum, and calcifications) are highly suggestive of ZIKV infection.
C1 [Gutierrez Sanchez, Luz A.; Sandoval Martinez, Diana K.; Diaz-Martinez, Luis A.; Becerra Mojica, Carlos H.] Univ Ind Santander, Sch Med, Hlth Fac, Bucaramanga, Colombia.
   [Gutierrez Sanchez, Luz A.; Becerra Mojica, Carlos H.] Hosp Univ Santander, Dept Gynecol & Obstet, Bucaramanga, Colombia.
   [Sandoval Martinez, Diana K.] Hosp Univ Santander, Dept Pathol, Bucaramanga, Colombia.
RP Sanchez, LAG (corresponding author), Carrera 18 158-72 Condominio Club House 1,Casa 30, Canaveral, Floridablanca, Colombia.
EM luangusa@hotmail.com
RI Martinez, Luis Alfonso Diaz/J-8069-2017
OI Martinez, Luis Alfonso Diaz/0000-0002-4498-6639; Gutierrez Sanchez, Luz
   Angela/0000-0002-2560-755X; SANDOVAL MARTINEZ, DIANA
   KATHERINE/0000-0001-8290-7834
CR Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Baptista T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2194
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 16
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD DEC
PY 2019
VL 39
IS 6
BP 434
EP 440
DI 10.1111/neup.12603
EA NOV 2019
PG 7
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA JS3WH
UT WOS:000495477400001
PM 31710135
DA 2020-07-08
ER

PT J
AU Mangueira, FFA
   Smania-Marques, R
   Fernandes, ID
   Albino, VA
   Olinda, R
   Santos-Silva, TA
   Traxler, J
   Matheson, D
   Santos, S
AF Abel Mangueira, Francisco Fernandes
   Smania-Marques, Roberta
   Fernandes, Izabelly Dutra
   Albino, Victor Alves
   Olinda, Ricardo
   Santos-Silva, Tais Acacia
   Traxler, John
   Matheson, David
   Santos, Silvana
TI The prevention of arboviral diseases using mobile devices: a preliminary
   study of the attitudes and behaviour change produced by educational
   interventions
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article; Early Access
DE arboviruses; health education; behaviour change; mobile health
ID AEDES-AEGYPTI; CHIKUNGUNYA; ZIKA; KNOWLEDGE; STUDENTS
AB Objectives In Brazil, the National Policy for Dengue Control seeks to incorporate the lessons of national and international experience in dengue control, emphasising the need for health education activities. The objective of this study was to evaluate and compare knowledge, attitudes and behaviours related to the prevention of arboviruses before and after a two-month educational intervention using a learning platform on mobile devices. Methods This quasi-experimental study corresponds to the first phase of the project 'Impact of mobile learning in the prevention and management of complications caused by arboviruses (Zika, Dengue, Chikungunya) - ZIKAMOB', sponsored as part of the British Council Newton Fund. Results Thirty of the 93 participants were first-year undergraduate university students (36.7% male), and 63 were police officers (84.1% male). The pattern of attitudes and behaviour was very similar in both groups before the intervention. The students changed their attitudes and behaviour (P = 0.032) in relation to their engagements in actions for the prevention of arboviral diseases and several other activities related to house inspections and precautions with water tanks (P < 0.01). However, recycling and surveillance activities were not as effective in changing behaviour. Female participants showed more motivation to participate in preventive activities, but living alone and working were barriers to participation. Individuals who already perform selective waste collection and are cultivating gardens demonstrated both a positive attitude and a positive behaviour towards actions for the prevention of arboviral diseases. Conclusion Mobile learning and behaviour change theories might be successful as the basis for school-based and community-based interventions to avoid arboviruses. These outcomes need to be confirmed in broader future studies.
C1 [Abel Mangueira, Francisco Fernandes; Fernandes, Izabelly Dutra; Albino, Victor Alves; Santos, Silvana] Univ Estadual Paraiba, Publ Hlth Programme, Campina Grande, Brazil.
   [Smania-Marques, Roberta] Univ Estadual Paraiba, Dept Biol, Campina Grande, Brazil.
   [Fernandes, Izabelly Dutra] Secretary Educ Sci & Technol, Campina Grande, Brazil.
   [Olinda, Ricardo] Univ Estadual Paraiba, Dept Stat, Campina Grande, Brazil.
   [Santos-Silva, Tais Acacia] Sorbonne Univ Paris Sorbonne, Fac Lettres, Paris, France.
   [Traxler, John; Matheson, David] Univ Wolverhampton, Inst Educ, Wolverhampton, W Midlands, England.
RP Santos, S (corresponding author), Univ Estadual Paraiba, Rua Baraunas S-N Predio Integracao Acad,Sala 329, Campina Grande, Paraiba, Brazil.
EM silvanaipe@gmail.com
OI Santos, Silvana/0000-0002-5252-0206
CR Ally M, 2009, ISS ONLINE EDUC, P1
   Argyris C, 1974, THEORY PRACTICE INCR
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Brusich M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0653-4
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Martinez JD, 2019, DERMATOL CLIN, V37, P95, DOI 10.1016/j.det.2018.07.008
   Darrow W, 2018, HEALTH EDUC BEHAV, V45, P967, DOI 10.1177/1090198118760687
   Feldstein LR, 2018, AM J TROP MED HYG, V98, P845, DOI 10.4269/ajtmh.17-0799
   Flamand C, 2017, AM J TROP MED HYG, V97, P344, DOI 10.4269/ajtmh.16-1028
   Free C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001363
   Goncalves RP, 2015, SAUDE SOC-SAO PAULO, V24, P578, DOI 10.1590/S0104-12902015000200015
   Gregory S, 2018, BMC PUBLIC HLTH, P18
   Kahneman Daniel, 2011, THINKING FAST SLOW
   Karageorgos G, 2018, IEEE REV BIOMED ENG, V12, P100
   Khun S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000143
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Koralek T, 2016, PLOS CURRENTS OUTBRE, P8, DOI [10.1371/currents.outbreaks.f1f5c05c37a5ff8954f38646cfffc6a2, DOI 10.1371/CURRENTS.0UTBREAKS.F1F5C05C37A5FF8954F38646CFFFC6A2]
   Lima EP, 2006, REV SOC BRAS MED TRO, V39, P259, DOI 10.1590/S0037-86822006000300006
   Lopes TRR, 2017, REV INST MED TROP SP, V2018, P60
   Lwin MO, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4657
   Lwin May Oo, 2017, JMIR Public Health Surveill, V3, pe65, DOI 10.2196/publichealth.7376
   Macoris MDG, 1999, REV SAUDE PUBL, V33, P521
   *MIN SAUD FUND NAC, 2002, PROGR NAC CONTR DENG
   Nyunt MH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1047-y
   Pittendrigh B. R., 2018, OUTLOOKS PEST MANAG, V29, P58, DOI DOI 10.1564/V29_APR_02]
   Plaster AN, 2018, J COMMUN HEALTH, V43, P647, DOI 10.1007/s10900-017-0463-z
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Ramaiah R, 2018, INT J COMMUN MED PUB, V5, P1402
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Storey JD, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5372-2
   Sukhralia S, 2019, EUR J CLIN MICROBIOL, V38, P3, DOI 10.1007/s10096-018-3375-7
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Traxler J., 2010, RES LEARNING TECHNOL, V18, P149, DOI DOI 10.1080/09687769.2010.492847
   Traxler J, 2012, P 2012 INT C INT MOB
   Traxler J, 2015, ENCY MOBILE PHONE BE, P506
   Traxler JM, 2013, HANDBOOK OF MOBILE LEARNING, P129
   Venables W, 2019, R FDN STAT COMPUTING
   Wong LP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002310
   World Health Organization, 2012, HLTH ED THEOR CONC E
   World Health Organization (WHO), 2009, SPEC PROGR RES TRAIN
   Zhao J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5692
NR 42
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
DI 10.1111/tmi.13316
EA NOV 2019
PG 16
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JL2ND
UT WOS:000495368000001
PM 31626375
DA 2020-07-08
ER

PT J
AU Khieu, C
   Kongyai, N
   Pathanapitoon, K
   Van Der Eijk, AA
   Rothova, A
AF Khieu, Chansathya
   Kongyai, Natedao
   Pathanapitoon, Kessara
   Van Der Eijk, Annemiek A.
   Rothova, Aniki
TI Causes of Hypertensive Anterior Uveitis in Thailand
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article; Early Access
DE Cytomegalovirus; herpes simplex virus; hypertensive anterior uveitis;
   polymerase chain reaction; varicella-zoster virus
ID CLINICAL-MANIFESTATIONS; GANCICLOVIR
AB Purpose: To determine the prevalence of viral infections in patients with hypertensive anterior uveitis in Thailand from polymerase chain reaction (PCR) of aqueous humor. Methods: Thirty-one patients with anterior uveitis with intraocular pressure (IOP) above 25 mmHg were included for PCR analysis for cytomegalovirus (CMV), herpes simplex (HSV), varicella-zoster (VZV), rubella, chikungunya and Zika virus. Results: The prevalence of PCR-positive results was 32%, including 19% for CMV, 10% for HSV, and 3% for VZV; PCR for other tested viruses demonstrated negative results. PCR-positive patients exhibited satisfactory IOP control with antiviral and anti-glaucomatous treatment compared to PCR-negative patients, and more than half of PCR-negative patients required glaucoma surgery within 12 months (P = .01). Conclusion: PCR evidence of infection with herpes group viruses was found in one-third of patients with hypertensive anterior uveitis; CMV being the most common pathogen. The PCR-positive group generally responded well to a combination of antiviral and anti-glaucoma treatment.
C1 [Khieu, Chansathya; Pathanapitoon, Kessara] Chiang Mai Univ, Fac Med, Dept Ophthalmol, 110 Intawaroros Rd, Chiang Mai 50200, Thailand.
   [Kongyai, Natedao] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiang Mai, Thailand.
   [Van Der Eijk, Annemiek A.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Rothova, Aniki] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands.
RP Khieu, C (corresponding author), Chiang Mai Univ, Fac Med, Dept Ophthalmol, 110 Intawaroros Rd, Chiang Mai 50200, Thailand.
EM chansathya.khieu@gmail.com
CR Amador-Patarroyo MJ, 2013, AUTOIMMUNITY BENCH B
   Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015
   Choi JA, 2016, J OPHTHALMIC INFLAMM, V6, DOI 10.1186/s12348-016-0100-5
   De Groot-Mijnes JDF, 2006, AM J OPHTHALMOL, V141, P313, DOI 10.1016/j.ajo.2005.09.017
   Groen-Hakan F, 2019, AM J OPHTHALMOL, V202, P37, DOI 10.1016/j.ajo.2019.02.002
   Groen-Hakan F, 2017, OCUL IMMUNOL INFLAMM, V25, P715, DOI 10.1080/09273948.2017.1353105
   Hsiao YT, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1093-2
   Hwang YS, 2010, GRAEF ARCH CLIN EXP, V248, P263, DOI 10.1007/s00417-009-1195-2
   Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
   Jap A, 2011, CURR OPIN OPHTHALMOL, V22, P483, DOI 10.1097/ICU.0b013e32834be021
   Keorochana N, 2019, OCUL IMMUNOL INFLAMM, DOI 10.1080/09273948.2019.1587471
   Kongyai N, 2012, EYE, V26, P529, DOI 10.1038/eye.2011.363
   Lewkowicz D, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/974870
   Miyazaki D, 2018, GRAEF ARCH CLIN EXP, V256, P2413, DOI 10.1007/s00417-018-4111-9
   Niesters H G, 2001, Expert Rev Mol Diagn, V1, P129
   Oliver GF, 2019, CLIN EXP OPHTHALMOL, V47, P372, DOI 10.1111/ceo.13450
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Pathanapitoon K, 2013, JAMA OPHTHALMOL, V131, P638, DOI 10.1001/jamaophthalmol.2013.2860
   Relvas LJ, 2018, OCUL IMMUNOL INFLAMM, V26, P726, DOI 10.1080/09273948.2018.1468470
   Su CC, 2014, AM J OPHTHALMOL, V158, P1024, DOI 10.1016/j.ajo.2014.08.007
   Tsirouki T, 2018, OCUL IMMUNOL INFLAMM, V26, P2, DOI 10.1080/09273948.2016.1196713
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wensing B, 2011, OPHTHALMOLOGY, V118, P1905, DOI 10.1016/j.ophtha.2011.03.033
NR 23
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
DI 10.1080/09273948.2019.1678651
EA NOV 2019
PG 7
WC Ophthalmology
SC Ophthalmology
GA JK7HJ
UT WOS:000495011400001
PM 31697590
DA 2020-07-08
ER

PT J
AU Alvim, RGF
   Itabaiana, I
   Castilho, LR
AF Alvim, Renata G. F.
   Itabaiana Jr, Ivaldo
   Castilho, Leda R.
TI Zika virus-like particles (VLPs): Stable cell lines and continuous
   perfusion processes as a new potential vaccine manufacturing platform
SO VACCINE
LA English
DT Article
DE Virus-like particles (VLPs); Zika virus; HEK293 cells; Stable
   expression; Perfusion; Upstream process
ID SECRETION; OUTBREAK; ANTIBODY; FUSION; REGION
AB Zika virus (ZIKV) was first detected in Brazil in 2015 and then rapidly spread to more than 80 countries in Africa, Asia and the Americas. ZIKV infection was correlated with severe congenital malformations in newborns from infected mothers, as well as with Guillain-Barre syndrome in adults. Although the number of infected people has declined in the affected countries lately, the development of a vaccine for ZIKV is of great importance to avoid the future resurgence of the virus in endemic areas or the future spread to currently non-endemic regions. Among many different platforms currently under study, virus-like particles (VLPs) are a promising alternative for the development of vaccines, since tridimensional particles mimicking the virus - but lacking its genome - can be produced and present the antigen in a repetitive way, potentially eliciting robust immune responses. In this work, we demonstrated the generation of stably transfected HEK293 cells constitutively expressing Zika VLPs. Small-scale shake flask studies using a stable cell pool enriched by Fluorescence-Activated Cell Sorting (FACS) showed that daily medium exchange (intermittent perfusion) significantly enhances viable cell density and VLP production (similar to 4-fold) over batch cultures. Continuous perfusion in a controlled bioreactor coupled to an ATF-2 cell retention device resulted in maximum VLP titers similar to those obtained under small-scale intermittent perfusion. Our results show that the use of cell lines constitutively expressing Zika VLPs, cultured in stirred-tank perfusion bioreactors, represents a promising system for the production of a VLP-based Zika vaccine candidate. (C) 2019 Elsevier Ltd.
C1 [Alvim, Renata G. F.; Castilho, Leda R.] Fed Univ Rio de Janeiro UFRJ, Cell Culture Engn Lab, COPPE, Cx Postal 68502, BR-21941972 Rio De Janeiro, RJ, Brazil.
   [Alvim, Renata G. F.; Itabaiana Jr, Ivaldo] Fed Univ Rio de Janeiro UFRJ, Sch Chem EQ, Dept Biochem Engn, BR-21941909 Rio De Janeiro, RJ, Brazil.
RP Castilho, LR (corresponding author), Fed Univ Rio de Janeiro UFRJ, Cell Culture Engn Lab, COPPE, Cx Postal 68502, BR-21941972 Rio De Janeiro, RJ, Brazil.
EM leda@peq.coppe.ufrj.br
RI Itabaiana, Ivaldo/A-6308-2014
OI Itabaiana, Ivaldo/0000-0003-0725-0881
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Janssen Brazil; JLabs
FX The authors wish to acknowledge financial support from the Brazilian
   funding agencies CNPq, CAPES and FAPERJ; financial support granted by
   JLabs and Janssen Brazil in the context of the "Latin-America Quick Fire
   Challenge 2016"; reagents and media donated by GE Healthcare, Xell AG
   and Merck Millipore; and the HEK293-3F6 cell line provided by NRC
   Canada. The authors also thank T. Brunswick and T. Gonsalves (CENABIO,
   Federal University of Rio de Janeiro) for technical help during cell
   sorting experiments, and B. S. Graham (Vaccine Research Center, NIH) for
   sharing analytical reagents.; All authors attest they meet the ICMJE
   criteria for authorship.
CR Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castilho LR, 2015, CONTINUOUS PROCESSING IN PHARMACEUTICAL MANUFACTURING, P115
   Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381
   Chang G.J.J., 1998, Patent, Patent No. [US8221768132, 8221768132]
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Esposito DLA, 2015, J GEN VIROL, V96, P1702, DOI 10.1099/vir.0.000113
   Fontana D, 2015, VACCINE, V33, P4238, DOI 10.1016/j.vaccine.2015.03.088
   Fuenmayor J, 2017, NEW BIOTECHNOL, V39, P174, DOI 10.1016/j.nbt.2017.07.010
   Fuenmayor J, 2019, J CHEM TECHNOL BIOT, V94, P302, DOI 10.1002/jctb.5777
   Goudar CT, 2015, J BIOTECHNOL, V213, P1, DOI 10.1016/j.jbiotec.2015.08.015
   Gutierrez-Granados S, 2018, CURR OPIN CHEM ENG, V22, P107, DOI 10.1016/j.coche.2018.09.009
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lima TM, 2019, VACCINE, V37, P7071
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Nikolay A, 2018, APPL MICROBIOL BIOT, V102, P8725, DOI 10.1007/s00253-018-9275-z
   Nikolay A, 2018, VACCINE, V36, P3140, DOI 10.1016/j.vaccine.2017.03.018
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Okumura T, 2015, J BIOSCI BIOENG, V120, P340, DOI 10.1016/j.jbiosc.2015.01.007
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pijlman GP, 2015, BIOTECHNOL J, V10, P659, DOI 10.1002/biot.201400427
   Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036
   Report S, 2017, ZIK VIR MICR GUILL B
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]
   Song M, 2011, J CHEM TECHNOL BIOT, V86, P935, DOI 10.1002/jctb.2618
   Trainor NB, 2007, VIROLOGY, V360, P398, DOI 10.1016/j.virol.2006.10.033
   Venereo-Sanchez A, 2017, VACCINE, V35, P4220, DOI 10.1016/j.vaccine.2017.06.024
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   World Health Organization, WHO ZIK VIR COMPL 20
NR 37
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 6970
EP 6977
DI 10.1016/j.vaccine.2019.05.064
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100006
PM 31164305
OA Other Gold
DA 2020-07-08
ER

PT J
AU Lima, TM
   Souza, MO
   Castilho, LR
AF Lima, Tulio M.
   Souza, Matheus O.
   Castilho, Leda R.
TI Purification of flavivirus VLPs by a two-step chomatographic process
SO VACCINE
LA English
DT Article
DE Virus-like particles (VLPs); Yellow fever virus; Zika virus; Downstream
   processing; Chromatographic purification
ID VIRUS-LIKE PARTICLES; EXCHANGE MEMBRANE CHROMATOGRAPHY; YELLOW-FEVER;
   OUTBREAK
AB Flaviviruses are enveloped viruses with positive-sense, single-stranded RNA, which are most commonly transmitted by infected mosquitoes. Zika virus (ZIKV) and yellow fever virus (YFV) are flaviviruses that have caused significant outbreaks in the last few years. Since there is no approved vaccine against ZIKV, and since the existing YF attenuated vaccine presents disadvantages related to limited supply and to rare, but fatal adverse effects, there is an urgent need for new vaccines to control these diseases. Virus-like particles (VLPs) represent a recombinant platform to produce safe and immunogenic vaccines. Thus, based on our experience of expressing in recombinant mammalian cells VLPs of most flaviviruses circulating in the Americas, this work focused on the evaluation of chromatographic purification processes for zika and yellow-fever VLPs. The clarified cell culture supernatant was processed by a membrane-based anion-exchange chromatography and then a multimodal chromatographic step. With this process, it was possible to obtain the purified VLPs with a yield (including the clarification step) of 66.4% for zika and 68.1% for yellow fever. DNA clearance was in the range of 99.8-99.9%, providing VLP preparations that meet the WHO limit for this critical contaminant. Correct size and morphology of the purified VLPs were confirmed by dynamic light scattering (DLS) and transmission electron microscopy (TEM). The promising results obtained for both zika and yellow fever VLPs indicate that this process could be potentially applied also to VLPs of other flaviviruses. (C) 2019 Elsevier Ltd.
C1 [Lima, Tulio M.; Souza, Matheus O.; Castilho, Leda R.] Fed Univ Rio Janeiro UFRJ, COPPE, Cell Culture Engn Lab, Av Horacio Macedo,2030 Sl G115,Cidade Univ, BR-21941598 Rio De Janeiro, Brazil.
   [Lima, Tulio M.] Fed Univ Rio Janeiro UFRJ, EQ, EPQB Grad Program, Av Horacio Macedo,2030 Sl E206,Cidade Univ, BR-21941598 Rio De Janeiro, Brazil.
   [Souza, Matheus O.] Univ Kansas, Dept Pharmaceut Chem, Immune Engn Lab, 2095 Constant Ave, Lawrence, KS 66047 USA.
RP Castilho, LR (corresponding author), Fed Univ Rio Janeiro UFRJ, COPPE, Cell Culture Engn Lab, Av Horacio Macedo,2030 Sl G115,Cidade Univ, BR-21941598 Rio De Janeiro, Brazil.
EM leda@peq.coppe.ufrj.br
FU Brazilian research funding agency CNPq; Brazilian research funding
   agency CapesCAPES; Brazilian research funding agency Faperj
FX Financial support from the Brazilian research funding agencies CNPq,
   Capes and Faperj is gratefully acknowledged.
CR Alvim RGF, 2019, VACCINE, V37, P6970, DOI 10.1016/j.vaccine.2019.05.064
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Soler JC, 2009, GAC SANIT, V23, P295, DOI 10.1016/j.gaceta.2008.09.008
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen Y, 2015, VACCINE, V33, P4300, DOI 10.1016/j.vaccine.2015.03.078
   DAI S, 2018, J IMMUNOL SCI, V2, P36, DOI DOI 10.29245/2578-3009/2018/2.1118
   Effio CL, 2016, J CHROMATOGR A, V1429, P142, DOI 10.1016/j.chroma.2015.12.006
   ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Foster KR, 1998, SCI AM, V279, P88, DOI 10.1038/scientificamerican0898-88
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018
   Hughson MD, 2017, BIOTECHNOL PROGR, V33, P931, DOI 10.1002/btpr.2501
   Kaaijk P, 2018, HUM VACC IMMUNOTHER, V14, P337, DOI 10.1080/21645515.2017.1389363
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   Litvoc MN, 2018, REV ASSOC MED BRAS, V64, P106, DOI 10.1590/1806-9282.64.02.106
   Martins RD, 2018, VACCINE, V36, P4112, DOI 10.1016/j.vaccine.2018.05.041
   Middelberg PJA, 2013, PHARM BIOPROCESS, V1, P407
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Native Antigen Company (NAC), 2019, ZIK VIR VLP CERT AN
   Native Antigen Company (NAC), 2019, DENG VIR SER 2 ENV P
   Nestola P, 2015, J CHROMATOGR A, V1426, P91, DOI 10.1016/j.chroma.2015.11.037
   O'Higgins T, 2014, ECOL SOC, V19, DOI 10.5751/ES-06507-190446
   Ohtaki N, 2011, J VIROL METHODS, V174, P131, DOI 10.1016/j.jviromet.2011.03.021
   PAHO/WHO, 2015, ZIK CAS CONG SYNDR A
   Pato TP, 2019, VACCINE, V37, P3214, DOI 10.1016/j.vaccine.2019.04.077
   Pato TP, 2014, VACCINE, V32, P2789, DOI 10.1016/j.vaccine.2014.02.036
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Vicente T, 2008, J MEMBRANE SCI, V311, P270, DOI 10.1016/j.memsci.2007.12.021
   Vicente T, 2011, J INVERTEBR PATHOL, V107, pS42, DOI 10.1016/j.jip.2011.05.004
   Vogel JH, 2012, BIOTECHNOL BIOENG, V109, P3049, DOI 10.1002/bit.24578
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   World Health Organization, 2007, WHO STUD GROUP CELL
   World Hlth Org, 2017, VACCINE, V35, P5753, DOI 10.1016/j.vaccine.2017.05.069
   Zhao D, 2015, J APPL MICROBIOL, V119, P1196, DOI 10.1111/jam.12922
NR 41
TC 3
Z9 3
U1 3
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 8
PY 2019
VL 37
IS 47
SI SI
BP 7061
EP 7069
DI 10.1016/j.vaccine.2019.05.066
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JN4GT
UT WOS:000496858100016
PM 31201056
OA Other Gold
DA 2020-07-08
ER

PT J
AU Cataneo, AHD
   Kuczera, D
   Koishi, AC
   Zanluca, C
   Silveira, GF
   de Arruda, TB
   Suzukawa, AA
   Bortot, LO
   Dias-Baruffi, M
   Verri, WA
   Robert, AW
   Stimamiglio, MA
   dos Santos, CND
   Wowk, PF
   Bordignon, J
AF Depieri Cataneo, Allan Henrique
   Kuczera, Diogo
   Koishi, Andrea Cristine
   Zanluca, Camila
   Silveira, Guilherme Ferreira
   de Arruda, Thais Bonato
   Suzukawa, Andreia Akemi
   Bortot, Leandro Oliveira
   Dias-Baruffi, Marcelo
   Verri, Waldiceu Aparecido, Jr.
   Robert, Anny Waloski
   Stimamiglio, Marco Augusto
   Duarte dos Santos, Claudia Nunes
   Wowk, Pryscilla Fanini
   Bordignon, Juliano
TI The citrus flavonoid naringenin impairs the in vitro infection of human
   cells by Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NS2B-NS3 PROTEASE; NONCOMPETITIVE INHIBITORS; ANTIVIRAL ACTIVITY;
   FRENCH-POLYNESIA; DENDRITIC CELLS; SOUTH-PACIFIC; OPTIMIZATION;
   TRANSMISSION; APOPTOSIS; EPIDEMIC
AB The Zika virus (ZIKV) is an arthropod-borne virus that belongs to the Flaviviridae family. The ZIKV infection is usually asymptomatic or is associated with mild clinical manifestations; however, increased numbers of cases of microcephaly and birth defects have been recently reported. To date, neither a vaccine nor an antiviral treatment has become available to control ZIKV replication. Among the natural compounds recognized for their medical properties, flavonoids, which can be found in fruits and vegetables, have been found to possess biological activity against a variety of viruses. Here, we demonstrate that the citrus flavanone naringenin (NAR) prevented ZIKV infection in human A549 cells in a concentration-dependent and ZIKV-lineage independent manner. NAR antiviral activity was also observed when primary human monocyte-derived dendritic cells were infected by ZIKV. NAR displayed its antiviral activity when the cells were treated after infection, suggesting that NAR acts on the viral replication or assembly of viral particles. Moreover, a molecular docking analysis suggests a potential interaction between NAR and the protease domain of the NS2B-NS3 protein of ZIKV which could explain the anti-ZIKV activity of NAR. Finally, the results support the potential of NAR as a suitable candidate molecule for developing anti-ZIKV treatments.
C1 [Depieri Cataneo, Allan Henrique; Kuczera, Diogo; Koishi, Andrea Cristine; Zanluca, Camila; Silveira, Guilherme Ferreira; de Arruda, Thais Bonato; Suzukawa, Andreia Akemi; Duarte dos Santos, Claudia Nunes; Wowk, Pryscilla Fanini; Bordignon, Juliano] Inst Carlos Chagas Fiocruz PR, Mol Virol Lab, Curitiba, Parana, Brazil.
   [Bortot, Leandro Oliveira] Univ Sao Paulo, Lab Fis Biol, Dept Quim & Fis, Fac Ciencias Farmaceut, Ribeirao Preto, SP, Brazil.
   [Dias-Baruffi, Marcelo] Univ Sao Paulo, Lab Glicoimunol, Dept Anal Clin Toxicol & Bromatol, Fac Ciencias Farmaceut, Ribeirao Preto, SP, Brazil.
   [Verri, Waldiceu Aparecido, Jr.] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Parana, Brazil.
   [Robert, Anny Waloski; Stimamiglio, Marco Augusto] Inst Carlos Chagas Fiocruz PR, Lab Celulas Tronco, Curitiba, Parana, Brazil.
RP Wowk, PF; Bordignon, J (corresponding author), Inst Carlos Chagas Fiocruz PR, Mol Virol Lab, Curitiba, Parana, Brazil.
EM pryscilla.wowk@fiocruz.br; juliano.bordignon@fiocruz.br
RI Wowk, Pryscilla Fanini/AAR-7230-2020; Bortot, Leandro
   Oliveira/C-7055-2018; Kulig, Anny/AAE-2529-2020; Cataneo,
   Allan/AAB-7997-2020; WA, Verri/I-1330-2013; Bordignon,
   Juliano/Z-6268-2019; Baruffi, Marcelo D/I-7199-2015
OI Bortot, Leandro Oliveira/0000-0002-0915-8205; WA,
   Verri/0000-0003-2756-9283; Bordignon, Juliano/0000-0002-1965-6152;
   Baruffi, Marcelo D/0000-0002-2039-1884; Zanluca,
   Camila/0000-0001-7350-9105; Koishi, Andrea/0000-0002-3542-1353; Wowk,
   Pryscilla/0000-0002-8976-2647; Silveira, Guilherme/0000-0002-1866-0563;
   Robert, Anny/0000-0002-7837-2790; Cataneo, Allan Henrique
   Depieri/0000-0002-3567-7471; Bonato de Arruda, Thais/0000-0001-8015-7152
FU Fundacao Araucaria (PPSUS/2016)Fundacao Araucaria; Fundacao
   Araucaria/SESA-PR/CNPq/MSDecit PPSUS/2015 [009/2017, 019/2017];
   Brazilian Ministry of Health
FX The authors thank the Flow Cytometry Facility at the Instituto Carlos
   Chagas/Fiocruz (ICC/Fiocruz), Brazil (RPT08 L). We also thanks Wagner
   Nagib de Souza (ICC/Fiocruz) for the support on figure preparation and
   Dra. Hellen Geremias dos Santos (ICC/Fiocruz) for the statistical
   analysis. This research was funded by the Brazilian Ministry of Health
   and the Fundacao Araucaria (PPSUS/2016) and Fundacao
   Araucaria/SESA-PR/CNPq/MSDecit PPSUS/2015 - projetcts 009/2017 and
   019/2017. CNDS (309432/2015-4), MDB (31.1947/2015-8), WAVJr
   (308052/2013-7) and JB (303306/2017-3) are CNPq fellows.
CR Bhargava S., 2017, NATURAL PRODUCT RES, V33, P851
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Breinholt VM, 2004, BASIC CLIN PHARMACOL, V94, P30, DOI 10.1111/j.1742-7843.2004.pto_940106.x
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Castrillo M, 2015, AV BIOMED, V4, P69
   Conversano C, 2015, HEMATOL REP, V7, P5, DOI 10.4081/hr.2015.5632
   Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330
   de Carvalho OV, 2017, INT J ANTIMICROB AG, V50, P718, DOI 10.1016/j.ijantimicag.2017.08.016
   de Mello CPP, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01983-17
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dong WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07237
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]
   Evers DL, 2005, ANTIVIR RES, V68, P124, DOI 10.1016/j.antiviral.2005.08.002
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Goldwasser J, 2011, J HEPATOL, V55, P963, DOI 10.1016/j.jhep.2011.02.011
   Grienke U, 2016, SCI REP-UK, V6, DOI 10.1038/srep27156
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9
   Jin LT, 2017, J IMMUNOL, V199, P3466, DOI 10.4049/jimmunol.1602016
   Kumar SP, 2015, INT J BIOL MACROMOL, V78, P87, DOI 10.1016/j.ijbiomac.2015.03.045
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee JL, 2019, ANTIVIR RES, V167, P13, DOI 10.1016/j.antiviral.2019.04.003
   Lee MH, 2004, BIOL PHARM BULL, V27, P72, DOI 10.1248/bpb.27.72
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215
   Manchope MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153015
   Ministerio da Saude, 2018, MON INT ALT CRESC DE
   Ministerio da Saude, 2018, MON CAS DENG FEBR CH
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Oo A, 2019, ARCH VIROL, V164, P585, DOI 10.1007/s00705-018-4083-4
   Othman R, 2008, J CHEM INF MODEL, V48, P1582, DOI 10.1021/ci700388k
   Pasetto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115323
   Pinho-Ribeiro FA, 2016, J NUTR BIOCHEM, V33, P8, DOI 10.1016/j.jnutbio.2016.03.013
   Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, P6, DOI DOI 10.1128/AAC.00411-17.E00411-17
   SALEHI B, 2019, PHARMAC, V12, pE11
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Silveira GF, 2011, J VIROL, V85, P5374, DOI 10.1128/JVI.01915-10
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007
   Spencer JPE, 2004, ARCH BIOCHEM BIOPHYS, V423, P148, DOI 10.1016/j.abb.2003.11.010
   Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x
   STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336
   Stompor M, 2017, MOLECULES, V22, DOI 10.3390/molecules22071092
   Strottmann DM, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190150
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Suroengrit A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14121-5
   Sze A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100287
   Tian Y, 2010, FITOTERAPIA, V81, P799, DOI 10.1016/j.fitote.2010.04.012
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wong G, 2017, VIROL SIN, V32, P545, DOI 10.1007/s12250-017-4057-9
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zandi K, 2011, J MED PLANTS RES, V5, P5534
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029774
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 78
TC 1
Z9 1
U1 4
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 8
PY 2019
VL 9
AR 16348
DI 10.1038/s41598-019-52626-3
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JL2OO
UT WOS:000495371900024
PM 31705028
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Giron, S
   Franke, F
   Decoppet, A
   Cadiou, B
   Travaglini, T
   Thirion, L
   Durand, G
   Jeannin, C
   L'Ambert, G
   Grard, G
   Noel, H
   Fournet, N
   Auzet-Caillaud, M
   Zandotti, C
   Aboukais, S
   Chaud, P
   Guedj, S
   Hamouda, L
   Naudot, X
   Ovize, A
   Lazarus, C
   de Valk, H
   Paty, MC
   Leparc-Goffart, I
AF Giron, Sandra
   Franke, Florian
   Decoppet, Anne
   Cadiou, Bernard
   Travaglini, Thierry
   Thirion, Laurence
   Durand, Guillaume
   Jeannin, Charles
   L'Ambert, Gregory
   Grard, Gilda
   Noel, Harold
   Fournet, Nelly
   Auzet-Caillaud, Michelle
   Zandotti, Christine
   Aboukais, Samer
   Chaud, Pascal
   Guedj, Saby
   Hamouda, Lakri
   Naudot, Xavier
   Ovize, Anne
   Lazarus, Clement
   de Valk, Henriette
   Paty, Marie-Claire
   Leparc-Goffart, Isabelle
TI Vector-borne transmission of Zika virus in Europe, southern France,
   August 2019
SO EUROSURVEILLANCE
LA English
DT Article
ID INFECTION
AB On 1 October 2019, a locally-acquired Zika virus disease case was laboratory confirmed in Hyeres, Var department. Active case finding identified two additional locally-acquired cases living within go m, with symptom onset 8 days before the index case. Extensive patient interviews did not yield information supporting transmission through sexual contact or substances of human origin. Vector-borne transmission by local Aedes albopictus mosquitoes is the most likely mode of transmission. Here we describe the public health response.
C1 [Giron, Sandra; Franke, Florian; Chaud, Pascal] French Natl Publ Hlth Agcy, Sante Publ France, Marseille, France.
   [Decoppet, Anne; Auzet-Caillaud, Michelle; Aboukais, Samer] Reg Hlth Agcy Provence Alpes Cotes Azur ARS Paca, Marseille, France.
   [Cadiou, Bernard; Travaglini, Thierry; Jeannin, Charles; L'Ambert, Gregory] Entente Interdept Demousticat Littoral Mediterran, Montpellier, France.
   [Thirion, Laurence; Durand, Guillaume; Grard, Gilda; Leparc-Goffart, Isabelle] Aix Marseille Univ, UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
   [Durand, Guillaume; Grard, Gilda; Zandotti, Christine; Leparc-Goffart, Isabelle] Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, Marseille, France.
   [Noel, Harold; Fournet, Nelly; de Valk, Henriette; Paty, Marie-Claire] French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.
   [Guedj, Saby; Hamouda, Lakri] Med Generaliste, Hyeres, France.
   [Naudot, Xavier; Ovize, Anne] Eurofins Biomnis, Lyon, France.
   [Lazarus, Clement] Minist Hlth, Publ Hlth Emergency Operat Ctr, Div Surveillance & Hlth Secur, Gen Directorate Hlth,Hlth Emergencies Crisis Mana, Paris, France.
RP Noel, H (corresponding author), French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.
EM harold.noel@santepubliquefrance.fr
CR [Anonymous], 2013, PROVENCE ALPES COTE
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   European Centre for Disease Prevention and Control (ECDC), 2016, FACTSH ZIK VIR DIS
   European Centre for Disease Prevention and Control (ECDC), 2019, RAP RISK ASS ZIK VIR
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Larkman C, 2019, INT J STROKE, V14, P5
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   PAHO/WHO, 2016, ZIK EP UPD
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Spiteri G, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.41.17-00254
   World Health Organization (WHO), 2019, DIS OUTBR NEWS ZIK V
NR 16
TC 6
Z9 6
U1 0
U2 1
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD NOV 7
PY 2019
VL 24
IS 45
BP 2
EP 5
AR 1900655
DI 10.2807/1560-7917.ES.2019.24.45.1900655
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA JM0IC
UT WOS:000495906600001
PM 31718742
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pilz, HL
   de Lemos, AB
   de Almeida, KN
   Corcao, G
   Schrekker, HS
   Silva, CE
   da Silva, OS
AF Pilz-Junior, Harry Luiz
   de Lemos, Alessandra Bittencourt
   de Almeida, Kauana Nunes
   Corcao, Gertrudes
   Schrekker, Henri Stephan
   Silva, Carlos Eugenio
   da Silva, Onilda Santos
TI Microbiota potentialized larvicidal action of imidazolium salts against
   Aedes aegypti (Diptera: Culicidae)
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GUT MICROBIOTA; BACTERIA; RESISTANCE
AB Mosquitoes are important vectors of pathogens due to their blood feeding behavior. Aedes aegypti (Diptera: Culicidae) transmits arboviruses, such as dengue, Zika, and Chikungunya. This species carries several bacteria that may be beneficial for its biological and physiological development. Therefore, studying the response of its microbiota to chemical products could result in vector control. Recently, imidazolium salts (IS) were identified as effective Ae. aegypti larvicides. Considering the importance of the mosquito microbiota, this study addressed the influence of IS on the bacteria of Ae. aegypti larvae. After exposition of larvae to different IS concentrations, the cultured microbiota was identified through culturomics and mass spectrometry, and the non-cultivated microbiota was characterized by molecular markers. In addition, the influence of the IS on axenic larvae was studied for comparison. There was an alteration in both cultivable species and in their diversity, including modifications in bacterial communities. The axenic larvae were less susceptible to the IS, which was increased after exposing these larvae to bacteria of laboratory breeding water. This highlights the importance of understanding the role of the larval microbiota of Ae. aegypti in the development of imidazolium salt-based larvicides. Such effect of IS towards microbiota of Ae. aegypti larvae, through their antimicrobial action, increases their larvicidal potential.
C1 [Pilz-Junior, Harry Luiz; de Lemos, Alessandra Bittencourt; Corcao, Gertrudes; Silva, Carlos Eugenio; da Silva, Onilda Santos] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Microbiol Immunol & Parasitol, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.
   [de Almeida, Kauana Nunes; Schrekker, Henri Stephan] Univ Fed Rio Grande do Sul, Inst Chem, Lab Technol Proc & Catalysis, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
RP da Silva, OS (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Microbiol Immunol & Parasitol, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.; Schrekker, HS (corresponding author), Univ Fed Rio Grande do Sul, Inst Chem, Lab Technol Proc & Catalysis, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM henri.schrekker@ufrgs.br; onilda.silva@ufrgs.br
OI Silva, Onilda/0000-0003-4806-8285; Luiz Pilz Junior,
   Harry/0000-0002-3379-4885
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - Brasil (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado de Rio Grande do Sul - Brasil (FAPERGS); Institute of
   Petroleumand and Natural Resources (PUCRS)
FX This study was financed in part by: the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior -Brasil (CAPES) -Finance Code 001; the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brasil
   (CNPq); and the Fundacao de Amparo a Pesquisa do Estado de Rio Grande do
   Sul -Brasil (FAPERGS); Institute of Petroleum and Natural Resources
   (PUCRS) for providing the primers used in this study.
CR Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95
   Ciesielski S, 2013, CURR MICROBIOL, V67, P240, DOI 10.1007/s00284-013-0353-2
   Correa MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07014-2
   Dickson LB, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700585
   Dong Y., 2009, PLOS PATHOG, V5
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Egorova KS, 2017, CHEM REV, V117, P7132, DOI 10.1021/acs.chemrev.6b00562
   Furlani RE, 2013, EUR J MED CHEM, V62, P59, DOI 10.1016/j.ejmech.2012.12.005
   Gaio AD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-105
   Goellner E, 2018, PEST MANAG SCI, V74, P1013, DOI 10.1002/ps.4803
   Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371
   Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011
   Joyce JD, 2011, J MED ENTOMOL, V48, P389, DOI 10.1603/ME09268
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x
   Patil CD, 2013, PARASITOL RES, V112, P3283, DOI 10.1007/s00436-013-3507-z
   Raucci MG, 2018, ACS APPL MATER INTER, V10, P42766, DOI 10.1021/acsami.8b12696
   Robinson ML, 2017, CURR OPIN INFECT DIS, V30, P449, DOI 10.1097/QCO.0000000000000394
   Rosso F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34640-z
   Schrekker CML, 2016, ACS APPL MATER INTER, V8, P21163, DOI 10.1021/acsami.6b06005
   Schrekker HS, 2008, J BRAZIL CHEM SOC, V19, P426, DOI 10.1590/S0103-50532008000300009
   Solaiman Z., 2007, V11, P167
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Tandina F., 2016, PARASITE VECTOR, V9, P1
   Tetreau G, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2741-8
   Toppino A, 2013, CHEM-EUR J, V19, P720, DOI 10.1002/chem.201201634
   Wei G, 2017, P NATL ACAD SCI USA, V114, P5994, DOI 10.1073/pnas.1703546114
   WHO, 2017, DENG DENG HAEM FEV
   Yadav K. K., 2015, PARASITE VECTOR, V8, P1
NR 33
TC 1
Z9 1
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 7
PY 2019
VL 9
AR 16164
DI 10.1038/s41598-019-52687-4
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JK6IK
UT WOS:000494945300003
PM 31700056
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cunze, S
   Kochmann, J
   Koch, LK
   Genthner, E
   Klimpel, S
AF Cunze, Sarah
   Kochmann, Judith
   Koch, Lisa K.
   Genthner, Elisa
   Klimpel, Sven
TI Vector distribution and transmission risk of the Zika virus in South and
   Central America
SO PEERJ
LA English
DT Article
DE Aedes albopictus; Aedes aegypti; Species distribution modelling; Vector
   borne diseases; Biogeography of disease; Tiger mosquito; Yellow fever
   mosquito; Climatic habitat suitability; Vector-pathogen-host; Maxent
ID SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; DENGUE VIRUS; NICHE; DISEASE;
   MODELS; FRAMEWORK
AB Background: Zika is of great medical relevance due to its rapid geographical spread in 2015 and 2016 in South America and its serious implications, for example, certain birth defects. Recent epidemics urgently require a better understanding of geographic patterns of the Zika virus transmission risk. This study aims to map the Zika virus transmission risk in South and Central America. We applied the maximum entropy approach, which is common for species distribution modelling, but is now also widely in use for estimating the geographical distribution of infectious diseases.
   Methods: As predictor variables we used a set of variables considered to be potential drivers of both direct and indirect effects on the emergence of Zika. Specifically, we considered (a) the modelled habitat suitability for the two main vector species Aedes aegypti and Ae. albopictus as a proxy of vector species distributions; (b) temperature, as it has a great influence on virus transmission; (c) commonly called evidence consensus maps (ECM) of human Zika virus infections on a regional scale as a proxy for virus distribution; (d) ECM of human dengue virus infections and, (e) as possibly relevant socio-economic factors, population density and the gross domestic product.
   Results: The highest values for the Zika transmission risk were modelled for the eastern coast of Brazil as well as in Central America, moderate values for the Amazon basin and low values for southern parts of South America. The following countries were modelled to be particularly affected: Brazil, Colombia, Cuba, Dominican Republic, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Puerto Rico and Venezuela. While modelled vector habitat suitability as predictor variable showed the highest contribution to the transmission risk model, temperature of the warmest quarter contributed only comparatively little. Areas with optimal temperature conditions for virus transmission overlapped only little with areas of suitable habitat conditions for the two main vector species. Instead, areas with the highest transmission risk were characterised as areas with temperatures below the optimum of the virus, but high habitat suitability modelled for the two main vector species.
   Conclusion: Modelling approaches can help estimating the spatial and temporal dynamics of a disease. We focused on the key drivers relevant in the Zika transmission cycle (vector, pathogen, and hosts) and integrated each single component into the model. Despite the uncertainties generally associated with modelling, the approach applied in this study can be used as a tool and assist decision making and managing the spread of Zika.
C1 [Cunze, Sarah; Kochmann, Judith; Koch, Lisa K.; Genthner, Elisa; Klimpel, Sven] Goethe Univ, Inst Ecol Evolut & Divers, Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany.
RP Cunze, S (corresponding author), Goethe Univ, Inst Ecol Evolut & Divers, Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany.
EM cunze@bio.uni-frankfurt.de
OI Koch, Lisa/0000-0002-3064-8401; Kochmann, Judith/0000-0001-6312-7859
FU Uniscientia Stiftung; LOEWE-Centre TBG - Hessen State Ministry of Higher
   Education, Research, and the Arts (HMWK)
FX The present study was supported by the Uniscientia Stiftung. The present
   study was also supported by the LOEWE-Centre TBG funded by the Hessen
   State Ministry of Higher Education, Research, and the Arts (HMWK). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132
   Allen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00923-8
   Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264
   Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Arino O., 2012, GLOBAL LAND COVER MA
   Avsic Zupanc Tatjana, 2016, Zdr Varst, V55, P228
   Baak-Baak CM, 2017, J MED ENTOMOL, V54, P854, DOI 10.1093/jme/tjw243
   Balogun Emmanuel O, 2016, Trop Med Health, V44, P38, DOI 10.1186/s41182-016-0039-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brand SPC, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0481
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Cohen J, 2017, SCIENCE, V355, P1362, DOI 10.1126/science.355.6332.1362
   Cunze S, 2015, ENVIRON MODELL SOFTW, V72, P250, DOI 10.1016/j.envsoft.2015.05.004
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   ESA GlobeCover 2009 Project, 2010, DAT LAND COV CENTR S
   Escobar LE, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00105
   Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174
   Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, P1, DOI DOI 10.1371/J0URNAL.PNTD.0006194
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Johnson EE, 2019, TRENDS ECOL EVOL, V34, P655, DOI 10.1016/j.tree.2019.03.004
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lo D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192120
   Lounibos LP, 2018, BIOL INVASIONS, V20, P1913, DOI 10.1007/s10530-018-1674-7
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Phillips S. J., MAXENT SOFTWARE MODE
   Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Romeo-Aznar V, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0826
   Samuel GH, 2016, CURR OPIN INSECT SCI, V16, P108, DOI 10.1016/j.cois.2016.06.005
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Samy AM, 2014, REV SOC BRAS MED TRO, V47, P57, DOI 10.1590/0037-8682-0189-2013
   Suparit P, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0083-z
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Tsai CH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2493-x
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P698, DOI 10.1016/j.apjtm.2016.05.014
   World Bank, 2016, WORLD BANK OP DAT
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, 2019, ZIK EP UPD JUL 2019
NR 53
TC 0
Z9 0
U1 7
U2 8
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD NOV 7
PY 2019
VL 7
AR e7920
DI 10.7717/peerj.7920
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JK6FV
UT WOS:000494937900003
PM 31745446
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tchouassi, DP
   Jacob, JW
   Ogola, EO
   Sang, R
   Torto, B
AF Tchouassi, David P.
   Jacob, Juliah W.
   Ogola, Edwin O.
   Sang, Rosemary
   Torto, Baldwyn
TI Aedes vector-host olfactory interactions in sylvatic and domestic dengue
   transmission environments
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE cyclohexanone; sulcatone; non-human primate; skin odours; sylvatic and
   domestic environments; Aedes (Stegomyia) mosquitoes
ID VIRUS; FEVER; CHIKUNGUNYA; MOSQUITOS; SKIN; SURVEILLANCE; CATCHES;
   HUMANS
AB Interactions between Aedes (Stegomyia) species and non-human primate (NHP) and human hosts govern the transmission of the pathogens, dengue, zika, yellow fever and chikungunya viruses. Little is known about Aedes mosquito olfactory interactions with these hosts in the domestic and sylvatic cycles where these viruses circulate. Here, we explore how the different host-derived skin odours influence Aedes mosquito responses in these two environments. In field assays, we show that the cyclic ketone cyclohexanone is a signature cue for Aedes mosquitoes to detect theNHP baboon, sykes and vervet, whereas for humans, it is the unsaturated aliphatic keto-analogue 6-methyl-5-hepten-2one (sulcatone). We find that in the sylvatic environment, CO2-baited traps combined with either cyclohexanone or sulcatone increased trap catches of Aedes mosquitoes compared to traps either baited with CO2 alone or CO2 combined with NHP- or human-derived crude skin odours. In the domestic environment, each of these odourants and crude human skin odours increased Aedes aegypti catches in CO2-baited traps. These results expand our knowledge on the role of host odours in the ecologies of Aedes mosquitoes, and the likelihood of associated spread of pathogens between primates and humans. Both cyclohexanone and sulcatone have potential practical applications as lures for monitoring Aedes disease vectors.
C1 [Tchouassi, David P.; Jacob, Juliah W.; Ogola, Edwin O.; Sang, Rosemary; Torto, Baldwyn] Int Ctr Insect Physiol & Ecol, POB 30772-00100, Nairobi, Kenya.
RP Tchouassi, DP (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772-00100, Nairobi, Kenya.
EM dtchouassi@icipe.org
OI Tchouassi, David P/0000-0001-9910-4704
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [1R01AI099736-01A1]; UK's Department for International Development
   (DFID); Swedish International Development Cooperation Agency (Sida);
   Swiss Agency for Development and Cooperation (SDC); Kenyan Government
FX This study was funded by National Institutes of Health (NIH), grant no.
   1R01AI099736-01A1 to R.S. We gratefully acknowledge the financial
   support for this research by the following organizations and agencies:
   UK's Department for International Development (DFID); Swedish
   International Development Cooperation Agency (Sida); the Swiss Agency
   for Development and Cooperation (SDC); and the Kenyan Government. The
   views expressed herein do not necessarily reflect the official opinion
   of the donors. The funders had no role in study design, data collection
   and analysis, decision to publish or preparation of the manuscript.
CR Agha SB, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005858
   Ben M, 2018, INT J ZOOL APPL BIOS, V3, P294
   Bernier UR, 2002, J AM MOSQUITO CONTR, V18, P186
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Busula AO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0635-1
   Chan HK, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006536
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Cohnstaedt LW, 2012, ANN ENTOMOL SOC AM, V105, P135, DOI 10.1603/AN11127
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Edwards FW, 1941, MOSQUITOES ETHIOPIAN
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Huang YM, 2004, ZOOTAXA, P1
   Jacob JW, 2018, ACTA TROP, V185, P98, DOI 10.1016/j.actatropica.2018.04.027
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   KOKERNOT RH, 1962, AM J TROP MED HYG, V11, P678, DOI 10.4269/ajtmh.1962.11.678
   KOVARIK J, 2013, R LANG ENV STAT COMP, V80, P275, DOI DOI 10.1159/000346960
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39
   Nyasembe VO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089818
   Ogutu JO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169730
   Owino EA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0866-6
   Owino EA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-451
   Ray A, 2015, CURR OPIN NEUROBIOL, V34, P158, DOI 10.1016/j.conb.2015.06.014
   Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319
   Syed Z, 2015, CURR OPIN INSECT SCI, V10, P83, DOI 10.1016/j.cois.2015.04.011
   Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013
   Tchouassi DP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1473-x
   Tchouassi DP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002007
   Tchouassi DP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001879
   Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220
   Wilcox B. A., 2006, Unasylva (English ed.), V57, P11
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 36
TC 0
Z9 0
U1 0
U2 0
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD NOV 6
PY 2019
VL 286
IS 1914
AR 20192136
DI 10.1098/rspb.2019.2136
PG 10
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA JZ1II
UT WOS:000504858100020
PM 31690238
OA Bronze
DA 2020-07-08
ER

PT J
AU Zhang, YP
   Zhang, YK
   Liu, ZY
   Cheng, ML
   Ma, JF
   Wang, Y
   Qin, CF
   Fang, XY
AF Zhang, Yupeng
   Zhang, Yikan
   Liu, Zhong-Yu
   Cheng, Meng-Li
   Ma, Junfeng
   Wang, Yan
   Qin, Cheng-Feng
   Fang, Xianyang
TI Long non-coding subgenomic flavivirus RNAs have extended 3D structures
   and are flexible in solution
SO EMBO REPORTS
LA English
DT Article
DE 3D structure; computational modeling; long non-coding RNA; small angle
   X-ray scattering; subgenomic flavivirus RNA
ID X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; PSEUDOKNOT STRUCTURE;
   STEM-LOOP; SECONDARY; RESOLUTION; CLASSIFICATION; PATHOGENESIS;
   RESISTANT; RECEPTOR
AB Most mosquito-borne flaviviruses, including Zika virus (ZIKV), Dengue virus (DENV), and West Nile virus (WNV), produce long non-coding subgenomic RNAs (sfRNAs) in infected cells that link to pathogenicity and immune evasion. Until now, the structural characterization of these lncRNAs remains limited. Here, we studied the 3D structures of individual and combined subdomains of sfRNAs, and visualized the accessible 3D conformational spaces of complete sfRNAs from DENV2, ZIKV, and WNV by small angle X-ray scattering (SAXS) and computational modeling. The individual xrRNA1s and xrRNA2s adopt similar structures in solution as the crystal structure of ZIKV xrRNA1, and all xrRNA1-2s form compact structures with reduced flexibility. While the DB12 of DENV2 is extended, the DB12s of ZIKV and WNV are compact due to the formation of intertwined double pseudoknots. All 3 ' stem-loops (3 ' SLs) share similar rod-like structures. Complete sfRNAs are extended and sample a large conformational space in solution. Our work not only provides structural insight into the function of flavivirus sfRNAs, but also highlights strategies of visualizing other lncRNAs in solution by SAXS and computational methods.
C1 [Zhang, Yupeng; Zhang, Yikan; Ma, Junfeng; Wang, Yan; Fang, Xianyang] Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China.
   [Liu, Zhong-Yu; Cheng, Meng-Li; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Liu, Zhong-Yu] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Liu, Zhong-Yu] Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou, Guangdong, Peoples R China.
RP Fang, XY (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
EM qincf@bmi.ac.cn; fangxy@tsinghua.edu.cn
OI Fang, Xianyang/0000-0001-9432-9736
FU DOE Office of ScienceUnited States Department of Energy (DOE)
   [DE-AC02-06CH11357]; National Key Research and Development Project of
   China [2016YFA0500700, 2016YFD0500304, 2018ZX09711003]; China Youth
   1000-Talent Program of the State Council of China; Tsinghua University
   Initiative Scientific Research Program; Beijing Advanced Innovation
   Center for Structural Biology; Tsinghua-Peking Joint Center for Life
   Sciences; National Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81522025, 81621005, 31770190]
FX This research used resources of the Advanced Photon Source, a U.S.
   Department of Energy (DOE) Office of Science User Facility operated for
   the DOE Office of Science by Argonne National Laboratory under Contract
   No. DE-AC02-06CH11357. We thank Dr. Xiaobing Zuo at the beamline
   12-ID-B, Advanced Photon Source, Argonne National Laboratory and the
   staffs of beamline BL19U2 at National Facility for Protein Science
   Shanghai (NFPS), and Shanghai Synchrotron Radiation Facility, Shanghai,
   People's Republic of China for assistance during data collection. This
   work was supported by grants from the National Key Research and
   Development Project of China (2016YFA0500700), the China Youth
   1000-Talent Program of the State Council of China, Tsinghua University
   Initiative Scientific Research Program, the Beijing Advanced Innovation
   Center for Structural Biology, the Tsinghua-Peking Joint Center for Life
   Sciences to X.F., and the National Key Research and Development Project
   of China (2016YFD0500304, 2018ZX09711003), and the National Natural
   Science Foundation of China (No. 81522025, 81621005, 31770190) to C.F.Q.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Bailor MH, 2011, CURR OPIN STRUC BIOL, V21, P296, DOI 10.1016/j.sbi.2011.03.009
   Bermejo GA, 2016, STRUCTURE, V24, P806, DOI 10.1016/j.str.2016.03.007
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997
   Blythe AJ, 2016, BBA-GENE REGUL MECH, V1859, P46, DOI 10.1016/j.bbagrm.2015.08.009
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Charley PA, 2016, VIRUS RES, V212, P70, DOI 10.1016/j.virusres.2015.09.009
   Cheng CY, 2015, METHOD ENZYMOL, V553, P35, DOI 10.1016/bs.mie.2014.10.051
   Chillon I, 2015, METHOD ENZYMOL, V558, P3, DOI 10.1016/bs.mie.2015.01.008
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07
   Davis WG, 2013, J VIROL, V87, P7622, DOI 10.1128/JVI.00212-13
   Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009
   Fang XY, 2017, BIOCHEMISTRY-US, V56, P3549, DOI 10.1021/acs.biochem.7b00284
   Fang XY, 2015, CURR OPIN STRUC BIOL, V30, P147, DOI 10.1016/j.sbi.2015.02.010
   Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008
   Fernandez-Sanles A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00546
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Fortes P, 2016, VIRUS RES, V212, P1, DOI 10.1016/j.virusres.2015.10.002
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gortz GP, 2015, CELL HOST MICROBE, V18, P133, DOI 10.1016/j.chom.2015.07.009
   Hermann T, 2016, WIRES RNA, V7, P726, DOI 10.1002/wrna.1373
   Jones CP, 2014, P NATL ACAD SCI USA, V111, P3395, DOI 10.1073/pnas.1319658111
   Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004
   Liu F, 2017, NAT CHEM BIOL, V13, P282, DOI [10.1038/NCHEMBIO.2272, 10.1038/nchembio.2272]
   Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P1099, DOI 10.1016/j.bbrc.2009.12.030
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   McFadden EJ, 2016, BIOCHEMISTRY-US, V55, P1615, DOI 10.1021/acs.biochem.5b01141
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Nogales E, 2016, CURR OPIN STRUC BIOL, V40, P120, DOI 10.1016/j.sbi.2016.09.009
   Novikova IV, 2013, INT J MOL SCI, V14, P23672, DOI 10.3390/ijms141223672
   Novikova IV, 2013, J MOL BIOL, V425, P3731, DOI 10.1016/j.jmb.2013.02.030
   Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Ostareck DH, 2014, WIRES RNA, V5, P659, DOI 10.1002/wrna.1237
   Perard J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2611
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070
   Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638
   Reyes FE, 2014, METHOD ENZYMOL, V549, P235, DOI 10.1016/B978-0-12-801122-5.00011-8
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320
   Sanbonmatsu KY, 2016, BBA-GENE REGUL MECH, V1859, P41, DOI 10.1016/j.bbagrm.2015.09.011
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Schwieters CD, 2014, PROG NUCL MAG RES SP, V80, P1, DOI 10.1016/j.pnmrs.2014.03.001
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao SC, 2016, CELL, V167, P1229, DOI 10.1016/j.cell.2016.10.046
   Shi PY, 1996, BIOCHEMISTRY-US, V35, P4222, DOI 10.1021/bi952398v
   Somarowthu S, 2016, J MOL BIOL, V428, P736, DOI 10.1016/j.jmb.2015.11.011
   Somarowthu S, 2015, MOL CELL, V58, P353, DOI 10.1016/j.molcel.2015.03.006
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Sztuba-Solinska J, 2017, NUCLEIC ACIDS RES, V45, P6805, DOI 10.1093/nar/gkx241
   Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115
   Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249
   Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zuo XB, 2006, P NATL ACAD SCI USA, V103, P3534, DOI 10.1073/pnas.0600022103
NR 80
TC 1
Z9 1
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD NOV 5
PY 2019
VL 20
IS 11
AR e47016
DI 10.15252/embr.201847016
PG 20
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA JM5BM
UT WOS:000496229500007
PM 31502753
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lynch, CA
   Foguel, MV
   Reed, AJ
   Balcarcel, AM
   Calvo-Marzal, P
   Gerasimova, YV
   Chumbimuni-Torres, KY
AF Lynch, Charles A., III
   Foguel, Marcos V.
   Reed, Adam J.
   Balcarcel, Angelica M.
   Calvo-Marzal, Percy
   Gerasimova, Yulia V.
   Chumbimuni-Torres, Karin Y.
TI Selective Determination of Isothermally Amplified Zika Virus RNA Using a
   Universal DNA-Hairpin Probe in Less than 1 Hour
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID SNP ANALYSIS; ASSAY
AB The recent outbreak of the Zika virus (ZIKV) in the Americas and multiple studies that linked the virus to the cases of microcephaly and neurological complications have revealed the need for cost efficient and rapid ZIKV diagnostics tests. Here, a diagnostic platform relying on a four-way junction (4WJ)-based biosensor with electrochemical readout using a Universal DNA-Hairpin (UDH) probe for the selective recognition of an isothermally amplified ZIKV RNA fragment is developed. The 4WJ structure utilizes an electrode-immobilized stem-loop (DNA-hairpin) probe and two DNA adaptor strands complementary to both the stem-loop probe and the targeted fragment of a ZIKV amplicon. One of the adaptor strands is responsible for high selectivity of the target recognition, while another helps unwinding the target secondary structure. The first adaptor strand contains a redox label methylene blue to trigger the current change in response to the target-dependent formation of the 4WJ structure on the surface of the electrode. The amplicon can be analyzed directly from the amplification sample without the need for its purification. The proposed diagnostic methodology exhibits the limit of ZIKV RNA detection of 1.11 fg/mu L (similar to 0.3 fM) and high selectivity that allows for reliable discrimination of ZIKV from West Nile virus and four dengue virus serotypes. Overall, the analysis of ZIKV RNA can be completed in less than 1 h, including amplification and electrochemical detection.
C1 [Lynch, Charles A., III; Foguel, Marcos V.; Reed, Adam J.; Balcarcel, Angelica M.; Calvo-Marzal, Percy; Gerasimova, Yulia V.; Chumbimuni-Torres, Karin Y.] Univ Cent Florida, Dept Chem, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
   [Lynch, Charles A., III] Rose Hulman Inst Technol, 5500 Wabash Ave, Terre Haute, IN 47803 USA.
RP Chumbimuni-Torres, KY (corresponding author), Univ Cent Florida, Dept Chem, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
EM Karin.ChumbimuniTorres@ucf.edu
RI Foguel, Marcos Vinicius/AAD-5767-2020
OI Foguel, Marcos Vinicius/0000-0001-9584-1029; Gerasimova,
   Yulia/0000-0001-8804-9770
FU NSF-CBETNational Science Foundation (NSF) [1706802]; Florida Health
   Department [7ZKO5, 7ZK33]
FX The authors acknowledge NSF-CBET Grant Number 1706802 and Florida Health
   Department Grant Numbers 7ZKO5 and 7ZK33. The authors are thankful to
   Dr. Hyeryun Choe (Scripps Research Institute, Jupiter, FL) for providing
   viral RNA.
CR Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   Alves RD, 2019, SENSOR ACTUAT B-CHEM, V296, DOI 10.1016/j.snb.2019.126681
   [Anonymous], 2009, IUPAC COMPENDIUM CHE
   Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   El Galil KHA, 2005, APPL ENVIRON MICROB, V71, P7113, DOI 10.1128/AEM.71.11.7113-7116.2005
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Galan-Huerta K, 2016, MED U, V18, P115, DOI DOI 10.1016/J.RMU.2016.05.003
   Gerasimova YV, 2013, BIOSENS BIOELECTRON, V41, P386, DOI 10.1016/j.bios.2012.08.058
   Gerasimova YV, 2010, CHEMBIOCHEM, V11, P1762, DOI 10.1002/cbic.201000287
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Grimes J, 2010, ANGEW CHEM INT EDIT, V49, P8950, DOI 10.1002/anie.201004475
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Kolpashchikov DM, 2006, J AM CHEM SOC, V128, P10625, DOI 10.1021/ja0628093
   Kolpashchikov DM, 2010, CHEM REV, V110, P4709, DOI 10.1021/cr900323b
   Labib M, 2015, ANAL CHEM, V87, P1395, DOI 10.1021/ac504331c
   Labib M, 2013, ANAL CHEM, V85, P9422, DOI 10.1021/ac402416z
   Liu SQ, 2018, J MED VIROL, V90, P389, DOI 10.1002/jmv.24970
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Manzano M, 2018, BIOSENS BIOELECTRON, V100, P89, DOI 10.1016/j.bios.2017.08.043
   Faria HAM, 2019, BIOSENS BIOELECTRON, V131, P149, DOI 10.1016/j.bios.2019.02.018
   Mills DM, 2019, SENSOR ACTUAT B-CHEM, V293, P11, DOI 10.1016/j.snb.2019.04.149
   Mills DM, 2018, BIOSENS BIOELECTRON, V109, P35, DOI 10.1016/j.bios.2018.02.059
   Mills DM, 2017, ELECTROANAL, V29, P873, DOI 10.1002/elan.201600548
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nguyen C, 2011, CHEM-EUR J, V17, P13052, DOI 10.1002/chem.201101987
   Peters R, 2019, CLIN MICROBIOL INFEC, V25, P142, DOI 10.1016/j.cmi.2018.12.002
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Powell L, 2018, ANALYST, V143, P2596, DOI 10.1039/c8an00552d
   Qi HJ, 2018, BIOSENS BIOELECTRON, V110, P207, DOI 10.1016/j.bios.2018.03.065
   Reed AJ, 2019, SENSOR ACTUAT B-CHEM, V282, P945, DOI 10.1016/j.snb.2018.11.147
   Steinmetz M, 2019, BIOSENS BIOELECTRON, V141, DOI 10.1016/j.bios.2019.111351
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   WEUSTEN JJAM, 2002, NUCLEIC ACIDS RES, V30
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 46
TC 2
Z9 2
U1 17
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD NOV 5
PY 2019
VL 91
IS 21
BP 13458
EP 13464
DI 10.1021/acs.analchem.9b02455
PG 7
WC Chemistry, Analytical
SC Chemistry
GA JL3YW
UT WOS:000495469100021
PM 31571484
DA 2020-07-08
ER

PT J
AU Napflin, K
   O'Connor, EA
   Becks, L
   Bensch, S
   Ellis, VA
   Hafer-Hahmand, N
   Harding, KC
   Linden, SK
   Olsen, MT
   Roved, J
   Sackton, TB
   Shultz, AJ
   Venkatakrishnans, V
   Videvall, E
   Westerdahl, H
   Winternitz, JC
   Edwards, SV
AF Naepflin, Kathrin
   O'Connor, Emily A.
   Becks, Lutz
   Bensch, Staffan
   Ellis, Vincenzo A.
   Hafer-Hahmand, Nina
   Harding, Karin C.
   Linden, Sara K.
   Olsen, Morten T.
   Roved, Jacob
   Sackton, Timothy B.
   Shultz, Allison J.
   Venkatakrishnans, Vignesh
   Videvall, Elin
   Westerdahl, Helena
   Winternitz, Jamie C.
   Edwards, Scott, V
TI Genomics of host-pathogen interactions: challenges and opportunities
   across ecological and spatiotemporal scales
SO PEERJ
LA English
DT Article
DE Plasmodium; MHC; Immunotoxins; Mucus; Natural selection; GWAS;
   Infectious diseases; Anthropogenic stressors; Co-evolution;
   Epidemiological surveillance
ID HELICOBACTER-PYLORI; NATURAL-SELECTION; GUT MICROBIOTA; CLASS-I; MALARIA
   PARASITES; IMMUNE-SYSTEM; INFECTIOUS-DISEASES; ZIKA VIRUS; EVOLUTION;
   MHC
AB Evolutionary genomics has recently entered a new era in the study of host-pathogen interactions. A variety of novel genomic techniques has transformed the identification, detection and classification of both hosts and pathogens, allowing a greater resolution that helps decipher their underlying dynamics and provides novel insights into their environmental context. Nevertheless, many challenges to a general understanding of host-pathogen interactions remain, in particular in the synthesis and integration of concepts and findings across a variety of systems and different spatiotemporal and ecological scales. In this perspective we aim to highlight some of the commonalities and complexities across diverse studies of host-pathogen interactions, with a focus on ecological, spatiotemporal variation, and the choice of genomic methods used. We performed a quantitative review of recent literature to investigate links, patterns and potential tradeoffs between the complexity of genomic, ecological and spatiotemporal scales undertaken in individual host-pathogen studies. We found that the majority of studies used whole genome resolution to address their research objectives across a broad range of ecological scales, especially when focusing on the pathogen side of the interaction. Nevertheless, genomic studies conducted in a complex spatiotemporal context are currently rare in the literature. Because processes of host-pathogen interactions can be understood at multiple scales, from molecular-, cellular-, and physiological-scales to the levels of populations and ecosystems, we conclude that a major obstacle for synthesis across diverse host-pathogen systems is that data are collected on widely diverging scales with different degrees of resolution. This disparity not only hampers effective infrastructural organization of the data but also data granularity and accessibility. Comprehensive metadata deposited in association with genomic data in easily accessible databases will allow greater inference across systems in the future, especially when combined with open data standards and practices. The standardization and comparability of such data will facilitate early detection of emerging infectious diseases as well as studies of the impact of anthropogenic stressors, such as climate change, on disease dynamics in humans and wildlife.
C1 [Naepflin, Kathrin; Edwards, Scott, V] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
   [Naepflin, Kathrin; Edwards, Scott, V] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.
   [O'Connor, Emily A.; Bensch, Staffan; Ellis, Vincenzo A.; Roved, Jacob; Videvall, Elin; Westerdahl, Helena] Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, Lund, Sweden.
   [Becks, Lutz] Univ Konstanz, Aquat Ecol & Evolut, Limnol Inst, Constance, Germany.
   [Hafer-Hahmand, Nina; Winternitz, Jamie C.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Plon, Germany.
   [Hafer-Hahmand, Nina] Swiss Fed Inst Aquat Sci & Technol, EAWAG, Dubendorf, Switzerland.
   [Harding, Karin C.] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.
   [Harding, Karin C.; Edwards, Scott, V] Chalmers Univ Technol, Gothenburg Ctr Adv Studies Sci & Technol, Gothenburg, Sweden.
   [Harding, Karin C.; Edwards, Scott, V] Univ Gothenburg, Gothenburg, Sweden.
   [Linden, Sara K.; Venkatakrishnans, Vignesh] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Chem & Cell Biol, Gothenburg, Sweden.
   [Olsen, Morten T.] Univ Copenhagen, Dept Biol, Sect Evolutionary Genom, Nat Hist Museum Denmark, Copenhagen, Denmark.
   [Sackton, Timothy B.] Harvard Univ, Informat Grp, Cambridge, MA 02138 USA.
   [Shultz, Allison J.] Nat Hist Museum Los Angeles Cty, Dept Ornithol, Los Angeles, CA USA.
   [Videvall, Elin] Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Conservat Genom, Washington, DC USA.
   [Winternitz, Jamie C.] Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany.
RP Napflin, K (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Napflin, K (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.
EM knaepflin@fas.harvard.edu
RI Roved, Jacob/S-9159-2019; Winternitz, JC/G-9775-2012; Edwards, Scott
   V./D-9071-2018
OI Roved, Jacob/0000-0001-6977-714X; Winternitz, JC/0000-0002-1113-9126;
   Edwards, Scott V./0000-0003-2535-6217; Napflin,
   Kathrin/0000-0002-1088-5282; Videvall, Elin/0000-0002-9998-3689
FU Chalmers University of Technology; University of Gothenburg; Swedish
   Government Research Council FormasSwedish Research Council Formas;
   Swedish Research CouncilSwedish Research Council; Alexander von Humboldt
   FoundationAlexander von Humboldt Foundation; Kungliga Fysiografiska
   Sallskapet i Lund; US National Science FoundationNational Science
   Foundation (NSF); Carl Tryggers Foundation; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [168911, 180862]
FX The themed activities of "Origins of Biodiversity'', of which our
   host-pathogen workshop was a part and during which the writing of this
   piece began, were funded by Chalmers University of Technology and the
   University of Gothenburg. The research of the authors of this article
   were supported by the Swedish Government Research Council Formas, the
   Swedish Research Council, the Alexander von Humboldt Foundation,
   Kungliga Fysiografiska Sallskapet i Lund, the US National Science
   Foundation, the Carl Tryggers Foundation (postdoctoral fellowship to
   Vincenzo Ellis), and the Swiss National Science Foundation (postdoctoral
   fellowships nr.168911 and 180862 to Kathrin Napflin). No additional
   external funding was received for this study. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adrian J, 2019, CURR BIOL, V29, P616, DOI 10.1016/j.cub.2019.01.058
   Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694
   Asghar M, 2015, SCIENCE, V347, P436, DOI 10.1126/science.1261121
   Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801
   Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105
   Bachmann NL, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00363
   Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29
   Band G, 2015, NATURE, V526, P253, DOI 10.1038/nature15390
   Bartha I, 2013, ELIFE, V2, DOI 10.7554/eLife.01123
   Bastian F, 2008, LECT N BIOINFORMAT, V5109, P124, DOI 10.1007/978-3-540-69828-9_12
   Beaulieu-Jones BK, 2016, BIORXIV, DOI [10.1101/056473, DOI 10.1101/056473]
   Beltran PMJ, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167062
   Ben-Ami F, 2011, J EVOLUTION BIOL, V24, P1307, DOI 10.1111/j.1420-9101.2011.02264.x
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x
   Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x
   BERGMAN A, 1985, FINNISH GAME RES, V44, P47
   Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x
   Biek R, 2007, P NATL ACAD SCI USA, V104, P7993, DOI 10.1073/pnas.0700741104
   Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005
   Blasco-Costa I, 2017, J HELMINTHOL, V91, P647, DOI 10.1017/S0022149X16000924
   Bolnick DI, 2017, NATURE, V546, P285, DOI 10.1038/nature22351
   Bonds MH, 2010, P ROY SOC B-BIOL SCI, V277, P1185, DOI 10.1098/rspb.2009.1778
   Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549
   Bourgeois Y, 2017, EVOLUTION, V71, P1106, DOI 10.1111/evo.13209
   Bugaytsova JA, 2017, CELL HOST MICROBE, V21, P376, DOI 10.1016/j.chom.2017.02.013
   Bullman S, 2017, ANNU REV PATHOL-MECH, V12, P217, DOI 10.1146/annurev-pathol-012615-044305
   Cairns J, 2017, MOL ECOL, V26, P1848, DOI 10.1111/mec.13950
   Carlin AF, 2018, P NATL ACAD SCI USA, V115, pE9172, DOI 10.1073/pnas.1807690115
   Chang WE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1231-2
   Cheng Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-87
   Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001
   Chomwong S, 2018, DEV COMP IMMUNOL, V89, P54, DOI 10.1016/j.dci.2018.08.002
   Clark AG, 1997, GENETICS, V147, P713
   Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   Datta Sibnarayan, 2015, World J Virol, V4, P265, DOI 10.5501/wjv.v4.i3.265
   Daub JT, 2013, MOL BIOL EVOL, V30, P1544, DOI 10.1093/molbev/mst080
   De Vienne DM, 2007, J EVOLUTION BIOL, V20, P1428, DOI 10.1111/j.1420-9101.2007.01340.x
   de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150
   Desforges JPW, 2016, ENVIRON INT, V86, P126, DOI 10.1016/j.envint.2015.10.007
   Dilthey A, 2015, NAT GENET, V47, P682, DOI 10.1038/ng.3257
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Dugan VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099979
   Edwards HS, 2019, REAL TIME SELECTIVE, DOI [10.1101/460014, DOI 10.1101/460014]
   Enard D, 2018, CELL, V175, P360, DOI 10.1016/j.cell.2018.08.034
   Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107
   Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110
   Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355
   Gerber LR, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00336.1
   Gilpatrick T., 2019, BIORXIV, DOI [10.1101/604173, DOI 10.1101/604173]
   Gomez-Diaz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003007
   Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105
   Gregory AC, 2019, CELL, V177, P1109, DOI 10.1016/j.cell.2019.03.040
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hall MD, 2017, TRENDS ECOL EVOL, V32, P612, DOI 10.1016/j.tree.2017.05.009
   Harding KC, 2012, J THEOR BIOL, V298, P1, DOI 10.1016/j.jtbi.2011.12.009
   Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x
   Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115
   Harpur BA, 2019, GENOME BIOL EVOL, V11, P937, DOI 10.1093/gbe/evz018
   Hasan MR, 2016, J CLIN MICROBIOL, V54, P919, DOI 10.1128/JCM.03050-15
   Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1
   Hellgren Olof, 2010, Immunome Res, V6, P3, DOI 10.1186/1745-7580-6-3
   Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002
   HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0
   Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608
   Kamath PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11448
   Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734
   Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405
   Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856
   Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7
   Koonin EV, 2017, ANNU REV MICROBIOL, V71, P233, DOI 10.1146/annurev-micro-090816-093830
   Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144
   Kratochwil CF, 2015, BIOESSAYS, V37, P213, DOI 10.1002/bies.201400142
   Kumar SS, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00406
   Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970
   Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519
   Laine VN, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5378-2
   Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Ley DH, 2016, J WILDLIFE DIS, V52, P669, DOI 10.7589/2015-09-244
   Libertucci J, 2019, NAT MICROBIOL, V4, P35, DOI 10.1038/s41564-018-0278-4
   Lighten J, 2014, MOL ECOL RESOUR, V14, P753, DOI 10.1111/1755-0998.12225
   Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5
   Linden S, 2010, HELICOBACTER, V15, P251, DOI 10.1111/j.1523-5378.2010.00765.x
   Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002
   Lipkin WI, 2013, NAT REV MICROBIOL, V11, P133, DOI 10.1038/nrmicro2949
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Lotterhos KE, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000070
   Maganga GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100172
   McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538
   Melnikov A, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-8-r73, 10.1186/gb-2011-12-8-R73]
   Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x
   Minias P, 2019, GENOME BIOL EVOL, V11, P17, DOI 10.1093/gbe/evy253
   Napflin K, 2018, J ANIM ECOL, V87, P331, DOI 10.1111/1365-2656.12768
   Napflin K, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0312
   Nature Editorial, 2017, NATURE, V546, DOI [10.1038/546008a, DOI 10.1038/546008A]
   Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420
   Nunez-Iglesias J., 2015, WHY SCI SHOULD CODE
   O'Connor E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080848
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525
   Padra JT, 2014, INFECT IMMUN, V82, P5235, DOI 10.1128/IAI.01931-14
   Padra M, 2018, VIRULENCE, V9, P898, DOI 10.1080/21505594.2018.1460979
   Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350
   Palinauskas V, 2013, EXP PARASITOL, V133, P275, DOI 10.1016/j.exppara.2012.12.003
   Parker GA, 2003, NATURE, V425, P480, DOI 10.1038/nature02012
   Penczykowski RM, 2016, EVOL APPL, V9, P37, DOI 10.1111/eva.12294
   Peona V, 2018, MOL ECOL RESOUR, V18, P1188, DOI 10.1111/1755-0998.12933
   Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6
   Pittman KJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005680
   Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086
   Poulin R, 2014, INT J PARASITOL, V44, P581, DOI 10.1016/j.ijpara.2014.02.003
   Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050
   Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024
   Quintana-Hayashi MP, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6020055
   Qutob N, 2012, IMMUNOGENETICS, V64, P165, DOI 10.1007/s00251-011-0576-y
   Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2
   Rini J. M., 2015, ESSENTIALS GLYCOBIOL, P65, DOI DOI 10.1101/GLYCOBIOLOGY.3E.006
   Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10
   Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161
   Rogalski MA, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0043
   Rolhion N, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0504
   Rydell GE, 2011, REV MED VIROL, V21, P370, DOI 10.1002/rmv.704
   Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60
   Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555
   Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108
   Scanlan PD, 2015, MOL BIOL EVOL, V32, P1425, DOI 10.1093/molbev/msv032
   Scharsack JP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-109
   Schmid-Hempel P., 2011, EVOLUTIONARY PARASIT, DOI [10.1093/acprof:oso/9780199229482.001.0001, DOI 10.1093/ACPROF:OSO/9780199229482.001.0001]
   Schwarz RS, 2016, P NATL ACAD SCI USA, V113, P9345, DOI 10.1073/pnas.1606631113
   Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009
   Shan SJ, 2018, FISH SHELLFISH IMMUN, V72, P187, DOI 10.1016/j.fsi.2017.09.081
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494
   Shultz AJ, 2019, ELIFE, V8, DOI 10.7554/eLife.41815
   Singh I, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-018-2580-9
   Skoog EC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40656
   Snall T, 2008, AM NAT, V171, P238, DOI 10.1086/525051
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084
   Spyrou MA, 2019, NAT REV GENET, V20, P323, DOI 10.1038/s41576-019-0119-1
   Streicker DG, 2016, P NATL ACAD SCI USA, V113, P10926, DOI 10.1073/pnas.1606587113
   Swiderska Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36226-1
   TAGLE DA, 1993, NATURE, V361, P751, DOI 10.1038/361751a0
   Takahashi MK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05864-4
   Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333
   Tennessen JA, 2005, J EVOLUTION BIOL, V18, P1387, DOI 10.1111/j.1420-9101.2005.00925.x
   Teytelman L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002538
   Thomas F, 1999, OIKOS, V84, P167, DOI 10.2307/3546879
   Thompson JN, 2009, COEVOLUTIONARY PROCE
   Titcomb GC, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00126
   Tschirren B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0364
   Tso GHW, 2018, SCIENCE, V362, P589, DOI 10.1126/science.aat0537
   VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550
   Venkatakrishnan V, 2019, J PROTEOME RES, V18, P1760, DOI 10.1021/acs.jproteome.8b00973
   Venkatakrishnan V, 2017, J PROTEOME RES, V16, P1728, DOI 10.1021/acs.jproteome.7b00002
   Venkatakrishnan V, 2013, EXPERT REV RESP MED, V7, P553, DOI 10.1586/17476348.2013.837752
   Videvall E, 2019, TRENDS PARASITOL, V35, P254, DOI 10.1016/j.pt.2018.12.005
   Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113
   Vitiazeva V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130197
   Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526
   Wang JX, 2015, INTEGR BIOL-UK, V7, P1466, DOI 10.1039/c5ib00191a
   Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210
   Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x
   Westermann AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006033
   Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660
   Windsor DA, 1998, INT J PARASITOL, V28, P1939, DOI 10.1016/S0020-7519(98)00153-2
   Wohl S, 2016, ANNU REV VIROL, V3, P173, DOI 10.1146/annurev-virology-110615-035747
   Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x
   Wood CL, 2015, FRONT ECOL ENVIRON, V13, P425, DOI 10.1890/140368
   Zhang Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-305
   Zhang YF, 2015, INT J MOL SCI, V16, P26263, DOI 10.3390/ijms161125957
NR 178
TC 1
Z9 1
U1 8
U2 11
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD NOV 5
PY 2019
VL 7
AR e8013
DI 10.7717/peerj.8013
PG 37
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JJ5YI
UT WOS:000494231300010
PM 31720122
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nelson, BR
   Roby, JA
   Dobyns, WB
   Rajagopa, L
   Gale, M
   Waldorf, KMA
AF Nelson, Branden R.
   Roby, Justin A.
   Dobyns, William B.
   Rajagopa, Lakshmi
   Gale, Michael, Jr.
   Waldorf, Kristina M. Adams
TI Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and
   Brain
SO VIRAL IMMUNOLOGY
LA English
DT Article
DE Zika virus; innate immunity; pregnancy; neural stem cell; placenta;
   brain
ID WEST-NILE-VIRUS; DOUBLE-STRANDED-RNA; MHC CLASS-I; INTERFERON ANTAGONIST
   FUNCTION; COMPLEX ANTIGEN-EXPRESSION; UNFOLDED PROTEIN RESPONSE; NEURAL
   STEM-CELLS; NF-KAPPA-B; DENGUE VIRUS; HIPPOCAMPAL NEUROGENESIS
AB Zika virus (ZIKV) is a mosquito-transmitted flavivirus that caused a public health emergency in the Americas when an outbreak in Brazil became linked to congenital microcephaly. Understanding how ZIKV could evade the innate immune defenses of the mother, placenta, and fetus has become central to determining how the virus can traffic into the fetal brain. ZIKV, like other flaviviruses, evades host innate immune responses by leveraging viral proteins and other processes that occur during viral replication to allow spread to the placenta. Within the placenta, there are diverse cell types with coreceptors for ZIKV entry, creating an opportunity for the virus to establish a reservoir for replication and infect the fetus. The fetal brain is vulnerable to ZIKV, particularly during the first trimester, when it is beginning a dynamic process, to form highly complex and specialized regions orchestrated by neuroprogenitor cells. In this review, we provide a conceptual framework to understand the different routes for viral trafficking into the fetal brain and the eye, which are most likely to occur early and later in pregnancy. Based on the injury profile in human and nonhuman primates, ZIKV entry into the fetal brain likely occurs across both the blood/cerebrospinal fluid barrier in the choroid plexus and the blood/brain barrier. ZIKV can also enter the eye by trafficking across the blood/retinal barrier. Ultimately, the efficient escape of innate immune defenses by ZIKV is a key factor leading to viral infection. However, the host immune response against ZIKV can lead to injury and perturbations in developmental programs that drive cellular division, migration, and brain growth. The combined effect of innate immune evasion to facilitate viral propagation and the maternal/placental/fetal immune response to control the infection will determine the extent to which ZIKV can injure the fetal brain.
C1 [Nelson, Branden R.; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, 1900 9th Ave, Seattle, WA 98101 USA.
   [Roby, Justin A.; Rajagopa, Lakshmi; Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Univ Washington, Ctr Innate Immun & Immune Dis, 750 Republican St,Box 35809, Seattle, WA 98109 USA.
   [Roby, Justin A.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98109 USA.
   [Dobyns, William B.; Rajagopa, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98109 USA.
   [Rajagopa, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.
   [Rajagopa, Lakshmi; Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98109 USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, 750 Republican St,Box 358070, Seattle, WA 98109 USA.
   [Waldorf, Kristina M. Adams] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.
RP Nelson, BR (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, 1900 9th Ave, Seattle, WA 98101 USA.; Gale, M (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, 750 Republican St,Box 35809, Seattle, WA 98109 USA.; Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, 750 Republican St,Box 358070, Seattle, WA 98109 USA.
EM branden.nelson@seattlechildrens.org; mgale@uw.edu; adamsk@uw.edu
RI Dobyns, William/AAI-2768-2020
OI Dobyns, William/0000-0002-7681-2844
FU [R01AI133976];  [AI144938];  [OD010425];  [AI43265];  [AI083019]; 
   [AI104002];  [AI145296]
FX This work was supported by theNational Institutes ofHealth, grant
   numbers R01AI133976 (L.R and K.M.A.W), AI144938 (K.M.A.W), OD010425
   (K.M.A.W. and M.G.), AI43265 (K.M.A.W. and M.G.), AI083019 (M.G.),
   AI104002 (M.G.), and AI145296 (M.G.). The funders had no role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the article.
CR Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Amarilla AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44642
   Ambrose RL, 2013, J VIROL, V87, P2206, DOI 10.1128/JVI.02097-12
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Arjona A, 2007, J IMMUNOL, V179, P8403, DOI 10.4049/jimmunol.179.12.8403
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Augustin HG, 2017, SCIENCE, V357, DOI 10.1126/science.aal2379
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Baronti C, 2010, VIROLOGY, V404, P319, DOI 10.1016/j.virol.2010.05.020
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397
   Berg Daniel A, 2018, F1000Res, V7, P277, DOI 10.12688/f1000research.12684.1
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007
   Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015
   Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003
   Bowen JR, 2018, VIRUS RES, V254, P21, DOI 10.1016/j.virusres.2017.08.018
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bustos-Arriaga J, 2018, VACCINE, V36, P3460, DOI 10.1016/j.vaccine.2018.04.087
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen WC, 2018, VIRULENCE, V9, P588, DOI 10.1080/21505594.2017.1421893
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coletti AM, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.170100
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   Cook BWM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004871
   Cook BWM, 2012, VIRUS RES, V163, P431, DOI 10.1016/j.virusres.2011.11.002
   Courtney SC, 2012, J VIROL, V86, P3647, DOI 10.1128/JVI.06549-11
   Crook KR, 2014, VIROLOGY, V458, P172, DOI 10.1016/j.virol.2014.04.036
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DELLAPORTA AJ, 1977, INFECT IMMUN, V15, P874, DOI 10.1128/IAI.15.3.874-882.1977
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   El Kalamouni C, 2018, VIRUSES, V11, pE2
   Espada-Murao LA, 2011, J VIROL, V85, P6736, DOI 10.1128/JVI.00233-11
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Glasner A, 2017, J VIROL, V91, DOI [10.1128/JVI.00785-17, 10.1128/jvi.00785-17]
   Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Hoenen A, 2007, J GEN VIROL, V88, P3013, DOI 10.1099/vir.0.83125-0
   Hoenen A, 2014, VIROLOGY, V448, P104, DOI 10.1016/j.virol.2013.10.005
   Hoshino A, 2017, DEV CELL, V43, P763, DOI 10.1016/j.devcel.2017.10.029
   Hunt TA, 2007, CELL MICROBIOL, V9, P2756, DOI 10.1111/j.1462-5822.2007.01046.x
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Kavitha Y, 2004, ARCH VIROL, V149, P2079, DOI 10.1007/s00705-004-0375-y
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kesson AM, 2001, J INFECT DIS, V184, P947, DOI 10.1086/323603
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   KING NJC, 1988, J GEN VIROL, V69, P2535, DOI 10.1099/0022-1317-69-10-2535
   KING NJC, 1989, P NATL ACAD SCI USA, V86, P911, DOI 10.1073/pnas.86.3.911
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   Lauer AN, 2018, AM J PHYSIOL-CELL PH, V314, pC152, DOI 10.1152/ajpcell.00137.2017
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lee PD, 2013, J VIROL, V87, P13729, DOI 10.1128/JVI.02340-13
   Li CY, 2017, J VIROL, V91, DOI 10.1128/JVI.01160-17
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Lin CW, 2008, VIRUS RES, V137, P49, DOI 10.1016/j.virusres.2008.05.015
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lobigs M, 1996, IMMUNOL REV, V152, P5, DOI 10.1111/j.1600-065X.1996.tb00908.x
   Lobigs M, 2004, IMMUNOL CELL BIOL, V82, P184, DOI 10.1046/j.0818-9641.2004.01218.x
   Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Ma JZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01350
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Marques VD, 2019, PEDIATR NEUROL, V91, P3, DOI 10.1016/j.pediatrneurol.2018.11.003
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miorin L, 2019, J VIROL, V93, DOI 10.1128/JVI.00151-19
   Miorin L, 2012, VIRUS RES, V163, P660, DOI 10.1016/j.virusres.2011.11.020
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9
   Morrison CR, 2014, VIROLOGY, V456, P96, DOI 10.1016/j.virol.2014.03.017
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   MULLBACHER A, 1995, IMMUNITY, V3, P207, DOI 10.1016/1074-7613(95)90090-X
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Mustafa YM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00525
   Nelson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022817
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Pierson TC, 2007, FIELDS VIROLOGY
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Rayner JO, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050229
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10
   Rydell GE, 2017, VIROLOGY, V509, P67, DOI 10.1016/j.virol.2017.05.017
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046
   Schaub B, 2017, ULTRASOUND OBST GYN, V49, P658, DOI 10.1002/uog.17210
   Scherbik SV, 2013, J VIROL, V87, P7952, DOI 10.1128/JVI.02842-12
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Setoh YX, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110326
   Setoh YX, 2015, J GEN VIROL, V96, P1297, DOI 10.1099/vir.0.000069
   Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Singh PK, 2019, OCUL SURF, V17, P551, DOI 10.1016/j.jtos.2019.03.006
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Singh S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100530
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Snyder JS, 2019, TRENDS NEUROSCI, V42, P164, DOI 10.1016/j.tins.2018.12.001
   Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975
   Soto-Acosta R, 2018, ELIFE, V7, DOI 10.7554/eLife.39023
   Spadoni I, 2017, NAT REV IMMUNOL, V17, P761, DOI 10.1038/nri.2017.100
   STOLLAR V, 1969, VIROLOGY, V39, P426, DOI 10.1016/0042-6822(69)90091-9
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12
   Uchida L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07395
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang J, 2016, J IMMUNOL, V197, P4704, DOI 10.4049/jimmunol.1502317
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yamane D, 2019, NAT MICROBIOL, V4, P1096, DOI 10.1038/s41564-019-0425-6
   Ye J, 2017, J VIROL, V91, DOI [10.1128/jvi.00039-17, 10.1128/JVI.00039-17]
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
   Yu C, 2013, VIRUS RES, V178, P471, DOI 10.1016/j.virusres.2013.10.012
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zhao DM, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1781-4
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 186
TC 1
Z9 2
U1 3
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD FEB 1
PY 2020
VL 33
IS 1
BP 22
EP 37
DI 10.1089/vim.2019.0082
EA NOV 2019
PG 16
WC Immunology; Virology
SC Immunology; Virology
GA KF2KV
UT WOS:000495001300001
PM 31687902
DA 2020-07-08
ER

PT J
AU Sanchez, CHM
   Wu, SL
   Bennett, JB
   Marshall, JM
AF Sanchez, Hector M. C.
   Wu, Sean L.
   Bennett, Jared B.
   Marshall, John M.
TI MGDrivE: A modular simulation framework for the spread of gene drives
   through spatially explicit mosquito populations
SO METHODS IN ECOLOGY AND EVOLUTION
LA English
DT Article
DE Aedes aegypti; Anopheles gambiae; inheritance pattern; landscape; life
   history; mathematical model; population dynamics; r package
ID MALARIA VECTOR; AEDES-AEGYPTI; DYNAMICS; MODEL; SYSTEM; TRANSMISSION;
   REPLACEMENT; TEMPERATURE; EVOLUTION; WILD
AB Malaria, dengue, Zika and other mosquito-borne diseases continue to pose a major global health burden through much of the world, despite the widespread distribution of insecticide-based tools and antimalarial drugs. The advent of CRISPR/Cas9-based gene editing and its demonstrated ability to streamline the development of gene drive systems has reignited interest in the application of this technology to the control of mosquitoes and the diseases they transmit. The versatility of this technology has enabled a wide range of gene drive architectures to be realized, creating a need for their population-level and spatial dynamics to be explored. We present MGDrivE (Mosquito Gene Drive Explorer): a simulation framework designed to investigate the population dynamics of a variety of gene drive architectures and their spread through spatially explicit mosquito populations. A key strength of the MGDrivE framework is its modularity: (a) a genetic inheritance module accommodates the dynamics of gene drive systems displaying user-defined inheritance patterns, (b) a population dynamic module accommodates the life history of a variety of mosquito disease vectors and insect agricultural pests, and (c) a landscape module generates the metapopulation model by which insect populations are connected via migration over space. Example MGDrivE simulations are presented to demonstrate the application of the framework to CRISPR/Cas9-based homing gene drive for: (a) driving a disease-refractory gene into a population (i.e. population replacement), and (b) disrupting a gene required for female fertility (i.e. population suppression), incorporating homing-resistant alleles in both cases. Further documentation and use examples are provided at the project's Github repository. MGDrivE is an open-source r package freely available on CRAN. We intend the package to provide a flexible tool capable of modelling novel inheritance-modifying constructs as they are proposed and become available. The field of gene drive is moving very quickly, and we welcome suggestions for future development.
C1 [Sanchez, Hector M. C.; Wu, Sean L.; Marshall, John M.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.
   [Bennett, Jared B.] Univ Calif Berkeley, Coll Letters & Sci, Div Biol Sci, Biophys Grad Grp, Berkeley, CA 94720 USA.
   [Marshall, John M.] Innovat Genom Inst, Berkeley, CA 94720 USA.
RP Sanchez, CHM; Marshall, JM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.; Marshall, JM (corresponding author), Innovat Genom Inst, Berkeley, CA 94720 USA.
EM sanchez.hmsc@berkeley.edu; john.marshall@berkeley.edu
OI Sanchez, Hector/0000-0001-7378-8853
FU Innovative Genomics Institute; UC Irvine Malaria Initiative; Defense
   Advanced Research Projects AgencyUnited States Department of
   DefenseDefense Advanced Research Projects Agency (DARPA)
   [HR0011-17-2-0047]
FX Innovative Genomics Institute; UC Irvine Malaria Initiative; Defense
   Advanced Research Projects Agency, Grant/Award Number: HR0011-17-2-0047
CR Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059
   Buchman AB, 2018, ACS SYNTH BIOL, V7, P1359, DOI 10.1021/acssynbio.7b00451
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Carey JR, 1995, EXP GERONTOL, V30, P605, DOI 10.1016/0531-5565(95)00013-5
   Champer J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006796
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595
   CHRISTOPHERS SR, 1960, AEDES AEGYPTI YELLOW
   Daszykowski M, 2009, COMPREHENSIVE CHEMOMETRICS: CHEMICAL AND BIOCHEMICAL DATA ANALYSIS, VOLS 1-4, pA635
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29
   Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108
   Diamantidis AD, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.33
   Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   FAY RICHARD W., 1964, MOSQUITO NEWS, V24, P300
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Gantz V., 2014, HUM MOL GENET, V348, P1
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Haller BC, 2017, MOL BIOL EVOL, V34, P230, DOI 10.1093/molbev/msw211
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121
   Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98
   Horsfall WR, 1955, MOSQUITOES THEIR BIO
   Kandul NP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07964-7
   Legros M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052235
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Marshall JM, 2018, ACS CHEM BIOL, V13, P424, DOI 10.1021/acschembio.7b00923
   Marshall JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02744-7
   Marshall JM, 2012, EVOLUTION, V66, P2150, DOI 10.1111/j.1558-5646.2012.01582.x
   Marshall JM, 2011, GENETICS, V187, P535, DOI 10.1534/genetics.110.124479
   Molineaux L., 1980, GARKI PROJECT RES EP
   Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964
   Nyamukondiwa C, 2013, J INSECT PHYSIOL, V59, P1199, DOI 10.1016/j.jinsphys.2013.09.004
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Prowse TAA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0799
   Schmidt TL, 2018, HEREDITY, V120, P386, DOI 10.1038/s41437-017-0039-9
   Simoy MI, 2015, ECOL MODEL, V314, P100, DOI 10.1016/j.ecolmodel.2015.07.007
   Taylor C, 2001, GENETICS, V157, P743
   Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285
   Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0
   Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937
NR 44
TC 2
Z9 2
U1 4
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2041-210X
EI 2041-2096
J9 METHODS ECOL EVOL
JI Methods Ecol. Evol.
PD FEB
PY 2020
VL 11
IS 2
BP 229
EP 239
DI 10.1111/2041-210X.13318
EA NOV 2019
PG 11
WC Ecology
SC Environmental Sciences & Ecology
GA KH6YU
UT WOS:000494306200001
OA Other Gold
DA 2020-07-08
ER

PT J
AU Ximenes, R
   Ramsay, LC
   Miranda, RN
   Morris, SK
   Murphy, K
   Sander, B
   Gonzalez, C
   Kulkarni, M
   Miretti, M
   Espinel, M
   Wu, JH
   Cevallos, V
AF Ximenes, Raphael
   Ramsay, Lauren C.
   Miranda, Rafael Neves
   Morris, Shaun K.
   Murphy, Kellie
   Sander, Beate
   Gonzalez, Camila
   Kulkarni, Manisha
   Miretti, Marcos
   Espinel, Mauricio
   Wu, Jianhong
   Cevallos, Varsovia
CA RADAM LAC Res Team
TI Health outcomes associated with Zika virus infection in humans: a
   systematic review of systematic reviews
SO BMJ OPEN
LA English
DT Review
ID BRAZIL
AB Objective With the emergence of Zika virus (ZIKV) disease in Central and South America in the mid-2010s and recognition of the teratogenic effects of congenital exposure to ZIKV, there has been a substantial increase in new research published on ZIKV. Our objective is to synthesise the literature on health outcomes associated with ZIKV infection in humans.
   Methods We conducted a systematic review (SR) of SRs following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched MEDLINE, Embase, Cochrane and LILACS (Literatura Latino-Americana e do Caribe em Ciencias da Sande) databases from inception to 22 July 2019, and included SRs that reported ZIKV-associated health outcomes. Three independent reviewers selected eligible studies, extracted data and assessed the quality of included SRs using the AMSTAR 2 (A MeaSurement Tool to Assess Systematic Reviews 2) tool. Conflicts were resolved by consensus or consultation with a third reviewer.
   Results The search yielded 1382 unique articles, of which 21 SRs met our inclusion criteria. The 21 SRs ranged from descriptive to quantitative data synthesis, including four meta-analyses. The most commonly reported ZIKV-associated manifestations and health outcomes were microcephaly, congenital abnormalities, brain abnormalities, neonatal death and Guillain-Barre syndrome. The included reviews were highly heterogeneous. The overall quality of the SRs was critically low with all studies having more than one critical weakness.
   Conclusion The evolving nature of the literature on ZIKV-associated health outcomes, together with the critically low quality of existing SRs, demonstrates the need for high-quality SRs to guide patient care and inform policy decision making.
C1 [Ximenes, Raphael; Ramsay, Lauren C.; Miranda, Rafael Neves; Sander, Beate] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada.
   [Ramsay, Lauren C.; Sander, Beate] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Morris, Shaun K.] Hosp Sick Children, Div Infect Dis, Toronto, ON, Canada.
   [Morris, Shaun K.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada.
   [Morris, Shaun K.] Univ Toronto, Fac Med, Dept Pediat, Toronto, ON, Canada.
   [Murphy, Kellie] Mt Sinai Hosp, Dept Obstet & Gynecol, Toronto, ON, Canada.
   [Sander, Beate] Publ Hlth Ontario, Toronto, ON, Canada.
   [Sander, Beate] ICES, Toronto, ON, Canada.
RP Ximenes, R (corresponding author), Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada.
EM raphael.ximenes@theta.utoronto.ca
RI Ximenes, Raphael/G-2881-2014
OI Ximenes, Raphael/0000-0003-2536-951X
FU Canadian Institutes of Health Research-TeamCanadian Institutes of Health
   Research (CIHR) [grant-FRN149784]; International Development Research
   Centre (IDRC)
FX This project was funded by the Canadian Institutes of Health
   Research-Team grant-FRN149784 and the International Development Research
   Centre (IDRC).
CR Anthony Boadle LP., 2016, REUTERS
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Barbosa MH de M, 2019, BRAZ J OTORHINOLARYN
   dos Santos GRB, 2018, REV ASSOC MED BRAS, V64, P635, DOI 10.1590/1806-9282.64.07.635
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Honein MA, 2017, JAMA, V317
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Marques VD, 2019, PEDIATR NEUROL, V91, P3, DOI 10.1016/j.pediatrneurol.2018.11.003
   Masel J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007060
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Minhas AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1399
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2015, PREFERRED REPORTING
   Nasir S, 2018, ADVAN LIFE SCI, V5, P88
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Nithiyanantham SF, 2019, CAN J PUBLIC HLTH
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Omar AF, 2018, AUSTRALAS PLANT DIS, V13, DOI 10.1007/s13314-018-0326-1
   Padilla C, 2016, J CLIN ANESTH, V35, P136, DOI 10.1016/j.jclinane.2016.07.034
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization/World Health Organization, 2017, ZIK SUSP CONF CAS RE
   Pomar L, 2019, PRENATAL DIAG, V39, P420, DOI 10.1002/pd.5446
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shea BJ, 2017, BMJ
   Simoes R, 2016, REV ASSOC MED BRAS, V62, P108, DOI [10.1590/1806-9282.62.02.106, 10.1590/1806-9282.62.02.108]
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wachira VK, 2018, SYSTEMATIC REV FACTO
   Wahid B, 2018, ASIAN PAC J TROP MED, V11, P1, DOI 10.4103/1995-7645.223527
   Wilder-Smith A, 2018, J TRAVEL MED, V25
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2017, HIST ZIK VIR
NR 52
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD NOV
PY 2019
VL 9
IS 11
AR e032275
DI 10.1136/bmjopen-2019-032275
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA KK5IG
UT WOS:000512774800295
PM 31685512
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barigye, SJ
   de la Vega, JMG
   Castillo-Garit, JA
AF Barigye, Stephen J.
   Garcia de la Vega, Jose Manuel
   Castillo-Garit, Juan A.
TI Undersampling: case studies of flaviviral inhibitory activities
SO JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
LA English
DT Article
DE Dengue virus; West nile virus; Zika virus; Undersampling; Support vector
   machine; Information index
ID DENGUE VIRUS; ZIKA; IDENTIFICATION; INFECTION; MEDICINE
AB Imbalanced datasets, comprising of more inactive compounds relative to the active ones, are a common challenge in ligand-based model building workflows for drug discovery. This is particularly true for neglected tropical diseases since efforts to identify therapeutics for these diseases are often limited. In this report, we analyze the performance of several undersampling strategies in modeling the Dengue Virus 2 (DENV2) inhibitory activity, as well as the anti-flaviviral activities for the West Nile (WNV) and Zika (ZIKV) viruses. To this end, we build datasets comprising of 1218 (159 actives and 1059 inactives), 1044 (132 actives and 912 inactives) and 302 (75 actives and 227 inactives) molecules with known DENV2, WNV and ZIKV inhibitory activity profiles, respectively. We develop ensemble classifiers for these endpoints and compare the performance of the different undersampling algorithms on external sets. It is observed that data pruning algorithms yield superior performance relative to data selection algorithms. The best overall performance is provided by the one-sided selection algorithm with test set balanced accuracy (BACC) values of 0.84, 0.74 and 0.77 for the DENV2, WNV and ZIKV inhibitory activities, respectively. For the model building, we use the recently proposed GT-STAF information indices, and compare the predictivity of 3 molecular fragmentation approaches: connected subgraphs, substructure and alogp atom types, which are observed to show comparable performance. On the other hand, a combination of indices based on these fragmentation strategies enhances the predictivity of the built ensembles. The built models could be useful for screening new molecules with possible DENV, WNV and ZIKV inhibitory activities. ADMET modelers are encouraged to adopt undersampling algorithms in their workflows when dealing with imbalanced datasets.
   [GRAPHICS]
   .
C1 [Barigye, Stephen J.; Garcia de la Vega, Jose Manuel] UAM, Fac Ciencias, Dept Quim Fis Aplicada, Madrid 28049, Spain.
   [Castillo-Garit, Juan A.] Univ Ciencias Med Villa Clara, Unidad Toxicol Expt, Santa Clara 50200, Villa Clara, Cuba.
RP Barigye, SJ (corresponding author), UAM, Fac Ciencias, Dept Quim Fis Aplicada, Madrid 28049, Spain.
EM sjbarigye@gmail.com
RI Barigye, Stephen J/U-9734-2019; Castillo-Garit, Juan A./J-1648-2015
OI Barigye, Stephen J/0000-0003-3547-8293; Castillo-Garit, Juan
   A./0000-0003-0896-9484
CR Aravapalli S, 2012, BIOORGAN MED CHEM, V20, P4140, DOI 10.1016/j.bmc.2012.04.055
   Barigye SJ, 2013, SAR QSAR ENVIRON RES, V24, P3, DOI 10.1080/1062936X.2012.728994
   Barigye SJ, 2016, ENVIRON SCI POLLUT R, P1, DOI DOI 10.1007/S11356-016-6097-3
   Barigye SJ, 2018, ACS COMB SCI, V20, P75, DOI 10.1021/acscombsci.7b00155
   Barigye SJ, 2015, B CHEM SOC JPN, V88, P97, DOI 10.1246/bcsj.20140037
   Barigye SJ, 2014, MOL DIVERS, V18, P673, DOI 10.1007/s11030-014-9517-7
   Barigye SJ, 2013, CURR COMPUT-AID DRUG, V9, P164, DOI 10.2174/1573409911309020003
   Barigye SJ, 2013, CHEM PHYS LETT, V570, P147, DOI 10.1016/j.cplett.2013.03.057
   Barigye SJ, 2013, J COMPUT CHEM, V34, P259, DOI 10.1002/jcc.23123
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brito-Sanchez Y, 2015, MOL INFORM, V34, P308, DOI 10.1002/minf.201400118
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Fernandez A., 2018, LEARNING IMBALANCED
   Gadaleta D, 2018, J CHEM INF MODEL, V58, P1501, DOI 10.1021/acs.jcim.8b00297
   Goodell JR, 2006, J MED CHEM, V49, P2127, DOI 10.1021/jm051229y
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   He GX, 2005, PROCEEDINGS OF THE 2005 INTERNATIONAL CONFERENCE ON NEURAL NETWORKS AND BRAIN, VOLS 1-3, P537
   He H, 2013, IMBALANCED LEARNING: FOUNDATIONS, ALGORITHMS, AND APPLICATIONS, P1, DOI 10.1002/9781118646106
   Hoens TR, 2013, IMBALANCED LEARNING: FOUNDATIONS, ALGORITHMS, AND APPLICATIONS, P43
   Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142
   Kubat M, 1997, ADDRESSING CURSE IMB, P179
   Mani I, 2003, P WORKSH LEARN IMB D
   Marrero-Ponce Y, 2012, J COMPUT AID MOL DES, V26, P1229, DOI 10.1007/s10822-012-9591-9
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   Newby D, 2013, J CHEM INF MODEL, V53, P461, DOI 10.1021/ci300348u
   Normile D, 2017, SCIENCE, V358, P1514, DOI 10.1126/science.358.6370.1514
   Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415
   Urias RWP, 2015, MOL DIVERS, V19, P305, DOI 10.1007/s11030-014-9565-z
   TOMEK I, 1976, IEEE T SYST MAN CYB, V6, P448
   Waring MJ, 2015, NAT REV DRUG DISCOV, V14, P475, DOI 10.1038/nrd4609
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zang QD, 2013, J CHEM INF MODEL, V53, P3244, DOI 10.1021/ci400527b
NR 35
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-654X
EI 1573-4951
J9 J COMPUT AID MOL DES
JI J. Comput.-Aided Mol. Des.
PD NOV
PY 2019
VL 33
IS 11
BP 997
EP 1008
DI 10.1007/s10822-019-00255-3
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Computer Science,
   Interdisciplinary Applications
SC Biochemistry & Molecular Biology; Biophysics; Computer Science
GA KN4XM
UT WOS:000514841900007
PM 31773464
DA 2020-07-08
ER

PT J
AU Cashman, JS
   Cozier, GE
   Harrison, C
   Isaac, RE
   Acharya, KR
AF Cashman, John S.
   Cozier, Gyles E.
   Harrison, Charlotte
   Isaac, R. Elwyn
   Acharya, K. Ravi
TI Crystal structures of angiotensin-converting enzyme from Anopheles
   gambiae in its native form and with a bound inhibitor
SO BIOCHEMICAL JOURNAL
LA English
DT Article
ID N-DOMAIN; ACE; COMPLEX; REFINEMENT; CAPTOPRIL; ROLES
AB The mosquitoes of the Anopheles and Aedes genus are some of the most deadly insects to humans because of their effectiveness as vectors of malaria and a range of arbo-viruses, including yellow fever, dengue, chikungunya, West Nile and Zika. The use of insecticides from different chemical classes is a key component of the integrated strategy against An. gambiae and Ae. aegypti, but the problem of insecticide resistance means that new compounds with different modes of action are urgently needed to replace chemicals that fail to control resistant mosquito populations. We have previously shown that feeding inhibitors of peptidyl dipeptidase A to both An. gambiae and Ae. aegypti mosquito larvae lead to stunted growth and mortality. However, these compounds were designed to inhibit the mammalian form of the enzyme (angiotensin-converting enzyme, ACE) and hence can have lower potency and lack selectivity as inhibitors of the insect peptidase. Thus, for the development of inhibitors of practical value in killing mosquito larvae, it is important to design new compounds that are both potent and highly selective. Here, we report the first structures of AnoACE2 from An. gambiae in its native form and with a bound human ACE inhibitor fosinoprilat. A comparison of these structures with human ACE (sACE) and an insect ACE homologue from Drosophila melanogaster (AnCE) revealed that the AnoACE2 structure is more similar to AnCE. In addition, important elements that differ in these structures provide information that could potentially be utilised in the design of chemical leads for selective mosquitocide development.
C1 [Cashman, John S.; Cozier, Gyles E.; Harrison, Charlotte; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.
   [Isaac, R. Elwyn] Univ Leeds, Fac Biol Sci, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.
RP Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.
EM bsskra@bath.ac.uk
OI Cozier, Gyles/0000-0003-2851-0902; Acharya, K. Ravi/0000-0002-3009-4058
CR Abu Hasan ZI, 2017, SCI REP-UK, V7, DOI 10.1038/srep45409
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Akif M, 2010, J MOL BIOL, V400, P502, DOI 10.1016/j.jmb.2010.05.024
   Anthony CS, 2010, J BIOL CHEM, V285, P35685, DOI 10.1074/jbc.M110.167866
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Burnham S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-172
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   CORNEL MJ, 1995, J BIOL CHEM, V270, P13613, DOI 10.1074/jbc.270.23.13613
   Corradi HR, 2007, BIOCHEMISTRY-US, V46, P5473, DOI 10.1021/bi700275e
   Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048
   Dive V, 1999, P NATL ACAD SCI USA, V96, P4330, DOI 10.1073/pnas.96.8.4330
   Douglas RG, 2014, CLIN SCI, V126, P305, DOI 10.1042/CS20130403
   Ekbote U, 1999, FEBS LETT, V455, P219, DOI 10.1016/S0014-5793(99)00870-4
   Ekbote UV, 2003, INSECT BIOCHEM MOLEC, V33, P989, DOI 10.1016/S0965-1748(03)00105-X
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Georgiadis D, 2003, CIRC RES, V93, P148, DOI 10.1161/01.RES.0000081593.33848.FC
   Hemingway J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0431
   Isaac RE, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P494, DOI 10.1016/B978-0-12-382219-2.00099-5
   Isaac RE, 2007, PEPTIDES, V28, P153, DOI 10.1016/j.peptides.2006.08.029
   Isaac RE, 1999, ANN NY ACAD SCI, V897, P342, DOI 10.1111/j.1749-6632.1999.tb07904.x
   Isaac RE, 1997, ANN NY ACAD SCI, V814, P339, DOI 10.1111/j.1749-6632.1997.tb46179.x
   Kim HM, 2003, FEBS LETT, V538, P65, DOI 10.1016/S0014-5793(03)00128-5
   Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u
   Lubbe L, 2016, FEBS J, V283, P3941, DOI 10.1111/febs.13900
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n
   Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Sturrock ED, 2019, BIOCHEM J, V476, P1553, DOI 10.1042/BCJ20190290
   Thomsen EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099822
   Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187
   Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z
NR 36
TC 0
Z9 0
U1 3
U2 3
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD NOV
PY 2019
VL 476
BP 3505
EP 3520
DI 10.1042/BCJ20190635
PN 22
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KG3YJ
UT WOS:000509879100005
PM 31682720
OA Bronze
DA 2020-07-08
ER

PT J
AU Hamilton, B
   Exeter, D
   Beable, S
   Coleman, L
   Milne, C
AF Hamilton, Bruce
   Exeter, Dan
   Beable, Sarah
   Coleman, Lynne
   Milne, Chris
TI Zika Virus and the Rio Olympic Games
SO CLINICAL JOURNAL OF SPORT MEDICINE
LA English
DT Article
DE Zika; virus; olympics; management
ID SEXUAL TRANSMISSION; DE-JANEIRO; INFECTION; OUTBREAK; EXPOSURE; STATES;
   RISK
AB Objective: To evaluate the impact of Zika virus on preparation and management of the New Zealand (NZ) Olympic team. Design: Descriptive manuscript. Setting: New Zealand Olympic Health team preparation and management during the Rio de Janeiro Olympic Games, 2016. Patients (or Participants): New Zealand Olympic Team members. Interventions (or Assessment of Risk Factors): This manuscript describes the approaches used by the NZ Olympic Health team to the minimization of risk from Zika virus. Main Outcome Measures: Although descriptive of approach forms most of the article, the results of Zika virus serology are presented. Results: The NZ Olympic Health team took a proactive approach to risk mitigation, including extensive education, clothing changes, mosquito spray, mosquito nets, and voluntary postexposure testing. No positive serology was observed in those tested. Conclusions: The outbreak of Zika virus in Brazil, the associated complication of microcephaly, and the evolving understanding of virus transmission created significant uncertainty for NZ Olympic team members. The proactive approach taken by the health team to the mitigation of risk, combined with the anticipated low risk of arbovirus transmission over the period of the games, resulted in enhanced confidence from team members and no reports of positive serology.
C1 [Hamilton, Bruce; Exeter, Dan; Beable, Sarah; Coleman, Lynne; Milne, Chris] Millenium Inst Sport & Hlth, High Performance Sport NZ, Auckland, New Zealand.
   [Hamilton, Bruce] New Zealand Olymp Comm, Auckland, New Zealand.
   [Exeter, Dan; Beable, Sarah] Axis Sports Med Specialists, Auckland, New Zealand.
   [Coleman, Lynne] Apollo Med Ctr, Hamilton, New Zealand.
   [Milne, Chris] Anglesea Sports Med, Hamilton, New Zealand.
RP Hamilton, B (corresponding author), High Performance Sport NZ, Performance Hlth, Auckland 0632, New Zealand.
EM bruce.hamilton@hpsnz.org.nz
CR [Anonymous], 2016, LANCET INFECT DIS, V16, P619, DOI 10.1016/S1473-3099(16)30069-X
   [Anonymous], 2016, 2016 R ZIK VIR INF R
   Attaran A, 2016, COMMUNICATION
   Attaran A, 2016, LANCET, V388, P657, DOI 10.1016/S0140-6736(16)31227-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Budgett R, 2016, HLTH ADVICE RELEVANT
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erdener U, 2016, IOC STATEMENT ZIKA
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   GJULLIN CM, 1947, J ECON ENTOMOL, V40, P326, DOI 10.1093/jee/40.3.326
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tavernise S, 2016, NY TIMES
   WHO, 2016, ZIK VIR OL PAR GAM R
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1050-642X
EI 1536-3724
J9 CLIN J SPORT MED
JI Clin. J. Sport Med.
PD NOV
PY 2019
VL 29
IS 6
BP 523
EP 526
DI 10.1097/JSM.0000000000000551
PG 4
WC Orthopedics; Physiology; Sport Sciences
SC Orthopedics; Physiology; Sport Sciences
GA KG1IB
UT WOS:000509694100022
PM 31688184
DA 2020-07-08
ER

PT J
AU Zhang, LD
   Chen, CJ
   Chen, ZX
   He, SZ
   Song, YZ
   Xia, XS
   Han, QQ
   Zhang, JY
AF Zhang, Liding
   Chen, Congjie
   Chen, Zhixin
   He, Shuzhen
   Song, Yuzhu
   Xia, Xueshan
   Han, Qinqin
   Zhang, Jinyang
TI Generation and Characterization of a Polyclonal Antibody Against NS1
   Protein for Detection of Zika Virus
SO JUNDISHAPUR JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE NS1 Protein; Zika Virus; Prokaryotic Expression; Antibody
ID MEMBRANE ASSOCIATION; SEXUAL TRANSMISSION; STRUCTURAL BIOLOGY;
   MOLECULAR-BIOLOGY
AB Background: Zika Virus (ZIKV) is a new type of flaviviruses transmitted by mosquitoes to cause severe diseases including Guillain-Barre syndrome and congenital malformations during recent outbreaks. The early diagnosis of ZIKV infection and efficient vaccines would be effective in controlling epidemics and timelytreatment. However, the native nonstructural protein1(NS1) mainly acquired from cells infected with ZIKV, which largely limits its application.
   Objectives: This study aimed to express and purify the recombinant NS1 protein and prepare its antibody that efficiently reacted with the native NS1 protein secreted in the supernatant of ZIKV infected host-cells.
   Methods: We constructed a prokaryotic expression vector containing the full length of the NS1 gene. Thus, the recombinant NS1 protein was efficiently expressed and purified. The purified NS1 protein was used to prepare an antibody. The Enzyme-linked Immunosorbent Assay (ELISA), Western blot, and Indirect Immunofluorescent Assay (IFA) were used to assess the reactivity and specificity of the antibody.
   Results: The recombinant NS1 protein from a prokaryotic expression vector had good immunogenicity and the prepared antibody could specifically react with the native NS1 produced in Vero, BHK-21 cells infected with ZIKV. Besides, the ELISA and Western blot showed that the native ZIKV-NS1 protein was secreted extracellularly and could play the role of an early diagnostic biomarker for ZIKV infection.
   Conclusions: The prepared antibody against the recombinant NS1 protein is a reliable biological tool that enables the rapid and sensitive detection of secreted NS1 from host cells infected with ZIKV. The recombinant NS1 protein and its antibody can contribute to developing vaccines and antibodies targeting the NS1 protein to prevent flavivirus disease progression.
C1 [Zhang, Liding; Chen, Congjie; Chen, Zhixin; He, Shuzhen; Song, Yuzhu; Xia, Xueshan; Han, Qinqin; Zhang, Jinyang] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Res Ctr Mol Med Yunnan Prov, Kunming, Yunnan, Peoples R China.
RP Zhang, JY (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Res Ctr Mol Med Yunnan Prov, Kunming, Yunnan, Peoples R China.
EM jyzhang@kust.edu.cn
RI Zhang, Jinyang/S-9625-2019
OI Zhang, Jinyang/0000-0001-7533-998X
FU Yunnan Province Biomedical Science and Technology Plan Project
   [2019ZF004]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81860625]; applied basic research
   projects of Yunnan Province [2018FB128]; Analysis and Testing Foundation
   of Kunming University of Science and Technology [2019M20172118042]
FX This work was supported by Yunnan Province Biomedical Science and
   Technology Plan Project (grant No. 2019ZF004), National Natural Science
   Foundation of China (grant No. 81860625), applied basic research
   projects of Yunnan Province (grant No. 2018FB128), and the Analysis and
   Testing Foundation of Kunming University of Science and Technology
   (grant No., 2019M20172118042).
CR Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Carossino M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2852-4
   Cheng MJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050244
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Zhang LD, 2019, J BIOMED NANOTECHNOL, V15, P1061, DOI 10.1166/jbn.2019.2736
   Zhang LD, 2018, JUNDISHAPUR J MICROB, V11, DOI 10.5812/jjm.68858
   Zhang LD, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00094
NR 35
TC 0
Z9 0
U1 2
U2 2
PU KOWSAR PUBL
PI HOENSBROEK
PA PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS
SN 2008-3645
EI 2008-4161
J9 JUNDISHAPUR J MICROB
JI Jundishapur J. Microbiol.
PD NOV
PY 2019
VL 12
IS 11
AR e96070
DI 10.5812/jjm.96070
PG 9
WC Microbiology
SC Microbiology
GA KD6DW
UT WOS:000507955800004
OA Other Gold
DA 2020-07-08
ER

PT J
AU Kostkova, P
   dos Santos, WP
   Massoni, T
AF Kostkova, P.
   Pinheiro dos Santos, W.
   Massoni, T.
TI ZIKA: improved surveillance and forecast of Zika virus in Brazil
SO EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Meeting Abstract
C1 [Kostkova, P.] UCL, UCL IRDR Ctr Digital Publ Hlth Emergencies, London, England.
   [Pinheiro dos Santos, W.] Univ Fed Pernambuco, Dept Biomed Engn, Recife, PE, Brazil.
   [Massoni, T.] Univ Fed Campina Grande, Dept Syst & Comp, Campina Grande, Paraiba, Brazil.
EM p.kostkova@ucl.ac.uk
RI Massoni, Tiago/AAE-9376-2020
OI Massoni, Tiago/0000-0002-9423-7556
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1101-1262
EI 1464-360X
J9 EUR J PUBLIC HEALTH
JI Eur. J. Public Health
PD NOV
PY 2019
VL 29
SU 4
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KC0RL
UT WOS:000506895303210
DA 2020-07-08
ER

PT J
AU Pham, HP
   Schwartz, J
AF Pham, Huy P.
   Schwartz, Joseph
TI Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic
   inflammatory demyelinating polyradiculoneuropathy
SO PRESSE MEDICALE
LA English
DT Review
ID CEREBROSPINAL-FLUID; INTRAVENOUS IMMUNOGLOBULIN; AMERICAN SOCIETY;
   FIBRINOGEN REPLACEMENT; ZIKA VIRUS; APHERESIS; IMMUNOADSORPTION;
   POLYNEUROPATHY; QUALITY; SERUM
AB Therapeutic plasma exchange (TPE) has been used as a treatment modality in many autoimmune disorders, including neurological conditions, such as Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The American Society for Apheresis (ASFA) publishes its guidelines on the use of therapeutic apheresis every 3 years based on published evidence to assist physicians with both the medical and technical aspects of apheresis consults. The ASFA Guidelines included the use of TPE in both GBS and CIDP as an acceptable first-line therapy, either alone and/or in conjunction with other therapeutic modalities. In this article, we briefly reviewed GBS and CIDP, discussed the role of apheresis in these conditions as well as various technical aspects of the TPE procedure, such as apheresis calculation, number of volume exchange, replacement fluid, and management of potential complications.
C1 [Pham, Huy P.] Univ Southern Calif, Keck Sch Med, Dept Pathol, 1450 San Pablo St,Bldg HC4 Room 2426, Los Angeles, CA 90033 USA.
   [Schwartz, Joseph] Columbia Univ, Med Ctr, New York, NY USA.
   [Schwartz, Joseph] New York Presbyterian Hosp, Dept Pathol & Cell Biol, New York, NY USA.
RP Pham, HP (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Pathol, 1450 San Pablo St,Bldg HC4 Room 2426, Los Angeles, CA 90033 USA.
EM phamh@usc.edu
CR Arakawa H, 2005, BRAIN DEV-JPN, V27, P431, DOI 10.1016/j.braindev.2004.09.013
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Basic-Jukic N, 2005, THER APHER DIAL, V9, P391, DOI 10.1111/j.1744-9987.2005.00319.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chevret S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub3
   Chi LJ, 2010, J PERIPHER NERV SYST, V15, P345, DOI 10.1111/j.1529-8027.2010.00294.x
   COURIEL D, 1994, J CLIN APHERESIS, V9, P1, DOI 10.1002/jca.2920090102
   DALAKAS MC, 1980, ARCH NEUROL-CHICAGO, V37, P637, DOI 10.1001/archneur.1980.00500590061010
   Darweesh SKL, 2014, J PERIPHER NERV SYST, V19, P24, DOI 10.1111/jns5.12051
   DERKSEN RHWM, 1984, J LAB CLIN MED, V104, P346
   Doets AY, 2018, BRAIN, V141, P2866, DOI 10.1093/brain/awy232
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dyck PJB, 2018, MAYO CLIN PROC, V93, P777, DOI 10.1016/j.mayocp.2018.03.026
   Dyck PJ, 2015, MUSCLE NERVE, V52, P488, DOI 10.1002/mus.24707
   DYCK PJ, 1994, ANN NEUROL, V36, P838, DOI 10.1002/ana.410360607
   DYCK PJ, 1986, NEW ENGL J MED, V314, P461, DOI 10.1056/NEJM198602203140801
   Feldman AZ, 2017, J CLIN APHERESIS, V32, P203, DOI 10.1002/jca.21467
   FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Galldiks N, 2011, EUR NEUROL, V66, P183, DOI 10.1159/000331011
   Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Hahn AF, 1996, BRAIN, V119, P1055, DOI 10.1093/brain/119.4.1055
   Hahn AF, 1998, LANCET, V352, P635, DOI 10.1016/S0140-6736(97)12308-X
   HARTUNG HP, 1991, ANN NEUROL, V30, P48, DOI 10.1002/ana.410300110
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Hughes RAC, 2003, NEUROLOGY, V61, P736, DOI 10.1212/WNL.61.6.736
   Hughes RAC, 1997, LANCET, V349, P225
   Hughes RE, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00177
   Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Hughes RAC, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002062.pub4
   Hughes RAC, 2009, EXPERT REV NEUROTHER, V9, P789, DOI 10.1586/ern.09.30
   Illa I, 2017, J PERIPHER NERV SYST, V22, P418, DOI 10.1111/jns.12237
   Jones H R Jr, 2000, Semin Pediatr Neurol, V7, P91
   Lehmann Helmar C, 2009, Ther Adv Neurol Disord, V2, P261, DOI 10.1177/1756285609104792
   Lewis RA, 2017, CURR OPIN NEUROL, V30, P508, DOI 10.1097/WCO.0000000000000481
   Lieker I, 2017, J CLIN APHERESIS, V32, P486, DOI 10.1002/jca.21546
   Mathey EK, 2015, J NEUROL NEUROSUR PS, V86, P973, DOI 10.1136/jnnp-2014-309697
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   McLeod BC, 2002, J CLIN APHERESIS, V17, P124, DOI 10.1002/jca.10029
   McLeod BC, 2010, APHERESIS PRINCIPLES
   Misawa S, 2001, NEUROLOGY, V56, P666, DOI 10.1212/WNL.56.5.666
   NADLER SB, 1962, SURGERY, V51, P224
   Nobile-Orazio E, 2017, EXPERT REV NEUROTHER, V17, P755, DOI 10.1080/14737175.2017.1340832
   Nobile-Orazio E, 2015, J NEUROL NEUROSUR PS, V86, P729, DOI 10.1136/jnnp-2013-307515
   Nobile-Orazio E, 2012, LANCET NEUROL, V11, P493, DOI 10.1016/S1474-4422(12)70093-5
   Oaklander AL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010369.pub2
   Okamiya S, 2004, THER APHER DIAL, V8, P248, DOI 10.1111/j.1526-0968.2004.00138.x
   Okerberg CK, 2016, VOX SANG, V111, P292, DOI 10.1111/vox.12417
   Peltier AC, 2012, SEMIN NEUROL, V32, P187, DOI 10.1055/s-0032-1329194
   Pernat AM, 2009, THER APHER DIAL, V13, P310, DOI 10.1111/j.1744-9987.2009.00730.x
   Pham HP, 2015, ISBT SCI SER, V10, P79, DOI 10.1111/voxs.12113
   Pham HP, 2016, J CLIN APHERESIS, V31, P353, DOI 10.1002/jca.21405
   Pham HP, 2015, J CLIN APHERESIS, V30, P382, DOI 10.1002/jca.21392
   Pham HP, 2015, TRANSFUSION, V55, P2306, DOI 10.1111/trf.13210
   Press R, 2003, J CLIN IMMUNOL, V23, P259, DOI 10.1023/A:1024532715775
   Querol L, 2014, NEUROLOGY, V82, P879, DOI 10.1212/WNL.0000000000000205
   RAPHAEL JC, 1987, ANN NEUROL, V22, P753
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   Reeves HM, 2014, BRIT J HAEMATOL, V164, P342, DOI 10.1111/bjh.12629
   Rentzos M, 2012, NEUROL RES, V34, P842, DOI 10.1179/1743132812Y.0000000074
   Ruts L, 2005, NEUROLOGY, V65, P138, DOI 10.1212/01.wnl.0000167549.09664.b8
   Sainaghi PP, 2010, CYTOKINE, V51, P138, DOI 10.1016/j.cyto.2010.05.005
   Saperstein DS, 2001, MUSCLE NERVE, V24, P311, DOI 10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A
   Schwartz J, 2016, J CLIN APHERESIS, V31, P149, DOI 10.1002/jca.21470
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Seta T, 2005, CLIN NEUROL NEUROSUR, V107, P491, DOI 10.1016/j.clineuro.2004.12.019
   Shemin D, 2007, J CLIN APHERESIS, V22, P270, DOI 10.1002/jca.20143
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Takei Hiroyuki, 2002, Journal of Nippon Medical School, V69, P557, DOI 10.1272/jnms.69.557
   Taylor CJ, 2017, J NEUROL, V264, P564, DOI 10.1007/s00415-016-8380-0
   Vallat JM, 2010, LANCET NEUROL, V9, P402, DOI 10.1016/S1474-4422(10)70041-7
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x
   Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976
   Ward DM, 2011, J CLIN APHERESIS, V26, P230, DOI 10.1002/jca.20302
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Winters JL, 2012, HEMATOL-AM SOC HEMAT, P7, DOI 10.1182/asheducation-2012.1.7
   Winters JL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-101
   Yan WX, 2000, ANN NEUROL, V47, P765
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 82
TC 0
Z9 1
U1 0
U2 0
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0755-4982
EI 2213-0276
J9 PRESSE MED
JI Presse Med.
PD NOV
PY 2019
VL 48
IS 11
BP E338
EP E346
DI 10.1016/j.lpm.2019.03.016
PN 2
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA JZ6UM
UT WOS:000505242400004
PM 31679897
DA 2020-07-08
ER

PT J
AU Vieira, CJDP
   Machado, LC
   Pena, LJ
   Bronzoni, RVD
   Wallau, GL
AF da Silva Pessoa Vieira, Carla Julia
   Machado, Lais Ceschini
   Pena, Lindomar Jose
   de Morais Bronzoni, Roberta Vieira
   Wallau, Gabriel Luz
TI Spread of two Zika virus lineages in Midwest Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Arboviruses; Dissemination; Souther Amazon; Human infection
ID SOUTH-PACIFIC; EASTER-ISLAND; TRANSMISSION; OUTBREAK
AB Zika virus (ZIKV) has been intensively studied in South America and across the globe since 2015-2016 epidemics. However, in Brazil - the largest and the most affected country in terms of human infection by this virus, most of the viral molecular information is restricted to metropolitan centers distributed along the Brazilian coast and almost no information is known about the virus spread in most difficult access areas such as the Midwest region of the country. Here, we report two ZIKV complete genomes from samples obtained during arboviral surveillance at the Sinop city, southern border of the Amazonian forest, Midwest Brazil in 2015. Our results show that the virus was introduced in this region through two independent introductions: one occurred at the end of 2014, around the period that the virus was already distributed in other regions of the country and abroad, and a second at the end of 2015. Moreover, these genomes were clustered with other viral strains sampled at distant Brazilian states in line with other findings about the rapid spread of the virus throughout the country.
C1 [da Silva Pessoa Vieira, Carla Julia; de Morais Bronzoni, Roberta Vieira] Univ Fed Mato Grosso, Hlth Sci Inst, Sinop, Mato Grosso, Brazil.
   [Machado, Lais Ceschini; Wallau, Gabriel Luz] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Entomol Dept, Av Prof Moraes Rego S-N,Cidade Univ, BR-50740465 Recife, PE, Brazil.
   [Pena, Lindomar Jose] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, LaVITE Lab Virol & Expt Therapy, Recife, PE, Brazil.
RP Wallau, GL (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Entomol Dept, Av Prof Moraes Rego S-N,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM gabriel.wallau@cpqam.fiocruz.br
RI Vieira, Carla Julia S P/Y-9722-2018; Wallau, Gabriel/B-5911-2008
OI Vieira, Carla Julia S P/0000-0003-3880-6758; Wallau,
   Gabriel/0000-0002-1419-5713
FU Fundacao de Amparo a Pesquisa do Estado de Mato Grosso [FAPEMAT
   PPSUS-002/2013 - 228398/2013]; Fundacao de Amparo a Ciencia e Tecnologia
   do Estado de Pernambuco [FACEPE APQ-0078-2.02/16]
FX This study has been supported by the Fundacao de Amparo a Pesquisa do
   Estado de Mato Grosso (FAPEMAT PPSUS-002/2013 - 228398/2013) and
   Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE APQ-0078-2.02/16).
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Campos TD, 2018, INT J GENOMICS, DOI 10.1155/2018/6941735
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   da Saude Ministerio, 2016, MON CAS DENG FEBR CH, V47, P1
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Delatorre E, 2018, EMERG INFECT DIS, V24, P2119, DOI 10.3201/eid2411.180586
   Depoux A, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0087-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Khongwichit S, 2018, MICROBES INFECT, V20, P670, DOI 10.1016/j.micinf.2018.01.007
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Ladner JT, 2019, NAT MED, V25, P206, DOI 10.1038/s41591-019-0345-2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Rambaut A., 2014, FIGTREE TREE FIGURE
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Woon YL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3786-9
   Xavier Analúcia R., 2017, J. Bras. Patol. Med. Lab., V53, P252, DOI 10.5935/1676-2444.20170039
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 43
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD NOV
PY 2019
VL 75
AR 103974
DI 10.1016/j.meegid.2019.103974
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA JL3CK
UT WOS:000495408600039
PM 31340185
DA 2020-07-08
ER

PT J
AU Stauft, CB
   Song, YT
   Gorbatsevych, O
   Pantoja, P
   Rodriguez, IV
   Futcher, B
   Sariol, CA
   Wimmer, E
AF Stauft, Charles B.
   Song, Yutong
   Gorbatsevych, Oleksandr
   Pantoja, Petraleigh
   Rodriguez, Idia V.
   Futcher, Bruce
   Sariol, Carlos A.
   Wimmer, Eckard
TI Extensive genomic recoding by codon-pair deoptimization selective for
   mammals is a flexible tool to generate attenuated vaccine candidates for
   dengue virus 2
SO VIROLOGY
LA English
DT Article
DE Vaccine; Dengue virus; Antibody-dependent enhancement; Rhesus macaques;
   Codon-pair-bias; Codon usage; Arbovirus; Zika virus
ID INFLUENZA-VIRUS; DISEASE VIRUS; BIAS; IMMUNIZATION; REDUCTION; EFFICACY;
   NS1
AB The four serotypes of dengue virus (DENV) are the leading etiologic agent of disease caused by arthropod-borne viruses (arboviruses) in the world, with billions at risk of DENV infection spread by infected mosquitoes. DENV causes illness ranging from dengue fever (DF) to life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). DENV proliferates well in two different host systems, an invertebrate mosquito vector and vertebrate primate host, which have a distinct difference in their preference of codon pairs (CP) for translation (different "codon pair bias"). Consequently, arboviruses must delicately balance the use of codon pairs between mammals and arthropods, which presents an Achilles' heel that we have exploited by specifically shifting the codon pair preference in the E and NS3 ORFs away from mammals while keeping the CPB favorable for mosquito ORFs. Here we report that recoding of the ORFs has led to variants that were over-attenuated in rhesus macaques although induction of protective antibodies in animals vaccinated with the smallest recoded ORF (E) was observed. The flexibility of our synthetic vaccine design (by decreasing the number of unfavorable CPs in the E ORF), allowed us to construct two new vaccine candidates (E-hminA and E-hminB) with intermediate attenuation in cell culture and neonatal mice, a result demonstrating proof of concept. New DENV vaccine candidates are being developed based on selective attenuation by dramatic recoding, with flexibility in balancing the attenuation and immunogenicity by marrying rational design and empirical modification.
C1 [Stauft, Charles B.; Song, Yutong; Gorbatsevych, Oleksandr; Futcher, Bruce; Wimmer, Eckard] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.
   [Pantoja, Petraleigh; Rodriguez, Idia V.; Sariol, Carlos A.] Univ Puerto Rico, Caribbean Primate Res Ctr, Virol Lab, Unit Comparat Med, San Juan, PR 00936 USA.
   [Stauft, Charles B.] Codagenix Inc, Melville, NY USA.
RP Wimmer, E (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.
EM charles.stauft@stonybrook.edu; yutong.song@stonybrook.edu;
   oleksandr.gorbatsevych@stonybrook.edu; petraleigh.pantoja@upr.edu;
   idia.rodriguez1@upr.edu; bruce.futcher@stonybrook.edu;
   carlos.sariol1@upr.edu; eckard.wimmer@stonybrook.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21 AI126048]; NIGMS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [R01
   GM119175]; NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U42 OD021458, P40
   OD012217]
CR Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034
   Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Broadbent AJ, 2016, VACCINE, V34, P563, DOI 10.1016/j.vaccine.2015.11.054
   Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266
   Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761
   Conrad SJ, 2018, VIROLOGY, V516, P219, DOI 10.1016/j.virol.2018.01.020
   Diamond M.S., FIELDS VIROLOGY, P747
   Eschke K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006857
   Futcher B, 2015, P NATL ACAD SCI USA, V112, pE3635, DOI 10.1073/pnas.1507710112
   Galula JU, 2014, J VIROL, V88, P10813, DOI 10.1128/JVI.00810-14
   GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kaplan BS, 2018, VACCINE, V36, P1101, DOI 10.1016/j.vaccine.2018.01.027
   Le Nouen C, 2017, P NATL ACAD SCI USA, V114, pE386, DOI 10.1073/pnas.1619242114
   Le Nouen C, 2014, P NATL ACAD SCI USA, V111, P13169, DOI 10.1073/pnas.1411290111
   Leary S, 2013, AVMA GUIDELINES EUTH, P102
   Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]
   Li YZ, 2015, INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND COMMUNICATION ENGINEERING (CSCE 2015), P6
   Martrus G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-78
   MUELLER S, 2005, NOVA ACTA LEOPOLDINA, V92, P1
   Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06
   Ni YY, 2014, VIROLOGY, V450, P132, DOI 10.1016/j.virol.2013.12.009
   Rice C.M., FIELDS VIROLOGY, P712
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   Segundo FDS, 2016, J VIROL, V90, P1298, DOI 10.1128/JVI.02167-15
   Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112
   Song YT, 2017, P NATL ACAD SCI USA, V114, pE8731, DOI 10.1073/pnas.1714385114
   Stauft CB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198303
   Weatherall D, 2006, WEATHERALL REPORT US, P1
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Yang C, 2013, P NATL ACAD SCI USA, V110, P9481, DOI 10.1073/pnas.1307473110
NR 33
TC 1
Z9 1
U1 2
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD NOV
PY 2019
VL 537
BP 237
EP 245
DI 10.1016/j.virol.2019.09.003
PG 9
WC Virology
SC Virology
GA JX7LY
UT WOS:000503913400026
PM 31539771
DA 2020-07-08
ER

PT J
AU Xu, G
   Li, SH
   Liu, XY
   Gao, P
   Chen, XT
   Wang, HY
   Zhang, MX
   Yang, Y
   Gao, GF
   Zhang, FP
AF Xu, Gang
   Li, Shihua
   Liu, Xinyuan
   Gao, Ping
   Chen, Xiaotong
   Wang, Haiyan
   Zhang, Mingxia
   Yang, Yang
   Gao, George Fu
   Zhang, Fuping
TI PARP-1 mediated cell death is directly activated by ZIKV infection
SO VIROLOGY
LA English
DT Article
DE Zika virus; PARP-1; NS3; Programmed cell death; NAD(+)
ID POLY(ADP-RIBOSE) POLYMERASE; VIRUS; APOPTOSIS; MECHANISMS; PROTEINS;
   INSIGHTS; BINDING; NAD(+)
AB Zika virus (ZIKV) has emerged as a severe health threat due to its association with microcephaly. It has been reported that the strong cytopathic effects, including cell-cycle arrest and cell death are responsible for the nervous system disease. However, the mechanisms by which ZIKV infection induced cell death were largely unknown. Here, we reported that cell death is readily detected after ZIKV infection as indicated by PI staining and the reduction of cell viability. Importantly, cell death can be induced by overexpression of ZIKV NS3 protein alone but not the other non-structure proteins. Mass spectrometry analysis revealed that NS3 bond to and activated PARP-1. In agreement with these observations, we found that PARP-1 was massively activated during ZIKV infection and the intracellular ATP and NAD(+) concentrations rapidly declined. Finally, PARP-1 knockdown simultaneously restrained ZIKV infection-induced cell death and ablated host restriction of virus infection. Our finding indicates that PARP-1 activation is an important cellular event during ZIKV infection, which contributes to the cell death.
C1 [Xu, Gang; Wang, Haiyan; Zhang, Mingxia; Yang, Yang; Gao, George Fu; Zhang, Fuping] Shenzhen Third Peoples Hosp, Guangdong Key Lab Diag & Treatment Emerging Infec, Shenzhen 518112, Guangdong, Peoples R China.
   [Li, Shihua; Liu, Xinyuan; Gao, Ping; Chen, Xiaotong; Gao, George Fu; Zhang, Fuping] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Liu, Xinyuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Xu, G; Zhang, FP (corresponding author), Shenzhen Third Peoples Hosp, Guangdong Key Lab Diag & Treatment Emerging Infec, Shenzhen 518112, Guangdong, Peoples R China.
EM xugang2513@sina.com; zhangfp@im.ac.cn
RI , xg/AAG-9760-2020
FU National Key Research and Development Project [SZSM201412001]; 
   [2016YFC1200302]
FX This work was supported by grants from Jin Qi team of Sanming Project of
   Medicine in Shenzhen (SZSM201412001) and the National Key Research and
   Development Project (2016YFC1200302).
CR Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010
   Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103
   Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004
   Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chow J, 2015, VIROLOGY, V479, P104, DOI 10.1016/j.virol.2015.02.051
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Erdelyi K, 2009, FASEB J, V23, P3553, DOI 10.1096/fj.09-133264
   Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416
   Gaburro J, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0989-4
   Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006
   Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379
   Gero D, 2006, CURR PHARM DESIGN, V12, P2903, DOI 10.2174/138161206777947579
   Ghouzzi Vincent El, 2017, Cell Death Dis, V8, pe2567, DOI 10.1038/cddis.2016.446
   Hacker G, 2018, MICROBES INFECT, V20, P552, DOI 10.1016/j.micinf.2017.10.006
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038
   Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805
   Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011
   Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Li X, 2014, ANTIOXID REDOX SIGN, V20, P1853, DOI 10.1089/ars.2013.5600
   Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Robaszkiewicz A, 2012, FREE RADICAL BIO MED, V53, P1552, DOI 10.1016/j.freeradbiomed.2012.08.567
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004
   Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007
   Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872
   Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103
   Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221
   Yuan SF, 2016, ANTIVIR RES, V125, P34, DOI 10.1016/j.antiviral.2015.11.005
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 43
TC 1
Z9 1
U1 1
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD NOV
PY 2019
VL 537
BP 254
EP 262
DI 10.1016/j.virol.2019.08.024
PG 9
WC Virology
SC Virology
GA JX7LY
UT WOS:000503913400028
PM 31539774
DA 2020-07-08
ER

PT J
AU Dumitrascu, MC
   Iliescu, M
   Petca, RC
   Sandru, F
   Mehedintu, C
   Farcasanu, PD
   Maru, N
   Chibelean, C
   Petca, A
AF Dumitrascu, Mihai Cristian
   Iliescu, Madalina
   Petca, Razvan Cosmin
   Sandru, Florica
   Mehedintu, Claudia
   Farcasanu, Patricia Delia
   Maru, Nicoleta
   Chibelean, Calin
   Petca, Aida
TI The Chemical Pregnancy
SO REVISTA DE CHIMIE
LA English
DT Article
DE miscarriage; risk factor; early pregnancy loss; exposure; environmental
   factors
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANTIEPILEPTIC DRUGS; SUBCLINICAL
   HYPOTHYROIDISM; ALCOHOL INTAKE; MATERNAL USE; RISK; MISCARRIAGE; WOMEN;
   FETAL; MISOPROSTOL
AB The chemical pregnancy is an early pregnancy loss occurring shortly after implantation. 50-75% of all miscarriages are considered to be chemical pregnancies. Although the pregnancy test is positive, the fetus cannot be detected on ultrasounds; it can be asymptomatic or it can have menstrual-like cramping and bleeding. There are numerous risk factors associated with miscarriage, such as: epidemiological, genetic, anatomical, end ometrial, endocrine and immune factors, infections, inherited thrombophilia and antiphospholipid syndrome. Many drugs are related with spontaneous miscarriage, significant evidence being found for nonsteroidal anti-inflammatory drugs, inhaled corticosteroids, antidepressant medication, antiepileptic and antihypertensive drugs, the artemisinin-based combination therapy and for the diclofenac/misoprostol combination. Besides the common diseases like asthma, chronic hypertension, chronic kidney disease, thyroid disorders, diabetes mellitus, polycystic ovary syndrome and rheumatoid arthritis, there was also found a higher correlation with the risk of miscarriage for the Zika Virus infection. In conclusion, chemical pregnancy is a type of early pregnancy loss which usually doesn't need prevention, associated with multiple risk factors.
C1 [Dumitrascu, Mihai Cristian; Petca, Razvan Cosmin; Sandru, Florica; Mehedintu, Claudia; Farcasanu, Patricia Delia; Maru, Nicoleta; Petca, Aida] Carol Davila Univ Med & Pharm, 8 Eroii Sanit Bvd, Bucharest 050474, Romania.
   [Dumitrascu, Mihai Cristian] Univ Emergency Hosp, Splaiul Independentei 169, Bucharest 050098, Romania.
   [Iliescu, Madalina; Sandru, Florica; Petca, Aida] Elias Emergency Hosp, 17 Marasti Blvd, Bucharest 011461, Romania.
   [Petca, Razvan Cosmin] Prof Th Burghele Clin Hosp, 20 Panduri Str, Bucharest 050653, Romania.
   [Mehedintu, Claudia] Malaxa Clin Hosp, 12 Vergului Str, Bucharest 022441, Romania.
   [Chibelean, Calin] George Emil Palade Univ Med Pharm Sci & Technol T, 38 Gheorghe Marinescu Str, Targu Mures 540139, Romania.
RP Petca, RC; Sandru, F (corresponding author), Carol Davila Univ Med & Pharm, 8 Eroii Sanit Bvd, Bucharest 050474, Romania.; Sandru, F (corresponding author), Elias Emergency Hosp, 17 Marasti Blvd, Bucharest 011461, Romania.; Petca, RC (corresponding author), Prof Th Burghele Clin Hosp, 20 Panduri Str, Bucharest 050653, Romania.
EM drpetca@gmail.com; florysandru@yahoo.com
RI MARU, NICOLETA/G-9240-2018; MARU, NICOLETA/B-5423-2011; Petca,
   Aida/AAM-9912-2020; Petca, Razvan-Cosmin/AAH-2462-2020
OI Petca, Aida/0000-0002-4890-0978; Petca,
   Razvan-Cosmin/0000-0003-4496-1535
CR Al-Biate MAS, 2015, TAIWAN J OBSTET GYNE, V54, P266, DOI 10.1016/j.tjog.2013.06.020
   Almeida ND, 2016, EPIDEMIOLOGY, V27, P538, DOI 10.1097/EDE.0000000000000484
   Andersen JT, 2016, ARCH GYNECOL OBSTET, V294, P245, DOI 10.1007/s00404-015-3966-9
   ANNEGERS JF, 1988, EPILEPSIA, V29, P451, DOI 10.1111/j.1528-1157.1988.tb03745.x
   [Anonymous], 2013, WORLD MALARIA REPORT
   [Anonymous], 2011, INVESTIGATION TREATM
   AXELSSON G, 1989, OCCUP ENVIRON MED, V46, P393
   BALEN AH, 1993, HUM REPROD, V8, P959, DOI 10.1093/oxfordjournals.humrep.a138174
   Bech BH, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5159
   Benhadi N, 2009, EUR J ENDOCRINOL, V160, P985, DOI 10.1530/EJE-08-0953
   Bjorn Anne-Mette B, 2013, Clin Epidemiol, V5, P287, DOI 10.2147/CLEP.S46893
   Bjorn AMB, 2015, BASIC CLIN PHARMACOL, V116, P308, DOI 10.1111/bcpt.12367
   Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318
   CHETTY M., 2014, OBSTET GYNAECOL REPR, V25, P31
   Chisolm MS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h5918
   Christiansen OB, 2005, FERTIL STERIL, V83, P821, DOI 10.1016/j.fertnstert.2004.12.018
   Chrousos GP., 2007, BASIC CLIN PHARM, P635
   Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7
   Dellicour S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0950-6
   Diav-Citrin O, 2011, REPROD TOXICOL, V31, P540, DOI 10.1016/j.reprotox.2011.02.008
   Diejomaoh MFE, 2015, MED PRIN PRACT, V24, P38, DOI 10.1159/000365973
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502
   Ericson A, 2001, REPROD TOXICOL, V15, P371, DOI 10.1016/S0890-6238(01)00137-X
   Fenster L, 1997, EPIDEMIOLOGY, V8, P515, DOI 10.1097/00001648-199709000-00008
   GADSBY R, 1993, BRIT J GEN PRACT, V43, P245
   Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39
   Jauniaux E, 2006, HUM REPROD, V21, P2216, DOI 10.1093/humrep/del150
   Johansen RLR, 2015, PAEDIATR PERINAT EP, V29, P72, DOI 10.1111/ppe.12160
   Jones DC, 1996, NEW ENGL J MED, V335, P226, DOI 10.1056/NEJM199607253350402
   Kaczynski P, 2016, REPRODUCTION, V151, P539, DOI 10.1530/REP-15-0496
   Karthikeyan VJ, 2011, J HYPERTENS, V29, P396, DOI 10.1097/HJH.0b013e328341885d
   Kesmodel U, 2002, AM J EPIDEMIOL, V155, P305, DOI 10.1093/aje/155.4.305
   Knudsen LB, 1998, DAN MED BULL, V45, P320
   Laskin CA, 1997, NEW ENGL J MED, V337, P148, DOI 10.1056/NEJM199707173370302
   Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S6
   Lawson CC, 2004, REPROD TOXICOL, V18, P625, DOI 10.1016/j.reprotox.2004.03.004
   Lennestal R, 2009, EUR J CLIN PHARMACOL, V65, P615, DOI 10.1007/s00228-009-0620-0
   Li DK, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.06.002
   Li DK, 2003, BRIT MED J, V327, P368, DOI 10.1136/bmj.327.7411.368
   Liu HX, 2014, THYROID, V24, P1642, DOI 10.1089/thy.2014.0029
   Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCowan LME, 1996, BRIT J OBSTET GYNAEC, V103, P123, DOI 10.1111/j.1471-0528.1996.tb09662.x
   Mehedintu C, 2019, REV CHIM-BUCHAREST, V70, P2375
   Mellor AL, 2000, ANNU REV IMMUNOL, V18, P367, DOI 10.1146/annurev.immunol.18.1.367
   Mirza FG, 2016, GYNECOL ENDOCRINOL, V32, P97, DOI 10.3109/09513590.2015.1121982
   Nall R, 2018, MED NEWS TODAY
   Nielsen GL, 2001, BRIT MED J, V322, P266, DOI 10.1136/bmj.322.7281.266
   Petca A, 2019, REV CHIM-BUCHAREST, V70, P2021
   Petca A, 2019, ROM J LEG MED, V27, P43, DOI 10.4323/rjlm.2019.43
   Petca AT, 2017, ROM J MORPHOL EMBRYO, V58, P619
   Petca RC, 2018, PROCEEDINGS OF THE 6TH CONGRESS OF THE ULTRASOUND SOCIETY IN OBSTETRICS AND GYNECOLOGY / 34TH FETUS AS A PATIENT INTERNATIONAL CONGRESS, P478
   Pittschieler S, 2008, J NEUROL, V255, P1926, DOI 10.1007/s00415-008-0029-1
   PORTER T. F., 2006, COCHRANE DATABASE SY, V19
   Pucci M, 2015, EXPERT REV CLIN PHAR, V8, P221, DOI 10.1586/17512433.2015.1005074
   Radulescu A, 2015, ROM J MIL MED, V118, P20
   Ray JG, 2001, EARLY HUM DEV, V64, P129, DOI 10.1016/S0378-3782(01)00181-5
   REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3
   Rusu MC, 2018, ROM J MORPHOL EMBRYO, V59, P663
   SAGLE M, 1988, BMJ-BRIT MED J, V297, P1027, DOI 10.1136/bmj.297.6655.1027
   Salmon JE, 2004, J CLIN INVEST, V114, P15, DOI 10.1172/JCI200422258
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schatz M, 1997, J ALLERGY CLIN IMMUN, V100, P301, DOI 10.1016/S0091-6749(97)70241-0
   Schupf N, 1997, EPILEPSIA, V38, P824, DOI 10.1111/j.1528-1157.1997.tb01470.x
   SHEPARD TH, 1995, LANCET, V346, P780, DOI 10.1016/S0140-6736(95)91540-0
   Sibai BM, 2000, AM J OBSTET GYNECOL, V183, P1520, DOI 10.1067/mob.2000.107621
   Spinu D, 2015, ROM J MIL MED, V118, P12
   Tang J, 2013, INT J GYNECOL OBSTET, V121, P186, DOI 10.1016/j.ijgo.2012.12.009
   Tanha FD, 2013, ARCH GYNECOL OBSTET, V287, P65, DOI 10.1007/s00404-012-2508-y
   Tata LJ, 2007, AM J RESP CRIT CARE, V175, P991, DOI 10.1164/rccm.200611-1641OC
   Tolstrup JS, 2003, HUM REPROD, V18, P2704, DOI 10.1093/humrep/deg480
   Tomson T, 2015, NEUROLOGY, V85, P580, DOI 10.1212/WNL.0000000000001840
   Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van Dijk MM, 2016, REPROD BIOMED ONLINE, V33, P745, DOI 10.1016/j.rbmo.2016.09.002
   vanderWeiden RMF, 1997, BRIT J RHEUMATOL, V36, P605
   Vauzelle C, 2013, REPROD TOXICOL, V36, P98, DOI 10.1016/j.reprotox.2012.11.009
   Veduta A, 2017, PROCEEDINGS OF THE 14TH NATIONAL CONGRESS OF UROGYNECOLOGY AND THE NATIONAL CONFERENCE OF THE ROMANIAN ASSOCIATION FOR THE STUDY OF PAIN, P199
   Vellanki K, 2013, ADV CHRONIC KIDNEY D, V20, P223, DOI 10.1053/j.ackd.2013.02.001
   Wallenius M, 2015, J RHEUMATOL, V42, P1570, DOI 10.3899/jrheum.141553
   Williams D, 2008, BRIT MED J, V336, P211, DOI 10.1136/bmj.39406.652986.BE
   Windham GC, 1997, EPIDEMIOLOGY, V8, P509, DOI 10.1097/00001648-199709000-00007
   Zaha DC, 2019, SCI TOTAL ENVIRON, V687, P118, DOI 10.1016/j.scitotenv.2019.06.076
   Zaqout M, 2015, PEDIATR CARDIOL, V36, P1483, DOI 10.1007/s00246-015-1190-9
   Zgura A, 2019, REV CHIM-BUCHAREST, V70, P2362
   Zvanca ME, 2019, J MATERN-FETAL NEO M, V32, P604, DOI 10.1080/14767058.2017.1387532
   Zvanca ME, 2014, REV ROMANA MED LAB, V22, P515, DOI 10.2478/rrlm-2014-0045
NR 88
TC 0
Z9 0
U1 1
U2 1
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD NOV
PY 2019
VL 70
IS 11
BP 3818
EP 3823
PG 6
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA JW6UU
UT WOS:000503185300010
DA 2020-07-08
ER

PT J
AU Fredericks, AC
   Russell, TA
   Wallace, LE
   Davidson, AD
   Fernandez-Sesma, A
   Maringer, K
AF Fredericks, Anthony C.
   Russell, Tiffany A.
   Wallace, Louisa E.
   Davidson, Andrew D.
   Fernandez-Sesma, Ana
   Maringer, Kevin
TI Aedes aegypti (Aag2)-derived clonal mosquito cell lines reveal the
   effects of pre-existing persistent infection with the insect-specific
   bunyavirus Phasi Charoen-like virus on arbovirus replication
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VECTOR COMPETENCE; CULEX FLAVIVIRUS; BLOCKS DENGUE; RNA VIRUSES; EILAT
   VIRUS; HOST-RANGE; TRANSMISSION; STRAIN; COINFECTION; DROSOPHILA
AB Background Aedes aegypti is a vector mosquito of major public health importance, transmitting arthropod-borne viruses (arboviruses) such as chikungunya, dengue, yellow fever and Zika viruses. Wild mosquito populations are persistently infected at high prevalence with insect-specific viruses that do not replicate in vertebrate hosts. In experimental settings, acute infections with insect-specific viruses have been shown to modulate arbovirus infection and transmission in Ae. aegypti and other vector mosquitoes. However, the impact of persistent insect-specific virus infections, which arboviruses encounter more commonly in nature, has not been investigated extensively. Cell lines are useful models for studying virus-host interactions, however the available Ae. aegypti cell lines are poorly defined and heterogenous cultures. Methodology/Principle findings We generated single cell-derived clonal cell lines from the commonly used Ae. aegypti cell line Aag2. Two of the fourteen Aag2-derived clonal cell lines generated harboured markedly and consistently reduced levels of the insect-specific bunyavirus Phasi Charoen-like virus (PCLV) known to persistently infect Aag2 cells. In contrast to studies with acute insect-specific virus infections in cell culture and in vivo, we found that pre-existing persistent PCLV infection had no major impact on the replication of the flaviviruses dengue virus and Zika virus, the alphavirus Sindbis virus, or the rhabdovirus vesicular stomatitis virus. We also performed a detailed characterisation of the morphology, transfection efficiency and immune status of our Aag2-derived clonal cell lines, and have made a clone that we term Aag2-AF5 available to the research community as a well-defined cell culture model for arbovirus-vector interaction studies.
   Author summary Mosquito-borne viruses usually only infect humans through the bite of a mosquito that carries the virus. Viruses transmitted by the 'yellow fever mosquito' Aedes aegypti, including dengue virus, Zika virus, yellow fever virus and chikungunya virus, are causing an ever-increasing number of human disease cases globally. Mosquito-borne viruses have to infect and replicate inside the mosquito before they are transmitted to humans, and the presence of other infectious agents can change the efficiency of virus transmission. Mosquitoes are known to be infected with 'insect-specific viruses' that only infect mosquitoes and cannot cause human disease. We have shown here that in laboratory cell cultures derived from the Aedes aegypti mosquito, pre-existing infection with an insect-specific virus called Phasi Charoen-like virus does not affect the infection and growth of the mosquito-borne viruses dengue virus, Zika virus, Sindbis virus or vesicular stomatitis virus. Our research provides important new insights into whether and how insect-specific viruses may affect mosquito-borne virus replication. Ultimately, this information could inform ongoing research into whether insect-specific viruses could be used to prevent the transmission of mosquito-borne viruses to reduce global disease burdens.
C1 [Fredericks, Anthony C.; Fernandez-Sesma, Ana; Maringer, Kevin] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Russell, Tiffany A.; Wallace, Louisa E.; Maringer, Kevin] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial Sci, Guildford, Surrey, England.
   [Davidson, Andrew D.; Maringer, Kevin] Univ Bristol, Sch Cellular & Mol Med, Fac Life Sci, Bristol, Avon, England.
RP Fernandez-Sesma, A; Maringer, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Maringer, K (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Dept Microbial Sci, Guildford, Surrey, England.; Maringer, K (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Fac Life Sci, Bristol, Avon, England.
EM ana.sesma@mssm.edu; k.maringer@surrey.ac.uk
OI Maringer, Kevin/0000-0003-0977-8807; Wallace, Louisa/0000-0002-6210-8645
FU Wellcome TrustWellcome Trust [096062]; Department for International
   Development (DFID); MRCMedical Research Council UK (MRC) [G0801973];
   Department of Defence (DOD)/Defense Advanced Research Projects Agency
   (DARPA) [HR0011-11-C-0094]; National Institutes of Health (NIH)/National
   Institutes of Allergy and Infectious Diseases (NIAID)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI073450, R21AI116022, U19AI118610]; University of Surrey; Medical
   Research Council (MRC)Medical Research Council UK (MRC) [MR/R010315/1]
FX This work was funded by Wellcome Trust (wellcome.ac.uk) grant 096062 and
   grant MR/R010315/1 cofunded by the Medical Research Council (MRC;
   mrc.ukri.org) and the Department for International Development (DFID;
   https://www.gov.uk/government/organisations/department-for-international
   -development) to KM, MRC grant G0801973 to AD, Department of Defence
   (DOD)/Defense Advanced Research Projects Agency (DARPA)
   (defense.gov/darpa.mil) grant HR0011-11-C-0094 (PROPHECY) and National
   Institutes of Health (NIH)/National Institutes of Allergy and Infectious
   Diseases (NIAID) (niaid.nih.gov) grants R01AI073450, R21AI116022 and
   U19AI118610 to AF-S, and a University of Surrey (surrey.ac.uk) Doctoral
   College studentship to LEW. The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x
   Baidaliuk A, 2019, J VIROL, V93, DOI 10.1128/JVI.00705-19
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032
   Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148
   Franzke K, 2018, J GEN VIROL, V99, P1739, DOI 10.1099/jgv.0.001173
   Fujita R, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00736
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Goertz GP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030271
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P276
   Hardwick M, 2013, METHOD ENZYMOL, V322, P1
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Horst AMT, 2018, J VIROL, DOI [10.1128/jvi.02124-18, DOI 10.1128/JVI.02124-18]
   Huhtamo E, 2009, J VIROL, V83, P9532, DOI 10.1128/JVI.00529-09
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kramer LD, 2016, CURR OPIN VIROL, V21, P81, DOI 10.1016/j.coviro.2016.08.008
   Kramer MC, 2015, GENE DEV, V29, P2168, DOI 10.1101/gad.270421.115
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059
   Lambrechts L, 2012, P R SOC B, V280, P20122437, DOI [10.1101/gad.1482006, DOI 10.1101/GAD.1482006]
   LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669
   Levine B, 1996, P NATL ACAD SCI USA, V93, P4810, DOI 10.1073/pnas.93.10.4810
   Maringer K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3432-5
   Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mullane K, 2017, BIOCHEM PHARMACOL, V138, P7, DOI 10.1016/j.bcp.2017.04.008
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Ohlund P, 2019, VIRUS GENES, V55, P127, DOI 10.1007/s11262-018-01629-9
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003
   Parry R, 2018, J VIROL, V92, DOI [10.1128/JVI.00224-18, 10.1128/jvi.00224-18]
   Romo H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0180-4
   Sangdee K, 2013, SE ASIAN J TROP MED, V44, P586
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Talavera S, 2018, PARASITE VECTOR, V11, P405, DOI [10.1186/s13071-018-2985-3, DOI 10.1186/S13071-018-2985-3]
   van Cleef KWR, 2014, NUCLEIC ACIDS RES, V42, P8732, DOI 10.1093/nar/gku528
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vasilakis N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-97
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walker T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-382
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weger-Lucarelli J, 2018, VIROLOGY, V521, P175, DOI 10.1016/j.virol.2018.06.007
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yamao T, 2009, ARCH VIROL, V154, P153, DOI 10.1007/s00705-008-0285-5
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
   Zhang RD, 2017, FRONT CELL INFECT MI, V7, DOI [10.3382/fcimb.2017.00022, 10.3389/fcimb.2017.00022]
   Zhang XM, 2018, VIROLOGY, V523, P35, DOI 10.1016/j.virol.2018.07.021
NR 81
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2019
VL 13
IS 11
AR e0007346
DI 10.1371/journal.pntd.0007346
PG 25
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JW8DT
UT WOS:000503278100035
PM 31693659
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Johari, NA
   Voon, K
   Toh, SY
   Sulaiman, LH
   Yap, IKS
   Lim, PKC
AF Johari, Nur Alia
   Voon, Kenny
   Toh, Shen Yung
   Sulaiman, Lokman Hakim
   Yap, Ivan Kok Seng
   Lim, Patricia Kim Chooi
TI Sylvatic dengue virus type 4 in Aedes aegypti and Aedes albopictus
   mosquitoes in an urban setting in Peninsular Malaysia
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PHENOTYPIC CHARACTERIZATION; MOLECULAR EVOLUTION; YELLOW-FEVER; ZIKA
   VIRUS; EMERGENCE; TRANSMISSION; STRAINS; LARVAE
AB Dengue fever is endemic in Malaysia, contributing to significant economic and health burden in the country. Aedes aegypti and Ae. albopictus are the main vectors of the dengue virus (DENV), which circulates in sylvatic and human transmission cycles and has been present in Malaysia for decades. The study investigated the presence and distribution of DENV in urban localities in the Klang Valley, Peninsular Malaysia. A total of 364 Ae. aegypti and 1,025 Ae. albopictus larvae, and 10 Ae. aegypti and 42 Ae. albopictus adult mosquitoes were screened for the presence of DENV. In total, 31 (2.2%) samples were positive, of which 2 Ae. albopictus larvae were co-infected with two serotypes, one with DENV-2 and DENV-3 and the other with DENV-3 and DENV-4. Phylogenetic analysis determined that the isolates belonged to DENV-1 genotype I (1 Ae. aegypti adult), DENV-2 (1 Ae. albopictus larva), DENV-3 genotype V (3 Ae. aegypti larvae and 10 Ae. albopictus larvae) and DENV-4 genotype IV (6 Ae. aegypti larvae and 12 Ae. albopictus larvae), a sylvatic strain of DENV-4 which was most closely related with sylvatic strains isolated from arboreal mosquitoes and sentinel monkeys in Peninsular Malaysia in the 1970s. All four DENV serotypes were co-circulating throughout the study period. The detection of a sylvatic strain of DENV-4 in Ae. aegypti and Ae. albopictus mosquitoes in urban areas in Peninsular Malaysia highlights the susceptibility of these vectors to infection with sylvatic DENV. The infectivity and vector competence of these urban mosquitoes to this strain of the virus needs further investigation, as well as the possibility of the emergence of sylvatic virus into the human transmission cycle.
   Author summary Dengue is a mosquito-borne disease that has re-emerged as a major public health problem in the 21(st) Century. The four serotypes of dengue virus are capable of infecting humans with a range of symptoms and clinical outcomes, with the change in predominating serotypes often responsible for new dengue outbreaks. In this study, we surveyed urban sites in the Klang Valley, Malaysia, for Aedes aegypti and Aedes albopictus mosquito vectors and confirmed the presence of all four serotypes of the virus. We detected the presence of genotype V of dengue serotype 3, which has previously not been reported in the country, as well as a sylvatic strain of dengue serotype 4 that was closely related to strains obtained from forest-dwelling mosquito vectors and sentinel monkeys in Malaysia. The detection of a sylvatic strain of dengue virus in urban vectors raises questions over the risk of virus transmission to humans, especially with recent reports of severe clinical cases as a result of infection with sylvatic dengue virus serotypes. Further studies will be needed to determine the source and origins of these strains as well as the severity of dengue disease upon infection, especially with the development of new dengue vaccines.
C1 [Johari, Nur Alia; Sulaiman, Lokman Hakim] Int Med Univ, IRDI, Kuala Lumpur, Malaysia.
   [Voon, Kenny; Toh, Shen Yung; Lim, Patricia Kim Chooi] Int Med Univ, Sch Med, Pathol Div, Kuala Lumpur, Malaysia.
   [Sulaiman, Lokman Hakim] Int Med Univ, Sch Med, Dept Community Med, Kuala Lumpur, Malaysia.
   [Yap, Ivan Kok Seng] Minist Educ Sci & Technol Res, Sarawak Res & Dev Council, Sarawak, Malaysia.
RP Johari, NA (corresponding author), Int Med Univ, IRDI, Kuala Lumpur, Malaysia.
EM nuraliajohari@imu.edu.my
FU International Medical University (IMU) [IMU 334/2015]
FX This work was supported by the International Medical University (IMU)
   internal research grant [Project ID: IMU 334/2015] awarded to PLKC. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abubakar Sazaly, 2002, Malays J Pathol, V24, P23
   Aguilar-Setien A, 2008, EPIDEMIOL INFECT, V136, P1678, DOI 10.1017/S0950268808000460
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Aquino VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007299
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cardosa J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000423
   CDC, 2016, SURV CONTR AED AEG A
   de Thoisy B, 2004, T ROY SOC TROP MED H, V98, P409, DOI 10.1016/j.trstmh.2003.12.003
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   Durbin AP, 2013, VIROLOGY, V439, P34, DOI 10.1016/j.virol.2013.01.018
   Franco L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001251
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Johari NA, 2019, TROP BIOMED, V36, P310
   Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Liu WJ, 2016, EMERG INFECT DIS, V22, P2146, DOI 10.3201/eid2212.160813
   Mudin RN, 2015, INT MED J MALAYS, V14, P5
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
   Pyke AT, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomea.00546-17, 10.1128/genomeA.00546-17]
   Pyke AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep22356
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Rossi SL, 2012, VIROLOGY, V423, P58, DOI 10.1016/j.virol.2011.11.018
   RUDNICK A, 1978, Asian Journal of Infectious Diseases, V2, P156
   RUDNICK A, 1984, P INT C DENG DHF, P7
   RUDNICK A, 1986, I MED RES MALAYS B, V23, P51
   RUDNICK ALBERT, 1965, J MED ENTOMOL, V2, P203, DOI 10.1093/jmedent/2.2.203
   Rueda LM, 2004, DTIC DOCUMENT
   Sittivicharpinyo T, 2018, VIRUS RES, V244, P27, DOI 10.1016/j.virusres.2017.10.021
   Suppiah J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006817
   TAMURA K, 1992, MOL BIOL EVOL, V9, P678
   Tan KK, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1175-4
   Teo CHJ, 2017, TROP BIOMED, V34, P583
   Teoh BT, 2010, EMERG INFECT DIS, V16, P1783, DOI 10.3201/eid1611.100721
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thavara Usavadee, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P468
   Thongyuan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180013
   Usme-Ciro JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-101
   Vasilakis N, 2008, VIROLOGY, V377, P296, DOI 10.1016/j.virol.2008.04.044
   Vasilakis N, 2007, VIROLOGY, V358, P402, DOI 10.1016/j.virol.2006.08.049
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis N, 2010, J VIROL, V84, P3726, DOI 10.1128/JVI.02640-09
   Wang BH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0908-x
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 49
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2019
VL 13
IS 11
AR e0007889
DI 10.1371/journal.pntd.0007889
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JW8DT
UT WOS:000503278100010
PM 31730672
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pena-Garcia, VH
   Christofferson, RC
AF Pena-Garcia, Victor Hugo
   Christofferson, Rebecca C.
TI Correlation of the basic reproduction number (R-0) and eco-environmental
   variables in Colombian municipalities with chikungunya outbreaks during
   2014-2016
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; DENGUE VIRUS; INFECTIOUS-DISEASES; VECTOR-BORNE; ZIKA
   VIRUS; TEMPERATURE; TRANSMISSION; INACTIVATION; HISTORY; SPACE
AB Chikungunya virus (CHIKV) emerged in Colombia in 2014 into a population presumed fully susceptible. This resulted in a quick and intense spread across Colombia, resulting in an epidemic that affected an estimated 450,000 people. The reported Colombian cases accounted for over 49% of all the cases reported to the PAHO. Eco-environmental factors are known to be associated with the spread of arboviruses such as CHIKV, and likely contribute to the differences in transmission profiles that were observed across several municipalities. To determine the association of eco-environmental factors and CHIKV, the basic reproduction number (R-0) in 85 municipalities, which accounted for 65.6% of reported CHIKV cases in Colombia, was estimated. Estimates of R-0 ranged from 1 to 9, where over 76% of municipalities had R-0 values between 1 and 2. When we looked at the distribution of R-0, the cumulative proportions were 20% with R-0>2, 14% with R-0>3, and 9% with R-0>4. Next, we determined that there were different patterns of correlation between environmental and/or ecological variables and R-0 when we considered different R-0 lower-thresholds. Broadly, we found that temperature-related variables are significantly and positively correlated to R-0 regardless of the lower threshold, while other variables like duration of outbreak and size of the urban area are inversely related to R-0. Specifically, we conclude that high values of temperature-related variables where R-0 > 1 will result in a fast growth of cases in a shorter time period (with faster cessation of outbreak transmission) but will result overall in a fewer total cases compared to outbreak areas (R-0 > 1, but classified as lower). Thus, in the absence of vector control, a less explosive outbreak may be more advantageous for the virus in terms of transmission.
   Author summary Chikungunya virus emerged in Colombia in 2014 into a presumed fully susceptible population and rapidly spread in the country. Numerous municipalities were differently affected by this virus across the country. The main purpose of this work was understanding why those differences were produced and, in turn, what are the variables addressing such differences. For this purpose, we estimated for 85 municipalities the basic reproduction number (R-0), a crucial parameter to understand epidemics that is expressed as the number of secondary cases produced by a primary case. Such parameter was correlated with numerous variables resulting evident a crucial role of temperature in the increase of R-0. Interestingly, other variables like size of the urban area and cases showed to be negatively correlated with R-0. Results shows that high temperatures produce high R-0, but those municipalities that showed high R-0 showed an explosive epidemic with faster increase of cases that ceased equally fast, so the duration of epidemic is short producing small amount of cases. In this way, more cases are expected with municipalities with lower values of R-0, which is suitably explained by the tortoise-hare model, where the less explosive outbreak results to be more advantageous for the virus.
C1 [Pena-Garcia, Victor Hugo] Univ Antioquia, Fac Med, PECET, Medellin, Colombia.
   [Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
RP Pena-Garcia, VH (corresponding author), Univ Antioquia, Fac Med, PECET, Medellin, Colombia.; Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
EM victorhugopega@gmail.com; rcarri1@lsu.edu
OI Pena-Garcia, Victor Hugo/0000-0002-4856-3166
FU NIH/NIGMSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM12207]; National Aeronautics and Space
   Administration (NASA)National Aeronautics & Space Administration (NASA)
   [80NSSC18k0517]
FX This work was supported by NIH/NIGMS grant R01GM12207 (PI: RCC)
   (https://www.nigms.nih.gov). And by the National Aeronautics and Space
   Administration (NASA) grant number 80NSSC18k0517. The funders played no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x
   Althouse BM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0299
   Alto BW, 2018, J MED ENTOMOL, V55, P217, DOI 10.1093/jme/tjx182
   Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   Piedrahita LD, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/2308095
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Grech MG, 2015, ACTA TROP, V146, P1, DOI 10.1016/j.actatropica.2015.02.010
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Heesterbeek J. A. P., 1996, STAT NEERL, V50, P89, DOI DOI 10.1111/J.1467-9574.1996.TB01482.X
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Huang YJS, 2015, VECTOR-BORNE ZOONOT, V15, P674, DOI 10.1089/vbz.2015.1795
   Pena-Garcia VH, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2339
   Kakarla SG, 2019, SCI TOTAL ENVIRON, V647, P66, DOI 10.1016/j.scitotenv.2018.07.461
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337
   Lopez LF, 2002, CR BIOL, V325, P1073, DOI 10.1016/S1631-0691(02)01534-2
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7
   Mordecai EA, 2019, ECOL LETT, V22, P1690, DOI 10.1111/ele.13335
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Ndenga BA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189971
   Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373
   Overgaard HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2295-1
   Oviedo-Pastrana M, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0284-2
   Park SL, 2016, J VIROL METHODS, V234, P152, DOI 10.1016/j.jviromet.2016.04.004
   Philip C, 2019, J PUBLIC HEALTH MAN, V25, P277, DOI [10.1097/PHH.0000000000000990, 10.1097/phh.0000000000000990]
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sanches Rosangela Peregrina, 2016, Infect Dis Model, V1, P88, DOI 10.1016/j.idm.2016.08.002
   Stone CM, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0336
   Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136
   Wimalasiri-Yapa BMCR, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030149
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
NR 45
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2019
VL 13
IS 11
AR e0007878
DI 10.1371/journal.pntd.0007878
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JW8DT
UT WOS:000503278100054
PM 31697681
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Patel, I
   Attarabeen, O
   Kummer, M
   Dykes, D
   Arbogast, Z
   Khanfar, NM
   Srivastava, P
   Parihar, A
   Sharma, R
   Guy, J
   Gunaseelan, S
   Dhingra, S
   Rodriguez-Cintron, F
   Maldonado-Davila, W
AF Patel, I
   Attarabeen, O.
   Kummer, M.
   Dykes, D.
   Arbogast, Z.
   Khanfar, N. M.
   Srivastava, P.
   Parihar, A.
   Sharma, R.
   Guy, J.
   Gunaseelan, S.
   Dhingra, S.
   Rodriguez-Cintron, F.
   Maldonado-Davila, W.
TI KNOWLEDGE, ATTITUDE AND PRACTICES ABOUT ZIKA VIRUS AMONG PHARMACY
   STUDENTS IN MAINLAND UNITED STATES (US) AND NON-MAINLAND US (PUERTO RICO
   AND WEST INDIES
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Patel, I; Attarabeen, O.; Kummer, M.; Dykes, D.; Arbogast, Z.] Marshall Univ, Huntington, WV USA.
   [Khanfar, N. M.] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA.
   [Srivastava, P.] Dr APJ Abdul Kalam Tech Univ, Varanasi, Uttar Pradesh, India.
   [Parihar, A.] Bhupal Nobles Inst Pharmaceut Sci, Udaipur, Rajasthan, India.
   [Sharma, R.] Touro Coll, New York, NY USA.
   [Sharma, R.] Univ Syst, New York, NY USA.
   [Guy, J.] Univ Findlay, Findlay, OH USA.
   [Gunaseelan, S.] Texas A&M Univ, Kingsville, TX USA.
   [Dhingra, S.] Univ West Indies, St Augustine, Trinidad Tobago.
   [Rodriguez-Cintron, F.; Maldonado-Davila, W.] Univ Puerto Rico, San Juan, PR 00936 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD NOV
PY 2019
VL 22
SU 3
MA PIN84
BP S653
EP S653
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA JW6NT
UT WOS:000503167001537
DA 2020-07-08
ER

PT J
AU Bos, S
   Viranaicken, W
   Frumence, E
   Li, G
   Despres, P
   Zhao, RY
   Gadea, G
AF Bos, Sandra
   Viranaicken, Wildriss
   Frumence, Etienne
   Li, Ge
   Despres, Philippe
   Zhao, Richard Y.
   Gadea, Gilles
TI The Envelope Residues E152/156/158 of Zika Virus Influence the Early
   Stages of Virus Infection in Human Cells
SO CELLS
LA English
DT Article
DE flavivirus; Zika virus; envelope protein; glycosylation; fusion loop;
   viral fusion; cell entry
ID BORNE ENCEPHALITIS-VIRUS; PROTEIN; GLYCOSYLATION; LOCALIZATION;
   GLYCOPROTEIN; SECRETION; APOPTOSIS; EPIDEMIC; MONKEYS; GLYCAN
AB Emerging infections of mosquito-borne Zika virus (ZIKV) pose an increasing threat to human health, as documented over the recent years in South Pacific islands and the Americas in recent years. To better understand molecular mechanisms underlying the increase in human cases with severe pathologies, we recently demonstrated the functional roles of structural proteins capsid (C), pre-membrane (prM), and envelop (E) of ZIKV epidemic strains with the initiation of viral infection in human cells. Specifically, we found that the C-prM region contributes to permissiveness of human host cells to ZIKV infection and ZIKV-induced cytopathic effects, whereas the E protein is associated with viral attachment and early infection. In the present study, we further characterize ZIKV E proteins by investigating the roles of residues isoleucine 152 (Ile152), threonine 156 (Thr156), and histidine 158 (His158) (i.e., the E-152/156/158 residues), which surround a unique N-glycosylation site (E-154), in permissiveness of human host cells to epidemic ZIKV infection. For comparison purpose, we generated mutant molecular clones of epidemic BeH819015 (BR15) and historical MR766-NIID (MR766) strains that carry each other's E-152/156/158 residues, respectively. We observed that the BR15 mutant containing the E-152/156/158 residues from MR766 was less infectious in A549-Dual (TM) cells than parental virus. In contrast, the MR766 mutant containing E-152/156/158 residues from BR15 displayed increased infectivity. The observed differences in infectivity were, however, not correlated with changes in viral binding onto host-cells or cellular responses to viral infection. Instead, the E-152/156/158 residues from BR15 were associated with an increased efficiency of viral membrane fusion inside infected cells due to conformational changes of E protein that enhance exposure of the fusion loop. Our data highlight an important contribution of E-152/156/158 residues to the early steps of ZIKV infection in human cells.
C1 [Bos, Sandra; Viranaicken, Wildriss; Frumence, Etienne; Despres, Philippe; Gadea, Gilles] Univ La Reunion, INSERM U1187, CNRS UMR 9192,Plateforme Technol CYROI, IRD UMR 249,Unite Mixte Proc Infectieux Milieu In, F-94791 St Clotilde, La Reunion, France.
   [Li, Ge; Zhao, Richard Y.] Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA.
   [Zhao, Richard Y.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Zhao, Richard Y.] Univ Maryland, Inst Global Hlth, Baltimore, MD 21201 USA.
   [Zhao, Richard Y.] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA.
RP Gadea, G (corresponding author), Univ La Reunion, INSERM U1187, CNRS UMR 9192,Plateforme Technol CYROI, IRD UMR 249,Unite Mixte Proc Infectieux Milieu In, F-94791 St Clotilde, La Reunion, France.; Zhao, RY (corresponding author), Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Inst Global Hlth, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA.
EM sandrabos.lab@gmail.com; wildriss.viranaicken@univ-reunion.fr;
   etienne.frumence@univ-reunion.fr; lige_cn@hotmail.com;
   philippe.despres@univ-reunion.fr; RZhao@som.umaryland.edu;
   gilles.gadea@inserm.fr
OI BOS, Sandra/0000-0001-5036-0336; Zhao, Richard Y./0000-0003-3424-2852;
   viranaicken, wildriss/0000-0002-0915-8635; Gilles,
   Gadea/0000-0001-6325-4866
FU ZIKAlert project (POE FEDER 2014-2020 Ile de la Reunion action 1.05)
   [SYNERGY:RE0001902]; National Institute of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [NIH R21 AI129369]; University of Maryland Medical Center; FEDER
   Region (ZIKALIVax 2.0 program) [SYNERGIE RE0012406]; La Reunion
   University; La Reunion Island University (Ecole Doctorale STS) - French
   ministry, MESRI
FX This work was supported by ZIKAlert project (POE FEDER 2014-2020 Ile de
   la Reunion action 1.05 under grant agreement n SYNERGY:RE0001902). G.L.
   and R.Y.Z. were supported in part by funding from the National Institute
   of Health (NIH R21 AI129369) and an intramural fund from the University
   of Maryland Medical Center (to R.Y.Z.). E.F. received funding from FEDER
   Region (ZIKALIVax 2.0 program, N SYNERGIE RE0012406) and La Reunion
   University. S.B. has a PhD degree scholarship from La Reunion Island
   University (Ecole Doctorale STS), funded by the French ministry, MESRI.
CR Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Bos S, 2018, PATHOG GLOB HEALTH, V112, P294, DOI 10.1080/20477724.2018.1514136
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Bradt V, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0133-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   Frumence E, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030066
   Frumence E, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7020055
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020157
   Lindquist L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay006
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mattioli L, 2006, J CELL SCI, V119, P2532, DOI 10.1242/jcs.02977
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Monath TP, 2002, J VIROL, V76, P1932, DOI 10.1128/JVI.76.4.1932-1943.2002
   Montecillo-Aguado MR, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7239347
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Viranaicken W, 2017, BIOCHIMIE, V142, P179, DOI 10.1016/j.biochi.2017.09.011
   Wang Y, 2011, J CELL SCI, V124, P3568, DOI 10.1242/jcs.084053
   Yoshii K, 2013, J GEN VIROL, V94, P2249, DOI 10.1099/vir.0.055269-0
   Zaidi MB, 2020, ACTA TROP, V201, DOI 10.1016/j.actatropica.2019.105201
   Zhang SN, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104547
NR 49
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD NOV
PY 2019
VL 8
IS 11
AR 1444
DI 10.3390/cells8111444
PG 15
WC Cell Biology
SC Cell Biology
GA JV3LB
UT WOS:000502266700142
PM 31731738
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Costamagna, G
   Andreoli, L
   Corti, S
   Faravelli, I
AF Costamagna, Gianluca
   Andreoli, Luca
   Corti, Stefania
   Faravelli, Irene
TI iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease
   Modeling and Drug Discovery
SO CELLS
LA English
DT Review
DE brain organoids; neurological disorders; iPSCs; drug discovery; disease
   modeling; neural chimera
ID PLURIPOTENT STEM-CELLS; HUMAN BRAIN-DEVELOPMENT; ZIKA VIRUS-INFECTION;
   CEREBRAL ORGANOIDS; SELF-ORGANIZATION; PROGENITOR CELLS; MOUSE;
   DIFFERENTIATION; NEURONS; GLIOBLASTOMA
AB Induced pluripotent stem cells (iPSCs)-based two-dimensional (2D) protocols have offered invaluable insights into the pathophysiology of neurological diseases. However, these systems are unable to reproduce complex cytoarchitectural features, cell-cell and tissue-tissue interactions like their in vivo counterpart. Three-dimensional (3D)-based culture protocols, though in their infancy, have offered new insights into modeling human diseases. Human neural organoids try to recapitulate the cellular diversity of complex tissues and can be generated from iPSCs to model the pathophysiology of a wide spectrum of pathologies. The engraftment of iPSCs into mice models and the improvement of differentiation protocols towards 3D cultures has enabled the generation of more complex multicellular systems. Consequently, models of neuropsychiatric disorders, infectious diseases, brain cancer and cerebral hypoxic injury can now be investigated from new perspectives. In this review, we consider the advancements made in modeling neuropsychiatric and neurological diseases with iPSC-derived organoids and their potential use to develop new drugs.
C1 [Costamagna, Gianluca; Andreoli, Luca; Corti, Stefania; Faravelli, Irene] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr,Neurosci Sect,Neurol Unit, I-20122 Milan, Italy.
RP Faravelli, I (corresponding author), Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr,Neurosci Sect,Neurol Unit, I-20122 Milan, Italy.
EM gianluca.costamagna@unimi.it; luca.andreoli95@gmail.com;
   stefania.corti@unimi.it; irene.faravelli@unimi.it
RI Faravelli, Irene/AAP-6300-2020
OI Faravelli, Irene/0000-0001-8126-7353; Costamagna,
   Gianluca/0000-0002-7989-585X
FU European UnionEuropean Union (EU) [778003]; Italian Ministery of Health
FX This project has received funding from the European Union's Horizon 2020
   research and innovation programme under the Marie Sklodowska-Curie grant
   agreement No 778003 to S.C. The project received partial support from
   Italian Ministery of Health to S.C.
CR AGUAYO AJ, 1977, NATURE, V268, P753, DOI 10.1038/268753a0
   Amin N, 2019, PROG NEURO-PSYCHOPH, V95, DOI 10.1016/j.pnpbp.2019.109674
   Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007
   Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011
   Barker RA, 2017, CELL STEM CELL, V21, P569, DOI 10.1016/j.stem.2017.09.014
   Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014
   Basuodan R, 2018, J ANAT, V233, P155, DOI 10.1111/joa.12827
   Ben-David U, 2017, NAT GENET, V49, P1567, DOI 10.1038/ng.3967
   Ben-Shushan E, 2015, STEM CELLS, V33, P403, DOI 10.1002/stem.1873
   Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078
   Bian S, 2018, NAT METHODS, V15, P631, DOI 10.1038/s41592-018-0070-7
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Blair JD, 2020, DEV DYNAM, V249, P46, DOI 10.1002/dvdy.60
   Blair JD, 2018, NAT MED, V24, P1568, DOI 10.1038/s41591-018-0139-y
   Brown RM, 2019, J VIROL, V93, DOI 10.1128/JVI.00957-19
   Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042
   Cho DY, 2013, CELL TRANSPLANT, V22, P731, DOI 10.3727/096368912X655136
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Crino PB, 2016, NAT REV NEUROL, V12, P379, DOI 10.1038/nrneurol.2016.81
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Curatolo P, 2015, LANCET NEUROL, V14, P733, DOI 10.1016/S1474-4422(15)00069-1
   Cyranoski D, 2018, NATURE, V557, P619, DOI 10.1038/d41586-018-05278-8
   Czerniecki SM, 2018, CELL STEM CELL, V22, P929, DOI 10.1016/j.stem.2018.04.022
   D'Aiuto L, 2019, J VIROL, V93, DOI 10.1128/JVI.00111-19
   Daviaud N, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0219-18.2018
   Decimo I, 2012, CURR PHARM DESIGN, V18, P1755, DOI 10.2174/138161212799859611
   Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P209, DOI 10.1093/schbul/sbr100
   Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107
   Dye BR, 2016, ELIFE, V5, DOI 10.7554/eLife.19732
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Ellison D, 2012, NEUROPATHOLOGY E BOO
   Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011
   Fan WJ, 2019, NEUROSCI LETT, V711, DOI 10.1016/j.neulet.2019.134433
   Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967
   Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x
   Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gelman D. M., 2012, JASPERS BASIC MECH E
   Geschwind DH, 2015, SCIENCE, V349, P1489, DOI 10.1126/science.aaa8954
   Groveman BR, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0742-2
   Guloglu M Oktar, 2016, Methods Mol Biol, V1341, P235, DOI 10.1007/7651_2015_235
   HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027
   Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2
   Hoffmann A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194896
   Hor JH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1081-0
   Hou SR, 2018, SLAS DISCOV, V23, P574, DOI 10.1177/2472555218766842
   Hubert CG, 2016, CANCER RES, V76, P2465, DOI 10.1158/0008-5472.CAN-15-2402
   Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Insel TR, 2013, NEURON, V80, P561, DOI 10.1016/j.neuron.2013.09.041
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935
   Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725
   Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523
   Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983
   Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004
   Knipe DM, 2015, P NATL ACAD SCI USA, V112, P11993, DOI 10.1073/pnas.1516224112
   Kratochvil MJ, 2019, NAT REV MATER, V4, P606, DOI 10.1038/s41578-019-0129-9
   Krefft O, 2018, JOVE-J VIS EXP, DOI 10.3791/56768
   Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lapointe S, 2018, LANCET, V392, P432, DOI 10.1016/S0140-6736(18)30990-5
   Lee DF, 2015, CELL, V161, P240, DOI 10.1016/j.cell.2015.02.045
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Linkous A, 2019, CELL REP, V26, P3203, DOI 10.1016/j.celrep.2019.02.063
   Liu C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156166
   Ma HT, 2018, P NATL ACAD SCI USA, V115, P3924, DOI 10.1073/pnas.1702059115
   Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7
   Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368
   Manley NC, 2017, STEM CELL TRANSL MED, V6, P1917, DOI 10.1002/sctm.17-0065
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Maria S., 2013, STEM CELLS, V31, P1548
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109
   Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834
   Marton RM, 2019, NAT NEUROSCI, V22, P484, DOI 10.1038/s41593-018-0316-9
   McCauley HA, 2017, DEVELOPMENT, V144, P958, DOI 10.1242/dev.140731
   Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Mizuguchi M, 2001, BRAIN DEV-JPN, V23, P508, DOI 10.1016/S0387-7604(01)00304-7
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Muller William J., 2010, Current Immunology Reviews, V6, P38
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ogawa J, 2018, CELL REP, V23, P1220, DOI 10.1016/j.celrep.2018.03.105
   Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y
   Ormel PR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06684-2
   Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071
   Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041
   Pasca AM, 2019, NAT MED, V25, P784, DOI 10.1038/s41591-019-0436-0
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Phan N, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0305-x
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   Rasmussen S.A., ZIKA VIRUS BIRTH DEF, DOI 10.1056/NEJMsr1604338
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   ROCK DL, 1983, NATURE, V302, P523, DOI 10.1038/302523a0
   Roubal Ivan, 2016, Methods Mol Biol, V1341, P345, DOI 10.1007/7651_2014_152
   Sabatini DM, 2017, P NATL ACAD SCI USA, V114, P11818, DOI 10.1073/pnas.1716173114
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604
   Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189
   Smoller JW, 2019, MOL PSYCHIATR, V24, P409, DOI 10.1038/s41380-017-0010-4
   Stachowiak EK, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0054-x
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Sugimura R, 2017, NATURE, V545, P432, DOI 10.1038/nature22370
   Takahashi J, 2019, REGEN MED, V14, P93, DOI 10.2217/rme-2018-0158
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111
   Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu RJ, 2019, CELL STEM CELL, V24, P908, DOI 10.1016/j.stem.2019.04.014
   Xu YP, 2019, CELL RES, V29, P265, DOI 10.1038/s41422-019-0152-9
   Yoshida M, 2015, STEM CELL REP, V4, P561, DOI 10.1016/j.stemcr.2015.02.010
   Yuan T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt224
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 137
TC 3
Z9 3
U1 4
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD NOV
PY 2019
VL 8
IS 11
AR 1438
DI 10.3390/cells8111438
PG 21
WC Cell Biology
SC Cell Biology
GA JV3LB
UT WOS:000502266700136
PM 31739555
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saver, AE
   Crawford, SA
   Joyce, JD
   Bertke, AS
AF Saver, Ashley E.
   Crawford, Stephanie A.
   Joyce, Jonathan D.
   Bertke, Andrea S.
TI Route of Infection Influences Zika Virus Shedding in a Guinea Pig Model
SO CELLS
LA English
DT Article
DE Zika virus; ZIKV; virus host interactions; pathogenesis; MR766; guinea
   pig; subcutaneous; vaginal; sexual transmission; virus transmission
ID JAPANESE ENCEPHALITIS-VIRUS; MALE SEXUAL TRANSMISSION; VAGINAL
   SECRETIONS; MOUSE MODEL; PERSISTENCE; ANIMALS; HISTORY; DISEASE; VECTOR;
   SYSTEM
AB Due to the recent epidemic of Zika virus (ZIKV) infection and resulting sequelae, as well as concerns about both the sexual and vertical transmission of the virus, renewed attention has been paid to the pathogenesis of this unique arbovirus. Numerous small animal models have been used in various ZIKV pathogenicity studies, however, they are often performed using immunodeficient or immunosuppressed animals, which may impact disease progression in a manner not relevant to immunocompetent humans. The use of immunocompetent animal models, such as macaques, is constrained by small sample sizes and the need for specialized equipment/staff. Here we report the establishment of ZIKV infection in an immunocompetent small animal model, the guinea pig, using both subcutaneous and vaginal routes of infection to mimic mosquito-borne and sexual transmission. Guinea pigs developed clinical signs consistent with mostly asymptomatic and mild disease observed in humans. We demonstrate that the route of infection does not significantly alter viral tissue tropism but does impact mucosal shedding mechanics. We also demonstrate persistent infection in sensory and autonomic ganglia, identifying a previously unrecognized niche of viral persistence that could contribute to viral shedding in secretions. We conclude that the guinea pig represents a useful and relevant model for ZIKV pathogenesis.
C1 [Saver, Ashley E.; Crawford, Stephanie A.] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA.
   [Joyce, Jonathan D.; Bertke, Andrea S.] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA.
RP Bertke, AS (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA.
EM aes27@vt.edu; stepc08@vt.edu; jjoyce84@vt.edu; asbertke@vt.edu
OI Bertke, Andrea/0000-0002-8941-8010
FU Virginia-Maryland College of Veterinary Medicine - Virginia Tech
   Subvention Fund
FX This research received no external funding. AS and SC were participants
   in the Summer Veterinary Student Research Program and were funded by
   Virginia-Maryland College of Veterinary Medicine. The article processing
   charge is partially funded by the Virginia Tech Subvention Fund.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Bertke AS, 2009, J VIROL, V83, P10007, DOI 10.1128/JVI.00559-09
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bierle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187720
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Freppel W, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3115
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Goodfellow FT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100550
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   GRIFFITH BP, 1991, TRANSPLANT P, V23, P29
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Holbrook MR, 2008, ANTIVIR RES, V78, P69, DOI 10.1016/j.antiviral.2007.10.004
   Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee HH, 2012, APPL BIOCHEM BIOTECH, V167, P259, DOI 10.1007/s12010-012-9668-x
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Miller LJ, 2018, AM J TROP MED HYG, V98, P864, DOI 10.4269/ajtmh.17-0686
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Peloggia A, 2018, INT J GYNECOL OBSTET, V143, P277, DOI 10.1002/ijgo.12663
   Pena LJ, 2018, J GEN VIROL, V99, P1529, DOI 10.1099/jgv.0.001153
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Reyes Y, 2019, EMERG INFECT DIS, V25, P808, DOI 10.3201/eid2504.180977
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   RYU E, 1976, International Journal of Zoonoses, V3, P145
   Schleiss MR, 2006, ILAR J, V47, P65, DOI 10.1093/ilar.47.1.65
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   STANBERRY LR, 1991, REV INFECT DIS, V13, pS920
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Swartwout BK, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040049
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Xiaojiang Liu, 2010, Proceedings of the 2010 WASE International Conference on Information Engineering (ICIE 2010), P24, DOI 10.1109/ICIE.2010.365
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 83
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD NOV
PY 2019
VL 8
IS 11
AR 1437
DI 10.3390/cells8111437
PG 18
WC Cell Biology
SC Cell Biology
GA JV3LB
UT WOS:000502266700135
PM 31739508
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Turpin, J
   Frumence, E
   Despres, P
   Viranaicken, W
   Krejbich-Trotot, P
AF Turpin, Jonathan
   Frumence, Etienne
   Despres, Philippe
   Viranaicken, Wildriss
   Krejbich-Trotot, Pascale
TI The ZIKA Virus Delays Cell Death Through the Anti-Apoptotic Bcl-2 Family
   Proteins
SO CELLS
LA English
DT Article
DE Zika virus; apoptosis; viral replication; Bcl-2 protein family
ID INFECTION; EPIDEMIC
AB Zika virus (ZIKV) is an emerging human mosquito-transmitted pathogen of global concern, known to be associated with complications such as congenital defects and neurological disorders in adults. ZIKV infection is associated with induction of cell death. However, previous studies suggest that the virally induced apoptosis occurs at a slower rate compared to the course of viral production. In this present study, we investigated the capacity of ZIKV to delay host cell apoptosis. We provide evidence that ZIKV has the ability to interfere with apoptosis whether it is intrinsically or extrinsically induced. In cells expressing viral replicon-type constructions, we show that this control is achieved through replication. Finally, our work highlights an important role for anti-apoptotic Bcl-2 family protein in the ability of ZIKV to control apoptotic pathways, avoiding premature cell death and thereby promoting virus replication in the host-cell.
C1 [Turpin, Jonathan; Frumence, Etienne; Despres, Philippe; Viranaicken, Wildriss; Krejbich-Trotot, Pascale] Univ La Reun, INSERM UMR 1187, CNRS 9192, PIMIT,Plateforme CYROI,IRD 249, F-97490 St Clotilde, Ile De La Reuni, France.
RP Viranaicken, W; Krejbich-Trotot, P (corresponding author), Univ La Reun, INSERM UMR 1187, CNRS 9192, PIMIT,Plateforme CYROI,IRD 249, F-97490 St Clotilde, Ile De La Reuni, France.
EM jonathan.turpin@univ-reunion.fr; etiennefrum@gmail.com;
   philippe.despres@univ-reunion.fr; wildriss.viranaicken@univ-reunion.fr;
   pascale.krejbich@univ-reunion.fr
OI TURPIN, Jonathan/0000-0003-2667-345X; viranaicken,
   wildriss/0000-0002-0915-8635; Krejbich Trotot,
   Pascale/0000-0001-7329-1716
FU Federation BioST from Reunion Island University (Zikapone project);
   ZIKAlert project (European Union-Region Reunion program) [SYNERGY:
   RE0001902]; Regional Council of Reunion Island (European Union-Region
   Reunion program) [SYNERGY: RE0012406]; La Reunion Island University
   (Ecole Doctorale STS) - French ministry MEESR
FX This work was supported by the Federation BioST from Reunion Island
   University (Zikapone project), the ZIKAlert project (European
   Union-Region Reunion program under grant agreement nffi SYNERGY:
   RE0001902). E.F. holds a fellowship from the Regional Council of Reunion
   Island (European Union-Region Reunion program under grant agreement nffi
   SYNERGY: RE0012406). J.T. has a PhD degree scholarship from La Reunion
   Island University (Ecole Doctorale STS), funded by the French ministry
   MEESR.
CR Antwerp D. J. V., 1998, TRENDS CELL BIOL, V8, P107
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Barnard TR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120728
   Bhuvanakantham R, 2010, MICROBES INFECT, V12, P615, DOI 10.1016/j.micinf.2010.04.005
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   El Kalamouni C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010002
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147
   Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026
   Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li ML, 2004, INT REV IMMUNOL, V23, P7, DOI 10.1080/08830180490265529
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Liu J, 2018, INT J BIOL SCI, V14, P1099, DOI 10.7150/ijbs.26400
   Lover AA, 2016, LANCET INFECT DIS, V16, P1331, DOI 10.1016/S1473-3099(16)30462-5
   McKenzie BA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216794
   Mehrbod P, 2019, VIRULENCE, V10, P376, DOI 10.1080/21505594.2019.1605803
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039
   Okamoto T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090243
   Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470
   Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Suzuki T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007299
   Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Viranaicken W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022296
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
NR 41
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD NOV
PY 2019
VL 8
IS 11
AR 1338
DI 10.3390/cells8111338
PG 19
WC Cell Biology
SC Cell Biology
GA JV3LB
UT WOS:000502266700036
PM 31671831
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Macleod, D
   Caminade, C
AF Macleod, David
   Caminade, Cyril
TI The Moderate Impact of the 2015 El Nino over East Africa and Its
   Representation in Seasonal Reforecasts
SO JOURNAL OF CLIMATE
LA English
DT Article
ID ZIKA VIRUS; RAINFALL; PRECIPITATION; VARIABILITY; MALARIA; ENSO;
   MECHANISMS; ANOMALIES; FORECASTS; EPIDEMIC
AB El Nino-Southern Oscillation (ENSO) has large socioeconomic impacts worldwide. The positive phase of ENSO, El Nino, has been linked to intense rainfall over East Africa during the short rains season (October-December). However, we show here that during the extremely strong 2015 El Nino the precipitation anomaly over most of East Africa during the short rains season was less intense than experienced during previous El Ninos, linked to less intense easterlies over the Indian Ocean. This moderate impact was not indicated by re-forecasts from the ECMWF operational seasonal forecasting system, SEAS5, which instead forecast large probabilities of an extreme wet signal, with stronger easterly anomalies over the surface of the Indian Ocean and a colder eastern Indian Ocean/western Pacific than was observed. To confirm the relationship of the eastern Indian Ocean to East African rainfall in the forecast for 2015, atmospheric relaxation experiments are carried out that constrain the east Indian Ocean lower troposphere to reanalysis. By doing so the strong wet forecast signal is reduced. These results raise the possibility that link between ENSO and Indian Ocean dipole events is too strong in the ECMWF dynamical seasonal forecast system and that model predictions for the East African short rains rainfall during strong El Nino events may have a bias toward high probabilities of wet conditions.
C1 [Macleod, David] Univ Oxford, Atmospher Ocean & Planetary Phys, Oxford, England.
   [Caminade, Cyril] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Merseyside, England.
RP Macleod, D (corresponding author), Univ Oxford, Atmospher Ocean & Planetary Phys, Oxford, England.
EM macleod@atm.ox.ac.uk
OI MacLeod, Dave/0000-0001-5504-6450; Caminade, Cyril/0000-0002-3846-7082
FU NERC/DfID project ForPAc: Toward Forecast-based Preparedness Action
   [NE/P000673/1]; NERC project "Impact of El Nino on malaria vector
   dynamics in Tanzania: Observation, improvement and unleashing
   forecasting potential'' [NE/P004407/1]; National Institute for Health
   Research Health Protection Research Unit in Emerging and Zoonotic
   Infections at the University of Liverpool; Public Health England;
   Liverpool School of Tropical Medicine
FX DM is supported by the NERC/DfID project ForPAc: Toward Forecast-based
   Preparedness Action (NE/P000673/1). CC was funded by the NERC project
   "Impact of El Nino on malaria vector dynamics in Tanzania: Observation,
   improvement and unleashing forecasting potential'' (NE/P004407/1) as
   well as by the National Institute for Health Research Health Protection
   Research Unit in Emerging and Zoonotic Infections at the University of
   Liverpool in partnership with Public Health England and Liverpool School
   of Tropical Medicine. The views expressed are those of the authors and
   not necessarily those of the NHS, the NIHR, the Department of Health, or
   Public Health England. Reforecast and reanalysis data were downloaded
   from the Copernicus Data Store, CHIRPS data from the Climate Hazards
   Group of UCSB, and climate model experiments were carried out using a
   member state special project at ECMWF, where data are archived (details
   available on request).
CR Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2
   Anyamba A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38034-z
   Berhane F, 2014, J CLIMATE, V27, P6016, DOI 10.1175/JCLI-D-13-00693.1
   Black E, 2003, MON WEATHER REV, V131, P74, DOI 10.1175/1520-0493(2003)131<0074:AOSOTR>2.0.CO;2
   Brown V, 1998, LANCET, V352, P1356, DOI 10.1016/S0140-6736(05)60747-7
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cash BA, 2019, J CLIMATE, V32, P2843, DOI 10.1175/JCLI-D-18-0181.1
   Chretien J.P., 2015, PLOS CURR, DOI [10.1371/currents.outbreaks.95fbc4a8fb4695e049baabfc2fc8289f, DOI 10.1371/CURRENTS.OUTBREAKS.95FBC4A8FB4695E049BAABFC2FC8289F]
   Claar DC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190957
   de la Poterie AST, 2018, INT J DISAST RISK RE, V30, P81, DOI 10.1016/j.ijdrr.2018.02.025
   Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828
   Emerton R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14796
   Field RD, 2016, P NATL ACAD SCI USA, V113, P9204, DOI 10.1073/pnas.1524888113
   FONTAINE RE, 1961, AM J TROP MED HYG, V10, P795, DOI 10.4269/ajtmh.1961.10.795
   Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50
   Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364
   HASTENRATH S, 1993, J GEOPHYS RES-OCEANS, V98, P20219, DOI 10.1029/93JC02330
   Hastenrath S, 2011, J CLIMATE, V24, P404, DOI 10.1175/2010JCLI3599.1
   Huang BY, 2016, GEOPHYS RES LETT, V43, P9165, DOI 10.1002/2016GL070888
   Indeje M, 2000, INT J CLIMATOL, V20, P19, DOI 10.1002/(SICI)1097-0088(200001)20:1&lt;19::AID-JOC449&gt;3.0.CO;2-0
   Ineson S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29130-1
   International Federation of Red Cross and Red Crescent Societies, 2017, EM PLAN ACT UPD ETH
   Jung T, 2011, Q J ROY METEOR SOC, V137, P598, DOI 10.1002/qj.781
   Kilavi M, 2018, ATMOSPHERE-BASEL, V9, DOI 10.3390/atmos9120472
   Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7
   Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8
   L'Heureux ML, 2017, B AM METEOROL SOC, V98, P1363, DOI 10.1175/BAMS-D-16-0009.1
   Lim YK, 2018, J CLIMATE, V31, P5825, DOI 10.1175/JCLI-D-17-0218.1
   MacLachlan C, 2015, Q J ROY METEOR SOC, V141, P1072, DOI 10.1002/qj.2396
   MacLeod D., 2019, SEASONAL FORECAST 2
   MacLeod D., 2019, TECH REP
   Mason S., 2009, 0902 IRI, DOI [10.7916/D85T3SB0, DOI 10.7916/D85T3SB0]
   Mason SJ, 2001, B AM METEOROL SOC, V82, P619, DOI 10.1175/1520-0477(2001)082<0619:PPAAWE>2.3.CO;2
   McGregor GR, 2018, ATMOSPHERE-BASEL, V9, DOI 10.3390/atmos9070282
   McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588
   Molteni F, 2015, CLIM DYNAM, V45, P3119, DOI 10.1007/s00382-015-2528-y
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Mutai CC, 2000, J CLIMATE, V13, P3915, DOI 10.1175/1520-0442(2000)013<3915:EARATT>2.0.CO;2
   Nicholson SE, 2017, REV GEOPHYS, V55, P590, DOI 10.1002/2016RG000544
   Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12
   Quan XW, 2018, B AM METEOROL SOC, V99, pS49, DOI [10.1175/BAMS-D-17-0118.1, 10.1175/bams-d-17-0118.1]
   Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670
   Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854
   Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245
   Siler N, 2017, J CLIMATE, V30, P10067, DOI 10.1175/JCLI-D-17-0177.1
   Sorensen CJ, 2017, GEOHEALTH, V1, P298, DOI 10.1002/2017GH000104
   Tseng YH, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa67c3
   Vicente-Serrano SM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016039
   Wanders N, 2017, J HYDROMETEOROL, V18, P177, DOI 10.1175/JHM-D-16-0230.1
   Weisheimer A, 2017, Q J ROY METEOR SOC, V143, P917, DOI 10.1002/qj.2976
   Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724
   Zaitchik BF, 2017, ATMOS RES, V184, P88, DOI 10.1016/j.atmosres.2016.10.002
   Zhang T, 2018, J CLIMATE, V31, P555, DOI 10.1175/JCLI-D-17-0396.1
NR 53
TC 0
Z9 0
U1 0
U2 0
PU AMER METEOROLOGICAL SOC
PI BOSTON
PA 45 BEACON ST, BOSTON, MA 02108-3693 USA
SN 0894-8755
EI 1520-0442
J9 J CLIMATE
JI J. Clim.
PD NOV
PY 2019
VL 32
IS 22
BP 7989
EP 8001
DI 10.1175/JCLI-D-19-0201.1
PG 13
WC Meteorology & Atmospheric Sciences
SC Meteorology & Atmospheric Sciences
GA JW8EW
UT WOS:000503281400001
OA Other Gold
DA 2020-07-08
ER

PT J
AU Trus, I
   Udenze, D
   Cox, B
   Berube, N
   Nordquist, RE
   van der Staay, FJ
   Huang, YY
   Kobinger, G
   Safronetz, D
   Gerdts, V
   Karniychuk, U
AF Trus, Ivan
   Udenze, Daniel
   Cox, Brian
   Berube, Nathalie
   Nordquist, Rebecca E.
   van der Staay, Franz Josef
   Huang, Yanyun
   Kobinger, Gary
   Safronetz, David
   Gerdts, Volker
   Karniychuk, Uladzimir
TI Subclinical in utero Zika virus infection is associated with interferon
   alpha sequelae and sex-specific molecular brain pathology in
   asymptomatic porcine offspring
SO PLOS PATHOGENS
LA English
DT Article
ID PRENATAL IMMUNE ACTIVATION; IFN-ALPHA; VIRAL-INFECTION;
   POSTNATAL-GROWTH; DENDRITIC CELLS; HAIR CORTISOL; FETAL; PIG; MODEL;
   STRESS
AB Zika virus (ZIKV) infection during human pregnancy may lead to severe fetal pathology and debilitating impairments in offspring. However, the majority of infections are subclinical and not associated with evident birth defects. Potentially detrimental life-long health outcomes in asymptomatic offspring evoke high concerns. Thus, animal models addressing sequelae in offspring may provide valuable information. To induce subclinical infection, we inoculated selected porcine fetuses at the mid-stage of development. Inoculation resulted in trans-fetal virus spread and persistent infection in the placenta and fetal membranes for two months. Offspring did not show congenital Zika syndrome (e.g., microcephaly, brain calcifications, congenital clubfoot, arthrogryposis, seizures) or other visible birth defects. However, a month after birth, a portion of offspring exhibited excessive interferon alpha (IFN-alpha) levels in blood plasma in a regular environment. Most affected offspring also showed dramatic IFN-alpha shutdown during social stress providing the first evidence for the cumulative impact of prenatal ZIKV exposure and postnatal environmental insult. Other eleven cytokines tested before and after stress were not altered suggesting the specific IFN-alpha pathology. While brains from offspring did not have histopathology, lesions, and ZIKV, the whole genome expression analysis of the prefrontal cortex revealed profound sex-specific transcriptional changes that most probably was the result of subclinical in utero infection. RNA-seq analysis in the placenta persistently infected with ZIKV provided independent support for the sex-specific pattern of in utero-acquired transcriptional responses. Collectively, our results provide strong evidence that two hallmarks of fetal ZIKV infection, altered type I IFN response and molecular brain pathology can persist after birth in offspring in the absence of congenital Zika syndrome.
C1 [Trus, Ivan; Udenze, Daniel; Berube, Nathalie; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, VIDO, Int Vaccine Ctr InterVac, Saskatoon, SK, Canada.
   [Udenze, Daniel; Karniychuk, Uladzimir] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.
   [Cox, Brian] Univ Toronto, Dept Physiol, Dept Obstet & Gynaecol, Toronto, ON, Canada.
   [Nordquist, Rebecca E.; van der Staay, Franz Josef] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Behav & Welf Grp, Utrecht, Netherlands.
   [Nordquist, Rebecca E.] Univ Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.
   [Huang, Yanyun] Prairie Diagnost Serv, Saskatoon, SK, Canada.
   [Kobinger, Gary] CHUL, Quebec City, PQ, Canada.
   [Kobinger, Gary] Univ Laval, Quebec City, PQ, Canada.
   [Safronetz, David] Publ Hlth Agcy Canada, Canada Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK, Canada.
RP Karniychuk, U (corresponding author), Univ Saskatchewan, VIDO, Int Vaccine Ctr InterVac, Saskatoon, SK, Canada.; Karniychuk, U (corresponding author), Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.; Karniychuk, U (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK, Canada.
EM u.karniychuk@usask.ca
RI Nordquist, Rebecca E./B-7455-2013
OI Nordquist, Rebecca E./0000-0002-8541-5285; Trus,
   Ivan/0000-0003-2849-5140; van der Staay, F. Josef/0000-0002-8704-3366
FU Genome Canada, Emerging Issue ProgramGenome Canada [418402]; Public
   Health Agency of Canada; Government of Saskatchewan through Innovation
   Saskatchewan [418836]
FX Financial support was provided by Genome Canada, Emerging Issue Program
   grant #418402, the Public Health Agency of Canada and the Government of
   Saskatchewan through Innovation Saskatchewan #418836. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
   https://www.genomecanada.ca/https://innovationsask.ca/research/saskatche
   wanadvantage-innovation-fund
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Andersen AD, 2016, AM J PHYSIOL-REG I, V310, pR481, DOI 10.1152/ajpregu.00349.2015
   Antonson AM, 2017, BRAIN BEHAV IMMUN, V59, P300, DOI 10.1016/j.bbi.2016.09.019
   AREY DS, 1995, APPL ANIM BEHAV SCI, V45, P23, DOI 10.1016/0168-1591(95)00600-W
   BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x
   Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004
   Blomstrom A, 2016, SCHIZOPHRENIA BULL, V42, P125, DOI 10.1093/schbul/sbv112
   Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013
   Boulanger-Bertolus J, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00230
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Brenhouse HC, 2016, NEUROSCI BIOBEHAV R, V70, P288, DOI 10.1016/j.neubiorev.2016.05.035
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Cha L, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.1
   Cheong JN, 2016, J PHYSIOL-LONDON, V594, P4727, DOI 10.1113/JP271745
   Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   da Paz VRF, 2017, LIFE SCI, V185, P46, DOI 10.1016/j.lfs.2017.07.021
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005
   Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864
   Dawson HD, 2017, VET MICROBIOL, V202, P2, DOI 10.1016/j.vetmic.2016.05.013
   Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Vianna RAD, 2019, J TROP PEDIATRICS, V65, P592, DOI 10.1093/tropej/fmz019
   DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002
   DIEZ B, 1989, PARASITOLOGY, V99, P11, DOI 10.1017/S0031182000060972
   DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7
   Duran N, 2004, INDIAN J MED RES, V120, P106
   Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995
   Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Garay PA, 2013, BRAIN BEHAV IMMUN, V31, P54, DOI 10.1016/j.bbi.2012.07.008
   Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112
   Giovanoli S, 2016, BRAIN BEHAV IMMUN, V55, P25, DOI 10.1016/j.bbi.2015.09.015
   Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261
   GOCO RV, 1963, ANN NY ACAD SCI, V106, P555
   Gyorffy BA, 2016, BRAIN BEHAV IMMUN, V56, P289, DOI 10.1016/j.bbi.2016.04.002
   Hansmann L, 2008, CLIN IMMUNOL, V127, P252, DOI 10.1016/j.clim.2008.01.014
   HAYDEN GF, 1980, J PEDIATR-US, V96, P869, DOI 10.1016/S0022-3476(80)80562-2
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hoarau C, SANTE, V9, P38
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huckans M, 2015, J PSYCHOSOM RES, V78, P184, DOI 10.1016/j.jpsychores.2014.07.020
   Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Juengling FD, 2000, PSYCHOPHARMACOLOGY, V152, P383, DOI 10.1007/s002130000549
   Kanitz E, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00227
   Karniychuk UU, 2009, PLACENTA, V30, P497, DOI 10.1016/j.placenta.2009.03.016
   Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001
   Kasper C, 2004, LEUKEMIA RES, V28, P1217, DOI 10.1016/j.leukres.2004.03.012
   Kieffer F, 2002, ARCH PEDIATRIE, V9, P7, DOI 10.1016/S0929-693X(01)00687-X
   Kranendonk G, 2006, HORM BEHAV, V49, P663, DOI 10.1016/j.yhbeh.2005.12.008
   KURANE I, 1993, AM J TROP MED HYG, V48, P222, DOI 10.4269/ajtmh.1993.48.222
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Le Pen G, 2006, NEUROSCIENCE, V143, P395, DOI 10.1016/j.neuroscience.2006.08.004
   Lieb K, 2006, EUR PSYCHIAT, V21, P204, DOI 10.1016/j.eurpsy.2004.09.030
   Lind NM, 2005, BRAIN RES BULL, V65, P1, DOI 10.1016/j.brainresbull.2004.08.007
   Lind NM, 2004, BEHAV BRAIN RES, V155, P217, DOI 10.1016/j.bbr.2004.04.014
   Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179
   Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639
   Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019
   MCGLONE JJ, 1986, BEHAV PROCESS, V12, P135, DOI 10.1016/0376-6357(86)90052-5
   MEESE GB, 1973, ANIM BEHAV, V21, P326, DOI 10.1016/S0003-3472(73)80074-0
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Mostafavi S, 2014, MOL PSYCHIATR, V19, P1267, DOI 10.1038/mp.2013.161
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Murray D M, 2000, Eur J Paediatr Neurol, V4, P295, DOI 10.1053/ejpn.2000.0388
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Novakovic P, 2016, VET RES, V47, DOI 10.1186/s13567-016-0364-7
   PABST R, 1994, VET IMMUNOL IMMUNOP, V43, P151, DOI 10.1016/0165-2427(94)90131-7
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x
   Prendergast AM, 2017, HAEMATOLOGICA, V102, P445, DOI 10.3324/haematol.2016.151209
   Raison CL, 2005, CNS DRUGS, V19, P105, DOI 10.2165/00023210-200519020-00002
   Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07
   Rault JL, 2015, ANIMALS, V5, P545, DOI 10.3390/ani5030371
   Rho MB, 1995, BRAIN BEHAV IMMUN, V9, P366, DOI 10.1006/brbi.1995.1034
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rothkotter HJ, 2002, HUM EXP TOXICOL, V21, P533, DOI 10.1191/0960327102ht293oa
   Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009
   Saha Dipongkor, 2014, Virologica Sinica, V29, P176, DOI 10.1007/s12250-014-3431-0
   Schaefer M, 2002, PROG NEURO-PSYCHOPH, V26, P731, DOI 10.1016/S0278-5846(01)00324-4
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Shakil AO, 1996, J HEPATOL, V24, P48, DOI 10.1016/S0168-8278(96)80185-1
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835
   Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007
   SMOLENIEC JS, 1994, LANCET, V343, P1100, DOI 10.1016/S0140-6736(94)90212-7
   Spann MN, 2018, J NEUROSCI, V38, P2877, DOI 10.1523/JNEUROSCI.2272-17.2018
   Splichal I, 1997, RES IMMUNOL, V148, P247, DOI 10.1016/S0923-2494(97)80866-8
   STAGNO S, 1977, PEDIATRICS, V59, P669
   Stanelle-Bertram S, 2018, NAT MICROBIOL, V3, P1161, DOI 10.1038/s41564-018-0236-1
   STERZL J, 1966, FOLIA MICROBIOL, V11, P7, DOI 10.1007/BF02877148
   Straley ME, 2017, BRAIN BEHAV IMMUN, V63, P21, DOI 10.1016/j.bbi.2016.06.002
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tayade C, 2006, J IMMUNOL, V176, P148, DOI 10.4049/jimmunol.176.1.148
   The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7
   Tobler LH, 2008, J INFECT DIS, V198, P979, DOI 10.1086/591466
   Trus I, 2018, VIRULENCE, V9, P1338, DOI 10.1080/21505594.2018.1504558
   Turpin DL, 2016, ANIMALS, V6, DOI 10.3390/ani6030024
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   Van der Staay FJ, 2007, J VET PHARMACOL THER, V30, P410, DOI 10.1111/j.1365-2885.2007.00884.x
   van der Staay FJ, 2009, PSYCHOPHARMACOLOGY, V206, P715, DOI 10.1007/s00213-009-1599-z
   van der Stalay FJ, 2008, PHYSIOL BEHAV, V93, P453, DOI 10.1016/j.physbeh.2007.10.002
   Vanderhaeghe C, 2010, ANIM REPROD SCI, V120, P78, DOI 10.1016/j.anireprosci.2010.02.010
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WAYSBORT A, 1993, ANTIMICROB AGENTS CH, V37, P1232, DOI 10.1128/AAC.37.6.1232
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zupan M, 2017, REV BRAS ZOOTECN, V46, P33, DOI [10.1590/s1806-92902017000100006, 10.1590/S1806-92902017000100006]
NR 132
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD NOV
PY 2019
VL 15
IS 11
AR e1008038
DI 10.1371/journal.ppat.1008038
PG 32
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA JW4NK
UT WOS:000503029900011
PM 31725819
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Domanovic, D
   Ushiro-Lumb, I
   Compernolle, V
   Brusin, S
   Funk, M
   Gallian, P
   Georgsen, J
   Janssen, M
   Jimenez-Marco, T
   Knutson, F
   Liumbruno, GM
   Mali, P
   Marano, G
   Maryuningsih, Y
   Niederhauser, C
   Politis, C
   Pupella, S
   Rautmann, G
   Saadat, K
   Sandid, I
   Sousa, AP
   Vaglio, S
   Velati, C
   Verdun, N
   Vesga, M
   Rebulla, P
AF Domanovic, Dragoslav
   Ushiro-Lumb, Ines
   Compernolle, Veerle
   Brusin, Sergio
   Funk, Markus
   Gallian, Pierre
   Georgsen, Jorgen
   Janssen, Mart
   Jimenez-Marco, Teresa
   Knutson, Folke
   Liumbruno, Giancarlo M.
   Mali, Polonca
   Marano, Giuseppe
   Maryuningsih, Yuyun
   Niederhauser, Christoph
   Politis, Constantina
   Pupella, Simonetta
   Rautmann, Guy
   Saadat, Karmin
   Sandid, Imad
   Sousa, Ana P.
   Vaglio, Stefania
   Velati, Claudio
   Verdun, Nicole
   Vesga, Miguel
   Rebulla, Paolo
TI Pathogen reduction of blood components during outbreaks of infectious
   diseases in the European Union: an expert opinion from the European
   Centre for Disease Prevention and Control consultation meeting
SO BLOOD TRANSFUSION
LA English
DT Article
DE pathogen reduction technologies; blood safety; infectious diseases
   outbreaks; blood components
ID WEST-NILE-VIRUS; WAVELENGTH ULTRAVIOLET-LIGHT; BUFFY-COAT PLATELETS;
   RESPIRATORY SYNDROME CORONAVIRUS; PSORALEN AMOTOSALEN HCL; FRESH-FROZEN
   PLASMA; PHOTOCHEMICAL INACTIVATION; CHIKUNGUNYA VIRUS; WHOLE-BLOOD; ZIKA
   VIRUS
AB Pathogen reduction (PR) of selected blood components is a technology that has been adopted in practice in various ways. Although they offer great advantages in improving the safety of the blood supply, these technologies have limitations which hinder their broader use, e.g. increased costs. In this context, the European Centre for Disease Prevention and Control (ECDC), in co-operation with the Italian National Blood Centre, organised an expert consultation meeting to discuss the potential role of pathogen reduction technologies (PRT) as a blood safety intervention during outbreaks of infectious diseases for which (in most cases) laboratory screening of blood donations is not available. The meeting brought together 26 experts and representatives of national competent authorities for blood from thirteen European Union and European Economic Area (EU/EEA) Member States (MS), Switzerland, the World Health Organization, the European Directorate for the Quality of Medicines and Health Care of the Council of Europe, the US Food and Drug Administration, and the ECDC. During the meeting, the current use of PRTs in the EU/EEA MS and Switzerland was verified, with particular reference to emerging infectious diseases (see Appendix). In this article, we also present expert discussions and a common view on the potential use of PRT as a part of both preparedness and response to threats posed to blood safety by outbreaks of infectious disease.
C1 [Domanovic, Dragoslav; Brusin, Sergio] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
   [Ushiro-Lumb, Ines] NHS Blood & Transplant, Natl Transfus Microbiol Reference Lab, London, England.
   [Ushiro-Lumb, Ines] Publ Hlth England, London, England.
   [Compernolle, Veerle] Belgian Red Cross Flanders, Transfus Res Ctr, Ghent, Belgium.
   [Funk, Markus] Paul Ehrlich Inst, Fed Inst Vaccines & Biomed, Pharmacovigilance 2, Langen, Germany.
   [Gallian, Pierre] Etab Francais Sang Provence Alpes Cote dAzur & Co, Marseille, France.
   [Georgsen, Jorgen] Odense Univ Hosp, Dept Clin Immunol, South Danish Transfus Serv, Odense, Denmark.
   [Janssen, Mart] Sanquin Res, Transfus Technol Assessment, Dept Donor Med Res, Amsterdam, Netherlands.
   [Jimenez-Marco, Teresa] Balearic Isl Blood & Tissue Bank Fdn, Palma De Mallorca, Spain.
   [Knutson, Folke] Uppsala Univ, Clin Immunol & Transfus Med IGP, Uppsala, Sweden.
   [Liumbruno, Giancarlo M.; Marano, Giuseppe; Pupella, Simonetta; Vaglio, Stefania; Velati, Claudio] Natl Inst Hlth, Italian Natl Blood Ctr, Rome, Italy.
   [Mali, Polonca] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia.
   [Maryuningsih, Yuyun] WHO, Geneva, Switzerland.
   [Niederhauser, Christoph] Interreg Blood Transfus Swiss Red Cross, Lab Diagnost, Bern, Switzerland.
   [Politis, Constantina] Hellen Natl Publ Hlth Org, Hellen Coordinating Hemovigilance Ctr, Athens, Greece.
   [Rautmann, Guy] European Directorate Qual Med & HealthCare, Strasbourg, France.
   [Saadat, Karmin] Austrian Agcy Hlth & Food Safety, Vienna, Austria.
   [Sandid, Imad] French Natl Agcy Med & Hlth Prod Safety ANSM, St Denis, France.
   [Sousa, Ana P.] Portuguese Blood & Transplantat Ctr, Lisbon, Portugal.
   [Verdun, Nicole] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Vesga, Miguel] Spanish Sci Comm Transfus Safety, Basque Ctr Transfus & Human Tissues, Galdakao, Spain.
   [Rebulla, Paolo] IRCCS Fdn Ca Granda Maggiore Policlin Hosp, Milan, Italy.
RP Domanovic, D (corresponding author), European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
EM Dragoslav.Domanovic@ecdc.europa.eu
RI Karabulut, Erman/G-6679-2011
OI Karabulut, Erman/0000-0002-0787-905X
FU World Health OrganizationWorld Health Organization [001]
CR Adlhoch C, 2011, EXPERT REV ANTI-INFE, V9, P1133
   Agapova M, 2015, TRANSFUS MED HEMOTH, V42, P158, DOI 10.1159/000371664
   Allain JP, 2017, TRANSFUSION MED, V27, P320, DOI 10.1111/tme.12456
   Allain JP, 2016, LANCET, V387, P1753, DOI 10.1016/S0140-6736(16)00581-X
   Allain JP, 2004, VOX SANG, V86, P83, DOI 10.1111/j.0042-9007.2004.00406.x
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bah A, 2018, TRANSFUS APHER SCI, V57, P683, DOI 10.1016/j.transci.2018.09.004
   Bakonyi T, 2006, EMERG INFECT DIS, V12, P618
   Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005
   Bartlow A.W., 2019, VET SCI, V6
   Bashir S, 2013, TRANSFUSION, V53, P990, DOI 10.1111/j.1537-2995.2012.03854.x
   Bell CF, 2003, CLIN THER, V25, P2464, DOI 10.1016/S0149-2918(03)80288-6
   Benjamin RJ, 2017, TRANSFUSION, V57, P2946, DOI 10.1111/trf.14284
   Berger K, 2013, ONKOLOGIE, V36, P53, DOI 10.1159/000346309
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Biggerstaff BJ, 2002, TRANSFUSION, V42, P1019, DOI 10.1046/j.1537-2995.2002.00167.x
   Birger R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16302-8
   Brecher ME, 2007, TRANSFUSION, V47, P1896, DOI 10.1111/j.1537-2995.2007.01413.x
   Brixner V, 2018, TRANSFUSION, V58, P905, DOI 10.1111/trf.14528
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Burnouf T, 2000, BLOOD REV, V14, P94, DOI 10.1054/blre.2000.0129
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012
   Cap AP, 2016, TRANSFUSION, V56, pS6, DOI 10.1111/trf.13393
   Cappy P, 2019, TRANSFUSION, V59, P2046, DOI 10.1111/trf.15203
   Cardo LJ, 2006, VOX SANG, V90, P85, DOI 10.1111/j.1423-0410.2005.00736.x
   Carvalho H, 2006, TRANSFUS APHER SCI, V34, P187, DOI 10.1016/j.transci.2005.09.041
   Castro E, 2007, TRANSFUSION, V47, P434, DOI 10.1111/j.1537-2995.2007.01133.x
   Chavarin P, 2011, VOX SANG, V100, P247, DOI 10.1111/j.1423-0410.2010.01389.x
   Cicchetti A, 2018, BLOOD TRANSFUS-ITALY, V16, P483, DOI 10.2450/2018.0115-18
   Coene J, 2014, TRANSFUSION, V54, P1321, DOI 10.1111/trf.12460
   Custer B, 2010, TRANSFUSION, V50, P2461, DOI 10.1111/j.1537-2995.2010.02704.x
   Dodd RY, 2019, TRANSFUSION, V59, P1162, DOI 10.1111/trf.15223
   Vilarino MD, 2017, TRANSFUS MED HEMOTH, V44, P5, DOI 10.1159/000447643
   Domanovic D, 2017, EUROSURVEILLANCE, V22, P6, DOI 10.2807/1560-7917.ES.2017.22.16.30514
   Domanovic D, 2019, EMERG INFECT DIS, V25, P1050, DOI 10.3201/eid2506.181755
   Douki T, 2003, NUCLEIC ACIDS RES, V31, P3134, DOI 10.1093/nar/gkg408
   Eastman RT, 2005, TRANSFUSION, V45, P1459, DOI 10.1111/j.1537-2995.2005.00552.x
   Epstein JS, 2003, TRANSFUSION, V43, P1347, DOI 10.1046/j.1537-2995.2003.00584.x
   European Centre for Disease Prevention and Control, MAL ANN EP REP 2016
   European Centre for Disease Prevention and Control, CHIK VIR DIS ANN EP
   European Centre for Disease Prevention and Control, EUR SURV SYST TESSY
   European Centre for Disease Prevention and Control, 2017, RAP RISK ASS CLUST A
   European Centre for Disease Prevention and Control, DENG ANN EP REP 2017
   Faddy HM, 2019, TRANSFUSION, V59, P2223, DOI 10.1111/trf.15332
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Faddy HM, 2015, TRANSFUSION, V55, P824, DOI 10.1111/trf.12899
   Feys HB, 2014, VOX SANG, V106, P307, DOI 10.1111/vox.12106
   Feys HB, 2019, TRANSFUS MED REV, V33, P29, DOI 10.1016/j.tmrv.2018.06.002
   Fryk JJ, 2017, TRANSFUSION, V57, P2677, DOI 10.1111/trf.14256
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Garban F, 2018, JAMA ONCOL, V4, P468, DOI 10.1001/jamaoncol.2017.5123
   Girona-Llobera E, 2014, TRANSFUSION, V54, P158, DOI 10.1111/trf.12232
   Goodrich RP, 2009, TRANSFUSION, V49, P1205, DOI 10.1111/j.1537-2995.2009.02126.x
   Gravemann U, 2019, TRANSFUSION, V59, P1324, DOI 10.1111/trf.15119
   Grellier P, 2008, TRANSFUSION, V48, P1676, DOI 10.1111/j.1537-2995.2007.01762.x
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hauser L, 2014, BLOOD, V123, P796, DOI 10.1182/blood-2013-09-524348
   Henschler R, 2011, TRANSFUS MED HEMOTH, V38, P33, DOI 10.1159/000324458
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Janssen MP, 2006, TRANSFUSION, V46, P956, DOI 10.1111/j.1537-2995.2006.00828.x
   Jauvin V, 2005, TRANSFUSION, V45, P1151, DOI 10.1111/j.1537-2995.2005.04400.x
   Jimenez-Marco T, 2018, TRANSFUSION, V58, P1881, DOI 10.1111/trf.14797
   Jimenez-Marco T, 2018, BLOOD TRANSFUS-ITALY, V16, P130, DOI 10.2450/2017.0201-16
   Jimenez-Marco T, 2017, TRANSFUSION, V57, P1440, DOI 10.1111/trf.14071
   Jimenez-Marco T, 2015, TRANSFUS APHER SCI, V52, P84, DOI 10.1016/j.transci.2014.12.004
   Jimenez-Marco T, 2014, TRANSFUS MED HEMOTH, V41, P172, DOI 10.1159/000363205
   Jutzi M, 2018, TRANSFUS MED HEMOTH, V45, P151, DOI 10.1159/000489900
   Kaiser-Guignard J, 2014, BLOOD REV, V28, P235, DOI 10.1016/j.blre.2014.07.005
   Keil SD, 2016, TRANSFUSION, V56, P2948, DOI 10.1111/trf.13860
   Kightlinger L., 2007, Morbidity and Mortality Weekly Report, V56, P76
   Knutson F, 2015, VOX SANG, V109, P343, DOI 10.1111/vox.12287
   Kumar V, 2004, PHOTOCHEM PHOTOBIOL, V80, P15, DOI 10.1562/2003-12-23-RA-036.1
   Lai CF, 2008, ANAL CHEM, V80, P8790, DOI 10.1021/ac801520m
   Larrea L, 2015, TRANSFUS APHER SCI, V52, P305, DOI 10.1016/j.transci.2015.01.008
   Laughhunn A, 2018, TRANSFUSION, V58, P748, DOI 10.1111/trf.14442
   Lin L, 2004, TRANSFUSION, V44, P1496, DOI 10.1111/j.1537-2995.2004.04125.x
   Lin L, 2001, SEMIN HEMATOL, V38, P27, DOI 10.1053/shem.2001.29498
   Lin LL, 2005, TRANSFUSION, V45, P580, DOI 10.1111/j.0041-1132.2005.04316.x
   Lozano M, 2011, BRIT J HAEMATOL, V153, P393, DOI 10.1111/j.1365-2141.2011.08635.x
   Maire F, PROPOS CAS PALUDISME
   Marano G, 2017, BLOOD TRANSFUS-ITALY, V15, P489, DOI 10.2450/2017.0215-17
   Marschner S, 2011, TRANSFUS MED HEMOTH, V38, P8, DOI 10.1159/000324160
   McCullough J, 2019, TRANSFUSION, V59, P1132, DOI 10.1111/trf.15103
   McCullough J, 2015, TRANSFUSION, V55, P2312, DOI 10.1111/trf.13149
   Mertes PM, 2020, TRANSFUSION, V60, P507, DOI 10.1111/trf.15275
   Moeremans K, 2006, TRANSFUSION MED, V16, P17, DOI 10.1111/j.1365-3148.2006.00644.x
   Nelson KE, 2011, EXPERT REV ANTI-INFE, V9, P1133, DOI [10.1586/ERI.11.138, 10.1586/eri.11.138]
   Noens L, 2017, VOX SANG, V112, P352, DOI 10.1111/vox.12510
   Nussbaumer W, 2007, TRANSFUSION, V47, P1125, DOI 10.1111/j.1537-2995.2007.01247.x
   Osman A, 2018, PLATELETS, V29, P140, DOI 10.1080/09537104.2017.1293806
   Ostrowski SR, 2011, TRANSFUSION, V51, P344, DOI 10.1111/j.1537-2995.2010.02821.x
   Ostrowski SR, 2010, TRANSFUSION, V50, P2210, DOI 10.1111/j.1537-2995.2010.02681.x
   Owada T, 2014, TRANSFUSION, V54, P2820, DOI 10.1111/trf.12686
   Pinna D, 2005, TRANSFUSION MED, V15, P269, DOI 10.1111/j.0958-7578.2005.00588.x
   Piotrowski D, 2018, BLOOD TRANSFUS-ITALY, V16, P348, DOI 10.2450/2017.0268-16
   Pistone T, 2014, TRAVEL MED INFECT DI, V12, P48, DOI 10.1016/j.tmaid.2013.08.006
   Politis C, 2014, TRANSFUSION MED, V24, P316, DOI 10.1111/tme.12144
   Postma MJ, 2005, TRANSFUSION MED, V15, P379, DOI 10.1111/j.1365-3148.2005.00609.x
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   Rebulla P, 2017, TRANSFUSION, V57, P1171, DOI 10.1111/trf.14042
   Rentas F, 2007, TRANSFUSION, V47, P240, DOI 10.1111/j.1537-2995.2007.01094.x
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Ruane PH, 2004, TRANSFUSION, V44, P877, DOI 10.1111/j.1537-2995.2004.03355.x
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Seed CR, 2017, VOX SANG, V112, P473, DOI 10.1111/vox.12516
   Seghatchian J, 2011, TRANSFUS MED HEMOTH, V38, P55, DOI 10.1159/000323786
   Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845
   Semenza JC, 2013, NAT CLIM CHANGE, V3, P432, DOI 10.1038/nclimate1867
   Sigle JP, 2013, TRANSFUSION, V53, P1788, DOI 10.1111/j.1537-2995.2012.03959.x
   Simonsen AC, 2006, TRANSFUSION, V46, P424, DOI 10.1111/j.1537-2995.2006.00739.x
   Simonsen AC, 1999, VOX SANG, V77, P210, DOI 10.1046/j.1423-0410.1999.7740210.x
   Singh Y, 2006, TRANSFUSION, V46, P1168, DOI 10.1111/j.1537-2995.2006.00867.x
   Staginnus U, 2004, INT J HEMATOL, V80, P317, DOI 10.1532/IJH97.04131
   Steinmann E, 2013, TRANSFUSION, V53, P1010, DOI 10.1111/j.1537-2995.2012.03858.x
   Stensballe J, 2018, ANESTH ANALG, V127, P920, DOI 10.1213/ANE.0000000000003545
   Stormer M, 2008, TRANSFUSION MED, V18, P371, DOI 10.1111/j.1365-3148.2008.00895.x
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Sundhedsstyrelsen, 2010, STAT PAT BLODK
   Tonnetti L, 2010, TRANSFUSION, V50, P1019, DOI 10.1111/j.1537-2995.2009.02538.x
   Trakhtman P, 2019, VOX SANG, V114, P223, DOI 10.1111/vox.12757
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   U.S. Food and Drug Administration, 2010, US NUCL AC TESTS RED
   U.S. Food and Drug Administration, 2018, BACT REV REC RED RIS
   U.S. Food and Drug Administration, 2017, IMPL PATH RED TECHN
   U.S. Food and Drug Administration, 2018, BACT RISK CONTR STRA
   U.S. Food and Drug Administration, 2018, REV REC RED RISK ZIK
   Van Aelst B, 2016, J BIOL CHEM, V291, P24364, DOI 10.1074/jbc.M116.735126
   Van Aelst B, 2015, TRANSFUSION, V55, P2404, DOI 10.1111/trf.13137
   van der Meer PF, 2016, VOX SANG, V111, P127, DOI 10.1111/vox.12404
   van der Meer PF, 2018, BLOOD, V132, P223, DOI 10.1182/blood-2018-02-831289
   van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812
   Van Voorhis WC, 2003, ANTIMICROB AGENTS CH, V47, P475, DOI 10.1128/AAC.47.2.475-479.2003
   Vanlandingham DL, 2013, TRANSFUSION, V53, P284, DOI 10.1111/j.1537-2995.2012.03717.x
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   Wollowitz S, 2004, TRANSFUS MED HEMOTH, V31, P11, DOI 10.1159/000076975
   Word Health Organization, 2017, STAND WECOB ANN 4 GU
NR 140
TC 1
Z9 1
U1 0
U2 0
PU SIMTIPRO SRL
PI MILAN
PA VIA DESIDERIO 21, MILAN, 20131, ITALY
SN 1723-2007
J9 BLOOD TRANSFUS-ITALY
JI Blood Transf.
PD NOV-DEC
PY 2019
VL 17
IS 6
BP 433
EP 448
DI 10.2450/2019.0288-19
PG 16
WC Hematology
SC Hematology
GA JV7QL
UT WOS:000502555900007
PM 31846608
DA 2020-07-08
ER

PT J
AU Gao, W
   Ghanbari, B
   Baskonus, HM
AF Gao, Wei
   Ghanbari, Behzad
   Baskonus, Haci Mehmet
TI New numerical simulations for some real world problems with
   Atangana-Baleanu fractional derivative
SO CHAOS SOLITONS & FRACTALS
LA English
DT Article
DE Computational method; Fractional derivative; Differential operator
ID TRAVELING-WAVES; ZIKA VIRUS; MATHEMATICAL-ANALYSIS; HBV MODEL; EPIDEMIC;
   DIFFUSION; HIV/AIDS; DYNAMICS; SPREAD; CAPUTO
AB In this work, we introduce ABC-Caputo operator with ML kernel and its main characteristics are discussed. Viral diseases models for AIDS and Zika are considered, and finally, as third model, the macroeconomic model involving ABC fractional derivatives is investigated, respectively. It is presented that the AB Caputo derivatives satisfy the Lipschitz condition along with superposition property. The numerical methods for solving the fractional models are presented by means of ABC fractional derivative in a detailed manner. Finally the simulation results obtained in this paper according to the suitable values of parameters are also manifested. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Gao, Wei] Yunnan Normal Univ, Sch Informat Sci & Technol, Kunming 650500, Yunnan, Peoples R China.
   [Ghanbari, Behzad] Kermanshah Univ Technol, Dept Engn Sci, Kermanshah, Iran.
   [Ghanbari, Behzad] Bahcesehir Univ, Fac Engn & Nat Sci, Dept Biomed Engn, TR-34349 Istanbul, Turkey.
   [Baskonus, Haci Mehmet] Harran Univ, Fac Educ, Dept Math & Sci Educ, Sanliurfa, Turkey.
RP Gao, W (corresponding author), Yunnan Normal Univ, Sch Informat Sci & Technol, Kunming 650500, Yunnan, Peoples R China.
EM gaowei@ynnu.edu.cn
OI BASKONUS, HACI MEHMET/0000-0003-4085-3625
CR Abdeljawad T, 2017, J NONLINEAR SCI APPL, V10, P1098, DOI 10.22436/jnsa.010.03.20
   Abro KA, 2019, EUR PHYS J PLUS, V134, DOI 10.1140/epjp/i2019-12507-4
   Abro KA, 2019, J THERM ANAL CALORIM, V135, P2197, DOI 10.1007/s10973-018-7302-z
   Allen MP, 2018, RISK ANAL, V38, P2507, DOI 10.1111/risa.13232
   Anderson RMRMM, 1995, INFECT DIS HUMANS DY
   Atangana A, 2016, THERM SCI, V20, P763, DOI 10.2298/TSCI160111018A
   BAGLEY RL, 1983, J RHEOL, V27, P201, DOI 10.1122/1.549724
   Baskonus HM, 2017, AIP CONF PROC, V1863, DOI 10.1063/1.4992767
   Baskonus HM, 2016, AIP CONF PROC, V1738, DOI 10.1063/1.4952076
   Baskonus HM, 2016, AIP CONF PROC, V1738, DOI 10.1063/1.4952077
   Baskonus HM, 2015, OPEN MATH, V13, P547, DOI 10.1515/math-2015-0052
   Baskonus HM, 2015, ENTROPY-SWITZ, V17, P5771, DOI 10.3390/e17085771
   Binder M, 2019, INT J BIOMATH, V12, DOI 10.1142/S1793524519500451
   Bonyah E, 2019, CHAOS SOLITON FRACT
   Bonyah E, 2014, COMPUT MATH METHOD M, DOI 10.1155/2014/576039
   Brzezinski D.W., 2017, APPL MATH NONLINEAR, V2, P237, DOI DOI 10.21042/AMNS.2017.1.00020
   Brzeziski D.W., 2018, APPL MATH NONLINEAR, V3, P487, DOI [10.2478/AMNS.2018.2.00038, DOI 10.2478/AMNS.2018.2.00038]
   Cruz-Pacheco G, 2019, J BIOL SYST, V27, P83, DOI 10.1142/S0218339019500050
   Debnath L., 2004, FRACTIONAL CALCULUS, V7, P21
   Morales-Delgado VF, 2019, MATH METHOD APPL SCI, V42, P1167, DOI 10.1002/mma.5421
   Feliu-Batlle V, 2007, CONTROL ENG PRACT, V15, P673, DOI 10.1016/j.conengprac.2006.11.018
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Ghalib MM, 2020, DISCRETE CONT DYN-S, V13, P683, DOI 10.3934/dcdss.2020037
   Ghanbari B, 2019, CHAOS, V29, DOI 10.1063/1.5094546
   HOSONO Y, 1995, MATH MOD METH APPL S, V5, P935, DOI 10.1142/S0218202595000504
   Houwe A., 2019, NONLINEAR SCHRDINGER
   Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Khan MA, 2019, NONLINEAR ANAL-REAL, V50, P144, DOI 10.1016/j.nonrwa.2019.04.006
   Kheiri H, 2018, INT J BIOMATH, V11, DOI 10.1142/S1793524518500869
   Koca I, 2019, DISCRETE CONT DYN-S, V12, P475, DOI 10.3934/dcdss.2019031
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lewis M, 2006, B MATH BIOL, V68, P3, DOI 10.1007/s11538-005-9018-z
   Ma JH, 2012, NONLINEAR DYNAM, V70, P2313, DOI 10.1007/s11071-012-0336-z
   Mukhopadhyay B, 2007, INT J SYST SCI, V38, P699, DOI 10.1080/00207720701596417
   Nah K, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0062-9
   Naresh R, 2006, APPL MATH COMPUT, V178, P262, DOI 10.1016/j.amc.2005.11.041
   Nyabadza F, 2011, J THEOR BIOL, V280, P167, DOI 10.1016/j.jtbi.2011.04.021
   Otunuga OM, 2018, MATH BIOSCI, V299, P138, DOI 10.1016/j.mbs.2018.03.013
   Owolabi KM, 2019, CHAOS SOLITON FRACT, V126, P41, DOI 10.1016/j.chaos.2019.06.001
   Owolabi KM, 2019, PHYSICA A, V523, P1072, DOI 10.1016/j.physa.2019.04.017
   Owolabi KM, 2019, CHAOS SOLITON FRACT, V122, P89, DOI 10.1016/j.chaos.2019.03.014
   Owolabi KM, 2019, CHAOS, V29, DOI 10.1063/1.5085490
   Prakash A, 2019, CHAOS SOLITON FRACT, V124, P134, DOI 10.1016/j.chaos.2019.05.005
   Prakasha DG, 2019, EUR PHYS J PLUS, V134, DOI 10.1140/epjp/i2019-12590-5
   Saqib M, 2019, J THERM ANAL CALORIM, V135, P523, DOI 10.1007/s10973-018-7054-9
   Silva CJ, 2015, DISCRETE CONT DYN-A, V35, P4639, DOI 10.3934/dcds.2015.35.4639
   Terefe YA, 2018, THEOR BIOSCI, V137, P209, DOI 10.1007/s12064-018-0272-7
   Ucar S, 2019, CHAOS SOLITON FRACT, V118, P300, DOI 10.1016/j.chaos.2018.12.003
   Wang KF, 2008, J THEOR BIOL, V253, P36, DOI 10.1016/j.jtbi.2007.11.007
   Wang K, 2007, MATH BIOSCI, V210, P78, DOI 10.1016/j.mbs.2007.05.004
   Wang WM, 2012, NONLINEAR ANAL-REAL, V13, P2240, DOI 10.1016/j.nonrwa.2012.01.018
   Weng PX, 2006, J DIFFER EQUATIONS, V229, P270, DOI 10.1016/j.jde.2006.01.020
   West B. J., 2003, PHYS FRACTIONAL OPER
   Xu H, 2009, COMMUN NONLINEAR SCI, V14, P1978, DOI 10.1016/j.cnsns.2008.07.006
   Xu R, 2009, J THEOR BIOL, V257, P499, DOI 10.1016/j.jtbi.2009.01.001
   Yamamoto N, 2019, MATH BIOSCI ENG, V16, P3272, DOI 10.3934/mbe.2019163
   YOKUS A, 2019, APPL MATH NONLINEAR, V4, P35, DOI DOI 10.2478/AMNS.2019.1.00004
   YOUNG A, 1954, PROC R SOC LON SER-A, V224, P552, DOI 10.1098/rspa.1954.0179
   Youssef I. K., 2017, APPL MATH NONLINEAR, V2, P271, DOI DOI 10.21042/AMNS.2017.1.00023
   Zhang HB, 2018, STAT MED, V37, P167, DOI 10.1002/sim.7515
NR 61
TC 37
Z9 36
U1 4
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0779
EI 1873-2887
J9 CHAOS SOLITON FRACT
JI Chaos Solitons Fractals
PD NOV
PY 2019
VL 128
BP 34
EP 43
DI 10.1016/j.chaos.2019.07.037
PG 10
WC Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary;
   Physics, Mathematical
SC Mathematics; Physics
GA JT3XZ
UT WOS:000500927400005
DA 2020-07-08
ER

PT J
AU Alvarado-Socarras, JL
   Aux-Cadena, CP
   Murillo-Garcia, DR
   Rodriguez-Morales, AJ
AF Alvarado-Socarras, Jorge L.
   Paola Aux-Cadena, Claudia
   Murillo-Garcia, David R.
   Rodriguez-Morales, Alfonso J.
TI Ophthalmologic evaluation in infants of mothers with Zika: A report from
   Colombia
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika virus; Congenital Zika disease; Eye diseases; Zika virus infection
   epidemiology; Colombia
ID VIRUS
C1 [Alvarado-Socarras, Jorge L.] Fdn Cardiovasc Colombia, Dept Pediat, Neonatal Unit, Bucaramanga, Santander, Colombia.
   [Alvarado-Socarras, Jorge L.; Rodriguez-Morales, Alfonso J.] Colombian Network Collaborat Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Paola Aux-Cadena, Claudia] Oftalmosanitas Clin Sebastian Belalcazar, Cali, Valle Del Cauca, Colombia.
   [Murillo-Garcia, David R.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Privada Franz Tamayo UNIFRANZ, Cochabamba, Bolivia.
RP Rodriguez-Morales, AJ (corresponding author), Colombian Network Collaborat Zika RECOLZIKA, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Univ Privada Franz Tamayo UNIFRANZ, Cochabamba, Bolivia.
EM arodriguezm@utp.edu.co
CR Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   Fandino-Cardenas M, 2019, J TROP PEDIATRICS, V65, P328, DOI 10.1093/tropej/fmy055
   Ministerio de Salud y Proteccion Social, 2016, LIN PROV AB CLIN GES
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD NOV-DEC
PY 2019
VL 32
AR 101449
DI 10.1016/j.tmaid.2019.07.005
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JV8PX
UT WOS:000502623800025
PM 31299301
DA 2020-07-08
ER

PT J
AU Feng, X
   Sun, W
   Birkhead, GS
   Wang, XZ
   Guo, ZM
   Lu, JH
AF Feng, Xue
   Sun, Wei
   Birkhead, Guthrie S.
   Wang, Xuanzhuo
   Guo, Zhongmin
   Lu, Jiahai
TI The surveillance of four mosquito-borne diseases in international
   travelers arriving at Guangzhou Baiyun International Airport, China,
   2016-2017
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Mosquito-borne virus; Malaria; Imported disease; Travel-related
   infection; Epidemiology
ID DENGUE-FEVER; CHIKUNGUNYA VIRUS; INFECTIOUS-DISEASES; OUTBREAK; MALARIA
AB Background: Little comprehensive analysis combining epidemiological and clinical data has been done with mosquito-borne diseases imported into Guangzhou by air travelers.
   Methods: We screened international travelers (body temperature > 36.5 degrees C) arriving at Guangzhou Baiyun International Airport, and recorded their epidemiological and clinical information. Whole-blood samples were collected for laboratory diagnosis of dengue virus (DENV), chikungunya virus (CHIKV), zika virus (ZIKV) infections and malaria.
   Results: Between March 1, 2016 and December 31, 2017, 155 (6.6%) cases (100 of DENV, 21 of CHIKV, 1 of ZIKV, 34 of malaria, including one co-infection of DENV and CHIKV) were identified among 2350 febrile travelers. DENV (90.0%) and CHIKV (100.0%) cases mainly came from Southern and Southeast Asia. Malaria cases (91.2%) mainly came from sub-Saharan Africa. Traveling abroad (28/74, 37.8%) and living/working abroad (11/22, 50.0%) were the most common causes of DENV infection and malaria for Chinese, respectively. Cases with these four mosquito-borne diseases were more likely to have nervous, musculoskeletal and skin symptoms and signs than other febrile diseases (P < 0.001).
   Conclusions: It is important to strengthen the surveillance of mosquito-borne diseases among tourists and workers returning from Southeast Asia, Southern Asia and sub-Saharan Africa, especially those with nervous, musculoskeletal and skin symptoms and signs.
C1 [Feng, Xue; Wang, Xuanzhuo; Lu, Jiahai] Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
   [Sun, Wei] Guangzhou Baiyun Airport Customs Dist Peoples Rep, Guangzhou, Guangdong, Peoples R China.
   [Birkhead, Guthrie S.] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Albany, NY USA.
   [Guo, Zhongmin] Sun Yat Sen Univ, Expt Anim Ctr, Guangzhou, Guangdong, Peoples R China.
   [Lu, Jiahai] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Guangdong, Peoples R China.
   [Lu, Jiahai] Sun Yat Sen Univ, One Hlth Res Ctr, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
RP Lu, JH (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
EM lujiahai@mail.sysu.edu.cn
FU National Science and Technology Major Project [2018ZX10101002-001-001];
   Guangdong Provincial Science and Technology Project [2018B020241002]
FX This work was supported by The National Science and Technology Major
   Project [grant number 2018ZX10101002-001-001] and Guangdong Provincial
   Science and Technology Project [grant number 2018B020241002].
CR [Anonymous], 2012, GLOB STRAT DENG PREV
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025
   Choe YJ, 2017, TRAVEL MED INFECT DI, V19, P22, DOI 10.1016/j.tmaid.2017.09.003
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   Findlater A, 2019, TRAVEL MED INFECT DI, V31, DOI 10.1016/j.tmaid.2019.07.002
   Frank C, 2011, VECTOR-BORNE ZOONOT, V11, P631, DOI 10.1089/vbz.2010.0269
   Hossain MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006561
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Jia H, 2016, IEEE INT CONF GROUP, P58, DOI 10.1109/GROUP4.2016.7739113
   Jun D, 2015, CHIN FRONT HLTH QUAR, V38, P342, DOI [10.16408/j.1004-9770.2015.05.013, DOI 10.16408/J.1004-9770.2015.05.013]
   Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746
   Lagi F, 2014, J TRAVEL MED, V21, P340, DOI 10.1111/jtm.12144
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   LI Z, 2016, MALARIA J, V15, P1, DOI DOI 10.1186/S12936-016-1188-7
   Liu YB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-29
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   Qiaoli Z., 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Riddell A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax015
   Ruche GL, 2010, EUROSURVEILLANCE, V15, P1, DOI [10.2807/ese.15.39, DOI 10.2807/ESE.15.39]
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X
   Shi L, 2016, TRAVEL MED INFECT DI, V14, P123, DOI 10.1016/j.tmaid.2016.02.002
   Shi YX, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3257-3
   Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800
   Tavakolipoor P, 2016, TRAVEL MED INFECT DI, V14, P39, DOI 10.1016/j.tmaid.2016.01.007
   Trojanek M, 2016, TRAVEL MED INFECT DI, V14, P32, DOI 10.1016/j.tmaid.2015.06.005
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   Verschueren J, 2015, CLIN MICROBIOL INFEC, V21, P867, DOI 10.1016/j.cmi.2015.05.029
   World Health Organisation, 2018, MALARIA
   World Health Organization, 2016, ICD 10 VERS
   World Health Organization, 2017, CHIK
   Yang L, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.57
   Yeruva SLH, 2016, KOREAN J PARASITOL, V54, P261, DOI 10.3347/kjp.2016.54.3.261
   Zhou S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1093-0
NR 38
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD NOV-DEC
PY 2019
VL 32
AR 101513
DI 10.1016/j.tmaid.2019.101513
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JV8PX
UT WOS:000502623800035
PM 31712181
OA Other Gold
DA 2020-07-08
ER

PT J
AU Le Hingrat, Q
   Perrier, M
   Charpentier, C
   Jacquot, A
   Houhou-Fidouh, N
   Descamps, D
   Visseaux, B
AF Le Hingrat, Quentin
   Perrier, Marine
   Charpentier, Charlotte
   Jacquot, Alaric
   Houhou-Fidouh, Nadhira
   Descamps, Diane
   Visseaux, Benoit
TI Was Zika introduced to Brazil by participants at the 2013 Beach Soccer
   World Cup held in Tahiti: A phylogeographical analysis
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Brazil; French Polynesia; Evolution; Phylogeny
ID VIRUS-INFECTION; FRENCH-POLYNESIA; TRANSMISSION; ALIGNMENT
AB Background: Zika virus (ZIKV) was initially responsible for a limited number of punctual epidemics throughout Africa and Asia. Recently, large epidemics occurred in French Polynesia, Brazil and Pan-America. These outbreaks were associated with severe outcomes such as Guillain-Barre Syndrome and microcephaly of in-utero infected newborns. Previous studies demonstrated that ZIKV was introduced in Brazil from French Polynesia but failed to identify a founding event.
   Method: All publicly available ZIKV full-genome sequences (n = 182) were phylogenetically analyzed, using Bayesian method, to estimate the introduction date of ZIKV into Brazil.
   Results: Introduction date into Brazil was estimated between 8th of July 2013 and 4th of November 2013, encompassing the Beach Soccer World Cup held in French Polynesia, in September 2013, which gathered Brazilian athletes and supporters. We also observed that ZIKV sequences from travelers infected in South-East Asia or in Pacific islands were closely related to viruses identified prior to the French Polynesian epidemic, underlining an endemic circulation of ZIKV in those countries since 2007, at least.
   Conclusion: This work provides a narrower estimation of ZIKV introduction into Brazil and illustrates the need for a better exploration of ZIKV circulation and endemicity in South-East Asia, while epidemiological and prevention efforts have been mainly focused on the Pan-American epidemic.
C1 [Le Hingrat, Quentin; Perrier, Marine; Charpentier, Charlotte; Houhou-Fidouh, Nadhira; Descamps, Diane; Visseaux, Benoit] Univ Paris, INSERM UMR IAME 1137, F-75018 Paris, France.
   [Le Hingrat, Quentin; Perrier, Marine; Charpentier, Charlotte; Jacquot, Alaric; Houhou-Fidouh, Nadhira; Descamps, Diane; Visseaux, Benoit] Hop Bichat Claude Bernard, AP HP, Lab Virol, F-75018 Paris, France.
RP Le Hingrat, Q (corresponding author), Hop Bichat Claude Bernard, AP HP, Lab Virol, F-75018 Paris, France.
EM quentin.lehingrat@aphp.fr
FU Assistance Publique - Hopitaux de Paris (AP-HP)
FX No particular funding was received for this study. A grant of the
   Assistance Publique - Hopitaux de Paris (AP-HP) supported Q.L.H.
CR Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Magalhaes-Barbosa MC, 2017, TRAVEL MED INFECT DI, V16, P52, DOI 10.1016/j.tmaid.2017.03.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Faria NR, 2017, NATURE, P546, DOI [10.1038/nature22401.nature22401, DOI 10.1038/NATURE22401.NATURE22401]
   Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Rodriguez-Morales AJ, 2018, TRAVEL MED INFECT DI, V25, P20, DOI 10.1016/j.tmaid.2018.06.006
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Dinh TC, 2019, EUR J CLIN MICROBIOL, V38, P1585, DOI 10.1007/s10096-019-03563-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 37
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD NOV-DEC
PY 2019
VL 32
AR 101512
DI 10.1016/j.tmaid.2019.101512
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JV8PX
UT WOS:000502623800036
PM 31704483
DA 2020-07-08
ER

PT J
AU Zambrano, LI
   Rodriguez, E
   Espinoza-Salvado, IA
   Fuentes-Barahona, IC
   de Oliveira, TL
   da Veiga, GL
   da Silva, JC
   Valle-Reconco, JA
   Rodriguez-Morales, AJ
AF Zambrano, Lysien, I
   Rodriguez, Edith
   Espinoza-Salvado, Ivan Alfonso
   Fuentes-Barahona, Itzel Carolina
   de Oliveira, Tales Lyra
   da Veiga, Glaucia Luciano
   da Silva, Jose Claudio
   Valle-Reconco, Jorge Alberto
   Rodriguez-Morales, Alfonso J.
TI Spatial distribution of dengue in Honduras during 2016-2019 using a
   geographic information systems (GIS)-Dengue epidemic implications for
   public health and travel medicine
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Dengue virus (DENV); Geographical information systems (GIS); Public
   health; Travelers; Arboviruses; Infectious diseases epidemiology
ID ZIKA VIRUS; OUTBREAK IMPLICATIONS; CHIKUNGUNYA VIRUS; MAPPING ZIKA;
   COLOMBIA; DISEASE; COINFECTION; FEVER; GIS; MUNICIPALITIES
AB Background: After serious epidemics of chikungunya (CHIKV) and Zika (ZIKV) in the Americas, dengue (DENV) have reemerged in most countries. We analyzed the incidence, incidence rates, and evolution of DENV cases in Honduras from 2015 to 2018 and the ongoing 2019 epidemic.
   Methods: Using epidemiological weeks (EW) surveillance data on the DENV in Honduras, we estimated incidence rates (cases/100,000 population), and developed maps at national, departmental, and municipal levels.
   Results: From January 1, 2016 to July 21, 2019, a total of 109,557 cases of DENV were reported, 28,603 in 2019, with an incidence rate of 312.32 cases/100,000 population this year; 0.13% laboratory-confirmed. The highest peak was reached on the EW 28 degrees, 2019 (5299 cases; 57.89 cases/100,000 population). The department with the highest number of cases and incidence rate was Cortes (8404 cases, 479.68 cases/100,000 population in 2019).
   Discussion: The pattern and evolution of DENV epidemic in 2019 in Honduras has been similar to that which occurred for in 2015. As previously reported, this epidemic involved the north and central areas of the country predominantly, reaching municipality incidences there > 1000 cases/100,000 population (or 1%). Studies using geographical information systems linked with clinical disease characteristics are necessary to obtain accurate epidemiological data for public health systems. Such information is also useful for assessment of risk for travelers who visit specific areas in a destination country.
C1 [Zambrano, Lysien, I] UNAH, Sch Med, Dept Morphol Sci, Sci, Tegucigalpa, Honduras.
   [Zambrano, Lysien, I] Univ Fed Sao Paulo, Dept Physiol, Cardiovasc Div, Escola Paulista Med UNIFESP EPM, Sao Paulo, SP, Brazil.
   [Zambrano, Lysien, I; Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Rodriguez, Edith] Secretaria Salud, Unidad Vigilancia Salud, Tegucigalpa, Honduras.
   [Espinoza-Salvado, Ivan Alfonso] UNAH, Fac Ciencias Med, Unidad Invest Cient, Tegucigalpa, Honduras.
   [Fuentes-Barahona, Itzel Carolina; Valle-Reconco, Jorge Alberto] UNAH, Sch Med Sci, Tegucigalpa, Honduras.
   [Fuentes-Barahona, Itzel Carolina] Hosp Escuela Tegucigalpa, Dept Gynecol & Obstet, Tegucigalpa, Honduras.
   [de Oliveira, Tales Lyra] Univ Municipal Sao Caetano do Sul, Fac Med, Sao Paulo, SP, Brazil.
   [de Oliveira, Tales Lyra] Univ Sao Paulo, Fac Med, Inst Coracao, Unidade Hipertensao, Sao Paulo, SP, Brazil.
   [da Veiga, Glaucia Luciano] Fac Med ABC, Dept Anal Clin, Santo Andre, SP, Brazil.
   [da Silva, Jose Claudio] Ctr Univ CESMAC, Maceio, Alagoas, Brazil.
   [da Silva, Jose Claudio] Univ Estadual Ciencias Saude Alagoas, Maceio, Alagoas, Brazil.
   [Rodriguez-Morales, Alfonso J.] UTP, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Asociac Panamer Infectol, Comm Travel Med, Panama City, Panama.
   [Rodriguez-Morales, Alfonso J.] UniFranz, Med Sch, Fac Hlth Sci, Cochabamba, Bolivia.
   [Rodriguez-Morales, Alfonso J.] Fdn Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), UTP, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI de Oliveira, Tales Lyra/W-7524-2018; da Silva, Jose Claudio/D-8731-2016;
   Zambrano, Lysien Ivania/N-8843-2015
OI de Oliveira, Tales Lyra/0000-0003-4831-3009; da Silva, Jose
   Claudio/0000-0003-3749-2822; Zambrano, Lysien
   Ivania/0000-0001-9002-5807; Fuentes Barahona, Itzel
   Carolina/0000-0002-9995-2276
FU Direccion de Investigacion Cientifica (DICU), National Autonomous
   University of Honduras, Tegucigalpa, MDC, Honduras, Central America;
   UNAH. Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia
   [CU-0-041-05-2014/03-2014]; Universidad Tecnologica de Pereira, Pereira,
   Risaralda, Colombia [5-15-5 [2015-2017]]
FX From the Direccion de Investigacion Cientifica (DICU), National
   Autonomous University of Honduras, Tegucigalpa, MDC, Honduras, Central
   America, for funding of the Golden Open Access of this article. L.I.Z.
   was recipient of UNAH (CU-0-041-05-2014/03-2014 Sholarship). Universidad
   Tecnologica de Pereira, Pereira, Risaralda, Colombia. This study is part
   of the project "Desarrollo de Mapas Epidemiologicos a traves de Sistemas
   de Informacion Geografica para la Caracterizacion Geografica de
   Enfermedades Infecciosas y Tropicales en el Eje Cafetero de Colombia"
   (Code 5-15-5 [2015-2017]), Universidad Tecnologica de Pereira, Pereira,
   Risaralda, Colombia. Training on GIS for A. J. Rodriguez-Morales was
   funded by Universidad Tecnologica de Pereira, Pereira, Risaralda,
   Colombia.
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Bangert M, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0288-0
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Brissett DI, 2018, AM J TROP MED HYG, V99, P211, DOI 10.4269/ajtmh.18-0014
   Brooks T, 2017, EMERG INFECT DIS, V23, P1360, DOI 10.3201/eid2308.161944
   Buekens P, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0200-6
   Cardona-Ospina Jaime A, 2018, Trop Med Infect Dis, V3, DOI 10.3390/tropicalmed3040123
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Corrales-Reyes IE, 2019, MEDICC REV, V21, P3
   Elsinga J, 2018, TRAVEL MED INFECT DI, V23, P34, DOI 10.1016/j.tmaid.2018.03.008
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Figueroa M, 1982, Bull Pan Am Health Organ, V16, P130
   Jaramillo-Martinez GA, 2018, J INFECT PUBLIC HEAL, V11, P145, DOI 10.1016/j.jiph.2017.03.001
   Lee JS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7282-3
   Liu-Helmersson J, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00148
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Mesa Despaigne Arelis, 2013, MEDISAN, V17, P3001
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Nicoletti L, 2008, EMERG INFECT DIS, V14, P177, DOI 10.3201/eid1401.070618
   Noor R, 2018, J INFECT PUBLIC HEAL, V11, P611, DOI 10.1016/j.jiph.2018.04.007
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   PAHO, 2019, HLTH INF PLATF AM PL
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Consuegra-Rodriguez MP, 2018, TRAVEL MED INFECT DI, V21, P62, DOI 10.1016/j.tmaid.2017.11.013
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Perich MJ, 2001, J AM MOSQUITO CONTR, V17, P221
   Quintero-Herrera LL, 2015, J INFECT PUBLIC HEAL, V8, P291, DOI 10.1016/j.jiph.2014.11.005
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Rodriguez-Morales AJ, 2018, CURRENT TOPICS ZIKA, P3
   Rodriguez-Morales AJ, 2017, J PREV EPIDEMIOL, V3, DOI [10.15171/jpe.2018.01.e01, DOI 10.15171/JPE.2018.01.E01]
   Rodriguez-Morales AJ, 2019, INT J INFECT DIS, V83, P160, DOI 10.1016/j.ijid.2019.03.002
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Sanchez-Duque JA, 2018, CURRENT TOPICS ZIKA, P71
   Chaves TDS, 2018, TRAVEL MED INFECT DI, V23, P1, DOI 10.1016/j.tmaid.2018.05.001
   Tami A, 2016, TRAVEL MED INFECT DI, V14, P9, DOI 10.1016/j.tmaid.2016.01.002
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   Villamil-Gomez WE, 2017, J INFECT PUBLIC HEAL, V10, P133, DOI 10.1016/j.jiph.2016.02.003
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
   Zambrano LI, 2012, TROP BIOMED, V29, P499
   Zambrano LI, 2019, TRAVEL MED INFECT DI, V31, DOI 10.1016/j.tmaid.2019.07.012
   Zambrano LI, 2019, INT J INFECT DIS, V84, P136, DOI 10.1016/j.ijid.2019.05.008
   Zambrano LI, 2019, TRAVEL MED INFECT DI, V31, DOI 10.1016/j.tmaid.2019.01.017
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
NR 56
TC 0
Z9 0
U1 4
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD NOV-DEC
PY 2019
VL 32
AR 101517
DI 10.1016/j.tmaid.2019.101517
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JV8PX
UT WOS:000502623800031
PM 31715270
OA Other Gold
DA 2020-07-08
ER

PT J
AU Goh, GKM
   Dunker, AK
   Foster, JA
   Uversky, VN
AF Goh, Gerard Kian-Meng
   Dunker, A. Keith
   Foster, James A.
   Uversky, Vladimir N.
TI Zika and Flavivirus Shell Disorder: Virulence and Fetal Morbidity
SO BIOMOLECULES
LA English
DT Article
DE Zika; protein intrinsic disorder; shell disorder; dengue; virulence;
   microcephaly; vaccine; yellow fever; morbidity; fetal
ID PROTEIN INTRINSIC DISORDER; WEST NILE VIRUS; FIGHTING CANCER; CAPSID
   PROTEIN; TRANSMISSION; MATURATION; INFECTION
AB Zika virus (ZIKV) was first discovered in 1947 in Africa. Since then, sporadic ZIKV infections of humans have been reported in Africa and Asia. For a long time, this virus was mostly unnoticed due to its mild symptoms and low fatality rates. However, during the 2015-2016 epidemic in Central and South America, when millions of people were infected, it was discovered that ZIKV causes microcephaly in the babies of mothers infected during pregnancy. An examination of the M and C proteins of the ZIKV shell using the disorder predictor PONDR VLXT revealed that the M protein contains relatively high disorder levels comparable only to those of the yellow fever virus (YFV). On the other hand, the disorder levels in the C protein are relatively low, which can account for the low case fatality rate (CFR) of this virus in contrast to the more virulent YFV, which is characterized by high disorder in its C protein. A larger variation was found in the percentage of intrinsic disorder (PID) in the C protein of various ZIKV strains. Strains of African lineage are characterized by higher PIDs. Using both in vivo and in vitro experiments, laboratories have also previously shown that strains of African origin have a greater potential to inflict higher fetal morbidity than do strains of Asian lineage, with dengue-2 virus (DENV-2) having the least potential. Strong correlations were found between the potential to inflict fetal morbidity and shell disorder in ZIKV (r(2) = 0.9) and DENV-2 (DENV-2 + ZIKV, r(2) = 0.8). A strong correlation between CFR and PID was also observed when ZIKV was included in an analysis of sets of shell proteins from a variety of flaviviruses (r(2) = 0.8). These observations have potential implications for antiviral vaccine development and for the design of cancer therapeutics in terms of developing therapeutic viruses that penetrate hard-to-reach organs.
C1 [Goh, Gerard Kian-Meng] Gohs BioComp, Singapore 548957, Singapore.
   [Dunker, A. Keith] Indiana Univ Sch Med, Ctr Computat Biol Indiana & Bioinformat, Indianapolis, IN 46202 USA.
   [Foster, James A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.
   [Foster, James A.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA.
   [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA.
   [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia.
RP Goh, GKM (corresponding author), Gohs BioComp, Singapore 548957, Singapore.
EM gohsbiocomputing@yahoo.com; kedunker@iupui.edu; foster@uidaho.edu;
   vuversky@health.usf.edu
RI Goh, Gerard/AAM-5152-2020; Uversky, Vladimir N./F-4515-2011
OI Goh, Gerard/0000-0003-3635-0806; Uversky, Vladimir
   N./0000-0002-4037-5857
FU NSFNational Science Foundation (NSF) [DBI0939454]; BEACON Center for
   Evolution in Action
FX J.A.F. was funded in part by NSF DBI0939454 and the BEACON Center for
   Evolution in Action.
CR Acheson N., 2007, FUNDAMENTALS MOL VIR
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bhuvanakantham R, 2013, CELL MICROBIOL, V15, P1688, DOI 10.1111/cmi.12143
   Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108
   Chaurasiya S, 2018, CANCERS, V10, DOI 10.3390/cancers10040124
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273
   Chernajovsky Y, 2006, BRIT MED J, V332, P170, DOI 10.1136/bmj.332.7534.170
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Diaz-Quijano FA, 2012, AM J TROP MED HYG, V86, P328, DOI 10.4269/ajtmh.2012.11-0074
   Dolan PT, 2015, PROTEIN SCI, V24, P221, DOI 10.1002/pro.2608
   Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g
   Fonseca AA, 2010, ARCH VIROL, V155, P1687, DOI 10.1007/s00705-010-0747-4
   Garner E, 1999, GENOME INFORM SER WO, V10, P41
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Goh G.K., 2019, SCON SUMM VACC HIVAI
   Goh G.K., 2017, VIRAL SHAPESHIFTERS
   Goh G.K.-M., 2013, PLOS CURR, V5, DOI [DOI 10.1371/CURRENTS.OUTBREAKS.22254B58675CDEBC256DBE3C5AA6498B, 10.1371/currents.outbreaks.22254b58675cdebc256dbe3c5aa6498b]
   Goh GKM, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9050178
   Goh GKM, 2016, MOL BIOSYST, V12, P1881, DOI 10.1039/c6mb00228e
   Goh GKM, 2012, J PATHOG, V2012, DOI 10.1155/2012/738590
   Goh GKM, 2015, MOL BIOSYST, V11, P2337, DOI 10.1039/c5mb00240k
   Goh GKM, 2015, MOL BIOSYST, V11, P2312, DOI 10.1039/c5mb00277j
   Goh GKM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-126
   Goh GKM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-69
   Goh GKM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S4
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Goudsmit J., 1997, VIRAL SEX NATURE AID
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Hafiz MY, 2016, INFECT DRUG RESIST, V9, DOI 10.2147/IDR.S108057
   Halstead SB, 2012, MOLECULAR VIROLOGY AND CONTROL OF FLAVIVIRUSES, P185
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   McKenna JP, 2008, INSIGHT, V50, P70, DOI 10.1784/insi.2008.50.2.70
   Meng FC, 2015, FEBS J, V282, P3368, DOI 10.1111/febs.13349
   Mickiene A, 2005, PROGRESS IN ENCEPHALITIS RESEARCH, P1
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e
   Pena LJ, 2018, J GEN VIROL, V99, P1529, DOI 10.1099/jgv.0.001153
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   R Core Team, 2019, R LANG ENV STAT COMP
   Redwan EM, 2019, CELL MOL LIFE SCI, V76, P577, DOI 10.1007/s00018-018-2968-8
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3
   Romero P, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P90, DOI 10.1109/ICNN.1997.611643
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Singh A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23969-0
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388
   Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7
   Wei D, 2018, HUM GENE THER, V29, P151, DOI 10.1089/hum.2017.212
   Whelan JN, 2016, MOL BIOSYST, V12, P1507, DOI 10.1039/c6mb00122j
   Winkler CW, 2018, IMMUNOLOGY, V153, P443, DOI 10.1111/imm.12883
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Xue B, 2014, CHEM REV, V114, P6880, DOI 10.1021/cr4005692
   Xue B, 2014, CURR PHARM DESIGN, V20, P1274, DOI 10.2174/13816128113199990072
   Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145
   Xue B, 2012, CELL MOL LIFE SCI, V69, P1211, DOI 10.1007/s00018-011-0859-3
   Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984
   Zhang ZY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01127
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 70
TC 4
Z9 4
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD NOV
PY 2019
VL 9
IS 11
AR 710
DI 10.3390/biom9110710
PG 18
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JV3LN
UT WOS:000502267900071
PM 31698857
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU El Moustaid, F
   Johnson, LR
AF El Moustaid, Fadoua
   Johnson, Leah R.
TI Modeling Temperature Effects on Population Density of the Dengue
   Mosquito Aedes aegypti
SO INSECTS
LA English
DT Article
DE mathematical modeling; mosquito density; temperature; dengue;
   mosquito-borne disease
ID VECTOR-BORNE DISEASES; DYNAMICS; DIPTERA; TRANSMISSION
AB Mosquito density plays an important role in the spread of mosquito-borne diseases such as dengue and Zika. While it remains very challenging to estimate the density of mosquitoes, modelers have tried different methods to represent it in mathematical models. The goal of this paper is to investigate the various ways mosquito density has been quantified, as well as to propose a dynamical system model that includes the details of mosquito life stages leading to the adult population. We first discuss the mosquito traits involved in determining mosquito density, focusing on those that are temperature dependent. We evaluate different forms of models for mosquito densities based on these traits and explore their dynamics as temperature varies. Finally, we compare the predictions of the models to observations of Aedes aegypti abundances over time in Vitoria, Brazil. Our results indicate that the four models exhibit qualitatively and quantitatively different behaviors when forced by temperature, but that all seem reasonably consistent with observed abundance data.
C1 [El Moustaid, Fadoua; Johnson, Leah R.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24060 USA.
   [El Moustaid, Fadoua; Johnson, Leah R.] Virginia Polytech Inst & State Univ, Global Change Ctr, Blacksburg, VA 24060 USA.
   [Johnson, Leah R.] Virginia Polytech Inst & State Univ, Dept Stat, Blacksburg, VA 24060 USA.
RP El Moustaid, F (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24060 USA.; El Moustaid, F (corresponding author), Virginia Polytech Inst & State Univ, Global Change Ctr, Blacksburg, VA 24060 USA.
EM fadoua@vt.edu; lrjohn@vt.edu
FU National Science Foundation Career grant (NSF DMSDEB)National Science
   Foundation (NSF) [1750113]
FX L.R.J. and F.E.M. were supported by a National Science Foundation Career
   grant (NSF DMSDEB #1750113).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   ANDERSON R M, 1991
   Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9
   Bacaer N, 2006, J MATH BIOL, V53, P421, DOI 10.1007/s00285-006-0015-0
   Brand SPC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004837
   CDC, CDC REP COMP DENG VE
   Dengue Virus Net, AED AEG AED ALB
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Johnson LR, 2015, ECOLOGY, V96, P203, DOI 10.1890/13-1964.1
   Keeling M. J., 2011, MODELING INFECT DIS
   Koyoc-Cardena E, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3503-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lana RM, 2014, ACTA TROP, V129, P25, DOI 10.1016/j.actatropica.2013.07.025
   Lana RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190673
   Lana RM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006070
   Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301
   Liu-Helmersson J, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00148
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Robert MA, 2019, EPIDEMICS-NETH, V28, DOI 10.1016/j.epidem.2019.05.003
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Ryan SJ, 2015, VECTOR-BORNE ZOONOT, V15, P718, DOI 10.1089/vbz.2015.1822
   Scott TW, 2010, CURR TOP MICROBIOL, V338, P115, DOI 10.1007/978-3-642-02215-9_9
   Shaukat M.A., 2019, AM J CLIN NEUROL NEU, V4, P21
   Shocket MS, 2018, ELIFE, V7, DOI 10.7554/eLife.37762
   Taylor RA, 2019, J APPL ECOL, V56, P2057, DOI 10.1111/1365-2664.13455
   Taylor RA, 2016, PEERJ, V4, DOI 10.7717/peerj.2642
   The American Mosquito Control Association, AM MOSQ CONTR ASS RE
   Walsh RK, 2013, AM J TROP MED HYG, V89, P68, DOI 10.4269/ajtmh.12-0378
NR 34
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4450
J9 INSECTS
JI Insects
PD NOV
PY 2019
VL 10
IS 11
AR 393
DI 10.3390/insects10110393
PG 20
WC Entomology
SC Entomology
GA JU6RO
UT WOS:000501801800020
PM 31703421
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stern, M
   Cohen, M
   Danielli, A
AF Stern, Moshe
   Cohen, Meir
   Danielli, Amos
TI Configuration and Design of Electromagnets for Rapid and Precise
   Manipulation of Magnetic Beads in Biosensing Applications
SO MICROMACHINES
LA English
DT Article
DE magnetic tweezers; magnetic beads; biosensing; pole tip; Zika virus
ID TWEEZERS
AB Rapid and precise manipulation of magnetic beads on the nano and micro scales is essential in many biosensing applications, such as separating target molecules from background molecules and detecting specific proteins and DNA sequences in plasma. Accurately moving magnetic beads back and forth requires at least two adjustable magnetic field gradients. Unlike permanent magnets, electromagnets are easy to design and can produce strong and adjustable magnetic field gradients without mechanical motion, making them desirable for use in robust and safe medical devices. However, using multiple magnetic field sources to manipulate magnetic beads presents several challenges, including overlapping magnetic fields, added bulk, increased cost, and reduced durability. Here, we provide a thorough analysis, including analytical calculations, numerical simulations, and experimental measurements, of using two electromagnets to manipulate magnetic beads inside a miniature glass cell. We analyze and experimentally demonstrate different aspects of the electromagnets' design, such as their mutual influence, the advantages and disadvantages of different pole tip geometries, and the correlation between the electromagnets' positions and the beads' aggregation during movement. Finally, we have devised a protocol to maximize the magnetic forces acting on magnetic beads in a two-electromagnet setup while minimizing the electromagnets' size. We used two such electromagnets in a small footprint magnetic modulation biosensing system and detected as little as 13 ng/L of recombinant Zika virus antibodies, which enables detection of Zika IgM antibodies as early as 5 days and as late as 180 days post symptoms onset, significantly extending the number of days that the antibodies are detectable.
C1 [Stern, Moshe; Cohen, Meir; Danielli, Amos] Bar Ilan Univ, Fac Engn, IL-5290002 Ramat Gan, Israel.
RP Danielli, A (corresponding author), Bar Ilan Univ, Fac Engn, IL-5290002 Ramat Gan, Israel.
EM moshikst1@gmail.com; meircohen486@gmail.com; amos.danielli@biu.ac.il
FU Israel Science Foundation (ISF)Israel Science Foundation [2152/15,
   1142/15]
FX This work was supported by the Israel Science Foundation (ISF), grants
   2152/15 and 1142/15.
CR Alon N, 2015, LAB CHIP, V15, P2030, DOI 10.1039/c5lc00035a
   Anker JN, 2005, J MAGN MAGN MATER, V293, P655, DOI 10.1016/j.jmmm.2005.01.031
   Anker JN, 2003, APPL PHYS LETT, V82, P1102, DOI 10.1063/1.1544435
   Bijamov A, 2010, J APPL PHYS, V108, DOI 10.1063/1.3510481
   Chen L, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4916255
   Choi JW, 2000, SENSOR ACTUAT B-CHEM, V68, P34, DOI 10.1016/S0925-4005(00)00458-5
   Chung YC, 2016, J MAGN MAGN MATER, V407, P209, DOI 10.1016/j.jmmm.2016.01.075
   Danielli A, 2008, OPT EXPRESS, V16, P19253, DOI 10.1364/OE.16.019253
   Danielli A, 2010, CURR PHARM BIOTECHNO, V11, P128, DOI 10.2174/138920110790725375
   Danielli A, 2009, BIOSENS BIOELECTRON, V25, P858, DOI 10.1016/j.bios.2009.08.047
   de Vries AHB, 2005, BIOPHYS J, V88, P2137, DOI 10.1529/biophysj.104.052035
   Fonnum G, 2005, J MAGN MAGN MATER, V293, P41, DOI 10.1016/j.jmmm.2005.01.041
   Gijs MAM, 2004, MICROFLUID NANOFLUID, V1, P22, DOI 10.1007/s10404-004-0010-y
   Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5
   Joung J, 2000, IEEE T MAGN, V36, P2012, DOI 10.1109/20.875300
   Koffi D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1043-2
   Kollmannsberger P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804771
   Martel S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713229
   Michelson Y, 2019, J INFECT DIS, V219, P1035, DOI 10.1093/infdis/jiy606
   Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218
   Perraut R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-410
   Peyman SA, 2009, LAB CHIP, V9, P3110, DOI 10.1039/b904724g
   Ramadan Q, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2149150
   Ruffert C, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7020021
   Shevkoplyas SS, 2007, LAB CHIP, V7, P1294, DOI 10.1039/b705045c
   Tanase M, 2007, METHOD CELL BIOL, V83, P473, DOI 10.1016/S0091-679X(07)83020-2
   Verbarg J, 2017, SENSOR ACTUAT B-CHEM, V241, P614, DOI 10.1016/j.snb.2016.10.089
   Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905
NR 28
TC 0
Z9 0
U1 7
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-666X
J9 MICROMACHINES-BASEL
JI Micromachines
PD NOV
PY 2019
VL 10
IS 11
AR 784
DI 10.3390/mi10110784
PG 15
WC Nanoscience & Nanotechnology; Instruments & Instrumentation
SC Science & Technology - Other Topics; Instruments & Instrumentation
GA JV3GS
UT WOS:000502255300070
PM 31731737
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cui, YJ
   Grant, DG
   Lin, JY
   Yu, XD
   Franz, AWE
AF Cui, Yingjun
   Grant, DeAna G.
   Lin, Jingyi
   Yu, Xiudao
   Franz, Alexander W. E.
TI Zika Virus Dissemination from the Midgut of Aedes aegypti is Facilitated
   by Bloodmeal-Mediated Structural Modification of the Midgut Basal Lamina
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; dengue 4 virus; mosquito; midgut; dissemination; basal
   lamina; nanoparticles; consecutive bloodmeals; electron microscopy;
   immunofluorescence assay
ID FUNCTIONAL-MORPHOLOGY; ENCEPHALITIS-VIRUS; HEMORRHAGIC FEVERS; DENGUE
   VIRUS; MOSQUITO; REPLICATION; INFECTION; ORGANIZATION; PHILIPPINES;
   MATURATION
AB The arboviral disease cycle requires that key tissues in the arthropod vector become persistently infected with the virus. The midgut is the first organ in the mosquito that needs to be productively infected with an orally acquired virus. Following midgut infection, the virus then disseminates to secondary tissues including the salivary glands. Once these are productively infected, the mosquito is able to transmit the virus to a vertebrate host. Recently, we described the midgut dissemination pattern for chikungunya virus in Aedes aegypti. Here we assess the dissemination pattern in the same mosquito species for Zika virus (ZIKV), a human pathogenic virus belonging to the Flaviviridae. ZIKV infection of secondary tissues, indicative of dissemination from the midgut, was not observed before 72 h post infectious bloodmeal (pibm). Virion accumulation at the midgut basal lamina (BL) was only sporadic, although at 96-120 h pibm, virions were frequently observed between strands of the BL indicative of their dissemination. Our data suggest that ZIKV dissemination from the mosquito midgut occurs after digestion of the bloodmeal. Using gold-nanoparticles of 5 nm and 50 nm size, we show that meal ingestion leads to severe midgut tissue distention, causing the mesh width of the BL to remain enlarged after complete digestion of the meal. This could explain how ZIKV can exit the midgut via the BL after bloodmeal digestion. Ingestion of a subsequent, non-infectious bloodmeal five days after acquisition of an initial, dengue 4 virus containing bloodmeal resulted in an increased number of virions present in the midgut epithelium adjacent to the BL. Thus, subsequent bloodmeal ingestion by an infected mosquito may primarily stimulate de novo synthesis of virions leading to increased viral titers in the vector.
C1 [Cui, Yingjun; Lin, Jingyi; Yu, Xiudao; Franz, Alexander W. E.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Grant, DeAna G.] Univ Missouri, Electron Microscopy Core Facil, Columbia, MO 65211 USA.
RP Franz, AWE (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
EM cuiyingj@missouri.edu; GrantDe@missouri.edu; LinJin@missouri.edu;
   yuxiadao@163.com; franza@missouri.edu
OI Cui, Yingjun/0000-0002-7416-0934
FU National Institutes of Health - National Institute of Allergy and
   Infectious Diseases (NIH-NIAID)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [1R01AI134661]
FX This research was funded by National Institutes of Health - National
   Institute of Allergy and Infectious Diseases (NIH-NIAID) grant
   1R01AI134661.
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Dong SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24729
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Girard YA, 2005, J MED ENTOMOL, V42, P429, DOI 10.1603/0022-2585(2005)042[0429:USOWNV]2.0.CO;2
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   HAMMON WM, 1960, T ASSOC AM PHYSICIAN, V73, P140
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Hernandez R, 2014, ADV VIROL, V2014, DOI 10.1155/2014/259382
   HOUK EJ, 1981, ACTA TROP, V38, P163
   Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89
   Jose J, 2017, MBIO, V8, DOI [10.1128/mBio.02294-16, 10.1128/mbio.02294-16]
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kantor AM, 2017, INSECT MOL BIOL, V26, P113, DOI 10.1111/imb.12275
   Kantor AM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100571
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NATORI Y, 1992, AM J PHYSIOL, V262, pF131
   Okuda K, 2002, TISSUE CELL, V34, P210, DOI 10.1016/S0040-8166(02)00032-0
   Plevka P, 2014, J STRUCT BIOL, V185, P27, DOI 10.1016/j.jsb.2013.11.001
   REINHARDT C, 1973, Acta Tropica, V30, P213
   RUDIN W, 1979, CELL TISSUE RES, V200, P193, DOI 10.1007/BF00236412
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas Irma, 2018, PLoS Negl Trop Dis, V12, pe0006754, DOI 10.1371/journal.pntd.0006754
   SCOTT TW, 1984, AM J TROP MED HYG, V33, P300, DOI 10.4269/ajtmh.1984.33.300
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wendell MD, 2000, INSECT MOL BIOL, V9, P119, DOI 10.1046/j.1365-2583.2000.00166.x
   WHITFIELD SG, 1973, VIROLOGY, V56, P70, DOI 10.1016/0042-6822(73)90288-2
   YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 46
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1056
DI 10.3390/v11111056
PG 18
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300084
PM 31739432
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gao, YN
   Tai, WB
   Wang, N
   Li, X
   Jiang, SB
   Debnath, AK
   Du, LY
   Chen, SZ
AF Gao, Yaning
   Tai, Wanbo
   Wang, Ning
   Li, Xiang
   Jiang, Shibo
   Debnath, Asim K.
   Du, Lanying
   Chen, Shizhong
TI Identification of Novel Natural Products as Effective and Broad-Spectrum
   Anti-Zika Virus Inhibitors
SO VIRUSES-BASEL
LA English
DT Article
DE flaviviruses; Zika virus; natural products; antiviral inhibitors;
   broad-spectrum activity; combinatorial effect
ID ENTRY INHIBITORS; INFECTION; GOSSYPOL; CELLS; DRUG; CHOLESTEROL;
   ANTIBODIES; CURCUMIN; RELEASE; DESIGN
AB Zika virus (ZIKV) infection during pregnancy leads to severe congenital Zika syndrome, which includes microcephaly and other neurological malformations. No therapeutic agents have, so far, been approved for the treatment of ZIKV infection in humans; as such, there is a need for a continuous effort to develop effective and safe antiviral drugs to treat ZIKV-caused diseases. After screening a natural product library, we have herein identified four natural products with anti-ZIKV activity in Vero E6 cells, including gossypol, curcumin, digitonin, and conessine. Except for curcumin, the other three natural products have not been reported before to have anti-ZIKV activity. Among them, gossypol exhibited the strongest inhibitory activity against almost all 10 ZIKV strains tested, including six recent epidemic human strains. The mechanistic study indicated that gossypol could neutralize ZIKV infection by targeting the envelope protein domain III (EDIII) of ZIKV. In contrast, the other natural products inhibited ZIKV infection by targeting the host cell or cell-associated entry and replication stages of ZIKV. A combination of gossypol with any of the three natural products identified in this study, as well as with bortezomib, a previously reported anti-ZIKV compound, exhibited significant combinatorial inhibitory effects against three ZIKV human strains tested. Importantly, gossypol also demonstrated marked potency against all four serotypes of dengue virus (DENV) human strains in vitro. Taken together, this study indicates the potential for further development of these natural products, particularly gossypol, as the lead compound or broad-spectrum inhibitors against ZIKV and other flaviviruses, such as DENV.
C1 [Gao, Yaning; Li, Xiang; Chen, Shizhong] Peking Univ, Sch Pharmaceut Sci, Dept Nat Med, Beijing 100191, Peoples R China.
   [Gao, Yaning; Tai, Wanbo; Wang, Ning; Jiang, Shibo; Debnath, Asim K.; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
   [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China.
RP Chen, SZ (corresponding author), Peking Univ, Sch Pharmaceut Sci, Dept Nat Med, Beijing 100191, Peoples R China.; Debnath, AK; Du, LY (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
EM gyn9225@bjmu.edu.cn; wtai@nybc.org; NWang@nybc.org;
   lixiang2013@bjmu.edu.cn; sjiang@nybc.org; adebnath@nybc.org;
   ldu@nybc.org; chenshizhong@bjmu.edu.cn
RI Tai, Wanbo/G-3838-2018
OI Tai, Wanbo/0000-0002-9864-8993
FU New York Blood Center [NYB616, NYB540]
FX This study was supported by the intramural funds of the New York Blood
   Center (NYB616 and NYB540). ZIKV strains (PAN2016, PAN2015, R116265,
   FLR, R103451, PRVABC59, PLCal_ZV, IbH 30656, MEX 2-81, and MR 766), as
   well as the DENV strains (DENV-1-V1792, DENV-2-V594, DENV-3-V1043, and
   DENV-4-PR 06-65-740), were obtained from BEI Resources.
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Agrelli A, 2019, INFECT GENET EVOL, V69, P22, DOI 10.1016/j.meegid.2019.01.018
   AOKIUTSUBO C, 2018, BIO PROTOCOL, V8, DOI DOI 10.21769/BioProtoc.2830
   BANERJEE P, 1995, CHEM PHYS LIPIDS, V77, P65, DOI 10.1016/0009-3084(95)02455-R
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basu A, 2011, J VIROL, V85, P3106, DOI 10.1128/JVI.01456-10
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16130-w
   Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodou K, 2005, EXPERT OPIN INV DRUG, V14, P1419, DOI 10.1517/13543784.14.11.1419
   DORSETT PH, 1975, J PHARM SCI, V64, P1073, DOI 10.1002/jps.2600640654
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Dua VK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-194
   ESPARISOGANDO A, 1994, AM J PHYSIOL, V267, pC166
   Goriunova L V, 1969, Farmakol Toksikol, V32, P615
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Harder T, 1997, MOL BIOL CELL, V8, P533
   HE L, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/v11020166
   Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004
   Keukens EAJ, 1996, BBA-BIOMEMBRANES, V1279, P243, DOI 10.1016/0005-2736(95)00253-7
   Kovacic P, 2003, CURR MED CHEM, V10, P2711, DOI 10.2174/0929867033456369
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lian WL, 2018, ACS INFECT DIS, V4, P1395, DOI 10.1021/acsinfecdis.8b00127
   LIN TS, 1989, ANTIMICROB AGENTS CH, V33, P2149, DOI 10.1128/AAC.33.12.2149
   Lu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-104
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Merin NM, 2015, PHARMACEUTICALS, V8, P1, DOI 10.3390/ph8010001
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Padilla L, 2014, ARCH VIROL, V159, P573, DOI 10.1007/s00705-013-1849-6
   Qi QQ, 2017, J INFECTION, V75, P68, DOI 10.1016/j.jinf.2017.03.006
   Rayichandran S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09914-3
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   ROYER RE, 1995, J MED CHEM, V38, P2427, DOI 10.1021/jm00013a018
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Si LL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau8408
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tai WB, 2019, J VIROL, V93, DOI 10.1128/JVI.02187-18
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Wang C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010031
   XIE MS, 1995, BIOCHEM J, V305, P529, DOI 10.1042/bj3050529
   Yu MR, 2014, J MED CHEM, V57, P10058, DOI 10.1021/jm5014067
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zbidah M, 2012, TOXICOLOGY, V302, P101, DOI 10.1016/j.tox.2012.09.010
   Zhao GY, 2018, J VIROL, V92, DOI 10.1128/JVI.00837-18
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 59
TC 0
Z9 0
U1 5
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1019
DI 10.3390/v11111019
PG 18
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300047
PM 31684080
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hanley, KA
   Azar, SR
   Campos, RK
   Vasilakis, N
   Rossi, SL
AF Hanley, Kathryn A.
   Azar, Sasha R.
   Campos, Rafael K.
   Vasilakis, Nikos
   Rossi, Shannan L.
TI Support for the Transmission-Clearance Trade-Off Hypothesis from a Study
   of Zika Virus Delivered by Mosquito Bite to Mice
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; Aedes albopictus; evolution of virulence;
   transmission-clearance trade-off; within-host dynamics; flavivirus;
   arbovirus; A129 mice
ID VIRULENCE EVOLUTION; AEDES-ALBOPICTUS; MODEL; PATHOGENESIS; COMPETENCE;
   INFECTION; DYNAMICS; AEGYPTI; MALARIA; HOST
AB Evolutionary theory indicates that virus virulence is shaped by a trade-off between instantaneous rate of transmission and duration of infection. For most viruses, infection is curtailed by immune clearance, but there are few empirical tests of the transmission-clearance trade-off hypothesis. We exposed A129 mice to bites from groups of 1, 2-4, or 6-9 Aedes albopictus mosquitoes infected with Zika virus (ZIKV). We predicted that a higher number of infectious mosquito bites would deliver a higher total dose of the virus, and that increasing dose would result in earlier onset, higher magnitude, and shorter duration of viremia, as well as a more robust neutralizing antibody response. We found that increases in the number of mosquito bites delivered resulted in significantly different virus replication dynamics with higher, earlier peak titers. All mice experienced a transient weight loss following infection, but the nadir in weight loss was delayed in the mice that received the highest number of bites. Viremia persisted past the period of measurement in this study, so we did not capture its duration. However, the association at the level of the individual mouse between the estimated virus dose delivered and neutralizing antibody titer was remarkably strong, supporting the transmission-clearance trade-off hypothesis.
C1 [Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Azar, Sasha R.; Vasilakis, Nikos; Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Campos, Rafael K.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos; Rossi, Shannan L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Vasilakis, N; Rossi, SL (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.; Vasilakis, N; Rossi, SL (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM khanley@nmsu.edu; srazar@utmb.edu; rkkroonc@utmb.edu; nivasila@utmb.edu;
   slrossi@utmb.edu
RI Campos, Rafael Kroon/AAB-5135-2020
OI Campos, Rafael Kroon/0000-0002-4852-0449; Vasilakis,
   Nikos/0000-0002-0708-3289; Azar, Sasha/0000-0002-9182-216X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI147017, 1U01 AI115577]
FX This work was supported in part by NIH grants R21 AI147017 and 1U01
   AI115577. The funding agencies had no involvement in the writing of the
   report or in the decision to submit this article for publication.
CR Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x
   Alizon S, 2008, AM NAT, V172, pE113, DOI 10.1086/589892
   Althouse BM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0299
   Althouse BM, 2014, VIROLOGY, V452, P237, DOI 10.1016/j.virol.2014.01.015
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   AZAR SR, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/v10110661
   Ben-Shachar R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04595-w
   Bull JJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004387
   Chao L, 2000, Q REV BIOL, V75, P261, DOI 10.1086/393499
   Che-Mendoza A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006283
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Durbin AP, 2013, VIROLOGY, V439, P34, DOI 10.1016/j.virol.2013.01.018
   Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3
   Ewald PW, 2004, INFECT DIS CLIN N AM, V18, P1, DOI 10.1016/S0891-5520(03)00099-0
   Feng ZL, 2015, MATH BIOSCI, V270, P204, DOI 10.1016/j.mbs.2015.02.012
   Frank SA, 2008, J EVOLUTION BIOL, V21, P396, DOI 10.1111/j.1420-9101.2007.01480.x
   Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Nunes PCG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060326
   Hastings AK, 2019, J VIROL, V93, DOI 10.1128/JVI.00395-19
   Humplik J, 2014, J THEOR BIOL, V360, P149, DOI 10.1016/j.jtbi.2014.06.039
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Kamo M, 2007, J THEOR BIOL, V244, P588, DOI 10.1016/j.jtbi.2006.08.013
   LaRocque RL, 2016, ANN INTERN MED, V165, P589, DOI 10.7326/M16-1397
   Le Coupanec A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002237
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Long GH, 2011, EVOL APPL, V4, P278, DOI 10.1111/j.1752-4571.2010.00178.x
   Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Ng DHL, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3211-9
   Patel RV, 2016, PHARMACOTHERAPY, V36, P1272, DOI 10.1002/phar.1854
   Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704
   Serman TM, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100970
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Thangamani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012137
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
NR 45
TC 1
Z9 1
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1072
DI 10.3390/v11111072
PG 14
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300100
PM 31752097
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Imran, M
   Saleemi, MK
   Chen, Z
   Wang, XG
   Zhou, DY
   Li, YC
   Zhao, ZK
   Zheng, BH
   Li, QY
   Cao, SB
   Ye, J
AF Imran, Muhammad
   Saleemi, Muhammad Kashif
   Chen, Zheng
   Wang, Xugang
   Zhou, Dengyuan
   Li, Yunchuan
   Zhao, Zikai
   Zheng, Bohan
   Li, Qiuyan
   Cao, Shengbo
   Ye, Jing
TI Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That
   Acts against Flaviviruses through the Inhibition of Furin-Mediated prM
   Cleavage
SO VIRUSES-BASEL
LA English
DT Article
DE flavivirus; Zika virus; Japanese encephalitis virus; furin inhibitor;
   precursor membrane protein
ID PROPROTEIN CONVERTASE FURIN; POTENT INHIBITORS; VIRUS-REPLICATION;
   DENGUE VIRUS; PROTEIN; ACTIVATION; MATURATION; INFECTION; PATHWAY
AB Flaviviruses, such as Zika virus (ZIKV), Japanese encephalitis virus (JEV), Dengue virus (DENV), and West Nile virus (WNV), are important arthropod-borne pathogens that present an immense global health problem. Their unpredictable disease severity, unusual clinical features, and severe neurological manifestations underscore an urgent need for antiviral interventions. Furin, a host proprotein convertase, is a key contender in processing flavivirus prM protein to M protein, turning the inert virus to an infectious particle. For this reason, the current study was planned to evaluate the antiviral activity of decanoyl-Arg-Val-Lys-Arg-chloromethylketone, a specific furin inhibitor, against flaviviruses, including ZIKV and JEV. Analysis of viral proteins revealed a significant increase in the prM/E index of ZIKV or JEV in dec-RVKR-cmk-treated Vero cells compared to DMSO-treated control cells, indicating dec-RVKR-cmk inhibits prM cleavage. Plaque assay, qRT-PCR, and immunofluorescence assay revealed a strong antiviral activity of dec-RVKR-cmk against ZIKV and JEV in terms of the reduction in virus progeny titer and in viral RNA and protein production in both mammalian cells and mosquito cells. Time-of-drug addition assay revealed that the maximum reduction of virus titer was observed in post-infection treatment. Furthermore, our results showed that dec-RVKR-cmk exerts its inhibitory action on the virus release and next round infectivity but not on viral RNA replication. Taken together, our study highlights an interesting antiviral activity of dec-RVKR-cmk against flaviviruses.
C1 [Imran, Muhammad; Chen, Zheng; Wang, Xugang; Zhou, Dengyuan; Li, Yunchuan; Zhao, Zikai; Zheng, Bohan; Li, Qiuyan; Cao, Shengbo; Ye, Jing] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
   [Imran, Muhammad; Chen, Zheng; Wang, Xugang; Zhou, Dengyuan; Li, Yunchuan; Zhao, Zikai; Zheng, Bohan; Li, Qiuyan; Cao, Shengbo; Ye, Jing] Huazhong Agr Univ, Coll Vet Med, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China.
   [Imran, Muhammad; Chen, Zheng; Wang, Xugang; Zhou, Dengyuan; Li, Yunchuan; Zhao, Zikai; Zheng, Bohan; Li, Qiuyan; Cao, Shengbo; Ye, Jing] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Hubei, Peoples R China.
   [Imran, Muhammad; Saleemi, Muhammad Kashif] Univ Agr Faisalabad, Fac Vet Sci, Dept Pathol, Faisalabad 38040, Pakistan.
RP Cao, SB; Ye, J (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.; Cao, SB; Ye, J (corresponding author), Huazhong Agr Univ, Coll Vet Med, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Hubei, Peoples R China.; Cao, SB; Ye, J (corresponding author), Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Hubei, Peoples R China.
EM dr.mimran@uaf.edu.pk; drkashif313@gmail.com; chenzheng19860227@163.com;
   wangxugang@webmail.hzau.edu.cn; zhoudy6@webmail.hzau.edu.cn;
   liyunchuan@webmail.hzau.edu.cn; zikaizhao@hotmail.com;
   zhengbohan@webmail.hzau.edu.cn; lqylqy6@webmail.hzau.edu.cn;
   sbcao@mail.hzau.edu.cn; yej@mail.hzau.edu.cn
RI Saleemi, Muhammad Kashif/AAE-2461-2020
FU National Key Research and Development Program of China [2016YFD0500407];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31825025, 31572517, 31972721]; Fundamental Research
   Funds for the Central UniversitiesFundamental Research Funds for the
   Central Universities [2662018QD025]; Natural Science Foundation of Hubei
   ProvinceNatural Science Foundation of Hubei Province [2019CFA010]
FX This work was supported by National Key Research and Development Program
   of China (2016YFD0500407), National Natural Science Foundation of China
   (31825025, 31572517, 31972721), Fundamental Research Funds for the
   Central Universities (2662018QD025), and Natural Science Foundation of
   Hubei Province (2019CFA010).
CR Becker GL, 2012, J BIOL CHEM, V287, P21992, DOI 10.1074/jbc.M111.332643
   Becker GL, 2010, J MED CHEM, V53, P1067, DOI 10.1021/jm9012455
   Bolt G, 2000, VIRUS RES, V68, P25, DOI 10.1016/S0168-1702(00)00149-0
   Chen Z, 2016, J VIROL, V90, P3722, DOI 10.1128/JVI.03242-15
   Couture F, 2015, EXPERT OPIN THER PAT, V25, P379, DOI 10.1517/13543776.2014.1000303
   Couture Frederic, 2011, Biomol Concepts, V2, P421
   Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055
   Day PM, 2009, FUTURE MICROBIOL, V4, P1255, DOI 10.2217/FMB.09.86
   DECROLY E, 1994, J BIOL CHEM, V269, P12240
   Elshuber S, 2005, J VIROL, V79, P11813, DOI 10.1128/JVI.79.18.11813-11823.2005
   GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Kovanich D, 2019, J PROTEOME RES, V18, P3203, DOI 10.1021/acs.jproteome.9b00318
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8
   Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Pang YJ, 2013, LIVER INT, V33, P1230, DOI 10.1111/liv.12185
   Peng MH, 2017, ANTIVIR RES, V143, P176, DOI 10.1016/j.antiviral.2017.03.026
   Presser LD, 2011, VIROLOGY, V412, P284, DOI 10.1016/j.virol.2010.12.051
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200
   Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934
   Tong YP, 2010, J VIROL, V84, P4569, DOI 10.1128/JVI.02281-09
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yoshii K, 2012, J GEN VIROL, V93, P27, DOI 10.1099/vir.0.035964-0
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
NR 34
TC 2
Z9 2
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1011
DI 10.3390/v11111011
PG 15
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300039
PM 31683742
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu, DD
   Tedbury, PR
   Lan, SY
   Huber, AD
   Puray-Chavez, MN
   Ji, J
   Michailidis, E
   Saeed, M
   Ndongwe, TP
   Bassit, LC
   Schinazi, RF
   Ralston, R
   Rice, CM
   Sarafianos, SG
AF Liu, Dandan
   Tedbury, Philip R.
   Lan, Shuiyun
   Huber, Andrew D.
   Puray-Chavez, Maritza N.
   Ji, Juan
   Michailidis, Eleftherios
   Saeed, Mohsan
   Ndongwe, Tanyaradzwa P.
   Bassit, Leda C.
   Schinazi, Raymond F.
   Ralston, Robert
   Rice, Charles M.
   Sarafianos, Stefan G.
TI Visualization of Positive and Negative Sense Viral RNA for Probing the
   Mechanism of Direct-Acting Antivirals against Hepatitis C Virus
SO VIRUSES-BASEL
LA English
DT Article
DE hepatitis C virus; Zika virus; positive-sense; negative-sense; direct
   acting antivirals; RNA FISH
ID IN-SITU HYBRIDIZATION; NS5A INHIBITOR; PERIPHERAL-BLOOD; DENGUE VIRUS;
   REPLICATION; INTERFERON; INFECTION; CELLS; DACLATASVIR; POTENT
AB RNA viruses are highly successful pathogens and are the causative agents for many important diseases. To fully understand the replication of these viruses it is necessary to address the roles of both positive-strand RNA ((+)RNA) and negative-strand RNA ((-)RNA), and their interplay with viral and host proteins. Here we used branched DNA (bDNA) fluorescence in situ hybridization (FISH) to stain both the abundant (+)RNA and the far less abundant (-)RNA in both hepatitis C virus (HCV)- and Zika virus-infected cells, and combined these analyses with visualization of viral proteins through confocal imaging. We were able to phenotypically examine HCV-infected cells in the presence of uninfected cells and revealed the effect of direct-acting antivirals on HCV (+)RNA, (-)RNA, and protein, within hours of commencing treatment. Herein, we demonstrate that bDNA FISH is a powerful tool for the study of RNA viruses that can provide insights into drug efficacy and mechanism of action.
C1 [Liu, Dandan; Tedbury, Philip R.; Huber, Andrew D.; Puray-Chavez, Maritza N.; Ji, Juan; Ndongwe, Tanyaradzwa P.; Ralston, Robert; Sarafianos, Stefan G.] Univ Missouri, CS Bond Life Sci Ctr, Columbia, MO 65201 USA.
   [Liu, Dandan; Tedbury, Philip R.; Puray-Chavez, Maritza N.; Ndongwe, Tanyaradzwa P.; Ralston, Robert; Sarafianos, Stefan G.] Univ Missouri, Dept Mol Microbiol & Immunol, Sch Med, Columbia, MO 65212 USA.
   [Tedbury, Philip R.; Lan, Shuiyun; Bassit, Leda C.; Schinazi, Raymond F.; Sarafianos, Stefan G.] Emory Univ, Ctr AIDS Res, Dept Pediat, Lab Biochem Pharmacol,Sch Med, Atlanta, GA 30322 USA.
   [Huber, Andrew D.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Michailidis, Eleftherios; Saeed, Mohsan; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Sarafianos, Stefan G.] Univ Missouri, Dept Biochem, Columbia, MO 65201 USA.
RP Sarafianos, SG (corresponding author), Univ Missouri, CS Bond Life Sci Ctr, Columbia, MO 65201 USA.; Sarafianos, SG (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, Sch Med, Columbia, MO 65212 USA.; Sarafianos, SG (corresponding author), Emory Univ, Ctr AIDS Res, Dept Pediat, Lab Biochem Pharmacol,Sch Med, Atlanta, GA 30322 USA.; Sarafianos, SG (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65201 USA.
EM Dandan.liu2@pfizer.com; philip.tedbury@emory.edu; shuiyun.lan@emory.edu;
   Andrew.Huber@STJUDE.ORG; mpuraychavez@wustl.edu; JiJ@missouri.edu;
   emichailid@mail.rockefeller.edu; msaeed1@bu.edu;
   Tanya.ndongwe@outlook.com; lbassit@emory.edu; rschina@emory.edu;
   Robert.ralston@gmail.com; ricec@rockefeller.edu; ssarafi@emory.edu
OI Tedbury, Philip/0000-0001-8151-4967; Huber, Andrew/0000-0002-3790-8368;
   Michailidis, Eleftherios/0000-0002-9907-4346
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI121315, AI120860, GM103368,
   AI099284]; Emory University Center for AIDS Research [2P30-AI-050409]
FX This work was supported by the NIH (AI121315, AI120860, and GM103368 to
   S.G.S., AI099284 to C.M.R. and by the Emory University Center for AIDS
   Research 2P30-AI-050409 to R.F.S.).
CR ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J
   Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657
   Baxter AE, 2016, CELL HOST MICROBE, V20, P368, DOI 10.1016/j.chom.2016.07.015
   Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019
   Bishop JA, 2012, AM J SURG PATHOL, V36, P1874, DOI 10.1097/PAS.0b013e318265fb2b
   Carossino M, 2016, ARCH VIROL, V161, P3125, DOI 10.1007/s00705-016-3014-5
   Chang SY, 2015, HUM PATHOL, V46, P1592, DOI 10.1016/j.humpath.2015.07.012
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036
   CLEAVES GR, 1981, VIROLOGY, V111, P73, DOI 10.1016/0042-6822(81)90654-1
   Deleage Claire, 2016, Pathog Immun, V1, P68
   DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Forestier N, 2011, J HEPATOL, V54, P1130, DOI 10.1016/j.jhep.2010.11.001
   Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960
   GOMATOS PJ, 1963, P NATL ACAD SCI USA, V49, P707, DOI 10.1073/pnas.49.5.707
   Grau-Exposito J, 2017, MBIO, V8, DOI [10.1128/mBio.00876-17, 10.1128/mbio.00876-17]
   Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110
   Hamborsky J., 2015, EPIDEMIOLOGY PREVENT
   Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456
   Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kim A., 2016, ANN INTERNAL MED, V165, pITC33
   Klepper A, 2017, HEPATOLOGY, V66, P357, DOI 10.1002/hep.28846
   Komurian-Pradel F, 2004, J VIROL METHODS, V116, P103, DOI 10.1016/j.jviromet.2003.10.004
   Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029
   Leveque N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004825
   Lim SM, 2013, J VIROL METHODS, V194, P146, DOI 10.1016/j.jviromet.2013.07.050
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Liu DD, 2015, ANTIMICROB AGENTS CH, V59, P3482, DOI 10.1128/AAC.00223-15
   Mahmood Radma, 2008, V461, P675, DOI 10.1007/978-1-60327-483-8_45
   Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226
   Martrus G, 2016, J VIROL, V90, P9018, DOI 10.1128/JVI.01448-16
   Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550
   McGivern DR, 2014, GASTROENTEROLOGY, V147, P453, DOI 10.1053/j.gastro.2014.04.021
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   NOVAK JE, 1991, J VIROL, V65, P3384, DOI 10.1128/JVI.65.6.3384-3387.1991
   Osada N, 2014, DNA RES, V21, P673, DOI 10.1093/dnares/dsu029
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002
   Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507
   Porichis F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6641
   Puray-Chavez M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01693-z
   Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005
   Ramanan V, 2016, VIROLOGY, V494, P236, DOI 10.1016/j.virol.2016.04.020
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08
   STEGER G, 1980, BIOCHIM BIOPHYS ACTA, V606, P274, DOI 10.1016/0005-2787(80)90037-4
   Ukpo OC, 2011, AM J SURG PATHOL, V35, P1343, DOI 10.1097/PAS.0b013e318220e59d
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Wang HW, 2014, JOVE-J VIS EXP, DOI 10.3791/51426
   Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770
   Yang G, 2004, J VIROL, V78, P10202, DOI 10.1128/JVI.78.18.10202-10205.2004
   Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102
   Zhou XJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-273
NR 61
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1039
DI 10.3390/v11111039
PG 17
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300067
PM 31717338
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lu, CY
   Lin, CS
   Lai, HC
   Yu, YW
   Liao, CY
   Su, WC
   Ko, BH
   Chang, YS
   Huang, SH
   Lin, CW
AF Lu, Chien-Yi
   Lin, Chen-Sheng
   Lai, Hsueh-Chou
   Yu, Ya-Wen
   Liao, Chih-Yi
   Su, Wen-Chi
   Ko, Bo-Han
   Chang, Young-Sheng
   Huang, Su-Hua
   Lin, Cheng-Wen
TI The Rescue and Characterization of Recombinant, Microcephaly-Associated
   Zika Viruses as Single-Round Infectious Particles
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; single-round infectious particle; replicon; reporter; cell
   susceptibility
ID EXPRESSION; PROTEIN
AB Zika virus (ZIKV) is transmitted by Aedes mosquitoes and exhibits genetic variation with African and Asian lineages. ZIKV Natal RGN strain, an Asian-lineage virus, has been identified in brain tissues from fetal autopsy cases with microcephaly and is suggested to be a neurotropic variant. However, ZIKV Natal RGN strain has not been isolated; its biological features are not yet illustrated. This study rescued and characterized recombinant, single-round infectious particles (SRIPs) of the ZIKV Natal RGN strain using reverse genetic and synthetic biology techniques. The DNA-launched replicon of ZIKV Natal RGN was constructed and contains the EGFP reporter, lacks prM-E genes, and replicates under CMV promoter control. The peak in the ZIKV Natal RGN SRIP titer reached 6.25 x 10(6) TCID50/mL in the supernatant of prM-E-expressing packaging cells 72 h post-transfection with a ZIKV Natal RGN replicon. The infectivity of ZIKV Natal RGN SRIPs has been demonstrated to correlate with the green florescence intensity of the EGFP reporter, the SRIP-induced cytopathic effect, and ZIKV's non-structural protein expression. Moreover, ZIKV Natal RGN SRIPs effectively self-replicated in rhabdomyosarcoma/muscle, glioblastoma/astrocytoma, and retinal pigmented epithelial cells, displaying unique cell susceptibility with differential attachment activity. Therefore, the recombinant ZIKV Natal RGN strain was rescued as SRIPs that could be used to elucidate the biological features of a neurotropic strain regarding cell tropism and pathogenic components, apply for antiviral agent screening, and develop vaccine candidates.
C1 [Lu, Chien-Yi; Yu, Ya-Wen; Liao, Chih-Yi; Ko, Bo-Han; Chang, Young-Sheng; Lin, Cheng-Wen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung 404, Taiwan.
   [Lin, Chen-Sheng] Kuang Tien Gen Hosp, Div Gastroenterol, Taichung 433, Taiwan.
   [Lai, Hsueh-Chou] China Med Univ, Sch Chinese Med, Taichung 404, Taiwan.
   [Lai, Hsueh-Chou] China Med Univ Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung 404, Taiwan.
   [Su, Wen-Chi; Ko, Bo-Han; Chang, Young-Sheng] China Med Univ, Grad Inst Biomed Sci, Taichung 404, Taiwan.
   [Huang, Su-Hua; Lin, Cheng-Wen] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan.
   [Lin, Cheng-Wen] China Med Univ, Chinese Med Res Ctr, Taichung 404, Taiwan.
RP Lin, CW (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung 404, Taiwan.; Lin, CW (corresponding author), Asia Univ, Dept Biotechnol, Taichung 413, Taiwan.; Lin, CW (corresponding author), China Med Univ, Chinese Med Res Ctr, Taichung 404, Taiwan.
EM cylu0424@gmail.com; b8401126@yahoo.com.tw; t674233@ms54.hinet.net;
   chloe830628@gmail.com; angelliaoj302@gmail.com; t23514@mail.cmuh.org.tw;
   pig60666@gmail.com; a0989016192@gmail.com; shhuang@asia.edu.tw;
   cwlin@mail.cmu.edu.tw
OI Lu, Chien-YI/0000-0002-7379-664X
FU China Medical University under the Featured Areas Research Center
   Program [CHM106-6-2, CMRC-CHM-2]; Ministry of Science and Technology,
   TaiwanMinistry of Science and Technology, Taiwan
   [MOST107-2923-B-039-001-MY3, MOST108-2320-B-039-039-MY3]; China Medical
   UniversityChina Medical University [CMU106-BC-1, CMU106-ASIA-06,
   CMU107-ASIA-12, CMU107-S-14]
FX This study was supported by China Medical University under the Featured
   Areas Research Center Program within the framework of the Higher
   Education Sprout Project by the Ministry of Education, Taiwan
   (CHM106-6-2 and CMRC-CHM-2). This project was also funded by grants from
   the Ministry of Science and Technology, Taiwan
   (MOST107-2923-B-039-001-MY3 and MOST108-2320-B-039-039-MY3) and China
   Medical University (CMU106-BC-1, CMU106-ASIA-06, CMU107-ASIA-12, and
   CMU107-S-14).
CR Avila-Perez G, 2019, JOVE-J VIS EXP, DOI 10.3791/59537
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Chen Y, 2018, VIRUS RES, V257, P14, DOI 10.1016/j.virusres.2018.08.016
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Leardkamolkarn V, 2012, VIRUS RES, V163, P552, DOI 10.1016/j.virusres.2011.12.007
   Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64
   Li SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep25754
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Lu CY, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040076
   Matsuda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34865-y
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Roby JA, 2014, J GEN VIROL, V95, P2176, DOI 10.1099/vir.0.064121-0
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Simon D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120698
   Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Varnavski AN, 1999, VIROLOGY, V255, P366, DOI 10.1006/viro.1998.9564
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 30
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1005
DI 10.3390/v11111005
PG 13
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300033
PM 31683628
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lundberg, R
   Melen, K
   Westenius, V
   Jiang, M
   Osterlund, P
   Khan, H
   Vapalahti, O
   Julkunen, I
   Kakkola, L
AF Lundberg, Rickard
   Melen, Krister
   Westenius, Veera
   Jiang, Miao
   Osterlund, Pamela
   Khan, Hira
   Vapalahti, Olli
   Julkunen, Ilkka
   Kakkola, Laura
TI Zika Virus Non-Structural Protein NS5 Inhibits the RIG-I Pathway and
   Interferon Lambda 1 Promoter Activation by Targeting IKK Epsilon
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; innate immunity; interferon; IKK epsilon
ID DENGUE VIRUS; ANTIVIRAL RESPONSE; EXPRESSION; CELLS; ROLES; ANTAGONIST;
   INDUCTION; INFECTION; NS4B
AB The Zika virus (ZIKV) is a member of the Flaviviridae family and an important human pathogen. Most pathogenic viruses encode proteins that interfere with the activation of host innate immune responses. Like other flaviviruses, ZIKV interferes with the expression of interferon (IFN) genes and inhibits IFN-induced antiviral responses. ZIKV infects through epithelial barriers where IFN-lambda 1 is an important antiviral molecule. In this study, we analyzed the effects of ZIKV proteins on the activation of IFN-lambda 1 promoter. All ZIKV proteins were cloned and transiently expressed. ZIKV NS5, but no other ZIKV protein, was able to interfere with the RIG-I signaling pathway. This inhibition took place upstream of interferon regulatory factor 3 (IRF3) resulting in reduced phosphorylation of IRF3 and reduced activation of IFN-lambda 1 promoter. Furthermore, we showed that ZIKV NS5 interacts with the protein kinase IKK epsilon, which is likely critical to the observed inhibition of phosphorylation of IRF3.
C1 [Lundberg, Rickard; Khan, Hira; Julkunen, Ilkka; Kakkola, Laura] Univ Turku, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.
   [Melen, Krister; Westenius, Veera; Jiang, Miao; Osterlund, Pamela] Natl Inst Hlth & Welf, Expert Microbiol Unit, Mannerheimintie 166, Helsinki 00300, Finland.
   [Vapalahti, Olli] Univ Helsinki, Dept Virol, Haartmaninkatu 3, FIN-00290 Helsinki, Finland.
   [Julkunen, Ilkka] Turku Univ, Clin Microbiol, Cent Hosp, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.
RP Kakkola, L (corresponding author), Univ Turku, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.
EM rickard.lundberg@utu.fi; krister.melen@thl.fi; veera.westenius@thl.fi;
   miao.jiang@helsinki.fi; pamela.osterlund@thl.fi; hira.khan@utu.fi;
   olli.vapalahti@helsinki.fi; ilkka.julkunen@utu.fi; laura.kakkola@utu.fi
RI ; Osterlund, Pamela/L-2528-2015
OI Vapalahti, Olli/0000-0003-2270-6824; Kakkola, Laura/0000-0001-9271-4059;
   Osterlund, Pamela/0000-0002-2229-6661
FU Medical Research Council of the Academy of FinlandAcademy of Finland
   [297329]; Jane and Aatos Erkko Foundation, Finland [3067-84b53]; Sigrid
   Juselius Foundation, FinlandSigrid Juselius Foundation
FX This research was funded by the Medical Research Council of the Academy
   of Finland (grant no: 297329); Jane and Aatos Erkko Foundation, Finland
   (grant no: 3067-84b53) and Sigrid Juselius Foundation, Finland.
CR Airenne KJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng102
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2018, VIRUS RES, V254, P21, DOI 10.1016/j.virusres.2017.08.018
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Delgoffe Greg M, 2013, JAKSTAT, V2, pe23060, DOI 10.4161/jkst.23060
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Feldherr C, 1998, J CELL SCI, V111, P1889
   Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127
   Fournier E, 2012, NUCLEIC ACIDS RES, V40, P2197, DOI 10.1093/nar/gkr985
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HAGEN M, 1994, J VIROL, V68, P1509, DOI 10.1128/JVI.68.3.1509-1515.1994
   Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jiang M, 2015, J LEUKOCYTE BIOL, V97, P307, DOI 10.1189/jlb.2A0114-059RR
   Kaukinen P, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-66
   Kaukinen P, 2013, J MED VIROL, V85, P71, DOI 10.1002/jmv.23442
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006
   Melen K, 2017, J VIROL METHODS, V242, P35, DOI 10.1016/j.jviromet.2016.12.014
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Munir M, 2013, VIRULENCE, V4, P85, DOI 10.4161/viru.23134
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028
   NAKABAYASHI H, 1982, CANCER RES, V42, P3858
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434
   Pythoud C, 2012, J VIROL, V86, P7728, DOI 10.1128/JVI.00187-12
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07
   SUMMERS MD, 1986, TEX AGR EXP STN B, V1555, P1
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vladimer GI, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00094
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17554
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 58
TC 0
Z9 0
U1 3
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1024
DI 10.3390/v11111024
PG 20
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300052
PM 31690057
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martinet, JP
   Ferte, H
   Failloux, AB
   Schaffner, F
   Depaquit, J
AF Martinet, Jean-Philippe
   Ferte, Hubert
   Failloux, Anna-Bella
   Schaffner, Francis
   Depaquit, Jerome
TI Mosquitoes of North-Western Europe as Potential Vectors of Arboviruses:
   A Review
SO VIRUSES-BASEL
LA English
DT Review
DE Aedes; Culex; Anopheles; Culiseta; transmission; West Nile; Usutu;
   dengue; Zika; chikungunya
ID AEDES-JAPONICUS-JAPONICUS; NILE-VIRUS; USUTU-VIRUS; DIPTERA-CULICIDAE;
   CHIKUNGUNYA-VIRUS; ZIKA VIRUS; CULEX-PIPIENS; COMPETENCE; ALBOPICTUS;
   SURVEILLANCE
AB Background: The intensification of trade and travel is linked to the growing number of imported cases of dengue, chikungunya or Zika viruses into continental Europe and to the expansion of invasive mosquito species such as Aedes albopictus and Aedes japonicus. Local outbreaks have already occurred in several European countries. Very little information exists on the vector competence of native mosquitoes for arboviruses. As such, the vectorial status of the nine mosquito species largely established in North-Western Europe (Aedes cinereus and Aedes geminus, Aedes cantans, Aedes punctor, Aedes rusticus, Anopheles claviger s.s., Anopheles plumbeus, Coquillettidia richiardii, Culex pipiens s.l., and Culiseta annulata) remains mostly unknown. Objectives: To review the vector competence of both invasive and native mosquito populations found in North-Western Europe (i.e., France, Belgium, Germany, United Kingdom, Ireland, The Netherlands, Luxembourg and Switzerland) for dengue, chikungunya, Zika, West Nile and Usutu viruses. Methods: A bibliographical search with research strings addressing mosquito vector competence for considered countries was performed. Results: Out of 6357 results, 119 references were related to the vector competence of mosquitoes in Western Europe. Eight species appear to be competent for at least one virus. Conclusions: Aedes albopictus is responsible for the current outbreaks. The spread of Aedes albopictus and Aedes japonicus increases the risk of the autochthonous transmission of these viruses. Although native species could contribute to their transmission, more studies are still needed to assess that risk.
C1 [Martinet, Jean-Philippe; Ferte, Hubert; Depaquit, Jerome] Univ Reims, Fac Pharm, SFR Cap Sante, ANSES,EA7510,ESCAPE,USC,VECPAR, 51 Rue Cognacq Jay, F-51096 Reims, France.
   [Martinet, Jean-Philippe; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Arbovirus & Insectes Vecteurs, 25-28 Rue docteur Roux, F-75015 Paris, France.
   [Ferte, Hubert; Depaquit, Jerome] CHU Reims, Hop Maison Blanche, Lab Parasitol, 45 Rue Cognacq Jay, F-51100 Reims, France.
   [Schaffner, Francis] Univ Zurich, Vetsuisse Fac, Inst Parasitol, Natl Ctr Vector Entomol, Ramistr 71, CH-8006 Zurich, Switzerland.
   [Schaffner, Francis] Francis Schaffner Consultancy, Lorracherstr 50, CH-4125 Basel, Switzerland.
RP Martinet, JP (corresponding author), Univ Reims, Fac Pharm, SFR Cap Sante, ANSES,EA7510,ESCAPE,USC,VECPAR, 51 Rue Cognacq Jay, F-51096 Reims, France.; Martinet, JP (corresponding author), Inst Pasteur, Dept Virol, Arbovirus & Insectes Vecteurs, 25-28 Rue docteur Roux, F-75015 Paris, France.
EM j.martinet.p@gmail.com; hubert.ferte@univ-reims.fr;
   anna-bella.failloux@pasteur.fr; fschaffner.consult@gmail.com;
   jerome.depaquit@univ-reims.fr
OI Martinet, Jean-Philippe/0000-0003-2754-0165; FAILLOUX,
   Anna-Bella/0000-0001-6890-0820
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Amraoui F, 2016, CURR OPIN VIROL, V21, P146, DOI 10.1016/j.coviro.2016.09.014
   Anderson JF, 2015, AM J TROP MED HYG, V92, P377, DOI 10.4269/ajtmh.14-0291
   Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360
   Bahuon C, 2016, REV SCI TECH OIE, V35, P811, DOI 10.20506/rst.35.3.2571
   Balenghien T, 2006, J MED ENTOMOL, V43, P936, DOI 10.1603/0022-2585(2006)43[936:HBAHBA]2.0.CO;2
   Balenghien T, 2008, VECTOR-BORNE ZOONOT, V8, P589, DOI 10.1089/vbz.2007.0266
   Balenghien T, 2007, J AM MOSQUITO CONTR, V23, P233, DOI 10.2987/8756-971X(2007)23[233:EOLVCO]2.0.CO;2
   Beck Matthias, 2003, European Mosquito Bulletin, V14, P21
   Becker N, 2016, PARASITOL RES, V115, P2671, DOI 10.1007/s00436-016-5014-5
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blagrove MSC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1739-3
   Boukraa S, 2015, J VECTOR ECOL, V40, P398, DOI 10.1111/jvec.12180
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164
   Buchebner N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-153
   Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0
   Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Cadar D, 2015, EMERG INFECT DIS, V21, P1647, DOI 10.3201/eid2109.142026
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Camp JV, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3316-z
   Camp JV, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3030-2
   CDC, MOSQ SPEC WHICH W NI
   Ciocchetta S, 2018, PATHOG GLOB HEALTH, V112, P107, DOI 10.1080/20477724.2018.1464780
   Cle M, 2018, M S-MED SCI, V34, P709, DOI 10.1051/medsci/20183408018
   Dekoninck W, 2011, J MED ENTOMOL, V48, P924, DOI 10.1603/ME10235
   Del Giudice P, 2004, EMERG INFECT DIS, V10, P1885, DOI 10.3201/eid1010.031021
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Dibernardo A, 2017, J AM MOSQUITO CONTR, V33, P276, DOI 10.2987/17-6664.1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eiden M, 2018, INFECT GENET EVOL, V61, P151, DOI 10.1016/j.meegid.2018.03.020
   European Center for Disease Prevention and Control, 2018, ZIK VIR INF
   European Center for Disease Prevention and Control, WEEKL UPD 2018 W NIL
   European Center for Disease Prevention and Control, AED KOR CURR KNOWN D
   European Center for Disease Prevention and Control, AED ALB CURR KNOWN D
   European Center for Disease Prevention and Control, 2018, 2016 CHIK VIR DIS
   European Center for Disease Prevention and Control, 2018, DENG ANN EP REP 2016
   European Center for Disease Prevention and Control, AED JAP CURR KNOWN D
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   Fros JJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003956
   Garigliany MM, 2014, VET J, V199, P191, DOI 10.1016/j.tvjl.2013.10.017
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Gutierrez-Lopez R, 2019, EMERG INFECT DIS, V25, P346, DOI 10.3201/eid2502.171123
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hernandez-Triana LM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2959-5
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Hubalek Z, 2010, J MED ENTOMOL, V47, P466, DOI 10.1603/ME09219
   Huber K, 2014, PARASITOL RES, V113, P3195, DOI 10.1007/s00436-014-3983-9
   Jansen S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0195-x
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kemenesi Gabor, 2014, VirusDisease, V25, P500, DOI 10.1007/s13337-014-0234-8
   Koban MB, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3349-3
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lecollinet S, 2016, EMERG INFECT DIS, V22, P2225, DOI 10.3201/eid2212.161272
   Leggewie M, 2016, ONE HEALTH, V2, P88, DOI 10.1016/j.onehlt.2016.04.001
   Lim SM, 2018, ZOONOSES PUBLIC HLTH, V65, P96, DOI 10.1111/zph.12375
   Linke S, 2008, J ORNITHOL, V149, P271, DOI 10.1007/s10336-007-0270-x
   Mancini G, 2017, VET ITAL, V53, P97, DOI 10.12834/VetIt.114.933.4764.2
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Medlock Jolyon M., 2010, Dipterists Digest Second Series, V17, P1
   Michel F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010171
   Moher D, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-1
   Murgue B, 2001, EMERG INFECT DIS, V7, P692
   Murgue B, 2001, ANN NY ACAD SCI, V951, P117
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Pachler K, 2014, EMERG INFECT DIS, V20, P2119, DOI 10.3201/eid2012.140921
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Pietsch C, 2019, TRANSBOUND EMERG DIS, V66, P1033, DOI 10.1111/tbed.13079
   Prudhomme J, 2019, EMERG MICROBES INFEC, V8, P962, DOI 10.1080/22221751.2019.1634489
   Puggioli A, 2017, ACTA TROP, V172, P192, DOI 10.1016/j.actatropica.2017.05.006
   Rabel PO, 2011, EUROSURVEILLANCE, V16, P5
   Robert V, 2019, J EUR MOSQ CONTROL A, V37, P1
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rubel F, 2017, METEOROL Z, V26, P115, DOI 10.1127/metz/2016/0816
   Rudolf I, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2399-7
   Schaffner F, 2000, CR ACAD SCI III-VIE, V323, P373, DOI 10.1016/S0764-4469(00)00143-8
   Schaffner F, 2001, MOSQUITOES EUROPE ID
   Schaffner F., 2013, SPATIO TEMPORAL DIVE
   Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141
   Scheuch DE, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070389
   Sieg M, 2017, VECTOR-BORNE ZOONOT, V17, P662, DOI 10.1089/vbz.2016.2096
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Takken W, 2007, ECOL CONT VECTOR-BOR, V1, P465
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   Timmermann U, 2010, J VECTOR ECOL, V35, P140, DOI 10.1111/j.1948-7134.2010.00039.x
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Van Den Bossche D, 2015, EPIDEMIOL INFECT, V143, P2227, DOI 10.1017/S0950268814000685
   Vasquez V, 2018, INT J INFECT DIS, V72, P34, DOI 10.1016/j.ijid.2018.05.007
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0705-9
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Verdonschot P.F.M., FAMILY CULICIDAE
   Vermeil C., 1960, B SOC PATHOL EXOT, V53, P300
   Veronesi E, 2018, PARASITOL RES, V117, P1925, DOI 10.1007/s00436-018-5886-7
   Vittecoq M, 2013, VECTOR-BORNE ZOONOT, V13, P610, DOI 10.1089/vbz.2012.1166
   Vogels CBF, 2017, MED VET ENTOMOL, V31, P358, DOI 10.1111/mve.12251
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Wagner S, 2018, MED VET ENTOMOL, V32, P121, DOI 10.1111/mve.12273
   Walther D, 2017, J MED ENTOMOL, V54, P1790, DOI 10.1093/jme/tjx166
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P1000, DOI 10.1016/j.apjtm.2016.07.032
   Wong N, 2017, J INFECTION, V74, P616, DOI 10.1016/j.jinf.2017.03.004
   WOODALL JP, 1964, P E AFR ACAD, V2, P141
   Ziegler U, 2019, ANTIVIR RES, V162, P39, DOI 10.1016/j.antiviral.2018.12.005
   Ziegler U, 2015, VECTOR-BORNE ZOONOT, V15, P481, DOI 10.1089/vbz.2014.1746
NR 119
TC 3
Z9 3
U1 9
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1059
DI 10.3390/v11111059
PG 18
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300087
PM 31739553
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Sippert, E
   Rocha, BC
   Assis, FL
   Ok, S
   Rios, M
AF Sippert, Emilia
   Rocha, Bruno C.
   Assis, Felipe L.
   Ok, Suzan
   Rios, Maria
TI Use of Monocyte-Derived Macrophage Culture Increases Zika Virus
   Isolation Rate from Human Plasma
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; cell culture; primary isolation; in vitro model; infection
ID WEST-NILE-VIRUS; SEXUAL TRANSMISSION; TARGET; ANTIBODIES; INFECTION
AB Viral isolation is desirable for many reasons, including development of diagnostic assays and reference materials, and for virology basic research. Zika virus (ZIKV) isolation from clinical samples is challenging, but isolates are known to infect various cell lines. Here, we evaluated suitability of Vero, C6/36 and JEG-3 as host cells, for direct isolation of ZIKV from human plasma. We also assessed the use of primary monocyte-derived macrophages (MDMs) culture to enhance ZIKV isolation from human plasma samples followed by virus expansion in Vero, C6/36 and JEG-3 cultures. Direct inoculation of cell lines with 42 ZIKV-RNA positive samples resulted in isolation rates of 9.52% (4/42) in Vero and C6/36, and of 7.14% (3/42) in JEG-3 cells. Inoculation of plasma in MDMs followed by supernatant testing by TaqMan RT-PCR, resulted in 33/42 (78.57%) ZIKV-RNA-positive supernatants, which expansion in cell lines increased isolation rates to 24.24% (8/33) in Vero and to 27.27% (9/33) in C6/36 and JEG-3 regardless of the presence of ZIKV-antibody. Isolates generated in JEG-3 cells were also produced in Vero and C6/36 with similar viral titers. These results suggest that efficiency of ZIKV isolation from human plasma can be enhanced when MDM culture is used before viral expansion in cell lines.
C1 [Sippert, Emilia; Rocha, Bruno C.; Assis, Felipe L.; Ok, Suzan; Rios, Maria] US FDA, LEP, DETTD, OBRR,CBER, Silver Spring, MD 20993 USA.
RP Rios, M (corresponding author), US FDA, LEP, DETTD, OBRR,CBER, Silver Spring, MD 20993 USA.
EM Emilia.Sippert@fda.hhs.gov; brunocr2@gmail.com;
   Felipe.Assis@fda.hhs.gov; suzan.ok@gmail.com; Maria.Rios@fda.hhs.gov
RI Sippert, Emilia Angela/B-3033-2013; Rocha, Bruno C/M-6397-2015
OI Sippert, Emilia Angela/0000-0002-6341-3879; Rocha, Bruno
   C/0000-0003-0118-3913
FU Medical Countermeasures initiative (MCMi) [OCET 2016331]
FX This work was supported by the Medical Countermeasures initiative (MCMi)
   intramural Funding Grant OCET 2016331. Fellows E.S., B.C.R., F.L.A. and
   S.O. were supported by appointments to the ORISE Research Fellowship
   Program at the Center for Biologics Evaluation and Research. The
   fellowship was administered by the Oak Ridge Institute for Science and
   Education through an interagency agreement between the U.S. Department
   of Energy and the FDA.
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Center for Disease Control and Prevention (CDC), ZIK BLOOD TRANSF
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Fares-Gusmao R, 2018, TRANSFUSION, V58, P2171, DOI 10.1111/trf.14870
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   Jarman RG, 2011, AM J TROP MED HYG, V84, P218, DOI 10.4269/ajtmh.2011.09-0798
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nikolay A, 2018, VACCINE, V36, P3140, DOI 10.1016/j.vaccine.2017.03.018
   Rios M, 2008, J INFECT DIS, V198, P1300, DOI 10.1086/592277
   Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x
   Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Viedma MDM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110649
NR 34
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1058
DI 10.3390/v11111058
PG 11
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300086
PM 31739467
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Versiani, AF
   Rocha, RP
   Mendes, TAO
   Pereira, GC
   dos Reis, JGAC
   Bartholomeu, DC
   da Fonseca, FG
AF Versiani, Alice F.
   Rocha, Raissa Prado
   Mendes, Tiago A. O.
   Pereira, Glauco C.
   Coelho dos Reis, Jordana Graziella A.
   Bartholomeu, Daniella C.
   da Fonseca, Flavio G.
TI Identification of B-Cell Epitopes with Potential to Serologicaly
   Discrimnate Dengue from Zika Infections
SO VIRUSES-BASEL
LA English
DT Article
DE dengue diagnose; Zika; peptides; epitopes; pepELISA
ID COMPLETE NUCLEOTIDE-SEQUENCE; VIRUS; PROTEIN; TYPE-3; GENES; ELISA
AB Dengue is currently one of the most important arbovirus infections worldwide. Early diagnosis is important for disease outcome, particularly for those afflicted with the severe forms of infection. The goal of this work was to identify conserved and polymorphic linear B-cell Dengue virus (DENV) epitopes that could be used for diagnostic purposes. To this end, we aligned the predicted viral proteome of the four DENV serotype and performed in silico B-cell epitope mapping. We developed a script in Perl integrating alignment and prediction information to identify potential serotype-specific epitopes. We excluded epitopes that were similarly present in the yellow fever and zika viruses' proteomes. A total of 15 polymorphic and nine conserved peptides among DENV serotypes were selected. Peptides were spotted on cellulose membranes and tested against sera from rabbits that were monoinfected with each DENV serotype. Although serotype-specific peptides failed to recognize any sera, three conserved peptides were recognized by all anti-dengue sera and were included on an ELISA test employing a well-characterized human sera bank. Of the three peptides, one was able to efficiently identify sera from all four DENV serotypes and to discriminate them from Zika virus positive sera.
C1 [Versiani, Alice F.; Rocha, Raissa Prado; Coelho dos Reis, Jordana Graziella A.; da Fonseca, Flavio G.] Univ Fed Minas Gerais, Dept Microbiol, Lab Virol Bas & Aplicada, BR-31270901 Belo Horizonte, MG, Brazil.
   [Versiani, Alice F.] Fac Med Sao Jose do Rio Preto, Dept Doencas Infecciosas & Parasitarias, Lab Pesquisa Virol, BR-15090000 Sao Jose Do Rio Preto, Brazil.
   [Mendes, Tiago A. O.; Bartholomeu, Daniella C.] Univ Fed Minas Gerais, Dept Parasitol, Lab Imunol & Genom Parasitos, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pereira, Glauco C.] FUNED, Fundacao Ezequiel Dias, BR-30510010 Belo Horizonte, MG, Brazil.
RP da Fonseca, FG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Lab Virol Bas & Aplicada, BR-31270901 Belo Horizonte, MG, Brazil.
EM afversiani@gmail.com; raissa.biotec@gmail.com;
   tiagomgmendes@yahoo.com.br; glaiconep@gmail.com; reisjordana@gmail.com;
   daniellaufmg@gmail.com; fdafonseca@icb.ufmg.br
RI Versiani, Alice/M-9782-2018
OI Versiani, Alice/0000-0003-1378-5380; Mendes, Tiago Antonio de
   Oliveira/0000-0002-5569-4893
FU CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CBB-APQ-04295-17]; FINEPCiencia Tecnologia e Inovacao (FINEP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); C.A.P.E.S. studentshipCAPES
FX This work was supported by CAPES, FAPEMIG, FINEP and CNPq. The grant
   from FAPEMIG was CBB-APQ-04295-17 (EDITAL 007/2017-PROGRAMA DE PESQUISA
   PARA O SUS/PPSUS). A FINEP-ZIKA institutional grant was used in the
   development of this work. F.G. da Fonseca, T.A.O. Mendes and D.C.
   Bartholomeu are CNPq fellowship recipients. A.F. Versiani and RP Rocha
   were/are C.A.P.E.S. studentship recipients. A.F. Versiani is currently a
   FAPESP fellow.
CR Abdelgawad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138370
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   AnandaRao R, 2005, PROTEIN EXPRES PURIF, V41, P136, DOI 10.1016/j.pep.2005.01.009
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BLOK J, 1992, VIROLOGY, V187, P573, DOI 10.1016/0042-6822(92)90460-7
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Chan HB, 2017, SINGAP MED J, V58, P632, DOI 10.11622/smedj.2017100
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   CHU MC, 1989, J GEN VIROL, V70, P1701, DOI 10.1099/0022-1317-70-7-1701
   Mendes TAD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002524
   DEUBEL V, 1988, VIROLOGY, V165, P234, DOI 10.1016/0042-6822(88)90677-0
   Dubois ME, 2012, VECTOR-BORNE ZOONOT, V12, P400, DOI 10.1089/vbz.2011.0779
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0
   FU JL, 1992, VIROLOGY, V188, P953, DOI 10.1016/0042-6822(92)90560-C
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   HAHN YS, 1988, VIROLOGY, V162, P167, DOI 10.1016/0042-6822(88)90406-0
   Halstead SB, 2019, LANCET CHILD ADOLESC, V3, P734, DOI 10.1016/S2352-4642(19)30205-6
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Lin RJ, 2017, EXPERT REV ANTI-INFE, V15, P729, DOI 10.1080/14787210.2017.1358610
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   del Angel RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003551
   Narayan R, 2016, INDIAN J MED RES, V143, P128, DOI 10.4103/0971-5916.193300
   OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Peyrefitte CN, 2003, J CLIN MICROBIOL, V41, P5195, DOI 10.1128/JCM.41.11.5195-5198.2003
   Puri B, 1998, VIRUS GENES, V17, P85, DOI 10.1023/A:1008009202695
   Rathakrishnan Anusyah, 2013, Expert Opin Med Diagn, V7, P99, DOI 10.1517/17530059.2012.718759
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Sahili A. E, 2017, VIRUSES, V9, P1
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274
   Tian H, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-245
   Valadon P, 1996, J IMMUNOL METHODS, V197, P171, DOI 10.1016/0022-1759(96)00133-0
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yoong L.F., DENGUE VIRUS TYPE 4
   Yuan X., DENGUE VIRUS TYPE 3
   ZHAO B, 1986, VIROLOGY, V155, P77, DOI 10.1016/0042-6822(86)90169-8
NR 46
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1079
DI 10.3390/v11111079
PG 16
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300107
PM 31752352
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, XH
   Xia, S
   Zou, P
   Lu, L
AF Wang, Xiaohuan
   Xia, Shuai
   Zou, Peng
   Lu, Lu
TI Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral
   Entry as a Viral Inactivator
SO VIRUSES-BASEL
LA English
DT Article
DE erythromycin estolate; ZIKV; viral entry inhibitor; inactivator
AB Recently, Zika virus (ZIKV) has attracted much attention in consideration of its association with severe neurological complications including fetal microcephaly. However, there are currently no prophylactic vaccines or therapeutic drugs approved for clinical treatments of ZIKV infection. To determine the potential anti-ZIKV inhibitors, we screened a library of clinical drugs with good safety profiles. Erythromycin estolate (Ery-Est), one of the macrolide antibiotics, was found to effectively inhibit ZIKV infection in different cell types and significantly protect A129 mice from ZIKV-associated neurological signs and mortality. Through further investigation, Ery-Est was verified to inhibit ZIKV entry by disrupting the integrity of the viral membrane which resulted in the loss of ZIKV infectivity. Furthermore, Ery-Est also showed inhibitory activity against dengue virus (DENV) and yellow fever virus (YFV). Thus, Ery-Est may be a promising drug for patients with ZIKV infection, particularly pregnant women.
C1 [Zou, Peng; Lu, Lu] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China.
   Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.
RP Zou, P; Lu, L (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China.
EM 18111010062@fudan.edu.cn; 15111010053@fudan.edu.cn;
   zoupeng@shphc.org.cn; lul@fudan.edu.cn
RI Lu, Lu/K-7070-2014
OI Lu, Lu/0000-0002-2255-0391
FU National Megaprojects of China for Major Infectious Diseases
   [2018ZX10301403]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81661128041, 81672019, 81822045];
   Shanghai Public Health Clinical Center [2016-27, KY-GW-2017-17]; China
   Postdoctoral Science FoundationChina Postdoctoral Science Foundation
   [2018M640341, 2019T120302]
FX This work was supported by the National Megaprojects of China for Major
   Infectious Diseases (2018ZX10301403 to L.L.), the National Natural
   Science Foundation of China (81661128041, 81672019, and 81822045 to
   L.L.), grants from the Shanghai Public Health Clinical Center (2016-27
   to L.L. and KY-GW-2017-17 to P.Z.), and China Postdoctoral Science
   Foundation (2018M640341 and 2019T120302 to S.X.).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Altunaiji S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004404.pub3
   Arabi YM, 2019, INT J INFECT DIS, V81, P184, DOI 10.1016/j.ijid.2019.01.041
   Bosseboeuf E., 2018, J ANTIVIR ANTIRETROV, V10, P6, DOI [10.4172/1948-5964.1000173, DOI 10.4172/1948-5964.1000173]
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Conzelmann C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070591
   CROTEAU D, 1988, ANTIMICROB AGENTS CH, V32, P561, DOI 10.1128/AAC.32.4.561
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Moraes C Gustavo, 2018, JMM Case Rep, V5, pe005161, DOI 10.1099/jmmcr.0.005161
   DeCocker K, 2019, NURS CLIN N AM, V54, P285, DOI 10.1016/j.cnur.2019.02.005
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong SZ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007681
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Espano E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47956-1
   Gorshkov K, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03252
   Grazel R, 2018, ADV NEONAT CARE, V18, P350, DOI 10.1097/ANC.0000000000000557
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Gunawardana SA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3572-0
   Iannetta M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01152-17
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   Langley JM, 2004, PEDIATRICS, V114, pE96, DOI 10.1542/peds.114.1.e96
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200478
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Lok SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050995
   Lu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4067
   Lu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-104
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Morrone SR, 2019, CURR OPIN VIROL, V36, P1, DOI 10.1016/j.coviro.2019.02.002
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Park JG, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00718
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Raynes-Greenow C.H., 2004, COCHRANE DB SYST REV, pCd003767, DOI [10.1002/14651858.CD003767.pub2, DOI 10.1002/14651858.CD003767.PUB2]
   Raza Saad, 2019, IEEE/ACM Trans Comput Biol Bioinform, DOI 10.1109/TCBB.2019.2911081
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Mota VMR, 2018, REV BRAS GINECOL OBS, V40, P417, DOI 10.1055/s-0038-1648219
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Si LL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau8408
   Tsetsarkin KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07782-x
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Wu YH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006848
   Xie J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2921-x
   Yokota S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/528568
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zhao GY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-266
NR 57
TC 1
Z9 1
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2019
VL 11
IS 11
AR 1064
DI 10.3390/v11111064
PG 17
WC Virology
SC Virology
GA JV3UX
UT WOS:000502292300092
PM 31731598
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vouga, M
   Pomar, L
   Panchaud, A
   Musso, D
   Baud, D
AF Vouga, Manon
   Pomar, Leo
   Panchaud, Alice
   Musso, Didier
   Baud, David
TI A critical analysis of the neurodevelopmental and neurosensory outcomes
   after 2 years for children with in utero Zika virus exposure
SO NATURE MEDICINE
LA English
DT Letter
C1 [Vouga, Manon; Pomar, Leo; Baud, David] Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Pomar, Leo] Ctr Hosp Ouest Guyanais Franck Joly, Dept Obstet & Gynaecol, St Laurent Du Maroni, France.
   [Panchaud, Alice] Lausanne Univ Hosp, Pharm Serv, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Sch Pharmaceut Sci, Lausanne, Switzerland.
   [Musso, Didier] Aix Marseille Univ, IHU Mediterranee Infect, AP HM, IRD,SSA,VITROME, Marseille, France.
   [Musso, Didier] Eurofins Labazur Guyane, Cayenne, French Guiana.
RP Baud, D (corresponding author), Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496
CR Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
NR 5
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD NOV
PY 2019
VL 25
IS 11
BP 1641
EP 1642
DI 10.1038/s41591-019-0630-0
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA JT2KI
UT WOS:000500824300008
PM 31649352
DA 2020-07-08
ER

PT J
AU Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Vasconcelos, Z
   Gabaglia, CR
   Moreira, ME
AF Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Vasconcelos, Zilton
   Gabaglia, Claudia Raja
   Moreira, Maria Elisabeth
TI Reply to 'A critical analysis of neurodevelopmental and neurosensory
   outcomes after 2 years for children with in utero Zika virus exposure'
SO NATURE MEDICINE
LA English
DT Letter
C1 [Nielsen-Saines, Karin; Kerin, Tara] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
   [Brasil, Patricia; Vasconcelos, Zilton; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
RP Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI140718]
CR Ballot DE, 2017, INT SCH RES NOTICES, V2017, DOI DOI 10.1155/2017/1631760
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.2307/1126464
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Vouga M, 2019, NAT MED, V25, P1641, DOI 10.1038/s41591-019-0630-0
NR 6
TC 0
Z9 0
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD NOV
PY 2019
VL 25
IS 11
BP 1642
EP 1643
DI 10.1038/s41591-019-0631-z
PG 3
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA JT2KI
UT WOS:000500824300009
PM 31649351
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Nimegeer, A
   Patterson, C
   Hilton, S
AF Nimegeer, Amy
   Patterson, Chris
   Hilton, Shona
TI Readers' comments of UK online news media about the Zika virus: a
   qualitative content analysis
SO LANCET
LA English
DT Meeting Abstract
CT National Conference on Public Health Science Dedicated to New Research
   in UK Public Health
CY NOV 29, 2019
CL London, ENGLAND
C1 [Nimegeer, Amy; Patterson, Chris; Hilton, Shona] Univ Glasgow, MRC & CSO Social & Publ Hlth Sci Unit, Glasgow G2 3AX, Lanark, Scotland.
EM amy.nimegeer@glasgow.ac.uk
FU Informing Healthy Public Policy programme of the MRC/CSO Social and
   Public Health Sciences Unit, University of Glasgow [MC_UU_12017-15,
   SPHSU15]
FX AN, CP, and SH were funded by the Informing Healthy Public Policy
   programme (MC_UU_12017-15 and SPHSU15) of the MRC/CSO Social and Public
   Health Sciences Unit, University of Glasgow. The funding bodies had no
   role in the design, collection, analysis, or interpretation of this
   study.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD NOV
PY 2019
VL 394
SU 2
BP 73
EP 73
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA JS4BV
UT WOS:000500253100074
DA 2020-07-08
ER

PT J
AU Vinton, CL
   Magaziner, SJ
   Dowd, KA
   Robertson, SJ
   Amaro-Carambot, E
   Karmele, EP
   Ortiz, AM
   Starke, CE
   Mudd, JC
   Whitehead, SS
   Best, SM
   Pierson, TC
   Hickman, HD
   Brenchley, JM
AF Vinton, Carol L.
   Magaziner, Samuel J.
   Dowd, Kimberly A.
   Robertson, Shelly J.
   Amaro-Carambot, Emerito
   Karmele, Erik P.
   Ortiz, Alexandra M.
   Starke, Carly E.
   Mudd, Joseph C.
   Whitehead, Stephen S.
   Best, Sonja M.
   Pierson, Theodore C.
   Hickman, Heather D.
   Brenchley, Jason M.
TI Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in
   Delayed Zika Virus Clearance
SO MBIO
LA English
DT Article
DE SIV; ZIKV; innate immunity; type I interferon
ID WEST-NILE-VIRUS; ANTIBODY-MEDIATED NEUTRALIZATION; I INTERFERON
   RESPONSES; B-CELL RESPONSES; SIV INFECTION; IMMUNE ACTIVATION; ENVELOPE
   PROTEIN; DNA VACCINE; MOUSE MODEL; DEPLETION
AB Flaviviruses are controlled by adaptive immune responses but are exquisitely sensitive to interferon-stimulated genes (ISGs). How coinfections, particularly simian immunodeficiency viruses (SIVs), that induce robust ISG signatures influence flavivirus clearance and pathogenesis is unclear. Here, we studied how Zika virus (ZIKV) infection is modulated in SIV-infected nonhuman primates. We measured ZIKV replication, cellular ZIKV RNA levels, and immune responses in non-SIV-infected and SIV-infected rhesus macaques (RMs), which we infected with ZIKV. Coinfected animals had a 1- to 2-day delay in peak ZIKV viremia, which was 30% of that in nonSIV-infected animals. However, ZIKV viremia was significantly prolonged in SIVpositive (SIV+) RMs. ISG levels at the time of ZIKV infection were predictive for lower ZIKV viremia in the SIV+ RMs, while prolonged ZIKV viremia was associated with muted and delayed adaptive responses in SIV+ RMs.
   IMPORTANCE Immunocompromised individuals often become symptomatic with infections which are normally fairly asymptomatic in healthy individuals. The particular mechanisms that underlie susceptibility to coinfections in human immunodeficiency virus (HIV)-infected individuals are multifaceted. ZIKV and other flaviviruses are sensitive to neutralizing antibodies, whose production can be limited in HIV-infected individuals but are also sensitive to type I interferons, which are expressed at high levels in HIV-infected individuals. Data in this study highlight how individual components of the innate and adaptive immune responses which become perturbed in HIV-infected individuals influence ZIKV infection.
C1 [Vinton, Carol L.; Ortiz, Alexandra M.; Starke, Carly E.; Mudd, Joseph C.; Brenchley, Jason M.] NIAID, Barrier Immun Sect, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Magaziner, Samuel J.; Hickman, Heather D.] NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Dowd, Kimberly A.; Amaro-Carambot, Emerito; Whitehead, Stephen S.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Robertson, Shelly J.; Best, Sonja M.] NIAID, Innate Immun & Pathogenesis Sect, Lab Virol, NIH, Hamilton, MT USA.
   [Karmele, Erik P.] NIAID, Mucosal Immunobiol Sect, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Brenchley, JM (corresponding author), NIAID, Barrier Immun Sect, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM jbrenchl@mail.nih.gov
OI Hickman, Heather/0000-0003-4168-4894; Magaziner,
   Samuel/0000-0002-5345-217X; Starke, Carly Elizabeth/0000-0002-9548-9368
FU Division of Intramural Research/NIAID/NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
FX Funding for this study was provided in part by the Division of
   Intramural Research/NIAID/NIH.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Anderson JF, 2002, EMERG INFECT DIS, V8, P107, DOI 10.3201/eid0801.010252
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Appay V, 2017, VIRULENCE, V8, P529, DOI 10.1080/21505594.2016.1195536
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Bidokhti MRM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006811
   Bosinger SE, 2015, CURR HIV-AIDS REP, V12, P41, DOI 10.1007/s11904-014-0244-6
   Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115
   Bradley MP, 2017, COMPARATIVE MED, V67, P242
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Brenchley JM, 2013, MUCOSAL IMMUNOL, V6, P657, DOI 10.1038/mi.2013.15
   Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301
   BURNS DPW, 1991, J VIROL, V65, P1843, DOI 10.1128/JVI.65.4.1843-1854.1991
   Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Barros JBD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00821
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x
   dos Santos EA, 2018, ADV EXP MED BIOL, V1062, P215, DOI 10.1007/978-981-10-8727-1_16
   Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Estes JD, 2018, NAT REV IMMUNOL, V18, P390, DOI 10.1038/s41577-018-0005-7
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hansen SG, 2017, NATURE, V547, P123, DOI 10.1038/nature22984
   Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38
   Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065
   Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001
   Klatt NR, 2012, J VIROL, V86, P1203, DOI 10.1128/JVI.06033-11
   Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874
   Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298
   Moysi E, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0437-y
   Moysi E, 2018, J CLIN INVEST, V128, P3171, DOI 10.1172/JCI99884
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   National Research Council, 2011, GUIDE CARE USE LAB A
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Ortiz AM, 2018, NAT MED, V24, P1313, DOI 10.1038/s41591-018-0132-5
   Ortiz AM, 2011, J CLIN INVEST, V121, P4433, DOI 10.1172/JCI46023
   ORTONA L, 1988, Bollettino dell'Istituto Sieroterapico Milanese, V67, P135
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Overton ET, 2007, J VIRAL HEPATITIS, V14, P189, DOI 10.1111/j.1365-2893.2006.00822.x
   Overton Edgar Turner, 2007, Curr HIV/AIDS Rep, V4, P105, DOI 10.1007/s11904-007-0016-7
   Pallikkuth S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01380
   Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932
   Petrovas C, 2014, CURR OPIN HIV AIDS, V9, P235, DOI 10.1097/COH.0000000000000053
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Poultsidi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02233
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Roff SR, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00498
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   RUEGG CL, 1990, ANN NY ACAD SCI, V616, P307
   Ryan ES, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005412
   Saeidi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02569
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Snyder B, 2018, J MED VIROL, V90, P8, DOI 10.1002/jmv.24932
   Thurmond S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120712
   Weatherall D., 2006, USE NONHUMAN PRIMATE
   Xu Y, 2019, CURR OPIN HIV AIDS, V14, P71, DOI [10.1097/coh.0000000000000525, 10.1097/COH.0000000000000525]
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 89
TC 0
Z9 0
U1 2
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD NOV-DEC
PY 2019
VL 10
IS 6
AR e02790-19
DI 10.1128/mBio.02790-19
PG 17
WC Microbiology
SC Microbiology
GA JS7LF
UT WOS:000500484800051
PM 31796542
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Carvalho, GC
   Borget, MY
   Bernier, S
   Garneau, D
   Duarte, AJD
   Dumais, N
AF de Carvalho, Gabriel Costa
   Borget, Marie-Yolande
   Bernier, Stephane
   Garneau, Daniel
   da Silva Duarte, Alberto Jose
   Dumais, Nancy
TI RAGE and CCR7 mediate the transmigration of Zika-infected monocytes
   through the blood-brain barrier
SO IMMUNOBIOLOGY
LA English
DT Article
DE Zika virus; Monocytes; Blood-brain barrier; RAGE; CCR7; HMGB1
ID MOBILITY GROUP BOX-1; GLYCATION END-PRODUCTS; HUMAN PLACENTAL CELLS;
   VIRUS-INFECTION; DENDRITIC CELLS; DOPAMINERGIC-NEURONS;
   ENDOTHELIAL-CELLS; ALPHA PRODUCTION; IN-VITRO; 1 HMGB1
AB Details of the "Trojan Horse" mechanism by which Zika virus (ZIKV) crosses the blood-brain barrier (BBB) remain unclear. However, the migration of ZIKV-infected monocytes to the brain is thought to be dependent on both pattern-recognition and chemokine receptors. In this study, we investigated whether the migration of ZIKV-infected MonoMac-1 (MM-1) cells through the BBB is dependent on chemokine receptor 7 (CCR7) and receptor for advanced glycation end (RAGE); we also determined whether high mobility group box protein 1 (HMGB1) could facilitate the permeabilization of endothelial cells. We demonstrated that ZIKV infects MM-1 cells, leading to milieu accumulation of HMGB1. Our results suggest that HMGB1 is involved in the dysregulation of primary human brain microvascular endothelial cell junction markers. Our results also indicate that the migration of ZIKV-infected monocytes is dependent on chemokine ligand 19 (CCL19), the natural ligand of CCR7, in conditions recapitulating inflammation. RAGE-dependent migration of ZIKV-infected cells declined during transmigration assays in the presence of RAGE receptor antagonist FPS-ZM1. Understanding the molecular role of monocyte trafficking during ZIKV infections could facilitate the development of new therapeutic strategies to prevent the deleterious consequences of ZIKV neuroinfection.
C1 [de Carvalho, Gabriel Costa; Borget, Marie-Yolande; Bernier, Stephane; Garneau, Daniel; Dumais, Nancy] Univ Sherbrooke, Fac Sci, Dept Biol, 2500 Boul Univ, Sherbrooke, PQ J1K 2R1, Canada.
   [de Carvalho, Gabriel Costa; da Silva Duarte, Alberto Jose] Univ Sao Paulo, Inst Trop Med, Med Sch, Dept Dermatol,Lab Dermatol & Immunodeficiencies, LIM 56, Sao Paulo, SP, Brazil.
RP Dumais, N (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, 2500 Boul Univ, Sherbrooke, PQ J1K 2R1, Canada.
EM nancy.dumais@usherbrooke.ca
RI Costa de Carvalho, Gabriel/G-6602-2011
OI Costa de Carvalho, Gabriel/0000-0002-7377-9807
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2017/22539-0, 2016/08061-7];
   Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada [RGPIN-2015-06306]
FX This work was supported, in part, by the Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (2017/22539-0) and (2016/08061-7), Laboratory of
   Medical Research, Unit 56 of the Hospital das Clinicas-Faculty of
   Medicine of Sao Paulo. This study was also supported by The Natural
   Sciences and Engineering Research Council of Canada (Funding Reference
   Number RGPIN-2015-06306).
CR Abreu CM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02766
   Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010
   Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565
   Anzilotti S, 2012, BRAIN RES BULL, V87, P350, DOI 10.1016/j.brainresbull.2011.01.009
   Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516
   Borde C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016145
   Brenn Anja, 2011, Int J Alzheimers Dis, V2011, P690121, DOI 10.4061/2011/690121
   BRETT J, 1993, AM J PATHOL, V143, P1699
   Casula M, 2011, NEUROSCIENCE, V179, P233, DOI 10.1016/j.neuroscience.2011.02.001
   Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0
   Columba-Cabezas S, 2003, BRAIN PATHOL, V13, P38
   Cote SC, 2009, MOL IMMUNOL, V46, P2682, DOI 10.1016/j.molimm.2008.08.269
   Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506
   Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Fraisier C, 2015, VIRUS RES, V195, P9, DOI 10.1016/j.virusres.2014.08.017
   Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x
   Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772
   Han YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004319
   HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752
   Hu XM, 2012, J NEUROIMMUNE PHARM, V7, P187, DOI 10.1007/s11481-011-9309-0
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kawano Y., 2011, CYTOKINE, V56, P180
   Kempuraj D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00216
   King NJC, 2003, IMMUNOL CELL BIOL, V81, P207, DOI 10.1046/j.1440-1711.2003.01167.x
   Kobayashi D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09113-4
   Krumbholz M, 2007, J NEUROIMMUNOL, V190, P72, DOI 10.1016/j.jneuroim.2007.07.024
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu YY, 2010, ATHEROSCLEROSIS, V208, P34, DOI 10.1016/j.atherosclerosis.2009.06.007
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nosaka N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0983-9
   Nowak P, 2007, AIDS, V21, P869, DOI 10.1097/QAD.0b013e3280b079b6
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Olajide OA, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/459723
   Ong SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041932
   Ott TR, 2006, BIOCHEM BIOPH RES CO, V348, P1089, DOI 10.1016/j.bbrc.2006.07.165
   Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Paradis A, 2016, J NEUROIMMUNOL, V295, P12, DOI 10.1016/j.jneuroim.2016.03.019
   Paradis A, 2016, METHODSX, V3, P25, DOI 10.1016/j.mex.2015.11.009
   Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005
   Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200
   Rai V, 2012, J EXP MED, V209, P2339, DOI 10.1084/jem.20120873
   Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Saeki H, 1999, J IMMUNOL, V162, P2472
   Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shirasuna K, 2016, AM J REPROD IMMUNOL, V75, P557, DOI 10.1111/aji.12506
   Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201
   Steube KG, 1997, LEUKEMIA RES, V21, P327, DOI 10.1016/S0145-2126(96)00129-4
   Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008
   Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taguchi A, 2000, NATURE, V405, P354
   Teismann P, 2012, BIOFACTORS, V38, P395, DOI 10.1002/biof.1035
   van Zoelen MAD, 2009, VIROLOGY, V391, P265, DOI 10.1016/j.virol.2009.05.032
   Vande Walle L, 2011, VIRULENCE, V2, P162, DOI 10.4161/viru.2.2.15480
   Vogel S, 2016, BIOCHEM BIOPH RES CO, V478, P143, DOI 10.1016/j.bbrc.2016.07.078
   Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77
   Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16
   West KL, 2004, MOL CELL BIOL, V24, P3747, DOI 10.1128/MCB.24.9.3747-3756.2004
   Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0
   Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067
   Youn JH, 2011, EUR J IMMUNOL, V41, P2753, DOI 10.1002/eji.201141391
   Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82
   Zeh HJ, 2005, J IMMUNOTHER, V28, P1, DOI 10.1097/00002371-200501000-00001
   Zhu XW, 2016, ACTA OTO-LARYNGOL, V136, P87, DOI 10.3109/00016489.2015.1082192
NR 85
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD NOV
PY 2019
VL 224
IS 6
BP 792
EP 803
DI 10.1016/j.imbio.2019.08.007
PG 12
WC Immunology
SC Immunology
GA JS9XW
UT WOS:000500653500010
PM 31493920
DA 2020-07-08
ER

PT J
AU Ali, R
   Mohammed, A
   Jayaraman, J
   Nandram, N
   Feng, RS
   Lezcano, RD
   Seeramsingh, R
   Daniel, B
   Lovin, DD
   Severson, DW
   Ramsubhag, A
AF Ali, Renee
   Mohammed, Azad
   Jayaraman, Jayaraj
   Nandram, Naresh
   Feng, Rachel Shui
   Lezcano, Raul Diosany
   Seeramsingh, Roshan
   Daniel, Brent
   Lovin, Diane D.
   Severson, David W.
   Ramsubhag, Adesh
TI Changing patterns in the distribution of the Mayaro virus vector
   Haemagogus species in Trinidad, West Indies
SO ACTA TROPICA
LA English
DT Article
DE Mayaro virus; Yellow fever; Haemagogus; Trinidad; Distribution
ID DIEL OVIPOSITION PERIODICITY; SEASONAL INCIDENCE; MOSQUITOS DIPTERA;
   BITING CYCLE; MATO-GROSSO; INFECTION; CULICIDAE; EQUINUS; PARITY;
   LEUCOCELAENUS
AB The Mayaro virus disease (MAYVD) is an emerging mosquito borne zoonosis that was first reported on the island of Trinidad in 1954. The viral agent for this disease is known to presently be endemic to Central and South America. The enzootic cycle of the Mayaro virus (MAYV) is not fully characterized, though primates are thought to be the main reservoir with Haemagogus species of mosquitoes as the primary vector. This virus has been responsible for several sporadic cases of infections and limited outbreaks, but it is postulated that the MAYVD will become a major epidemic in the future, following in the steps of the recent pandemics caused by Chikungunya and Zika viruses. Mitigating possible major outbreaks of MAYVD in the future would require effective strategies for vector control, for which knowledge on the ecology and distribution of the Haemagogus mosquitoes would be vitally important. In Trinidad, Haemagogus species have only been reported in the northwestern peninsula of the island based on studies up to 1995. However, no recent investigations have been completed to determine the status of this important vector on the island. The aim of this study was to investigate the current spatial distribution of Haemagogus species in the island of Trinidad, West Indies. Adult Haemagogus (Hag.) mosquitoes and larvae were surveyed during a twenty-month period using human bait trapping and ovitraps in major forested areas on the island. Mosquito species were identified using classical taxonomic keys. Haemagogus species were widespread and found in all forest types surveyed. Hag. janthinomys (85.7%) was the most widely distributed and dominant species on the island. Lower levels of Hag. leucocelaneus (7.3%), Hag. equinus (6.4%) and Hag. celeste (0.6%) were also collected. Overall, the proportion of mosquitoes collected in the wet season (June-December) was 3.5 times more than in the dry season (January-May). Mangroves, young secondary forests, semi-evergreen and evergreen forest types had relatively high mean abundance levels of Haemagogus species as compared to deciduous and montane forests. Proximity analysis suggests that population settlements within a 1 km buffer of the forest peripherals may be at risk for any emerging arboviral disease associated with these mosquito vectors. Haemagogus species showed a much wider distribution in Trinidad as compared to previous reports from up to 20 years ago and were prevalent in areas with no known presence of non-human primates. Since the MAYV has been previously implicated in causing infections in vertebrate hosts like rodents, birds and small mammals, the findings of this study suggest that there may be alternative hosts and reservoirs of this virus in the sylvatic cycle in Trinidad, other than primates. This has significant epidemiological implications for mosquito-borne viral infections in the region.
C1 [Ali, Renee; Mohammed, Azad; Jayaraman, Jayaraj; Feng, Rachel Shui; Daniel, Brent; Severson, David W.; Ramsubhag, Adesh] Univ West Indies, Fac Sci & Technol, Dept Life Sci, St Augustine Campus, St Augustine, Trinidad Tobago.
   [Nandram, Naresh; Lezcano, Raul Diosany; Seeramsingh, Roshan] Govt Trinidad & Tobago, Insect Vector Control Div, Minist Hlth, St Augustine, Trinidad Tobago.
   [Lovin, Diane D.; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Lovin, Diane D.; Severson, David W.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
RP Ramsubhag, A (corresponding author), Univ West Indies, Fac Sci & Technol, Dept Life Sci, St Augustine Campus, St Augustine, Trinidad Tobago.
EM Adesh.Ramsubhag@sta.uwi.edu
CR AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986
   Alencar J, 2018, J AM MOSQUITO CONTR, V34, P85, DOI 10.2987/18-6739.1
   ARNELL J H, 1973, Contributions of the American Entomological Institute, V10, P1
   Arredondo-Garcia JL, 2016, ACTA PEDIATR MEX, V37, P111, DOI 10.18233/APM37No2pp111-131
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   BATES M, 1945, J ANIM ECOL, V14, P17, DOI 10.2307/1396
   Bates M, 1944, ECOLOGY, V25, P159, DOI 10.2307/1930689
   Benenson A.S., 1995, CONTROL COMMUNICABLE, V217
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   CHADEE D D, 1985, Mosquito Systematics, V17, P147
   CHADEE DD, 1990, ANN TROP MED PARASIT, V84, P267, DOI 10.1080/00034983.1990.11812466
   CHADEE DD, 1981, MOSQ NEWS, V41, P568
   CHADEE DD, 1989, ANN TROP MED PARASIT, V83, P507, DOI 10.1080/00034983.1989.11812379
   CHADEE DD, 1992, MED VET ENTOMOL, V6, P143, DOI 10.1111/j.1365-2915.1992.tb00592.x
   CHADEE DD, 1995, MED VET ENTOMOL, V9, P372, DOI 10.1111/j.1365-2915.1995.tb00006.x
   CHADEE DD, 1993, MED VET ENTOMOL, V7, P141, DOI 10.1111/j.1365-2915.1993.tb00667.x
   CHADEE DD, 1991, ANN TROP MED PARASIT, V85, P543, DOI 10.1080/00034983.1991.11812607
   DARSIE R F JR, 1985, Mosquito Systematics, V17, P153
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   GOTT, 2016, TRIN TOB 5 NAT REP U, P225
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   Helmer EH, 2012, FOREST ECOL MANAG, V279, P147, DOI 10.1016/j.foreco.2012.05.016
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   Izurieta R.O., 2018, VIRUS ADAPT TREAT, V10, P9, DOI [10.2147/VAAT.S128711, DOI 10.2147/VAAT.S128711]
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   PAHO/WHO-Pan American Health Organization/World Health Organization, 2019, EP AL MAYAR FEV
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Pego P.N., 2014, J HUM VIROL RETROVIR, V1
   Pena CJ, 2004, J VECTOR ECOL, V29, P374
   Sant Rosemarie, 2018, TRINIDAD TOBAGO 0915
   Scruggs Gregory, 2018, THOMPSON REUTER 0723
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   WRBU Walter Reed Biosystematics Unit, 2012, MED IMP ARTHR SPEC S
   ZAVORTINK TJ, 1972, CONTRIB AM ENTOMOL I, V8, P1
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 41
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2019
VL 199
AR UNSP 105108
DI 10.1016/j.actatropica.2019.105108
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JS3BZ
UT WOS:000500185500036
PM 31351893
DA 2020-07-08
ER

PT J
AU Du, WT
   Hu, CM
   Yu, CJ
   Tong, JF
   Qiu, J
   Zhang, SH
   Liu, Y
AF Du, Wenting
   Hu, Chunming
   Yu, Chaoju
   Tong, Jianfei
   Qiu, Jie
   Zhang, Shaohua
   Liu, Yang
TI Comparison between pupal and adult X-ray radiation, designed for the
   sterile insect technique for Aedes albopictus control
SO ACTA TROPICA
LA English
DT Article
DE Sterile insect technique; X-ray irradiation; Aedes albopictus; Induced
   sterility; Male mating competiveness
ID DOSIMETRY; DIPTERA; MALES
AB Aedes albopictus is a vector of several human viral diseases, including dengue, chikungunya, and Zika. New control method for Aedes albopictus is needed to replace traditional methods such as chemical insecticides which induce resistance, environmental contamination and toxicity to human. In sterile insect technique (SIT), male mosquitoes are sterilized by gamma-ray or X-ray irradiation before released. In this study, the relative effectiveness of X-ray irradiation as a mosquito SIT was investigated. Both pupal and adult Aedes albopictus were subjected to different radiation doses and their emergence, survivorship, longevity, induced sterility, and male mating competitiveness were evaluated. Relative to controls, irradiation had no significant effect on emergence and survivorship but significantly reduce adult longevity. Induced sterility were essentially same for both irradiated pupal and adult. At a dose of 40 Gy, 97% and 100% sterility was respectively achieved for males and females. Mating competitiveness was reduced both in adult males and those derived from pupae exposed to 40 Gy. However, populations can be suppressed by increasing the release ratio (sterile: normal). When the release ratio was 7:1, 74% of the wild population could be suppressed. Overall, the results of the present study showed that SIT based on X-Ray irradiation is scientific and feasible to control Aedes albopictus.
C1 [Du, Wenting; Hu, Chunming; Yu, Chaoju; Tong, Jianfei; Qiu, Jie] Dongguan Neutron Sci Ctr, Dongguan 523808, Peoples R China.
   [Du, Wenting; Hu, Chunming; Yu, Chaoju; Tong, Jianfei; Qiu, Jie] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China.
   [Qiu, Jie] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Zhang, Shaohua; Liu, Yang] Shenzhen Ctr Dis Control & Prevent, Shenzhen 518055, Guangdong, Peoples R China.
RP Hu, CM (corresponding author), Dongguan Neutron Sci Ctr, Dongguan 523808, Peoples R China.; Hu, CM (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China.
EM hucm@ihep.ac.cn
FU Provincial Science and Technology Plan Project of Guangdong
   [2015A020213001]
FX This research was supported by the Provincial Science and Technology
   Plan Project of Guangdong (No. 2015A020213001).
CR Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Dyck V.A., 2005, STERILE INSECT TECHN, DOI [10.5860/CHOICE.43-5894, DOI 10.5860/CHOICE.43-5894]
   FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869
   Gray P., 2011, PACKAG TRANSP STORAG, DOI [10.1007/s00381-018-3872-0, DOI 10.1007/S00381-018-3872-0]
   Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2
   Madakacherry O, 2014, ACTA TROP, V132, pS124, DOI 10.1016/j.actatropica.2013.11.020
   Mastrangelo T, 2010, J ECON ENTOMOL, V103, P85, DOI 10.1603/EC09139
   Mehta K, 2011, RADIAT PHYS CHEM, V80, P107, DOI 10.1016/j.radphyschem.2010.08.011
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547
   Robinson A.S., 2009, MED VET ENTOMOL, DOI [10.1111/j.1365-2915.2008, DOI 10.1111/J.1365-2915.2008]
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223
   Zhang D., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL
NR 17
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2019
VL 199
AR UNSP 105110
DI 10.1016/j.actatropica.2019.105110
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JS3BZ
UT WOS:000500185500034
PM 31351072
DA 2020-07-08
ER

PT J
AU Singh, H
   Singh, OP
   Akhtar, N
   Sharma, G
   Sindhania, A
   Gupta, N
   Valecha, N
AF Singh, Himmat
   Singh, Om P.
   Akhtar, Nasreen
   Sharma, Gunjan
   Sindhania, Ankita
   Gupta, Nivedita
   Valecha, Neena
TI First report on the transmission of Zika virus by Aedes (Stegomyia)
   aegypti (L.) (Diptera: Culicidae) during the 2018 Zika outbreak in India
SO ACTA TROPICA
LA English
DT Article
DE Entomological surveillance; RT-PCR; Transmission risk; Outbreak
ID PREVENTION; INFECTION; GUIDANCE
AB In a recent outbreak of Zika virus (ZIKV) infection in Jaipur city (Rajasthan, India), a total of 159 cases were reported in September 2018. In order to identify vector responsible for Zika transmission, mosquitoes were collected from houses with reported Zika cases and nearby houses. A total of 108 pools containing 522 mosquitoes were tested for presence of ZIKV using RT-PCR and Real Time RT-PCR. We detected presence of ZIKV in three pools of Aedes (Stegomyia) aegypti (L.), out of a total of 79 pools with 383 Ae. aegypti through RT-PCR as well as real-time RT-PCR. The presence of ZIKV in Ae. aegypti was further confirmed by DNA sequencing of the partial envelope region of ZIKV. Homology search of DNA sequence revealed highest identity (100%) with a ZIKV isolate from human from the study area which support the role of Ae. aegypti acting as a ZIKV vector. All other mosquitoes (Aedes vittatus and Culex quinquefasciatus) were negative for ZIKV. None of the F1 generation mosquito pools (276 mosquitoes in 43 pools) were found positive. This is the first report of presence of ZIKV in Ae. aegypti from the Indian subcontinent.
C1 [Singh, Himmat; Singh, Om P.; Akhtar, Nasreen; Sharma, Gunjan; Sindhania, Ankita; Valecha, Neena] Natl Inst Malaria Res, Sect 8 Dwarka, New Delhi 110077, India.
   [Gupta, Nivedita] Indian Council Med Res, New Delhi 110029, India.
RP Singh, OP (corresponding author), Natl Inst Malaria Res, Sect 8 Dwarka, New Delhi 110077, India.
EM hspawar@rediffmail.com; singh@nimr.org.in; nasreen84akhtar@gmail.com;
   guunjan.sharma@gmail.com; ankitasindhania@gmail.com; ngupta@icmr.org.in;
   neenavalecha@gmail.com
RI Singh, Om Prakash/B-7958-2011
OI Singh, Om Prakash/0000-0001-5135-6654
FU State Health Department, Jaipur (Rajasthan, India)
FX The authors are thankful to the State Health Department, Jaipur
   (Rajasthan, India) for supporting necessary help during survey, the
   Ministry of Health and Family Welfare for sending teams for
   entomological investigations, and to the National Institute of Virology,
   Pune, India for supplying reagents and protocol.
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   [Anonymous], 2017, TOURISM DEP ANN PROG, V18
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barraud P.J., 1934, DIPTERA, V5, P463
   Bhardwaj S, 2017, INDIAN J MED RES, V146, P572, DOI 10.4103/ijmr.IJMR_1160_17
   Cabral GB, 2018, MEM I OSWALDO CRUZ, V113, P38, DOI 10.1590/0074-02760170248
   Charrel RN, 2014, CLIN MICROBIOL INFEC, V20, P662, DOI 10.1111/1469-0691.12694
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gu W, 2004, MED VET ENTOMOL, V18, P200, DOI 10.1111/j.0269-283X.2004.00482.x
   Hugo LE, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007281
   IAMAT, 2018, MALD GEN HLTH RISKS
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lan Phan Trong, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   Muraduzzaman AKM, 2017, ASIAN PAC J TROP MED, V10, P925, DOI 10.1016/j.apjtm.2017.08.015
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Rolph MS, 2019, LANCET INFECT DIS, V19, P469, DOI 10.1016/S1473-3099(19)30169-0
   SCOTT TW, 2004, ECOLOGICAL ASPECTS A, P187
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Swofford DL, 2002, PAUP PHYLOGENETIC AN
   The Health Protection Surveillance Centre, 2019, ZIK VIR INF LIST AFF
   Trosemeier JH, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00917-16
   Tun MMN, 2018, AM J TROP MED HYG, V98, P868, DOI 10.4269/ajtmh.17-0708
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   World Health Organization Emergencies Preparedness Response Zika Virus Infection-India, 2017, WHO EM PREP RESP ZIK
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
NR 34
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2019
VL 199
AR UNSP 105114
DI 10.1016/j.actatropica.2019.105114
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JS3BZ
UT WOS:000500185500031
PM 31442386
DA 2020-07-08
ER

PT J
AU Michalski, D
   Ontiveros, JG
   Russo, J
   Charley, PA
   Anderson, JR
   Heck, AM
   Geiss, BJ
   Wilusz, J
AF Michalski, Daniel
   Ontiveros, J. Gustavo
   Russo, Joseph
   Charley, Phillida A.
   Anderson, John R.
   Heck, Adam M.
   Geiss, Brian J.
   Wilusz, Jeffrey
TI Zika virus noncoding sfRNAs sequester multiple host-derived RNA-binding
   proteins and modulate mRNA decay and splicing during infection
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE flavivirus; RNA splicing; RNA turnover; RNA editing; RNA virus;
   5??3?-exoribonuclease (XRN1); post-transcriptional regulation;
   subgenomic flavivirus RNA (sfRNA); Zika virus
ID SUBGENOMIC RNA; GENE-EXPRESSION; GLOBAL ANALYSIS; FLAVIVIRUSES;
   DEGRADATION; INTERFERENCE; ASSOCIATION; PSEUDOKNOT; NETWORKS; SNORNA
AB Insect-borne flaviviruses produce a 300?500?base long noncoding RNA, termed subgenomic flavivirus RNA (sfRNA), by stalling the cellular 5??3?-exoribonuclease 1 (XRN1) via structures located in their 3? UTRs. In this study, we demonstrate that sfRNA production by Zika virus represses XRN1 analogous to what we have previously shown for other flaviviruses. Using protein?RNA reconstitution and a stringent RNA pulldown assay with human choriocarcinoma (JAR) cells, we demonstrate that the sfRNAs from both dengue type 2 and Zika viruses interact with a common set of 21 RNA-binding proteins that contribute to the regulation of post-transcriptional processes in the cell, including splicing, RNA stability, and translation. We found that four of these sfRNA-interacting host proteins, DEAD-box helicase 6 (DDX6) and enhancer of mRNA decapping 3 (EDC3) (two RNA decay factors), phosphorylated adaptor for RNA export (a regulator of the biogenesis of the splicing machinery), and apolipoprotein B mRNA-editing enzyme catalytic subunit 3C (APOBEC3C, a nucleic acid?editing deaminase), inherently restrict Zika virus infection. Furthermore, we demonstrate that the regulations of cellular mRNA decay and RNA splicing are compromised by Zika virus infection as well as by sfRNA alone. Collectively, these results reveal the large extent to which Zika virus?derived sfRNAs interact with cellular RNA-binding proteins and highlight the potential for widespread dysregulation of post-transcriptional control that likely limits the effective response of these cells to viral infection.
C1 [Michalski, Daniel; Russo, Joseph; Charley, Phillida A.; Anderson, John R.; Geiss, Brian J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Ontiveros, J. Gustavo; Heck, Adam M.; Geiss, Brian J.; Wilusz, Jeffrey] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.
RP Wilusz, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Wilusz, J (corresponding author), Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.
EM jeffrey.wilusz@colostate.edu
OI Wilusz, Jeffrey/0000-0001-8535-3435
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI123136, AI130497,
   AI32668]; National Science Foundation NRT Award [1450032]; National
   Science Foundation GRFP award
FX This work was supported by National Institutes of Health Grants AI123136
   and AI130497 (to J. W.) and Grant AI32668 (to B. J. G.). The authors
   declare that they have no conflicts of interest with the contents of
   this article. The content is solely the responsibility of the authors
   and does not necessarily represent the official views of the National
   Institutes of Health.; Supported in part by National Science Foundation
   NRT Award 1450032 and by a National Science Foundation GRFP award.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Ashraf U, 2019, TRENDS MICROBIOL, V27, P268, DOI 10.1016/j.tim.2018.11.004
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Charley PA, 2018, J BIOL CHEM, V293, P285, DOI [10.1074/jbc.m117.805796, 10.1074/jbc.M117.805796]
   Cheadle C, 2005, ANN NY ACAD SCI, V1058, P196, DOI 10.1196/annals.1359.026
   Chemudupati M, 2019, BBA-MOL CELL RES, V1866, P382, DOI 10.1016/j.bbamcr.2018.09.012
   Cross ST, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1536
   Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Ezegbunam W, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1455
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   Flobinus A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030137
   Flobinus A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100272
   Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188
   Frabutt DA, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090255
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004
   Gee P, 2011, J VIROL, V85, P9726, DOI 10.1128/JVI.05288-11
   Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Gonzalez MC, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-96
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012
   Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Iwakawa HO, 2008, J VIROL, V82, P10162, DOI 10.1128/JVI.01027-08
   Kfir N, 2015, CELL REP, V11, P618, DOI 10.1016/j.celrep.2015.03.048
   Kung CP, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00762
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lerner T, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010013
   Liao KC, 2018, RNA, V24, P803, DOI 10.1261/rna.064006.117
   Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708
   Moon SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003762
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Mourao A, 2010, RNA, V16, P1205, DOI 10.1261/rna.2009910
   Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165
   Nandy A, 2017, PROTEINS, V85, P1983, DOI 10.1002/prot.25352
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Neumann T, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2849-7
   Ostareck DH, 2014, WIRES RNA, V5, P659, DOI 10.1002/wrna.1237
   Peng ZG, 2011, HEPATOLOGY, V53, P1080, DOI 10.1002/hep.24160
   Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Raices M, 2017, CURR OPIN CELL BIOL, V46, P26, DOI 10.1016/j.ceb.2016.12.006
   Russo J, 2017, METHODS, V120, P39, DOI 10.1016/j.ymeth.2017.02.003
   Scheller U, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0358-6
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160
   Schott J, 2010, WIRES RNA, V1, P432, DOI 10.1002/wrna.13
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39100
   Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881
   Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296
   Slonchak A, 2018, ANTIVIR RES, V159, P13, DOI 10.1016/j.antiviral.2018.09.006
   Smith HC, 2017, RNA BIOL, V14, P1153, DOI 10.1080/15476286.2016.1259783
   Sokoloski KJ, 2008, METHOD ENZYMOL, V448, P139, DOI 10.1016/S0076-6879(08)02608-6
   Soto-Acosta R, 2018, ELIFE, V7, DOI 10.7554/eLife.39023
   St John AL, 2013, NAT REV MICROBIOL, V11, P420, DOI 10.1038/nrmicro3030
   Steckelberg AL, 2018, P NATL ACAD SCI USA, V115, P6404, DOI 10.1073/pnas.1802429115
   Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Wu G, 2018, RNA, V24, P1056, DOI 10.1261/rna.065383.117
   Yeh SC, 2018, DNA CELL BIOL, V37, P154, DOI 10.1089/dna.2017.4059
   Yoshimoto R, 2017, RNA, V23, P47, DOI 10.1261/rna.058065.116
   Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608
NR 79
TC 1
Z9 1
U1 4
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 1
PY 2019
VL 294
IS 44
BP 16282
EP 16296
DI 10.1074/jbc.RA119.009129
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JR2RL
UT WOS:000499478600033
PM 31519749
DA 2020-07-08
ER

PT J
AU Julian, D
   Hollingsworth, EW
   Julian, K
   Imitola, J
AF Julian, Dominic
   Hollingsworth, Ethan W.
   Julian, Katherine
   Imitola, Jaime
TI Convergence of human cellular models and genetics to study neural stem
   cell signaling to enhance central nervous system regeneration and repair
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE Genetics; Human cell models; Phenogenetics; Neurodegeneration;
   Regeneration; Stem cells; Cellular atlas
ID SUBVENTRICULAR ZONE; CEREBRAL ORGANOIDS; HUMAN BRAIN; ZIKA VIRUS;
   MULTIPLE-SCLEROSIS; EPENDYMAL CELLS; VASCULAR NICHE; NEUROGENESIS;
   REVEALS; NEURONS
AB Human central nervous system (CNS) regeneration is considered the holy grail of neuroscience research, and is one of the most pressing and difficult questions in biology and science. Despite more than 20 years of work in the field of neural stem cells (NSCs), the area remains in its infancy as our understanding of the fundamental mechanisms that can be leveraged to improve CNS regeneration in neurological diseases is still growing. Here, we focus on the recent lessons from lower organism CNS regeneration genetics and how such findings are starting to illuminate our understanding of NSC signaling pathways in humans. These findings will allow us to improve upon our knowledge of endogenous NSC function, the utility of exogenous NSCs, and the limitations of NSCs as therapeutic vehicles for providing relief from devastating human neurological diseases. We also discuss the limitations of activating NSC signaling for CNS repair in humans, especially the potential for tumor formation. Finally, we will review the recent advances in new culture techniques, including patient-derived cells and cerebral organoids to model the genetic regulation of signaling pathways controlling the function of NSCs during injury and disease states.
C1 [Julian, Dominic; Hollingsworth, Ethan W.; Julian, Katherine; Imitola, Jaime] Div Neuroimmunol & Multiple Sclerosis, Lab Neural Stem Cells & Funct Neurogenet, Columbus, OH USA.
   [Julian, Dominic; Julian, Katherine; Imitola, Jaime] Ohio State Univ, Wexner Med Ctr, Dept Neurol, Columbus, OH 43210 USA.
   [Julian, Dominic; Julian, Katherine; Imitola, Jaime] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.
   [Imitola, Jaime] James Comprehens Canc Hosp, Columbus, OH USA.
   [Hollingsworth, Ethan W.] Univ Calif Irvine, Med Scientist Training Program, Irvine, CA 92697 USA.
RP Imitola, J (corresponding author), UConn Sch Med, Dept Neurol, Div Multiple Sclerosis & Translat Neuroimmunol, Lab Neural Stem Cells & Funct Neurogenet, Farmington, CT 06032 USA.
EM imitola@uchc.edu
FU OSU neurological institute research Award
FX This work was funded by a OSU neurological institute research Award to
   JI.
CR Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25
   Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347
   Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5
   Amamoto R, 2016, ELIFE, V5, DOI 10.7554/eLife.13998
   Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437
   Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940
   Ardhanareeswaran K, 2017, NAT REV NEUROL, V13, P265, DOI 10.1038/nrneurol.2017.45
   Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035
   Bergstrom T, 2012, UPSALA J MED SCI, V117, P132, DOI 10.3109/03009734.2012.665096
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bhattarai P, 2016, CELL REP, V17, P941, DOI 10.1016/j.celrep.2016.09.075
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Bowman M, 2015, JAMA NEUROL, V72, P1342, DOI 10.1001/jamaneurol.2015.1891
   Burr HS, 1916, J COMP NEUROL, V26, P203, DOI 10.1002/cne.900260203
   Cajal R.S., 1928, DEGENERATION REGENER, V2, P750
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Cao L., 2018, STEM CELL NICHE NEUR
   Carcamo-Orive I, 2017, CELL STEM CELL, V20, P518, DOI 10.1016/j.stem.2016.11.005
   Chen H.I., 2018, DEV DYN
   Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281
   DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0
   DeBoever C, 2017, CELL STEM CELL, V20, P533, DOI 10.1016/j.stem.2017.03.009
   Deboux C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057430
   El Waly B, 2018, STEM CELL REP, V10, P1492, DOI 10.1016/j.stemcr.2018.02.015
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322
   Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002
   Ferguson JF, 2015, HUM MOL GENET, V24, P1801, DOI 10.1093/hmg/ddu589
   Ferraro F, 2010, ADV EXP MED BIOL, V695, P155, DOI 10.1007/978-1-4419-7037-4_11
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304
   Gotz M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018853
   Hollingsworth EW, 2017, EMBO MOL MED, V9, P1742, DOI 10.15252/emmm.201708191
   Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102
   Imitola J, 2004, PHILOS T R SOC B, V359, P823, DOI 10.1098/rstb.2004.1474
   Imitola J, 2015, AM J MED GENET A, V167, P2808, DOI 10.1002/ajmg.a.37268
   Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Johnson MB, 2018, NATURE, V556, P370, DOI 10.1038/s41586-018-0035-0
   Julian K, 2018, SEMIN NEUROL, V38, P176, DOI 10.1055/s-0038-1649338
   Kawabata S, 2016, STEM CELL REP, V6, P1, DOI 10.1016/j.stemcr.2015.11.013
   Khurana V, 2017, CELL SYST, V4, P147, DOI 10.1016/j.cels.2017.02.007
   Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754
   Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587
   Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Laterza C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3597
   Lee JH, 2018, NATURE, V560, P243, DOI 10.1038/s41586-018-0389-3
   Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X
   Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973
   Madhavan M, 2018, NAT METHODS, V15, P700, DOI 10.1038/s41592-018-0081-4
   Magavi SS, 2000, NATURE, V405, P951
   Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029
   Merzaban JS, 2015, GLYCOBIOLOGY, V25, P1392, DOI 10.1093/glycob/cwv046
   Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185
   Ming GL, 2017, CELL STEM CELL, V20, P749, DOI 10.1016/j.stem.2017.05.010
   Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9
   Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104
   Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0
   Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809
   Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005
   Nowoshilow S, 2018, NATURE, V554, P50, DOI 10.1038/nature25458
   OBERNIER K, 2019, DEV CAMBRIDGE ENGLAN, V146, DOI DOI 10.1242/DEV.156059
   Ogai K, 2014, NEUROSCI RES, V88, P84, DOI 10.1016/j.neures.2014.07.010
   Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006
   Orack JC, 2015, STEM CELL TRANSL MED, V4, P252, DOI 10.5966/sctm.2014-0133
   Patterson M, 2017, NAT GENET, V49, P1346, DOI 10.1038/ng.3929
   Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Rasmussen S, 2011, ANN NEUROL, V69, P878, DOI 10.1002/ana.22299
   Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041
   Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301
   Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487
   Shah PT, 2018, CELL, V173, P1045, DOI 10.1016/j.cell.2018.03.063
   Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276
   Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527
   Skaggs K, 2014, GLIA, V62, P2061, DOI 10.1002/glia.22726
   Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975
   Starossom SC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08140-7
   Starossom SC, 2011, BRAIN BEHAV IMMUN, V25, P991, DOI 10.1016/j.bbi.2010.11.002
   Sun AX, 2018, P NATL ACAD SCI USA, V115, pEB256, DOI 10.1073/pnas.1803780115
   Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   Tazaki A, 2017, DEV BIOL, V432, P63, DOI 10.1016/j.ydbio.2017.09.034
   Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174
   Theis JL, 2014, HUM MOL GENET, V23, P5793, DOI 10.1093/hmg/ddu297
   Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Woodworth MB, 2017, NAT REV GENET, V18, P230, DOI 10.1038/nrg.2016.159
   Yan D, 2014, DEV CELL, V28, P459, DOI 10.1016/j.devcel.2014.01.020
NR 95
TC 0
Z9 0
U1 8
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD NOV
PY 2019
VL 95
SI SI
BP 84
EP 92
DI 10.1016/j.semcdb.2019.07.002
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA JR9QP
UT WOS:000499951200009
PM 31310810
DA 2020-07-08
ER

PT J
AU Setia, H
   Muotri, AR
AF Setia, Harpreet
   Muotri, Alysson R.
TI Brain organoids as a model system for human neurodevelopment and disease
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE Brain organoids; Human neurodevelopment; Zika virus; Neurotrophic
   viruses; Neurological genetic disorders; Autism; Brain tumor
ID PLURIPOTENT STEM-CELLS; CEREBRAL ORGANOIDS; ZIKA VIRUS; DRUG DISCOVERY;
   CULTURE; NICOTINE; DIFFERENTIATION; ESTABLISHMENT; CULTIVATION;
   MATURATION
AB The ability to reproduce early stages of human neurodevelopment in the laboratory is one of the most exciting fields in modern neuroscience. The inaccessibility of the healthy human brain developing in utero has delayed our understanding of the initial steps in the formation of one of the most complex tissues in the body. Animal models, postmortem human tissues and cellular systems have been instrumental in contributing to our understanding of the human brain. However, all model systems have intrinsic limitations. The emerging field of brain organoids, which are three-dimensional self-assembled multicellular structures derived from human pluripotent stem cells, offers a promising complementary cellular model for the study of the human brain. Here, we will discuss the initial experiments that were the foundation for this emerging field, highlight recent uses of the technology and offer our perspective on future directions that might guide further exploratory experimentation to improve the human brain organoid model system.
C1 [Setia, Harpreet; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat, Rady Childrens Hosp San Diego, La Jolla, CA 92093 USA.
   [Muotri, Alysson R.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA.
   [Muotri, Alysson R.] CARTA, La Jolla, CA 92093 USA.
RP Muotri, AR (corresponding author), 2880 Torrey Pines Scen Dr,MC0695, La Jolla, CA 92093 USA.
EM muotri@ucsd.edu
FU California Institute for Regenerative Medicine (CIRM)California
   Institute for Regenerative Medicine [DISC2-09649]; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01MH108528, R01MH094753, R01MH109885,
   R01MH100175, R56MH109587]; SFARI grant [345469]; NARSAD Independent
   Investigator GrantNARSAD
FX This work was supported by a grant from the California Institute for
   Regenerative Medicine (CIRM, DISC2-09649), grants from the National
   Institutes of Health (R01MH108528, R01MH094753, R01MH109885,
   R01MH100175, and R56MH109587), an SFARI grant (#345469), and a NARSAD
   Independent Investigator Grant to A.R.M.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Allende ML, 2018, J LIPID RES, V59, P550, DOI 10.1194/jlr.M081323
   AUGUSTIT.G, 1969, P NATL ACAD SCI USA, V64, P311, DOI 10.1073/pnas.64.1.311
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Bley AE, 2011, PEDIATRICS, V128, pE1233, DOI 10.1542/peds.2011-0078
   Bonnier F, 2015, TOXICOL IN VITRO, V29, P124, DOI 10.1016/j.tiv.2014.09.014
   Brown J, 2018, CURR TOP DEV BIOL, V129, P99, DOI 10.1016/bs.ctdb.2018.03.002
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carrel A, 1911, J EXP MED, V14, P244, DOI 10.1084/jem.14.3.244
   Carrel A, 1911, J EXP MED, V13, P387, DOI 10.1084/jem.13.3.387
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chen H.I., 2018, DEV DYN
   Choi SW, 2010, SMALL, V6, P1492, DOI 10.1002/smll.201000544
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887
   da Silva B, 2018, SLAS DISCOV, V23, P862, DOI 10.1177/2472555218764623
   Daviaud N, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0219-18.2018
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Farahany NA, 2018, NATURE, V556, P429, DOI 10.1038/d41586-018-04813-x
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FELL HB, 1972, J EXP BIOL, V57, P1
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048
   Harrison RG, 1907, P SOC EXP BIOL MED, V4, P140
   Hermetter C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00706
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   HYDEN H, 1959, NATURE, V184, P433, DOI 10.1038/184433a0
   Ihalainen TO, 2015, NAT MATER, V14, P1252, DOI [10.1038/NMAT4389, 10.1038/nmat4389]
   Jabaudon D, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.172049
   Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037
   KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9
   KENT NH, 1960, ARCH BIOCHEM BIOPHYS, V89, P59, DOI 10.1016/0003-9861(60)90012-6
   Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Langley GR, 2017, DRUG DISCOV TODAY, V22, P327, DOI 10.1016/j.drudis.2016.10.011
   LAPHAM LW, 1971, SCIENCE, V173, P829, DOI 10.1126/science.173.3999.829
   Lavazza A, 2018, J MED ETHICS, V44, P606, DOI 10.1136/medethics-2017-104555
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26959-4
   Meyerson M, 1998, TOXICOL LETT, V103, P41, DOI 10.1016/S0378-4274(98)00278-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Nadadhur AG, 2018, STEM CELL RES, V32, P25, DOI 10.1016/j.scr.2018.08.017
   Perkhofer L, 2018, PERS MED, V15, P461, DOI 10.2217/pme-2018-0071
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Sacco MG, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-5
   SANFORD KK, 1950, J NATL CANCER I, V11, P351
   SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   SCHUBERT D, 1969, P NATL ACAD SCI USA, V64, P316, DOI 10.1073/pnas.64.1.316
   Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245
   Smith AM, 2010, J PEDIATR BIOCHEM, V1, P125, DOI 10.3233/JPB-2010-0012
   Stepanenko A A, 2012, Tsitol Genet, V46, P36
   Stoyanov GS, 2018, MED ONCOL, V35, DOI 10.1007/s12032-018-1083-x
   Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009
   THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7
   Trujillo C.A., 2018, BIORXIV, DOI [10.1101/358622, DOI 10.1101/358622]
   Trujillo C.A., 2018, TRENDS MOL MED
   Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30
   Wang YQ, 2018, LAB CHIP, V18, P851, DOI 10.1039/c7lc01084b
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Zhang BY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0763-y
   Zhang ZN, 2016, P NATL ACAD SCI USA, V113, P3185, DOI 10.1073/pnas.1521255113
NR 75
TC 7
Z9 6
U1 10
U2 13
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD NOV
PY 2019
VL 95
SI SI
BP 93
EP 97
DI 10.1016/j.semcdb.2019.03.002
PG 5
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA JR9QP
UT WOS:000499951200010
PM 30904636
DA 2020-07-08
ER

PT J
AU Muruato, AE
   Shan, C
   Fontes-Garfias, CR
   Liu, Y
   Cao, ZG
   Gao, Q
   Weaver, SC
   Shi, PY
AF Muruato, Antonio E.
   Shan, Chao
   Fontes-Garfias, Camila R.
   Liu, Yang
   Cao, Zengguo
   Gao, Qiang
   Weaver, Scott C.
   Shi, Pei-Yong
TI Genetic stability of live-attenuated Zika vaccine candidates
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Live-attenuated vaccine; Flavivirus; Virulence; Vaccine
   development
ID DNA VACCINE; IN-VITRO; INITIATES REPLICATION; IMMUNE-RESPONSE;
   VIRUS-VACCINE; PROTECTION; COMPETENCE; STRAIN
AB Zika virus (ZIKV) has drawn global attention as the etiologic agent of Zika Congenital Syndrome in babies born to infected pregnant women. To prevent future ZIKV outbreaks and protect persons at risk for severe disease, we developed two live-attenuated vaccine (LAV) candidates containing 10- or 20-nucleotide deletions in the 3'UTR of the viral genome (Delta 10 and Delta 20). After a single-dose immunization, both Delta 10 and Delta 20 LAVs protected mice and non-human primates against ZIKV infection. Here, we characterized the stability, safety, and efficacy of the LAVs after continuously culturing them on manufacture Vero cells for ten rounds. Whole genome sequencing showed that passage 10 (P10) LAVs retained the engineered Delta 10 and Delta 20 deletions; one to four additional mutations emerged at different regions of the genome. In A129 mice, the P10 LAVs exhibited viremia higher than the un-passaged LAVs, but lower than wild-type ZIKV; unlike wild-type ZIKV-infected mice, none of the P10 LAV-infected mice developed disease or death, demonstrating that the P10 LAVs remained attenuated. Mice immunized with a single dose of the P10 LAVs developed robust neutralizing antibody titers (1/1,000 to 1/10,000) and were protected against epidemic ZIKV challenge. The P10 LAVs did not exhibit increased neurovirulence. Intracranial inoculation of one-day-old CD1 pups with 10(3) focus-forming units of the P10 Delta 10 and Delta 20 LAVs resulted in 100% and >= 80% survival, respectively. Furthermore, the P10 LAVs remained incompetent in infecting Aedes aegypti mosquitoes after intrathoracic microinjection. Our results support the phenotypic stability and further development of these promising LAVs for ZIKV.
C1 [Muruato, Antonio E.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Shan, Chao; Fontes-Garfias, Camila R.; Liu, Yang; Cao, Zengguo; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Gao, Qiang] Sinovac Bioteck Co Ltd, Beijing, Peoples R China.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM peshi@utmb.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI120942, AI142759, AI127744,
   AI136126]; Kleberg Foundation; John S. Dunn Foundation; Amon G. Carter
   Foundation; Gilson Longenbaugh Foundation; Summerfield Robert
   Foundation; Western Gulf Center of Excellence for Vector-Borne Diseases
   (CDC) [U01CK000512]
FX We thank colleagues from the University of Texas of Medical Branch at
   Galveston for helpful discussions and support during the course of the
   work. P.-Y.S. was supported by NIH grants AI142759, AI127744, and
   AI136126; and awards from the Kleberg Foundation, John S. Dunn
   Foundation, Amon G. Carter Foundation, Gilson Longenbaugh Foundation,
   and Summerfield Robert Foundation. This research was also supported by
   NIH grant AI120942 and the Western Gulf Center of Excellence for
   Vector-Borne Diseases (CDC grant U01CK000512) to S.C.W.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Anez G, 2009, J VIROL, V83, P10384, DOI 10.1128/JVI.01083-09
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   BARRETT ADT, 1986, J GEN VIROL, V67, P631, DOI 10.1099/0022-1317-67-4-631
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hall RA, 2003, P NATL ACAD SCI USA, V100, P10460, DOI 10.1073/pnas.1834270100
   Hidajat R, 2016, VIROLOGY, V490, P83, DOI 10.1016/j.virol.2016.01.009
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025800
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mittal R., 2017, JAMA OTOLARYNGOL, P2168
   Mittal R, 2018, JAMA OTOLARYNGOL, V144, P3, DOI 10.1001/jamaoto.2017.1798
   Nickols B, 2017, VIROLOGY, V512, P66, DOI 10.1016/j.virol.2017.09.005
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner J.M., 2017, CELL, P273
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Shan C., 2017, NAT MED, V36, P92
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Tretyakova I, 2014, VIROLOGY, V468, P28, DOI 10.1016/j.virol.2014.07.050
   Tretyakova I, 2014, J INFECT DIS, V209, P1882, DOI 10.1093/infdis/jiu114
   Tretyakova I, 2013, VACCINE, V31, P1019, DOI 10.1016/j.vaccine.2012.12.050
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Xia HJ, 2018, ACS INFECT DIS, V4, P656, DOI 10.1021/acsinfecdis.8b00004
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie X, 2017, C PROC SOC EXP MECH, P89, DOI 10.1007/978-3-319-51439-0_22
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yun SI, 2016, J GEN VIROL, V97, P2575, DOI 10.1099/jgv.0.000574
   Zou J, 2019, CURR OPIN VIROL, V35, P19, DOI 10.1016/j.coviro.2019.01.005
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 44
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD NOV
PY 2019
VL 171
AR 104596
DI 10.1016/j.antiviral.2019.104596
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9LE
UT WOS:000499937000008
PM 31493417
DA 2020-07-08
ER

PT J
AU Rothan, HA
   Zhong, YW
   Sanborn, MA
   Teoh, TC
   Ruan, JJ
   Yusof, R
   Hang, J
   Henderson, MJ
   Fang, SY
AF Rothan, Hussin A.
   Zhong, Yongwang
   Sanborn, Mark A.
   Teoh, Teow Chong
   Ruan, Jingjing
   Yusof, Rohana
   Hang, Jun
   Henderson, Mark J.
   Fang, Shengyun
TI Small molecule grp94 inhibitors block dengue and Zika virus replication
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE ERAD; CDDO-me; Dengue virus; Zika virus; grp94; Antiviral
ID DRUG TARGET ENGAGEMENT; TRITERPENOID CDDO-ME; NF-KAPPA-B;
   ENDOPLASMIC-RETICULUM; BARDOXOLONE METHYL; QUALITY-CONTROL; HOST
   FACTORS; PROTEIN; APOPTOSIS; CANCER
AB Two major flaviviruses, dengue virus (DENV) and Zika virus (ZIKV), cause severe health and economic burdens worldwide. Recently, genome-wide screenings have uncovered the importance of regulators of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway for flavivirus replication in host cells. Here we report the identification of the compound Bardoxolone methyl (CDDO-me) as a potent inhibitor of the Hrd1 ubiquitin ligase-mediated ERAD, which possesses a broad-spectrum activity against both DENV and ZIKV. Cellular thermal shift assay (CETSA) suggested that CDDO-me binds to grp94, a key component of the Hrd1 pathway, at a low nanomolar concentration, whereas interaction was not detected with its paralog Hsp90. CDDO-me and the grp94 inhibitor PU-WS13 substantially suppressed DENV2 replication and the cytopathic effects caused by DENV and ZIKV infection. The antiviral activities of both compounds were demonstrated for all four DENV serotypes and four ZIKV strains in multiple human cell lines. This study defines grp94 as a crucial host factor for flavivirus replication and identified CDDO-me as a potent small molecule inhibitor of flavivirus infection. Inhibition of grp94 may contribute to the antiviral activity of CDDO- me. Further investigation of grp94 inhibitors may lead to a new class of broad-spectrum anti-flaviviral medications.
C1 [Rothan, Hussin A.; Zhong, Yongwang; Ruan, Jingjing; Fang, Shengyun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Ctr Biomed Engn & Technol,Dept Physiol, Baltimore, MD 21201 USA.
   [Sanborn, Mark A.; Hang, Jun] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Teoh, Teow Chong] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
   [Yusof, Rohana] Univ Malaya, Dept Mol Med, Fac Sci, Kuala Lumpur 50603, Malaysia.
   [Henderson, Mark J.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA.
   [Rothan, Hussin A.] Georgia State Univ, Coll Arts & Sci, Dept Biol, Atlanta, GA 30303 USA.
RP Rothan, HA (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Ctr Biomed Engn & Technol,Dept Physiol, Baltimore, MD 21201 USA.; Fang, SY (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St,Room 307A, Baltimore, MD 21201 USA.; Rothan, HA (corresponding author), Georgia State Univ, Coll Arts & Sci, Dept Biol, Atlanta, GA 30303 USA.
EM hrothan@gsu.edu
OI Sanborn, Mark/0000-0001-5308-4680
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [UO1GM117175_2018];
   Intramural Research Program of the NIH, National Center for Advancing
   Translational Sciences, US Military Infectious Diseases Research Program
   (MIDRP) [S0622_19_WR]; Ministry of Higher Education of MalaysiaMinistry
   of Education, Malaysia [FP007-2017A]
FX This work was primarily supported by the National Institutes of Health
   [UO1GM117175_2018to S. F.], and supported in part by the Intramural
   Research Program of the NIH, National Center for Advancing Translational
   Sciences, US Military Infectious Diseases Research Program (MIDRP)
   [S0622_19_WR to J.H.], and Ministry of Higher Education of Malaysia
   [FP007-2017A to R. Y.].
CR Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200
   Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cerezo M, 2016, CANCER CELL, V29, P805, DOI 10.1016/j.ccell.2016.04.013
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Chiappelli F, 2014, BIOINFORMATION, V10, P726, DOI 10.6026/97320630010726
   Chintharlapalli S, 2005, MOL PHARMACOL, V68, P119, DOI 10.1124/mol.105.011437
   Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9
   Gerold G, 2017, MOL CELL PROTEOMICS, V16, pS75, DOI 10.1074/mcp.R116.065649
   Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Hueston L, 2017, J INFECT DIS, V216, P612, DOI 10.1093/infdis/jix344
   Jeong SA, 2015, ONCOTARGET, V6, P21173, DOI 10.18632/oncotarget.4065
   Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Lee SH, 2008, HEPATOLOGY, V47, P854, DOI 10.1002/hep.22107
   Liberman E, 1999, J VIROL, V73, P3718, DOI 10.1128/JVI.73.5.3718-3722.1999
   Lim SO, 2005, WORLD J GASTROENTERO, V11, P2072, DOI 10.3748/wjg.v11.i14.2072
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Maillard RA, 2014, J AM CHEM SOC, V136, P10315, DOI 10.1021/ja503318x
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013
   Masullo M, 2017, EXPERT OPIN THER PAT, V27, P237, DOI 10.1080/13543776.2017.1253680
   Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5
   Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715
   Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606
   Morra ME, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1979
   Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692
   Patel PD, 2013, NAT CHEM BIOL, V9, P677, DOI [10.1038/NCHEMBIO.1335, 10.1038/nchembio.1335]
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Qin DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132337
   Qin D, 2016, ONCOTARGET, V7, P77096, DOI 10.18632/oncotarget.12801
   RAMAKRISHNAN M, 1995, DNA CELL BIOL, V14, P373, DOI 10.1089/dna.1995.14.373
   Romero-Brey I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060160
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Rothan HA, 2016, ANTIVIR RES, V127, P50, DOI 10.1016/j.antiviral.2016.01.006
   Rothan HA, 2014, ANTIVIR RES, V108, P173, DOI 10.1016/j.antiviral.2014.05.019
   Samudio I, 2008, MOL CANCER THER, V7, P1130, DOI 10.1158/1535-7163.MCT-07-0553
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schein CH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-40
   Seidler PM, 2014, J MOL BIOL, V426, P3590, DOI 10.1016/j.jmb.2014.08.024
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Silveira GF, 2016, CLIN EXP IMMUNOL, V183, P114, DOI 10.1111/cei.12701
   Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016
   Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802
   Sulczewski FB, 2018, ARCH VIROL, V163, P2313, DOI 10.1007/s00705-018-3856-0
   Tappe D., 2014, EURO SURVEILL
   To C, 2010, J BIOL CHEM, V285, P27944, DOI 10.1074/jbc.M110.103036
   Valk PJM, 1999, J VIROL, V73, P3595, DOI 10.1128/JVI.73.5.3595-3602.1999
   Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546
   Wang YY, 2014, DRUG DES DEV THER, V8, P2075, DOI 10.2147/DDDT.S68872
   Wang Y, 2017, VIROL SIN, V32, P23, DOI 10.1007/s12250-016-3902-6
   Wong MHL, 2016, J MED CHEM, V59, P2396, DOI 10.1021/acs.jmedchem.5b01292
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798
   Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318
NR 68
TC 2
Z9 2
U1 3
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD NOV
PY 2019
VL 171
AR 104590
DI 10.1016/j.antiviral.2019.104590
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9LE
UT WOS:000499937000002
PM 31421166
DA 2020-07-08
ER

PT J
AU Ahn, HB
   Kim, NY
   Shin, YK
   Shin, S
AF Ahn, H. B.
   Kim, N. Y.
   Shin, Y. K.
   Shin, S.
TI Induction of humoral and cellular immune responses in mice immunized
   with a DNA vaccine for Zika virus
SO HUMAN GENE THERAPY
LA English
DT Meeting Abstract
CT ESGCT 27th Annual Congress in collaboration with SETGyc Meeting
CY OCT 22-25, 2019
CL Barcelona, SPAIN
SP European Soc Gene & Cell Therapy, Soc Espanola Terapia Genica & Cellular
C1 [Ahn, H. B.; Shin, Y. K.; Shin, S.] Seoul Natl Univ, Seoul, South Korea.
   [Kim, N. Y.] ABION Inc, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1043-0342
EI 1557-7422
J9 HUM GENE THER
JI Hum. Gene Ther.
PD NOV 1
PY 2019
VL 30
IS 11
MA P341
BP A117
EP A117
PG 1
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA JK9QR
UT WOS:000495173100331
DA 2020-07-08
ER

PT J
AU Desole, G
   Sinigaglia, A
   Riccetti, S
   Masi, G
   Pacenti, M
   Trevisan, M
   Barzon, L
AF Desole, Giovanna
   Sinigaglia, Alessandro
   Riccetti, Silvia
   Masi, Giulia
   Pacenti, Monia
   Trevisan, Marta
   Barzon, Luisa
TI Modelling Neurotropic Flavivirus Infection in Human Induced Pluripotent
   Stem Cell-Derived Systems
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Zika virus; West Nile virus; dengue virus; flavivirus; neural stem cell;
   neuron; induced pluripotent stem cell; innate immune response; viral
   replication; infection; apoptosis
ID ZIKA VIRUS-INFECTION; WEST-NILE-VIRUS; NEURAL PROGENITORS; BRAIN;
   ORGANOIDS; NEURONS; DENGUE; DIFFERENTIATION; RESISTANCE
AB Generation of human induced pluripotent stem cells (hiPSCs) and their differentiation into a variety of cells and organoids have allowed setting up versatile, non-invasive, ethically sustainable, and patient-specific models for the investigation of the mechanisms of human diseases, including viral infections and host-pathogen interactions. In this study, we investigated and compared the infectivity and replication kinetics in hiPSCs, hiPSC-derived neural stem cells (NSCs) and undifferentiated neurons, and the effect of viral infection on host innate antiviral responses of representative flaviviruses associated with diverse neurological diseases, i.e., Zika virus (ZIKV), West Nile virus (WNV), and dengue virus (DENV). In addition, we exploited hiPSCs to model ZIKV infection in the embryo and during neurogenesis. The results of this study confirmed the tropism of ZIKV for NSCs, but showed that WNV replicated in these cells with much higher efficiency than ZIKV and DENV, inducing massive cell death. Although with lower efficiency, all flaviviruses could also infect pluripotent stem cells and neurons, inducing similar patterns of antiviral innate immune response gene expression. While showing the usefulness of hiPSC-based infection models, these findings suggest that additional virus-specific mechanisms, beyond neural tropism, are responsible for the peculiarities of disease phenotype in humans.
C1 [Desole, Giovanna; Sinigaglia, Alessandro; Riccetti, Silvia; Masi, Giulia; Trevisan, Marta; Barzon, Luisa] Univ Padua, Dept Mol Med, I-35121 Padua, Italy.
   [Pacenti, Monia; Barzon, Luisa] Padova Univ Hosp, Microbiol & Virol Unit, I-35128 Padua, Italy.
RP Trevisan, M; Barzon, L (corresponding author), Univ Padua, Dept Mol Med, I-35121 Padua, Italy.; Barzon, L (corresponding author), Padova Univ Hosp, Microbiol & Virol Unit, I-35128 Padua, Italy.
EM giovanna.desole88@gmail.com; alessandro.sinigaglia@unipd.it;
   silvia.riccetti@studenti.unipd.it; giulia.masi@unipd.it;
   monia.pacenti@aopd.veneto.it; marta.trevisan@unipd.it;
   luisa.barzon@unipd.it
RI Barzon, Luisa/K-7961-2016; TREVISAN, MARTA/K-6591-2016
OI Barzon, Luisa/0000-0003-0720-8456; TREVISAN, MARTA/0000-0002-3148-7240
FU University of Padova, DOR grants
FX This research was funded by the University of Padova, DOR grants to L.B.
   and M.T.
CR Barzon L, 2018, J CLIN VIROL, V107, P38, DOI 10.1016/j.jcv.2018.08.007
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792
   Cho H, 2013, J VIROL, V87, P8363, DOI 10.1128/JVI.01097-13
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejarnac O, 2018, CELL REP, V23, P1779, DOI 10.1016/j.celrep.2018.04.013
   dos Santos EA, 2018, ADV EXP MED BIOL, V1062, P215, DOI 10.1007/978-981-10-8727-1_16
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14
   Ferreira RO, 2019, NEURON, V101, P989, DOI 10.1016/j.neuron.2019.03.009
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Li Y, 2019, P NATL ACAD SCI USA, V116, P9527, DOI 10.1073/pnas.1900867116
   Lucas M, 2003, IMMUNOL CELL BIOL, V81, P230, DOI 10.1046/j.1440-1711.2003.01166.x
   Marinho PES, 2019, EMERG INFECT DIS, V25, P1567, DOI [10.3201/eid2508.181479, 10.3201/eid2508/181479]
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   Nazerai L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010029
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Riedl W, 2019, CELL HOST MICROBE, V26, P493, DOI 10.1016/j.chom.2019.09.012
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trevisan M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010206
   Trevisan M, 2015, VIRUSES-BASEL, V7, P3835, DOI 10.3390/v7072800
   Wang RX, 2013, J BIOL CHEM, V288, P15926, DOI 10.1074/jbc.M112.421438
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 46
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2019
VL 20
IS 21
AR 5404
DI 10.3390/ijms20215404
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA JQ4VU
UT WOS:000498946100162
PM 31671583
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hoen, B
   Carpentier, M
   Gaete, S
   Tressieres, B
   Herrmann-Storck, C
   Vingadassalom, I
   Huc-Anais, P
   Funk, AL
   Fontanet, A
   de Lamballerie, X
AF Hoen, Bruno
   Carpentier, Mathieu
   Gaete, Stanie
   Tressieres, Benoit
   Herrmann-Storck, Cecile
   Vingadassalom, Ingrid
   Huc-Anais, Patricia
   Funk, Anna Louise
   Fontanet, Arnaud
   de lamballerie, Xavier
CA ZIKA-DFA-FE Study Grp
TI Kinetics of Anti-Zika Virus Antibodies after Acute Infection in Pregnant
   Women
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Letter
DE diagnosis; Zika; pregnancy; serology
C1 [Hoen, Bruno; Carpentier, Mathieu; Tressieres, Benoit; Vingadassalom, Ingrid] CHU Pointe a Pitre, INSERM, Ctr Invest Clin 1424, Pointe A Pitre, Guadeloupe, France.
   [Hoen, Bruno] CHU Pointe a Pitre, Serv Malad Infect & Trop, Dermatol, Med Interne, Pointe A Pitre, Guadeloupe, France.
   [Hoen, Bruno] Univ Antilles Guyane, Fac Med Hyacinthe Bastaraud, Pointe A Pitre, Guadeloupe, France.
   [Gaete, Stanie] CHU Pointe a Pitre, Ctr Ressources Biol Karubiotec, Pointe A Pitre, Guadeloupe, France.
   [Herrmann-Storck, Cecile] CHU Pointe A Pitre Abymes, Lab Microbiol, Pointe A Pitre, Guadeloupe, France.
   [Huc-Anais, Patricia] Lab Biol Mol, St Martin Dheres, France.
   [Funk, Anna Louise; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, PACRI Unit, Paris, France.
   [de lamballerie, Xavier] Aix Marseille Univ, INSERM 1207, IRD 190, IHU Mediterranee Infect,UVE, Marseille, France.
RP Hoen, B (corresponding author), CHU Pointe a Pitre, INSERM, Ctr Invest Clin 1424, Pointe A Pitre, Guadeloupe, France.; Hoen, B (corresponding author), CHU Pointe a Pitre, Serv Malad Infect & Trop, Dermatol, Med Interne, Pointe A Pitre, Guadeloupe, France.; Hoen, B (corresponding author), Univ Antilles Guyane, Fac Med Hyacinthe Bastaraud, Pointe A Pitre, Guadeloupe, France.
EM bruno.hoen@inserm.fr
OI GAETE, Stanie/0000-0002-2248-8989
FU French Ministry of Health (Soutien Exceptionnel a la Recherche et a
   l'Innovation); European Union's Horizon 2020 Research and Innovation
   Programme under ZIKAlliance grant [734548]
FX This study was funded by the French Ministry of Health (Soutien
   Exceptionnel a la Recherche et a l'Innovation) and by the European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   grant agreement no. 734548.
CR Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Matheus S, 2019, EMERG INFECT DIS, V25, P1153, DOI 10.3201/eid2506.180361
   Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
NR 7
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2019
VL 57
IS 11
AR e01151-19
DI 10.1128/JCM.01151-19
PG 3
WC Microbiology
SC Microbiology
GA JP8QG
UT WOS:000498523100025
PM 31462546
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Gois, AL
   Freire, BO
   de Almeida, DC
   MacKeen, LD
   Ventura, MC
   Berrocal, AM
   Chan, RVP
   Belfort, R
   Maia, M
   Ventura, LO
AF Ventura, Camila V.
   Gois, Adriana L.
   Freire, Barbara O.
   de Almeida, Danielle C.
   MacKeen, Leslie D.
   Ventura Filho, Marcelo C.
   Berrocal, Audina M.
   Chan, R. V. Paul
   Belfort, Rubens
   Maia, Mauricio
   Ventura, Liana O.
TI Fluorescein Angiography Findings in Children With Congenital Zika
   Syndrome
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID OPHTHALMIC MANIFESTATIONS; VIRUS; INFANTS
AB BACKGROUND AND OBJECTIVE: To evaluate the retinal and vasculature changes in infants with congenital Zika syndrome (CZS) using fluorescein angiography (FA).
   PATIENTS AND METHODS: This consecutive case series included six infants with CZS. FA and color fundus imaging were performed under general anesthesia in both eyes of all infants using a contact widefield digital imaging system. All color fundus images were obtained using a 130 degrees field of view lens, and the FA images were captured using either a 130 degrees or 80 degrees field of view lens. The immunoglobulin M antibody capture enzyme-linked immunosorbent assay was positive for Zika virus in the cerebrospinal fluid samples of all infants. Other congenital infections were ruled out.
   RESULTS: The mean +/- standard deviation age of the infants at the time of examination was 1.4 years +/- 0.1 years (range: 1.3 years to 1.5 years). Contact fundus photographs showed macular abnormalities in seven eyes (58%) and retinal vasculature changes in two eyes (17%). FA detected macular abnormalities in all 12 eyes (100%) and retinal vasculature changes in five eyes (42%). The main retinal vasculature changes were peripheral avascularity in five eyes (42%) and microvasculature abnormalities in three eyes (25%).
   CONCLUSION: FA may be an important tool for detecting subtle macular and retinal vasculature changes in CZS.
C1 [Ventura, Camila V.; Gois, Adriana L.; Freire, Barbara O.; de Almeida, Danielle C.; Ventura Filho, Marcelo C.; Ventura, Liana O.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Gois, Adriana L.; Ventura, Liana O.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Belfort, Rubens; Maia, Mauricio] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [MacKeen, Leslie D.] Hosp Sick Children, Dept Ophthalmol & Visual Sci, Toronto, ON, Canada.
   [Berrocal, Audina M.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Coral Gables, FL 33124 USA.
   [Chan, R. V. Paul] Univ Illinois, Dept Ophthalmol & Visual Sci, Illinois Eye & Ear Infirm, Chicago, IL USA.
RP Ventura, CV (corresponding author), Fundacao Altino Ventura, Rua Soledade 170, BR-50070040 Recife, PE, Brazil.
EM camilaventuramd@gmail.com
OI Gois, Adriana/0000-0001-5542-1097
FU National Institute of Health, Bethesda, MarylandUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30
   EY001792]; Research to Prevent Blindness, New York, NYResearch to
   Prevent Blindness (RPB); Blind Children's Center Research Grant
FX Supported by P30 EY001792 from the National Institute of Health,
   Bethesda, Maryland (RVPC), an Unrestricted Departmental Grant from
   Research to Prevent Blindness, New York, NY (RVPC), and a Blind
   Children's Center Research Grant.
CR Blair MP, 2012, J AAPOS, V16, P234, DOI 10.1016/j.jaapos.2011.12.157
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   John VJ, 2016, OSLI RETINA, V47, P14, DOI 10.3928/23258160-20151214-02
   KENO DD, 1978, ARCH OPHTHALMOL-CHIC, V96, P854
   Lepore D, 2011, OPHTHALMOLOGY, V118, P168, DOI 10.1016/j.ophtha.2010.04.021
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   PAHO, 2017, ZIK EP UPD SIT SUMM
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   Shane Thomas S, 2011, Ophthalmic Surg Lasers Imaging, V42 Online, pe15, DOI 10.3928/15428877-20110203-03
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Tzu JH, 2013, OPHTHAL SURG LAS IM, V44, P91, DOI 10.3928/23258160-20121221-20
   Velia P, 2012, J MATERN-FETAL NEO M, V25, P53, DOI 10.3109/14767058.2012.712313
   Ventura CV, 2018, OSLI RETINA, V49, pE93, DOI 10.3928/23258160-20180907-14
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   World Health Organization (WHO), EP AL NEUR SYNDR CON
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 28
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD NOV
PY 2019
VL 50
IS 11
BP 702
EP +
DI 10.3928/23258160-20191031-05
PG 9
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA JQ3VF
UT WOS:000498876000015
PM 31755969
DA 2020-07-08
ER

PT J
AU Mendes, EA
   de Pilger, DRB
   Nastri, ACDS
   Malta, FD
   Pascoalino, BD
   D'Albuquerque, LAC
   Balan, A
   Jr, LHGD
   Durigon, EL
   Carrilho, FJ
   Pinho, JRR
AF Mendes, Erica Araujo
   Bairros de Pilger, Denise Regina
   de Seixas Santos Nastri, Ana Catharina
   Malta, Fernanda de Mello
   Pascoalino, Bruno dos Santos
   Carneiro D'Albuquerque, Luiz Augusto
   Balan, Andrea
   Gondim de Freitas Jr, Lucio Holanda
   Durigon, Edison Luis
   Carrilho, Flair Jose
   Rebello Pinho, Joao Renato
TI Sofosbuvir inhibits yellow fever virus in vitro and in patients with
   acute liver failure
SO ANNALS OF HEPATOLOGY
LA English
DT Article
DE Acute hepatitis; Flavivirus; YFV; Treatment; Antiviral
ID ZIKA VIRUS; RIBAVIRIN; INTERFERON; INFECTION; OUTBREAK; BRAZIL
AB Introduction and objectives: Direct antiviral agents (DAAs) are very efficient in inhibiting hepatitis C virus and might be used to treat infections caused by other flaviviruses whose worldwide detection has recently increased. The aim of this study was to verify the efficacy of DAAs in inhibiting yellow fever virus (YFV) by using drug repositioning (a methodology applied in the pharmaceutical industry to identify new uses for approved drugs).
   Materials and methods: Three DAAs were evaluated: daclatasvir, sofosbuvir and ledipasvir or their combinations. For in vitro assays, the drugs were diluted in 100% dimethyl sulfoxide. Vaccine strain 17D and a 17D strain expressing the reporter fluorescent protein were used in the assays. A fast and reliable cell-based screening assay using Vero cells or Huh-7 cells (a hepatocyte-derived carcinoma ell line) was carried out. Two patients who acquired yellow fever virus with acute liver failure were treated with sofosbuvir for one week as a compassionate use.
   Results: Using a high-content screening assay, we verified that sofosbuvir presented the best antiviral activity against YFV. Moreover, after an off-label treatment with sofosbuvir, the two female patients diagnosed with yellow fever infection displayed a reduction in blood viremia and an improvement in the course of the disease, which was observed in the laboratory medical parameters related to disease evolution.
   Conclusions: Sofosbuvir may be used as an option for treatment against YFV until other drugs are identified and approved for human use. These results offer insights into the role of nonstructural protein 5 (NS5) in YFV inhibition and suggest that nonstructural proteins may be explored as drug targets for YFV treatment. (C) 2019 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U.
C1 [Mendes, Erica Araujo; Bairros de Pilger, Denise Regina; Pascoalino, Bruno dos Santos; Balan, Andrea; Gondim de Freitas Jr, Lucio Holanda; Durigon, Edison Luis] Univ Sao Paulo, Biomed Sci Inst, Dept Microbiol, Sao Paulo, SP, Brazil.
   [Bairros de Pilger, Denise Regina; Gondim de Freitas Jr, Lucio Holanda] Butantan Inst, Sao Paulo, SP, Brazil.
   [de Seixas Santos Nastri, Ana Catharina] Univ Sao Paulo, Sch Med, Dept Parasit & Infect Dis, Sao Paulo, SP, Brazil.
   [Rebello Pinho, Joao Renato] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.
   [Rebello Pinho, Joao Renato] Univ Sao Paulo, Sao Paulo Sch Med, Clin Hosp, Cent Labs Div,LIM 03, Sao Paulo, SP, Brazil.
   [de Seixas Santos Nastri, Ana Catharina; Malta, Fernanda de Mello; Carneiro D'Albuquerque, Luiz Augusto; Carrilho, Flair Jose; Rebello Pinho, Joao Renato] Univ Sao Paulo, Sch Med, Inst Trop Med, Dept Gastroenterol,LIM 07, Sao Paulo, SP, Brazil.
RP Pinho, JRR (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.; Pinho, JRR (corresponding author), Univ Sao Paulo, Sao Paulo Sch Med, Clin Hosp, Cent Labs Div,LIM 03, Sao Paulo, SP, Brazil.; Pinho, JRR (corresponding author), Univ Sao Paulo, Sch Med, Inst Trop Med, Dept Gastroenterol,LIM 07, Sao Paulo, SP, Brazil.
EM jrrpinho@usp.br
RI Carneiro D'Albuquerque, Luiz Augusto/A-8812-2013; Pinho,
   Joao/G-2850-2012; Freitas-Junior, Lucio/C-8677-2011
OI Carneiro D'Albuquerque, Luiz Augusto/0000-0001-7607-7168; Pinho,
   Joao/0000-0003-3999-0489; Freitas-Junior, Lucio/0000-0002-8904-7897
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/20045-7]; FAPESP
   (Erica Aradjo Mendes and Bruno dos Santos Pascoalino)Fundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional para o
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX We thank Professor Amadou Alpha Sall from Institute Pasteur, Senegal,
   and Dr. Laura H. V. G. Gil from the Research Center Aggeu Magalhaes,
   FIOCRUZ, Brazil for providing the YFV used in this study. A. albopictus
   C6/36 cells and the human hepatoma cell line Huh7 were kindly provided
   by Dr. Amilcar Tanuri from Universidade Federal do Rio de Janeiro, Rio
   de Janeiro, Brazil. This work was supported by Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) Grant number 2016/20045-7.
   Scholarship funding was granted by FAPESP (Erica Aradjo Mendes and Bruno
   dos Santos Pascoalino) and Conselho Nacional para o Desenvolvimento
   Cientifico e Tecnologico (CNPq) for Denise Regina Bairros de Pilger.
CR [Anonymous], 2016, WKLY EPIDEMIOL REC, V92, P442
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Casadio LVB, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190033
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006
   Duarte-Neto AN, 2019, HISTOPATHOLOGY, V75, P638, DOI 10.1111/his.13904
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freitas CS, 2019, PLOS NEGLECT TROP D, V13, pe7072
   Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953
   Gara N, 2013, CLIN INFECT DIS, V56, P1629, DOI 10.1093/cid/cit074
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Gorcea CM, 2017, J HOSP INFECT, V95, P214, DOI 10.1016/j.jhin.2016.11.012
   Gritsenko Diana, 2015, P T, V40, P256
   Guedj J, 2014, ANTIVIR THER, V19, P152
   Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412
   Julander JG, 2007, ANTIVIR RES, V73, P140, DOI 10.1016/j.antiviral.2006.08.008
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09
   Leyssen P, 2006, MOL PHARMACOL, V69, P1461, DOI 10.1124/mol.105.020057
   Medina F, 2012, CURR PROTOC MICROBIO
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neyts J, 1996, ANTIVIR RES, V30, P125, DOI 10.1016/0166-3542(96)89697-5
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Poordad F, 2016, HEPATOLOGY, V63, P1493, DOI 10.1002/hep.28446
   Reddy KR, 2015, HEPATOLOGY, V15
   Reznik SE, 2016, INT J INFECT DIS, V55, P29
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sato K, 2018, HEPATOL RES, V48, pE347, DOI 10.1111/hepr.12971
   Zhang JH, 2012, J BIOMOL SCREEN, V1999
NR 34
TC 3
Z9 3
U1 2
U2 2
PU ELSEVIER ESPANA
PI MADRID
PA CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN
SN 1665-2681
J9 ANN HEPATOL
JI Ann. Hepatol.
PD NOV-DEC
PY 2019
VL 18
IS 6
BP 816
EP 824
DI 10.1016/j.aohep.2019.09.001
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA JN5MT
UT WOS:000496943100008
PM 31594756
OA Other Gold
DA 2020-07-08
ER

PT J
AU Huong, LT
   Hung, NH
   Dai, DN
   Tai, TA
   Hien, VT
   Satyal, P
   Setzer, WN
AF Huong, Le Thi
   Hung, Nguyen Huy
   Dai, Do Ngoc
   Tai, Thieu Anh
   Hien, Vu Thi
   Satyal, Prabodh
   Setzer, William N.
TI Chemical Compositions and Mosquito Larvicidal Activities of Essential
   Oils from Piper Species Growing Wild in Central Vietnam
SO MOLECULES
LA English
DT Article
DE piperaceae; mosquito-borne diseases; natural pest control
ID AEDES-AEGYPTI; INSECTICIDE RESISTANCE; CULEX-QUINQUEFASCIATUS;
   YELLOW-FEVER; ZIKA VIRUS; DENGUE; VECTORS; LARVAE; ANTIFUNGAL;
   CHALLENGES
AB Mosquitoes are the deadliest animals on earth and are the vectors of several neglected tropical diseases. Recently, essential oils have emerged as potential renewable, cost-effective, and environmentally benign alternatives to synthetic pesticides for control of mosquitoes. In this work, thirteen species of Piper were collected from different areas of central Vietnam. The essential oils were obtained by hydrodistillation and analyzed by gas chromatography-mass spectrometry. The essential oils were screened for mosquito larvicidal activity against Aedes aegypti. Four of the Piper essential oils showed outstanding larvicidal activity against Ae. aegypti, namely P. caninum, P. longum, P. montium, and P. mutabile, with LC50 and LC90 values less than 10 mu g/mL. Multivariate analysis has correlated concentrations of beta-caryophyllene, beta-bisabolene, alpha-pinene, and beta-pinene with mosquito larvicidal activity.
C1 [Huong, Le Thi] Vinh Univ, Sch Nat Sci Educ, 182 Le Duan, Vinh City 43000, Vietnam.
   [Hung, Nguyen Huy] Duy Tan Univ, Inst Res & Dev, Ctr Adv Chem, 03 Quang Trung, Da Nang 50000, Vietnam.
   [Dai, Do Ngoc] Nghe An Econ Univ, Fac Agr Forestry & Fishery, Vinh City 43000, Vietnam.
   [Tai, Thieu Anh] Duy Tan Univ, Dept Pharm, 03 Quang Trung, Da Nang 50000, Vietnam.
   [Hien, Vu Thi] Ho Chi Minh City Univ Nat Resources & Environm, Fac Hydrometerol, Ho Chi Minh City 70000, Vietnam.
   [Satyal, Prabodh; Setzer, William N.] Aromat Plant Res Ctr, 230 N 1200 E,Suite 100, Lehi, UT 84043 USA.
   [Setzer, William N.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
RP Hung, NH (corresponding author), Duy Tan Univ, Inst Res & Dev, Ctr Adv Chem, 03 Quang Trung, Da Nang 50000, Vietnam.; Setzer, WN (corresponding author), Aromat Plant Res Ctr, 230 N 1200 E,Suite 100, Lehi, UT 84043 USA.; Setzer, WN (corresponding author), Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
EM lehuong223@gmail.com; nguyenhuyhung@duytan.edu.vn; daidn23@gmail.com;
   anhtai0808qn@gmail.com; hiensphoa@gmail.com; psatyal@aromaticplant.org;
   wsetzer@chemistry.uah.edu
RI Satyal, Prabodh/AAA-4627-2020
OI Setzer, William N./0000-0002-3639-0528
FU Duy Tan University
FX This research was funded by Duy Tan University.
CR Ab Rahman S.F., 2016, J ANAL PHARM RES, V2, P31
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Albuquerque CMR, 1999, MEM I OSWALDO CRUZ, V94, P591, DOI 10.1590/S0074-02761999000500005
   Andrade-Ochoa Sergio, 2017, Biomédica, V37, P224, DOI 10.7705/biomedica.v34i2.3475
   [Anonymous], 2017, NIST17
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Chauhan Khushbu, 2011, International Journal of Research in Ayurveda and Pharmacy (IJRAP), V2, P157
   Chaveerach A., 2006, Ethnobotany Research and Applications, V4, P223
   CHIENG T. C., 2008, MALAYSIAN J ANAL SCI, V12, P234
   da Costa JGM, 2010, LAT AM J PHARM, V29, P463
   da Silva JK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122571
   da Silva JKR, 2016, NAT PROD COMMUN, V11, P1907
   da Trindade R., 2019, BRAGANTINA PLANTS, V8, DOI [10.3390/plants8110442, DOI 10.3390/PLANTS8110442]
   de Morals SM, 2007, BIOCHEM SYST ECOL, V35, P670, DOI 10.1016/j.bse.2007.05.002
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hieu LD, 2018, AM J ESSENT OIL NAT, V6, P16
   Hieu LD, 2014, J OLEO SCI, V63, P211, DOI 10.5650/jos.ess13175
   Intirach J., 2012, Psyche: A Journal of Entomology, V2012, P591616, DOI 10.1155/2012/591616
   Johnson S, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8040088
   Rodriguez EJ, 2013, NAT PROD COMMUN, V8, P1325
   Kamrin M.A, 1997, PESTICIDE PROFILES T
   Thi KLP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2422-z
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lesueur D, 2009, J ESSENT OIL RES, V21, P16, DOI 10.1080/10412905.2009.9700095
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Mabberley D.J., 2008, MABBERLEYS PLANT BOO
   Marques André M, 2015, Univ. Sci., V20, P61, DOI 10.11144/Javeriana.SC20-1.amgp
   Masetti A, 2016, B INSECTOL, V69, P307
   Mondello L., 2016, FFNSC 3
   Moraes MS, 2004, J ESSENT OIL RES, V16, P15, DOI 10.1080/10412905.2004.9698637
   Morandim-Giannetti AD, 2010, J MED PLANTS RES, V4, P1810
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Hung NH, 2019, INSECTS, V10, DOI 10.3390/insects10020047
   Parthasarathy U, 2008, CURR SCI INDIA, V94, P1632
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Perigo CV, 2016, IND CROP PROD, V94, P528, DOI 10.1016/j.indcrop.2016.09.028
   Perumalsamy H, 2009, J MED ENTOMOL, V46, P1420, DOI 10.1603/033.046.0624
   PHAM HH, 1999, ILLUSTRATED FLORA VI, V1
   Lien PTK, 2016, ASIAN PAC J TROP MED, V9, P36, DOI 10.1016/j.apjtm.2015.12.008
   Qin WQ, 2010, PESTIC BIOCHEM PHYS, V96, P132, DOI 10.1016/j.pestbp.2009.10.006
   Salehi B, 2019, MOLECULES, V24, DOI 10.3390/molecules24071364
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   Van Chinh H., 2019, VNU J SCI NAT SCI TE, V35, P32
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Varughese T, 2016, J ESSENT OIL BEAR PL, V19, P52, DOI 10.1080/0972060X.2015.1119065
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vo V.C., 2012, DICT MED PLANTS VIET
   Vogler B., 2006, Journal of Essential Oil-Bearing Plants, V9, P230
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xiang CP, 2017, J AGR FOOD CHEM, V65, P3702, DOI 10.1021/acs.jafc.7b01350
   Zachariah TJ, 2010, SCI HORTIC-AMSTERDAM, V123, P418, DOI 10.1016/j.scienta.2009.09.017
   Zaveri M, 2010, INT J PHARM SCI REV, V5, P67
NR 64
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD NOV
PY 2019
VL 24
IS 21
AR 3871
DI 10.3390/molecules24213871
PG 30
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA JP1TW
UT WOS:000498055500060
PM 31717867
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sam, IC
   Montoya, M
   Chua, CL
   Chan, YF
   Pastor, A
   Harris, E
AF Sam, I-Ching
   Montoya, Magelda
   Chua, Chong Long
   Chan, Yoke Fun
   Pastor, Andrew
   Harris, Eva
TI Low seroprevalence rates of Zika virus in Kuala Lumpur, Malaysia
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE dengue virus; Malaysia; neutralization test; NS1 blockade-of-binding
   ELISA; seroprevalence; Zika virus
ID INFECTION; TRANSMISSION; ANTIBODIES; SINGAPORE; UPDATE
AB Background: Zika virus (ZIKV) is believed to be endemic in Southeast Asia. However, there have been few Zika cases reported to date in Malaysia, which could be due to high pre-existing levels of population immunity.
   Methods: To determine Zika virus (ZIKV) seroprevalence in Kuala Lumpur, Malaysia, 1085 serum samples from 2012, 2014-2015 and 2017 were screened for anti-ZIKV antibodies using a ZIKV NS1 blockade-of-binding assay. Reactive samples were confirmed using neutralization assays against ZIKV and the four dengue virus (DENV) serotypes. A sample was possible ZIKV seropositive with a ZIKV 50% neutralization (NT50) titre >= 20. A sample was probable ZIKV seropositive if, in addition, all DENV NT50 titres were <20 or the ZIKV NT50 titre was >4-fold greater than the highest DENV NT50 titre.
   Results: We found low rates of possible ZIKV seropositivity (3.3% [95% confidence interval {CI} 2.4 to 4.6]) and probable ZIKV seropositivity (0.6% [95% CI 0.3 to 1.4]). Possible ZIKV seropositivity was independently associated with increasing age (odds ratio [OR] 1.04 [95% CI 1.02 to 1.06], p<0.0001) and male gender (OR 3.5 [95% CI 1.5 to 8.6], p=0.005).
   Conclusions: The low ZIKV seroprevalence rate, a proxy for population immunity, does not explain the low incidence of Zika in dengue-hyperendemic Kuala Lumpur. Other factors, such as the possible protective effects of pre-existing flavivirus antibodies or reduced transmission by local mosquito vectors, should be explored. Kuala Lumpur is at high risk of a large-scale Zika epidemic.
C1 [Sam, I-Ching; Chua, Chong Long; Chan, Yoke Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
   [Montoya, Magelda; Pastor, Andrew; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Sam, IC (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.; Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM jicsam@ummc.edu.my; eharris@berkeley.edu
RI Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010; Chua, Chong
   Long/J-3028-2016
OI Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke
   Fun/0000-0001-7089-0510; Chua, Chong Long/0000-0002-8854-4955
FU National Institute of Allergy and Infectious Diseases/National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P01 AI106695]; Malaysia One
   Health University Network; US Agency for International DevelopmentUnited
   States Agency for International Development (USAID)
FX This study was funded in part by a National Institute of Allergy and
   Infectious Diseases/National Institutes of Health grant (P01 AI106695 to
   EH) and a grant from the Malaysia One Health University Network and the
   US Agency for International Development (to I-CS).
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bhardwaj S, 2017, INDIAN J MED RES, V146, P572, DOI 10.4103/ijmr.IJMR_1160_17
   Chew CH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3496-9
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chua CL, 2019, EMERG INFECT DIS, V25, P374, DOI 10.3201/eid2502.180258
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dony JJF, PLOS CURR OUTBREAKS
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Institut Pasteur du Laos, 2016, ARB SURV
   Khongwichit S, 2018, MICROBES INFECT, V20, P670, DOI 10.1016/j.micinf.2018.01.007
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Ministry of Health Malaysia, 2016, PRESS STAT DIR GEN H
   Ministry of Health Malaysia, 2017, PRESS STAT DIR GEN H
   Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Musso D, 2017, LANCET INFECT DIS, V17, P782, DOI 10.1016/S1473-3099(17)30251-7
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
   Pastorino B, 2019, AM J TROP MED HYG, V100, P639, DOI 10.4269/ajtmh.18-0439
   Perkins TA, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.51
   Perng GC, 2019, EMERG INFECT DIS, V25, P814, DOI 10.3201/eid2504.181449
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Saifur RGM, 2012, J AM MOSQUITO CONTR, V28, P84, DOI 10.2987/11-6220R.1
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   Sornjai W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35643-6
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 40
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD NOV
PY 2019
VL 113
IS 11
BP 678
EP 684
DI 10.1093/trstmh/trz056
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JP3MD
UT WOS:000498170700004
PM 31294807
DA 2020-07-08
ER

PT J
AU Garcia, M
   Fares-Gusmao, R
   Sapsford, K
   Chancey, C
   Grinev, A
   Lovell, S
   Scherf, U
   Rios, M
AF Garcia, Mayra
   Fares-Gusmao, Rafaelle
   Sapsford, Kim
   Chancey, Caren
   Grinev, Andriyan
   Lovell, Stephen
   Scherf, Uwe
   Rios, Maria
TI A Zika Reference Panel for Molecular-Based Diagnostic Devices as a US
   Food and Drug Administration Response Tool to a Public Health Emergency
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Article
ID VIRUS-RNA
AB In 2015, Zika virus (ZIKV) appeared as an emerging pathogen, generating a global and urgent need for accurate diagnostic devices. During this public health crisis, several nucleic acid testing (NAT)-based Zika assays were submitted to the US Food and Drug Administration (FDA) for Emergency Use Authorization. The FDA's Center for Devices and Radiological Health, in collaboration with the FDA's Center for Biologics Evaluation and Research, responded to this Zika emergency by developing and producing a reference panel (RP) for Zika RNA (Zika FDA-RP) suitable for performance assessment of ZIKV NAT-based in vitro diagnostic devices. Reference panels are a fundamental tool for performance assessment of molecular tests. The panel is composed of five vials: two different heat-inactivated ZIKV strains (PRVABC59 and FSS13025) in concentrated stocks and three blinded concentrations prepared from those strains. The Zika FDA-RP was shared with developers who had devices in the final stages of validation. In vitro diagnostic developers tested the Zika FDA-RP using the FDA-provided protocol. Depending on sample type, 85% (12/14) of the NAT assays had analytical sensitivities between 500 and 5000 RNA NAT-detectable units/m L (NDUs/mL). One device showed better performance (100 NDUs/mL), and another one showed lower performance (10,000 to 30,000 NDUs/mL). Vials of the Zika FDA-RP are available on request to developers who have interacted with the FDA through the review process.
C1 [Garcia, Mayra; Sapsford, Kim; Lovell, Stephen; Scherf, Uwe] US FDA, Off In Vitro Diagnost & Radiol Devices, Ctr Devices & Radiol Hlth, Silver Spring, MD USA.
   [Fares-Gusmao, Rafaelle; Chancey, Caren; Grinev, Andriyan; Rios, Maria] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Garcia, M (corresponding author), US FDA, 10903 New Hampshire Ave,Bldg 66,Room 3206, Silver Spring, MD 20993 USA.
EM mayra.garcia@fda.hhs.gov
FU US Food and Drug Administration (FDA) Medical Countermeasure Initiative
   grant [OCET 2016-331]
FX Supported by US Food and Drug Administration (FDA) Medical
   Countermeasure Initiative grant OCET 2016-331 (M.R.). This project was
   supported in part by an appointment to the Research Participation
   Program at the Office of Blood Research and Review/Center for Biologics
   Evaluation and Research, FDA, administered by the Oak Ridge Institute
   for Science and Education through an interagency agreement between the
   US Department of Energy and the FDA.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, p574D
   COLLET D, 1991, MODELING BINARY DATA
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fares-Gusmao R, 2018, TRANSFUSION, V58, P2171, DOI 10.1111/trf.14870
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Saldanha J, 1999, VOX SANG, V76, P149, DOI 10.1046/j.1423-0410.1999.7630149.x
   Saldanha J, 2005, TRANSFUSION, V45, P97, DOI 10.1111/j.1537-2995.2005.04151.x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2019
VL 21
IS 6
BP 1025
EP 1033
DI 10.1016/j.jmoldx.2019.06.004
PG 9
WC Pathology
SC Pathology
GA JN6HH
UT WOS:000496996500011
PM 31628040
OA Other Gold
DA 2020-07-08
ER

PT J
AU Laiton-Donato, K
   Alvarez-Diaz, DA
   Rengifo, AC
   Torres-Fernandez, O
   Usme-Ciro, JA
   Rivera, JA
   Santamaria, G
   Naizaque, J
   Monroy-Gomez, J
   Sarmiento, L
   Gunturiz, ML
   Munoz, A
   Vanegas, R
   Rico, A
   Pardo, L
   Pelaez-Carvajal, D
AF Laiton-Donato, Katherine
   Alvarez-Diaz, Diego A.
   Caterine Rengifo, Aura
   Torres-Fernandez, Orlando
   Usme-Ciro, Jose A.
   Alonso Rivera, Jorge
   Santamaria, Gerardo
   Naizaque, Julian
   Monroy-Gomez, Jeison
   Sarmiento, Ladys
   Gunturiz, Maria Luz
   Munoz, Alejandra
   Vanegas, Ricardo
   Rico, Angelica
   Pardo, Lissethe
   Pelaez-Carvajal, Dioselina
TI Complete Genome Sequence of a Colombian Zika Virus Strain Obtained from
   BALB/c Mouse Brain after Intraperitoneal Inoculation
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB A Zika virus (ZIKV) strain was isolated from an acute febrile patient during the Zika epidemics in Colombia. The strain was intraperitoneally inoculated into BALB/c mice, and 7 days postinoculation, neurological manifestations and ZIKV infection in the brain were demonstrated. The reported genome sequence is highly related to strains circulating in the Americas.
C1 [Laiton-Donato, Katherine; Usme-Ciro, Jose A.; Rico, Angelica; Pardo, Lissethe; Pelaez-Carvajal, Dioselina] Inst Nacl Salud, Direcc Redes Salud Publ, Grp Virol, Bogota, DC, Colombia.
   [Alvarez-Diaz, Diego A.; Caterine Rengifo, Aura; Torres-Fernandez, Orlando; Alonso Rivera, Jorge; Santamaria, Gerardo; Naizaque, Julian; Monroy-Gomez, Jeison; Sarmiento, Ladys] Inst Nacl Salud, Direcc Invest Salud Publ, Grp Morfol Celular, Bogota, DC, Colombia.
   [Munoz, Alejandra; Vanegas, Ricardo] Inst Nacl Salud, Direcc Prod, Grp Anim Lab, Bogota, DC, Colombia.
   [Monroy-Gomez, Jeison] Escuela Colombiana Rehabil, Bogota, DC, Colombia.
   [Gunturiz, Maria Luz] Direcc Invest Salud Publ, Equipo Banco Proyectos, Bogota, DC, Colombia.
   [Usme-Ciro, Jose A.] Univ Cooperat Colombia, CIST, Santa Marta, Colombia.
RP Rengifo, AC (corresponding author), Inst Nacl Salud, Direcc Invest Salud Publ, Grp Morfol Celular, Bogota, DC, Colombia.
EM arengifo@ins.gov.co
OI Monroy Gomez, Jeison Alexander/0000-0001-9765-0461; GUNTURIZ, MARIA
   LUZ/0000-0001-9803-7909; Alvarez-Diaz, Diego
   Alejandro/0000-0002-6534-0079
FU Administrative Department of Science, Technology and Innovation
   (COLCIENCIAS)Departamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias; Instituto Nacional de Salud (INS-Colombia)
   [210474455818, 672]
FX This work was funded with resources from the Administrative Department
   of Science, Technology and Innovation (COLCIENCIAS) and the Instituto
   Nacional de Salud (INS-Colombia) (project code 210474455818, contract
   number 672 of 2017).
CR Comesana M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193480
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Tsunoda Ikuo, 2016, Acta Med Kinki Univ, V41, P37
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 10
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD NOV
PY 2019
VL 8
IS 46
AR UNSP e01719-18
DI 10.1128/MRA.01719-18
PG 3
WC Microbiology
SC Microbiology
GA JN6BR
UT WOS:000496981900030
PM 31727724
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Worsnop, CZ
AF Worsnop, Catherine Z.
TI Concealing Disease: Trade and Travel Barriers and the Timeliness of
   Outbreak Reporting
SO INTERNATIONAL STUDIES PERSPECTIVES
LA English
DT Article
DE international organizations; World Health Organization; compliance;
   disease outbreaks; global health
ID INTERNATIONAL HEALTH REGULATIONS; INFECTIOUS-DISEASES; PANDEMIC
   INFLUENZA; COMMITMENT; CAPACITY; POLITICS; LAW; SURVEILLANCE; FRAMEWORK;
   TRENDS
AB Slow outbreak reporting by states is a key challenge to effectively responding to global health emergencies like Zika, Ebola, and H1N1. Current policy focuses on improving domestic outbreak surveillance capacity globally in order to reduce reporting lags. However, governments also face economic and political incentives to conceal outbreaks, and these incentives largely are ignored in policy discussions. In spite of the policy implications for outbreak response, the "capacity" and "will" explanations have not been systematically examined. Analysis of a dataset coding the timeliness of outbreak reporting from 1996-2014 finds evidence that states' unwillingness to report-rather than just their inability-leads to delayed reporting. The findings suggest that though building surveillance capacity is critical, doing so may not be sufficient to reduce reporting lags. Policy aimed at encouraging rapid reporting must also mitigate the associated economic and political costs.
C1 [Worsnop, Catherine Z.] Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA.
RP Worsnop, CZ (corresponding author), Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA.
CR Abbott KW, 2000, INT ORGAN, V54, P421, DOI 10.1162/002081800551280
   Allee TL, 2006, AM POLIT SCI REV, V100, P219, DOI 10.1017/S0003055406062125
   [Anonymous], 2014, ECONOMIST
   Beck T, 2001, WORLD BANK ECON REV, V15, P165, DOI 10.1093/wber/15.1.165
   BEIRMAN DAVID, 2017, CONVERSATION
   BEIRMAN DAVID, 2012, CONVERSATION
   BLAYNEY DON P., 2005, DIS RELATED TRADE RE
   Box-Steffensmeier Janet M., 2004, EVENT HIST MODELING
   Box-Steffensmeier JM, 2001, AM J POLIT SCI, V45, P972, DOI 10.2307/2669335
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   CARVALHO SIMON, 2001, PLAGUES POLITICS INF, P235
   Cash RA, 2000, B WORLD HEALTH ORGAN, V78, P1358
   Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107
   Chayes Abram, 1998, NEW SOVEREIGNTY COMP
   Chorev Nitsan, 2012, WORLD HLTH ORG N S
   Cole WM, 2015, INT ORGAN, V69, P405, DOI 10.1017/S002081831400040X
   Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013
   Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212
   Copeland DL, 2013, CLIN INFECT DIS, V56, P509, DOI 10.1093/cid/cis890
   Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82
   Dai XY, 2006, J CONFLICT RESOLUT, V50, P690, DOI 10.1177/0022002706291048
   Davies S. E., 2015, DIS DIPLOMACY INT NO
   Davies SE, 2012, GLOB CHANG PEACE SEC, V24, P95, DOI 10.1080/14781158.2012.641272
   DONALDSON ANDREW, 2006, CTR RURAL EC DISCUSS, V6
   Downs GW, 1996, INT ORGAN, V50, P379, DOI 10.1017/S0020818300033427
   Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920
   FEARON JD, 1994, AM POLIT SCI REV, V88, P577, DOI 10.2307/2944796
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Fidler DP, 2006, J LAW MED ETHICS, V34, P85, DOI 10.1111/j.1748-720X.2006.00011.x
   Finnemore M, 1998, INT ORGAN, V52, P887, DOI 10.1162/002081898550789
   Fischer JE, 2013, BIOSECUR BIOTERROR, V11, P153, DOI 10.1089/bsp.2013.0030
   Frisby E., 2003, J VACAT MARK, V9, P89, DOI DOI 10.1177/135676670200900107
   Gaubatz KT, 1996, INT ORGAN, V50, P109, DOI 10.1017/S0020818300001685
   Gostin LO, 2016, MILBANK Q, V94, P264, DOI 10.1111/1468-0009.12186
   Graham ER, 2017, GLOB POLICY, V8, P15, DOI 10.1111/1758-5899.12450
   Graham ER, 2014, EUR J INT RELAT, V20, P366, DOI 10.1177/1354066113476116
   Gray J, 2014, COMP POLIT STUD, V47, P55, DOI 10.1177/0010414013488535
   Hafner-Burton EM, 2008, INT SOCIOL, V23, P115, DOI 10.1177/0268580907084388
   HANRIEDER TINE, 2014, EUROPEAN J INT RELAT, V21, P1
   Henderson J. C., 2007, TOURISM CRISES CAUSE
   Huang Y., 2004, LEARNING SARS PREPAR, P116
   Huang Y, 2013, GOVERNING HLTH CONT
   Huang ZY, 2017, PREV VET MED, V139, P67, DOI 10.1016/j.prevetmed.2017.02.002
   Imai K., 2007, ZELIG EVERYONES STAT
   Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898
   INSTITUTE OFMEDICINE, 2010, INFECT DIS MOVEMENT
   Jang SooCheong [Jang S. C. S. ], 2002, Journal of Travel & Tourism Marketing, V13, P111, DOI 10.1300/J073v13n03_06
   JOHNSON RENEE, 2009, POTENTIAL FARM SECTO
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kamradt-Scott A., 2015, MANAGING GLOBAL HLTH
   Kamradt-Scott A, 2018, LANCET, V392, P2250, DOI 10.1016/S0140-6736(18)32068-3
   Kamradt-Scott A, 2016, THIRD WORLD Q, V37, P401, DOI 10.1080/01436597.2015.1112232
   Kamradt-Scott A, 2012, GLOB CHANG PEACE SEC, V24, P57, DOI 10.1080/14781158.2012.641284
   Katz R, 2017, GLOB HEALT DIPL, V5, P141
   KATZ REBECCA, 2010, GLOBAL HLTH GOVERNAN, V3, P599
   Kaufman JA, 2008, J INFECT DIS, V197, pS7, DOI 10.1086/524990
   KAUFMANN DANIEL, 2010, 1682130 SSRN
   Kelley J, 2007, AM POLIT SCI REV, V101, P573, DOI 10.1017/S0003055407070426
   Keohane Robert, 1984, HEGEMONY COOPERATION
   King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235
   Kluberg Sheryl A, 2016, Emerg Infect Dis, V22, pE1, DOI 10.3201/eid2210.151956
   Laws E, 2007, CRISIS MANAGEMENT IN TOURISM, P1, DOI 10.1079/9781845930479.0000
   Lempel H, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1051
   Lynch M, 2011, PERSPECT POLIT, V9, P301, DOI 10.1017/S1537592711000910
   Mackey TK, 2012, J PUBLIC HEALTH POL, V33, P119, DOI 10.1057/jphp.2011.51
   Madoff LC, 2005, ARCH MED RES, V36, P724, DOI 10.1016/j.arcmed.2005.06.005
   Mansfield ED, 2002, INT ORGAN, V56, P477, DOI 10.1162/002081802760199863
   Artigas EM, 2017, J DESTIN MARK MANAGE, V6, P327, DOI 10.1016/j.jdmm.2017.03.003
   Marshall Monty G., 2014, POLITY 4 PROJECT POL
   Martin LL, 1998, INT ORGAN, V52, P729, DOI 10.1162/002081898550734
   McAlarnen Lindsey, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cecdec16fa17091eea4c4a725dba9e16
   McConnell A, 2002, PARLIAMENT AFF, V55, P664, DOI 10.1093/parlij/55.4.664
   MCNAMARA KATHLEEN R., 2004, INT LAW ORG CLOSING, P41
   MITCHELL RB, 1994, INT ORGAN, V48, P425, DOI 10.1017/S0020818300028253
   Mondor L, 2012, EMERG INFECT DIS, V18, P1184, DOI 10.3201/eid1807.120249
   MOORE TOBY, 2006, CAST COMMENTARY QTA2
   Morens DM, 2008, LANCET INFECT DIS, V8, P710, DOI 10.1016/S1473-3099(08)70256-1
   Mydans S., 2003, NY TIMES
   National Academy of Medicine, 2016, NEGL DIM GLOB SEC FR
   Neumayer E, 2002, J PEACE RES, V39, P139, DOI 10.1177/0022343302039002001
   ONISHI NORIMITSU, 2014, NY TIMES
   Poletto, 2014, EUROSURVEILLANCE, V19, P8
   PORTER D, 1999, HLTH CIVILIZATION ST
   Rahmani K, 2019, J TRAVEL RES, V58, P192, DOI 10.1177/0047287517753072
   Rhymer W, 2017, B WORLD HEALTH ORGAN, V95, P10, DOI 10.2471/BLT.16.171579
   Searcey D., 2017, NY TIMES
   Selvey LA, 2015, EMERG INFECT DIS, V21, P197, DOI 10.3201/eid2102.131610
   Simmons BA, 2000, INT ORGAN, V54, P573, DOI 10.1162/002081800551334
   Simmons BA, 2004, AM POLIT SCI REV, V98, P171, DOI 10.1017/S0003055404001078
   Simmons BA, 2002, J CONFLICT RESOLUT, V46, P829, DOI 10.1177/002200202237931
   Simmons B, 2010, ANNU REV POLIT SCI, V13, P273, DOI 10.1146/annurev.polisci.12.040907.132713
   SLAUGHTER Anne-Marie, 1995, EUROPEAN J INT LAW, V6, P503
   Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950
   Smolinski MS, 2017, HEALTH SECUR, V15, P215, DOI 10.1089/hs.2016.0069
   STEIN F, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3397
   Tallberg J, 2002, INT ORGAN, V56, P609, DOI 10.1162/002081802760199908
   Tomz M, 2007, INT ORGAN, V61, P821, DOI 10.1017/S0020818307070282
   Tsai Peggy, 2009, SUSTAINING GLOBAL SU, P165
   United Nations, 2017, SUST DEV GOAL 3 ENS
   UNSIC OFFICE, 2017, AV INFL PAND THREATS
   VICTOR DG, 1998, IMPLEMENTATION EFFEC
   Vincent AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008367
   Von Stein J, 2005, AM POLIT SCI REV, V99, P611, DOI 10.1017/S0003055405051919
   von Tigerstrom Barbara, 2005, Health Law J, V13, P35
   VU TUONG, 2011, GLOBAL HLTH GOVERNAN, V4, P1
   Weiss E. B., 2000, ENGAGING COUNTRIES S
   *WHO, 2009, NO RAT TRAV RESTR
   Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]
   Worknop C, 2017, GLOB HLTH GOV, V11, P7
   WORLD BANK, 2017, TCDATA360
   World Bank, 2017, PAN NEGL INV HLTH SE
   World Bank, 2016, WORLD DEV IND
   World Bank, 2014, EC IMP 2014 EB EP SH
   WORLD HEALTH ORGANIZATION, 2015, A6824 WHO
   WORLD HEALTH ORGANIZATION, 2004, AIHRIGWG2 WHO
   World Health Organization, 2003, UPD 95 SARS CHRON SE
   WORLD HEALTH ORGANIZATION, 2018, EB1423 WHO
   WORLD HEALTH ORGANIZATION, 1964, WH0IQ143 WHO
   WORLD HEALTH ORGANIZATION, 2003, VIET NAM SARS FREE
   WORLD HEALTH ORGANIZATION, 1962, WH0IQ134 WHO
   WORLD HEALTH ORGANIZATION, 1966, WEEKLY EPIDEMIOLOGIC, V41, P509
   WORLD HEALTH ORGANIZATION, 1965, WH0IQ14565 WHO
   WORLD HEALTH ORGANIZATION, 1967, WH0IQ67147 WHO, VII
   WORLD HEALTH ORGANIZATION, 2016, WHO HLTH EM PROGR RE
   Worsnop CZ, 2017, REV INT ORGAN, V12, P365, DOI 10.1007/s11558-016-9260-1
NR 125
TC 2
Z9 2
U1 13
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1528-3577
EI 1528-3585
J9 INT STUD PERSPECT
JI Int. Stud. Perspect.
PD NOV
PY 2019
VL 20
IS 4
BP 344
EP 372
DI 10.1093/isp/ekz005
PG 29
WC International Relations
SC International Relations
GA JN2YG
UT WOS:000496765800002
OA Bronze
DA 2020-07-08
ER

PT J
AU Kramer, LD
   Ciota, AT
   Kilpatrick, AM
AF Kramer, Laura D.
   Ciota, Alexander T.
   Kilpatrick, A. Marm
TI Introduction, Spread, and Establishment of West Nile Virus in the
   Americas
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE West Nile Virus; arboviral transmission; arbovirology; mosquito-borne
   disease
ID CULEX-TARSALIS DIPTERA; ST-LOUIS ENCEPHALITIS; LIFE-HISTORY TRAITS;
   VECTOR COMPETENCE; NEW-YORK; EQUINE ENCEPHALOMYELITIS; MOSQUITOS
   DIPTERA; UNITED-STATES; EXPERIMENTAL-INFECTION; GEOGRAPHIC-VARIATION
AB The introduction of West Nile virus (WNV) to North America in 1999 and its subsequent rapid spread across the Americas demonstrated the potential impact of arboviral introductions to new regions, and this was reinforced by the subsequent introductions of chikungunya and Zika viruses. Extensive studies of host-pathogen-vector-environment interactions over the past two decades have illuminated many aspects of the ecology and evolution of WNV and other arboviruses, including the potential for pathogen adaptation to hosts and vectors, the influence of climate, land use and host immunity on transmission ecology, and the difficulty in preventing the establishment of a zoonotic pathogen with abundant wildlife reservoirs. Here, we focus on outstanding questions concerning the introduction, spread, and establishment of WNV in the Americas, and what it can teach us about the future of arboviral introductions. Key gaps in our knowledge include the following: viral adaptation and coevolution of hosts, vectors and the virus; the mechanisms and species involved in the large-scale spatial spread of WNV; how weather modulates WNV transmission; the drivers of large-scale variation in enzootic transmission; the ecology of WNV transmission in Latin America; and the relative roles of each component of host-virus-vector interactions in spatial and temporal variation in WNV transmission. Integrative studies that examine multiple factors and mechanisms simultaneously are needed to advance our knowledge of mechanisms driving transmission.
C1 [Kramer, Laura D.; Ciota, Alexander T.] New York State Dept Hlth, Arbovirus Lab, Wadsworth Ctr, Slingerlands, NY 12159 USA.
   [Kramer, Laura D.; Ciota, Alexander T.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.
   [Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.
RP Kramer, LD (corresponding author), New York State Dept Hlth, Arbovirus Lab, Wadsworth Ctr, Slingerlands, NY 12159 USA.; Kramer, LD (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.
EM laura.kramer@health.ny.gov
OI Kilpatrick, A. Marm/0000-0002-3612-5775
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1717498, EF-0914866]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1R01AI090159]; New York State Department of Health; Centers for
   Disease Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [U01CK000509,
   NU50CK000423]
FX We acknowledge funding from National Science Foundation grants
   (DEB-1717498, EF-0914866) and National Institutes of Health grant
   (1R01AI090159), which supported the development of these ideas, as well
   as support from the New York State Department of Health. Additional
   support was provided by the Cooperative Agreements U01CK000509 and
   NU50CK000423, funded by the Centers for Disease Control and Prevention.
   Contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the Centers for Disease
   Control and Prevention or the Department of Health and Human Services.
   We thank W. Reisen and two anonymous reviewers for helpful comments on
   the manuscript.
CR Amore G, 2010, PHILOS T R SOC B, V365, P1871, DOI 10.1098/rstb.2010.0054
   Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360
   Barker CM, 2010, J MED ENTOMOL, V47, P759, DOI 10.1603/ME09139
   BERNKOPF H, 1953, J INFECT DIS, V93, P207, DOI 10.1093/infdis/93.3.207
   Bialosuknia SM, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vez020
   Bin H, 2001, ANN NY ACAD SCI, V951, P127
   Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134
   Brault AC, 2015, J MED ENTOMOL, V52, P491, DOI 10.1093/jme/tjv021
   Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6
   Calisher C H, 1974, Bull Pan Am Health Organ, V8, P243
   CALISHER CH, 1971, AM J EPIDEMIOL, V94, P172, DOI 10.1093/oxfordjournals.aje.a121309
   Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P303
   Ciota AT, 2008, J GEN VIROL, V89, P1633, DOI 10.1099/vir.0.2008/000893-0
   Ciota AT, 2007, J GEN VIROL, V88, P2398, DOI 10.1099/vir.0.83061-0
   Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021
   Ciota AT, 2014, J MED ENTOMOL, V51, P55, DOI 10.1603/ME13003
   Ciota AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007876
   Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022
   Di Giallonardo F, 2016, J VIROL, V90, P862, DOI 10.1128/JVI.02305-15
   Diaz A, 2018, EMERG INFECT DIS, V24, P2150, DOI 10.3201/eid2412.180372
   Douglas KO, 2007, W INDIAN MED J, V56, P394
   Duggal N. K., 2019, J MED ENTOMOL, P8
   Duggal NK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003262
   Dusek RJ, 2009, AM J TROP MED HYG, V81, P1151, DOI 10.4269/ajtmh.2009.09-0106
   Eastwood G, 2014, ECOHEALTH, V11, P53, DOI 10.1007/s10393-014-0911-5
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   Ehrbar DJ, 2017, INFECT GENET EVOL, V51, P219, DOI 10.1016/j.meegid.2017.04.010
   Gomez A, 2008, EMERG INFECT DIS, V14, P962, DOI 10.3201/eid1406.070352
   Gubler DJ, 2000, VIRAL IMMUNOL, V13, P469, DOI 10.1089/vim.2000.13.469
   Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123
   Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767
   Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268
   Hassan HK, 2003, AM J TROP MED HYG, V69, P641, DOI 10.4269/ajtmh.2003.69.641
   HAYES CG, 1989, ARBOVIRUSES EPIDEMIO, V5, P59
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hofmeister EK, 2015, AM J TROP MED HYG, V93, P701, DOI 10.4269/ajtmh.14-0590
   Huang Y. S., 2017, INSECTS, P8
   Karabatsos N., 1985, INT CATALOG ARBOVIRU
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226
   Keyel AC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217854
   Kilpatrick A. M., 2006, CONSERV BIOL
   Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2
   Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575
   Kilpatrick AM, 2013, BIOL CONSERV, V165, P79, DOI 10.1016/j.biocon.2013.05.015
   Kilpatrick AM, 2013, AM J EPIDEMIOL, V178, P829, DOI 10.1093/aje/kwt046
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082
   KILPATRICK AM, 2004, ECOHEALTH, V1, P205
   Klenk K, 2003, AM J TROP MED HYG, V69, P260, DOI 10.4269/ajtmh.2003.69.260
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   Kovach TJ, 2018, AM J TROP MED HYG, V99, P222, DOI 10.4269/ajtmh.18-0120
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Kwan JL, 2012, EMERG INFECT DIS, V18, P1298, DOI 10.3201/eid1808.111558
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   LaPointe DA, 2009, J WILDLIFE DIS, V45, P257, DOI 10.7589/0090-3558-45.2.257
   Levine RS, 2016, AM J TROP MED HYG, V95, P1174, DOI 10.4269/ajtmh.15-0809
   Mann BR, 2013, INT J ENV RES PUB HE, V10, P5111, DOI 10.3390/ijerph10105111
   Mann BR, 2013, EMERG INFECT DIS, V19, P1418, DOI 10.3201/eid1909.130377
   Mann BR, 2013, VIROLOGY, V436, P75, DOI 10.1016/j.virol.2012.10.023
   MELNICK JL, 1951, P SOC EXP BIOL MED, V77, P661, DOI 10.3181/00379727-77-18884
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Murgue B, 2002, CURR TOP MICROBIOL, V267, P195
   Nelson CW, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey013
   Paull SH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2078
   Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561
   Philip C, 2019, J PUBLIC HEALTH MAN, V25, P277, DOI [10.1097/PHH.0000000000000990, 10.1097/phh.0000000000000990]
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Rappole JH, 2006, VECTOR-BORNE ZOONOT, V6, P128, DOI 10.1089/vbz.2006.6.128
   Reisen W. K., 2019, J MED ENTOMOL
   Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2
   Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2
   Reisen WK, 2013, VIRUSES-BASEL, V5, P2079, DOI 10.3390/v5092079
   Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2
   REISEN WK, 1995, J MED ENTOMOL, V32, P636, DOI 10.1093/jmedent/32.5.636
   Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19
   Ruybal JE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1402-z
   Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Smolinski M. S., 2003, MICROBIAL THREATS HL, P367
   Snapinn KW, 2007, J VIROL, V81, P2531, DOI 10.1128/JVI.02169-06
   Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589
   Wekesa JW, 1997, J MED ENTOMOL, V34, P219, DOI 10.1093/jmedent/34.2.219
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   ZEHMER RB, 1974, HEALTH SERV REP, V89, P278, DOI 10.2307/4595031
NR 90
TC 1
Z9 1
U1 16
U2 18
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2019
VL 56
IS 6
BP 1448
EP 1455
DI 10.1093/jme/tjz151
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JN2YQ
UT WOS:000496766800002
PM 31549719
DA 2020-07-08
ER

PT J
AU Chaves, BA
   Vieira, AB
   Silveira, KRD
   Paz, AD
   Vaz, EBD
   Araujo, RGP
   Rodrigues, NB
   Campolina, TB
   Orfano, AD
   Nacif-Pimenta, R
   Villegas, LEM
   de Melo, FF
   Silva, BD
   Monteiro, WM
   Guerra, MDVB
   de Lacerda, MVG
   Norris, DE
   Secundino, NFC
   Pimenta, PFP
AF Chaves, Barbara Aparecida
   Vieira Junior, Ademir Bentes
   Dias Silveira, Karine Renata
   Paz, Andreia da Costa
   da Costa Vaz, Evelyn Beatriz
   Pereira Araujo, Raphaela Guedes
   Rodrigues, Nilton Barnabe
   Campolina, Thais Bonifacio
   Orfano, Alessandra da Silva
   Nacif-Pimenta, Rafael
   Martinez Villegas, Luis Eduardo
   de Melo, Fabricio Freire
   Silva, Breno de Mello
   Monteiro, Wuelton Marcelo
   Vale Barbosa Guerra, Maria das Gracas
   Guimaraes de Lacerda, Marcus Vinicius
   Norris, Douglas Eric
   Costa Secundino, Nagila Francinete
   Paolucci Pimenta, Paulo Filemon
TI Vertical Transmission of Zika Virus (Flaviviridae, Flavivirus) in
   Amazonian Aedes aegypti (Diptera: Culicidae) Delays Egg Hatching and
   Larval Development of Progeny
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Zika virus; vertical transmission; Aedes aegypti; fitness cost
ID ALBOPICTUS; MOSQUITOS; EPIDEMIC
AB Zika virus (ZIKV) has emerged as a globally important arbovirus and has been reported from all states of Brazil. The virus is primarily transmitted to humans through the bite of an infective Aedes aegypti (Linnaeus, 1762) or Aedes albopictus (Skuse, 1895). However, it is important to know if ZIKV transmission also occurs from Ae. aegypti through infected eggs to her offspring. Therefore, a ZIKV and dengue virus (DENV) free colony was established from eggs collected in Manaus and maintained until the third-fourth generation in order to conduct ZIKV vertical transmission (VT) experiments which used an infectious bloodmeal as the route of virus exposure. The eggs from ZIKV-infected females were allowed to hatch. The resulting F1 progeny (larvae, pupae, and adults) were quantitative polymerase chain reaction (qPCR) assayed for ZIKV. The viability of ZIKV vertically transmitted to F1 progeny was evaluated by cultivation in C6/36 cells. The effects of ZIKV on immature development of Ae. aegypti was assessed and compared with noninfected mosquitoes. Amazonian Ae. aegypti were highly susceptible to ZIKV infection (96.7%), and viable virus passed to their progeny via VT. Moreover, eggs from the ZIKV-infected mosquitoes had a significantly lower hatch rate and the slowest hatching. In addition, the larval development period was slower when compared to noninfected, control mosquitoes. This is the first study to illustrate VT initiated by oral infection of the parental population by using mosquitoes, which originated from the field and a ZIKV strain that is naturally circulating in-country. Additionally, this study suggests that ZIKV present in the Ae. aegypti can modify the mosquito life cycle. The data reported here suggest that VT of ZIKV to progeny from naturally infected females may have a critical epidemiological role in the dissemination and maintenance of the virus circulating in the vector.
C1 [Chaves, Barbara Aparecida; Vieira Junior, Ademir Bentes; Paz, Andreia da Costa; da Costa Vaz, Evelyn Beatriz; Monteiro, Wuelton Marcelo; Vale Barbosa Guerra, Maria das Gracas; Guimaraes de Lacerda, Marcus Vinicius; Paolucci Pimenta, Paulo Filemon] Trop Med Fdn Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Chaves, Barbara Aparecida; Monteiro, Wuelton Marcelo; Vale Barbosa Guerra, Maria das Gracas] Amazonas State Univ, Manaus, Amazonas, Brazil.
   [Dias Silveira, Karine Renata; Pereira Araujo, Raphaela Guedes; Rodrigues, Nilton Barnabe; Campolina, Thais Bonifacio; Orfano, Alessandra da Silva; Nacif-Pimenta, Rafael; Martinez Villegas, Luis Eduardo; Costa Secundino, Nagila Francinete; Paolucci Pimenta, Paulo Filemon] Fiocruz MS, Rene Rachou Res Inst, Lab Med Entomol, Belo Horizonte, MG, Brazil.
   [de Melo, Fabricio Freire] Univ Fed Bahia, Multidisciplinary Hlth Inst, Salvador, BA, Brazil.
   [Silva, Breno de Mello] Univ Fed Ouro Preto, Dept Biol Sci, Ouro Preto, MG, Brazil.
   [Guimaraes de Lacerda, Marcus Vinicius] Fiocruz MS, Leonidas & Maria Deane Res Inst, Manaus, Amazonas, Brazil.
   [Norris, Douglas Eric] Johns Hopkins Bloomberg Sch Publ Hlth, Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
RP Pimenta, PFP (corresponding author), Trop Med Fdn Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.; Pimenta, PFP (corresponding author), Fiocruz MS, Rene Rachou Res Inst, Lab Med Entomol, Belo Horizonte, MG, Brazil.
EM paulo.pimenta@fiocruz.br
RI Villegas, Luis/AAG-2655-2019; silva, breno/W-5122-2018; Secundino,
   Nagila/AAM-4553-2020; Pimenta, Paulo/AAH-1502-2020; de Melo,
   Fabricio/AAN-5517-2020
OI silva, breno/0000-0003-2472-8111; de Melo, Fabricio/0000-0002-5680-2753;
   Norris, Douglas/0000-0002-4631-2777; Martinez Villegas, Luis
   Eduardo/0000-0002-9628-4081
FU Brazilian agency: Foundation of the Institute Oswaldo Cruz (FIOCRUZ);
   Brazilian agency: Strategic Program for Supporting Health Research
   (PAPES VI); Brazilian agency: Brazilian Council for Scientific and
   Technological Development (CNPq/MS/CAPES/DECIT); Brazilian agency:
   Program Science without Borders; Brazilian agency: INCT-Instituto
   Nacional de Ciencia e Tecnologia - Entomologia Molecular; Brazilian
   agency: Minas Gerais State Research Support Foundation (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG); Brazilian agency: Amazonas
   State Research Support Foundation (FAPEAM); CNPqNational Council for
   Scientific and Technological Development (CNPq); CAPESCAPES; FAPEAM
FX This study was partially funded by the following Brazilian agencies:
   Foundation of the Institute Oswaldo Cruz (FIOCRUZ), Strategic Program
   for Supporting Health Research (PAPES VI), Brazilian Council for
   Scientific and Technological Development (CNPq/MS/CAPES/DECIT), Program
   Science without Borders, INCT-Instituto Nacional de Ciencia e Tecnologia
   - Entomologia Molecular, Minas Gerais State Research Support Foundation
   (FAPEMIG), and Amazonas State Research Support Foundation (FAPEAM).
   Support Program to Young Ph.D. Professors - Federal University of Bahia
   (PROPESQ/UFBA). N.F.C.S., M.V.G.L., M.G.V.B.G., and P.F.P.P. are
   research fellows, supported by CNPq. B.A.C., T.B.C., A.S.O., E.B.C.V.,
   and N.B.R. are student fellows supported by CAPES and K.R.D.S.,
   L.E.M.V., and R.N.P. are supported by CNPq; A.C.P. and A.B.V.J. are
   supported by FAPEAM.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brazilian Ministry of Health, 2017, MON CAS DENG FEBR CH, V4
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Secundino NFC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2286-2
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fontenille D, 1997, T ROY SOC TROP MED H, V91, P533, DOI 10.1016/S0035-9203(97)90013-4
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Keating JA, 2013, VECTOR-BORNE ZOONOT, V13, P590, DOI 10.1089/vbz.2012.1110
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Municipal Health Secretariat (Semsa) Manaus City Hall, 2017, 68O INF EP
   Nelms BM, 2013, J MED ENTOMOL, V50, P371, DOI 10.1603/ME12264
   POWER AG, 1992, CRIT REV PLANT SCI, V11, P351, DOI 10.1080/713608036
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 4
Z9 4
U1 2
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2019
VL 56
IS 6
BP 1739
EP 1744
DI 10.1093/jme/tjz110
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JN2YQ
UT WOS:000496766800036
PM 31278737
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cooper, JS
   Hubble, LJ
   Chow, E
   Sosa-Pintos, A
   Patel, N
   Chai, R
   Raguse, B
AF Cooper, James S.
   Hubble, Lee J.
   Chow, Edith
   Sosa-Pintos, Andrea
   Patel, Nereus
   Chai, Roger
   Raguse, Burkhard
TI Detecting and discriminating pyrethroids with chemiresistor sensors
SO ENVIRONMENTAL CHEMISTRY
LA English
DT Article
ID NANOPARTICLE; DISINSECTION; ARRAY
AB Australia and other island nations are protected from stowaway pest vectors, like mosquitos, by aircraft disinsection - spraying the airplane interior with an insecticide. It is a simple biosecurity measure that can reduce the spread of malaria, Zika and other mosquito-borne diseases. However, checking airline compliance and the efficacy of the insecticide residue is a difficult task for border protection officials, which requires either a live fly bioassay or off-site laboratory testing. Neither of these methods are ideal for the hectic schedules of airlines. As such, we propose using gold nanoparticle chemiresistor sensor arrays, to detect and identify insecticide residue on the interior surface of aircraft. We have shown that hexanethiol functionalised sensors have a limit of detection of 3 parts per billion (ppb) for permethrin in solution and have a broad dynamic range responding to concentrations up to 1000 ppb. The chemical residues of three different insecticide products were lifted off an interior aircraft surface and identified with an array of seven uniquely functionalised sensors. This is the first ever demonstration of gold nanoparticle chemiresistor sensors being used for the analysis of chemical residues. These sensors have the potential to rapidly check the efficacy of insecticide residues on aircraft surfaces.
C1 [Cooper, James S.; Hubble, Lee J.; Chow, Edith; Sosa-Pintos, Andrea; Patel, Nereus; Chai, Roger; Raguse, Burkhard] CSIRO Mfg, Lindfield, NSW 2070, Australia.
RP Cooper, JS (corresponding author), CSIRO Mfg, Lindfield, NSW 2070, Australia.
EM james.cooper@csiro.au
RI ; Cooper, James/H-7579-2013; Hubble, Lee/D-2195-2013; Chow,
   Edith/D-1871-2013
OI Patel, Nereus/0000-0002-7511-9773; Cooper, James/0000-0003-4176-9951;
   Hubble, Lee/0000-0003-1170-6511; Chow, Edith/0000-0002-2342-3810
FU Australian Government Business Research Innovation Initiative Grant
   [BRII54755]
FX This work was partially funded by an Australian Government Business
   Research Innovation Initiative Grant (grant number: BRII54755). The
   authors thank Gertraud Norton from the Australian Department of
   Agriculture and Richard Savoie and Michael Cejnar from Micropace.
CR [Anonymous], 2016, INT HLTH REG
   Chow E, 2019, SENSOR ACTUAT B-CHEM, V284, P316, DOI 10.1016/j.snb.2018.12.128
   Chow E, 2010, SENSOR ACTUAT B-CHEM, V143, P704, DOI 10.1016/j.snb.2009.10.024
   Colume A, 2004, INT J ENVIRON AN CH, V84, P835, DOI 10.1080/0306731031000149697
   Cooper JS, 2015, ANALYST, V140, P3233, DOI 10.1039/c5an00223k
   Cooper JS, 2014, SENSOR ACTUAT B-CHEM, V202, P279, DOI 10.1016/j.snb.2014.05.094
   Cooper JS, 2010, ANAL CHEM, V82, P3788, DOI 10.1021/ac1001788
   Deziel NC, 2011, SCI TOTAL ENVIRON, V409, P4442, DOI 10.1016/j.scitotenv.2011.07.002
   Gratz NG, 2000, B WORLD HEALTH ORGAN, V78, P995
   Griffitts THD, 1931, PUBLIC HEALTH REP, V46, P2775, DOI 10.2307/4580253
   Hengel MJ, 1997, B ENVIRON CONTAM TOX, V59, P171, DOI 10.1007/s001289900461
   Hubble LJ, 2015, ACS COMB SCI, V17, P120, DOI 10.1021/co500129v
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   MCGUIRE JU, 1966, B WORLD HEALTH ORGAN, V34, P151
   Mier-y-Teran-Romero L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005683
   Mohan KR, 2010, J EXPO SCI ENV EPID, V20, P320, DOI 10.1038/jes.2009.26
   Raguse B, 2007, ANAL CHEM, V79, P7333, DOI 10.1021/ac070887i
   Raguse B, 2009, J PHYS CHEM C, V113, P15390, DOI 10.1021/jp9034453
   Rayman RB, 2006, AVIAT SPACE ENVIR MD, V77, P733
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   RUSSELL RC, 1989, B WORLD HEALTH ORGAN, V67, P543
   Sassolas A., 2012, AM J ANAL CHEM, P210, DOI DOI 10.4236/AJAC.2012.33030
   Shan GM, 2000, J AGR FOOD CHEM, V48, P4032, DOI 10.1021/jf000351x
   Smith SC, 2007, AM J TROP MED HYG, V77, P243, DOI 10.4269/ajtmh.2007.77.243
   United States Department of Transportation, 2017, AIRCR DIS REQ
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 27
TC 0
Z9 0
U1 1
U2 2
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1448-2517
EI 1449-8979
J9 ENVIRON CHEM
JI Environ. Chem.
PD NOV
PY 2019
VL 16
IS 7
BP 553
EP 559
DI 10.1071/EN19133
PG 7
WC Chemistry, Analytical; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA JL2NN
UT WOS:000495369100006
DA 2020-07-08
ER

PT J
AU Wang, YX
   McKee, M
   Torbica, A
   Stuckler, D
AF Wang, Yuxi
   McKee, Martin
   Torbica, Aleksandra
   Stuckler, David
TI Systematic Literature Review on the Spread of Health-related
   Misinformation on Social Media
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Review
DE Misinformation; Fake news; Health; Social media
ID ZIKA VIRUS; FAKE NEWS; VACCINATION DECISIONS; INFORMATION; ONLINE; WEB;
   CREDIBILITY; YOUTUBE; INTERNET; TWITTER
AB Contemporary commentators describe the current period as "an era of fake news" in which misinformation, generated intentionally or unintentionally, spreads rapidly. Although affecting all areas of life, it poses particular problems in the health arena, where it can delay or prevent effective care, in some cases threatening the lives of individuals. While examples of the rapid spread of misinformation date back to the earliest days of scientific medicine, the internet, by allowing instantaneous communication and powerful amplification has brought about a quantum change. In democracies where ideas compete in the marketplace for attention, accurate scientific information, which may be difficult to comprehend and even dull, is easily crowded out by sensationalized news. In order to uncover the current evidence and better understand the mechanism of misinformation spread, we report a systematic review of the nature and potential drivers of health-related misinformation. We searched PubMed, Cochrane, Web of Science, Scopus and Google databases to identify relevant methodological and empirical articles published between 2012 and 2018. A total of 57 articles were included for full-text analysis. Overall, we observe an increasing trend in published articles on health-related misinformation and the role of social media in its propagation. The most extensively studied topics involving misinformation relate to vaccination, Ebola and Zika Virus, although others, such as nutrition, cancer, fluoridation of water and smoking also featured. Studies adopted theoretical frameworks from psychology and network science, while co-citation analysis revealed potential for greater collaboration across fields. Most studies employed content analysis, social network analysis or experiments, drawing on disparate disciplinary paradigms. Future research should examine susceptibility of different sociodemographic groups to misinformation and understand the role of belief systems on the intention to spread misinformation. Further interdisciplinary research is also warranted to identify effective and tailored interventions to counter the spread of health-related misinformation online.
C1 [Wang, Yuxi; Torbica, Aleksandra] Bocconi Univ, Ctr Res Hlth & Social Care, Dept Social & Polit Sci, Milan, Italy.
   [McKee, Martin] London Sch Hyg & Trop Med, London, England.
   [Stuckler, David] Bocconi Univ, Dept Social & Polit Sci, Via Guglielmo Rontgen 1, I-20136 Milan, MI, Italy.
RP Wang, YX (corresponding author), Bocconi Univ, Dept Social & Polit Sci, Via Guglielmo Rontgen 1, I-20136 Milan, MI, Italy.
EM yuxi.wang@phd.unibocconi.it
RI McKee, Martin/E-6673-2018
OI McKee, Martin/0000-0002-0121-9683; Wang, Yuxi/0000-0002-9897-7316
FU EU's Research and Innovation Horizon 2020 Framework [721402]; Wellcome
   Trust Investigator AwardWellcome Trust; ERCEuropean Research Council
   (ERC) [HRES 313590]
FX YW is funded by the EU's Research and Innovation Horizon 2020 Framework
   under grant agreement 721402.; DS is funded by a Wellcome Trust
   Investigator Award and ERC HRES 313590.
CR Abbasi Mohammad-Ali, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P441, DOI 10.1007/978-3-642-37210-0_48
   Abroms LC, 2013, AM J PREV MED, V45, P732, DOI 10.1016/j.amepre.2013.07.008
   Adebimpe Wasiu Olalekan, 2015, Pan Afr Med J, V22 Suppl 1, P7, DOI 10.11694/pamj.supp.2015.22.1.6165
   Al Khaja KAJ, 2018, J PUBLIC HEALTH POL, V39, P343, DOI 10.1057/s41271-018-0131-2
   Albarracin D, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9959
   Allport G.W., 1947, PSYCHOL RUMOR
   Alnemer KA, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4898
   Aquino F, 2017, VACCINE, V35, P4494, DOI 10.1016/j.vaccine.2017.07.029
   Bahk CY, 2016, HEALTH AFFAIR, V35, P341, DOI 10.1377/hlthaff.2015.1092
   Bartlett Frederick, 1932, REMEMBERING STUDY EX
   Basch CH, 2017, CHILD CARE HLTH DEV, V43, P499, DOI 10.1111/cch.12442
   Bessi A, 2016, EUR PHYS J-SPEC TOP, V225, P2047, DOI 10.1140/epjst/e2015-50319-0
   Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134641
   Betsch C, 2012, VACCINE, V30, P3723, DOI 10.1016/j.vaccine.2012.03.078
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Bode L, 2015, J COMMUN, V65, P619, DOI 10.1111/jcom.12166
   Bora K, 2018, PATHOG GLOB HEALTH, V112, P320, DOI 10.1080/20477724.2018.1507784
   Bordia P, 2004, SOC PSYCHOL QUART, V67, P33, DOI 10.1177/019027250406700105
   Boutyline A, 2017, POLIT PSYCHOL, V38, P551, DOI 10.1111/pops.12337
   Bryant AG, 2014, CONTRACEPTION, V90, P601, DOI 10.1016/j.contraception.2014.07.003
   Castillo C., 2011, P 20 INT C WORLD WID, P675, DOI DOI 10.1145/1963405.1963500
   Chen B, 2018, JMIR PUBLIC HLTH SUR, V4, P106, DOI 10.2196/publichealth.8198
   Chen HM, 2013, INTERACT J MED RES, V2, P90, DOI 10.2196/ijmr.2669
   Chen L, 2018, J MED INTERNET RES, V20, DOI 10.2196/11515
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Chua AYK, 2018, COMPUT HUM BEHAV, V87, P1, DOI 10.1016/j.chb.2018.05.021
   Chua AYK, 2017, INT J MED INFORM, V108, P36, DOI 10.1016/j.ijmedinf.2017.08.010
   Datta SS, 2018, VACCINE, V36, P5408, DOI 10.1016/j.vaccine.2017.06.042
   Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113
   Donzelli G, 2018, HUM VACC IMMUNOTHER, V14, P1654, DOI 10.1080/21645515.2018.1454572
   Dubey D, 2014, CLIN MED RES, V12, P129, DOI 10.3121/cmr.2013.1194
   Eng DS, 2013, PEDIATR DIABETES, V14, P231, DOI 10.1111/pedi.12034
   Filia A., 2017, EURO SURVEILL, V22
   Free C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001363
   Fung ICH, 2016, PUBLIC HEALTH REP, V131, P461, DOI 10.1177/003335491613100312
   Garg N, 2015, NEPHROLOGY, V20, P315, DOI 10.1111/nep.12397
   Ghenai A., 2017, ARXIV170703778CS
   Grant L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4153
   Groshek J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7624
   Grunig J. E., 1997, PUBLIC RELATIONS RES, P3, DOI DOI 10.4135/9781452276236.N450
   Harris JK, 2014, J MED INTERNET RES, V16, P162, DOI [10.2196/jmir.2972, 10.2196/jmir.3622]
   He ZB, 2015, INT CON DISTR COMP S, P205, DOI 10.1109/ICDCS.2015.29
   Jerit J, 2012, J POLIT, V74, P672, DOI 10.1017/S0022381612000187
   Jin F, 2014, COMPUTER, V47, P90, DOI 10.1109/MC.2014.361
   Johnson TJ, 1998, JOURNALISM MASS COMM, V75, P325, DOI 10.1177/107769909807500208
   Jost JT, 2018, CURR OPIN PSYCHOL, V23, P77, DOI 10.1016/j.copsyc.2018.01.003
   Karlova N., 2013, INF RES, V18
   Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112
   Kaufman AB, 2018, PSEUDOSCIENCE: THE CONSPIRACY AGAINST SCIENCE, pXXI
   Kim D., 2009, INT COMMUNICATION GA, V71, P283, DOI DOI 10.1177/1748048509102182
   Kirkpatrick C, 1932, AM J SOCIOL, V38, P194, DOI 10.1086/216029
   Krishna A, 2017, J PUBLIC RELAT RES, V29, P176, DOI 10.1080/1062726X.2017.1363047
   Kumar N, 2014, J AM SOC HYPERTENS, V8, P481, DOI 10.1016/j.jash.2014.05.001
   Lavorgna L, 2018, MULT SCLER RELAT DIS, V25, P175, DOI 10.1016/j.msard.2018.07.046
   Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998
   Leong AY, 2018, CAN J DIABETES, V42, P395, DOI 10.1016/j.jcjd.2017.10.056
   Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637
   Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018
   Li A, 2018, 2018 IEEE SYMPOSIUM ON PRIVACY-AWARE COMPUTING (PAC), P10, DOI 10.1109/PAC.2018.00008
   Li HY, 2015, P ANN HICSS, P2003, DOI 10.1109/HICSS.2015.240
   Lupia A, 2013, P NATL ACAD SCI USA, V110, P14048, DOI 10.1073/pnas.1212726110
   Mahoney L Meghan, 2015, JMIR Public Health Surveill, V1, pe2, DOI 10.2196/publichealth.3310
   MCKEE M, 2010, BMJ-BRIT MED J, V341, DOI DOI 10.1136/BMJ.C6950
   McKernon E., 1925, HAPERS MAGAZINE
   Mertz Aaron, 2014, J Mass Dent Soc, V63, P32
   Metzger MJ, 2007, J AM SOC INF SCI TEC, V58, P2078, DOI 10.1002/asi.20672
   Metzger MJ, 2010, J COMMUN, V60, P413, DOI 10.1111/j.1460-2466.2010.01488.x
   Metzger MJ, 2003, COMM YEARB, V27, P293, DOI 10.1207/s15567419cy2701_10
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Murray E, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1052
   Nicholson MS, 2012, VACCINE, V30, P3806, DOI 10.1016/j.vaccine.2011.10.072
   Noack A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026102
   Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2
   Okuhara Tsuyoshi, 2017, Asian Pac J Cancer Prev, V18, P1069
   Ozturk P, 2015, P ANN HICSS, P2406, DOI 10.1109/HICSS.2015.288
   Panatto D, 2018, HUM VACC IMMUNOTHER, V14, P969, DOI 10.1080/21645515.2017.1407483
   Pathak R, 2015, N AM J MED SCI, V7, P306, DOI 10.4103/1947-2714.161244
   Pennycook G, 2019, COGNITION, V188, P39, DOI 10.1016/j.cognition.2018.06.011
   Porat T, 2019, EUR J PUBLIC HEALTH, V29, P117, DOI 10.1093/eurpub/cky144
   Primack BA, 2012, AM J PREV MED, V42, P150, DOI 10.1016/j.amepre.2011.10.013
   Qi J, 2016, DERMATOL ONLINE J, V22
   Radzikowski Jacek, 2016, JMIR Public Health Surveill, V2, pe1, DOI 10.2196/publichealth.5059
   Reyna VF, 2012, VACCINE, V30, P3790, DOI 10.1016/j.vaccine.2011.11.070
   Ritterband LM, 2009, ANN BEHAV MED, V38, P1, DOI 10.1007/s12160-009-9132-5
   ROSNOW RL, 1991, AM PSYCHOL, V46, P484, DOI 10.1037/0003-066X.46.5.484
   Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199
   Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004
   Schmidt AL, 2018, VACCINE, V36, P3606, DOI 10.1016/j.vaccine.2018.05.040
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Serrano E, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P811, DOI 10.1145/2740908.2742466
   Seymour B, 2015, AM J PUBLIC HEALTH, V105, P517, DOI 10.2105/AJPH.2014.302437
   Shao CC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196087
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Shin DH, 2017, COMPUT HUM BEHAV, V67, P292, DOI 10.1016/j.chb.2016.11.007
   Sicilia R, 2017, IEEE INT C BIOINFORM, P1599, DOI 10.1109/BIBM.2017.8217899
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Sommariva S, 2018, AM J HEALTH EDUC, V49, P246, DOI 10.1080/19325037.2018.1473178
   Song J, 2017, CYBERPSYCH BEH SOC N, V20, P22, DOI 10.1089/cyber.2016.0126
   Steinhubl SR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3487
   Stone CB, 2019, TOP COGN SCI, V11, P774, DOI 10.1111/tops.12369
   Strychowsky JE, 2013, INT J PEDIATR OTORHI, V77, P972, DOI 10.1016/j.ijporl.2013.03.023
   Swire B, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160802
   Syed-Abdul S, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2237
   Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x
   Tustin JL, 2018, JMIR PUBLIC HLTH SUR, V4, P129, DOI 10.2196/10090
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820
   Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559
   Vraga EK, 2017, SCI COMMUN, V39, P621, DOI 10.1177/1075547017731776
   Wakamiya S., 2016, BOOM ONE TWEETS MICR, P17, DOI [10.1145/3007818.3007822, DOI 10.1145/3007818.3007822]
   Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0
   Wardle C, 2017, FAKE NEWS ITS COMPLI
   WARDLE C., 2017, INFORM DISORDER INTE
   Waszak PM, 2018, HEALTH POLICY TECHN, V7, P115, DOI 10.1016/j.hlpt.2018.03.002
   Wood MJ, 2018, CYBERPSYCH BEH SOC N, V21, P485, DOI 10.1089/cyber.2017.0669
   World Economic Forum, 2013, WORLD EC FOR GLOB RI
   Xu Z, 2018, COMMUN STUD, V69, P103, DOI 10.1080/10510974.2017.1414068
   Yuelin Li, 2017, Proceedings of the Association for Information Science and Technology, V54, DOI 10.1002/pra2.2017.14505401139
NR 118
TC 21
Z9 21
U1 28
U2 38
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD NOV
PY 2019
VL 240
AR 112552
DI 10.1016/j.socscimed.2019.112552
PG 12
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA JL4FG
UT WOS:000495485800001
PM 31561111
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Blanchard, J
   Douglass, K
   Gidwani, S
   Khatri, U
   Gaballa, D
   Pousson, A
   Mangla, N
   Smith, J
AF Blanchard, Janice
   Douglass, Katherine
   Gidwani, Shweta
   Khatri, Usha
   Gaballa, Daniel
   Pousson, Amelia
   Mangla, Neeraj
   Smith, Jeffrey
TI Seasonal dengue surge: Providers' perceptions about the impact of dengue
   on patient volume, staffing and use of point of care testing in Indian
   emergency departments
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Dengue; Surge
ID NONSTRUCTURAL PROTEIN-1; TEST KIT; MANAGEMENT; DIAGNOSIS; ZIKA
AB Background: Global health emergencies, such as from diseases like dengue fever, can lead to rapid surges in visits to emergency departments. The objective of our study was to evaluate the impact of dengue on factors that could impact emergency department flow, including patient volume and staffing, on Indian emergency departments.
   Methods: This was a prospective cohort study of Indian emergency providers. Respondents were queried via online survey about a number of domains including practice environment, use of rapid testing, changes in ED volume and ED staffing adjustments occurring during dengue season. Data was analyzed using multivariate analysis.
   Results: We had a total of 210 respondents to our online survey. Less than half of respondents reported that their institutions used rapid point of care testing. When asked how dengue impacted ED flow, the most common response was that dengue increased the total number of ED visits (84%). Despite this increase, only about 32% of respondents reported that their institutions increased hospital staffing. In multivariate analysis, respondents at hospitals that experienced ED visit surges over 40% of baseline were more likely to also report that their institutions also increased staffing during this time (OR 3.28, 95% CI 1.44-7.46).
   Conclusions: Our study shows that despite increases in visits during dengue season, ED providers noted that their EDs did not respond with staffing increases. More research is needed to better understand how emergency departments can adjust to dengue to provide optimal care for patients in India. (C) 2019 Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creative.commons.org/licenses/by-nc-nd/4.0/).
C1 [Blanchard, Janice; Douglass, Katherine] George Washington Univ, Dept Emergency Med, 2120 L St NW Suite 450, Washington, DC 20037 USA.
   [Gidwani, Shweta] Chelsea & Westminster Hosp, Emergency Dept, 369 Fulham Rd, London SW10 9NH, England.
   [Khatri, Usha] 3400 Spruce St, Philadelphia, PA 19104 USA.
   [Gaballa, Daniel] M S Hershey Med Ctr, Dept Med Penn State, 500 Univ Dr,POB 850 Mail Code H039, Hershey, PA 16802 USA.
   [Pousson, Amelia] Johns Hopkins Univ, 1800 Orleans St, Baltimore, MD 21287 USA.
   [Mangla, Neeraj] Gleneagles Global Hlth City, Chennai, Tamil Nadu, India.
   [Smith, Jeffrey] George Washington Univ, Dept Emergency Med, 2120 L St NW Suite 450, Washington, DC 20037 USA.
RP Blanchard, J (corresponding author), George Washington Univ, Dept Emergency Med, 2120 L St NW Suite 450, Washington, DC 20037 USA.
EM jblanchard@mfa.gwu.edu
CR Afilalo M, 2012, EMERG MED CLIN N AM, V30, P271, DOI 10.1016/j.emc.2011.10.011
   Aikat Aditi, 2011, J Indian Med Assoc, V109, P543
   [Anonymous], 2015, GOVT PLANS BAN SALE
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Zanotto PMD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01964
   de Silva PK, 2017, INT J ADV RES, V5, P1152
   Ganeshkumar P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006618
   Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015
   Gupta B, 2013, PARASITOL RES, V112, P1367, DOI 10.1007/s00436-013-3342-2
   Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014
   India Ministry of Health and Family Welfare, NAT VECT DIS CONTR P
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Lum LCS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003836
   Mariappan T, 2013, TROP DOCT, V43, P116, DOI 10.1177/0049475513491944
   Mishra B, 2014, J GLOB INFECT DIS, V6, P109, DOI 10.4103/0974-777X.138504
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Rubinson L, 2013, MED CARE, V51, P259, DOI 10.1097/MLR.0b013e31827da8ea
   Shepard Donald S, 2014, AM J TROP MED HYG, V91, P1235
   Singhi S, 2014, INDIAN J CRIT CARE M, V18, P62, DOI 10.4103/0972-5229.126074
   Stephen S, 2014, INDIAN J PATHOL MICR, V57, P81, DOI 10.4103/0377-4929.130905
   Sugerman D, 2011, CLIN INFECT DIS, V52, pS177, DOI 10.1093/cid/ciq035
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   World Health Organization, DENG SEV DENG
   Zongo S, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118794589
NR 26
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD NOV-DEC
PY 2019
VL 12
IS 6
BP 794
EP 798
DI 10.1016/j.jiph.2019.04.001
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JJ2OD
UT WOS:000494000800008
PM 31006636
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Morais, LMO
   Jussiani, EI
   Zequi, JAC
   dos Reis, PJ
   Andrello, AC
AF Oliveira de Morais, Lilian Mirian
   Jussiani, Eduardo Inocente
   Cyrino Zequi, Joao Antonio
   dos Reis, Paulo Jose
   Andrello, Avacir Casanova
TI Morphological study of Aedes aegypti and Aedes albopictus (Diptera:
   Culicidae) eggs by X-ray computed microtomography
SO MICRON
LA English
DT Article
DE Eggs; Aedes aegypti; Aedes albopictus; Micro-CT
ID DIFFERENTIATION
AB Aedes aegypti and Aedes albopictus are vectors of several arboviruses responsible for causing dengue, chikungunya, Zika, and yellow fever viruses and microcephaly, resulting in a public health problem in several countries worldwide. Even in this scenario, studies on the morphology of mosquito eggs are still lacking. In this paper, X-ray microtomography was used to study mosquito egg morphology. Several parameters such as length, surface area, volume, area-by-volume ratio, eccentricity and center of mass of the eggs were determined. The results obtained showed that micro-CT is an efficient technique for the morphological study of insect eggs and provides information that cannot be obtained with other techniques.
C1 [Oliveira de Morais, Lilian Mirian; Cyrino Zequi, Joao Antonio] Univ Estadual Londrina, Dept Anim & Plant Biol, Londrina, Parana, Brazil.
   [Jussiani, Eduardo Inocente; Andrello, Avacir Casanova] Univ Estadual Londrina, Phys Dept, Appl Nucl Phys Lab LFNA, Londrina, Parana, Brazil.
   [dos Reis, Paulo Jose] State Univ Ctr West, Phys Dept, Guarapuava, Parana, Brazil.
RP Jussiani, EI (corresponding author), Rodovia Celso Garcia Cid,PR 445 Km 380,Campus, BR-86057970 Londrina, PR, Brazil.
EM inocente@uel.br
RI Jussiani, Eduardo/AAG-8306-2020
OI Morais, Lilian/0000-0002-3124-8442; Inocente Jussiani,
   Eduardo/0000-0002-8500-5710
FU FINEP (CT INFRA 2009) [01.10.0534.01]
FX The authors would like to thank FINEP (CT INFRA 2009 -Grant
   01.10.0534.01) for financial support.
CR Bova J, 2016, J AM MOSQUITO CONTR, V32, P244, DOI 10.2987/15-6535.1
   Farnesi LC, 2015, J INSECT PHYSIOL, V83, P43, DOI 10.1016/j.jinsphys.2015.10.006
   Faull KJ, 2016, ARTHROPOD STRUCT DEV, V45, P273, DOI 10.1016/j.asd.2016.01.009
   Ferreira AC, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000414, 10.11606/s1518-8787.2018052000414]
   Jain N, 2018, PHARMATUTOR, V6, P30, DOI [10.29161/pt.v6.i1.2018.30, DOI 10.29161/PT.V6.I1.2018.30]
   Pan American Health Organization (PAHO), 2018, ZIK VIR INF
   Pan American Health Organization (PAHO), 2019, 10 VECT BORN DES PUT
   Suman DS, 2011, ARTHROPOD STRUCT DEV, V40, P479, DOI 10.1016/j.asd.2011.04.003
   Terra M.R, 2017, REV UNINGA REV, V30
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   WHO (World Health Organization), 2019, INS BORN DIS
   WHO (World Health Organization), 2018, VAC DENG
   Win M.M, 2018, J BIOL ENG RES REV, V5
NR 13
TC 0
Z9 0
U1 1
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD NOV
PY 2019
VL 126
AR UNSP 102734
DI 10.1016/j.micron.2019.102734
PG 5
WC Microscopy
SC Microscopy
GA JK5OQ
UT WOS:000494893100009
PM 31494346
DA 2020-07-08
ER

PT J
AU Logue, T
   Muse, N
   Mejia-Echeverry, A
   Zhang, GY
   Etienne, M
   Rojas, M
   Timoszyk, E
   Fernandez, D
   Calle, S
   Goldberg, C
   Arshad, A
   Rico, E
   Noya-Chaveco, P
   Jean, R
   Rivera, L
   Mendoza, R
   White, S
   Gillis, LD
   Heberlein-Larson, L
   Villalta, Y
   Blackmore, C
AF Logue, Teresa
   Muse, Nicole
   Mejia-Echeverry, Alvaro
   Zhang, Guoyan
   Etienne, Marie
   Rojas, Mercedes
   Timoszyk, Elizabeth
   Fernandez, Danielle
   Calle, Stephanie
   Goldberg, Cynthia
   Arshad, Amena
   Rico, Edhelene
   Noya-Chaveco, Pedro
   Jean, Reynald
   Rivera, Lillian
   Mendoza, Rafael
   White, Stephen
   Gillis, Leah D.
   Heberlein-Larson, Lea
   Villalta, Yesenia
   Blackmore, Carina
TI Routine screening of pregnant women for Zika virus in the setting of
   local transmission-Miami-Dade County, Florida, 2016-2017
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Editorial Material
C1 [Logue, Teresa; Muse, Nicole; Mejia-Echeverry, Alvaro; Zhang, Guoyan; Etienne, Marie; Rojas, Mercedes; Timoszyk, Elizabeth; Fernandez, Danielle; Calle, Stephanie; Goldberg, Cynthia; Arshad, Amena; Rico, Edhelene; Noya-Chaveco, Pedro; Jean, Reynald; Rivera, Lillian] Florida Dept Hlth Miami Dade Cty, Epidemiol Dis Control & Immunizat Serv, Miami, FL 33125 USA.
   [Mendoza, Rafael] Florida Dept Hlth Broward Cty, Epidemiol, Ft Lauderdale, FL USA.
   [White, Stephen; Gillis, Leah D.] Bur Publ Hlth Labs, Miami, FL USA.
   [Heberlein-Larson, Lea] Bur Publ Hlth Labs, Tampa, FL USA.
   [Villalta, Yesenia] Florida Dept Hlth Miami Dade Cty, Womens Hlth & Prevent Serv, Miami, FL USA.
   [Blackmore, Carina] Florida Dept Hlth, Bur Epidemiol, Tallahassee, FL USA.
   [Logue, Teresa] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA.
RP Logue, T (corresponding author), Florida Dept Hlth Miami Dade Cty, Epidemiol Dis Control & Immunizat Serv, Miami, FL 33125 USA.; Logue, T (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA.
EM teresalogue@gmail.com
OI White, Stephen/0000-0002-2112-1560
CR Centers for Disease Control and Prevention, 2016, CDC GUID TRAV TEST P
   Centers for Disease Control and Prevention, 2017, KEY MESS ZIK VIR DIS
   Florida Department of Health, ZIK VIR DIS INF REP
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
NR 4
TC 0
Z9 0
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD NOV
PY 2019
VL 221
IS 5
BP 528
EP 530
DI 10.1016/j.ajog.2019.06.049
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JJ1TQ
UT WOS:000493944800055
PM 31255628
DA 2020-07-08
ER

PT J
AU Cardona-Ospina, JA
   Henao-SanMartin, V
   Acevedo-Mendoza, WF
   Nasner-Posso, KM
   Martinez-Pulgarin, DF
   Restrepo-Lopez, A
   Valencia-Gallego, V
   Collins, MH
   Rodriguez-Morales, AJ
AF Cardona-Ospina, Jaime A.
   Henao-SanMartin, Valentina
   Acevedo-Mendoza, Wilmer F.
   Melissa Nasner-Posso, Katherinn
   Martinez-Pulgarin, Dayron F.
   Restrepo-Lopez, Abril
   Valencia-Gallego, Valentina
   Collins, Matthew H.
   Rodriguez-Morales, Alfonso J.
TI Fatal Zika virus infection in the Americas: A systematic review
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Zika; Fatal; Complications; Severe; Epidemiology; Americas
ID DISEASE; EPIDEMIC; MODEL
AB Introduction: While death due to Zika virus (ZIKV) infection has been described, reports of fatal cases have been infrequent and no systematic reviews on the subject have been published.
   Methods: A systematic review of the literature in four databases was performed to assess fatal outcomes of postnatal ZIKV infection and the available evidence that links ZIKV infection to death.
   Results: Three hundred and eleven articles were retrieved; 20 of them were epidemiological reports from surveillance agencies and ministries of health. After screening by abstract and title, 59 articles were selected for full-text assessment. Of these, 35 were excluded (with reasons) and 24 were finally included for qualitative analysis. A total of 51 reported deaths associated with ZIKV infection in nine countries were identified. The majority of cases (56.9%) were not related to Guillain-Barre syndrome. Cases from three countries accounted for 67.6% of the deaths. ZIKV infection was laboratory-confirmed in the majority of cases (64.7%).
   Discussion: ZIKV was not considered to be a dangerous, and much less a lethal pathogen, until very recently. However, an increasing number of fatalities have been published in the literature since the first death was reported in 2016. Additional research is needed to elucidate factors that may mediate the pathogenesis of severe, atypical, and fatal disease. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Cardona-Ospina, Jaime A.; Henao-SanMartin, Valentina; Acevedo-Mendoza, Wilmer F.; Melissa Nasner-Posso, Katherinn; Martinez-Pulgarin, Dayron F.; Restrepo-Lopez, Abril; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Cardona-Ospina, Jaime A.; Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika & Other Arbovir, Pereira, Risaralda, Colombia.
   [Cardona-Ospina, Jaime A.] Univ Tecnol Pereira, Fac Hlth Sci, Grp Invest Infecc & Inmunidad, Pereira, Risaralda, Colombia.
   [Cardona-Ospina, Jaime A.; Valencia-Gallego, Valentina] Fdn Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Risaralda, Colombia.
   [Cardona-Ospina, Jaime A.; Valencia-Gallego, Valentina] Fdn Univ Autonoma Amer, Fac Med, Semillero Invest Infecc Emergentes & Med Trop, Pereira, Risaralda, Colombia.
   [Cardona-Ospina, Jaime A.; Rodriguez-Morales, Alfonso J.] Inst Invest Ciencias Biomed Sci Help, Emerging Infect Dis & Trop Med Res Grp, Pereira, Risaralda, Colombia.
   [Collins, Matthew H.] Emory Univ, Sch Med, Dept Med, Hope Clin,Emory Vaccine Ctr,Div Infect Dis, Decatur, GA 30030 USA.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Collins, MH (corresponding author), Emory Univ, Sch Med, Dept Med, Hope Clin,Emory Vaccine Ctr,Div Infect Dis, Decatur, GA 30030 USA.
EM matthew.collins@emory.edu; arodriguezm@utp.edu.co
OI Martinez-Pulgarin, Dayron Fernando/0000-0002-9942-3868;
   Rodriguez-Morales, Alfonso J./0000-0001-9773-2192
FU Universidad Tecnologica de Pereira, Risaralda, Colombia; Emory
   University, Atlanta, GA, United States of America
FX Universidad Tecnologica de Pereira, Risaralda, Colombia, and Emory
   University, Atlanta, GA, United States of America. The study sponsors
   had no role in the study design, in the collection, analysis and
   interpretation of data, in the writing of the manuscript, or in the
   decision to submit the manuscript for publication.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Agence Regionale de Sante, 2017, SURV VIR ZIK ANT GUY
   Agence Regionale de Sante, 2016, SURV VIR ZIK ANT GUY
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Brent C., 2016, MMWR-MORBID MORTAL W, V2016, P65
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   (IHE). IoHE, 2014, QUAL APPR CAS SER ST
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Ministerio de Salud Publica de Republica Dominicana, 2017, B EPIDEMIOLOGICO SEM
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP GUAD
   Pan American Health Organization/World Health Organization, 2017, ZIK REP
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP BOL
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Rajahram GS, 2019, INT J INFECT DIS, V83, P163, DOI 10.1016/j.ijid.2019.01.047
   Rodriguez-Morales AJ, 2019, INT J INFECT DIS, V83, P160, DOI 10.1016/j.ijid.2019.03.002
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Walker WL, 2016, MMWR-MORBID MORTAL W, V2016, P65
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 44
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD NOV
PY 2019
VL 88
BP 49
EP 59
DI 10.1016/j.ijid.2019.08.033
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA JJ1DO
UT WOS:000493901000009
PM 31499212
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Piyasena, TBH
   Newton, ND
   Hobson-Peters, J
   Vet, LJ
   Setoh, YX
   Bielefeldt-Ohmann, H
   Khromykh, AA
   Hall, RA
AF Piyasena, Thisun B. H.
   Newton, Natalee D.
   Hobson-Peters, Jody
   Vet, Laura J.
   Setoh, Yin X.
   Bielefeldt-Ohmann, Helle
   Khromykh, Alexander A.
   Hall, Roy A.
TI Chimeric viruses of the insect-specific flavivirus Palm Creek with
   structural proteins of vertebrate-infecting flaviviruses identify
   barriers to replication of insect-specific flaviviruses in vertebrate
   cells
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Flavivirus; CPER; Zika virus; dengue virus; insect-specific flavivirus
ID ANTIGENIC DETERMINANTS; MODOC-VIRUS; TRANSMISSION; ENVELOPE; LINE
AB Here we report the generation of novel chimeric flaviviruses, which express the prM and E proteins of either dengue or Zika viruses on the genomic backbone of Palm Creek virus (PCV), an insect-specific flavivirus. The chimeric virus particles were antigenically indistinguishable from their parental prM-E donors, but were unable to infect vertebrate cells. An additional chimera (PCV structural genes in the backbone of West Nile virus - WNV/PCV-prME) was also unable to infect vertebrate cells, but transfection with RNA from this virus resulted in detectable RNA replication and translation but no infectious virion production. These data suggest multiple blocks at the entry, RNA replication and assembly/release stages of insect-specific flavivirus (ISF) infection in vertebrate cells. Serial passaging of these chimeric viruses in mosquito cells identified amino acid substitutions that may lead to increased replication efficiency. These chimeric viruses provide unique tools to further dissect the mechanisms of the host restriction of ISFs.
C1 [Piyasena, Thisun B. H.; Newton, Natalee D.; Hobson-Peters, Jody; Vet, Laura J.; Setoh, Yin X.; Bielefeldt-Ohmann, Helle; Khromykh, Alexander A.; Hall, Roy A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
RP Khromykh, AA; Hall, RA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
EM alexander.khromykh@uq.edu.au; roy.hall@uq.edu.au
RI Khromykh, Alexander/X-7200-2018; Piyasena, Thisun/I-3247-2016
OI Khromykh, Alexander/0000-0001-6206-6935; Piyasena,
   Thisun/0000-0002-1657-8558; Vet, Laura/0000-0001-7587-2936;
   Hobson-Peters, Jody/0000-0003-0139-9829; Newton,
   Natalee/0000-0002-5617-8639
FU Australian Government National Health and Medical Research Council
   (NHMRC)National Health and Medical Research Council of Australia
   [APP1138611]; University of Queensland strategic funding grant [612023];
   Australian Government Research Training Program ScholarshipsAustralian
   Government
FX This study was funded by the Australian Government National Health and
   Medical Research Council (NHMRC) project number APP1138611 and a
   University of Queensland strategic funding grant (612023). A. A. K. is
   an NHMRC Research Fellow. T. B. H. P., N. D. D. and L. J. V. are
   supported by Australian Government Research Training Program
   Scholarships.
CR ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Charlier N, 2004, J VIROL, V78, P7418, DOI 10.1128/JVI.78.14.7418-7426.2004
   Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0
   DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   HALL RA, 1990, J GEN VIROL, V71, P2923, DOI 10.1099/0022-1317-71-12-2923
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   Nandakumar R, 2013, GASTROENTEROLOGY, V145, P1414, DOI 10.1053/j.gastro.2013.08.037
   Piyasena TBH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03120-1
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Saiyasombat R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-150
   Setoh YX, 2015, J GEN VIROL, V96, P1297, DOI 10.1099/vir.0.000069
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Thibodeaux BA, 2009, CLIN VACCINE IMMUNOL, V16, P679, DOI 10.1128/CVI.00354-08
   Tumban E, 2013, J GEN VIROL, V94, P783, DOI 10.1099/vir.0.046664-0
NR 22
TC 0
Z9 0
U1 5
U2 6
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD NOV
PY 2019
VL 100
IS 11
BP 1580
EP 1586
DI 10.1099/jgv.0.001326
PG 7
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA JJ2FF
UT WOS:000493976100012
PM 31524580
OA Bronze
DA 2020-07-08
ER

PT J
AU Nainu, F
   Trenerry, A
   Johnson, KN
AF Nainu, Firzan
   Trenerry, Alice
   Johnson, Karyn N.
TI Wolbachia-mediated antiviral protection is cell-autonomous
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Wolbachia; arbovirus; Drosophila C virus; insect virus; antiviral
   protection
ID VIRUS-INFECTION; DENGUE VIRUS; ZIKA VIRUS; AEDES; TRANSMISSION; STRAIN
AB Vector-borne viral diseases pose significant risks to human health. To control the transmission of these viruses, a number of approaches are required. The ability of the intracellular bacteria Wolbachia to limit viral accumulation and transmission in some arthropod hosts, highlights its potential as a biocontrol agent. Whilst Wolbachia can reduce the transmission of several epidemiologically important viruses, protection is not consistent amongst all insects, viruses and strains of Wolbachia, which confounds elucidation of the mechanisms that underly this protection. Evidence of different mechanisms has emerged, but is not always consistent, suggesting the tripartite interaction may be complex. Here we provide evidence that Wolbachia-mediated antiviral protection is dependent on the presence of Wolbachia in individual cells, and cannot be conferred to surrounding cells. Our results suggest that protection is cell-autonomous, and this has several mechanistic implications, which can direct future research.
C1 [Nainu, Firzan; Trenerry, Alice; Johnson, Karyn N.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.
   [Nainu, Firzan] Hasanuddin Univ, Fac Pharm, Makassar, Indonesia.
RP Johnson, KN (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.
EM karynj@uq.edu.au
RI Nainu, Firzan/E-2447-2017; Johnson, Karyn/B-7980-2008
OI Nainu, Firzan/0000-0003-0989-4023; Johnson, Karyn/0000-0001-8647-8985;
   Trenerry, Alice/0000-0002-8424-4250
FU Department of Education and Training, Australia
FX F.N. is a recipient of 2018 Endeavour Research Fellowship from The
   Department of Education and Training, Australia.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   Kuraishi T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00375
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Micieli MV, 2014, J MED ENTOMOL, V51, P189, DOI 10.1603/ME13152
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010
   Serbus LR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002922
   Serbus LR, 2011, J CELL SCI, V124, P4299, DOI 10.1242/jcs.092510
   Sigle LT, 2019, INSECT BIOCHEM MOLEC, V109, P72, DOI 10.1016/j.ibmb.2019.04.004
   Skelton E, 2016, J MED ENTOMOL, V53, P401, DOI 10.1093/jme/tjv235
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   White PM, 2017, GENETICS, V205, P1473, DOI 10.1534/genetics.116.198903
   Wong ZS, 2015, APPL ENVIRON MICROB, V81, P3001, DOI 10.1128/AEM.03847-14
   Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 44
TC 0
Z9 0
U1 1
U2 7
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD NOV
PY 2019
VL 100
IS 11
BP 1587
EP 1592
DI 10.1099/jgv.0.001342
PG 6
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA JJ2FF
UT WOS:000493976100013
PM 31599711
OA Bronze
DA 2020-07-08
ER

PT J
AU Johnson, BA
   Hage, A
   Kalveram, B
   Mears, M
   Plante, JA
   Rodriguez, SE
   Ding, Z
   Luo, X
   Bente, D
   Bradrick, SS
   Freiberg, AN
   Popov, V
   Rajsbaum, R
   Rossi, S
   Russell, WK
   Menachery, VD
AF Johnson, Bryan A.
   Hage, Adam
   Kalveram, Birte
   Mears, Megan
   Plante, Jessica A.
   Rodriguez, Sergio E.
   Ding, Zhixia
   Luo, Xuemei
   Bente, Dennis
   Bradrick, Shelton S.
   Freiberg, Alexander N.
   Popov, Vsevolod
   Rajsbaum, Ricardo
   Rossi, Shannan
   Russell, William K.
   Menachery, Vineet D.
TI Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE MERS-CoV; SARS-CoV; coronavirus; cyclic lipopeptide; microbiome;
   surfactin
ID SURFACTIN; VIRUS; BIOSURFACTANT; PATHOGENESIS; MICROBIOTA; PARTICLES;
   MECHANISM; DYNAMICS; BLOCK; MICE
AB Enteric viruses exploit bacterial components, including lipopolysaccharides (LPS) and peptidoglycan (PG), to facilitate infection in humans. Because of their origin in the bat enteric system, we wondered if severe acute respiratory syndrome coronavirus (SARS-CoV) or Middle East respiratory syndrome CoV (MERS-CoV) also use bacterial components to modulate infectivity. To test this question, we incubated CoVs with LPS and PG and evaluated infectivity, finding no change following LPS treatment. However, PG from Bacillus subtilis reduced infection >10,000-fold, while PG from other bacterial species failed to recapitulate this. Treatment with an alcohol solvent transferred inhibitory activity to the wash, and mass spectrometry revealed surfactin, a cyclic lipopeptide antibiotic, as the inhibitory compound. This antibiotic had robust dose- and temperature-dependent inhibition of CoV infectivity. Mechanistic studies indicated that surfactin disrupts CoV virion integrity, and surfactin treatment of the virus inoculum ablated infection in vivo. Finally, similar cyclic lipopep-tides had no effect on CoV infectivity, and the inhibitory effect of surfactin extended broadly to enveloped viruses, including influenza, Ebola, Zika, Nipah, chikungunya, Una, Mayaro, Dugbe, and Crimean-Congo hemorrhagic fever viruses. Overall, our results indicate that peptidoglycan-associated surfactin has broad viricidal activity and suggest that bacteria by-products may negatively modulate virus infection.
   IMPORTANCE In this article, we consider a role for bacteria in shaping coronavirus infection. Taking cues from studies of enteric viruses, we initially investigated how bacterial surface components might improve CoV infection. Instead, we found that peptidoglycan-associated surfactin is a potent viricidal compound that disrupts virion integrity with broad activity against enveloped viruses. Our results indicate that interactions with commensal bacterial may improve or disrupt viral infections, highlighting the importance of understanding these microbial interactions and their implications for viral pathogenesis and treatment.
C1 [Johnson, Bryan A.; Hage, Adam; Plante, Jessica A.; Rodriguez, Sergio E.; Bente, Dennis; Rajsbaum, Ricardo; Rossi, Shannan; Menachery, Vineet D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Kalveram, Birte; Mears, Megan; Ding, Zhixia; Freiberg, Alexander N.; Popov, Vsevolod; Rossi, Shannan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Plante, Jessica A.] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Galveston, TX 77555 USA.
   [Luo, Xuemei; Bradrick, Shelton S.; Russell, William K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Ding, Zhixia; Popov, Vsevolod] Univ Texas Med Branch, UTMB Electron Microscopy Lab, Galveston, TX 77555 USA.
   [Luo, Xuemei; Russell, William K.] Univ Texas Med Branch, UTMB Mass Spectrometry Facil, Galveston, TX 77555 USA.
   [Rajsbaum, Ricardo; Menachery, Vineet D.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Menachery, VD (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Menachery, VD (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM Vimenach@utmb.edu
RI Rajsbaum, Ricardo/AAD-4775-2020
OI Hage, Adam/0000-0001-7668-892X; Menachery, Vineet/0000-0001-8803-7606;
   Mears, Megan/0000-0003-1293-7696
FU NIAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA);
   NIAID of the NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI100625, R00AG049092,
   R01AI134907, R21AI126012, R21AI132479-01, R24AI120942]; University of
   Texas System; McLaughlin Endowment at UTMB
FX Research was supported by grants from NIA and NIAID of the NIH
   (U19AI100625 and R00AG049092 to V.D.M.; R01AI134907, R21AI126012, and
   R21AI132479-01 to R.R.; and R24AI120942 to WRCEVA). Research was also
   supported by a STARs Award provided by the University of Texas System to
   V.D.M. and by trainee funding provided by the McLaughlin Endowment at
   UTMB.
CR Abdel-Mawgoud AM, 2008, APPL BIOCHEM BIOTECH, V150, P289, DOI 10.1007/s12010-008-8153-z
   Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500
   Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10
   Berger AK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006768
   BERRYMAN MA, 1990, J HISTOCHEM CYTOCHEM, V38, P159, DOI 10.1177/38.2.1688894
   Bharaj P, 2017, J VIROL, V91, DOI [10.1128/jvi.00833-17, 10.1128/JVI.00833-17]
   Bradrick SS, 2001, J VIROL, V75, P6472, DOI 10.1128/JVI.75.14.6472-6481.2001
   Brown R. S, 2018, VIRUSES, V10, pE89
   Burja AM, 2002, J MICROBIOL METH, V48, P207, DOI 10.1016/S0167-7012(01)00324-4
   Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4
   Chen HM, 1998, ADV DRUG DELIVER REV, V34, P339, DOI 10.1016/S0169-409X(98)00047-7
   Cochrane SA, 2016, MED RES REV, V36, P4, DOI 10.1002/med.21321
   Dalili D, 2015, COLLOID SURFACE B, V135, P425, DOI 10.1016/j.colsurfb.2015.07.005
   Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013
   Freiberg AN, 2010, J GEN VIROL, V91, P765, DOI 10.1099/vir.0.017269-0
   Gilling DH, 2014, APPL ENVIRON MICROB, V80, P4898, DOI 10.1128/AEM.00402-14
   Gralinski LE, 2017, G3-GENES GENOM GENET, V7, P1653, DOI 10.1534/g3.117.041434
   Harrison MS, 2010, INT J BIOCHEM CELL B, V42, P1416, DOI 10.1016/j.biocel.2010.04.005
   Hoefler BC, 2012, P NATL ACAD SCI USA, V109, P13082, DOI 10.1073/pnas.1205586109
   Ivanova PT, 2015, ACS INFECT DIS, V1, P435, DOI 10.1021/acsinfecdis.5b00040
   Jezewska-Frackowiak J, 2018, ACTA BIOCHIM POL, V65, P509, DOI 10.18388/abp.2018_2652
   Johnson BA, 2019, BIORXIV, DOI [10.1101/635854, DOI 10.1101/635854]
   Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13
   Karst SM, 2016, NAT REV MICROBIOL, V14, P197, DOI 10.1038/nrmicro.2015.25
   Kim HS, 1997, J FERMENT BIOENG, V84, P41, DOI 10.1016/S0922-338X(97)82784-5
   Kindler E, 2013, MBIO, V4, DOI 10.1128/mBio.00611-12
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057
   Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14
   Meena KR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/473050
   Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031359
   MORIKAWA M, 1993, J BACTERIOL, V175, P6459, DOI 10.1128/JB.175.20.6459-6466.1993
   Mustafa S, 2018, J INFECT PUBLIC HEAL, V11, P9, DOI 10.1016/j.jiph.2017.08.009
   Nielsen DS, 2017, CHEM REV, V117, P8094, DOI 10.1021/acs.chemrev.6b00838
   Pang X, 2017, J ANTIBIOT, V70, P105, DOI 10.1038/ja.2016.63
   Piters WAAD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0294
   Plante KS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004007
   Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059
   Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005
   Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003
   Rowe HM, 2019, NAT MICROBIOL, V4, P1328, DOI 10.1038/s41564-019-0447-0
   Seydlova G, 2008, CENT EUR J MED, V3, P123, DOI 10.2478/s11536-008-0002-5
   She AQ, 2012, J PHYS CHEM B, V116, P12735, DOI 10.1021/jp302413c
   Sheahan T, 2011, J VIROL, V85, P217, DOI 10.1128/JVI.01805-10
   Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240
   Sims AC, 2013, J VIROL, V87, P3885, DOI 10.1128/JVI.02520-12
   Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001
   Taylor SD, 2016, BIOORGAN MED CHEM, V24, P6253, DOI 10.1016/j.bmc.2016.05.052
   Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847
   Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x
   Wang XQ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170082
   *WHO, 2004, WHO SARS RISK ASS PR
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   World Health Organization (WHO), 2017, WHO MERS COV GLOB SU
   Wu YS, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00761
   Yang H, 2015, ANAL BIOANAL CHEM, V407, P2529, DOI 10.1007/s00216-015-8486-8
   Yoshino N, 2018, IMMUN INFLAMM DIS, V6, P117, DOI 10.1002/iid3.204
   Yuan LF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215227
   Yuan LF, 2018, J VIROL, V92, DOI 10.1128/JVI.00809-18
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
NR 62
TC 3
Z9 3
U1 10
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2019
VL 93
IS 22
AR e01282-19
DI 10.1128/JVI.01282-19
PG 15
WC Virology
SC Virology
GA JI8LI
UT WOS:000493714000028
PM 31462558
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Weisblum, Y
   Oiknine-Djian, E
   Vorontsov, OM
   Haimov-Kochman, R
   Zakay-Rones, Z
   Meir, K
   Shveiky, D
   Elgavish, S
   Nevo, Y
   Roseman, M
   Bronstein, M
   Stockheim, D
   From, I
   Eisenberg, I
   Lewkowicz, AA
   Yagel, S
   Panet, A
   Wolf, DG
AF Weisblum, Yiska
   Oiknine-Djian, Esther
   Vorontsov, Olesya M.
   Haimov-Kochman, Ronit
   Zakay-Rones, Zichria
   Meir, Karen
   Shveiky, David
   Elgavish, Sharona
   Nevo, Yuval
   Roseman, Moshe
   Bronstein, Michal
   Stockheim, David
   From, Ido
   Eisenberg, Iris
   Lewkowicz, Aya A.
   Yagel, Simcha
   Panet, Amos
   Wolf, Dana G.
TI Zika Virus Infects Early- and Midgestation Human Maternal Decidual
   Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal
   Interface (vol 91, e01905-16, 2017)
SO JOURNAL OF VIROLOGY
LA English
DT Correction
C1 [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya M.; From, Ido; Wolf, Dana G.] Hadassah Hebrew Univ, Med Ctr, Clin Virol Unit, Jerusalem, Israel.
   [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya M.; Zakay-Rones, Zichria; From, Ido; Panet, Amos] Hebrew Univ Jerusalem, Fac Med, Dept Biochem, Jerusalem, Israel.
   [Weisblum, Yiska; Oiknine-Djian, Esther; Vorontsov, Olesya M.; Zakay-Rones, Zichria; From, Ido; Panet, Amos] Hebrew Univ Jerusalem, IMRIC, Dept Biochem, Chanock Ctr Virol, Jerusalem, Israel.
   [Haimov-Kochman, Ronit; Shveiky, David; Eisenberg, Iris; Lewkowicz, Aya A.; Yagel, Simcha] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel.
   [Meir, Karen] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel.
   [Elgavish, Sharona; Nevo, Yuval; Roseman, Moshe] Hebrew Univ Jerusalem, I CORE Computat Ctr, Bioinformat Unit, Jerusalem, Israel.
   [Elgavish, Sharona; Nevo, Yuval; Roseman, Moshe] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel.
   [Bronstein, Michal] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Ctr Genom Technol, Jerusalem, Israel.
   [Stockheim, David] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel.
RP Wolf, DG (corresponding author), Hadassah Hebrew Univ, Med Ctr, Clin Virol Unit, Jerusalem, Israel.
EM dana.wolf@ekmd.huji.ac.il
CR Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2019
VL 93
IS 22
AR e01451-19
DI 10.1128/JVI.01451-19
PG 1
WC Virology
SC Virology
GA JI8LI
UT WOS:000493714000033
PM 31662489
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Hiramatsu, N
   Tago, T
   Satoh, T
   Satoh, AK
AF Hiramatsu, Naoki
   Tago, Tatsuya
   Satoh, Takunori
   Satoh, Akiko K.
TI ER membrane protein complex is required for the insertions of
   late-synthesized transmembrane helices of Rh1 in Drosophila
   photoreceptors
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; ZIKA VIRUS; RHODOPSIN; TRANSLOCATION;
   RECOGNITION; IDENTIFICATION; BIOSYNTHESIS; INTEGRATION; MECHANISMS;
   TOPOLOGY
AB Most membrane proteins are synthesized on and inserted into the membrane of the endoplasmic reticulum (ER), in eukaryote. The widely conserved ER membrane protein complex (EMC) facilitates the biogenesis of a wide range of membrane proteins. In this study, we investigated the EMC function using Drosophila photoreceptor as a model system. We found that the EMC was necessary only for the biogenesis of a subset of multipass membrane proteins such as rhodopsin (Rh1), TRP, TRPL, Csat, Cni, SERCA, and Na(+)K(-)ATPase alpha, but not for that of secretory or single-pass membrane proteins. Additionally, in EMC-deficient cells, Rh1 was translated to its C terminus but degraded independently from ER-associated degradation. Thus, EMC exerted its effect after translation but before or during the membrane integration of transmembrane domains (TMDs). Finally, we found that EMC was not required for the stable expression of the first three TMDs of Rh1 but was required for that of the fourth and fifth TMDs. Our results suggested that EMC is required for the ER membrane insertion of succeeding TM Ds of multipass membrane proteins.
C1 [Hiramatsu, Naoki; Tago, Tatsuya; Satoh, Takunori; Satoh, Akiko K.] Hiroshima Univ, Grad Sch Integral Sci Life, Program Life & Environm Sci, 1-7-1 Kagamiyama, Hiroshima 7398521, Japan.
RP Satoh, T; Satoh, AK (corresponding author), Hiroshima Univ, Grad Sch Integral Sci Life, Program Life & Environm Sci, 1-7-1 Kagamiyama, Hiroshima 7398521, Japan.
EM tsatoh3@hiroshima-u.ac.jp; aksatoh@hiroshima-u.ac.jp
RI Satoh, Akiko/AAH-6218-2019
FU Precursory Research for Embryonic Science and Technology [25-J-J4215];
   Japan Society for the Promotion of Science, KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [15K07050, 15H01538]; Takeda Life Science Foundation;
   KAKENHIMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [19K06566]
FX We thank U. Tepass, C. Montell, R. Burke, S. Goto, T. Chihara, and T.
   Miyashita for kindly providing fly stocks and reagents. We also thank
   the Bloomington Drosophila Stock Center for fly stocks. This work was
   supported by Precursory Research for Embryonic Science and Technology
   (Grant no. 25-J-J4215), Japan Society for the Promotion of Science,
   KAKENHI (Grant no. 15K07050 and Grant no. 15H01538), the Takeda Life
   Science Foundation to A.K.S., and KAKENHI (Grant no. 19K06566) for T.S.
CR Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006
   Bagchi P, 2016, ELIFE, V5, DOI 10.7554/eLife.21470
   Bano-Polo M, 2017, BBA-BIOMEMBRANES, V1859, P903, DOI 10.1016/j.bbamem.2017.01.027
   Barrows NJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45910-9
   Bircham PW, 2011, MOL BIOSYST, V7, P2589, DOI 10.1039/c1mb05175j
   Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307
   Chitwood PJ, 2019, TRENDS CELL BIOL, V29, P371, DOI 10.1016/j.tcb.2019.01.007
   Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009
   Coelho JPL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08632-0
   Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014
   Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08
   Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013
   Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Kida Y, 2016, MOL BIOL CELL, V27, P930, DOI 10.1091/mbc.E15-09-0672
   Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404
   Marino J, 2018, RSC ADV, V8, P9858, DOI [10.1039/C8RA01520A, 10.1039/c8ra01520a]
   Martinez-Gil L, 2011, FEBS J, V278, P3846, DOI 10.1111/j.1742-4658.2011.08185.x
   Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x
   Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]
   Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002
   Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384
   Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110
   Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064
   Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704
   Satoh T, 2016, BIOL OPEN, V5, P1420, DOI 10.1242/bio.020958
   Satoh Takunori, 2015, Seikagaku, V87, P781
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Satoh T, 2013, DEVELOPMENT, V140, P385, DOI 10.1242/dev.083683
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256
   Tamborero S, 2011, J MOL BIOL, V406, P571, DOI 10.1016/j.jmb.2011.01.009
   Volkmar N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223453
   Xiong LY, 2020, CELL DEATH DIFFER, V27, P646, DOI 10.1038/s41418-019-0378-6
   Zhou YC, 2018, J MOL CELL BIOL, V10, P503, DOI 10.1093/jmcb/mjy024
NR 41
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV 1
PY 2019
VL 30
IS 23
BP 2890
EP 2900
DI 10.1091/mbc.E19-08-0434
PG 11
WC Cell Biology
SC Cell Biology
GA JJ1BP
UT WOS:000493895700009
PM 31553680
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leonhard, SE
   Mandarakas, MR
   Gondim, FAA
   Bateman, K
   Ferreira, MLB
   Cornblath, DR
   van Doorn, PA
   Dourado, ME
   Hughes, RAC
   Islam, B
   Kusunoki, S
   Pardo, CA
   Reisin, R
   Sejvar, JJ
   Shahrizaila, N
   Soares, C
   Umapathi, T
   Wang, YZ
   Yiu, EM
   Willison, HJ
   Jacobs, BC
AF Leonhard, Sonja E.
   Mandarakas, Melissa R.
   Gondim, Francisco A. A.
   Bateman, Kathleen
   Ferreira, Maria L. B.
   Cornblath, David R.
   van Doorn, Pieter A.
   Dourado, Mario E.
   Hughes, Richard A. C.
   Islam, Badrul
   Kusunoki, Susumu
   Pardo, Carlos A.
   Reisin, Ricardo
   Sejvar, James J.
   Shahrizaila, Nortina
   Soares, Cristiane
   Umapathi, Thirugnanam
   Wang, Yuzhong
   Yiu, Eppie M.
   Willison, Hugh J.
   Jacobs, Bart C.
TI Diagnosis and management of Guillain-Barre syndrome in ten steps
SO NATURE REVIEWS NEUROLOGY
LA English
DT Review
ID INTRAVENOUS IMMUNOGLOBULIN; MECHANICAL VENTILATION; INFLUENZA
   VACCINATION; FISHER-SYNDROME; ELECTRODIAGNOSTIC CRITERIA;
   CLINICAL-FEATURES; VIRUS-INFECTION; UNITED-STATES; MORTALITY; FATIGUE
AB Guillain-Barre syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics in 2013 in French Polynesia and 2015 in Latin America. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available. To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. The guideline is based on current literature and expert consensus, and has a ten-step structure to facilitate its use in clinical practice. We first provide an introduction to the diagnostic criteria, clinical variants and differential diagnoses of GBS. The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae.
C1 [Leonhard, Sonja E.; Mandarakas, Melissa R.; van Doorn, Pieter A.; Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Gondim, Francisco A. A.] Univ Fed Ceara, Hosp Univ Walter Cantidio, Fortaleza, Ceara, Brazil.
   [Bateman, Kathleen] Univ Cape Town, Groote Schuur Hosp, Cape Town, South Africa.
   [Ferreira, Maria L. B.] Hosp Restauracao, Dept Neurol, Recife, PE, Brazil.
   [Cornblath, David R.; Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Dourado, Mario E.] Univ Fed Rio Grande do Norte, Dept Integrat Med, Hosp Univ Onofre Lopes, Natal, RN, Brazil.
   [Hughes, Richard A. C.] UCL, UCL Queen Sq Inst Neurol, London, England.
   [Islam, Badrul] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Kusunoki, Susumu] Kindai Univ, Fac Med, Osaka, Japan.
   [Reisin, Ricardo] Hosp Britanico, Buenos Aires, DF, Argentina.
   [Sejvar, James J.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Shahrizaila, Nortina] Univ Malaya, Dept Neurol, Kuala Lumpur, Malaysia.
   [Soares, Cristiane] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Umapathi, Thirugnanam] Natl Neurosci Inst, Singapore, Singapore.
   [Wang, Yuzhong] Jining Med Univ, Affiliated Hosp, Dept Neurol, Jining, Shandong, Peoples R China.
   [Yiu, Eppie M.] Royal Childrens Hosp Melbourne, Dept Neurol, Melbourne, Vic, Australia.
   [Yiu, Eppie M.] Murdoch Childrens Res Inst, Neurosci Res, Melbourne, Vic, Australia.
   [Yiu, Eppie M.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Willison, Hugh J.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
RP Jacobs, BC (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.; Jacobs, BC (corresponding author), Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
EM b.jacobs@erasmusmc.nl
RI SHAHRIZAILA, NORTINA/B-9402-2010; Gondim, Francisco de Assis/J-1463-2014
OI Bateman, Kathleen/0000-0002-0213-7102; Gondim, Francisco de
   Assis/0000-0002-8957-5796
FU European UnionEuropean Union (EU) [734584]; Wellcome Trust
   FoundationWellcome Trust; Prinses Beatrix Spierfonds; GBS/CIDP
   Foundation International; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq); Prinses Beatrix Foundation; Ministry
   of Education, Culture, Sports, Science and Technology of JapanMinistry
   of Education, Culture, Sports, Science and Technology, Japan (MEXT)
   [18H02745]; Ministry of Health, Labour and Welfare of JapanMinistry of
   Health, Labour and Welfare, Japan; Malaysian Ministry of Education
   [FP043-2018A]; ALS Association; National Health and Medical Research
   Council of AustraliaNational Health and Medical Research Council of
   Australia
FX The authors thank Lisa Butler (Executive Director, GBS/CIDP Foundation
   International) for her contribution in reviewing the manuscript. C.A.P.,
   C.S., M.L.B.F., M.R.M., and S.E.L. are supported by a grant from the
   European Union (Horizon 2020, ZikaPLAN Grant Agreement No. 734584).
   H.J.W. is supported by a grant from the European Union (Horizon 2020,
   ZikaPLAN Grant Agreement No. 734584) and by the Wellcome Trust
   Foundation. B.C.J. is supported by a grant from the European Union
   (Horizon 2020, ZikaPLAN Grant Agreement No. 734584) and has received
   funding from Prinses Beatrix Spierfonds and GBS/CIDP Foundation
   International. F.d.A.A.G. is supported by a grant from the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico. D.R.C. is on the
   Board of Directors for the Peripheral Nerve Society. P.A.v.D. received a
   grant from the Prinses Beatrix Foundation for the SID-GBS randomized
   controlled trial. S.K. is supported by a grant from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan
   (Grants-in-Aid for Scientific Research, 18H02745) and the Ministry of
   Health, Labour and Welfare of Japan (Health and Labour Sciences Research
   Grant). N.S. is supported by grants from the Malaysian Ministry of
   Education (FP043-2018A) and ALS Association. T.U. is supported by a
   grant from the GBS/CIDP Foundation International. E.M.Y. is supported by
   a grant from the National Health and Medical Research Council of
   Australia (Early Career Fellowship).
CR Annane D, 1997, ANN NEUROL, V41, P298
   [Anonymous], 1978, Ann Neurol, V3, P565
   Arsenault NS, 2016, PHYSIOTHER CAN, V68, P367, DOI 10.3138/ptc.2015-58
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Berciano J, 2017, J NEUROL, V264, P221, DOI 10.1007/s00415-016-8204-2
   Bernsen RAJAM, 2010, MUSCLE NERVE, V41, P533, DOI 10.1002/mus.21536
   Bersano A, 2006, J NEUROL, V253, P214, DOI 10.1007/s00415-005-0958-x
   Blum S, 2013, J PERIPHER NERV SYST, V18, P316, DOI 10.1111/jns5.12045
   Branch DW, 2001, J ALLERGY CLIN IMMUN, V108, pS133, DOI 10.1067/mai.2001.117821
   Burwen DR, 2010, AM J PREV MED, V39, P296, DOI 10.1016/j.amepre.2010.05.022
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chevret S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub3
   CORNBLATH DR, 1987, ANN NEUROL, V21, P32, DOI 10.1002/ana.410210107
   Davidson I, 2009, PHYSIOTHERAPY, V95, P157, DOI 10.1016/j.physio.2009.04.001
   Dhar R, 2008, J NEUROL SCI, V264, P121, DOI 10.1016/j.jns.2007.08.005
   Doets AY, 2018, BRAIN, V141, P2866, DOI 10.1093/brain/awy232
   Dominguez-Moreno R, 2014, REV NEUROLOGIA, V58, P4, DOI 10.33588/rn.5801.2013370
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   El-Bayoumi MA, 2011, CRIT CARE, V15, DOI 10.1186/cc10305
   Elrick MJ, 2019, JAMA PEDIATR, V173, P134, DOI 10.1001/jamapediatrics.2018.4890
   Farcas P, 1997, LANCET, V350, P1747, DOI 10.1016/S0140-6736(97)24050-X
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Forsberg A, 2012, J NEUROL SCI, V317, P74, DOI 10.1016/j.jns.2012.02.026
   Gallardo E, 2015, CLIN NEUROPHYSIOL, V126, P810, DOI 10.1016/j.clinph.2014.06.051
   Garssen MPJ, 2006, J NEUROL, V253, P1143, DOI 10.1007/s00415-006-0163-6
   Garssen MPJ, 2004, NEUROLOGY, V63, P2393, DOI 10.1212/01.WNL.0000148589.87107.9C
   Gorson KC, 1996, NEUROLOGY, V47, P813, DOI 10.1212/WNL.47.3.813
   Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9
   Guillain G, 1916, B MEMOIRES SOCIETE M, V40, P1462
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hiew FL, 2017, CLIN NEUROL NEUROSUR, V158, P114, DOI 10.1016/j.clineuro.2017.05.006
   Hiew FL, 2017, J NEUROL SCI, V375, P275, DOI 10.1016/j.jns.2017.02.024
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Hopkins SE, 2019, JAMA PEDIATR, V173, P117, DOI 10.1001/jamapediatrics.2018.4896
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Ishaque T, 2017, J PERIPHER NERV SYST, V22, P121, DOI 10.1111/jns.12215
   Islam B, 2018, EUR J CLIN MICROBIOL, V37, P511, DOI 10.1007/s10096-018-3199-5
   Islam Md Badrul, 2017, Pilot Feasibility Stud, V3, P40, DOI 10.1186/s40814-017-0185-0
   Ito M, 2008, J NEUROL, V255, P674, DOI 10.1007/s00415-008-0775-0
   Ito M, 2011, J NEUROL NEUROSUR PS, V82, P294, DOI 10.1136/jnnp.2010.222836
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jitraruch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113609
   Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217
   Kanikannan MAK, 2014, J CRIT CARE, V29, P219, DOI 10.1016/j.jcrc.2013.10.026
   Kao JC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0878-7
   KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698
   KLEYWEG RP, 1991, J NEUROL NEUROSUR PS, V54, P957, DOI 10.1136/jnnp.54.11.957
   Korinthenberg R, 2007, NEUROPEDIATRICS, V38, P10, DOI 10.1055/s-2007-981686
   Korinthenberg R, 2005, PEDIATRICS, V116, P8, DOI 10.1542/peds.2004-1324
   Kuijf ML, 2005, J NEUROL SCI, V239, P37, DOI 10.1016/j.jns.2005.07.009
   Kuitwaard K, 2009, J PERIPHER NERV SYST, V14, P310, DOI 10.1111/j.1529-8027.2009.00243.x
   Kuwabara S, 2017, CLIN NEUROPHYSIOL, V128, P215, DOI 10.1016/j.clinph.2016.11.009
   Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501
   Lawn ND, 2001, ARCH NEUROL-CHICAGO, V58, P893, DOI 10.1001/archneur.58.6.893
   Maloney JA, 2015, AM J NEURORADIOL, V36, P245, DOI 10.3174/ajnr.A4188
   Mehta S, 2006, RESP CARE, V51, P1016
   Merkies ISJ, 1999, NEUROLOGY, V53, P1648, DOI 10.1212/WNL.53.8.1648
   MEULSTEE J, 1995, J NEUROL NEUROSUR PS, V59, P482, DOI 10.1136/jnnp.59.5.482
   Michon B, 2007, TRANSFUSION, V47, P1837, DOI 10.1111/j.1537-2995.2007.01405.x
   Misawa S, 2018, LANCET NEUROL, V17, P519, DOI 10.1016/S1474-4422(18)30114-5
   Mitsui Y, 2015, J NEUROL NEUROSUR PS, V86, P110, DOI 10.1136/jnnp-2013-306509
   Oczko-Walker Malgorzata, 2010, J Clin Neuromuscul Dis, V12, P55, DOI 10.1097/CND.0b013e3181f3dbbf
   Odaka M, 2003, BRAIN, V126, P2279, DOI 10.1093/brain/awg233
   Overell JR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004761.pub2
   Pacheco LD, 2016, OBSTET GYNECOL, V128, P1105, DOI 10.1097/AOG.0000000000001716
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Peric S, 2014, J PERIPHER NERV SYST, V19, P317, DOI 10.1111/jns.12096
   Principi N, 2019, VACCINE, V37, P5544, DOI 10.1016/j.vaccine.2018.05.119
   Rajabally YA, 2015, J NEUROL NEUROSUR PS, V86, P115, DOI 10.1136/jnnp-2014-307815
   Raphael JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub2
   Razali SNO, 2016, CLIN NEUROPHYSIOL, V127, P1652, DOI 10.1016/j.clinph.2015.06.030
   Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62
   Ropper A. H, 1991, GUILLAIN BARRE SYNDR, P155
   Rudant J, 2018, NEUROLOGY, V91, pE1220, DOI 10.1212/WNL.0000000000006246
   Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345
   Ruts L, 2010, NEUROLOGY, V74, P1680, DOI 10.1212/WNL.0b013e3181e07d14
   SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sekiguchi Y, 2016, EUR J NEUROL, V23, P1058, DOI 10.1111/ene.12983
   Soysal A, 2011, ACTA NEUROL SCAND, V123, P181, DOI 10.1111/j.1600-0404.2010.01366.x
   THORNTON CA, 1991, NEUROLOGY, V41, P812, DOI 10.1212/WNL.41.6.812
   Tomimatsu T, 2016, EUR J OBSTET GYN R B, V201, P225, DOI 10.1016/j.ejogrb.2016.03.031
   Uchibori A, 2016, J NEUROIMMUNOL, V298, P172, DOI 10.1016/j.jneuroim.2016.07.021
   Uncini A, 2018, CLIN NEUROPHYSIOL, V129, P2586, DOI 10.1016/j.clinph.2018.09.025
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   Uncini A, 2012, MUSCLE NERVE, V45, P464, DOI 10.1002/mus.22298
   van den Berg B, 2018, J NEUROL NEUROSUR PS, V89, P949, DOI 10.1136/jnnp-2018-317968
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van den Berg B, 2014, NEUROLOGY, V82, P491, DOI 10.1212/WNL.0000000000000111
   van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc
   Van den Bergh PYK, 2018, MUSCLE NERVE, V58, P23, DOI 10.1002/mus.26056
   van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X
   Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005
   Verboon C, 2019, NEUROLOGY, V93, pE59, DOI 10.1212/WNL.0000000000007719
   Verboon C, 2017, J NEUROL NEUROSUR PS, V88, P346, DOI 10.1136/jnnp-2016-314862
   Vereninging Spierziekten Nederland Nederlandse Vereniging voor Neurologie & Nederlandse Vereniging van Revalidatieartsen [Dutch Association of Muscular Diseases & Dutch Society of Rehabilitation Specialists], 2011, MULT RICHTL GUILL BA
   Vucic S, 2004, CLIN NEUROPHYSIOL, V115, P2329, DOI 10.1016/j.clinph.2004.05.009
   Wakerley BR, 2016, J NEUROL SCI, V369, P43, DOI 10.1016/j.jns.2016.08.002
   Wakerley Benjamin R, 2015, Pract Neurol, V15, P90, DOI 10.1136/practneurol-2014-000937
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407
   Walgaard C, 2018, J PERIPHER NERV SYST, V23, P210, DOI 10.1111/jns.12286
   Walgaard C, 2017, NEUROCRIT CARE, V26, P6, DOI 10.1007/s12028-016-0311-5
   Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976
   Wang YZ, 2017, EXP NEUROL, V291, P134, DOI 10.1016/j.expneurol.2017.02.010
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wong AHY, 2015, J PERIPHER NERV SYST, V20, P47, DOI 10.1111/jns.12104
   World Health Organization, 2016, ZIK SIT REP 5 FEBR 2
   Yikilmaz A, 2010, CHILD NERV SYST, V26, P1103, DOI 10.1007/s00381-010-1197-8
   Yoshikawa K, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000501
   Yuki N, 2001, Lancet Infect Dis, V1, P29
   Yuki N, 2012, J NEUROL, V259, P1181, DOI 10.1007/s00415-011-6330-4
   Zhang G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133520
NR 120
TC 12
Z9 12
U1 5
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4758
EI 1759-4766
J9 NAT REV NEUROL
JI Nat. Rev. Neurol.
PD NOV
PY 2019
VL 15
IS 11
BP 671
EP 683
DI 10.1038/s41582-019-0250-9
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA JI9ZN
UT WOS:000493822500012
PM 31541214
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Villanueva, J
   Schweitzer, B
   Odle, M
   Aden, T
AF Villanueva, Julie
   Schweitzer, Beth
   Odle, Marcella
   Aden, Tricia
TI Detecting Emerging Infectious Diseases: An Overview of the Laboratory
   Response Network for Biological Threats
SO PUBLIC HEALTH REPORTS
LA English
DT Article
DE public health preparedness; emerging infectious diseases; emergency
   preparedness; laboratory; terrorism; counterterrorism; bioterrorism
ID ZIKA VIRUS-INFECTION; UPDATE INTERIM GUIDANCE; UNITED-STATES; INFANTS;
   GUIDELINES; MANAGEMENT
AB The Laboratory Response Network (LRN) was established in 1999 to ensure an effective laboratory response to high-priority public health threats. The LRN for biological threats (LRN-B) provides a laboratory infrastructure to respond to emerging infectious diseases. Since 2012, the LRN-B has been involved in 3 emerging infectious disease outbreak responses. We evaluated the LRN-B role in these responses and identified areas for improvement. LRN-B laboratories tested 1097 specimens during the 2014 Middle East Respiratory Syndrome Coronavirus outbreak, 180 specimens during the 2014-2015 Ebola outbreak, and 92 686 specimens during the 2016-2017 Zika virus outbreak. During the 2014-2015 Ebola outbreak, the LRN-B uncovered important gaps in biosafety and biosecurity practices. During the 2016-2017 Zika outbreak, the LRN-B identified the data entry bottleneck as a hindrance to timely reporting of results. Addressing areas for improvement may help LRN-B reference laboratories improve the response to future public health emergencies.
C1 [Villanueva, Julie; Schweitzer, Beth; Odle, Marcella; Aden, Tricia] Ctr Dis Control & Prevent, Lab Preparedness & Response Branch, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd NE,MS H24-11, Atlanta, GA 30329 USA.
RP Villanueva, J (corresponding author), Ctr Dis Control & Prevent, Lab Preparedness & Response Branch, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd NE,MS H24-11, Atlanta, GA 30329 USA.
EM jfv3@cdc.gov
FU CDC Office of Public Health Preparedness and Response
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   supported by the CDC Office of Public Health Preparedness and Response.
CR American Society for Microbiology, 2013, LAB RESP NETW LRN SE
   Association of Public Health Laboratories, 2018, CDC APHL BIOS BIOS P
   Bausch DG, 2017, CURR TOP MICROBIOL, V411, P63, DOI 10.1007/82_2017_69
   Centers for Disease Control and Prevention, 2014 2016 EB OUTBR W
   Centers for Disease Control and Prevention, MIDDL E RESP SYNDR M
   Centers for Disease Control and Prevention, HIST EB VIR DIS
   Centers for Disease Control and Prevention, 2015, GUID US LAB MAN TEST
   Centers for Disease Control and Prevention, EB VIR DIS DISTR MAP
   Centers for Disease Control and Prevention, EB EB VIR DIS
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, ZIK VIR ZIK
   Centers for Disease Control and Prevention, 2015, 1 CAS ZIK VIR REP PU
   Centres for Disease Control and Prevention, SEV AC RESP SYNDR SA
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399
   Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13
   Mangal CN, 2014, BIOSECUR BIOTERROR, V12, P274, DOI 10.1089/bsp.2014.0039
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schneider E, 2015, EMERG INFECT DIS, V21, P1220, DOI 10.3201/eid2107.141888
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   US Department of Health and Human Services, 2017, PUBL HLTH EM DECL
   US Food and Drug Administration, 2013, EM US AUTH
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   World Health Organization, 2019, ZIK OR SPREAD MOSQ B
NR 25
TC 2
Z9 2
U1 3
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0033-3549
EI 1468-2877
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD NOV
PY 2019
VL 134
IS 2_SUPPL
SU 2_
SI SI
BP 16S
EP 21S
DI 10.1177/0033354919874354
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JJ2WV
UT WOS:000494023600004
PM 31682559
OA Bronze
DA 2020-07-08
ER

PT J
AU Heberlein-Larson, L
   Gillis, LD
   Morrison, A
   Scott, B
   Cook, M
   Cannons, A
   Quaye, E
   White, S
   Cone, M
   Mock, V
   Schiffer, J
   Lonsway, D
   Petway, M
   Otis, A
   Stanek, D
   Hamilton, J
   Crowe, S
AF Heberlein-Larson, Lea
   Gillis, Leah D.
   Morrison, Andrea
   Scott, Blake
   Cook, Mary
   Cannons, Andrew
   Quaye, Elesi
   White, Stephen
   Cone, Marshall
   Mock, Valerie
   Schiffer, Jarad
   Lonsway, David
   Petway, Marla
   Otis, Aaron
   Stanek, Danielle
   Hamilton, Janet
   Crowe, Susanne
TI Partnerships Involved in Public Health Testing for Zika Virus in
   Florida, 2016
SO PUBLIC HEALTH REPORTS
LA English
DT Article
DE public health; emerging infectious diseases; laboratory; public health
   systems; testing; disease outbreaks
AB The emergence of Zika virus in the Americas in 2015 and its association with birth defects and other adverse health outcomes triggered an unprecedented public health response and a demand for testing. In 2016, when Florida exceeded state public health laboratory capacity for diagnostic testing, the state formed partnerships with federal and commercial laboratories. Eighty-two percent of the testing (n = 33 802 of 41 008 specimens) by the laboratory partners, including Florida's Bureau of Public Health Laboratories (BPHL; n = 13 074), a commercial laboratory (n = 19 214), and the Centers for Disease Control and Prevention (CDC; n = 1514), occurred from July through November 2016, encompassing the peak period of local transmission. These partnerships allowed BPHL to maintain acceptable test turnaround times of 1 to 4 days for nucleic acid testing and 3 to 7 days for serologic testing. Lessons learned from this response to inform future outbreaks included the need for early planning to establish outside partnerships, adding specimen triage strategies to surge plans, and integrating state and CDC information systems.
C1 [Heberlein-Larson, Lea; Cannons, Andrew; Cone, Marshall] Bur Publ Hlth Labs, Florida Dept Hlth, 3602 Spectrum Blvd, Tampa, FL 33612 USA.
   [Gillis, Leah D.; Cook, Mary; Quaye, Elesi; White, Stephen] Bur Publ Hlth Labs, Florida Dept Hlth, Miami, FL USA.
   [Morrison, Andrea; Scott, Blake; Stanek, Danielle; Hamilton, Janet] Bur Epidemiol, Florida Dept Hlth, Tallahassee, FL USA.
   [Mock, Valerie; Crowe, Susanne] Bur Publ Hlth Labs, Florida Dept Hlth, Jacksonville, FL USA.
   [Schiffer, Jarad] Ctr Dis Control & Prevent, Div Bacterial Dis, Meningitis & Vaccine Preventable Dis Branch, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Lonsway, David] Ctr Dis Control & Prevent, Div Hlth Care Qual Promot, Clin & Environm Microbiol Branch, Natl Ctr Emerging Infect Dis, Atlanta, GA USA.
   [Petway, Marla] Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot & Infect Dis, Atlanta, GA USA.
   [Otis, Aaron] Ctr Dis Control & Prevent, Div State & Local Readiness, Program Serv Branch, Ctr Preparedness & Response, Tallahassee, FL USA.
RP Heberlein-Larson, L (corresponding author), Bur Publ Hlth Labs, Florida Dept Hlth, 3602 Spectrum Blvd, Tampa, FL 33612 USA.
EM lea.heberlein-larson@flhealth.gov
FU Centers for Disease Control and Prevention (CDC) Epidemiology and
   Laboratory Capacity for Infectious Diseases grantUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   supported in part by the Centers for Disease Control and Prevention
   (CDC) Epidemiology and Laboratory Capacity for Infectious Diseases
   grant. The findings and conclusions in this article are those of the
   authors and do not necessarily represent the official position of CDC.
CR Association of Public Health Laboratories, 2014, COR FUNCT STAT PUBL
   Centers for Disease Control and Prevention, 2019, DENG DIAGN
   Centers for Disease Control and Prevention, 2017, FACTS MICR
   Centers for Disease Control and Prevention, 2019, TYP ZIK VIR TESTS
   Florida Department of Health, 2017, ZIK INC RESP PLAYB 2
   Florida Department of Health, ZIK FREE FLOR
   Florida Department of Health, 2016, DEP HLTH DAIL ZIK UP
   Florida Department of Health, SURV SYST
   Health Level Seven International, INTR HL7 STAND
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   State of Florida Office of the Governor, 2016, 1629 STAT FL OFF GOV
   US Department of Homeland Security, 2017, NAT INC MAN SYST
   US Food and Drug Administration, MED DEV EM US AUTH
   US Food and Drug Administration, 2018, LAB DEV TESTS
   US Food and Drug Administration, FACT SHEET HEALTHC P
NR 17
TC 1
Z9 1
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0033-3549
EI 1468-2877
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD NOV
PY 2019
VL 134
IS 2_SUPPL
SU 2_
SI SI
BP 43S
EP 52S
DI 10.1177/0033354919867720
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JJ2WV
UT WOS:000494023600008
PM 31682557
OA Bronze
DA 2020-07-08
ER

PT J
AU Petway, M
   Anderson, L
   Humes, R
   Sincock, S
   Kuhnert-Tallman, W
   Miller, J
   Wallace, RL
AF Petway, Marla
   Anderson, Laura
   Humes, Rosemary
   Sincock, Stephanie
   Kuhnert-Tallman, Wendi
   Miller, Joseph
   Wallace, Rodney L.
TI Implementation of the US Department of Health and Human Services Zika
   Specimen Repository and Its Effect on Zika Diagnostic Test Development,
   2016
SO PUBLIC HEALTH REPORTS
LA English
DT Article
DE Zika; diagnostics; partnership; repository; verification panel;
   validation panel; outbreak response
ID VIRUS-INFECTION
AB This study describes the efforts and outcomes associated with the establishment of a clinical sample repository during the 2016 Zika virus epidemic. To overcome the challenge of limited access to clinical samples to support diagnostic test development, multiple US Department of Health and Human Services (HHS) agencies formed a partnership to create the HHS Zika Specimen Repository. In 2016-2017, the Biomedical Advanced Research and Development Authority and the Centers for Disease Control and Prevention collected patient specimens (4420 convalescent sera aliquots from 100 donors and 7171 plasma aliquots from 239 donors), confirmed Zika virus test results, assembled 1 panel for molecular testing (n = 25 sets) and 7 panels for serologic testing (n = 92), and distributed the panels to test developers. We manufactured 8 test panels and distributed 74 sets of panels to 32 commercial companies, public health partners, and research institutions. Manufacturers used these panels to generate data that supported 14 US Food and Drug Administration (FDA) emergency use authorizations and 1 FDA approval. To develop a repository that can respond immediately to future disease outbreaks, we recommend that organizations pre-position procedures, resources, and partnerships to optimize each partner's contribution.
C1 [Petway, Marla; Anderson, Laura; Miller, Joseph] Ctr Dis Control & Prevent, Div Sci Resources, 1660 Clifton Rd NE, Atlanta, GA 30029 USA.
   [Humes, Rosemary; Sincock, Stephanie; Wallace, Rodney L.] US Dept Hlth & Human Serv, Off Assistant Secretary Preparedness & Response, Washington, DC USA.
   [Kuhnert-Tallman, Wendi] Natl Ctr Emerging & Zoonot Infect Dis, Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Petway, M (corresponding author), Ctr Dis Control & Prevent, Div Sci Resources, 1660 Clifton Rd NE, Atlanta, GA 30029 USA.
EM vtw6@cdc.gov
FU Biomedical Advanced Research Development Authority; Centers for Disease
   Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   supported by the Biomedical Advanced Research Development Authority and
   the Centers for Disease Control and Prevention.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2016, WALL STREET J
   Biomedical Advanced Research Development Authority, 2016, BARDA MED COUNT CLIN
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Holtzman M, 2018, CLIN OBSTET GYNECOL, V61, P177, DOI 10.1097/GRF.0000000000000343
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Shrivastava Saurabh RamBihariLal, 2016, J Res Med Sci, V21, P55
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   US Food and Drug Administration, 2018, EM US AUTH
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 11
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0033-3549
EI 1468-2877
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD NOV
PY 2019
VL 134
IS 2_SUPPL
SU 2_
SI SI
BP 53S
EP 57S
DI 10.1177/0033354919878172
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JJ2WV
UT WOS:000494023600009
PM 31682562
OA Bronze
DA 2020-07-08
ER

PT J
AU Tisoncik-Go, J
   Gale, M
AF Tisoncik-Go, Jennifer
   Gale, Michael, Jr.
TI Microglia in Memory Decline from Zika Virus and West Nile Virus
   Infection
SO TRENDS IN NEUROSCIENCES
LA English
DT Editorial Material
ID INTERFERON-GAMMA
AB Neurotropic viral infection can result in complications underscored by persistent T cell presence in the brain linked with cognitive decline. A recent study by Garber et al. showed that sustained T cell production of interferon (IFN)-gamma mediating microglia activation triggers cognitive decline during recovery from Zika virus (ZIKV) or West Nile virus (WNV) infection.
C1 [Tisoncik-Go, Jennifer; Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.] Washington Natl Primate Res Ctr, Seattle, WA 98121 USA.
   [Gale, Michael, Jr.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
RP Gale, M (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Gale, M (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Gale, M (corresponding author), Washington Natl Primate Res Ctr, Seattle, WA 98121 USA.; Gale, M (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
EM mgale@uw.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI145296]
CR Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626
   Garber C, 2019, NAT NEUROSCI, V22, P1276, DOI 10.1038/s41593-019-0427-y
   Hokkanen L, 1997, J NEUROL NEUROSUR PS, V62, P679
   Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879
   Ni C, 2014, AM J PATHOL, V184, P3308, DOI 10.1016/j.ajpath.2014.08.019
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
NR 10
TC 0
Z9 0
U1 3
U2 5
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0166-2236
EI 1878-108X
J9 TRENDS NEUROSCI
JI Trends Neurosci.
PD NOV
PY 2019
VL 42
IS 11
BP 757
EP 759
DI 10.1016/j.tins.2019.08.009
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA JJ1AE
UT WOS:000493891900003
PM 31495452
DA 2020-07-08
ER

PT J
AU von Essen, BS
   Kortsmit, K
   Warner, L
   D'Angelo, DV
   Shulman, HB
   Virella, WH
   Taraporewalla, A
   Harrison, L
   Ellington, S
   Shapiro-Mendoza, C
   Barfield, W
   Smith, RA
   Jamieson, DJ
   Cox, S
   Pazol, K
   Diaz, PG
   Herrera, BR
   Bernal, MV
AF von Essen, Beatriz Salvesen
   Kortsmit, Katie
   Warner, Lee
   D'Angelo, Denise, V
   Shulman, Holly B.
   Virella, Wanda Hernandez
   Taraporewalla, Aspy
   Harrison, Leslie
   Ellington, Sascha
   Shapiro-Mendoza, Carrie
   Barfield, Wanda
   Smith, Ruben A.
   Jamieson, Denise J.
   Cox, Shanna
   Pazol, Karen
   Diaz, Patricia Garcia
   Herrera, Beatriz Rios
   Bernal, Manuel Vargas
CA Puerto Rico Dept Hlth
   Womens Hlth Fertility Branch
   Div Reprod Hlth
   Natl Ctr Chronic Dis Prevent Hlth
   Ctr Dis Control Prevention
TI Preventing Sexual Transmission of Zika Virus Infection during Pregnancy,
   Puerto Rico, USA, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES
AB We examined condom use throughout pregnancy during the Zika outbreak in Puerto Rico during 2016. Overall, <25% of women reported consistent condom use during pregnancy. However, healthcare provider counseling was associated with a 3-fold increase in consistent use, reinforcing the value of provider counseling in Zika prevention efforts.
C1 [von Essen, Beatriz Salvesen; Kortsmit, Katie; Warner, Lee; D'Angelo, Denise, V; Shulman, Holly B.; Taraporewalla, Aspy; Harrison, Leslie; Ellington, Sascha; Shapiro-Mendoza, Carrie; Barfield, Wanda; Smith, Ruben A.; Cox, Shanna; Pazol, Karen] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [von Essen, Beatriz Salvesen; Virella, Wanda Hernandez; Diaz, Patricia Garcia; Herrera, Beatriz Rios; Bernal, Manuel Vargas] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Jamieson, Denise J.] Emory Univ, Sch Med, Atlanta, GA USA.
RP von Essen, BS (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Hwy,Mailstop S107-2, Chamblee, GA 30341 USA.
EM omo2@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Centers for Disease Control and Prevention, 2015, SEX TRANSM DIS TREAT
   Centers for Disease Control and Prevention, 2017, SEX TRANSM DIS SURV
   Centers for Disease Control and Prevention (CDC), 2018, CONG ZIK SYNDR OTH B
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Puerto Rico Department of Health, 2017, PRAMS ZPER 2 0 PROT
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   The American College of Obstetricians and Gynecologists Women's Health Care Physicians Society for Maternal-Fetal Medicine, 2017, PRACT ADV INT GUID C
NR 9
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2019
VL 25
IS 11
BP 2115
EP 2119
DI 10.3201/eid2511.190915
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA JI4NR
UT WOS:000493444900019
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Clavijo, BDR
   Guerrero, GDP
   Lengua, M
   Daza, M
   Osorio, J
   Caceres, R
   Ospina, M
   Mercado, M
AF Rodriguez Clavijo, B. D.
   Guerrero, G. D. P.
   Lengua, M.
   Daza, M.
   Osorio, J.
   Caceres, R.
   Ospina, M.
   Mercado, M.
TI Epilepsy Characteristics In Colombian Infants With Congenital Zika
   Syndrome
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 33rd International Epilepsy Congress
CY JUN 22-26, 2019
CL Bangkok, THAILAND
C1 [Rodriguez Clavijo, B. D.] Univ Nacl Colombia, Farm, Bogota, Colombia.
   [Rodriguez Clavijo, B. D.] Asociac Colombiana Neurol Infantil, Neurol Pediat, Bogota, Colombia.
   [Guerrero, G. D. P.] Mil Univ New Granada, Cent Mil Hosp, Pediat, Bogota, Colombia.
   [Lengua, M.] Naval Hosp Cartagena, Pediat, Cartagena, Colombia.
   [Daza, M.; Osorio, J.; Caceres, R.] Zika Res, Div Vysnova Partners, Bogota, Colombia.
   [Ospina, M.] Inst Nacl Salud, Bogota, Colombia.
   [Mercado, M.] Inst Nacl Salud, Publ Hlth Res, Bogota, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
EI 1528-1167
J9 EPILEPSIA
JI Epilepsia
PD NOV
PY 2019
VL 60
SU 2
MA P042
BP 26
EP 27
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA JI6NX
UT WOS:000493585100053
DA 2020-07-08
ER

PT J
AU Ford, SA
   Allen, SL
   Ohm, JR
   Sigle, LT
   Sebastian, A
   Albert, I
   Chenoweth, SF
   McGraw, EA
AF Ford, Suzanne A.
   Allen, Scott L.
   Ohm, Johanna R.
   Sigle, Leah T.
   Sebastian, Aswathy
   Albert, Istvan
   Chenoweth, Stephen F.
   McGraw, Elizabeth A.
TI Selection on Aedes aegypti alters Wolbachia-mediated dengue virus
   blocking and fitness
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ALBOPICTUS DIPTERA; INFECTION; LARVAL; STRAIN; TRANSMISSION;
   POPULATIONS; CHIKUNGUNYA
AB The dengue, Zika and chikungunya viruses are transmitted by the mosquito Aedes aegypti and pose a substantial threat to global public health. Current vaccines and mosquito control strategies have limited efficacy, so novel interventions are needed(1,2) . Wolbachia are bacteria that inhabit insect cells and have been found to reduce viral infection-a phenotype that is referred to as viral 'blocking'(3). Although not naturally found in A. aegypti(4), Wolbachia were stably introduced into this mosquito in 2011(4,5) and were shown to reduce the transmission potential of dengue, Zika and chikungunya(6,7). Subsequent field trials showed Wolbachia's ability to spread through A. aegypti populations and reduce the local incidence of dengue fever(8). Despite these successes, the evolutionary stability of viral blocking is unknown. Here, we utilized artificial selection to reveal genetic variation in the mosquito that affects Wolbachia-mediated dengue blocking. We found that mosquitoes exhibiting weaker blocking also have reduced fitness, suggesting the potential for natural selection to maintain blocking. We also identified A. aegypti genes that affect blocking strength, shedding light on a possible mechanism for the trait. These results will inform the use of Wolbachia as biocontrol agents against mosquito-borne viruses and direct further research into measuring and improving their efficacy.
C1 [Ford, Suzanne A.; Ohm, Johanna R.; Sigle, Leah T.; Sebastian, Aswathy; Albert, Istvan; McGraw, Elizabeth A.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, Huck Inst Life Sci, University Pk, PA 16802 USA.
   [Ford, Suzanne A.; McGraw, Elizabeth A.] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.
   [Ford, Suzanne A.] Univ Oxford, Dept Zool, Oxford, England.
   [Allen, Scott L.; Chenoweth, Stephen F.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.
   [Allen, Scott L.] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.
RP Ford, SA; McGraw, EA (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, Huck Inst Life Sci, University Pk, PA 16802 USA.; Ford, SA; McGraw, EA (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.; Ford, SA (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM suzanne.abigail.ford@gmail.com; eam7@psu.edu
RI McGraw, Elizabeth/A-6658-2012
OI McGraw, Elizabeth/0000-0001-7973-088X
FU National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia [APP1103804]
FX We thank E. Kerton, M. Jones, E. Kennedy, H. Amuzu, G. Terradas, M.
   Novelo Canto, S. Mole, D. Guy, L. Jimenez, C. Hammer and C. Koh for
   technical support throughout the experiment. We thank D. Marshall, C.
   Godfray and K. King for helpful discussions on the manuscript. This work
   was supported by a grant (APP1103804) from the National Health and
   Medical Research Council of Australia to E.A.M.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1559-5
   Colpitts TM, 2011, VIROLOGY, V417, P179, DOI 10.1016/j.virol.2011.06.002
   Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844
   Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   FRANKHAM R, 1990, GENET RES, V56, P35, DOI 10.1017/S0016672300028858
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gloria-Soria A, 2018, J MED ENTOMOL, V55, P1354, DOI 10.1093/jme/tjy084
   Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296
   Jha AR, 2016, MOL BIOL EVOL, V33, P501, DOI 10.1093/molbev/msv248
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Joy TK, 2010, EXP GERONTOL, V45, P685, DOI 10.1016/j.exger.2010.04.009
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001
   KOZLOWSKI J, 1993, TRENDS ECOL EVOL, V8, P84, DOI 10.1016/0169-5347(93)90056-U
   Kriventseva EV, 2019, NUCLEIC ACIDS RES, V47, pD807, DOI 10.1093/nar/gky1053
   Lindsey ARI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040141
   Longdon B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004728
   Mains JW, 2008, J AM MOSQUITO CONTR, V24, P496, DOI 10.2987/5740.1
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   Ohm JR, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1392-x
   Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Sheehan KB, 2016, MBIO, V7, DOI 10.1128/mBio.00622-16
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2589-3
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Ye YXH, 2016, EVOLUTION, V70, P2459, DOI 10.1111/evo.13039
   Ye YXH, 2014, AM J TROP MED HYG, V90, P422, DOI 10.4269/ajtmh.13-0186
   Yeap HL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-58
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x
NR 48
TC 5
Z9 5
U1 9
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD NOV
PY 2019
VL 4
IS 11
BP 1832
EP 1839
DI 10.1038/s41564-019-0533-3
PG 8
WC Microbiology
SC Microbiology
GA JH9UC
UT WOS:000493113000011
PM 31451771
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Krol, E
   Brzuska, G
   Szewczyk, B
AF Krol, Ewelina
   Brzuska, Gabriela
   Szewczyk, Boguslaw
TI Production and Biomedical Application of Flavivirus-like Particles
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID VIRUS-LIKE PARTICLES; ANTIBODY-DEPENDENT ENHANCEMENT; NUCLEOCAPSID-LIKE
   PARTICLES; CROSS-REACTIVE ANTIBODIES; ENVELOPE DOMAIN III; STEM-ANCHOR
   REGION; DENGUE VIRUS; JAPANESE ENCEPHALITIS; ZIKA VIRUS; PICHIA-PASTORIS
AB Many viruses belonging to the Flaviviridae family are transmitted by invertebrate vectors. Among those transmitted by mosquitos, there are many human pathogens of great medical importance, such as Japanese encephalitis virus, West Nile virus, dengue virus, Zika virus, or yellow fever virus. Millions of people contract mosquito-borne diseases each year, leading to thou sands of deaths. Co-circulation of genetically similar flaviviruses in the same areas result in the generation of crossreactive antibodies, which is of serious concern for the development of effective vaccines and diagnostic tests. This review provides comprehensive insight into the potential use of virus-like particles as safe and effective antigens in both diagnostics tests, as well as in the development of vaccines against several mosquito-borne flaviviruses.
C1 [Krol, Ewelina; Brzuska, Gabriela; Szewczyk, Boguslaw] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Recombinant Vaccines, Abrahama 58, PL-80307 Gdansk, Poland.
   [Krol, Ewelina; Brzuska, Gabriela; Szewczyk, Boguslaw] Med Univ Gdansk, Abrahama 58, PL-80307 Gdansk, Poland.
RP Szewczyk, B (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Recombinant Vaccines, Abrahama 58, PL-80307 Gdansk, Poland.; Szewczyk, B (corresponding author), Med Univ Gdansk, Abrahama 58, PL-80307 Gdansk, Poland.
EM szewczyk@biotech.ug.gda.pl
OI Brzuska, Gabriela/0000-0001-5228-404X; Krol,
   Ewelina/0000-0001-8573-4254; Szewczyk, Boguslaw/0000-0003-4957-4059
FU National Centre for Research and Development, Poland
   [LIDER/1/0031/L-7/15/NCBR/2016]; National Science Centre, Poland
   [UMO-2015/19/D/NZ6/01717]
FX This work was funded by The National Centre for Research and
   Development, Poland [grant number LIDER/1/0031/L-7/15/NCBR/2016] and the
   National Science Centre, Poland [grant number UMO-2015/19/D/NZ6/01717].
   We would like to thank Dr Arvind Patel (MRC-University of Glasgow Centre
   for Virus Research) for critical reading of the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aguiar M, 2018, LANCET INFECT DIS, V18, P245, DOI 10.1016/S1473-3099(17)30752-1
   Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   Arora U, 2013, VACCINE, V31, P873, DOI 10.1016/j.vaccine.2012.12.016
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Boigard H, 2018, VACCINE, V36, P7728, DOI 10.1016/j.vaccine.2018.10.072
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Calvert AE, 2011, VIROLOGY, V410, P30, DOI 10.1016/j.virol.2010.10.033
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004686
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Chiou SS, 2008, CLIN VACCINE IMMUNOL, V15, P825, DOI 10.1128/CVI.00004-08
   Chua AJS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-129
   Cielens I, 2014, MOL BIOTECHNOL, V56, P459, DOI 10.1007/s12033-014-9743-3
   Contigiani M.S, 2017, ARTHROPOD BORNE DIS, P73
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dai SY, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070365
   Dai SY, 2018, VIROL SIN, V33, P213, DOI 10.1007/s12250-018-0030-5
   Dayan GH, 2013, VIRUSES-BASEL, V5, P3048, DOI 10.3390/v5123048
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Du RK, 2015, J GEN VIROL, V96, P1006, DOI 10.1099/vir.0.000052
   Fuenmayor J, 2017, NEW BIOTECHNOL, V39, P174, DOI 10.1016/j.nbt.2017.07.010
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gil L, 2012, J GEN VIROL, V93, P1204, DOI 10.1099/vir.0.037721-0
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Hegde NR, 2017, HUM VACC IMMUNOTHER, V13, P1320, DOI 10.1080/21645515.2017.1285472
   Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041
   Hsieh SC, 2014, J BIOL CHEM, V289, P33149, DOI 10.1074/jbc.M114.610428
   Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09
   Hua RH, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-62
   Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9
   Khetarpal N, 2017, AM J TROP MED HYG, V96, P126, DOI 10.4269/ajtmh.16-0503
   Kojima A, 2003, J VIROL, V77, P8745, DOI 10.1128/JVI.77.16.8745-8755.2003
   KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U
   Konishi E, 2001, J VIROL, V75, P2204, DOI 10.1128/JVI.75.5.2204-2212.2001
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Kummerer BM., 2006, MOL BIOL FLAVIVIRUS, P1
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Liu Yan, 2014, BMC Microbiol, V14, P233, DOI 10.1186/s12866-014-0233-3
   Lopez C, 2009, ARCH VIROL, V154, P695, DOI 10.1007/s00705-009-0350-8
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Luo YY, 2015, APPL MICROBIOL BIOT, V99, P5917, DOI 10.1007/s00253-015-6538-9
   Mani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064595
   Mareze VA, 2016, APPL MICROBIOL BIOT, V100, P125, DOI 10.1007/s00253-015-6973-7
   Metz SW, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0970-2
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055
   Okamoto S, 2012, CLIN VACCINE IMMUNOL, V19, P17, DOI 10.1128/CVI.05412-11
   Poddar A, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0280-y
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036
   Qiao M, 2004, J INFECT DIS, V190, P2104, DOI 10.1086/425933
   Qing Min, 2009, Virologica Sinica, V24, P136, DOI 10.1007/s12250-009-3023-6
   Rajpoot RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26904-5
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006191
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11
   Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06
   Saga R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28688
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shukla R, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02644
   Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Taylor TJ, 2016, VIROLOGY, V496, P186, DOI 10.1016/j.virol.2016.06.006
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Tripathi L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01005
   Urakami A, 2017, J VIROL, V91, DOI [10.1128/JVI.01181-17, 10.1128/jvi.01181-17]
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Watanabe S, 2015, J VIROL, V89, P5847, DOI 10.1128/JVI.00216-15
   WHO, 2017, ZIK SIT REP
   Yamaji H, 2013, APPL MICROBIOL BIOT, V97, P1071, DOI 10.1007/s00253-012-4371-y
   Yamaji H, 2012, J BIOSCI BIOENG, V114, P657, DOI 10.1016/j.jbiosc.2012.06.012
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yoshii K, 2009, J VIROL METHODS, V161, P173, DOI 10.1016/j.jviromet.2009.05.016
   Zhang FQ, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-17
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 96
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
EI 1879-3096
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD NOV
PY 2019
VL 37
IS 11
BP 1202
EP 1216
DI 10.1016/j.tibtech.2019.03.013
PG 15
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA JI2HS
UT WOS:000493285300010
PM 31003718
OA Other Gold
DA 2020-07-08
ER

EF